PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hayashi, K; Ti, LP; Dong, HR; Bingham, B; Day, A; Joe, R; Barrios, R; DeBeck, K; Milloy, MJ; Kerr, T				Hayashi, Kanna; Ti, Lianping; Dong, Huiru; Bingham, Brittany; Day, Andrew; Joe, Ronald; Barrios, Rolando; DeBeck, Kora; Milloy, M-J; Kerr, Thomas			Moving into an urban drug scene among people who use drugs in Vancouver, Canada: Latent class growth analysis	PLOS ONE			English	Article							PUBLIC-HEALTH; INDIVIDUALS; EXPERIENCES; MIGRATION; PATTERNS; HOMELESS; MOBILITY; VIOLENCE; HOTELS; IMPACT	Background Urban drug scenes are characterized by high prevalence of illicit drug dealing and use, violence and poverty, much of which is driven by the criminalization of people who use illicit drugs (PWUD) and the associated stigma. Despite significant public health needs, little is understood about patterns of moving into urban drug scenes among PWUD. Therefore, we sought to identify trajectories of residential mobility (hereafter `mobility') among PWUD into the Downtown Eastside (DTES), an urban neighbourhood with an open drug scene in Vancouver, Canada, as well as characterize distinct trajectory groups among PWUD. Methods Data were derived from three prospective cohort studies of community-recruited PWUD in Vancouver between 2005 and 2016. We used latent class growth analysis (LCGA) to identify distinct patterns of moving into the DTES among participants residing outside of DTES at baseline. Multivariable multinomial logistic regression was used to determine baseline factors associated with each trajectory group. Results In total, 906 eligible participants (30.9% females) provided 9,317 observations. The LCGA assigned four trajectories: consistently living outside of DTES (52.8%); early move into DTES (11.9%); gradual move into DTES (19.5%); and move in then out (15.8%). Younger PWUD, those of Indigenous ancestry, those who were homeless or living in a single-room occupancy hotel (SRO), and those injecting drugs daily were more likely to move in then out of DTES (all p<0.05). Living in an SRO, daily injection drug use, and recent incarceration were also positively associated with early mobility (all p<0.05). Conclusions Nearly half of the participants moved into the DTES. Younger PWUD and Indigenous peoples appeared to have particularly high mobility, as did those with markers of social-structural vulnerability and high intensity drug use. These findings indicate a need to tailor existing social and health services within the DTES and expand affordable housing options outside the DTES.	[Hayashi, Kanna; Ti, Lianping; Dong, Huiru; DeBeck, Kora; Milloy, M-J; Kerr, Thomas] British Columbia Ctr Subst Use, Vancouver, BC, Canada; [Hayashi, Kanna; Bingham, Brittany] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Ti, Lianping; Milloy, M-J; Kerr, Thomas] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Dong, Huiru] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Bingham, Brittany; Day, Andrew; Joe, Ronald; Barrios, Rolando] Vancouver Coastal Hlth Author, Vancouver, BC, Canada; [DeBeck, Kora] Simon Fraser Univ, Sch Publ Policy, Vancouver, BC, Canada	Simon Fraser University; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Simon Fraser University	Hayashi, K (corresponding author), British Columbia Ctr Subst Use, Vancouver, BC, Canada.; Hayashi, K (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	bccsu-kh@bccsu.ubc.ca	Milloy, M-J/AAY-3618-2020	DeBeck, Kora/0000-0003-2045-1653	US National Institutes of Health (NIH) [U01DA038886, U01DA021525]; Vancouver Coastal Health Research Institute Team Grant [F16-02139]; Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine; Canadian Institutes of Health Research (CIHR) Canadian Research Initiative on Substance Misuse [SMN139148]; BC Centre for Excellence in HIV/AIDS; CIHR New Investigator Award [MSH-141971]; Michael Smith Foundation for Health Research (MSFHR) Scholar Award; St. Paul's Hospital Foundation; US NIH [U01DA021525]; MSFHR Scholar Award; CIHR New Investigator Award; MSFHR/St. Paul's Hospital FoundationProvidence Health Care Career Scholar Award; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA021525, U01DA038886] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vancouver Coastal Health Research Institute Team Grant; Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine(Canada Research Chairs); Canadian Institutes of Health Research (CIHR) Canadian Research Initiative on Substance Misuse(Canadian Institutes of Health Research (CIHR)); BC Centre for Excellence in HIV/AIDS; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR) Scholar Award(Michael Smith Foundation for Health Research); St. Paul's Hospital Foundation; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSFHR Scholar Award(Michael Smith Foundation for Health Research); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); MSFHR/St. Paul's Hospital FoundationProvidence Health Care Career Scholar Award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by the US National Institutes of Health (NIH) (U01DA038886, U01DA021525) and the Vancouver Coastal Health Research Institute Team Grant (F16-02139). This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports Evan Wood, Professor of Medicine, Department of Medicine, University of British Columbia and Executive Director of BC Centre on Substance Use, and the Canadian Institutes of Health Research (CIHR) Canadian Research Initiative on Substance Misuse (SMN139148) as well as support from the BC Centre for Excellence in HIV/AIDS. Kanna Hayashi is supported by a CIHR New Investigator Award (MSH-141971), a Michael Smith Foundation for Health Research (MSFHR) Scholar Award, and the St. Paul's Hospital Foundation. Lianping Ti is supported by a MSFHR Scholar Award. M-J Milloy is supported by a CIHR New Investigator Award, a MSFHR Scholar Award and the US NIH (U01DA021525). He is the Canopy Growth professor of cannabis science at the University of British Columbia, a position established by arms' length gifts to the university by Canopy Growth, a licensed producer of cannabis, and the Government of British Columbia's Ministry of Mental Health and Addictions. The funder did not play any role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. Kora DeBeck is supported by a MSFHR/St. Paul's Hospital FoundationProvidence Health Care Career Scholar Award and a CIHR New Investigator Award.	Adair CE, 2017, CAN J PSYCHIAT, V62, P30, DOI 10.1177/0706743716645302; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Belanger YD, 2013, ABORIG POLICY STUD, V2, P4, DOI 10.5663/aps.v2i2.19006; Bless R, 1995, EUR ADDICT RES, V1, P128, DOI [10.1159/000259053, DOI 10.1159/000259053]; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Buxton J., 2005, VANCOUVER DRUG USE E; Campbell L, 2009, 1000 DREAMS VANC DOW; Connolly Johnny, 2006, RESPONDING OPEN DRUG; Csete J, 2016, LANCET, V387, P1427, DOI 10.1016/S0140-6736(16)00619-X; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; Distasio J., 2013, GEOGR RES FORUM, V33, P38; Dumont DM, 2012, ANNU REV PUBL HEALTH, V33, P325, DOI 10.1146/annurev-publhealth-031811-124614; Fast D, 2010, HEALTH PLACE, V16, P51, DOI 10.1016/j.healthplace.2009.07.004; Fleming T, 2019, INT J DRUG POLICY, V71, P169, DOI 10.1016/j.drugpo.2018.12.012; Fuchs WJ, 1995, EUR ADDICT RES, V1, P106, DOI DOI 10.1159/000259049; Goodman A, 2017, SOC SCI MED, V178, P87, DOI 10.1016/j.socscimed.2017.01.053; Hayashi K, 2018, DRUG ALCOHOL DEPEN, V183, P1, DOI 10.1016/j.drugalcdep.2017.10.020; Johnston C., 2013, CANADIAN AIDS TREATM; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kerr T, 2005, INT J DRUG POLICY, V16, P210, DOI 10.1016/j.drugpo.2005.04.005; Knight KR, 2014, INT J DRUG POLICY, V25, P556, DOI 10.1016/j.drugpo.2013.10.011; Knight R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4313-9; Lennon H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020683; McCoy HV, 1996, POPUL RES POLICY REV, V15, P249, DOI 10.1007/BF00127051; McNeil R, 2014, INT J DRUG POLICY, V25, P608, DOI 10.1016/j.drugpo.2013.11.006; McNeil R, 2014, SOC SCI MED, V105, P59, DOI 10.1016/j.socscimed.2014.01.010; Milloy MJ, 2016, CLIN INFECT DIS, V62, P640, DOI 10.1093/cid/civ929; Norris M.J., 2007, ABORIGINAL POLICY RE; Norris M.J., 2003, NOT STRANGERS THESE, P51; Norris Mary J., 2013, URBAN ABORIGINAL COM, P173; Piat M, 2015, URBAN STUD, V52, P2366, DOI 10.1177/0042098014548138; Rachlis B, 2007, DRUG ALCOHOL DEPEN, V90, P107, DOI 10.1016/j.drugalcdep.2007.03.014; Rachlis BS, 2008, HEALTH PLACE, V14, P536, DOI 10.1016/j.healthplace.2007.10.006; Reuter P, 2009, CRIME LAW SOCIAL CH, V52, P275, DOI 10.1007/s10611-009-9197-x; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Sandberg S, 2008, INT J DRUG POLICY, V19, P459, DOI 10.1016/j.drugpo.2007.02.001; Shannon K, 2008, INT J DRUG POLICY, V19, P140, DOI 10.1016/j.drugpo.2007.11.024; Shannon K, 2006, INT J DRUG POLICY, V17, P107, DOI 10.1016/j.drugpo.2005.09.002; Snyder M, 2015, HEALTH PLACE, V34, P181, DOI 10.1016/j.healthplace.2015.05.009; Somers JM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009043; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; To MJ, 2016, CAN J PUBLIC HEALTH, V107, pE550, DOI [10.17269/cjph.107.5607, 10.17269/CJPH.107.5607]; To MJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3711-8; Truth and Reconcilliation Commission of Canada, 2015, WINNIPEG MANITOBA TR; Urban Health Research Initiative, 2013, DRUG SIT VANC; van de Schoot R, 2017, STRUCT EQU MODELING, V24, P451, DOI 10.1080/10705511.2016.1247646; Waal H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-853; Werb D, 2011, INT J DRUG POLICY, V22, P87, DOI 10.1016/j.drugpo.2011.02.002; Wood Evan, 2006, Harm Reduct J, V3, P18, DOI 10.1186/1477-7517-3-18; Wood Evan, 2009, BMJ, V338, pb1649, DOI 10.1136/bmj.b1649	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224993	10.1371/journal.pone.0224993	http://dx.doi.org/10.1371/journal.pone.0224993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2HK	31725737	Green Published, gold			2022-12-26	WOS:000532764500040
J	Elbasyoni, IS; El-Orabey, WM; Morsy, S; Baenziger, PS; Al Ajlouni, Z; Dowikat, I				Elbasyoni, Ibrahim S.; El-Orabey, Walid M.; Morsy, Sabah; Baenziger, P. S.; Al Ajlouni, Zakaria; Dowikat, Ismail			Evaluation of a global spring wheat panel for stripe rust: Resistance loci validation and novel resources identification	PLOS ONE			English	Article							F-SP TRITICI; YELLOW RUST; LEAF RUST; DIVERSITY; GENES; IMPROVEMENT; LANDRACES; PATHOGENS; SELECTION; MARKERS	Stripe rust (incited by Puccinia striiformis f. sp. tritici) is airborne wheat (Triticum aestivum L.) disease with dynamic virulence evolution. Thus, anticipatory and continued screening in hotspot regions is crucial to identify new pathotypes and integrate new resistance resources to prevent potential disease epidemics. A global wheat panel consisting of 882 landraces and 912 improved accessions was evaluated in two locations in Egypt during 2016 and 2017. Five prevalent and aggressive pathotypes of stripe rust were used to inoculate the accessions during the two growing seasons and two locations under field conditions. The objectives were to evaluate the panel for stripe rust resistance at the adult plant stage, identify potentially novel QTLs associated with stripe rust resistance, and validate previously reported stripe rust QTLs under the Egyptian conditions. The results indicated that 42 land races and 140 improved accessions were resistant to stripe rust. Moreover, 24 SNPs were associated with stripe rust resistance and were within 18 wheat functional genes. Four of these genes were involved in several plant defense mechanisms. The number of favorable alleles, based upon the associated SNPs, was significant and negatively correlated with stripe rust resistance score, i.e., as the number of resistances alleles increased the observed resistance increased. In conclusion, generating new stripe rust phenotypic information on this panel while using the publicly available molecular marker data, contributed to identifying potentially novel QTLs associated with stripe rust and validated 17 of the previously reported QTLs in one of the global hotspots for stripe rust.	[Elbasyoni, Ibrahim S.; Morsy, Sabah] Damanhur Univ, Crop Sci Dept, Damanhur, Egypt; [Elbasyoni, Ibrahim S.; Baenziger, P. S.; Dowikat, Ismail] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; [El-Orabey, Walid M.] ARC, Plant Pathol Res Inst, Wheat Dis Res Dept, Giza, Egypt; [Al Ajlouni, Zakaria] Jordan Univ Sci & Technol, Dept Plant Pathol, Irbid, Jordan	Egyptian Knowledge Bank (EKB); Damanhour University; University of Nebraska System; University of Nebraska Lincoln; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Jordan University of Science & Technology	Elbasyoni, IS (corresponding author), Damanhur Univ, Crop Sci Dept, Damanhur, Egypt.; Elbasyoni, IS (corresponding author), Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA.	ielbasyoni2@unl.edu		El-Orabey, Walid/0000-0003-0201-5284; El-Basyoni, Ibrahim/0000-0002-7210-8788	STDF [14935]	STDF(Science and Technology Development Fund (STDF))	This study was supported by STDF grant14935 to ISE.	Ali S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01057; Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; Bahri B, 2011, PLANT PATHOL, V60, P649, DOI 10.1111/j.1365-3059.2010.02420.x; Basnet BR, 2014, MOL BREEDING, V33, P385, DOI 10.1007/s11032-013-9957-2; Borrill P, 2019, PLANT J, V97, P56, DOI 10.1111/tpj.14150; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bryant RRM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-10; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chan AW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160733; Chen WQ, 2009, PLANT DIS, V93, P1093, DOI 10.1094/PDIS-93-11-1093; Cobb JN, 2013, THEOR APPL GENET, V126, P867, DOI 10.1007/s00122-013-2066-0; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Ding GJ, 2016, J BIOL CHEM, V291, P20125, DOI 10.1074/jbc.M116.727214; Dong ZZ, 2017, THEOR APPL GENET, V130, P2127, DOI 10.1007/s00122-017-2946-9; Dracatos PM, 2016, THEOR APPL GENET, V129, P65, DOI 10.1007/s00122-015-2609-7; Elad Y, 2014, J CROP IMPROV, V28, P99, DOI 10.1080/15427528.2014.865412; Elbasyoni IS, 2018, PLANTS-BASEL, V7, DOI 10.3390/plants7030056; Ellis Jessica J, 2014, Front Psychol, V5, P679, DOI 10.3389/fpsyg.2014.00679; Federer WT, 2006, VARIATIONS SPLIT PLO, P1; Friedmann M, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8070089; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Giesbrecht FG, 2011, PLANNING CONSTRUCTIO; Goff KE, 2007, GENE REGUL SYST BIO, V1, P167; Hadi Bux, 2012, Australian Journal of Crop Science, V6, P116; Hsieh MH, 2002, PLANT PHYSIOL, V130, P1797, DOI 10.1104/pp.007484; Kertho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129580; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kumar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167702; Lee DJ, 2018, 2018 3RD IEEE INTERNATIONAL CONFERENCE ON INTEGRATED CIRCUITS AND MICROSYSTEMS (ICICM), P15, DOI 10.1109/ICAM.2018.8596522; Li Q, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01120; Liu W, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00774; Lombardi M, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0150-3; Lopes MS, 2015, J EXP BOT, V66, P3477, DOI 10.1093/jxb/erv122; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; McIntosh R, 2018, CROP J, V6, P321, DOI 10.1016/j.cj.2018.02.001; Mert Z, 2016, PLANT DIS, V100, P528, DOI 10.1094/PDIS-07-15-0827-PDN; Miedaner T, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2394-5; Muleta KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179087; Nanda S, 2016, PLANT PATHOLOGY J, V32, P519, DOI 10.5423/PPJ.OA.02.2016.0034; Naruoka Y, 2016, CROP SCI, V56, P3055, DOI 10.2135/cropsci2016.03.0189; Pauli D., 2014, PLANT GENOME, V7, P3, DOI DOI 10.3835/PLANTGEN0ME2013.11.0037; R Core Team, 2021, R LANGUAGE ENV STAT; Safavi Safar Ali, 2013, Archives of Phytopathology and Plant Protection, V46, P774, DOI 10.1080/03235408.2012.752142; Shahin A., 2015, J AM SCI, V11, P7; Shahin S, 2014, ADV CROP SCI TECHNOL, V3, P1511, DOI [10.4172/2329-8863.1000161, DOI 10.4172/2329-8863.1000161]; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; STEEL R. G. D., 1960, Principles and procedures of statistics.; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tsilo TJ, 2014, PHYTOPATHOLOGY, V104, P865, DOI 10.1094/PHYTO-10-13-0276-R; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wabila C, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1694-1; Wang L, 2018, IMAGE ANAL STEREOL, V37, P9, DOI 10.5566/ias.1791; Wang L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00120; Weinig C, 2004, BIOSCIENCE, V54, P627, DOI 10.1641/0006-3568(2004)054[0627:EEOTEO]2.0.CO;2; Xanthopoulos P., 2013, ROBUST DATA MINING, P27, DOI DOI 10.1007/978-1-4419-9878-1_4; Zhang HY, 2017, PLANT DIS, V101, P1533, DOI 10.1094/PDIS-08-16-1131-RE; Zhong C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00044	59	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0222755	10.1371/journal.pone.0222755	http://dx.doi.org/10.1371/journal.pone.0222755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721783	Green Published, gold			2022-12-26	WOS:000532720700006
J	Minami, Y; Kanemura, S; Kawai, M; Nishino, Y; Tadao, H; Miyashita, M; Ishida, T; Kakugawa, Y				Minami, Yuko; Kanemura, Seiki; Kawai, Masaaki; Nishino, Yoshikazu; Tadao, Hiroshi; Miyashita, Minoru; Ishida, Takanori; Kakugawa, Yoichiro			Alcohol consumption and survival after breast cancer diagnosis in Japanese women: A prospective patient cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DRINKING PATTERNS; PHYSICAL-ACTIVITY; MORTALITY; HEALTH; RISK; METAANALYSIS; ASSOCIATIONS; EXPOSURES; TRENDS	Background It is unclear whether alcohol consumption may impact survival after breast cancer diagnosis. To clarify the association between pretreatment alcohol consumption and survival in breast cancer patients, a prospective patient cohort study was conducted. Methods The cohort comprised 1,420 breast cancer patients diagnosed during 1997-2013 at a single institute in Japan. Alcohol drinking and other lifestyle factors were assessed by questionnaire survey at the initial admission. The patients were followed until December 31, 2016. The crude associations of pretreatment alcohol intake with survival were evaluated by Kaplan-Meier analysis. The Cox proportional hazards model was used to estimate hazard ratios (HRs) and 95% confidence intervals (Cis) controlled by confounders. Results During a median follow-up period of 8.6 years, 261 all-cause and 193 breast cancer-specific deaths were documented. Survival curves showed that ever-drinkers tended to have better survival than never-drinkers (breast cancer-specific survival, log-rank p = 0.0381). Better survival was also observed for light drinkers with an intake of <5.0 g per day. In the Cox model, ever-drinking was associated with a decreased risk of all-cause (HR: 0.75; 95% CI: 0.54-1.05) and breast cancer-specific death (HR: 0.68; 95% CI: 0.46-0.99). Light drinkers had a lower risk of breast cancer-specific death (frequency of drinking, HR = 0.57 for occasional or 1-2 times per week and 0.72 for 3-7 times per week; amount of alcohol consumed per day, HR = 0.57 for <5.0 g and 0.68 for >= 5.0 g compared with never-drinking). In terms of hormone receptor status, a significantly decreased risk of death associated with ever-drinking was observed among women with receptor-negative cancer (ER-/PR-, HR = 0.41; 95% CI: 0.20-0.84 for breast cancer-specific death). Conclusions Pretreatment, i.e., pre-diagnosis alcohol consumption is unlikely to have an adverse effect on survival after breast cancer diagnosis. Light alcohol consumption may have a beneficial effect on patient survival.	[Minami, Yuko] Tohoku Univ, Div Community Hlth, Grad Sch Med, Sendai, Miyagi, Japan; [Minami, Yuko; Kanemura, Seiki; Nishino, Yoshikazu] Miyagi Canc Ctr, Div Canc Epidemiol & Prevent, Res Inst, Natori, Miyagi, Japan; [Minami, Yuko] Osaki Citizen Hosp, Ctr Prevent Med, Osaki, Miyagi, Japan; [Kawai, Masaaki; Tadao, Hiroshi; Kakugawa, Yoichiro] Miyagi Canc Ctr Hosp, Dept Breast Surg, Natori, Miyagi, Japan; [Nishino, Yoshikazu] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, 1-1 Daigaku, Kahoku, Ishikawa, Japan; [Miyashita, Minoru; Ishida, Takanori] Tohoku Univ, Dept Breast & Endocrine Surg Oncol, Grad Sch Med, Sendai, Miyagi, Japan; [Kakugawa, Yoichiro] Japanese Red Cross Sendai Hosp, Dept Surg, Sendai, Miyagi, Japan	Tohoku University; Miyagi Cancer Center; Miyagi Cancer Center; Kanazawa Medical University; Tohoku University	Minami, Y (corresponding author), Tohoku Univ, Div Community Hlth, Grad Sch Med, Sendai, Miyagi, Japan.; Minami, Y (corresponding author), Miyagi Canc Ctr, Div Canc Epidemiol & Prevent, Res Inst, Natori, Miyagi, Japan.; Minami, Y (corresponding author), Osaki Citizen Hosp, Ctr Prevent Med, Osaki, Miyagi, Japan.	adym@med.tohoku.ac.jp	Kanemura, Seiki/AAS-5390-2021; Miyashita, Minoru/P-7571-2016	Kanemura, Seiki/0000-0003-0454-0322; Miyashita, Minoru/0000-0002-4151-8725; Minami, Yuko/0000-0003-3147-6661	Japan Society for the Promotion of Science (JSPS) [23390169, 16H05240]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	YM received Grant number: Scientific Research (B) (23390169) and Scientific Research (B) (16H05240) from Japan Society for the Promotion of Science (JSPS); https://nrid.nii.ac.jp/en/nrid/1000060239316/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AMG, 2014, CANCER EPIDEM BIOMAR, V23, P934, DOI 10.1158/1055-9965.EPI-13-0901; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Allemani C, 2011, TUMORI, V97, P142, DOI 10.1700/667.7774; [Anonymous], CANC SURV RAT JAP AS; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Candelaria NR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145061; Chan AM, 2009, MATURITAS, V62, P294, DOI 10.1016/j.maturitas.2009.01.005; Chen P, 2014, BRIT J CANCER, V110, P2327, DOI 10.1038/bjc.2014.155; Christensen BC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001043; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Gou YJ, 2013, ASIAN PAC J CANCER P, V14, P4785, DOI 10.7314/APJCP.2013.14.8.4785; Green CA, 2004, ALCOHOL CLIN EXP RES, V28, P754, DOI 10.1097/01.ALC.0000125342.28367.A1; Harris HR, 2012, BRIT J CANCER, V106, P592, DOI 10.1038/bjc.2011.561; Hebert JR, 1998, BREAST CANCER RES TR, V51, P17, DOI 10.1023/A:1006056915001; Holm M, 2013, INT J CANCER, V132, P686, DOI 10.1002/ijc.27652; Jain MG, 2000, BREAST CANCER RES TR, V64, P201, DOI 10.1023/A:1006402323445; Kakugawa Y, 2017, BREAST CANCER RES TR, V162, P115, DOI 10.1007/s10549-016-4094-3; Kakugawa Y, 2015, CANCER SCI, V106, P1066, DOI 10.1111/cas.12716; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Kawai M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-149; Kawai M, 2011, BREAST CANCER RES TR, V128, P817, DOI 10.1007/s10549-011-1381-x; Key J, 2006, CANCER CAUSE CONTROL, V17, P759, DOI 10.1007/s10552-006-0011-0; Kim YI, 2004, AM J CLIN NUTR, V80, P1123, DOI 10.1093/ajcn/80.5.1123; Lin YS, 2005, INT J CANCER, V116, P779, DOI 10.1002/ijc.20980; Lowry SJ, 2016, CANCER EPIDEM BIOMAR, V25, P1268, DOI 10.1158/1055-9965.EPI-16-0151; Minami Y, 2019, BREAST CANCER-TOKYO, V26, P687, DOI 10.1007/s12282-019-00972-5; Minami Y, 2015, BREAST CANCER RES TR, V150, P675, DOI 10.1007/s10549-015-3364-9; Newcomb PA, 2013, J CLIN ONCOL, V31, P1939, DOI 10.1200/JCO.2012.46.5765; Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411; Parada H, 2019, EPIDEMIOLOGY, V30, P83, DOI 10.1097/EDE.0000000000000933; Reding KW, 2008, CANCER EPIDEM BIOMAR, V17, P1988, DOI 10.1158/1055-9965.EPI-07-2897; Rock Cheryl L, 2012, CA Cancer J Clin, V62, P243, DOI 10.3322/caac.21142; Romeo J, 2007, BRIT J NUTR, V98, pS111, DOI 10.1017/S0007114507838049; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P345; Saito E, 2018, J EPIDEMIOL, V28, P140, DOI 10.2188/jea.JE20160200; Scott RG, 2020, GERONTOLOGIST, V60, P80, DOI 10.1093/geront/gny129; Singletary KW, 2001, JAMA-J AM MED ASSOC, V286, P2143, DOI 10.1001/jama.286.17.2143; Stranges S, 2006, ADDICTION, V101, P1265, DOI 10.1111/j.1360-0443.2006.01517.x; Suzuki R, 2010, INT J CANCER, V127, P685, DOI 10.1002/ijc.25079; Takizawa Y, 2018, TOHOKU J EXP MED, V244, P63, DOI 10.1620/tjem.244.63; Uomori T, 2017, BREAST CANCER-TOKYO, V24, P702, DOI 10.1007/s12282-017-0761-4; Valencia-Martin JL, 2013, PREV MED, V57, P703, DOI 10.1016/j.ypmed.2013.09.007; Vrieling A, 2012, BREAST CANCER RES TR, V136, P195, DOI 10.1007/s10549-012-2230-2; Wan SG, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-340; Weaver AM, 2013, BREAST CANCER RES TR, V139, P245, DOI 10.1007/s10549-013-2533-y; Wei EK, 2010, J CLIN ONCOL, V28, P4052, DOI 10.1200/JCO.2009.26.9324; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Xie J, 2005, STAT MED, V24, P3089, DOI 10.1002/sim.2174; Yoshimura A, 2018, J EPIDEMIOL, V28, P420, DOI 10.2188/jea.JE20170103; Zeinomar N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189118	51	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224797	10.1371/journal.pone.0224797	http://dx.doi.org/10.1371/journal.pone.0224797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721806	gold, Green Submitted, Green Published			2022-12-26	WOS:000532720700032
J	Ogawa, Y; Nakano, R; Kasahara, K; Mizuno, T; Hirai, N; Nakano, A; Suzuki, Y; Kakuta, N; Masui, T; Yano, H; Mikasa, K				Ogawa, Yoshihiko; Nakano, Ryuichi; Kasahara, Kei; Mizuno, Tomoki; Hirai, Nobuyasu; Nakano, Akiyo; Suzuki, Yuki; Kakuta, Naoki; Masui, Takashi; Yano, Hisakazu; Mikasa, Keiichi			Comparison of the inoculum size effects of antibiotics on IMP-6 beta-lactamase-producing Enterobacteriaceae co-harboring plasmid-mediated quinolone resistance genes	PLOS ONE			English	Article							PARC MUTATIONS; CIPROFLOXACIN; PCR; MECHANISMS; CARBAPENEM; GYRA; QNR	Almost all cases of carbapenemase-producing Enterobacteriaceae infections in Japan are caused by biaimp-positive Enterobacteriaceae (especially bla(IMP-6)) and infections caused by other types of carbapenemase-producing Enterobacteriaceae are quite rare. We examined drug resistance genes co-harboring with bla(IMP-6) and their inoculum size effects. We screened beta-lactamase genes, plasmid-mediated quinolone resistance (PMQR) genes, and aminoglycoside-modifying enzyme genes by PCR and performed sequencing for 14 bla(IMP-6) -positive Enterobacteriaceae. Further, all PMQR-positive isolates were submitted to conjugation and inoculum effect evaluation. Our data showed that 13 of the 14 isolates harbored CTX-M-2 and one co-harbored CTX-M-2 and CTX-M-1 as extended-spectrum beta-lactamases. All isolates carried one or more PMQRs; aac(6)-Ib-cr was the most prevalent (92.8%), and was followed by oqxA (64.3%), qnrS (50%), oqxAB (21.4%), and qnrB (14.3%). However, Klebsiella pneumoniae contains chromosomal OqxAB. Inoculum size effects were significant in all strains for meropenem, 13 strains for imipenem, 7 for levofloxa-cin, and 3 for amikacin. We observed that 11 of the experimental strains (100%), 8 strains (72.7%), and 1 strain showed inoculum size effects for meropenem, imipenem, and amikacin, respectively. However, four strains harbored qnrgenes and two strains harbored qnr genes and QRDR mutations concurrently; no inoculum size effect was seen for levofloxacin. The bla(IMP-6)-positive Enterobacteriaceae that we studied was found to harbor at least one plasmid-mediated drug resistance gene. The inoculum size effect for carbapenems was thought to be mainly due to IMP-6-type metallo-beta-lactamase; however qnrB and qnrS also had a minimal impact on the inoculum size effect for levofloxacin.	[Ogawa, Yoshihiko; Kasahara, Kei; Hirai, Nobuyasu; Mikasa, Keiichi] Nara Med Univ, Ctr Infect Dis, Kashihara, Nara, Japan; [Ogawa, Yoshihiko; Nakano, Ryuichi; Mizuno, Tomoki; Hirai, Nobuyasu; Nakano, Akiyo; Suzuki, Yuki; Kakuta, Naoki; Masui, Takashi; Yano, Hisakazu] Nara Med Univ, Dept Microbiol & Infect Dis, Kashihara, Nara, Japan	Nara Medical University; Nara Medical University	Nakano, R (corresponding author), Nara Med Univ, Dept Microbiol & Infect Dis, Kashihara, Nara, Japan.	rnakano@naramed-u.ac.jp		Mizuno, Tomoki/0000-0002-0487-7147	JSPS KAKENHI [17K10027, 16K09940]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (grant number: 17K10027 and 16K09940).	Adler A, 2015, ANTIMICROB AGENTS CH, V59, P5014, DOI 10.1128/AAC.00533-15; Casin I, 2003, ANTIMICROB AGENTS CH, V47, P697, DOI 10.1128/AAC.47.2.697-703.2003; Clinical and Laboratory Standards Institute, METHODS DILUTION ANT, VSeventh; Clinical and Laboratory Standards Institute (CLSI, PERFORMANCE STANDARD; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; EUCAST, BREAKPOINT TABLES IN; Galani I, 2010, INT J ANTIMICROB AG, V36, P252, DOI 10.1016/j.ijantimicag.2010.05.004; Garoff L, 2018, J ANTIMICROB CHEMOTH, V73, P348, DOI 10.1093/jac/dkx375; Guillard T, 2011, DIAGN MICR INFEC DIS, V70, P253, DOI 10.1016/j.diagmicrobio.2011.01.004; Kanazawa S, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00576-17; Kim HB, 2009, ANTIMICROB AGENTS CH, V53, P3582, DOI 10.1128/AAC.01574-08; Margaritis A, 2017, J MED MICROBIOL, V66, P266, DOI 10.1099/jmm.0.000397; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Morrill HJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv050; Nakano A, 2018, ANN LAB MED, V38, P378, DOI 10.3343/alm.2018.38.4.378; Nakano R, 2013, J MICROBIOL METH, V94, P213, DOI 10.1016/j.mimet.2013.06.019; Pang F, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0267-8; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Qiang YZ, 2002, J ANTIMICROB CHEMOTH, V49, P549, DOI 10.1093/jac/49.3.549; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Rice LB, 2012, MAYO CLIN PROC, V87, P198, DOI 10.1016/j.mayocp.2011.12.003; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Shibata N, 2006, ANTIMICROB AGENTS CH, V50, P791, DOI 10.1128/AAC.50.2.791-795.2006; van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009; Weisenberg SA, 2009, DIAGN MICR INFEC DIS, V64, P233, DOI 10.1016/j.diagmicrobio.2009.02.004; Wu N, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/s12941-014-0045-1; Yanat B, 2017, EUR J CLIN MICROBIOL, V36, P421, DOI 10.1007/s10096-016-2847-x; Yano H, 2001, ANTIMICROB AGENTS CH, V45, P1343, DOI 10.1128/AAC.45.5.1343-1348.2001; Yano H, 2012, ANTIMICROB AGENTS CH, V56, P4554, DOI 10.1128/AAC.00617-12	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225210	10.1371/journal.pone.0225210	http://dx.doi.org/10.1371/journal.pone.0225210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721789	Green Submitted, Green Published, gold			2022-12-26	WOS:000532720700044
J	Ziegler, I; Lindstrom, S; Kallgren, M; Stralin, K; Molling, P				Ziegler, Ingrid; Lindstrom, Sofia; Kallgren, Magdalena; Stralin, Kristoffer; Molling, Paula			16S rDNA droplet digital PCR for monitoring bacterial DNAemia in bloodstream infections	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; WHOLE-BLOOD; DNA LOAD; BACTEREMIA; MORTALITY; ASSAY; APPROPRIATENESS; QUANTIFICATION; QUANTITATION	Repeated quantitative measurement of bacterial DNA on whole blood has been shown to be a promising method for monitoring bloodstream infection (BSI) with selected bacterial species. To enable broad use of this method, we developed a quantitative droplet digital PCR (ddPCR) method for 16S rDNA. It was validated with species-specific ddPCRs for Staphylococcus aureus (nuc), Streptococcus pneumoniae (lytA), and Escherichia coli (uidA) on spiked whole blood samples and on repeated whole blood samples (days 0, 1-2, 3-4, 6-8, and 13-15) from 83 patients with BSI with these pathogens. In these patients, 16S rDNA and species-specific DNA were detected in 60% and 61%, respectively, at least at one time-point. The highest positivity rates were seen in S. aureus BSI, where 92% of the patients were 16S rDNA-positive and 85% nuc-positive. Quantitative 16S rDNA and species-specific DNA showed strong correlations in spiked samples (r = 0.98; p < 0.0001) and clinical samples (r = 0.84; p < 0.0001). Positivity for 16S rDNA was rapidly cleared in patients with S. pneumoniae and E. coli BSI, but more slowly and sometimes persisted, in those with S. aureus BSI. The initial 16S rDNA load was higher in BSI patients with sepsis (Sepsis-3 definition) than without sepsis (median 2.38 vs. 0 Ig10 copies/mL; p = 0.031) and in non-survivors than in survivors (median 2.83 vs. 0 Ig10 copies/mL; p = 0.006). 16S rDNA ddPCR appears to be a promising method for bacterial DNA monitoring during BSI. The clinical value of such monitoring should be further studied.	[Ziegler, Ingrid] Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden; [Ziegler, Ingrid; Stralin, Kristoffer; Molling, Paula] Orebro Univ, Sch Hlth & Med Sci, Orebro, Sweden; [Lindstrom, Sofia] Vasteras Hosp, Dept Lab Med, Vasteras, Sweden; [Kallgren, Magdalena] Karlskoga Hosp, Dept Lab Med, Karlskoga, Sweden; [Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Stralin, Kristoffer] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden; [Molling, Paula] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden	Orebro University; Orebro University; Vasteras Central Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University	Ziegler, I (corresponding author), Orebro Univ Hosp, Dept Infect Dis, Orebro, Sweden.; Ziegler, I (corresponding author), Orebro Univ, Sch Hlth & Med Sci, Orebro, Sweden.	ingrid.ziegler@regionorebrolan.se			research committee of Orebro County Council [OLL-885741, OLL-652771]; Orebro University Hospital Research Foundation [OLL-117771]	research committee of Orebro County Council; Orebro University Hospital Research Foundation	The study was supported by grants from the research committee of Orebro County Council, grant numbers OLL-885741 and OLL-652771 and from the Orebro University Hospital Research Foundation, grant number OLL-117771. The funders had no role in the study design, data collection and analysis or decision to publish.	Bacconi A, 2014, J CLIN MICROBIOL, V52, P3164, DOI 10.1128/JCM.00801-14; Berglund C, 2005, CLIN MICROBIOL INFEC, V11, P447, DOI 10.1111/j.1469-0691.2005.01150.x; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; Bogestam K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192782; Cajander S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192883; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chuang YC, 2012, CRIT CARE MED, V40, P2273, DOI 10.1097/CCM.0b013e3182515190; Chuang YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014133; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Ho YC, 2009, J CLIN MICROBIOL, V47, P1443, DOI 10.1128/JCM.01197-08; Jordana-Lluch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140865; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Khatib R, 2005, CLIN INFECT DIS, V41, P594, DOI 10.1086/432472; Kramski M, 2011, J CLIN MICROBIOL, V49, P3691, DOI 10.1128/JCM.01018-11; Lamy B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00697; Laupland KB, 2014, CLIN MICROBIOL REV, V27, P647, DOI 10.1128/CMR.00002-14; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; Morley Alexander A, 2014, Biomol Detect Quantif, V1, P1; Opota O, 2015, CLIN MICROBIOL INFEC, V21, P323, DOI 10.1016/j.cmi.2015.02.005; Ovstebo R, 2004, J CLIN MICROBIOL, V42, P2980, DOI 10.1128/JCM.42.7.2980-2987.2004; Peters RPH, 2009, J CLIN MICROBIOL, V47, P3308, DOI 10.1128/JCM.01071-09; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Sheppard CL, 2004, J MED MICROBIOL, V53, P189, DOI 10.1099/jmm.0.05460-0; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Sze MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110351; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Van Zanten ARH, 2012, CRIT CARE MED, V40, P2492, DOI 10.1097/CCM.0b013e318258e7f3; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; WERNER AS, 1967, J AMER MED ASSOC, V202, P199; Yoshitomi KJ, 2003, MOL CELL PROBE, V17, P275, DOI 10.1016/j.mcp.2003.07.001; Ziegler I, 2019, INFECT DIS-NOR, V51, P216, DOI 10.1080/23744235.2018.1562205; Ziegler I, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-155	40	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224656	10.1371/journal.pone.0224656	http://dx.doi.org/10.1371/journal.pone.0224656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721817	gold, Green Published			2022-12-26	WOS:000532720700025
J	Borshchev, YY; Minasian, SM; Burovenko, IY; Borshchev, VY; Protsak, ES; Semenova, NY; Borshcheva, OV; Galagudza, MM				Borshchev, Yury Yu; Minasian, Sarkis M.; Burovenko, Inessa Yu; Borshchev, Victor Yu; Protsak, Egor S.; Semenova, Natalia Yu; Borshcheva, Olga, V; Galagudza, Michael M.			Effects of tetracycline on myocardial infarct size in obese rats with chemically-induced colitis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; ANTIOXIDANT PROPERTIES; MINOCYCLINE PROTECTS; GUT MICROBIOTA; FATTY-ACIDS; CARDIOPROTECTION; LIPOPOLYSACCHARIDE; COMORBIDITIES; MECHANISMS	Background Recent evidence suggests that antibiotic-induced changes in the composition of intestinal microflora, as well as the systemic immunoendocrine effects that result from them, can modulate myocardial tolerance to ischemia-reperfusion injury. The aim of this study was to investigate the effects of tetracycline (TTC) on myocardial infarct size in the isolated hearts obtained from obese rats with chemically-induced colitis (CIC). The association between TTC-induced changes in infarct size and intestinal microbiome composition as well as plasma levels of cytokines and short-chain fatty acids (SCFAs) was also studied. Methods Obesity was induced in Wistar rats by feeding them a high-fat, high-carbohydrate diet for five weeks. A single rectal administration of 3% acetic acid (2 mL) to the rats resulted in CIC. Healthy rats as well as obese rats with CIC received TTC (15 mg daily for 3 days) via gavage. The rats were euthanized, after which isolated heart perfusion with simulated global ischemia and reperfusion was performed. Infarct size was determined histochemically. Lipopolysaccharide (LPS) and cytokine levels in plasma were measured by enzyme-linked immunosorbent assay, whereas SCFA levels in plasma were measured by gas chromatography/mass spectrometry. The intestinal microbiome was analyzed using reverse transcription polymerase chain reaction. Results The treatment with TTC resulted in significant infarct size limitation (50 +/- 7 vs. 62 +/- 4% for the control mice, p < 0.05) in the hearts from intact animals. However, infarct size was not different between the control rats and the obese rats with CIC. Furthermore, infarct size was significantly larger in TTC-treated obese rats with CIC than it was in the control animals (77 +/- 5%, p < 0.05). The concentrations of proinflammatory cytokines and LPS in serum were elevated in the obese rats with CIC. Compared to the control rats, the rats with both obesity and CIC had lower counts of Lactobacillus and Bifidobacterium spp. but higher counts of Escherichia coli. The effects of TTC on infarct size were not associated with specific changes in SCFA levels. Conclusions TTC reduced infarct size in the healthy rats. However, this effect was reversed in the obese animals with CIC. Additionally, it was associated with specific changes in gut microbiota and significantly elevated levels of cytokines and LPS.	[Borshchev, Yury Yu; Minasian, Sarkis M.; Protsak, Egor S.; Semenova, Natalia Yu; Borshcheva, Olga, V; Galagudza, Michael M.] Almazov Natl Med Res Ctr, Inst Expt Med, St Petersburg, Russia; [Borshchev, Yury Yu; Burovenko, Inessa Yu; Borshcheva, Olga, V] Sci Res Ctr Probiocode SP, Moscow, Russia; [Minasian, Sarkis M.; Protsak, Egor S.; Galagudza, Michael M.] St Petersburg Pavlov State Med Univ, Dept Pathophysiol, St Petersburg, Russia; [Burovenko, Inessa Yu] Shevchenko Transnistria State Univ, Dept Physiol & Sanocreatol, Tiraspol, Moldova; [Borshchev, Victor Yu] Tech Univ Moldova, Dept Microelect & Biomed Engn, Kishinev, Moldova	Almazov National Medical Research Centre; Institute of Experimental Medicine; Pavlov First Saint Petersburg State Medical University; Technical University Moldova	Galagudza, MM (corresponding author), Almazov Natl Med Res Ctr, Inst Expt Med, St Petersburg, Russia.; Galagudza, MM (corresponding author), St Petersburg Pavlov State Med Univ, Dept Pathophysiol, St Petersburg, Russia.	galagudza@almazovcentre.ru	Semenova, Natalia/R-1145-2017	Semenova, Natalia/0000-0003-4069-0678; Protsak, Egor/0000-0002-9217-9890; Burovenko, Inessa/0000-0001-6637-3633; Galagudza, Michael/0000-0001-5129-9944	Russian Science Foundation [18-15-00153]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Science Foundation (project 18-15-00153). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Darraji A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200474; Asgeri M, 2015, IMMUNOL INVEST, V44, P23, DOI 10.3109/08820139.2014.921689; Behr C, 2017, ARCH TOXICOL, V91, P3439, DOI 10.1007/s00204-017-1949-2; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Collins KH, 2018, BONE JOINT RES, V7, P274, DOI 10.1302/2046-3758.74.BJR-2017-0201.R2; Corremans R, 2019, CLIN EXP PHARMACOL P, V46, P204, DOI 10.1111/1440-1681.13036; Danner MC, 2019, SCI TOTAL ENVIRON, V664, P793, DOI 10.1016/j.scitotenv.2019.01.406; El-Akabawy G, 2019, BIOMED PHARMACOTHER, V111, P841, DOI 10.1016/j.biopha.2019.01.001; Ferdinandy P, 2014, PHARMACOL REV, V66, P1142, DOI 10.1124/pr.113.008300; Gorelik E, 2019, DRUG SAFETY, V42, P529, DOI 10.1007/s40264-018-0751-2; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Hausenloy DJ, 2017, CARDIOVASC RES, V113, P564, DOI 10.1093/cvr/cvx049; Heusch G, 2017, CIRC RES, V120, P1477, DOI 10.1161/CIRCRESAHA.117.310820; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; Hoshida S, 2002, CARDIOVASC RES, V55, P495, DOI 10.1016/S0008-6363(02)00337-1; Hoshida S, 2002, J AM COLL CARDIOL, V40, P826, DOI 10.1016/S0735-1097(02)02001-6; Iliodromitis EK, 2006, ATHEROSCLEROSIS, V188, P356, DOI 10.1016/j.atherosclerosis.2005.11.023; Inserte J, 2019, J MOL CELL CARDIOL, V133, P164, DOI 10.1016/j.yjmcc.2019.06.001; Kagawa N, 2005, FRONT BIOSCI-LANDMRK, V10, P608, DOI 10.2741/1557; Kain V, 2019, FASEB J, V33, P6456, DOI 10.1096/fj.201802477R; Kraus RL, 2005, J NEUROCHEM, V94, P819, DOI 10.1111/j.1471-4159.2005.03219.x; Lam Vy, 2016, PLoS One, V11, pe0160840, DOI 10.1371/journal.pone.0160840; Lam V, 2012, FASEB J, V26, P1727, DOI 10.1096/fj.11-197921; Lee SM, 2004, J NEUROCHEM, V91, P568, DOI 10.1111/j.1471-4159.2004.02780.x; Li YN, 2015, BIOMED REP, V3, P19, DOI 10.3892/br.2014.381; Meng FQ, 2019, ENDOCR METAB IMMUNE, V19, P1046, DOI 10.2174/1871530319666190326143254; Minasian SM, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-60; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Mujico JR, 2013, BRIT J NUTR, V110, P711, DOI 10.1017/S0007114512005612; Nader ND, 2015, J CARDIOVASC THORAC, V7, P81, DOI 10.15171/jcvtr.2015.19; Naderi Y, 2017, BRAIN RES BULL, V131, P207, DOI 10.1016/j.brainresbull.2017.04.010; Candido TLN, 2018, NUTR HOSP, V35, P1432, DOI 10.20960/nh.1792; Przyklenk K, 2011, ANTIOXID REDOX SIGN, V14, P781, DOI 10.1089/ars.2010.3343; Romero-Perez D, 2008, J AM COLL CARDIOL, V52, P1086, DOI 10.1016/j.jacc.2008.06.028; Sack MN, 2011, J CARDIOVASC PHARM T, V16, P267, DOI 10.1177/1074248411408313; Salie R, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0109-8; Scarabelli TM, 2004, J AM COLL CARDIOL, V43, P865, DOI 10.1016/j.jacc.2003.09.050; Stover KR, 2014, EXPERT OPIN DRUG SAF, V13, P5, DOI 10.1517/14740338.2013.829036; Sturgeon C, 2017, ANN NY ACAD SCI, V1397, P130, DOI 10.1111/nyas.13343; Tao R, 2010, J CARDIOVASC PHARM, V56, P659, DOI 10.1097/FJC.0b013e3181faeaf0; Thind GS, 2015, FUTUR CARDIOL, V11, P61, DOI [10.2217/FCA.14.76, 10.2217/fca.14.76]; Wu T, 2019, LIFE SCI, V231, DOI 10.1016/j.lfs.2019.116569; Zhang MD, 2017, CARDIOVASC TOXICOL, V17, P434, DOI 10.1007/s12012-017-9401-7	43	4	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225185	10.1371/journal.pone.0225185	http://dx.doi.org/10.1371/journal.pone.0225185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714931	Green Published, gold			2022-12-26	WOS:000532710400034
J	Marmelat, V; Duncan, A; Meltz, S				Marmelat, Vivien; Duncan, Austin; Meltz, Shane			Effect of sampling frequency on fractal fluctuations during treadmill walking	PLOS ONE			English	Article							STRIDE-INTERVAL; GAIT; RELIABILITY; DYNAMICS; REASSESSMENT; VARIABILITY	The temporal dynamics of stride-to-stride fluctuations in steady-state walking reveal important information about locomotor control and can be quantified using so-called fractal analyses, notably the detrended fluctuation analysis (DFA). Gait dynamics are often collected during treadmill walking using 3-D motion capture to identify gait events from kinematic data. The sampling frequency of motion capture systems may impact the precision of event detection and consequently impact the quantification of stride-to-stride variability. This study aimed i) to determine if collecting multiple walking trials with different sampling frequency affects DFA values of spatiotemporal parameters during treadmill walking, and ii) to determine the reliability of DFA values across downsampled conditions. Seventeen healthy young adults walked on a treadmill while their gait dynamics was captured using different sampling frequency (60, 120 and 240 Hz) in each condition. We also compared data from the highest sampling frequency to downsampled versions of itself. We applied DFA to the following time series: step length, time and speed, and stride length, time and speed. Reliability between experimental conditions and between downsampled conditions were measured with 1) intraclass correlation estimates and their 95% confident intervals, calculated based on a single-measurement, absolute-agreement, two-way mixed-effects model (ICC 3,1), and 2) Bland-Altman bias and limits of agreement. Both analyses revealed a poor reliability of DFA results between conditions using different sampling frequencies, but a relatively good reliability between original and downsampled spatiotemporal variables. Collectively, our results suggest that using sampling frequencies of 120 Hz or 240 Hz provide similar results, but that using 60 Hz may alter DFA values. We recommend that gait kinematics should be collected at around 120 Hz, which provides a compromise between event detection accuracy and processing time.	[Marmelat, Vivien; Duncan, Austin; Meltz, Shane] Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA	University of Nebraska System	Marmelat, V (corresponding author), Univ Nebraska, Dept Biomech, Omaha, NE 68182 USA.	vmarmelat@unomaha.edu			Center for Research in Human Movement Variability of the University of Nebraska at Omaha [NIH P20GM109090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	Center for Research in Human Movement Variability of the University of Nebraska at Omaha; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Center for Research in Human Movement Variability of the University of Nebraska at Omaha (NIH P20GM109090, https://www.nih.gov/) to VM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almurad ZMH, 2016, PHYSICA A, V451, P63, DOI 10.1016/j.physa.2015.12.155; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Choi JS, 2015, J BIOMECH, V48, P1336, DOI 10.1016/j.jbiomech.2015.02.047; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Delignieres D, 2006, J MATH PSYCHOL, V50, P525, DOI 10.1016/j.jmp.2006.07.004; Delignieres D, 2009, J APPL PHYSIOL, V106, P1272, DOI 10.1152/japplphysiol.90757.2008; Dingwell JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124879; Dingwell JB, 2010, GAIT POSTURE, V32, P348, DOI 10.1016/j.gaitpost.2010.06.004; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuznetsov NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174144; Liddy JJ, 2019, PHYSICA A, V532, DOI 10.1016/j.physa.2019.121784; Liddy JJ, 2018, PHYSICA A, V491, P233, DOI 10.1016/j.physa.2017.08.099; Marmelat V, 2019, GAIT POSTURE, V70, P229, DOI 10.1016/j.gaitpost.2019.02.023; Marmelat V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00861; Marmelat V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091949; Marmelat V, 2011, MEDICINA-LITHUANIA, V47, P393, DOI 10.3390/medicina47070056; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Pierrynowski MR, 2005, GAIT POSTURE, V22, P46, DOI 10.1016/j.gaitpost.2004.06.007; Raffalt PC, 2019, MED BIOL ENG COMPUT, V57, P759, DOI 10.1007/s11517-018-1920-2; Rhea CK, 2015, GAIT POSTURE, V41, P731, DOI 10.1016/j.gaitpost.2015.01.008; Rhea CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106755; Rhea CK, 2014, HUM MOVEMENT SCI, V36, P20, DOI 10.1016/j.humov.2014.04.006; Rock CG, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.181834; Roerdink M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134148; Terrier P, 2016, ANN BIOMED ENG, V44, P2785, DOI 10.1007/s10439-016-1573-y; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Warlop T., 2018, HUM MOVEMENT SCI, V55, P31; Warlop T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00068; Warlop T, 2016, J REHABIL MED, V48, P865, DOI 10.2340/16501977-2158; Wiens C, 2019, J BIOMECH, V83, P221, DOI 10.1016/j.jbiomech.2018.11.051; Wijnants ML, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00495; Wittstein MW, 2019, AGING CLIN EXP RES, V31, P367, DOI 10.1007/s40520-018-0962-5; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0218908	10.1371/journal.pone.0218908	http://dx.doi.org/10.1371/journal.pone.0218908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697684	Green Submitted, gold, Green Published			2022-12-26	WOS:000532694400005
J	Wiegmann, M; Backhaus, A; Seiffert, U; Thomas, WTB; Flavell, AJ; Pillen, K; Maurer, A				Wiegmann, Mathias; Backhaus, Andreas; Seiffert, Udo; Thomas, William T. B.; Flavell, Andrew J.; Pillen, Klaus; Maurer, Andreas			Optimizing the procedure of grain nutrient predictions in barley via hyperspectral imaging	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PARTIAL LEAST-SQUARES; REFLECTANCE SPECTROSCOPY; PROTEIN-CONTENT; PLANT; CALIBRATION; FOOD; SELECTION; QUALITY; NITROGEN	Hyperspectral imaging enables researchers and plant breeders to analyze various traits of interest like nutritional value in high throughput. In order to achieve this, the optimal design of a reliable calibration model, linking the measured spectra with the investigated traits, is necessary. In the present study we investigated the impact of different regression models, calibration set sizes and calibration set compositions on prediction performance. For this purpose, we analyzed concentrations of six globally relevant grain nutrients of the wild barley population HEB-YIELD as case study. The data comprised 1,593 plots, grown in 2015 and 2016 at the locations Dundee and Halle, which have been entirely analyzed through traditional laboratory methods and hyperspectral imaging. The results indicated that a linear regression model based on partial least squares outperformed neural networks in this particular data modelling task. There existed a positive relationship between the number of samples in a calibration model and prediction performance, with a local optimum at a calibration set size of similar to 40% of the total data. The inclusion of samples from several years and locations could clearly improve the predictions of the investigated nutrient traits at small calibration set sizes. It should be stated that the expansion of calibration models with additional samples is only useful as long as they are able to increase trait variability. Models obtained in a certain environment were only to a limited extent transferable to other environments. They should therefore be successively upgraded with new calibration data to enable a reliable prediction of the desired traits. The presented results will assist the design and conceptualization of future hyperspectral imaging projects in order to achieve reliable predictions. It will in general help to establish practical applications of hyperspectral imaging systems, for instance in plant breeding concepts.	[Wiegmann, Mathias; Pillen, Klaus; Maurer, Andreas] Martin Luther Univ Halle Wittenberg MLU, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany; [Backhaus, Andreas; Seiffert, Udo] Fraunhofer Inst Factory Operat & Automat, Magdeburg, Germany; [Thomas, William T. B.] James Hutton Inst JHI, Dundee, Scotland; [Flavell, Andrew J.] Univ Dundee, Sch Life Sci, JHI, Dundee, Scotland	Fraunhofer Gesellschaft; James Hutton Institute; James Hutton Institute; University of Dundee	Maurer, A (corresponding author), Martin Luther Univ Halle Wittenberg MLU, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany.	andreas.maurer@landw.uni-halle.de	Pillen, Klaus/I-6511-2012	Pillen, Klaus/0000-0003-4646-6351; Seiffert, Udo/0000-0002-6043-7947; Maurer, Andreas/0000-0002-2916-7475	German Research Foundation (DFG) [Pi339/7-1, Pi339/7-2]; German Research Foundation (DFG) via ERA-NET for Coordinating Action in Plant Sciences (ERA-CAPS) [Pi339/8-1]; German Research Foundation (DFG) via German Federal Ministry of Research and Education (BMBF) IPAS grant BARLEYDIVERSITY [FZ 031A352A]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG) via ERA-NET for Coordinating Action in Plant Sciences (ERA-CAPS)(German Research Foundation (DFG)); German Research Foundation (DFG) via German Federal Ministry of Research and Education (BMBF) IPAS grant BARLEYDIVERSITY	This work was financially supported by the German Research Foundation (DFG) via the priority program 1530: Flowering time control from natural variation to crop improvement (grants Pi339/7-1 and Pi339/7-2 to MW, KP, AM) and via ERA-NET for Coordinating Action in Plant Sciences (ERA-CAPS) (grant Pi339/8-1 to WT, AF, KP, AM) and via the German Federal Ministry of Research and Education (BMBF) IPAS grant BARLEYDIVERSITY (grant FZ 031A352A to AB, US, KP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to a multitude of research assistants from the James Hutton Institute in Dundee and the Martin Luther University in Halle for their excellent technical support in conducting the field trials. In addition, we thankfully acknowledge the support from Nico Markus from the Martin Luther University Halle-Wittenberg for performing the mineral analysis, as well as Paul Herzig from the same institution for his guidance during hyperspectral image recording.	Agelet LE, 2014, TALANTA, V121, P288, DOI 10.1016/j.talanta.2013.12.038; Agelet LE, 2010, CRIT REV ANAL CHEM, V40, P246, DOI 10.1080/10408347.2010.515468; Amigo JM, 2015, ANAL CHIM ACTA, V896, P34, DOI 10.1016/j.aca.2015.09.030; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Balabin RM, 2011, FUEL, V90, P2007, DOI 10.1016/j.fuel.2010.11.038; Batten GD, 1998, AUST J EXP AGR, V38, P697, DOI 10.1071/EA97146; Bernardo R., 2010, BREEDING QUANTITATIV, V2; Black J. L., 2001, P AUSTR POULTR SCI S; Cao N., 2013, CALIBRATION OPTIMIZA; Caporaso N, 2018, FOOD CHEM, V240, P32, DOI 10.1016/j.foodchem.2017.07.048; Carvalho SMP, 2013, FOOD RES INT, V54, P961, DOI 10.1016/j.foodres.2012.12.021; Cen HY, 2007, TRENDS FOOD SCI TECH, V18, P72, DOI 10.1016/j.tifs.2006.09.003; Chao K, 2001, APPL ENG AGRIC, V17, P99; Chen QS, 2012, J PHARMACEUT BIOMED, V60, P92, DOI 10.1016/j.jpba.2011.10.020; Diepenbrock CH, 2015, CROP SCI, V55, P1437, DOI 10.2135/cropsci2014.08.0555; Elleuch M, 2011, FOOD CHEM, V124, P411, DOI 10.1016/j.foodchem.2010.06.077; Falconer DS., 2009, INTRO QUANTITATIVE G, V4; FAO, 2016, OECD FAO AGR OUTLOOK; Ferre J, 1996, ANAL CHEM, V68, P1565, DOI 10.1021/ac950482a; Feundale RN, 2002, CHEMOMETR INTELL LAB, V64, P181; Fisher RA, 1914, BIOMETRIKA, V10, P507; FLIGNER MA, 1976, J AM STAT ASSOC, V71, P210, DOI 10.2307/2285771; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Fox GP, 2003, AUST J AGR RES, V54, P1081, DOI 10.1071/AR02237; Fox GP, 2012, GENETICS IMPROVEMENT; Fu Y, 2015, THEOR APPL GENET, V128, P1029, DOI 10.1007/s00122-015-2487-z; Gaudichon CC, 2015, PROTEIN QUALITY HUMA; Gupta M, 2010, COMPR REV FOOD SCI F, V9, P318, DOI 10.1111/j.1541-4337.2010.00112.x; Hadley W., 2009, GGPLOT2 ELEGANT GRAP; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; ISAKSSON T, 1990, APPL SPECTROSC, V44, P1152, DOI 10.1366/0003702904086533; Kamruzzaman M, 2012, ANAL CHIM ACTA, V714, P57, DOI 10.1016/j.aca.2011.11.037; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kooistra L, 2001, ANAL CHIM ACTA, V446, P97, DOI 10.1016/S0003-2670(01)01265-X; Lagacherie P, 2008, REMOTE SENS ENVIRON, V112, P825, DOI 10.1016/j.rse.2007.06.014; Leardi R, 2000, J CHEMOMETR, V14, P643, DOI 10.1002/1099-128X(200009/12)14:5/6<643::AID-CEM621>3.0.CO;2-E; Lehermeier C, 2015, GENETICS, V201, P323, DOI 10.1534/genetics.115.177394; Leon L, 2004, J AGR FOOD CHEM, V52, P4957, DOI 10.1021/jf0496853; Li L, 2014, SENSORS-BASEL, V14, P20078, DOI 10.3390/s141120078; Lin C, 2014, FOOD CHEM, V162, P10, DOI 10.1016/j.foodchem.2014.04.056; Liu YL, 2014, REMOTE SENS-BASEL, V6, P4305, DOI 10.3390/rs6054305; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; Lorber A., 1988, J CHEMOMETR, V2, P67, DOI [10.1002/cem.1180020108, DOI 10.1002/CEM.1180020108]; MARTINETZ TM, 1993, IEEE T NEURAL NETWOR, V4, P558, DOI 10.1109/72.238311; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; McKevith B., 2004, Nutrition Bulletin, V29, P111, DOI 10.1111/j.1467-3010.2004.00418.x; Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010; Menz P, 2019, ESANN 2019 P COMP IN; Mondal A, 2008, J FOOD ENG, V86, P465, DOI 10.1016/j.jfoodeng.2007.11.014; Montes JM, 2007, TRENDS PLANT SCI, V12, P433, DOI 10.1016/j.tplants.2007.08.006; Moody J, 1989, NEURAL COMPUT, V1, P281, DOI 10.1162/neco.1989.1.2.281; Morellos A, 2016, BIOSYST ENG, V152, P104, DOI 10.1016/j.biosystemseng.2016.04.018; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; Osborne BG, 2006, J NEAR INFRARED SPEC, V14, P93, DOI 10.1255/jnirs.595; Park B, 2015, FOOD ENG SER, P1, DOI 10.1007/978-1-4939-2836-1; R Core Team, 2018, R LANG ENV STAT COMP; Rady A, 2015, FOOD BIOPROCESS TECH, V8, P995, DOI 10.1007/s11947-014-1461-0; ROBERTS CA, 2004, NEAR INFRARED SPECTR; Roger JM, 2008, J NEAR INFRARED SPEC, V16, P311, DOI 10.1255/jnirs.793; Schmid B., 1992, EVOLUTIONARY TRENDS, P46; Shetty N, 2012, CHEMOMETR INTELL LAB, V111, P59, DOI 10.1016/j.chemolab.2011.11.013; Shetty N, 2012, CHEMOMETR INTELL LAB, V111, P34, DOI 10.1016/j.chemolab.2011.11.004; Sileoni V, 2013, FOOD CHEM, V141, P2639, DOI 10.1016/j.foodchem.2013.04.110; Sileoni V, 2011, J AGR FOOD CHEM, V59, P1541, DOI 10.1021/jf104439x; Spielbauer G, 2009, CEREAL CHEM, V86, P556, DOI 10.1094/CCHEM-86-5-0556; Stuth J, 2003, FIELD CROP RES, V84, P45, DOI 10.1016/S0378-4290(03)00140-0; Sun D.-W., 2010, HYPERSPECTRAL IMAGIN, V1, P3, DOI DOI 10.1016/B978-0-12-374753-2.10001-2; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Velasco L, 2002, EUPHYTICA, V123, P89, DOI 10.1023/A:1014452700465; Verrelst J, 2015, ISPRS J PHOTOGRAMM, V108, P273, DOI 10.1016/j.isprsjprs.2015.05.005; Verstegen MWA, 2009, 25 CURS ESP FEDNA 5; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Wiegmann M, 2019, PLANT SCI, V283, P83, DOI 10.1016/j.plantsci.2018.12.030; Wiegmann M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42673-1; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wrigley Colin, 2017, CEREAL GRAINS ASSESS; Wu GY, 2014, ANN NY ACAD SCI, V1321, P1, DOI 10.1111/nyas.12500; Zhou MX, 2009, ADV TOP SCI TECH CHI, P1, DOI 10.1007/978-3-642-01279-2_1	79	11	11	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224491	10.1371/journal.pone.0224491	http://dx.doi.org/10.1371/journal.pone.0224491			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697705	Green Published, gold			2022-12-26	WOS:000532694400028
J	Bae, IS; Kim, JM; Cheong, JH; Han, MH; Ryu, JI				Bae, In-Suk; Kim, Jae Min; Cheong, Jin Hwan; Han, Myung-Hoon; Ryu, Je Il			Association between cerebral atrophy and osteoporotic vertebral compression fractures	PLOS ONE			English	Article							VENTRICULAR ENLARGEMENT; ALZHEIMERS-DISEASE; BONE-FORMATION; RISK-FACTORS; WOMEN; FALLS; MEN	Purpose Osteoporotic vertebral compression fractures (OVCFs) have a serious impact on people's health and quality of life. The purpose of this study was to analyze brain volume in patients with osteoporosis using brain magnetic resonance imaging (MRI) and to investigate the relationship with osteoporotic vertebral compression fractures. Materials and methods We included 246 patients with osteoporosis who underwent thoracolumbar radiographs and brain MRI at our hospital. Clinical data on age, sex, bone mineral density, height, weight, osteoporosis medication, hypertension, diabetes, alcohol drinking, and smoking were collected. Intracranial cavity, brain parenchyma, and lateral ventricles volumes were measured using brain MRI with a semiautomated tool. Results We founded an independent correlation between age and volume percentages of the brain parenchyma and lateral ventricles. We observed a statistically significant decrease in volume percentage of the brain parenchyma and an increase in volume percentage of the lateral ventricles with increasing age. In addition, we confirmed that patients with OVCF showed a significantly lower volume percentage of brain parenchyma than patients without OVCF. Conclusion We observed a significant association between OVCF and volume percentage of brain parenchyma. Degeneration of the brain may lead to a high incidence of falls, and OVCF may occur more frequently in patients with osteoporosis.	[Bae, In-Suk; Kim, Jae Min; Cheong, Jin Hwan; Han, Myung-Hoon; Ryu, Je Il] Hanyang Univ Gun Hosp, Dept Neurosurg, Guri, Gyonggi Do, South Korea		Ryu, JI (corresponding author), Hanyang Univ Gun Hosp, Dept Neurosurg, Guri, Gyonggi Do, South Korea.	ryujeil@hanyang.ac.kr	Ryu, Je Il/E-5511-2018	Ryu, Je Il/0000-0003-2885-5839	Hanyang University	Hanyang University	This work was supported by the research fund of Hanyang University (HY-2018). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperin N, 2013, AM J NEURORADIOL, V34, P29, DOI 10.3174/ajnr.A3171; Apostolova LG, 2012, ALZ DIS ASSOC DIS, V26, P17, DOI 10.1097/WAD.0b013e3182163b62; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bliuc D, 2013, J BONE MINER RES, V28, P2317, DOI 10.1002/jbmr.1968; Cagdas, 2011, ANKUNIVERSITESI VET, V58, P73, DOI [10.1501/Vetfak_0000002453, DOI 10.1501/VETFAK_0000002453]; CRITCHLEY M, 1948, Geriatrics, V3, P364; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Fisher C M, 1980, Trans Am Neurol Assoc, V105, P29; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Dominguez MG, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0510-9; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; KAYE JA, 1992, J AM GERIATR SOC, V40, P225, DOI 10.1111/j.1532-5415.1992.tb02073.x; Li MY, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.745; Ma ZL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15653; Masdeu J C, 1986, Acta Radiol Suppl, V369, P392; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Qin Weiping, 2010, Curr Osteoporos Rep, V8, P212, DOI 10.1007/s11914-010-0029-9; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Toepper M, 2017, J ALZHEIMERS DIS, V57, P331, DOI 10.3233/JAD-161099; Wang HK, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0175-2; Zhao Y, 2012, SCI WORLD J, DOI 10.1100/2012/872173	30	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224439	10.1371/journal.pone.0224439	http://dx.doi.org/10.1371/journal.pone.0224439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689324	Green Published, gold			2022-12-26	WOS:000532680100023
J	Contreras-Baeza, Y; Sandoval, PY; Alarcon, R; Galaz, A; Cortes-Molina, F; Alegria, K; Baeza-Lehnert, F; Arce-Molina, R; Guequen, A; Flores, CA; San Martin, A; Barros, LF				Contreras-Baeza, Yasna; Sandoval, Pamela Y.; Alarcon, Romina; Galaz, Alex; Cortes-Molina, Francisca; Alegria, Karin; Baeza-Lehnert, Felipe; Arce-Molina, Robinson; Guequen, Anita; Flores, Carlos A.; San Martin, Alejandro; Felipe Barros, L.			Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; pyruvate; transporter; cancer; macrophage; Michaelis-Menten; monocarboxylate transporter	PLASMA-MEMBRANE; CELL; INHIBITOR; PH; ASTROCYTES; MODULATION; EXPRESSION; HYPOXIA; GLUCOSE; CD147	Monocarboxylate transporter 4 (MCT4) is an H+-coupled symporter highly expressed in metastatic tumors and at inflammatory sites undergoing hypoxia or the Warburg effect. At these sites, extracellular lactate contributes to malignancy and immune response evasion. Intriguingly, at 30?40 mm, the reported K-m of MCT4 for lactate is more than 1 order of magnitude higher than physiological or even pathological lactate levels. MCT4 is not thought to transport pyruvate. Here we have characterized cell lactate and pyruvate dynamics using the FRET sensors Laconic and Pyronic. Dominant MCT4 permeability was demonstrated in various cell types by pharmacological means and by CRISPR/Cas9-mediated deletion. Respective K-m values for lactate uptake were 1.7, 1.2, and 0.7 mm in MDA-MB-231 cells, macrophages, and HEK293 cells expressing recombinant MCT4. In MDA-MB-231 cells MCT4 exhibited a K-m for pyruvate of 4.2 mm, as opposed to >150 mm reported previously. Parallel assays with the pH-sensitive dye 2?,7?-bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) indicated that previous K-m estimates based on substrate-induced acidification were severely biased by confounding pH-regulatory mechanisms. Numerical simulation using revised kinetic parameters revealed that MCT4, but not the related transporters MCT1 and MCT2, endows cells with the ability to export lactate in high-lactate microenvironments. In conclusion, MCT4 is a high-affinity lactate transporter with physiologically relevant affinity for pyruvate.	[Contreras-Baeza, Yasna; Sandoval, Pamela Y.; Alarcon, Romina; Galaz, Alex; Cortes-Molina, Francisca; Alegria, Karin; Baeza-Lehnert, Felipe; Arce-Molina, Robinson; Guequen, Anita; Flores, Carlos A.; San Martin, Alejandro; Felipe Barros, L.] Ctr Estudios Cient, Ctr Estudios Cient, Arturo Prat 514, Valdivia 5110466, Chile; [Alarcon, Romina; Baeza-Lehnert, Felipe; Arce-Molina, Robinson] Univ Austral Chile, Valdivia 5110566, Chile	Universidad Austral de Chile	San Martin, A; Barros, LF (corresponding author), Ctr Estudios Cient, Ctr Estudios Cient, Arturo Prat 514, Valdivia 5110466, Chile.	aalejo@cecs.cl; fbarros@cecs.cl	Cortes, Francisca/AAV-9485-2020; Sandoval, Pamela Y./AAL-8719-2020	Sandoval, Pamela Y./0000-0002-6514-3980; San Martin, Alejandro/0000-0002-5608-5117; Flores, Carlos/0000-0002-3813-1909	Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	We thank Karen Everett for critical reading of the manuscript and Jose ' Sarmiento (Universidad Austral de Chile) for help with confocal microscopy of MCT4 in human macrophages. We thank Drs. Brandon Faubert and Ralph J. DeBerardinis (Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX) for a generous gift of the MCT4-Lenti-CRISPR_V2 construct. The Centro de Estudios Cientificos (CECs) is funded by the Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT.	Baeza-Lehnert F, 2019, CELL METAB, V29, P668, DOI 10.1016/j.cmet.2018.11.005; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Becker HM, 2010, J MEMBRANE BIOL, V234, P125, DOI 10.1007/s00232-010-9240-y; Bittner Carla X, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00026; BONANNO JA, 1990, CURR EYE RES, V9, P707, DOI 10.3109/02713689008999587; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; CARPENTER L, 1994, BIOCHEM J, V304, P751, DOI 10.1042/bj3040751; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CLAYCOMB WC, 1971, DEV BIOL, V24, P413, DOI 10.1016/0012-1606(71)90089-3; Contreras-Baeza Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224527; Deitmer JW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00291; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; EPPIG JJ, 1976, IN VITRO CELL DEV B, V12, P173; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Delgado MG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19595-5; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong CS, 2016, CELL REP, V14, P1590, DOI 10.1016/j.celrep.2016.01.057; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Hussien R, 2011, PHYSIOL GENOMICS, V43, P255, DOI 10.1152/physiolgenomics.00177.2010; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Moreau A, 2011, FUND CLIN PHARMACOL, V25, P743, DOI 10.1111/j.1472-8206.2010.00913.x; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Park SJ, 2018, AM J CANCER RES, V8, P1967; Peetz J, 2015, PFLUG ARCH EUR J PHY, V467, P1469, DOI 10.1007/s00424-014-1594-z; Placais PY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15510; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; RACKER E, 1972, AM SCI, V60, P56; Rosafio K, 2014, GLIA, V62, P477, DOI 10.1002/glia.22618; Russell DG, 2019, NAT REV IMMUNOL, V19, P291, DOI 10.1038/s41577-019-0124-9; Rusu V, 2017, CELL, V170, P199, DOI 10.1016/j.cell.2017.06.011; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; San-Millan I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127; Sasaki S, 2016, DRUG METAB PHARMACOK, V31, P218, DOI 10.1016/j.dmpk.2016.03.004; Sotelo-Hitschfeld T, 2015, J NEUROSCI, V35, P4168, DOI 10.1523/JNEUROSCI.5036-14.2015; Tan Z, 2015, J BIOL CHEM, V290, P46, DOI 10.1074/jbc.M114.603589; Theparambil SM, 2014, J NEUROSCI, V34, P1148, DOI 10.1523/JNEUROSCI.2377-13.2014; Tobar N, 2017, J CELL PHYSIOL, V232, P136, DOI 10.1002/jcp.25398; Tosco M, 2000, AM J PHYSIOL-REG I, V278, pR1190, DOI 10.1152/ajpregu.2000.278.5.R1190; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Walenta S, 2000, CANCER RES, V60, P916; Warburg O., 1925, J CANCER RES CLIN, V9, P148, DOI [10.1158/jcr.1925.148, DOI 10.1158/JCR.1925.148]; Weber B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020396; WIDDAS WF, 1954, J PHYSIOL-LONDON, V125, P163, DOI 10.1113/jphysiol.1954.sp005148; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	53	60	62	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20135	20147		10.1074/jbc.RA119.009093	http://dx.doi.org/10.1074/jbc.RA119.009093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31719150	Green Published, hybrid			2022-12-26	WOS:000505005800025
J	Reiding, KR; Franc, V; Huitema, MG; Brouwer, E; Heeringa, P; Heck, AJR				Reiding, Karli R.; Franc, Vojtech; Huitema, Minke G.; Brouwer, Elisabeth; Heeringa, Peter; Heck, Albert J. R.			Neutrophil myeloperoxidase harbors distinct site-specific peculiarities in its glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myeloperoxidase; MPO; neutrophil; glycosylation; mannose-6-phosphate (M6P); mass spectrometry (MS); autoimmune disease; anti-neutrophil cytoplasmic autoantibody (ANCA); glycoproteomics; paucimannose; self-antigen; phosphomannose	RAY CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; AZUROPHILIC GRANULES; PROTEINS; PROPEPTIDE; VASCULITIS	Anti-neutrophil cytoplasmic autoantibodies (ANCAs) are directed against lysosomal components of neutrophils. ANCAs directed to proteinase 3 and myeloperoxidase (MPO) in particular are associated with distinct forms of small vessel vasculitides. MPO is an abundant neutrophil-derived heme protein that is part of the antimicrobial defense system. The protein is typically present in the azurophilic granules of neutrophils, but a large portion may also enter the extracellular space. It remains unclear why MPO is frequently the target of antibody-mediated autoimmune responses. MPO is a homodimeric glycoprotein, posttranslationally modified with complex sugars at specific sites. Glycosylation can strongly influence protein function, affecting its folding, receptor interaction, and backbone accessibility. MPO potentially can be heavily modified as it harbors 5 putative N-glycosylation sites (10 in the mature dimer). Although considered important for MPO structure and function, the full scope and relative abundance of the glycans attached to MPO is unknown. Here, combining bottom-up glycoproteomics and native MS approaches, we structurally characterized MPO from neutrophils of healthy human donors. We quantified the relative occupancy levels of the glycans at each of the five sites and observed complex heterogeneity and site-specific glycosylation. In particular, we detected glycosylation phenotypes uncommon for glycoproteins in the extracellular space, such as a high abundance of phosphorylated high-mannose species and severely truncated small glycans having the size of paucimannose or smaller. We hypothesize that the atypical glycosylation pattern found on MPO might contribute to its specific processing and presentation as a self-antigen by antigen-presenting cells.	[Reiding, Karli R.; Franc, Vojtech; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Reiding, Karli R.; Franc, Vojtech; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Reiding, Karli R.; Franc, Vojtech; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Huitema, Minke G.; Brouwer, Elisabeth] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9700 AB Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 AB Groningen, Netherlands	Utrecht University; Utrecht University; University of Groningen; University of Groningen	Reiding, KR (corresponding author), Padualaan 8, NL-3584 CH Utrecht, Netherlands.	k.r.reiding@uu.nl	Brouwer, Elisabeth/AAL-9029-2020; Heck, Albert/D-7098-2011; Heeringa, Peter/A-6008-2009	Brouwer, Elisabeth/0000-0002-5652-4423; Heck, Albert/0000-0002-2405-4404; Heeringa, Peter/0000-0001-8684-763X; Franc, Vojtech/0000-0003-4114-2382	NWO TOP-Punt Grant [718.015.003]; European Union's Horizon 2020 Research and Innovation Program [668036]	NWO TOP-Punt Grant; European Union's Horizon 2020 Research and Innovation Program	This work was supported by the NWO TOP-Punt Grant 718.015.003 (to A.J.R.H.) and the European Union's Horizon 2020 Research and Innovation Program under Grant 668036 (RELENT). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson E, 1998, J BIOL CHEM, V273, P4747, DOI 10.1074/jbc.273.8.4747; [Anonymous], PYMOL MOL GRAPH SYST; Bern Marshall, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1320s40; Bossuyt X, 2017, NAT REV RHEUMATOL, V13, P683, DOI 10.1038/nrrheum.2017.140; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Caval T, 2019, MOL CELL PROTEOMICS, V18, P16, DOI 10.1074/mcp.RA118.000967; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; Cornec D, 2016, NAT REV RHEUMATOL, V12, P570, DOI 10.1038/nrrheum.2016.123; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Gao YP, 2017, ONCOTARGET, V8, P7420, DOI 10.18632/oncotarget.14558; Grishkovskaya I, 2017, J BIOL CHEM, V292, P8244, DOI 10.1074/jbc.M117.775031; Heeringa P, 1997, AM J PATHOL, V151, P131; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lee LY, 2016, J PROTEOME RES, V15, P3904, DOI 10.1021/acs.jproteome.6b00438; Lin YH, 2018, J PROTEOME RES, V17, P2861, DOI 10.1021/acs.jproteome.8b00318; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; NAUSEEF WM, 1983, J CLIN INVEST, V71, P1297, DOI 10.1172/JCI110880; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Potel CM, 2019, ANAL CHEM, V91, P5542, DOI 10.1021/acs.analchem.9b00734; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P2046, DOI 10.1016/j.bbapap.2010.07.001; Reiding KR, 2018, TRAC-TREND ANAL CHEM, V108, P260, DOI 10.1016/j.trac.2018.09.007; Rosati S, 2014, NAT PROTOC, V9, P967, DOI 10.1038/nprot.2014.057; Roth AJ, 2013, J CLIN INVEST, V123, P1773, DOI 10.1172/JCI65292; Scott David L, 2010, Lancet, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Teng N, 2017, REDOX REP, V22, P51, DOI 10.1080/13510002.2016.1256119; Thaysen-Andersen M, 2015, J BIOL CHEM, V290, P8789, DOI 10.1074/jbc.M114.631622; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; van der Geest KSM, 2018, RHEUMATOLOGY, V57, P1332, DOI 10.1093/rheumatology/kex367; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wang J, 2018, NEPHROLOGY, V23, P46, DOI 10.1111/nep.12926; Woods R.J., 2005, GLYCAM WEB; Yang Y, 2017, MABS-AUSTIN, V9, P638, DOI 10.1080/19420862.2017.1290033; Yang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13397; Yogalingam G, 2017, J BIOL CHEM, V292, P4255, DOI 10.1074/jbc.M116.739441; Yu JT, 2017, KIDNEY INT, V91, P1410, DOI 10.1016/j.kint.2016.12.012; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	43	24	24	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20233	20245		10.1074/jbc.RA119.011098	http://dx.doi.org/10.1074/jbc.RA119.011098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31719144	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000505005800033
J	Grinter, R; Lithgow, T				Grinter, Rhys; Lithgow, Trevor			The structure of the bacterial iron?catecholate transporter Fiu suggests that it imports substrates via a two-step mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; X-ray crystallography; Escherichia coli (E; coli); protein structure; outer membrane; siderophore; bacterial outer membrane; ferric iron uptake (Fiu); iron acquisition; solute uptake; TonB-dependent transporter	OUTER-MEMBRANE PERMEABILITY; FERRIC-ENTEROBACTIN; CHROMOSOMAL GENES; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; IRON; SIDEROPHORE; PROTEIN; RECEPTOR; FEPA	The ferric iron uptake (Fiu) transporter from Escherichia coli functions in the transport of iron?catecholate complexes across the bacterial outer membrane, providing the bacterium with iron, which is essential for growth. Recently it has become clear that Fiu also represents a liability for E. coli because its activity allows import of antimicrobial compounds that mimic catecholate. This inadvertent import suggests the potential utility of antimicrobial catechol siderophore mimetics in managing bacterial infections. However, to fully exploit these compounds, a detailed understanding of the mechanism of transport through Fiu and related transporters is required. To address this question, we determined the crystal structure of Fiu at 2.1?2.9 ? and analyzed its function in E. coli. Through analysis of the Fiuo crystal structure, in combination with in silico docking and mutagenesis, we provide insight into how Fiu and related transporters bind catecholate in a surface-exposed cavity. Moreover, through determination of the structure of Fiu in multiple crystal states, we revealed the presence of a large, selectively gated cavity in the interior of this transporter. This chamber is large enough to accommodate the Fiu substrate and may allow import of substrates via a two-step mechanism. This would avoid channel formation through the transporter and inadvertent import of toxic molecules. As Fiu and its homologs are the targets of substrate-mimicking antibiotics, these results may assist in the development of these compounds.	[Grinter, Rhys] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Grinter, Rhys; Lithgow, Trevor] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Grinter, Rhys; Lithgow, Trevor] Monash Univ, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Grinter, Rhys; Lithgow, Trevor] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University; Monash University	Grinter, R (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.; Grinter, R (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia.; Grinter, R (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Grinter, R (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	rhys.grinter@monash.edu		Grinter, Rhys/0000-0002-8195-5348	Australian Research Council [FL130100038]; National Health and Medical Research Council (NHMRC Program in Cellular Microbiology) [1092262]	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC Program in Cellular Microbiology)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (FL130100038) and the National Health and Medical Research Council(NHMRCProgram in Cellular Microbiology, 1092262). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2012, P NATL ACAD SCI USA, V109, P4425, DOI 10.1073/pnas.1114224109; ARMSTRONG SK, 1990, J BIOL CHEM, V265, P14536; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bolam DN, 2018, CURR OPIN STRUC BIOL, V51, P35, DOI 10.1016/j.sbi.2018.03.001; Braun V, 2002, CURR OPIN MICROBIOL, V5, P194, DOI 10.1016/S1369-5274(02)00298-9; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Brillet K, 2011, J AM CHEM SOC, V133, P16503, DOI 10.1021/ja205504z; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Calmettes C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8996; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chakraborty R, 2003, BIOMETALS, V16, P507, DOI 10.1023/A:1023485632520; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018910; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Cornelis P, 2009, ENV MICROBIOL REP, V1, P256, DOI 10.1111/j.1758-2229.2009.00041.x; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; CRITCHLEY IA, 1991, J ANTIMICROB CHEMOTH, V28, P377, DOI 10.1093/jac/28.3.377; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Destoumieux-Garzon D, 2006, BIOMETALS, V19, P181, DOI 10.1007/s10534-005-4452-9; Doublet B, 2008, J MICROBIOL METH, V75, P359, DOI 10.1016/j.mimet.2008.06.010; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Ghequire MGK, 2017, MBIO, V8, DOI 10.1128/mBio.01961-16; Ghequire MGK, 2014, FEMS MICROBIOL REV, V38, P523, DOI 10.1111/1574-6976.12079; Grinter R, 2019, IUCRJ, V6, P401, DOI 10.1107/S2052252519002926; Grinter R, 2014, MOL MICROBIOL, V93, P234, DOI 10.1111/mmi.12655; Grinter R, 2013, FEMS MICROBIOL LETT, V338, P1, DOI 10.1111/1574-6968.12011; HANTKE K, 1990, FEMS MICROBIOL LETT, V67, P5, DOI 10.1111/j.1574-6968.1990.tb13826.x; Hickman SJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14804; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Josts I, 2019, ELIFE, V8, DOI 10.7554/eLife.48528; Khan A, 2018, MICROBIOL RES, V212, P103, DOI 10.1016/j.micres.2017.10.012; King DT, 2016, PROTEIN SCI, V25, P787, DOI 10.1002/pro.2889; Kong HM, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111615; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Luscher A, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00097-18, 10.1128/aac.00097-18]; Machuca A, 2007, LETT APPL MICROBIOL, V44, P7, DOI 10.1111/j.1472-765X.2006.02046.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; Moynie L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11508-y; Moynie L, 2018, ELIFE, V7, DOI 10.7554/eLife.42270; Moynie L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02531-16; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; NIKAIDO H, 1990, J BACTERIOL, V172, P1361, DOI 10.1128/jb.172.3.1361-1367.1990; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIERCE JR, 1983, J BACTERIOL, V155, P330, DOI 10.1128/JB.155.1.330-336.1983; Portsmouth S, 2018, LANCET INFECT DIS, V18, P1319, DOI 10.1016/S1473-3099(18)30554-1; PUGSLEY AP, 1987, J GEN MICROBIOL, V133, P3505; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; REIKOFSKI J, 1992, BIOTECHNOL ADV, V10, P535, DOI 10.1016/0734-9750(92)91451-J; Saleem M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056746; Strahsburger E, 2005, ANTIMICROB AGENTS CH, V49, P3083, DOI 10.1128/AAC.49.7.3083-3086.2005; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24648; van Delden C, 2013, ANTIMICROB AGENTS CH, V57, P2095, DOI 10.1128/AAC.02474-12; van den Berg B, 2015, P NATL ACAD SCI USA, V112, pE2991, DOI 10.1073/pnas.1424835112; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; White P, 2017, P NATL ACAD SCI USA, V114, P12051, DOI 10.1073/pnas.1713741114	70	7	8	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19523	19534		10.1074/jbc.RA119.011018	http://dx.doi.org/10.1074/jbc.RA119.011018			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31712312	Green Published, hybrid			2022-12-26	WOS:000504093200007
J	Graves, JP; Bradbury, JA; Gruzdev, A; Li, H; Duval, C; Lih, FB; Edin, ML; Zeldin, DC				Graves, Joan P.; Bradbury, J. Alyce; Gruzdev, Artiom; Li, Hong; Duval, Caroline; Lih, Fred B.; Edin, Matthew L.; Zeldin, Darryl C.			Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice	FASEB JOURNAL			English	Article						cytochromes P450; ipopolysaccharide; gene expression; fatty acids; eicosanoids	SOLUBLE EPOXIDE HYDROLASE; CYTOCHROME-P450 ENZYMES; EPOXYEICOSATRIENOIC ACIDS; TISSUE DISTRIBUTION; THERAPEUTIC TARGET; QUANTITATIVE PCR; GENE; LIPOPOLYSACCHARIDE; BIOACTIVATION; ARACHIDONATE	Inflammatory stimuli, such as bacterial LPS, alter the expression of many cytochromes P450. CYP2C and CYP2J subfamily members actively metabolize fatty acids to bioactive eicosanoids, which exhibit potent anti-inflammatory effects. Herein, we examined mRNA levels of the 15 mouse Cyp2c and 7 mouse Cyp2j isoforms in liver, kidney, duodenum, and brain over a 96-h time course of LPS-induced inflammation and resolution. Plasma and liver eicosanoid levels were also measured by liquid chromatography with tandem mass spectrometry. Expression changes in Cyp2c and Cyp2j isoforms were both isoform and tissue specific. Total liver Cyp2c and Cyp2j mRNA content was reduced by 80% 24 h after LPS but recovered to baseline levels by 96 h. Total Cyp2c and Cyp2j mRNA in kidney (-19%) and duodenum (-64%) were reduced 24 h after LPS but recovered above baseline by 72 h. Total Cyp2c and Cyp2j mRNA content in brain was elevated at all time points after LPS dosing. Plasma eicosanoids transiently increased 3-6 h after administration of LPS. In liver, esterified oxylipin levels decreased during acute inflammation and before recovering. The biphasic suppression and recovery of mouse Cyp2c and Cyp2j isoforms and associated changes in eicosanoid levels during LPS-induced inflammation and resolution may have important physiologic consequences.	[Graves, Joan P.; Bradbury, J. Alyce; Gruzdev, Artiom; Li, Hong; Duval, Caroline; Lih, Fred B.; Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, 111 TW Alexander Dr,Bldg 101,Room A214, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zeldin, DC (corresponding author), NIEHS, Div Intramural Res, NIH, 111 TW Alexander Dr,Bldg 101,Room A214, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Li, Hong/ABE-3959-2021; Zeldin, Darryl/Y-7091-2018	Zeldin, Darryl/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X	Division of Intramural Research, NIEHS/NIH [Z01 ES025034]	Division of Intramural Research, NIEHS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Lois Wyrick [National Institute of Environmental Health Sciences (NIEHS), U.S. National Institutes of Health (NIH); contractor] for graphic arts assistance. This work was supported by the Division of Intramural Research, NIEHS/NIH, (Z01 ES025034 to D.C.Z.). The authors declare no conflicts of interest.	Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Askari A, 2013, PROSTAG OTH LIPID M, V107, P56, DOI 10.1016/j.prostaglandins.2013.02.003; Askari AA, 2014, BIOCHEM BIOPH RES CO, V446, P633, DOI 10.1016/j.bbrc.2014.03.020; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Capdevila JH, 2000, J LIPID RES, V41, P163; Cheng PY, 2003, J PHARMACOL EXP THER, V307, P1205, DOI 10.1124/jpet.103.057174; Deng BQ, 2017, P NATL ACAD SCI USA, V114, P12608, DOI 10.1073/pnas.1705615114; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Duval C, 2017, ENVIRON HEALTH PERSP, V125, P428, DOI 10.1289/EHP316; Edin ML, 2018, J BIOL CHEM, V293, P3281, DOI 10.1074/jbc.RA117.000298; Falck JR, 2011, J MED CHEM, V54, P4109, DOI 10.1021/jm200132q; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Graves JP, 2017, DRUG METAB DISPOS, V45, P807, DOI 10.1124/dmd.117.075697; Graves JP, 2015, DRUG METAB DISPOS, V43, P1169, DOI 10.1124/dmd.115.064139; Grkovich A, 2009, BBA-MOL CELL BIOL L, V1791, P975, DOI 10.1016/j.bbalip.2009.02.002; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Imig JD, 2016, ADV PHARMACOL, V77, P105, DOI 10.1016/bs.apha.2016.04.003; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014; Klett Eric L, 2013, J Biol Chem, V288, P21618, DOI 10.1074/jbc.M113.481077; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Ma JX, 2002, BIOCHEM PHARMACOL, V64, P1447, DOI 10.1016/S0006-2952(02)01393-X; Ma M, 2019, P NATL ACAD SCI USA, V116, P7083, DOI 10.1073/pnas.1819234116; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Moriya N, 2012, BIOL PHARM BULL, V35, P473, DOI 10.1248/bpb.35.473; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seemann S, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0370-8; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Temesvari M, 2012, J PHARMACOL EXP THER, V341, P294, DOI 10.1124/jpet.111.189597; Theken KN, 2011, DRUG METAB DISPOS, V39, P22, DOI 10.1124/dmd.110.035287; Tyden E, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0069-8; Zhang WY, 2012, DIGEST DIS SCI, V57, P2580, DOI 10.1007/s10620-012-2217-1	46	7	7	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14784	14797		10.1096/fj.201901872R	http://dx.doi.org/10.1096/fj.201901872R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690125	Green Published, Bronze			2022-12-26	WOS:000507466100132
J	Huang, HP; Kolibabka, M; Eshwaran, R; Chatterjee, A; Schlotterer, A; Willer, H; Bieback, K; Hammes, HP; Feng, YX				Huang, Hongpeng; Kolibabka, Matthias; Eshwaran, Rachana; Chatterjee, Anupriya; Schlotterer, Andrea; Willer, Helene; Bieback, Karen; Hammes, Hans-Peter; Feng, Yuxi			Intravitreal injection of mesenchymal stem cells evokes retinal vascular damage in rats	FASEB JOURNAL			English	Article						retina; inflammation; vessels	BONE-MARROW; DIABETIC-RETINOPATHY; STROMAL CELLS; DEGENERATION; PHENOTYPE; PERICYTES	The aim of this study is to investigate the vascular outcome after intravitreal mesenchymal stem cell (MSC) administration in rats without or with damage to the neurovascular unit [transgenic (TGR) rats]. Male Sprague-Dawley (SD) and TGR rats received an intravitreal injection of 2 x 10(4) rat bone marrow-derived MSCs (BMSCs) or human adipose-derived stem cells (ASCs) at postnatal d 30. After 4 wk, vasculature, neuronal function, and gene expression in the retinas were evaluated using retinal morphometry, electroretinography, immunofluorescence, Western blot, and quantitative PCR. Intravitreal administration of rat BMSCs and human ASCs in both SD and TGR eyes induced cataract, loss of pericytes, and increased formation of acellular capillaries. BMSCs remained in the vitreous cavity and did not migrate into the retinas. Intravitreal administration of BMSCs impacted retinal neuronal function in neither SD nor TGR rats. Retinal glial activation, elevation of IL-1 beta, C3, arginase 1, and heat shock protein 90 were detected in BMSC-injected SD rats. Intravitreal administration of MSCs induces cataract, retinal vasoregression, activation of retinal glial cells, and inflammatory response in rat eyes.	[Huang, Hongpeng; Eshwaran, Rachana; Chatterjee, Anupriya; Feng, Yuxi] Heidelberg Univ, Med Fac Mannheim, Expt Pharmacol, Ludolf Krehl Str 13-17, D-68167 Mannheim, Germany; [Kolibabka, Matthias; Schlotterer, Andrea; Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Med Clin 5, Mannheim, Germany; [Willer, Helene; Bieback, Karen] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, Mannheim, Germany; [Hammes, Hans-Peter; Feng, Yuxi] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci ECAS, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Feng, YX (corresponding author), Heidelberg Univ, Med Fac Mannheim, Expt Pharmacol, Ludolf Krehl Str 13-17, D-68167 Mannheim, Germany.	yuxi.feng@medma.uni-heidelberg.de	Schlotterer, Andrea/GWC-7442-2022		Deutsche Forschungsgemeinschaft (DFG) [FE 969/2-1, HA 1755/10-1, IRTG 1874 DIAMICOM-SP2]; Deutsche Diabetes Gesellschaft (DDG); European Foundation for the Study of Diabetes (EFSD); Novartis	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Diabetes Gesellschaft (DDG); European Foundation for the Study of Diabetes (EFSD); Novartis(Novartis)	The authors thank Ulrike Kaiser (Fifth Medical Clinic), Susanne Elvers-Hornung (Institute of Transfusion Medicine and Immunology), Nadine Dietrich (Fifth Medical Clinic), and Heike Rauscher (Experimental Pharmacology) for their excellent technical assistance. This research was funded by the Deutsche Forschungsgemeinschaft (DFG; FE 969/2-1 to Y.F., HA 1755/10-1 to H.-P.H., IRTG 1874 DIAMICOM-SP2 to Y.F., SP5 to H.-P.H., and SP6 to K.B.), the Deutsche Diabetes Gesellschaft (DDG), and the European Foundation for the Study of Diabetes (EFSD; Novartis-2014 to Y.F.). The funders had no role in the design of the study, the collection, analyses, or interpretation of data, writing of the manuscript, or the decision to publish the results. The authors declare no conflicts of interest.	Abcouwer SF, 2017, DIABETES, V66, P261, DOI 10.2337/dbi16-0047; Aguila M, 2016, ADV EXP MED BIOL, V854, P161, DOI 10.1007/978-3-319-17121-0_22; Altmann C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010110; BARNETT NL, 1995, EXP EYE RES, V61, P83, DOI 10.1016/S0014-4835(95)80061-1; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bieback K, 2012, CYTOTHERAPY, V14, P570, DOI 10.3109/14653249.2011.652809; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chakravarthy H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146829; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Dutescu RM, 2013, INVEST OPHTH VIS SCI, V54, P2582, DOI 10.1167/iovs.12-11446; Elshaer SL, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1059-y; Ezquer M, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0299-y; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; GUREVICH L, 1993, VISION RES, V33, P2431, DOI 10.1016/0042-6989(93)90122-D; Hammes HP, 2018, DIABETOLOGIA, V61, P29, DOI 10.1007/s00125-017-4435-8; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ikwegbue PC, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010002; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P960, DOI 10.1167/iovs.09-3884; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kuriyan AE, 2017, NEW ENGL J MED, V376, P1047, DOI 10.1056/NEJMoa1609583; Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Otani A, 2004, J CLIN INVEST, V114, P765, DOI 10.1172/JCI200421686; Perdiguero EG, 2011, J BIOL CHEM, V286, P36841, DOI 10.1074/jbc.M111.220061; Qiu Y, 2016, ACTA DIABETOL, V53, P81, DOI 10.1007/s00592-015-0752-x; Rajashekhar G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00059; Rajashekhar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084671; Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116; Satarian Leila, 2017, J Ophthalmic Vis Res, V12, P58, DOI 10.4103/2008-322X.200164; Siqueira RC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0020-6; Terlizzi V, 2018, STEM CELLS, V36, P240, DOI 10.1002/stem.2726; Tomita M, 2002, STEM CELLS, V20, P279, DOI 10.1634/stemcells.20-4-279; Urbak Larke, 2010, Int J Proteomics, V2010, P479571, DOI 10.1155/2010/479571; Wang JD, 2017, ACTA OPHTHALMOL, V95, pE453, DOI 10.1111/aos.13154; Zhang Y, 2017, MOL VIS, V23, P228; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51, P3742, DOI 10.1167/iovs.08-3314	44	11	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14668	14679		10.1096/fj.201901500R	http://dx.doi.org/10.1096/fj.201901500R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690119	Bronze			2022-12-26	WOS:000507466100123
J	Lei, X; Liu, LL; Terrillion, CE; Karuppagounder, SS; Cisternas, P; Lay, M; Martinelli, DC; Aja, S; Dong, XZ; Pletnikov, MV; Wong, GW				Lei, Xia; Liu, Lili; Terrillion, Chantelle E.; Karuppagounder, Senthilkumar S.; Cisternas, Pedro; Lay, Mark; Martinelli, David C.; Aja, Susan; Dong, Xinzhong; Pletnikov, Mikhail, V; Wong, G. William			FAM19A1, a brain-enriched and metabolically responsive neurokine, regulates food intake patterns and mouse behaviors	FASEB JOURNAL			English	Article						chemokine-like; dopamine; locomotor hyperactivity; TAFA1	CEREBELLAR INTERPOSITUS NUCLEAR; SENSORIMOTOR GATING DEFICITS; PREPULSE INHIBITION; INSULIN SENSITIVITY; SECRETED PROTEIN; EXPRESSION; MICE; DOPAMINE; NEURONS; HYPOTHALAMUS	Cytokines and chemokines play diverse roles in different organ systems. Family with sequence similarity 19, member A1-5 (FAM19A1-A5; also known as TAFA1-5) is a group of conserved chemokine-like proteins enriched in the CNS of mice and humans. Their functions are only beginning to emerge. Here, we show that the expression of Fam19a1-a5 in different mouse brain regions are induced or suppressed by unfed and refed states. The striking nutritional regulation of Fam19a family members in the brain suggests a potential central role in regulating metabolism. Using a knockout (KO) mouse model, we show that loss of FAM19A1 results in sexually dimorphic phenotypes. In male mice, FAM19A1 deficiency alters food intake patterns during the light and dark cycle. Fam19a1 KO mice are hyperactive, and locomotor hyperactivity is more pronounced in female KO mice. Behavior tests indicate that Fam19a1 KO female mice have reduced anxiety and sensitivity to pain. Spatial learning and exploration, however, is preserved in Fam19a1 KO mice. Altered behaviors are associated with elevated norepinephrine and dopamine turnover in the striatum. Our results establish an in vivo function of FAM19A1 and highlight central roles for this family of neurokines in modulating animal physiology and behavior.	[Lei, Xia; Liu, Lili; Cisternas, Pedro; Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA; [Lei, Xia; Liu, Lili; Aja, Susan; Wong, G. William] Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, Baltimore, MD 21205 USA; [Terrillion, Chantelle E.; Pletnikov, Mikhail, V] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21205 USA; [Karuppagounder, Senthilkumar S.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21205 USA; [Karuppagounder, Senthilkumar S.] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21205 USA; [Lay, Mark; Aja, Susan; Dong, Xinzhong; Pletnikov, Mikhail, V] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; [Liu, Lili] Hunan Univ Sci & Technol, Coll Life Sci, Changsha, Hunan, Peoples R China; [Cisternas, Pedro] Pontificia Univ Catolica Chile, Ctr Envejecimiento & Regenerac CARE UC, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Martinelli, David C.] Univ Connecticut, Hlth Ctr, Dept Neurosci, Farmington, CT USA; [Dong, Xinzhong] Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Hunan University of Science & Technology; Pontificia Universidad Catolica de Chile; University of Connecticut; Howard Hughes Medical Institute; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Liu, Lili/HHC-6357-2022; Karuppagounder, Senthilkumar/I-6752-2013	Karuppagounder, Senthilkumar/0000-0002-3281-9913; Lei, Xia/0000-0003-4241-6576; Martinelli, David/0000-0002-8318-3986	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK084171]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Valina Dawson and Ted Dawson (Johns Hopkins University School of Medicine) for providing resources to measure brain monoamine levels. This work was supported by a grant from the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (DK084171 to G.W.W.). The authors declare no conflicts of interest.	Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Ahmari SE, 2012, NEUROPSYCHOPHARMACOL, V37, P1216, DOI 10.1038/npp.2011.308; Allison KC, 2010, INT J EAT DISORDER, V43, P241, DOI 10.1002/eat.20693; Andermann ML, 2017, NEURON, V95, P757, DOI 10.1016/j.neuron.2017.06.014; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; Berman SM, 2013, CEREBELLUM, V12, P59, DOI 10.1007/s12311-012-0360-z; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Campbell JN, 2017, NAT NEUROSCI, V20, P484, DOI 10.1038/nn.4495; Delfini MC, 2013, CELL REP, V5, P378, DOI 10.1016/j.celrep.2013.09.013; Dong XT, 2018, NEURON, V98, P482, DOI 10.1016/j.neuron.2018.03.023; El Messari S, 1998, J COMP NEUROL, V399, P492, DOI 10.1002/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X; Geyer MA, 1999, PSYCHOPHARMACOLOGY, V147, P11, DOI 10.1007/s002130051130; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Guan XM, 1997, MOL CELL ENDOCRINOL, V133, P1, DOI 10.1016/S0303-7207(97)00138-X; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Jafari A, 2019, STEM CELLS, V37, P407, DOI 10.1002/stem.2955; Jones MD, 2003, PHARMACOL BIOCHEM BE, V75, P209, DOI 10.1016/S0091-3057(03)00073-X; Kambrun C, 2018, CELL REP, V22, P2886, DOI 10.1016/j.celrep.2018.02.068; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karuppagounder SS, 2016, J CHEM NEUROANAT, V76, P90, DOI 10.1016/j.jchemneu.2016.01.007; Koebis M, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0437-4; Koros C, 2009, NUTRITION, V25, P85, DOI 10.1016/j.nut.2008.06.033; Li B, 2009, NEUROSIGNALS, V17, P132, DOI 10.1159/000197913; Little HC, 2018, MOL CELL PROTEOMICS, V17, P1546, DOI 10.1074/mcp.RA118.000794; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundgren JD, 2013, EAT BEHAV, V14, P447, DOI 10.1016/j.eatbeh.2013.08.006; MAHLER P, 1993, PHYSIOL BEHAV, V54, P1063, DOI 10.1016/0031-9384(93)90325-A; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Miller LR, 2017, FASEB J, V31, P29, DOI 10.1096/fj.201600781R; Miller VM, 2014, AM J PHYSIOL-HEART C, V306, pH781, DOI 10.1152/ajpheart.00994.2013; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Ouagazzal AM, 2001, PSYCHOPHARMACOLOGY, V156, P273, DOI 10.1007/s002130100763; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Park MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15586-0; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Petersen PS, 2014, AM J PHYSIOL-REG I, V307, pR1458, DOI 10.1152/ajpregu.00335.2014; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Schuske K, 2007, NAT NEUROSCI, V10, P846, DOI 10.1038/nn1920; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Shao YK, 2015, FEBS LETT, V589, P467, DOI 10.1016/j.febslet.2015.01.003; Song CH, 2012, J NEUROPHYSIOL, V107, P3397, DOI 10.1152/jn.00692.2011; Swerdlow NR, 2016, CURR TOP BEHAV NEURO, V28, P305, DOI 10.1007/7854_2015_5012; Tang YT, 2004, GENOMICS, V83, P727, DOI 10.1016/j.ygeno.2003.10.006; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Terrillion CE, 2017, NEUROPSYCHOPHARMACOL, V42, P2242, DOI 10.1038/npp.2017.129; Tiveron MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157052; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Varlamov Oleg, 2014, Front Endocrinol (Lausanne), V5, P241, DOI 10.3389/fendo.2014.00241; Walford GA, 2016, DIABETES, V65, P3200, DOI 10.2337/db16-0199; Wang WY, 2015, CELL MOL IMMUNOL, V12, P615, DOI 10.1038/cmi.2014.61; Wang XY, 2018, ACTA BIOCH BIOPH SIN, V50, P984, DOI 10.1093/abbs/gmy097; Wang YB, 2018, CIRCULATION, V138, P48, DOI 10.1161/CIRCULATIONAHA.117.032398; Wei ZK, 2014, AM J PHYSIOL-ENDOC M, V306, pE779, DOI 10.1152/ajpendo.00593.2013; Wen YQ, 2004, NEUROSCI LETT, V370, P25, DOI 10.1016/j.neulet.2004.07.072; Zheng C., 2018, FASEB J; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zhu JN, 2008, CELL MOL NEUROBIOL, V28, P469, DOI 10.1007/s10571-007-9236-z; Zhu JN, 2006, J NEUROSCI RES, V84, P1597, DOI 10.1002/jnr.21059; Zhu JN, 2004, NEUROSCI RES, V48, P405, DOI 10.1016/j.neures.2003.12.009; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	66	10	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14734	14747		10.1096/fj.201901232RR	http://dx.doi.org/10.1096/fj.201901232RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689372	Bronze, Green Published			2022-12-26	WOS:000507466100128
J	Zhang, T; Du, XH; Zhao, LH; He, MN; Lin, L; Guo, CH; Zhang, XR; Han, J; Yan, H; Huang, K; Sun, GH; Yan, L; Zhou, B; Xia, GL; Qin, YY; Wang, C				Zhang, Tuo; Du, Xinhua; Zhao, Lihua; He, Meina; Lin, Lin; Guo, Chuanhui; Zhang, Xinran; Han, Jun; Yan, Hao; Huang, Kun; Sun, Guanghong; Yan, Lei; Zhou, Bo; Xia, Guoliang; Qin, YingYing; Wang, Chao			SIRT1 facilitates primordial follicle recruitment independent of deacetylase activity through directly modulating Akt1 and mTOR transcription	FASEB JOURNAL			English	Article						primordial follicle activation; ovary; in vitro activation; resveratrol	IN-VITRO ACTIVATION; PRIMARY OVARIAN INSUFFICIENCY; OOCYTES; STIMULATION; INFERTILITY; DISRUPTION; MATURATION; FERTILITY; INTERACTS; GROWTH	In female mammals, the majority of primordial follicles (PFs) are physiologically quiescent, and only a few of them are activated and enter the growing follicle pool. Specific molecules, such as mammalian target of rapamycin (mTOR) and the serine/threonine kinase Akt (AKT), have been proven to be important for PF activation. However, how the transcription of these genes is regulated is not clear. Although activators of mTOR or AKT have been successfully used to rescue the fertility of patients with premature ovarian insufficiency, the low efficacy and unclear safety profile of these drugs hinder their clinical use in the in vitro activation (IVA) of PFs. Here, sirtuin 1 (SIRT1), an NAD-dependent deacetylase, was demonstrated to activate mouse PFs independent of its deacetylase activity. SIRT1 was prominently expressed in pregranulosa cells (pGCs) and oocytes, and its expression was increased during PF activation. PF activation was achieved by either up-regulating SIRT1 with a specific activator or overexpressing SIRT1. Moreover, SIRT1 knockdown in oocytes or pGCs could significantly suppress PF activation. Further studies demonstrated that SIRT1 enhanced both Aka and mTOR expression by acting more as a transcription cofactor, directly binding to the respective gene promoters, than as a deacetylase. Importantly, we explored the potential clinical applications of targeting SIRT1 in IVA via short-term treatment of cultured ovaries from mice and human ovarian tissues to activate PFs by applying the SIRT1 activator resveratrol. RSV-induced IVA could be a candidate strategy to develop more efficient procedures for future clinical treatment of infertility.	[Zhang, Tuo; Du, Xinhua; Zhao, Lihua; He, Meina; Lin, Lin; Guo, Chuanhui; Zhang, Xinran; Han, Jun; Yan, Hao; Huang, Kun; Sun, Guanghong; Zhou, Bo; Xia, Guoliang; Wang, Chao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Zhao, Lihua] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Pathol & Hepatol, Beijing, Peoples R China; [Yan, Lei; Qin, YingYing] Shandong Univ, Ctr Reprod Med, Shandong Prov Hosp, Jinan 250021, Peoples R China; [Yan, Lei; Qin, YingYing] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Yan, Lei; Qin, YingYing] Shandong Univ, Key Lab Reprod Endocrinol, Minist Educ, Jinan, Peoples R China; [Yan, Lei; Qin, YingYing] Shandong Prov Key Lab Reprod Med, Jinan, Peoples R China; [Xia, Guoliang] Ningxia Univ, Western China Coll Life Sci, Minist Educ Conservat & Utilizat Special Biol Res, Key Lab, Yinchuan, Peoples R China	China Agricultural University; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Ningxia University	Wang, C (corresponding author), China Agr Univ, Ctr Life Sci, 2 Yuan Ming Yuan West Rd, Beijing 100193, Peoples R China.	qinyingying1006@163.com; wangcam@126.com		Yan, Hao/0000-0003-1468-6165	National Key Research and Developmental Program of China [2017YFC1001100]; National Basic Research Program of China [2014CB943202, 2013CB945501, 2014CB138503]; National Natural Science Foundation of China [31872792, 31371448, 31571540]; Beijing Natural Science Foundation [5182015, 7182090]; Project of State Key Laboratory of Agrobiotechnology [2015SKLAB4-1, 2016SKLAB-1]; Institution of Higher Education Projects of Building First-Class Discipline Construction in Ningxia Region (Biology) [NXYLXK2017B05]	National Key Research and Developmental Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Project of State Key Laboratory of Agrobiotechnology; Institution of Higher Education Projects of Building First-Class Discipline Construction in Ningxia Region (Biology)	The authors thank each member of the G.X. Laboratory for their valuable discussions, and Nature Research Editing Service for language revision. This study was supported by the National Key Research and Developmental Program of China (Grant 2017YFC1001100 to G.X.); the National Basic Research Pro-gram of China (Grants 2014CB943202 to C.W., 2013CB945501 to G.X., and 2014CB138503 to B.Z.); the National Natural Science Foundation of China (Grants 31872792 to C.W. and 31371448 and 31571540 to G.X.); the Beijing Natural Science Foundation (Grants 5182015 to C.W. and 7182090 to G.X.); the Project of State Key Laboratory of Agrobiotechnology (Grants 2015SKLAB4-1 to C.W. and 2016SKLAB-1 to G.X.); and the Institution of Higher Education Projects of Building First-Class Discipline Construction in Ningxia Region (Biology) (Grant NXYLXK2017B05 to G.X.). The authors declare no conflicts of interest.	Adhikari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039034; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Adhikari D, 2009, ENDOCR REV, V30, P438, DOI 10.1210/er.2008-0048; Bell EL, 2014, DEVELOPMENT, V141, P3495, DOI 10.1242/dev.110627; Bezerra MES, 2018, REPROD DOMEST ANIM, V53, P1298, DOI 10.1111/rda.13274; Bidet M, 2011, J CLIN ENDOCR METAB, V96, P3864, DOI 10.1210/jc.2011-1038; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003; Cordeiro CN, 2016, REPROD SCI, V23, P429, DOI 10.1177/1933719115625842; Gorre N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110491; Guo J, 2018, P NATL ACAD SCI USA, V115, pE5326, DOI 10.1073/pnas.1800352115; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Kawamura K, 2016, CURR OPIN OBSTET GYN, V28, P217, DOI 10.1097/GCO.0000000000000268; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Ladanyi C, 2017, J ASSIST REPROD GEN, V34, P709, DOI 10.1007/s10815-017-0899-1; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Liu C, 2017, DEVELOPMENT, V144, P441, DOI 10.1242/dev.147074; Liu K, 2006, DEV BIOL, V299, P1, DOI 10.1016/j.ydbio.2006.07.038; Liu MJ, 2018, FERTIL STERIL, V109, P900, DOI 10.1016/j.fertnstert.2018.01.020; Liu MY, 2013, HUM REPROD, V28, P707, DOI 10.1093/humrep/des437; Liu WJ, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0114-8; Long GY, 2019, GENE, V686, P194, DOI 10.1016/j.gene.2018.10.040; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; PEDERSEN T, 1970, J REPROD FERTIL, V21, P81, DOI 10.1530/jrf.0.0210081; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Qin YY, 2015, HUM REPROD UPDATE, V21, P787, DOI 10.1093/humupd/dmv036; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sun XH, 2015, CELL CYCLE, V14, P721, DOI 10.1080/15384101.2014.995496; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Suzuki S, 2018, MOL CELL ENDOCRINOL, V461, P178, DOI 10.1016/j.mce.2017.09.012; Tatone C, 2018, HUM REPROD UPDATE, V24, P267, DOI 10.1093/humupd/dmy003; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang C, 2017, CELL MOL LIFE SCI, V74, P2547, DOI 10.1007/s00018-017-2480-6; Wang XQ, 2016, WOMENS HEALTH, V12, P275, DOI 10.2217/whe-2016-0019; Yan H, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0541-4; Yin O, 2016, J CLIN ENDOCR METAB, V101, P3568, DOI 10.1210/jc.2016-2837; Zhai J, 2016, J CLIN ENDOCR METAB, V101, P4405, DOI 10.1210/jc.2016-1589; Zhang H, 2015, HUM REPROD UPDATE, V21, P779, DOI 10.1093/humupd/dmv037; Zhang H, 2014, CURR BIOL, V24, P2501, DOI 10.1016/j.cub.2014.09.023; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang M, 2017, FRONT IMMUNOL, V8, P1, DOI 10.3389/fimmu.2017.00942; Zhou XL, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0097-z	49	20	25	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14703	14716		10.1096/fj.201900782R	http://dx.doi.org/10.1096/fj.201900782R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31693862	Bronze			2022-12-26	WOS:000507466100126
J	van der Westhuizen, C; Myers, B; Malan, M; Naledi, T; Roelofse, M; Stein, DJ; Lahri, S; Sorsdahl, K				van der Westhuizen, Claire; Myers, Bronwyn; Malan, Megan; Naledi, Tracey; Roelofse, Marinda; Stein, Dan J.; Lahri, Sa'ad; Sorsdahl, Katherine			Implementation of a screening, brief intervention and referral to treatment programme for risky substance use in South African emergency centres: A mixed methods evaluation study	PLOS ONE			English	Article							HEALTH-SERVICES; SBIRT IMPLEMENTATION; CARE; MISUSE; FACILITATORS; METAANALYSIS; DISORDERS; FRAMEWORK; BARRIERS; CONTEXT	Background Screening, brief intervention, and referral to treatment (SBIRT) for risky substance use is infrequently included in routine healthcare in low-resourced settings. A SBIRT programme, adopted by the Western Cape provincial government within an alcohol harm reduction strategy, employed various implementation strategies executed by a diverse team to translate an evidence-based intervention into services at three demonstration sites before broader programme scale-up. This paper evaluates the implementation of this programme delivered by facility-based counsellors in South African emergency centres. Method Guided by the Consolidated Framework for Implementation Research, this mixed methods study evaluated the feasibility, acceptability, appropriateness and adoption of this task-shared SBIRT programme. Quantitative data were extracted from routinely collected health information. Qualitative interviews were conducted with 40 stakeholders in the programme's second year. Results In the first year, 13 136 patients were screened and 4 847 (37%) patients met criteria for risky substance use. Of these patients, 83% received the intervention, indicating programme feasibility. The programme was adopted into routine services and found to be acceptable and appropriate, particularly by stakeholders familiar with the emergency environment. These stakeholders highlighted the burden of substance-related harm in emergency centres and favourable patient responses to SBIRT. However, some stakeholders expressed scepticism of the behaviour change approach and programme compatibility with emergency centre operations. Furthermore, adoption was both facilitated and hampered by a top-down directive from provincial leadership to implement SBIRT, while rapid implementation limited effective engagement with a diverse stakeholder group. Conclusion This is one of the first studies to address SBIRT implementation in low-resourced settings. The results show that SBIRT implementation and adoption was largely successful, and provide valuable insights that should be considered prior to implementation scale-up. Recommendations include ensuring ongoing monitoring and evaluation, and early stakeholder engagement to improve implementation readiness and programme compatibility in the emergency setting.	[van der Westhuizen, Claire; Malan, Megan; Sorsdahl, Katherine] Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, Cape Town, South Africa; [Myers, Bronwyn] South African Med Res Council, Alcohol Tobacco & Other Drug Res Unit, Cape Town, South Africa; [Myers, Bronwyn] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [Naledi, Tracey; Roelofse, Marinda] Western Cape Dept Hlth, Cape Town, South Africa; [Naledi, Tracey] Univ Cape Town, Sch Publ Hlth Med & Family Med, Cape Town, South Africa; [Stein, Dan J.] Univ Cape Town, Dept Psychiat, SA MRC Unit Risk Resilience Mental Disorders, Cape Town, South Africa; [Stein, Dan J.] Univ Cape Town, Neurosci Inst, SA MRC Unit Risk Resilience Mental Disorders, Cape Town, South Africa; [Lahri, Sa'ad] Univ Stellenbosch, Dept Emergency Med, Stellenbosch, South Africa; [Lahri, Sa'ad] Khayelitsha Hosp, Emergency Serv, Cape Town, South Africa	University of Cape Town; South African Medical Research Council; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; Stellenbosch University	van der Westhuizen, C (corresponding author), Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, Cape Town, South Africa.	claire.vanderwesthuizen@uct.ac.za	Sorsdahl, Katherine/AAQ-6161-2020; Naledi, Tracey/AAR-6791-2021; Lahri, Sa'ad/ABB-2704-2021; Myers, Bronwyn/AAT-7788-2021; Stein, Dan/A-1752-2008; van der Westhuizen, Claire/ABI-8363-2020	Sorsdahl, Katherine/0000-0002-5517-1697; Naledi, Tracey/0000-0002-7039-9964; Lahri, Sa'ad/0000-0002-4012-4097; Myers, Bronwyn/0000-0003-0235-6716; Stein, Dan/0000-0001-7218-7810; van der Westhuizen, Claire/0000-0002-2138-8978	DELTAS Africa Initiative [DEL-15-01]; African Academy of Sciences - Wellcome Trust; Western Cape Office of the Premier	DELTAS Africa Initiative; African Academy of Sciences - Wellcome Trust; Western Cape Office of the Premier	CvdW received research funding via a postdoctoral fellowship award via the DELTAS Africa Initiative [DEL-15-01], African Academy of Sciences (https://www.aasciences.ac.ke/), funded by the Wellcome Trust (https://wellcome.ac.uk/).KS recieved funding from the Western Cape Office of the Premier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, TASK SHIFT GLOB REC; Areesantichai Chitlada, 2010, Journal of the Medical Association of Thailand, V93, P992; Assanangkornchai S, 2013, PUBLIC HEALTH, V127, P1140, DOI 10.1016/j.puhe.2013.08.011; Babor TF, 2005, J TRAUMA, V59, pS80, DOI 10.1097/01.ta.0000174664.88603.21; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Babor TF, 2017, ADDICTION, V112, P110, DOI 10.1111/add.13675; Barata IA, 2017, WEST J EMERG MED, V18, P1143, DOI 10.5811/westjem.2017.7.34373; Bernstein Edward, 2007, Subst Abus, V28, P79, DOI 10.1300/J465v28n04_01; Bernstein SL, 2009, ACAD EMERG MED, V16, P1054, DOI 10.1111/j.1553-2712.2009.00564.x; Birken S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0843-5; Brooke-Sumner C, 2019, HEALTH POLICY PLANN, V34, P132, DOI 10.1093/heapol/czz017; Bunbury N., 2013, Aliens: The Invasive Species Bulletin, P18; Cruvinel E, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-4; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Del Boca FK, 2017, ADDICTION, V112, P12, DOI 10.1111/add.13656; Department of Health Republic of South Africa, 2013, NATL MENTAL HLTH POL; Derges J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4476-4; Elzerbi C, 2015, ADDICTION, V110, P1082, DOI 10.1111/add.12960; Geerligs L, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0726-9; Gentilello L, 2005, J TRAUMA, V59, pS94, DOI 10.1097/01.ta.0000177256.55277.23; Hanson WE, 2005, J COUNS PSYCHOL, V52, P224, DOI 10.1037/0022-0167.52.2.224; Hargraves D, 2017, PUBLIC HEALTH REV, V38, DOI 10.1186/s40985-017-0077-0; Herman AA, 2009, SAMJ S AFR MED J, V99, P339; Higgins-Biddle J, 2009, SCREENING BRIEF INTE; Hoeft TJ, 2018, J RURAL HEALTH, V34, P48, DOI 10.1111/jrh.12229; Johnson M, 2011, J PUBLIC HEALTH-UK, V33, P412, DOI 10.1093/pubmed/fdq095; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Kaiser DJ, 2016, J SUBST ABUSE TREAT, V60, P21, DOI 10.1016/j.jsat.2015.08.001; Kirk MA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0437-z; Li SA, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0734-5; Mendel P, 2008, ADM POLICY MENT HLTH, V35, P21, DOI 10.1007/s10488-007-0144-9; Mitchell SG, 2016, J SUBST ABUSE TREAT, V60, P81, DOI 10.1016/j.jsat.2015.06.011; Myers B, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024277; Myers B, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2568-9; Nilsen P, 2008, NORD STUD ALCOHOL DR, V25, P453, DOI DOI 10.1177/145507250802500608; Nilsen P, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4015-3; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; Parry CDH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-500; Peltzer K, 2008, CROAT MED J, V49, P392, DOI 10.3325/cmj.2008.3.392; Peltzer K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-699; Pengpid S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-644; Pillay-van Wyk V, 2016, LANCET GLOB HEALTH, V4, pE642, DOI 10.1016/S2214-109X(16)30113-9; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Proctor EK, 2009, ADM POLICY MENT HLTH, V36, P24, DOI 10.1007/s10488-008-0197-4; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Ronzani Telmo Mota, 2009, Rev. Saúde Pública, V43, P51; Rosen CS, 2016, ADM POLICY MENT HLTH, V43, P957, DOI 10.1007/s10488-016-0755-0; Schmidt CS, 2016, ADDICTION, V111, P783, DOI 10.1111/add.13263; Sorsdahl K, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0042-1; Sorsdahl K, 2015, COMMUNITY MENT HLT J, V51, P962, DOI 10.1007/s10597-015-9853-9; Stetler CB, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-8; Van Der Westhuizen C, 2016, DRUG ALCOHOL REV, V35, P702, DOI 10.1111/dar.12424; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Vellios NG, 2018, SAMJ S AFR MED J, V108, P33, DOI [10.7196/SAMJ.2018.v108i1.12615, 10.7196/samj.2018.v108i1.12615, 10.7196/SAMJ.2017.v108i1.12615]; Vendetti J, 2017, ADDICTION, V112, P23, DOI 10.1111/add.13652; Ward CL, 2015, ALCOHOL ALCOHOLISM, V50, P302, DOI 10.1093/alcalc/agv007; Western Cape Government: Department of the Premier, 2014, PROV STRAT PLAN 2014; Williams EC, 2016, J SUBST ABUSE TREAT, V60, P27, DOI 10.1016/j.jsat.2015.07.011; World Health Organization, 2010, GLOB STRAT RED HARMF; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization, 2018, AIR POLL CHILD HLTH; World Health Organization, 2018, GLOB HLTH OBS GHO DA; Xi JT, 2012, J NANOPHOTONICS, V6, DOI 10.1117/1.JNP.6.063519; Young MM, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-50; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492	66	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224951	10.1371/journal.pone.0224951	http://dx.doi.org/10.1371/journal.pone.0224951			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2YM	31730623	Green Published, gold			2022-12-26	WOS:000532809500015
J	Didone, V; van Ingelgom, T; Tirelli, E; Quertemont, E				Didone, Vincent; van Ingelgom, Theo; Tirelli, Ezio; Quertemont, Etienne			Long-term exposure to daily ethanol injections in DBA/2J and Swiss mice: Lessons for the interpretation of ethanol sensitization	PLOS ONE			English	Article							INDUCED BEHAVIORAL SENSITIZATION; CONDITIONED PLACE PREFERENCE; NUCLEUS-ACCUMBENS; LOCOMOTOR SENSITIZATION; NEURAL BASIS; TIME-COURSE; EXPRESSION; ADOLESCENT; ALCOHOL; BINDING	Most mice ethanol sensitization studies focused on neurobiology at the expense of its behavioral characterization. Furthermore, relatively short ethanol exposures (10 to 20 injections) were used in these studies. The first aim of the present study is to better characterize the development and expression of ethanol sensitization after an extended exposure of 45 daily injections. In some previous studies, mice were classified as "respondent" and "resistant" to ethanol sensitization. The second aim of the present study is to test the long-term reliability of such categorizations and the consequences of their use on the interpretation of the ethanol sensitization results. Swiss and DBA/2J female mice received 45 consecutive daily ethanol administrations (respectively 2.5 and 2.0 g/kg) and their locomotor activity was daily recorded to test the development of ethanol sensitization. At the end of the procedure, a challenge test assessed the inter-group ethanol sensitization.The results of the present study show that ethanol sensitization continues to develop beyond 20 days to reach maximal levels after about 25 injections in DBA/2J mice and 40 injections in Swiss mice, although the core phase of the development of ethanol sensitization occurred in both strains during the first 20 days. Remarkably, ethanol sensitization after such a long daily ethanol treatment resulted in both an upward shift of the magnitude of ethanol stimulant effects and a prolongation of these effects in time (up to 30 minutes). Mice classified as "resistant to ethanol sensitization" according to previous studies developed very significant levels of ethanol sensitization when tested after 45 ethanol injections and are best described as showing a delayed development of ethanol sensitization. Furthermore, mice classified as respondent or resistant to ethanol sensitization also differ in their acute response to ethanol, such that it is difficult to ascertain whether these classifications are specifically related to the sensitization process.	[Didone, Vincent; van Ingelgom, Theo; Tirelli, Ezio; Quertemont, Etienne] Univ Liege, Psychol & Neurosci Cognit Res Unit PsyNCog, Anim Models Cognit, Liege, Belgium	University of Liege	Quertemont, E (corresponding author), Univ Liege, Psychol & Neurosci Cognit Res Unit PsyNCog, Anim Models Cognit, Liege, Belgium.	equertemont@uliege.be	Quertemont, Etienne/AGQ-2658-2022	Quertemont, Etienne/0000-0002-9859-0779				Abrahao KP, 2008, NEUROSCIENCE, V156, P857, DOI 10.1016/j.neuroscience.2008.08.012; Abrahao KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098296; Abrahao KP, 2013, J NEUROSCI, V33, P4834, DOI 10.1523/JNEUROSCI.5839-11.2013; Abrahao KP, 2012, BEHAV BRAIN RES, V235, P218, DOI 10.1016/j.bbr.2012.07.034; Abrahao KP, 2012, NEUROPHARMACOLOGY, V62, P882, DOI 10.1016/j.neuropharm.2011.09.017; Abrahao KP, 2009, BEHAV BRAIN RES, V197, P404, DOI 10.1016/j.bbr.2008.10.009; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Araujo NP, 2006, PHARMACOL BIOCHEM BE, V84, P142, DOI 10.1016/j.pbb.2006.04.019; Botia B, 2015, ALCOHOL CLIN EXP RES, V39, P45, DOI 10.1111/acer.12595; Botia B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047527; Brabant C, 2005, PSYCHOPHARMACOLOGY, V180, P33, DOI 10.1007/s00213-004-2138-6; Brabant C, 2011, BEHAV BRAIN RES, V221, P227, DOI 10.1016/j.bbr.2011.02.040; Camarini R, 2016, BRAIN RES BULL, V125, P53, DOI 10.1016/j.brainresbull.2016.04.006; Camarini Rosana, 2010, Curr Drug Abuse Rev, V3, P205; Ceyhan M, 2005, J PSYCHIATR RES, V39, P191, DOI 10.1016/j.jpsychires.2004.06.002; Coune F, 2017, SYNAPSE, V71, DOI 10.1002/syn.21899; de Araujo NP, 2009, PHYSIOL BEHAV, V96, P12, DOI 10.1016/j.physbeh.2008.07.029; Didone V, 2008, PSYCHOPHARMACOLOGY, V201, P249, DOI 10.1007/s00213-008-1266-9; Didone V, 2016, BEHAV PHARMACOL, V27, P173, DOI 10.1097/FBP.0000000000000161; DURCAN MJ, 1988, PSYCHOPHARMACOLOGY, V96, P67, DOI 10.1007/BF02431535; Faria RR, 2008, BRAIN RES, V1239, P127, DOI 10.1016/j.brainres.2008.08.056; Ferreira SE, 2013, PHARMACOL BIOCHEM BE, V110, P245, DOI 10.1016/j.pbb.2013.07.014; HUNT WA, 1992, ALCOHOL, V9, P327, DOI 10.1016/0741-8329(92)90075-L; Irwin JR, 2003, J MARKETING RES, V40, P366, DOI 10.1509/jmkr.40.3.366.19237; Itzhak Y, 2000, BRAIN RES, V858, P402, DOI 10.1016/S0006-8993(00)01940-5; Itzhak Y, 2008, ALCOHOL CLIN EXP RES, V32, P1839, DOI 10.1111/j.1530-0277.2008.00766.x; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Legastelois R, 2014, ADDICT BIOL, V19, P210, DOI 10.1111/adb.12104; Legastelois R, 2013, ALCOHOL CLIN EXP RES, V37, P1143, DOI 10.1111/acer.12088; LEWIS MJ, 1990, ALCOHOL, V7, P213, DOI 10.1016/0741-8329(90)90007-Y; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; MASUR J, 1986, PHARMACOL BIOCHEM BE, V24, P1225, DOI 10.1016/0091-3057(86)90175-9; MASUR J, 1980, PHARMACOL BIOCHEM BE, V13, P777, DOI 10.1016/0091-3057(80)90206-3; Meyer PJ, 2003, BEHAV NEUROSCI, V117, P641, DOI 10.1037/0735-7044.117.3.641; NEWLIN DB, 1990, PSYCHOL BULL, V108, P383, DOI 10.1037/0033-2909.108.3.383; Newlin DB, 1999, EXP CLIN PSYCHOPHARM, V7, P234, DOI 10.1037/1064-1297.7.3.234; Nona CN, 2018, BEHAV BRAIN RES, V336, P269, DOI 10.1016/j.bbr.2017.09.024; Nona CN, 2016, PHARMACOL BIOCHEM BE, V142, P15, DOI 10.1016/j.pbb.2015.12.006; Nona CN, 2015, SYNAPSE, V69, P607, DOI 10.1002/syn.21862; Nona CN, 2014, BEHAV BRAIN RES, V260, P58, DOI 10.1016/j.bbr.2013.11.037; Nona CN, 2013, BEHAV BRAIN RES, V242, P25, DOI 10.1016/j.bbr.2012.12.035; Pildervasser JVN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00267; Post R M, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p650A; Procopio-Souza R, 2011, DRUG ALCOHOL DEPEN, V118, P349, DOI 10.1016/j.drugalcdep.2011.04.017; Quadros IMH, 2005, ALCOHOL, V37, P99, DOI 10.1016/j.alcohol.2005.12.001; Quadros IMH, 2003, BEHAV PHARMACOL, V14, P129, DOI 10.1097/00008877-200303000-00004; Quadros IMH, 2002, ADDICT BIOL, V7, P291, DOI 10.1080/13556210220139505; Quadros IMH, 2002, EUR J PHARMACOL, V442, P55, DOI 10.1016/S0014-2999(02)01503-0; Quoilin C, 2012, BEHAV BRAIN RES, V229, P1, DOI 10.1016/j.bbr.2011.12.039; Quoilin C, 2012, PSYCHOPHARMACOLOGY, V219, P1165, DOI 10.1007/s00213-011-2453-7; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Sershen H, 2002, GENES BRAIN BEHAV, V1, P156, DOI 10.1034/j.1601-183X.2002.10303.x; SMOOTHY R, 1985, PSYCHOPHARMACOLOGY, V85, P57, DOI 10.1007/BF00427322; Souza-Formigoni MLO, 1999, PSYCHOPHARMACOLOGY, V146, P262, DOI 10.1007/s002130051115; Vanderschuren LJMJ, 2010, CURR TOP BEHAV NEURO, V3, P179, DOI 10.1007/7854_2009_21	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0214696	10.1371/journal.pone.0214696	http://dx.doi.org/10.1371/journal.pone.0214696			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721780	Green Published, Green Submitted, gold			2022-12-26	WOS:000532720700001
J	Gao, HM; Wang, C; Zhang, RX; Wu, HY; Sun, SH; Xiao, DJ; Wang, YS; Zhang, MX				Gao, Hongmei; Wang, Chang; Zhang, Ruxia; Wu, Hanyang; Sun, Shanhui; Xiao, Dongjie; Wang, Yunshan; Zhang, Maoxiu			Application of CPI cutoff value based on parentage testing of duos and trios typed by four autosomal kits	PLOS ONE			English	Article							PATERNITY; LOCI; MUTATIONS; MARKERS; DNA	In this study, we analyzed the application of four autosomal kits and the sensitivity of the combined paternity index (CPI) cutoff value (CPI>10000) in parentage testing. First, 1442 real trios and 803 real duos were tested using the Goldeneye 25A kit. The Goldeneye 25A kit covers the autosomal short tandem repeat (STR) loci of the other three kits, so we calculated the CPI value of every case for the four kits. Second, three complex close relative kinship cases were also analyzed to evaluate the application of the CPI cutoff value. The CPI values of all trio cases were higher than 10000 using the four kits; the CPI values of all duo cases were higher than 10000 using the Goldeneye 25A kit; and the CPI values of a portion of the duo cases were lower than 10000 using the other three kits. In the three complex close relative cases, the alleged father or mother was not excluded using 40 autosomal STRs. Adding X chromosome short tandem repeats (X-STR) and samples of biological fathers or mothers, the conclusions were confirmed. The four kits were adequate to draw conclusions in the trio cases; the Goldeneye 25A Kit was adequate to draw conclusions in the duo cases; and the other three kits were not sufficient for a portion of the duo cases. The CPI cutoff value was sensitive for real trio and duo cases. In complex close relative kinship cases, high CPI values may result in false conclusions.	[Gao, Hongmei; Wang, Chang; Sun, Shanhui; Xiao, Dongjie; Wang, Yunshan; Zhang, Maoxiu] Shandong Univ, Jinan Cent Hosp, Jinan, Shandong, Peoples R China; [Gao, Hongmei; Wang, Chang; Sun, Shanhui; Xiao, Dongjie; Wang, Yunshan; Zhang, Maoxiu] Jinan Cent Hosp, Jinan Dien Forens Inst, Jinan, Shandong, Peoples R China; [Zhang, Ruxia] Shandong Med Coll, Dept Nursing, Jinan, Shandong, Peoples R China; [Wu, Hanyang] Shandong Univ, Cheeloo Coll Med, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhang, MX (corresponding author), Shandong Univ, Jinan Cent Hosp, Jinan, Shandong, Peoples R China.; Zhang, MX (corresponding author), Jinan Cent Hosp, Jinan Dien Forens Inst, Jinan, Shandong, Peoples R China.	zhangmaoxiujn@126.com		Chang, Wang/0000-0003-2959-3818; Zhang, Maoxiu/0000-0002-9794-4619				Birus I, 2003, CROAT MED J, V44, P322; Dogan M, 2015, MOL BIOL REP, V42, P1025, DOI 10.1007/s11033-014-3839-5; Gao H M, 2018, Fa Yi Xue Za Zhi, V34, P405, DOI 10.12116/j.issn.1004-5619.2018.04.013; Hallenberg C, 2001, FORENSIC SCI INT, V116, P23, DOI 10.1016/S0379-0738(00)00351-0; Katsumata Y, 2001, Nihon Hoigaku Zasshi, V55, P205; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Lee HS, 2000, FORENSIC SCI INT, V114, P57, DOI 10.1016/S0379-0738(00)00293-0; Li Chengtao, 2016, SPECIFICATION PARENT; Liu QL, 2018, LEGAL MED-TOKYO, V35, P73, DOI 10.1016/j.legalmed.2018.09.012; Szibor R, 2003, INT J LEGAL MED, V117, P67, DOI 10.1007/s00414-002-0352-5; Szibor R, 2007, FORENSIC SCI INT-GEN, V1, P93, DOI 10.1016/j.fsigen.2007.03.003; Tong DY, 2010, ANN HUM BIOL, V37, P820, DOI 10.3109/03014461003660096; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wenk RE, 2006, TRANSFUSION, V46, P199, DOI 10.1111/j.1537-2995.2006.00701.x; Xiao C, 2019, INT J LEGAL MED, V133, P999, DOI 10.1007/s00414-018-1900-y; Zhang Mao-Xiui, 2013, Fa Yi Xue Za Zhi, V29, P440	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225174	10.1371/journal.pone.0225174	http://dx.doi.org/10.1371/journal.pone.0225174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721797	gold, Green Published			2022-12-26	WOS:000532720700042
J	Belmar, M; Aly, S; Karle, BM; Pereira, RV				Belmar, Marlene; Aly, Sharif; Karle, Betsy M.; Pereira, Richard, V			Evaluation of four commercial tests for detecting ceftiofur in waste milk bulk tank samples	PLOS ONE			English	Article							SPECIFICITY RATES; RESIDUE; COWS; LACTOFERRIN; VALIDATION	The objective of this study was to identify factors affecting the accuracy of four commercial tests for ceftiofur drug residue in milk samples from bulk tank waste milk (WM). WM samples were collected from 12 California dairy farms which were initially tested using liquid chromatography (LC-MS/MS) to confirm their negative status for drug residues above the FDA established tolerance/safe levels. The milk samples were also tested for fat, protein, lactose, solids non-fat (SNF), somatic cell count (SCC), coliform count, and standard plate count (SPC). Each WM sample was divided into two aliquots, one labeled as negative for drug residues (WMN) and the second spiked with ceftiofur as positive for ceftiofur residues (WMPos). Both types of WM samples were tested to evaluate the performance of 4 commercially available tests: Penzyme (R) Milk Test, SNAP (R) beta-lactam, BetaStar (R) Plus and Delvo SP-NT (R). Three assays in triplicates for the WMN and WMPos were conducted for each WM sample. Test were evaluated using sensitivity, specificity, positive predictive value, negative predictive value and positive likelihood ratio. Kruskal-Wallis method was used to evaluate the effect of milk quality parameters on true positive (TP) and false negative (FN) test results. All WMPos samples were identified as positive by all four tests, rendering 100% sensitivity for each test. The specificity for Penzyme, BetaStar, Delvo, and SNAP tests were 59.2, 55.5, 44.4, and 29.6, respectively. Overall, all tests correctly identified samples with ceftiofur residues (WMPos), as shown by 100% sensitivity. Greater variability was observed regarding identification of samples free of any drug residue, with Penzyme and BetaStar having the highest risk for correctly identifying TN samples. Our findings indicate that when selecting commercial tests to detect drug residues in WM, milk quality parameters must be considered if the aim is to reduce FP test results.	[Belmar, Marlene; Pereira, Richard, V] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Aly, Sharif] Univ Calif Davis, Vet Med Teaching & Res Ctr, Sch Vet Med, Tulare, CA USA; [Karle, Betsy M.] Univ Calif, Div Agr & Nat Resources, Cooperat Extens, Orland, CA USA; [Pereira, Richard, V] Univ Calif Davis, One Shield, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Pereira, RV (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.; Pereira, RV (corresponding author), Univ Calif Davis, One Shield, Davis, CA 95616 USA.	rvpereira@ucdavis.edu	Aly, Sharif S./J-6586-2019; Karle, Betsy/GNP-3081-2022; Pereira, Richard/L-2684-2019	Aly, Sharif S./0000-0003-0330-5013; Pereira, Richard/0000-0003-2028-8761	U.S. Department of Agriculture [CA-V-PHR-4708-AH408]; University of California, Davis, Division of Agriculture and Natural Resources [1753]	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); University of California, Davis, Division of Agriculture and Natural Resources	Funding is provided by U.S. Department of Agriculture Project number CA-V-PHR-4708-AH408 and University of California, Davis, Division of Agriculture and Natural Resources (Grant #1753). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew SM, 2001, J DAIRY SCI, V84, P100, DOI 10.3168/jds.S0022-0302(01)74457-8; Andrew SM, 2000, J DAIRY SCI, V83, P2992, DOI 10.3168/jds.S0022-0302(00)75200-3; CARLSSON A, 1989, J DAIRY SCI, V72, P3166, DOI 10.3168/jds.S0022-0302(89)79475-3; CDFA CDoFaA, 2017, CAL DAIR STAT ANN 20; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Durel L, 2019, VET RECORD OPEN, V6, DOI 10.1136/vetreco-2018-000329; FDA, 2018, M A 85 REV 16 BET LA; FDA, 2012, M A 85 REV 14 BET LA; FDA, 2018, M I 18 9 TOL TARG TE; FDA, TITL 21 FOOD DRU 573; FDA, 2016, BET LACT OTH TEST ME; Gibbons-Burgener SN, 2001, AM J VET RES, V62, P1716, DOI 10.2460/ajvr.2001.62.1716; HARMON RJ, 1975, AM J VET RES, V36, P1001; Hillerton JE, 1999, J DAIRY SCI, V82, P704, DOI 10.3168/jds.S0022-0302(99)75287-2; Kang JH, 2005, J DAIRY SCI, V88, P908, DOI 10.3168/jds.S0022-0302(05)72757-0; Love WJ, 2016, J DAIRY SCI, V99, P1483, DOI 10.3168/jds.2015-9394; Navratilova P, 2008, SCREENING METHODS US, V26; Neogen, PENZ MILK TEST; Pereira RV, 2014, J DAIRY SCI, V97, P1513, DOI 10.3168/jds.2013-7421; Pereira RV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147525; Pereira RV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115223; Reybroeck W, 2010, FOOD ADDIT CONTAM A, V27, P1084, DOI 10.1080/19440041003724871; Ricci A, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4665; Stead SL, 2008, INT DAIRY J, V18, P3, DOI 10.1016/j.idairyj.2007.06.006; Tempini PN, 2018, J DAIRY SCI, V101, P8110, DOI 10.3168/jds.2018-14398; U.S. FDA, 2017, GRAD A PAST MILK ORD; USDA, 2016, DAIR CATTL MAN PRACT; VANEENENNAAM AL, 1993, J DAIRY SCI, V76, P3041, DOI 10.3168/jds.S0022-0302(93)77644-4	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224884	10.1371/journal.pone.0224884	http://dx.doi.org/10.1371/journal.pone.0224884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714908	Green Published, gold			2022-12-26	WOS:000532710400018
J	de Melo, CM; Terada, K				de Melo, Celso M.; Terada, Kazunori			Cooperation with autonomous machines through culture and emotion	PLOS ONE			English	Article							DECISION-MAKING; NEURAL BASIS; BIAS; RACE	As machines that act autonomously on behalf of others-e.g., robots-become integral to society, it is critical we understand the impact on human decision-making. Here we show that people readily engage in social categorization distinguishing humans ("us") from machines ("them"), which leads to reduced cooperation with machines. However, we show that a simple cultural cue-the ethnicity of the machine's virtual face-mitigated this bias for participants from two distinct cultures (Japan and United States). We further show that situational cues of affiliative intent-namely, expressions of emotion-overrode expectations of coalition alliances from social categories: When machines were from a different culture, participants showed the usual bias when competitive emotion was shown (e.g., joy following exploitation); in contrast, participants cooperated just as much with humans as machines that expressed cooperative emotion (e.g., joy following cooperation). These findings reveal a path for increasing cooperation in society through autonomous machines.	[de Melo, Celso M.] US Army Res Lab, CCDC, Playa Vista, CA 90094 USA; [Terada, Kazunori] Gifu Univ, Gifu, Yanagido, Japan	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); Gifu University	de Melo, CM (corresponding author), US Army Res Lab, CCDC, Playa Vista, CA 90094 USA.	celso.miguel.de.melo@gmail.com	Terada, Kazunori/AAX-6722-2020	Terada, Kazunori/0000-0002-8728-0943; de Melo, Celso/0000-0003-2680-8334	JSPS KAKENHI [JP16KK0004]; US Army	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); US Army(United States Department of DefenseUnited States Army)	This research was supported by JSPS KAKENHI Grant Number JP16KK0004 [KT], and the US Army. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axt JR, 2016, SOC COGNITION, V34, P1; Aylett R, 2012, EMOT REV, V4, P253, DOI 10.1177/1754073912439766; Balliet D, 2014, PSYCHOL BULL, V140, P1556, DOI 10.1037/a0037737; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; BETANCOURT H, 1993, AM PSYCHOL, V48, P629, DOI 10.1037/0003-066X.48.6.629; Bonnefon JF, 2016, SCIENCE, V352, P1573, DOI 10.1126/science.aaf2654; Brett JM, 1998, ACAD MANAGE J, V41, P495, DOI 10.2307/256938; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; Crisp RJ, 2007, ADV EXP SOC PSYCHOL, V39, P163, DOI 10.1016/S0065-2601(06)39004-1; Damasio A.R., 2005, DESCARTES ERROR EMOT; De Melo C, 2016, ACM T COMPUT-HUM INT, V23, DOI 10.1145/2890495; de Melo CM, 2019, P NATL ACAD SCI USA, V116, P3482, DOI 10.1073/pnas.1817656116; de Melo CM, 2014, J PERS SOC PSYCHOL, V106, P73, DOI 10.1037/a0034251; Dovidio JF, 2000, PSYCHOL SCI, V11, P315, DOI 10.1111/1467-9280.00262; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; Frank R., 2004, FEELINGS EMOTIONS AM, P422, DOI [10.1017/cbo9780511806582.024, DOI 10.1017/CBO9780511806582.024, 10.1017/CBO9780511806582.024]; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Goodman B, 2017, AI MAGAZINE      FAL, V2017, P51; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Khooshabeh P, 2017, AI SOC, V32, P9, DOI 10.1007/s00146-014-0568-1; Kircher T, 2009, NEUROSCI LETT, V454, P176, DOI 10.1016/j.neulet.2009.03.026; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Krach S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002597; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Marsella S., 2010, BLUEPRINT AFFECTIVE, P21; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Morris MW, 2000, RES ORGAN BEHAV, V22, P1, DOI 10.1016/S0191-3085(00)22002-9; Nass C, 1997, J APPL SOC PSYCHOL, V27, P864, DOI 10.1111/j.1559-1816.1997.tb00275.x; Nass C, 2000, EMBODIED CONVERSATIONAL AGENTS, P374; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pietraszewski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088534; Rau PLP, 2009, COMPUT HUM BEHAV, V25, P587, DOI 10.1016/j.chb.2008.12.025; Reeves B, 1996, CSLI PUBLICATIONS ST; RICHERSON P, 2016, BEHAV BRAIN SCI, V39, DOI DOI 10.1017/S0140525X1400106X; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Stone R, 2014, SCIENCE, V346, P178, DOI 10.1126/science.346.6206.178; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Terada K, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00724; Van Kleef GA, 2010, ADV EXP SOC PSYCHOL, V42, P45, DOI 10.1016/S0065-2601(10)42002-X; Waytz A, 2010, TRENDS COGN SCI, V14, P383, DOI 10.1016/j.tics.2010.05.006	42	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224758	10.1371/journal.pone.0224758	http://dx.doi.org/10.1371/journal.pone.0224758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710610	Green Published, gold			2022-12-26	WOS:000532699900018
J	Guo, ZZ; Tan, X; Pan, YF; Liu, X; Zhao, GZ; Wang, L; Peng, Z				Guo, Zizheng; Tan, Xi; Pan, Yufan; Liu, Xian; Zhao, Guozhen; Wang, Lin; Peng, Zhen			Contingent negative variation during a modified cueing task in simulated driving	PLOS ONE			English	Article							VISUAL INTERVENTION INFLUENCE; RUTTING MITIGATION; WILL REDUCE; MOTOR; CNV; INFORMATION; RELIABILITY; COMPONENTS; STABILITY; MODALITY	The obscured pedestrian-motor vehicle crash has become a serious danger to driving safety. The present study aims to investigate the contingent negative variation (CNV) during the anticipation of an obscured pedestrian-motor vehicle crash in simulated driving. We adopted two cueing tasks: (i) a traditional cognitive paradigm of cueing task that has been widely used to study anticipatory process, and (ii) a modified cueing task in simulated driving scenes, in which Electroencephalogram (EEG) signals of 32 participants were recorded to detect the CNV. Simulated car following and pedestrian crossing tasks were designed to measure anticipation-related driving behaviors. The results showed that both early and late CNVs were observed in two cueing tasks. The mean amplitude of the late CNV during a modified cueing task in simulated driving was significantly larger than that in a traditional cueing task, which was not the case for the early CNV potentials. In addition, both early and late CNVs elicited in simulated driving were significantly correlated with anticipatory driving behaviors (e.g., the minimum time to collision). These findings show that CNV potentials during the anticipation of an obscured pedestrian-motor vehicle crash might predict anticipation-related risky driving behaviors.	[Guo, Zizheng; Tan, Xi; Pan, Yufan; Liu, Xian; Wang, Lin] Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Peoples R China; [Guo, Zizheng; Tan, Xi; Pan, Yufan; Liu, Xian; Wang, Lin] Southwest Jiaotong Univ, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Peoples R China; [Guo, Zizheng; Tan, Xi; Pan, Yufan; Liu, Xian; Wang, Lin] Natl Dev & Reform Commiss, Natl Engn Lab Comprehens Transportat Big Date App, Beijing, Peoples R China; [Guo, Zizheng; Zhao, Guozhen] Inst Psychol, CAS Key Lab Behav Sci, Beijing, Peoples R China; [Peng, Zhen] Arizona State Univ, Sch Arts & Sci, Tempe, AZ USA	Southwest Jiaotong University; Southwest Jiaotong University; Arizona State University; Arizona State University-Tempe	Zhao, GZ (corresponding author), Inst Psychol, CAS Key Lab Behav Sci, Beijing, Peoples R China.	zhaogz@psych.ac.cn		Zhao, Guozhen/0000-0003-4438-5320	National Natural Science Foundation of China [31771226, 71601163]; National Key Research and Development Plan [2018YFC0831001]; Science and Technology Program of Sichuan Province [2019YFG0043]; Science and Technology Program of China Railway [2018F024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan; Science and Technology Program of Sichuan Province; Science and Technology Program of China Railway	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) #31771226 and #71601163, the National Key Research and Development Plan (http://www.most.gov.cn) #2018YFC0831001, the Science and Technology Program of Sichuan Province (http://kjt.sc.gov.cn) #2019YFG0043, and the Science and Technology Program of China Railway (http://www.china-railway.com.cn/) 2018F024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, LIFE MORNING NEWS; Arjona A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04526; Bluschke A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20484-0; Broyd SJ, 2012, J NEUROSCI METH, V209, P40, DOI 10.1016/j.jneumeth.2012.05.015; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Brunia CHM, 2011, CLIN NEUROPHYSIOL, V122, P858, DOI 10.1016/j.clinph.2010.12.039; Chai J, 2016, ACCIDENT ANAL PREV, V88, P159, DOI 10.1016/j.aap.2015.12.026; Chan E, 2010, TRANSPORT RES F-TRAF, V13, P343, DOI 10.1016/j.trf.2010.04.001; Chen FY, 2019, TUNN UNDERGR SP TECH, V88, P276, DOI 10.1016/j.tust.2019.03.013; CONNOR WH, 1969, J EXP PSYCHOL, V82, P310, DOI 10.1037/h0028181; Doecke S, 2012, P AUSTRALASIAN ROAD; Duma GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170370; Fisher DL, 2006, INJURY PREV, V12, P25, DOI 10.1136/ip.2006.012021; GAILLARD AWK, 1976, BIOL PSYCHOL, V4, P139, DOI 10.1016/0301-0511(76)90013-2; Garipelli G, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036014; Gheorghe L, 2013, INT C IEEE ENG MED B; IRWIN DA, 1966, ELECTROEN CLIN NEURO, V21, P538, DOI 10.1016/0013-4694(66)90172-6; Jermakian J. S., 2011, PRIMARY PEDESTRIAN C; Khaliliardali Z, 2012, INT C IEEE ENG MED B, DOI [10.1371/journal.pone.0170370, DOI 10.1371/JOURNAL.PONE.0170370]; Khaliliardali Z, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066006; Kirsch W, 2010, CLIN NEUROPHYSIOL, V121, P1285, DOI 10.1016/j.clinph.2010.02.151; Kropp P, 2000, APPL PSYCHOPHYS BIOF, V25, P33, DOI 10.1023/A:1009533405695; Lew E., 2012, FRONT NEUROENG, V5, P13, DOI [10.3389/fneng.2012.00013, DOI 10.3389/FNENG.2012.00013]; Leynes PA, 1998, INT J PSYCHOPHYSIOL, V31, P33, DOI 10.1016/S0167-8760(98)00032-4; Mai M, 2017, BEHAVIOUR, V61, P30; Muhrer E, 2010, 6 IFAC S ADV AUT CON; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Niazi IK, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066009; Park HS, 2013, ETRI J, V35, P1038, DOI 10.4218/etrij.13.2013.0041; Pradhan AK, 2009, ERGONOMICS, V52, P657, DOI 10.1080/00140130802550232; Pradhan AK, 2005, HUM FACTORS, V47, P840, DOI 10.1518/001872005775570961; Retting RA, 2003, AM J PUBLIC HEALTH, V93, P1456, DOI 10.2105/AJPH.93.9.1456; RITTER W, 1980, PSYCHOPHYSIOLOGY, V17, P222, DOI 10.1111/j.1469-8986.1980.tb00138.x; ROHRBAUGH JW, 1976, SCIENCE, V191, P1055, DOI 10.1126/science.1251217; RUCHKIN DS, 1986, ELECTROEN CLIN NEURO, V63, P445, DOI 10.1016/0013-4694(86)90127-6; Schevernels H, 2014, NEUROIMAGE, V84, P639, DOI 10.1016/j.neuroimage.2013.09.039; Shahar A, 2010, ACCIDENT ANAL PREV, V42, P1577, DOI 10.1016/j.aap.2010.03.016; Sheng P, 2018, ELECTRON ENG, V9, P118; Snyder M.B., 1971, PEDESTRIAN SAFETY ID; TECCE JJ, 1972, PSYCHOL BULL, V77, P73, DOI 10.1037/h0032177; van Boxtel GJM, 2004, J PSYCHOPHYSIOL, V18, P61, DOI 10.1027/0269-8803.18.23.61; van der Hulst M, 1999, ERGONOMICS, V42, P336, DOI 10.1080/001401399185694; VANBOXTEL GJM, 1994, BIOL PSYCHOL, V38, P37, DOI 10.1016/0301-0511(94)90048-5; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Weerts T C, 1973, Biol Psychol, V1, P1, DOI 10.1016/0301-0511(73)90010-0; Wu G, 2019, INT J PAVEMENT ENG, V20, P734, DOI 10.1080/10298436.2017.1334460; Yasuda K, 2011, CONSCIOUS COGN, V20, P912, DOI 10.1016/j.concog.2010.12.016; Zhao GZ, 2013, ACCIDENT ANAL PREV, V52, P19, DOI 10.1016/j.aap.2012.12.013; Zhu XY, 2019, INT J PAVEMENT ENG, V20, P573, DOI 10.1080/10298436.2017.1316646	49	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224966	10.1371/journal.pone.0224966	http://dx.doi.org/10.1371/journal.pone.0224966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710652	gold, Green Published			2022-12-26	WOS:000532699900032
J	Michowitz, Y; Klempfner, R; Shlomo, N; Goldenberg, I; Koren-Michowitz, M				Michowitz, Yoav; Klempfner, Robert; Shlomo, Nir; Goldenberg, Ilan; Koren-Michowitz, Maya			Thrombocytopenia and thrombocytosis are associated with different outcome in atrial fibrillation patients on anticoagulant therapy	PLOS ONE			English	Article							WARFARIN; MANAGEMENT	Background Information regarding the significance of platelet (PLT) count on outcome of atrial fibrillation (AF) patients who are treated with anticoagulants is limited. Methods We conducted a monocentric observational retrospective cohort study of AF patients treated with either warfarin (n = 6287) or non-vitamin K antagonist oral anticoagulants (NOACs) (n = 5240). Patient were divided into 3 subgroups; low, normal and high PLT for counts < 150 K/ mu l, 150-450 K/ mu l and > 450 K/ mu l, respectively. A multivariate Cox-regression was used to evaluate the association between PLT subgroups and clinical outcomes. Results During follow-up [median = 40.6 months (IQR 17.6-60)], mortality (HR 1.36, 95 CI 1.1-1.74, p = 0.01) and rate of myocardial infarction (MI) (HR 2.4, 95 CI 1.28-4.57, p = 0.007) were higher in patients with high compared to normal PLT. Transient ischemic attack or cerebrovascular accident (TIA/CVA) rate was lower in patients with low compared to normal PLT (HR 0.69, 95 CI 0.51-0.93, p = 0.02). A comparison between NOACs and warfarin demonstrated a significantly better clinical outcome for patients on NOACs in both the low (lower mortality rates) and normal PLT subgroup (lower mortality, TIA/CVA and systemic emboli rates). For patients on NOACs, low and high compared to normal PLT were associated with a higher combined outcome (HR 1.12, 95 CI 1-1.38, p = 0.047), and a higher systemic emboli rate (HR 7.07, 95 CI 1.66-30.25, p = 0.008), respectively. Conclusions Abnormal PLT count is associated with different clinical outcome of AF patients on anticoagulants. Further studies are needed in order assess whether PLT level should influence strategies of anticoagulation.	[Michowitz, Yoav] Shaare Zedek Med Ctr, Jesselson Integrated Heart Ctr, Dept Cardiol, Jerusalem, Israel; [Michowitz, Yoav; Klempfner, Robert; Shlomo, Nir; Koren-Michowitz, Maya] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Klempfner, Robert; Shlomo, Nir] Chaim Sheba Med Ctr, Leviev Heart Inst, Dept Cardiol, Tel Hashomer, Israel; [Goldenberg, Ilan] Univ Rochester, Med Ctr, Dept Med, Div Cardiol,Clin Cardiovasc Res Ctr, Rochester, NY 14642 USA; [Koren-Michowitz, Maya] Shamir Med Ctr Asaf Harofeh, Dept Hematol, Zerifin, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; University of Rochester; Shamir Medical Center (Assaf Harofeh)	Koren-Michowitz, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Koren-Michowitz, M (corresponding author), Shamir Med Ctr Asaf Harofeh, Dept Hematol, Zerifin, Israel.	korenm@shamir.gov.il		Koren-Michowitz, Maya/0000-0002-7223-328X	Eric and Sheila Samson Institute for Advanced Cardiovascular Clinical Research; Bayer; Pfizer	Eric and Sheila Samson Institute for Advanced Cardiovascular Clinical Research; Bayer(Bayer AG); Pfizer(Pfizer)	The study was supported by grants from the Eric and Sheila Samson Institute for Advanced Cardiovascular Clinical Research, Bayer and Pfizer. None of them was involved in data acquisition or preparation of the current manuscript.	Carrier M, 2019, NEW ENGL J MED, V380, P711, DOI 10.1056/NEJMoa1814468; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Ghoshal K, 2014, SCI WORLD J, DOI 10.1155/2014/781857; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hicks KA, 2018, J AM COLL CARDIOL; Janion-Sadowska A, 2018, J CARDIOVASC PHARM, V72, P153, DOI 10.1097/FJC.0000000000000607; January CT., 2019, J AM COLL CARDIOL, V2019, p104; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Koren-Michowitz M, 2017, ANN HEMATOL, V96, P87, DOI 10.1007/s00277-016-2826-4; Koupenova M, 2018, CIRC RES, V122, P337, DOI 10.1161/CIRCRESAHA.117.310795; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Park J, 2019, HEART RHYTHM, V16, P197, DOI 10.1016/j.hrthm.2018.08.023; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Scharf RE, 2016, HAMOSTASEOLOGIE, V36, P241, DOI 10.5482/HAMO-16-06-0016; Tefferi A, 2015, AM J HEMATOL, V90, P683, DOI 10.1002/ajh.24037; Wang CL, 2018, J THROMB THROMBOLYSI	17	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224709	10.1371/journal.pone.0224709	http://dx.doi.org/10.1371/journal.pone.0224709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697741	Green Published, gold			2022-12-26	WOS:000532694400047
J	Afkhami, M; Schmolze, D; Yost, SE; Frankel, PH; Dagis, A; Amanam, IU; Telatar, M; Nguyen, K; Yu, KW; Luu, T; Pillai, R; Aoun, PA; Mortimer, J; Yuan, Y				Afkhami, Michelle; Schmolze, Daniel; Yost, Susan E.; Frankel, Paul H.; Dagis, Andrew; Amanam, Idoroenyi U.; Telatar, Milhan; Nguyen, Kim; Yu, Kim Wai; Thehang Luu; Pillai, Raju; Aoun, Patricia A.; Mortimer, Joanne; Yuan, Yuan			Mutation and immune profiling of metaplastic breast cancer: Correlation with survival	PLOS ONE			English	Article								The goal of this study is to characterize the genomic and immune profiles of metaplastic breast cancer (MpBC) and identify the association with survival through an analysis of archived tumor tissue. A next-generation sequencing-based mutational assay (Onco-48) was performed for 21 MpBC patients. Clinicopathologic characteristics were captured, including relapse free survival (RFS) and overall survival (OS). Immunohistochemistry (IHC) for CD3, CD4, CD8, and programmed death-ligand 1 (PD-L1) was also performed. Recurrence free survival (RFS) at 5 years was 57% (95% CI 0.34-0.75) and overall survival (OS) at 5 years was 66% (95% CI 0.41-0.82). The most commonly altered genes were TP53 (68.4%, 13/19), PIK3CA (42.1%, 8/19), and PTEN (15.8%, 3/19. For patients with PIK3CA mutations, RFS and OS were significantly worse than for those without (HR 5.6, 95% CI 1.33-23.1 and HR 8.0, 95% CI 1.53-41.7, respectively). Cox regression estimated that PD L1 expression was associated with worse RFS and OS (HR 1.08, 95% CI 1.01-1.16 and HR 1.05, 95% CI 1.00-1.11, respectively, for an absolute increase in PD-L1 expression of 1%). In conclusion, PIK3CA mutation and PD-L1 expression confer poor prognosis in this cohort of patients with MpBC.	[Afkhami, Michelle; Schmolze, Daniel; Telatar, Milhan; Nguyen, Kim; Pillai, Raju; Aoun, Patricia A.] City Hope Comprehens Canc Ctr, Dept Pathol, Duarte, CA USA; [Yost, Susan E.; Amanam, Idoroenyi U.; Thehang Luu; Mortimer, Joanne; Yuan, Yuan] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA; [Frankel, Paul H.; Dagis, Andrew] City Hope Comprehens Canc Ctr, Dept Biostat, Duarte, CA USA; [Yu, Kim Wai] City Hope Comprehens Canc Ctr, Dept Clin Pharm, Duarte, CA USA	City of Hope; City of Hope; City of Hope; City of Hope	Yuan, Y (corresponding author), City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA.	yuyuan@coh.org	Michelle, Afkhami/GSD-5040-2022; Pillai, Raju/AAB-7230-2022	Yost, Susan/0000-0002-9422-0316; Dagis, Andrew/0000-0003-2649-0186; Pillai, Raju/0000-0001-8553-4252; Schmolze, Daniel/0000-0002-6947-2546	NIH [K12CA001727]; STOP Cancer Foundation; National Cancer Institute of the National Institutes of Health [P30CA033572]; NATIONAL CANCER INSTITUTE [K12CA001727, P30CA033572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STOP Cancer Foundation; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NIH Institutional Career Development (K12) Program K12CA001727 (https://www.nichd.nih.gov/grantscontracts/training-careers/extramural/FAQs/K12) (JM). This study was also supported by the STOP Cancer Foundation (no grant number) (https://stopcancer.org/) (YY). Research reported in this publication included work performed in the City of Hope Pathology Core and Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health (P30CA033572). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams S, 2015, P 38 ANN CTRC AACR S; Adams S, 2019, CHILD INDIC RES, V12, P545, DOI 10.1007/s12187-018-9531-x; Adams S, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0011-0; Alboukadel Kassambara MK, GGPLOT2; [Anonymous], 2017, PASCO S; Beckers RK, 2016, HISTOPATHOLOGY, V69, P25, DOI 10.1111/his.12904; Edenfield J, 2016, CLIN BREAST CANC; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Joneja U, 2016, J CLIN PATHOLOGY; Kurman R.J., 2014, WHO CLASSIFICATION T, V4th; Massard C, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.4502; Moroney J, 2012, CLIN CANCER RES, V18, P5796, DOI 10.1158/1078-0432.CCR-12-1158; Moulder S, 2015, ANN ONCOL; Moulder S, 2011, J CLIN ONCOL, V29, pE572, DOI 10.1200/JCO.2010.34.0604; Nanda R., 2017, PEMBROLIZUMAB PLUS S; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; Nelson RA, 2015, ANN SURG ONCOL, V22, P24, DOI 10.1245/s10434-014-3890-4; Ng CKY, 2017, CLIN CANCER RES, V23, P3859, DOI 10.1158/1078-0432.CCR-16-2857; Pezzi CM, 2007, ANN SURG ONCOL, V14, P166, DOI 10.1245/s10434-006-9124-7; Poirier N, 2017, NOUV QUINZ LITT, P9; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ross JS, 2015, ARCH PATHOL LAB MED, V139, P642, DOI 10.5858/arpa.2014-0200-OA; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Shah DR, 2012, ISRN ONCOLOGY; TAVASSOLI FAZ, 1992, PATHOL ANNU, V27, P89; Team RC, 2016, R LANG ENV STAT COMP; Therneau T, PACKAGE SURVIVAL ANA; Ventana Medical Systems, 2017, VENTANA PD L1 SP263; Weigelt B, 2009, BREAST CANCER RES TR, V117, P273, DOI 10.1007/s10549-008-0197-9	30	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224726	10.1371/journal.pone.0224726	http://dx.doi.org/10.1371/journal.pone.0224726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693690	Green Published, gold			2022-12-26	WOS:000532690100037
J	Bogicevic, L; Verhoeven, M; van Baar, AL				Bogicevic, Lilly; Verhoeven, Marjolein; van Baar, Anneloes L.			Toddler skills predict moderate-to-late preterm born children's cognition and behaviour at 6 years of age	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; ATTENTION CAPACITIES; SCHOOL-AGE; OUTCOMES; ABILITIES; PREMATURITY; ADULTS	Objective To compare moderate-to-late preterm born (32-36 weeks' gestation) to full term born (>37 weeks' gestation) children in cognitive and behavioural functioning at the age of 6 years and assess which toddler skills predict later cognitive and behavioural functioning. Design A prospective longitudinal study with a cohort of 88 moderate-to-late preterm and 83 full term born Dutch children, followed from 18 months to 6 years of age. Orienting, alerting and executive attention skills were assessed at 18 months (corrected for prematurity), and cognitive, motor and language skills (Bayley-III-NL) at 24 months (corrected for prematurity). At 6 years (corrected for prematurity), cognitive (indices of 10; WPPSI-III-NL) and behavioural functioning (CBCL/6-18) were assessed. Group differences and potential predictors were examined with MANCOVAs and hierarchical regression analyses. Results At 6 years, moderate-to-late preterm born children performed poorer than full term born children on cognitive processing speed, and they showed more behavioural attention problems. Attention problems at 6 years were predicted by poorer orienting attention skills at 18 months, while lower performance IQ was predicted by poorer alerting attention skills at 18 months. Full Scale IQ and Verbal IQ at 6 years were predicted by language skills at 24 months. Moderate-to-late preterm and full term born children showed some differing correlational patterns in the associations between early skills and later functioning, although in further analyses predictors appeared the same for both groups. Conclusions Moderate-to-late preterm born children show specific vulnerabilities at primary school-age, particularly in cognitive processing speed and behavioural attention problems. Cognitive and behavioural functioning at 6 years can be predicted by differentiated attention skills at 18 months and language skills at 24 months.	[Bogicevic, Lilly; Verhoeven, Marjolein; van Baar, Anneloes L.] Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands	Utrecht University	Bogicevic, L (corresponding author), Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands.	l.bogicevic@uu.nl		Bogicevic, Lilly/0000-0003-4229-6973				Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chan E, 2016, CHILD CARE HLTH DEV, V42, P297, DOI 10.1111/cch.12320; Cserjesi R, 2012, PEDIATRICS, V130, pE838, DOI 10.1542/peds.2011-2079; de Jong M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00669; de Jong M, 2016, J ATTEN DISORD, V20, P230, DOI 10.1177/1087054713516002; de Jong M, 2015, EARLY HUM DEV, V91, P761, DOI 10.1016/j.earlhumdev.2015.08.015; de Jong M, 2015, ARCH DIS CHILD, V100, P548, DOI 10.1136/archdischild-2014-307016; de Jong M, 2012, SEMIN FETAL NEONAT M, V17, P163, DOI 10.1016/j.siny.2012.02.003; Hall J, 2012, CHILD ADOL MENT H-UK, V17, P238, DOI 10.1111/j.1475-3588.2012.00649.x; Hendriksen J., 2010, WECHSLER PRIMARY PRE, V2nd ed; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Lawson KR, 2004, J DEV BEHAV PEDIATR, V25, P399, DOI 10.1097/00004703-200412000-00003; Lean RE, 2017, J INT NEUROPSYCH SOC, V23, P539, DOI 10.1017/S1355617717000388; Marchman VA, 2018, J DEV BEHAV PEDIATR, V39, P246, DOI 10.1097/DBP.0000000000000541; Mulder H, 2011, J INT NEUROPSYCH SOC, V17, P445, DOI 10.1017/S1355617711000373; Murray AL, 2014, NEUROPSYCHOLOGY, V28, P552, DOI 10.1037/neu0000071; Nomura Y, 2009, J PEDIATR PSYCHOL, V34, P406, DOI 10.1093/jpepsy/jsn092; Piek JP, 2010, HUM MOVEMENT SCI, V29, P777, DOI 10.1016/j.humov.2010.03.006; Piek JP, 2004, ARCH CLIN NEUROPSYCH, V19, P1063, DOI 10.1016/j.acn.2003.12.007; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Potharst ES, 2012, DEV MED CHILD NEUROL, V54, P240, DOI 10.1111/j.1469-8749.2011.04181.x; R Core Team, 2018, R LANG ENV STAT COMP; Ribeiro LA, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-59; Romeo DM, 2012, EUR J PAEDIATR NEURO, V16, P243, DOI 10.1016/j.ejpn.2011.07.012; Rose SA, 2011, INTELLIGENCE, V39, P198, DOI 10.1016/j.intell.2011.03.003; Shapiro-Mendoza CK, 2008, PEDIATRICS, V121, pE223, DOI 10.1542/peds.2006-3629; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Tomashek KM, 2007, J PEDIATR-US, V151, P450, DOI 10.1016/j.jpeds.2007.05.002; Van Baar AL., 2014, BAYLEY SCALES INFANT; van Baar AL, 2009, PEDIATRICS, V124, P251, DOI 10.1542/peds.2008-2315; van Veen S, 2016, J PEDIATR-US, V173, P90, DOI 10.1016/j.jpeds.2016.02.043; Verhulst F.C., 2013, HANDLEIDING ASEBA VR	34	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0223690	10.1371/journal.pone.0223690	http://dx.doi.org/10.1371/journal.pone.0223690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1FJ	31693682	gold, Green Published			2022-12-26	WOS:000532690100010
J	Ross, PA; Lau, MJ; Hoffmann, AA				Ross, Perran A.; Lau, Meng-Jia; Hoffmann, Ary A.			Does membrane feeding compromise the quality of Aedes aegypti mosquitoes?	PLOS ONE			English	Article							CARBON-DIOXIDE; GENE DRIVE; CULICIDAE; DIPTERA; WOLBACHIA; MALARIA; SYSTEM; HOST; ATTRACTION; VECTORS	Modified Aedes aegypti mosquitoes are being mass-reared for release in disease control programs around the world. Releases involving female mosquitoes rely on them being able to seek and feed on human hosts. To facilitate the mass-production of mosquitoes for releases, females are often provided blood through artificial membrane feeders. When reared across generations there is a risk that mosquitoes will adapt to feeding on membranes and lose their ability to feed on human hosts. To test adaptation to membrane feeding, we selected replicate populations of Ae. aegypti for feeding on either human arms or membrane feeders for at least 8 generations. Membrane-selected populations suffered fitness costs, likely due to inbreeding depression arising from bottlenecks. Membrane selected females had higher feeding rates on membranes than human-selected ones, suggesting adaptation to membrane feeding, but they maintained their attraction to host cues and feeding ability on humans despite a lack of selection for these traits. Host-seeking ability in small laboratory cages did not differ between populations selected on the two blood sources, but membrane-selected females were compromised in a semi-field enclosure where host-seeking was tested over a longer distance. Our findings suggest that Ae. aegypti may adapt to feeding on blood provided artificially, but this will not substantially compromise field performance or affect experimental assessments of mosquito fitness. However, large population sizes (thousands of individuals) during mass rearing with membrane feeders should be maintained to avoid bottlenecks which lead to inbreeding depression.	[Ross, Perran A.; Lau, Meng-Jia; Hoffmann, Ary A.] Univ Melbourne, Pest & Environm Adaptat Res Grp, Bio21 Inst, Parkville, Vic, Australia; [Ross, Perran A.; Lau, Meng-Jia; Hoffmann, Ary A.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia	University of Melbourne; University of Melbourne	Ross, PA (corresponding author), Univ Melbourne, Pest & Environm Adaptat Res Grp, Bio21 Inst, Parkville, Vic, Australia.	perran.ross@unimelb.edu.au	Ross, Perran/O-1049-2015	Ross, Perran/0000-0001-7645-7523; Lau, Meng-Jia/0000-0003-2943-7022; Hoffmann, Ary/0000-0001-9497-7645	National Health and Medical Research Council [1132412, 1118640]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	AAH was supported by the National Health and Medical Research Council (1132412, 1118640, www.nhmrc.gov.au).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baughman T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006142; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BIDLINGMAYER WL, 1980, B ENTOMOL RES, V70, P321, DOI 10.1017/S0007485300007604; Briegel H, 2002, J INSECT PHYSIOL, V48, P547, DOI 10.1016/S0022-1910(02)00072-0; Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4; Dutra HLC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16045-6; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579; Chadee DD, 1997, ANN TROP MED PARASIT, V91, P199, DOI 10.1080/00034983.1997.11813130; Choumet V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050464; Clark GG, 2011, J MED ENTOMOL, V48, P533, DOI 10.1603/ME10207; Costa-da-Silva AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053816; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Deng L, 2012, TROP BIOMED, V29, P169; Dias LD, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860045, 10.1590/s1678-9946201860045]; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023; Gonzales KK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29415-5; Gonzales KK, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121267; Grossman MK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0022; Gunathilaka N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3196924; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; Helinski MEH, 2013, ECOL CONT VECTOR-BOR, V3, P221; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 2018, J ECON ENTOMOL, V111, P501, DOI 10.1093/jee/toy024; Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245; Lacey ES, 2014, PHYSIOL ENTOMOL, V39, P60, DOI 10.1111/phen.12048; Liu MZ, 2019, CURR BIOL, V29, P2250, DOI 10.1016/j.cub.2019.06.001; Luo YP, 2014, J VECTOR ECOL, V39, P271, DOI 10.1111/jvec.12101; Mains JW, 2019, J MED ENTOMOL, V56, P1296, DOI 10.1093/jme/tjz051; Marques J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35886-3; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188; MEIER E, 2019, CASE REP ENDOCRINOL, V2019, DOI DOI 10.1101/695528; Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625; NOVAK MG, 1991, J AM MOSQUITO CONTR, V7, P327; Paris V, 2018, INSECTS, V9, DOI 10.3390/insects9040140; Phasomkusolsil S, 2013, J VECTOR ECOL, V38, P38, DOI 10.1111/j.1948-7134.2013.12006.x; Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988; Romano D, 2018, ACTA TROP, V183, P43, DOI 10.1016/j.actatropica.2018.04.009; Ross PA, 2019, ANNU REV GENET, V53, P93, DOI 10.1146/annurev-genet-112618-043609; Ross PA, 2019, EVOL APPL, V12, P572, DOI 10.1111/eva.12740; Ross PA, 2017, JOVE-J VIS EXP, DOI 10.3791/56124; Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320; Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; Siria DJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2823-7; van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046; Vinauger C, 2019, CURR BIOL, V29, P2509, DOI 10.1016/j.cub.2019.06.043; Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390; Zhang DJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2750-7	53	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224268	10.1371/journal.pone.0224268	http://dx.doi.org/10.1371/journal.pone.0224268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693672	gold, Green Published, Green Submitted			2022-12-26	WOS:000532690100019
J	Kim, YS; Vallur, PG; Jones, VM; Worley, BL; Shimko, S; Shin, DH; Crawford, LC; Chen, CW; Aird, KM; Abraham, T; Shepherd, TG; Warrick, JI; Lee, NY; Phaeton, R; Mythreye, K; Hempel, N				Kim, Yeon Soo; Vallur, Piyushi Gupta; Jones, Victoria M.; Worley, Beth L.; Shimko, Sara; Shin, Dong-Hui; Crawford, LaTaijah C.; Chen, Chi-Wei; Aird, Katherine M.; Abraham, Thomas; Shepherd, Trevor G.; Warrick, Joshua, I; Lee, Nam Y.; Phaeton, Rebecca; Mythreye, Karthikeyan; Hempel, Nadine			Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells	ONCOGENE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; METABOLISM; ANTIOXIDANT; EXPRESSION; DEACETYLATES; PROGRESSION; ANOIKIS; GROWTH; SOD2	Tumor cells must alter their antioxidant capacity for maximal metastatic potential. Yet the antioxidant adaptations required for ovarian cancer transcoelomic metastasis, which is the passive dissemination of cells in the peritoneal cavity, remain largely unexplored. Somewhat contradicting the need for oxidant scavenging are previous observations that expression of SIRT3, a nutrient stress sensor and regulator of mitochondrial antioxidant defenses, is often suppressed in many primary tumors. We have discovered that this mitochondrial deacetylase is specifically upregulated in a context-dependent manner in cancer cells. SIRT3 activity and expression transiently increased following ovarian cancer cell detachment and in tumor cells derived from malignant ascites of high-grade serous adenocarcinoma patients. Mechanistically, SIRT3 prevents mitochondrial superoxide surges in detached cells by regulating the manganese superoxide dismutase (SOD2). This mitochondrial stress response is under dual regulation by SIRT3. SIRT3 rapidly increases SOD2 activity as an early adaptation to cellular detachment, which is followed by SIRT3-dependent increases in SOD2 mRNA during sustained anchorage-independence. In addition, SIRT3 inhibits glycolytic capacity in anchorage-independent cells thereby contributing to metabolic changes in response to detachment. While manipulation of SIRT3 expression has few deleterious effects on cancer cells in attached conditions, SIRT3 upregulation and SIRT3-mediated oxidant scavenging are required for anoikis resistance in vitro following matrix detachment, and both SIRT3 and SOD2 are necessary for colonization of the peritoneal cavity in vivo. Our results highlight the novel context-specific, pro-metastatic role of SIRT3 in ovarian cancer.	[Kim, Yeon Soo; Vallur, Piyushi Gupta; Jones, Victoria M.; Worley, Beth L.; Shimko, Sara; Shin, Dong-Hui; Crawford, LaTaijah C.; Hempel, Nadine] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Chen, Chi-Wei; Aird, Katherine M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA; [Abraham, Thomas] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Shepherd, Trevor G.] Western Univ, Dept Obstet, Mary & John Knight Translat Ovarian Canc Res Unit, London, ON, Canada; [Shepherd, Trevor G.] Western Univ, Dept Gynecol Oncol, Mary & John Knight Translat Ovarian Canc Res Unit, London, ON, Canada; [Shepherd, Trevor G.] Western Univ, Dept Anat & Cell Biol, Mary & John Knight Translat Ovarian Canc Res Unit, London, ON, Canada; [Warrick, Joshua, I] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Lee, Nam Y.] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Phaeton, Rebecca] Penn State Univ, Coll Med, Dept Obstet & Gynecol & Microbiol & Immunol, Hershey, PA USA; [Mythreye, Karthikeyan] Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Mythreye, Karthikeyan] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of South Carolina System; University of South Carolina Columbia; University of Alabama System; University of Alabama Birmingham	Hempel, N (corresponding author), Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.; Mythreye, K (corresponding author), Univ South Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA.; Mythreye, K (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	mythreye@uab.edu; nhempel@psu.edu	Abraham, Thomas/AAJ-7950-2020; Karthikeyan, Mythreye/ABC-7345-2020; Aird, Katherine/AAY-3300-2020	Karthikeyan, Mythreye/0000-0001-5478-0098; Chen, Chi-Wei/0000-0001-8658-055X; Kim, Yeon Soo/0000-0002-9677-374X; Hempel, Nadine/0000-0002-5574-8783; Vallur, Piyushi/0000-0002-1906-7497; Crawford, LaTaijah/0000-0002-5129-3355	NIH [R00CA143229, R01CA230628, S100D018124]; Rivkin Center for Ovarian Cancer; Agilent; Penn State Cancer Institute Developmental Fund Award; DoD Pilot award [W81XWH-16-1-0117]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rivkin Center for Ovarian Cancer; Agilent; Penn State Cancer Institute Developmental Fund Award; DoD Pilot award	This work was supported by NIH grants R00CA143229 (NH), R01CA230628 (NH and KM), S100D018124 (TA), by the Rivkin Center for Ovarian Cancer (NH), an equipment grant from Agilent (NH), and the Penn State Cancer Institute Developmental Fund Award (NH). Collection of ascites was partially supported by DoD Pilot award W81XWH-16-1-0117 (NH).	Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alhazzazi TY, 2011, CANCER-AM CANCER SOC, V117, P1670, DOI 10.1002/cncr.25676; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Cai Q, 2015, ONCOGENE, V34, P3315, DOI 10.1038/onc.2014.264; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Correa RJM, 2012, CARCINOGENESIS, V33, P49, DOI 10.1093/carcin/bgr241; Davison CA, 2013, CANCER RES, V73, P3704, DOI 10.1158/0008-5472.CAN-12-2482; Desouki MM, 2014, HUM PATHOL, V45, P1071, DOI 10.1016/j.humpath.2014.01.004; Dier U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098479; Dong XC, 2016, BIOCHEM BIOPH RES CO, V475, P245, DOI 10.1016/j.bbrc.2016.05.098; Emmings E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010229; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Hemachandra LPMP, 2015, CANCER RES, V75, P4973, DOI 10.1158/0008-5472.CAN-14-3799; Hempel N, 2011, ANTI-CANCER AGENT ME, V11, P191, DOI 10.2174/187152011795255911; Hempel N, 2009, FREE RADICAL BIO MED, V46, P42, DOI 10.1016/j.freeradbiomed.2008.09.020; Hou J, 2018, CANCER RES, V78, P2503, DOI 10.1158/0008-5472.CAN-17-2618; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Kamarajan P, 2012, CANCER-AM CANCER SOC, V118, P5800, DOI 10.1002/cncr.27655; Kenny HA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7220; Kenny TC, 2017, ONCOGENE, V36, P4393, DOI 10.1038/onc.2017.52; Kenny TC, 2019, CELL REP, V27, P2292, DOI 10.1016/j.celrep.2019.04.095; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim YS, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040086; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Li M, 2019, CANCER CELL, V35, P916, DOI 10.1016/j.ccell.2019.05.002; McGlynn LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131344; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Park HK, 2019, CANCER RES, V79, P1369, DOI 10.1158/0008-5472.CAN-18-2558; Peart TM, 2012, CLIN EXP METASTAS, V29, P293, DOI 10.1007/s10585-011-9451-3; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rangarajan P, 2015, NEUROSCIENCE, V311, P398, DOI 10.1016/j.neuroscience.2015.10.048; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sehouli J, 2009, J SURG ONCOL, V99, P424, DOI 10.1002/jso.21288; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06812-y; Worley BL, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.11.009; Xiang XY, 2016, INT J ONCOL, V49, P773, DOI 10.3892/ijo.2016.3552; Yang B, 2014, BIOCHEM BIOPH RES CO, V443, P156, DOI 10.1016/j.bbrc.2013.11.068; Yu W, 2016, J BIOL CHEM, V291, P3268, DOI 10.1074/jbc.M115.702076; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051703; Zhou YP, 2018, ONCOTARGETS THER, V11, P2157, DOI 10.2147/OTT.S157836; Zou XH, 2017, CANCER RES, V77, P3990, DOI 10.1158/0008-5472.CAN-16-2393	51	22	22	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1619	1633		10.1038/s41388-019-1097-7	http://dx.doi.org/10.1038/s41388-019-1097-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31723239	Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000514923000001
J	Lentzsch, AM; Yao, J; Russell, R; Lambowitz, AM				Lentzsch, Alfred M.; Yao, Jun; Russell, Rick; Lambowitz, Alan M.			Template-switching mechanism of a group II intron-encoded reverse transcriptase and its implications for biological function and RNA-Seq	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical biology; DNA sequencing; enzyme kinetics; retrovirus; reverse transcription; RNA; RNA virus; structure?function; transposable element (TE); viral polymerase; group II intron reverse transcriptase; non-templated nucleotide addition; RNA sequencing; RNA-dependent RNA polymerase; thermostable group II intron reverse transcriptase	NONTEMPLATED NUCLEOTIDE ADDITION; SYNTHESIS DE-NOVO; CDNA SYNTHESIS; MITOCHONDRIAL PLASMIDS; MAURICEVILLE PLASMID; DNA; RETROTRANSPOSON; RECOMBINATION; REPLICATION; NEUROSPORA	The reverse transcriptases (RTs) encoded by mobile group II introns and other non-LTR retroelements differ from retroviral RTs in being able to template-switch efficiently from the 5? end of one template to the 3? end of another with little or no complementarity between the donor and acceptor templates. Here, to establish a complete kinetic framework for the reaction and to identify conditions that more efficiently capture acceptor RNAs or DNAs, we used a thermostable group II intron RT (TGIRT; GsI?IIC RT) that can template switch directly from synthetic RNA template/DNA primer duplexes having either a blunt end or a 3?-DNA overhang end. We found that the rate and amplitude of template switching are optimal from starter duplexes with a single nucleotide 3?-DNA overhang complementary to the 3? nucleotide of the acceptor RNA, suggesting a role for nontemplated nucleotide addition of a complementary nucleotide to the 3? end of cDNAs synthesized from natural templates. Longer 3?-DNA overhangs progressively decreased the template-switching rate, even when complementary to the 3? end of the acceptor template. The reliance on only a single bp with the 3? nucleotide of the acceptor together with discrimination against mismatches and the high processivity of group II intron RTs enable synthesis of full-length DNA copies of nucleic acids beginning directly at their 3? end. We discuss the possible biological functions of the template-switching activity of group II intron- and other non-LTR retroelement?encoded RTs, as well as the optimization of this activity for adapter addition in RNA- and DNA-Seq protocols.	[Lentzsch, Alfred M.; Yao, Jun; Russell, Rick; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Lentzsch, Alfred M.; Yao, Jun; Russell, Rick; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Oncol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lambowitz, AM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.; Lambowitz, AM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Oncol, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu		Lambowitz, Alan/0000-0001-6036-2423	National Institutes of Health [R01 GM37949, R35 GM131777]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM131777, R01GM037949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM37949 (to A. M. Lambowitz) and R35 GM131777 (to R. R.). Thermostable group II intron reverse transcriptase enzymes and methods for their use are the subject of patents and patent applications that have been licensed by the University of Texas and East Tennessee State University to InGex, LLC. A. M. Lambowitz, some former and present members of the Lambowitz laboratory, and the University of Texas are minority equity holders in InGex, LLC, and receive royalty payments from the sale of TGIRT enzymes and kits employing TGIRT template-switching activity for RNA-seq adapter addition and from the sublicensing of intellectual property to other companies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKINS RA, 1986, CELL, V47, P505, DOI 10.1016/0092-8674(86)90615-X; Baidyaroy D, 2012, FUNGAL BIOL-UK, V116, P919, DOI 10.1016/j.funbio.2012.06.003; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J MOL BIOL, V316, P459, DOI 10.1006/jmbi.2001.5369; Blocker FJH, 2005, RNA, V11, P14, DOI 10.1261/rna.7181105; Brenlla A, 2014, NUCLEIC ACIDS RES, V42, P2555, DOI 10.1093/nar/gkt1149; Buzdin AA, 2004, CELL MOL LIFE SCI, V61, P2046, DOI 10.1007/s00018-004-4041-z; Chen B, 1997, J MOL BIOL, V271, P311, DOI 10.1006/jmbi.1997.1185; Chiang CC, 1997, MOL CELL BIOL, V17, P4526, DOI 10.1128/MCB.17.8.4526; CHIANG CC, 1994, MOL CELL BIOL, V14, P6419, DOI 10.1128/MCB.14.10.6419; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; COLLINS RA, 1981, CELL, V24, P443, DOI 10.1016/0092-8674(81)90335-4; Coros CJ, 2008, RNA, V14, P2634, DOI 10.1261/rna.1247608; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Galligan Jeffrey T., 2007, V7, P163, DOI 10.1007/7171_2007_098; George JA, 1996, GENETICS, V142, P853; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Golinelli MP, 2002, BIOCHEMISTRY-US, V41, P5894, DOI 10.1021/bi0160415; Golinelli MP, 2002, VIROLOGY, V294, P122, DOI 10.1006/viro.2001.1322; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Jamburuthugoda VK, 2014, NUCLEIC ACIDS RES, V42, P8405, DOI 10.1093/nar/gku514; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KENNELL JC, 1994, MOL CELL BIOL, V14, P3094, DOI 10.1128/MCB.14.5.3094; Khadgi BB, 2019, NUCLEIC ACIDS RES, V47, P8708, DOI 10.1093/nar/gkz673; KUIPER MTR, 1988, CELL, V55, P693, DOI 10.1016/0092-8674(88)90228-0; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Luczkowiak J, 2018, J BIOL CHEM, V293, P13351, DOI 10.1074/jbc.RA118.004324; Malik O, 2017, NUCLEIC ACIDS RES, V45, P10190, DOI 10.1093/nar/gkx720; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mohr G, 2018, J MOL BIOL, V430, P2760, DOI 10.1016/j.jmb.2018.06.019; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Moldovan JB, 2019, P NATL ACAD SCI USA, V116, P20612, DOI 10.1073/pnas.1805404116; Motea EA, 2010, BBA-PROTEINS PROTEOM, V1804, P1151, DOI 10.1016/j.bbapap.2009.06.030; Nottingham RM, 2016, RNA, V22, P597, DOI 10.1261/rna.055558.115; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Oz-Gleenberg I, 2012, FEBS J, V279, P1894, DOI 10.1111/j.1742-4658.2012.08570.x; Oz-Gleenberg I, 2012, FEBS J, V279, P142, DOI 10.1111/j.1742-4658.2011.08406.x; Oz-Gleenberg I, 2011, NUCLEIC ACIDS RES, V39, P1042, DOI 10.1093/nar/gkq786; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Qin Y, 2016, RNA, V22, P111, DOI 10.1261/rna.054809.115; Raper AT, 2018, CHEM REV, V118, P6000, DOI 10.1021/acs.chemrev.7b00685; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Ritchie AJ, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0069-9; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Song HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04217-5; Stamos JL, 2017, MOL CELL, V68, P926, DOI 10.1016/j.molcel.2017.10.024; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; WANG H, 1993, CELL, V75, P1071, DOI 10.1016/0092-8674(93)90317-J; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; White TB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002534; Wu DC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09064-w; Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Xu HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44457-z; Yu Y, 2017, NEW PHYTOL, V216, P1002, DOI 10.1111/nph.14834; Zajac P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085270; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	67	10	12	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19764	19784		10.1074/jbc.RA119.011337	http://dx.doi.org/10.1074/jbc.RA119.011337			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31712313	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000504093200024
J	Aguiar, AC; Robinson, SA; French, K				Aguiar, Axton C.; Robinson, Sharon A.; French, Kristine			Friends with benefits: The effects of vegetative shading on plant survival in a green roof environment	PLOS ONE			English	Article							FACILITATION; COMPETITION; URBAN; SOIL; PHOTOINHIBITION; ESTABLISHMENT; URBANIZATION; MICROCLIMATE; BIODIVERSITY; TEMPERATURE	Green roofs help ameliorate some of the adverse social, economic and environmental effects of urbanisation. However, green roofs are harsh environments for plants, as they must cope with shallow soils, low nutrient availability, high solar radiation, low water availability and high pollution/disturbances. The effect of shade plants on vegetation survivability was investigated using green roof mesocosms with four different native species pairs (shade plant and a target ground cover plant). To examine the effect of shading and competition on plant growth and survival, plant pairs were subjected to four treatments; naturally shaded with a shade plant shading the target plant, artificially shaded with an artificial plant shading the target plant, unshaded natural which had a trimmed shade plant providing no shade to the target plant and an unshaded treatment with the target plant being the sole occupant of the mesocosm. The experiment ran for 11 months with measurements taken monthly to record growth and visual health of the target plant. Soil moisture and biomass data was collected at the end of the experiment. Overall, natural shade treated plants had the highest biomass while unshaded plants had the lowest biomass. Contrary to our predictions, the shaded artificial and the unshaded natural had similar moderate biomass. This similarity suggests that while shading had a positive influence on plant growth, there was also a positive influence of growing with a shade plant which is not accounted for by shading. The results highlight the complexity of biotic relations between plants and emphasises that the presence of a nurse plants can be benefit to the survival and growth of other species within a green roof ecosystem.	[Aguiar, Axton C.; Robinson, Sharon A.; French, Kristine] Univ Wollongong, Sch Earth Atmosphere & Life Sci, Ctr Sustainable Ecosyst Solut, Wollongong, NSW, Australia	University of Wollongong	Aguiar, AC (corresponding author), Univ Wollongong, Sch Earth Atmosphere & Life Sci, Ctr Sustainable Ecosyst Solut, Wollongong, NSW, Australia.	aca665@uowmail.edu.au	Robinson, Sharon/B-2683-2008; French, Kris/I-8202-2012	Robinson, Sharon/0000-0002-7130-9617; French, Kris/0000-0001-6938-2017				[Anonymous], 2019, WORLD URB PROSP 2018; [Anonymous], 2007, SOIL SAMPLING METHOD, DOI DOI 10.1201/9781420005271.CH7; Anthelme F, 2012, PERSPECT PLANT ECOL, V14, P363, DOI 10.1016/j.ppees.2012.05.002; Arabi R., 2015, ALAM CIPTA, V8, P10; Badano EI, 2009, PERSPECT PLANT ECOL, V11, P191, DOI 10.1016/j.ppees.2009.03.002; Benvenuti Stefano, 2010, Urban Ecosystems, V13, P349, DOI 10.1007/s11252-010-0124-9; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Brown C, 2015, LANDSCAPE URBAN PLAN, V143, P134, DOI 10.1016/j.landurbplan.2015.07.009; Butler C, 2011, ECOL ENG, V37, P1796, DOI 10.1016/j.ecoleng.2011.06.025; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 1995, POSITIVE INTERACTION, P61; CONNELL JH, 1983, AM NAT, V122, P661, DOI 10.1086/284165; Cook-Patton SC, 2012, J ENVIRON MANAGE, V106, P85, DOI 10.1016/j.jenvman.2012.04.003; Demmig-Adams B, 2003, ANNU REV PLANT PHYS, V43, P599, DOI [10.1146/annurev.pp.43, DOI 10.1146/ANNUREV.PP.43]; Filazzola A, 2014, GLOBAL ECOL BIOGEOGR, V23, P1335, DOI 10.1111/geb.12202; French K, 2017, NEOBIOTA, P17, DOI 10.3897/neobiota.36.13842; Fujita T, 2018, ECOL EVOL, V8, P3702, DOI 10.1002/ece3.3935; Getter KL, 2009, URBAN FOR URBAN GREE, V8, P269, DOI 10.1016/j.ufug.2009.06.005; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; He XH, 2003, CRIT REV PLANT SCI, V22, P531, DOI 10.1080/713608315; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; KASPAR TC, 1992, SOIL SCI, V154, P290, DOI 10.1097/00010694-199210000-00005; Ksiazek-Mikenas Kelly, 2018, Journal of Urban Ecology, V4, pjuy016, DOI 10.1093/jue/juy016; Lanfranco L, 2018, NEW PHYTOL, V220, P1031, DOI 10.1111/nph.15230; Lavorel S, 2011, J ECOL, V99, P135, DOI 10.1111/j.1365-2745.2010.01753.x; le Roux PC, 2010, OECOLOGIA, V162, P733, DOI 10.1007/s00442-009-1484-9; Lee KE, 2015, J ENVIRON PSYCHOL, V42, P182, DOI 10.1016/j.jenvp.2015.04.003; Lopez RP, 2007, OECOLOGIA, V152, P779, DOI 10.1007/s00442-007-0698-y; Lundholm J.T., 2018, URBAN NATURALIST, V1, P39; Lundholm JT, 2015, J APPL ECOL, V52, P726, DOI 10.1111/1365-2664.12425; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; McGranahan G, 2014, URBANISATION CONCEPT, DOI [10.1641/b571005, DOI 10.1641/B571005]; McIntire EJB, 2014, NEW PHYTOL, V201, P403, DOI 10.1111/nph.12478; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Moghbel M, 2017, URBAN CLIM, V20, P46, DOI 10.1016/j.uclim.2017.02.012; Molenda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037223; Montesinos-Navarro A, 2019, ECOGRAPHY, V42, P447, DOI 10.1111/ecog.03926; Montesinos-Navarro A, 2017, ECOLOGY, V98, P1300, DOI 10.1002/ecy.1771; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; Pugnaire FI, 2004, J VEG SCI, V15, P85, DOI 10.1111/j.1654-1103.2004.tb02240.x; Roig-Villanova I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00236; Sklenar P, 2009, FLORA, V204, P270, DOI 10.1016/j.flora.2008.04.001; Sol D, 2014, ECOL LETT, V17, P942, DOI 10.1111/ele.12297; Sydney Council, 2014, GREEN ROOF DES RES M; Tyystjarvi E, 2013, INT REV CEL MOL BIO, V300, P243, DOI 10.1016/B978-0-12-405210-9.00007-2; Van Mechelen C, 2014, ECOL ENG, V67, P48, DOI 10.1016/j.ecoleng.2014.03.043; van Noordwijk M, 2015, TREE-CROP INTERACTIONS: AGROFORESTRY IN A CHANGING CLIMATE, 2ND EDITION, P221, DOI 10.1079/9781780645117.0221; Walder F, 2012, PLANT PHYSIOL, V159, P789, DOI 10.1104/pp.112.195727; Williams NSG, 2014, J APPL ECOL, V51, P1643, DOI 10.1111/1365-2664.12333; Wright A, 2015, J ECOL, V103, P648, DOI 10.1111/1365-2745.12397; Wright A, 2014, ECOLOGY, V95, P2213, DOI 10.1890/13-1855.1; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zhang Z, 2018, SCI TOTAL ENVIRON, V625, P775, DOI 10.1016/j.scitotenv.2017.12.231	56	7	8	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225078	10.1371/journal.pone.0225078	http://dx.doi.org/10.1371/journal.pone.0225078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725779	gold, Green Published			2022-12-26	WOS:000532764500048
J	Lee, PC; Chiang, JC; Chen, CY; Chien, YC; Chen, WM; Huang, CW; Weng, WC; Chen, CI; Lee, PH; Chen, CN; Lee, H				Lee, Po-Chu; Chiang, Jui-Chung; Chen, Chih-Yu; Chien, Yin-Chieh; Chen, Wei-Min; Huang, Chin-Wei; Weng, Wen-Chin; Chen, Chia-, I; Lee, Po-Huang; Chen, Chiung-Nien; Lee, Hsinyu			Calreticulin regulates vascular endothelial growth factor-A mRNA stability in gastric cancer cells	PLOS ONE			English	Article							RICH ELEMENTS; VEGF-A; GENE-EXPRESSION; TUMOR-GROWTH; ANGIOGENESIS; TRANSLATION; IDENTIFICATION; TUMORIGENESIS; SUPPRESSES; HYPOXIA	Calreticulin (CRT) and vascular endothelial growth factor-A (VEGF-A) are crucial for angiogenesis, and mediate multiple malignant behaviors in gastric cancer. In this study, we report that CRT is positively correlated with VEGF-A in gastric cancer patients. Moreover, high expressions of both CRT and VEGF-A are markedly associated with the pathological stage, progression, and poor prognosis in the patients. Therefore, we sought to elucidate the mechanism by which CRT affects VEGF-A in gastric cancer. Firstly, we demonstrate the novel finding that knockdown of CRT reduced VEGF-A mRNA stability in two gastric cancer cell lines, AGS and MKN45. The AU-Rich element (ARE) is believed to play a crucial role in the maintenance of VEGF-A mRNA stability. Luciferase reporter assay shows that knockdown of CRT significantly decreased the activity of renilla luciferase with VEGF-A ARE sequence. Additionally, competition results from RNA-binding/electrophoretic mobility shift assay indicate that CRT forms an RNA-protein complex with the VEGF-A mRNA by binding to the ARE. In addition, the proliferation rate of human umbilical vein endothelial cells (HUVEC) was significantly reduced when treated with conditioned medium from CRT knockdown cells; this was rescued by exogenous VEGF-A recombinant protein. Our results demonstrate that CRT is involved in VEGF-A ARE binding protein complexes to stabilize VEGF-A mRNA, thereby promoting the angiogenesis, and progression of gastric cancer.	[Lee, Po-Chu] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Lee, Po-Chu; Chen, Chia-, I; Lee, Po-Huang; Chen, Chiung-Nien] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Lee, Po-Chu] Natl Taiwan Univ, Grad Inst Clin Med, Taipei, Taiwan; [Chiang, Jui-Chung; Chen, Chih-Yu; Chien, Yin-Chieh; Chen, Wei-Min; Huang, Chin-Wei; Lee, Hsinyu] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Weng, Wen-Chin] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan; [Weng, Wen-Chin] Natl Taiwan Univ, Dept Pediat, Taipei, Taiwan; [Weng, Wen-Chin] Natl Taiwan Univ, Childrens Hosp, Dept Pediat Neurol, Taipei, Taiwan; [Lee, Po-Huang] E DA Hosp, Dept Surg, Kaohsiung, Taiwan; [Lee, Hsinyu] Natl Taiwan Univ, Dept Elect Engn, Taipei, Taiwan; [Lee, Hsinyu] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei, Taiwan; [Lee, Hsinyu] Natl Taiwan Univ, Res Ctr Dev Biol, Taipei, Taiwan; [Lee, Hsinyu] Natl Taiwan Univ, Regenerat Med & Ctr Biotechnol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; E-Da Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chen, CN (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.; Lee, H (corresponding author), Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan.; Lee, H (corresponding author), Natl Taiwan Univ, Dept Elect Engn, Taipei, Taiwan.; Lee, H (corresponding author), Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei, Taiwan.; Lee, H (corresponding author), Natl Taiwan Univ, Res Ctr Dev Biol, Taipei, Taiwan.; Lee, H (corresponding author), Natl Taiwan Univ, Regenerat Med & Ctr Biotechnol, Taipei, Taiwan.	cnchen@ntu.edu.tw; hsinyu@ntu.edu.tw		LEE, PO-HUANG/0000-0001-5831-035X; LEE, PO-CHU/0000-0001-5053-1895; weng, wen-chin/0000-0002-6923-9138; Chiang, Jui-Chung/0000-0001-9979-8347; Chen, Wei-min/0000-0002-5247-7826; CHEN, CHIUNG-NIEN/0000-0003-1192-5220	Ministry of Science and Technology, Taiwan [MOST 106-2314-B-002-216-MY3, MOST 106-2314-B-002-193-, 107-2314-B-002-161-]; Technology Commons in College of Life Science, National Taiwan University, Taiwan; Center for Systems Biology, National Taiwan University, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Technology Commons in College of Life Science, National Taiwan University, Taiwan; Center for Systems Biology, National Taiwan University, Taiwan	This work was supported by Ministry of Science and Technology, Taiwan, MOST 106-2314-B-002-216-MY3, to Chiung-Nien Chen, https://www.most.gov.tw/?l=en. CN Chen provided clinical samples and conceived the project; Ministry of Science and Technology, Taiwan, MOST 106-2314-B-002-193-and 107-2314-B-002-161- to Wen-Chin Weng, https://www.most.gov.tw/?l=en. WC Weng contributed to conception of the project.; We are grateful to Dr. Chia-Ying Chu (Department of Life Science, National Taiwan University, Taiwan) for technical instruction for the dual-luciferase assay, RNA immunoprecipitation assay and biotin pull-down assay. We appreciate the staff of the Core Labs, Department of Medical Research, National Taiwan University Hospital for technical support. Techniques from this research are also supported by Technology Commons in College of Life Science and Center for Systems Biology, National Taiwan University, Taiwan.	Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bini L, 1997, ELECTROPHORESIS, V18, P2832, DOI 10.1002/elps.1150181519; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chang SH, 2013, J BIOL CHEM, V288, P4908, DOI 10.1074/jbc.M112.423871; Chen CN, 2009, ANN SURG ONCOL, V16, P524, DOI 10.1245/s10434-008-0243-1; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Ding H, 2014, CLIN EXP IMMUNOL, V178, P236, DOI 10.1111/cei.12411; Du XL, 2009, ONCOGENE, V28, P3714, DOI 10.1038/onc.2009.237; Fukumura D, 2001, CANCER RES, V61, P6020; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Helbling D, 2005, BLOOD, V106, P1369, DOI 10.1182/blood-2004-11-4392; Hong SH, 2004, CANCER RES, V64, P5504, DOI 10.1158/0008-5472.CAN-04-0077; Hsia K, 2017, ACTA BIOMATER, V51, P341, DOI 10.1016/j.actbio.2017.01.050; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Kerr BA, 2010, BLOOD, V115, P3181, DOI 10.1182/blood-2010-01-262766; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Lee HH, 2010, INT J CANCER, V126, P1817, DOI 10.1002/ijc.24847; Lee JW, 2012, CANCER LETT, V318, P221, DOI 10.1016/j.canlet.2011.12.014; Lee J, 2011, CANCER LETT, V309, P145, DOI 10.1016/j.canlet.2011.05.026; Levy AP, 1998, TRENDS CARDIOVAS MED, V8, P246, DOI 10.1016/S1050-1738(98)00020-6; Liu DH, 2001, WORLD J GASTROENTERO, V7, P500; Lu YC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/526524; Lu YC, 2014, BIOCHEM J, V460, P69, DOI 10.1042/BJ20131424; Lu YC, 2011, AM J PATHOL, V179, P1425, DOI 10.1016/j.ajpath.2011.05.015; Lwin ZM, 2010, MODERN PATHOL, V23, P1559, DOI 10.1038/modpathol.2010.173; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mimori K, 2008, CLIN CANCER RES, V14, P2609, DOI 10.1158/1078-0432.CCR-07-4354; Nickenig G, 2002, CIRC RES, V90, P53, DOI 10.1161/hh0102.102503; Ozawa K, 2001, CANCER RES, V61, P4206; Sheng WW, 2014, J CELL PHYSIOL, V229, P887, DOI 10.1002/jcp.24519; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; SINGH NK, 1994, P NATL ACAD SCI USA, V91, P12770, DOI 10.1073/pnas.91.26.12770; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Totary-Jain H, 2005, CIRC RES, V97, P1001, DOI 10.1161/01.RES.0000189260.46084.e5; Tseng CW, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-99; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Weng WC, 2015, MOL NEUROBIOL, V52, P758, DOI 10.1007/s12035-014-8901-8; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Yoon GS, 2000, CANCER RES, V60, P1117; Zamanian M, 2013, PATHOL ONCOL RES, V19, P149, DOI 10.1007/s12253-012-9600-2	48	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225107	10.1371/journal.pone.0225107	http://dx.doi.org/10.1371/journal.pone.0225107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725767	gold, Green Published			2022-12-26	WOS:000532764500056
J	Abs, V; Bonicelli, J; Kacza, J; Zizzadoro, C; Abraham, G				Abs, Vanessa; Bonicelli, Jana; Kacza, Johannes; Zizzadoro, Claudia; Abraham, Getu			Equine bronchial fibroblasts enhance proliferation and differentiation of primary equine bronchial epithelial cells co-cultured under air-liquid interface	PLOS ONE			English	Article							COLLAGEN	Interaction between epithelial cells and fibroblasts play a key role in wound repair and remodelling in the asthmatic airway epithelium. We present the establishment of a co-culture model using primary equine bronchial epithelial cells (EBECs) and equine bronchial fibroblasts (EBFs). EBFs at passage between 4 and 8 were seeded on the bottom of 24-well plates and treated with mitomycin C at 80% confluency. Then, freshly isolated (PO) or passaged (P1) EBECs were seeded on the upper surface of membrane inserts that had been placed inside the EBF-containing well plates and grown first under liquid-liquid interface (LLI) then under air-liquid interface (ALI) conditions to induce epithelial differentiation. Morphological, structural and functional markers were monitored in co-cultured P0 and P1 EBEC monolayers by phase-contrast microscopy, scanning and transmission electron microscopy, hematoxylin-eosin, immunocytochemistry as well as by measuring the transepithelial electrical resistance (TEER) and transepithelial transport of selected drugs. After about 15-20 days of co-culture at ALI, P-0 and P-1 EBEC monolayers showed pseudo-stratified architecture, presence of ciliated cells, typically honeycomb-like pattern of tight junction protein 1 (TJP1) expression, and intact selective barrier functions. Interestingly, some notable differences were observed in the behaviour of co-cultured EBECs (adhesion to culture support, growth rate, differentiation rate) as compared to our previously described EBEC mono-culture system, suggesting that cross-talk between epithelial cells and fibroblasts actually takes place in our current co-culture setup through paracrine signalling. The EBEC-EBF co-culture model described herein will offer the opportunity to investigate epithelial-mesenchymal cell interactions and underlying disease mechanisms in the equine airways, thereby leading to a better understanding of their relevance to pathophysiology and treatment of equine and human asthma.	[Abs, Vanessa; Bonicelli, Jana; Abraham, Getu] Univ Leipzig, Fac Vet Med, Inst Pharmacol Pharm & Toxicol, Leipzig, Germany; [Kacza, Johannes] Univ Leipzig, Saxonian Incubator Clin Translat, Philipp Rosenthal Str, Leipzig, Germany; [Zizzadoro, Claudia] Univ Bari, Div Vet Pharmacol & Toxicol, Dept Vet Med, SP 62 Casamassima, Valenzano, BA, Italy	Leipzig University; Leipzig University; Universita degli Studi di Bari Aldo Moro	Abraham, G (corresponding author), Univ Leipzig, Fac Vet Med, Inst Pharmacol Pharm & Toxicol, Leipzig, Germany.	gabraham@rz.uni-leipzig.de			Federal Ministry for Economic Affairs and Energy and by Frankenforder Forschungsgesellschaft mbH (FFG)	Federal Ministry for Economic Affairs and Energy and by Frankenforder Forschungsgesellschaft mbH (FFG)	Research reported in this work was supported by the Federal Ministry for Economic Affairs and Energy and by Frankenforder Forschungsgesellschaft mbH (FFG). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abraham G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-26; Barton AK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5693205; Bogdanowicz DR, 2013, BIOTECHNOL J, V8, P395, DOI 10.1002/biot.201300054; Bullone M, 2015, MOL IMMUNOL, V66, P97, DOI 10.1016/j.molimm.2014.12.005; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Franke J, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-119; Goto Y, 1999, AM J RESP CELL MOL, V20, P312, DOI 10.1165/ajrcmb.20.2.3062; Haag S, 2008, EUR RESPIR J, V32, P555, DOI 10.1183/09031936.00129307; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holgate Stephen T, 2004, Proc Am Thorac Soc, V1, P93, DOI 10.1513/pats.2306034; Humlicek AL, 2007, J IMMUNOL, V178, P6395, DOI 10.4049/jimmunol.178.10.6395; Leclere M, 2012, AM J RESP CELL MOL, V47, P589, DOI 10.1165/rcmb.2011-0363OC; Malavia NK, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-27; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Nolte SV, 2008, CELLS TISSUES ORGANS, V187, P165, DOI 10.1159/000111805; Osei ET, 2016, EUR RESPIR J, V48, P359, DOI 10.1183/13993003.01911-2015; Papazian D, 2016, INT ARCH ALLERGY IMM, V170, P1, DOI 10.1159/000445833; Setlakwe EL, 2014, AM J PHYSIOL-LUNG C, V307, pL252, DOI 10.1152/ajplung.00019.2014; Shibeshi W, 2008, IN VITRO CELL DEV-AN, V44, P179, DOI 10.1007/s11626-008-9099-8; Skibinski G, 2007, AM J PHYSIOL-LUNG C, V293, pL69, DOI 10.1152/ajplung.00299.2006; Wenzel SE, 2002, J IMMUNOL, V169, P4613, DOI 10.4049/jimmunol.169.8.4613; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Wiszniewski L, 2006, AM J RESP CELL MOL, V34, P39, DOI 10.1165/rcmb.2005-0161OC; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225025	10.1371/journal.pone.0225025	http://dx.doi.org/10.1371/journal.pone.0225025			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721813	Green Published, gold			2022-12-26	WOS:000532720700036
J	Kim, CH; Kim, JS; Choi, Y; Kyong, JS; Kim, Y; Yi, SW; Chung, CK				Kim, Chan Hee; Kim, June Sic; Choi, Yunhee; Kyong, Jeong-Sug; Kim, Youn; Yi, Suk Won; Chung, Chun Kee			Change in left inferior frontal connectivity with less unexpected harmonic cadence by musical expertise	PLOS ONE			English	Article							PITCH PERCEPTION; BRAIN; SYNTAX; MUSICIANS; RESPONSES	In terms of harmonic expectancy, compared to an expected dominant-to-tonic and an unexpected dominant-to-supertonic, a dominant-to-submediant is a less unexpected cadence, the perception of which may depend on the subject's musical expertise. The present study investigated how aforementioned 3 different cadences are processed in the networks of bilateral inferior frontal gyri (IFGs) and superior temporal gyri (STGs) with magnetoencephalography. We compared the correct rate and brain connectivity in 9 music-majors (mean age, 23.5 +/- 3.4 years; musical training period, 18.7 +/- 4.0 years) and 10 non-music-majors (mean age, 25.2 +/- 2.6 years; musical training period, 4.2 +/- 1.5 years). For the brain connectivity, we computed the summation of partial directed coherence (PDC) values for inflows/ outflows to/from each area (sPDC(i)/sPDC(o)) in bilateral IFGs and STGs. In the behavioral responses, music-majors were better than non-music-majors for all 3 cadences (p < 0.05). However, sPDC(i)/sPDC(o) was prominent only for the dominant-to-submediant in the left IFG. The sPDC(i) was more strongly enhanced in music-majors than in non-music-majors (p = 0.002, Bonferroni corrected), while the sPDC(o) was vice versa (p = 0.005, Bonferroni corrected). Our data show that music-majors, with higher musical expertise, are better in identifying a less unexpected cadence than non-music-majors, with connectivity changes centered on the left IFG.	[Kim, Chan Hee; Chung, Chun Kee] Seoul Natl Univ, Interdisciplinary Program Neurosci, Coll Nat Sci, Seoul, South Korea; [Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea; [Kim, June Sic] Seoul Natl Univ, Res Inst Basic Sci, Seoul, South Korea; [Choi, Yunhee] Seoul Natl Univ, Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Coll Med, Seoul, South Korea; [Kyong, Jeong-Sug; Chung, Chun Kee] Seoul Natl Univ, Neurosci Res Inst, Med Res Ctr, Seoul, South Korea; [Kyong, Jeong-Sug] Hallym Univ Grad Studies, Audiol Inst, Seoul, South Korea; [Kim, Youn] Univ Hong Kong, Sch Humanities, Dept Mus, Hong Kong, Peoples R China; [Yi, Suk Won] Seoul Natl Univ, Coll Mus, Seoul, South Korea; [Yi, Suk Won] Seoul Natl Univ, Western Mus Res Inst, Seoul, South Korea; [Chung, Chun Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hallym University; University of Hong Kong; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Chung, CK (corresponding author), Seoul Natl Univ, Interdisciplinary Program Neurosci, Coll Nat Sci, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ, Neurosci Res Inst, Med Res Ctr, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea.	chungc@snu.ac.kr	; Kim, Youn/A-8440-2010	Kim, Chan Hee/0000-0001-5395-7613; Kim, Youn/0000-0003-4133-5360	Seoul National University	Seoul National University	This work was supported by Seoul National University Research Grant in 2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Bhattacharya J, 2005, SIGNAL PROCESS, V85, P2161, DOI 10.1016/j.sigpro.2005.07.007; Biancorosso G, 2008, MUSIC LETT, V89, P396, DOI 10.1093/ml/gcn015; Dohn A, 2015, CEREB CORTEX, V25, P1379, DOI 10.1093/cercor/bht334; Evers S, 1999, BRAIN, V122, P75, DOI 10.1093/brain/122.1.75; Huron DB, 2006, SWEET ANTICIPATION M, Vxii; Jancke L, 2012, J COGNITIVE NEUROSCI, V24, P1447, DOI 10.1162/jocn_a_00227; James CE, 2008, NEUROIMAGE, V42, P1597, DOI 10.1016/j.neuroimage.2008.06.025; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Jentschke S, 2009, NEUROIMAGE, V47, P735, DOI 10.1016/j.neuroimage.2009.04.090; Kim CH, 2014, BRAIN RES, V1560, P36, DOI 10.1016/j.brainres.2014.02.045; Kim SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017337; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; Koelsch S, 2008, BRAIN RES, V1212, P55, DOI 10.1016/j.brainres.2007.10.078; Koelsch S, 2010, J COGNITIVE NEUROSCI, V22, P2251, DOI 10.1162/jocn.2009.21338; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Murphy HA, 1951, CREATIVE HARMONY MUS, Vxix; Nan Y, 2008, HUM BRAIN MAPP, V29, P312, DOI 10.1002/hbm.20390; Obleser J, 2011, NEUROIMAGE, V56, P2310, DOI 10.1016/j.neuroimage.2011.03.035; Patel AD, 2001, NAT NEUROSCI, V4, P839, DOI 10.1038/90557; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Piston W, 1987, HARMONY, Vxvi; Rohrmeier MA, 2007, P SMC 07 4 SOUND MUS; Sammler D, 2009, ANN NY ACAD SCI, V1169, P494, DOI 10.1111/j.1749-6632.2009.04792.x; Sammler D, 2011, CORTEX, V47, P659, DOI 10.1016/j.cortex.2010.04.007; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Sears D, 2014, MUSIC PERCEPT, V31, P397, DOI 10.1525/MP.2014.31.5.397; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2009, HUM BRAIN MAPP, V30, P1524, DOI 10.1002/hbm.20627	31	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0223283	10.1371/journal.pone.0223283	http://dx.doi.org/10.1371/journal.pone.0223283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1MV	31714920	Green Published, gold			2022-12-26	WOS:000532710400003
J	Li, C; Xu, J; Deng, Y; Sun, HY; Li, YD				Li, Chen; Xu, Jian; Deng, Yu; Sun, Haiyue; Li, Yadong			Selection of reference genes for normalization of cranberry (Vaccinium macrocarpon Ait.) gene expression under different experimental conditions	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; QUANTITATIVE PCR; RT-PCR; QUANTIFICATION; IDENTIFICATION; TECHNOLOGY	Real-time fluorescent quantitative PCR (qRT-PCR) is often chosen as an effective experimental method for analyzing gene expression. However, an appropriate reference gene as a standard is needed to obtain accurate gene expression data. To date, no internal reference genes have been reported for research on cranberries. Expanding the selection of internal reference genes for cranberry will enable reliable gene expression analysis, and, at the same time, can also lay a solid foundation for revealing the biological characteristics of cranberry. Here, we selected ten candidate reference gene families and used three statistical software tools-geNorm, NormFinder and BestKeeper-to evaluate their expression stability under the influence of different experimental factors. The results showed that protein phosphatase 2A regulatory subunit (PP2A) or RNA helicase-like 8 (RH 8) was the best choice for an internal reference gene when analyzing different cranberry cultivars. In two sample sets comprising different cranberry organs and three abiotic stress treatments, sand family protein (SAND) was the best choice as a reference gene. In this study, we screened genes that are stably expressed under the influence of various experimental factors by qRT-PCR. Our results will guide future studies involving gene expression analysis of cranberry.	[Li, Chen; Xu, Jian; Sun, Haiyue; Li, Yadong] Jilin Agr Univ, Coll Hort, Engn Ctr Genet Breeding & Innovat Utilizat Small, Changchun, Peoples R China; [Deng, Yu] Jilin Agr Univ, Coll Life Sci, Changchun, Peoples R China	Jilin Agricultural University; Jilin Agricultural University	Sun, HY; Li, YD (corresponding author), Jilin Agr Univ, Coll Hort, Engn Ctr Genet Breeding & Innovat Utilizat Small, Changchun, Peoples R China.	haiyue-sun@hotmail.com; blueberryli@163.com			Project of Science and Technology Development of Jilin Province, China [20170414023GH, 20180201076NY]	Project of Science and Technology Development of Jilin Province, China	This work was supported by the Project of Science and Technology Development of Jilin Province, China (20170414023GH and 20180201076NY).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Diretto G, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-11; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; He XJ, 2006, J AGR FOOD CHEM, V54, P7069, DOI 10.1021/jf061058l; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; ROYEEN CB, 1986, AM J OCCUP THER, V40, P569, DOI 10.5014/ajot.40.8.569; Sun HY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1842-4; Thellin O, 2009, BIOTECHNOL ADV, V27, P323, DOI 10.1016/j.biotechadv.2009.01.010; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vashisth T, 2011, PLANT CELL REP, V30, P2167, DOI 10.1007/s00299-011-1121-z; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Zhang YJ, 2007, PROG BIOCHEM BIOPHYS, V34, P546; Zhong W, 2004, ENV HYGIENE, V31, P370; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	30	4	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224798	10.1371/journal.pone.0224798	http://dx.doi.org/10.1371/journal.pone.0224798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31715627	Green Published, gold			2022-12-26	WOS:000532710400014
J	Castaneda, ARS; Torres, ER; Goris, NAV; Gonzalez, MM; Reyes, JB; Gonzalez, VGS; Schonbek, M; Montijano, JI; Cabrales, LEB				Selva Castaneda, Antonio Rafael; Torres, Erick Ramirez; Villar Goris, Narciso Antonio; Gonzalez, Maraelys Morales; Reyes, Juan Bory; Sierra Gonzalez, Victoriano Gustavo; Schonbek, Maria; Montijano, Juan Ignacio; Bergues Cabrales, Luis Enrique			New formulation of the Gompertz equation to describe the kinetics of untreated tumors	PLOS ONE			English	Article							GROWTH; CANCER; CONTOURS; FRACTALS; MASSES; CURVE	Background Different equations have been used to describe and understand the growth kinetics of undisturbed malignant solid tumors. The aim of this paper is to propose a new formulation of the Gompertz equation in terms of different parameters of a malignant tumor: the intrinsic growth rate, the deceleration factor, the apoptosis rate, the number of cells corresponding to the tumor latency time, and the fractal dimensions of the tumor and its contour. Methods Furthermore, different formulations of the Gompertz equation are used to fit experimental data of the Ehrlich and fibrosarcoma Sa-37 tumors that grow in male BALB/c/Cenp mice. The parameters of each equation are obtained from these fittings. Results The new formulation of the Gompertz equation reveals that the initial number of cancerous cells in the conventional Gompertz equation is not a constant but a variable that depends nonlinearly on time and the tumor deceleration factor. In turn, this deceleration factor depends on the apoptosis rate of tumor cells and the fractal dimensions of the tumor and its irregular contour. Conclusions It is concluded that this new formulation has two parameters that are directly estimated from the experiment, describes well the growth kinetics of unperturbed Ehrlich and fibrosarcoma Sa-37 tumors, and confirms the fractal origin of the Gompertz formulation and the fractal property of tumors.	[Selva Castaneda, Antonio Rafael; Montijano, Juan Ignacio; Bergues Cabrales, Luis Enrique] Univ Zaragoza, Inst Univ Matemat & Aplicac, Dept Matemat Aplicada, Zaragoza, Spain; [Selva Castaneda, Antonio Rafael] Univ Oriente, Fac Ingn Telecomunicac Informat & Biomed, Dept Telecomunicac, Santiago De Cuba, Cuba; [Torres, Erick Ramirez] Univ Oriente, Fac Ingn Telecomunicac Informat & Biomed, Dept Biomed, Santiago De Cuba, Cuba; [Villar Goris, Narciso Antonio] Univ Autonoma Santo Domingo, Santo Domingo, Dominican Rep; [Villar Goris, Narciso Antonio] Univ Catolica Tecnol CIBAO, Ucateci, La Vega, Dominican Rep; [Villar Goris, Narciso Antonio; Bergues Cabrales, Luis Enrique] Univ Oriente, Ctr Nacl Electromagnetismo Aplicado, Dept Ciencia & Innovac, Santiago De Cuba, Cuba; [Gonzalez, Maraelys Morales] Univ Oriente, Fac Ciencias Nat & Exactas, Dept Farm, Santiago De Cuba, Cuba; [Reyes, Juan Bory] Inst Politecn Nacl, ESIME Zacatenco, Cd Mx, Mexico; [Sierra Gonzalez, Victoriano Gustavo] Grp Ind Biotecnol & Farmaceut BioCubaFarma, Havana, Cuba; [Schonbek, Maria] Univ Calif Santa Cruz, Dept Math, Santa Cruz, CA 95064 USA	University of Zaragoza; Universidad de Oriente Santiago de Cuba; Universidad de Oriente Santiago de Cuba; Universidad Autonoma de Santo Domingo; Universidad de Oriente Santiago de Cuba; Universidad de Oriente Santiago de Cuba; University of California System; University of California Santa Cruz	Montijano, JI; Cabrales, LEB (corresponding author), Univ Zaragoza, Inst Univ Matemat & Aplicac, Dept Matemat Aplicada, Zaragoza, Spain.; Cabrales, LEB (corresponding author), Univ Oriente, Ctr Nacl Electromagnetismo Aplicado, Dept Ciencia & Innovac, Santiago De Cuba, Cuba.	monti@unizar.es; berguesc@yahoo.com	Reyes, Juan Bory/K-7658-2017; Bory-Reyes, Juan/HGA-6623-2022; Montijano, Juan Ignacio/B-8873-2014	Reyes, Juan Bory/0000-0002-7004-1794; Montijano, Juan Ignacio/0000-0001-6120-4427; Selva Castaneda, Antonio Rafael/0000-0001-5436-1897; Villar Goris, Narciso Antonio/0000-0003-0161-3565	Oriente University, Cuba [7227, 7228]; MINECO, Spain [MTM2016-77735-C3-1-P]	Oriente University, Cuba; MINECO, Spain	This work has been partially supported by the Oriente University, Cuba, under the grants #7227 and 7228, Cuba, and MINECO, Spain, under the Project MTM2016-77735-C3-1-P. The University of the East paid for the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baish JW, 2000, CANCER RES, V60, P3683; Cabrales LEB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-589; Cabrales LEB, 2008, MATH COMPUT SIMULAT, V78, P112, DOI 10.1016/j.matcom.2007.06.004; Breki CM, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0216-5; Cabrales LEB, 2003, THESIS; Ciria HC, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-87; Cotran RS, 1999, PATOLOGIA ESTRUCTURA, P277; d'Onofrio A, 2009, CHAOS SOLITON FRACT, V41, P875, DOI 10.1016/j.chaos.2008.04.014; Enderling H, 2014, CURR PHARM DESIGN, V20, P4934; EtehadTavakol M, 2010, J HEALTHC ENG, V1, P27, DOI 10.1260/2040-2295.1.1.27; Falconer K, 2003, MATH FDN APPL, P33; GAZIT Y, 1995, PHYS REV LETT, V75, P2428, DOI 10.1103/PhysRevLett.75.2428; Grizzi F, 2015, FRACTAL GEOMETRY NON, V1, P16; Hahnfeldt P, 1999, CANCER RES, V59, P4770; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang DS, 2015, INT J CLIN EXP MED, V8, P8369; Izquierdo-Kulich E, 2013, REV CUB FIS, V30, P26; Izquierdo-Kulich E, 2009, MATH BIOSCI ENG, V6, P547, DOI 10.3934/mbe.2009.6.547; Kremheller J, 2018, COMPUT METHOD APPL M, V340, P657, DOI 10.1016/j.cma.2018.06.009; Molski M., 2012, CHAOTIC MODEL SIMUL, V1, P169; Mombach JCM, 2002, EUROPHYS LETT, V59, P923, DOI 10.1209/epl/i2002-00244-6; Gonzalez MM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3159-y; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Perthame B., 2014, SOME MATH MODELS TUM, P23; Rangayyan RM, 2007, J DIGIT IMAGING, V20, P223, DOI 10.1007/s10278-006-0860-9; Ribeiro F. L., 2017, REV BRAS ENSINO FIS, V39, P1311; Ribeiro FL, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042406; Ribeiro FL, 2015, B MATH BIOL, V77, P409, DOI 10.1007/s11538-014-0059-z; Shim EB, 2007, PREPRINT; Sokolov I, 2015, FUTURE ONCOL, V11, P3049, DOI 10.2217/fon.15.211; Steel GG, 1997, BASIC CLIN RADIOBIOL, P1; Stepien R, 2010, BIOCYBERN BIOMED ENG, V30, P49; Tjorve KMC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178691; Verma A, 2017, INT COMMUN HEAT MASS, V81, P51, DOI 10.1016/j.icheatmasstransfer.2016.11.008; Waliszewski P, 2003, CHAOS SOLITON FRACT, V16, P665, DOI 10.1016/S0960-0779(02)00469-1; Win TT, 2014, SOUTH ASIAN J CANCER, V3, P171, DOI 10.4103/2278-330X.136799; Yang WY, 2005, APPLIED NUMERICAL METHODS USING MATLAB (R), P117; Zhong JT, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317697562	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224978	10.1371/journal.pone.0224978	http://dx.doi.org/10.1371/journal.pone.0224978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31715625	Green Published, gold			2022-12-26	WOS:000532710400022
J	Subotic, S; Boddicker, AM; Nguyen, VM; Rivers, J; Briles, CE; Mosier, AC				Subotic, Sladjana; Boddicker, Andrew M.; Nguyen, Vy M.; Rivers, James; Briles, Christy E.; Mosier, Annika C.			Honey bee microbiome associated with different hive and sample types over a honey production season	PLOS ONE			English	Article							GUT SYMBIONT; FRISCHELLA-PERRARA; COLONY LOSSES; SP NOV.; DIVERSITY; SYSTEM; HOST	Western honey bees (Apis mellifera) are important pollinators in natural and agricultural ecosystems, and yet are in significant decline due to several factors including parasites, pathogens, pesticides, and habitat loss. A new beehive construction called the FlowTM hive was developed in 2015 to allow honey to be harvested directly from the hive without opening it, resulting in an apparent decrease in stress to the bees. Here, we compared the Flow and traditional Langstroth hive constructions to determine if there were any significant differences in the bee microbiome. The bee-associated bacterial communities did not differ between hive constructions and varied only slightly over the course of a honey production season. Samples were dominated by taxa belonging to the Lactobacillus, Bifidobacterium, Bartonella, Snodgrassella, Gilliamella, and Frischella genera, as observed in previous studies. The top ten most abundant taxa made up the majority of the sequence data; however, many low abundance organisms were persistent across the majority of samples regardless of sampling time or hive type. We additionally compared different preparations of whole bee and dissected bee samples to elaborate on previous bee microbiome research. We found that bacterial sequences were overwhelming derived from the bee guts, and microbes on the bee surfaces (including pollen) contributed little to the overall microbiome of whole bees. Overall, the results indicate that different hive constructions and associated disturbance levels do not influence the bee gut microbiome, which has broader implications for supporting hive health.	[Subotic, Sladjana; Boddicker, Andrew M.; Nguyen, Vy M.; Rivers, James; Mosier, Annika C.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Briles, Christy E.] Univ Colorado, Dept Geog & Environm Sci, Denver, CO 80202 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Mosier, AC (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	annika.mosier@ucdenver.edu		Boddicker, Andrew/0000-0001-7957-8283; Mosier, Annika/0000-0001-5333-4854	University of Colorado, Denver (College of Liberal Arts and Sciences); University of Colorado, Denver (Undergraduate Research Opportunity Program)	University of Colorado, Denver (College of Liberal Arts and Sciences); University of Colorado, Denver (Undergraduate Research Opportunity Program)	Funding was provided by the University of Colorado, Denver (through the College of Liberal Arts and Sciences and the Undergraduate Research Opportunity Program). Flow frame kits were provided by BeeInventive Pty Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WHITE HOUSE FACT SHE; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CLARK TB, 1978, AM BEE J, V118, P18; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Emery O, 2017, MOL ECOL, V26, P2576, DOI 10.1111/mec.14058; Engel P, 2015, MBIO, V6, DOI 10.1128/mBio.00193-15; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Galac MR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-612; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Hammer TJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1190; Hung KLJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2140; Jones JC, 2018, ECOL EVOL, V8, P441, DOI 10.1002/ece3.3597; Kesnerova L, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003467; Kesnerova L, 2016, INT J SYST EVOL MICR, V66, P414, DOI 10.1099/ijsem.0.000736; Khan KA, 2017, SAUDI J BIOL SCI, V24, P1061, DOI 10.1016/j.sjbs.2017.01.055; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Kwong WK, 2014, P NATL ACAD SCI USA, V111, P11509, DOI 10.1073/pnas.1405838111; Lopez-Uribe MM, 2017, CONSERV GENET, V18, P659, DOI 10.1007/s10592-017-0942-x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludvigsen J, 2015, MICROBES ENVIRON, V30, P235, DOI 10.1264/jsme2.ME15019; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Morimoto T, 2011, ECOL EVOL, V1, P201, DOI 10.1002/ece3.21; Naqib A, 2018, METHODS MOL BIOL, V1783, P149, DOI 10.1007/978-1-4939-7834-2_7; National Research Council, 2007, STAT POLL N AM; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Raymann K, 2018, CURR OPIN INSECT SCI, V26, P97, DOI 10.1016/j.cois.2018.02.012; Raymann K, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001861; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schwarz RS, 2014, MICROBIOLOGYOPEN, V3, P341, DOI 10.1002/mbo3.172; Segers FHID, 2017, ISME J, V11, P1232, DOI 10.1038/ismej.2016.201; Simone-Finstrom M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32023; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Youngsteadt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142031	52	11	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0223834	10.1371/journal.pone.0223834	http://dx.doi.org/10.1371/journal.pone.0223834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703071	Green Published, Green Submitted, gold			2022-12-26	WOS:000532697200007
J	Kim, IY; Grodstein, F; Kraft, P; Curhan, GC; Hughes, KC; Huang, HY; Kang, JH; Hunter, DJ				Kim, Iris Y.; Grodstein, Francine; Kraft, Peter; Curhan, Gary C.; Hughes, Katherine C.; Huang, Hongyan; Kang, Jae H.; Hunter, David J.			Interaction between apolipoprotein E genotype and hypertension on cognitive function in older women in the Nurses' Health Study	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; HIGH BLOOD-PRESSURE; APOE GENOTYPE; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; DECLINE; EPSILON-4; ASSOCIATION; ALLELE; IMPAIRMENT	Objective To examine the interaction between APOE genotypes and both treated and untreated hypertension on cognitive function in an updated analysis of Nurses' Health Study (NHS) data. Design At baseline (1995-2001) and 3 biennial follow-up assessments over similar to 6 years, cognitive function was assessed. Setting and participants 8300 NHS participants aged 70+ years underwent a cognitive battery, which comprised 6 tests including the Telephone Interview for Cognitive Status (TICS) and tests of verbal memory, category fluency, and working memory. Measures We estimated the mean differences in average cognitive scores across up to 4 assessments using multiple linear regression. We also tested for interaction between APOE e4 allele carrier status and hypertension overall, as well as for apparently untreated and treated hypertension. Results We confirmed that, compared with those with APOE e3/3 genotype, APOE e4 allele carriers scored lower by 0.55 units on the average TICS score (95%CI:-0.67,-0.43). We also observed a significantly worse average TICS score among women with untreated hypertension compared with women without hypertension (difference = -0.23, 95%CI:-0.37,-0.09), while no significant difference was observed for women with treated hypertension. Significant interaction was detected between the APOE e4 allele and untreated hypertension (p- int = 0.02 for the TICS; p-int = 0.045 for global score), but not with treated hypertension. Specifically, compared with normotensive women with the APOE e3/3 genotype, APOE e4 allele carriers with treated hypertension scored lower by 0.50 units (95%CI:-0.69,-0.31); however, the APOE e4 allele carriers with untreated hypertension scored lower by 1.02 units on the TICS score (95%CI:-1.29, -0.76). This interaction of APOE e4 and untreated hypertension was also consistently observed for the global score. Conclusions Women with hypertension and at least one APOE e4 allele had worse average cognitive function compared with women without hypertension with the e3/3 genotype; this difference was amplified among APOE e4 allele carriers with untreated hypertension.	[Kim, Iris Y.; Grodstein, Francine; Kraft, Peter; Curhan, Gary C.; Huang, Hongyan; Hunter, David J.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kim, Iris Y.; Hunter, David J.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Grodstein, Francine; Curhan, Gary C.; Kang, Jae H.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Grodstein, Francine; Curhan, Gary C.; Kang, Jae H.; Hunter, David J.] Harvard Med Sch, Boston, MA 02115 USA; [Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hughes, Katherine C.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kim, IY (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Kim, IY (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.	iykim@mail.harvard.edu	Kraft, Peter/GQH-8448-2022	Kim, Iris/0000-0001-6210-2684; Kang, Jae/0000-0003-4812-0557	NIH [UM1 CA186107]; Harvard-Oxford Program in Epidemiology; NATIONAL CANCER INSTITUTE [UM1CA186107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard-Oxford Program in Epidemiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH grants UM1 CA186107, and the Harvard-Oxford Program in Epidemiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S, 2015, J ALZHEIMERS DIS, V44, P1087, DOI 10.3233/JAD-140630; Aronow WS, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.99; Bangen KJ, 2013, J STROKE CEREBROVASC, V22, P1361, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.013; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Frias CM, 2014, PSYCHOL AGING, V29, P431, DOI 10.1037/a0036828; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FIEBACH NH, 1989, AM J EPIDEMIOL, V130, P646; Gao X, 2009, ANN NEUROL, V65, P76, DOI 10.1002/ana.21535; Goldman JS, 2011, GENET MED, V13, P597, DOI 10.1097/GIM.0b013e31821d69b8; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Haring B, 2016, AM J HYPERTENS, V29, P202, DOI 10.1093/ajh/hpv081; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Hughes TM, 2016, AM J HYPERTENS, V29, P149, DOI 10.1093/ajh/hpv180; Iadecola C, 2016, HYPERTENSION, V68, pE67, DOI 10.1161/HYP.0000000000000053; Kalmijn S, 1996, STROKE, V27, P2230, DOI 10.1161/01.STR.27.12.2230; Kang JE, 2005, NEUROBIOL AGING, V26, P475, DOI 10.1016/j.neurobiolaging.2004.05.003; Kang JH, 2003, NEUROLOGY, V60, P1591; Kester MI, 2010, J ALZHEIMERS DIS, V20, P1083, DOI 10.3233/JAD-2010-091198; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Korrick SA, 1999, AM J PUBLIC HEALTH, V89, P330, DOI 10.2105/AJPH.89.3.330; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; Lindstrom S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173997; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; MCDONALD LM, 2017, J HYPERTENS, P35; Nation DA, 2016, ALZ DIS ASSOC DIS, V30, P210, DOI 10.1097/WAD.0000000000000127; Peila R, 2001, STROKE, V32, P2882, DOI 10.1161/hs1201.100392; Qiu CX, 2003, NEUROLOGY, V61, P655, DOI 10.1212/WNL.61.5.655; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rodrigue KM, 2013, JAMA NEUROL, V70, P600, DOI 10.1001/jamaneurol.2013.1342; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Skoog I, 1998, DEMENT GERIATR COGN, V9, P13, DOI 10.1159/000051184; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Tadic M, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0386-0; Tzourio C, 1999, NEUROLOGY, V53, P1948, DOI 10.1212/WNL.53.9.1948; Wang R, 2015, NEUROLOGY, V84, P1128, DOI 10.1212/WNL.0000000000001379; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442; Yasuno F, 2012, NEUROBIOL AGING, V33, P2633, DOI 10.1016/j.neurobiolaging.2011.12.028	42	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224975	10.1371/journal.pone.0224975	http://dx.doi.org/10.1371/journal.pone.0224975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697783	Green Published, gold			2022-12-26	WOS:000532694400086
J	Bhatnagar, K; Wong, A				Bhatnagar, Kamya; Wong, Alex			The mutational landscape of quinolone resistance in Escherichia coli	PLOS ONE			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; DNA-GYRASE; FLUOROQUINOLONE RESISTANCE; FITNESS COSTS; COMPENSATORY MUTATIONS; STAPHYLOCOCCUS-AUREUS; FLUCTUATION ANALYSIS; NEGATIVE REGULATOR; ADAPTIVE EVOLUTION; DETERMINING REGION	The evolution of antibiotic resistance is influenced by a variety of factors, including the availability of resistance mutations, and the pleiotropic effects of such mutations. Here, we isolate and characterize chromosomal quinolone resistance mutations in E. coli, in order to gain a systematic understanding of the rate and consequences of resistance to this important class of drugs. We isolated over fifty spontaneous resistance mutants on nalidixic acid, ciprofloxacin, and levofloxacin. This set of mutants includes known resistance mutations in gyrA, gyrB, and marR, as well as two novel gyrB mutations. We find that, for most mutations, resistance tends to be higher to nalidixic acid than relative to the other two drugs. Resistance mutations had deleterious impacts on one or more growth parameters, suggesting that quinolone resistance mutations are generally costly. Our findings suggest that the prevalence of specific gyrA alleles amongst clinical isolates are driven by high levels of resistance, at no more cost than other resistance alleles.	[Bhatnagar, Kamya; Wong, Alex] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Carleton University	Wong, A (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	alex.wong@carleton.ca			Natural Sciences and Engineering Research Council (NSERC) [435248]; Canadian Institutes for Health Research (CIHR) [141995]; Ontario Graduate Scholarship (OGS)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	This work was funded by a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant 435248 to AW, a Canadian Institutes for Health Research (CIHR) New Investigator Award 141995 to AW, and by an Ontario Graduate Scholarship (OGS) to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 1999, J BACTERIOL, V181, P3303, DOI 10.1128/JB.181.10.3303-3306.1999; Alekshun MN, 2000, MOL MICROBIOL, V35, P1394, DOI 10.1046/j.1365-2958.2000.01802.x; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Andersson MI, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg212; Azema J, 2011, EUR J MED CHEM, V46, P6025, DOI 10.1016/j.ejmech.2011.10.014; Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868, DOI 10.1128/AAC.43.4.868; Barnard FM, 2001, ANTIMICROB AGENTS CH, V45, P1994, DOI 10.1128/AAC.45.7.1994-2000.2001; Bartlett JG, 2013, CLIN INFECT DIS, V56, P1445, DOI 10.1093/cid/cit070; Basra P, 2018, GENOME BIOL EVOL, V10, P667, DOI 10.1093/gbe/evy030; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Betitra Y, 2014, ASIAN PAC J TROP MED, V7, P462, DOI 10.1016/S1995-7645(14)60075-4; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyd LB, 2009, ANTIMICROB AGENTS CH, V53, P229, DOI 10.1128/AAC.00722-08; Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468; Canadian antimicrobial resistance alliance (CARA), 2015, CANW SUSC REP; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; COHEN SP, 1993, J BACTERIOL, V175, P1484, DOI 10.1128/JB.175.5.1484-1492.1993; DOMAGALA JM, 1994, J ANTIMICROB CHEMOTH, V33, P685, DOI 10.1093/jac/33.4.685; Dong YZ, 1999, ANTIMICROB AGENTS CH, V43, P1756, DOI 10.1128/AAC.43.7.1756; Everett MJ, 1996, ANTIMICROB AGENTS CH, V40, P2380, DOI 10.1128/AAC.40.10.2380; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; Friedman SM, 2001, ANTIMICROB AGENTS CH, V45, P2378, DOI 10.1128/AAC.45.8.2378-2380.2001; Fukuda H, 1999, ANTIMICROB AGENTS CH, V43, P410, DOI 10.1128/AAC.43.2.410; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; GENSBERG K, 1995, FEMS MICROBIOL LETT, V132, P57, DOI 10.1016/0378-1097(95)00287-F; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gould IM, 2013, VIRULENCE, V4, P185, DOI 10.4161/viru.22507; Gross M, 2013, CURR BIOL, V23, pR1063, DOI 10.1016/j.cub.2013.11.057; Gubaev A, 2014, DNA REPAIR, V16, P23, DOI 10.1016/j.dnarep.2014.01.011; Hall AR, 2011, GENETICS, V187, P817, DOI 10.1534/genetics.110.124628; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; HALLETT P, 1991, ANTIMICROB AGENTS CH, V35, P335, DOI 10.1128/AAC.35.2.335; Heddle J, 2002, ANTIMICROB AGENTS CH, V46, P1805, DOI 10.1128/AAC.46.6.1805-1815.2002; HEISIG P, 1994, ANTIMICROB AGENTS CH, V38, P1284, DOI 10.1128/AAC.38.6.1284; Heisig P, 1996, ANTIMICROB AGENTS CH, V40, P879, DOI 10.1128/AAC.40.4.879; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; Hooper DC, 1995, ADV EXP MED BIOL, V390, P49; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; Jorgensen JH, 1999, ANTIMICROB AGENTS CH, V43, P329, DOI 10.1128/AAC.43.2.329; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Kugelberg E, 2005, J ANTIMICROB CHEMOTH, V55, P22, DOI 10.1093/jac/dkh505; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazar V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.57; Levin BR, 2000, GENETICS, V154, P985; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgren PK, 2005, ANTIMICROB AGENTS CH, V49, P2343, DOI 10.1128/AAC.49.6.2343-2351.2005; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; Lu T, 1999, ANTIMICROB AGENTS CH, V43, P2969, DOI 10.1128/AAC.43.12.2969; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; Luria SE, 1943, GENETICS, V28, P491; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; MacLean R. Craig, 2015, Evolution Medicine and Public Health, P4, DOI 10.1093/emph/eou032; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; MAXWELL A, 1992, J ANTIMICROB CHEMOTH, V30, P409, DOI 10.1093/jac/30.4.409; Melnyk AH, 2015, EVOL APPL, V8, P273, DOI 10.1111/eva.12196; Michot JM, 2005, ANTIMICROB AGENTS CH, V49, P2429, DOI 10.1128/AAC.49.6.2429-2437.2005; Moon DC, 2010, INT J ANTIMICROB AG, V35, P76, DOI 10.1016/j.ijantimicag.2009.08.003; Morgan-Linnell SK, 2007, ANTIMICROB AGENTS CH, V51, P4205, DOI 10.1128/AAC.00647-07; Morgan-Linnell SK, 2009, ANTIMICROB AGENTS CH, V53, P235, DOI 10.1128/AAC.00665-08; NAKAMURA S, 1989, ANTIMICROB AGENTS CH, V33, P254, DOI 10.1128/AAC.33.2.254; ORAM M, 1991, ANTIMICROB AGENTS CH, V35, P387, DOI 10.1128/AAC.35.2.387; Pal C, 2015, TRENDS MICROBIOL, V23, P401, DOI 10.1016/j.tim.2015.02.009; Pestova E, 2000, J ANTIMICROB CHEMOTH, V45, P583, DOI 10.1093/jac/45.5.583; Peterson LR, 2001, CLIN INFECT DIS, V33, pS180, DOI 10.1086/321846; Piddock LJV, 2012, LANCET INFECT DIS, V12, P249, DOI 10.1016/S1473-3099(11)70316-4; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; Reynolds MG, 2000, GENETICS, V156, P1471; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Sanders CC, 2001, CLIN INFECT DIS, V32, pS1, DOI 10.1086/319369; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; Sissi C, 2010, CELL MOL LIFE SCI, V67, P2001, DOI 10.1007/s00018-010-0299-5; Stanger FV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107289; SULAVIK MC, 1995, MOL MED, V1, P436, DOI 10.1007/BF03401581; SULLIVAN EA, 1995, LANCET, V345, P1148, DOI 10.1016/S0140-6736(95)90980-X; Tenover FC, 2006, AM J INFECT CONTROL, V34, pS3, DOI 10.1016/j.ajic.2006.05.219; Tillotson GS, 1996, J MED MICROBIOL, V44, P320, DOI 10.1099/00222615-44-5-320; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; Vila J, 1996, ANTIMICROB AGENTS CH, V40, P491, DOI 10.1128/AAC.40.2.491; Viswanathan VK, 2014, GUT MICROBES, V5, P3, DOI 10.4161/gmic.28027; Vogwill T, 2015, EVOL APPL, V8, P284, DOI 10.1111/eva.12202; Weigel LM, 2002, ANTIMICROB AGENTS CH, V46, P2582, DOI 10.1128/AAC.46.8.2582-2587.2002; Wilke CO, 2004, GENETICS, V167, P2045, DOI 10.1534/genetics.104.027136; Winkler J, 2012, METAB ENG, V14, P487, DOI 10.1016/j.ymben.2012.07.004; Wong A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002928; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; YOSHIDA H, 1990, J BACTERIOL, V172, P6942, DOI 10.1128/jb.172.12.6942-6949.1990; YOSHIDA H, 1991, ANTIMICROB AGENTS CH, V35, P1647, DOI 10.1128/AAC.35.8.1647; Zhang QJ, 2006, MICROBES INFECT, V8, P1972, DOI 10.1016/j.micinf.2005.12.031; Zhao XL, 2001, CLIN INFECT DIS, V33, pS147, DOI 10.1086/321841; Zhao XL, 1998, ANTIMICROB AGENTS CH, V42, P956, DOI 10.1128/AAC.42.4.956; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0	104	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224650	10.1371/journal.pone.0224650	http://dx.doi.org/10.1371/journal.pone.0224650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689338	Green Published, gold			2022-12-26	WOS:000532680100035
J	Salataj, E; Stathopoulou, C; Hafporsson, RA; Nikolaou, C; Spilianakis, CG				Salataj, Eralda; Stathopoulou, Chrysoula; Hafporsson, Robert A.; Nikolaou, Christoforos; Spilianakis, Charalampos G.			Developmental conservation of microRNA gene localization at the nuclear periphery	PLOS ONE			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; NONCODING RNAS; GENOME ORGANIZATION; DOMAIN ORGANIZATION; LAMINA INTERACTIONS; KEY REGULATORS; STEM-CELLS; CHROMATIN; EXPRESSION	microRNAs are of vital importance for the regulation of the adaptive and innate immune responses, modulating gene expression at the post transcriptional level. Although there is cumulative information regarding the steady state mature microRNA levels and their respective targets, little is known about the effect of the three-dimensional chromatin architecture on the transcriptional regulation of microRNA gene loci. Here, we sought to investigate the effect of subnuclear localization on the transcriptional activation of eight murine microRNA loci in the immune system. Our results show that microRNA genes display a preferential monoallelic gene expression profile accompanied with perinuclear localization irrespectively of their transcription status or differentiation state. The expression profile and perinuclear localization are developmentally conserved while microRNA gene loci localization outside constitutive lamin associated domains is cross-species conserved. Our findings provide support for an active nuclear periphery and its role in chromatin organization of the non-coding genome.	[Salataj, Eralda; Stathopoulou, Chrysoula; Nikolaou, Christoforos; Spilianakis, Charalampos G.] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Salataj, Eralda; Nikolaou, Christoforos; Spilianakis, Charalampos G.] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Stathopoulou, Chrysoula] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Hafporsson, Robert A.] Lund Univ, Dept Biol, Lund, Sweden	Foundation for Research & Technology - Hellas (FORTH); University of Crete; Democritus University of Thrace; Lund University	Spilianakis, CG (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece.; Spilianakis, CG (corresponding author), Univ Crete, Dept Biol, Iraklion, Crete, Greece.	spiliana@imbb.forth.gr	Spilianakis, Charalampos G/C-9893-2011	Spilianakis, Charalampos G/0000-0003-0921-1923; SALATAJ, ERALDA/0000-0001-8661-1686	CGS; European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program THALES (miREG) [Mis: 380247]; Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program ARISTEIA [MIRACLE 42]	CGS; European Union (European Social Fund ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program THALES (miREG); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program ARISTEIA	This research is funded by CGS, European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Programs THALES (miREG, Mis: 380247) and ARISTEIA (MIRACLE 42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Amendola M, 2015, EMBO REP, V16, P610, DOI 10.15252/embr.201439789; Andreadis C, 2014, NUCLEIC ACIDS RES, V42, P12650, DOI 10.1093/nar/gku915; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohmdorfer G, 2015, TRENDS CELL BIOL, V25, P623, DOI 10.1016/j.tcb.2015.07.002; Breuer M, 2015, GENE DEV, V29, P1789, DOI 10.1101/gad.264341.115; Buchwalter A, 2019, NAT REV GENET, V20, P39, DOI 10.1038/s41576-018-0063-5; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; D'Angelo MA, 2018, NUCLEUS-PHILA, V9, P142, DOI 10.1080/19491034.2017.1395542; de Vosse DWV, 2011, WIRES SYST BIOL MED, V3, P147, DOI 10.1002/wsbm.101; Deligianni C, 2012, EMBO REP, V13, P819, DOI 10.1038/embor.2012.112; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dillon N, 2008, DEV CELL, V15, P182, DOI 10.1016/j.devcel.2008.07.013; Doxaki C, 2015, J IMMUNOL, V195, P5750, DOI 10.4049/jimmunol.1500615; Fiserova J, 2017, J CELL SCI, V130, P2066, DOI 10.1242/jcs.198424; Franks TM, 2017, GENE DEV, V31, P2222, DOI 10.1101/gad.306753.117; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hadjimichael C, 2016, STEM CELL REP, V6, P292, DOI 10.1016/j.stemcr.2016.01.004; Hao B, 2015, J EXP MED, V212, P809, DOI 10.1084/jem.20142207; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ibarra A, 2016, GENE DEV, V30, P2253, DOI 10.1101/gad.287417.116; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Jacinto FV, 2015, GENE DEV, V29, P1224, DOI 10.1101/gad.260919.115; Jeong G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3252-7; Jost KL, 2011, NUCLEIC ACIDS RES, V39, pE113, DOI 10.1093/nar/gkr486; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim SH, 2004, CYTOGENET GENOME RES, V105, P292, DOI 10.1159/000078201; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Ktistaki E, 2010, J IMMUNOL, V184, P5686, DOI 10.4049/jimmunol.1000170; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lee HY, 2011, J BIOL CHEM, V286, P18834, DOI 10.1074/jbc.M111.221481; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Levantini E, 2011, EMBO J, V30, P4059, DOI 10.1038/emboj.2011.285; Liang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003308; Luo L, 2009, J CELL SCI, V122, P3729, DOI 10.1242/jcs.052555; Marini B, 2015, NATURE, V521, P227, DOI 10.1038/nature14226; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Nozaki T, 2017, MOL CELL, V67, P282, DOI 10.1016/j.molcel.2017.06.018; Patil S.S., 2011, PD ADMAS NEWS, V1, P8; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Roberts TC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.40; Robson MI, 2017, GENOME RES, V27, P1126, DOI 10.1101/gr.212308.116; Savova V, 2016, NUCLEIC ACIDS RES, V44, pD753, DOI 10.1093/nar/gkv1106; Schmitt AD, 2016, NAT REV MOL CELL BIO, V17, P743, DOI 10.1038/nrm.2016.104; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shachar S, 2015, CELL, V162, P911, DOI 10.1016/j.cell.2015.07.035; So AYL, 2012, BLOOD, V120, P2428, DOI 10.1182/blood-2012-04-426247; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Starling S, 2017, NAT REV GENET, V18, P273, DOI 10.1038/nrg.2017.29; Stathopoulou C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184788; Stratigi K, 2015, P NATL ACAD SCI USA, V112, pE1577, DOI 10.1073/pnas.1502182112; Sun QY, 2018, TRENDS GENET, V34, P142, DOI 10.1016/j.tig.2017.11.005; Tempel S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-246; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Toda T, 2017, CELL STEM CELL, V21, P618, DOI 10.1016/j.stem.2017.08.012; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022; van Wolfswinkel JC, 2010, J CELL SCI, V123, P1825, DOI 10.1242/jcs.061713; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Wang HF, 2018, CELL, V175, P1405, DOI 10.1016/j.cell.2018.09.013; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Xu JQ, 2018, CELL REP, V24, P873, DOI 10.1016/j.celrep.2018.06.085; Yu M, 2017, ANNU REV CELL DEV BI, V33, P265, DOI 10.1146/annurev-cellbio-100616-060531; Zhao HL, 2015, MOL CELL, V59, P984, DOI 10.1016/j.molcel.2015.07.019; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	94	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2019	14	11							e0223759	10.1371/journal.pone.0223759	http://dx.doi.org/10.1371/journal.pone.0223759			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ8IU	31682635	Green Published, gold			2022-12-26	WOS:000499183000001
J	Tarpey, MD; Amorese, AJ; Balestrieri, NP; Fisher-Wellman, KH; Spangenburg, EE				Tarpey, Michael D.; Amorese, Adam J.; Balestrieri, Nicholas P.; Fisher-Wellman, Kelsey H.; Spangenburg, Espen E.			Doxorubicin causes lesions in the electron transport system of skeletal muscle mitochondria that are associated with a loss of contractile function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						skeletal muscle; muscle physiology; bioenergetics; electron transport system (ETS); mitochondrial metabolism; anthracycline drug; doxorubicin; mitochondriopathy; muscle wasting; myotoxicity	ATP HYDROLYSIS EQUILIBRIA; SARCOPLASMIC-RETICULUM; ADENYLATE KINASE; CREATINE-KINASE; CALCIUM-RELEASE; CANCER; CA2+; CHEMOTHERAPY; CARDIOTOXICITY; DYSFUNCTION	Doxorubicin is an anthracycline-based chemotherapeutic that causes myotoxicity with symptoms persisting beyond treatment. Patients experience muscle pain, weakness, fatigue, and atrophy, but the underlying mechanisms are poorly understood. Studies investigating doxorubicin-induced myotoxicity have reported disrupted mitochondrial function. Mitochondria are responsible for regulating both cellular energy status and Ca2+ handling, both of which impact contractile function. Moreover, loss of mitochondrial integrity may initiate muscle atrophy. Skeletal muscle mitochondrial dysregulation may therefore contribute to an overall loss of skeletal muscle quality and performance that may be mitigated by appropriately targeted mitochondrial therapies. We therefore assessed the impact of doxorubicin on muscle performance and applied a multiplexed assay platform to diagnose alterations in mitochondrial respiratory control. Mice received a clinically relevant dose of doxorubicin delivered systemically and were euthanized 72 h later. We measured extensor digitorum longus and soleus muscle forces, fatigue, and contractile kinetics in vitro, along with Ca2+ uptake in isolated sarcoplasmic reticulum. Isolated skeletal muscle mitochondria were used for real-time respirometry or frozen for protein content and activity assays. Doxorubicin impaired muscle performance, which was indicated by reduced force production, fatigue resistance, and sarcoplasmic reticulum?Ca2+ uptake, which were associated with a substrate-independent reduction in respiration and membrane potential but no changes in the NAD(P)H/NAD(P)(+) redox state. Protein content and dehydrogenase activity results corroborated these findings, indicating that doxorubicin-induced mitochondrial impairments are located upstream of ATP synthase within the electron transport system. Collectively, doxorubicin-induced lesions likely span mitochondrial complexes I?IV, providing potential targets for alleviating doxorubicin myotoxicity.	[Tarpey, Michael D.; Amorese, Adam J.; Balestrieri, Nicholas P.; Fisher-Wellman, Kelsey H.; Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA; [Fisher-Wellman, Kelsey H.; Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Spangenburg, Espen E.] East Carolina Univ, Brody Sch Med, Dept Physiol, East Carolina Diabet & Obes Inst, 115 Heart Dr, Greenville, NC 27834 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Spangenburg, EE (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA.; Spangenburg, EE (corresponding author), East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.; Spangenburg, EE (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, East Carolina Diabet & Obes Inst, 115 Heart Dr, Greenville, NC 27834 USA.	spangenburge14@ecu.edu			National Institutes of Health [R01AR06660]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01AR06660 (to E. E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASAYAMA J, 1992, CARDIOVASC RES, V26, P371, DOI 10.1093/cvr/26.4.371; Bonifati DM, 2000, CANCER CHEMOTH PHARM, V46, P517, DOI 10.1007/s002800000175; Bredahl EC, 2017, NUTR CANCER, V69, P607, DOI 10.1080/01635581.2017.1295089; Bredahl EC, 2016, MED SCI SPORT EXER, V48, P1468, DOI 10.1249/MSS.0000000000000926; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cappetta D, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1521020; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Cunha-Oliveira T, 2018, TOXICOL APPL PHARM, V348, P1, DOI 10.1016/j.taap.2018.04.009; Fabris S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139070; Fisher-Wellman KH, 2018, CELL REP, V24, P3593, DOI 10.1016/j.celrep.2018.08.091; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Gammella E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00025; Gilliam LAA, 2016, AM J PHYSIOL-ENDOC M, V311, pE293, DOI 10.1152/ajpendo.00540.2015; Gilliam LAA, 2013, FREE RADICAL BIO MED, V65, P988, DOI 10.1016/j.freeradbiomed.2013.08.191; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Gilliam LAA, 2009, J APPL PHYSIOL, V107, P1935, DOI 10.1152/japplphysiol.00776.2009; GOLDING EM, 1995, J EXP BIOL, V198, P1775; Gouspillou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08717; Hanna AD, 2014, MOL PHARMACOL, V86, P438, DOI 10.1124/mol.114.093849; Hydock DS, 2011, ANTICANCER RES, V31, P2023; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jacobsen PB, 1999, J PAIN SYMPTOM MANAG, V18, P233, DOI 10.1016/S0885-3924(99)00082-2; Janssen E, 2003, J BIOL CHEM, V278, P30441, DOI 10.1074/jbc.M303150200; KEIZER HG, 1990, PHARMACOL THERAPEUT, V47, P219, DOI 10.1016/0163-7258(90)90088-J; Koopman WJH, 2003, AM J PHYSIOL-CELL PH, V285, pC1263, DOI 10.1152/ajpcell.00097.2003; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; LOIRAT MJ, 1988, BIOSCIENCE REP, V8, P369, DOI 10.1007/BF01115228; McLaughlin KL, 2018, BIOCHEM BIOPH RES CO, V504, P742, DOI 10.1016/j.bbrc.2018.09.022; Mukakami T, 2005, J NUTR SCI VITAMINOL, V51, P48, DOI 10.3177/jnsv.51.48; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; OBRIEN PJ, 1990, MOL CELL BIOCHEM, V94, P113, DOI 10.1007/BF00214118; Olson RD, 2000, TOXICOL APPL PHARM, V169, P168, DOI 10.1006/taap.2000.9065; ONDRIAS K, 1990, CIRC RES, V67, P1167, DOI 10.1161/01.RES.67.5.1167; PAWELCZYK T, 1992, BIOCHEM J, V288, P369, DOI 10.1042/bj2880369; Rossi AE, 2009, EXERC SPORT SCI REV, V37, P29, DOI 10.1097/JES.0b013e3181911fa4; SAKS VA, 1994, MOL CELL BIOCHEM, V133, P155, DOI 10.1007/BF01267954; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schmidt CA, 2017, J VASC SURG, V65, P1504, DOI 10.1016/j.jvs.2016.04.041; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; Simunek T, 2009, PHARMACOL REP, V61, P154; Sin TK, 2016, J GERONTOL A-BIOL, V71, P730, DOI 10.1093/gerona/glv175; Smuder AJ, 2011, J APPL PHYSIOL, V111, P1190, DOI 10.1152/japplphysiol.00429.2011; Stone P, 1999, BRIT J CANCER, V79, P1479, DOI 10.1038/sj.bjc.6690236; Tarpey MD, 2019, J PHYSIOL-LONDON, V597, P869, DOI 10.1113/JP276863; Tarpey MD, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0160-3; Teague WE, 1996, J EXP BIOL, V199, P509; Tozer RG, 2008, ANTIOXID REDOX SIGN, V10, P395, DOI 10.1089/ars.2007.1919; Tupling R, 2001, AM J PHYSIOL-ENDOC M, V281, pE224, DOI 10.1152/ajpendo.2001.281.2.E224; van Norren K, 2009, BRIT J CANCER, V100, P311, DOI 10.1038/sj.bjc.6604858; Xu WJ, 2013, CELL METAB, V17, P319, DOI 10.1016/j.cmet.2013.02.004; Xu XX, 2005, MOL PHARMACOL, V68, P261, DOI 10.1124/mol.105.013383; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711	52	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19709	19722		10.1074/jbc.RA119.008426	http://dx.doi.org/10.1074/jbc.RA119.008426			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31690631	Green Published, hybrid			2022-12-26	WOS:000504093200020
J	Kohri, N; Akizawa, H; Iisaka, S; Bai, H; Yanagawa, Y; Takahashi, M; Komatsu, M; Kawai, M; Nagano, M; Kawahara, M				Kohri, Nanami; Akizawa, Hiroki; Iisaka, Sakie; Bai, Hanako; Yanagawa, Yojiro; Takahashi, Masashi; Komatsu, Masaya; Kawai, Masahito; Nagano, Masashi; Kawahara, Manabu			Trophectoderm regeneration to support full-term development in the inner cell mass isolated from bovine blastocyst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						blastocyst; cattle; embryo; gene expression; Hippo pathway; inner cell mass; mouse; protein-protein interaction; trophectoderm; yes-associated protein	EARLY LINEAGE SEGREGATION; PRIMITIVE ENDODERM; TROPHOBLAST DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE TROPHECTODERM; EXPRESSION; FATE; PREIMPLANTATION; DIFFERENTIATION; POLARITY	Which comes first: tissue structure or cell differentiation? While different cell types establish distinct structures delineating the in- and outside of an embryo, they progressively become specified by the blastocyst stage, when two types of cell lineages are formed: inner cell mass (ICM) and trophectoderm (TE). This inside-outside aspect can be experimentally converted by the isolation of the ICM from a blastocyst, leading to a posteriori externalization of the blastomeres composing the outermost layer of the ICM. Here, we investigated the totipotency of isolated mouse and bovine ICMs to determine whether they are competent for TE regeneration. Surprisingly, a calf was generated from the bovine isolated ICM with re-formed blastocoel (re-iICM), but no mouse re-iICMs developed to term. To further explore the cause of difference in developmental competency between the mouse and bovine re-iICMs, we investigated the SOX17 protein expression that is a representative molecular marker of primitive endoderm. The localization pattern of SOX17 was totally different between mouse and bovine embryos. Particularly, the ectopic SOX17 localization in the TE might be associated with lethality of mouse re-iICMs. Meanwhile, transcriptome sequencing revealed that some of the bovine re-iICMs showed transcriptional patterns of TE-specific genes similar to those of whole blastocysts. Our findings suggest that TE regeneration competency is maintained longer in bovine ICMs than in mouse ICMs and provide evidence that the ICM/TE cell fate decision is influenced by structural determinants, including positional information of each blastomere in mammalian embryos.	[Kohri, Nanami; Akizawa, Hiroki; Iisaka, Sakie; Bai, Hanako; Takahashi, Masashi; Komatsu, Masaya; Kawahara, Manabu] Hokkaido Univ, Res Fac Agr, Lab Anim Breeding & Reprod, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan; [Yanagawa, Yojiro; Nagano, Masashi] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Theriogenol, Sapporo, Hokkaido 0600818, Japan; [Kawai, Masahito] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Shizunai Livestock Farm, Sapporo, Hokkaido 0560141, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Kawahara, M (corresponding author), Hokkaido Univ, Grad Sch Agr, Lab Anim Breeding & Reprod, Sapporo, Hokkaido 0608589, Japan.	k-hara@anim.agr.hokudai.ac.jp	Akizawa, Hiroki/GYD-4542-2022; Bai, Hanako/K-4769-2019	Bai, Hanako/0000-0001-9940-1880; Akizawa, Hiroki/0000-0003-1091-5629; Nagano, Masashi/0000-0002-1890-6842	Japan Society for the Promotion of Science [18H02321, 17J03585]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) to Manabu K (grant number, 18H02321) and Grant-in-Aid for JSPS Fellows to N.K. (No., 17J03585) from the Japan Society for the Promotion of Science.	Akizawa H, 2018, REPRODUCTION, V155, P563, DOI 10.1530/REP-18-0043; Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; Aono A, 2013, THERIOGENOLOGY, V79, P1146, DOI 10.1016/j.theriogenology.2013.02.009; Artus J, 2011, DEV BIOL, V350, P393, DOI 10.1016/j.ydbio.2010.12.007; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Boroviak T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0541; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Cao ZB, 2015, DEVELOPMENT, V142, P1606, DOI 10.1242/dev.120238; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng XX, 2016, DEV GROWTH DIFFER, V58, P327, DOI 10.1111/dgd.12276; Clements D, 2000, MECH DEVELOP, V99, P65, DOI 10.1016/S0925-4773(00)00476-7; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033; Gerbe F, 2008, DEV BIOL, V313, P594, DOI 10.1016/j.ydbio.2007.10.048; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Gwatkin R. B. L, 2008, REPRODUCTION, V7, P99; Hirate Y, 2015, DEV GROWTH DIFFER, V57, P544, DOI 10.1111/dgd.12235; Home P, 2017, DEVELOPMENT, V144, P876, DOI 10.1242/dev.145318; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; HYAFIL F, 1980, CELL, V21, P927, DOI 10.1016/0092-8674(80)90456-0; Isaji Y, 2013, J REPROD DEVELOP, V59, P196, DOI 10.1262/jrd.2012-156; Jang JW, 2017, ONCOGENE, V36, P999, DOI 10.1038/onc.2016.266; JOHNSON MH, 1983, DEV BIOL, V95, P211, DOI 10.1016/0012-1606(83)90019-2; Katagiri S, 2006, ANIM REPROD SCI, V95, P54, DOI 10.1016/j.anireprosci.2005.09.001; Kawahara M, 2015, SCI REP, V5, P1; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kishigami S, 2006, FEBS LETT, V580, P1801, DOI 10.1016/j.febslet.2006.02.036; Krawchuk D, 2013, DEV BIOL, V384, P65, DOI 10.1016/j.ydbio.2013.09.023; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kurowski A, 2019, DEV BIOL, V446, P94, DOI 10.1016/j.ydbio.2018.12.008; Le Bin GC, 2014, DEVELOPMENT, V141, P1001, DOI 10.1242/dev.096875; Lilly AJ, 2017, SEMIN CELL DEV BIOL, V63, P50, DOI 10.1016/j.semcdb.2016.07.021; Lorthongpanich C, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127803; Lorthongpanich C, 2013, GENE DEV, V27, P1441, DOI 10.1101/gad.219618.113; Lorthongpanich C, 2012, DEVELOPMENT, V139, P3722, DOI 10.1242/dev.086454; Mallol A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120033; Mitalipov S, 2009, ADV BIOCHEM ENG BIOT, V114, P185, DOI 10.1007/10_2008_45; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Ogura A, 2012, PHILOS T R SOC B, V4, P13; PIERCE GB, 1988, AM J PATHOL, V132, P356; QUINN P, 1985, FERTIL STERIL, V44, P493; Quinn P, 2004, REPRODUCTION, V66, P161; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; ROSSANT J, 1979, DEV BIOL, V70, P255, DOI 10.1016/0012-1606(79)90022-8; Rossant J, 2018, ANNU REV GENET, V52, P185, DOI 10.1146/annurev-genet-120116-024544; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sasaki H, 2017, DEV GROWTH DIFFER, V59, P12, DOI 10.1111/dgd.12335; SHIRAYOSHI Y, 1983, CELL, V35, P631, DOI 10.1016/0092-8674(83)90095-8; Simmet K, 2018, CELL CYCLE, V17, P1688, DOI 10.1080/15384101.2018.1496747; Simmet K, 2018, P NATL ACAD SCI USA, V115, P2770, DOI 10.1073/pnas.1718833115; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Viotti M, 2014, NAT CELL BIOL, V16, P1146, DOI 10.1038/ncb3070; Whitten W. K, 1956, NATURE, V12, P260; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wigger M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15427-0; Yamazaki W, 2016, J BIOL CHEM, V291, P20924, DOI 10.1074/jbc.M116.744144; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564	64	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19209	19223		10.1074/jbc.RA119.010746	http://dx.doi.org/10.1074/jbc.RA119.010746			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31704705	Green Published, hybrid			2022-12-26	WOS:000516527800021
J	Casanova-Morales, N; Figueroa, NL; Alfaro, K; Montenegro, F; Barrera, NP; Maze, JR; Wilson, CAM; Conejeros, P				Casanova-Morales, Nathalie; Figueroa, Nataniel L.; Alfaro, Karol; Montenegro, Felipe; Barrera, Nelson P.; Maze, J. R.; Wilson, Christian A. M.; Conejeros, Pablo			Structural characterization of the saxitoxin-targeting APTSTX1 aptamer using optical tweezers and molecular dynamics simulations	PLOS ONE			English	Article							WEB SERVER; DNA; RNA; BIOSENSORS; TOXINS; SENSOR; BIND	Optical tweezers have enabled the exploration of picoNewton forces and dynamics in single-molecule systems such as DNA and molecular motors. In this work, we used optical tweezers to study the folding/unfolding dynamics of the APTSTX1-aptamer, a single-stranded DNA molecule with high affinity for saxitoxin (STX), a lethal neurotoxin. By measuring the transition force during (un)folding processes, we were able to characterize and distinguish the conformational changes of this aptamer in the presence of magnesium ions and toxin. This work was supported by molecular dynamics (MD) simulations to propose an unfolding mechanism of the aptamer-Mg+2 complex. Our results are a step towards the development of new aptamer-based STX sensors that are potentially cheaper and more sensitive than current alternatives.	[Casanova-Morales, Nathalie; Figueroa, Nataniel L.; Maze, J. R.] Pontificia Univ Catolica Chile, Inst Fis, Santiago, Chile; [Alfaro, Karol; Conejeros, Pablo] Univ Valparaiso, Fac Ciencias, Inst Biol, CIGREN, Valparaiso, Chile; [Montenegro, Felipe; Barrera, Nelson P.] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Santiago, Chile; [Casanova-Morales, Nathalie; Wilson, Christian A. M.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile; [Casanova-Morales, Nathalie] Univ Adolfo Ibanez, Fac Artes Liberales, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Valparaiso; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad Adolfo Ibanez	Maze, JR (corresponding author), Pontificia Univ Catolica Chile, Inst Fis, Santiago, Chile.; Conejeros, P (corresponding author), Univ Valparaiso, Fac Ciencias, Inst Biol, CIGREN, Valparaiso, Chile.; Barrera, NP (corresponding author), Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Santiago, Chile.; Wilson, CAM (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile.	nbarrera@bio.puc.cl; jmaze@fis.puc.cl; yitowilson@gmail.com; pablo.conejeros@uv.cl		Casanova-Morales, Nathalie/0000-0002-9706-0952; Conejeros, Pablo/0000-0001-5073-7121; Figueroa Leigh, Nataniel/0000-0001-7703-1129; Barrera, Nelson/0000-0001-7825-1406	FONDECYT [11130263, 1181361]; U-INICIA Vicerrectoria de Investigacion, Universidad de Chile [PCI PII20150073]; Newton Picarte [PCI-DPI-Conicyt 20140080, ICM P10-035F, Anillo ACT-1108]; Conicyt grants [FONDECYT 11110050, FONDEF ID18I10147]; Conicyt-Fondecyt [1180673]; Air Force Office of Scientific Research award [FA9550-18-1-0438, FA9550-18-1-0513]; Office of Naval Research [N62909-18-1-2180]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); U-INICIA Vicerrectoria de Investigacion, Universidad de Chile; Newton Picarte; Conicyt grants; Conicyt-Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Air Force Office of Scientific Research award(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research)	This work was supported by: FONDECYT 11130263 and 1181361, PCI PII20150073 U-INICIA Vicerrectoria de Investigacion, Universidad de Chile (C.A.M.W.); Newton Picarte PCI-DPI-Conicyt 20140080, ICM P10-035F, Anillo ACT-1108 (N.P.B.). P.C. acknowledges support from Conicyt grants FONDECYT 11110050 and FONDEF ID18I10147. J.R.M. acknowledges support from Conicyt-Fondecyt grant number 1180673, Air Force Office of Scientific Research award numbers FA9550-18-1-0438 and FA9550-18-1-0513, and Office of Naval Research grant number N62909-18-1-2180.; This work was supported by; C.A.M.W. FONDECYT 11130263 and 1181361, PCI PII20150073 U-INICIA Vicerrectoria de Investigacion, Universidad de Chile. N.P.B. Newton Picarte PCI-DPI-Conicyt 20140080, ICM P10-035F, Anillo ACT-1108. P.C. acknowledges support from Conicyt grants FONDECYT 11110050 and FONDEF ID18I10147. J.R.M. acknowledges support from Conicyt-Fondecyt grant number 1180673, Air Force Office of Scientific Research award numbers FA9550-18-1-0438 and FA9550-18-1-0513, and Office of Naval Research grant number N62909-18-1-2180. Also, thanks to Steven B. Smith from Steven B. Smith Engineering and Norberto A. Guzman for helpful discussions.	Alemany A, 2014, BIOPOLYMERS, V101, P1193, DOI 10.1002/bip.22533; Alfaro K, 2015, FOOD TECHNOL BIOTECH, V53, P337; [Anonymous], 2008, EFSA J; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Baldrich E, 2004, ANAL CHEM, V76, P7053, DOI 10.1021/ac049258o; Brandao MM, 2003, EUR J HAEMATOL, V70, P207, DOI 10.1034/j.1600-0609.2003.00027.x; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Bustamante C. J., 2006, US Patent, Patent No. [7133132, 7,133,132 B2]; Chen H, 2012, P NATL ACAD SCI USA, V109, P799, DOI 10.1073/pnas.1119057109; Cheng AKH, 2007, ANAL CHEM, V79, P5158, DOI 10.1021/ac062214q; Chi QJ, 2013, PHYSICA A, V392, P1072, DOI 10.1016/j.physa.2012.09.022; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fahrner R L, 2001, Biotechnol Genet Eng Rev, V18, P301; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frauendorf C, 2001, BIOORGAN MED CHEM, V9, P2521, DOI 10.1016/S0968-0896(01)00027-X; Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2; Han K, 2010, SENSORS-BASEL, V10, P4541, DOI 10.3390/s100504541; Handy SM, 2013, TOXICON, V61, P30, DOI 10.1016/j.toxicon.2012.10.015; Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y; Hong KL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/419318; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kerrin ES, 2017, ANAL BIOANAL CHEM, V409, P1481, DOI 10.1007/s00216-016-0091-y; Le Floch F, 2006, ANAL CHEM, V78, P4727, DOI 10.1021/ac0521955; LEVIN RE, 1992, J FOOD BIOCHEM, V15, P405; McFail-Isom L, 1998, BIOCHEMISTRY-US, V37, P17105, DOI 10.1021/bi982201+; Mir M, 2007, MOL BIOSYST, V3, P620, DOI 10.1039/b708858b; Mons MN, 1998, PARALYTIC SHELLFISH; Munoz P., 1999, PLAN NACL FLORACIONE; Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003; Ozaki H, 2006, BIOORG MED CHEM LETT, V16, P4381, DOI 10.1016/j.bmcl.2006.05.054; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHOCHETMAN G, 1988, J INFECT DIS, V158, P1154, DOI 10.1093/infdis/158.6.1154; Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Song KM, 2012, SENSORS-BASEL, V12, P612, DOI 10.3390/s120100612; Stojanovic MN, 2001, J AM CHEM SOC, V123, P4928, DOI 10.1021/ja0038171; Stojanovic MN, 2000, J AM CHEM SOC, V122, P11547, DOI 10.1021/ja0022223; Tombelli S, 2007, BIOMOL ENG, V24, P191, DOI 10.1016/j.bioeng.2007.03.003; Tombelli S, 2010, COMB CHEM HIGH T SCR, V13, P641, DOI 10.2174/1386207311004070641; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Usleber E, 2001, J AOAC INT, V84, P1649; Wang DZ, 2008, MAR DRUGS, V6, P349, DOI 10.3390/md20080016; Wang DY, 2001, J MOL BIOL, V310, P723, DOI 10.1006/jmbi.2001.4811; Westfall PH, 1989, RESAMPLING BASED MUL, P1359; Yang CJ, 2005, P NATL ACAD SCI USA, V102, P17278, DOI 10.1073/pnas.0508821102; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; Zheng X, 2015, TOXICON, V101, P41, DOI 10.1016/j.toxicon.2015.04.017; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	3	3	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0222468	10.1371/journal.pone.0222468	http://dx.doi.org/10.1371/journal.pone.0222468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697710	gold, Green Published			2022-12-26	WOS:000532694400008
J	Jankovic, MJ; Kapadia, PP; Krishnan, V				Jankovic, Miranda J.; Kapadia, Paarth P.; Krishnan, Vaishnav			Home-cage monitoring ascertains signatures of ictal and interictal behavior in mouse models of generalized seizures	PLOS ONE			English	Article							EPILEPTIC SEIZURES; GABA(A) RECEPTORS; DRAVET SYNDROME; VALPROIC ACID; MICE; SLEEP; ANXIETY; SUSCEPTIBILITY; PARTICIPATION; CONTRIBUTES	Epilepsy is a significant contributor to worldwide disability. In epilepsy, disability can be broadly divided into two components: ictal (pertaining to the burden of unpredictable seizures and associated medical complications including death) and interictal (pertaining to more pervasive debilitating changes in cognitive and emotional behavior). In this study, we objectively and noninvasively appraise aspects of ictal and interictal behavior in mice using instrumented home-cage chambers designed to assay kinematic and appetitive behavioral measures. Through daily intraperitoneal injections of the chemoconvulsant pentylenetetrazole (PTZ) applied to C57BL/6J mice, we coordinately measure how "behavioral severity" (complex dynamic changes in movement and sheltering behavior) and convulsive severity (latency and occurrence of convulsive seizures) evolve or kindle with repeated injections. By closely studying long epochs between PTZ injections, we identify an interictal syndrome of nocturnal hypoactivity and increased sheltering behavior which remits with the cessation of seizure induction. We observe elements of this interictal behavioral syndrome in seizureprone DBA/2J mice and in mice with a pathogenic Scn1a mutation (modeling Dravet syndrome). Through analyzing their responses to PTZ, we illustrate how convulsive severity and "behavioral" severity are distinct and independent aspects of the overall severity of a PTZ-induced seizure. Our results illustrate the utility of an ethologically centered automated approach to quantitatively appraise murine expressions of disability in mouse models of seizures and epilepsy. In doing so, this study highlights the very unique psychopharmacological profile of PTZ.	[Jankovic, Miranda J.; Kapadia, Paarth P.; Krishnan, Vaishnav] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Baylor College of Medicine	Krishnan, V (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.	vkrish@bcm.edu		Jankovic, Miranda/0000-0002-4441-1632; Kapadia, Paarth/0000-0003-3033-3351	Baylor College of Medicine Office of Research; National Institutes of Neurological Disorders and Stroke [1K08NS110924-01]; American Academy of Neurology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS110924] Funding Source: NIH RePORTER	Baylor College of Medicine Office of Research; National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Academy of Neurology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	VK received funding for all of this work from the Baylor College of Medicine Office of Research (seed funding), a clinical neurology training fellowship from the American Academy of Neurology (https://www.aan.com/PressRoom/Home/PressRelease/1462), and a K08 Award from the National Institutes of Neurological Disorders and Stroke (1K08NS110924-01).	Aarts E, 2015, BEHAV BRAIN RES, V294, P123, DOI 10.1016/j.bbr.2015.06.011; Aiba I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4050; Ajmone-Marsan C., 1957, EPILEPTIC SEIZURE IT; Ambree O, 2006, NEUROBIOL AGING, V27, P955, DOI 10.1016/j.neurobiolaging.2005.05.009; Angelakos CC, 2019, NEUROBIOL LEARN MEM, V165, DOI 10.1016/j.nlm.2019.02.010; Angelakos CC, 2017, AUTISM RES, V10, P572, DOI 10.1002/aur.1707; Balci Fuat, 2013, PLoS Curr, V5, DOI 10.1371/currents.hd.124aa0d16753f88215776fba102ceb29; Balzekas I, 2016, NEUROSCI LETT, V622, P30, DOI 10.1016/j.neulet.2016.04.033; BEDFORD JM, 1982, INT J ANDROL, P48; Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(18)30454-X; Bonasera SJ, 2017, GENES BRAIN BEHAV, V16, P564, DOI 10.1111/gbb.12374; Bureau M, 2011, EPILEPSIA, V52, P13, DOI 10.1111/j.1528-1167.2011.02996.x; Chen BB, 2017, EPILEPSY BEHAV, V76, P24, DOI 10.1016/j.yebeh.2017.08.039; Colas D, 2013, BRIT J PHARMACOL, V169, P963, DOI 10.1111/bph.12169; Dhir A., 2012, CURR PROT NEUROSCI, V58, p9.37.1, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; Dispersyn G, 2017, J SLEEP RES, V26, P531, DOI 10.1111/jsr.12541; Faizi M, 2011, NEUROBIOL DIS, V43, P397, DOI 10.1016/j.nbd.2011.04.011; Farnworth B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145432; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fukata Y, 2010, P NATL ACAD SCI USA, V107, P3799, DOI 10.1073/pnas.0914537107; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Guignet M, 2020, NEUROBIOL DIS, V133, DOI 10.1016/j.nbd.2019.03.019; Hansen CC, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/2064027; Holmes GL, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a028043; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Ito S, 2013, NEUROBIOL DIS, V49, P29, DOI 10.1016/j.nbd.2012.08.003; Kadam SD, 2017, EPILEPSIA, V58, P10, DOI 10.1111/epi.13903; Kadiyala SB, 2015, EPILEPSY RES, V109, P183, DOI 10.1016/j.eplepsyres.2014.11.009; Kanner AM, 2013, EPILEPSIA, V54, P3, DOI 10.1111/epi.12100; Koch-Stoecker SC, 2017, EPILEPSIA, V58, P983, DOI 10.1111/epi.13736; Kopp C, 2003, EUR J NEUROSCI, V17, P2226, DOI 10.1046/j.1460-9568.2003.02651.x; Krishnan V, 2017, NATURE, V543, P507, DOI 10.1038/nature21678; Kwan P, 2009, EPILEPSIA, V50, P1059, DOI 10.1111/j.1528-1167.2008.01938.x; Kyriakou EI, 2018, J NEUROSCI METH, V300, P48, DOI 10.1016/j.jneumeth.2017.08.012; Lightfoot JT, 2010, J APPL PHYSIOL, V109, P623, DOI 10.1152/japplphysiol.00525.2010; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Logan S, 2018, GEROSCIENCE, V40, P123, DOI 10.1007/s11357-018-0019-x; Long C, 2016, EPILEPSY CURR, V16, P179, DOI 10.5698/1535-7511-16.3.179; Loos M, 2017, METHODS MOL BIOL, V1488, P519, DOI 10.1007/978-1-4939-6427-7_25; Loos M, 2015, MAMM GENOME, V26, P348, DOI 10.1007/s00335-015-9578-7; Loos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108563; Mathews HL, 2019, PSYCHOPHARMACOLOGY, V236, P1335, DOI 10.1007/s00213-018-5139-6; Medel-Matus JS, 2017, EXP NEUROL, V289, P64, DOI 10.1016/j.expneurol.2016.12.008; Mizoguchi H, 2011, J NEUROSCI, V31, P12963, DOI 10.1523/JNEUROSCI.3118-11.2011; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; MOE PG, 1971, AM J DIS CHILD, V121, P307, DOI 10.1001/archpedi.1971.02100150081008; NAU H, 1982, J PHARMACOL EXP THER, V220, P654; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Peters SM, 2015, EUR J PHARMACOL, V759, P42, DOI 10.1016/j.ejphar.2015.03.043; Pfammatter JA, 2019, EPILEPSIA OPEN, V4, P110, DOI 10.1002/epi4.12303; Pitsch J, 2017, EPILEPSIA, V58, P1159, DOI 10.1111/epi.13795; Remmelink E, 2016, GENES BRAIN BEHAV, V15, P558, DOI 10.1111/gbb.12301; Ribeiro RL, 2002, PROG NEURO-PSYCHOPH, V26, P861, DOI 10.1016/S0278-5846(01)00331-1; Robinson L, 2013, BEHAV BRAIN RES, V250, P148, DOI 10.1016/j.bbr.2013.04.041; Sajobi TT, 2015, EPILEPSIA, V56, P1463, DOI 10.1111/epi.13102; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Singh E, 2014, BASIC CLIN PHARMACOL, V115, P373, DOI 10.1111/bcpt.12238; Steel D, 2017, EPILEPSIA, V58, P1807, DOI 10.1111/epi.13889; Tai P, 2010, NEUROLOGY, V74, P932, DOI 10.1212/WNL.0b013e3181d561b4; Tang LJ, 2017, SEIZURE-EUR J EPILEP, V51, P95, DOI 10.1016/j.seizure.2017.08.001; Tatsukawa T, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-019-0265-5; Teran FA, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00278; Van Erum J, 2019, EPILEPSY BEHAV, V95, P51, DOI 10.1016/j.yebeh.2019.02.029; Volker LA, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12516; Walia V, 2018, PHARMACOL BIOCHEM BE, V173, P96, DOI 10.1016/j.pbb.2018.06.001; Watanabe Y, 2011, EPILEPSIA, V52, P140, DOI 10.1111/j.1528-1167.2010.02764.x; Watanabe Y, 2010, J PHARMACOL SCI, V112, P282, DOI 10.1254/jphs.09225FP; Wells AM, 2017, J NEUROSCI, V37, P7656, DOI 10.1523/JNEUROSCI.0885-17.2017; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x; Wright S, 2016, EPILEPSY BEHAV, V55, P24, DOI 10.1016/j.yebeh.2015.11.028; Yuskaitis CJ, 2018, NEUROBIOL DIS, V111, P91, DOI 10.1016/j.nbd.2017.12.010	74	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224856	10.1371/journal.pone.0224856	http://dx.doi.org/10.1371/journal.pone.0224856			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697745	Green Submitted, Green Published, gold			2022-12-26	WOS:000532694400070
J	Pascual-Diaz, S; Pineda, J; Serra, L; Varriano, F; Prats-Galino, A				Pascual-Diaz, Saul; Pineda, Jose; Serra, Laura; Varriano, Federico; Prats-Galino, Alberto			Default Mode Network structural alterations in Kocher-Monro trajectory white matter transection: A 3 and 7 tesla simulation modeling approach	PLOS ONE			English	Article							DIFFUSION MRI; BRAIN NETWORKS; TRACTOGRAPHY; ACCURACY; RESOLUTION; ANATOMY; GUIDE	The Kocher-Monro trajectory to the cerebral ventricular system represents one of the most common surgical procedures in the field of neurosurgery. Several studies have analyzed the specific white matter disruption produced during this intervention, which has no reported adverse neurological outcomes. In this study, a graph-theoretical approach was applied to quantify the structural alterations in whole-brain level connectivity. To this end, 132 subjects were randomly selected from the Human Connectome Project dataset and used to create 3 independent 44 subjects groups. Two of the groups underwent a simulated left/right Kocher-Monro trajectory and the third was kept as a control group. For the right Kocher-Monro approach, the nodal analysis revealed decreased strength in the anterior cingulate gyrus of the transected hemisphere. The network-based statistic analysis revealed a set of right lateralized subnetworks with decreased connectivity strength that is consistent with a subset of the Default Mode Network, Salience Network, and Cingulo-Opercular Network. These findings could allow for a better understanding of structural alterations caused by Kocher-Monro approaches that could reveal previously undetected clinical alterations and inform the process of designing safer and less invasive cerebral ventricular approaches.	[Pascual-Diaz, Saul; Pineda, Jose; Serra, Laura; Varriano, Federico; Prats-Galino, Alberto] Univ Barcelona, Lab Surg Neuroanat, Barcelona, Spain; [Pascual-Diaz, Saul; Pineda, Jose] Carrer Casanova 143, Barcelona 08036, Spain	University of Barcelona	Pascual-Diaz, S (corresponding author), Univ Barcelona, Lab Surg Neuroanat, Barcelona, Spain.; Pascual-Diaz, S (corresponding author), Carrer Casanova 143, Barcelona 08036, Spain.	saulpascualdiaz@gmail.com	Prats-Galino, Alberto/J-6319-2013; Pascual-Diaz, Saül/AAY-4358-2021; Pineda, Jose/AHA-6929-2022	Prats-Galino, Alberto/0000-0002-2710-6433; Pascual-Diaz, Saül/0000-0001-5871-5867; Varriano, Federico/0000-0001-6742-4746; Pineda, Jose/0000-0001-8486-6802				Abdoh MG, 2012, ACTA NEUROCHIR, V154, P153, DOI 10.1007/s00701-011-1136-9; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Atasoy S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10340; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Brown CA, 2018, CORTEX, V104, P58, DOI 10.1016/j.cortex.2018.04.006; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calamante F, 2017, MAGN RESON MATER PHY, V30, P317, DOI 10.1007/s10334-017-0608-1; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Civier O, 2019, NEUROIMAGE, V194, P68, DOI 10.1016/j.neuroimage.2019.02.039; Collin G, 2017, BIOL PSYCHIAT, V82, P746, DOI 10.1016/j.biopsych.2017.06.013; Connelly A, 2010, ISMRM, V88, P2010; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Garcia S, 2017, WORLD NEUROSURG, V99, P232, DOI 10.1016/j.wneu.2016.11.112; GHAJAR JBG, 1985, J NEUROSURG, V63, P985, DOI 10.3171/jns.1985.63.6.0985; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Grandhi R, 2012, SCHMIDEK SWEET OPERA, V2, P1495, DOI [10.1016/B978-1-4160-6839-6.10132-7, DOI 10.1016/B978-1-4160-6839-6.10132-7]; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horn A, 2014, NEUROIMAGE, V102, P142, DOI 10.1016/j.neuroimage.2013.09.069; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kong XZ, 2018, P NATL ACAD SCI USA, V115, pE5154, DOI 10.1073/pnas.1718418115; Kwon HG, 2015, CLIN NEURORADIOL, V25, P65, DOI 10.1007/s00062-013-0269-z; Lin P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46088; Lovasik BP, 2016, WORLD NEUROSURG, V94, P309, DOI 10.1016/j.wneu.2016.07.022; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reess TJ, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.163; Roitberg BZ, 2001, BRIT J NEUROSURG, V15, P324; Sadaghiani S, 2015, CEREB CORTEX, V25, P2763, DOI 10.1093/cercor/bhu072; Schaumann A, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-428; Sethi A, 2018, DEV COGN NEUROS-NETH, V30, P87, DOI 10.1016/j.dcn.2018.01.004; Sotiropoulos SN, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3752; Sotiropoulos SN, 2016, NEUROIMAGE, V134, P396, DOI 10.1016/j.neuroimage.2016.04.014; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Toga AW, 2012, NEUROSURGERY, V71, P1, DOI 10.1227/NEU.0b013e318258e9ff; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van den Heuvel MP, 2016, TRENDS COGN SCI, V20, P345, DOI 10.1016/j.tics.2016.03.001; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Van Rossum G., 2011, PYTHON LANGUAGE REFE; Vu AT, 2015, NEUROIMAGE, V122, P318, DOI 10.1016/j.neuroimage.2015.08.004; Whitton AE, 2019, BIOL PSYCHIAT, V85, P872, DOI 10.1016/j.biopsych.2018.12.007; Willats L, 2014, NEUROIMAGE, V87, P18, DOI 10.1016/j.neuroimage.2013.11.016; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224598	10.1371/journal.pone.0224598	http://dx.doi.org/10.1371/journal.pone.0224598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697747	Green Published, gold			2022-12-26	WOS:000532694400035
J	Saini, A; Burns, D; Emmett, D; Song, YS				Saini, Anirudh; Burns, Devin; Emmett, Darian; Song, Yun Seong			Trunk velocity-dependent Light Touch reduces postural sway during standing	PLOS ONE			English	Article							BALANCE; STABILITY; STEADINESS; CONTACT; MODEL	Light Touch (LT) has been shown to reduce postural sway in a wide range of populations. While LT is believed to provide additional sensory information for balance modulation, the nature of this information and its specific effect on balance are yet unclear. In order to better understand LT and to potentially harness its advantages for a practical balance aid, we investigated the effect of LT as provided by a haptic robot. Postural sway during standing balance was reduced when the LT force (similar to 1 N) applied to the high back area was dependent on the trunk velocity. Additional information on trunk position, provided through orthogonal vibrations, further reduced the sway position-metric of balance but did not further improve the velocity-metric of balance. Our results suggest that limited and noisy information on trunk velocity encoded in LT is sufficient to influence standing balance.	[Saini, Anirudh; Emmett, Darian; Song, Yun Seong] Missouri Univ Sci & Technol, Dept Psychol Sci, Rolla, MO 65409 USA; [Burns, Devin] Missouri Univ Sci & Technol, Dept Mech & Aerosp Engn, Rolla, MO 65409 USA; [Saini, Anirudh] Asama Coldwater Mfg, Coldwater, MI USA; [Emmett, Darian] Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA	University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; Brigham Young University	Song, YS (corresponding author), Missouri Univ Sci & Technol, Dept Psychol Sci, Rolla, MO 65409 USA.	songyun@mst.edu		Song, Yun Seong/0000-0003-1826-586X; Burns, Devin/0000-0002-2011-9127				Baccini M, 2007, AGE AGEING, V36, P30, DOI 10.1093/ageing/afl072; Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Bonfim TR, 2008, NEUROSCI LETT, V441, P257, DOI 10.1016/j.neulet.2008.06.039; Boonsinsukh R, 2009, ARCH PHYS MED REHAB, V90, P919, DOI 10.1016/j.apmr.2008.12.022; Chiba R, 2016, NEUROSCI RES, V104, P96, DOI 10.1016/j.neures.2015.12.002; Cunha BP, 2012, NEUROSCI LETT, V513, P6, DOI 10.1016/j.neulet.2012.01.053; Dickstein R, 2001, GAIT POSTURE, V14, P238, DOI 10.1016/S0966-6362(01)00161-8; Ersal T, 2013, J NEUROENG REHABIL, V10, DOI [10.1186/1743-0003-10-14, 10.1186/1743-0003-10-93]; Franzen E, 2012, NEUROREHAB NEURAL RE, V26, P1007, DOI 10.1177/1545968312437942; Goodworth AD, 2012, J NEUROPHYSIOL, V107, P12, DOI 10.1152/jn.00670.2010; Goodworth AD, 2009, IEEE T NEUR SYS REH, V17, P397, DOI 10.1109/TNSRE.2009.2023309; Holden M, 1994, J Vestib Res, V4, P285; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Jeka JJ, 1997, PHYS THER, V77, P476, DOI 10.1093/ptj/77.5.476; Jeka JJ, 1997, EXP BRAIN RES, V113, P475, DOI 10.1007/PL00005600; Jiang P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163212; Johannsen L, 2014, RES SWEDISH ZOOL E 5, P1; Kouzaki M, 2008, EXP BRAIN RES, V188, P153, DOI 10.1007/s00221-008-1426-5; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Lackner JR, 2001, EXP BRAIN RES, V139, P454, DOI 10.1007/s002210100775; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Mergner T, 2010, ANNU REV CONTROL, V34, P177, DOI 10.1016/j.arcontrol.2010.08.001; Mientjes MIV, 1999, CLIN BIOMECH, V14, P710, DOI 10.1016/S0268-0033(99)00025-X; Moghadam M, 2011, GAIT POSTURE, V33, P651, DOI 10.1016/j.gaitpost.2011.02.016; MURRAY MP, 1975, J BONE JOINT SURG AM, VA 57, P510, DOI 10.2106/00004623-197557040-00012; Newell KM, 1998, MOTOR BEHAVIOR AND HUMAN SKILL, P143; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Qiu H, 2015, INT J IND ERGONOM, V47, P37, DOI 10.1016/j.ergon.2015.02.004; Qu XD, 2009, J BIOMECH, V42, P1850, DOI 10.1016/j.jbiomech.2009.05.036; Quant S, 2001, NEUROREPORT, V12, P2821, DOI 10.1097/00001756-200109170-00014; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Riach C.L., 1994, GAIT POSTURE, V2, P167, DOI [10.1016/0966-6362(94)90004-3, DOI 10.1016/0966-6362(94)90004-3]; Riley MA, 1999, HUM MOVEMENT SCI, V18, P795, DOI 10.1016/S0167-9457(99)00041-X; Shima K, 2013, INT SYM MED INFORM, P108, DOI 10.1109/ISMICT.2013.6521710; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; van Emmerik REA, 2000, J APPL BIOMECH, V16, P394, DOI 10.1123/jab.16.4.394; Verite F, 2014, IEEE T HAPTICS, V7, P150, DOI 10.1109/TOH.2013.64; Vuillerme N, 2008, EXP BRAIN RES, V186, P503, DOI 10.1007/s00221-007-1249-9; Wing AM, 2011, PHILOS T R SOC B, V366, P3133, DOI 10.1098/rstb.2011.0169	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224943	10.1371/journal.pone.0224943	http://dx.doi.org/10.1371/journal.pone.0224943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697773	Green Published, gold			2022-12-26	WOS:000532694400082
J	Yao, Q; Zhou, G; Xu, ML; Dai, JG; Qian, ZW; Cai, ZJ; Zhang, LY; Tan, Y; Hu, RK				Yao, Qi; Zhou, Ge; Xu, Meilin; Dai, Jianguo; Qian, Ziwei; Cai, Zijing; Zhang, Luyao; Tan, Yong; Hu, Rongkui			Blood metal levels and serum testosterone concentrations in male and female children and adolescents: NHANES 2011-2012	PLOS ONE			English	Article							PITUITARY-TESTICULAR AXIS; REPRODUCTIVE ENDOCRINE FUNCTION; SPRAGUE-DAWLEY RATS; SELENIUM NANOPARTICLES; PUBERTAL DEVELOPMENT; CADMIUM EXPOSURE; HORMONE-LEVELS; SEMEN QUALITY; SEX-HORMONES; LEAD	Environmental exposure to metals is ubiquitous, but its relation to androgen hormone levels is not well understood, especially in children and adolescents. This study aimed to explore the relationship between blood metal concentrations (lead, cadmium, total mercury, selenium, and manganese) and serum total testosterone (TT) levels in 6-19-year-old children and adolescents in the National Health and Nutrition Examination Survey (NHANES) 2011-2012. Weighted multivariable linear regression models using NHANES sampling weights were employed to evaluate the association between log-transformed serum TT and each metal categories in male and female children (age 6-11years) and adolescents (age 12-19 years). We established that blood cadmium and manganese levels were associated with significantly higher serum TT levels in the female adolescents. Additionally, the blood selenium levels in male adolescents were related to significantly higher serum TT. No significant associations between blood lead or total mercury levels and TT were observed in children or adolescents of either sex. These findings suggest that environmental exposure to certain metals could affect serum TT levels in adolescents, which might have important implications for the health of adolescents. Further research is required to confirm and extend our present findings.	[Yao, Qi; Dai, Jianguo; Qian, Ziwei; Cai, Zijing; Zhang, Luyao] Nanjing Univ Chinese Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Zhou, Ge; Tan, Yong; Hu, Rongkui] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Dept Reprod Med, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China; [Xu, Meilin] GE Healthcare China, Med Dept Life Sci China, Beijing, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; General Electric	Tan, Y; Hu, RK (corresponding author), Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Dept Reprod Med, Affiliated Hosp, Nanjing, Jiangsu, Peoples R China.	xijun1025@163.com; xiangyu198110@163.com			National Natural Science Fund for Young Scholars [81704164]; Natural Science Foundation of the Jiangsu Province [BK20151043]; Six Talent Peaks Project in the Jiangsu Province [WSN-044]; 333 Talent Project in the Jiangsu Province [2016.-3288]	National Natural Science Fund for Young Scholars; Natural Science Foundation of the Jiangsu Province(Natural Science Foundation of Jiangsu Province); Six Talent Peaks Project in the Jiangsu Province; 333 Talent Project in the Jiangsu Province	This work was supported by grants from the National Natural Science Fund for Young Scholars (Grant No. 81704164), Natural Science Foundation of the Jiangsu Province (Grant No. BK20151043), Six Talent Peaks Project in the Jiangsu Province (Grant No. WSN-044), and 333 Talent Project in the Jiangsu Province (Grant No. 2016.-3288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedara IA, 2017, CHEM-BIOL INTERACT, V263, P88, DOI 10.1016/j.cbi.2016.12.019; Ali I, 2014, ENVIRON RES, V134, P265, DOI 10.1016/j.envres.2014.08.009; BARREGARD L, 1994, OCCUP ENVIRON MED, V51, P536, DOI 10.1136/oem.51.8.536; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Cabrera SM, 2013, EXPERT OPIN DRUG SAF, V12, P375, DOI 10.1517/14740338.2013.782000; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chen C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37809; Cole TJ, 2015, CLIN ENDOCRINOL, V82, P862, DOI 10.1111/cen.12682; Cupertino MC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3405089; Das S, 2013, GEN COMP ENDOCR, V181, P107, DOI 10.1016/j.ygcen.2012.10.010; Davis Jennifer, 2013, J Carcinog, V12, P11, DOI 10.4103/1477-3163.114219; Davis SR, 2015, LANCET DIABETES ENDO, V3, P980, DOI 10.1016/S2213-8587(15)00284-3; De Ronde W, 2006, CLIN CHEM, V52, P1777, DOI 10.1373/clinchem.2005.063354; Dees WL, 2017, J ENDOCRINOL, V235, pR33, DOI 10.1530/JOE-17-0237; Escobar-Morreale HF, 2018, NAT REV ENDOCRINOL, V14, P270, DOI 10.1038/nrendo.2018.24; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Gandhi J, 2017, ZYGOTE, V25, P103, DOI 10.1017/S0967199417000028; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; He YD, 2014, LIFE SCI, V115, P44, DOI 10.1016/j.lfs.2014.08.023; Jurasovic J, 2004, BIOMETALS, V17, P735, DOI 10.1007/s10534-004-1689-7; Klap J, 2015, J UROLOGY, V193, P403, DOI 10.1016/j.juro.2014.07.123; Kresovich JK, 2015, ENVIRON RES, V142, P25, DOI 10.1016/j.envres.2015.05.026; Lafuente A, 2000, FOOD CHEM TOXICOL, V38, P913, DOI 10.1016/S0278-6915(00)00077-6; Lafuente A, 2001, EXP BIOL MED, V226, P605, DOI 10.1177/153537020122600615; LASKEY JW, 1991, TOXICOL APPL PHARM, V108, P296, DOI 10.1016/0041-008X(91)90119-Y; Lee B, 2006, REPROD TOXICOL, V22, P580, DOI 10.1016/j.reprotox.2006.03.011; Liu LJ, 2017, BIOL TRACE ELEM RES, V180, P81, DOI 10.1007/s12011-017-0980-8; Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003; Meeker JD, 2010, FERTIL STERIL, V93, P130, DOI 10.1016/j.fertnstert.2008.09.044; Menke A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-72; Mohammed AT, 2018, BIOMED PHARMACOTHER, V102, P739, DOI 10.1016/j.biopha.2018.03.086; Nagata C, 2005, CANCER EPIDEM BIOMAR, V14, P705, DOI 10.1158/1055-9965.EPI-04-0619; Pillai P, 2012, ANDROLOGIA, V44, P92, DOI 10.1111/j.1439-0272.2010.01109.x; Pluchino N, 2013, ARCH GYNECOL OBSTET, V288, P731, DOI 10.1007/s00404-013-2969-7; Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415; Ronis MJJ, 1996, TOXICOL APPL PHARM, V136, P361, DOI 10.1006/taap.1996.0044; Safarinejad MR, 2009, J UROLOGY, V181, P741, DOI 10.1016/j.juro.2008.10.015; Scinicariello F, 2016, ENVIRON HEALTH PERSP, V124, P1898, DOI 10.1289/EHP150; Shi L, 2017, THERIOGENOLOGY, V93, P24, DOI 10.1016/j.theriogenology.2017.01.022; Surampudi PN, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/625434; Telisman S, 2000, ENVIRON HEALTH PERSP, V108, P45, DOI 10.2307/3454294; Telisman S, 2007, ENVIRON RES, V105, P256, DOI 10.1016/j.envres.2007.05.011; ThoreuxManlay A, 1995, TOXICOLOGY, V103, P53, DOI 10.1016/0300-483X(95)03107-Q; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Zawatski W, 2013, J ENDOCRINOL, V218, pR1, DOI 10.1530/JOE-12-0449; Zhang QH, 2011, TOXICOL LETT, V205, P183, DOI 10.1016/j.toxlet.2011.06.003; Zheng W, 2000, TOXICOL SCI, V54, P295, DOI 10.1093/toxsci/54.2.295	47	11	11	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224892	10.1371/journal.pone.0224892	http://dx.doi.org/10.1371/journal.pone.0224892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697766	gold, Green Published			2022-12-26	WOS:000532694400078
J	Dmitrieva, AS; Ivnitsky, SB; Maksimova, IA; Panchenko, PL; Kachalkin, AV; Markov, AV				Dmitrieva, A. S.; Ivnitsky, S. B.; Maksimova, I. A.; Panchenko, P. L.; Kachalkin, A., V; Markov, A., V			Yeasts affect tolerance of Drosophila melanogaster to food substrate with high NaCl concentration	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; HOLOGENOME THEORY; GUT MICROBIOTA; ADAPTATION; EVOLUTION; BACTERIA; MICROORGANISMS; HETEROGENEITY; COMMUNITIES; HOMEOSTASIS	The ability of model animal species, such as Drosophila melanogaster, to adapt quickly to various adverse conditions has been shown in many experimental evolution studies. It is usually assumed by default that such adaptation is due to changes in the gene pool of the studied population of macroorganisms. At the same time, it is known that microbiome can influence biological processes in macroorganisms. In order to assess the possible impact of microbiome on adaptation, we performed an evolutionary experiment in which some D. melanogaster lines were reared on a food substrate with high NaCl concentration while the others were reared on the standard (favourable) substrate. We evaluated the reproductive efficiency of experimental lines on the high salt substrate three years after the experiment started. Our tests confirmed that the lines reared on the salty substrate became more tolerant to high NaCl concentration. Moreover, we found that pre-inoculation of the high salt medium with homogenized salt-tolerant flies tended to improve reproductive efficiency of naive flies on this medium (compared to pre-inoculation with homogenized control flies). The analysis of yeast microbiome in fly homogenates revealed significant differences in number and species richness of yeasts between salt-tolerant and control lines. We also found that some individual yeast lines extracted from the salt-tolerant flies improved reproductive efficiency of naive flies on salty substrate (compared to baker's yeast and no yeast controls), whereas the effect of the yeast lines extracted from the control flies tended to be smaller. The yeast Starmerella bacillaris extracted from the salt-tolerant flies showed the strongest positive effect. This yeast is abundant in all salt-tolerant lines, and very rare or absent in all control lines. The results are consistent with the hypothesis that some components of the yeast microbiome of D. melanogastercontribute to to flies' tolerance to food substrate with high NaCl concentration.	[Dmitrieva, A. S.; Ivnitsky, S. B.; Panchenko, P. L.; Markov, A., V] Lomonosov Moscow State Univ, Fac Biol, Dept Biol Evolut, Moscow, Russia; [Maksimova, I. A.; Kachalkin, A., V] Lomonosov Moscow State Univ, Fac Soil Sci, Dept Soil Biol, Moscow, Russia; [Kachalkin, A., V] Russian Acad Sci, GK Skryabin Inst Biochem & Physiol Microorganisms, Pushchino, Russia; [Markov, A., V] Russian Acad Sci, Borissiak Paleontol Inst, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences	Maksimova, IA (corresponding author), Lomonosov Moscow State Univ, Fac Soil Sci, Dept Soil Biol, Moscow, Russia.	maximova.irina@gmail.com	Kachalkin, Aleksey/D-6023-2013; Markov, Alexander V/R-8352-2016; Maximova, Irina/AAK-4713-2021	Kachalkin, Aleksey/0000-0002-4494-2468; Markov, Alexander V/0000-0002-7113-7181; Maximova, Irina/0000-0003-3030-6417	Russian Foundation for Fundamental Investigations [18-04-00915]	Russian Foundation for Fundamental Investigations(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Fundamental Investigations, grant No. 18-04-00915. URL of the funder: kias.rfbr.ru/index.php.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Arbuthnott D, 2014, ANIM BEHAV, V87, P45, DOI 10.1016/j.anbehav.2013.10.005; Belkina EG, 2018, J EVOLUTION BIOL, V31, P1803, DOI 10.1111/jeb.13375; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Chaston JM, 2016, APPL ENVIRON MICROB, V82, P671, DOI 10.1128/AEM.03301-15; Coluccio AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002873; Combe BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094729; Csoma H, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy021; Dmitrieva S, 2017, ZH OBSHCH BIOL, V7, P369; DODD DMB, 1989, EVOLUTION, V43, P1308, DOI 10.1111/j.1558-5646.1989.tb02577.x; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; Erkosar B, 2013, CELL HOST MICROBE, V13, P8, DOI 10.1016/j.chom.2012.12.004; Glushakova AM, 2011, EURASIAN SOIL SCI+, V44, P886, DOI 10.1134/S1064229311080059; Gorshkova AA, 2018, ZH OBSHCH BIOL, V79, P3; Gunduz EA, 2009, P ROY SOC B-BIOL SCI, V276, P987, DOI 10.1098/rspb.2008.1476; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Herbst DB, 2001, HYDROBIOLOGIA, V466, P209, DOI 10.1023/A:1014508026349; Hoang D, 2015, PEERJ, V3, DOI 10.7717/peerj.1116; Ivnitsky SB, 2018, ZH OBSHCH BIOL, V79, P393, DOI 10.1134/S0044459618050068; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Leftwich PT, 2017, P NATL ACAD SCI USA, V114, P12767, DOI 10.1073/pnas.1708345114; Long TAF, 2013, AM NAT, V181, P532, DOI 10.1086/669675; Margulis L, 1991, SYMBIOSISOURCE EVO; Markov AV, 2015, ZH OBSHCH BIOL, V76, P429; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; MUNSON MA, 1991, INT J SYST BACTERIOL, V41, P566, DOI 10.1099/00207713-41-4-566; Najarro MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1173; Newell PD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00576; Panchenko PL, 2017, BIOL BULL+, V44, P345, DOI 10.1134/S1062359017040100; PHAFF H J, 1956, Antonie Van Leeuwenhoek, V22, P117, DOI 10.1007/BF02538319; PHAFF H. J., 1956, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V22, P145, DOI 10.1007/BF02538322; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rosenberg E, 2009, ENVIRON MICROBIOL, V11, P2959, DOI 10.1111/j.1462-2920.2009.01995.x; Shaposhnikov G. Kh., 1961, Entomologicheskoe Obozrenie, V40, P739; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sipiczki M, 2003, INT J SYST EVOL MICR, V53, P2079, DOI 10.1099/ijs.0.02649-0; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; STARMER WT, 1981, EVOLUTION, V35, P38, DOI 10.1111/j.1558-5646.1981.tb04856.x; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; VELDE JHT, 1988, J EVOLUTION BIOL, V1, P139, DOI 10.1046/j.1420-9101.1988.1020139.x; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wong ACN, 2016, DIS MODEL MECH, V9, P271, DOI 10.1242/dmm.023408; Wong ACN, 2014, J EXP BIOL, V217, P1894, DOI 10.1242/jeb.101725; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Yamada R, 2015, CELL REP, V10, P865, DOI 10.1016/j.celrep.2015.01.018; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	57	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224811	10.1371/journal.pone.0224811	http://dx.doi.org/10.1371/journal.pone.0224811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693706	Green Published, gold			2022-12-26	WOS:000532690100042
J	Yuan, HW; Cui, Y; Ning, SW; Jiang, SM; Yuan, XJ; Tang, GM				Yuan, Hongwei; Cui, Yi; Ning, Shaowei; Jiang, Shangming; Yuan, Xianjiang; Tang, Guangmin			Estimation of maize evapotraspiration under drought stress - A case study of Huaibei Plain, China	PLOS ONE			English	Article							CROP COEFFICIENT; RIVER-BASIN; EVAPOTRANSPIRATION; IRRIGATION; EVAPORATION; MODEL	Given the importance and complexity of crop evapotranspiration estimation under drought stress, an experiment tailored for maize under drought stress was completed using six sets of large-scale weighing lysimeters at the Xinmaqiao Comprehensive Experimental Irrigation and Drainage Station, Anhui Province, China. Our aim was to analyze maize evapotranspiration under different drought conditions. Based on estimates of maize evapotranspiration under no drought stress using the dual crop coefficient approach, we optimized and calibrated basic crop coefficients K-cbini, K-cbmid, K-cbend, and the maximum crop coefficient K-cmax using a genetic algorithm. Measurements of solar radiation at the experimental station were used to derive the empirical parameters a and b from the Angstrom formula through the genetic algorithm, and then evapotranspiration was calculated for the reference crop (ET0). We then estimated the maize evapotranspiration under drought using the dual crop coefficient approach. The results indicated that a slight water deficit during the earlier stage of vegetative growth may stimulate the maize homeostatic mechanism and increase tolerance to drought stress in later growth periods. Maize evapotranspiration significantly decreased if drought stress continued into the elongation stage, and the same degree of drought stress had a greater influence on the middle and later stages of vegetative and reproductive growth. The calibrated results for K-cbini, K-cbmid, K-cbend, and K-cmax were 0.155, 1.218, 0.420 and 1.497 respectively. We calculated the root-mean-square error (RMSE), mean absolute error (MAE), and mean relative error (MRE) of maize evapotranspiration under no drought stress over the full growing season using a dual crop coefficient approach, and the results were 1.33 mm/day, 0.99 mm/day, and 1.30%, respectively, or 18.40%, 17.50%, and 91.11% lower than results using the recommended coefficients. The RMSE, MAE, and MRE results for maize under drought stress during two full growth periods were 1.18 mm/day, 0.98 mm/day, and 13.92%, respectively. These results were higher than maize without drought stress, but better than the estimated results based on FAO-56 recommended values. Therefore, maize evapotranspiration estimation under drought stress using the dual crop coefficient approach and genetic algorithm was reasonable and reliable. This study provides a theoretical basis for developing suitable regional irrigation programs and decreasing losses due to agricultural	[Yuan, Hongwei; Jiang, Shangming; Yuan, Xianjiang; Tang, Guangmin] Minist Water Resources, Water Resources Res Inst Anhui Prov & Huaihe Rive, Key Lab Water Conservancy & Water Resources Anhui, Hefei, Peoples R China; [Cui, Yi] Tianjin Univ, Stage Key Lab Hydraul Engn Simulat & Safety, Tianjin, Peoples R China; [Ning, Shaowei] Hefei Univ Technol, Sch Civil Engn, Hefei, Peoples R China; [Ning, Shaowei] Univ Yamanashi, Interdisciplinary Ctr River Basin Environm, Kofu, Yamanashi, Japan	Tianjin University; Hefei University of Technology; University of Yamanashi	Jiang, SM (corresponding author), Minist Water Resources, Water Resources Res Inst Anhui Prov & Huaihe Rive, Key Lab Water Conservancy & Water Resources Anhui, Hefei, Peoples R China.	jiangshangming@163.com	NING, Shaowei/GWV-0588-2022	yuan, hw/0000-0002-2663-8139	National Key Research and Development Program of China [2017YFD0301301]; National Natural Science Foundation of China [51409002, 51709071, 71273081]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Key Research and Development Program of China (2017YFD0301301) and the National Natural Science Foundation of China (51409002, 51709071 and 71273081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RG, 2005, J IRRIG DRAIN ENG, V131, P2, DOI 10.1061/(ASCE)0733-9437(2005)131:1(2); Bao YanSong, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P163; [陈南祥 CHEN Nanxiang], 2006, [水利学报, Journal of Hydraulic Engineering], V37, P308; DeJonge KC, 2012, AGR WATER MANAGE, V115, P92, DOI 10.1016/j.agwat.2012.08.013; Du Y., 2013, STUDY RISK ASSESSMEN; Duan HD, 2001, WATER RES PLAN DES, V2, P24; Duchemin B, 2006, AGR WATER MANAGE, V79, P1, DOI 10.1016/j.agwat.2005.02.013; Feng Yu, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P90; [付强 Fu Qiang], 2003, [水利学报, Journal of Hydraulic Engineering], V0, P123; Gao JQ, 2018, ADV METEOROL, V2018, DOI 10.1155/2018/2158168; [高媛媛 Gao Yuanyuan], 2013, [系统工程理论与实践, Systems Engineering-Theory & Practice], V33, P776; Girona J, 2004, ACTA HORTIC, P277, DOI 10.17660/ActaHortic.2004.664.33; Gontia NK, 2010, WATER RESOUR MANAG, V24, P1399, DOI 10.1007/s11269-009-9505-3; [胡庆芳 Hu Qingfang], 2010, [水科学进展, Advances in Water Science], V21, P644; Huo JunJun, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P23; Jin J., 2001, SYST ENG THEORY PRAC, V21, P8; Jin JL, 1998, GENETIC ALGORITHM IT; Lai MH, 2004, STUDY ECOLOGICAL WAT; [李德 Li De], 2015, [资源科学, Resources Science], V37, P700; Liu Yu, 2000, Transactions of the Chinese Society of Agricultural Engineering, V16, P26; Manuel WT, 2000, AGRON J, V92, P628; Martins JD, 2013, BIOSYST ENG, V115, P291, DOI 10.1016/j.biosystemseng.2013.03.016; Ministry of Water Resources of the People's Republic of China, SL 13 2015 SPEC IRR; [樊引琴 Pan Yinqin], 2002, [水利学报, Journal of Hydraulic Engineering], V0, P50; Pei H, 1999, J ARID LAND RESOURCE, V13, P73; Peng ShiZhang, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P30; [祁宦 QI Huan], 2009, [中国农业气象, Chinese Journal of Agrometeorology], V30, P596; Qie ZhiHong, 2011, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V42, P106; RICHARD W, 2000, AGR FOR METEOROL, V103, P335; Shi XiaoHu, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P131; Song SongBai, 2004, Transactions of the Chinese Society of Agricultural Engineering, V20, P40; Su MeiShuang, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P25; Sun J. S., 1993, J IRRIGATION DRAINAG, V13, P36; [孙月峰 SUN Yue-feng], 2009, [系统工程理论与实践, Systems Engineering-Theory & Practice], V29, P139; [王维 Wang Wei], 2015, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V46, P129; [王笑影 Wang Xiaoying], 2003, [农业系统科学与综合研究, System Sciences and Comprehensive Studies in Agriculture], V19, P81; Water Resources Research Institute of Anhui Province and Huaihe River Commission Ministry of Water Resource, 2010, DROUGHT REL PLAN ANH; Xing ZhenXiang, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P47; Xu XH, 2016, PROCEDIA ENGINEER, V154, P1018, DOI 10.1016/j.proeng.2016.07.591; [袁宏伟 Yuan Hongwei], 2018, [排灌机械工程学报, Journal of Drainage and Irrigation Machinery Engineering], V36, P426; Zhang Bing, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P12; Zhang Bing, 2005, Transactions of the Chinese Society of Agricultural Engineering, V21, P25; Zhang Bing, 2008, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V39, P129; Zhang X., 2004, ECOLOGICAL ENV WATER, P48; Zhao JS, 2003, STUDY HOLISTIC MODEL; Zhao LiWen, 2010, Scientia Agricultura Sinica, V43, P4016; [赵娜娜 Zhao Nana], 2010, [水利学报, Journal of Hydraulic Engineering], V41, P953; Zhao WS, 2007, WATER SCI ENG TECHNO, V6, P1; [郑珍 Zheng Zhen], 2016, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V47, P179	49	2	2	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0223756	10.1371/journal.pone.0223756	http://dx.doi.org/10.1371/journal.pone.0223756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689311	gold, Green Published			2022-12-26	WOS:000532680100009
J	Liu, TT; Sun, QS; Liu, Y; Cen, S; Zhang, Q				Liu, Tingting; Sun, Qingsong; Liu, Yong; Cen, Shan; Zhang, Quan			The MOV10 helicase restricts hepatitis B virus replication by inhibiting viral reverse transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis B virus (HBV; Hep B); DNA viruses; innate immunity; RNA helicase; viral replication; liver disease; Moloney leukemia virus 10 (MOV10); RNA silencing; viral reverse transcription; virus-host interactions	RNA HELICASE; GENE-PRODUCTS; EXPRESSION; INTEGRATION; APOBEC3G; COMPLEX	Interferons inhibit viruses by inducing antiviral protein expression. One of the interferon-induced antiviral proteins, human Moloney leukemia virus 10 (MOV10), a superfamily 1 RNA helicase, has been shown to inhibit retroviruses and several RNA viruses. However, it remains undetermined whether MOV10 also inhibits DNA viruses, including hepatitis B virus (HBV). Here, we report that MOV10 dramatically reduces the levels of intracellular HBV DNA, resulting in significant inhibition of both the HBV experimental strain and the clinical isolates. Mechanistic experiments revealed that MOV10 interacts with HBV RNA and blocks the early step of viral reverse transcription, thereby impairing viral DNA synthesis, without affecting viral gene expression and pregenomic RNA encapsidation. Moreover, mutation of the helicase domain of MOV10 caused loss of binding to HBV RNA and of the anti-HBV activity. Together, our results indicate that MOV10 restricts HBV replication, insights that may open new avenues to the development of anti-HBV therapeutics.	[Liu, Tingting] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Transfus Med,Affiliated Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Qingsong] Nanjing Med Univ, Affiliated Huaian 1 Peoples Hosp, Dept Emergency, Huaian 223301, Peoples R China; [Liu, Yong; Zhang, Quan] Nanjing Univ, Sch Med, Dept Lab Med, Nanjing Drum Tower Hosp,Affiliated Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Liu, Yong; Zhang, Quan] Nanjing Univ, Sch Med, Affiliated Hosp, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Zhang, Quan] Nanjing Med Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Dept Infect Dis, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing University; Nanjing University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Nanjing Medical University; Nanjing University	Cen, S (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China.; Zhang, Q (corresponding author), 321 Zhong Shan Rd, Nanjing 210008, Jiangsu, Peoples R China.	shancen@imb.pumc.edu.cn; huanlezq44@126.com			National Natural Science Foundation of China [81602400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81602400. The authors declare that they have no conflicts of interest with the contents of this article.	Amini-Bavil-Olyaee S, 2009, HEPATOLOGY, V49, P1158, DOI 10.1002/hep.22790; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; FALLOWS DA, 1995, J VIROL, V69, P3067, DOI 10.1128/JVI.69.5.3067-3073.1995; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Gregersen LH, 2014, MOL CELL, V54, P573, DOI 10.1016/j.molcel.2014.03.017; Guo JT, 2003, J VIROL, V77, P1885, DOI 10.1128/JVI.77.3.1885-1893.2003; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; HIRSCH RC, 1990, NATURE, V344, P552, DOI 10.1038/344552a0; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; Izumi T, 2013, J VIROL, V87, P11047, DOI 10.1128/JVI.02070-13; Ko C, 2014, J VIROL, V88, P13689, DOI 10.1128/JVI.02035-14; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Li XY, 2013, J BIOL CHEM, V288, P21148, DOI 10.1074/jbc.M113.465856; Liu YH, 2015, J VIROL, V89, P2287, DOI 10.1128/JVI.02760-14; Lu CY, 2012, J VIROL, V86, P10517, DOI 10.1128/JVI.00868-12; Lu HL, 2013, J IMMUNOL, V191, P3264, DOI 10.4049/jimmunol.1300512; Ma YX, 2015, VIRUS RES, V197, P85, DOI 10.1016/j.virusres.2014.12.011; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; MOOSLEHNER K, 1990, J VIROL, V64, P3056, DOI 10.1128/JVI.64.6.3056-3058.1990; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Nguyen DH, 2008, J VIROL, V82, P6852, DOI 10.1128/JVI.00465-08; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Okuyama-Dobashi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17047; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schultz U, 1999, J VIROL, V73, P5459, DOI 10.1128/JVI.73.7.5459-5465.1999; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wu S, 2017, J VIROL, V91, DOI 10.1128/JVI.00519-17; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zhang H, 2016, HEPATOLOGY, V64, P1033, DOI 10.1002/hep.28698; Zhang JS, 2016, J VIROL, V90, P3966, DOI 10.1128/JVI.03137-15; Zhang Q, 2018, VIRUS RES, V255, P165, DOI 10.1016/j.virusres.2018.07.021	40	12	12	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19804	19813		10.1074/jbc.RA119.009435	http://dx.doi.org/10.1074/jbc.RA119.009435			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31722967	Green Published, hybrid			2022-12-26	WOS:000504093200027
J	Matsusaki, M; Okuda, A; Matsuo, K; Gekko, K; Masuda, T; Naruo, Y; Hirose, A; Kono, K; Tsuchi, Y; Urade, R				Matsusaki, Motonori; Okuda, Aya; Matsuo, Koichi; Gekko, Kunihiko; Masuda, Taro; Naruo, Yurika; Hirose, Akiho; Kono, Keiichi; Tsuchi, Yuichiro; Urade, Reiko			Regulation of plant ER oxidoreductin 1 (ERO1) activity for efficient oxidative protein folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); protein-disulfide isomerase; protein folding; disulfide; oxidation-reduction (redox); ER oxidoreductin 1 (ERO1); GmERO1a; intrinsically disordered region; isomerization	DISULFIDE-ISOMERASE FAMILY; BOND FORMATION; SECONDARY-STRUCTURE; PDI FAMILY; ERO1-ALPHA; OXIDASE; SUBSTRATE; YEAST; MECHANISMS; REDUCTASE	In the endoplasmic reticulum (ER), ER oxidoreductin 1 (ERO1) catalyzes intramolecular disulfide-bond formation within its substrates in coordination with protein-disulfide isomerase (PDI) and related enzymes. However, the molecular mechanisms that regulate the ERO1?PDI system in plants are unknown. Reduction of the regulatory disulfide bonds of the ERO1 from soybean, GmERO1a, is catalyzed by enzymes in five classes of PDI family proteins. Here, using recombinant proteins, vacuum-ultraviolet circular dichroism spectroscopy, biochemical and protein refolding assays, and quantitative immunoblotting, we found that GmERO1a activity is regulated by reduction of intramolecular disulfide bonds involving Cys-121 and Cys-146, which are located in a disordered region, similarly to their locations in human ERO1. Moreover, a GmERO1a variant in which Cys-121 and Cys-146 were replaced with Ala residues exhibited hyperactive oxidation. Soybean PDI family proteins differed in their ability to regulate GmERO1a. Unlike yeast and human ERO1s, for which PDI is the preferred substrate, GmERO1a directly transferred disulfide bonds to the specific active center of members of five classes of PDI family proteins. Of these proteins, GmPDIS-1, GmPDIS-2, GmPDIM, and GmPDIL7 (which are group II PDI family proteins) failed to catalyze effective oxidative folding of substrate RNase A when there was an unregulated supply of disulfide bonds from the C121A/C146A hyperactive mutant GmERO1a, because of its low disulfide-bond isomerization activity. We conclude that regulation of plant ERO1 activity is particularly important for effective oxidative protein folding by group II PDI family proteins.	[Matsusaki, Motonori; Okuda, Aya; Masuda, Taro; Naruo, Yurika; Hirose, Akiho; Kono, Keiichi; Tsuchi, Yuichiro] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Uji, Kyoto 6110011, Japan; [Matsuo, Koichi; Gekko, Kunihiko; Urade, Reiko] Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Higashihiroshima, Hiroshima 7390046, Japan; [Matsusaki, Motonori] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan; [Okuda, Aya; Urade, Reiko] Kyoto Univ, Inst Integrated Radiat & Nucl Sci, Kumatori, Osaka 5900494, Japan	Kyoto University; Hiroshima University; Tohoku University; Kyoto University	Urade, R (corresponding author), Kyoto Univ, Inst Integrated Radiat & Nucl Sci, Kumatori, Osaka 5900494, Japan.	urade@kais.kyoto-u.ac.jp	Matsusaki, Motonori/ADS-0009-2022	Matsusaki, Motonori/0000-0002-7296-033X; Okuda, Aya/0000-0002-6222-8364; Urade, Reiko/0000-0002-9232-6176; Masuda, Taro/0000-0002-5549-375X	Japan Society for the Promotion of Science [18658055, 26660111, 16J05933]; Program for Promotion of Basic Research Activities for Innovative Biosciences; Fuji Foundation for Protein Research; Takano Life Science Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences; Fuji Foundation for Protein Research(Fuji Foundation for Protein Research); Takano Life Science Research Foundation	This work was supported by Grants-in-aid for Scientific Research 18658055 and 26660111, Grant-in-aid for JSPS Fellows 16J05933 from the Japan Society for the Promotion of Science, a grant from the Program for Promotion of Basic Research Activities for Innovative Biosciences, a grant from the Fuji Foundation for Protein Research, and a grant from the Takano Life Science Research Foundation.The authors declare that they have no conflicts of interest with the contents of this article.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; Asano S, 2011, PLANT BIOTECHNOL-NAR, V28, P51, DOI 10.5511/plantbiotechnology.10.1109a; Attacha S, 2017, PLANT CELL ENVIRON, V40, P1281, DOI 10.1111/pce.12919; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; CREIGHTON TE, 1977, J MOL BIOL, V113, P329, DOI 10.1016/0022-2836(77)90145-0; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Fan FG, 2019, PLANT PHYSIOL, V180, P2022, DOI 10.1104/pp.19.00020; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Hansen HG, 2014, BIOSCIENCE REP, V34, P155, DOI 10.1042/BSR20130124; Hansen HG, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405050; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jackson SE, 2013, TOP CURR CHEM, V328, P1, DOI 10.1007/128_2011_171; Kamauchi S, 2008, FEBS J, V275, P2644, DOI 10.1111/j.1742-4658.2008.06412.x; Kanemura S, 2016, J BIOL CHEM, V291, P23952, DOI 10.1074/jbc.M116.735662; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Kimura S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0460-2; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; Konno T, 2015, J CELL BIOL, V211, P253, DOI 10.1083/jcb.201506123; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Matsuo K, 2005, J BIOCHEM, V138, P79, DOI 10.1093/jb/mvi101; Matsuo K, 2004, J BIOCHEM, V135, P405, DOI 10.1093/jb/mvh048; Matsuo K, 2003, ANAL SCI, V19, P129, DOI 10.2116/analsci.19.129; Matsuo K, 2013, B CHEM SOC JPN, V86, P675, DOI 10.1246/bcsj.20120341; Matsuo Koichi, 2013, Methods Mol Biol, V974, P151, DOI 10.1007/978-1-62703-275-9_8; Matsusaki M, 2016, PLANT PHYSIOL, V170, P774, DOI 10.1104/pp.15.01781; Moilanen A, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800090; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Niu YB, 2016, J BIOL CHEM, V291, P8283, DOI 10.1074/jbc.M115.694257; Oka OBV, 2015, BIOCHEM J, V469, P279, DOI 10.1042/BJ20141423; Okuda A, 2017, FEBS J, V284, P414, DOI 10.1111/febs.13984; Onda Y, 2009, P NATL ACAD SCI USA, V106, P14156, DOI 10.1073/pnas.0904429106; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Ponsero AJ, 2017, MOL CELL, V67, P962, DOI 10.1016/j.molcel.2017.08.012; Ramming T, 2015, FREE RADICAL BIO MED, V83, P361, DOI 10.1016/j.freeradbiomed.2015.02.011; Ramming T, 2014, FREE RADICAL BIO MED, V70, P106, DOI 10.1016/j.freeradbiomed.2014.01.018; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Urade R, 2019, BIOSCI BIOTECH BIOCH, V83, P781, DOI 10.1080/09168451.2019.1571900; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Wadahama H, 2008, FEBS J, V275, P399, DOI 10.1111/j.1742-4658.2007.06199.x; Wadahama H, 2007, FEBS J, V274, P687, DOI 10.1111/j.1742-4658.2006.05613.x; Wang L, 2011, BIOCHEM J, V434, P113, DOI 10.1042/BJ20101357; Zhang LH, 2014, J BIOL CHEM, V289, P31188, DOI 10.1074/jbc.M114.602961; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	62	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18820	18835		10.1074/jbc.RA119.010917	http://dx.doi.org/10.1074/jbc.RA119.010917			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31685660	hybrid, Green Published			2022-12-26	WOS:000507618800026
J	Helassa, N; Nugues, C; Rajamanoharan, D; Burgoyne, RD; Haynes, LP				Helassa, Nordine; Nugues, Charlotte; Rajamanoharan, Dayani; Burgoyne, Robert D.; Haynes, Lee P.			A centrosome-localized calcium signal is essential for mammalian cell mitosis	FASEB JOURNAL			English	Article						GCaMP; regulation; cell division	INTRACELLULAR FREE CALCIUM; ENDOPLASMIC-RETICULUM; CYCLE PROGRESSION; ANAPHASE; DIVISION; CA-2+; INHIBITION; CALMODULIN; ONSET; ENTRY	Mitosis defects can lead to premature ageing and cancer. Understanding mitosis regulation therefore has important implications for human disease. Early data suggested that calcium (Ca2+) signals could influence mitosis, but these have hitherto not been observed in mammalian cells. Here, we reveal a prolonged yet spatially restricted Ca2+ signal at the centrosomes of actively dividing cells. Local buffering of the centrosomal Ca2+ signals, by flash photolysis of the caged Ca2+ chelator diazo-2-acetoxymethyl ester, arrests mitosis. We also provide evidence that this Ca2+ signal emanates from the endoplasmic reticulum. In summary, we characterize a unique centrosomal Ca2+ signal as a functionally essential input into mitosis.	[Helassa, Nordine; Nugues, Charlotte; Rajamanoharan, Dayani; Burgoyne, Robert D.; Haynes, Lee P.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Crown St, Liverpool L69 3GE, Merseyside, England	University of Liverpool	Haynes, LP (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Crown St, Liverpool L69 3GE, Merseyside, England.	leeh@liverpool.ac.uk	Helassa, Nordine/AAX-2880-2021	Helassa, Nordine/0000-0003-3743-1886	Leverhulme Trust [RPG-2014-194]; Wellcome Trust [105348/2/14/2, 096565/2/11/2]	Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome Trust)	The authors thank Alan Morgan and Alexei Tepikin (Department of Cellular and Molecular Physiology, University of Liverpool) for insightful comments on the manuscript. All light and electronmicroscopy was performed at the Biomedical Imaging Facility, Institute of Translational Medicine, University of Liverpool. The authors thank Dr. Alison Beckett (Institute of Translational Medicine, University of Liverpool) for assistance with transmission electron microscopy work at the Electron Microscopy Unit (University of Liverpool). This work was funded by Leverhulme Trust Project Grant RPG-2014-194 (to L.P.H.) and Wellcome Trust Prize Ph.D. Studentships (105348/2/14/2 to C.N. and 096565/2/11/2 to D.R.). The authors declare no conflicts of interest.	ADAMS SR, 1989, J AM CHEM SOC, V111, P7957, DOI 10.1021/ja00202a042; Casimiro Mathew C, 2012, Genes Cancer, V3, P649, DOI 10.1177/1947601913479022; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chun JT, 2009, BIOCHEM BIOPH RES CO, V384, P141, DOI 10.1016/j.bbrc.2009.04.087; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Farina F, 2019, EMBO J, V38, DOI 10.15252/embj.201899843; Farina F, 2016, NAT CELL BIOL, V18, P65, DOI 10.1038/ncb3285; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Groigno L, 1998, CELL, V92, P193, DOI 10.1016/S0092-8674(00)80914-9; Helassa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38276; HEPLER PK, 1980, J CELL BIOL, V86, P490, DOI 10.1083/jcb.86.2.490; HEPLER PK, 1994, CELL CALCIUM, V16, P322, DOI 10.1016/0143-4160(94)90096-5; HEPLER PK, 1987, J CELL BIOL, V105, P2137, DOI 10.1083/jcb.105.5.2137; Hubert T, 2011, BIOCHEM BIOPH RES CO, V404, P153, DOI 10.1016/j.bbrc.2010.11.084; Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950; KAO JPY, 1990, J CELL BIOL, V111, P183, DOI 10.1083/jcb.111.1.183; KEITH CH, 1985, NATURE, V316, P848, DOI 10.1038/316848a0; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Mccue HV, 2013, BIOCHEM J, V449, P449, DOI 10.1042/BJ20120898; Miller AL, 2011, CURR BIOL, V21, pR976, DOI 10.1016/j.cub.2011.10.044; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; POENIE M, 1986, SCIENCE, V233, P886, DOI 10.1126/science.3755550; POENIE M, 1985, NATURE, V315, P147, DOI 10.1038/315147a0; Potapova T, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010012; RASMUSSEN CD, 1989, EMBO J, V8, P73, DOI 10.1002/j.1460-2075.1989.tb03350.x; RATAN RR, 1986, P NATL ACAD SCI USA, V83, P5136, DOI 10.1073/pnas.83.14.5136; Saleem H, 2014, BRIT J PHARMACOL, V171, P3298, DOI 10.1111/bph.12685; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sawant DB, 2015, MOL BIOL CELL, V26, P3741, DOI 10.1091/mbc.E14-07-1248; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shigetomi E, 2010, NEURON GLIA BIOL, V6, P183, DOI 10.1017/S1740925X10000219; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Smyth JT, 2012, BIOCHEM SOC T, V40, P119, DOI 10.1042/BST20110612; STEINHARDT RA, 1988, NATURE, V332, P364, DOI 10.1038/332364a0; SWANN MM, 1957, CANCER RES, V17, P727; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thillaiappan NB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01644-8; TOMBES RM, 1989, J CELL BIOL, V109, P627, DOI 10.1083/jcb.109.2.627; Torok K, 1998, CURR BIOL, V8, P692, DOI 10.1016/S0960-9822(98)70275-1; TWIGG J, 1988, NATURE, V332, P366, DOI 10.1038/332366a0; Visweshwaran SP, 2018, EMBO J, V37, DOI 10.15252/embj.201797706; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; Whitaker M, 2006, CELL CALCIUM, V40, P585, DOI 10.1016/j.ceca.2006.08.018; Wilding M, 1996, J CELL BIOL, V135, P191, DOI 10.1083/jcb.135.1.191; Yoshino T, 2007, EUR J PHARMACOL, V560, P225, DOI 10.1016/j.ejphar.2007.01.012	50	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14602	14610		10.1096/fj.201901662R	http://dx.doi.org/10.1096/fj.201901662R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31682764	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000507466100118
J	Lin, HP; Ho, HM; Chang, CW; Yeh, SD; Su, YW; Tan, TH; Lin, WJ				Lin, Hsiu-Ping; Ho, Hui-Min; Chang, Cheng-Wei; Yeh, Shauh-Der; Su, Yu-Wen; Tan, Tse-Hua; Lin, Wen-Jye			DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis	FASEB JOURNAL			English	Article						dual-specificity phosphatases; MAP kinases; phosphorylation; dephosphorylation	ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; ANDROGEN RECEPTOR; SPLICE VARIANT; PHOSPHATASE 1; EXPRESSION; PROGRESSION; EPCAM; PHOSPHORYLATION; CONTRIBUTES	Dual-specificity phosphatases (DUSPs) regulate the activity of various downstream kinases through serine or threonine or tyrosine dephosphorylation. Loss of function and aberrant expression of DUSPs has been implicated in cancer progression and poor survival, yet the function of DUSP22 in prostate cancer (PCa) cells is not clear. Gene Expression Omnibus and cBioPortal microarray database analyses showed that DUSP22 expression was lower in PCa tissues than normal prostate tissues, and altered DUSP22 expression was associated with shorter progression-free and disease-free survival of patients with PCa. Exogenous DUSP22 expression in LNCaP, PC3, and C4-2B PCa cells inhibited cellular proliferation and colony formation, supporting a growth inhibitory role for DUSP22 in PCa cells. DUSP22 expression significantly attenuated epidermal growth factor (EGF) receptor (EGFR) and its downstream ERK1/2 signaling by dephosphorylation. However, DUSP22 failed to suppress the growth of CWR22Rv1 and DU145 cells with elevated phosphorylated (p-)ERK1/2 levels. A serine-to-alanine mutation at position 58, a potential ERK1/2-targeted phosphorylation site in DUSP22, was sufficient to suppress growth of CWR22Rv1 cells with elevated p-ERK1/2 levels, suggesting a mutually antagonistic relationship between DUSP22 and ERK1/2 dependent on phosphorylation status. We showed that DUSP22 can suppress prostate-specific antigen gene expression through phosphatase-dependent pathways, suggesting that DUSP22 is an important regulator of the androgen receptor (AR) in PCa cells. Mechanistically, DUSP22 can interact with AR as a regulatory partner and interfere with EGF-induced AR phosphorylation at Tyr534, suggesting that DUSP22 serves as a crucial suppressor of both EGFR and AR-dependent signaling in PCa cells via dephosphorylation. Our findings indicate that loss of function of DUSP22 in PCa cells leads to aberrant activation of both EGFR-ERKs and AR signaling and ultimately progression of PCa, supporting the potential for novel therapeutic design of harnessing DUSP22 in the treatment of PCa.	[Lin, Hsiu-Ping; Ho, Hui-Min; Chang, Cheng-Wei; Su, Yu-Wen; Tan, Tse-Hua; Lin, Wen-Jye] Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan; [Yeh, Shauh-Der] Taipei Med Univ, Grad Inst Clin Med, Dept Urol, Taipei, Taiwan	National Health Research Institutes - Taiwan; Taipei Medical University	Lin, WJ (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.	020808@nhri.edu.tw	Lin, Wen-Jye/GVW-3018-2022; Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Lin, Wen-Jye/0000-0001-8821-9813	National Health Research Institutes [06A1-IMPP05-015]; Taiwan Ministry of Science and Technology (MOST) [106-2314-B-400-010]; MOST postdoctoral fellowship [105-2811-B-400-014]	National Health Research Institutes(National Health Research Institutes, Japan); Taiwan Ministry of Science and Technology (MOST); MOST postdoctoral fellowship	The authors thank members of T.H.T.'s laboratory and the National RNAi Core Facility (Academia Sinica, Taipei, Taiwan) for technical assistance. The authors thank Dr. Loretta Collins (WriteScience, LLC, Hannewa Falls, NY, USA), for scientific editing. The authors thank Drs. C. P. Chuu [National Health Research Institutes (NHRI)] and Hsing-Jien Kung (University of California-Davis, Davis, CA, USA) for providing reagents and cell lines. This study was supported by funding from the National Health Research Institutes (06A1-IMPP05-015 to W.-J.L.), and a Taiwan Ministry of Science and Technology (MOST) grant (106-2314-B-400-010 to W.-J.L.). C.-W.C. is a recipient of a MOST postdoctoral fellowship (105-2811-B-400-014). The authors declare no conflicts of interest.	Arnoldussen YJ, 2008, CANCER RES, V68, P9255, DOI 10.1158/0008-5472.CAN-08-1224; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Cain E. L., 2013, ONCOGENE CANC; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Castellar ERP, 2014, BLOOD, V124, P1473, DOI 10.1182/blood-2014-04-571091; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Chen HF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112668; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Daniels G, 2013, AM J CLIN EXP UROL, V1, P25; Day KC, 2017, CANCER RES, V77, P74, DOI 10.1158/0008-5472.CAN-16-1656; DeHaan AM, 2009, PROSTATE, V69, P528, DOI 10.1002/pros.20903; Gil-Araujo B, 2014, MOL ONCOL, V8, P27, DOI 10.1016/j.molonc.2013.08.012; Gioeli D, 1999, CANCER RES, V59, P279; Gioeli D, 2011, MOL CANCER THER, V10, P1581, DOI 10.1158/1535-7163.MCT-10-1033; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Igawa T, 2017, INT J UROL, V24, P16, DOI 10.1111/iju.13197; Ilagan R, 2006, CANCER RES, V66, P10778, DOI 10.1158/0008-5472.CAN-05-3577; Isikbay M, 2014, HORM CANCER-US, V5, P72, DOI 10.1007/s12672-014-0173-2; Jamaspishvili T, 2018, NAT REV UROL, V15, P222, DOI 10.1038/nrurol.2018.9; Kharaziha P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.1; Kibel AS, 2004, INT J CANCER, V109, P668, DOI 10.1002/ijc.20060; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Li JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4618; Li JP, 2010, J BIOL CHEM, V285, P5472, DOI 10.1074/jbc.M109.060186; Lin HK, 2004, MOL ENDOCRINOL, V18, P2409, DOI 10.1210/me.2004-0117; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; Liu Y, 2010, ONCOGENE, V29, P3208, DOI 10.1038/onc.2010.103; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; MagiGalluzzi C, 1997, LAB INVEST, V76, P37; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Martowicz A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-501; Massoner P, 2014, BRIT J CANCER, V111, P955, DOI 10.1038/bjc.2014.366; Mukherjee R, 2011, BRIT J CANCER, V104, P1920, DOI 10.1038/bjc.2011.163; Ni J, 2013, INT J BIOCHEM CELL B, V45, P2736, DOI 10.1016/j.biocel.2013.09.008; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; RAVENNA L, 1995, PROSTATE, V26, P290, DOI 10.1002/pros.2990260604; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Sampson N, 2013, ENDOCR-RELAT CANCER, V20, pR49, DOI 10.1530/ERC-12-0401; Segawa N, 2001, CANCER RES, V61, P6060; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Sharp A, 2019, J CLIN INVEST, V129, P192, DOI 10.1172/JCI122819; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; THALMANN GN, 1994, CANCER RES, V54, P2577; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Wen Y, 2000, CANCER RES, V60, P6841; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Yoshida GJ, 2014, BIOCHEM BIOPH RES CO, V443, P239, DOI 10.1016/j.bbrc.2013.11.093	57	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14653	14667		10.1096/fj.201802558RR	http://dx.doi.org/10.1096/fj.201802558RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31693867	Bronze			2022-12-26	WOS:000507466100122
J	Ierano, C; Thursky, K; Peel, T; Rajkhowa, A; Marshall, C; Ayton, D				Ierano, Courtney; Thursky, Karin; Peel, Trisha; Rajkhowa, Arjun; Marshall, Caroline; Ayton, Darshini			Influences on surgical antimicrobial prophylaxis decision making by surgical craft groups, anaesthetists, pharmacists and nurses in public and private hospitals	PLOS ONE			English	Article							THEORETICAL DOMAINS FRAMEWORK; INTERVENTIONS; SURVEILLANCE; ASSISTANT; RECOVERY; SURGERY; AUDIT; UNIT; CARE	Background Surgical antimicrobial prophylaxis (SAP) is a leading indication for antibiotic use in the hospital setting, with demonstrated high rates of inappropriateness. Decision-making for SAP is complex and multifactorial. A greater understanding of these factors is needed to inform the design of targeted antimicrobial stewardship interventions and strategies to support the optimization of SAP and its impacts on patient care. Methods A qualitative case study exploring the phenomenon of SAP decision-making. Focus groups were conducted with surgeons, anaesthetists, theatre nurses and pharmacists across one private and two public hospitals in Australia. Thematic analysis was guided by the Theoretical Domains Framework (TDF) and the Capabilities, Opportunities, Motivators-Behaviour (COM-B) model. Results Fourteen focus groups and one paired interview were completed. Ten of the fourteen TDF domains were identified as relevant. Thematic analysis revealed six significant themes mapped to the COM-B model, and subthemes mapped to the relevant TDF domains in a combined framework. Key themes identified were: 1) Low priority for surgical antimicrobial prophylaxis prescribing skills; 2) Prescriber autonomy takes precedence over guideline compliance; 3) Social codes of prescribing reinforce established practices; 4) Need for improved communication, documentation and collection of data for action; 5) Fears and perceptions of risk hinder appropriate SAP prescribing; and 6) Lack of clarity regarding roles and accountability. Conclusions SAP prescribing is a complex process that involves multiple professions across the pre-, intra- and post-operative surgical settings. The utilisation of behaviour change frameworks to identify barriers and enablers to optimal SAP prescribing supports future development of theory-informed antimicrobial stewardship interventions. Interventions should aim to increase surgeon engagement, enhance the prioritisation of and accountability for SAP, and address the underlying social factors involved in SAP decision-making, such as professional hierarchy and varied perceptions or risks and fears.	[Ierano, Courtney; Thursky, Karin; Peel, Trisha; Rajkhowa, Arjun; Marshall, Caroline] Peter Doherty Res Inst Infect & Immun, Natl Ctr Antimicrobial Stewardship NCAS, Natl Hlth & Med Res Council Ctr Res Excellence, Melbourne, Vic, Australia; [Ierano, Courtney; Thursky, Karin; Rajkhowa, Arjun; Marshall, Caroline] Univ Melbourne, Fac Med Dent & Hlth Sci, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Thursky, Karin] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia; [Peel, Trisha] Monash Univ, Alfred Hlth, Fac Med Nursing & Hlth Sci, Dept Infect Dis, Melbourne, Vic, Australia; [Marshall, Caroline] Royal Melbourne Hosp, Infect Prevent & Surveillance Serv, Parkville, Vic, Australia; [Marshall, Caroline] Royal Melbourne Hosp, Victorian Infect Dis Serv VIDS, Parkville, Vic, Australia; [Ayton, Darshini] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; Peter Maccallum Cancer Center; Monash University; Royal Melbourne Hospital; Royal Melbourne Hospital; Monash University	Ierano, C (corresponding author), Peter Doherty Res Inst Infect & Immun, Natl Ctr Antimicrobial Stewardship NCAS, Natl Hlth & Med Res Council Ctr Res Excellence, Melbourne, Vic, Australia.; Ierano, C (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.	cierano@student.unimelb.edu.au	thursky, karin/AAV-4524-2021; Peel, Trisha/Y-5267-2019; Ierano, Courtney/V-1047-2017	Peel, Trisha/0000-0003-2370-2438; Marshall, Caroline/0000-0001-5901-2004; Ierano, Courtney/0000-0002-5472-8895; Rajkhowa, Arjun/0000-0002-3760-2182; thursky, karin/0000-0002-7400-232X	National Health and Medical Research Council (NHMRC) funds the Centre of Research Excellence-National Centre of Antimicrobial Stewardship (NCAS) [1079625]; NCAS	National Health and Medical Research Council (NHMRC) funds the Centre of Research Excellence-National Centre of Antimicrobial Stewardship (NCAS); NCAS	The National Health and Medical Research Council (NHMRC) funds the Centre of Research Excellence-National Centre of Antimicrobial Stewardship (NCAS) (Grant number: 1079625 to KT). NCAS provided funding of $1250.00to cover the costs of transcription services and catering at focus groups as a token of appreciation for the participants time taken for the project. Authors KT, TP and CM are chief investigators for NCAS; author CI is a PhD Fellow receiving stipend from NCAS and had a role in the study design, data collection and analysis, decision to publish and manuscript preparation.	Abdel-Aziz A, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/842593; [Anonymous], 2015, ANT PRESCR PRACT AUS; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Australian Commission on Safety and Quality in Health Care, 2016, ANT PRESCR PRACT AUS; Australian Commission on Safety and Quality in Health Care, SURG NAT ANT PRESCR; Australian Commission on Safety and Quality in Health Care, 2014, ANT STEW CLIN CAR ST; Australian Commission on Safety and Quality in Health Care, 2018, ANT STEW AUSTR HLTH; Australian Institute of Health and Welfare, 2016, ADM PAT CAR 2014 15; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brooks JJ, 2019, INT J MENT HEALTH AD, V17, P615, DOI 10.1007/s11469-018-9886-8; Broom A, 2016, J SOCIOL, V52, P824, DOI 10.1177/1440783315594486; Broom A, 2014, SOC SCI MED, V110, P81, DOI 10.1016/j.socscimed.2014.03.030; Broom J, 2018, J HOSP INFECT, V99, P124, DOI 10.1016/j.jhin.2017.12.007; Broom JK., 2017, AM J INFECT CONTROL; Buckley T, 2013, J CLIN NURS, V22, P2053, DOI 10.1111/jocn.12086; Bull AL, 2006, J HOSP INFECT, V63, P140, DOI 10.1016/j.jhin.2006.01.018; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Cech J, 2009, 4TH INTERNATIONAL CONGRESS ON COLD ATMOSPHERIC PRESSURE PLASMAS: SOURCES AND APPLICATIONS, PROCEEDINGS, P5; Charani E, 2019, CLIN INFECT DIS, V69, P12, DOI 10.1093/cid/ciy844; Charani E, 2017, CLIN MICROBIOL INFEC, V23, P752, DOI 10.1016/j.cmi.2017.03.013; Charani E, 2013, CLIN INFECT DIS, V57, P188, DOI 10.1093/cid/cit212; Charani E, 2011, CLIN INFECT DIS, V53, P651, DOI 10.1093/cid/cir445; Cotta MO, 2016, INTERN MED J, V46, P1182, DOI 10.1111/imj.13209; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Davey P, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub4; Davey P, 2015, INT J ANTIMICROB AG, V45, P203, DOI 10.1016/j.ijantimicag.2014.11.014; De Souza V, 2006, J ANTIMICROB CHEMOTH, V58, P840, DOI 10.1093/jac/dkl323; Fiore JF, 2016, J THORAC CARDIOV SUR, V151, P708, DOI 10.1016/j.jtcvs.2015.09.112; Fukushima R, 2018, ENHANCED RECOVERY SU; Hains T, 2017, ANZ J SURG, V87, P222, DOI 10.1111/ans.13900; Hains T, 2016, INT J NURS PRACT, V22, P546, DOI 10.1111/ijn.12462; Hale AR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003027; Hunter JG, 2007, J AM COLL SURGEONS, V205, pE4, DOI 10.1016/j.jamcollsurg.2007.06.318; Jayasuriya-Illesinghe V, 2016, BMC SURG, V16, DOI 10.1186/s12893-016-0177-7; Kaya S, 2016, EURASIAN J MED, V48, P24, DOI 10.5152/eurasianjmed.2015.15222; Kelly H., 2019, THERAPEUTIC GUIDELIN; Khalil V, 2016, J CLIN PHARM THER, V41, P662, DOI 10.1111/jcpt.12442; Latter S, 2011, EVALUATION NURSE PHA; Lipworth W, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-530; Livorsi D, 2015, INFECT CONT HOSP EP, V36, P1065, DOI 10.1017/ice.2015.136; Lorencatto F, 2018, J ANTIMICROB CHEMOTH, V73, P2613, DOI 10.1093/jac/dky222; Lyu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181970; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2014, BEHAV CHANGE WHEEL G, DOI DOI 10.1186/s13012-015-0322-1; Michie S., 2012, C P; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Moffatt-Bruce SD, 2017, J SURG ONCOL, V116, P601, DOI 10.1002/jso.24790; Mosavianpour M, 2016, J MULTIDISCIP HEALTH, V9, P303, DOI 10.2147/JMDH.S107796; Mousavi S, 2017, J RES PHARM PRACT, V6, P126, DOI 10.4103/jrpp.JRPP_16_164; Nguyen AD, J PHARM PRACTICE; Nursing and Midwifery Board of Australia, 2019, REG DAT REP PER 1 JA; Oh AL, 2014, J INFECT DEV COUNTR, V8, P193, DOI 10.3855/jidc.3076; ONeill J., 2014, REV ANTIMICROBIAL RE; Pharmacy Board of Australia, 2018, PHARM PRECR FOR REP; Phillips CJ, 2015, J MULTIDISCIP HEALTH, V8, P139, DOI 10.2147/JMDH.S78458; Pittalis S, 2013, SURG INFECT, V14, P381, DOI 10.1089/sur.2012.189; Poh Eng Whui, 2018, JBI Database System Rev Implement Rep, V16, P1823, DOI 10.11124/JBISRIR-2017-003697; Rawson TM, 2017, CLIN MICROBIOL INFEC, V23, P524, DOI 10.1016/j.cmi.2017.02.028; Royal Australasian College of Surgeons, 2015, BUILD RESP IMPR PAT; Shinnick JK, 2016, J SURG RES, V202, P165, DOI 10.1016/j.jss.2015.12.051; Spence BG, 2019, ORTHOP NURS, V38, P17, DOI 10.1097/NOR.0000000000000514; Taylor Sally, 2019, Journal of Pharmacy Practice and Research, V49, P176, DOI 10.1002/jppr.1464; The Joint Commission, 2019, UN PROT PREV WRONG S; Tong EY, 2016, J CLIN PHARM THER, V41, P414, DOI 10.1111/jcpt.12405; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Health Organisation, 2009, WGO GUID SAF SURG 20; World Health Organization, 2017, UPD ROADM GLOB FRAM; Zhou MM, 2019, INT J PHARM PRACT, V27, P479, DOI 10.1111/ijpp.12557	68	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225011	10.1371/journal.pone.0225011	http://dx.doi.org/10.1371/journal.pone.0225011			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725771	Green Published, gold, Green Submitted			2022-12-26	WOS:000532764500044
J	Neta, M; Harp, NR; Henley, DJ; Beckford, SE; Koehler, K				Neta, Maital; Harp, Nicholas R.; Henley, Daniel J.; Beckford, Safiya E.; Koehler, Karsten			One step at a time: Physical activity is linked to positive interpretations of ambiguity	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; EMOTION REGULATION; ACTIVITY QUESTIONNAIRE; COGNITIVE REAPPRAISAL; AEROBIC EXERCISE; ATTENTIONAL BIAS; DEPRESSION; RESPONSES; HEALTH; INTENSITY	Background Extensive research has established a clear positive relationship between physical activity (PA), even in small amounts, and psychological well-being, including benefits for emotional and mental health (e.g., decreased depression). However, little research has examined the relationship between PA and decision-making within emotionally ambiguous contexts. The purpose of the present cross-sectional study was to examine the relationship between reported amount and intensity of PA and interpretations of emotional ambiguity. Methods Adults (n = 611) recruited through Amazon's Mechanical Turk were assessed on their interpretations of ambiguous and clear (unambiguous) emotional stimuli and reported habitual PA and exercise. Results More positive ratings of ambiguity were associated with greater amount of vigorous activity (p = .002), but not with moderate activity (p = .826) or walking (p = .673). Subsequent analyses demonstrated that this relationship between vigorous PA and positive interpretations of ambiguity was most pronounced when comparing individuals who reported any amount of vigorous PA to those who reported no vigorous activity at all. Conclusions Our findings suggest that higher amounts of vigorous, but not moderate, PA are associated with more positive interpretations of ambiguity, and that even small amounts of PA seem to be sufficient to promote this more positive valence bias when compared to individuals conducting no vigorous PA at all. Future work should examine the longitudinal effects of PA among individuals participating in structured activity programs.	[Neta, Maital; Harp, Nicholas R.; Henley, Daniel J.] Univ Nebraska Lincoln, Dept Psychol, Lincoln, NE 68588 USA; [Neta, Maital; Harp, Nicholas R.; Henley, Daniel J.; Koehler, Karsten] Univ Nebraska Lincoln, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA; [Henley, Daniel J.] Michigan State Univ, Dept Advertising & Publ Relat, E Lansing, MI 48824 USA; [Beckford, Safiya E.; Koehler, Karsten] Univ Nebraska Lincoln, Dept Nutr & Hlth Sci, Lincoln, NE USA; [Koehler, Karsten] Tech Univ Munich, Dept Sport & Hlth Sci, Munich, Germany	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Michigan State University; University of Nebraska System; University of Nebraska Lincoln; Technical University of Munich	Harp, NR (corresponding author), Univ Nebraska Lincoln, Dept Psychol, Lincoln, NE 68588 USA.; Harp, NR (corresponding author), Univ Nebraska Lincoln, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA.	nharp@huskers.unl.edu	Neta, Maital/Q-6752-2019; Koehler, Karsten/ABD-6254-2021; Harp, Nicholas/HGC-4147-2022	Neta, Maital/0000-0001-8586-0963; Koehler, Karsten/0000-0002-9618-2069; Harp, Nicholas/0000-0002-8115-9309	Nebraska Tobacco Settlement Funds	Nebraska Tobacco Settlement Funds	This project was possible due to support from the Nebraska Tobacco Settlement Funds which provided start-up funds for MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2018 Physical Activity Guidelines Advisory Committee, 2018, 2018 PHYS ACT GUID A; Angevaren M, 2007, EUR J CARDIOV PREV R, V14, P825, DOI 10.1097/HJR.0b013e3282ef995b; [Anonymous], 2019, OFF DIS PREV HLTH PR, DOI [10.1177/0890117119835519, DOI 10.1177/0890117119835519]; Ball JW, 2014, RECREAT SPORTS J, V38, P130, DOI [10.1123/rsj.2013-0018, 10.1123/rsj.2014-0048]; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Berger BG, 1998, PERCEPT MOTOR SKILL, V87, P611, DOI 10.2466/pms.1998.87.2.611; Bernstein EE, 2019, EMOTION, V19, P637, DOI 10.1037/emo0000462; Bernstein EE, 2017, COGNITION EMOTION, V31, P834, DOI 10.1080/02699931.2016.1168284; Biddle S., 2003, PHYS ACTIVITY PSYCHO; Bray SR, 2006, J AM COLL HEALTH, V55, P77, DOI 10.3200/JACH.55.2.77-82; Brown CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14846-3; Browning M, 2010, COGN AFFECT BEHAV NE, V10, P8, DOI 10.3758/CABN.10.1.8; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Bushman BA, 2012, ACSMS HEALTH FIT J, V16, P5, DOI 10.1249/01.FIT.0000413045.15742.7b; Carek PJ, 2011, INT J PSYCHIAT MED, V41, P15, DOI 10.2190/PM.41.1.c; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Cox EP, 2016, J SCI MED SPORT, V19, P616, DOI 10.1016/j.jsams.2015.09.003; Crabbe JB, 2007, PHYSIOL BEHAV, V90, P394, DOI 10.1016/j.physbeh.2006.10.001; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Erickson KI, 2019, MED SCI SPORT EXER, V51, P1242, DOI 10.1249/MSS.0000000000001936; Giles GE, 2017, EXP BRAIN RES, V235, P3785, DOI 10.1007/s00221-017-5098-x; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Guiney H, 2013, PSYCHON B REV, V20, P73, DOI 10.3758/s13423-012-0345-4; Haga SM, 2009, J HAPPINESS STUD, V10, P271, DOI 10.1007/s10902-007-9080-3; Hansen CJ, 2001, HEALTH PSYCHOL, V20, P267, DOI 10.1037//0278-6133.20.4.267; Harvey SB, 2018, AM J PSYCHIAT, V175, P28, DOI 10.1176/appi.ajp.2017.16111223; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Joormann J, 2015, CLIN PSYCHOL SCI, V3, P126, DOI 10.1177/2167702614560748; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Karreman A, 2012, PERS INDIV DIFFER, V53, P821, DOI 10.1016/j.paid.2012.06.014; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Kim Y, 2013, PUBLIC HEALTH NUTR, V16, P440, DOI 10.1017/S1368980012002996; Koehler K, 2019, APPETITE, V140, P91, DOI 10.1016/j.appet.2019.05.010; LaCaille RA, 2004, PSYCHOL SPORT EXERC, V5, P461, DOI 10.1016/S1469-0292(03)00039-6; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Loprinzi PD, 2013, AGING MENT HEALTH, V17, P801, DOI 10.1080/13607863.2013.801066; Mata J, 2012, J ABNORM PSYCHOL, V121, P297, DOI 10.1037/a0023533; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Mattek AM, 2016, EMOTION, V16, P929, DOI 10.1037/emo0000148; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; Mullen SP, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00614; Neta M, 2018, MOTIV EMOTION, V42, P258, DOI 10.1007/s11031-018-9665-7; Neta M, 2017, EMOTION, V17, P1137, DOI 10.1037/emo0000349; Neta M, 2016, EMOTION, V16, P730, DOI 10.1037/emo0000181; Neta M, 2013, J COGNITIVE NEUROSCI, V25, P547, DOI 10.1162/jocn_a_00363; Neta M, 2010, PSYCHOL SCI, V21, P901, DOI 10.1177/0956797610373934; Neta M, 2009, EMOTION, V9, P640, DOI 10.1037/a0016819; Noh JW, 2015, J PHYS THER SCI, V27, P1233, DOI 10.1589/jpts.27.1233; Norton K, 2010, J SCI MED SPORT, V13, P496, DOI 10.1016/j.jsams.2009.09.008; Ohman A, 1998, KAROLINSKA DIRECTED; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Peruyero F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00921; Petro N, 2018, ANN M SOC AFF NEUR S; Petro NM, 2018, SOC COGN AFFECT NEUR, V13, P687, DOI 10.1093/scan/nsy049; R Core Team, 2018, R LANG ENV STAT COMP; Ray RD, 2005, COGN AFFECT BEHAV NE, V5, P156, DOI 10.3758/CABN.5.2.156; Reed J, 2006, PSYCHOL SPORT EXERC, V7, P477, DOI 10.1016/j.psychsport.2005.11.003; Richardson LP, 2003, ARCH PEDIAT ADOL MED, V157, P739, DOI 10.1001/archpedi.157.8.739; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; Robinson AM, 2012, BEHAV NEUROSCI, V126, P762, DOI 10.1037/a0030488; Schuch FB, 2018, AM J PSYCHIAT, V175, P631, DOI 10.1176/appi.ajp.2018.17111194; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Steptoe A, 1997, PREV MED, V26, P845, DOI 10.1006/pmed.1997.0224; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Tomporowski PD, 2006, INT J SPORT EXERC PS, V4, P57, DOI 10.1080/1612197X.2006.9671784; Tomporowski PD, 2019, PSYCHOL BULL, V145, P929, DOI 10.1037/bul0000200; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Troy AS, 2010, EMOTION, V10, P783, DOI 10.1037/a0020262; Tsukamoto H, 2016, PHYSIOL BEHAV, V155, P224, DOI 10.1016/j.physbeh.2015.12.021; Yeung RR, 1996, J PSYCHOSOM RES, V40, P123, DOI 10.1016/0022-3999(95)00554-4; Zhang ZJ, 2019, J HAPPINESS STUD, V20, P1305, DOI 10.1007/s10902-018-9976-0	80	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225106	10.1371/journal.pone.0225106	http://dx.doi.org/10.1371/journal.pone.0225106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2HK	31725769	gold, Green Published			2022-12-26	WOS:000532764500055
J	Sandblom, V; Spetz, J; Shubbar, E; Montelius, M; Stahl, I; Swanpalmer, J; Nilsson, O; Forssell-Aronsson, E				Sandblom, Viktor; Spetz, Johan; Shubbar, Emman; Montelius, Mikael; Stahl, Ingun; Swanpalmer, John; Nilsson, Ola; Forssell-Aronsson, Eva			Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer	PLOS ONE			English	Article							RECEPTOR RADIONUCLIDE THERAPY; PHASE-I TRIAL; RET PROTOONCOGENE; PANCREATIC-CANCER; CARCINOMA; SOMATOSTATIN; CONCURRENT; SURVIVAL; MODEL; PRRT	Patients with medullary thyroid cancer (MTC) are often diagnosed with spread tumour disease and the development of better systemic treatment options for these patients is important. Treatment with the radiolabelled somatostatin analogue Lu-177-octreotate is already a promising option but can be optimised. For example, combination treatment with another substance could increase the effect on tumour tissue. Gemcitabine is a nucleoside analogue that has been shown to sensitise tumour cells to radiation. The aim of this study was to investigate potentially additive or synergistic effects of combining radiation with gemcitabine for treatment of MTC. Nude mice transplanted with patient-derived MTC tumours (GOT2) were divided into groups and treated with radiation and/or gemcitabine. Radiation treatment was given as Lu-177-octreotate or external beam radiotherapy (EBRT). The volume of treated and untreated tumours was followed. The absorbed dose and amount of gemcitabine were chosen to give moderate tumour volume reduction when given as monotherapy to enable detection of increased effects from combination treatment. After follow-up, the mice were killed and tumours were immunohistochemically (IHC) analysed. Overall, the animals that received a combination of EBRT and gemcitabine showed the largest reduction in tumour volume. Monotherapy with EBRT or gemcitabine also resulted in a clear detrimental effect on tumour volume, while the animals that received Lu-177-octreotate monotherapy showed similar response as the untreated animals. The GOT2 tumour was confirmed in the IHC analyses by markers for MTC. The IHC analyses also revealed that the proliferative activity of tumour cells was similar in all tumours, but indicated that fibrotic tissue was more common after EBRT and/or gemcitabine treatment. The results indicate that an additive, or even synergistic, effect may be achieved by combining radiation with gemcitabine for treatment of MTC. Future studies should be performed to evaluate the full potential of combining Lu-177-octreotate with gemcitabine in patients.	[Sandblom, Viktor; Spetz, Johan; Shubbar, Emman; Montelius, Mikael; Stahl, Ingun; Swanpalmer, John; Forssell-Aronsson, Eva] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci, Gothenburg, Sweden; [Stahl, Ingun; Swanpalmer, John; Forssell-Aronsson, Eva] Sahlgrens Univ Hosp, Dept Med Phys & Biomed Engn, Gothenburg, Sweden; [Nilsson, Ola] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Pathol,Inst Biomed, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Sandblom, V (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci, Gothenburg, Sweden.	viktor.sandblom@gu.se	Spetz, Johan/P-1662-2017	Spetz, Johan/0000-0002-5216-9786; Forssell-Aronsson, Eva/0000-0002-7558-4368	Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE -a National Strategic Research Program at the University of Gothenburg; Swedish government [ALFGBG-725031]; county councils - the ALF agreement [ALFGBG-725031]; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Assar Gabrielsson Cancer Research Foundation; Adlerbertska Research Foundation; Herbert & Karin Jacobsson Foundation; Royal Society of Arts and Sciences in Gothenburg (KVVS); Wilhelm and Martina Lundgren Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE -a National Strategic Research Program at the University of Gothenburg; Swedish government; county councils - the ALF agreement; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Assar Gabrielsson Cancer Research Foundation; Adlerbertska Research Foundation; Herbert & Karin Jacobsson Foundation; Royal Society of Arts and Sciences in Gothenburg (KVVS); Wilhelm and Martina Lundgren Research Foundation	This study was supported by grants from the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE -a National Strategic Research Program at the University of Gothenburg, the Swedish state under the agreement between the Swedish government and the county councils -the ALF agreement (ALFGBG-725031), and the King Gustav V Jubilee Clinic Cancer Research Foundation to EFA, as well as grants from the Sahlgrenska University Hospital Research Funds, the Assar Gabrielsson Cancer Research Foundation, the Adlerbertska Research Foundation, the Herbert & Karin Jacobsson Foundation, the Royal Society of Arts and Sciences in Gothenburg (KVVS), and the Wilhelm and Martina Lundgren Research Foundation to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackstock AW, 1999, J CLIN ONCOL, V17, P2208, DOI 10.1200/JCO.1999.17.7.2208; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bodei L, 2004, CANCER BIOTHER RADIO, V19, P65, DOI 10.1089/108497804773391694; Bodei L, 2015, EUR J NUCL MED MOL I, V42, P5, DOI 10.1007/s00259-014-2893-5; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; Brabander T, 2017, CLIN CANCER RES, V23, P4617, DOI 10.1158/1078-0432.CCR-16-2743; Dadan J, 2001, FOLIA HISTOCHEM CYTO, V39, P187; Dalmo J, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-016-0247-y; Dalmo J, 2012, ONCOL REP, V27, P174, DOI 10.3892/or.2011.1494; Duenas-Gonzalez A, 2011, J CLIN ONCOL, V29, P1678, DOI 10.1200/JCO.2009.25.9663; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Eckerman K., 2008, Annals of the ICRP, V38, P9, DOI 10.1016/j.icrp.2008.10.004; Eisbruch A, 2001, J CLIN ONCOL, V19, P792, DOI 10.1200/JCO.2001.19.3.792; Forssell-Aronsson E, 2004, ACTA ONCOL, V43, P436, DOI 10.1080/02841860410030670; Forssell-Aronsson EB, 2000, J NUCL MED, V41, P636; Forssell-Aronsson E, 2013, NEUROENDOCRINOLOGY, V97, P86, DOI 10.1159/000336086; Fueger BJ, 2001, J NUCL MED, V42, P1856; Greco WR, 1996, J NATL CANCER I, V88, P699, DOI 10.1093/jnci/88.11.699; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; HOLM S, 1979, SCAND J STAT, V6, P65; Hung WW, 2009, PATHOL INT, V59, P660, DOI 10.1111/j.1440-1827.2009.02423.x; Iten F, 2007, CLIN CANCER RES, V13, P6696, DOI 10.1158/1078-0432.CCR-07-0935; Johanson V, 2007, ENDOCR-RELAT CANCER, V14, P433, DOI 10.1677/ERC-06-0033; Lawrence TS, 1996, INT J RADIAT ONCOL, V34, P867, DOI 10.1016/0360-3016(95)02134-5; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; Machens A, 2002, WORLD J SURG, V26, P22; Makis W, 2015, CLIN NUCL MED, V40, P408, DOI 10.1097/RLU.0000000000000706; Marsh DJ, 1996, CLIN ENDOCRINOL, V44, P249, DOI 10.1046/j.1365-2265.1996.681503.x; Mason KA, 1999, INT J RADIAT ONCOL, V44, P1125, DOI 10.1016/S0360-3016(99)00134-0; Mato E, 1998, J CLIN ENDOCR METAB, V83, P2417, DOI 10.1210/jc.83.7.2417; Matuszczyk A, 2010, HORM METAB RES, V42, P61, DOI 10.1055/s-0029-1238294; McGinn CJ, 2001, J CLIN ONCOL, V19, P4202, DOI 10.1200/JCO.2001.19.22.4202; Milas L, 1999, CANCER RES, V59, P107; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Montelius M, 2018, TRANSL ONCOL, V11, P193, DOI 10.1016/j.tranon.2017.12.003; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nayak TK, 2008, NUCL MED BIOL, V35, P673, DOI 10.1016/j.nucmedbio.2008.05.003; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Pauwels B, 2005, ONCOLOGIST, V10, P34, DOI 10.1634/theoncologist.10-1-34; Pauwels B, 2003, INT J RADIAT ONCOL, V57, P1075, DOI 10.1016/S0360-3016(03)01443-3; Pelizzo MR, 2007, EJSO-EUR J SURG ONC, V33, P493, DOI 10.1016/j.ejso.2006.10.021; Roman S, 2006, CANCER, V107, P2134, DOI 10.1002/cncr.22244; Salavati A, 2016, SEMIN NUCL MED, V46, P215, DOI 10.1053/j.semnuclmed.2016.01.010; SHEWACH DS, 1994, CANCER RES, V54, P3218; Strosberg J, 2017, NEW ENGL J MED, V376, P125, DOI 10.1056/NEJMoa1607427; Vaisman F, 2015, CLIN NUCL MED, V40, P123, DOI 10.1097/RLU.0000000000000628; Waldherr C, 2001, NUCL MED COMMUN, V22, P673, DOI 10.1097/00006231-200106000-00011; Wardman P, 2007, CLIN ONCOL-UK, V19, P397, DOI 10.1016/j.clon.2007.03.010; Wells SA, 2015, THYROID, V25, P567, DOI 10.1089/thy.2014.0335; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225260	10.1371/journal.pone.0225260	http://dx.doi.org/10.1371/journal.pone.0225260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725814	Green Published, gold			2022-12-26	WOS:000532764500074
J	Verbrugghe, E; Van Rooij, P; Favoreel, H; Martel, A; Pasmans, F				Verbrugghe, Elin; Van Rooij, Pascale; Favoreel, Herman; Martel, An; Pasmans, Frank			In vitro modeling of Batrachochytrium dendrobatidis infection of the amphibian skin	PLOS ONE			English	Article							FROGS LITORIA-CAERULEA; EMERGING DISEASE; IMMUNE DEFENSES; CHYTRID FUNGUS; CHYTRIDIOMYCOSIS; PATHOGENESIS; DECLINES; TIME	The largest current disease-induced loss of vertebrate biodiversity is due to chytridiomycosis and despite the increasing understanding of the pathogenesis, knowledge unravelling the early host-pathogen interactions remains limited. Batrachochytrium dendrobatidis (Bd) zoospores attach to and invade the amphibian epidermis, with subsequent invasive growth in the host skin. Availability of an in vitro assay would facilitate in depth study of this interaction while reducing the number of experimental animals needed. We describe a fluorescent cell-based in vitro infection model that reproduces host-Bd interactions. Using primary keratinocytes from Litoria caerulea and the epithelial cell line A6 from Xenopus laevis, we reproduced different stages of host cell infection and intracellular growth of Bd, resulting in host cell death, a key event in chytridiomycosis. The presented in vitro models may facilitate future mechanistic studies of host susceptibility and pathogen virulence.	[Verbrugghe, Elin; Van Rooij, Pascale; Martel, An; Pasmans, Frank] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Favoreel, Herman] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Ghent University; Ghent University	Verbrugghe, E (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	elin.verbrugghe@ugent.be	Pasmans, Frank/D-3667-2014; Favoreel, Herman/H-8712-2013	Favoreel, Herman/0000-0003-4993-6857	Research Foundation Flanders (FWO) [12E6616N, 1507119N]; Ghent University Special Research Fund [BOF13/PDO/130]	Research Foundation Flanders (FWO)(FWO); Ghent University Special Research Fund(Ghent University)	E. V. was supported by the Research Foundation Flanders (FWO grants 12E6616N and 1507119N). Financial support of P. V. R. is funded by the Ghent University Special Research Fund (BOF13/PDO/130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02967-w; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bletz MC, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0758; Blooi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181051; Bovo RP, 2016, DIS AQUAT ORGAN, V117, P245, DOI 10.3354/dao02940; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brannelly LA, 2017, PEERJ, V5, DOI 10.7717/peerj.2925; Brutyn M, 2012, FUNGAL GENET BIOL, V49, P830, DOI 10.1016/j.fgb.2012.07.002; Carver S, 2010, COPEIA, P487, DOI 10.1643/CH-09-128; Cramp RL, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou012; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Garner TWJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0207; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Greenspan SE, 2012, DIS AQUAT ORGAN, V100, P201, DOI 10.3354/dao02483; Grogan LF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26427-z; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Lips KR, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0465; Marcum RD, 2010, DIS AQUAT ORGAN, V91, P17, DOI 10.3354/dao02235; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; O'Hanlon SJ, 2018, SCIENCE, V360, P621, DOI 10.1126/science.aar1965; Ohmer MEB, 2015, FUNCT ECOL, V29, P674, DOI 10.1111/1365-2435.12370; Pasmans F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063639; RAFFERTY KA, 1969, BIOL AMPHIBIAN TUMOR, P52; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Russel W. M. S., 1959, PRINC HUM EXP TECH; Russo CJM, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.167445; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith HK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199295; Thomas V, 2018, TRANSBOUND EMERG DIS, V65, pe478, DOI 10.1111/tbed.12787; Van Rooij P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0266-0; Van Rooij P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041481; Van Rooij P, 2010, ATLA-ALTERN LAB ANIM, V38, P519, DOI 10.1177/026119291003800614; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Wu NC, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.191817; Young S, 2012, J ZOO WILDLIFE MED, V43, P330, DOI 10.1638/2011-0231.1	47	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225224	10.1371/journal.pone.0225224	http://dx.doi.org/10.1371/journal.pone.0225224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LC0NV	31725762	Green Submitted, Green Published, gold			2022-12-26	WOS:000525028400001
J	Peverill, RE; Romanelli, G; Donelan, L; Hassam, R; Corben, LA; Delatycki, MB				Peverill, Roger E.; Romanelli, Giovanni; Donelan, Lesley; Hassam, Rhonda; Corben, Louise A.; Delatycki, Martin B.			Left ventricular structural and functional changes in Friedreich ataxia - Relationship with body size, sex, age and genetic severity	PLOS ONE			English	Article							CLINICAL-FEATURES; REPEAT EXPANSION; HEALTHY INFANTS; CARDIOMYOPATHY; CHILDREN; FRATAXIN; HYPERTROPHY; PHENOTYPE; IMPACT; LENGTH	Introduction Although a concentric pattern of left ventricular (LV) geometry appears to be common in Friedreich ataxia (FRDA), there is no accepted method for diagnosing LV abnormalities in FRDA, sex and body size have often not been taken into consideration, and it has not been clear whether children and adults should be classified using the same criteria. The aim of this study was to better define the LV geometric changes in FRDA with respect to sex, body size and subject age, and to investigate the relationship of LV changes with genetic severity, as assessed by GAA repeat length within the shorter allele of the FXN gene (GAA1). Methods Echocardiography was performed in 216 subjects (68 children, 148 adults), measurements were made at end-diastole of LV internal diameter (LVEDID), septal wall thickness (SWT), LV length (LVEDL) and LV volume (LVEDV), and calculations were made of relative wall thickness (RWT), LV mass and LV ejection fraction (LVEF). Results The most common LV abnormalities in both adults and children with FRDA were increases in RWT and age-normalized RWT. In adults with a normal LVEF, all LV variables other than RWT were larger in males independent of body surface area (BSA), and all LV variables other than SWT and RWT were positively correlated with BSA. After adjustment for sex and BSA, GAA1 was a positive correlate of SWT and RWT (but not of LV mass), and was an inverse correlate of LVEDID, LVEDL and LVEDV. In children with a normal LVEF, SWT, LV mass and LVEDL were larger in males than females after adjusting for BSA, and in combination with sex, BSA was a positive correlate of all the LV variables except SWT and RWT. In children there were no correlations of GAA1 with any of the LV variables. Conclusion In FRDA, increases in RWT and age-normalized RWT are the most frequent LV structural abnormalities, sex and body size are important determinants of most other LV structural variables in both children and adults, and increased genetic severity is associated with a smaller left ventricle and increased LV wall thickness in adults, but not associated with LV size or wall thickness in children.	[Peverill, Roger E.; Romanelli, Giovanni; Donelan, Lesley; Hassam, Rhonda] Monash Univ, Monash Cardiovasc Res Ctr, Clayton, Vic, Australia; [Peverill, Roger E.; Romanelli, Giovanni; Donelan, Lesley; Hassam, Rhonda] Monash Univ, Dept Med, Sch Clin Sci, Monash Med Ctr, Clayton, Vic, Australia; [Peverill, Roger E.; Romanelli, Giovanni; Donelan, Lesley; Hassam, Rhonda] Monash Hlth, Clayton, Vic, Australia; [Corben, Louise A.; Delatycki, Martin B.] Royal Childrens Hosp, Bruce Lefroy Ctr Genet Hlth Res, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Delatycki, Martin B.] Royal Childrens Hosp, Victorian Clin Genet Serv, Parkville, Vic, Australia	Monash University; Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne	Peverill, RE (corresponding author), Monash Univ, Monash Cardiovasc Res Ctr, Clayton, Vic, Australia.; Peverill, RE (corresponding author), Monash Univ, Dept Med, Sch Clin Sci, Monash Med Ctr, Clayton, Vic, Australia.; Peverill, RE (corresponding author), Monash Hlth, Clayton, Vic, Australia.	roger.peverill@monash.edu		Peverill, Roger/0000-0002-3319-5356				Bit-Avragim N, 2001, J MOL MED-JMM, V78, P626, DOI 10.1007/s001090000162; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cantinotti M, 2014, J AM SOC ECHOCARDIOG, V27, P1279, DOI 10.1016/j.echo.2014.08.005; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Colan SD, 2013, J AM SOC ECHOCARDIOG, V26, P38, DOI 10.1016/j.echo.2012.11.005; de Simone G, 2005, HYPERTENSION, V45, P64, DOI 10.1161/01.HYP.0000150108.37527.57; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; DESIMONE G, 1995, HYPERTENSION, V26, P979, DOI 10.1161/01.HYP.26.6.979; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; Deutsch EC, 2010, MOL GENET METAB, V101, P238, DOI 10.1016/j.ymgme.2010.07.001; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Dutka DP, 1999, HEART, V81, P141, DOI 10.1136/hrt.81.2.141; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Filla A, 1996, AM J HUM GENET, V59, P554; Haland TF, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2016-000571; Hees PS, 2002, AM J CARDIOL, V90, P1231, DOI 10.1016/S0002-9149(02)02840-0; HEWER RL, 1968, BRIT MED J, V3, P649, DOI 10.1136/bmj.3.5619.649; Isnard R, 1997, CIRCULATION, V95, P2247, DOI 10.1161/01.CIR.95.9.2247; Kampmann C, 2000, HEART, V83, P667, DOI 10.1136/heart.83.6.667; Kou S, 2014, EUR HEART J-CARD IMG, V15, P680, DOI 10.1093/ehjci/jet284; Lamont PJ, 1997, BRAIN, V120, P673, DOI 10.1093/brain/120.4.673; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Meyer C, 2007, MOVEMENT DISORD, V22, P1615, DOI 10.1002/mds.21590; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; Mottram PM, 2011, J AM SOC ECHOCARDIOG, V24, P782, DOI 10.1016/j.echo.2011.04.004; Pettersen MD, 2008, J AM SOC ECHOCARDIOG, V21, P922, DOI 10.1016/j.echo.2008.02.006; Peverill RE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210277; Peverill RE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209410; Peverill RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158302; Pfaffenberger S, 2013, CIRC-CARDIOVASC IMAG, V6, P1073, DOI 10.1161/CIRCIMAGING.113.000690; Plehn JF, 2018, J CARD FAIL, V24, P672, DOI 10.1016/j.cardfail.2017.09.012; Pousset F, 2015, JAMA NEUROL, V72, P1334, DOI 10.1001/jamaneurol.2015.1855; Rajagopalan B, 2010, MOVEMENT DISORD, V25, P846, DOI 10.1002/mds.22864; Raman SV, 2011, EUR HEART J, V32, P561, DOI 10.1093/eurheartj/ehq443; Regner SR, 2012, AM J CARDIOL, V109, P401, DOI 10.1016/j.amjcard.2011.09.025; Ribai P, 2007, ARCH NEUROL-CHICAGO, V64, P558, DOI 10.1001/archneur.64.4.558; Rinaldi C, 2009, J NEUROL, V256, P1434, DOI 10.1007/s00415-009-5130-6; Sacca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017627; Stoylen A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000465; Sutton MS, 2014, ECHOCARDIOGR-J CARD, V31, P50, DOI 10.1111/echo.12287; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Weidemann F, 2015, INT J CARDIOL, V194, P50, DOI 10.1016/j.ijcard.2015.05.074; Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477	46	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225147	10.1371/journal.pone.0225147	http://dx.doi.org/10.1371/journal.pone.0225147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721791	Green Published, gold			2022-12-26	WOS:000532720700039
J	Vogt, JC; Abed, RMM; Albach, DC; Palinska, KA				Vogt, Janina C.; Abed, Raeid M. M.; Albach, Dirk C.; Palinska, Katarzyna A.			Latitudinal gradient of cyanobacterial diversity in tidal flats	PLOS ONE			English	Article							GLOBAL PATTERNS; INTERTIDAL FLATS; MICROBIAL MATS; COLORIMETRIC DETERMINATION; BIOGEOGRAPHIC PATTERNS; TAXONOMIC RESOLUTION; BACTERIAL DIVERSITY; NICHE CONSERVATISM; ARCHAEAL DIVERSITY; RARE BIOSPHERE	Latitudinal diversity gradients are well-known for plants and animals, but only recently similar patterns have been described for some specific microbial communities in distinct habitats. Although microbial diversity is well-investigated worldwide, most of the studies are spatially too restricted to allow general statements about global diversity patterns. Additionally, methodological differences make it hard and often impossible to compare several studies. This study investigated the cyanobacterial diversity in tidal flats along geographical and ecological gradients based on high-throughput sequencing of 16S rRNA gene fragments (Illumina MiSeq) and environmental data on a large spatial scale from the subtropics to the Arctic. Latitude and strongly correlated environmental parameters (e.g. temperature) were identified as important drivers of cyanobacterial diversity on global scale resulting in a latitudinal diversity gradient similar to that known from plants and animals. Other non-correlated parameters (e.g. grain size) were shown to be more important on local scales, although no consistent pattern occurred across different locations. Among a total number of 989 operational taxonomic units (OTUs) only one cosmopolitan (classified as Coleofasciculus chthonoplastes), but many location-specific and putative endemic ones (78%) were detected. High proportions of rare members of the community (up to 86%) were found in all samples. Phylogenetic beta diversity was shown to be influenced by the developmental stage of the mat community becoming increasingly similar with increasing stabilization.	[Vogt, Janina C.; Albach, Dirk C.] Carl Von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci IBU Biodivers & Evolut P, Oldenburg, Germany; [Abed, Raeid M. M.] Sultan Qaboos Univ, Coll Sci, Biol Dept, Muscat, Oman; [Palinska, Katarzyna A.] Univ Gdansk, Inst Oceanog, Dept Marine Biol & Ecol, Al Marszalka Jozefa Pilsudskiego 46, Gdynia, Poland	Carl von Ossietzky Universitat Oldenburg; Sultan Qaboos University; Fahrenheit Universities; University of Gdansk	Vogt, JC (corresponding author), Carl Von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci IBU Biodivers & Evolut P, Oldenburg, Germany.	janina.vogt@uni-oldenburg.de	Albach, Dirk C./D-8309-2013	Albach, Dirk C./0000-0001-9056-7382; Abed, Raeid/0000-0002-6201-6177	German Research Foundation (DFG) [PA 842/9-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG, http://www.dfg.de/en/) [project PA 842/9-1, Recipient KP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed RMM, 2008, FEMS MICROBIOL ECOL, V65, P449, DOI 10.1111/j.1574-6941.2008.00537.x; Abed RMM, 2015, J ARID ENVIRON, V115, P81, DOI 10.1016/j.jaridenv.2015.01.010; Allen MA, 2009, GEOBIOLOGY, V7, P82, DOI 10.1111/j.1472-4669.2008.00187.x; ALTMANN HJ, 1971, FRESEN Z ANAL CHEM, V256, P274, DOI 10.1007/BF00537892; Andam CP, 2016, MBIO, V7, DOI 10.1128/mBio.02200-15; Angermeyer A, 2018, PEERJ, V6, DOI 10.7717/peerj.4735; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2014, J APPL ECOL, DOI [DOI 10.1111/1365-2664.12306, DOI 10.1016/S0167-8809(99)00024-9]; Antunes JT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00473; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Beijerinck M. W., 1913, JB KONINKLIJKE AKAD, P119; BENESCH R, 1972, HELGOLAND WISS MEER, V23, P365, DOI 10.1007/BF01609682; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Billerbeck M, 2007, ESTUAR COAST SHELF S, V71, P704, DOI 10.1016/j.ecss.2006.09.019; Boenigk Jens, 2018, Metabarcoding and Metagenomics, V2, pe21519, DOI 10.3897/mbmg.2.21519; Bolhuis H, 2014, FEMS MICROBIOL ECOL, V90, P335, DOI 10.1111/1574-6941.12408; Bolhuis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063166; Bolhuis H, 2011, ISME J, V5, P1701, DOI [10.1038/Ismej.2011.52, 10.1038/ismej.2011.52]; Brandes M, 2015, MICROB ECOL, V70, P876, DOI 10.1007/s00248-015-0637-0; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Budel B, 2004, GEOBIOLOGY, V2, P261, DOI 10.1111/j.1472-4677.2004.00040.x; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Cutter AD, 2016, EVOLUTION, V70, P2171, DOI 10.1111/evo.13030; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darwin C, 1859, ORIGIN SPECIES VOYAG; de los Rios A, 2010, INT MICROBIOL, V13, P79, DOI 10.2436/20.1501.01.113; Dvorak P, 2015, BIODIVERS CONSERV, V24, P739, DOI 10.1007/s10531-015-0888-6; Dyer KR, 2000, CONT SHELF RES, V20, P1039, DOI 10.1016/S0278-4343(00)00011-X; Echenique-Subiabre I, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fan DD, 2013, J PALAEOGEOG-ENGLISH, V2, P66, DOI 10.3724/SP.J.1261.2013.00018; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fine PVA, 2015, ANNU REV ECOL EVOL S, V46, P369, DOI 10.1146/annurev-ecolsys-112414-054102; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Garcia-Pichel F, 1998, ARCH MICROBIOL, V169, P469, DOI 10.1007/s002030050599; GarciaPichel F, 1996, APPL ENVIRON MICROB, V62, P3284, DOI 10.1128/AEM.62.9.3284-3291.1996; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Gugger M, 2005, APPL ENVIRON MICROB, V71, P1097, DOI 10.1128/AEM.71.2.1097-1100.2005; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoffmann L, 1996, HYDROBIOLOGIA, V336, P33, DOI 10.1007/BF00010817; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kinlock NL, 2018, GLOBAL ECOL BIOGEOGR, V27, P125, DOI 10.1111/geb.12665; Komarek J, 2007, CYANOPROKARYOTA, V49; Komarek J., 2013, HETEROCYTOUS GENERA, V49, P1131; Komarek J, 2008, POLAR BIOL, V31, P853, DOI 10.1007/s00300-008-0424-1; Komarek Jiri, 2003, P59, DOI 10.1016/B978-012741550-5/50004-0; Komarek J, 2014, PRESLIA, V86, P295; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Krumbein W. E., 1994, BIOSTABILIZATION SED; Lacap-Bugler DC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00867; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mazard S, 2012, ENVIRON MICROBIOL, V14, P372, DOI 10.1111/j.1462-2920.2011.02514.x; Miller SR, 2007, APPL ENVIRON MICROB, V73, P4751, DOI 10.1128/AEM.02945-06; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Moreira C, 2014, CURR MICROBIOL, V69, P628, DOI 10.1007/s00284-014-0628-2; Mutke J., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P521; Namsaraev Z, 2010, ANN GLACIOL, V51, P171, DOI 10.3189/172756411795931930; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oren A, 2015, BIODIVERS CONSERV, V24, P781, DOI 10.1007/s10531-015-0882-z; Padisak J., 1997, ARCH HYDROBIOL, V4, P563; Palinska KA, 2017, GEOMICROBIOL J, V34, P903, DOI 10.1080/01490451.2017.1297512; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Patterson DJ, 2000, SYST ASSOC SPEC VOL, V59, P269; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Pessi IS, 2016, J PHYCOL, V52, P356, DOI 10.1111/jpy.12399; Peters MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13736; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Ramirez KS, 2018, NAT MICROBIOL, V3, P189, DOI 10.1038/s41564-017-0062-x; Ribeiro KF, 2018, HYDROBIOLOGIA, V820, P23, DOI 10.1007/s10750-018-3669-x; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rothrock MJ, 2005, ENVIRON MICROBIOL, V7, P593, DOI 10.1111/j.1462-2920.2005.00728.x; Salazar G, 2016, ISME J, V10, P596, DOI 10.1038/ismej.2015.137; Sarazin G, 1999, WATER RES, V33, P290, DOI 10.1016/S0043-1354(98)00168-7; SCHALL JJ, 1978, SCIENCE, V201, P679, DOI 10.1126/science.201.4357.679; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schluter D, 2016, AM NAT, V187, P1, DOI 10.1086/684193; Schnetger B, 2014, MAR CHEM, V160, P91, DOI 10.1016/j.marchem.2014.01.010; Scholz B, 2015, EUR J PHYCOL, V50, P182, DOI 10.1080/09670262.2015.1024286; Silva SMF, 2000, BOT MAR, V43, P11, DOI 10.1515/BOT.2000.002; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sjostedt J, 2012, APPL ENVIRON MICROB, V78, P1361, DOI 10.1128/AEM.05542-11; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Soininen J, 2012, ENV MICROBIOL REP, V4, P10, DOI 10.1111/j.1758-2229.2011.00308.x; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; STAL LJ, 1985, FEMS MICROBIOL ECOL, V31, P111, DOI 10.1111/j.1574-6968.1985.tb01138.x; Stal LJ, 2012, ECOLOGY CYANOBACTERI, P65, DOI [DOI 10.1007/978-94-007-3855-3_4, 10.1007/978-94-007-3855-3_4]; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stutz ML, 2002, J COASTAL RES, P694; Taton A, 2006, FEMS MICROBIOL ECOL, V57, P272, DOI 10.1111/j.1574-6941.2006.00110.x; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; USEPA, 1993, 3651 USEPA; van den Boogaart KG, 2008, COMPUT GEOSCI-UK, V34, P320, DOI 10.1016/j.cageo.2006.11.017; van Gremberghe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019561; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Vogt JC, 2018, HYDROBIOLOGIA, V811, P103, DOI 10.1007/s10750-017-3287-z; Vogt JC, 2018, MICROB ECOL, V75, P331, DOI 10.1007/s00248-017-1040-9; Von Humboldt A., 1807, IDEEN GEOGRAPHIE PFL; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, VI; Wallace AR, 1853, PALM TREES AMAZON TH; Wang J., 2016, NAT COMMUN, V7, P1, DOI DOI 10.1038/NC0MMS12744; Wang JJ, 2012, ENV MICROBIOL REP, V4, P217, DOI 10.1111/j.1758-2229.2011.00324.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487; Whitton BA, 2012, ECOLOGY CYANOBACTERI, VXV, P760; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Willig MR, 2017, REFERENCE MODULE LIF; Wilmotte A, 2002, DEEP-SEA RES PT II, V49, P3351, DOI 10.1016/S0967-0645(02)00087-5; Yergeau E, 2007, ENVIRON MICROBIOL, V9, P2670, DOI 10.1111/j.1462-2920.2007.01379.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	133	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224444	10.1371/journal.pone.0224444	http://dx.doi.org/10.1371/journal.pone.0224444			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721816	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000532720700022
J	Martins, ER; Diaz, IEC; Paciencia, MLB; Frana, SA; Marques, MOM; de Morais, DR; Eberlin, MN; Suffredini, IB				Martins, Erika Ramos; Collantes Diaz, Ingrit Elida; Barradas Paciencia, Mateus Luis; Frana, Sergio Alexandre; Mayo Marques, Marcia Ortiz; de Morais, Damila Rodrigues; Eberlin, Marcos Nogueira; Suffredini, Ivana Barbosa			Amazon climatic factors driving terpene composition of Iryanthera polyneura Ducke in terra-firme forest: A statistical approach	PLOS ONE			English	Article							ESSENTIAL-OIL; MYRISTICACEAE; DIVERSITY; DEFENSE	Iryanthera polyneura (Myristicaceae) is popularly known as cumala-colorada, and can be found in the Amazon rain forest. The present study aimed the evaluation of the chemical composition of the essential oils (EOs) obtained from the leaves of I. polyneura throughout a two-year period in order to correlate chemical findings with seasonality and climatic variation. Leaves from I. polyneura were collected 15 times from three different individuals, identified as 22EO, 80EO and 530EO, between the years of 2009 and 2011. The EOs were obtained and tested by gas-chromatography-mass spectrometry techniques. ANOVA and multivariate analyses were used to assess the relationship between the percentage of terpenes and seasonal/climatic variations. Fifty-nine compounds were detected in the EOs, of which 44 were identified (74.5%). The main components of the EOs were spathulenol (6.42 +/- 1.02%), alpha-cadinol (5.82 +/- 0.40%) and tau-muurolol (5.24 +/- 0.03%). Higher levels of spathulenol were observed in 22EO during rainy season, while tau-muurolol occurred in high amounts during the dry season, as did a- cadinol in 22EO and 80EO. Correspondence analysis revealed a distinction between two groups of EOs based on seasonality, whereas a canonic correspondence analysis and ANOVA determined how the major compounds were related to both seasonality and climatic factors. Non-metric multidimensional scaling in association with an analysis of similarities showed that the abundance and composition of terpenes in the samples varied moderately among the three Iryanthera individual plants. Present findings have shown that there is variation in the occurrence of the major compounds spathulenol, tau-muurolol and alpha-cadinol produced by I. polyneura and that the pattern of variation is related to season and climatic changes.	[Martins, Erika Ramos; Frana, Sergio Alexandre; Suffredini, Ivana Barbosa] Univ Paulista, Grad Program Environm & Expt Pathol, Sao Paulo, SP, Brazil; [Collantes Diaz, Ingrit Elida] Engineer Natl Univ, Dept Chem Engn, Chem & Text Engn Fac, Lima, Peru; [Barradas Paciencia, Mateus Luis; Frana, Sergio Alexandre; Suffredini, Ivana Barbosa] Univ Paulista, Ctr Res Biodivers, Sao Paulo, SP, Brazil; [Mayo Marques, Marcia Ortiz] Agron Inst, Campinas, SP, Brazil; [de Morais, Damila Rodrigues] Univ Campinas UNICAMP, ThomSon Lab, Inst Chem, Campinas, SP, Brazil; [Eberlin, Marcos Nogueira] Univ Prebiteriana Mackenzie, Sch Engn, Sao Paulo, SP, Brazil	Universidade Paulista; Universidade Paulista; Instituto Agronomico de Campinas (IAC); Universidade Estadual de Campinas; Universidade Presbiteriana Mackenzie	Suffredini, IB (corresponding author), Univ Paulista, Grad Program Environm & Expt Pathol, Sao Paulo, SP, Brazil.; Suffredini, IB (corresponding author), Univ Paulista, Ctr Res Biodivers, Sao Paulo, SP, Brazil.	ibsuffredini@yahoo.com.br	Suffredini, Ivana Barbosa/C-3565-2013; Braga, Erika Martins/GZL-7653-2022; Diaz, Ingrit/O-6085-2014	Suffredini, Ivana Barbosa/0000-0002-5237-101X; Braga, Erika Martins/0000-0001-5550-7157; Diaz, Ingrit/0000-0002-9726-2407; Eberlin, Marcos Nogueira/0000-0003-4868-0618	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/58704-6]; Universidade Paulista - UNIP [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidade Paulista - UNIP	The work was partially funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant #2008/58704-6 awarded to Ivana Barbosa Suffredini. A scholarship (grant#001) was granted to Erika Ramos Martins, by Universidade Paulista - UNIP. The funders did not play any role in the study, data collection, analyses, decision on publishing or preparation of the manuscript. There was no additional external funding received for this study.	AbSaber A, 2005, ESTUD AV-SAO PAULO, V19, P5; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Burow M, 2017, CURR OPIN PLANT BIOL, V38, P142, DOI 10.1016/j.pbi.2017.04.009; Chiu S, 2016, NAT PROD COMMUN, V11, P483; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CORREA DDB, 1979, PHYTOCHEMISTRY, V18, P351, DOI 10.1016/S0031-9422(00)91467-5; dos Santos PRD, 2001, PHYTOCHEMISTRY, V58, P547, DOI 10.1016/S0031-9422(01)00290-4; Friberg M, 2014, J CHEM ECOL, V40, P955, DOI 10.1007/s10886-014-0497-y; Furstenberg-Hagg J, 2013, INT J MOL SCI, V14, P10242, DOI 10.3390/ijms140510242; GOTTLIEB OR, 1979, J ETHNOPHARMACOL, V1, P309, DOI 10.1016/S0378-8741(79)80001-X; Hanlidou E, 2014, CHEM BIODIVERS, V11, P1205, DOI 10.1002/cbdv.201300408; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Pinheiro CG, 2016, BRAZ J BIOL, V76, P176, DOI [10.1590/1519-6984.16314, 10.15]; Pitarokili D, 2014, CHEM BIODIVERS, V11, P593, DOI 10.1002/cbdv.201300333; Ragusa A, 2017, FOODS, V6, DOI 10.3390/foods6100090; Revilla J., 2002, PLANTASU TEIS BACIA, V1, P350; Rodrigues WA, 1980, ACTA AMAZONICA, V10, P5; SCHULTES RE, 1985, J ETHNOPHARMACOL, V14, P125, DOI 10.1016/0378-8741(85)90083-2; Shultes RE, 1971, LLOYDIA, V34, P61; Silva DHS, 1999, J NAT PROD, V62, P1475, DOI 10.1021/np980509w; Suffredini IB, 2016, J ESSENT OIL BEAR PL, V19, P1380, DOI 10.1080/0972060X.2016.1215264; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Verpoorte R., 2000, METABOLIC ENG PLANT, P1, DOI [DOI 10.1007/978-94-015-9423-3_1, 10.1007/978-94-015-9423-3_1]; Zar JH, 1999, BIOSTATISTICAL ANAL	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224406	10.1371/journal.pone.0224406	http://dx.doi.org/10.1371/journal.pone.0224406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU2GU	31714916	gold, Green Published			2022-12-26	WOS:000501495100001
J	Couto, EGD; Cury, MN; Souza, MBE; Granato, ISC; Vidotti, MS; Garbuglio, DD; Crossa, J; Burgueno, J; Fritsche-Neto, R				de Oliveira Couto, Evellyn Giselly; Cury, Mayara Neves; Bandeira e Souza, Massaine; Correia Granato, Italo Stefanine; Vidotti, Miriam Suzane; Garbuglio, Deoclecio Domingos; Crossa, Jose; Burgueno, Juan; Fritsche-Neto, Roberto			Effect of F-1 and F-2 generations on genetic variability and working steps of doubled haploid production in maize	PLOS ONE			English	Article							INDUCTION; IDENTIFICATION; MARKER; MONOPLOIDS; VARIANCE; INDUCERS	For doubled haploid (DH) production in maize, F-1 generation has been the most frequently used for haploid induction due to facility in the process. However, using F-2 generation would be a good alternative to increase genetic variability owing to the additional recombination in meiosis. Our goals were to compare the effect of F-1 and F-2 generations on DH production in tropical germplasm, evaluating the R1-navajo expression in seeds, the working steps of the methodology, and the genetic variability of the DH lines obtained. Sources germplasm in F-1 and F-2 generations were crossed with the tropicalized haploid inducer LI-ESALQ. After harvest, for both induction crosses were calculated the haploid induction rate (HIR), diploid seed rate (DSR), and inhibition seed rate (ISR) using the total number of seeds obtained. In order to study the effectiveness of the DH working steps in each generation, the percentage per se and the relative percentage were verified. In addition, SNP markers were obtained for genetic variability studies. Results showed that the values for HIR, ISR, and DSR were 1.23%, 23.48%, and 75.21% for F-1 and 1.78%, 15.82%, and 82.38% for F-2, respectively. The effectiveness of the DH working step showed the same percentage per se value (0.4%) for F-1 and F-2, while the relative percentage was 27.2% for F-1 and 22.4% for F-2. Estimates of population parameters in DH lines from F-1 were higher than F-2. Furthermore, population structure and kinship analyses showed that one additional generation was not sufficient to create new genotype subgroups. Additionally, the relative efficiency of the response to selection in the F-1 was 31.88% higher than F-2 due to the number of cycles that are used to obtain the DH. Our results showed that in tropical maize, the use of F-1 generation is recommended due to a superior balance between time and genetic variability.	[de Oliveira Couto, Evellyn Giselly; Cury, Mayara Neves; Bandeira e Souza, Massaine; Correia Granato, Italo Stefanine; Vidotti, Miriam Suzane; Fritsche-Neto, Roberto] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil; [Garbuglio, Deoclecio Domingos] Inst Agron Parana IAPAR, Londrina, Parana, Brazil; [Crossa, Jose; Burgueno, Juan] Int Maize & Wheat Improvement Ctr CIMMYT, Biometr & Stat Unit, Mexico City, DF, Mexico	Universidade de Sao Paulo; Instituto Agronomico de Campinas (IAC); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Couto, EGD; Fritsche-Neto, R (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil.	evellyncoutoo@gmail.com; roberto.neto@usp.br	Fritsche-Neto, Roberto/B-2256-2013; Zhang, Lu/HGB-5048-2022; Granato, Italo/F-2516-2014	Fritsche-Neto, Roberto/0000-0003-4310-0047; Oliveira Couto, Evellyn Giselly/0000-0001-7984-3032; Granato, Italo/0000-0003-2093-6810	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior - Brasil (CAPES) [001]; National Council Coordination for the Scientific and Technological Development (CNPq) [400029/2016-2]	Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council Coordination for the Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This research was supported by Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior - Brasil (CAPES), finance Code 001, and National Council Coordination for the Scientific and Technological Development (CNPq, Process 400029/2016-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo R, 2009, THEOR APPL GENET, V119, P255, DOI 10.1007/s00122-009-1034-1; de Andrade LRB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163739; Chaikam V, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1968-3; Chaikam V, 2016, CROP SCI, V56, P1678, DOI 10.2135/cropsci2015.10.0653; Chaikam V, 2015, THEOR APPL GENET, V128, P159, DOI 10.1007/s00122-014-2419-3; CHASE SS, 1964, AM J BOT, V51, P928, DOI 10.2307/2440242; Choe E, 2012, PLANT BREEDING, V131, P399, DOI 10.1111/j.1439-0523.2012.01962.x; de Couto EGO, 2013, CIENC AGROTEC, V37, P25, DOI [10.1590/S1413-70542013000100003, DOI 10.1590/S1413-70542013000100003]; Eder J, 2002, THEOR APPL GENET, V104, P703, DOI 10.1007/s00122-001-0773-4; Geiger HH, 1997, METHODOLOGY GENETICS, V38, P203; Granato ISC, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0844-8; Hoisington DA, 1988, CORN CORN IMPROVEMEN; Jannink JL, 1999, CROP SCI, V39, P988, DOI 10.2135/cropsci1999.0011183X003900040006x; Mahuku G, 2012, DOUBLED HAPLOID TECH; Melchinger AE, 2005, P 41 ANN ILL CORN BR, P8; Melchinger AE, 2016, CROP SCI, V56, P559, DOI 10.2135/cropsci2015.06.0383; Melchinger AE, 2014, CROP SCI, V54, P1497, DOI 10.2135/cropsci2013.12.0851; Melchinger AE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02129; Molenaar WS, 2019, PLANT BREEDING, V138, P266, DOI 10.1111/pbr.12694; NANDA DK, 1966, CROP SCI, V6, P213, DOI 10.2135/cropsci1966.0011183X000600020036x; Prigge V, 2011, CROP SCI, V51, P1498, DOI 10.2135/cropsci2010.10.0568; RIGGS TJ, 1977, THEOR APPL GENET, V49, P111, DOI 10.1007/BF00281708; Rotarenco V., 2010, MAIZE GENET COOP, V84, P1; Sleper JA, 2016, THEOR APPL GENET, V129, P2429, DOI 10.1007/s00122-016-2781-4; Smith JSC, 2008, MOL BREEDING, V22, P51, DOI 10.1007/s11032-007-9155-1; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stinard PS, 2002, J HERED, V93, P421, DOI 10.1093/jhered/93.6.421; TATENO Y, 1982, J MOL EVOL, V18, P387, DOI 10.1007/BF01840887; Xu XW, 2013, J EXP BOT, V64, P1083, DOI 10.1093/jxb/ers393; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224631	10.1371/journal.pone.0224631	http://dx.doi.org/10.1371/journal.pone.0224631			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710611	gold, Green Published			2022-12-26	WOS:000532699900014
J	Powell-Roach, KL; Yao, YW; Jhun, EH; He, Y; Suarez, ML; Ezenwa, MO; Molokie, RE; Wang, ZJ; Wilkie, DJ				Powell-Roach, Keesha L.; Yao, Yingwei; Jhun, Ellie H.; He, Ying; Suarez, Marie L.; Ezenwa, Miriam O.; Molokie, Robert E.; Wang, Zaijie Jim; Wilkie, Diana J.			Vasopressin SNP pain factors and stress in sickle cell disease	PLOS ONE			English	Article							PATIENT-REPORTED OUTCOMES; ACUTE-CARE UTILIZATION; NITRIC-OXIDE; L-ARGININE; PSYCHOLOGICAL COMBINATIONS; BIOPSYCHOSOCIAL INFLUENCE; ADULTS; SENSITIVITY; CRISIS; METABOLOME	Purpose Frequencies of single nucleotide polymorphisms (SNPs) from pain related candidate genes are available for individuals with sickle cell disease (SCD). One of those genes, the arginine vasopressin receptor 1A gene (AVPR1A) and one of its SNPs, rs10877969, has been associated with pain and disability in other pain populations. In patients with SCD, clinical factors such as pain and stress have been associated with increased health care utilization, but it is not known if the presence of the AVPR1A SNP plays a role in this observation. The study purpose was to explore the relationships between rs10877969 and self-reported pain, stress, and acute care utilization events among individuals with SCD. Methods In a cross-sectional investigation of outpatients with SCD, participants completed PAINReportIt (R), a computerized pain measure, to describe their pain experience and contributed blood or saliva samples for genetic analysis. We extracted emergency department and acute care utilization from medical records. Results The SNP genotype frequencies (%) for this sample were CC 30 (28%), CT 44 (41%), TT 33 (31%). Acute care utilization and stress as an aggravator of pain were significantly associated with the rs10877969 genotype (p = .02 and p = .002, respectively). The CT genotype had the highest mean utilization and CC genotype was associated with not citing stress as a pain aggravator. Chronic pain was not associated with rs10877969 (p = .41). Conclusion This study shows that rs10877969 is related to indicators of stress and acute pain. Further research is recommended with other measures of stress and acute pain.	[Powell-Roach, Keesha L.] Univ Florida, Coll Dent, Dept Community Dent & Behav Sci, Gainesville, FL 32611 USA; [Powell-Roach, Keesha L.; Wilkie, Diana J.] Univ Florida, Coll Nursing, Ctr Palliat Care Res & Educ, Gainesville, FL 32611 USA; [Yao, Yingwei; Ezenwa, Miriam O.; Wilkie, Diana J.] Univ Florida, Dept Biobehav Nursing Sci, Coll Nursing, Gainesville, FL 32611 USA; [Yao, Yingwei; Suarez, Marie L.; Wilkie, Diana J.] Univ Illinois, Coll Nursing, Dept Biobehav Hlth Sci, Chicago, IL USA; [Jhun, Ellie H.] Univ Chicago, Comm Clin Pharmacol & Pharmacogenet, Chicago, IL 60637 USA; [Jhun, Ellie H.; He, Ying; Molokie, Robert E.; Wang, Zaijie Jim] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA; [He, Ying; Wang, Zaijie Jim] Univ Illinois, Canc Ctr, Chicago, IL USA; [Molokie, Robert E.] Univ Illinois, Coll Med, Div Hematol Oncol, Chicago, IL USA; [Molokie, Robert E.] Jessie Brown Vet Adm Med Ctr, Chicago, IL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Powell-Roach, KL (corresponding author), Univ Florida, Coll Dent, Dept Community Dent & Behav Sci, Gainesville, FL 32611 USA.; Powell-Roach, KL (corresponding author), Univ Florida, Coll Nursing, Ctr Palliat Care Res & Educ, Gainesville, FL 32611 USA.	keesharoach@ufl.edu		Molokie, Robert/0000-0003-3623-7395; Roach, Keesha/0000-0001-8117-3445	National Institutes of Health, National Heart Lung & Blood Institute (NHLBI) [R01HL12495, R01HL124945S, R01HL1249451, U54HL117658]; National Institutes of Aging (NIA) [T32AG049673]; National Institute of Dental and Craniofacial Research (NIDCR) [T32DE018381]; Robert Wood Johnson Future of Nursing Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL117658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG049673] Funding Source: NIH RePORTER	National Institutes of Health, National Heart Lung & Blood Institute (NHLBI); National Institutes of Aging (NIA); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Robert Wood Johnson Future of Nursing Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was approved by the Institutional Review Boards at the University of Illinois at Chicago and the University of Florida. The IRB numbers for this manuscript are: QST: 20140287 and SC PAIN: 2006-0266. All participants for this study provided written informed consent. The study was supported by grant numbers R01HL12495, R01HL124945S, R01HL1249451, U54HL117658 for the National Institutes of Health, National Heart Lung & Blood Institute (NHLBI), T32AG049673 from the National Institutes of Aging (NIA), T32DE018381 National Institute of Dental and Craniofacial Research (NIDCR), and the Robert Wood Johnson Future of Nursing Scholars Program. Its contents are solely the responsibility of authors and do not necessarily represent the official views of the NIH, NHLBI, NIA, NIDCR, or the Robert Wood Johnson foundation. The final peerreviewed manuscript is subject to the National Institutes of Health Public Access Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola Maxine, 2011, ISRN Nurs, V2011, P672579, DOI 10.5402/2011/672579; Bakshi N, 2018, J PAIN RES, V11, P313, DOI 10.2147/JPR.S150065; Bakshi N, 2016, J PAIN RES, V9, P167, DOI 10.2147/JPR.S55571; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Elias DBD, 2013, BRIT J HAEMATOL, V160, P410, DOI 10.1111/bjh.12114; Ezenwa MO, 2015, PAIN MANAG NURS, V16, P294, DOI 10.1016/j.pmn.2014.08.004; Ezenwa MO, 2014, J PAIN SYMPTOM MANAG, V48, P65, DOI 10.1016/j.jpainsymman.2013.08.020; Fillingim RB, 2008, ORAL DIS, V14, P673, DOI 10.1111/j.1601-0825.2008.01458.x; George SZ, 2016, ARTHRIT CARE RES, V68, P1671, DOI 10.1002/acr.22876; George SZ, 2014, J PAIN, V15, P68, DOI 10.1016/j.jpain.2013.09.012; Gil KM, 2004, HEALTH PSYCHOL, V23, P267, DOI 10.1037/0278-6133.23.3.267; Jha A, 2010, CIN-COMPUT INFORM NU, V28, P141, DOI 10.1097/NCN.0b013e3181d7820b; Jhun EH, 2018, PHARMACOGENOMICS, V19, P1003, DOI 10.2217/pgs-2018-0064; Jhun EH, 2018, PHARMACOGENOMICS, V19, P401, DOI 10.2217/pgs-2017-0198; Jhun EH, 2015, PHARMACOGENOMICS, V16, P1795, DOI 10.2217/pgs.15.126; Kim HS, 2004, PAIN, V109, P488, DOI 10.1016/j.pain.2004.02.027; Kim-Shapiro DB, 2018, CLIN HEMORHEOL MICRO, V68, P223, DOI 10.3233/CH-189009; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Lopez BL, 2002, BLOOD, V100, p452A; Lopez BL, 2003, BRIT J HAEMATOL, V120, P532, DOI 10.1046/j.1365-2141.2003.04109.x; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mogil JS, 2012, TRENDS GENET, V28, P258, DOI 10.1016/j.tig.2012.02.004; Mogil JS, 2011, NAT NEUROSCI, V14, P1569, DOI 10.1038/nn.2941; Molokie RE, 2018, AM J EMERG MED, V36, P88, DOI 10.1016/j.ajem.2017.07.037; Morris CR, 2014, HEMATOL ONCOL CLIN N, V28, P301, DOI 10.1016/j.hoc.2013.11.008; Morris CR, 2010, NITRIC OXIDE-BIOL CH, V22, pS25, DOI 10.1016/j.niox.2010.05.071; Morris CR, 2000, BRIT J HAEMATOL, V111, P498, DOI 10.1046/j.1365-2141.2000.02403.x; Morris CR, 2000, J PEDIAT HEMATOL ONC, V22, P515, DOI 10.1097/00043426-200011000-00009; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Wilkie DJ, 2015, PAIN MED, V16, P1341, DOI 10.1111/pme.12703; Wilkie DJ, 2010, J NATL MED ASSOC, V102, P18, DOI 10.1016/S0027-9684(15)30471-5	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224886	10.1371/journal.pone.0224886	http://dx.doi.org/10.1371/journal.pone.0224886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710639	Green Published, gold			2022-12-26	WOS:000532699900028
J	Bilardi, JE; Hulme-Chambers, A; Chen, MY; Fairley, CK; Huffam, SE; Tomnay, JE				Bilardi, Jade E.; Hulme-Chambers, Alana; Chen, Marcus Y.; Fairley, Christopher K.; Huffam, Sarah E.; Tomnay, Jane E.			The role of stigma in the acceptance and disclosure of HIV among recently diagnosed men who have sex with men in Australia: A qualitative study	PLOS ONE			English	Article							GAY MEN; EXPERIENCES; ADHERENCE; PARTNERS; AIDS	Background Our primary study aimed to explore the experiences of men who have sex with men (MSM) recently diagnosed with HIV and their partner notification practices. Themes relating to acceptance, and disclosure of, their HIV status strongly emerged during analysis in our larger study and are reported separately here. Method Fifteen MSM participated in semi-structured interviews by phone or face to face about their experience of a recent HIV diagnosis. In this paper we report on how they received and accepted the diagnosis, who they disclosed their diagnosis to and what is needed to improve support for MSM recently diagnosed with HIV. Results MSM's reactions to their HIV diagnosis ranged from shock, devastation and anger to a calm acceptance and feeling HIV would not have a significant impact on their lives. MSM who reported strong social support networks, or knew others with HIV, seemed better able to cope with and accept their diagnosis than those with fewer support networks. Due to prevailing stigma around HIV, most MSM were very selective about who they disclosed their status to, often only telling partners perceived to be at risk but no, or only few, close friends. Regardless of how well men accepted their diagnosis, most did not disclose their status to family members for fear of rejection or causing distress due to ideologies based on outdated information about HIV. Conclusion The prevailing stigma around HIV can have a significant impact on MSM's acceptance of, and willingness to disclose their HIV serostatus to others, and consequently the levels of professional and social support they receive. HIV-related stigma needs to be addressed through community campaigns which better educate the wider population about the current state of HIV prognosis and treatment.	[Bilardi, Jade E.; Chen, Marcus Y.; Fairley, Christopher K.; Huffam, Sarah E.] Monash Univ, Cent Clin Sch, Clayton, Vic, Australia; [Bilardi, Jade E.; Chen, Marcus Y.; Fairley, Christopher K.; Huffam, Sarah E.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bilardi, Jade E.] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Hulme-Chambers, Alana; Tomnay, Jane E.] Univ Melbourne, Ctr Excellence Rural Sexual Hlth, Melbourne, Vic, Australia	Monash University; University of Melbourne; University of Melbourne	Tomnay, JE (corresponding author), Univ Melbourne, Ctr Excellence Rural Sexual Hlth, Melbourne, Vic, Australia.	jtomnay@unimelb.edu.au		Hulme, Alana/0000-0001-9243-0371; Tomnay, Jane/0000-0003-4907-3107				Abler L, 2015, AIDS PATIENT CARE ST, V29, P550, DOI 10.1089/apc.2015.0122; [Anonymous], 2017, LANCET HIV, V4, pE475, DOI 10.1016/S2352-3018(17)30183-2; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Bell S, 2018, HEALTH SOCIOL REV, V27, P1, DOI 10.1080/14461242.2016.1271282; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BRAY F, 1991, AUST J PUBLIC HEALTH, V15, P107; Conrad P, 2010, J HEALTH SOC BEHAV, V51, pS67, DOI 10.1177/0022146510383495; Darlaston-Jones D, 2007, AUST COMMUNITY PSYCH, V19, P19; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Flowers P, 2011, PSYCHOL HEALTH, V26, P1378, DOI 10.1080/08870446.2010.551213; Gribch C, 2013, QUALITATIVE DATA ANA; Grubb IR, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19320; Holt M, 2017, AIDS BEHAV, V21, P331, DOI 10.1007/s10461-016-1642-0; Hult JR, 2009, AIDS CARE, V21, P185, DOI 10.1080/09540120802017602; Institute Kirby, 2017, HIV VIR HEP SEX TRAN; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Li HC, 2016, SEX HEALTH, V13, P516, DOI 10.1071/SH16089; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Martinez O, 2014, AIDS BEHAV, V18, P2485, DOI 10.1007/s10461-014-0790-3; Mey A, 2017, AIDS BEHAV, V21, P352, DOI 10.1007/s10461-016-1598-0; Newman C, 2009, HEALTH-LONDON, V13, P7, DOI 10.1177/1363459308097358; Power J, 2011, MOVEMENT KNOWLEDGE E; Reidpath DD, 2005, AIDS CARE, V17, P425, DOI 10.1080/09540120412331319769; Rueda S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011453; Sayles JN, 2007, J URBAN HEALTH, V84, P814, DOI 10.1007/s11524-007-9220-4; Skinta MD, 2014, PSYCHOL HEALTH, V29, P583, DOI 10.1080/08870446.2013.871283; Smith R, 2008, AIDS CARE, V20, P1266, DOI 10.1080/09540120801926977; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Stutterheim SE, 2011, AIDS EDUC PREV, V23, P382, DOI 10.1521/aeap.2011.23.4.382; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Tomnay JE, 2017, AIDS PATIENT CARE ST, V31, P269, DOI 10.1089/apc.2017.0080; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turan B, 2017, AM J PUBLIC HEALTH, V107, P863, DOI 10.2105/AJPH.2017.303744	34	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224616	10.1371/journal.pone.0224616	http://dx.doi.org/10.1371/journal.pone.0224616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1HV	31703087	Green Published, gold			2022-12-26	WOS:000532697200017
J	Benit, P; Kahn, A; Chretien, D; Bortoli, S; Huc, L; Schiff, M; Gimenez-Roqueplo, AP; Favier, J; Gressens, P; Rak, M; Rustin, P				Benit, Paule; Kahn, Agathe; Chretien, Dominique; Bortoli, Sylvie; Huc, Laurence; Schiff, Manuel; Gimenez-Roqueplo, Anne-Paule; Favier, Judith; Gressens, Pierre; Rak, Malgorzata; Rustin, Pierre			Evolutionarily conserved susceptibility of the mitochondrial respiratory chain to SDHI pesticides and its consequence on the impact of SDHIs on human cultured cells	PLOS ONE			English	Article							OXIDATIVE STRESS; SUCCINATE; DEHYDROGENASE; FIBROBLASTS; DEFICIENCY; EXPRESSION; INHIBITION; RESISTANCE; MECHANISM; TOXICITY	Succinate dehydrogenase (SDH) inhibitors (SDHIs) are used worldwide to limit the proliferation of molds on plants and plant products. However, as SDH, also known as respiratory chain (RC) complex II, is a universal component of mitochondria from living organisms, highly conserved through evolution, the specificity of these inhibitors toward fungi warrants investigation. We first establish that the human, honeybee, earthworm and fungal SDHs are all sensitive to the eight SDHIs tested, albeit with varying IC50 values, generally in the micromolar range. In addition to SDH, we observed that five of the SDHIs, mostly from the latest generation, inhibit the activity of RC complex III. Finally, we show that the provision of glucose ad libitum in the cell culture medium, while simultaneously providing sufficient ATP and reducing power for antioxidant enzymes through glycolysis, allows the growth of RC-deficient cells, fully masking the deleterious effect of SDHIs. As a result, when glutamine is the major carbon source, the presence of SDHIs leads to time-dependent cell death. This process is significantly accelerated in fibroblasts derived from patients with neurological or neurodegenerative diseases due to RC impairment (encephalopathy originating from a partial SDH defect) and/or hypersensitivity to oxidative insults (Friedreich ataxia, familial Alzheimer's disease).	[Benit, Paule; Kahn, Agathe; Chretien, Dominique; Schiff, Manuel; Gressens, Pierre; Rak, Malgorzata; Rustin, Pierre] Univ Paris, INSERM, NeuroDiderot, Paris, France; [Bortoli, Sylvie] Univ Paris, INSERM, UMR S 1124, Paris, France; [Huc, Laurence] Univ Toulouse, INRA UMR 1331, ToxAlim Res Ctr Food Toxicol, ENVT,INP,UPS, 180 Chemin Tournefeuille, Toulouse, France; [Schiff, Manuel; Gressens, Pierre] Hop Robert Debre, Assistance Publ Hop Paris AP HP, Serv Neurol & Malad Metab, Paris, France; [Gimenez-Roqueplo, Anne-Paule] Univ Paris, Equipe Labellisee Ligue Canc, INSERM, PARCC, Paris, France; [Gimenez-Roqueplo, Anne-Paule; Favier, Judith] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris AP HP, Serv Genet, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Rustin, P (corresponding author), Univ Paris, INSERM, NeuroDiderot, Paris, France.	pierre.rustin@inserm.fr	Favier, Judith/M-7601-2017; gressens, pierre/M-7557-2017; Bortoli, Sylvie/AFW-4994-2022; Gimenez-Roqueplo, Anne-Paule/T-6752-2018	Favier, Judith/0000-0001-8190-5853; gressens, pierre/0000-0002-0909-4221; Gimenez-Roqueplo, Anne-Paule/0000-0002-4816-670X; Bortoli, Sylvie/0000-0002-1008-1241	French Association POLLINIS; AAJI (Association pour l'Aide aux Jeunes Infirmes & aux Personnes Handicapees); AFAF (Association Francaise de l'Ataxie de Friedreich); Association OLY (Ouvrir Les Yeux); ANR MITOXDRUGS [ANR-16-CE18-0010]	French Association POLLINIS; AAJI (Association pour l'Aide aux Jeunes Infirmes & aux Personnes Handicapees); AFAF (Association Francaise de l'Ataxie de Friedreich); Association OLY (Ouvrir Les Yeux); ANR MITOXDRUGS(French National Research Agency (ANR))	No specific funding was initially provided for this work. After the work realization, PB and PR received a specific support grant from the French Association POLLINIS (https://www.pollinis.org/).General expenses were covered by grants from AAJI (Association pour l'Aide aux Jeunes Infirmes & aux Personnes Handicapees); AFAF (Association Francaise de l'Ataxie de Friedreich); Association OLY (Ouvrir Les Yeux); ANR MITOXDRUGS (ANR-16-CE18-0010). Sponsors or funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackrell B, 1990, STRUCTURE FUNCTION S; Ardissone A, 2015, MOLEC GENET METAB RE, V5, P51, DOI 10.1016/j.ymgmr.2015.10.006; Bayot A, 2013, HUM MOL GENET, V22, P2894, DOI 10.1093/hmg/ddt144; Benit P, 2018, REV FRANCOPHONE LAB, V501, P49; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Benit P, 2017, EBIOMEDICINE, V17, P75, DOI 10.1016/j.ebiom.2017.02.013; Benit P, 2014, BBA-BIOENERGETICS, V1837, P1330, DOI 10.1016/j.bbabio.2014.03.013; Boikos SA, 2016, EUR J HUM GENET, V24, P569, DOI 10.1038/ejhg.2015.142; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; BOURGERON T, 1993, J BIOL CHEM, V268, P19369; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Chretien D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003992; Dudek J, 2016, EMBO MOL MED, V8, P139, DOI 10.15252/emmm.201505644; El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004; Faske TR, 2015, J NEMATOL, V47, P316; Favier J, 2005, HORM RES, V63, P171, DOI 10.1159/000084685; Flannery PJ, 2019, MOL CELL NEUROSCI, V98, P109, DOI 10.1016/j.mcn.2019.06.009; Francis K, 2013, IUBMB LIFE, V65, P759, DOI 10.1002/iub.1195; Gault MD, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a002584; GERARD B, 1993, EUR J PEDIATR, V152, P270; Graillot V, 2012, MUTAT RES-GEN TOX EN, V748, P8, DOI 10.1016/j.mrgentox.2012.05.014; Helman G, 2016, ANN NEUROL, V79, P379, DOI 10.1002/ana.24572; Her YF, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/296167; Ishiyama A, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000184; Kruspig B, 2016, BBA-MOL CELL RES, V1863, P2065, DOI 10.1016/j.bbamcr.2016.04.026; Majd S, 2018, CURR ALZHEIMER RES, V15, P764, DOI 10.2174/1567205015666180223093020; Manel N, 2004, M S-MED SCI, V20, P277, DOI 10.1051/medsci/2004203277; Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Micheletti MV, 2011, CLIN NEPHROL, V76, P68, DOI 10.5414/CN106681; Miettinen M, 2014, INT J BIOCHEM CELL B, V53, P514, DOI 10.1016/j.biocel.2014.05.033; MORAIS R, 1980, BIOCHEM BIOPH RES CO, V94, P71, DOI 10.1016/S0006-291X(80)80189-6; Morin A, 2014, INT J CANCER, V135, P2237, DOI 10.1002/ijc.29080; Mota SI, 2015, BBA-MOL BASIS DIS, V1852, P1428, DOI 10.1016/j.bbadis.2015.03.015; MOWERY PC, 1976, BIOCHEM BIOPH RES CO, V71, P354, DOI 10.1016/0006-291X(76)90290-4; Neagu M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00348; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Qian L, 2019, ENVIRON POLLUT, V247, P775, DOI 10.1016/j.envpol.2019.01.054; Qian L, 2019, CHEMOSPHERE, V214, P184, DOI 10.1016/j.chemosphere.2018.09.117; Rodrigues ADS, 2008, J NEUROL SCI, V264, P182, DOI 10.1016/j.jns.2007.08.002; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sierotzki H, 2013, PHYTOPATHOLOGY, V103, P880, DOI 10.1094/PHYTO-01-13-0009-RVW; Simon-Delso N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24746-9; SINGER TP, 1995, BBA-MOL BASIS DIS, V1271, P211, DOI 10.1016/0925-4439(95)00030-8; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Strachan GD, 2004, BIOCHEMISTRY-US, V43, P12113, DOI 10.1021/bi0494166; TAKEDA M, 1992, PROG NEURO-PSYCHOPH, V16, P317; Teplova VV, 2017, TOXICOL LETT, V275, P108, DOI 10.1016/j.toxlet.2017.05.004; TESCO G, 1992, ANN NY ACAD SCI, V673, P149, DOI 10.1111/j.1749-6632.1992.tb27446.x; TESCO G, 1992, MECH AGEING DEV, V66, P117, DOI 10.1016/0047-6374(92)90129-2; Tomar R, 2012, AM J REPROD IMMUNOL, V68, P486, DOI 10.1111/aji.12023; Wu SY, 2018, ECOTOX ENVIRON SAFE, V153, P8, DOI 10.1016/j.ecoenv.2018.01.045; Yamashita M, 2018, PEST MANAG SCI, V74, P672, DOI 10.1002/ps.4761; Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420	57	22	22	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224132	10.1371/journal.pone.0224132	http://dx.doi.org/10.1371/journal.pone.0224132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697708	Green Published, gold, Green Submitted			2022-12-26	WOS:000532694400017
J	Ferrari, M; Piccinno, E; Marcon, A; Marchetti, P; Cazzoletti, L; Pirina, P; Battaglia, S; Grosso, A; Squillacioti, G; Antonicelli, L; Verlato, G; Pesce, G				Ferrari, Marcello; Piccinno, Elia; Marcon, Alessandro; Marchetti, Pierpaolo; Cazzoletti, Lucia; Pirina, Pietro; Battaglia, Salvatore; Grosso, Amelia; Squillacioti, Giulia; Antonicelli, Leonardo; Verlato, Giuseppe; Pesce, Giancarlo			Chronic bronchitis without airflow obstruction, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALLERGIC RHINITIS; INTERMITTENT CLAUDICATION; MYOCARDIAL-INFARCTION; MUCUS HYPERSECRETION; CIGARETTE-SMOKING; LUNG-DISEASE; DIAGNOSIS; ATHEROSCLEROSIS; PREVALENCE	Background and objectives Cardiovascular and respiratory diseases can frequently coexist. Understanding their link may improve disease management. We aimed at assessing the associations of chronic bronchitis (CB), asthma and rhinitis with cardiovascular diseases and risk factors in the general population. Methods We used data collected in the Gene Environment Interactions in Respiratory Diseases study, an Italian multicentre, multicase-control study. Among 2463 participants (age 21-86, female 50%) who underwent standardized interviews, skin prick and lung function tests, we identified 254 cases of CB without airflow obstruction, 418 cases of asthma without CB, 959 cases of rhinitis alone, and 832 controls. The associations of respiratory diseases with reported cardiovascular risk factors (lifestyles, hypertension, dyslipidaemia), heart disorders (myocardial infarction, coronary thrombosis, angina, aorta or heart surgery) and intermittent claudication were estimated through relative risk ratios (RRR) by multinomial logistic regression models. Results Compared to controls, CB cases were more likely to be heavy smokers, alcohol consumers, physically inactive, and to suffer from hypertension or dyslipidaemia; rhinitis cases were less obese but more likely to have hypertension. Asthma was significantly associated with current smoking. After adjusting for cardiovascular risk factors, heart disorders were associated with CB (RRR[95%CI]: 1.58[1.12-2.22]) and rhinitis (1.35[0.98-1.85]) and intermittent claudication was associated with CB (3.43[2.52-4.67]), asthma (1.51[1.04-2.21]) and rhinitis (2.03[1.34-3.07]). Conclusions CB, asthma and rhinitis were associated with cardiovascular risk factors and diseases. In particular, CB shared with cardiovascular diseases almost all risk factors and was strongly associated with a higher risk of heart disorders and intermittent claudication.	[Ferrari, Marcello; Piccinno, Elia] Univ Verona, Dept Med, Unit Resp Med, Verona, Italy; [Marcon, Alessandro; Marchetti, Pierpaolo; Cazzoletti, Lucia; Verlato, Giuseppe] Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy; [Pirina, Pietro] Univ Sassari, Unita Operat Pneumol, Dipartimento Sci Med Chirurg & Sperimentali, Sassari, Italy; [Battaglia, Salvatore] Univ Palermo, Dipartimento Univ Promoz Salute Materno Infantile, Palermo, Italy; [Grosso, Amelia] Univ Pavia, IRCCS San Matteo Hosp Fdn, Div Resp Dis, Pavia, Italy; [Squillacioti, Giulia] Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy; [Antonicelli, Leonardo] Azienda Ospedaliero Univ Osped Riuniti, Allergy Unit, Dept Internal Med, Ancona, Italy; [Pesce, Giancarlo] Sorbonne Univ, Epidemiol Allerg & Resp Dis Dept EPAR, Inst Pierre Louis Epiderniol & Sante Publ IPLESP, INSERM UMR S 1136, Paris, France	University of Verona; University of Verona; University of Sassari; University of Palermo; IRCCS Fondazione San Matteo; University of Pavia; University of Turin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Marcon, A (corresponding author), Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy.	alessandro.marcon@univr.it	Marcon, Alessandro/C-3349-2012; Squillacioti, Giulia/S-2646-2017; Battaglia, Salvatore/D-7042-2015	Marcon, Alessandro/0000-0002-2778-658X; Squillacioti, Giulia/0000-0002-0655-7550; Pesce, Giancarlo/0000-0003-4925-6325; Battaglia, Salvatore/0000-0002-2867-917X; Grosso, Amelia/0000-0002-4442-8522	Cariverona foundation; Italian Ministry of Health; Agenzia Italiana del Farmaco (AIFA); Chiesi Farmaceutici SpA	Cariverona foundation(Fondazione Cariverona); Italian Ministry of Health(Ministry of Health, Italy); Agenzia Italiana del Farmaco (AIFA); Chiesi Farmaceutici SpA(Chiesi Pharmaceuticals Inc)	The GEIRD study was funded by the Cariverona foundation, the Italian Ministry of Health, Chiesi Farmaceutici SpA, and the Agenzia Italiana del Farmaco (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accordini S, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0008-0; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Barnes PJ, 2017, CLIN SCI, V131, P1541, DOI 10.1042/CS20160487; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Capurso NA, 2016, AM J ADDICTION, V25, P188, DOI 10.1111/ajad.12347; Cazzola M, 2011, EUR RESPIR J, V38, P42, DOI 10.1183/09031936.00140310; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; Chen WJ, 2015, LANCET RESP MED, V3, P631, DOI 10.1016/S2213-2600(15)00241-6; Chinn S, 1997, EUR RESPIR J, V10, P2495, DOI 10.1183/09031936.97.10112495; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Marco R, 2012, EUR RESPIR J, V39, P883, DOI 10.1183/09031936.00061611; de Marco R, 2010, INT ARCH ALLERGY IMM, V152, P255, DOI 10.1159/000283034; Ekberg-Aronsson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-98; Eriksson J, 2013, ALLERGY, V68, P347, DOI 10.1111/all.12095; Ferrari M, 2014, ALLERGY, V69, P472, DOI 10.1111/all.12354; Frantz S, 2014, RESP MED, V108, P114, DOI 10.1016/j.rmed.2013.08.041; Godtfredsen NS, 2001, EUR RESPIR J, V18, P549, DOI 10.1183/09031936.01.00100801; Guerra S, 2009, THORAX, V64, P894, DOI 10.1136/thx.2008.110619; Hao WR, 2013, ATHEROSCLEROSIS, V226, P263, DOI 10.1016/j.atherosclerosis.2012.10.058; Hirsch AG, 2015, ALLERGY, V70, P1613, DOI 10.1111/all.12759; Hirshoren N, 2010, ACTA OTO-LARYNGOL, V130, P1065, DOI 10.3109/00016481003645727; Iribarren C, 2012, AM J EPIDEMIOL, V176, P1014, DOI 10.1093/aje/kws181; Jousilahti P, 1996, LANCET, V348, P567, DOI 10.1016/S0140-6736(96)02374-4; Kang JH, 2013, LARYNGOSCOPE, V123, P835, DOI 10.1002/lary.23829; Knoflach M, 2005, ARCH INTERN MED, V165, P2521, DOI 10.1001/archinte.165.21.2521; Konno S, 2012, ALLERGY, V67, P653, DOI 10.1111/j.1398-9995.2012.02793.x; Kony S, 2003, AM J RESP CRIT CARE, V167, P538, DOI 10.1164/rccm.200208-851OC; LANGE P, 1990, THORAX, V45, P579, DOI 10.1136/thx.45.8.579; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; Marcon A, 2013, INT ARCH ALLERGY IMM, V161, P181, DOI 10.1159/000345137; Nogami Y, 2010, J THORAC CARDIOV SUR, V140, P624, DOI 10.1016/j.jtcvs.2009.11.005; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Onufrak SJ, 2008, AM J CARDIOL, V101, P1247, DOI 10.1016/j.amjcard.2007.12.024; Pelkonen MK, 2017, RESP MED, V123, P87, DOI 10.1016/j.rmed.2016.12.018; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Saetta M, 1997, AM J RESP CRIT CARE, V156, P1633, DOI 10.1164/ajrccm.156.5.9701081; Schanen JG, 2005, THORAX, V60, P633, DOI 10.1136/thx.2004.026484; Sybilski AJ, 2015, PUBLIC HEALTH NUTR, V18, P530, DOI 10.1017/S1368980014000676; Tattersall MC, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003448; Tattersall MC, 2015, ARTERIOSCL THROM VAS, V35, P1520, DOI 10.1161/ATVBAHA.115.305452; Traphagen N, 2015, BIOMOLECULES, V5, P2840, DOI 10.3390/biom5042840; TROISI RJ, 1995, CHEST, V108, P1557, DOI 10.1378/chest.108.6.1557; Varghese M, 2010, CLIN EXP ALLERGY, V40, P381, DOI 10.1111/j.1365-2222.2009.03450.x; Vignoud L, 2011, RESP MED, V105, P1805, DOI 10.1016/j.rmed.2011.07.005; Vogelmeier CF, 2017, EUR RESPIR J, V49, DOI [10.1183/13993003.00214-2017, 10.1016/j.arbres.2017.02.001, 10.1111/resp.13012, 10.1164/rccm.201701-0218PP]; WILES FJ, 1991, RESP MED, V85, P27, DOI 10.1016/S0954-6111(06)80207-6; Zhang TT, 2009, J ASTHMA, V46, P1021, DOI 10.3109/02770900903350473; Zimerman A, 2016, AM HEART J, V174, P60, DOI 10.1016/j.ahj.2016.01.003	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224999	10.1371/journal.pone.0224999	http://dx.doi.org/10.1371/journal.pone.0224999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697758	Green Published, gold			2022-12-26	WOS:000532694400091
J	Jeon, SJ; Park, HYL; Jung, KI; Park, CK				Jeon, Soo Ji; Park, Hae-Young Lopilly; Jung, Kyoung In; Park, Chan Kee			Relationship between pattern electroretinogram and optic disc morphology in glaucoma	PLOS ONE			English	Article							STANDARD AUTOMATED PERIMETRY; HEIDELBERG RETINA TOMOGRAPH; VISUAL-FIELD DEFECTS; OCULAR HYPERTENSION; NERVE; ERG; REPRODUCIBILITY	Purpose To evaluate the relationship between pattern electroretinogram (PERG) and optic disc morphology in glaucoma suspect and glaucoma. Methods Eighty-six eyes of glaucoma suspect and 145 eyes of manifest glaucoma subjects were included in this study. Average peripapillary retinal nerve fiber layer (RNFL) thickness was obtained with spectral-domain optical coherence tomography, and optic disc imaging was performed using the Heidelberg Retinal Tomograph (HRT). Visual function was evaluated with perimetry (SITA and frequency doubling technology) and PERG. Scatter plots and correlation coefficients were evaluated between visual function and RNFL thickness or optic disc structure. Results Scatter plots of PERG and perimetry according to RNFL thickness change showed that PERG started to decrease earlier than did perimetry. The differences between linear and logarithmic R-2 were largest for the scatter plot of SITA 24-2 (linear R-2 = 0.415; logarithmic R-2 = 0.443) and the smallest for P50 amplitude of PERG (linear R-2 = 0.136, logarithmic R-2 = 0.138). In glaucoma suspect, HRT parameters such as cup shape measure (CSM) and linear cup-disc ratio (CDR) had significant correlations with PERG amplitudes (P = 0.016 for P50 and 0.049 for N95 in CSM, P = 0.012 for P50 in CDR). However, in glaucoma patients, mean RNFL thickness was associated with PERG amplitude (P = 0.011 for P50 and 0.002 for N95). Conclusions PERG deterioration occurred earlier than did perimetry according to RNFL thickness decrease. PERG amplitudes were significantly correlated with disc morphology in glaucoma suspect. These results suggest that PERG can detect ganglion cell dysfunction before the cells die.	[Jeon, Soo Ji; Park, Hae-Young Lopilly; Jung, Kyoung In; Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	ckpark@catholic.ac.kr						Aldebasi YH, 2004, VISION RES, V44, P2749, DOI 10.1016/j.visres.2004.06.015; ARDEN GB, 1982, ANN NY ACAD SCI, V388, P580, DOI 10.1111/j.1749-6632.1982.tb50818.x; Bach M, 2006, INVEST OPHTH VIS SCI, V47, P4881, DOI 10.1167/iovs.05-0875; Bach M, 2018, EXP EYE RES, V169, P48, DOI 10.1016/j.exer.2018.01.021; Bach M, 2013, CELL TISSUE RES, V353, P287, DOI 10.1007/s00441-013-1598-6; Choi JA, 2009, JPN J OPHTHALMOL, V53, P24, DOI 10.1007/s10384-008-0604-0; Cvenkel B, 2017, DOC OPHTHALMOL, V135, P17, DOI 10.1007/s10633-017-9595-9; Ferreras A, 2007, J GLAUCOMA, V16, P372, DOI 10.1097/IJG.0b013e31803bbb17; FIORENTINI A, 1981, INVEST OPHTH VIS SCI, V21, P490; Fortune B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077831; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Hatch WV, 1999, J GLAUCOMA, V8, P232; Hood DC, 2005, INVEST OPHTH VIS SCI, V46, P2411, DOI 10.1167/iovs.05-0238; JANKNECHT P, 1995, GRAEF ARCH CLIN EXP, V233, P523, DOI 10.1007/BF00183434; Jung KI, 2017, AM J OPHTHALMOL, V182, P35, DOI 10.1016/j.ajo.2017.07.007; Jung Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15329-1; Jung Y, 2015, INVEST OPHTH VIS SCI, V56, P7708, DOI 10.1167/iovs.15-17819; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Meredith SP, 2007, J GLAUCOMA, V16, P556, DOI 10.1097/IJG.0b013e3180575229; Nagaraju M, 2007, INVEST OPHTH VIS SCI, V48, P4573, DOI 10.1167/iovs.07-0582; Nucci C, 2012, BRIT J OPHTHALMOL, V96, P976, DOI 10.1136/bjophthalmol-2011-301280; Porciatti V, 2015, EXP EYE RES, V141, P164, DOI 10.1016/j.exer.2015.05.008; Prokosch V, 2014, GRAEF ARCH CLIN EXP, V252, P1599, DOI 10.1007/s00417-014-2718-z; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Rao HL, 2015, INVEST OPHTH VIS SCI, V56, P8063, DOI 10.1167/iovs.15-17922; ROHRSCHNEIDER K, 1994, OPHTHALMOLOGY, V101, P1044; Salgarello T, 1999, INVEST OPHTH VIS SCI, V40, P1989; Ventura LM, 2006, INVEST OPHTH VIS SCI, V47, P3904, DOI 10.1167/iovs.06-0161; Vergados A, 2015, SEMIN OPHTHALMOL, V30, P44, DOI 10.3109/08820538.2013.821509; Viswanathan S, 2000, INVEST OPHTH VIS SCI, V41, P2797; Wilsey LJ, 2016, CURR OPIN OPHTHALMOL, V27, P118, DOI 10.1097/ICU.0000000000000241	32	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0220992	10.1371/journal.pone.0220992	http://dx.doi.org/10.1371/journal.pone.0220992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697709	Green Published, gold			2022-12-26	WOS:000532694400007
J	Yang, J; Deng, XL; Wang, XX; Wang, JZ; Du, SY; Li, YS				Yang, Jing; Deng, Xiaolong; Wang, Xiaoxin; Wang, Jingzhang; Du, Shiyun; Li, Yangsheng			The calcium sensor OsCBL1 modulates nitrate signaling to regulate seedling growth in rice	PLOS ONE			English	Article							PROTEIN-KINASE; ARABIDOPSIS; EXPRESSION; PHASE	Nitrate signaling integrates and coordinates gene expression and plant growth; however, the underlying molecular mechanisms involved remain poorly understood. Our previous study revealed that rice calcineurin B-like protein 1 (OsCBL1) modulates lateral root elongation by affecting auxin biosynthesis. Here, we report that OsCBL1 also modulates nitrate signaling to regulate rice seedlings growth. Compared with wild-type seedlings, seedlings of OsCBL1-knockdown (OsCBL1-KD) plants showed a suppressed growth phenotype, which included reduced root and shoot fresh weights and shorter radicles, crown roots, and lateral roots, when grown in nitrogen-free conditions. Although the growth defects of OsCBL1-KD plants could be partially rescued by the addition of nitrate to the growth conditions, the nitrate uptake capability of the OsCBL1-KD plants did not differ from that of wild-type plants as assessed via nitrate content and (NO3-)-N-15 influx experiments. The nitrate-regulated expression of nitrate signal sentinel genes (OsNRT2.1 and OsNRT2.2) was affected in the OsCBL1-KD plants under both long- and short-term nitrate treatments. Overall, our results showed a novel role for OsCBL1 in the regulation of nitrate signaling and nitrate-mediated rice growth.	[Yang, Jing; Deng, Xiaolong; Wang, Xiaoxin; Wang, Jingzhang; Li, Yangsheng] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Peoples R China; [Du, Shiyun] Anhui Acad Agr Sci, Inst Rice Res, Hefei, Peoples R China	Wuhan University; Anhui Academy of Agricultural Sciences	Li, YS (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Peoples R China.	lysh2001@whu.edu.cn	li, yong/HDN-3885-2022; Li, Yuan/GXV-1310-2022; Li, Yang/GWM-7879-2022	Yang, Jing/0000-0002-5537-7783	National Key Basic Research Program of China [2017YFD0301305]; National Science and Technology Major Project of China [2016ZX08001001]	National Key Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project of China	This work is partly supported by the National Key Basic Research Program of China (2017YFD0301305) to SD, and by the National Science and Technology Major Project of China (2016ZX08001001) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboresi A, 2005, PLANT CELL ENVIRON, V28, P500, DOI 10.1111/j.1365-3040.2005.01292.x; Girin T, 2007, PLANT CELL ENVIRON, V30, P1366, DOI 10.1111/j.1365-3040.2007.01712.x; Guan PZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01697; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Krouk G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r123; Li J, 2014, PLANT CELL, V26, P3387, DOI 10.1105/tpc.114.123455; Liu KH, 2017, NATURE, V545, P311, DOI 10.1038/nature22077; Ma Q, 2015, BIOCHEM BIOPH RES CO, V468, P59, DOI 10.1016/j.bbrc.2015.10.164; Medici A, 2014, J EXP BOT, V65, P5567, DOI 10.1093/jxb/eru245; Rahayu YS, 2005, J EXP BOT, V56, P1143, DOI 10.1093/jxb/eri107; REDINBAUGH MG, 1993, PLANT PHYSIOL, V101, P1249, DOI 10.1104/pp.101.4.1249; Riveras E, 2015, PLANT PHYSIOL, V169, P1397, DOI 10.1104/pp.15.00961; Sanyal SK, 2015, PHYSIOL PLANTARUM, V155, P89, DOI 10.1111/ppl.12344; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Straub T, 2017, PLANT CELL; Vidal EA, 2014, J EXP BOT, V65, P5611, DOI 10.1093/jxb/eru326; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Wang RC, 2009, PLANT PHYSIOL, V151, P472, DOI 10.1104/pp.109.140434; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Yan DW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13179; Yan YS, 2014, PLANT J, V78, P44, DOI 10.1111/tpj.12446; Yang J, 2015, J GENET GENOMICS, V42, P331, DOI 10.1016/j.jgg.2015.03.004; Zhou R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010071	24	4	5	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224962	10.1371/journal.pone.0224962	http://dx.doi.org/10.1371/journal.pone.0224962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KR5AR	31697744	Green Published, gold			2022-12-26	WOS:000517631700001
J	Ferguson, ME; Shah, T; Kulakow, P; Ceballos, H				Ferguson, Morag E.; Shah, Trushar; Kulakow, Peter; Ceballos, Hernan			A global overview of cassava genetic diversity	PLOS ONE			English	Article							BROWN STREAK VIRUSES; R-PACKAGE; RESISTANCE; EAST; DISEASE; AFRICA; SNPS	Although numerous studies of diversity have been conducted in cassava, there is no comprehensive assessment of global genetic diversity. Here we draw on previous studies and breeders' knowledge to select diversity sets from the International Institute of Tropical Agriculture (IITA) and the International Center for Tropical Agriculture (CIAT) genebanks and breeders' germplasm, as well as elite germplasm and landraces from eastern, southern and central (ESC) Africa to make a global assessment of diversity in cassava, using a SNP based GoldenGate (Illumina Inc.) assay. A synthesis of results from genetic distance and ADMIXTURE analysis essentially revealed four populations (i) South American germplasm characterised by relatively higher genetic diversity with hypothetical ancestral founder genotypes from Brazil, (ii) a smaller group of African introduction germplasm which is more distantly related to all other germplasm, (iii) West Africa germplasm dominated by IITA breeding lines, containing sources of cassava mosaic disease resistance, and IITA gene bank accessions from West Africa, both characterised by slightly lower diversity, and (iv) a less cohesive group of African germplasm, termed 'Other', with moderate levels of diversity and a majority of germplasm from ESC Africa. This study highlights opportunities for heterosis breeding, purging of duplicates in genebanks and the need for conservation of ESC Africa landraces.	[Ferguson, Morag E.; Shah, Trushar] Int Inst Trop Agr, Nairobi, Kenya; [Kulakow, Peter] Int Inst Trop Agr, Ibadan, Nigeria; [Ceballos, Hernan] Int Ctr Trop Agr, Cali, Colombia	CGIAR; International Institute of Tropical Agriculture (IITA); Alliance; International Center for Tropical Agriculture - CIAT	Ferguson, ME (corresponding author), Int Inst Trop Agr, Nairobi, Kenya.	m.ferguson@cgiar.org		Shah, Trushar/0000-0002-0091-7981	Generation Challenge Program [G7010.01.01]	Generation Challenge Program	GoldenGate genotyping was funded by the Generation Challenge Program under G7010.01.01 `Improvement and Evaluation of Existing Cassava Reference Set for Africa' to IITA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bhattacharjee R, 2012, PLANT GENET RESOUR-C, V10, P119, DOI 10.1017/S1479262112000093; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Eke-okoro O.N, 2012, APRN J AGR BIOL SCI, V7, P59; Fairbaim, 1992, ATLAS CASSAVA AFRICA; Ferguson ME, 2012, THEOR APPL GENET, V124, P685, DOI 10.1007/s00122-011-1739-9; Fregene M, 2001, EUPHYTICA, V120, P159, DOI 10.1023/A:1017565317940; HAHN SK, 1989, CROP PROT, V8, P147, DOI 10.1016/0261-2194(89)90022-7; HAHN SK, 1980, EUPHYTICA, V29, P673, DOI 10.1007/BF00023215; Hurtado P, 2008, 1 SCI M GLOB CASS PA; Igartua E, 1998, GENET RESOUR CROP EV, V45, P475, DOI 10.1023/A:1008662515059; Jennings D. L., 1994, Tropical Science, V34, P110; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones W. O., 1959, MANIOC IN AFRICA; Kawuki RS, 2013, PLANT GENET RESOUR-C, V11, P170, DOI 10.1017/S1479262113000014; Legg JP, 2006, ADV VIRUS RES, V67, P355, DOI 10.1016/S0065-3527(06)67010-3; Mahungu N. M., 1994, African Crop Science Journal, V2, P539; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; Nichols R. F. W., 1947, EAST AFRICAN AGRIC JOUR, V12, P184; Olsen KM, 2004, PLANT MOL BIOL, V56, P517, DOI 10.1007/s11103-004-5043-9; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X, 2006, JACQUEMOUD COLLET J; R Core Team, 2018, R LANG ENV STAT COMP; Rossel G., 1987, E COMMUNICATION; Sheat S, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00567; Wang HL, 2016, PLANT DIS, V100, P1029, DOI 10.1094/PDIS-10-15-1228-PDN; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	31	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224763	10.1371/journal.pone.0224763	http://dx.doi.org/10.1371/journal.pone.0224763			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693686	gold, Green Published			2022-12-26	WOS:000532690100039
J	Kounta, CH; Sagaon-Teyssier, L; Coulaud, PJ; Mora, M; Maradan, G; Bourrelly, M; Keita, AA; Yoro, SAB; Anoma, C; Coulibaly, C; Dah, ET; Agbomadji, S; Mensah, E; Bernier, A; Couderc, C; Keita, BD; Laurent, C; Spire, B				Kounta, Cheick Haiballa; Sagaon-Teyssier, Luis; Coulaud, Pierre-Julien; Mora, Marion; Maradan, Gwenaelle; Bourrelly, Michel; Keita, Abdoul Aziz; Yoro, Stephane-Alain Babo; Anoma, Camille; Coulibaly, Christian; Dah, Elias Ter Tiero; Agbomadji, Selom; Mensah, Ephrem; Bernier, Adeline; Couderc, Clotilde; Keita, Bintou Dembele; Laurent, Christian; Spire, Bruno		CohMSM Study Grp	Transactional sex among men who have sex with men participating in the CohMSM prospective cohort study in West Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV PREVENTION; GENDER NONCONFORMITY; RISK BEHAVIORS; SOUTH-AFRICA; BLACK-MEN; WORKERS; PREVALENCE; INFECTION; MOMBASA	Although the HIV epidemic is generalized in West Africa, some population groups such as men who have sex with men (MSM), especially those engaged in transactional sex (TS), are thought to be particularly more vulnerable to HIV than others. However, few data are available to help identify their health-related needs with a view to implementing targeted prevention interventions. To fill this knowledge gap, we aimed to characterize MSM reporting TS (MSM-TS) and to identify factors associated with their sexual practices using data from the prospective cohort study CohMSM, which was conducted in Burkina Faso, Cote d'Ivoire, Mali and Togo. Three stigmatization sub-scores were constructed (experienced, perceived and internalized). The generalized estimating equation method was used for data analysis. Of the total 630 HIV-negative MSM recruited in CohMSM, 463, 410 and 244 had a follow-up visit at 6, 12 and 18 months, respectively. In a total of 1747 follow-up visits, 478 TS encounters were reported by 289 MSM-TS (45.9%). Of the latter, 91 regularly reported TS (31.5%), 55 (19.0%) stopped reporting TS after baseline, and 53 (18.3%) reported TS after baseline and 90 (31.1%) occasionally reported TS. The following variables, regarding the previous 6 months, were positively associated with TS: being younger (aOR[95%CI]:1.86[1.39-2.50]), less educated (aOR[95%CI]:1.49[1.09-2.03]), unmarried status (aOR[95%CI]:1.79[1.102.93]), satisfaction with current sex life (aOR[95%CI]:1.41[1.06-1.88]), group sex with men (aOR[95%CI]:2.07[1.46-2.94]), multiple male sexual partners (aOR[95%CI]:1.85[1.402.44]), receptive or versatile anal sex with male partners (aOR [95%Cl]:1.48[1.12-1.96]), giving benefits in exchange for sex with a man (aOR[95%CI]:2.80[1.97-3.98]), alcohol consumption (aOR[95%CI]:1.44[1.08-1.93]) and drug use (aOR[95%CI]:1.82[1.24-2.68]) during sex, and finally experiencing stigmatization (aOR [95%Cl]:1.15[1.07-1.25]). Condom use during anal sex (aOR[95%CI]:0.73[0.53-0.99]) was negatively associated with TS.	[Kounta, Cheick Haiballa; Sagaon-Teyssier, Luis; Coulaud, Pierre-Julien; Mora, Marion; Maradan, Gwenaelle; Bourrelly, Michel; Spire, Bruno] Aix Marseille Univ, Sci Econ & Sociales Sante & Traitement Informat M, INSERM, IRD,SESSTIM, Marseille, France; [Kounta, Cheick Haiballa; Sagaon-Teyssier, Luis; Coulaud, Pierre-Julien; Mora, Marion; Maradan, Gwenaelle; Bourrelly, Michel; Spire, Bruno] ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France; [Keita, Abdoul Aziz; Keita, Bintou Dembele] ARCAD Sida, Bamako, Mali; [Yoro, Stephane-Alain Babo; Anoma, Camille] Espace Confiance, Abidjan, Cote Ivoire; [Coulibaly, Christian; Dah, Elias Ter Tiero] Assoc Africaine Solidarite, Ouagadougou, Burkina Faso; [Dah, Elias Ter Tiero] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Agbomadji, Selom; Mensah, Ephrem] Espoir Vie Togo, Lome, Togo; [Bernier, Adeline] Coalit Int Sida, Pantin, France; [Couderc, Clotilde; Laurent, Christian] Univ Montpellier, IRD, INSERM, TransVIHMI, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre Muraz; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Kounta, CH (corresponding author), Aix Marseille Univ, Sci Econ & Sociales Sante & Traitement Informat M, INSERM, IRD,SESSTIM, Marseille, France.; Kounta, CH (corresponding author), ORS PACA, Observ Reg Sante Provence Alpes Cote Azur, Marseille, France.	kountacheick80@yahoo.fr	Spire, Bruno/F-5546-2013	Spire, Bruno/0000-0002-3546-8020; Sagaon-Teyssier, Luis/0000-0001-7318-6596; Laurent, Christian/0000-0003-2658-7113; KOUNTA, Cheick Haiballa/0000-0001-6800-0742; Bernier, Adeline/0000-0003-3023-429X; AGBOYIBOR, Kouamivi Mawuenyegan/0000-0002-7459-6914	French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [ANRS12324]; Expertise France; A*MIDEX; French Government "Investissements d'Avenir" programme [ANR-11-IDEX-0001-02]; ANRS [ANRS 12409 B106]	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); Expertise France; A*MIDEX(French National Research Agency (ANR)); French Government "Investissements d'Avenir" programme(French National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR))	The CohMSM study was funded by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS; grant ANRS12324) and Expertise France (Initiative 5%). This article was written thanks to the support of the A*MIDEX; under grant (noANR-11-IDEX-0001-02) funded by the French Government "Investissements d'Avenir" programme, and ANRS [grant ANRS 12409 B106]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSInfos/UNAIDS, UNAIDS REP GLOB AIDS; Akoku DA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198853; Anderson AM, 2015, AIDS CARE, V27, P63, DOI 10.1080/09540121.2014.951597; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Baral SD, 2015, LANCET, V385, P260, DOI 10.1016/S0140-6736(14)60801-1; Barros AB, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0129-9; Berg RC, 2015, INT J SEX HEALTH, V27, P286, DOI 10.1080/19317611.2014.982263; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bui TC, 2014, AIDS BEHAV, V18, P2432, DOI 10.1007/s10461-014-0808-x; Choudhry V, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27249; Cluver L, 2013, LANCET GLOB HEALTH, V1, pE362, DOI 10.1016/S2214-109X(13)70115-3; Cook SH, 2013, ARCH SEX BEHAV, V42, P327, DOI 10.1007/s10508-013-0087-z; Crowell TA, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.01.21489; Cui J., 2007, STATA J, V7, P12; Deiss RG, 2013, DRUG ALCOHOL DEPEN, V132, P134, DOI 10.1016/j.drugalcdep.2013.01.011; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; Ha Huy, 2013, J Sex Transm Dis, V2013, P174506, DOI 10.1155/2013/174506; Henry E, 2010, SEX TRANSM INFECT, V86, P136, DOI 10.1136/sti.2009.036939; Jenness SM, 2011, J URBAN HEALTH, V88, P329, DOI 10.1007/s11524-010-9534-5; Jerome RC, 2009, J BLACK PSYCHOL, V35, P343, DOI 10.1177/0095798409333620; Johnston LG, 2010, INT J DRUG POLICY, V21, P485, DOI 10.1016/j.drugpo.2010.06.001; Kim Min, 2016, JMIR Public Health Surveill, V2, pe7, DOI 10.2196/publichealth.5298; Klingelschmidt J, 2017, AIDS CARE, V29, P689, DOI 10.1080/09540121.2016.1234680; Kounta CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212245; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; Liu SS, 2012, SEX TRANSM DIS, V39, P251, DOI 10.1097/OLQ.0b013e31824a0903; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Matovu J K B, 2013, Afr Health Sci, V13, P1027, DOI 10.4314/ahs.v13i4.24; Moller LM, 2015, AIDS, V29, pS211, DOI 10.1097/QAD.0000000000000890; Musinguzi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132297; Myers T, 2004, ADDICT RES THEORY, V12, P213, DOI 10.1080/16066350310001640161; Nyoni JE, 2013, AIDS CARE, V25, P223, DOI 10.1080/09540121.2012.699671; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Oldenburg CE, 2015, AIDS BEHAV, V19, P2177, DOI 10.1007/s10461-015-1010-5; Oldenburg CE, 2015, AM J PUBLIC HEALTH, V105, pE95, DOI 10.2105/AJPH.2014.302402; Oldenburg CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103549; Ranganathan M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20749; Risher K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18715; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sanders EJ, 2013, AIDS, V27, P437, DOI 10.1097/QAD.0b013e32835b0f81; Sandfort T, 2016, ARCH SEX BEHAV, V45, P661, DOI 10.1007/s10508-015-0565-6; Scheibe A, 2012, SAHARA J-J SOC ASP H, V9, P167, DOI 10.1080/17290376.2012.743809; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Semugoma P, 2012, SAHARA J-J SOC ASP H, V9, P173, DOI 10.1080/17290376.2012.744177; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Smith AMA, 2004, SEX TRANSM INFECT, V80, P455, DOI 10.1136/sti.2004.010355; Stahlman Shauna, 2016, JMIR Public Health Surveill, V2, pe35, DOI 10.2196/publichealth.5824; Stoebenau K, 2016, SOC SCI MED, V168, P186, DOI 10.1016/j.socscimed.2016.09.023; Stoebenau K, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-13; Traore IT, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20088; UNAIDS, 2017, HIV AIDS JUNPO GENE; United Nations Department of Economic and Social Affairs Population Division, 2019, WORLD POP PROSP; Vuylsteke B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032627; Wamoyi J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20992; Wheeler DP, 2008, ARCH SEX BEHAV, V37, P697, DOI 10.1007/s10508-008-9372-7; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; World Bank, 2018, WORLD DEV IND, DOI [10.1596/978-1-4648-0683-4, DOI 10.1596/978-1-4648-0683-4]	61	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0217115	10.1371/journal.pone.0217115	http://dx.doi.org/10.1371/journal.pone.0217115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1FJ	31693669	Green Published, gold, Green Submitted			2022-12-26	WOS:000532690100006
J	Calamita, E; Schmid, M; Kunz, M; Ndebele-Murisa, MR; Magadza, CHD; Nyambe, I; Wehrli, B				Calamita, Elisa; Schmid, Martin; Kunz, Manuel; Ndebele-Murisa, Mzime Regina; Magadza, Christopher H. D.; Nyambe, Imasiku; Wehrli, Bernhard			Sixty years since the creation of Lake Kariba: Thermal and oxygen dynamics in the riverine and lacustrine sub-basins	PLOS ONE			English	Article							ZAMBEZI RIVER; SPATIAL HETEROGENEITY; ECOSYSTEM CHANGE; RETENTION TIME; WATER; RESERVOIR; CARBON; TANGANYIKA; LIMNOLOGY; DEPLETION	The current boom of dam construction at low latitudes endangers the integrity and function of major tropical river systems. A deeper understanding of the physical and chemical functioning of tropical reservoirs is essential to mitigate dam-related impacts. However, the development of predictive tools is hampered by a lack of consistent data on physical mixing and biogeochemistry of tropical reservoirs. In this study, we focus on Lake Kariba (Southern Africa), the largest artificial lake in the world by volume. Kariba Dam forms a transboundary reservoir between Zambia and Zimbabwe, and therefore its management represents a socio-politically sensitive issue because the Kariba Dam operation completely changed the downstream hydrological regime. Although Lake Kariba represents a unique and scientifically interesting case study, there is no consistent dataset documenting its physical and chemical behaviour over time. This limits the scope for quantitative studies of this reservoir and its downstream impacts. To address this research gap, we aggregated a consistent database of in situ measurements of temperature and oxygen depth profiles for the entire 60 years of Lake Kariba's lifetime and performed a detailed statistical analysis of the thermal and oxygen regime of the artificial lake to classify the different behaviours of the lake's sub-basins. We demonstrate that the seasonal stratification strongly depends on the depth of the water column and on the distance from the lake inflow. Satellite data confirm these spatiotemporal variations in surface temperature, and reveal a consistent longitudinal warming trend of the lake surface water temperature of about 1.5 degrees C from the inflow to the dam. Finally, our results suggest that the stratification dynamics of the lacustrine sub-basins have the potential to alter the downstream Zambezi water quality. Future research should focus on assessing such alterations and developing strategies to mitigate them.	[Calamita, Elisa; Wehrli, Bernhard] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Schmid, Martin; Kunz, Manuel] Eawag, Swiss Fed Inst Aquat Sci & Technol, Surface Waters Res & Management, Kastanienbaum, Switzerland; [Ndebele-Murisa, Mzime Regina; Wehrli, Bernhard] Chinhoyi Univ Technol, Dept Freshwater & Fishery Sci, Chinhoyi, Zimbabwe; [Magadza, Christopher H. D.] Univ Zimbabwe, Dept Biol Sci, Harare, Zimbabwe; [Nyambe, Imasiku] UNZA, Sch Mines, Lusaka, Zambia; [Kunz, Manuel] Fed Off Environm FOEN, Water Div, Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Zimbabwe; University of Zambia	Calamita, E (corresponding author), Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.	elisa.calamita@usys.ethz.ch	Wehrli, Bernhard/B-4420-2008; Murisa, Mzime/AFS-0432-2022; Schmid, Martin/C-3953-2009; Calamita, Elisa/AAU-4075-2020; Wehrli, Bernhard/M-3847-2019	Wehrli, Bernhard/0000-0001-7029-1972; Schmid, Martin/0000-0001-8699-5691; Calamita, Elisa/0000-0002-2614-2942; Wehrli, Bernhard/0000-0001-7029-1972	European Union [690268]; ADAPT project via the Competence Center Environment and Sustainability of the ETH domain	European Union(European Commission); ADAPT project via the Competence Center Environment and Sustainability of the ETH domain	This project has received funding by the European Union's Horizon 2020 research and innovation programme under grant agreement No 690268. Part of the data gathering effort was funded by the ADAPT project via the Competence Center Environment and Sustainability of the ETH domain.	Balon E.K., 1974, MONOGRAPHIAE BIOL, V24, P428, DOI [10.1007/978-94-010-2334-4, DOI 10.1007/978-94-010-2334-4, 10.1007/978-94-010-2334-4_19, DOI 10.1007/978-94-010-2334-4_19]; BEGG GW, 1970, LIMNOL OCEANOGR, V15, P776, DOI 10.4319/lo.1970.15.5.0776; Bello AD, 2017, CLIMATE, V5, DOI 10.3390/cli5030058; Best J, 2019, NAT GEOSCI, V12, P7, DOI 10.1038/s41561-018-0262-x; Boehrer B, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000210; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Calamita E, 2019, 60 YEARS LAKE KARIBA, DOI [10.3929/ETHZ-B-000334971, DOI 10.3929/ETHZ-B-000334971]; Chao BF, 2008, SCIENCE, V320, P212, DOI 10.1126/science.1154580; Chin TM, 2017, REMOTE SENS ENVIRON, V200, P154, DOI 10.1016/j.rse.2017.07.029; Coche AG, 1968, DESCRIPTION PHYSICO; Cohen AS, 2016, P NATL ACAD SCI USA, V113, P9563, DOI 10.1073/pnas.1603237113; Deas ML, 2000, WATER TEMPERATURE MO; DelSontro T, 2011, ENVIRON SCI TECHNOL, V45, P9866, DOI 10.1021/es2005545; Donlon C, 2007, B AM METEOROL SOC, V88, P1197, DOI 10.1175/BAMS-88-8-1197; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Friedl G, 2002, AQUAT SCI, V64, P55, DOI 10.1007/s00027-002-8054-0; Gholizadeh MH, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081298; Hamel P, 2018, ECOHYDROLOGY, V11, DOI 10.1002/eco.1921; Hansen GJA, 2015, FISHERIES, V40, P56, DOI 10.1080/03632415.2014.996804; Hutchinson P., 1973, Weather, V28, P499, DOI 10.1002/j.1477-8696.1973.tb00816.x; Khan O, 2014, P I CIVIL ENG-WAT M, V167, P585, DOI 10.1680/wama.13.00122; Kunz MJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010996; Kunz MJ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001538; Ledec G, 2003, LATIN AM CARIBBEAN R; Lewis WM, 2010, INT VER THEOR ANGEW, V30, P1595; Lewis William M. Jr., 2000, Lakes Reservoirs Research and Management, V5, P35, DOI 10.1046/j.1440-1770.2000.00091.x; Lopez H, 2018, NAT CLIM CHANGE, V8, P414, DOI 10.1038/s41558-018-0116-y; Macklin PA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198678; Magadza C. H. D., 2010, Lakes & Reservoirs Research and Management, V15, P167, DOI 10.1111/j.1440-1770.2010.00438.x; Magadza CHD, 1987, ULKRS B; Magadza CHD, 1988, ULKRS B, V1, P1; Magadza Christopher H. D., 2006, Lakes & Reservoirs Research and Management, V11, P271, DOI 10.1111/j.1440-1770.2006.00308.x; Mahere TS, 2014, AFR J AQUAT SCI, V39, P215, DOI 10.2989/16085914.2014.927350; Marshall Brian E., 2017, Lakes & Reservoirs Research and Management, V22, P229, DOI 10.1111/lre.12185; Matthews DA, 2006, LIMNOL OCEANOGR, V51, P702, DOI 10.4319/lo.2006.51.1_part_2.0702; Muller B, 2012, ENVIRON SCI TECHNOL, V46, P9964, DOI 10.1021/es301422r; Mwedzi T, 2016, WATER SA, V42, P194, DOI [10.4314/wsa.v42i2.03, 10.4314/wsa.v42i2.3]; Ndebele-Murisa MR, 2011, THESIS; Ndebele-Murisa MR, 2014, HYDROBIOLOGIA, V721, P185, DOI 10.1007/s10750-013-1660-0; NdebeleMurisa MR, 2014, PHYTOPLANKTON BIOL C, P37; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Pacheco FS, 2015, BIOGEOSCIENCES, V12, P147, DOI 10.5194/bg-12-147-2015; Parker F, 1975, EVALUATION MATH MODE; Rueda F, 2006, ECOL MODEL, V191, P260, DOI 10.1016/j.ecolmodel.2005.04.030; Ruttner F, 1953, FUNDAMENTALS LIMNOLO; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Soares MCS, 2012, LIMNOLOGICA, V42, P197, DOI 10.1016/j.limno.2011.11.002; Soares Maria Carolina S., 2008, Lakes & Reservoirs Research and Management, V13, P257, DOI 10.1111/j.1440-1770.2008.00379.x; Steinsberger T, 2017, BIOGEOSCIENCES, V14, P3275, DOI 10.5194/bg-14-3275-2017; Straskraba M., 1993, COMP RESERVOIR LIMNO, V77, P213, DOI [10.1007/978-94-017-1096-1_13, DOI 10.1007/978-94-017-1096-1_13]; Svendsen MBS, 2016, J FISH BIOL, V88, P51, DOI 10.1111/jfb.12851; Teodoru CR, 2015, BIOGEOSCIENCES, V12, P2431, DOI 10.5194/bg-12-2431-2015; Van Cappellen P, 2016, ECOHYDROL HYDROBIOL, V16, P106, DOI 10.1016/j.ecohyd.2016.04.001; Vasek M, 2016, ECOL INDIC, V63, P219, DOI 10.1016/j.ecolind.2015.11.061; Verburg P, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012839; WALKER WW, 1979, WATER RESOUR RES, V15, P1463, DOI 10.1029/WR015i006p01463; WARD JV, 1982, ANNU REV ENTOMOL, V27, P97, DOI 10.1146/annurev.en.27.010182.000525; Wilcox BP, 2018, ECOHYDROLOGY, V11, DOI 10.1002/eco.1970; Wilcox BP, 2010, ECOHYDROLOGY, V3, P126, DOI 10.1002/eco.104; Winton RS, 2019, BIOGEOSCIENCES, V16, P1657, DOI 10.5194/bg-16-1657-2019; Wohl E, 2012, NAT CLIM CHANGE, V2, P655, DOI [10.1038/NCLIMATE1556, 10.1038/nclimate1556]; Woolway RI, 2019, NAT GEOSCI, V12, P271, DOI 10.1038/s41561-019-0322-x; Woolway RI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04058-0; World Bank, 2010, MULT INV OPP AN; Yu H, 2010, LIMNOLOGY, V11, P251, DOI 10.1007/s10201-010-0310-8; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0; Zhang GQ, 2014, J GEOPHYS RES-ATMOS, V119, P8552, DOI 10.1002/2014JD021615; Zuijdgeest AL, 2015, BIOGEOSCIENCES, V12, P7535, DOI 10.5194/bg-12-7535-2015; Zuijdgeest A, 2017, CHEM GEOL, V467, P1, DOI 10.1016/j.chemgeo.2017.07.025	70	9	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224679	10.1371/journal.pone.0224679	http://dx.doi.org/10.1371/journal.pone.0224679			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689335	Green Published, gold			2022-12-26	WOS:000532680100037
J	Wang, Z; Li, YJ; Wu, DL; Yu, S; Wang, YL; Chan, FL				Wang, Zhu; Li, Youjia; Wu, Dinglan; Yu, Shan; Wang, Yuliang; Chan, Franky Leung			Nuclear receptor HNF4 alpha performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; FACTOR 4-ALPHA; GENE-EXPRESSION; EPITHELIAL-CELLS; THERAPEUTIC TARGET; ANDROGEN RECEPTOR; FACTOR-4-ALPHA; PROLIFERATION; PROMOTES; GROWTH	Hepatocyte nuclear factor 4 alpha (HNF4 alpha, NR2A1) is a highly conserved member of the nuclear receptor superfamily. Recent advances reveal that it is a key transcriptional regulator of genes, broadly involved in xenobiotic and drug metabolism and also cancers of gastrointestinal tract. However, the exact functional roles of HNF4 alpha in prostate cancer progression are still not fully understood. In this study, we determined the functional significance of HNF4 alpha in prostate cancer. Our results showed that HNF4 alpha exhibited a reduced expression pattern in clinical prostate cancer tissues, prostate cancer cell lines and xenograft model of castration-relapse prostate cancer. Stable HNF4 alpha knockdown not only could promote cell proliferation and suppress doxorubicin (Dox)-induced cellular senescence in prostate cancer cells, but also confer resistance to paclitaxel treatment and enhance colony formation capacity and in vivo tumorigenicity of prostate cancer cells. On the contrary, ectopic overexpression of HNF4 alpha could significantly inhibit the cell proliferation of prostate cancer cells, induce cell-cycle arrest at G(2)/M phase and trigger the cellular senescence in prostate cancer cells by activation of p21 signal pathway in a p53-independent manner via its direct transactivation of CDKN1A. Together, our results show that HNF4 alpha performs a tumor suppressor function in prostate cancer via a mechanism of p21-driven cellular senescence.	[Wang, Zhu] Southern Med Univ, Peoples Hosp Longhua, Dept Urol, Shenzhen 518109, Guangdong, Peoples R China; [Wang, Zhu; Li, Youjia; Wu, Dinglan; Yu, Shan; Wang, Yuliang; Chan, Franky Leung] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China	Southern Medical University - China; Chinese University of Hong Kong	Wang, YL; Chan, FL (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China.	yuliang.wang816@gmail.com; franky-chan@cuhk.edu.hk		Wang, Zhu/0000-0002-5457-3731; Wu, Dinglan/0000-0002-5057-9626	CUHK [2015.1.064]; Research Grants Council of Hong Kong [461012]; Shenzhen Science and Technology Program (Basic Research Project) [JCYJ20180228163919346]	CUHK(Chinese University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Shenzhen Science and Technology Program (Basic Research Project)	This work was supported by a Direct Grant for Research 2015-2016 from CUHK (grant no. 2015.1.064), a General Research Fund (project number 461012) from the Research Grants Council of Hong Kong (to Chan FL), and Shenzhen Science and Technology Program (Basic Research Project; project number JCYJ20180228163919346 to ZW)	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Cairns P, 1997, CANCER RES, V57, P4997; CHARTIER FL, 1994, GENE, V147, P269, DOI 10.1016/0378-1119(94)90079-5; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/j.yexcr.2004.08.014; Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Drewa T., 2010, Experimental Oncology, V32, P228; Duncan SA, 1997, DEVELOPMENT, V124, P279; Erdmann S, 2007, BIOL CHEM, V388, P91, DOI 10.1515/BC.2007.011; Grigo K, 2008, BIOL CHEM, V389, P179, DOI 10.1515/BC.2008.011; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li JX, 2000, GENE DEV, V14, P464; Loaiza N, 2016, BBA-REV CANCER, V1865, P155, DOI 10.1016/j.bbcan.2016.01.007; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Marcil V, 2012, GENES IMMUN, V13, P556, DOI 10.1038/gene.2012.37; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; Moschini M, 2017, EUR UROL, V72, P238, DOI 10.1016/j.eururo.2017.03.009; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Oshima T, 2007, PATHOL INT, V57, P82, DOI 10.1111/j.1440-1827.2006.02061.x; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pihlajamaa P, 2014, EMBO J, V33, P312, DOI 10.1002/embj.201385895; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rieck S, 2012, MOL ENDOCRINOL, V26, P1590, DOI 10.1210/me.2012-1019; Sel S, 1996, CANCER LETT, V101, P205, DOI 10.1016/0304-3835(96)04136-5; Sharma S, 2010, PATHOLOGY, V42, P507, DOI 10.3109/00313025.2010.508791; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Sugai M, 2008, PATHOL INT, V58, P681, DOI 10.1111/j.1440-1827.2008.02293.x; Sugano M, 2013, AM J SURG PATHOL, V37, P211, DOI 10.1097/PAS.0b013e31826be303; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; Tang DG, 2001, SCIENCE, V291, P868, DOI 10.1126/science.1056780; THALMANN GN, 1994, CANCER RES, V54, P2577; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Walesky C, 2013, AM J PHYSIOL-GASTR L, V304, pG26, DOI 10.1152/ajpgi.00064.2012; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang Z, 2018, ENDOCR-RELAT CANCER, V25, P35, DOI 10.1530/ERC-17-0280; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wu DL, 2015, J PATHOL, V236, P103, DOI 10.1002/path.4505; Xiang X, 2015, CANCER LETT, V359, P187, DOI 10.1016/j.canlet.2015.01.008; Xiao LJ, 2018, CANCER RES, V78, P2205, DOI 10.1158/0008-5472.CAN-17-2341; Xu L, 2001, CANCER RES, V61, P3176; Yamagata K, 2014, VITAM HORM, V95, P407, DOI 10.1016/B978-0-12-800174-5.00016-8; Yu S, 2008, ONCOGENE, V27, P3313, DOI 10.1038/sj.onc.1210986; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Yu S, 2014, J PATHOL, V234, P514, DOI 10.1002/path.4413; Yu S, 2013, CANCER LETT, V328, P83, DOI 10.1016/j.canlet.2012.09.006; Yu S, 2009, BIOCHEM BIOPH RES CO, V382, P756, DOI 10.1016/j.bbrc.2009.03.110; Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24; Zou C, 2014, J PATHOL, V233, P61, DOI 10.1002/path.4329	66	17	17	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	7					1572	1589		10.1038/s41388-019-1080-3	http://dx.doi.org/10.1038/s41388-019-1080-3			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KL2WP	31695151	Green Published, hybrid			2022-12-26	WOS:000513289600013
J	Gordon, U; Marom, S; Brenner, N				Gordon, Urit; Marom, Shimon; Brenner, Naama			Visual detection of time-varying signals: Opposing biases and their timescales	PLOS ONE			English	Article							PERCEPTION; ADAPTATION; HISTORY; NOISE	Human visual perception is a complex, dynamic and fluctuating process. In addition to the incoming visual stimulus, it is affected by many other factors including temporal context, both external and internal to the observer. In this study we investigate the dynamic properties of psychophysical responses to a continuous stream of visual near-threshold detection tasks. We manipulate the incoming signals to have temporal structures with various characteristic timescales. Responses of human observers to these signals are analyzed using tools that highlight their dynamical features as well. Our experiments show two opposing biases that shape perceptual decision making simultaneously: positive recency, biasing towards repeated response; and adaptation, entailing an increased probability of changed response. While both these effects have been reported in previous work, our results shed new light on the timescales involved in these effects, and on their interplay with varying inputs. We find that positive recency is a short-term bias, inversely correlated with response time, suggesting it can be compensated by afterthought. Adaptation, in contrast, reflects trends over longer times possibly including multiple previous trials. Our entire dataset, which includes different input signal temporal structures, is consistent with a simple model with the two biases characterized by a fixed parameter set. These results suggest that perceptual biases are inherent features which are not flexible to tune to input signals.	[Gordon, Urit; Marom, Shimon] Technion, Fac Med, Haifa, Israel; [Brenner, Naama] Technion, Fac Chem Engn, Haifa, Israel; [Gordon, Urit; Marom, Shimon; Brenner, Naama] Technion, Network Biol Res Lab, Lorry Lockey Interdisciplinary Ctr Life Sci & Eng, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Brenner, N (corresponding author), Technion, Fac Chem Engn, Haifa, Israel.; Brenner, N (corresponding author), Technion, Network Biol Res Lab, Lorry Lockey Interdisciplinary Ctr Life Sci & Eng, Haifa, Israel.	nbrenner@technion.ac.il		Marom, Shimon/0000-0002-9138-4833	Israel Science Foundation [487 886/12, 155/18]	Israel Science Foundation(Israel Science Foundation)	This work was supported in part by the Israel Science Foundation (grant no. 487 886/12, SM; no. 155/18, NB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan A, 2016, P NATL ACAD SCI USA, V113, pE3548, DOI 10.1073/pnas.1518786113; Akaishi R, 2014, NEURON, V81, P195, DOI 10.1016/j.neuron.2013.10.018; ANDERSON NH, 1971, J EXP PSYCHOL, V87, P57, DOI 10.1037/h0030151; Barack DL, 2016, CURR OPIN NEUROBIOL, V37, P121, DOI 10.1016/j.conb.2016.01.015; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; BLACKWELL HR, 1952, J OPT SOC AM, V42, P606, DOI 10.1364/JOSA.42.000606; Braun A, 2018, J NEUROSCI, V38, P2418, DOI 10.1523/JNEUROSCI.2189-17.2017; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Chopin A, 2012, PREDICTIVE PROPERTIE; CROSS DV, 1973, PERCEPT PSYCHOPHYS, V14, P547, DOI 10.3758/BF03211196; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Freiberg AD, 1937, AM J PSYCHOL, V49, P23, DOI 10.2307/1416049; Fritsche M, 2017, CURR BIOL, V27, P590, DOI 10.1016/j.cub.2017.01.006; Frund I, 2014, J VISION, V14, DOI 10.1167/14.7.9; Gepshtein S, 2005, EXP BRAIN RES, V160, P487, DOI 10.1007/s00221-004-2038-3; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; HOLLAND MK, 1968, PERCEPT PSYCHOPHYS, V3, P409, DOI 10.3758/BF03205747; HOWARTH CI, 1956, Q J EXP PSYCHOL, V8, P163, DOI 10.1080/17470215608416816; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Laughlin S., 1981, SIMPLE CODING PROCED; Liberman A, 2014, CURR BIOL, V24, P2569, DOI 10.1016/j.cub.2014.09.025; LOCKHEAD GR, 1970, J EXP PSYCHOL, V85, P1, DOI 10.1037/h0029508; LUCE RD, 1982, PERCEPT PSYCHOPHYS, V32, P397, DOI 10.3758/BF03202769; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; Marom S, 2011, FRONT COMPUT NEUROSC, V5, DOI [10.3389/fncom.2011.00016, 10.3389/fneng.2011.00003]; Maus GW, 2013, CURR BIOL, V23, pR438, DOI 10.1016/j.cub.2013.03.024; MCGILL WJ, 1957, J EXP PSYCHOL, V53, P297, DOI 10.1037/h0044268; Pape AA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13098; PARDUCCI A, 1965, J EXP PSYCHOL, V69, P450, DOI 10.1037/h0021719; PARDUCCI A, 1964, PSYCHOL BULL, V61, P163, DOI 10.1037/h0048411; POLLACK I, 1954, J ACOUST SOC AM, V26, P1056, DOI 10.1121/1.1907448; Raviv O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002731; Sanabria D, 2004, EXP BRAIN RES, V157, P537, DOI 10.1007/s00221-004-1993-z; Schwiedrzik CM, 2014, CEREB CORTEX, V24, P1152, DOI 10.1093/cercor/bhs396; Snyder JS, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00594; VERPLANCK WS, 1952, J EXP PSYCHOL, V44, P273, DOI 10.1037/h0054948; WARD LM, 1973, PERCEPT PSYCHOPHYS, V13, P193, DOI 10.3758/BF03214126; Wu JH, 2009, J NEUROSCI, V29, P12035, DOI 10.1523/JNEUROSCI.2346-09.2009	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224256	10.1371/journal.pone.0224256	http://dx.doi.org/10.1371/journal.pone.0224256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725731	Green Published, gold, Green Submitted			2022-12-26	WOS:000532764500015
J	Buglione, M; Petrelli, S; Maselli, V; Trapanese, M; Salvemini, M; Aceto, S; Di Cosmo, A; Fulgione, D				Buglione, Maria; Petrelli, Simona; Maselli, Valeria; Trapanese, Martina; Salvemini, Marco; Aceto, Serena; Di Cosmo, Anna; Fulgione, Domenico			Fixation of genetic variation and optimization of gene expression: The speed of evolution in isolated lizard populations undergoing Reverse Island Syndrome	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; BODY-SIZE; MITOCHONDRIAL GENOMES; PURIFYING SELECTION; EPIGENETICS; DIVERSIFICATION; POLYMORPHISM; ADAPTATION; COLORATION; DROSOPHILA	The ecological theory of island biogeography suggests that mainland populations should be more genetically divergent from those on large and distant islands rather than from those on small and close islets. Some island populations do not evolve in a linear way, but the process of divergence occurs more rapidly because they undergo a series of phenotypic changes, jointly known as the Island Syndrome. A special case is Reversed Island Syndrome (RIS), in which populations show drastic phenotypic changes both in body shape, skin colouration, age of sexual maturity, aggressiveness, and food intake rates. The populations showing the RIS were observed on islets nearby mainland and recently raised, and for this they are useful models to study the occurrence of rapid evolutionary change. We investigated the timing and mode of evolution of lizard populations adapted through selection on small islets. For our analyses, we used an ad hoc model system of three populations: wild-type lizards from the mainland and insular lizards from a big island (Capri, Italy), both Podarcis siculus siculus not affected by the syndrome, and a lizard population from islet (Scopolo) undergoing the RIS (called P. s. coerulea because of their melanism). The split time of the big (Capri) and small (Scopolo) islands was determined using geological events, like sea-level rises. To infer molecular evolution, we compared five complete mitochondrial genomes for each population to reconstruct the phylogeography and estimate the divergence time between island and mainland lizards. We found a lower mitochondrial mutation rate in Scopolo lizards despite the phenotypic changes achieved in approximately 8,000 years. Furthermore, transcriptome analyses showed significant differential gene expression between islet and mainland lizard populations, suggesting the key role of plasticity in these unpredictable environments.	[Buglione, Maria; Petrelli, Simona; Maselli, Valeria; Trapanese, Martina; Salvemini, Marco; Aceto, Serena; Di Cosmo, Anna; Fulgione, Domenico] Univ Naples Federico II Naples, Dept Biol, Naples, Italy	University of Naples Federico II	Fulgione, D (corresponding author), Univ Naples Federico II Naples, Dept Biol, Naples, Italy.	fulgione@unina.it	Salvemini, Marco/AAJ-5560-2021; Buglione, Maria/ABH-1103-2021	Maselli, Valeria/0000-0002-1452-8063; BUGLIONE, MARIA/0000-0001-6022-707X; Aceto, Serena/0000-0003-3906-4872; FULGIONE, DOMENICO/0000-0002-5121-3298; SALVEMINI, Marco/0000-0003-2297-9267				ADLER GH, 1994, Q REV BIOL, V69, P473, DOI 10.1086/418744; Ancel LW, 2000, THEOR POPUL BIOL, V58, P307, DOI 10.1006/tpbi.2000.1484; Andrade P, 2019, P NATL ACAD SCI USA, V116, P5633, DOI 10.1073/pnas.1820320116; Andreone F, 2003, AMPHIBIA-REPTILIA, V24, P459, DOI 10.1163/156853803322763927; [Anonymous], 1999, BIOL WILDLIFE MEDITE; Aubret F, 2015, HEREDITY, V115, P349, DOI 10.1038/hdy.2014.65; Bagnara JT, 2007, PIGM CELL RES, V20, P14, DOI 10.1111/j.1600-0749.2006.00360.x; Bardocz S, 1998, EUR COMMISS SCI RES, P1; Bernardo PH, 2019, EXTREME MITONUCLEAR; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Champagne FA, 2013, DEV PSYCHOBIOL, V55, P33, DOI 10.1002/dev.21036; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; Corti C., 2011, FAUNA DITALIA; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duncan EJ, 2014, J EXP ZOOL PART B, V322, P208, DOI 10.1002/jez.b.22571; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Eldredge N., 1972, P82; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Eo SH, 2010, P ROY SOC B-BIOL SCI, V277, P3587, DOI 10.1098/rspb.2010.0965; Fay JC, 2001, GENETICS, V158, P1227; Fulgione D, 2015, J ZOOL, V296, P278, DOI 10.1111/jzo.12242; Fulgione D, 2008, ZOOL SCI, V25, P465, DOI 10.2108/zsj.25.465; Fulgione D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37587-3; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Ghalambor CK, 2015, NATURE, V525, P372, DOI 10.1038/nature15256; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant P.R., 1999, RECOGNITION STATES L, V2; Guarino FM, 2003, J BIOSCIENCES, V28, P775, DOI 10.1007/BF02708438; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hofman CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118240; Hu J, 2017, J EVOLUTION BIOL, V30, P1612, DOI 10.1111/jeb.13130; JAENIKE JR, 1973, AM NAT, V107, P793, DOI 10.1086/282878; Jin YT, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4569-1; Johnson Kevin P., 2003, Comments on Theoretical Biology, V8, P339, DOI 10.1080/08948550302435; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lambeck K, 2004, QUATERNARY SCI REV, V23, P1567, DOI 10.1016/j.quascirev.2004.02.009; Lambeck K, 2011, QUATERN INT, V232, P250, DOI 10.1016/j.quaint.2010.04.026; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MCNAB BK, 1994, AM NAT, V144, P643, DOI 10.1086/285698; Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321; Millien V, 2011, EVOLUTION, V65, P1935, DOI 10.1111/j.1558-5646.2011.01268.x; Monti DM, 2013, BIOL J LINN SOC, V108, P144, DOI 10.1111/j.1095-8312.2012.02019.x; Morales HE, 2015, MOL ECOL, V24, P2820, DOI 10.1111/mec.13203; Musacchia F, 2015, BIOINFORMATICS, V31, P2199, DOI 10.1093/bioinformatics/btv106; Nei M., 1987, MOL EVOLUTIONARY GEN; Omland KE, 1997, EVOLUTION, V51, P1636, DOI 10.1111/j.1558-5646.1997.tb01486.x; Paenke I, 2007, AM NAT, V170, pE47, DOI 10.1086/518952; Pavlova A, 2017, HEREDITY, V118, P466, DOI 10.1038/hdy.2016.120; Pereira AGT, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0148947, 10.1371/journal.pone.0158165]; Perez-Mellado V., 1993, P85; Petrella V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2088-x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Raia P, 2012, AM NAT, V179, P328, DOI 10.1086/664081; Raia P, 2011, EVOLUTION, V65, P1927, DOI 10.1111/j.1558-5646.2011.01263.x; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Rambaut A., 2014, TRACER V14; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROFF DA, 1994, EVOL ECOL, V8, P639, DOI 10.1007/BF01237847; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sagonas K, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1301-8; Sagonas K, 2015, NORTH-WEST J ZOOL, V11, P117; Sagonas K, 2014, BIOL J LINN SOC, V112, P469, DOI 10.1111/bij.12290; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Scoville AG, 2011, NEW PHYTOL, V191, P251, DOI 10.1111/j.1469-8137.2011.03656.x; Thomas GH, 2009, EVOLUTION, V63, P2017, DOI 10.1111/j.1558-5646.2009.00694.x; Thorson JLM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14673-6; Trapanese M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185227; Waterhouse RM, 2017, MOL BIOL EVOL, DOI [10.1016/j.diagmicrobio.2015.11.008, DOI 10.1016/J.DIAGMICROBIO.2015.11.008]; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wright S, 1931, GENETICS, V16, P0097; Yu L, 2011, MITOCHONDRION, V11, P497, DOI 10.1016/j.mito.2011.01.004; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010	83	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224607	10.1371/journal.pone.0224607	http://dx.doi.org/10.1371/journal.pone.0224607			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31711071	Green Published, gold			2022-12-26	WOS:000532699900013
J	Ezzalfani, M				Ezzalfani, Monia			How to design a dose-finding study on combined agents: Choice of design and development of R functions	PLOS ONE			English	Article							CONTINUAL REASSESSMENT METHOD; I ONCOLOGY TRIALS; DRUG-COMBINATION; CLINICAL-TRIALS; COMPETING DESIGNS; SINGLE	Background In oncology, the aim of dose-finding phase I studies is to find the maximum tolerated dose for further studies. The use of combinations of two or more agents is increasing. Several dose-finding designs have been proposed for this situation. Numerous publications have however pointed out the complexity of evaluating therapies in combination due to difficulties in choosing between different designs for an actual trial, as well as complications related to their implementation and application in practice. Methods In this work, we propose R functions for Wang and Ivanova's approach. These functions compute the dose for the next patients enrolled and provide a simulation study in order to calibrate the design before it is applied and to assess the performance of the design in different scenarios of dose-toxicity relationships. This choice of the method was supported by a simulation study which the aim was to compare two designs in the context of an actual phase I trial: i) in 2005, Wang and Ivanova developed an empirical three-parameter model-based method in Bayesian inference, ii) in 2008, Yuan and Yin proposed a simple, adaptive two-dimensional dose-finding design. In particular, they converted the two-dimensional dose-finding trial to a series of one-dimensional dose-finding sub-trials by setting the dose of one drug at a fixed level. The performance assessment of Wang's design was then compared with those of designs presented in the paper by Hirakawa et al. (2015) in their simulation context. Results and conclusion It is recommended to assess the performances of the designs in the context of the clinical trial before beginning the trial. The two-dimensional dose-finding design proposed by Wang and Ivanova is a comprehensive approach that yields good performances. The two R functions that we propose can facilitate the use of this design in practice.	[Ezzalfani, Monia] PSL Res Univ, Inst Curie, Biometry Unit, Paris, France; [Ezzalfani, Monia] Inst Curie, Biometry Unit, 25 Rue Ulm, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Ezzalfani, M (corresponding author), PSL Res Univ, Inst Curie, Biometry Unit, Paris, France.; Ezzalfani, M (corresponding author), Inst Curie, Biometry Unit, 25 Rue Ulm, Paris, France.	monia.ezzalfani@curie.fr						Braun TM, 2010, BIOMETRICS, V66, P805, DOI 10.1111/j.1541-0420.2009.01363.x; Conaway MR, 2004, BIOMETRICS, V60, P661, DOI 10.1111/j.0006-341X.2004.00215.x; Hirakawa A, 2016, STAT MED, V35, P479, DOI 10.1002/sim.6751; Hirakawa A, 2015, STAT MED, V34, P3194, DOI 10.1002/sim.6533; Hirakawa A, 2013, STAT MED, V32, P4515, DOI 10.1002/sim.5843; Iasonos A, 2008, CLIN TRIALS, V5, P465, DOI 10.1177/1740774508096474; Ivanova A, 2004, STAT MED, V23, P1861, DOI 10.1002/sim.1796; Ivanova A, 2009, BIOMETRICS, V65, P307, DOI 10.1111/j.1541-0420.2008.01045.x; Mandrekar SJ, 2007, STAT MED, V26, P2317, DOI 10.1002/sim.2707; Mandrekar SJ, 2010, STAT MED, V29, P1077, DOI 10.1002/sim.3706; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Riviere MK, 2015, STAT MED, V34, P1, DOI 10.1002/sim.6094; Riviere MK, 2014, PHARM STAT, V13, P247, DOI 10.1002/pst.1621; Wages NA, 2011, CLIN TRIALS, V8, P380, DOI 10.1177/1740774511408748; Wages NA, 2011, BIOMETRICS, V67, P1555, DOI 10.1111/j.1541-0420.2011.01560.x; Wang K, 2005, BIOMETRICS, V61, P217, DOI 10.1111/j.0006-341X.2005.030540.x; Yin GS, 2015, STAT MED, V34, P13, DOI 10.1002/sim.6338; Yin GS, 2009, J ROY STAT SOC C-APP, V58, P211, DOI 10.1111/j.1467-9876.2009.00649.x; Yuan Y, 2008, STAT MED, V27, P5664, DOI 10.1002/sim.3372	19	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224940	10.1371/journal.pone.0224940	http://dx.doi.org/10.1371/journal.pone.0224940			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710632	gold, Green Published			2022-12-26	WOS:000532699900031
J	Turk, SP; Lumbard, K; Liepshutz, K; Williams, C; Hu, L; Dardick, K; Wormser, GP; Norville, J; Scavarda, C; McKenna, D; Follmann, D; Marques, A				Turk, Siu P.; Lumbard, Keith; Liepshutz, Kelly; Williams, Carla; Hu, Linden; Dardick, Kenneth; Wormser, Gary P.; Norville, Joshua; Scavarda, Carol; McKenna, Donna; Follmann, Dean; Marques, Adriana			Post-treatment Lyme disease symptoms score: Developing a new tool for research	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM OUTCOMES; ANTIBIOTIC-TREATMENT; ERYTHEMA MIGRANS; FOLLOW-UP; FATIGUE; THERAPY; CHILDREN; DURATION; HISTORY	Some patients have residual non-specific symptoms after therapy for Lyme disease, referred to as post-treatment Lyme disease symptoms or syndrome, depending on whether there is functional impairment. A standardized test battery was used to characterize a diverse group of Lyme disease patients with and without residual symptoms. There was a strong correlation between sleep disturbance and certain other symptoms such as fatigue, pain, anxiety, and cognitive complaints. Results were subjected to a Logistic Regression model using the Neuro-QoL Fatigue t-score together with Short Form-36 Physical Functioning scale and Mental Health component scores; and to a Decision Tree model using only the QoL Fatigue t-score. The Logistic Regression model had an accuracy of 97% and Decision Tree model had an accuracy of 93%, when compared with clinical categorization. The Logistic Regression and Decision Tree models were then applied to a separate cohort. Both models performed with high sensitivity (90%), but moderate specificity (62%). The overall accuracy was 74%. Agreement between 2 time points, separated by a mean of 4 months, was 89% using the Decision Tree model and 87% with the Logistic Regression model. These models are simple and can help to quantitate the level of symptom severity in post-treatment Lyme disease symptoms. More research is needed to increase the specificity of the models, exploring additional approaches that could potentially strengthen an operational definition for post-treatment Lyme disease symptoms. Evaluation of how sleep disturbance, fatigue, pain and cognitive complains interrelate can potentially lead to new interventions that will improve the overall health of these patients.	[Turk, Siu P.; Marques, Adriana] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lumbard, Keith] Frederick Natl Lab Canc Res, Clin Monitoring Res Program Directorate, Frederick, MD USA; [Liepshutz, Kelly; Williams, Carla] Leidos Biomed Res Inc, Clin Serv Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Hu, Linden; Norville, Joshua] Tufts Univ Sch Med, Boston, MA USA; [Dardick, Kenneth] Mansfield Family Practice, Storrs, CT USA; [Wormser, Gary P.; Scavarda, Carol; McKenna, Donna] New York Med Coll, Infect Dis, Valhalla, NY 10595 USA; [Follmann, Dean] NIAID, Biostat Res Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University; New York Medical College; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Marques, A (corresponding author), NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	amarques@niaid.nih.gov	Marques, Adriana/AAU-2099-2021	Marques, Adriana/0000-0002-5403-4551	Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health; National Institute of Allergy and Infectious Diseases [U01AI109656]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI109656] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health (AM, SPT, DF). This research was also supported by the National Institute of Allergy and Infectious Diseases (award U01AI109656 (LH, KD, GPW, JN, CS, DMK). Authors KL, KL and CW are employees of Leidos Biomedical Research, Inc. a subsidiary of Leidos dedicated to a single contract to the Frederick National Laboratory for Cancer Research, which is sponsored by the National Cancer Institute, National Institutes of Health. Therefore, this project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. Leidos Biomedical Research, Inc., provided support in the form of salaries for the authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication does not necessarily reflect the views of or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Arnez M, 2015, PEDIATR INFECT DIS J, V34, P1045, DOI 10.1097/INF.0000000000000804; Aucott JN, 2013, INT J INFECT DIS, V17, pE443, DOI 10.1016/j.ijid.2013.01.008; Aucott JN, 2013, QUAL LIFE RES, V22, P75, DOI 10.1007/s11136-012-0126-6; Batheja S, 2013, J NEUROPSYCH CLIN N, V25, P176, DOI 10.1176/appi.neuropsych.12090223; Bechtold KT, 2017, ARCH CLIN NEUROPSYCH, V32, P129, DOI 10.1093/arclin/acw098; Berende A, 2016, NEW ENGL J MED, V374, P1209, DOI 10.1056/NEJMoa1505425; Borsic K, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120506; CDC, 2017, LYM DIS BORR BURG 20; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011; Chandra A, 2010, BRAIN BEHAV IMMUN, V24, P1018, DOI 10.1016/j.bbi.2010.03.002; Corporation R, 2008, 36 IT SHORT FORM SUR; Djukic M, 2011, EUR J NEUROL, V18, P547, DOI 10.1111/j.1468-1331.2010.03229.x; Eikeland R, 2013, ACTA NEUROL SCAND, V127, P154, DOI 10.1111/j.1600-0404.2012.01690.x; Eikeland R, 2011, ACTA NEUROL SCAND, V124, P349, DOI 10.1111/j.1600-0404.2010.01482.x; Eliassen KE, 2017, SCAND J PRIM HEALTH, V35, P75, DOI 10.1080/02813432.2017.1288812; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Geebelen L, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0202-z; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Jares TM, 2014, TICKS TICK-BORNE DIS, V5, P58, DOI 10.1016/j.ttbdis.2013.09.002; JE Ware Jr, 2005, SCORE VERSION 2 SF 3; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Koffel E, 2016, HEALTH PSYCHOL, V35, P41, DOI 10.1037/hea0000245; Kowalski TJ, 2011, INFECTION, V39, P239, DOI 10.1007/s15010-011-0107-7; Kowalski TJ, 2010, CLIN INFECT DIS, V50, P512, DOI 10.1086/649920; Krause AJ, 2019, J NEUROSCI, V39, P2291, DOI 10.1523/JNEUROSCI.2408-18.2018; Krause AJ, 2017, NAT REV NEUROSCI, V18, P404, DOI 10.1038/nrn.2017.55; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Marques A, 2014, CLIN INFECT DIS, V58, P937, DOI 10.1093/cid/cit939; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nijrolder I, 2015, EUR J GEN PRACT, V21, P164, DOI 10.3109/13814788.2015.1055556; Nizic T, 2012, WIEN KLIN WOCHENSCHR, V124, P427, DOI 10.1007/s00508-012-0194-1; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Petrie KJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005374; Rebman AW, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00224; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; Scoggins JF, 2009, CONTEMP CLIN TRIALS, V30, P289, DOI 10.1016/j.cct.2009.02.005; Seltzer EG, 2000, JAMA-J AM MED ASSOC, V283, P609, DOI 10.1001/jama.283.5.609; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402; Tory HO, 2010, J RHEUMATOL, V37, P1049, DOI 10.3899/jrheum.090711; Touradji P, 2019, ARCH CLIN NEUROPSYCH, V34, P455, DOI 10.1093/arclin/acy051; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Weinstein ER, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy035; Wills AB, 2016, CLIN INFECT DIS, V62, P1546, DOI 10.1093/cid/ciw189; Wolfe F, 2016, SEMIN ARTHRITIS RHEU, V46, P319, DOI 10.1016/j.semarthrit.2016.08.012; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2016, DIAGN MICR INFEC DIS, V86, P322, DOI 10.1016/j.diagmicrobio.2016.07.026; Wormser GP, 2015, CLIN INFECT DIS, V61, P244, DOI 10.1093/cid/civ277; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005	55	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0225012	10.1371/journal.pone.0225012	http://dx.doi.org/10.1371/journal.pone.0225012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710647	gold, Green Published			2022-12-26	WOS:000532699900035
J	Bolten, M; Bernardini, JP; Mayor, T				Bolten, Marcel; Bernardini, Jonathan P.; Mayor, Thibault			Unfolding or aggregation, that is the question	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEASOME; RPN13	Cellular processes accompanying protein aggregation are diverse and entangled, making it difficult to investigate the underlying molecular processes in a time-resolved way. Gottlieb, Thompson, and colleagues address this shortcoming using a chemical biology approach to monitor ubiquitination within the first 10 min after the initiation of protein aggregation. Intriguingly, unfolding rather than aggregation seems to trigger the observed events. This work might provide a method to answer open questions regarding the regulation of the proteostasis network upon protein misfolding.	[Bolten, Marcel; Bernardini, Jonathan P.; Mayor, Thibault] Univ British Columbia, Michael Smith Labs, Dept Biochem & Mol Biol, 2125 East Mall, Vancouver, BC V5T 1Z4, Canada	University of British Columbia	Mayor, T (corresponding author), Univ British Columbia, Michael Smith Labs, Dept Biochem & Mol Biol, 2125 East Mall, Vancouver, BC V5T 1Z4, Canada.	mayor@mail.ubc.ca		Bernardini, Jonathan/0000-0002-5767-7624	Canadian Institute of Health Research (CIHR) [PJT-148489, PJT-159804]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research (CIHR) Grants PJT-148489 and PJT-159804. The authors declare that they have no conflicts of interest with the contents of this article.	Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chu BW, 2013, J BIOL CHEM, V288, P34575, DOI 10.1074/jbc.M113.499350; Galves M, 2019, TRENDS BIOCHEM SCI, V44, P872, DOI 10.1016/j.tibs.2019.04.007; Gottlieb CD, 2019, J BIOL CHEM, V294, P16511, DOI 10.1074/jbc.RA119.009654; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kuo CL, 2017, P NATL ACAD SCI USA, V114, pE3404, DOI 10.1073/pnas.1701734114; Miyazaki Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11689	7	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16525	16526		10.1074/jbc.H119.011242	http://dx.doi.org/10.1074/jbc.H119.011242			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31704773	Green Published, hybrid			2022-12-26	WOS:000501801900005
J	Huang, YQ; Lu, WW; Ji, JF; Zhang, XL; Zhang, PF; Chen, W				Huang, Yanqun; Lu, Weiwei; Ji, Jiefei; Zhang, Xiangli; Zhang, Pengfei; Chen, Wen			Heteroplasmy in the complete chicken mitochondrial genome	PLOS ONE			English	Article							SEQUENCE HETEROPLASMY; DNA; MUTATIONS	Chicken mitochondrial DNA is a circular molecule comprising similar to 16.8 kb. In this study, we used next-generation sequencing to investigate mitochondrial heteroplasmy in the whole chicken mitochondrial genome. Based on heteroplasmic detection thresholds at the 0.5% level, 178 cases of heteroplasmy were identified in the chicken mitochondrial genome, where 83% were due to nucleotide transitions. D-loop regionwas hot spot region for mtDNA heteroplasmy in the chicken since 130 cases of heteroplasmy were located in these regions. Heteroplasmy varied among intraindividual tissues with allele-specific, position-specific, and tissue-specific features. Skeletal muscle had the highest abundance of heteroplasmy. Cases of heteroplasmy at mt.G8682A and mt.G16121A were validated by PCR-restriction fragment length polymorphism analysis, which showed that both had low ratios of heteroplasmy occurrence in five natural breeds. Polymorphic sites were easy to distinguish. Based on NGS data for crureus tissues, mitochondrial mutation/heteroplasmy exhibited clear maternal inheritance features at the whole mitochondrial genomic level. Further investigations of the heterogeneity of the mt.A5694T and mt.T5718G transitions between generations using pyrosequencing based on pedigree information indicated that the degree of heteroplasmy and the occurrence ratio of heteroplasmy decreased greatly from the F0 to F1 generations in the mt.A5694T and mt.T5718G site. Thus, the intergenerational transmission of heteroplasmy in chicken mtDNA exhibited a rapid shift toward homoplasmy within a single generation. Our findings indicate that heteroplasmy is a widespread phenomenon in chicken mitochondrial genome, in which most sites exhibit low heteroplasmy and the allele frequency at heteroplasmic sites changes significantly during transmission events. It suggests that heteroplasmy may be under negative selection to some degree in the chicken.	[Huang, Yanqun; Lu, Weiwei; Ji, Jiefei; Zhang, Xiangli; Zhang, Pengfei; Chen, Wen] Henan Agr Univ, Coll Livestock Husb & Vet Engn, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Chen, W (corresponding author), Henan Agr Univ, Coll Livestock Husb & Vet Engn, Zhengzhou, Henan, Peoples R China.	cchenwen@aliyun.com			National Natural Science Foundation of China [31272434]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (31272434). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Cagnone G, 2016, GENETICS, V202, P931, DOI 10.1534/genetics.115.181321; Cui H, 2013, GENET MED, V15, P388, DOI 10.1038/gim.2012.144; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Giuliani C, 2014, AGING-US, V6, P454, DOI 10.18632/aging.100661; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; Guo Y, 2013, J GENET GENOMICS, V40, P607, DOI 10.1016/j.jgg.2013.10.003; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Holland MM, 2011, CROAT MED J, V52, P299, DOI 10.3325/cmj.2011.52.299; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Lu WW, 2016, MITOCHONDRIAL DNA A, V27, P2303, DOI 10.3109/19401736.2014.971022; Luo SY, 2018, P NATL ACAD SCI USA, V115, P13039, DOI 10.1073/pnas.1810946115; Moslemi AR, 1998, NEUROMUSCULAR DISORD, V8, P345, DOI 10.1016/S0960-8966(98)00029-7; Naue J, 2015, MITOCHONDRION, V20, P82, DOI 10.1016/j.mito.2014.12.002; Pereira SL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-17; Ramos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074636; Rebolledo-Jaramillo B, 2014, P NATL ACAD SCI USA, V111, P15474, DOI 10.1073/pnas.1409328111; Rensch T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0996-y; Rohlin A, 2009, HUM MUTAT, V30, P1012, DOI 10.1002/humu.20980; Santibanez-Koref M, 2019, MITOCHONDRION, V46, P302, DOI 10.1016/j.mito.2018.08.003; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Spicer AM, 2014, FORENSIC SCI INT-GEN, V11, P7, DOI 10.1016/j.fsigen.2014.02.006; Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966; Tang S, 2010, BIOTECHNIQUES, V48, P287, DOI 10.2144/000113389; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; Wu JM, 2000, BIOCHEM GENET, V38, P323, DOI 10.1023/A:1002061101697; Ye F, 2014, MITOCHONDRION, V17, P157, DOI 10.1016/j.mito.2014.05.004; Yin T, 2019, BIOL CHEM, V400, P613, DOI 10.1515/hsz-2018-0273; Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438	32	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224677	10.1371/journal.pone.0224677	http://dx.doi.org/10.1371/journal.pone.0224677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JZ4GJ	31703075	Green Published, gold			2022-12-26	WOS:000505059600001
J	Booth, WT; Davis, RR; Deora, R; Hollis, T				Booth, William T.; Davis, Ryan R.; Deora, Rajendar; Hollis, Thomas			Structural mechanism for regulation of DNA binding of BpsR, a Bordetella regulator of biofilm formation, by 6-hydroxynicotinic acid	PLOS ONE			English	Article							FAMILY TRANSCRIPTION FACTORS; CRYSTAL-STRUCTURE; MARR FAMILY; PSEUDOMONAS-AERUGINOSA; MEXR REPRESSOR; PERTUSSIS; POLYSACCHARIDE; COLONIZATION; VIRULENCE; PROTEIN	Bordetella bacteria are respiratory pathogens of humans, birds, and livestock. Bordetella pertussis the causative agent of whopping cough remains a significant health issue. The transcriptional regulator, BpsR, represses a number of Bordetella genes relating to virulence, cell adhesion, cell motility, and nicotinic acid metabolism. DNA binding of BpsR is allosterically regulated by interaction with 6-hydroxynicotinic acid (6HNA), the first product in the nicotinic acid degradation pathway. To understand the mechanism of this regulation, we have determined the crystal structures of BpsR and BpsR in complex with 6HNA. The structures reveal that BpsR binding of 6HNA induces a conformational change in the protein to prevent DNA binding. We have also identified homologs of BpsR in other Gram negative bacteria in which the amino acids involved in recognition of 6HNA are conserved, suggesting a similar mechanism for regulating nicotinic acid degradation.	[Booth, William T.; Davis, Ryan R.; Hollis, Thomas] Wake Forest Sch Med, Ctr Struct Biol, Dept Biochem, Winston Salem, NC 27101 USA; [Deora, Rajendar] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Deora, Rajendar] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA	Wake Forest University; Ohio State University; Ohio State University	Hollis, T (corresponding author), Wake Forest Sch Med, Ctr Struct Biol, Dept Biochem, Winston Salem, NC 27101 USA.	thollis@wakehealth.edu		Davis, Ryan/0000-0002-9695-4356; Hollis, Thomas/0000-0002-4996-6346; Booth, William/0000-0001-8876-7262	National Institutes of Health, Department of Health and Human Services [1R21AI123805-0, R01AI125560, K12GM102773, 5T32GM095440-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125560, R21AI123805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM102773, T32GM095440] Funding Source: NIH RePORTER	National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was supported through federal funds from the National Institutes of Health, Department of Health and Human Services by grants 1R21AI123805-0, R01AI125560 to RD, as well as K12GM102773 to WB and 5T32GM095440-10 to RRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brickman TJ, 2018, MOL MICROBIOL, V108, P397, DOI 10.1111/mmi.13943; Cattelan N, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00373-17; Cattelan N, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv108; Conover MS, 2012, J BACTERIOL, V194, P233, DOI 10.1128/JB.06020-11; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Deochand DK, 2017, CRIT REV BIOCHEM MOL, V52, P595, DOI 10.1080/10409238.2017.1344612; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Dorji D, 2018, MED MICROBIOL IMMUN, V207, P3, DOI 10.1007/s00430-017-0524-z; DUGAL F, 1990, APPL ENVIRON MICROB, V56, P1523, DOI 10.1128/AEM.56.6.1523-1529.1990; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ganguly T, 2014, CELL MICROBIOL, V16, P1105, DOI 10.1111/cmi.12264; Gao YR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01705-4; Gong Z, 2019, J CELL PHYSIOL, V234, P19237, DOI 10.1002/jcp.28720; Guragain M, 2018, J BACTERIOL, V200, DOI [10.1128/JB.00712-17, 10.1128/jb.00712-17]; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Jimenez JI, 2011, ENVIRON MICROBIOL, V13, P1718, DOI 10.1111/j.1462-2920.2011.02471.x; Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nicholson TL, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00261-17; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; Pryor EE, 2012, ACTA CRYSTALLOGR F, V68, P985, DOI 10.1107/S1744309112025316; Saito K, 2003, J BACTERIOL, V185, P6195, DOI 10.1128/JB.185.20.6195-6198.2003; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Soane MC, 2000, RESP MED, V94, P791, DOI 10.1053/rmed.2000.0823; Stevenson CEM, 2013, NUCLEIC ACIDS RES, V41, P7009, DOI 10.1093/nar/gkt523; Sukumar N, 2014, INFECT IMMUN, V82, P1627, DOI 10.1128/IAI.01453-13; Sukumar N, 2009, INFECT IMMUN, V77, P885, DOI 10.1128/IAI.01076-08; Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105; Wilkinson SP, LIGAND RESPONSIVE TR; Zhu RF, 2017, J BIOL INORG CHEM, V22, P685, DOI 10.1007/s00775-017-1442-7	44	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0223387	10.1371/journal.pone.0223387	http://dx.doi.org/10.1371/journal.pone.0223387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697703	Green Published, gold			2022-12-26	WOS:000532694400014
J	Turner, JS; Kellogg, ML; Massey, GM; Friedrichs, CT				Turner, Jessica S.; Kellogg, M. Lisa; Massey, Grace M.; Friedrichs, Carl T.			Minimal effects of oyster aquaculture on local water quality: Examples from southern Chesapeake Bay	PLOS ONE			English	Article							SHELLFISH AQUACULTURE; BENGUELA SYSTEM; FILTRATION-RATE; MUSSEL CULTURE; SALDANHA BAY; RESTORATION; IMPACT; NITROGEN; EUTROPHICATION; BIODEPOSITION	As the oyster aquaculture industry grows and becomes incorporated into management practices, it is important to understand its effects on local environments. This study investigated how water quality and hydrodynamics varied among farms as well as inside versus outside the extent of caged grow-out areas located in southern Chesapeake Bay. Current speed and water quality variables (chlorophyll-a fluorescence, turbidity, and dissolved oxygen) were measured along multiple transects within and adjacent to four oyster farms during two seasons. At the scale of individual aquaculture sites, we were able to detect statistically significant differences in current speed and water quality variables between the areas inside and outside the farms. However, the magnitudes of the water quality differences were minor. Differences between sites and between seasons for water quality variables were typically an order of magnitude greater than those observed within each site (i.e. inside and outside the farm footprint). The relatively small effect of the presence of oysters on water quality is likely attributable to a combination of high background variability, relatively high flushing rates, relatively low oyster density, and small farm footprints. Minimal impacts overall suggest that low-density oyster farms located in adequately-flushed areas are unlikely to negatively impact local water quality.	[Turner, Jessica S.; Kellogg, M. Lisa; Massey, Grace M.; Friedrichs, Carl T.] William & Mary, Virginia Inst Marine Sci, Williamsburg, VA 23185 USA	William & Mary; Virginia Institute of Marine Science	Turner, JS (corresponding author), William & Mary, Virginia Inst Marine Sci, Williamsburg, VA 23185 USA.	jsturner@vims.edu	Turner, Jessica/GRR-3991-2022	Friedrichs, Carl/0000-0002-1810-900X	Nature Conservancy [ADL110416-01]; Virginia Institute of Marine Science	Nature Conservancy; Virginia Institute of Marine Science	This work was supported by The Nature Conservancy award number ADL110416-01 to GMM, MLK, and JST. Further support for all authors was provided by the Virginia Institute of Marine Science. The funders had no role in the data collection, data analysis, decision to publish, or preparation of the manuscript.	BAUDINET D, 1990, HYDROBIOLOGIA, V207, P187, DOI 10.1007/BF00041456; BAYNE B, 1983, MOLLUSCA 1, V4; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; BOUCHER G, 1988, MAR ECOL PROG SER, V44, P229, DOI 10.3354/meps044229; Boyd AJ, 1998, J SHELLFISH RES, V17, P25; Burkholder JM, 2011, SHELLFISH AQUACULTURE AND THE ENVIRONMENT, P155; CASTEL J, 1989, ESTUAR COAST SHELF S, V28, P71, DOI 10.1016/0272-7714(89)90042-5; CBP, 2019, CHES BAY PROGR; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; Clausen I, 1996, MAR ECOL PROG SER, V141, P37, DOI 10.3354/meps141037; Coen LD, 2000, HARD CLAM MERCENARIA, P38; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Comeau LA, 2013, AQUACULTURE, V410, P57, DOI 10.1016/j.aquaculture.2013.06.017; Cranford PJ, 2009, AQUACULTURE, V292, P189, DOI 10.1016/j.aquaculture.2009.04.039; Crawford C, 2003, AQUACULTURE, V226, P129, DOI 10.1016/S0044-8486(03)00473-3; Crawford CM, 2003, AQUACULTURE, V224, P117, DOI 10.1016/S0044-8486(03)00210-2; DAME RF, 1992, J EXP MAR BIOL ECOL, V164, P147, DOI 10.1016/0022-0981(92)90171-6; Duarte P, 2008, AQUACULTURE, V274, P300, DOI 10.1016/j.aquaculture.2007.11.025; Ehrich MK, 2015, ECOL MODEL, V297, P201, DOI 10.1016/j.ecolmodel.2014.11.023; Fabi G, 2009, AQUACULTURE, V289, P54, DOI 10.1016/j.aquaculture.2008.12.026; Fan X, 2009, CONT SHELF RES, V29, P2345, DOI 10.1016/j.csr.2009.10.007; Ferreira JG, 2007, AQUACULTURE, V264, P160, DOI 10.1016/j.aquaculture.2006.12.017; Forrest BM, 2009, AQUACULTURE, V298, P1, DOI 10.1016/j.aquaculture.2009.09.032; Gentry RR, 2017, NAT ECOL EVOL, V1, P1317, DOI 10.1038/s41559-017-0257-9; GIBBS MM, 1991, NEW ZEAL J MAR FRESH, V25, P239, DOI 10.1080/00288330.1991.9516476; GRANT J, 1995, ESTUARIES, V18, P124, DOI 10.2307/1352288; Grant J, 2001, CAN J FISH AQUAT SCI, V58, P1003, DOI 10.1139/cjfas-58-5-1003; Grant J, 1998, J SHELLFISH RES, V17, P41; Grant J, 2011, SHELLFISH AQUACULTURE AND THE ENVIRONMENT, P135; HAVEN DS, 1970, BIOL BULL, V139, P248, DOI 10.2307/1540081; HAVEN DS, 1966, LIMNOL OCEANOGR, V11, P487, DOI 10.4319/lo.1966.11.4.0487; Hayakawa Y, 2001, ICES J MAR SCI, V58, P435, DOI 10.1006/jmsc.2000.1036; Hernandez AB, 2018, FRONT ECOL ENVIRON, V16, P463, DOI 10.1002/fee.1935; Hilborn R, 2018, FRONT ECOL ENVIRON, V16, P329, DOI 10.1002/fee.1822; Holyoke RR, 2008, THESIS; Hudson K., 2018, 20189 VIMS; ITO SUSUMU, 1955, TOHOKU JOUR AGRIC RES, V5, P251; Kaiser MJ, 2001, SHEFF BIOL SCI, P51; Kellogg ML, 2018, ENV ECOLOGICAL BENEF, DOI [10.25773/hdb1-xf91, DOI 10.25773/HDB1-XF91]; Kellogg ML, 2018, ENV ECOLOGICAL BEN S, DOI [10.25773/r01b-tg44, DOI 10.25773/R01B-TG44]; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kusuki Y., 1981, B HIROSHIMA FISH EXP, V11, P1; Mallet AL, 2006, AQUACULTURE, V255, P362, DOI 10.1016/j.aquaculture.2005.11.054; Mann R, 2007, J SHELLFISH RES, V26, P905, DOI 10.2983/0730-8000(2007)26[905:WORGIT]2.0.CO;2; NEWELL RIE, 1983, MAR ECOL PROG SER, V13, P47, DOI 10.3354/meps013047; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Newell Roger I.E., 1996, P185; Nielsen P, 2016, AQUACULT ENV INTERAC, V8, P311, DOI 10.3354/aei00175; NMFS, 2018, US DEP COMM NOAA CUR; North EW, 2010, ECOL APPL, V20, P851, DOI 10.1890/08-1733.1; PALMER RE, 1980, OPHELIA, V19, P163, DOI 10.1080/00785326.1980.10425514; Pietros JM, 2003, AQUACULTURE, V220, P407, DOI 10.1016/S0044-8486(02)00574-4; Pilditch CA, 2001, CAN J FISH AQUAT SCI, V58, P241, DOI 10.1139/cjfas-58-2-241; Plew DR, 2011, AQUACULT ENV INTERAC, V1, P201, DOI 10.3354/aei00020; Porter ET, 2018, MAR ECOL PROG SER, V586, P21, DOI 10.3354/meps12417; Ray NE, 2015, AQUACULT ENG, V68, P35, DOI 10.1016/j.aquaeng.2015.08.001; RIBELIN BW, 1977, J MORPHOL, V151, P439, DOI 10.1002/jmor.1051510308; RIISGARD HU, 1988, MAR ECOL PROG SER, V45, P217, DOI 10.3354/meps045217; Smedinghoff J., 2017, CHESAPEAKE BAY PROGR; TENORE KR, 1982, J MAR RES, V40, P701; Testa JM, 2015, AQUACULT ENV INTERAC, V7, P205, DOI 10.3354/aei00151; Thorn AJ, 1997, ALTERATIONS STRUCTUR; Turner JS, 2019, W M SCHOLARWORKS, DOI [10.25773/wwva-tz18, DOI 10.25773/WWVA-TZ18]; Virnstein R.W., 1978, P261; Ward JE, 2004, J EXP MAR BIOL ECOL, V300, P83, DOI 10.1016/j.jembe.2004.03.002; Wilberg MJ, 2011, MAR ECOL PROG SER, V436, P131, DOI 10.3354/meps09161; Zieba A, 2011, METROL MEAS SYST, V18, P529, DOI 10.2478/v10178-011-0052-x	67	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224768	10.1371/journal.pone.0224768	http://dx.doi.org/10.1371/journal.pone.0224768			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697739	gold, Green Published			2022-12-26	WOS:000532694400059
J	Norman, A; Nyberg, G; Berlin, A				Norman, Asa; Nyberg, Gisela; Berlin, Anita			School-based obesity prevention for busy low-income families-Organisational and personal barriers and facilitators to implementation	PLOS ONE			English	Article							CHILDRENS DIETARY; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; OVERWEIGHT; INDICATORS	Background Little research has targeted multiple-level barriers and facilitators in school-based parental support programmes. This qualitative study aims to describe barriers and facilitators, at organisational and personal levels, that teachers and parents in disadvantaged settings in Sweden perceived as influencing the implementation of the Healthy School Start II (HSS II) intervention. Methods Data collection, analysis and interpretation were guided by the Consolidated Framework for Implementation Research (CFIR). Focus groups and interviews were conducted with 14 parents and ten teachers within the HSS II trial. Data were analysed using qualitative content analysis in a deductive step using the three CFIR domains-inner and outer setting, and personal characteristics-followed by an inductive analysis. Results The theme 'being on the same page-getting burdened teachers and parents to work on common ground' was found. Among teachers, barriers and facilitators were related to the structure of the schoolwork and curriculum, involvement from other staff and school management, the practical school workday, perception of high family needs but low parental interest, insufficient resources in the families, and teacher's personal knowledge, interests, and opinions about health and food. For parents, barriers and facilitators were related to the perceived family needs and resources, parents' health knowledge, consensus about healthy behaviours and ability to cooperate, and school involvement in health issues and the intervention. Conclusion Interventions should facilitate parents' and teachers' work on common ground, with activities suitable for a stressful and burdensome workday and everyday life. This could be achieved by integrating evidence-based practices within school routines, and including activities that are practicable despite parents' stressful lives, and that increase parental consensus about promoting health. Strategies to increase involvement of parents in families with high needs are necessary. Also, this study suggests an expansion of the CFIR to capture the interface between different micro-level organisations, and account for several delivering/receiving organisations.	[Norman, Asa; Nyberg, Gisela] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Nyberg, Gisela] Swedish Sch Sport & Hlth Sci, Stockholm, Sweden; [Berlin, Anita] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden	Karolinska Institutet; Swedish School of Sport & Health Sciences; Karolinska Institutet	Norman, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	asa.norman@ki.se	Norman, Åsa/AAX-3246-2020	Norman, Åsa/0000-0002-0313-3066	Martin Rind Foundation; Sven Jerring Foundation	Martin Rind Foundation; Sven Jerring Foundation	GN received funding from Martin Rind Foundation, http://www.martinrind.nu/.GN & AN received funding from Sven Jerring Foundation, https://jerringfonden.se/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; [Anonymous], 2013, ANN REP CHILD HLTH C; Bandura A., 1986, SOCIAL FOUNDATIONS O; Bergstrom H, MANAGING IMPLEMENTAT; Bergstrom H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1896-x; Birken SA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-015-0362-6; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX; Cason-Wilkerson R, 2015, CHILD OBES, V11, P170, DOI 10.1089/chi.2014.0147; Christian D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1557-0; Cui ZH, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1089-z; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dietz WH, 2015, PEDIATRICS, V135, pE559, DOI 10.1542/peds.2014-2972; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Howard-Drake EJ, 2016, J PUBLIC HEALTH-UK, V38, P44, DOI 10.1093/pubmed/fdv021; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kader M, 2015, PREV MED, V77, P52, DOI 10.1016/j.ypmed.2015.05.005; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Krippendorff K., 2013, CONTENT ANAL INTRO I; Krueger RA, 1994, FOCUS GROUPS PRACTIC, V2nd; Langford R, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0167-7; Li XJ, 2014, OBESITY FACTS, V7, P253, DOI 10.1159/000365955; Lincoln Y.S., 1985, NATURALISTIC INQUIRY, DOI DOI 10.1016/0147-1767(85)90062-8; Lumeng JC, 2015, JAMA PEDIATR, V169, P484, DOI 10.1001/jamapediatrics.2014.3554; May C, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4040029; Miller J, 2013, STRUCTURES OF LAW AND LITERATURE: DUTY, JUSTICE, AND EVIL IN THE CULTURAL IMAGINATION, P3; Miller W.R., 2013, MOTIVATIONAL INTERVI, V3rd; Ministry of Employment Sweden, 2012, A20124115IU DNR MIN; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Norman A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2701-1; Norman A, 2015, APPETITE, V87, P137, DOI 10.1016/j.appet.2014.12.208; Nyberg G, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0327-4; Nyberg G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116876; Nyberg G, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-185; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Perry RA, 2017, J NUTR EDUC BEHAV, V49, P43, DOI 10.1016/j.jneb.2016.08.018; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; van den Berg V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101160; von Haartman F SE, 2009, FORALDRASTOD HALSOSA; Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195; Weihrauch-Bluher S, 2018, OBESITY FACTS, V11, P263, DOI 10.1159/000486512; Yung TKC, 2010, MATERN CHILD NUTR, V6, P190, DOI 10.1111/j.1740-8709.2009.00198.x	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224512	10.1371/journal.pone.0224512	http://dx.doi.org/10.1371/journal.pone.0224512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1BP	31689329	gold, Green Published			2022-12-26	WOS:000532680100028
J	Senok, A; Slickers, P; Hotzel, H; Boswihi, S; Braun, SD; Gawlik, D; Muller, E; Nabi, A; Nasser, R; Nitschke, H; Reissig, A; Ruppelt-Lorz, A; Mafofo, J; Somily, AM; Udo, E; Ehricht, R; Monecke, S				Senok, Abiola; Slickers, Peter; Hotzel, Helmut; Boswihi, Samar; Braun, Sascha D.; Gawlik, Darius; Mueller, Elke; Nabi, Anju; Nasser, Rania; Nitschke, Hedda; Reissig, Annett; Ruppelt-Lorz, Antje; Mafofo, Joseph; Somily, Ali M.; Udo, Edet; Ehricht, Ralf; Monecke, Stefan			Characterisation of a novel SCCmec VI element harbouring fusC in an emerging Staphylococcus aureus strain from the Arabian Gulf region	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; PANTON-VALENTINE LEUKOCIDIN; FUSIDIC ACID; MOLECULAR CHARACTERIZATION; CLONAL COMPLEXES; RESISTANCE; EPIDEMIOLOGY; EMERGENCE; GENOME	Fusidic acid is a steroid antibiotic known since the 1960s. It is frequently used in topical preparations, i.e., ointments, for the treatment of skin and soft tissue infections caused by Staphylococcus aureus. There is an increasing number of methicillin-resistant S. aureus (MRSA) strains that harbour plasmid-borne fusB/far1 or fusC that is localised on SCC elements. In this study we examined a series of related CC30-MRSA isolates from the Arabian Gulf countries that presented with SCCmec elements and fusC, including a variant that-to the best of our knowledge-has not yet formally been described. It consisted of a class B mec complex and ccrA/B-4 genes. The fusidic acid resistance gene fusC was present, but contrary to the previously sequenced element of HDE288, it was not accompanied by tirS. This element was identified in CC30 MRSA from Kuwait, Saudi Arabia and the United Arab Emirates that usually also harbour the Panton-Valentin leukocidin (PVL) genes. It was also identified in CC8 and ST834 isolates. In addition, further CC30 MRSA strains with other SCCmec VI elements harbouring fusC were found to circulate in the Arabian Gulf region. It can be assumed that MRSA strains with SCCmec elements that include fusC have a selective advantage in both hospital and community settings warranting a review of the use of topical antibiotics and indicating the necessity of reducing over-the-counter sale of antibiotics, including fusidic acid, without prescription.	[Senok, Abiola; Nasser, Rania] Mohammed Bin Rashid Univ Med & Hlth Sci, Coll Med, Dubai, U Arab Emirates; [Slickers, Peter; Braun, Sascha D.; Mueller, Elke; Reissig, Annett; Ehricht, Ralf; Monecke, Stefan] InfectoGnost Res Campus, Jena, Germany; [Slickers, Peter] Abbott Alere Technol GmbH, Jena, Germany; [Hotzel, Helmut] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Fed Res Inst Anim Hlth, Jena, Germany; [Boswihi, Samar; Udo, Edet] Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait; [Braun, Sascha D.; Mueller, Elke; Reissig, Annett; Ehricht, Ralf; Monecke, Stefan] Leibniz Inst Photon Technol IPHT, Jena, Germany; [Gawlik, Darius] PTC Phage Technol Ctr GmbH Bonen, Bonen, Germany; [Nabi, Anju] Dubai Hlth Author, Rashid Hosp, Pathol Dept, Microbiol & Infect Control Unit, Dubai, U Arab Emirates; [Nitschke, Hedda] Hosp Dresden Neustadt, Dept Lab Med, Dresden, Germany; [Ruppelt-Lorz, Antje; Monecke, Stefan] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Med Microbiol & Hyg, Dresden, Germany; [Mafofo, Joseph] Agiomix FZ LLC, Dubai Sci Pk Warehouse Complex, Dubai, U Arab Emirates; [Somily, Ali M.] King Khalid Univ Hosp, Coll Med, Dept Pathol & Lab Med, Riyadh, Saudi Arabia; [Somily, Ali M.] King Saud Univ, Riyadh, Saudi Arabia	Alere; Friedrich Loeffler Institute; Kuwait University; Leibniz Institut fur Photonische Technologien; Technische Universitat Dresden; Municipal Hospital Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; King Saud University; King Khalid University Hospital; King Saud University	Monecke, S (corresponding author), InfectoGnost Res Campus, Jena, Germany.; Monecke, S (corresponding author), Leibniz Inst Photon Technol IPHT, Jena, Germany.; Monecke, S (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Med Microbiol & Hyg, Dresden, Germany.	monecke@rocketmail.com	Udo, Edet E/H-7367-2016; Somily, Ali/AAJ-5897-2020	Udo, Edet E/0000-0002-7269-7949; Senok, Abiola/0000-0001-6382-198X; Hotzel, Helmut/0000-0002-2413-296X; Mafofo, Joseph/0000-0003-1964-1708; Somily, Ali/0000-0002-9634-6107	College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, UAE [MBRUCM-RG2018-07]; Leibniz Society	College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, UAE; Leibniz Society	The project was partially funded by internal research grant from the College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, UAE (Ref#: MBRUCM-RG2018-07). The Leibniz Society supported the open access publication of the present work. Agiomix FZ-LLC provided support in the form of salary for author JM. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Basset P, 2015, J INFECT DEV COUNTR, V9, P206, DOI 10.3855/jidc.4620; Becker K, 2014, INT J MED MICROBIOL, V304, P794, DOI 10.1016/j.ijmm.2014.06.007; Ben Slama K, 2011, EUR J CLIN MICROBIOL, V30, P499, DOI 10.1007/s10096-010-1109-6; Boswihi SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195933; Boswihi SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162744; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; Dawkins R., 1994, DAS EGOISTISCHE GEN; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P2027, DOI 10.1128/JCM.41.5.2027-2032.2003; Ellington MJ, 2015, INT J ANTIMICROB AG, V45, P477, DOI 10.1016/j.ijantimicag.2015.01.009; Farrell DJ, 2011, CLIN INFECT DIS, V52, pS487, DOI 10.1093/cid/cir164; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kinnevey PM, 2013, ANTIMICROB AGENTS CH, V57, P524, DOI 10.1128/AAC.01689-12; Lannergard J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028366; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2012, EUR J CLIN MICROBIOL, V31, P1497, DOI 10.1007/s10096-011-1469-6; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2017, GMS HYG INFECT CONTR, V12, DOI 10.3205/dgkh000304; Monecke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162654; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Patot S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006092; Scerri J, 2013, J EPIDEMIOL GLOB HEA, V3, P165, DOI 10.1016/j.jegh.2013.05.003; Schofer H, 2010, EUR J DERMATOL, V20, P6, DOI 10.1684/ejd.2010.0833; Senok A., 2016, New Microbes and New Infections, V14, P13, DOI 10.1016/j.nmni.2016.07.009; Senok AC, 2017, INFECT DRUG RESIST, V10, P307, DOI 10.2147/IDR.S145394; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Turnidge J, 1999, INT J ANTIMICROB AG, V12, pS35, DOI 10.1016/S0924-8579(98)00072-7; Udo EE, 2010, J MED MICROBIOL, V59, P193, DOI 10.1099/jmm.0.013268-0; Vourli S, 2005, Euro Surveill, V10, P78; Williamson Deborah A, 2017, Clin Microbiol Rev, V30, P827, DOI 10.1128/CMR.00112-16; Williamson DA, 2014, CLIN INFECT DIS, V59, P1451, DOI 10.1093/cid/ciu658	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0223985	10.1371/journal.pone.0223985	http://dx.doi.org/10.1371/journal.pone.0223985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689288	Green Submitted, Green Published, gold			2022-12-26	WOS:000532680100011
J	Nejo, YT; Olaleye, DO; Odaibo, GN				Nejo, Yewande T.; Olaleye, David O.; Odaibo, Georgina N.			Molecular characterisation of genital human papillomavirus among women in Southwestern, Nigeria	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; GENOMIC DIVERSITY; NATURAL-HISTORY; HPV INFECTION; VARIANTS; PREVALENCE; TYPE-16; RISK; E6; DNA	Background Persistent infections with high-risk genital Human papillomavirus (HPV) especially types 16 and 18, are associated with cervical cancer. However, distribution of HPV types varies greatly across geographical regions and the available vaccines target only few types. This study was designed to determine the HPV types circulating in Southwestern Nigeria, thereby providing necessary information for effective control of the virus. Methods Endocervical swab samples were collected from a total of 295 consenting women attending routine cervical cancer screening, STI clinics and community-based outreach programme. Viral DNA was extracted from the samples and the consensus region of the HPV DNA was amplified by PCR using GP-E6/E7 primers. Type-specific nested multiplex PCR and Sanger sequencing were used to genotype the HPV isolates. Results In this study, 51 (17.3%) individuals were positive for HPV DNA using consensus primers that target the E6/E7 genes but only 48 (16.3%) were genotyped. A total of 15 HPV types (HPV-6, 16, 18, 31, 33, 35, 42, 43, 44, 52, 58, 66, 74, 81, 86) were detected, with HPV-31 being the most predominant (32.8%), followed by HPV-35 (17.2%) and HPV-16 (15.5%). Two rare HPV types; 74 and 86 were also detected. The HPV-74 isolate had three nucleotide (CCT) insertions at E7 gene that translated into amino acid proline. Highest nucleotide substitutions (n = 32) were found in HPV-44 genotype. Among positive individuals, 20.8% had dual infections and 86.2% had High-risk HPV types. Conclusions Multiple Human papillomavirus types co-circulated in the study. Most of the circulating Human papillomavirus are high-risk type with type 31 being the most predominant. Although the implication of HPV-74 with proline insertion detected for the first time is unknown, it may have effect on the transformation potential of the virus. Polyvalent HPV vaccine will be more effective for the infection control in Nigeria.	[Nejo, Yewande T.] Bowen Univ, Dept Biol Sci, Iwo, Osun State, Nigeria; [Nejo, Yewande T.; Olaleye, David O.; Odaibo, Georgina N.] Univ Ibadan, Coll Med, Dept Virol, Ibadan, Nigeria	University of Ibadan	Odaibo, GN (corresponding author), Univ Ibadan, Coll Med, Dept Virol, Ibadan, Nigeria.	foreodaibo@hotmail.com	Nejo, Yewande Tolulope/AAX-4473-2021	Nejo, Yewande Tolulope/0000-0002-0701-5833				Adegbesan OM, 2014, INT J RES MED SCI, V2, P625; Akarolo-Anthony SN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-521; Ali-Risasi C, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0015-z; Arroyo SL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-258; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Boumba LMA, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0010-4; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Calleja-Macias IE, 2005, J VIROL, V79, P6565, DOI 10.1128/JVI.79.10.6565-6569.2005; Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Choi YD, 2009, KOREAN J PATHOL, V43, P250, DOI 10.4132/KoreanJPathol.2009.43.3.250; Chow VTK, 2000, PATHOLOGY, V32, P204, DOI 10.1080/713688930; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Co NNC., 2013, ISRN VIROLOGY, V2013, P312706, DOI [10.5402/2013/312706, DOI 10.5402/2013/312706]; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; Danielewski JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063892; Dareng EO, 2016, EPIDEMIOL INFECT, V144, P123, DOI 10.1017/S0950268815000965; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Denny L, 2014, INT J CANCER, V134, P1389, DOI 10.1002/ijc.28425; DEVILLIERS EM, 1989, J VIROL, V63, P4898, DOI 10.1128/JVI.63.11.4898-4903.1989; Ellis JRM, 1997, LANCET, V349, P1069, DOI 10.1016/S0140-6736(05)62292-1; Ezechi OC, 2014, VIROL J, V11, P15, DOI [10.1186/1743-422X-11-15, DOI 10.1186/1743-422X-11-15]; Fadahunsi OO., 2013, GYNAECOL OBSTET, V3; Fernandes JV, 2013, ANN MED HEALTH SCI R, V3, P504, DOI 10.4103/2141-9248.122060; Food and Drug Administration (FDA), 2014, APPR LETT GARDASIL, V9; Freitas LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100746; Gagnon S, 2005, J MED VIROL, V75, P213, DOI 10.1002/jmv.20259; Georgieva S, 2009, J BUON, V14, P391; Gravitt PE, 2002, INT J CANCER, V100, P729, DOI 10.1002/ijc.10538; Kennedy NT, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.85.8510; Kocjan BJ, 2009, VIROLOGY, V391, P274, DOI 10.1016/j.virol.2009.06.030; Kovelman R, 1999, J GEN VIROL, V80, P2445, DOI 10.1099/0022-1317-80-9-2445; Kuhn L, 2000, JNCI-J NATL CANCER I, V92, P818, DOI 10.1093/jnci/92.10.818; Lee K, 2008, VIRUS RES, V131, P106, DOI 10.1016/j.virusres.2007.08.003; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Longuet M, 1996, J CLIN MICROBIOL, V34, P1859, DOI 10.1128/JCM.34.7.1859-1862.1996; Maver PJ, 2014, J MED VIROL, V86, P272, DOI 10.1002/jmv.23822; Molden T, 2016, PAPILLOMAVIRUS RES, V2, P153, DOI 10.1016/j.pvr.2016.05.002; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nejo YT, 2018, ARCH BASIC APPL MED, V6, P5; Nweke I. G., 2013, British Microbiology Research Journal, V3, P400; Odetola TD, 2012, J COMMUNITY MED HLTH, V2, P1; Perez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104678; Piras F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-514; Prado JC, 2005, VIROLOGY, V340, P95, DOI 10.1016/j.virol.2005.06.024; Qmichou Z., 2013, British Microbiology Research Journal, V3, P692; Schlecht NF, 2005, J GEN VIROL, V86, P2709, DOI 10.1099/vir.0.81060-0; Schnatz PF, 2008, J WOMENS HEALTH, V17, P279, DOI 10.1089/jwh.2006.0295; Shen MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057667; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Smith B, 2011, PLOS ONE, V6, DOI [10.1371/journal. pone.0021375, DOI 10.1371/J0URNAL.P0NE.0021375P]; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Stoppler MC, 1996, J VIROL, V70, P6987; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terai M, 2001, J GEN VIROL, V82, P2035, DOI 10.1099/0022-1317-82-9-2035; Thomas JO, 2004, BRIT J CANCER, V90, P638, DOI 10.1038/sj.bjc.6601515; Traore IMA, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7092583; Tu JJ, 2006, INT J GYNECOL CANCER, V16, P736, DOI 10.1111/j.1525-1438.2006.00401.x; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; WHO/ICO HPV information centre on HPV and cervical cancer (HPV information centre), HUM PAP REL CANC NIG; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Zohoncon TM, 2013, MEDITERRANEAN J HEMA; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706	74	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2019	14	11							e0224748	10.1371/journal.pone.0224748	http://dx.doi.org/10.1371/journal.pone.0224748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1AJ	31682636	gold, Green Published			2022-12-26	WOS:000532676800030
J	Dasari, TK; Geiger, R; Karki, R; Banoth, B; Sharma, BR; Gurung, P; Burton, A; Kanneganti, TD				Dasari, Tejasvi K.; Geiger, Rechel; Karki, Rajendra; Banoth, Balaji; Sharma, Bhesh Raj; Gurung, Prajwal; Burton, Amanda; Kanneganti, Thirumala-Devi			The nonreceptor tyrosine kinase SYK drives caspase-8/NLRP3 inflammasome-mediated autoinflammatory osteomyelitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; inflammation; spleen tyrosine kinase (Syk); NLRP3; caspase 1 (CASP1); autoimmunity; caspase-8; chronic multifocal osteomyelitis (cmo); chronic recurrent multifocal osteomyelitis (CRMO); IL-1?	NLRP3 INFLAMMASOME; SIGNALING PATHWAY; ACTIVATION; IL-1-BETA; PROTEIN; PHOSPHORYLATION; PATHOGENESIS; RECEPTORS; COMPLEX; PSTPIP2	Chronic recurrent multifocal osteomyelitis (CRMO) in humans can be modeled in Pstpip2(cmo) mice, which carry a missense mutation in the proline?serine?threonine phosphatase?interacting protein 2 (Pstpip2) gene. As cmo disease in mice, the experimental model analogous to human CRMO, is mediated specifically by IL-1? and not by IL-1?, delineating the molecular pathways contributing to pathogenic IL-1? production is crucial to developing targeted therapies. In particular, our earlier findings support redundant roles of NLR family pyrin domain-containing 3 (NLRP3) and caspase-1 with caspase-8 in instigating cmo. However, the signaling components upstream of caspase-8 and pro-IL-1? cleavage in Pstpip2(cmo) mice are not well-understood. Therefore, here we investigated the signaling pathways in these mice and discovered a central role of a nonreceptor tyrosine kinase, spleen tyrosine kinase (SYK), in mediating osteomyelitis. Using several mutant mouse strains, immunoblotting, and microcomputed tomography, we demonstrate that absent in melanoma 2 (AIM2), receptor-interacting serine/ threonine protein kinase 3 (RIPK3), and caspase recruitment domain?containing protein 9 (CARD9) are each dispensable for osteomyelitis induction in Pstpip2(cmo) mice, whereas genetic deletion of Syk completely abrogates the disease phenotype. We further show that SYK centrally mediates signaling upstream of caspase-1 and caspase-8 activation and principally up-regulates NF-?B and IL-1? signaling in Pstpip2(cmo) mice, thereby inducing cmo. These results provide a rationale for directly targeting SYK and its downstream signaling components in CRMO.	[Dasari, Tejasvi K.; Geiger, Rechel; Karki, Rajendra; Banoth, Balaji; Sharma, Bhesh Raj; Gurung, Prajwal; Burton, Amanda; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, MS 351,570 St Jude Pl,Ste E7004, Memphis, TN 38105 USA; [Dasari, Tejasvi K.] Baylor Coll Med, Sch Med, Houston, TX 77030 USA; [Gurung, Prajwal] Univ Iowa, Inflammat Program, Iowa City, IA 52241 USA	St Jude Children's Research Hospital; Baylor College of Medicine; University of Iowa	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, MS 351,570 St Jude Pl,Ste E7004, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Karki, Rajendra/H-6647-2019; Banoth, Balaji/ABF-7350-2020; Sharma, Bhesh Raj/H-3782-2014	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Karki, Rajendra/0000-0003-4436-9128; Sharma, Bhesh Raj/0000-0003-3609-833X; Gurung, Prajwal/0000-0002-7451-9433; Banoth, Balaji/0000-0002-7467-2198	National Institutes of Health [CA163507, AR056296, AI124346, AI101935]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by National Institutes of Health Grants CA163507, AR056296, AI124346, and AI101935 and by the American Lebanese Syrian Associated Charities (to T.-D. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bast A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003986; Chitu V, 2012, BLOOD, V120, P3126, DOI 10.1182/blood-2012-04-425595; Chitu V, 2009, BLOOD, V114, P2497, DOI 10.1182/blood-2009-02-204925; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Daheshia M, 2008, J RHEUMATOL, V35, P2306, DOI 10.3899/jrheum.080346; Drobek A, 2015, J IMMUNOL, V195, P3416, DOI 10.4049/jimmunol.1401494; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Gurung P, 2017, IMMUNITY, V46, P635, DOI 10.1016/j.immuni.2017.03.014; Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113; Gurung P, 2015, AM J PATHOL, V185, P17, DOI 10.1016/j.ajpath.2014.08.025; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; Hofmann SR, 2017, CURR OSTEOPOROS REP, V15, P542, DOI 10.1007/s11914-017-0405-9; Jurik AG, 2004, SEMIN MUSCULOSKEL R, V8, P243, DOI 10.1055/s-2004-835364; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karki R, 2019, NAT REV CANCER, V19, P197, DOI 10.1038/s41568-019-0123-y; Karki R, 2018, CELL, V173, P920, DOI 10.1016/j.cell.2018.02.055; Karki R, 2015, CELL HOST MICROBE, V17, P357, DOI 10.1016/j.chom.2015.01.006; Li YJ, 2016, HEMATOLOGY, V21, P144, DOI 10.1179/1607845415Y.0000000029; Lin YC, 2015, J LEUKOCYTE BIOL, V97, P825, DOI 10.1189/jlb.3HI0814-371RR; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788; Lukens JR, 2014, P NATL ACAD SCI USA, V111, P1066, DOI 10.1073/pnas.1318688111; Malik A, 2018, IMMUNITY, V49, P515, DOI 10.1016/j.immuni.2018.08.024; Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moriwaki K, 2015, J IMMUNOL, V194, P1938, DOI 10.4049/jimmunol.1402167; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Roberts-Galbraith RH, 2010, CELL CYCLE, V9, P4091, DOI 10.4161/cc.9.20.13587; Sharma BR, 2019, CELL DEATH DIFFER, V26, P741, DOI 10.1038/s41418-018-0159-7; Stern SM, 2013, RHEUM DIS CLIN N AM, V39, P735, DOI 10.1016/j.rdc.2013.05.002; Tartey S, 2018, J CLIN INVEST, V128, P2042, DOI 10.1172/JCI98446; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Wagener M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00225	40	8	8	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3394	3400		10.1074/jbc.RA119.010623	http://dx.doi.org/10.1074/jbc.RA119.010623			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31719149	Green Published, hybrid			2022-12-26	WOS:000527725300001
J	Kollenstart, L; de Groot, AJL; Janssen, GMC; Cheng, X; Vreeken, K; Martino, F; Cote, J; van Veelen, PA; van Attikum, H				Kollenstart, Leonie; de Groot, Anton J. L.; Janssen, George M. C.; Cheng, Xue; Vreeken, Kees; Martino, Fabrizio; Cote, Jacques; van Veelen, Peter A.; van Attikum, Haico			Gcn5 and Esa1 function as histone crotonyltransferases to regulate crotonylation-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone modification; gene transcription; post-translational modification (PTM); chromatin modification; crotonylation; Esa1-Yng2-Epl1 (Piccolo NuA4) complex; Gcn5-Ada (ADA) complex	POSTTRANSLATIONAL MODIFICATIONS; LYSINE SUCCINYLATION; METABOLIC-REGULATION; CRYSTAL-STRUCTURE; ACETYL-COENZYME; RECOGNITION; EXPRESSION; COMPLEXES; H3; H4	Histone post-translational modifications (PTMs) are critical for processes such as transcription. The more notable among these are the nonacetyl histone lysine acylation modifications such as crotonylation, butyrylation, and succinylation. However, the biological relevance of these PTMs is not fully understood because their regulation is largely unknown. Here, we set out to investigate whether the main histone acetyltransferases in budding yeast, Gcn5 and Esa1, possess crotonyltransferase activity. In vitro studies revealed that the Gcn5-Ada2-Ada3 (ADA) and Esa1-Yng2-Epl1 (Piccolo NuA4) histone acetyltransferase complexes have the capacity to crotonylate histones. Mass spectrometry analysis revealed that ADA and Piccolo NuA4 crotonylate lysines in the N-terminal tails of histone H3 and H4, respectively. Functionally, we show that crotonylation selectively affects gene transcription in vivo in a manner dependent on Gcn5 and Esa1. Thus, we identify the Gcn5- and Esa1-containing ADA and Piccolo NuA4 complexes as bona fide crotonyltransferases that promote crotonylation-dependent transcription.	[Kollenstart, Leonie; de Groot, Anton J. L.; Vreeken, Kees; van Attikum, Haico] Leiden Univ, Med Ctr, Dept Human Genet, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands; [Janssen, George M. C.; van Veelen, Peter A.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Albinusdreef 2, NL-2333 ZC Leiden, Netherlands; [Cheng, Xue; Cote, Jacques] Laval Univ, Ctr Rech Ctr Hosp Univ Quebec Axe Oncol, Canc Res Ctr, St Patrick Res Grp Basic Oncol, Quebec City, PQ G1R 3S3, Canada; [Martino, Fabrizio] CSIC, Spanish Natl Res Council, Ctr Invest Biol, Ramiro de Maeztu 9, E-28040 Madrid, Spain	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Laval University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	van Attikum, H (corresponding author), Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	h.van.attikum@lumc.nl	Cote, Jacques/I-8901-2014; van Attikum, Haico/A-4596-2010	Cote, Jacques/0000-0001-6751-555X; Janssen, George/0000-0001-9091-4030; van Veelen, Peter/0000-0002-7898-9408; Van Attikum, Haico/0000-0001-8590-0240; Kollenstart, Leonie/0000-0003-3401-2512	Canadian Institutes of Health Research (CIHR) [FDN-143314]; Investment Grant NWO Medium (ZonMw) [91116004]; ERC Consolidator grant [617485]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Investment Grant NWO Medium (ZonMw); ERC Consolidator grant(European Research Council (ERC))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant FDN-143314 (to J. C.), Investment Grant NWO Medium 91116004 (partly financed by ZonMw) (to P. A. v. V.), and an ERC Consolidator grant 617485 (to H. v. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Arnaudo N, 2013, NAT STRUCT MOL BIOL, V20, P1119, DOI 10.1038/nsmb.2641; Barrios A, 2007, METHODS, V41, P271, DOI 10.1016/j.ymeth.2006.08.007; Bellush JM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0287; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P2091, DOI 10.1021/bi602366n; Bos J, 2018, J AM CHEM SOC, V140, P4757, DOI 10.1021/jacs.7b13141; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Cobb J, 2010, METHODS MOL BIOL, V587, P113, DOI 10.1007/978-1-60327-355-8_8; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Dantuma NP, 2016, EMBO J, V35, P6, DOI 10.15252/embj.201592595; Decker PV, 2008, GENETICS, V178, P1209, DOI 10.1534/genetics.107.080135; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Fu HF, 2018, STEM CELL REP, V11, P70, DOI 10.1016/j.stemcr.2018.05.003; Galdieri L, 2014, EUKARYOT CELL, V13, P1472, DOI 10.1128/EC.00189-14; Goudarzi A, 2016, MOL CELL, V62, P169, DOI 10.1016/j.molcel.2016.03.014; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Kebede AF, 2017, NAT STRUCT MOL BIOL, V24, P1048, DOI 10.1038/nsmb.3490; Kelly RDW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32927-9; Klein BJ, 2017, STRUCTURE, V25, P650, DOI 10.1016/j.str.2017.02.003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Liu XG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.16; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Montgomery DC, 2015, CHEM BIOL, V22, P1030, DOI 10.1016/j.chembiol.2015.06.015; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ringel AE, 2016, ACTA CRYSTALLOGR D, V72, P841, DOI 10.1107/S2059798316007907; Riss A, 2015, J BIOL CHEM, V290, P28997, DOI 10.1074/jbc.M115.668533; Rossetto D, 2014, EMBO J, V33, P1397, DOI 10.15252/embj.201386433; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Simithy J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01384-9; Soltani J, 2009, FEMS MICROBIOL LETT, V298, P228, DOI 10.1111/j.1574-6968.2009.01723.x; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vlaming H, 2016, ELIFE, V5, DOI 10.7554/eLife.18919; Wang Y, 2018, P NATL ACAD SCI USA, V115, P2365, DOI 10.1073/pnas.1717664115; Wang YG, 2017, NATURE, V552, P273, DOI 10.1038/nature25003; Wei W, 2017, CELL RES, V27, P898, DOI 10.1038/cr.2017.68; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036; Xiong XZ, 2016, NAT CHEM BIOL, V12, P1111, DOI [10.1038/nchembio.2218, 10.1038/NCHEMBIO.2218]; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Zhang Q, 2016, STRUCTURE, V24, P1606, DOI 10.1016/j.str.2016.05.023; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao D, 2016, CELL RES, V26, P629, DOI 10.1038/cr.2016.49	57	33	33	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20122	20134		10.1074/jbc.RA119.010302	http://dx.doi.org/10.1074/jbc.RA119.010302			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31699900	hybrid, Green Published			2022-12-26	WOS:000505005800024
J	de Andrade, LRB; Sousa, MBE; Oliveira, EJ; de Resende, MDV; Azevedo, CF				Braatz de Andrade, Luciano Rogerio; Bandeira e Sousa, Massaine; Oliveira, Eder Jorge; Vilela de Resende, Marcos Deon; Azevedo, Camila Ferreira			Cassava yield traits predicted by genomic selection methods	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; ASSISTED PREDICTION; DIALLEL ANALYSIS; GENETIC VALUE; REGRESSION; DISEASE	Genomic selection (GS) has been used to optimize genetic gains when phenotypic selection is considered costly and difficult to measure. The objective of this work was to evaluate the efficiency and consistency of GS prediction for cassava yield traits (Manihot esculenta Crantz) using different methods, taking into account the effect of population structure. BLUPs and deregressed BLUPs were obtained for 888 cassava accessions and evaluated for fresh root yield, dry root yield and dry matter content in roots in 21 trials conducted from 2011 to 2016. The deregressed BLUPs obtained for the accessions from a 48K single nucleotide polymorphism dataset were used for genomic predictions based on the BayesB, BLASSO, RR-BLUP, G-BLUP and RKHS methods. The accessions' BLUPs were used in the validation step using four cross-validation strategies, taking into account population structure and different GS methods. Similar estimates of predictive ability and bias were identified for the different genomic selection methods in the first cross-validation strategy. Lower predictive ability was observed for fresh root yield (0.4569 -RR-BLUP to 0.4756-RKHS) and dry root yield (0.4689 -G-BLUP to 0.4818-RKHS) in comparison with dry matter content (0.5655 - BLASSO to 0.5670 -RKHS). However, the RKHS method exhibited higher efficiency and consistency in most of the validation scenarios in terms of prediction ability for fresh root yield and dry root yield. The correlations of the genomic estimated breeding values between the genomic selection methods were quite high (0.99-1.00), resulting in high coincidence of clone selection regardless of the genomic selection method. The deviance analyses within and between the validation clusters formed by the discriminant analysis of principal components were significant for all traits. Therefore, this study indicated that i) the prediction of dry matter content was more accurate compared to that of yield traits, possibly as a result of the smaller influence of non-additive genetic effects; ii) the RKHS method resulted in high and stable prediction ability in most of the validation scenarios; and iii) some kinship between the validation and training populations is desirable in order for genomic selection to succeed due to the significant effect of population structure on genomic selection predictions.	[Braatz de Andrade, Luciano Rogerio] Univ Fed Vicosa, Dept Plant Sci, Vicosa, MG, Brazil; [Bandeira e Sousa, Massaine] Univ Fed Reconcavo da Bahia, Ctr Agr Environm & Biol Sci, Cruz Das Almas, BA, Brazil; [Oliveira, Eder Jorge] Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil; [Vilela de Resende, Marcos Deon] Univ Fed Vicosa, Dept Forestry Engn, Vicosa, MG, Brazil; [Vilela de Resende, Marcos Deon] Embrapa Florestas, Colombo, Parana, Brazil; [Vilela de Resende, Marcos Deon; Azevedo, Camila Ferreira] Univ Fed Vicosa, Dept Stat, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa	Oliveira, EJ (corresponding author), Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil.	eder.oliveira@embrapa.br	Azevedo, Camila Ferreira/AGE-4725-2022; Oliveira, Eder Jorge/N-2216-2017	Azevedo, Camila Ferreira/0000-0003-0438-5123; Oliveira, Eder Jorge/0000-0001-8992-7459	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); NEXTGEN Cassava project through Bill & Melinda Gates Foundation; UK Department for International Development	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); NEXTGEN Cassava project through Bill & Melinda Gates Foundation; UK Department for International Development	LRBA was supported by scholarships from Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES). MDVR and EJO was supported by research productivity scholarships from Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq). The authors are grateful for the financial support provided by Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) and Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq). This work was also supported by the NEXTGEN Cassava project, through a grant to Cornell University by the Bill & Melinda Gates Foundation and the UK Department for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir D, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0116-6; Azevedo CF, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0264-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernardo R, 2016, THEOR APPL GENET, V129, P2323, DOI 10.1007/s00122-016-2772-5; Bredeson JV, 2016, NAT BIOTECHNOL, V34, P562, DOI 10.1038/nbt.3535; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Calle F, 2005, EUPHYTICA, V144, P177, DOI 10.1007/s10681-005-5810-y; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Ceballos H, 2015, THEOR APPL GENET, V128, P1647, DOI 10.1007/s00122-015-2555-4; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooper M, 1999, TRENDS AGRON, V2, P33; COVARRUBIASPAZARAN, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0156744; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; de Los Campos Gustavo, 2013, Methods Mol Biol, V1019, P299, DOI 10.1007/978-1-62703-447-0_12; de Oliveira EJ, 2012, EUPHYTICA, V187, P263, DOI 10.1007/s10681-012-0722-0; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edriss V, 2017, CROP SCI, V57, P2361, DOI 10.2135/cropsci2016.08.0715; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Habier David, 2010, Genet Sel Evol, V42, P5, DOI 10.1186/1297-9686-42-5; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hamblin MT, 2014, CROP SCI, V54, P2603, DOI 10.2135/cropsci2014.02.0160; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Isidro J, 2015, THEOR APPL GENET, V128, P145, DOI 10.1007/s00122-014-2418-4; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; KAWANO K, 1987, CROP SCI, V27, P69, DOI 10.2135/cropsci1987.0011183X002700010018x; Kayondo SI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19696-1; Legarra A, 2011, GENET RES, V93, P77, DOI 10.1017/S0016672310000534; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ly D, 2013, CROP SCI, V53, P1312, DOI 10.2135/cropsci2012.11.0653; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Meuwissen THE, 2001, GENETICS, V157, P1819; Morota G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00363; Oliveira EJ, 2014, GENET MOL RES, V13, P6472, DOI 10.4238/2014.August.25.11; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Parkes EY, 2013, EUPHYTICA, V194, P13, DOI 10.1007/s10681-013-0936-9; Pereira HD, 2018, J APPL GENET, V59, P1, DOI 10.1007/s13353-017-0417-2; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; R Core Team, 2021, R LANGUAGE ENV STAT; RESENDE M. D. V., 2014, ESTATISTICA MATEMATI; Resende M.D.V., 2008, PESQUISA FLORESTAL B, V56, P63; Resende RMS, 2014, CROP SCI, V54, P143, DOI 10.2135/cropsci2013.05.0353; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Sorkheh K, 2008, GENET MOL BIOL, V31, P805, DOI 10.1590/S1415-47572008000500001; Tumuhimbise R, 2014, FIELD CROP RES, V167, P86, DOI 10.1016/j.fcr.2014.07.006; VanRaden PM., 2007, INTERBULL B, V37, P33; Wientjes YCJ, 2013, GENETICS, V193, P621, DOI 10.1534/genetics.112.146290; Wolfe MD, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2017.03.0015; Wolfe MD, 2016, G3-GENES GENOM GENET, V6, P3497, DOI 10.1534/g3.116.033332; Wolfe MD, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.11.0118; de Freitas JPX, 2016, EUPHYTICA, V209, P137, DOI 10.1007/s10681-016-1649-7; Zacarias AM, 2010, EUPHYTICA, V176, P309, DOI 10.1007/s10681-010-0203-2	62	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224920	10.1371/journal.pone.0224920	http://dx.doi.org/10.1371/journal.pone.0224920			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725759	Green Published, gold			2022-12-26	WOS:000532764500035
J	Loureiro, RB; Macie, ELN; Caetano, R; Peres, RL; Fregona, G; Golub, JE; Braga, JU				Loureiro, Rafaela Borge; Noia Macie, Ethel Leonor; Caetano, Rosangela; Peres, Renata Lyrio; Fregona, Geisa; Golub, Jonathan E.; Braga, Jose Ueleres			Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; BLOOD INTERFERON-GAMMA; ISONIAZID PREVENTIVE THERAPY; MYCOBACTERIUM-TUBERCULOSIS; INCREASED RISK; UNITED-STATES; HEPATOTOXICITY; RECOMMENDATIONS; TRANSMISSION; PERFORMANCE	Objectives The goal of this study was to perform a cost-effectiveness analysis from the public health system perspective, comparing five strategies for Latent Tuberculosis Infection (LTBI) diagnosis in primary health care workers in Brazil. Design Analytical model for decision making, characterized by cost-effectiveness analysis. Setting Primary Care Level, considering primary health care workers in Brazil. Participants An analytical model for decision making, characterized by a tree of probabilities of events, was developed considering a hypothetical cohort of 10,000 primary health care workers, using the software TreeAge ProT 2013 to simulate the clinical and economic impacts of new diagnostic technology (QuantiFERON (R)-TB Gold in-Tube) versus the traditional tuberculin skin test. Methods This model simulated five diagnostic strategies for LTBI in primary health care workers (HCW) in Brazil: tuberculin skin testing using >= 5 mm cut-off, tuberculin skin testing >= 10 mm cut-off, QuantiFERON (R)-TB Gold in-Tube, tuberculin skin testing using >= 5 mm cut-off confirmed by QuantiFERON (R)-TB Gold In-Tube if TST positive, tuberculin skin testing using >= 10 mm cut-off confirmed by QuantiFERON (R)-TB Gold In-Tube if TST positive. Primary and secondary outcome measures The outcome measures are the number of individuals correctly classified by the test and the number of Tuberculosis cases avoided. Results The most cost-effective strategy was the tuberculin skin test considering >= 10mm cut-off. The isolated use of the QuantiFERON (R)-TB Gold In-Tube revealed the strategy of lower efficiency with incremental cost-effectiveness ratio (ICER) of US$ 146.05 for each HCW correctly classified by the test. Conclusions The tuberculin skin test using >= 10 mm cut-off was the most cost-effective strategy in the diagnosis of Latent Tuberculosis Infection in primary health care works in Brazil.	[Loureiro, Rafaela Borge; Braga, Jose Ueleres] Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Loureiro, Rafaela Borge; Noia Macie, Ethel Leonor; Peres, Renata Lyrio; Fregona, Geisa] Univ Fed Espirito Santo UFES, Lab Epidemiol Lab Epi, Vitoria, ES, Brazil; [Noia Macie, Ethel Leonor] Univ Fed Espirito Santo UFES, Grad Program Collect Hlth PPGSC, Vitoria, ES, Brazil; [Caetano, Rosangela] Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Hlth Policy Planning & Adm, Rio De Janeiro, RJ, Brazil; [Peres, Renata Lyrio] Univ Fed Espirito Santo UFES, Ctr Infect Dis NDI, Vitoria, ES, Brazil; [Golub, Jonathan E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Infect Dis, Baltimore, MD USA	Universidade do Estado do Rio de Janeiro; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade do Estado do Rio de Janeiro; Universidade Federal do Espirito Santo; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Braga, JU (corresponding author), Univ Estado Rio de Janeiro UERJ, Inst Social Med IMS, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.	ueleres@gmail.com	Golub, Jonathan/AAM-5928-2021; Braga, Jose Ueleres/AAB-1326-2021; Maciel, Ethel Leonor/G-1027-2012	Braga, Jose Ueleres/0000-0001-5247-007X; Fregona, Geisa/0000-0001-5835-8222; Borge Loureiro, Rafaela/0000-0002-5173-6160; Maciel, Ethel Leonor/0000-0003-4826-3355	CNPq (Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico) MCT/CNPq - Universal [14/2009]; International Clinical, Operational and Health Services Research Training Award grant ICOHRTA [AIDS/TB]	CNPq (Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico) MCT/CNPq - Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Clinical, Operational and Health Services Research Training Award grant ICOHRTA [AIDS/TB]	This study was supported by CNPq (Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico) MCT/CNPq No. 14/2009 - Universal and by the International Clinical, Operational and Health Services Research Training Award grant ICOHRTA [AIDS/TB]. None of the funding agencies is responsible for the statements in this article. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; [Anonymous], 1972, Bull World Health Organ, V46, P371; [Anonymous], 2019, GLOB TUB REP 2018; Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; BRASIL Sau de Md Secretaria de TeIE Tecnologia DdCe, 2009, DIR MET EST EC TECN; Canada C Health Mo Diseases CfC Control I of PHA, 2014, CANADIAN TUBERCULOSI; Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Control ECfDPa, 2011, US INT GAMM REL ASS; de Leon DP, 2008, J RHEUMATOL, V35, P776; de Perio MA, 2009, ARCH INTERN MED, V169, P179, DOI 10.1001/archinternmed.2008.524; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2007, CHEST, V131, P1424, DOI 10.1378/chest.06-2728; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; Do AN, 1999, INT J TUBERC LUNG D, V3, P377; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Esteban J, 2001, INT J TUBERC LUNG D, V5, P583; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116; Fox BD, 2009, LUNG, V187, P413, DOI 10.1007/s00408-009-9182-2; Garcia-Garcia MD, 2001, INFECT CONT HOSP EP, V22, P88, DOI 10.1086/501869; Harada N, 2006, INFECT CONT HOSP EP, V27, P442, DOI 10.1086/504358; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; Kowada A, 2015, J HOSP INFECT, V89, P99, DOI 10.1016/j.jhin.2014.10.002; Lee JY, 2006, EUR RESPIR J, V28, P24, DOI 10.1183/09031936.06.00016906; Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; MALONEY SA, 1995, ANN INTERN MED, V122, P90, DOI 10.7326/0003-4819-122-2-199501150-00002; Mancuso JD, 2011, INT J TUBERC LUNG D, V15, P1223, DOI 10.5588/ijtld.10.0542; Marra F, 2008, INT J TUBERC LUNG D, V12, P1414; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Mazurek Gerald H, 2003, MMWR Recomm Rep, V52, P15; McKenna MT, 1996, AM J RESP CRIT CARE, V154, P587, DOI 10.1164/ajrccm.154.3.8810591; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Millard PS, 1996, WESTERN J MED, V164, P486; Nienhaus A, 2008, INT ARCH OCC ENV HEA, V81, P295, DOI 10.1007/s00420-007-0212-1; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Nolan CM, 2003, AM J RESP CRIT CARE, V168, P412, DOI 10.1164/rccm.2306004; Ozdemir D, 2007, JPN J INFECT DIS, V60, P102; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Player S, 1998, Healthc Financ Manage, V52, P66; Pollock NR, 2008, INFECT CONT HOSP EP, V29, P878, DOI 10.1086/590262; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Roth VR, 2005, INT J TUBERC LUNG D, V9, P1335; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Saude B Saude Md em SdV, 2014, B EPIDEMIOLOGICO, V44, P1; Saude Md em SdV, 2019, B EPIDEMIOLOGICO, V50, P1; Saude Md Saude SdVe Vigilancia Dd, 2011, VIG DD MAN REC BRAS; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; SEPKOWITZ KA, 1995, CLIN INFECT DIS, V21, P1098, DOI 10.1093/clinids/21.5.1098; Shahidi N, 2012, INFLAMM BOWEL DIS, V18, P2034, DOI 10.1002/ibd.22901; STEELE MA, 1991, CHEST, V99, P465, DOI 10.1378/chest.99.2.465; Steffen RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059546; Tan LH, 2002, INFECT CONT HOSP EP, V23, P584, DOI 10.1086/501975; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Tissot F, 2005, CLIN INFECT DIS, V40, P211, DOI 10.1086/426434; Trajman A, 2010, INT J TUBERC LUNG D, V14, P551; Transmissiveis B, 2017, BRASIL LIVRE TUBERCU; UK NCCfCC NICE CfCPa, 2011, TUB CLIN DIAGN MAN T; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; WHO Department ST Epidemic Alert P Department R Department HA, 2009, WHO POL TB INF CONTR; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	83	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225197	10.1371/journal.pone.0225197	http://dx.doi.org/10.1371/journal.pone.0225197			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725786	Green Submitted, gold, Green Published			2022-12-26	WOS:000532764500066
J	Park, JW; Kim, T; Kim, D; Hong, Y; Gong, HS				Park, Jin Woo; Kim, Taehoon; Kim, Daesik; Hong, Yongtaek; Gong, Hyun Sik			Measurement of finger joint angle using stretchable carbon nanotube strain sensor	PLOS ONE			English	Article							HAND	Strain sensors capable of monitoring complex human motions are highly desirable for the development of wearable electronic devices and healthcare monitoring systems. Excellent sensitivity and a wide working range of the sensor material are important requirements for distinguishing dynamic human motion. In this study, a highly stretchable strain sensor was fabricated via inkjet printing of single-walled carbon nanotube (SWCNT) thin films on a stretchable polydimethylsiloxane substrate. The sensor was attached to the metacarpophalangeal (MCP) joint of the hand in 12 healthy male subjects. The subjects placed their hands next to a conventional goniometer and flexed the MCP joint to predetermined angles. A linear relationship was found between the change in the length of the strain sensor and the intended angle of the MCP joint. The fabricated thin films showed high durability during repeated cycling (1,000 cycles) and good sensitivity with a gauge factor of 2.75. This study demonstrates that the newly developed stretchable CNT strain sensor can be used for effectively measuring MCP joint angles. This sensor may also be useful for the analysis of complex and dynamic hand motions that are difficult to measure using a conventional goniometer.	[Park, Jin Woo] Kangwon Natl Univ, Dept Orthopaed Surg, Coll Med, Chunchon, South Korea; [Kim, Taehoon; Kim, Daesik; Hong, Yongtaek] Seoul Natl Univ, Interuniv Semicond Res Ctr ISRC, Dept Elect & Comp Engn, Seoul, South Korea; [Gong, Hyun Sik] Seoul Natl Univ, Dept Orthopaed Surg, Coll Med, Seoul, South Korea	Kangwon National University; Seoul National University (SNU); Seoul National University (SNU)	Hong, Y (corresponding author), Seoul Natl Univ, Interuniv Semicond Res Ctr ISRC, Dept Elect & Comp Engn, Seoul, South Korea.; Gong, HS (corresponding author), Seoul Natl Univ, Dept Orthopaed Surg, Coll Med, Seoul, South Korea.	yongtaek@snu.ac.kr; hsgong@snu.ac.kr		Park, Jin Woo/0000-0002-7598-1152	research fund for translational researches from the authors' university (Seoul National University) [80020140166]	research fund for translational researches from the authors' university (Seoul National University)	This work was supported by a research fund for translational researches from the authors' university (Seoul National University, No. 80020140166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amjadi M, 2016, ADV FUNCT MATER, V26, P1678, DOI 10.1002/adfm.201504755; Bazanski T, 2010, ACTA BIOENG BIOMECH, V12, P79; Cai L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03048; Chapleau J, 2011, CLIN ORTHOP RELAT R, V469, P3134, DOI 10.1007/s11999-011-1986-8; Chen J, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8030345; Chortos A, 2016, NAT MATER, V15, P937, DOI 10.1038/NMAT4671; Dipietro L, 2003, J REHABIL RES DEV, V40, P179; Hu N, 2010, CARBON, V48, P680, DOI 10.1016/j.carbon.2009.10.012; Kato M, 2007, J HAND THER, V20, P12, DOI 10.1197/j.jht.2006.11.015; Kim JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18209-w; Kim T, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868633; Lee KS, 2016, ERGONOMICS, V59, P890, DOI 10.1080/00140139.2015.1108458; Liu H, 2016, NANOSCALE, V8, P12977, DOI 10.1039/c6nr02216b; Marks M, 2011, J HAND THER, V24, P303, DOI 10.1016/j.jht.2011.04.004; Oess NP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-2; Ryu S, 2015, ACS NANO, V9, P5929, DOI 10.1021/acsnano.5b00599; Simone Lisa K, 2005, J Neuroeng Rehabil, V2, P5, DOI 10.1186/1743-0003-2-5; Tortorich RP, 2013, NANOMATERIALS-BASEL, V3, P453, DOI 10.3390/nano3030453; Wessendorf AM, 2012, IEEE T BIO-MED ENG, V59, P3432, DOI 10.1109/TBME.2012.2215859; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/nnano.2011.36, 10.1038/NNANO.2011.36]	20	14	14	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225164	10.1371/journal.pone.0225164	http://dx.doi.org/10.1371/journal.pone.0225164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725818	Green Published, gold			2022-12-26	WOS:000532764500063
J	Weingarten, EA; Atkinson, CL; Jackson, CR				Weingarten, Eric A.; Atkinson, Carla L.; Jackson, Colin R.			The gut microbiome of freshwater Unionidae mussels is determined by host species and is selectively retained from filtered seston	PLOS ONE			English	Article							CRASSOSTREA-GIGAS; PACIFIC OYSTERS; COMMUNITY; DIVERSITY; HEMOLYMPH; BIVALVES; MARINE	Freshwater mussels are a species -rich group of aquatic invertebrates that are among the most endangered groups of fauna worldwide. As filter-feeders that are constantly exposed to new microbial inoculants, mussels represent an ideal system to investigate the effects of species or the environment on gut microbiome composition. In this study, we examined if host species or site exerts a greater influence on microbiome composition. Individuals of four co-occurring freshwater mussel species, Cyclonaias asperata, Fusconaia cerina, Lampsilis ornata, and Obovaria unicolorwere collected from six sites along a 50 km stretch of the Sipsey River in Alabama, USA. High throughput 16S rRNA gene sequencing revealed that mussel gut bacterial microbiota were distinct from bacteria on seston suspended in the water column, and that the composition of the gut microbiota was influenced by both host species and site. Despite species and environmental variation, the most frequently detected sequences within the mussel microbiota were identified as members of the Clostridiales. Sequences identified as the nitrogen -fixing taxon Methylocystis sp. were also abundant in all mussel species, and sequences of both bacterial taxa were more abundant in mussels than in water. Site physicochemical conditions explained almost 45% of variation in seston bacterial communities but less than 8% of variation in the mussel bacterial microbiome. Together, these findings suggest selective retention of bacterial taxa by the freshwater mussel host, and that both species and the environment are important in determining mussel gut microbiome composition.	[Weingarten, Eric A.; Jackson, Colin R.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Atkinson, Carla L.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA	University of Mississippi; University of Alabama System; University of Alabama Tuscaloosa	Jackson, CR (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	cjackson@olemiss.edu		Atkinson, Carla/0000-0002-6430-7613	National Science Foundation [1831512, 1831531]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357, P20GM103476, P30GM103328, P20GM121334] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by National Science Foundation (www.nsf.gov) support to CLA (award 1831512) and CRJ (award 1831531). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves AK, 2018, J MOLLUS STUD, V84, P240, DOI 10.1093/mollus/eyy014; Allen DC, 2009, J N AM BENTHOL SOC, V28, P93, DOI 10.1899/07-170.1; Atkinson CL, 2018, ECOSYSTEMS, V21, P521, DOI 10.1007/s10021-017-0166-4; Atkinson CL, 2015, FRESHWATER BIOL, V60, P563, DOI 10.1111/fwb.12498; Atkinson CL, 2014, BIOL CONSERV, V176, P30, DOI 10.1016/j.biocon.2014.04.029; Atkinson CL, 2013, ECOLOGY, V94, P1359, DOI 10.1890/12-1531.1; Augspurger T, 2003, ENVIRON TOXICOL CHEM, V22, P2569, DOI 10.1897/02-339; Belova SE, 2013, INT J SYST EVOL MICR, V63, P1096, DOI 10.1099/ijs.0.043505-0; Black EM, 2017, PEERJ, V5, DOI 10.7717/peerj.3536; Cao R, 2009, CZECH J FOOD SCI, V27, P102, DOI 10.17221/166/2008-CJFS; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Chauhan A, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01083-14; Colston TJ, 2016, MOL ECOL, V25, P3776, DOI 10.1111/mec.13730; Dam B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074767; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Green TJ, 2019, MICROB ECOL, V77, P736, DOI 10.1007/s00248-018-1242-9; Jackson CR, 2001, ENVIRON MICROBIOL, V3, P532, DOI 10.1046/j.1462-2920.2001.00221.x; King GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051475; King WL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00473; King WL, 2019, MICROB ECOL, V77, P502, DOI 10.1007/s00248-018-1226-9; Konig S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.193; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lokmer A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01367; Lokmer A, 2015, ISME J, V9, P670, DOI 10.1038/ismej.2014.160; Maidak BL, 2000, NUCLEIC ACIDS RES, V28, P173, DOI 10.1093/nar/28.1.173; McCullagh WH, 2002, AM MALACOL BULL, V17, P1; Miller WA, 2006, MICROB ECOL, V52, P198, DOI 10.1007/s00248-006-9080-6; Moulton OM, 2016, FRONT ECOL ENVIRON, V14, P200, DOI 10.1002/fee.1262; Murphy AE, 2019, MICROB ECOL, V77, P343, DOI 10.1007/s00248-018-01312-4; Neves Richard J., 1997, P43; Oksanen J., 2008, COMMUNITY ECOL PACKA, V10, P631; OLAFSEN JA, 1993, APPL ENVIRON MICROB, V59, P1848, DOI 10.1128/AEM.59.6.1848-1854.1993; Ossai S, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00729-17; Parmalee P., 1998, FRESHWATER MUSSELS T; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pfeiffer JM, 2019, ZOOL SCR, V48, P106, DOI 10.1111/zsc.12322; Pierce ML, 2016, HYDROBIOLOGIA, V765, P97, DOI 10.1007/s10750-015-2405-z; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Rietl AJ, 2016, MICROB ECOL, V71, P290, DOI 10.1007/s00248-015-0651-2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stone BWG, 2016, MICROB ECOL, V71, P954, DOI 10.1007/s00248-016-0738-4; Strayer DL, 2004, BIOSCIENCE, V54, P429, DOI 10.1641/0006-3568(2004)054[0429:CPOPMN]2.0.CO;2; Thomas JC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00149; Fernandez NT, 2014, FEMS MICROBIOL ECOL, V88, P69, DOI 10.1111/1574-6941.12270; Vaughn CC, 2008, J N AM BENTHOL SOC, V27, P409, DOI 10.1899/07-058.1; Vaughn CC, 2001, FRESHWATER BIOL, V46, P1431, DOI 10.1046/j.1365-2427.2001.00771.x; Wegner KM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-252; Williams JD., 2008, FRESHWATER MUSSELS A	51	20	20	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224796	10.1371/journal.pone.0224796	http://dx.doi.org/10.1371/journal.pone.0224796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721801	Green Published, gold			2022-12-26	WOS:000532720700031
J	Post, GR; Yuan, YZ; Holthoff, ER; Quick, CM; Post, SR				Post, Ginell R.; Yuan, Youzhong; Holthoff, Emily R.; Quick, Charles M.; Post, Steven R.			Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment	PLOS ONE			English	Article							MACROPHAGE SCAVENGER RECEPTOR; CLASS-A; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; ADHESION; CELLS; GROWTH; CSF-1; ACTIVATION; SURVIVAL	Classic Hodgkin lymphoma (CHL) characteristically shows few malignant cells in a microenvironment comprised of mixed inflammatory cells. Although CHL is associated with a high cure rate, recent studies have associated poor prognosis with absolute monocyte count in peripheral blood and increased monocyte/macrophages in involved lymph nodes. Thus, the role of monocytic infiltration and macrophage differentiation in the tumor microenvironment of CHL may be more relevant than absolute macrophage numbers to defining prognosis in CHL patients and potentially have therapeutic implications. Most studies identify tumor-associated macrophages (TAMs) using markers (e.g., CD68) expressed by macrophages and other mononuclear phagocytes, such as monocytes. In contrast, Class A Scavenger Receptor (SR-A/CD204) is expressed by tissue macrophages but not monocytic precursors. In this study, we examined SR-A expression in CHL (n = 43), and compared its expression with that of other macrophage markers. We confirmed a high prevalence of mononuclear cells that stained with CD68, CD163, and CD14 in CHL lymph nodes. However, SR-A protein expression determined by immunohistochemistry was limited to macrophages localized in sclerotic bands characteristic of nodular sclerosis CHL. In contrast, SR-A protein was readily detectable in lymph nodes with metastatic tumor, extra-nodal CHL, T cell/histiocyte-rich large B cell lymphoma, and resident macrophages in non-malignant tissues, including spleen, lymph node, liver and lung. The results of SR-A protein expression paralleled the expression of SR-A mRNA determined by quantitative RT-PCR. These data provide evidence that tumor-infiltrating monocyte/macrophages in CHL have a unique phenotype that likely depends on the microenvironment of nodal CHL.	[Post, Ginell R.; Yuan, Youzhong; Holthoff, Emily R.; Quick, Charles M.; Post, Steven R.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Post, SR (corresponding author), Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA.	spost@uams.edu		Post, Steven/0000-0002-4711-1723	NIH [R21CA185691]; Department of Pathology; NATIONAL CANCER INSTITUTE [R21CA185691] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by an NIH award to SRP (R21CA185691) and intramural funding from the Department of Pathology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur A, 2015, LEUKEMIA LYMPHOMA, V56, P1315, DOI 10.3109/10428194.2014.963081; Aldinucci D, 2004, LEUKEMIA LYMPHOMA, V45, P1731, DOI 10.1080/10428190410001683633; Aldinucci D, 2010, J PATHOL, V221, P248, DOI 10.1002/path.2711; Azambuja D, 2012, ANN ONCOL, V23, P736, DOI 10.1093/annonc/mdr157; BOTTALICO LA, 1991, J BIOL CHEM, V266, P22866; Cattaruzza L, 2009, INT J CANCER, V125, P1092, DOI 10.1002/ijc.24389; Crane GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163559; DEVILLIERS WJS, 1994, J EXP MED, V180, P705, DOI 10.1084/jem.180.2.705; DOI T, 1993, J BIOL CHEM, V268, P2126; ELKHOURY J, 1994, J BIOL CHEM, V269, P10197; FALINI B, 1993, AM J PATHOL, V142, P1359; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; Fukuhara-Takaki K, 2005, J BIOL CHEM, V280, P3355, DOI 10.1074/jbc.M408715200; GENG YJ, 1994, ARTERIOSCLER THROMB, V14, P798, DOI 10.1161/01.ATV.14.5.798; GENG YJ, 1992, J CLIN INVEST, V89, P1322, DOI 10.1172/JCI115718; Gough P.J., 1999, THROMB VASC BIOL, V3, P461, DOI DOI 10.1161/01.ATV.19.3.461; Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9; Gowen BB, 2001, J LEUKOCYTE BIOL, V69, P575; Guo BP, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0711-6; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Harris JA, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-12; Hirayama S, 2012, J THORAC ONCOL, V7, P1790, DOI 10.1097/JTO.0b013e3182745968; Hogger P, 1998, J IMMUNOL, V161, P1883; HORVAI A, 1995, P NATL ACAD SCI USA, V92, P5391, DOI 10.1073/pnas.92.12.5391; Hsu HY, 1996, J BIOL CHEM, V271, P7767, DOI 10.1074/jbc.271.13.7767; Kirkham PA, 2003, FREE RADICAL BIO MED, V35, P697, DOI 10.1016/S0891-5849(03)00390-3; Koh YW, 2014, AM J CLIN PATHOL, V141, P573, DOI 10.1309/AJCPR92TDDFARISU; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Komohara Y, 2015, PATHOL INT, V65, P170, DOI 10.1111/pin.12259; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Kuppers R, 2012, J CLIN INVEST, V122, P3439, DOI [10.1172/JCI6124.5, 10.1172/JCI61245]; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kunisch E, 2004, ANN RHEUM DIS, V63, P774, DOI 10.1136/ard.2003.013029; Landmann R, 2000, MICROBES INFECT, V2, P295, DOI 10.1016/S1286-4579(00)00298-7; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Liao HS, 1999, ARTERIOSCL THROM VAS, V19, P1872, DOI 10.1161/01.ATV.19.8.1872; Marmey M, 2006, HUM PATHOL, V37, P68, DOI 10.1016/j.humpath.2005.09.016; Mazur A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150287; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; MOULTON KS, 1992, P NATL ACAD SCI USA, V89, P8102, DOI 10.1073/pnas.89.17.8102; NAITO M, 1991, AM J PATHOL, V139, P1411; Neyen C, 2009, BIOCHEMISTRY-US, V48, P11858, DOI 10.1021/bi9013769; Nikolic D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-37; Ott G, 2017, WHO CLASSIFICATION T, P289, DOI [10.1161/01.atv.19.8.1872, DOI 10.1161/01.ATV.19.8.1872]; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; PrabhuDas MR, 2017, J IMMUNOL, V198, P3775, DOI 10.4049/jimmunol.1700373; PULFORD KAF, 1989, J CLIN PATHOL, V42, P414, DOI 10.1136/jcp.42.4.414; Saito Y, 2014, J CLIN EXP HEMATOP, V54, P59, DOI 10.3960/jslrt.54.59; Sanchez-Espiridion B, 2012, HAEMATOL-HEMATOL J, V97, P1080, DOI 10.3324/haematol.2011.055459; Santiago-Garcia J, 2003, J BIOL CHEM, V278, P6942, DOI 10.1074/jbc.M208358200; Santiago-Garcia J, 2001, J BIOL CHEM, V276, P30655, DOI 10.1074/jbc.M102879200; Scott DW, 2014, HEMATOL-AM SOC HEMAT, P144, DOI 10.1182/asheducation-2014.1.144; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Sweet MJ, 2003, ARCH IMMUNOL THER EX, V51, P169; Tadmor T, 2015, MAYO CLIN PROC, V90, P756, DOI 10.1016/j.mayocp.2015.03.025; Takeya M, 2016, PATHOL INT, V66, P491, DOI 10.1111/pin.12440; Thiele J, 2017, WHO CLASSIFICATION T, V4th, P435; Touati M, 2015, LEUKEMIA LYMPHOMA, V56, P332, DOI 10.3109/10428194.2014.917636; van Velzen AG, 1999, EXP CELL RES, V250, P264, DOI 10.1006/excr.1999.4530; vanderKooij MA, 1996, ARTERIOSCL THROM VAS, V16, P106, DOI 10.1161/01.ATV.16.1.106; Vari F, 2018, BLOOD, V131, P1809, DOI 10.1182/blood-2017-07-796342; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; Xu WY, 2007, MOL IMMUNOL, V44, P2315, DOI 10.1016/j.molimm.2006.11.013; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8	67	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224621	10.1371/journal.pone.0224621	http://dx.doi.org/10.1371/journal.pone.0224621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714922	gold, Green Published			2022-12-26	WOS:000532710400010
J	Gonzalez-Canete, FJ; Rodriguez, JLL; Galdon, PM; Diaz-Estrella, A				Gonzalez-Canete, F. J.; Lopez Rodriguez, J. L.; Galdon, P. M.; Diaz-Estrella, A.			Improvements in the learnability of smartphone haptic interfaces for visually impaired users	PLOS ONE			English	Article							ICONS; RECOGNITION; DESIGN; PEOPLE; BLIND	We report the results of a study on the learnability of haptic icons used as alerts or notifications in smartphones. The aim was to explore the feasibility of using haptic icons to create assistive technologies for people with visual impairments. We compared the performance and satisfaction of users with different visual capacities (visually impaired vs. sighted) and using different learning processes (with or without a reinforcement learning stage). The reinforcement learning stage improves the recognition rate in both types of users, although the improvement obtained by the visually impaired users is even better as their recognition rates become very similar to those obtained by the sighted users. Finally, it was observed that the better recognized haptic icons are those assigned to the most employed applications by the user.	[Gonzalez-Canete, F. J.; Lopez Rodriguez, J. L.; Galdon, P. M.; Diaz-Estrella, A.] Univ Malaga, Dept Elect Technol, Campus Teatinos, Malaga, Spain	Universidad de Malaga	Gonzalez-Canete, FJ (corresponding author), Univ Malaga, Dept Elect Technol, Campus Teatinos, Malaga, Spain.	fgc@uma.es	GONZALEZ CANETE, FRANCISCO JAVIER/M-5538-2014	GONZALEZ CANETE, FRANCISCO JAVIER/0000-0002-7430-1100; Diaz Estrella, Antonio/0000-0002-2773-0113				Adam Swerdfeger B, 2009, THESIS; [Anonymous], 2000, TOUCH REPRESENTATION; [Anonymous], 2010, HAPTICS WHITE PAPER; [Anonymous], 2017, IMMERSION LG ELECTRO; Azadi M, 2014, IEEE T HAPTICS, V7, P14, DOI 10.1109/TOH.2013.2296051; Ballesteros S, 2005, BRIT J VISUAL IMPA, V23, P11, DOI 10.1177/0264619605051717; Brewster S., 2004, AUSTR US INT C 04, P18; Brown L M., 2006, P C HUM FACT COMP SY, P610; Cohen Joseph, 2018, ARXIV181110120; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Csapo A, 2015, J MULTIMODAL USER IN, V9, P275, DOI 10.1007/s12193-015-0182-7; D'Angiulli A, 2002, INT J REHABIL RES, V25, P143, DOI 10.1097/00004356-200206000-00008; Enriquez M, 2008, 16 S HAPT INT VIRT E; Ferguson J, 2018, NORDICHI'18: PROCEEDINGS OF THE 10TH NORDIC CONFERENCE ON HUMAN-COMPUTER INTERACTION, P215, DOI 10.1145/3240167.3240175; Gallace A, 2007, PRESENCE-VIRTUAL AUG, V16, P655, DOI 10.1162/pres.16.6.655; Gallace A, 2009, PSYCHOL BULL, V135, P380, DOI 10.1037/a0015325; Glover I., 2013, 2013 PRESENTED EDMED, P1999; Griffin-Shirley N, 2017, J VISUAL IMPAIR BLIN, V111, P307; Hoggan E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2253; Jimenez R, 2018, 1 INT C HUM SYST ENG, P16; Jones LA, 2009, PERCEPTION, V38, P52, DOI 10.1068/p5914; Korn O., 2012, P 4 ACM SIGCHI S ENG, P313, DOI DOI 10.1145/2305484.2305539; Lai HH, 2006, INT J IND ERGONOM, V36, P565, DOI 10.1016/j.ergon.2006.01.015; Maclean K., 2003, P EUROHAPTICS, P351, DOI DOI 10.1109/HAPTICS.2006.171; MacLean K.E, 2008, REV HUMAN FACTORS ER, V4, P149, DOI DOI 10.1518/155723408X342826; Maclean KE, 2008, IEEE ROBOT AUTOM MAG, V15, P104, DOI 10.1109/M-RA.2007.914919; Galdon PM, 2013, ASSIST TECHNOL, V25, P80, DOI 10.1080/10400435.2012.715112; Moreno R, 1999, J EDUC PSYCHOL, V91, P358, DOI 10.1037/0022-0663.91.2.358; Paivio A., 1990, MENTAL REPRESENTATIO, P348, DOI [10.1093/acprof:oso/9780195066661.003.0004, DOI 10.1093/ACPROF:OSO/9780195066661.003.0004]; Rantala J, 2009, IEEE T HAPTICS, V2, P28, DOI 10.1109/ToH.2009.3; Salvador-Ullauri L, 2017, PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON EDUCATION TECHNOLOGY AND COMPUTERS (ICETC 2017), P84, DOI 10.1145/3175536.3175576; Sanchez J, 2011, ASSETS 11: PROCEEDINGS OF THE 13TH INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P227; Stephan KL, 2006, HUM FACTORS, V48, P288, DOI 10.1518/001872006777724426; Swerdfeger B., P133; Ternes D, 2008, LECT NOTES COMPUT SC, V5024, P199, DOI 10.1007/978-3-540-69057-3_24; Tullis T., 2013, MEASURING USER EXPER; Wagoner B., 2011, PRINC LEADERSH, V12, P56; YanFi, 2017, PROCEDIA COMPUT SCI, V116, P638, DOI 10.1016/j.procs.2017.10.032	38	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0225053	10.1371/journal.pone.0225053	http://dx.doi.org/10.1371/journal.pone.0225053			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710628	Green Published, gold			2022-12-26	WOS:000532699900039
J	Su, YD; Lee, TC; Lin, YC; Chen, SK				Su, Yu-De; Lee, Tien-Ching; Lin, Yu-Chuan; Chen, Shen-Kai			Arthroscopic release for frozen shoulder: Does the timing of intervention and diabetes affect outcome?	PLOS ONE			English	Article							CAPSULAR RELEASE; INJECTION	Purpose To evaluate the effect of timing of arthroscopic release and manipulation under anesthesia for frozen shoulder in patients with diabetes and non-diabetes. Methods One hundred and twenty-seven patients with frozen shoulder were included in the study. Each patient was assigned to: 1) one of four groups according to the duration from symptom onset to surgery (group A: <= 3 months; group B: 3-6 months; group C: 6-12 months; group D: > 12 months), 2) diabetic or nondiabetic group. The outcomes were measured by shoulder range of motion (ROM), Disabilities of the Arm, Shoulder, and Hand (DASH) score, American Shoulder and Elbow Surgeons (ASES) Shoulder score, the period of pain relief, overall duration of disease, and satisfaction. Results All the patients got great improvement in shoulder ROM (P < .0001) after arthroscopic surgery, but there was no statistical difference in the pre-operative and post-operative shoulder ROM between the four groups and between diabetic and nondiabetic groups. The overall duration of disease was mean 55.4 similar to 68.7 weeks, which demonstrated much shorter disease course compared with nature course. Improvement were also seen in shoulder ROM at one week to one month, and the period of total pain relief was at a mean time of 3.7 to 3.8 weeks. There were higher ASES Shoulder score in group B than in group C (P = 0.02) and higher DASH score in diabetic group in short term follow-up. Conclusions Arthroscopic release provides effective and rapid improvements to shoulder motion and function, unrelated to the timing of surgery, in patients with frozen shoulder. The diabetic patients do not have functional outcomes as good as the nondiabetic patient at short-term follow-up.	[Su, Yu-De; Lin, Yu-Chuan; Chen, Shen-Kai] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Lee, Tien-Ching] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Lee, Tien-Ching] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lee, Tien-Ching; Chen, Shen-Kai] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Orthoped, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital	Lee, TC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan.; Lee, TC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.; Lee, TC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Orthoped, Kaohsiung, Taiwan.	tn916943@gmail.com	Lee, Tien-Ching/ABF-4544-2021	Lee, Tien-Ching/0000-0002-1510-8079	Kaohsiung Municipal Ta-Tung Hospital [kmtth104-031, kmtth-107-043]	Kaohsiung Municipal Ta-Tung Hospital	This study was funded by grants from Kaohsiung Municipal Ta-Tung Hospital (kmtth104-031, kmtth-107-043).	Baums MH, 2007, KNEE SURG SPORT TR A, V15, P638, DOI 10.1007/s00167-006-0203-x; Berghs BM, 2004, J SHOULDER ELB SURG, V13, P180, DOI 10.1016/j.jse.2003.12.004; Chambler AFW, 2003, J BONE JOINT SURG BR, V85B, P789, DOI 10.1302/0301-620X.85B6.14379; Chen SK, 2008, KAOHSIUNG J MED SCI, V24, P78, DOI 10.1016/S1607-551X(08)70101-3; Cho CH, 2016, ARTHROSCOPY, V32, P1515, DOI 10.1016/j.arthro.2016.01.040; Dattani R, 2013, BONE JOINT J, V95B, P942, DOI 10.1302/0301-620X.95B7.31197; Favejee MM, 2011, BRIT J SPORT MED, V45, P49, DOI 10.1136/bjsm.2010.071431; Hand C, 2008, J SHOULDER ELB SURG, V17, P231, DOI 10.1016/j.jse.2007.05.009; Hand GCR, 2007, J BONE JOINT SURG BR, V89B, P928, DOI 10.1302/0301-620X.89B7.19097; Hsu JE, 2011, J SHOULDER ELB SURG, V20, P502, DOI 10.1016/j.jse.2010.08.023; Le Lievre HMJ, 2012, J BONE JOINT SURG AM, V94A, P1208, DOI 10.2106/JBJS.J.00952; Massoud SN, 2002, J SHOULDER ELB SURG, V11, P609, DOI 10.1067/mse.2002.127301; Mehta SS, 2014, BONE JOINT J, V96B, P1355, DOI 10.1302/0301-620X.96B10.34476; Mukherjee RN, 2017, WORLD J ORTHOP, V8, P394, DOI 10.5312/wjo.v8.i5.394; Richards R R, 1994, J Shoulder Elbow Surg, V3, P347, DOI 10.1016/S1058-2746(09)80019-0; Robinson CM, 2012, J BONE JOINT SURG BR, V94B, P1, DOI 10.1302/0301-620X.94B1.27093; Sharma S, 2011, ANN ROY COLL SURG, V93, P343, DOI 10.1308/147870811X582080; Smith CD, 2014, ANN ROY COLL SURG, V96, P55, DOI 10.1308/003588414X13824511650452; Thomas WJC, 2011, J BONE JOINT SURG BR, V93B, P1377, DOI 10.1302/0301-620X.93B10.27224; Wong PLK, 2010, SINGAP MED J, V51, P694	20	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224986	10.1371/journal.pone.0224986	http://dx.doi.org/10.1371/journal.pone.0224986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710642	gold, Green Published			2022-12-26	WOS:000532699900034
J	Yao, JJ; Wang, HP; Yin, X; Yin, J; Guo, XL; Sun, Q				Yao, Jingjing; Wang, Haipeng; Yin, Xiao; Yin, Jia; Guo, Xiaolei; Sun, Qiang			The association between self-efficacy and self-management behaviors among Chinese patients with type 2 diabetes	PLOS ONE			English	Article							SOCIAL COGNITIVE THEORY; MELLITUS; PREVALENCE; EDUCATION; MODEL; CARE	Background Self-management is the cornerstone of diabetes care, however, despite the numerous recommendations available for self-management, type-2 diabetes mellitus (T2DM) patients' performance is suboptimal in China. This study aimed to explore the association between self-efficacy and self-management behaviors among Chinese T2DM patients, which might provide evidence to inform effective self-management interventions for these patients. Methods A cross-sectional survey was conducted using a multi-stage stratified randomized sampling in Shandong Province, China. The Diabetes Empowerment Scale-Short Form (DES-SF) was used to measure patients' self-efficacy to manage diabetes. Latent class analysis (LCA) was used to explore the observed classes of self-management behaviors (dietary control, physical exercise, regular medication and self-monitoring of blood glucose). A two-class solution for self-management behaviors was tested to be the fittest based on LCA; we labelled active and inactive self-management groups. Univariate and multivariate logistic regression analysis were used to examine the associations between self-efficacy and self-management behaviors. Results A total of 2166 T2DM patients were included in the analysis. The mean DES-SF score was 31.9 (standard deviation: 5.2). The estimated proportions of T2DM in the active and inactive groups were 54.8% and 45.2%, respectively. The multivariate logistic regression showed that higher DES-SF score was significantly associated with higher possibility of active self-management behaviors (odds ratio = 1.06; 95% confidence interval: 1.04-1.08). Conclusions Self-efficacy in managing diabetes is associated with self-management behaviors among Chinese T2DM patients. To improve self-management behaviors, multiple strategies should be conducted to improve patients' self-efficacy.	[Yao, Jingjing; Wang, Haipeng; Yin, Jia; Sun, Qiang] Shandong Univ, Sch Hlth Care Management, NHC Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China; [Yin, Xiao] Jinan Cent Hosp, Jinan, Peoples R China; [Guo, Xiaolei] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Sun, Q (corresponding author), Shandong Univ, Sch Hlth Care Management, NHC Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China.	qiangs@sdu.edu.cn		Yao, Jiansen/0000-0002-9985-0405	Natural Science Foundation of Shandong Province of China [ZR2016GQ02]	Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This study was funded by the Natural Science Foundation of Shandong Province of China, grant number ZR2016GQ02. HW received the grant. URL: http://cloud.sdstc.gov.cn/uc/login/login.htm#.	Al-Dwaikat TN, 2017, J NURS MEAS, V25, pE74, DOI 10.1891/1061-3749.25.2.E74; Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a; [Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; [Anonymous], 2014, DIABETES RES CLIN PR, V104, P1, DOI 10.1016/j.diabres.2012.10.001; Browning C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009319; Cai L, 2016, DIABETES RES CLIN PR, V121, P9, DOI 10.1016/j.diabres.2016.07.032; Chau YS, 2005, J CLIN NURS, V14, P1257, DOI 10.1111/j.1365-2702.2005.01221.x; Chinese Medical Association Diabetes Branch, 2012, CHINA DIABETES J, V20, pS1; Chrvala CA, 2016, PATIENT EDUC COUNS, V99, P926, DOI 10.1016/j.pec.2015.11.003; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Coulter A, 2013, COCHRANE DB SYST REV, V3; Do V, 2015, F1000RES, V4, pe150; Garabedian LF, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0680-8; Geng ZH, 2018, CANCER NURS, V41, pE1, DOI 10.1097/NCC.0000000000000571; He M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2039-0; He XQ, 2017, ENDOCRINE, V55, P712, DOI 10.1007/s12020-016-1168-2; [胡贝贝 Hu Beibei], 2011, [中华护理杂志, Chinese Journal of Nursing], V46, P225; Huang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095138; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Jang Y, 2012, CONTEMP NURSE, V40, P147, DOI 10.5172/conu.2012.40.2.147; Kalkura MP, 2018, J CLIN DIAGN RES, V12, pLC1, DOI 10.7860/JDCR/2018/36584.11993; KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308; Kurnia AD, 2017, Int J Nurs Sci, V4, P260, DOI 10.1016/j.ijnss.2017.06.010; Lee Nantawadee P, 2005, J Appl Meas, V6, P366; Li, 2017, CHIN GEN PRAC, V20, P367, DOI [10.1371/journal.pone.0224869, DOI 10.1371/JOURNAL.PONE.0224869]; Lin TH, 1997, J EDUC BEHAV STAT, V22, P249, DOI 10.2307/1165284; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Meng QY, 2015, LANCET, V386, P1484, DOI 10.1016/S0140-6736(15)00342-6; Mishali M, 2011, FAM PRACT, V28, P82, DOI 10.1093/fampra/cmq086; Ong WM, 2014, PATIENT PREFER ADHER, V8, P237, DOI 10.2147/PPA.S57567; Reyes J, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617713097; Sabourin BC, 2013, CAN J DIABETES, V37, P36, DOI 10.1016/j.jcjd.2013.01.002; Sarkar U, 2006, DIABETES CARE, V29, P823, DOI 10.2337/diacare.29.04.06.dc05-1615; Schiotz M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-160; Stajkovic AD, 1998, ORGAN DYN, V26, P62, DOI 10.1016/S0090-2616(98)90006-7; Tang TS, 2011, DIABETES EDUCATOR, V37, P67, DOI 10.1177/0145721710387308; Tougas ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134977; Tung HH, 2012, HEART ASIA, V4, P114, DOI 10.1136/heartasia-2012-010155; Van Hecke A, 2017, J ADV NURS, V73, P775, DOI 10.1111/jan.13159; Wang LM, 2017, JAMA-J AM MED ASSOC, V317, P2515, DOI 10.1001/jama.2017.7596; [魏魏 Wei Wei], 2015, [中国全科医学, Chinese General Practice], V18, P4039; Weinger K, 2005, DIABETES CARE, V28, P1346, DOI 10.2337/diacare.28.6.1346; WHO, 2016, GLOB REP PSOR; Wu D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017611; Yeh JZ, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5972-x; Zhang GH, 2017, CHIN J PREV CONTR CH, V25, P881	47	15	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224869	10.1371/journal.pone.0224869	http://dx.doi.org/10.1371/journal.pone.0224869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710631	gold, Green Submitted, Green Published			2022-12-26	WOS:000532699900025
J	Kuroda, K; Yashiro, M; Sera, T; Yamamoto, Y; Kushitani, Y; Sugimoto, A; Kushiyama, S; Nishimura, S; Togano, S; Okuno, T; Tamura, T; Toyokawa, T; Tanaka, H; Muguruma, K; Hire, M				Kuroda, Kenji; Yashiro, Masakazu; Sera, Tomohiro; Yamamoto, Yurie; Kushitani, Yukako; Sugimoto, Atsushi; Kushiyama, Syuhei; Nishimura, Sadaaki; Togano, Shingo; Okuno, Tomohisa; Tamura, Tatsuro; Toyokawa, Takahiro; Tanaka, Hiroaki; Muguruma, Kazuya; Hire, Masaichi			The clinicopathological significance of Thrombospondin-4 expression in the tumor microenvironment of gastric cancer	PLOS ONE			English	Article							THBS4	Introduction Thrombospondin-4 [1] is an extracellular glycoprotein involved in wound healing and tissue remodeling. Although THBS4 is reportedly frequently expressed in solid tumors, there are few reports of the clinicopathological features of carcinomas with THBS4 expression. We evaluated the clinicopathologic significance of THBS4 expression in gastric carcinoma (GC). Materials and methods We retrospectively analyzed the cases of 584 GC patients. The expression of THBS4 in each tumor was evaluated by immunohistochemistry. We then divided the patients into the THBS4-high (n = 223, 38.2%) group and THBS4-low (n = 361, 61.8%) group. THBS4 expression in cancer-associated fibroblasts (CAFs), normal-associated fibroblasts (NFs) and gastric cancer cell lines was examined by western blotting. Results THBS4 is expressed on stromal cells with alpha SMA or Podoplanin expression in the GC microenvironment, but not expressed on cancer cells with cytokeratin expression. The western blot analysis results showed that CAFs (but not NFs and cancer cells) expressed THBS4. Compared to the THBS4-low expression status, the THBS4-high expression status was correlated with higher alpha SMA expression, higher invasion depth, lymph-node metastasis, lymphatic invasion, peritoneal cytology, peritoneal metastasis, larger tumor size, microscopic diffuse type, and the macroscopic diffuse infiltrating type. The THBS4-high group's 5-year overall survival rate was significantly poorer than that of the THBS4-low group. A multivariate analysis revealed that THBS4 expression was an independent prognostic factor. Conclusion THBS4 is expressed on CAFs in the gastric cancer microenvironment. THBS4 from CAFs is associated with the metastasis of cancer cells, and is a useful prognostic indicator for gastric cancer patients.	[Kuroda, Kenji; Yashiro, Masakazu; Sera, Tomohiro; Kushitani, Yukako; Sugimoto, Atsushi; Kushiyama, Syuhei; Nishimura, Sadaaki; Togano, Shingo; Okuno, Tomohisa; Tamura, Tatsuro; Toyokawa, Takahiro; Tanaka, Hiroaki; Muguruma, Kazuya; Hire, Masaichi] Osaka City Univ, Dept Gastroenterol Surg, Grad Sch Med, Osaka, Japan; [Kuroda, Kenji; Yashiro, Masakazu; Sera, Tomohiro; Yamamoto, Yurie; Kushitani, Yukako; Sugimoto, Atsushi; Kushiyama, Syuhei; Nishimura, Sadaaki; Togano, Shingo; Okuno, Tomohisa] Osaka City Univ, Mol Oncol & Therapeut, Grad Sch Med, Osaka, Japan; [Kuroda, Kenji; Yashiro, Masakazu; Sera, Tomohiro; Yamamoto, Yurie; Kushitani, Yukako; Sugimoto, Atsushi; Kushiyama, Syuhei; Nishimura, Sadaaki; Togano, Shingo; Okuno, Tomohisa] Osaka City Univ, Canc Ctr Translat Res, Grad Sch Med, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Yashiro, M (corresponding author), Osaka City Univ, Dept Gastroenterol Surg, Grad Sch Med, Osaka, Japan.; Yashiro, M (corresponding author), Osaka City Univ, Mol Oncol & Therapeut, Grad Sch Med, Osaka, Japan.; Yashiro, M (corresponding author), Osaka City Univ, Canc Ctr Translat Res, Grad Sch Med, Osaka, Japan.	m9312510@med.osaka-cu.ac.jp		Sugimoto, Atsushi/0000-0003-3311-2562	Japan Society for the Promotion of Science KAKENHI [JP18H02883]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is partially supported by Japan Society for the Promotion of Science KAKENHI (Grant-in-Aid for Scientific Research B; Grant Number JP18H02883 (https://www.jsps.go.jp/english/e-grants/) to MY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Chen XB, 2019, J PHYSIOL BIOCHEM, V75, P117, DOI 10.1007/s13105-019-00665-9; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Forster S, 2011, MODERN PATHOL, V24, P1390, DOI 10.1038/modpathol.2011.99; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Greco SA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-494; Huang TT, 2018, CELL PHYSIOL BIOCHEM, V50, P1332, DOI 10.1159/000494590; Ishimoto T, 2017, GASTROENTEROLOGY, V153, P191, DOI 10.1053/j.gastro.2017.03.046; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Lin XD, 2016, CANCER GENET-NY, V209, P215, DOI 10.1016/j.cancergen.2016.04.003; Liu JL, 2016, MOL MED REP, V14, P1451, DOI 10.3892/mmr.2016.5443; Muppala S, 2017, ONCOGENE, V36, P5189, DOI 10.1038/onc.2017.140; Nakazawa K, 2003, CANCER RES, V63, P8848; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reed AEM, 2013, VIRCHOWS ARCH, V463, P535, DOI 10.1007/s00428-013-1468-3; Song J, 2010, ANN SURG ONCOL, V17, P1777, DOI 10.1245/s10434-010-0932-4; Stenina-Adognravi O, 2019, MATRIX BIOL, V75-76, P300, DOI 10.1016/j.matbio.2017.11.006; Su F, 2017, ONCOTARGET, V8, P23277, DOI 10.18632/oncotarget.15054; van Doorn R, 2005, J CLIN ONCOL, V23, P3886, DOI 10.1200/JCO.2005.11.353; Wu HF, 2019, GENE, V696, P219, DOI 10.1016/j.gene.2019.02.049; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Yashiro M, 2010, INT J CANCER, V126, P1004, DOI 10.1002/ijc.24763	23	13	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224727	10.1371/journal.pone.0224727	http://dx.doi.org/10.1371/journal.pone.0224727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703077	gold, Green Published			2022-12-26	WOS:000532697200020
J	Moreyra, NN; Mensch, J; Hurtado, J; Almeida, F; Laprida, C; Hasson, E				Nahuel Moreyra, Nicolas; Mensch, Julian; Hurtado, Juan; Almeida, Francisca; Laprida, Cecilia; Hasson, Esteban			What does mitogenomics tell us about the evolutionary history of the Drosophila buzzatii cluster (repleta group)?	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CACTOPHILIC DROSOPHILA; GENE TREES; PHYLOGENETIC ANALYSIS; COMPARATIVE GENOMICS; POPULATION-GENETICS; SERIDO DIPTERA; INTROGRESSION; DIVERGENCE; SPECIATION	The Drosophila repleta group is an array of more than 100 species endemic to the "New World", many of which are cactophilic. The ability to utilize decaying cactus tissues as breeding and feeding sites is a key aspect that allowed the successful diversification of the repleta group in American deserts and arid lands. Within this group, the Drosophila buzzatii cluster is a South American clade of seven closely related species in different stages of divergence, making them a valuable model system for evolutionary research. Substantial effort has been devoted to elucidating the phylogenetic relationships among members of the D. buzzatii cluster, including molecular phylogenetic studies that have generated ambiguous results where different tree topologies have resulted dependent on the kinds of molecular marker used. Even though mitochondrial DNA regions have become useful markers in evolutionary biology and population genetics, none of the more than twenty Drosophila mitogenomes assembled so far includes this cluster. Here, we report the assembly of six complete mitogenomes of five species: D. antonietae, D. borborema, D. buzzatii, two strains of D. koepferae and D. seriema, with the aim of revisiting phylogenetic relationships and divergence times by means of mitogenomic analyses. Our recovered topology using complete mitogenomes supports the hypothesis of monophyly of the D. buzzatii cluster and shows two main clades, one including D. buzzatii and D. koepferae (both strains), and the other containing the remaining species. These results are in agreement with previous reports based on a few mitochondrial and/or nuclear genes, but conflict with the results of a recent large-scale nuclear phylogeny, indicating that nuclear and mitochondrial genomes depict different evolutionary histories.	[Nahuel Moreyra, Nicolas; Mensch, Julian; Hurtado, Juan; Almeida, Francisca; Laprida, Cecilia; Hasson, Esteban] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Nahuel Moreyra, Nicolas; Mensch, Julian; Hurtado, Juan; Almeida, Francisca; Hasson, Esteban] Consejo Nacl Invest Cient & Tecn, Inst Ecol Genet & Evoluc Buenos Aires, Buenos Aires, DF, Argentina; [Laprida, Cecilia] CONICET UBA, Inst Estudios Andinos, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Moreyra, NN; Hasson, E (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina.; Moreyra, NN; Hasson, E (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Ecol Genet & Evoluc Buenos Aires, Buenos Aires, DF, Argentina.	nmoreyra@ege.fcen.uba.ar; ehasson@ege.fcen.uba.ar	MENSCH, JULIAN/GYD-5497-2022	MENSCH, JULIAN/0000-0002-2298-4309; Moreyra, Nicolas Nahuel/0000-0003-0451-2399; Hurtado, Juan/0000-0002-6496-3477	University of Buenos Aires (UBA); CONICET; ANPCyT	University of Buenos Aires (UBA)(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT)	This work was supported by University of Buenos Aires (UBA), CONICET and ANPCyT grants awarded to EH. UBA: http://www.uba.ar/; CONICET: https://www.conicet.gov.ar/; ANPCyT: https://www.argentina.gob.ar/ciencia/agencia.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBERT J, 1990, EVOLUTION, V44, P1272, DOI 10.1111/j.1558-5646.1990.tb05231.x; Bachli G., DATABASE; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Ballard JWO, 2000, J MOL EVOL, V51, P64, DOI 10.1007/s002390010067; Balloux F, 2010, HEREDITY, V104, P419, DOI 10.1038/hdy.2009.122; Barker J.S.F., 1982, ECOLOGICAL GENETICS; Barrios-Leal DY, 2019, J HERED, V110, P22, DOI 10.1093/jhered/esy042; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Cameron SL, 2001, ANNU REV ENTOMOL, V59, P95; Chan KMA, 2005, EVOLUTION, V59, P720; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; de Lima LG, 2017, G3-GENES GENOM GENET, V7, P2831, DOI 10.1534/g3.117.042093; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; De Panis DN, 2016, MOL ECOL, V25, P4534, DOI 10.1111/mec.13785; Duchene S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027138; ENDLER JA, 1982, AM ZOOL, V22, P441; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Fogleman JC, 2001, AM ZOOL, V41, P877, DOI 10.1668/0003-1569(2001)041[0877:CIITCM]2.0.CO;2; FONTDEVILA A, 1988, ANN ENTOMOL SOC AM, V81, P380, DOI 10.1093/aesa/81.3.380; Fontdevila A., 2012, EVOLUTIONARY BIOL TR; Franco FF, 2013, J BIOGEOGR, V40, P142, DOI 10.1111/j.1365-2699.2012.02777.x; Franco FF, 2010, J ZOOL SYST EVOL RES, V48, P322, DOI 10.1111/j.1439-0469.2010.00564.x; Friedrich T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501923; Fritz SC, 2012, PALAEOGEOGR PALAEOCL, P317; Gomez GA, 2003, MOL BIOL EVOL, V20, P410, DOI 10.1093/molbev/msg051; Gosling WD, 2008, PALAEOGEOGR PALAEOCL, V259, P35, DOI 10.1016/j.palaeo.2007.02.050; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guillen Y, 2015, GENOME BIOL EVOL, V7, P349, DOI 10.1093/gbe/evu291; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; HASSON E, 1992, REV CHIL HIST NAT, V65, P319; Hasson E, 2019, J HERED, V110, P46, DOI 10.1093/jhered/esy043; Hasson Esteban, 2009, P89; Heed W.G., 1986, P311; Heed W. B., 1978, ECOLOGICAL GENETICS, P109, DOI DOI 10.1007/978-1-4612-6330-2; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Hoorn C, 2011, SCIENCE, V331, P399, DOI 10.1126/science.331.6016.399; Hughes PD, 2018, QUATERNARY RES, V90, P222, DOI 10.1017/qua.2018.37; Hurtado J, 2019, ARTHROPOD SYST PHYLO, V77, P239, DOI 10.26049/ASP77-2-2019-03; Iglesias PP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176119; Keck BP, 2010, EVOLUTION, V64, P1410, DOI 10.1111/j.1558-5646.2009.00901.x; Knaus Brian J., 2011, BMC Ecology, V11, P10, DOI 10.1186/1472-6785-11-10; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lagomarsino LP, 2016, NEW PHYTOL, V210, P1430, DOI 10.1111/nph.13920; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Machado L. P. B., 2006, Braz. J. Biol., V66, P279, DOI 10.1590/S1519-69842006000200010; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MadiRavazzi L, 1997, CYTOBIOS, V89, P21; Manfrin MH, 2006, GENETICA, V126, P57, DOI 10.1007/s10709-005-1432-5; Manfrin MH, 2001, ANN ENTOMOL SOC AM, V94, P333, DOI 10.1603/0013-8746(2001)094[0333:SAEOTD]2.0.CO;2; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Markow T.A., 2005, DROSOPHILA GUIDE SPE; Markow TA, 2019, CURR OPIN INSECT SCI, V31, P139, DOI 10.1016/j.cois.2019.01.006; Montooth KL, 2009, J MOL EVOL, V69, P94, DOI 10.1007/s00239-009-9255-0; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; Mosblech NAS, 2012, NAT GEOSCI, V5, P817, DOI [10.1038/ngeo1588, 10.1038/NGEO1588]; O'Grady PM, 2018, GENETICS, V209, P1, DOI 10.1534/genetics.117.300583; Oliveira DCSG, 2012, MOL PHYLOGENET EVOL, V64, P533, DOI 10.1016/j.ympev.2012.05.012; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V69, P339, DOI 10.1016/j.ympev.2013.07.016; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Patterson JT, 1942, DESCRIPTION NEW SPEC; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Piccinali R, 2004, MOL BIOL EVOL, V21, P141, DOI [10.1093/molbev/msh006, 10.1093/molbev.msh006]; POWELL JR, 1983, P NATL ACAD SCI-BIOL, V80, P492, DOI 10.1073/pnas.80.2.492; Quipildor VB, 2018, J BIOGEOGR, V45, P116, DOI 10.1111/jbi.13106; Rambaut A, 2007, FIGTREE TREE FIGURE; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rincon-Martinez D, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001868; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Trelles F, 2000, MOL BIOL EVOL, V17, P1112, DOI 10.1093/oxfordjournals.molbev.a026392; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos J, 2007, MOL PHYLOGENET EVOL, V45, P663, DOI 10.1016/j.ympev.2007.06.018; Ruiz A, 2000, GENETICA, V108, P217, DOI 10.1023/A:1004195007178; RUIZ A, 1993, HEREDITY, V70, P582, DOI 10.1038/hdy.1993.85; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Smith DR, 2016, BRIEF FUNCT GENOMICS, V15, P47, DOI 10.1093/bfgp/elv027; Soto EM, 2008, ENTOMOL EXP APPL, V126, P18, DOI 10.1111/j.1570-7458.2007.00631.x; Soto IM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-77; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Throckmorton LH, 1975, PHYLOGENY ECOLOGY GE, V3, P421; Tian Y, 2016, MOL PHYLOGENET EVOL, V98, P57, DOI 10.1016/j.ympev.2016.01.017; Tidon-Sklorz Rosana, 2001, Iheringia Serie Zoologia, P141, DOI 10.1590/S0073-47212001000100014; TIDONSKLORZ R, 1995, ANN ENTOMOL SOC AM, V88, P139, DOI 10.1093/aesa/88.2.139; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; VILELA C R, 1977, Papeis Avulsos de Zoologia (Sao Paulo), V30, P295; Vilela CA, 1983, REV BRAS ENTOMOL, V27, P5; Wasserman M., 1982, Genetics and Biology of Drosophila, V3b, P61; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95; Wong A, 2007, MOL PHYLOGENET EVOL, V43, P1138, DOI 10.1016/j.ympev.2006.09.002; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zachos FE, 2009, J ZOOL SYST EVOL RES, V47, P209, DOI 10.1111/j.1439-0469.2009.00541.x; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; Zhang S., 2016, CHINESE J OCEANOLOGY, V35, P1018	110	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0220676	10.1371/journal.pone.0220676	http://dx.doi.org/10.1371/journal.pone.0220676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697700	Green Submitted, gold, Green Published			2022-12-26	WOS:000532694400006
J	Poupet, C; Saraoui, T; Veisseire, P; Bonnet, M; Dausset, C; Gachinat, M; Camares, O; Chassard, C; Nivoliez, A; Bornes, S				Poupet, Cyril; Saraoui, Taous; Veisseire, Philippe; Bonnet, Muriel; Dausset, Caroline; Gachinat, Marylise; Camares, Olivier; Chassard, Christophe; Nivoliez, Adrien; Bornes, Stephanie			Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights	PLOS ONE			English	Article							PROBIOTIC STRAIN; IN-VITRO; MANUFACTURING PROCESSES; CASEI-RHAMNOSUS; IDENTIFICATION; COLONIZATION; LONGEVITY; SELECTION; BACTERIA; CACO-2	The increased recurrence of Candida albicans infections is associated with greater resistance to antifungal drugs. This involves the establishment of alternative therapeutic protocols, such as probiotic microorganisms whose antifungal potential has already been demonstrated using preclinical models (cell cultures, laboratory animals). Understanding the mechanisms of action of probiotic microorganisms has become a strategic need for the development of new therapeutics for humans. In this study, we investigated the prophylactic anti-C. albicans properties of Lactobacillus rhamnosus Lcr35 (R) using the in vitro Caco-2 cell model and the in vivo Caenorhabditis elegans model. In Caco-2 cells, we showed that the strain Lcr35 (R) significantly inhibited the growth (similar to 2 log CFU.mL(-1)) and adhesion (150 to 6,300 times less) of the pathogen. Moreover, in addition to having a pro-longevity activity in the nematode (+42.9%, p = 3.56.10(-6)), Lcr35 (R) protects the animal from the fungal infection (+267% of survival, p < 2.10(-16)) even if the yeast is still detectable in its intestine. At the mechanistic level, we noticed the repression of genes of the p38 MAPK signalling pathway and genes involved in the antifungal response induced by Lcr35 (R), suggesting that the pathogen no longer appears to be detected by the worm immune system. However, the DAF-16/FOXO transcription factor, implicated in the longevity and antipathogenic response of C. elegans, is activated by Lcr35 (R). These results suggest that the probiotic strain acts by stimulating its host via DAF-16 but also by suppressing the virulence of the pathogen.	[Poupet, Cyril; Saraoui, Taous; Veisseire, Philippe; Bonnet, Muriel; Gachinat, Marylise; Camares, Olivier; Chassard, Christophe; Bornes, Stephanie] Univ Clermont Auvergne, INRA, VetAgro Sup, Aurillac, France; [Dausset, Caroline; Nivoliez, Adrien] Biose Ind, Aurillac, France	INRAE; Universite Clermont Auvergne (UCA); VetAgro Sup	Poupet, C (corresponding author), Univ Clermont Auvergne, INRA, VetAgro Sup, Aurillac, France.	cyril.poupet@uca.fr		Bornes, Stephanie/0000-0003-3944-6192; Poupet, Cyril/0000-0001-9343-4390; Dausset, Caroline/0000-0001-8281-1111	European funds FEDER; Auvergne-RhoneAlpes Region; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	European funds FEDER(European Commission); Auvergne-RhoneAlpes Region(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the European funds FEDER and the Auvergne-RhoneAlpes Region in the form of grants to CP, as well as biose, as part of the doctoral thesis of CP. The funder biose provided support in the form of salaries for authors CD and AN. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not otherwise have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, MYCOSES, V58, P642, DOI 10.1111/myc.12368; Allonsius CN, 2017, MICROB BIOTECHNOL, V10, P1753, DOI [10.1, 10.1111/1751-7915.12799]; [Anonymous], CLIN MICROBIOL INFEC; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; BRENNER S, 1974, GENETICS, V77, P71; Cauchie M, 2017, RES MICROBIOL, V168, P802, DOI 10.1016/j.resmic.2017.02.005; Coudeyras S, 2008, APPL ENVIRON MICROB, V74, P2679, DOI 10.1128/AEM.02286-07; Coudeyras Sophie, 2008, Infect Dis Obstet Gynecol, V2008, P549640, DOI 10.1155/2008/549640; Coudeyras S, 2010, CAN J MICROBIOL, V56, P611, DOI 10.1139/w10-052; Dausset C, 2018, EUR J CLIN MICROBIOL, V37, P1869, DOI 10.1007/s10096-018-3321-8; de Barros PP, 2018, MICROB PATHOGENESIS, V117, P80, DOI 10.1016/j.micpath.2018.02.019; De Champs C, 2003, J CLIN MICROBIOL, V41, P1270, DOI 10.1128/JCM.41.3.1270-1273.2003; do Carmo MS, 2018, FOOD FUNCT, V9, P5074, DOI 10.1039/c8fo00376a; Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735; FAO WHO, 2001, REP JOINT FAO WHO EX, DOI DOI 10.1201/9781420009613.CH16; Farmakiotis D, 2017, INT J ANTIMICROB AG, V50, P318, DOI 10.1016/j.ijantimicag.2017.05.019; Fatima S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113986; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Grompone G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052493; Guantario B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00595; Heestand BN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003651; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hu HJ, 2017, PEDIATR NEONATOL, V58, P103, DOI 10.1016/j.pedneo.2016.06.001; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Isolauri E, 2002, GUT, V50, P54, DOI 10.1136/gut.50.suppl_3.iii54; Jankowska A, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/357964; Kadosh D, 2016, CELL MOL LIFE SCI, V73, P4265, DOI 10.1007/s00018-016-2294-y; Kassambara A, 2017, SURVMINER DRAWING SU; Kim Y, 2012, INFECT IMMUN, V80, P2500, DOI 10.1128/IAI.06350-11; Komura T, 2013, BIOGERONTOLOGY, V14, P73, DOI 10.1007/s10522-012-9411-6; Lacroix C, 2015, CURR OPIN BIOTECH, V32, P149, DOI 10.1016/j.copbio.2014.12.009; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Matsubara VH, 2016, PROBIOTICS ANTIFUNGA; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Muller C, 2014, EUR J PHARM BIOPHARM, V88, P787, DOI 10.1016/j.ejpb.2014.07.014; Nakagawa H, 2016, AGING CELL, V15, P227, DOI 10.1111/acel.12431; Neville BA, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov081; Nivoliez A, 2015, APPL MICROBIOL BIOT, V99, P399, DOI 10.1007/s00253-014-6110-z; Nivoliez A, 2012, J BIOTECHNOL, V160, P236, DOI 10.1016/j.jbiotec.2012.04.005; Nowak A, 2016, INT J DAIRY TECHNOL, V69, P532, DOI 10.1111/1471-0307.12286; Olle B., 2013, NAT BIOTECHNOL; Papadimitriou K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00058; Park MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25333-8; Petricevic L, 2008, BJOG-INT J OBSTET GY, V115, P1369, DOI 10.1111/j.1471-0528.2008.01882.x; Phelan JP, 2005, AGEING RES REV, V4, P339, DOI 10.1016/j.arr.2005.06.001; PINTO M, 1983, BIOL CELL, V47, P323; Pukkila-Worley R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002074; Pukkila-Worley R, 2009, EUKARYOT CELL, V8, P1750, DOI 10.1128/EC.00163-09; R Core Team, 2018, R LANG ENV STAT COMP; Souza ACR, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080401; Roselli M, 2006, BRIT J NUTR, V95, P1177, DOI 10.1079/BJN20051681; Ruas-Madiedo P, 2006, J FOOD PROTECT, V69, P2011, DOI 10.4315/0362-028X-69.8.2011; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Scorzoni L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00036; Semple JI, 2010, NAT METHODS, V7, P725, DOI 10.1038/nmeth.1495; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Tan X, 2014, PLOS ONE, V9, P1; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Tullet JMA, 2015, BIOGERONTOLOGY, V16, P221, DOI 10.1007/s10522-014-9527-y; Vinderola G, 2017, TRENDS FOOD SCI TECH, V68, P83, DOI 10.1016/j.tifs.2017.08.005; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Wu K, 2010, CLIN MICROBIOL INFEC, V16, P245, DOI 10.1111/j.1469-0691.2009.02765.x; Zanni E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621709; Zhao L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07974-3	70	15	15	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0216184	10.1371/journal.pone.0216184	http://dx.doi.org/10.1371/journal.pone.0216184			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693670	Green Published, gold			2022-12-26	WOS:000532690100005
J	Ajah, LO; Onu, FA; Ogbuinya, OC; Ajah, MI; Ozumba, BC; Agbata, AT; Onoh, RC; Ekwedigwe, KC				Ajah, Leonard O.; Onu, Fidelis A.; Ogbuinya, Oliver C.; Ajah, Monique, I; Ozumba, Benjamin C.; Agbata, Anthony T.; Onoh, Robinson C.; Ekwedigwe, Kenneth C.			Choice of birth place among antenatal clinic attendees in rural mission hospitals in Ebonyi State, South-East Nigeria	PLOS ONE			English	Article							CARE	Background Low utilization of health facilities for delivery by pregnant women poses a public health challenge in Nigeria. Aim To determine the factors that influence the choice of birth place among antenatal clinic attendees. Methodology This was a cross-sectional study of the eligible antenatal clinic attendees recruited at Mater Misericordiae Hospital, Afikpo and Saint Vincent Hospital, Ndubia in Ebonyi State from February 1, 2016 to June 30, 2016. Analysis was done using EPI Info 7.21 software (CDC Atlanta Georgia). Results A total of 397(99.3%) completely filled questionnaires were collated and analysed. Approximately 71% of the health facilities closest to the respondents had maternity services. It took at least 1 hour for 80.9% of the respondents to access health facilities with maternity services. Most (60.2%) of the respondents had at least one antenatal clinic attendance and majority of them did so at public hospitals. Approximately 43.8% of the respondents were delivered by the skilled birth attendants. The respondents' age and the couple's educational level, history of antenatal clinic attendance, distance of the health facility and availability of transport fare had a significant effect on delivery by skilled birth attendants. The common determinants of birth place were nearness of the health facilities, familiarity of healthcare providers, improved services, sudden labour onset and cost. Also 61.7% of the respondents chose to deliver in public health facilities due to favourable reasons but this could be hampered by the rudeness of some healthcare providers at such facilities. A significant proportion of private health facilities had unskilled manpower and shortage of drugs. Conclusion A greater proportion of women will prefer to deliver in health facilities. However there are barriers to utilization of these facilities hence the need to address such barriers.	[Ajah, Leonard O.; Ozumba, Benjamin C.] Univ Nigeria, Fac Med Sci, Dept Obstet & Gynaecol, Ituku Ozalla Campus, Enugu, Nigeria; [Ajah, Leonard O.; Onu, Fidelis A.; Ogbuinya, Oliver C.; Agbata, Anthony T.; Onoh, Robinson C.; Ekwedigwe, Kenneth C.] Fed Teaching Hosp, Dept Obstet & Gynaecol, Abakaliki, Nigeria; [Ajah, Monique, I] Univ Nigeria, Inst Maternal & Childhlth, Ituku Ozalla Campus, Enugu, Nigeria	University of Nigeria; University of Nigeria	Ajah, LO (corresponding author), Univ Nigeria, Fac Med Sci, Dept Obstet & Gynaecol, Ituku Ozalla Campus, Enugu, Nigeria.; Ajah, LO (corresponding author), Fed Teaching Hosp, Dept Obstet & Gynaecol, Abakaliki, Nigeria.	leonard.ajah@unn.edu.ng						Abouzahr C, MATERNAL MORTALITY 2; Adam YM, 2002, NIGER J OBSTET GYNEA, V22, P600; Alastair A, 2005, HLTH POPUL PLANNING, V20, P76; Ambreen N, 2013, ISRA MED J, V5; Anthony Kkonde, 2010, FACTORS INFLUENCE PR; Bhatia J, 2004, HEALTH POLICY PLANN, V19, P402, DOI 10.1093/heapol/czh055; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Department of Health Service (DOHS), 200910 DOHS MOHP; Dickson Kwamena Sekyi, 2017, ADV PUBLIC HLTH, V2017, P1, DOI 10.1155/2017/9102808; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Idowu A, 2017, ETHIOP J HEALTH SCI, V27, P291, DOI 10.4314/ejhs.v27i3.11; Kimani H, 2015, PUBLIC HLTH RES, V5, P1, DOI DOI 10.5923/J.PHR.20150501.01; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Lwelamira J, 2012, ASIAN J MED SCI, V4, P105; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Pardeshi GS, 2011, J HEALTH POPUL NUTR, V29, P71; Ramesh KD, 2013, INT J MATERNAL CHILD, P30; Ravi RP., 2014, AM J PUBLIC HLTH RES, V2, P75, DOI [DOI 10.12691/AJPHR-2-3-2, 10.12691/ajphr-2-3-2]; Russell S, 2005, SOC SCI MED, V61, P1396, DOI 10.1016/j.socscimed.2004.11.077; Seljeskog Line, 2006, Afr J Reprod Health, V10, P66; United Nations, 2018, PROGR INF SUST DEV G, V3; WHO Reproductive Health Library, 2018, WHO REC RESP MAT CAR; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT	23	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0211306	10.1371/journal.pone.0211306	http://dx.doi.org/10.1371/journal.pone.0211306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689292	Green Published, Green Submitted, gold			2022-12-26	WOS:000532680100001
J	Arce, DY; Bellavia, A; Cantonwine, DE; Napoli, OJ; Meeker, JD; James-Todd, T; McElrath, TF; Tsen, LC				Arce, Dominique Y.; Bellavia, Andrea; Cantonwine, David E.; Napoli, Olivia J.; Meeker, John D.; James-Todd, Tamarra; McElrath, Thomas F.; Tsen, Lawrence C.			Average and time-specific maternal prenatal inflammatory biomarkers and the risk of labor epidural associated fever	PLOS ONE			English	Article							INTRAPARTUM FEVER; CYTOKINES; INTERLEUKIN-6; TEMPERATURE; CHORIOAMNIONITIS; ENCEPHALOPATHY; IL-1-BETA; ANALGESIA; PREGNANCY; ALPHA	Background The use of labor epidural analgesia has been associated with intrapartum fever, known as labor epidural associated fever (LEAF). LEAF is most commonly non-infectious in origin and associated with elevated inflammatory cytokines. Methods The LIFECODES pregnancy cohort was designed to prospectively collect data to evaluate the association of maternal inflammatory biomarkers with preterm birth in women who delivered between 2007 and 2008 at Brigham and Women's Hospital. Our secondary analysis of the data from the cohort identified 182 women for whom inflammatory biomarkers (i.e. interleukin-10, interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha and C-reactive protein) collected longitudinally over four prenatal visits was available. Maternal temperature and other clinical variables were abstracted from medical records. The primary outcome, the presence of LEAF, was defined as oral temperature >= 38 degrees C (>= 100.4 degrees F) after epidural analgesia initiation. Multivariable logistic regression estimated the association between inflammatory biomarker concentrations and the odds of developing an intrapartum fever after adjusting for a number of potential confounders. Results Women who developed LEAF were more likely to have a longer duration of epidural analgesia, whereas women who did not develop LEAF were more likely to have induced labor and positive or unknown Group B Streptococcus colonization status. However, no differences were seen by nulliparity, mode of delivery, white blood cell count at admission, baseline temperature, length of rupture of membranes and number of cervical exams performed during labor. Unadjusted and multivariable logistic regression models did not provide evidence for or exclude an association between individual maternal inflammatory biomarkers and the odds of developing LEAF, regardless of visit time-period. Conclusion The predictive value of maternal inflammatory biomarkers measured during early- and midpregnancy for the risk of developing LEAF cannot be excluded.	[Arce, Dominique Y.; Tsen, Lawrence C.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Obstetr Anesthesia, Boston, MA 02115 USA; [Bellavia, Andrea; James-Todd, Tamarra] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Cantonwine, David E.; McElrath, Thomas F.] Harvard Med Sch, Dept Obstet & Gynecol, Div Maternal Fetal Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Napoli, Olivia J.] Lake Erie Coll Osteopath Med, Erie, PA USA; [Meeker, John D.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan	Arce, DY (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Obstetr Anesthesia, Boston, MA 02115 USA.	DArce@bwh.harvard.edu	Bellavia, Andrea/ABE-8431-2020	Meeker, John/0000-0001-8357-5085	Harvard Anesthesia Departments National Institutes of Health T32 training grant [5T32GM007592-40]; National Institute of Environmental Health Sciences by the National Institutes of Health [R01ESO18872]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER	Harvard Anesthesia Departments National Institutes of Health T32 training grant; National Institute of Environmental Health Sciences by the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Harvard Anesthesia Departments National Institutes of Health T32 training grant (https://www.nigms.nih.gov/training/instpostdoc/pages/PostdocInst-Anesthesiology.aspx) (5T32GM007592-40) (DYA). This research was also supported by the National Institute of Environmental Health Sciences by the National Institutes of Health (https://www.niehs.nih.gov) (R01ESO18872) (JDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; American College of Obstetricians and Gynecologists, 2017, OBSTET GYNECOL, V130, pe95, DOI [10.1097/AOG.0000000000002236, DOI 10.1097/AOG.000, DOI 10.1097/AOG.0000000000002236]; Bergeron J, 2016, PLACENTA, V47, P116, DOI 10.1016/j.placenta.2016.09.016; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blume HK, 2008, DEV MED CHILD NEUROL, V50, P19, DOI 10.1111/j.1469-8749.2007.02007.x; Brennan FM, 2008, EUR J IMMUNOL, V38, P1106, DOI 10.1002/eji.200737821; Butwick AJ, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6567; Cahill AG, 2012, OBSTET GYNECOL, V119, P1096, DOI 10.1097/AOG.0b013e318256ce3f; Cartmell T, 2000, J PHYSIOL-LONDON, V526, P653, DOI 10.1111/j.1469-7793.2000.00653.x; Chai Z, 1996, J EXP MED, V183, P311, DOI 10.1084/jem.183.1.311; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Christian LM, 2014, AM J OBSTET GYNECOL, V211, P275, DOI 10.1016/j.ajog.2014.06.042; Clodi M, 2008, AM J PHYSIOL-ENDOC M, V295, pE686, DOI 10.1152/ajpendo.90263.2008; Curtin WM, 2015, J PERINATOL, V35, P396, DOI 10.1038/jp.2014.235; del Arroyo AG, 2019, BRIT J ANAESTH, V122, P92, DOI 10.1016/j.bja.2018.09.024; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Ferguson KK, 2014, AM J REPROD IMMUNOL, V72, P326, DOI 10.1111/aji.12265; Ferguson KK, 2014, JAMA PEDIATR, V168, P61, DOI 10.1001/jamapediatrics.2013.3699; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Goetzl L, 2002, AM J OBSTET GYNECOL, V187, P834, DOI 10.1067/mob.2002.127135; Goetzl Laura, 2004, J Perinatol, V24, P471, DOI 10.1038/sj.jp.7211128; Greenwell EA, 2012, PEDIATRICS, V129, pE447, DOI 10.1542/peds.2010-2301; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Impey L, 2001, BRIT J OBSTET GYNAEC, V108, P594, DOI 10.1111/j.1471-0528.2001.00145.x; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; LEMAY L G, 1990, Cytokine, V2, P199, DOI 10.1016/1043-4666(90)90016-M; Lieberman E, 1997, PEDIATRICS, V99, P415, DOI 10.1542/peds.99.3.415; Maayan-Metzger A, 2006, FETAL PEDIATR PATHOL, V25, P169, DOI 10.1080/15513810600908461; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Riley LE, 2011, OBSTET GYNECOL, V117, P588, DOI 10.1097/AOG.0b013e31820b0503; Segal S., 2010, ANESTHESIA ANALGESIA, V111; Segal S, 2017, ANESTH ANALG, V125, P2134, DOI 10.1213/ANE.0000000000002479; Sharma SK, 2014, ANESTHESIA ANALGESIA, V118, P2054; Sun X, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201808868; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Wang JP, 1997, NEUROIMMUNOMODULAT, V4, P230, DOI 10.1159/000097341; Wang LZ, 2011, INT J GYNECOL OBSTET, V113, P40, DOI 10.1016/j.ijgo.2010.10.026; Zaretsky MV, 2004, OBSTET GYNECOL, V103, P546, DOI 10.1097/01.AOG.0000114980.40445.83; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	40	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0222958	10.1371/journal.pone.0222958	http://dx.doi.org/10.1371/journal.pone.0222958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689293	Green Published, gold			2022-12-26	WOS:000532680100005
J	Pech-Cervantes, AA; Ogunade, IM; Jiang, Y; Irfan, M; Arriola, KG; Amaro, FX; Gonzalez, CF; DiLorenzo, N; Bromfield, JJ; Vyas, D; Adesogan, AT				Pech-Cervantes, Andres A.; Ogunade, Ibukun M.; Jiang, Yun; Irfan, Muhammad; Arriola, Kathy G.; Amaro, Felipe X.; Gonzalez, Claudio F.; DiLorenzo, Nicolas; Bromfield, John J.; Vyas, Diwakar; Adesogan, Adegbola T.			An expansin-like protein expands forage cell walls and synergistically increases hydrolysis, digestibility and fermentation of livestock feeds by fibrolytic enzymes	PLOS ONE			English	Article							VITRO GAS-PRODUCTION; BACTERIAL EXPANSIN; RUMINAL FERMENTATION; BACILLUS-SUBTILIS; BINDING CHARACTERISTICS; ENZYMATIC-HYDROLYSIS; PRODUCTION KINETICS; METHANE PRODUCTION; CRYSTAL-STRUCTURE; PLANT EXPANSINS	Bacterial expansin-like proteins have synergistically increased cellulose hydrolysis by cellulolytic enzymes during the initial stages of biofuel production, but they have not been tested on livestock feeds. The objectives of this study were to: isolate and express an expansin-like protein (BsEXLX1), to verify its disruptive activity (expansion) on cotton fibers by immunodetection (Experiment 1), and to determine the effect of dose, pH and temperature for BsEXLX1 and cellulase to synergistically hydrolyze filter paper (FP) and carboxymethyl cellulose (CMC) under laboratory (Experiment 2) and simulated ruminal (Experiment 3) conditions. In addition, we determined the ability of BsEXLX1 to synergistically increase hydrolysis of corn and bermudagrass silages by an exogenous fibrolytic enzyme (EFE) (Experiment 4) and how different doses of BsEXLX1 and EFE affect the gas production (GP), in vitro digestibility and fermentation of a diet for dairy cows (Experiment 5). In Experiment 1, immunofluorescence-based examination of cotton microfiber treated without or with recombinant expansin-like protein expressed from Bacillus subtilis (BsEXLX1) increased the surface area by > 100% compared to the untreated control. In Experiment 2, adding BsEXLX1 (100 pg/g FP) to cellulase (0.0148 FPU) increased release of reducing sugars compared to cellulase alone by more than 40% (P < 0.01) at optimal pH (4.0) and temperature (50 C) after 24 h. In Experiment 3 and 4, adding BsEXLX1 to cellulase or EFE, synergistically increased release of reducing sugars from FP, corn and bermudagrass silages under simulated ruminal conditions (pH 6.0, 39 C). In Experiment 5, increasing the concentration of BsEXLX1 linearly increased (P < 0.01) GP from fermentation of a diet for dairy cows by up to 17.8%. Synergistic effects between BsEXLX1 and EFE increased in vitro NDF digestibility of the diet by 23.3% compared to the control. In vitro digestibility of hemicellulose and butyrate concentration were linearly increased by BsEXLX1 compared to the control. This study demonstrated that BsEXLX1 can improve the efficacy of cellulase and EFE at hydrolyzing pure substrates and dairy cow feeds, respectively.	[Pech-Cervantes, Andres A.; Ogunade, Ibukun M.; Jiang, Yun; Arriola, Kathy G.; Amaro, Felipe X.; DiLorenzo, Nicolas; Bromfield, John J.; Vyas, Diwakar; Adesogan, Adegbola T.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Ogunade, Ibukun M.] Kentucky State Univ, Div Food & Anim Sci, Frankfort, KY USA; [Irfan, Muhammad; Gonzalez, Claudio F.] Univ Florida, Dept Microbiol & Cell Sci, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32611 USA; [Pech-Cervantes, Andres A.] Ft Valley State Univ, Ft Valley, GA USA	State University System of Florida; University of Florida; Kentucky State University; State University System of Florida; University of Florida; University System of Georgia; Fort Valley State University	Adesogan, AT (corresponding author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	adesogan@ufl.edu	Cervantes, Andres Alfredo Pech/AAA-5485-2020; Vyas, Diwakar/V-4976-2019; Irfan, Muhamamd/AAT-4828-2021; Ogunade, Ibukun Michael/J-7661-2019; Cervantes, Andres Alfredo Pech/AAE-7506-2019	Vyas, Diwakar/0000-0002-7657-0267; Ogunade, Ibukun Michael/0000-0003-3875-6156; Cervantes, Andres Alfredo Pech/0000-0003-4709-9098	National Research Council of Mexico (CONACYT)	National Research Council of Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Andres Pech-Cervantes thanks the National Research Council of Mexico (CONACYT) for the scholarship provided for his Ph.D. studies.	Adesogan AT, 2014, J ANIM SCI, V92, P1317, DOI 10.2527/jas.2013-7273; Adesogan AT, 2005, ANIM FEED SCI TECH, V123, P211, DOI 10.1016/j.anifeedsci.2005.04.058; Adney B., 2008, RENEW ENERGY, V8; Alvarez G, 2009, LIVEST SCI, V121, P150, DOI 10.1016/j.livsci.2008.05.024; AlZahal O, 2008, J DAIRY SCI, V91, P202, DOI 10.3168/jds.2007-0535; [Anonymous], 1997, AGR HDB, V379, P12, DOI [10.1593/neo.08450, DOI 10.1593/NEO.08450]; Archimede H, 2011, ANIM FEED SCI TECH, V166-67, P59, DOI 10.1016/j.anifeedsci.2011.04.003; Arriola KG, 2011, J DAIRY SCI, V94, P832, DOI 10.3168/jds.2010-3424; Arriola KG, 2017, J DAIRY SCI, V100, P4513, DOI 10.3168/jds.2016-12103; Beauchemin K a, 2003, J ANIM SCI, P37; Bera-Maillet C, 2004, APPL ENVIRON MICROB, V70, P2172, DOI 10.1128/AEM.70.4.2172-2179.2004; Bernard JK, 2010, J DAIRY SCI, V93, P5280, DOI 10.3168/jds.2010-3111; Borreani G, 2010, J DAIRY SCI, V93, P2620, DOI 10.3168/jds.2009-2919; Bunterngsook B, 2015, BIORESOURCE TECHNOL, V176, P129, DOI 10.1016/j.biortech.2014.11.042; Bunterngsook B, 2014, BIORESOURCE TECHNOL, V159, P64, DOI 10.1016/j.biortech.2014.02.004; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chung YH, 2012, J DAIRY SCI, V95, P1419, DOI 10.3168/jds.2011-4552; Colombatto D, 2003, ANIM FEED SCI TECH, V107, P201, DOI 10.1016/S0377-8401(03)00126-3; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dean DB, 2005, J DAIRY SCI, V88, P994, DOI 10.3168/jds.S0022-0302(05)72767-3; Denicol AC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01266; Tovar-Herrera OE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122296; Elghandour MMY, 2013, ANIM FEED SCI TECH, V179, P46, DOI 10.1016/j.anifeedsci.2012.11.010; Elwakeel EA, 2007, J DAIRY SCI, V90, P5226, DOI 10.3168/jds.2007-0305; Eun JS, 2007, ANIM FEED SCI TECH, V132, P298, DOI 10.1016/j.anifeedsci.2006.02.014; Georgelis N, 2015, APPL MICROBIOL BIOT, V99, P3807, DOI 10.1007/s00253-015-6534-0; Georgelis N, 2014, CARBOHYD POLYM, V100, P17, DOI 10.1016/j.carbpol.2013.04.094; Georgelis N, 2011, J BIOL CHEM, V286, P16814, DOI 10.1074/jbc.M111.225037; Giraldo LA, 2007, BRIT J NUTR, V98, P753, DOI 10.1017/S0007114507744446; Halavaty AS, 2015, ACTA CRYSTALLOGR D, V71, P1159, DOI 10.1107/S1399004715004228; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Hanna WW, 2007, TROPICAL SUBTROPICAL, P245; Hegarty R. S., 1999, Recent Advances in Animal Nutrition in Australia, V12, P37; Himmel ME, 2007, BIOMASS RECALCITRANC, P804; Jalilvand G, 2008, ANIM FEED SCI TECH, V146, P289, DOI 10.1016/j.anifeedsci.2008.01.007; Kebreab E, 2009, J ANIM SCI, V87, pE111, DOI 10.2527/jas.2008-1313; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kim ES, 2009, BIOTECHNOL BIOENG, V102, P1342, DOI 10.1002/bit.22193; Kim IJ, 2013, APPL MICROBIOL BIOT, V97, P5381, DOI 10.1007/s00253-012-4412-6; Krueger NA, 2008, ANIM FEED SCI TECH, V145, P84, DOI 10.1016/j.anifeedsci.2007.05.041; Liu XW, 2015, BIOTECHNOL LETT, V37, P1541, DOI 10.1007/s10529-015-1842-0; Mamiatis T., 1985, ACTA BIOTECHNOL, V5, P104, DOI [10.1002/abio.370050118, DOI 10.1002/ABIO.370050118/ABSTRACT]; Mandebvu P, 1999, ANIM FEED SCI TECH, V77, P317, DOI 10.1016/S0377-8401(98)00247-8; Mauricio RM, 1999, ANIM FEED SCI TECH, V79, P321, DOI 10.1016/S0377-8401(99)00033-4; MCALLISTER TA, 1993, J ANIM SCI, V71, P205, DOI 10.2527/1993.711205x; MCDONALD I, 1981, J AGR SCI, V96, P251, DOI 10.1017/S0021859600032081; Miettinen H, 1996, J DAIRY SCI, V79, P851, DOI 10.3168/jds.S0022-0302(96)76434-2; Morgavi DP, 2004, J SCI FOOD AGR, V84, P1083, DOI 10.1002/jsfa.1790; MUCK RE, 1988, T ASAE, V31, P1005; Tirado-Gonzalez DN, 2018, J APPL ANIM RES, V46, P771, DOI 10.1080/09712119.2017.1399135; Offermann LR, 2015, J AGR FOOD CHEM, V63, P6567, DOI 10.1021/acs.jafc.5b02159; Pagliai FA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01314; Phakachoed N, 2013, LIVEST SCI, V157, P100, DOI 10.1016/j.livsci.2013.06.020; Ribeiro GO, 2016, ANIM FRONT, V6, P20, DOI 10.2527/af.2016-0019; Romero JJ, 2016, J DAIRY SCI, V99, P3486, DOI 10.3168/jds.2015-10082; Romero JJ, 2015, J DAIRY SCI, V98, P2555, DOI 10.3168/jds.2014-8059; Romero JJ, 2015, J DAIRY SCI, V98, P406, DOI 10.3168/jds.2014-8285; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Silveira RL, 2016, PHYS CHEM CHEM PHYS, V18, P3510, DOI 10.1039/c5cp06674c; Togtokhbayar N, 2015, ANIM SCI J, V86, P765, DOI 10.1111/asj.12364; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103; Zhang N, 2015, MODEL SIMUL MATER SC, V23, DOI 10.1088/0965-0393/23/8/085010	64	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224381	10.1371/journal.pone.0224381	http://dx.doi.org/10.1371/journal.pone.0224381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX5UO	31689330	Green Published, gold			2022-12-26	WOS:000521946100001
J	Sarkar, C; Saklani, BK; Singh, PK; Asthana, RK; Sharma, TR				Sarkar, Chiranjib; Saklani, Banita Kumari; Singh, Pankaj Kumar; Asthana, Ravi Kumar; Sharma, Tilak Raj			Variation in the LRR region of Pi54 protein alters its interaction with the AvrPi54 protein revealed by in silico analysis	PLOS ONE			English	Article							LEUCINE-RICH REPEATS; CONFERS RESISTANCE; HYDROGEN-BONDS; PIZ-T; GENE; BLAST; PLANT; SPECIFICITY; POPULATION; DIVERSITY	Rice blast, caused by the ascomycete fungus Magnaporthe oryzae is a destructive disease of rice and responsible for causing extensive damage to the crop. Pi54, a dominant blast resistance gene cloned from rice line Tetep, imparts a broad spectrum resistance against various M. oryzae isolates. Many of its alleles have been explored from wild Oryza species and landraces whose sequences are available in the public domain. Its cognate effector gene AvrPi54 has also been cloned from M. oryzae. Complying with the Flor's gene-for-gene system, Pi54 protein interacts with AvrPi54 protein following fungal invasion leading to the resistance responses in rice cell that prevents the disease development. In the present study Pi54 alleles from 72 rice lines were used to understand the interaction of Pi54 (R) proteins with AvrPi54 (Avr) protein. The physiochemical properties of these proteins varied due to the nucleotide level polymorphism. The ab initio tertiary structures of these R- and Avr-proteins were generated and subjected to the in silico interaction. In this interaction, the residues in the LRR region of R-proteins were shown to interact with the Avr protein. These R proteins were found to have variable strengths of binding due to the differential spatial arrangements of their amino acid residues. Additionally, molecular dynamic simulations were performed for the protein pairs that showed stronger interaction than Pi54(tetep) (original Pi54 from Tetep) protein. We found these proteins were forming h-bond during simulation which indicated an effective binding. The root mean square deviation values and potential energy values were stable during simulation which validated the docking results. From the interaction studies and the molecular dynamics simulations, we concluded that the AvrPi54 protein interacts directly with the resistant Pi54 proteins through the LRR region of Pi54 proteins. Some of the Pi54 proteins from the landraces namely Casebatta, Tadukan, Varun dhan, Govind, Acharmita, HPR-2083, Budda, Jatto, MTU-4870, Dobeja-1, CN-1789, Indira sona, Kulanji pille and Motebangarkaddi cultivars show stronger binding with the AvrPi54 protein, thus these alleles can be effectively used for the rice blast resistance breeding program in future.	[Sarkar, Chiranjib] ICAR Indian Agr Res Inst, New Delhi, India; [Sarkar, Chiranjib] ICAR Indian Agr Stat Res Inst, New Delhi, India; [Sarkar, Chiranjib; Saklani, Banita Kumari; Singh, Pankaj Kumar; Sharma, Tilak Raj] ICAR Natl Res Ctr Plant Biotechnol, New Delhi, India; [Saklani, Banita Kumari; Asthana, Ravi Kumar] Banaras Hindu Univ, Varanasi, Uttar Pradesh, India; [Singh, Pankaj Kumar; Sharma, Tilak Raj] Natl Agrifood Biotechnol Inst, Mohali, Punjab, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Banaras Hindu University (BHU); Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Sharma, TR (corresponding author), ICAR Natl Res Ctr Plant Biotechnol, New Delhi, India.; Sharma, TR (corresponding author), Natl Agrifood Biotechnol Inst, Mohali, Punjab, India.	trsharma@nabi.res.in	SINGH, PANKAJ KUMAR/AAZ-1192-2020	SINGH, PANKAJ KUMAR/0000-0002-0845-3464; Sarkar, Chiranjib/0000-0003-1536-7449; tr, sharma/0000-0001-6723-2330	Department of Science and Technology, Govt of India; IARI, New Delhi, India; CSIR, New Delhi, India; Department of Biotechnology, Govt. of India	Department of Science and Technology, Govt of India(Department of Science & Technology (India)); IARI, New Delhi, India; CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	TRS is thankful to the Department of Biotechnology, Govt. of India, for financial help and Department of Science and Technology, Govt of India, for JC Bose National Fellowship. CS is thankful to IARI, New Delhi, India, for the financial assistance and BKS is thankful to CSIR, New Delhi, India, for research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TRS is thankful to the Department of Biotechnology, Govt. of India for financial help and Department of Science and Technology, Govt of India for JC Bose National Fellowship. CS is thankful to IARI, New Delhi, India for the financial assistance and the staffs of TAC, IASRI and CAS Lab. BKS is thankful to CSIR, New Delhi, India for research grant.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Das A, 2012, FUNCT INTEGR GENOMIC, V12, P215, DOI 10.1007/s10142-012-0284-1; Devanna NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104840; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Ehrenfeld N, 2008, J GEN VIROL, V89, P809, DOI 10.1099/vir.0.83355-0; Eildal JNN, 2013, J AM CHEM SOC, V135, P12998, DOI 10.1021/ja402875h; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fukuoka S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04550; Gupta SK, 2012, J EXP BOT, V63, P757, DOI 10.1093/jxb/err297; Gupta SK, 2012, PLOS ONE, V7; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jiang L, 2002, J BIOL CHEM, V277, P37732, DOI 10.1074/jbc.M204514200; Kanzaki H, 2012, PLANT J, V72, P894, DOI 10.1111/j.1365-313X.2012.05110.x; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Leckie F, 1999, EMBO J, V18, P2352, DOI 10.1093/emboj/18.9.2352; Ma J, 2015, MOL PLANT MICROBE IN, V28, P558, DOI 10.1094/MPMI-11-14-0367-R; Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146; Rai AK, 2011, J PLANT BIOCHEM BIOT, V20, P55, DOI 10.1007/s13562-010-0026-1; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Ray S., 2016, PI54 FRONT PLANT SCI, V7, P1140, DOI DOI 10.3389/FPLS.2016.01140; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sharma TR, 2012, AGR RES, V1, P37, DOI 10.1007/s40003-011-0003-5; Sharma TR, 2010, J PLANT BIOCHEM BIOT, V19, P87, DOI 10.1007/BF03323441; Sharma TR, 2005, MOL GENET GENOMICS, V274, P569, DOI 10.1007/s00438-005-0035-2; Singh PK, 2014, FUNCT INTEGR GENOMIC, V14, P419, DOI 10.1007/s10142-014-0369-0; Singh PK, 2018, FUNGAL GENET BIOL, V115, P9, DOI 10.1016/j.fgb.2018.04.005; Singh PK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041141; Sirisathaworn Thanyaluk, 2017, Agriculture and Natural Resources, V51, P7, DOI 10.1016/j.anres.2016.08.005; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Thakur S, 2013, FUNCT INTEGR GENOMIC, V13, P309, DOI 10.1007/s10142-013-0325-4; Thakur S, 2013, J PLANT INTERACT, V8, P34, DOI 10.1080/17429145.2012.721523; Thakur S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00345; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Wulff BBH, 2001, PLANT CELL, V13, P255, DOI 10.1105/tpc.13.2.255; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yavuz C, 2017, TURK J AGR FOOD SCI, V5, P65, DOI [10.24925/turjaf.v5i1.65-70.926, DOI 10.24925/TURJAF.V5I1.65-70.926]; Zhou B, 2006, MOL PLANT MICROBE IN, V19, P1216, DOI 10.1094/MPMI-19-1216; Zipfel C, 2008, CURR BIOL, V18, pR218, DOI 10.1016/j.cub.2008.01.016	49	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224088	10.1371/journal.pone.0224088	http://dx.doi.org/10.1371/journal.pone.0224088			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689303	Green Submitted, gold, Green Published			2022-12-26	WOS:000532680100012
J	Yao, XL; Deng, HW; Zhang, T; Qin, YG				Yao, Xuelin; Deng, Hongwei; Zhang, Ti; Qin, Yaguang			Multistage fuzzy comprehensive evaluation of landslide hazards based on a cloud model	PLOS ONE			English	Article								To accurately study the risk assessment of landslide disasters, firstly, the environmental conditions of induced landslide disasters are regarded as a fuzzy system, and the landslide risk factors in the multi-level analysis system are constructed to build a multi-level fuzzy evaluation index system. Then, the cloud model theory is introduced to improve the importance scale and membership degree involved in the evaluation process, and the multi-level fuzzy comprehensive evaluation method of landslide risk improved by a cloud model is proposed. Thus, a multi-level fuzzy evaluation cloud model for evaluating landslide risk is established. Finally, using the improved cloud model method, a multistage fuzzy comprehensive evaluation of landslide risk is conducted for the K112+210-K112 +630 section of the Long Chuan to Huaiji Highway Project in Guangdong Province. The results show that the improved cloud model can solve the problem of uncertainty in the process of landslide preparation and occurrence, greatly improve the effectiveness of landslide evaluation results, and provide an effective reference for landslide disaster prevention.	[Yao, Xuelin; Deng, Hongwei; Zhang, Ti; Qin, Yaguang] Cent South Univ, Sch Resource & Safety Engn, Changsha, Peoples R China	Central South University	Yao, XL (corresponding author), Cent South Univ, Sch Resource & Safety Engn, Changsha, Peoples R China.	xuelin472736226@csu.edu.cn						Al-Homoud AS, 1998, ENVIRON GEOL, V34, P59, DOI 10.1007/s002540050256; Arabameri A, 2019, SCI TOTAL ENVIRON, V658, P160, DOI 10.1016/j.scitotenv.2018.12.115; Bagheri V, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7983-4; Barredo J.I., 2000, INT J APPL EARTH OBS, V2000, P9, DOI [10.1016/s0303-2434(00)85022-9, DOI 10.1016/S0303-2434(00)85022-9, 10.1016/S0303-2434(00)85022-9]; [樊晓一 Fan Xiaoyi], 2004, [自然灾害学报, Journal of Natural Disasters], V13, P72; Fausto Guzzetti, ENVIRON MANAGE, V36, P15, DOI [10.1007/s00267-003-0257-1, DOI 10.1007/S00267-003-0257-1]; [冯杭建 Feng Hangjian], 2017, [工程地质学报, Journal of Engineering Geology], V25, P436; GUPTA RP, 1990, ENG GEOL, V28, P119, DOI 10.1016/0013-7952(90)90037-2; Huang J., 2007, CHIN J ROCK MECH ENG, V26, P2627; Li D.Y., 1995, COMPUT RES DEV, V32, P16; Li De-Yi, 2004, Journal of Software, V15, P1583; Li Hai-lin, 2011, Control and Decision, V26, P1525; Lin ST, 2017, IMPROVEMENT JANBU ME; Liu Li, 2008, Journal of China Three Gorges University, V30, P43; Luo XG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215134; Miles SB, 2009, ENG GEOL, V104, P1, DOI 10.1016/j.enggeo.2008.08.004; Qiao JP, 2000, J NATURAL DISASTERS, V9, P68; Satty T L., 1988, AHP APPL RESOURCE AL; [唐红梅 Tang Hongmei], 2004, [灾害学, Journal of Catastrophology], V19, P1; Uromeihy A, 2011, IRAN ENV SCI TECHNOL, P318; Uromeihy A, 2011, INT PR CHEM BIO ENV, V6, P318; Van Dijke J.J., 1990, ITC J, V1, P40; Wang CH, 1998, DIFFERENTIATED MODEL, P66; WANG Cheng-hua J., 2001, J ENG GEOLOGY, V9, P127; Wang Z, 2009, J NATURAL DISASTERS, V18, P19; ZHANG Ji-jun, 2000, FUZZY SYST MATH, P80; Zhang Jiangwei, 2015, Journal of Natural Disasters, V24, P42, DOI 10.13577/j.jnd.2015.0605; [张秋文 Zhang Qiuwen], 2014, [水利学报, Journal of Hydraulic Engineering], V45, P87; Zheng QQ, 1999, JIANGXI GEOLOGY, V13, P299; Zhu HL, 2015, J QING HAI U NATURAL, V33, P51	30	6	8	12	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224312	10.1371/journal.pone.0224312	http://dx.doi.org/10.1371/journal.pone.0224312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689296	Green Published, gold			2022-12-26	WOS:000532680100016
J	Zhang, JY; Choi, EH; Tworak, A; Salom, D; Leinonen, H; Sander, CL; Hoang, TV; Handa, JT; Blackshaw, S; Palczewska, G; Kiser, PD; Palczewski, K				Zhang, Jianye; Choi, Elliot H.; Tworak, Aleksander; Salom, David; Leinonen, Henri; Sander, Christopher L.; Hoang, Thanh V.; Handa, James T.; Blackshaw, Seth; Palczewska, Grazyna; Kiser, Philip D.; Palczewski, Krzysztof			Photic generation of 11-cis-retinal in bovine retinal pigment epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzymatic photoisomerization; 11-cis-retinal; 13-cis-retinal; visual chromophore; RPE-retinal G protein-coupled receptor (RGR); retinal pigment epithelium-specific 65 kDa protein (RPE65); visible light; cellular retinaldehyde-binding protein (CRALBP); rhodopsin; cone opsin	COUPLED RECEPTOR OPSIN; ALL-TRANS-RETINOIDS; BINDING-PROTEIN; VISUAL CYCLE; VITAMIN-A; DARK-ADAPTATION; ISOMERIZATION; RHODOPSIN; RPE65; LIGHT	Photoisomerization of the 11-cis-retinal chromophore of rod and cone visual pigments to an all-trans configuration is the initiating event for vision in vertebrates. The regeneration of 11-cis-retinal, necessary for sustained visual function, is an endergonic process normally conducted by specialized enzyme systems. However, 11-cis-retinal also can be formed through reverse photoisomerization from all-trans-retinal. A non-visual opsin known as retinal pigment epithelium (RPE)-retinal G protein-coupled receptor (RGR) was previously shown to mediate visual chromophore regeneration in photic conditions, but conflicting results have cast doubt on its role as a photoisomerase. Here, we describe high-level production of 11-cis-retinal from RPE membranes stimulated by illumination at a narrow band of wavelengths. This activity was associated with RGR and enhanced by cellular retinaldehyde-binding protein (CRALBP), which binds the 11-cisretinal produced by RGR and prevents its reisomerization to all-trans-retinal. The activity was recapitulated with cells heterologously expressing RGR and with purified recombinant RGR. Using an RGR variant, K255A, we confirmed that a Schiff base linkage at Lys-255 is critical for substrate binding and isomerization. Single-cell RNA-Seq analysis of the retina and RPE tissue confirmed that RGR is expressed in human and bovine RPE and Muller glia, whereas mouse RGR is expressed in RPE, but not in Muller glia. These results provide key insights into the mechanisms of physiological retinoid photoisomerization and suggest a novel mechanism by which RGR, in concert with CRALBP, regenerates the visual chromophore in the RPE under sustained light conditions.	[Zhang, Jianye; Choi, Elliot H.; Tworak, Aleksander; Salom, David; Leinonen, Henri; Sander, Christopher L.; Palczewski, Krzysztof] Univ Calif Irvine, Dept Ophthalmol, Gavin Herbert Eye Inst, Irvine, CA 92697 USA; [Choi, Elliot H.; Sander, Christopher L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoang, Thanh V.; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Handa, James T.; Blackshaw, Seth] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21287 USA; [Palczewska, Grazyna] Polgenix Inc, Dept Med Devices, 5171 Calif Ave,Suite 150, Irvine, CA 92617 USA; [Kiser, Philip D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Kiser, Philip D.] VA Long Beach Healthcare Syst, Res Serv, Long Beach, CA 90822 USA	University of California System; University of California Irvine; Case Western Reserve University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Palczewski, K (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA 92697 USA.; Palczewski, K (corresponding author), Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA.	kpalczew@uci.edu	Leinonen, Henri/V-2684-2019; Sander, Christopher/GRR-4165-2022	Leinonen, Henri/0000-0002-0388-832X; Tworak, Aleksander/0000-0002-3256-8990; Palczewska, Grazyna/0000-0003-4030-4685; Salom, David/0000-0002-3208-1509; Sander, Christopher/0000-0002-1680-6637	NATIONAL EYE INSTITUTE [T32EY007157, R01EY027691, R24EY027283, R01EY020560] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY020560, R01 EY009339, U01 EY025451, R01 EY027691, T32 EY007157, R24 EY027283] Funding Source: Medline; NIGMS NIH HHS [T32 GM007250, T32 GM008803] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albalat R, 2012, MOL BIOL EVOL, V29, P1461, DOI 10.1093/molbev/msr313; ALCHALEL A, 1975, J AM CHEM SOC, V97, P2161, DOI 10.1021/ja00841a029; Arno G, 2016, INVEST OPHTH VIS SCI, V57, P4806, DOI 10.1167/iovs.16-19687; BARRY B, 1982, J CELL BIOL, V94, P479, DOI 10.1083/jcb.94.2.479; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BERNSTEIN PS, 1986, BIOCHEMISTRY-US, V25, P6473, DOI 10.1021/bi00369a020; Bolze CS, 2014, J AM CHEM SOC, V136, P137, DOI 10.1021/ja411366w; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chance B, 1999, ADV ENZYMOL RAMB, V73, P1, DOI 10.1002/9780470123195.ch1; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen YY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04261-1; Cook JD, 2017, J BIOL CHEM, V292, P21407, DOI [10.1074/jbc.M117.812701, 10.1074/jbc.m117.812701]; Crabb JW, 1998, METH MOL B, V89, P91; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FEX G, 1988, BIOCHIM BIOPHYS ACTA, V944, P249, DOI 10.1016/0005-2736(88)90438-5; FEX G, 1987, BIOCHIM BIOPHYS ACTA, V901, P255, DOI 10.1016/0005-2736(87)90122-2; Filipek S, 2003, ANNU REV BIOPH BIOM, V32, P375, DOI 10.1146/annurev.biophys.32.110601.142520; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Frederiksen R, 2016, J GEN PHYSIOL, V148, P1, DOI 10.1085/jgp.201511538; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HARA T, 1973, NATURE-NEW BIOL, V242, P39, DOI 10.1038/newbio242039a0; He MF, 2013, J CHROMATOGR A, V1271, P67, DOI 10.1016/j.chroma.2012.11.022; Hecht S, 1937, P NATL ACAD SCI USA, V23, P227, DOI 10.1073/pnas.23.4.227; Hofmann L, 2015, PROG RETIN EYE RES, V49, P46, DOI 10.1016/j.preteyeres.2015.07.004; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; JIANG MS, 1995, EXP EYE RES, V60, P401, DOI 10.1016/S0014-4835(05)80096-X; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kaylor JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00018-4; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kim EJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21104-7; Kiser PD, 2019, FASEB J, V33, P5782, DOI 10.1096/fj.201802493R; Kiser PD, 2018, J GEN PHYSIOL, V150, P571, DOI 10.1085/jgp.201711815; Kiser PD, 2016, ANNU REV VIS SCI, V2, P197, DOI 10.1146/annurev-vision-111815-114407; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lyubarsky AL, 2005, BIOCHEMISTRY-US, V44, P9880, DOI 10.1021/bi0505363; Maeda A, 2006, BIOCHEMISTRY-US, V45, P4210, DOI 10.1021/bi052382x; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Mahroo OAR, 2004, J PHYSIOL-LONDON, V554, P417, DOI 10.1113/jphysiol.2003.051250; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; McBee JK, 2001, J BIOL CHEM, V276, P48483, DOI 10.1074/jbc.M105840200; Miyagawa Y, 2003, BIOCHEM BIOPH RES CO, V300, P669, DOI 10.1016/S0006-291X(02)02888-7; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molday LL, 2014, METHODS MOL BIOL, V1177, P1, DOI 10.1007/978-1-4939-1034-2_1; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Morshedian A, 2019, NEURON, V102, P1172, DOI 10.1016/j.neuron.2019.04.004; NOY N, 1995, J LIPID RES, V36, P375; Nymark S, 2012, J PHYSIOL-LONDON, V590, P2353, DOI 10.1113/jphysiol.2012.228627; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; Ortega JT, 2019, J BIOL CHEM, V294, P8101, DOI 10.1074/jbc.RA119.007808; OZAKI K, 1983, BIOPHYS J, V44, P127, DOI 10.1016/S0006-3495(83)84285-4; OZAKI K, 1987, VISION RES, V27, P1057, DOI 10.1016/0042-6989(87)90020-4; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; RANDO RR, 1982, BIOCHEM BIOPH RES CO, V104, P430, DOI 10.1016/0006-291X(82)90655-6; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Rodieck R.W., 1998, 1 STEPS SEEING; RUSHTON WAH, 1977, BIOPHYS STRUCT MECH, V3, P159, DOI 10.1007/BF00535812; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; Sahu B, 2015, J BIOL CHEM, V290, P27239, DOI 10.1074/jbc.M115.682096; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; SHEN DW, 1994, BIOCHEMISTRY-US, V33, P13117, DOI 10.1021/bi00248a022; Shen P, 1999, BRAIN RES, V826, P157, DOI 10.1016/S0006-8993(99)01179-8; SHICHI H, 1974, J BIOL CHEM, V249, P6570; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Tao L, 1998, Mol Vis, V4, P25; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; TERAKITA A, 1989, VISION RES, V29, P639, DOI 10.1016/0042-6989(89)90026-6; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Widjaja-Adhi M.A.K., 2018, FASEB J; Xue YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02549-8; Yang M, 2002, J BIOL CHEM, V277, P3318, DOI 10.1074/jbc.M108946200; Zhang JY, 2015, J CLIN INVEST, V125, P2781, DOI 10.1172/JCI80950	90	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19137	19154		10.1074/jbc.RA119.011169	http://dx.doi.org/10.1074/jbc.RA119.011169			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694912	Green Published, hybrid			2022-12-26	WOS:000516527800016
J	Clements, J; Groves, RL; Cava, J; Barry, CC; Chapman, S; Olson, JM				Clements, Justin; Groves, Russell L.; Cava, JoAnn; Barry, Caroline C.; Chapman, Scott; Olson, Jake M.			Conjugated linoleic acid as a novel insecticide targeting the agricultural pest Leptinotarsa decemlineata	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; EGG-YOLK; HATCHABILITY; INFLAMMATION; MODULATION; RESISTANCE; PREVENTS; CLA	The Colorado Potato Beetle, Leptinotarsa decemlineata, is a major agricultural pest of solanaceous crops in the United States. Historically, a multitude of insecticides have been used to control problematic populations. Due to increasing resistance to insecticides, novel compounds and methodologies are warranted for the control of beetle populations. Mixed-isomer conjugated linoleic acid has been studied in-depth for its beneficial properties to mammalian systems. At the same time, studies have demonstrated that conjugated linoleic acid can manipulate fatty acid composition in non-mammalian systems, resulting in embryo mortality. Consequently, experiments were conducted to assess the effects of foliar-applied conjugated linoleic acid on larval growth, embryogenesis, and feeding preference in Colorado potato beetle. Both maternal and deterrent effects of dietary conjugated linoleic acid were assessed. Conjugated linoleic acid demonstrated desirable insecticidal properties, including increased larval mortality, slowed larval development, antifeedant effects, and decreased egg viability after maternal ingestion.	[Clements, Justin; Groves, Russell L.; Cava, JoAnn; Chapman, Scott] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; [Barry, Caroline C.; Olson, Jake M.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Olson, JM (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	jmolson22@wisc.edu			University of Wisconsin - Madison Office of the Vice Chancellor for Research and Graduate Education; Wisconsin Alumni Research Foundation	University of Wisconsin - Madison Office of the Vice Chancellor for Research and Graduate Education; Wisconsin Alumni Research Foundation	The support for this research was provided by the University of Wisconsin - Madison Office of the Vice Chancellor for Research and Graduate Education with funding from the Wisconsin Alumni Research Foundation to JO and RG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; Aydin R, 2004, POULTRY SCI, V83, P2016, DOI 10.1093/ps/83.12.2016; Aydin R, 1999, FASEB J, V13, pA541; Aydin R, 2001, J NUTR, V131, P800, DOI 10.1093/jn/131.3.800; Aydin R, 2009, J SCI FOOD AGR, V89, P2687, DOI 10.1002/jsfa.3755; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boiteau G., 1992, COLORADO POTATO BEET; Bretschneider T, 2003, CHIMIA, V57, P697, DOI 10.2533/000942903777678588; Butz DE, 2007, AM J PHYSIOL-REG I, V293, pR669, DOI 10.1152/ajpregu.00005.2007; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Clements J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147844; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; CRIPPS C, 1986, BIOCHIM BIOPHYS ACTA, V876, P572, DOI 10.1016/0005-2760(86)90046-9; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fuke G, 2017, CRIT REV FOOD SCI, V57, P1, DOI 10.1080/10408398.2012.716800; Gereszek LJ, 2008, ANN ENTOMOL SOC AM, V101, P430, DOI 10.1603/0013-8746(2008)101[430:EODCLA]2.0.CO;2; Huebner SM, 2014, J NUTR, V144, P177, DOI 10.3945/jn.113.182550; Huebner SM, 2010, J NUTR, V140, P1454, DOI 10.3945/jn.109.120527; Huseth AS, 2013, J ECON ENTOMOL, V106, P2491, DOI 10.1603/EC13277; Huseth AS, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14009; IRAC International MoA Working Group, IRAC MOD ACT CLASS S; Krzymanska J., 1976, Symposia Biologica Hungarica, V16, P129; Lee K.N., 1996, THESIS; Lee KN, 1998, BIOCHEM BIOPH RES CO, V248, P817, DOI 10.1006/bbrc.1998.8994; Muhlenbeck JA, 2017, LIPIDS, V52, P303, DOI 10.1007/s11745-017-4241-6; Olson JM, 2017, LIPIDS, V52, P151, DOI 10.1007/s11745-016-4228-8; Palli SR, 2014, CURR OPIN INSECT SCI, V6, P1, DOI 10.1016/j.cois.2014.09.011; Park CG, 2006, J AGR FOOD CHEM, V54, P6572, DOI 10.1021/jf052579w; Park Chung Gyoo, 2000, Journal of Asia-Pacific Entomology, V3, P59, DOI 10.1016/S1226-8615(08)60056-4; Park Y, 2007, FOOD RES INT, V40, P311, DOI 10.1016/j.foodres.2006.11.002; Parodi PW, 1999, ADVANCES IN CONJUGATED LINOLEIC ACID RESEARCH, VOL 1, P1; Politz M., BIOPROTOCOL, V3, pe950; Shang XG, 2005, POULTRY SCI, V84, P1886, DOI 10.1093/ps/84.12.1886; Smid I, 2015, PESTIC BIOCHEM PHYS, V122, P59, DOI 10.1016/j.pestbp.2014.12.022; Szafranek B, 2008, CHEMOECOLOGY, V18, P205, DOI 10.1007/s00049-008-0407-2; Twibell RG, 2000, LIPIDS, V35, P155, DOI 10.1007/BF02664765; Viladomiu M, 2016, EUR J PHARMACOL, V785, P87, DOI 10.1016/j.ejphar.2015.03.095; Whalon M.E., ARTHROPOD PESTICIDE; Yang B, 2015, J FUNCT FOODS, V15, P314, DOI 10.1016/j.jff.2015.03.050; Yu J.Y., 2015, TOXICOLOGY BIOCH INS	41	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0220830	10.1371/journal.pone.0220830	http://dx.doi.org/10.1371/journal.pone.0220830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725728	gold, Green Published, Green Submitted			2022-12-26	WOS:000532764500003
J	Prussing, C; Emerson, KJ; Bickersmith, SA; Sallum, MAM; Conn, JE				Prussing, Catharine; Emerson, Kevin J.; Bickersmith, Sara A.; Mureb Sallum, Maria Anice; Conn, Jan E.			Minimal genetic differentiation of the malaria vector Nyssorhynchus darlingi associated with forest cover level in Amazonian Brazil	PLOS ONE			English	Article							ANOPHELES-DARLINGI; POPULATION-STRUCTURE; R-PACKAGE; SPATIAL-DISTRIBUTION; ENDEMIC REGION; DEFORESTATION; DIPTERA; TRANSMISSION; GAMBIAE; LANDSCAPE	The relationship between deforestation and malaria in Amazonian Brazil is complex, and a deeper understanding of this relationship is required to inform effective control measures in this region. Here, we are particularly interested in characterizing the impact of land use and land cover change on the genetics of the major regional vector of malaria, Nyssorhynchus darlingi (Root). We used nextera-tagmented, Reductively Amplified DNA (nextRAD) genotyping-by-sequencing to genotype 164 Ny. darlingi collected from 16 collection sites with divergent forest cover levels in seven municipalities in four municipality groups that span the state of Amazonas in northwestern Amazonian Brazil: Sao Gabriel da Cachoeira, Presidente Figueiredo, four municipalities in the area around Cruzeiro do Sul, and Labrea. Using a dataset of 5,561 Single Nucleotide Polymorphisms (SNPs), we investigated the genetic structure of these Ny. darlingi populations with a combination of model- and non-model-based analyses. We identified weak to moderate genetic differentiation among the four municipality groups. There was no evidence for microgeographic genetic structure of Ny. darlingi among forest cover levels within the municipality groups, indicating that there may be gene flow across areas of these municipalities with different degrees of deforestation. Additionally, we conducted an environmental association analysis using two outlier detection methods to determine whether individual SNPs were associated with forest cover level without affecting overall population genetic structure. We identified 14 outlier SNPs, and investigated functions associated with their proximal genes, which could be further characterized in future studies.	[Prussing, Catharine; Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA; [Emerson, Kevin J.] St Marys Coll Maryland, Dept Biol, St Marys City, MD 20686 USA; [Bickersmith, Sara A.; Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA; [Mureb Sallum, Maria Anice] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center; Universidade de Sao Paulo	Prussing, C; Conn, JE (corresponding author), SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA.; Conn, JE (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12203 USA.	cprussing@gmail.com; jan.conn@health.ny.gov	Prussing, Catharine/AAB-4546-2019; Sallum, Maria Anice Mureb/B-8537-2012	Prussing, Catharine/0000-0001-6425-6839; Sallum, Maria Anice Mureb/0000-0002-7051-2891; Bickersmith, Sara/0000-0002-2748-0425	National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) [R01AI110112]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/26229-7]; Conselho Nacional de Pesquisa (CNPq) [301877/2016-5]; Biodefense and Emerging Infectious Disease training fellowship [T32AI05532901]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110112] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Biodefense and Emerging Infectious Disease training fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health-National Institute of Allergy and Infectious Diseases (NIH-NIAID) R01AI110112 to JEC and MAMS (https://www.niaid.nih.gov), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant No. 2014/26229-7 to MAMS (http://www.fapesp.br), and Conselho Nacional de Pesquisa (CNPq) no. 301877/2016-5 to MAMS (http://cnpq.br).The Biodefense and Emerging Infectious Disease training fellowship grant T32AI05532901 provided partial support for CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adde A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164685; Afrane YA, 2008, EMERG INFECT DIS, V14, P1533, DOI 10.3201/eid1410.070781; Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660; Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; Alexa A, 2018, TOPGO ENRICHMENT ANA, DOI [10.1111/MEC.13852, DOI 10.1111/MEC.13852]; Angella AF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-203; Ayala D, 2019, MOL ECOL, V28, P1333, DOI 10.1111/mec.14880; Barros FSM, 2015, AM J TROP MED HYG, V93, P939, DOI 10.4269/ajtmh.15-0042; Campos M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2014-y; Canelas Tiago, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.8f23fe5f0c2052bfaaa648e6931e4e1a; Caputo B, 2014, MOL ECOL, V23, P4574, DOI 10.1111/mec.12866; Carlos BC, 2019, PATHOG GLOB HEALTH, V113, P1, DOI 10.1080/20477724.2019.1581463; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chhatre VE, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1593-0; Chu VM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41651-x; Conn JE, 2006, AM J TROP MED HYG, V74, P798, DOI 10.4269/ajtmh.2006.74.798; Conn JE, 1999, J AM MOSQUITO CONTR, V15, P468; Conn JE., 2018, MALAR ELIMINLEAP FOR, DOI [10.5772/intechopen.76964, DOI 10.5772/INTECHOPEN.76964]; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emerson KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130773; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira MU, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1335-1; Foster PG, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170758; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Frichot E, 2013, MOL BIOL EVOL, V30, P1687, DOI 10.1093/molbev/mst063; Fryxell RTT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-133; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Jaffe R, 2016, MOL ECOL, V25, P5345, DOI 10.1111/mec.13852; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039453; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Lainhart W, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0863-4; Landaverde-Gonzalez P, 2017, CONSERV GENET, V18, P631, DOI 10.1007/s10592-017-0950-x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lima JMT, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0125; LINTHICUM KJ, 1988, MOSQ SYST, V20, P99; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Marinotti O, 2013, NUCLEIC ACIDS RES, V41, P7387, DOI 10.1093/nar/gkt484; Martins LMO, 2018, J VECTOR ECOL, V43, P235, DOI 10.1111/jvec.12307; Mirabello Lisa, 2008, BMC Ecology, V8, P3, DOI 10.1186/1472-6785-8-3; de Barros FSM, 2011, J VECTOR ECOL, V36, P159, DOI 10.1111/j.1948-7134.2011.00153.x; Chaves LSM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25344-5; Mueller-Wilm U, 2017, SEN2COR, DOI [10.1093/NAR/GKT484, DOI 10.1093/NAR/GKT484]; Naranjo-Diaz N, 2016, INFECT GENET EVOL, V39, P64, DOI 10.1016/j.meegid.2016.01.004; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; Pavlidis P, 2012, MOL BIOL EVOL, V29, P3237, DOI 10.1093/molbev/mss136; Pedro PM, 2009, BIOL J LINN SOC, V97, P854, DOI 10.1111/j.1095-8312.2009.01226.x; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Pritchard JK, 2000, GENETICS, V155, P945; Prussing C, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2234-4; R Core Team, 2017, R LANG ENV STAT COMP, DOI [10.1111/1755-0998.12129, DOI 10.1111/1755-0998.12129]; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Reinbold-Wasson DD, 2012, AM J TROP MED HYG, V86, P459, DOI 10.4269/ajtmh.2012.11-0547; Riehle M, 2011, SCI, V331; Rosero CY, 2017, NEOTROP ENTOMOL, V46, P487, DOI 10.1007/s13744-017-0488-0; Russello MA, 2015, PEERJ, V3, DOI 10.7717/peerj.1106; Sallum MAM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2753-7; Sanford Michelle R, 2014, F1000Res, V3, P243, DOI 10.12688/f1000research.5485.1; Santos AS, 2018, ECOL ECON, V154, P247, DOI 10.1016/j.ecolecon.2018.08.005; Scarpassa VM, 2007, MEM I OSWALDO CRUZ, V102, P319, DOI 10.1590/S0074-02762007005000045; Soare TW, 2014, MOL ECOL, V23, P96, DOI 10.1111/mec.12573; Stefani A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-192; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Valle D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057519; VectorBase, 2018, AN DARL ADARC38; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Wang XM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1611-5; Wellenreuther M, 2019, MOL ECOL, V28, P1203, DOI 10.1111/mec.15066; WHO, 2018, WORLD MAL REP 2018	80	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225005	10.1371/journal.pone.0225005	http://dx.doi.org/10.1371/journal.pone.0225005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725789	Green Submitted, gold, Green Published			2022-12-26	WOS:000532764500042
J	Ross, LL; Walker, AS; Lou, Y; Tenorio, AR; Gibb, DM; Double, J; Gilks, C; McCoig, CC; Munderi, P; Musoro, G; Kityo, CM; Grosskurth, H; Hakim, J; Mugyenyi, PN; Cutrell, A; Perger, T; Shaefer, MS				Ross, Lisa L.; Walker, A. Sarah; Lou, Yu; Tenorio, Allan R.; Gibb, Diana M.; Double, Julia; Gilks, Charles; McCoig, Cynthia C.; Munderi, Paula; Musoro, Godfrey; Kityo, Cissy M.; Grosskurth, Heiner; Hakim, James; Mugyenyi, Peter N.; Cutrell, Amy; Perger, Teodora; Shaefer, Mark S.			Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs >= 50 mL/min	PLOS ONE			English	Article							RISK-FACTORS; DYSFUNCTION	A retrospective analysis of the randomized controlled DART (Development of AntiRetroviral Therapy in Africa; ISRCTN13968779) trial in HIV-1-positive adults initiating antiretroviral therapy with co-formulated zidovudine/lamivudine plus either tenofovir, abacavir, or nevirapine was conducted to evaluate the safety of initiating standard lamivudine dosing in patients with impaired creatinine clearance (CLcr). Safety data collected through 96 weeks were analyzed after stratification by baseline CLcr (estimated using Cockcroft-Gault) of 3049 mL/min (n = 168) versus >= 50 mL/min (n = 3,132) and treatment regimen. The Grade 3-4 adverse events (AEs) and serious AEs (for hematological, hepatic and gastrointestinal events), maximal toxicities for liver enzymes, serum creatinine and bilirubin and maximum treatment-emergent hematology toxicities were comparable for groups with baseline CLcr 30-49 versus CLcr >= 50 mL/min. No new risks or trends were identified from this dataset. Substantial and similar increases in the mean creatinine clearance (> 25 mL/min) were observed from baseline though Week 96 among participants who entered the trial with CLcr 30-49 mL/min, while no increase or smaller median changes in creatinine clearance (< 7 mL/min) were observed for participants who entered the trial with CLcr >= 50 mL/min. Substantial increases (> 150 cells/mm(3)) in mean CD4+ cells counts from baseline to Week 96 were also observed for participants who entered the trial with CLcr 30-49 mL/min and those with baseline CLcr >= 50 mL/min. Though these results are descriptive, they suggest that HIV-positive patients with CLcr of 30-49 mL/min would have similar AE risks in comparison to patients with CLcr >= 50 mL/min when initiating antiretroviral therapy delivering doses of 300 mg of lamivudine daily through 96 weeks of treatment. Overall improvements in CLcr were observed for patients with baseline CLcr 30-49 mL/min.	[Ross, Lisa L.; Shaefer, Mark S.] ViiV Healthcare, Med Affairs, Res Triangle Pk, NC 27709 USA; [Walker, A. Sarah; Gibb, Diana M.] UCL, Clin Trials Unit, MRC, London, England; [Lou, Yu] PAREXEL Int, Stat, Durham, NC USA; [Tenorio, Allan R.] ViiV Healthcare, Phys Grp, Res Triangle Pk, NC USA; [Double, Julia] GlaxoSmithKline, Safety & Med Governance, Stockley Pk, Uxbridge, Middx, England; [Gilks, Charles] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [McCoig, Cynthia C.] ViiV Healthcare, Phys Grp, Tres Cantos, Spain; [Munderi, Paula; Grosskurth, Heiner] MRC UVRI Uganda Res Unit AIDS, HIV Care Res Programme, Entebbe, Uganda; [Musoro, Godfrey; Hakim, James] Univ Zimbabwe, Dept Med, Harare, Zimbabwe; [Kityo, Cissy M.; Mugyenyi, Peter N.] Joint Clin Res Ctr, HIV Clin Trials Unit, Kampala, Uganda; [Cutrell, Amy] ViiV Healthcare, Healthcare Stat, Res Triangle Pk, NC USA; [Perger, Teodora] ViiV Healthcare, Safety & Pharmacovigilance, London, England	GlaxoSmithKline; Medical Research Council Clinical Trials Unit; University of London; University College London; Parexel International; GlaxoSmithKline; GlaxoSmithKline; University of Queensland; Sanofi-Aventis; University of Zimbabwe; Joint Clinic Research Center - United Arab Emirates; GlaxoSmithKline; GlaxoSmithKline	Ross, LL (corresponding author), ViiV Healthcare, Med Affairs, Res Triangle Pk, NC 27709 USA.	lisa.l.ross@viivhealthcare.com	Walker, Sarah/HDM-8717-2022	Ross, Lisa/0000-0001-7388-2655; Gibb, Diana/0000-0002-9738-5490; Grosskurth, Heiner/0000-0001-9960-7280	Medical Research Council (MRC) UK [G0600344]; UK Department for International Development (DFID); Rockefeller Foundation; MRC Clinical Trials Unit at UCL [MC_UU_12023/23]; ViiV Healthcare; Medical Research Council of the United Kingdom; MRC [G0600344, MR/R010161/1] Funding Source: UKRI	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID); Rockefeller Foundation; MRC Clinical Trials Unit at UCL(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ViiV Healthcare; Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DART was funded by the Medical Research Council (MRC) UK [grant number G0600344] [ASW DMG CG PM HG] (https://mrc.ukri.org/), the UK Department for International Development (DFID) and the Rockefeller Foundation [ASW DMG GM CMK JH PNM]. Additional funding support was provided by core support to the MRC Clinical Trials Unit at UCL [MC_UU_12023/23] [ASW DMG]. ViiV Healthcare/GlaxoSmithKline, Gilead Sciences, and Boehringer Ingelheim donated first-line drugs for DART. The funders had no role in DART trial design, data collection and analysis, decision to publish, or preparation of the DART trial manuscripts. This retrospective analysis of data through 96 weeks from the DART trial was supported by ViiV Healthcare using data provided by the DART trial sponsors, the Medical Research Council of the United Kingdom. LLR, ART, CCM, AC, TP and MSS are employed by ViiV Healthcare. ViiV Healthcare provided support in the form of salaries for authors LLR, ART, CCM, AC, TP and MSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. YL was employed by PAREXEL International during the course of the study. PAREXEL International provided support in the form of salary for author YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. JD is employed by GlaxoSmithKline. GlaxoSmithKline provided support in the form of salary for author JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all these authors are articulated in the `author contributions' section.	COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Elion R, 2006, HIV CLIN TRIALS, V7, P324, DOI 10.1310/hct0706-324; Fischetti B, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy225; Heald AE, 1996, ANTIMICROB AGENTS CH, V40, P1514, DOI 10.1128/AAC.40.6.1514; Husain Nazik Elmalaika, 2018, J Clin Med Res, V10, P1, DOI 10.14740/jocmr3235w; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Michienzi SM, 2019, INT J STD AIDS, V30, P181, DOI 10.1177/0956462418800865; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Squires KE, 2010, HIV CLIN TRIALS, V11, P69, DOI 10.1310/hct1102-69; Stohr W, 2011, ANTIVIR THER, V16, P1011, DOI 10.3851/IMP1832; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; Wyatt CM, 2008, SEMIN NEPHROL, V28, P513, DOI 10.1016/j.semnephrol.2008.08.005	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225199	10.1371/journal.pone.0225199	http://dx.doi.org/10.1371/journal.pone.0225199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725787	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000532764500067
J	Suriyapakorn, B; Chairat, P; Boonyoprakarn, S; Rojanarattanangkul, P; Pisetcheep, W; Hunsakunachai, N; Vivithanaporn, P; Wongwiwatthananukit, S; Khemawoot, P				Suriyapakorn, Bovornpat; Chairat, Pun; Boonyoprakarn, Suwanan; Rojanarattanangkul, Pimonwan; Pisetcheep, Wassana; Hunsakunachai, Natthaphon; Vivithanaporn, Pornpun; Wongwiwatthananukit, Supakit; Khemawoot, Phisit			Comparison of potential drug-drug interactions with metabolic syndrome medications detected by two databases	PLOS ONE			English	Article								Background Drug-drug interactions (DDIs) are one of the most common drug-related problems. Recently, electronic databases have drug interaction tools to search for potential DDIs, for example, Micromedex and Drugs.com. However, Micromedex and Drugs.com have different abilities in detecting potential DDIs, and this might cause misinformation to occur between patients and health care providers. Methods and findings The aim of this study was to compare the ability of Micromedex and Drugs.com to detect potential DDIs with metabolic syndrome medications using the drug list from the U-central database, King Chulalongkorn Memorial Hospital in April 2019. There were 90 available drugs for the treatment of the metabolic syndrome and its associated complications, but six were not found in the Micromedex and Drugs.com databases; therefore, only 84 items were used in the present study. There were 1,285 potential DDI pairs found by the two databases. Micromedex reported DDIs of 724 pairs, while, Drugs.com reported 1,122 pairs. For the severity of the potential DDI reports, the same severity occurred between the two databases of 481 pairs (37.43%) and a different severity for 804 pairs (62.57%). Conclusion Drugs.com had a higher sensitivity to detect potential DDIs by approximately 1.5-fold, but Micromedex supplied more informative documentation for the severity classification. Therefore, pharmacists should use at least two databases to evaluate potential DDIs and determine the appropriate drug regimens for physician communications and patient consultations.	[Suriyapakorn, Bovornpat] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Bangkok, Thailand; [Chairat, Pun] Chulalongkorn Univ, Fac Pharmaceut Sci, Osotsala Community Pharm, Bangkok, Thailand; [Boonyoprakarn, Suwanan; Rojanarattanangkul, Pimonwan; Pisetcheep, Wassana; Hunsakunachai, Natthaphon] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacol & Physiol, Bangkok, Thailand; [Vivithanaporn, Pornpun] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok, Thailand; [Vivithanaporn, Pornpun] Mahidol Univ, Ramathibodhi Hosp, Chakri Naruebodindra Med Inst, Fac Med, Samut Prakan, Thailand; [Wongwiwatthananukit, Supakit] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharm Practice, Hilo, HI 96720 USA; [Khemawoot, Phisit] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Biochem & Microbiol, Bangkok, Thailand; [Khemawoot, Phisit] Chulalongkorn Univ, Preclin Pharmacokinet & Interspecies Scaling Drug, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Mahidol University; Mahidol University; University of Hawaii System; University Hawaii Hilo; Chulalongkorn University; Chulalongkorn University	Khemawoot, P (corresponding author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Biochem & Microbiol, Bangkok, Thailand.; Khemawoot, P (corresponding author), Chulalongkorn Univ, Preclin Pharmacokinet & Interspecies Scaling Drug, Bangkok, Thailand.	phisit.k@chula.ac.th	Khemawoot, Phisit/ABE-2110-2020; Suriyapakorn, Bovornpat/AAR-8564-2020	Suriyapakorn, Bovornpat/0000-0002-1081-8493; Khemawoot, Phisit/0000-0001-7994-4503	Faculty of Pharmaceutical Sciences, Chulalongkorn University [Phar2563-RG001]	Faculty of Pharmaceutical Sciences, Chulalongkorn University(Chulalongkorn University)	The authors express their gratitude to the Faculty of Pharmaceutical Sciences, Chulalongkorn University for providing research funding to Bovornpat Suriyapakorn (Phar2563-RG001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bossaer JB, 2017, J ONCOL PRACT, V13, pE217, DOI 10.1200/JOP.2016.016212; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Clauson KA, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-7; Dechanont S, 2014, PHARMACOEPIDEM DR S, V23, P489, DOI 10.1002/pds.3592; Ersoy S, 2018, CLIN INTERV AGING, V13, P2003, DOI 10.2147/CIA.S176329; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Kheshti R, 2016, J RES PHARM PRACT, V5, P257, DOI 10.4103/2279-042X.192461; Marston L., 2010, INTRO STAT HLTH NURS; Menditto E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210701; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Patel RI, 2016, J MED LIBR ASSOC, V104, P290, DOI 10.3163/1536-5050.104.4.007; Ramos GV, 2015, J CLIN PHARM THER, V40, P63, DOI 10.1111/jcpt.12222; Reimche L, 2011, J CLIN PHARMACOL, V51, P1043, DOI 10.1177/0091270010378858; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Unbound Medicine Inc., MDCU KCMH HOSP FORM	18	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225239	10.1371/journal.pone.0225239	http://dx.doi.org/10.1371/journal.pone.0225239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725785	Green Published, gold			2022-12-26	WOS:000532764500072
J	Park, HW; Her, SH; Park, BH; Han, DS; Yuk, SM; Kim, DW; Youn, CS; Jang, H				Park, Ha-Wook; Her, Sung-Ho; Park, Bong-Hee; Han, Dong-Seok; Yuk, Seung Mo; Kim, Dae-Won; Youn, Chang Shik; Jang, Hoon			Correlation between internal pudendal artery stenosis and erectile dysfunction in patients with suspected coronary artery disease	PLOS ONE			English	Article							RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; PREVALENCE; LIFE	Background Stenoses of internal pudendal arteries (IPAs) appear to be related to erectile dysfunction (ED). Nevertheless, the correlation between the severity of ED and stenosis of the IPAs is not well established. Objectives To evaluate angiographic findings of IPAs in patients with suspected coronary artery disease (CAD) and to assess the correlation between the severity of ED and IPA stenosis. Materials and methods Ninety-one patients who were scheduled for cardiac angiogram (CAG) because of suspected CAD participated. ED was assessed using the International Index of Erectile Function (IIEF) questionnaire. Erectile function (EF) domain scoring was used to assess the severity of ED: severe (EF score = 1-10); moderate (11-16); mild-moderate (17-21); mild (22-25); and no ED (26-30). Angiography was performed in bilateral common, internal iliac, and IPAs and the location and extent of stenoses were measured. We divided patients according to those with maximum stenosis of less than 50% (Group I) and those with more than 50% (Group II), regardless of direction. Results We diagnosed 88 patients (88/91, 96.70%) with ED. There was no correlation between increasing age and severity of ED (r = - 0.063, p = 0.555). There were 72 patients in Group I and 19 in Group II. In Group I, 62 patients were diagnosed with ED even though there was no stenosis. There was no significant correlation between the severity of ED and the extent of stenosis in IPAs (r = -0.118, p = 0.265). Conclusions There was no significant correlation between the severity of ED and the extent of stenosis of IPAs. We believe that this is because the progression of ED is induced by endothelial cell dysfunction, not by mechanical obstruction leading to blood flow reduction.	[Park, Ha-Wook; Her, Sung-Ho; Kim, Dae-Won] Catholic Univ Korea, Coll Med, Dept Cardiol, Seoul, South Korea; [Park, Bong-Hee; Han, Dong-Seok; Yuk, Seung Mo; Youn, Chang Shik; Jang, Hoon] Catholic Univ Korea, Coll Med, Dept Urol, Seoul, South Korea; [Park, Ha-Wook; Her, Sung-Ho; Kim, Dae-Won] Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Cardiol, Daejeon, South Korea; [Park, Bong-Hee] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Urol, Uijeongbu Si, Gyeonggi Do, South Korea; [Han, Dong-Seok; Yuk, Seung Mo; Youn, Chang Shik; Jang, Hoon] Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Urol, Daejeon, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Jang, H (corresponding author), Catholic Univ Korea, Coll Med, Dept Urol, Seoul, South Korea.; Jang, H (corresponding author), Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Urol, Daejeon, South Korea.	urjang@gmail.com		Jang, Hoon/0000-0003-0534-549X				Azab SS, 2018, J SEX MED, V15, P880, DOI 10.1016/j.jsxm.2018.04.639; Bacon CG, 2006, J UROLOGY, V176, P217, DOI 10.1016/S0022-5347(06)00589-1; Blick C, 2016, CURR VASC PHARMACOL, V14, P163, DOI 10.2174/1570161114666151202205950; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Camacho ME, 2005, INT J IMPOT RES, V17, pS52, DOI 10.1038/sj.ijir.3901429; Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0; Chiurlia E, 2005, J AM COLL CARDIOL, V46, P1503, DOI 10.1016/j.jacc.2005.06.068; Dong JY, 2011, J AM COLL CARDIOL, V58, P1378, DOI 10.1016/j.jacc.2011.06.024; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; El-Sakka AI, 2004, J UROLOGY, V172, P251, DOI 10.1097/01.ju.0000128572.31000.f0; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Ganz P, 2003, CIRCULATION, V108, P2049, DOI 10.1161/01.CIR.0000089507.19675.F9; Ghiadoni L, 2008, CURR PHARM DESIGN, V14, P3715, DOI 10.2174/138161208786898761; Jackson G, 2013, ARAB J UROL, V11, P212, DOI 10.1016/j.aju.2013.03.003; Kasprzak Jaroslaw D, 2006, Pharmacol Rep, V58 Suppl, P33; MANCINI GBJ, 1991, J AM COLL CARDIOL, V17, pB23; McKinlay JB, 2000, INT J IMPOT RES, V12, pS6, DOI 10.1038/sj.ijir.3900567; Meuleman EJH, 2002, INT J IMPOT RES, V14, pS22, DOI 10.1038/sj/ijir/3900793; Montorsi F, 2003, EUR UROL, V44, P360, DOI 10.1016/S0302-2838(03)00305-1; Montorsi P, 2006, EUR HEART J, V27, P2632, DOI 10.1093/eurheartj/ehl142; Mudau M, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-068; Osondu CU, 2018, VASC MED, V23, P9, DOI 10.1177/1358863X17725809; Park KH, 2015, J KOREAN MED SCI, V30, P1213, DOI 10.3346/jkms.2015.30.9.1213; Rogers JH, 2012, J AM COLL CARDIOL, V60, P2618, DOI 10.1016/j.jacc.2012.08.1016; Rogers JH, 2010, CATHETER CARDIO INTE, V76, P882, DOI 10.1002/ccd.22646; Selvin E, 2007, AM J MED, V120, P151, DOI 10.1016/j.amjmed.2006.06.010; Sullivan ME, 2001, BJU INT, V87, P838, DOI 10.1046/j.1464-410x.2001.02211.x; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P2996, DOI 10.1001/jama.294.23.2996; Tousoulis D, 2014, PHARMACOL THERAPEUT, V144, P253, DOI 10.1016/j.pharmthera.2014.06.003; Willke RJ, 1998, INT J IMPOT RES, V10, P239, DOI 10.1038/sj.ijir.3900364; Woywodt A, 2002, NEPHROL DIAL TRANSPL, V17, P1728, DOI 10.1093/ndt/17.10.1728; Zaki H, 2013, EGYPT HEART J, V65, P87, DOI 10.1016/j.ehj.2012.11.003	32	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225179	10.1371/journal.pone.0225179	http://dx.doi.org/10.1371/journal.pone.0225179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714923	Green Published, gold			2022-12-26	WOS:000532710400033
J	Alese, OO; Mabandla, MV				Alese, Oluwole Ojo; Mabandla, Musa, V			Transgenerational deep sequencing revealed hypermethylation of hippocampal mGluR1 gene with altered mRNA expression of mGluR5 and mGluR3 associated with behavioral changes in Sprague Dawley rats with history of prolonged febrile seizure	PLOS ONE			English	Article							DEPRESSIVE-LIKE BEHAVIOR; DNA METHYLATION; PRENATAL STRESS; MATERNAL-CARE; UP-REGULATION; ANIMAL-MODEL; GLUTAMATE; CORTICOSTERONE; EPIGENETICS; MECHANISMS	The impact of febrile seizure has been shown to transcend immediate generation with the alteration of glutamatergic pathway being implicated. However, transgenerational effects of this neurological disorder particularly prolonged febrile seizure (PFS) on neurobehavioral study and methylation profile is unknown. We therefore hypothesized that transgenerational impact of prolonged febrile seizure is dependent on methylation of hippocampal mGluR1 gene. Prolonged febrile seizure was induced on post-natal day (PND) 14, by injecting lipopolysaccharide (LPS; 217 mu g/kg ip) and kainic acid (KA; 1.83 mg/kg ip). Sucrose preference test (SPT) and Forced swim test (FST) were carried out in the first generation (F-0) of animals at PND37 and PND60. The F-0 rats were decapitated at PND 14, 37 and 60 which corresponded to childhood, adolescent and adulthood respectively and their hippocampal tissue collected. The second generation (F-1) rats were obtained by mating F-0 generation at PND 60 across different groups, F-1 rats were subjected to SPT and FST test on PND 37 only. Decapitation of F(1)rats and collection of hippocampal tissues were done on PND 14 and 37. Assessment of mGluR5 and mGluR3 mRNA was done with PCR while mGluR1 methylation profile was assessed with the Quantitative MassARRAY analysis. Results showed that PFS significantly leads to decreased sucrose consumption in the SPT and increased immobility time in the FST in both generations of rats. It also leads to significant decrease in mGluR5 mRNA expression with a resultant increased expression of mGluR3 mRNA expression and hypermethylation of mGluR1 gene across both generations of rats. This study suggested that PFS led to behavioral changes which could be transmitted on to the next generation in rats.	[Alese, Oluwole Ojo; Mabandla, Musa, V] Univ Kwazulu Natal, Coll Hlth Sci, Dept Human Physiol, Durban, South Africa	University of Kwazulu Natal	Alese, OO (corresponding author), Univ Kwazulu Natal, Coll Hlth Sci, Dept Human Physiol, Durban, South Africa.	alese44@yahoo.com	Oluwole, Alese/AAL-9437-2020		College of Health Sciences grant University of Kwazulunatal Durban [85017060-425085]	College of Health Sciences grant University of Kwazulunatal Durban	This research was funded by the College of Health Sciences grant University of Kwazulunatal Durban (85017060-425085). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann S, 2011, CONTINUING MED ED, V29; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Aronica E, 2000, EUR J NEUROSCI, V12, P2333, DOI 10.1046/j.1460-9568.2000.00131.x; Bagot RC, 2012, P NATL ACAD SCI USA, V109, P17200, DOI 10.1073/pnas.1204599109; Bagot RC, 2012, BIOL PSYCHIAT, V72, P491, DOI 10.1016/j.biopsych.2012.03.016; Barker-Haliski M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022863; Bohacek J, 2013, BIOL PSYCHIAT, V73, P313, DOI 10.1016/j.biopsych.2012.08.019; Cassim S, 2015, NEUROBIOL LEARN MEM, V125, P195, DOI 10.1016/j.nlm.2015.09.002; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Crespo M, 2018, EPILEPSY BEHAV, V86, P173, DOI 10.1016/j.yebeh.2018.06.048; Cukor Daniel, 2006, J Child Sex Abus, V15, P19; Dai Y.J., 2019, CNS NEUROSCIENCE THE; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Fan A, 2013, REPRODUCTION; Frazier-Wood AC, 2014, J LIPID RES, V55, P1324, DOI 10.1194/jlr.M048504; Gulyaeva NV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P301, DOI 10.1134/S0006297917030087; Heida JG, 2009, BRAIN DEV-JPN, V31, P388, DOI 10.1016/j.braindev.2008.11.013; Hernandez HG, 2013, BIOTECHNIQUES, V55, P181, DOI 10.2144/000114087; Iyo AH, 2010, NEUROSCIENCE, V169, P1567, DOI 10.1016/j.neuroscience.2010.06.023; Kim HK, 2009, CRIM BEHAV MENT HEAL, V19, P125, DOI 10.1002/cbm.708; Kobow K, 2011, EPILEPSIA, V52, P15, DOI 10.1111/j.1528-1167.2011.03145.x; Lang UE, 2013, CELL PHYSIOL BIOCHEM, V31, P761, DOI 10.1159/000350094; Lason W, 2013, PHARMACOL REP, V65, P787, DOI 10.1016/S1734-1140(13)71060-0; Lin TW, 2018, J CLIN MED, V7, DOI 10.3390/jcm7060117; Lubin FD, 2012, EPILEPSY CURR, V12, P105, DOI 10.5698/1535-7511-12.3.105; Marchi N, 2014, TRENDS NEUROSCI, V37, P55, DOI 10.1016/j.tins.2013.11.002; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Murrough JW, 2017, NAT REV DRUG DISCOV, V16, P472, DOI 10.1038/nrd.2017.16; Notenboom RGE, 2006, BRAIN, V129, P96, DOI 10.1093/brain/awh673; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Porsolt R.D., 2001, CURRENT PROTOCOLS NE, V14, P8; Qulu L, 2012, METAB BRAIN DIS, V27, P399, DOI 10.1007/s11011-012-9300-3; Qureshi IA, 2010, NEUROBIOL DIS, V39, P53, DOI 10.1016/j.nbd.2010.02.005; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rakgantsho C, 2019, BRAIN RES B; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Santiago RM, 2015, NEUROSCIENCE, V300, P246, DOI 10.1016/j.neuroscience.2015.05.030; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Slattery DA, 2007, PSYCHOPHARMACOLOGY, V190, P555, DOI 10.1007/s00213-006-0630-x; Stam R, 2007, PSYCHOPHARMACOLOGY, V191, P365, DOI 10.1007/s00213-006-0659-x; Sterba SK, 2007, DEV PSYCHOPATHOL, V19, P345, DOI 10.1017/S0954579407070174; Thompson CI, 2003, PHYSIOL BEHAV, V80, P103, DOI 10.1016/S0031-9384(03)00224-5; Van den Hove DLA, 2013, EUR NEUROPSYCHOPHARM, V23, P1226, DOI 10.1016/j.euroneuro.2012.09.011; Wang Y, 2015, NEUROSCIENCE, V301, P363, DOI 10.1016/j.neuroscience.2015.06.008; Wu RY, 2017, PROG NEURO-PSYCHOPH, V73, P11, DOI 10.1016/j.pnpbp.2016.09.008; Yan MSC, 2010, J APPL PHYSIOL, V109, P916, DOI 10.1152/japplphysiol.00131.2010; YANKELEVITCHYAHAV, 2015, JOVE J VIS EXP MAR, DOI DOI 10.3791/52587; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010	53	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0225034	10.1371/journal.pone.0225034	http://dx.doi.org/10.1371/journal.pone.0225034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710636	Green Published, gold, Green Submitted			2022-12-26	WOS:000532699900036
J	Majekodunmi, AO; Addo, HO; Bagulo, H; Bimi, L				Majekodunmi, Ayodele O.; Addo, Henry Ofosu; Bagulo, Husein; Bimi, Langbong			Integrated value-chain and risk assessment of Pig-Related Zoonoses in Ghana	PLOS ONE			English	Article							HEPATITIS-E; VIRUS; INFECTIONS; EXPOSURE; FETAL	The marked increase in the pig-trade in Ghana has raised concerns about increased transmission of related zoonotic diseases. A study on pig-related zoonoses along the pork value-chain was conducted in Greater Accra and Upper East Regions of Ghana. Results showed significant taenia (60%) and trichinella (8%) seroprevalence in pigs in Upper East with little evidence of transmission to humans. Sero-prevalence of HEV was high in both pigs (85%) and humans (37%). Sero-prevalence rates were significantly higher in Upper East than Greater Accra. Pig handlers in Accra had significantly higher sero-prevalence rates (58%) than other community members (18%) but there was no such association in the Upper East. Given the high rates of mortality, miscarriage and stillbirth associated with HEV in pregnancy, it is a cause for concern that 31% women of child-bearing age tested sero-positive for HEV.	[Majekodunmi, Ayodele O.; Bagulo, Husein] Univ Ghana, Coll Basic & Appl Sci, Livestock & Poultry Res Ctr, Legon, Accra, Ghana; [Addo, Henry Ofosu; Bimi, Langbong] Univ Ghana, Coll Basic & Appl Sci, Dept Anim Biol & Conservat Sci, Legon, Accra, Ghana	University of Ghana; University of Ghana	Majekodunmi, AO (corresponding author), Univ Ghana, Coll Basic & Appl Sci, Livestock & Poultry Res Ctr, Legon, Accra, Ghana.	amajekodunmi@ug.edu.gh	Majekodunmi, Ayodele/ABR-1323-2022	Majekodunmi, Ayodele/0000-0003-4986-8284; BIMI, Langbong/0000-0002-8536-4828				Adjei A A, 2009, East Afr Med J, V86, P359; Adjei AA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-336; Akuffo R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1660-6; Amegashie E.A., 2017, J EPIDEMIOL RES, V32, P58, DOI [10.5430/jer.v3n2p58, DOI 10.5430/JER.V3N2P58]; Amemor EA, 2017, AFRICAN J INFECT DIS, V11; Amfo-Otu R, 2014, APPL RES J, V1; Antia Richard Edem, 2018, J Immunoassay Immunochem, V39, P509, DOI 10.1080/15321819.2018.1514507; Asenso NT, 2015, B ANIMAL HLTH PRODUC, V63; Atawalna J, 2015, INT J LIVESTOCK RES, V5; Banson KE, 2014, J LIFE SCI, V8, P699; Bonney JHK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002435; Bonney Joseph Humphrey Kofi, 2012, BMC Res Notes, V5, P478, DOI 10.1186/1756-0500-5-478; Feldt T, 2013, J CLIN VIROL, V58, P18, DOI 10.1016/j.jcv.2013.05.004; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Kim JH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-308; Klous G, 2016, ONE HEALTH, V2, P65, DOI 10.1016/j.onehlt.2016.03.001; Knopp S, 2012, INFECT DIS CLIN N AM, V26, P341, DOI 10.1016/j.idc.2012.02.006; Kpentey B., 2012, ENTERPRISE MAP GHANA; Krain LJ, 2014, AM J TROP MED HYG, V90, P365, DOI 10.4269/ajtmh.13-0265; Madden RG, 2016, WORLD J GASTROENTERO, V22, P9853, DOI 10.3748/wjg.v22.i44.9853; Martinson F E, 1999, West Afr J Med, V18, P76; Meldal BHM, 2013, VOX SANG, V104, P30, DOI 10.1111/j.1423-0410.2012.01637.x; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Ninkuu M. V., 2015, British Microbiology Research Journal, V7, P10; Otupiri E, 2000, ACTA TROP, V76, P15, DOI 10.1016/S0001-706X(00)00083-8; Owolodun OA, 2014, AM J TROP MED HYG, V91, P699, DOI 10.4269/ajtmh.14-0144; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Permin A, 1999, VET PARASITOL, V87, P63, DOI 10.1016/S0304-4017(99)00159-4; Robb K, 2017, AM J TROP MED HYG, V97, P1020, DOI 10.4269/ajtmh.16-0508; Temmam S, 2013, AM J TROP MED HYG, V88, P329, DOI 10.4269/ajtmh.2012.12-0615; Tettey Y., 2011, Journal of the Ghana Science Association, V13, P64; Traore KA, 2015, AM J TROP MED HYG, V93, P1356, DOI 10.4269/ajtmh.15-0321; Ukuli AQ, 2017, AFR HEALTH SCI, V17, P1022, DOI 10.4314/ahs.v17i4.9; UNICEF, 2015, PROGR SAN DRINK WAT; van der Poel W., 2017, GLOBAL WATER PATHO 3	35	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224918	10.1371/journal.pone.0224918	http://dx.doi.org/10.1371/journal.pone.0224918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710646	Green Published, gold			2022-12-26	WOS:000532699900029
J	Manthey, CL; Moore, BA; Chen, YQ; Loza, MJ; Yao, X; Liu, H; Belkowski, SM; Raymond-Parks, H; Dunford, PJ; Leon, F; Towne, JE; Plevy, SE				Manthey, Carl L.; Moore, Beverley A.; Chen, Yanqing; Loza, Matthew J.; Yao, Xiang; Liu, Hao; Belkowski, Stanley M.; Raymond-Parks, Holly; Dunford, Paul J.; Leon, Francisco; Towne, Jennifer E.; Plevy, Scott E.			The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis	PLOS ONE			English	Article							DENDRITIC CELLS; MONOCYTES; TISSUE; DISEASE; IL-23; DIFFERENTIATION; PATHOGENESIS; MUSCULARIS; EXPRESSION; BLOCKADE	Background & aims Originally believed to be primarily a disorder of T-cell signaling, evidence shows that macrophage-lineage cells also contribute to the pathogenesis of Crohn's disease (CD). Colony stimulating factor-1 (CSF-1) is a key regulator of the macrophage lineage, but its role in CD has not been well established. We examined transcriptional data from CD mucosa for evidence of CSF-1 pathway activation and tested JNJ-40346527 (PRV-6527), a small molecule inhibitor of CSF-1 receptor kinase (CSF-1R), for its ability to inhibit disease indices in murine colitis. Methods A CSF-1 pathway gene set was created from microarray data of human whole blood cultured ex vivo with CSF-1 and compared to a TNF alpha-induced gene set generated from epithelial-lineage cells. Gene set variation analysis was performed using existing Crohn's mucosa microarray data comparing patients who either responded or failed to respond to anti-TNF alpha therapy. Commencing day 14 or day 21, mice with T-cell transfer colitis were treated with vehicle or JNJ-40346527 until study termination (day 42). Endpoints included colon weight/length ratios and histopathology scores, and macrophage and T cells were assessed by immunohistochemistry. Mucosal gene expression was investigated using RNAseq. Results Both the CSF-1 and the TNF alpha gene sets were enriched in the colonic mucosal transcriptomes of Crohn's disease and in mouse colitis, and expression of both gene sets was highest in patients who did not respond to anti-TNF alpha therapy. In these patients neither set was reduced by therapy. In the mouse model, JNJ-40346527 inhibited the increase in colon weight/length ratio by similar to 50%, reduced histological disease scores by similar to 60%, and reduced F4/80(+) mononuclear cell and CD3(+) lymphocyte numbers. RNAseq analysis confirmed the CSF-1 gene set was sharply reduced in treated mice, as were gene sets enriched in "M1" inflammatory and "M0" resident macrophages and in activated T cells. Conclusions CSF-1 biology is activated in Crohn's disease and in murine T cell transfer colitis. Inhibition of CSF-1R by JNJ-40346527 was associated with attenuated clinical disease scores and reduced inflammatory gene expression in mice. These data provide rationale for testing JNJ-40346527 (PRV-6527) in human inflammatory bowel disease.	[Manthey, Carl L.; Moore, Beverley A.; Chen, Yanqing; Loza, Matthew J.; Yao, Xiang; Liu, Hao; Belkowski, Stanley M.; Raymond-Parks, Holly; Dunford, Paul J.; Leon, Francisco; Towne, Jennifer E.; Plevy, Scott E.] Janssen Res & Dev LLC, Spring House, PA 19477 USA; [Moore, Beverley A.] BA Moore Pharmaceut Consulting LLC, Collegeville, PA 19426 USA; [Liu, Hao] Incyte, Wilmington, DE USA; [Dunford, Paul J.; Leon, Francisco] Provent Bio, Oldwick, NJ USA; [Plevy, Scott E.] Synlogic, Cambridge, MA USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Incyte	Moore, BA (corresponding author), Janssen Res & Dev LLC, Spring House, PA 19477 USA.; Moore, BA (corresponding author), BA Moore Pharmaceut Consulting LLC, Collegeville, PA 19426 USA.	bamoore1786@gmail.com		Moore, Beverley/0000-0001-6355-8608	Janssen	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	At the time of study conduct, all authors were salaried employees of Janssen R&D. Financial support for the study was solely provided by Janssen. The supporting organization played a role in the timing of the decision to publish, but did not influence study design, data collection or analysis. BAM receives additional salary support from BA Moore Pharmaceutical Consulting, HL from Incyte Corporation, PJD and FL from Provention Bio, and SEP from Synlogic Therapeutics. The specific roles of these authors are articulated in the `author contributions' section.	Alexander KA, 2014, J CLIN INVEST, V124, P4266, DOI 10.1172/JCI75935; Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Billmeier U, 2016, WORLD J GASTROENTERO, V22, P9300, DOI 10.3748/wjg.v22.i42.9300; Chen ZY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40508; Dai J, 2007, EUR J IMMUNOL, V37, P706, DOI 10.1002/eji.200636643; Huynh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056951; Fontana MF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006046; Franze E, 2016, J CROHNS COLITIS, V10, P87, DOI 10.1093/ecco-jcc/jjv181; Gao CH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00037; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Genovese MC, 2015, J RHEUMATOL, V42, P1752, DOI 10.3899/jrheum.141580; Ghia JE, 2008, AM J PHYSIOL-GASTR L, V294, pG770, DOI 10.1152/ajpgi.00453.2007; Gren ST, 2016, INFLAMM BOWEL DIS, V22, P1992, DOI 10.1097/MIB.0000000000000824; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; HAMILTON JA, 1993, GROWTH FACTORS, V9, P157; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Kalff JC, 1998, J LEUKOCYTE BIOL, V63, P683, DOI 10.1002/jlb.63.6.683; Kamada N, 2005, J IMMUNOL, V175, P6900, DOI 10.4049/jimmunol.175.10.6900; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; Kolodziejczyk K SA, 2014, INVENTORPROCESS PREP; Kuhl AA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00613; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Lenzo JC, 2012, IMMUNOL CELL BIOL, V90, P429, DOI 10.1038/icb.2011.58; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Malyshev I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/341308; Marshall D, 2007, INFLAMM BOWEL DIS, V13, P219, DOI 10.1002/ibd.20055; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Niebel W, 2012, J CONTROL RELEASE, V160, P659, DOI 10.1016/j.jconrel.2012.03.004; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; POWRIE F, 1994, RES IMMUNOL, V145, P347, DOI 10.1016/S0923-2494(94)80198-3; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rubio CA, 2018, HISTOPATHOLOGY, V72, P580, DOI 10.1111/his.13417; Steinbach EC, 2014, INFLAMM BOWEL DIS, V20, P166, DOI 10.1097/MIB.0b013e3182a69dca; Tagliani E, 2011, J EXP MED, V208, P1901, DOI 10.1084/jem.20110866; Turler A, 2007, ANN SURG, V245, P734, DOI 10.1097/01.sla.0000255595.98041.6b; Waddell LA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02246; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wehner S, 2005, SURGERY, V137, P436, DOI 10.1016/j.surg.2004.11.003; West NR, 2017, NAT MED, V23, P579, DOI 10.1038/nm.4307; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	49	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0223918	10.1371/journal.pone.0223918	http://dx.doi.org/10.1371/journal.pone.0223918			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710624	Green Published, gold			2022-12-26	WOS:000532699900005
J	Trypsteen, W; White, CH; Mukim, A; Spina, CA; De Spiegelaere, W; Lefever, S; Planelles, V; Bosque, A; Woelk, CH; Vandekerckhove, L; Beliakova-Bethell, N				Trypsteen, Wim; White, Cory H.; Mukim, Amey; Spina, Celsa A.; De Spiegelaere, Ward; Lefever, Steve; Planelles, Vicente; Bosque, Alberto; Woelk, Christopher H.; Vandekerckhove, Linos; Beliakova-Bethell, Nadejda			Long non-coding RNAs and latent HIV - A search for novel targets for latency reversal	PLOS ONE			English	Article							GENE-EXPRESSION; CELL SUBSET; REPLICATION; RESERVOIR; TRANSCRIPTOME; REACTIVATION; PERSISTENCE; VORINOSTAT; EVOLUTION; PATHWAY	The latent cellular reservoir of HIV is recognized as the major barrier to cure from HIV infection. Long non-coding RNAs (lncRNAs) are more tissue and cell type-specific than protein coding genes, and may represent targets of choice for HIV latency reversal. Using two in vitro primary T-cell models, we identified lncRNAs dysregulated in latency. PVT1 and RP11-347C18.3 were up-regulated in common between the two models, and RP11-539L10.2 was down-regulated. The major component of the latent HIV reservoir, memory CD4+ T-cells, had higher expression of these lncRNAs, compared to naive T-cells. Guilt-by-association analysis demonstrated that lncRNAs dysregulated in latency were associated with several cellular pathways implicated in HIV latency establishment and maintenance: proteasome, spliceosome, p53 signaling, and mammalian target of rapamycin (MTOR). PVT1, RP11-347C18.3, and RP11-539L10.2 were down-regulated by latency reversing agents, suberoylanilide hydroxamic acid and Romidepsin, suggesting that modulation of lncRNAs is a possible secondary mechanism of action of these compounds. These results will facilitate prioritization of lncRNAs for evaluation as targets for HIV latency reversal. Importantly, our study provides insights into regulatory function of lncRNA during latent HIV infection.	[Trypsteen, Wim; Vandekerckhove, Linos] Univ Ghent, HIV Cure Res Ctr, Dept Internal Med, Ghent, Belgium; [Trypsteen, Wim; Vandekerckhove, Linos] Ghent Univ Hosp, Ghent, Belgium; [White, Cory H.; Woelk, Christopher H.] Univ Southampton, Fac Med, Southampton, Hants, England; [Mukim, Amey; Spina, Celsa A.; Beliakova-Bethell, Nadejda] San Diego VA Med Ctr, San Diego, CA 92161 USA; [Mukim, Amey; Spina, Celsa A.; Beliakova-Bethell, Nadejda] Vet Med Res Fdn, San Diego, CA 92161 USA; [Spina, Celsa A.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [De Spiegelaere, Ward] Univ Ghent, Fac Vet Sci, Dept Morphol, Ghent, Belgium; [Lefever, Steve] Univ Ghent, Ctr Med Genet, Ghent, Belgium; [Planelles, Vicente] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT USA; [Bosque, Alberto] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Beliakova-Bethell, Nadejda] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Woelk, Christopher H.] Merck Res Labs, Merck Exploratory Sci Ctr, Cambridge, MA USA	Ghent University; Ghent University; Ghent University Hospital; University of Southampton; Veterans Medical Research Foundation; University of California System; University of California San Diego; Ghent University; Ghent University; Utah System of Higher Education; University of Utah; George Washington University; University of California System; University of California San Diego; Merck & Company	Beliakova-Bethell, N (corresponding author), San Diego VA Med Ctr, San Diego, CA 92161 USA.; Beliakova-Bethell, N (corresponding author), Vet Med Res Fdn, San Diego, CA 92161 USA.; Beliakova-Bethell, N (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	nbeliako@ucsd.edu	De Spiegelaere, Ward/C-6245-2008; Vandekerckhove, Linos/J-6420-2013	De Spiegelaere, Ward/0000-0003-2097-8439; Vandekerckhove, Linos/0000-0002-8600-1631	Office of Research and Development, Veterans Health Administration [AI036214, IK2 BX002731]; National Institutes of Health [AI104282]; Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative [OPP1045955]; Research Foundation Flanders (FWO) [1.8.020.09.N.00]; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	Office of Research and Development, Veterans Health Administration; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative; Research Foundation Flanders (FWO)(FWO); James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding through a Developmental Grant to NBB from the San Diego CFAR (AI036214), a Career Developmental Award-II (IK2 BX002731) to NBB from the Office of Research and Development, Veterans Health Administration, the National Institutes of Health research grant (AI104282) to CAS, a grant from the Bill & Melinda Gates Foundation through the Grand Challenges Explorations initiative (OPP1045955) to AB, the Research Foundation Flanders (FWO 1.8.020.09.N.00) to LV, and the James B. Pendleton Charitable Trust. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The sponsors of this research were not involved in the study design, collection or interpretation of the data, manuscript preparation, or the decision to submit the article for publication.	Abdel-Mohsen M, 2015, AIDS, V29, P411, DOI 10.1097/QAD.0000000000000572; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Beliakova-Bethell N, 2019, J BIOL CHEM, V294, P5576, DOI 10.1074/jbc.RA118.005185; Beliakova-Bethell N, 2014, CYTOM PART A, V85A, P94, DOI 10.1002/cyto.a.22352; Beliakova-Bethell N, 2013, AIDS, V27, P29, DOI 10.1097/QAD.0b013e32835b3e26; Besnard E, 2016, CELL HOST MICROBE, V20, P785, DOI 10.1016/j.chom.2016.11.001; Bosque A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002288; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Castro-Gonzalez S, 2018, AIDS RES HUM RETROV, V34, P739, DOI [10.1089/aid.2018.0118, 10.1089/AID.2018.0118]; Chang ZW, 2018, GENE, V654, P36, DOI 10.1016/j.gene.2018.02.036; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Erkelenz S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0154-8; Farivar Shirin, 2018, Iranian Biomedical Journal, V22, P294, DOI 10.29252/ibj.22.5.294; Fu C, 2018, NEUROTHERAPEUTICS, V15, P1139, DOI 10.1007/s13311-018-0649-9; Guo JP, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0582-3; He F, 2018, ADV OPT PHYS, P1, DOI 10.1515/9783110304558; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Henderson Amanda L., 2018, Caribbean Naturalist, P1; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Huan C, 2018, J VIROL, V92, DOI 10.1128/JVI.01844-17; Huang FT, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0845-6; Imam H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08639; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; LaBonte MJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-67; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lefever S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax042; Li J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11730; Lin J, 2018, BIOCHEM PHARMACOL, V156, P511, DOI 10.1016/j.bcp.2018.08.042; Liu HB, 2018, VIROLOGY, V522, P193, DOI 10.1016/j.virol.2018.07.020; Macedo AB, 2018, AIDS RES HUM RETROV, V34, P769, DOI [10.1089/aid.2018.0098, 10.1089/AID.2018.0098]; Mahiet C, 2016, BIOCHEM SOC T, V44, P1417, DOI 10.1042/BST20160113; Martins LJ, 2016, AIDS RES HUM RETROV, V32, P187, DOI 10.1089/aid.2015.0106; Michaels KK, 2015, J IMMUNOL, V194, P3267, DOI 10.4049/jimmunol.1402581; Miller LK, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-120; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Noyce RS, 2006, J VIROL, V80, P226, DOI 10.1128/JVI.80.1.226-235.2006; Noyce RS, 2011, J VIROL, V85, P10926, DOI 10.1128/JVI.00862-11; Park J, 2014, AIDS, V28, P1719, DOI 10.1097/QAD.0000000000000309; Peng XX, 2014, J VIROL, V88, P8768, DOI 10.1128/JVI.00768-14; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qu D, 2019, NUCLEIC ACIDS RES, V47, P3013, DOI 10.1093/nar/gkz117; Rai R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166312; Rasmussen TA, 2016, CURR OPIN HIV AIDS, V11, P394, DOI 10.1097/COH.0000000000000279; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shkreta L, 2017, NUCLEIC ACIDS RES, V45, P4051, DOI 10.1093/nar/gkw1223; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Soriano-Sarabia N, 2014, J VIROL, V88, P14070, DOI 10.1128/JVI.01900-14; Spina CA, 1997, J CLIN INVEST, V99, P1774, DOI 10.1172/JCI119342; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Therneau T, R PACKAGE VERSION 1; Tranell A, 2011, VIRUS RES, V157, P82, DOI 10.1016/j.virusres.2011.02.010; Tranell A, 2010, J BIOL CHEM, V285, P31537, DOI 10.1074/jbc.M109.077453; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathy MK, 2015, J VIROL, V89, P8392, DOI 10.1128/JVI.00572-15; Trypsteen W, 2016, SCI REP-UK, V6, DOI 10.1038/srep36111; White CH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006026; White CH, 2015, ANTIVIR RES, V123, P78, DOI 10.1016/j.antiviral.2015.09.002; Wozniak MB, 2010, HAEMATOL-HEMATOL J, V95, P613, DOI 10.3324/haematol.2009.013870; Xu MD, 2017, CLIN CANCER RES, V23, P2071, DOI 10.1158/1078-0432.CCR-16-0742; Yang Q, 2018, BIOMED PHARMACOTHER, V106, P61, DOI 10.1016/j.biopha.2018.06.112; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927; Zhai NL, 2016, ONCOTARGETS THER, V9, P5713, DOI 10.2147/OTT.S110219; Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12; Zhang RY, 2016, ONCOTARGET, V7, P72546, DOI 10.18632/oncotarget.12466; Zhao YX, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180576	80	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224879	10.1371/journal.pone.0224879	http://dx.doi.org/10.1371/journal.pone.0224879			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710657	Green Published, Green Submitted, gold			2022-12-26	WOS:000532699900027
J	Sala, G; Jopp, D; Gobet, F; Ogawa, M; Ishioka, Y; Masui, Y; Inagakr, H; Nakagawa, T; Yasumoto, S; Ishizakr, T; Arai, Y; Ikebe, K; Kamide, K; Gondo, Y				Sala, Giovanni; Jopp, Daniela; Gobet, Fernand; Ogawa, Madoka; Ishioka, Yoshiko; Masui, Yukie; Inagakr, Hiroki; Nakagawa, Takeshi; Yasumoto, Saori; Ishizakr, Tatsuro; Arai, Yasumichi; Ikebe, Kazunori; Kamide, Kei; Gondo, Yasuyuki			The impact of leisure activities on older adults' cognitive function, physical function, and mental health	PLOS ONE			English	Article							JAPANESE VERSION; FAR TRANSFER; PERFORMANCE; DECLINE; PARTICIPATION; INTELLIGENCE; VALIDITY; LOSE; TIME	Engagement in leisure activities has been claimed to be highly beneficial in the elderly. Practicing such activities is supposed to help older adults to preserve cognitive function, physical function, and mental health, and thus to contribute to successful aging. We used structural equation modeling (SEM) to analyze the impact of leisure activities on these constructs in a large sample of Japanese older adults (N = 809; age range 72-74). The model exhibited an excellent fit (CFI = 1); engaging in leisure activities was positively associated with all the three successful aging indicators. These findings corroborate previous research carried out in Western countries and extend its validity to the population of Eastern older adults. Albeit correlational in nature, these results suggest that active engagement in leisure activities can help older adults to maintain cognitive, physical, and mental health. Future research will clarify whether there is a causal relationship between engagement in leisure activities and successful aging.	[Sala, Giovanni] Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Jopp, Daniela] Univ Lausanne, Inst Psychol, Lausanne, Switzerland; [Gobet, Fernand] London Sch Econ & Polit Sci, Ctr Philosophy Nat & Social Sci, London, England; [Ogawa, Madoka; Masui, Yukie; Inagakr, Hiroki; Ishizakr, Tatsuro] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Ishioka, Yoshiko] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa, Japan; [Nakagawa, Takeshi] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan; [Yasumoto, Saori; Gondo, Yasuyuki] Univ Osaka, Grad Sch Human Sci, Osaka, Japan; [Arai, Yasumichi] Keio Univ, Ctr Supercentenarian Med Res, Tokyo, Japan; [Ikebe, Kazunori] Osaka Univ, Grad Sch Dent, Osaka, Japan; [Kamide, Kei] Osaka Univ, Grad Sch Med, Osaka, Japan	Fujita Health University; University of Lausanne; University of London; London School Economics & Political Science; Tokyo Metropolitan Institute of Gerontology; Keio University; National Center for Geriatrics & Gerontology; Osaka University; Keio University; Osaka University; Osaka University	Gondo, Y (corresponding author), Univ Osaka, Grad Sch Human Sci, Osaka, Japan.	ygondo@hus.osaka-u.ac.jp	Sala, Giovanni/AAD-4214-2021	Sala, Giovanni/0000-0002-1589-3759; Nakagawa, Takeshi/0000-0001-5533-3169	Japan Society for the Promotion of Science [17F17313, 17H02633]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [21330152, 26310104]; Osaka university Graduate school of Human Sciences; International Joint Research Promotion Program at Osaka	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka university Graduate school of Human Sciences; International Joint Research Promotion Program at Osaka	This work was supported by the Japan Society for the Promotion of Science [17F17313 to GS; 17H02633 to YG], the Ministry of Education, Culture, Sports, Science, and Technology of Japan [21330152 to YG; 26310104 to YG], the Grant for promoting Human Sciences research by Osaka university Graduate school of Human Sciences and the International Joint Research Promotion Program at Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway Tracy Packiam, 2016, COGNITIVE TRAINING O, P167, DOI [10.1007/978-3-319-42662-4, 10.1007/978-3-319-42662-4_16, DOI 10.1007/978-3-319-42662-4_16]; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; [Anonymous], 2017, ESTIMATING NORMALIZA; Awata S, 2007, INT PSYCHOGERIATR, V19, P77, DOI 10.1017/S1041610206004212; Best JR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00353; Burgoyne AP, 2016, INTELLIGENCE, V59, P72, DOI 10.1016/j.intell.2016.08.002; Chao SF, 2016, GERONTOLOGIST, V56, P397, DOI 10.1093/geront/gnu052; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Daly M, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01044; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dodge HH, 2008, J GERONTOL A-BIOL, V63, P1193, DOI 10.1093/gerona/63.11.1193; Fuertes E, 2018, THORAX, V73, P376, DOI 10.1136/thoraxjnl-2017-210947; Ghisletta P, 2006, J GERONTOL B-PSYCHOL, V61, pP253, DOI 10.1093/geronb/61.5.P253; Gondo Y., 2016, ENCY GEROPSYCHOLOGY, P2227, DOI [10.1007/978-981-287-080-3_182-1, DOI 10.1007/978-981-287-080-3_182-1]; Gow AJ, 2017, J GERONTOL B-PSYCHOL, V72, P25, DOI 10.1093/geronb/gbw124; Havighurst R. J., 1968, MIDDLE AGE AGING, P161; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hsu HC, 2012, GERONTOLOGIST, V52, P843, DOI 10.1093/geront/gns005; Hultsch DF, 1999, PSYCHOL AGING, V14, P245, DOI 10.1037/0882-7974.14.2.245; Iwasa H, 2012, J PSYCHOSOM RES, V72, P159, DOI 10.1016/j.jpsychores.2011.10.002; Jopp D, 2007, PSYCHOL AGING, V22, P811, DOI 10.1037/0882-7974.22.4.811; Jopp DS, 2015, GERONTOLOGIST, V55, P91, DOI 10.1093/geront/gnu059; Jopp DS, 2010, PSYCHOL ASSESSMENT, V22, P108, DOI 10.1037/a0017662; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Kline, 2015, P PRACT STRUCT EQ MO; Kobayashi K, 2012, J PHYS THER SCI, V24, P747, DOI 10.1589/jpts.24.747; Kobayashi-Cuya KE, 2018, J EPIDEMIOL, V28, P373, DOI [10.2188/jea.JE20170041, 10.2188/jea.je20170041]; Kramer AF, 2004, J GERONTOL A-BIOL, V59, P940; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; Lovden M, 2005, PSYCHOL AGING, V20, P423, DOI 10.1037/0882-7974.20.3.423; Melby-Lervag M, 2016, PERSPECT PSYCHOL SCI, V11, P512, DOI 10.1177/1745691616635612; Menec VH, 2003, J GERONTOL B-PSYCHOL, V58, pS74, DOI 10.1093/geronb/58.2.S74; Nakahara J., 2011, JPN J GERONTOL, V32, P434, DOI [10.34393/rousha.32.4_434, DOI 10.34393/ROUSHA.32.4_434]; Paggi ME, 2016, GERONTOLOGY, V62, P450, DOI 10.1159/000444415; Pressman SD, 2009, PSYCHOSOM MED, V71, P725, DOI 10.1097/PSY.0b013e3181ad7978; Pruchno RA, 2010, J GERONTOL B-PSYCHOL, V65, P671, DOI 10.1093/geronb/gbq051; Puthoff Michael L, 2008, Cardiopulm Phys Ther J, V19, P17; Rizopoulos D, 2006, J STAT SOFTW, V17; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Rosseel Y., 2015, J STAT SOFTW, V48, P1; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Sala G, 2019, COLLABRA-PSYCHOL, V5, DOI 10.1525/collabra.203; Sala G, 2017, INTELLIGENCE, V61, P130, DOI 10.1016/j.intell.2017.01.013; Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Stern C, 2010, INT J EVID-BASED HEA, V8, P2, DOI 10.1111/j.1744-1609.2010.00150.x; Suzuki H, 2015, J AM GERIATR SOC, V63, P1874, DOI 10.1111/jgs.13595; Terrence J, 2018, SEMTOOLS USEFUL TOOL; Tsaousis I, 2007, PERS INDIV DIFFER, V42, P1441, DOI 10.1016/j.paid.2006.10.025; Yates LA, 2016, INT PSYCHOGERIATR, V28, P1791, DOI 10.1017/S1041610216001137	51	34	36	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225006	10.1371/journal.pone.0225006	http://dx.doi.org/10.1371/journal.pone.0225006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1HV	31703115	Green Published, gold, Green Accepted			2022-12-26	WOS:000532697200036
J	Sawaguchi, T; Nakajima, T; Haruyama, A; Hasegawa, T; Shibasaki, I; Nakajima, T; Kaneda, H; Arikawa, T; Obi, S; Sakuma, M; Ogawa, H; Takei, Y; Toyoda, S; Nakamura, F; Abe, S; Fukuda, H; Inoue, T				Sawaguchi, Tatsuya; Nakajima, Toshiaki; Haruyama, Akiko; Hasegawa, Takaaki; Shibasaki, Ikuko; Nakajima, Takafumi; Kaneda, Hiroyuki; Arikawa, Takuo; Obi, Syotaro; Sakuma, Masashi; Ogawa, Hironaga; Takei, Yuusuke; Toyoda, Shigeru; Nakamura, Fumitaka; Abe, Shichiro; Fukuda, Hirotsugu; Inoue, Teruo			Association of serum leptin and adiponectin concentrations with echocardiographic parameters and pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; PLASMA ADIPONECTIN; HEART-FAILURE; BODY-WEIGHT; HYPERTROPHY; OBESITY; MASS; MALNUTRITION; INFLAMMATION; COMMUNITY	Leptin and adiponectin are important regulators of energy metabolism and body composition. Leptin exerts cardiodepressive effects, whereas adiponectin has cardioprotective effects, but several conflicting findings have been reported. The aim of the present study was to assess the relationship between serum leptin and adiponectin levels and echocardiographic parameters and pathophysiological states in patients with cardiovascular disease (CVD) receiving cardiovascular surgery. A total of 128 patients (79 males, average age 69.6 years) that had surgery for CVD including coronary artery bypass graft (CABG) and valve replacement were recruited in this study. Preoperative serum adiponectin and leptin concentrations were measured by enzyme-linked immunosorbent assay and compared with preoperative echocardiographic findings. Body fat volume and skeletal muscle volume index (SMI) were estimated using bioelectrical impedance analysis. We also measured grip strength and gait speed. Sarcopenia was diagnosed based on the recommendations of the Asian Working Group on Sarcopenia. Positive correlations were found between adiponectin and brain natriuretic peptide (BNP), age, left atrial diameter (LAD), E/e' (early-diastolic left ventricular inflow velocity/early-diastolic mitral annular velocity), and left atrial volume index (LAVI). Negative correlations were observed between adiponectin and body mass index (BMI), estimated glomerular filtration rate (eGFR), triglyceride, hemoglobin, and albumin. Serum leptin was positively correlated with BMI, total cholesterol, triglyceride, albumin, body fat volume, and LV ejection fraction (LVEF), whereas it was negatively correlated with BNP and echocardiographic parameters (LAD, LV mass index (LVMI), and LAVI). Multiple regression analysis showed associations between log (leptin) and log (adiponectin) and echocardiographic parameters after adjusting for age, sex, and BMI. Serum adiponectin was negatively correlated with leptin, but positively correlated with tumor necrosis factor a (TNF alpha), an inflammatory cytokine. In males, serum leptin level had a positive correlation with skeletal muscle volume and SMI. However, adiponectin had a negative correlation with anterior mid-thigh muscle thickness, skeletal muscle volume and SMI. And, it was an independent predictive factor in males for sarcopenia even after adjusted by age. These results suggest that leptin and adiponectin may play a role in cardiac remodeling in CVD patients receiving cardiovascular surgery. And, adiponectin appears to be a marker of impaired metabolic signaling that is linked to heart failure progression including inflammation, poor nutrition, and muscle wasting in CVD patients receiving cardiovascular surgery.	[Sawaguchi, Tatsuya; Nakajima, Toshiaki; Haruyama, Akiko; Hasegawa, Takaaki; Nakajima, Takafumi; Kaneda, Hiroyuki; Arikawa, Takuo; Obi, Syotaro; Sakuma, Masashi; Toyoda, Shigeru; Abe, Shichiro; Inoue, Teruo] Dokkyo Med Univ, Dept Cardiovasc Med, Mibu, Tochigi, Japan; [Shibasaki, Ikuko; Ogawa, Hironaga; Takei, Yuusuke; Fukuda, Hirotsugu] Dokkyo Med Univ, Dept Cardiovasc Surg, Mibu, Tochigi, Japan; [Nakamura, Fumitaka] Teikyo Univ, Chiba Med Ctr, Dept Internal Med 3, Tokyo, Japan; [Nakajima, Toshiaki] Dokkyo Med Univ, Heart Ctr, Mibu, Tochigi, Japan	Dokkyo Medical University; Dokkyo Medical University; Teikyo University; Dokkyo Medical University	Nakajima, T (corresponding author), Dokkyo Med Univ, Dept Cardiovasc Med, Mibu, Tochigi, Japan.; Nakajima, T (corresponding author), Dokkyo Med Univ, Heart Ctr, Mibu, Tochigi, Japan.	nakat@dokkyomed.ac.jp	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	JSPS KAKENHI [16H03203, 19H03981]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI Grant Number 16H03203, and 19H03981 (to T.N.). The funding sources for this study had no role in study design, data collection, analysis, or interpretation.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Allison MA, 2013, AM J CARDIOL, V112, P726, DOI 10.1016/j.amjcard.2013.04.053; Amirkalali B, 2010, NUTR RES, V30, P314, DOI 10.1016/j.nutres.2010.05.002; Antonopoulos AS, 2014, ARTERIOSCL THROM VAS, V34, P2151, DOI 10.1161/ATVBAHA.114.303828; Baltruniene V, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3818292; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Bobbert P, 2011, EUR HEART J, V32, P1134, DOI 10.1093/eurheartj/ehq498; Bouillanne O, 2007, EUR J CLIN NUTR, V61, P647, DOI 10.1038/sj.ejcn.1602572; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Fontes-Carvalho R, 2015, EXPERT OPIN THER TAR, V19, P1283, DOI 10.1517/14728222.2015.1019468; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; George J, 2006, HEART, V92, P1420, DOI 10.1136/hrt.2005.083345; Gustafsson S, 2010, EUR J ENDOCRINOL, V162, P543, DOI 10.1530/EJE-09-1006; Harada H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178123; Haugen E, 2008, INT J CARDIOL, V125, P216, DOI 10.1016/j.ijcard.2007.12.002; Hong SJ, 2004, BLOOD PRESSURE, V13, P236, DOI 10.1080/08037050410021397; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Huang C, 2014, NUTR METAB CARDIOVAS, V24, P42, DOI 10.1016/j.numecd.2013.03.006; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kaneda H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201499; Karvonen-Gutierrez CA, 2016, J GERONTOL A-BIOL, V71, P508, DOI 10.1093/gerona/glv123; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kung T, 2011, J CACHEXIA SARCOPENI, V2, P63, DOI 10.1007/s13539-011-0020-z; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; Lee JH, 2001, INT J OBESITY, V25, P1471, DOI 10.1038/sj.ijo.0801736; Lieb W, 2009, AM J CARDIOL, V104, P602, DOI 10.1016/j.amjcard.2009.04.026; Lindberg S, 2012, AM J CARDIOL, V109, P492, DOI 10.1016/j.amjcard.2011.09.041; Loncar G, 2013, EUR J INTERN MED, V24, P818, DOI 10.1016/j.ejim.2013.09.011; Maresca F, 2015, ANGIOLOGY, V66, P8, DOI 10.1177/0003319713520463; Marinou K, 2010, INT J CARDIOL, V138, P3, DOI 10.1016/j.ijcard.2009.03.135; Martin SS, 2015, ATHEROSCLEROSIS, V239, P67, DOI 10.1016/j.atherosclerosis.2014.12.033; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; McGaffin KR, 2008, CARDIOVASC RES, V77, P54, DOI 10.1093/cvr/cvm023; Meier U, 2004, CLIN CHEM, V50, P1511, DOI 10.1373/clinchem.2004.032482; Mikkelsen MM, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-129; Mitsuhashi H, 2007, HYPERTENSION, V49, P1448, DOI 10.1161/HYPERTENSIONAHA.106.079509; Paulo Araujo J, 2009, EUR J HEART FAIL, V11, P567, DOI 10.1093/eurjhf/hfp046; Pisto P, 2012, SCAND J CLIN LAB INV, V72, P395, DOI 10.3109/00365513.2012.687759; Rajapurohitam V, 2003, CIRC RES, V93, P277, DOI 10.1161/01.RES.0000089255.37804.72; Sawaguchi T., 2017, INT J CARDIOL HEART, V18, P86, DOI [10.1016/j.ijcha.2017.11.004, DOI 10.1016/J.IJCHA.2017.11.004]; Sharma S, 2015, INT J CARDIOL, V193, P64, DOI 10.1016/j.ijcard.2015.05.068; Stofkova A, 2009, Endocr Regul, V43, P157; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Unno K, 2010, HEART, V96, P357, DOI 10.1136/hrt.2009.172320; von Haehling S, 2009, PHARMACOL THERAPEUT, V121, P227, DOI 10.1016/j.pharmthera.2008.09.009; Wilson SR, 2011, AM HEART J, V161, P1147, DOI 10.1016/j.ahj.2011.02.014; Wojciechowska C, 2017, ENDOKRYNOL POL, V68, P26, DOI 10.5603/EP.2017.0005; Won H, 2012, YONSEI MED J, V53, P91, DOI 10.3349/ymj.2012.53.1.91; Yamaji M, 2009, CIRC J, V73, P1067, DOI 10.1253/circj.CJ-08-1026; Yasuda T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17814-z	54	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225008	10.1371/journal.pone.0225008	http://dx.doi.org/10.1371/journal.pone.0225008			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703113	gold, Green Published			2022-12-26	WOS:000532697200037
J	Filcek, K; Vielfort, K; Muraleedharan, S; Henriksson, J; Valdivia, RH; Bavoil, PM; Sixt, BS				Filcek, Kimberly; Vielfort, Katarina; Muraleedharan, Samada; Henriksson, Johan; Valdivia, Raphael H.; Bavoil, Patrik M.; Sixt, Barbara S.			Insertional mutagenesis in the zoonotic pathogen Chlamydia caviae	PLOS ONE			English	Article							GENOME SEQUENCE; INCLUSION MEMBRANE; CHICKEN-EMBRYO; TRACHOMATIS; PSITTACI; PROTEIN; INCA; INFECTION; VIRULENCE; MODEL	The ability to introduce targeted genetic modifications in microbial genomes has revolutionized our ability to study the role and mode of action of individual bacterial virulence factors. Although the fastidious lifestyle of obligate intracellular bacterial pathogens poses a technical challenge to such manipulations, the last decade has produced significant advances in our ability to conduct molecular genetic analysis in Chlamydia trachomatis, a major bacterial agent of infertility and blindness. Similar approaches have not been established for the closely related veterinary Chlamydia spp., which cause significant economic damage, as well as rare but potentially life-threatening infections in humans. Here we demonstrate the feasibility of conducting site-specific mutagenesis for disrupting virulence genes in C. caviae, an agent of guinea pig inclusion conjunctivitis that was recently identified as a zoonotic agent in cases of severe community-acquired pneumonia. Using this approach, we generated C. caviae mutants deficient for the secreted effector proteins IncA and SinC. We demonstrate that C. caviae IncA plays a role in mediating fusion of the bacteria-containing vacuoles inhabited by C. caviae. Moreover, using a chicken embryo infection model, we provide first evidence for a role of SinC in C. caviae virulence in vivo.	[Filcek, Kimberly; Bavoil, Patrik M.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Vielfort, Katarina; Muraleedharan, Samada; Henriksson, Johan; Sixt, Barbara S.] Umea Univ, Umea Ctr Microbial Res, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Valdivia, Raphael H.; Sixt, Barbara S.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA	University System of Maryland; University of Maryland Baltimore; Umea University; Duke University	Bavoil, PM (corresponding author), Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA.; Sixt, BS (corresponding author), Umea Univ, Umea Ctr Microbial Res, Dept Mol Biol, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.; Sixt, BS (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	PBavoil@umaryland.edu; barbara.sixt@umu.se	Sixt, Barbara/AAY-5140-2020; Henriksson, Johan/ABD-2430-2021	Sixt, Barbara/0000-0002-5607-8902; Henriksson, Johan/0000-0002-7745-2844; Vielfort, Katarina/0000-0002-9988-6336; Muraleedharan, Samada/0000-0002-9045-9100	National Institutes of Health [R01AI100759]; National Institutes of Health (STI Cooperative Research Center) [U19 AI 084044]; European Union [PIOF-GA2013-626116]; Swedish Research Council [2018-02286, 201606598]; Kempe foundation [JCK-1834]; Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [SNIC 2019/8-143]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044, R01AI100759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (STI Cooperative Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe foundation; Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (RHV: R01AI100759, PMB: STI Cooperative Research Center U19 AI 084044), the European Union's Seventh Framework Program (BSS: PIOF-GA2013-626116), the Swedish Research Council (BSS: project 2018-02286, MIMS -The Swedish EMBL node for Molecular Medicine: project 201606598), and the Kempe foundation (SM: fellowship JCK-1834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Huizhong Shou (University of Maryland, Baltimore) for her continued help in cell culture and laboratory management. We are also grateful to Roger Rank (University of Arkansas for Medical Sciences), Daniel Rockey (Oregon State University), and Derek Fisher (Southern Illinois University), for sharing strains, antibodies, and vectors. Furthermore, Sven Bergstrom and Jorgen Johansson (Umea University) are acknowledged for their support and comments on the manuscript, and Anna Eriksson (Umea University and Chemical Biology Consortium Sweden) is acknowledged for technical support with the ArrayScan imaging platform. The computations were performed using resources provided by the Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under Project SNIC 2019/8-143.	Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Alnassan AA, 2013, PARASITOL RES, V112, P2299, DOI 10.1007/s00436-013-3392-5; Alzhanov D, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-24; Andersson C, 2015, NAT PROTOC, V10, P1155, DOI 10.1038/nprot.2015.073; Azuma Y, 2006, DNA RES, V13, P15, DOI 10.1093/dnares/dsi027; BANKS J, 1970, Infection and Immunity, V1, P259; Beeckman DSA, 2009, CLIN MICROBIOL INFEC, V15, P11, DOI 10.1111/j.1469-0691.2008.02669.x; Braukmann M, 2012, INFECT IMMUN, V80, P2976, DOI 10.1128/IAI.00437-12; Bullock HD, 2012, J BIOL CHEM, V287, P28078, DOI 10.1074/jbc.M112.386904; Burillo A, 2010, INFECT DIS CLIN N AM, V24, P61, DOI 10.1016/j.idc.2009.10.002; Chen YS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003954; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Geisler WM, 2001, J INFECT DIS, V184, P879, DOI 10.1086/323340; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Hsia RC, 2000, MICROBES INFECT, V2, P761, DOI 10.1016/S1286-4579(00)90356-3; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Johnson CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083989; Knittler MR, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu007; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Lowden Nicole M, 2015, BMC Res Notes, V8, P570, DOI 10.1186/s13104-015-1542-9; Lutz-Wohlgroth L, 2006, J VET MED A, V53, P185, DOI 10.1111/j.1439-0442.2006.00819.x; Mojica SA, 2015, MOL BIOL CELL, V26, P1918, DOI 10.1091/mbc.E14-11-1530; Mueller KE, 2016, MBIO, V7, DOI 10.1128/mBio.01817-15; MURRAY ES, 1964, J INFECT DIS, V114, P1, DOI 10.1093/infdis/114.1.1; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Oh JY, 2012, POULTRY SCI, V91, P370, DOI 10.3382/ps.2011-01807; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Polakowska K, 2012, MICROBES INFECT, V14, P1352, DOI 10.1016/j.micinf.2012.09.006; Ramakers BP, 2017, NEW ENGL J MED, V377, P992, DOI 10.1056/NEJMc1702983; Rank RG, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P285, DOI 10.1128/9781555817329.ch13; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; ROCKEY DD, 1995, MOL MICROBIOL, V15, P617, DOI 10.1111/j.1365-2958.1995.tb02371.x; Rockey DD, 1996, INFECT IMMUN, V64, P4269, DOI 10.1128/IAI.64.10.4269-4278.1996; Sachse K, 2015, SYST APPL MICROBIOL, V38, P99, DOI 10.1016/j.syapm.2014.12.004; SCHACHTER J, 1994, METHOD ENZYMOL, V236, P377; Sixt BS, 2017, CELL HOST MICROBE, V21, P113, DOI 10.1016/j.chom.2016.12.002; Sixt BS, 2016, ANNU REV MICROBIOL, V70, P179, DOI 10.1146/annurev-micro-102215-095539; SPEARS P, 1979, INFECT IMMUN, V24, P224, DOI 10.1128/IAI.24.1.224-232.1979; Suchland RJ, 2000, INFECT IMMUN, V68, P360, DOI 10.1128/IAI.68.1.360-367.2000; Suchland RJ, 2008, INFECT IMMUN, V76, P5438, DOI 10.1128/IAI.00984-08; Tan C, 2010, CELL MICROBIOL, V12, P174, DOI 10.1111/j.1462-5822.2009.01389.x; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; van Grootveld R, 2018, VECTOR-BORNE ZOONOT, V18, P635, DOI 10.1089/vbz.2018.2304; Voigt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035097; Ward ME, 1988, MICOBIOLOGY CHLAMYDI, P71; Weber MM, 2016, J BACTERIOL, V198, P1347, DOI 10.1128/JB.00933-15; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3	51	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224324	10.1371/journal.pone.0224324	http://dx.doi.org/10.1371/journal.pone.0224324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697687	gold, Green Published, Green Submitted			2022-12-26	WOS:000532694400023
J	Liddle, L; Reinders, R; South, S; Blacker, D; Knuckey, N; Colbourne, F; Meloni, B				Liddle, Lane; Reinders, Ryan; South, Samantha; Blacker, David; Knuckey, Neville; Colbourne, Frederick; Meloni, Bruno			Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POLY-ARGININE R18; ISCHEMIC-STROKE; MOUSE MODEL; NEUROPROTECTION; TRANSFORMATION; INHIBITION; HEMATOMA; RECOVERY; THERAPY	Background Cationic arginine-rich peptides (CARPs) have demonstrated neuroprotective and/or behavioural efficacy in ischemic and hemorrhagic stroke and traumatic brain injury models. Therefore, in this study we investigated the safety and neuroprotective efficacy of the CARPs poly-arginine-18 (R18; 18-mer of arginine) and its D-enantiomer R18D given in the acute bleeding phase in an intracerebral hemorrhage (ICH) model. Methods One hundred and fifty-eight male Sprague-Dawley rats received collagenase-induced ICH. Study 1 examined various doses of R18D (30, 100, 300, or 1000 nmol/kg) or R18 (100, 300, 1000 nmol/kg) administered intravenously 30 minutes post-collagenase injection on hemorrhage volume 24 hours after ICH. Study 2 examined R18D (single intravenous dose) or R18 (single intravenous dose, plus 6 daily intraperitoneal doses) at 300 or 1000 nmol/kg commencing 30 minutes post-collagenase injection on behavioural outcomes (Montoya staircase test, and horizontal ladder test) in the chronic post-ICH period. A histological assessment of tissue loss was assessed using a Nissl stain at 28 days after ICH. Results When administered during ongoing bleeding, neither R18 or R18D exacerbated hematoma volume or worsened functional deficits. Lesion volume assessment at 28 days post-ICH was not reduced by the peptides; however, animals treated with the lower R18D 300 nmol/kg dose, but not with the higher 1000 nmol/kg dose, demonstrated a statistically increased lesion size compared to saline treated animals. Conclusion Overall, both R18 and R18D appeared to be safe when administered during a period of ongoing bleeding following ICH. Neither peptide appears to have any statistically significant effect in reducing lesion volume or improving functional recovery after ICH. Additional studies are required to further assess dose efficacy and safety in pre-clinical ICH studies.	[Liddle, Lane; Reinders, Ryan; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [South, Samantha] Univ Western Australia, Off Res Enterprise, Perth, WA, Australia; [Blacker, David; Knuckey, Neville; Meloni, Bruno] Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia; [Blacker, David; Knuckey, Neville; Meloni, Bruno] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia; [Blacker, David] Sir Charles Gairdner Hosp, Dept Neurol, Nedlands, WA, Australia; [Knuckey, Neville; Meloni, Bruno] Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA, Australia; [Colbourne, Frederick] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada	University of Alberta; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Alberta	Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.; Colbourne, F (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082; Blacker, David/0000-0003-0046-9776	Canada Research Chair award; Branch Out Neurological Foundation	Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Branch Out Neurological Foundation	FC is supported by a Canada Research Chair award (http://www.chairs-chaires.gc.ca/homeaccueil-eng.aspx).LL is supported by a Branch Out Neurological Foundation award (https://www.branchoutfoundation.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye O, 2011, TRANSL STROKE RES, V2, P17, DOI 10.1007/s12975-010-0037-1; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Balami JS, 2011, LANCET NEUROL, V10, P357, DOI 10.1016/S1474-4422(10)70313-6; Ballarin B, 2018, ACTA PHARMACOL SIN, V39, P661, DOI 10.1038/aps.2018.5; Bao HJ, 2016, NEUROSCI LETT, V628, P219, DOI 10.1016/j.neulet.2016.06.046; Beray-Berthat V, 2010, J NEUROSCI METH, V191, P180, DOI 10.1016/j.jneumeth.2010.06.025; Birk AV, 2015, BBA-BIOENERGETICS, V1847, P1075, DOI 10.1016/j.bbabio.2015.06.006; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Chiu LS, 2017, TRANSL NEUROSCI, V8, P147, DOI 10.1515/tnsci-2017-0021; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Corbett D, 2017, NEUROREHAB NEURAL RE, V31, P699, DOI 10.1177/1545968317724285; da Silva-Candal A, 2015, J CEREBR BLOOD F MET, V35, P1206, DOI 10.1038/jcbfm.2015.28; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Edwards AB, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0352-0; Guptill JT, 2017, J CLIN PHARMACOL, V57, P770, DOI 10.1002/jcph.853; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Instrum R, 2013, ACTA PHARMACOL SIN, V34, P3, DOI 10.1038/aps.2012.175; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; Larrue V, 1997, STROKE, V28, P957, DOI 10.1161/01.STR.28.5.957; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Lei BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34834; Lei BL, 2012, TRANSL STROKE RES, V3, pS94, DOI 10.1007/s12975-012-0176-7; Li L, 2013, CELL MOL NEUROBIOL, V33, P893, DOI 10.1007/s10571-013-9955-2; LI Q, 2018, FRONT NEUROL, V9; LoPresti MA, 2014, J NEUROL SCI, V345, P3, DOI 10.1016/j.jns.2014.06.057; MacLellan CL, 2004, J CEREBR BLOOD F MET, V24, P432, DOI 10.1097/00004647-200404000-00008; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, J CEREBR BLOOD F MET, V26, P1031, DOI 10.1038/sj.jcbfm.9600255; Marshall J, 2015, J BIOL CHEM, V290, P22030, DOI 10.1074/jbc.M115.662791; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Meloni BP, 2015, PHARMACOL THERAPEUT, V153, P36, DOI 10.1016/j.pharmthera.2015.06.002; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Michel-Monigadon D, 2010, CEREBROVASC DIS, V29, P564, DOI 10.1159/000306643; Milani D, 2017, NEUROSCI RES, V114, P9, DOI 10.1016/j.neures.2016.09.002; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Moutal A, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00471; Nogueira RG, 2015, J NEUROINTERV SURG, V7, P16, DOI 10.1136/neurintsurg-2013-010743; Paciaroni M, 2008, STROKE, V39, P2249, DOI 10.1161/STROKEAHA.107.510321; Pandey AS, 2014, TRANSL STROKE RES, V5, P313, DOI 10.1007/s12975-014-0344-z; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Righy C, 2016, CURR NEUROPHARMACOL, V14, P392, DOI 10.2174/1570159X14666151230110058; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Sussman ES, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00069; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang J, 2005, BRAIN, V128, P1622, DOI 10.1093/brain/awh489; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang ZF, 2019, J CEREBR BLOOD F MET, V39, P1588, DOI 10.1177/0271678X18762637; Wilkinson CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210660; Williamson MR, 2017, STROKE, V48, P195, DOI 10.1161/STROKEAHA.116.015404; Zhang J, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.08	61	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224870	10.1371/journal.pone.0224870	http://dx.doi.org/10.1371/journal.pone.0224870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697775	gold, Green Published			2022-12-26	WOS:000532694400076
J	Sunderland, N; Westbrook, J; Urwin, R; Knights, Z; Taitz, J; Williams, H; Wiles, LK; Molloy, C; Hibbert, P; Ting, HP; Churruca, K; Arnolda, G; Braithwaite, J				Sunderland, Neroli; Westbrook, Johanna; Urwin, Rachel; Knights, Zoe; Taitz, Jonny; Williams, Helena; Wiles, Louise K.; Molloy, Charlotte; Hibbert, Peter; Ting, Hsuen P.; Churruca, Kate; Arnolda, Gaston; Braithwaite, Jeffrey		CareTrack Kids Investigative Team	Appropriate management of acute gastroenteritis in Australian children: A population-based study	PLOS ONE			English	Article							HEALTH-CARE; GUIDELINES; QUALITY; THERAPY; IMPACT; TRIAL	Objectives To determine the proportion of care provided to children with acute gastroenteritis (AGE) in Australia consistent with clinical practice guidelines. Methods Indicators were developed from national and international clinical practice guideline (CPG) recommendations and validated by an expert panel. Medical records from children <= 15 years presenting with AGE in three healthcare settings-Emergency Department (ED), hospital admissions and General Practitioner (GP) consultations-from randomly selected health districts across three Australian States were reviewed. Records were audited against 35 indicators by trained paediatric nurses, to determine adherence to CPGs during diagnosis, treatment, and ongoing management. Results A total of 14,434 indicator assessments were performed from 854 healthcare visits for AGE by 669 children, across 75 GPs, 34 EDs and 26 hospital inpatient services. Documented adherence to guidelines across all healthcare settings was 45.5% for indicators relating to diagnosis (95% CI: 40.7-50.4), 96.1% for treatment (95% CI: 94.8-97.1) and 57.6% for ongoing management (95% CI: 51.3-63.7). Adherence varied by healthcare setting, with adherence in GPs (54.6%; 95% CI: 51.1-58.1) lower than for either ED settings (84.7%; 95% CI: 82.4-86.9) or for inpatients (84.3%; 95% CI: 80.0-87.9); p<0.0001 for both differences. The difference between settings was driven by differences in the diagnosis and ongoing management phases of care. Conclusions Adherence to clinical guidelines for children presenting to healthcare providers with AGE varies according to phase of care and healthcare setting. Although appropriate diagnostic assessment and ongoing management phase procedures are not well documented in medical records (particularly in the GP setting), in the treatment phase children are treated in accordance with guidelines over 90% of the time.	[Sunderland, Neroli; Westbrook, Johanna; Urwin, Rachel] Macquarie Univ, Ctr Hlth Syst & Safety Res, Australian Inst Hlth Innovat, Sydney, NSW, Australia; [Knights, Zoe] Childrens Hosp Westmead, Emergency Dept, Westmead, NSW, Australia; [Taitz, Jonny] Clin Excellence Commiss, McKell Bldg, Sydney, NSW, Australia; [Williams, Helena] Womens & Childrens Hosp, SALHN, Australian Commiss Safety & Qual Hlth Care, Adelaide, SA, Australia; [Wiles, Louise K.; Molloy, Charlotte; Hibbert, Peter] Univ South Australia, Sch Hlth Sci, Canc Res Inst UniSA CRI, Australian Ctr Precis Hlth, Adelaide, SA, Australia; [Wiles, Louise K.; Molloy, Charlotte; Hibbert, Peter] South Australian Hlth & Med Res Inst SAHMRI, Adelaide, SA, Australia; [Wiles, Louise K.; Molloy, Charlotte; Hibbert, Peter; Ting, Hsuen P.; Churruca, Kate; Arnolda, Gaston; Braithwaite, Jeffrey] Macquarie Univ, Ctr Healthcare Resilience & Implementat Sci, Australian Inst Hlth Innovat, Sydney, NSW, Australia	Macquarie University; University of Sydney; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); Macquarie University	Braithwaite, J (corresponding author), Macquarie Univ, Ctr Healthcare Resilience & Implementat Sci, Australian Inst Hlth Innovat, Sydney, NSW, Australia.	jeffrey.braithwaite@mq.edu.au	Churruca, Kate/H-8623-2019; Arnolda, Gaston R/D-8528-2017; Westbrook, Johanna I/J-9045-2018; Braithwaite, Jeffrey/AAN-1467-2020; Wiles, Louise/I-3014-2015	Churruca, Kate/0000-0002-9923-3116; Arnolda, Gaston R/0000-0003-4948-7633; Westbrook, Johanna I/0000-0003-1083-8192; Braithwaite, Jeffrey/0000-0003-0296-4957; Molloy, Charlotte/0000-0001-7451-9751; Urwin, Rachel/0000-0001-7026-8043; Hibbert, Peter/0000-0001-7865-343X; Wiles, Louise/0000-0002-6557-6196; Sunderland, Neroli/0000-0002-4269-4915	Australian National Health and Medical Research Council [APP1065898]; National Health and Medical Research Council; Bupa Health Foundation; Sydney Children's Hospital Network; New South Wales Kids and Families; Children's Health Queensland; South Australian Department of Health (SA Health)	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bupa Health Foundation; Sydney Children's Hospital Network; New South Wales Kids and Families; Children's Health Queensland; South Australian Department of Health (SA Health)	This work was supported by an Australian National Health and Medical Research Council Partnership Grant (APP1065898), with contributions by the National Health and Medical Research Council, Bupa Health Foundation, Sydney Children's Hospital Network, New South Wales Kids and Families, Children's Health Queensland, and the South Australian Department of Health (SA Health).	Albano F, 2010, J PEDIATR-US, V156, P226, DOI 10.1016/j.jpeds.2009.07.065; Bahm A, 2016, ACAD EMERG MED, V23, P599, DOI 10.1111/acem.12915; Barker SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195759; Braithwaite J, 2018, JAMA-J AM MED ASSOC, V319, P1113, DOI 10.1001/jama.2018.0162; Brezerra JA, 1992, PEDIATRICS, V90, P1; Chen Y, 2016, EPIDEMIOL INFECT, V144, P241, DOI 10.1017/S0950268815001375; Davey HM, 2015, VACCINE, V33, P1726, DOI 10.1016/j.vaccine.2015.01.082; Dey A, 2012, MED J AUSTRALIA, V197, P453, DOI 10.5694/mja12.10062; Fitch K, 2001, MR1269DGXIIRE; Fonseca BK, 2004, ARCH PEDIAT ADOL MED, V158, P483, DOI 10.1001/archpedi.158.5.483; Fox J, 2012, ARCH DIS CHILD, V97, P415, DOI 10.1136/archdischild-2011-300881; Geurts D, 2017, EUR J PEDIATR, V176, P173, DOI 10.1007/s00431-016-2819-2; Gregorio GV, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007296.pub2; Guarino A, 2014, J PEDIATR GASTR NUTR, V59, P132, DOI 10.1097/MPG.0000000000000375; Health NSW, 2014, INF CHILDR MAN AC GA; Heath I, 2007, BRIT MED J, V335, P1075, DOI 10.1136/bmj.39377.387373.AD; Hooper TD, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007749; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Korn E, 1998, SURV METHODOL, V24, P193; Li STT, 2007, PLOS MED, V4, P495, DOI 10.1371/journal.pmed.0040098; Lo Vecchio A, 2014, PEDIATR INFECT DIS J, V33, P1103, DOI 10.1097/INF.0000000000000396; Mathioudakis A, 2016, BREATHE, V12, P371, DOI 10.1183/20734735.018016; National Institute for Health and Care Excellence, 2009, CONTR NO CLIN GUID 8; Nicastro E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132213; Owen Jm, 2015, Ir Med J, V108, P183; Perlstein PH, 1999, PEDIAT RES 2, V45; SNYDER JD, 1991, PEDIATRICS, V87, P28; The Royal Children's Hospital Melbourne, 2015, CLIN PRACT GUID GAST; Tieder JS, 2009, PEDIATRICS, V124, pE1081, DOI 10.1542/peds.2009-0473; Wiles LK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209637; Wiles LK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007748; Zolotor AJ, 2007, PEDIATRICS, V120, pE644, DOI 10.1542/peds.2006-1749	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224681	10.1371/journal.pone.0224681	http://dx.doi.org/10.1371/journal.pone.0224681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697706	Green Accepted, gold, Green Published			2022-12-26	WOS:000532694400041
J	Damanik, J; Mayza, A; Rachman, A; Sauriasari, R; Kristanti, M; Agustina, PS; Angianto, AR; Prawiroharjo, P; Yunir, E				Damanik, Johanda; Mayza, Andre; Rachman, Andhika; Sauriasari, Rani; Kristanti, Melly; Agustina, Putri Syahida; Angianto, Alexander Randy; Prawiroharjo, Pukovisa; Yunir, Em			Association between serum homocysteine level and cognitive function in middle-aged type 2 diabetes mellitus patients	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; IMPAIRMENT; DYSFUNCTION; DEMENTIA; DISEASE; HYPERHOMOCYSTEINEMIA; ABNORMALITIES; VALIDATION; EXERCISE; RISK	Type-2 diabetes mellitus (T2DM) is strongly associated with various complications, including cognitive impairment. Diabetic complication is related with structural and functional changes of brain. Studies investigated that homocysteine as an independent risk factor of several organ complications. This marker might have a role in pathogenesis of cognitive impairment in T2DM patients. We aimed to know the association between serum homocysteine level and cognitive impairment in middle-aged T2DM populations. The study was a cross-sectional study involving 97 T2DM patients aged <60 years old. Cognitive assessment was based on validated Indonesian version of Montreal Cognitive Assessment (MoCA-INA) test. Besides, serum homocysteine level (Hcy) was measured based on standard laboratory assay. Filling out the questionnaire of MoCA-INA was conducted when patients came to take the blood sample. This study used independent t-test, chi-square and multivariate logistic regression model to analyze the data. There were 47 subjects (48.5%) with mild cognitive impairment (MCI). Delayed recall was the most impaired domain (94.8%). There was no significant mean difference of serum Hcy level in MCI and non-MCI group (11.99 +/- 3.27 mu mol/L vs 12.36 +/- 4.07 mu mol/L respectively, p = 0.62). Final model of logistic regression showed no association between serum Hcy and cognitive function after adjusting confounding variables (OR: 1.778; 95%Cl: 0.69-4.54). Further investigation involving slight elderly T2DM patients with larger sample size should be conducted to confirm this finding.	[Damanik, Johanda; Angianto, Alexander Randy] Univ Indonesia, Cipto Mangunkusumo Natl Gen Hosp, Fac Med, Dept Internal Med, Jakarta, Indonesia; [Mayza, Andre; Prawiroharjo, Pukovisa] Univ Indonesia, Cipto Mangunkusumo Natl Gen Hosp, Fac Med, Dept Neurol, Jakarta, Indonesia; [Rachman, Andhika] Univ Indonesia, Cipto Mangunkusumo Natl Gen Hosp, Fac Med, Dept Internal Med,Div Haematol & Med Oncol, Jakarta, Indonesia; [Sauriasari, Rani; Agustina, Putri Syahida] Univ Indonesia, Fac Pharm, Jakarta, Indonesia; [Kristanti, Melly; Yunir, Em] Univ Indonesia, Dept Internal Med, Div Endocrinol & Metab, Cipto Mangunkusumo Natl Gen Hosp,Fac Med, Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia; University of Indonesia; University of Indonesia	Yunir, E (corresponding author), Univ Indonesia, Dept Internal Med, Div Endocrinol & Metab, Cipto Mangunkusumo Natl Gen Hosp,Fac Med, Jakarta, Indonesia.	e.yunir@ui.ac.id	Kristanti, Melly/AAC-5153-2021; Rachman, Andhika/AAE-3778-2022; Sauriasari, Rani/AAU-3424-2020	Kristanti, Melly/0000-0001-9668-5750; Rachman, Andhika/0000-0003-3246-3352; Sauriasari, Rani/0000-0001-7861-4369; Agustina, Putri/0000-0002-6552-8135; Yunir, Em/0000-0002-2004-9050	PITTA Grant 2018 by Directorate of Research and Community Engagement of Universitas Indonesia [2072/UN2.R3.1/HKP.05.00/2018]	PITTA Grant 2018 by Directorate of Research and Community Engagement of Universitas Indonesia	This work was supported by PITTA Grant 2018 by Directorate of Research and Community Engagement of Universitas Indonesia to EY, Grant numbers award: 2072/UN2.R3.1/HKP.05.00/2018, Funder website: research.ui.ac.id. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Angevaren M., 2008, COCHRANE DATABASE SY; Ansari R, 2014, J CLIN NEUROL, V10, P281, DOI 10.3988/jcn.2014.10.4.281; Aslan AKD, 2015, AGE AGEING, V44, P59, DOI 10.1093/ageing/afu108; Bajaj JS, 2010, GASTROENTEROLOGY, V138, P2332, DOI 10.1053/j.gastro.2010.02.015; Barbagallo M, 2014, WORLD J DIABETES, V5, P889, DOI 10.4239/wjd.v5.i6.889; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Biessels GJ, 2014, DIABETES, V63, P2244, DOI 10.2337/db14-0348; Bostom AG, 1997, KIDNEY INT, V52, P10, DOI 10.1038/ki.1997.298; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Cumming TB, 2013, ACTA NEUROL SCAND, V128, P122, DOI 10.1111/ane.12084; de la Monte SM, 2014, ENDOCRIN METAB CLIN, V43, P245, DOI 10.1016/j.ecl.2013.09.006; Deary IJ, 2019, BR MED B, V92, P135; Deminice R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151653; Ebesunun MO, 2012, PAN AFR MED J, V12; Freitas S, 2012, J GERIATR PSYCH NEUR, V25, P146, DOI 10.1177/0891988712455235; Ganguly P, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-6; Huang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-867; Husein N, 2010, NEURONA, V27, P15; Inoue M, 2015, JAPANESE J ANESTHESI, V64, P833; James P, 2014, J INTERN MED TAIWAN, V25, P165; Kandimalla R, 2017, BBA-MOL BASIS DIS, V1863, P1078, DOI 10.1016/j.bbadis.2016.08.018; Kim B, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.3; Langlois F, 2013, J GERONTOL B-PSYCHOL, V68, P400, DOI 10.1093/geronb/gbs069; Lee JY, 2008, J GERIATR PSYCH NEUR, V21, P104, DOI 10.1177/0891988708316855; Malaguarnerra G, 2014, BIOMED RES INT, V2014, P1; Masuda Yumi, 2008, Environmental Health and Preventive Medicine, V13, P148, DOI 10.1007/s12199-008-0024-2; Mayeda ER, 2013, DIABETES CARE, V36, P2600, DOI 10.2337/dc12-2158; McDowell IFW, 2000, J NUTR, V130, p369S, DOI 10.1093/jn/130.2.369S; Moheet A, 2015, ANN NY ACAD SCI, V1353, P60, DOI 10.1111/nyas.12807; Mood EH, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.16217; Morris JK, 2014, NEUROBIOL AGING, V35, P585, DOI 10.1016/j.neurobiolaging.2013.09.033; Murray AM, 2017, DIABETOLOGIA, V60, P69, DOI 10.1007/s00125-016-4118-x; Perkumpulan Endokrinologi Indonesia, 2015, PAND PENG DISL IND; Qiu CX, 2014, ANN NEUROL, V75, P138, DOI 10.1002/ana.24063; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Reijmer YD, 2013, DIABETES CARE, V36, P137, DOI 10.2337/dc12-0493; Reitz C, 2009, DEMENT GERIATR COGN, V27, P11, DOI 10.1159/000182421; Roalf DR, 2013, ALZHEIMERS DEMENT, V9, P529, DOI 10.1016/j.jalz.2012.10.001; Ryan DH, 2017, DIABETES CARE, V40, DOI 10.2337/dc1-er02a; Ryan JP, 2014, J GERIATR PSYCH NEUR, V27, P47, DOI 10.1177/0891988713516543; Schalinske KL, 2012, ADV NUTR, V3, P755, DOI 10.3945/an.112.002758; Sengwayo D, 2013, CARDIOVASC J AFR, V24, P265, DOI 10.5830/CVJA-2013-059; Setien-Suero E, 2016, NEUROSCI BIOBEHAV R, V69, P280, DOI 10.1016/j.neubiorev.2016.08.014; Shaikh MK, 2012, World Appl Sci J., V63, P1158, DOI [10.1007/s12199-008-0024-2, DOI 10.1007/S12199-008-0024-2]; Silveira CRA, 2018, NEUROSCI LETT, V671, P60, DOI 10.1016/j.neulet.2018.01.056; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Tian S, 2017, J ALZHEIMERS DIS, V58, P1163, DOI 10.3233/JAD-170162; Umegaki H, 2014, CLIN INTERV AGING, V9, DOI 10.2147/CIA.S48926; Wang C, 2015, LIFE SPAN, V2016, P1; Zhang YW, 2014, NEUROSCI LETT, V562, P1, DOI 10.1016/j.neulet.2014.01.006	50	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224611	10.1371/journal.pone.0224611	http://dx.doi.org/10.1371/journal.pone.0224611			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693691	Green Published, gold			2022-12-26	WOS:000532690100030
J	Sijpkens, MK; Lagendijk, J; van Minde, MRC; de Kroon, MLA; Bertens, LCM; Rosman, AN; Steegers, EAP				Sijpkens, Meertien K.; Lagendijk, Jacqueline; van Minde, Minke R. C.; de Kroon, Marlou L. A.; Bertens, Loes C. M.; Rosman, Ageeth N.; Steegers, Eric A. P.			Integrating interconception care in preventive child health care services: The Healthy Pregnancy 4 All program	PLOS ONE			English	Article							PRECONCEPTION CARE; EUROPEAN COUNTRIES; RISK-ASSESSMENT; INTERVENTION; BEHAVIORS; INTENTION; OUTCOMES; VISITS	Background Most parents with young children pay routine visits to Well-Baby Clinics, or so-called Preventive Child Health Care (PCHC) services. This offers a unique opportunity to promote and deliver interconception care. This study aimed to integrate such care and perform an implementation evaluation. Methods In seven Dutch municipalities, PCHC professionals were instructed to discuss the possibility of an interconception care consultation during each routine six-months well-baby visit. The primary outcome of this study was coverage of the intervention, quantified as the proportion of visits during which women were informed about interconception care. Secondary outcomes included adoption, fidelity, feasibility, appropriateness, acceptability and effectiveness of the intervention, studied by surveying PCHC professionals and women considering becoming pregnant. Results The possibility of interconception care was discussed during 29% (n = 1,849) of all visits, and 60% of the PCHC physicians adopted the promotion of interconception care by regularly informing women. About half of the PCHC professionals and most women judged integration of interconception care in PCHC appropriate and acceptable. Estimated feasibility was poor, since 13% of the professionals judged future integration in daily practice as probable. The uptake of interconception care consultations was low (n = 4 consultations). Conclusions Promotion of interconception care was achieved in approximately one-third of the routine PCHC consultations and appeared promising with regards to adoption, appropriateness and acceptability. However, concerns on feasibility and uptake of interconception care consultations in daily practice remain. Suggestions for improvement may include further integration of interconception care health promotion in routine PCHC consultations, while allocating sufficient resources.	[Sijpkens, Meertien K.; Lagendijk, Jacqueline; van Minde, Minke R. C.; de Kroon, Marlou L. A.; Bertens, Loes C. M.; Rosman, Ageeth N.; Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynaecol, Div Obstet & Prenatal Med, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [van Minde, Minke R. C.; de Kroon, Marlou L. A.] Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [de Kroon, Marlou L. A.] Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands; [Rosman, Ageeth N.] Rotterdam Univ Appl Sci, Dept Hlth Care Studies, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Sijpkens, MK (corresponding author), Erasmus MC, Dept Obstet & Gynaecol, Div Obstet & Prenatal Med, Univ Med Ctr Rotterdam, Rotterdam, Netherlands.	m.sijpkens@erasmusmc.nl	Bertens, Loes CM/AAV-4664-2020; de Kroon, Marlou MLA/M-4040-2014	Bertens, Loes CM/0000-0003-0897-0709; de Kroon, Marlou/0000-0003-1730-4994; van Minde, Minke/0000-0003-3316-336X; Lagendijk, Jacqueline/0000-0002-7178-8910	Dutch Ministry of Health, Welfare and Sport, The Hague [323911]	Dutch Ministry of Health, Welfare and Sport, The Hague	The Healthy Pregnancy 4 All study is funded by the Dutch Ministry of Health, Welfare and Sport, The Hague (grant number 323911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2017, MATERN CHILD HLTH J, V21, P387, DOI 10.1007/s10995-017-2283-2; Atrash HK, 2006, MATERN CHILD HLTH J, V10, pS3, DOI 10.1007/s10995-006-0100-4; Bloomfield J, 2013, J MIDWIFERY WOM HEAL, V58, P683, DOI 10.1111/jmwh.12132; Burgess CK, 2017, FAM PRACT; Chilukuri N, 2018, J PEDIATR-US, V192, P247, DOI 10.1016/j.jpeds.2017.09.020; Chuang CH, 2011, PREV MED, V53, P85, DOI 10.1016/j.ypmed.2011.04.009; Chuang CH, 2010, MATERN CHILD HLTH J, V14, P501, DOI 10.1007/s10995-009-0453-6; de Smit DJ, 2015, PUBLIC HEALTH NUTR, V18, P1119, DOI 10.1017/S1368980014000986; DeCesare JZ, 2015, OBSTET GYNECOL SURV, V70, P465, DOI 10.1097/OGX.0000000000000196; Denktas S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-253; Deville WLJM, 2012, HERIJKING STEDELIJKE; Fleuren M, 2014, INT J QUAL HLTH CARE; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Health Council of the Netherlands, 2007, USITC PUBL, V2007; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Jambroes M, 2015, HEALTH POLICY, V119, P1557, DOI 10.1016/j.healthpol.2015.08.002; Kuo AA, 2006, PEDIATRICS, V118, P1692, DOI 10.1542/peds.2006-0620; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Neta G, 2015, AM J PUBLIC HEALTH, V105, P49, DOI 10.2105/AJPH.2014.302206; Okah FA, 2014, AM J HEALTH BEHAV, V38, P316, DOI 10.5993/AJHB.38.2.17; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Poels M, 2016, OBSTET GYNECOL SURV, V71, P603, DOI 10.1097/OGX.0000000000000360; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Robbins CL, 2014, MMWR SURVEILL SUMM, V63, P1; Rosener SE, 2016, ANN FAM MED, V14, P350, DOI 10.1370/afm.1933; Sanchez A, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0585-5; Shawe J, 2015, EUR J CONTRACEP REPR, V20, P77, DOI 10.3109/13625187.2014.990088; Sijpkens MK, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3882-y; Sijpkens MK, 2016, MATERN CHILD HLTH J, V20, pS117, DOI 10.1007/s10995-016-2046-5; Srinivasan S, 2018, J AM BOARD FAM MED, V31, P201, DOI 10.3122/jabfm.2018.02.170227; Steegers-Theunissen RPM, 2013, HUM REPROD UPDATE, V19, P640, DOI 10.1093/humupd/dmt041; Stephenson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103085; Temel S, 2015, J COMMUN GENET, V6, P107, DOI 10.1007/s12687-014-0204-2; Toivonen KI, 2017, PREV MED, V96, P1, DOI 10.1016/j.ypmed.2016.11.022; van Voorst S, 2016, EUR J CONTRACEP REPR, V21, P251, DOI 10.3109/13625187.2016.1154524; Van Voorst SF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006284; van Voorst SF, 2017, HLTH EXPECT; Vink-van Os LCA, 2015, PUBLIC HEALTH GENOM, V18, P204, DOI 10.1159/000381449; Waelput AJM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1425-2; Wieske RCN, 2012, INT J PUBLIC HEALTH, V57, P637, DOI 10.1007/s00038-011-0305-1	40	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224427	10.1371/journal.pone.0224427	http://dx.doi.org/10.1371/journal.pone.0224427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1FJ	31693703	Green Published, gold			2022-12-26	WOS:000532690100025
J	Levran, O; Randesi, M; Rotrosen, J; Ott, J; Adelson, M; Kreek, MJ				Levran, Orna; Randesi, Matthew; Rotrosen, John; Ott, Jurg; Adelson, Miriam; Kreek, Mary Jeanne			A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction	PLOS ONE			English	Article							HEROIN-ADDICTION; NUCLEUS-ACCUMBENS; CLOCK; SUSCEPTIBILITY; EXPRESSION; AUTS2; ALCOHOL; STRESS; POLYMORPHISMS; DEPENDENCE	There is a reciprocal relationship between the circadian and the reward systems. Polymorphisms in several circadian rhythm-related (clock) genes were associated with drug addiction. This study aims to search for associations between 895 variants in 39 circadian rhythm-related genes and opioid addiction (OUD). Genotyping was performed with the Smokescreen (R) array. Ancestry was verified by principal/MDS component analysis and the sample was limited to European Americans (EA) (OUD; n = 435, controls; n = 138). Nominally significant associations (p < 0.01) were detected for several variants in genes encoding vasoactive intestinal peptide receptor 2 (VIPR2), period circadian regulator 2 (PER2), casein kinase 1 epsilon (CSNK1E), and activator of transcription and developmental regulator (AUTS2), but no signal survived correction for multiple testing. There was intriguing association signal for the untranslated region (3' UTR) variant rs885863 in VIPR2, (p = .0065; OR = 0.51; 95% CI 0.31-0.51). The result was corroborated in an independent EA OUD sample (n = 398, p = 0.0036; for the combined samples). Notably, this SNP is an expression quantitative trait locus (cis-eQTL) for VIPR2 and a long intergenic non-coding RNA, lincRNA 689, in a tissue-specific manner, based on the Genotype-Tissue Expression (GTEx) project. Vasoactive intestinal peptide (VIP) is an important peptide of light-activated suprachiasmatic nucleus cells. It regulates diverse physiological processes including circadian rhythms, learning and memory, and stress response. This is the first report of an association of a VIPR2 variant and OUD. Additionally, analysis of combinations of single nucleotide polymorphisms (SNPs) genotypes revealed an association of PER2 SNP rs80136044, and SNP rs4128839, located 41.6 kb downstream of neuropeptide Y receptor type 1 gene, NPY1R (p = 3.4 x 10(-6), OR = 11.4, 95% CI 2.7-48.2). The study provides preliminary insight into the relationship between genetic variants in circadian rhythm genes and long non-coding RNA (lncRNAs) in their vicinity, and opioid addiction.	[Levran, Orna; Randesi, Matthew; Kreek, Mary Jeanne] Rockefeller Univ, Lab Biol Addict Dis, 1230 York Ave, New York, NY 10021 USA; [Rotrosen, John] NYU, Sch Med, New York, NY USA; [Ott, Jurg] Rockefeller Univ, Lab Stat Genet, 1230 York Ave, New York, NY 10021 USA; [Adelson, Miriam] Dr Miriam & Sheldon G Adelson Clin Drug Abuse Tre, Las Vegas, NV USA	Rockefeller University; New York University; Rockefeller University	Levran, O (corresponding author), Rockefeller Univ, Lab Biol Addict Dis, 1230 York Ave, New York, NY 10021 USA.	levrano@rockefeller.edu		Levran, Orna/0000-0002-5136-4184	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences of The National Institute of Health [UL1RR024143]; NIDA National Drug Abuse Treatment Clinical Trials Network [U10DA013046, UG1/U10DA013035, UG1/U10DA013034, CTN-0051, U10DA013045, UG1/U10DA013720, UG1/U10DA013732, UG1/U10DA013714, UG1/U10DA015831, U10DA015833, HHSN271201200017C, HHSN271201500065C]; office of the director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NATIONAL INSTITUTE ON DRUG ABUSE [UG1DA013714, UG1DA013034, UG1DA015831, UG1DA013720, UG1DA013035, UG1DA013732] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences of The National Institute of Health; NIDA National Drug Abuse Treatment Clinical Trials Network; office of the director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Clinical and Translational Science Award UL1RR024143 from the National Center for Advancing Translational Sciences of The National Institute of Health (B. Coller). CTN-0051 was supported by grants and contracts from the NIDA National Drug Abuse Treatment Clinical Trials Network (U10DA013046, UG1/U10DA013035, UG1/U10DA013034, U10DA013045, UG1/U10DA013720, UG1/U10DA013732, UG1/U10DA013714, UG1/U10DA015831, U10DA015833, HHSN271201200017C, and HHSN271201500065C) to JR. The data used for the analyses described in this manuscript were obtained from the genotype-tissue expression (GTEx) project portal on 8/1/2019. The GTEx Project was supported by the common fund of the office of the director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago Y, 2017, NEUROBIOL LEARN MEM, V145, P222, DOI 10.1016/j.nlm.2017.10.010; Albertson DN, 2006, NEUROPSYCHOPHARMACOL, V31, P2304, DOI 10.1038/sj.npp.1301089; Baurley JW, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2495-7; Chen YH, 2013, DRUG ALCOHOL DEPEN, V128, P238, DOI 10.1016/j.drugalcdep.2012.08.029; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; Dang W, 2014, J MOL NEUROSCI, V54, P811, DOI 10.1007/s12031-014-0421-5; Engmann O., 2017, BIOL PSYCHIAT; Falcon E, 2009, NEUROPHARMACOLOGY, V56, P91, DOI 10.1016/j.neuropharm.2008.06.054; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gamble KL, 2014, NAT REV ENDOCRINOL, V10, P466, DOI 10.1038/nrendo.2014.78; Gulick D, 2018, PHARMACOL THERAPEUT, V188, P124, DOI 10.1016/j.pharmthera.2018.03.003; Guo XY, 2018, AM J HUM GENET, V102, P890, DOI 10.1016/j.ajhg.2018.03.016; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hosseini E, 2019, MOL ASPECTS MED; Hughes ATL, 2008, J BIOL RHYTHM, V23, P211, DOI 10.1177/0748730408316290; Kellogg SH, 2003, DRUG ALCOHOL DEPEN, V69, P137, DOI 10.1016/S0376-8716(02)00308-3; Kovanen L, 2010, ALCOHOL ALCOHOLISM, V45, P303, DOI 10.1093/alcalc/agq035; Kreek MJ, 2012, J CLIN INVEST, V122, P3387, DOI 10.1172/JCI60390; Lee JD, 2017, LANCET; Levran O, 2008, GENES BRAIN BEHAV, V7, P720, DOI 10.1111/j.1601-183X.2008.00410.x; Levran O, 2014, PSYCHONEUROENDOCRINO, V45, P67, DOI 10.1016/j.psyneuen.2014.03.017; Levran O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199951; Levran O, 2014, PHARMACOGENOMICS, V15, P2001, DOI [10.2217/PGS.14.145, 10.2217/pgs.14.145]; Liu X, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109069; Logan RW, 2014, BEHAV NEUROSCI, V128, P387, DOI 10.1037/a0036268; Mazuski C, 2018, NEURON, V99, P555, DOI 10.1016/j.neuron.2018.06.029; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Michelhaugh SK, 2011, J NEUROCHEM, V116, P459, DOI 10.1111/j.1471-4159.2010.07126.x; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oksenberg N, 2013, TRENDS GENET, V29, P600, DOI 10.1016/j.tig.2013.08.001; Parikshak NN, 2016, NATURE, V540, P423, DOI 10.1038/nature20612; Perreau-Lenz S, 2008, DRUG NEWS PERSPECT, V21, P211, DOI 10.1358/dnp.2008.21.4.1213350; Perreau-Lenz S, 2015, ALCOHOL, V49, P351, DOI 10.1016/j.alcohol.2015.04.003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ransohoff JD, 2018, NAT REV MOL CELL BIO, V19, P143, DOI 10.1038/nrm.2017.104; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Tamaru T, 2018, NEUROCHEM INT, V119, P11, DOI 10.1016/j.neuint.2017.12.013; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Walker Deena M, 2018, Handb Clin Neurol, V148, P747, DOI 10.1016/B978-0-444-64076-5.00048-X; Wang G, 2010, HUM HERED, V70, P34, DOI 10.1159/000293722; Wang YP, 2014, J MOL NEUROSCI, V53, P143, DOI 10.1007/s12031-013-0186-2; Wu YL, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006117, 10.1097/md.0000000000006117]; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang QR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-42; Zhou P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03725	51	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224399	10.1371/journal.pone.0224399	http://dx.doi.org/10.1371/journal.pone.0224399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689297	gold, Green Published			2022-12-26	WOS:000532680100022
J	Roche-Hakansson, H; Vansarla, G; Marks, LR; Hakansson, AP				Roche-Hakansson, Hazeline; Vansarla, Goutham; Marks, Laura R.; Hakansson, Anders P.			The human milk protein-lipid complex HAMLET disrupts glycolysis and induces death in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; Streptococcus; antibiotics; lactic acid; metabolism; cell death; enzyme inactivation; energy metabolism; membrane function; alpha-lactalbumin; glycolysis; HAMLET (human alpha-lactalbumin made lethal to tumor cells); human milk; Streptococcus pneumoniae; oleic acid	ALPHA-LACTALBUMIN; OLEIC-ACID; ESCHERICHIA-COLI; GENOME SEQUENCE; ESSENTIAL GENES; TUMOR-CELLS; INHIBITORS; BACTERIAL; ALDOLASE; DEHYDROGENASE	HAMLET is a complex of human ?-lactalbumin (ALA) and oleic acid and kills several Gram-positive bacteria by a mechanism that bears resemblance to apoptosis in eukaryotic cells. To identify HAMLET's bacterial targets, here we used Streptococcus pneumoniae as a model organism and employed a proteomic approach that identified several potential candidates. Two of these targets were the glycolytic enzymes fructose bisphosphate aldolase (FBPA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Treatment of pneumococci with HAMLET immediately inhibited their ATP and lactate production, suggesting that HAMLET inhibits glycolysis. This observation was supported by experiments with recombinant bacterial enzymes, along with biochemical and bacterial viability assays, indicating that HAMLET's activity is partially inhibited by high glucose?mediated stimulation of glycolysis but enhanced in the presence of the glycolysis inhibitor 2-deoxyglucose. Both HAMLET and ALA bound directly to each glycolytic enzyme in solution and solid-phase assays and effectively inhibited their enzymatic activities. In contrast, oleic acid alone had little to no inhibitory activity. However, ALA alone also exhibited no bactericidal activity and did not block glycolysis in whole cells, suggesting a role for the lipid moiety in the internalization of HAMLET into the bacterial cells to reach its target(s). This was verified by inhibition of enzyme activity in whole cells after HAMLET but not ALA exposure. The results of this study suggest that part of HAMLET's antibacterial activity relates to its ability to target and inhibit glycolytic enzymes, providing an example of a natural antimicrobial agent that specifically targets glycolysis.	[Roche-Hakansson, Hazeline] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14203 USA; [Vansarla, Goutham; Hakansson, Anders P.] Lund Univ, Dept Translat Med, Div Expt Infect Med, 53 Inga Marie Nilsson St, SE-21428 Malmo, Sweden; [Marks, Laura R.] Washington Univ, Dept Med, Barnes Jewish Hosp, St Louis, MO 63110 USA; [Roche-Hakansson, Hazeline] Allergan Pharmaceut Inc, Madison, NJ 07940 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Lund University; Barnes-Jewish Hospital; Washington University (WUSTL); AbbVie; Allergan	Hakansson, AP (corresponding author), Lund Univ, Dept Translat Med, Div Expt Infect Med, 53 Inga Marie Nilsson St, SE-21428 Malmo, Sweden.	anders_p.hakansson@med.lu.se	Hakansson, Anders P/AAX-1225-2020	Hakansson, Anders P/0000-0002-2834-6009; Vansarla, Goutham/0000-0002-8622-355X; Marks, Laura/0000-0002-5317-443X	Bill and Melinda Gates Foundation [53085]; American Lung Association [RG-123721-N]; Swedish Medical Research Council (VR) [K2015-99X-22878-01-6, 2018-05947]; Alfred Osterlund Foundation (Malmo, Sweden); Royal Physiographic Society (Lund, Sweden)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); American Lung Association; Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council); Alfred Osterlund Foundation (Malmo, Sweden); Royal Physiographic Society (Lund, Sweden)	This work was supported by Bill and Melinda Gates Foundation Grant 53085, American Lung Association Grant RG-123721-N, Swedish Medical Research Council (VR) Grants K2015-99X-22878-01-6 and 2018-05947, the Alfred Osterlund Foundation (Malmo, Sweden) (to A. P. H.), and the Royal Physiographic Society (Lund, Sweden) (to G. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Capodagli GC, 2014, BIOCHEMISTRY-US, V53, P202, DOI 10.1021/bi401022b; Clementi EA, 2012, J BIOL CHEM, V287, P27168, DOI 10.1074/jbc.M112.371070; CORI GT, 1948, J BIOL CHEM, V173, P605; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Fang B, 2016, J DAIRY SCI, V99, P5991, DOI 10.3168/jds.2016-10971; Ferrin G, 2011, CURR PHARM DESIGN, V17, P2002, DOI 10.2174/138161211796904803; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Frislev HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15003-6; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Gutowicz J, 2003, CELL MOL BIOL LETT, V8, P667; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson AP, 2007, J BIOL CHEM, V282, P29521, DOI 10.1074/jbc.M703144200; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Hewitt LF, 1932, BIOCHEM J, V26, P464, DOI 10.1042/bj0260464; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jensen PA, 2017, CELL REP, V20, P1705, DOI 10.1016/j.celrep.2017.07.062; Johnsborg O, 2009, J BACTERIOL, V191, P5859, DOI 10.1128/JB.00724-09; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Katebi AR, 2015, BIOCHEMISTRY-US, V54, P3543, DOI 10.1021/acs.biochem.5b00042; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Labbe G, 2012, J INORG BIOCHEM, V112, P49, DOI 10.1016/j.jinorgbio.2012.02.032; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LUNDHOLM L, 1963, ACTA PHYSIOL SCAND, V58, P243, DOI 10.1111/j.1748-1716.1963.tb02645.x; Marks LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063158; Marks LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043514; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; Martin WF, 2017, PROTOPLASMA, V254, P1823, DOI 10.1007/s00709-017-1095-y; Massidda O, 1998, MICROBIOL-SGM, V144, P3069, DOI 10.1099/00221287-144-11-3069; Meikle V, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01846-18; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Munch D, 2014, J BIOL CHEM, V289, P12063, DOI 10.1074/jbc.M113.537449; PAKOSKEY AM, 1965, J GEN MICROBIOL, V38, P73, DOI 10.1099/00221287-38-1-73; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Purves J, 2010, INFECT IMMUN, V78, P5223, DOI 10.1128/IAI.00762-10; Ramsay EE, 2011, PHARM RES-DORDR, V28, P2731, DOI 10.1007/s11095-011-0584-5; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schneider T, 2010, CURR OPIN INVEST DR, V11, P157; SEYMOUR CB, 1988, RADIAT ENVIRON BIOPH, V27, P49, DOI 10.1007/BF01211109; Shai Y, 2006, CURR PROTEIN PEPT SC, V7, P479, DOI 10.2174/138920306779025620; SIMPSON WJ, 1991, J BIOLUM CHEMILUM, V6, P97, DOI 10.1002/bio.1170060207; Singh M, 2017, J PHYS CHEM B, V121, P3925, DOI 10.1021/acs.jpcb.7b00324; Song JH, 2005, MOL CELLS, V19, P365; SPEERT DP, 1979, INFECT IMMUN, V26, P1202, DOI 10.1128/IAI.26.3.1202-1210.1979; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Sun XS, 2011, OMICS, V15, P683, DOI 10.1089/omi.2010.0133; Sun XS, 2011, OMICS, V15, P477, DOI 10.1089/omi.2010.0113; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 2002, ADV EXP MED BIOL, V503, P125; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tiwari K, 2016, COMB CHEM HIGH T SCR, V19, P667, DOI 10.2174/1386207319666160610080716; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yadav PK, 2013, BIOINFORMATION, V9, P158, DOI 10.6026/97320630009158	67	4	4	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19511	19522		10.1074/jbc.RA119.009930	http://dx.doi.org/10.1074/jbc.RA119.009930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31694917	Green Published, hybrid			2022-12-26	WOS:000504093200006
J	Caceres, FT; Gaspari, TA; Samuel, CS; Pinar, AA				Caceres, Felipe Tapia; Gaspari, Tracey A.; Samuel, Chrishan S.; Pinar, Anita A.			Serelaxin inhibits the profibrotic TGF-beta 1/IL-1 beta axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts	FASEB JOURNAL			English	Article						cardiac fibrosis; IL-1 beta serelaxin; cardiomyopathy; RXFP1; nNOS	AGE-RELATED PROGRESSION; MYOCARDIAL-INFARCTION; EXPERIMENTAL-MODEL; ANGIOTENSIN-II; RECEPTOR 4; RELAXIN; FIBROSIS; FIBROBLASTS; COLLAGEN; MICE	The recombinant form of the peptide hormone relaxin, serelaxin (RLX), mediates its anti-fibrotic actions by impeding the profibrotic activity of cytokines including TGF-beta 1 and IL-beta 3. As IL-1 beta can be produced by the nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domains-containing protein 3 (NLRP3) inflammasome, this study determined whether RLX targeted the inflammasome to inhibit the profibrotic TGF-beta 1/IL-1 beta axis in primary human cardiac myofibroblasts (HCMFs) in vitro and in mice with isoproterenol (ISO)-induced cardiomyopathy in vivo. HCMFs stimulated with TGF-beta 1 (5 ng/ml), LPS (100 ng/ml), and ATP (5 mM) (T+L+A) for 8 h, to induce the NLRP3 inflammasome, demonstrated significantly increased protein expression of markers of NLRP3 priming (NLRP3, apoptosis-associated speck-like protein containing a C-terminal caspase-recruitment domain, procaspase-1) and activity (IL-1 beta, IL-18). After 72 h, there was significantly increased neuronal NOS (nNOS), TLR-4, procaspase-1, myofibroblast differentiation, and collagen-I deposition. These measures, along with interstitial TGF-beta 1 expression and collagen deposition, were also increased in the left ventricle (LV) of ISO-injured mice 14 d postinjury. RLX [16.8 nM (100 ng/ml) in vitro; 0.5 mg/kg per day in vivo] inhibited T+L+A- and ISO-induced TLR-4 expression, NLRP3 priming, IL-1 beta, IL-18, myofibroblast differentiation, and interstitial collagen deposition at the time points studied, via the promotion of nNOS; with the NLRP3- and IL-1 beta-inhibitory effects of RLX in HCMFs being abrogated by pharmacological blockade of nNOS or TLR-4. Comparatively, the small molecule NLRP3 inhibitor, N-{(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl}-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide (1 mu M in vitro, 10 mg/kg/d in vivo), inhibited components of the NLRP3 inflammasome in vitro and in vivo and ISO-induced interstitial LV fibrosis in vivo but did not affect nNOS, TLR-4, myofibroblast differentiation, or myofibroblast-induced collagen deposition. Hence, RLX can inhibit the TGF-beta 1/IL-1 beta axis via a nNOS-TLR-4-NLRP3 inflammasome-dependent mechanism on cardiac myofibroblasts.	[Caceres, Felipe Tapia; Gaspari, Tracey A.; Samuel, Chrishan S.; Pinar, Anita A.] Monash Univ, Monash Biomed Discovery Inst, Cardiovasc Dis Program, Clayton, Vic, Australia; [Caceres, Felipe Tapia; Gaspari, Tracey A.; Samuel, Chrishan S.; Pinar, Anita A.] Monash Univ, Dept Pharmacol, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia; [Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia	Monash University; Monash University; University of Melbourne	Samuel, CS; Pinar, AA (corresponding author), Monash Univ, Dept Pharmacol, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia.; Samuel, CS; Pinar, AA (corresponding author), Monash Univ, Monash Biomed Discovery Inst BDI, 9 Ancora Imparo Way, Clayton, Vic 3800, Australia.	chrishan.samuel@monash.edu; anita.pinar@monash.edu			Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Programa Formacion de Capital Humano Avanzado/Becas Para Estudios de Postgrado en Chile y en el Extranjero (PFCHA/DOCTORADO BECAS CHILE) [2017 -72180028]; National Health and Medical Research Council (NHMRC) of Australia [GNT1041766]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Programa Formacion de Capital Humano Avanzado/Becas Para Estudios de Postgrado en Chile y en el Extranjero (PFCHA/DOCTORADO BECAS CHILE)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the facilities and technical assistance of the Monash Histology Platform, Department of Anatomy and Developmental Biology, Monash University. This work was supported by the Comision Nacional de Investigacion Cient ' ifica y Tecnologica (CONICYT) Programa Formaci ' on de Capital Humano Avanzado/Becas Para Estudios de Postgrado en Chile y en el Extranjero (PFCHA/DOCTORADO BECAS CHILE); 2017 -72180028 to F.T.C.), and a National Health and Medical Research Council (NHMRC) of Australia Senior Research Fellowship (GNT1041766 to C.S.S.). The authors declare no conflicts of interest.	Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Beiert T, 2017, BIOCHEM BIOPH RES CO, V490, P643, DOI 10.1016/j.bbrc.2017.06.091; Bhattacharyya S, 2013, AM J PATHOL, V182, P192, DOI 10.1016/j.ajpath.2012.09.007; Bolli P, 2010, ANN NY ACAD SCI, V1211, P113, DOI 10.1111/j.1749-6632.2010.05814.x; Boza P, 2016, MOL IMMUNOL, V74, P96, DOI 10.1016/j.molimm.2016.05.001; Brecht A, 2011, REGUL PEPTIDES, V166, P76, DOI 10.1016/j.regpep.2010.09.001; Chen L, 2017, ONCOTARGET, V8, P21044, DOI 10.18632/oncotarget.15483; Chow BSM, 2014, KIDNEY INT, V86, P75, DOI 10.1038/ki.2013.518; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Collino M, 2013, J CELL MOL MED, V17, P1494, DOI 10.1111/jcmm.12120; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Fang L, 2008, CLIN SCI, V115, P99, DOI 10.1042/CS20070365; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Frangogiannis NG, 2019, MOL ASPECTS MED, V65, P70, DOI 10.1016/j.mam.2018.07.001; Gan WQ, 2018, BBA-MOL BASIS DIS, V1864, P1, DOI 10.1016/j.bbadis.2017.10.001; Kocan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02916-5; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Krishnan SM, 2016, BRIT J PHARMACOL, V173, P752, DOI 10.1111/bph.13230; Krishnan SM, 2019, CARDIOVASC RES, V115, P776, DOI 10.1093/cvr/cvy252; Li L, 2018, MATRIX BIOL, V68-69, P490, DOI 10.1016/j.matbio.2018.01.013; Li X, 2018, EXP CELL RES, V362, P489, DOI 10.1016/j.yexcr.2017.12.013; Martin B, 2019, MOL CELL ENDOCRINOL, V487, P45, DOI 10.1016/j.mce.2018.12.016; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; Ng HH, 2019, MOL CELL ENDOCRINOL, V487, P59, DOI 10.1016/j.mce.2019.01.015; Nistri S, 2008, INFLAMM RES, V57, pS7, DOI 10.1007/s00011-007-0602-6; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Raleigh JV, 2017, CARDIOVASC RES, V113, P609, DOI 10.1093/cvr/cvw246; Royce SG, 2013, CLIN SCI, V124, P41, DOI 10.1042/CS20120024; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Samuel CS, 2014, HYPERTENSION, V64, P315, DOI 10.1161/HYPERTENSIONAHA.114.03594; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 2005, J INVEST DERMATOL, V125, P692, DOI 10.1111/j.0022-202X.2005.23880.x; Samuel CS, 2004, KIDNEY INT, V65, P2054, DOI 10.1111/j.1523-1755.2004.00628.x; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Sarwar M, 2015, BRIT J PHARMACOL, V172, P1005, DOI 10.1111/bph.12964; Sarwar M, 2017, BRIT J PHARMACOL, V174, P933, DOI 10.1111/bph.13523; Sasser JM, 2011, HYPERTENSION, V58, P197, DOI 10.1161/HYPERTENSIONAHA.110.164392; Sassoli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063896; Saxena A, 2013, J IMMUNOL, V191, P4838, DOI 10.4049/jimmunol.1300725; Schroer AK, 2015, J CELL SCI, V128, P1865, DOI 10.1242/jcs.162891; Sokolova M, 2017, BBA-MOL CELL BIOL L, V1862, P234, DOI 10.1016/j.bbalip.2016.11.003; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Vogel S, 2019, BIOCHEM BIOPH RES CO, V508, P614, DOI 10.1016/j.bbrc.2018.11.125; Wang C, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00091; Wang YL, 2013, CARDIOLOGY, V126, P1, DOI 10.1159/000351179; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Wu XP, 2018, EXP CELL RES, V362, P17, DOI 10.1016/j.yexcr.2017.10.004; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao H, 2018, EUR HEART J, V39, P60, DOI 10.1093/eurheartj/ehx261; Zhou WY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5702103	55	22	23	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14717	14733		10.1096/fj.201901079RR	http://dx.doi.org/10.1096/fj.201901079RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689135	Bronze			2022-12-26	WOS:000507466100127
J	de Souza, RB; Farinha-Arcieri, LLE; Catroxo, MHB; Martins, AMCRPD; Tedesco, RC; Alonso, LG; Koh, IHJ; Pereira, LV				de Souza, Rodrigo Barbosa; Farinha-Arcieri, Luis Ernesto L.; Braga Catroxo, Marcia Helena; Pinto da Fonseca Martins, Ana Maria Cristina Rebelo; Tedesco, Roberto Carlos; Alonso, Luis Garcia; Jun Koh, Ivan Hong; Pereira, Lygia, V			Association of thoracic spine deformity and cardiovascular disease in a mouse model for Marfan syndrome	PLOS ONE			English	Article							PHENOTYPE; FIBRILLIN; FAILURE	Aims Cardiovascular manifestations are a major cause of mortality in Marfan syndrome (MFS). Animal models that mimic the syndrome and its clinical variability are instrumental for understanding the genesis and risk factors for cardiovascular disease in MFS. This study used morphological and ultrastructural analysis to the understanding of the development of cardiovascular phenotypes of the the mg Delta(loxPneo) model for MFS. Methods and results We studied 6-month-old female mice of the 129/Sv background, 6 wild type (WT) and 24 heterozygous animals from the mg Delta(loxPneo) model. Descending thoracic aortic aneurysm and/or dissection (dTAAD) were identified in 75% of the MFS animals, defining two subgroups: MFS with (MFS+) and without (MFS-) dTAAD. Both subgroups showed increased fragmentation of elastic fibers, predominance of type I collagen surrounding the elastic fiber and fragmentation of interlaminar fibers when compared to WT. However, only MFS animals with spine tortuosity developed aortic aneurysm/dissection. The aorta of MFS+ animals were more tortuous compared to those of MFS- and WT mice, possibly causing perturbations of the luminal blood flow. This was evidenced by the detection of diminished aorta-blood flow in MFS+. Accordingly, only MFS+ animals presented a process of concentric cardiac hypertrophy and a significantly decreased ratio of left and right ventricle lumen area. Conclusions We show that mg Delta(loxPneo) model mimics the vascular disease observed in MFS patients. Furthermore, the study indicates role of thoracic spine deformity in the development of aorta diseases. We suggest that degradation of support structures of the aortic wall; deficiency in the sustenance of the thoracic vertebrae; and their compression over the adjacent aorta resulting in disturbed blood flow is a triad of factors involved in the genesis of dissection/aneurysm of thoracic aorta.	[de Souza, Rodrigo Barbosa; Farinha-Arcieri, Luis Ernesto L.; Pereira, Lygia, V] Univ Sao Paulo, Dept Genet & Evolutionary Biol, Sao Paulo, SP, Brazil; [Braga Catroxo, Marcia Helena; Pinto da Fonseca Martins, Ana Maria Cristina Rebelo] Biol Inst Sao Paulo, Dept Electron Microscopy, Sao Paulo, SP, Brazil; [Tedesco, Roberto Carlos; Alonso, Luis Garcia] Univ Fed Sao Paulo, Dept Morphol & Genet, Sao Paulo, SP, Brazil; [Jun Koh, Ivan Hong] Univ Fed Sao Paulo, Dept Surg, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Pereira, LV (corresponding author), Univ Sao Paulo, Dept Genet & Evolutionary Biol, Sao Paulo, SP, Brazil.	lpereira@usp.br	de Souza, Rodrigo Barbosa/AAV-8234-2021; Pereira, Lygia V/C-1049-2012; Koh, ivan/ABB-2084-2021	Pereira, Lygia V/0000-0002-0002-725X; Koh, ivan/0000-0001-5076-789X; Barbosa de Souza, Rodrigo/0000-0002-7068-3906; Catroxo, Marcia Helena Braga/0000-0003-2811-052X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Souza, RB, Farinha-Arcieri, LE, Caroxo, MHB, Martins, AMCRPF, Tedesco, RC, Alonso, LG, Koh, IHJ and Pereira LV were financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) - Finance Code 001; and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Alpendurada F, 2010, EUR J HEART FAIL, V12, P1085, DOI 10.1093/eurjhf/hfq127; Arunamata AA, 2018, CARDIOL YOUNG, V28, P1009, DOI 10.1017/S1047951118000707; Aubart M, 2018, EUR J HUM GENET, V26, P1759, DOI 10.1038/s41431-018-0164-9; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Cheng Y, 2016, BRIT J MATH STAT PSY, V69, P344, DOI 10.1111/bmsp.12075; Chiu HH, 2014, MAYO CLIN PROC, V89, P34, DOI 10.1016/j.mayocp.2013.08.022; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Crosas-Molist E, 2015, ARTERIOSCL THROM VAS, V35, P960, DOI 10.1161/ATVBAHA.114.304412; Dale M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186603; Dordoni C, 2017, AM J MED GENET A, V173, P200, DOI 10.1002/ajmg.a.37975; Franken R, 2015, INT J CARDIOL, V194, P7, DOI 10.1016/j.ijcard.2015.05.072; Gallo S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092164; Geiger J, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0347-5; Kielty CM, 2017, INT J EXP PATHOL, V98, P172, DOI 10.1111/iep.12239; Kingwell B, 2007, CLIN EXP PHARMACOL P, V34, P652, DOI 10.1111/j.1440-1681.2007.04655.x; Korneva A, 2019, BIOMECH MODEL MECHAN, V18, P261, DOI 10.1007/s10237-018-1080-1; Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003; Lima BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014136; Lindeman JHN, 2010, P NATL ACAD SCI USA, V107, P862, DOI 10.1073/pnas.0910312107; Lopez-Guimet J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01620-8; Pepe G, 2016, APPL CLIN GENET, V9, P55, DOI 10.2147/TACG.S96233; Pyeritz RE, 2019, GENET MED, V21, P1683, DOI 10.1038/s41436-018-0399-4; Querzoli G, 2014, J BIOMECH, V47, P3120, DOI 10.1016/j.jbiomech.2014.06.025; Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; Schrenk S, 2018, INT J MOL MED, V41, P1213, DOI 10.3892/ijmm.2017.3343; Tae HJ, 2016, AM J PHYSIOL-HEART C, V310, pH290, DOI 10.1152/ajpheart.00354.2015	27	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224581	10.1371/journal.pone.0224581	http://dx.doi.org/10.1371/journal.pone.0224581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725753	Green Published, gold			2022-12-26	WOS:000532764500020
J	Chanvatik, S; Donnua, S; Lekagul, A; Kaewkhankhaeng, W; Vongmongkol, V; Athipunyakom, P; Khamlar, S; Prommintara, M; Tangcharoensathien, V				Chanvatik, Sunicha; Donnua, Siriporn; Lekagul, Angkana; Kaewkhankhaeng, Wanwisa; Vongmongkol, Vuthiphan; Athipunyakom, Pornpimon; Khamlar, Saenchai; Prommintara, Maitree; Tangcharoensathien, Viroj			Antibiotic use in mandarin production (Citrus reticulata Blanco) in major mandarin-producing areas in Thailand: A survey assessment	PLOS ONE			English	Article							DISEASE; FLORIDA	Background Antimicrobial resistance (AMR), one of the major global threats to human security, has serious negative consequences for both health and economies. Excessive and inappropriate uses of antibiotics are the main drivers of the emergence of resistant bacterial strains. In Thailand, antibiotics have been used in citrus production since 2012 to treat citrus greening disease or Huanglongbing disease, despite no antibiotics being registered for use in mandarin. This raises concerns about irrational use of antibiotics, which can cause AMR. Objective To assess the status of greening disease and the use of antibiotics in mandarin production. Method A face-to-face interview survey in 2017 with 221 mandarin growers in two major mandarin producing areas. Findings Greening disease is one of the most serious diseases in mandarins and farmers in the two major mandarin-producing areas in Thailand used ampicillin, amoxicillin, tetracycline and penicillin to treat it. As no antibiotics are registered for use in plants, farmers used antibiotics (registered with the Thai Food and Drug Administration) for human use, either active pharmaceutical ingredients or finished products. They commonly purchased them from retail pharmacies or agrochemical suppliers. Farmers were influenced to use antibiotics by their orchard neighbours and advice from a few academics. The farmers injected antibiotics into the tree trunks approximately three to four times a year and stopped for more than two months before harvesting for in-season fruits. Conclusion Antibiotics registered for human use are being applied to control greening diseases. We recommend scaling up sustainable disease control measures and curtail the use of antibiotics through close and effective dialogue among 'One Health' partners.	[Chanvatik, Sunicha; Lekagul, Angkana; Kaewkhankhaeng, Wanwisa; Vongmongkol, Vuthiphan; Tangcharoensathien, Viroj] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand; [Donnua, Siriporn] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Plant Pathol, Bangkok, Thailand; [Athipunyakom, Pornpimon; Khamlar, Saenchai; Prommintara, Maitree] Minist Agr & Cooperatives, Dept Agr, Bangkok, Thailand	Ministry of Public Health - Thailand; Kasetsart University; Ministry of Agriculture & Cooperatives - Thailand	Tangcharoensathien, V (corresponding author), Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand.	viroj@ihpp.thaigov.net		Tangcharoensathien, Viroj/0000-0003-3235-0091; Donnua, Siriporn/0000-0003-4450-0747; Lekagul, Angkana/0000-0002-7335-9028; Vongmongkol, Vuthiphan/0000-0002-7603-2557; Chanvatik, Sunicha/0000-0001-8645-5097	Food and Agriculture Organization of the United Nations [LOA/RAP/2017/17]	Food and Agriculture Organization of the United Nations	This study was supported by funding from the Food and Agriculture Organization of the United Nations (Grant number: LOA/RAP/2017/17). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Abdullah TL, 2009, AFR J BIOTECHNOL, V8, P4007; [Anonymous], THAILAND NATL STRATE; Aubert B, P 9 C INT ORG CITR V, P100; Aubert B, 1990, P 4 INT AS PAC C CIT, P181; Badaracco A, 2017, AUSTRALAS PLANT PATH, V46, P171, DOI 10.1007/s13313-017-0473-4; Beattie GAC, 2008, INT C HUANGL ORL US, P25; Blaustein RA, 2018, PHYTOPATHOLOGY, V108, P424, DOI [10.1094/PHYTO-07-17-0260-RVW, 10.1094/phyto-07-17-0260-rvw]; Bove JM, 2006, J PLANT PATHOL, V88, P7; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Hu J, 2018, PHYTOPATHOLOGY, V108, P186, DOI 10.1094/PHYTO-05-17-0175-R; Khan MM., 2018, J HORTIC, V5, pe110, DOI [10.4172/2376-0354.1000e110, DOI 10.4172/2376-0354.1000E110]; Lopes SA, 2007, EUR J PLANT PATHOL, V119, P463, DOI 10.1007/s10658-007-9173-1; Manyi-Loh C, 2018, MOLECULES, V23, DOI 10.3390/molecules23040795; Martini X, 2016, FLA ENTOMOL, V99, P178, DOI 10.1653/024.099.0204; McCollum G, 2017, HORTIC REV, P315; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; Paradornuwat S. J. A., 2016, Agricultural Innovation for Global Value Chain, Proceedings of 54th Kasetsart University Annual Conference, 2-5 February 2016, Kasetsart University, Thailand. Vol. 1, Plants, Animals, Veterinary Medicine, Fisheries, Agricultural Extension and Home Economics, P108; Puttamuk T, 2014, CROP PROT, V65, P114, DOI 10.1016/j.cropro.2014.07.018; Schubert TS, 2001, PLANT DIS, V85, P340, DOI 10.1094/PDIS.2001.85.4.340; Springer Nature, 2019, SPRAYING DISEASED CI; Stockwell VO, 2012, REV SCI TECH OIE, V31, P199; The U.S. Centers for Disease Control and Prevention, 2018, IN ADDR ANT RES ENV; Toorawa P, DETECTION CANDIDATUS; WHO, 2017, LIST CRIT IMP ANT HU; World Health Organization, 2015, GLOB ACT PLAN ANT RE; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09; Yashiro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037131; You YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00284; Zhang M., 2015, ADV ANTIBIOTICS ANTI, V1, pe101; Zhang MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111032; Zheng YQ, 2018, SCI HORTIC-AMSTERDAM, V237, P89, DOI 10.1016/j.scienta.2018.04.017; 2012, EV THREAT ANT REOP, P1	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225172	10.1371/journal.pone.0225172	http://dx.doi.org/10.1371/journal.pone.0225172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721802	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000532720700041
J	Stossi, F; Dandekar, RD; Johnson, H; Lavere, P; Foulds, CE; Mancini, MG; Mancini, MA				Stossi, Fabio; Dandekar, Radhika D.; Johnson, Hannah; Lavere, Philip; Foulds, Charles E.; Mancini, Maureen G.; Mancini, Michael A.			Tributyltin chloride (TBT) induces RXRA down-regulation and lipid accumulation in human liver cells	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; OBESOGEN TRIBUTYLTIN; BUTYLTIN COMPOUNDS; PRENATAL EXPOSURE; STEM-CELLS; ADIPOGENESIS; ACTIVATION; ORGANOTINS; RECEPTORS; LANDSCAPE	A subset of environmental chemicals acts as "obesogens" as they increase adipose mass and lipid content in livers of treated rodents. One of the most studied class of obesogens are the tin-containing chemicals that have as a central moiety tributyltin (TBT), which bind and activate two nuclear hormone receptors, Peroxisome Proliferator Activated Receptor Gamma (PPARG) and Retinoid X Receptor Alpha (RXRA), at nanomolar concentrations. Here, we have tested whether TBT chloride at such concentrations may affect the neutral lipid level in two cell line models of human liver. Indeed, using high content image analysis (HCA), TBT significantly increased neutral lipid content in a time- and concentration-dependent manner. Consistent with the observed increased lipid accumulation, RNA fluorescence in situ hybridization (RNA FISH) and RT-qPCR experiments revealed that TBT enhanced the steady-state mRNA levels of two key genes for de novo lipogenesis, the transcription factor SREBF1 and its downstream enzymatic target, FASN. Importantly, pre-treatment of cells with 2-deoxy-D-glucose reduced TBT-mediated lipid accumulation, thereby suggesting a role for active glycolysis during the process of lipid accumulation. As other RXRA binding ligands can promote RXRA protein turnover via the 26S proteasome, TBT was tested for such an effect in the two liver cell lines. We found that TBT, in a time- and dose-dependent manner, significantly reduced steady-state RXRA levels in a proteasome-dependent manner. While TBT promotes both RXRA protein turnover and lipid accumulation, we found no correlation between these two events at the single cell level, thereby suggesting an additional mechanism may be involved in TBT promotion of lipid accumulation, such as glycolysis.	[Stossi, Fabio; Lavere, Philip; Foulds, Charles E.; Mancini, Maureen G.; Mancini, Michael A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Stossi, Fabio; Dandekar, Radhika D.; Johnson, Hannah; Mancini, Michael A.] Baylor Coll Med, Integrated Microscopy Core, Houston, TX 77030 USA; [Stossi, Fabio; Johnson, Hannah; Mancini, Maureen G.; Mancini, Michael A.] GCC Ctr Adv Microscopy & Image Informat, Houston, TX 77030 USA; [Foulds, Charles E.; Mancini, Michael A.] Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA; [Mancini, Michael A.] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Mancini, Michael A.] Baylor Coll Med, Dun L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Mancini, Michael A.] Texas A&M Univ, Ctr Translat Canc Res, Inst Biosci & Technol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System	Mancini, MA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Mancini, MA (corresponding author), Baylor Coll Med, Integrated Microscopy Core, Houston, TX 77030 USA.; Mancini, MA (corresponding author), GCC Ctr Adv Microscopy & Image Informat, Houston, TX 77030 USA.; Mancini, MA (corresponding author), Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA.; Mancini, MA (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.; Mancini, MA (corresponding author), Baylor Coll Med, Dun L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.; Mancini, MA (corresponding author), Texas A&M Univ, Ctr Translat Canc Res, Inst Biosci & Technol, Houston, TX 77030 USA.	mancini@bcm.edu	Johnson, Hannah/GRF-2692-2022	Stossi, Fabio/0000-0001-6029-5478	National Institute of Environmental Health Sciences [P30ES030285, ES027704, ES023206]; Cancer Prevention and Research Institute of Texas [RP170719]; National Institute of Diabetes and Digestive and Kidney Diseases [DK097748, DK56338]; Division of Cancer Epidemiology and Genetics, National Cancer Institute [CA125123]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES030285] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Prevention and Research Institute of Texas; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division of Cancer Epidemiology and Genetics, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the National Institute of Environmental Health Sciences, P30ES030285 to CLW and MAM; the National Institute of Environmental Health Sciences, ES023206 to CLW, BWO'M, MTB and MAM; the National Institute of Environmental Health Sciences, ES027704 to IR and MAM; the Cancer Prevention and Research Institute of Texas, RP170719 to MAM, the National Institute of Diabetes and Digestive and Kidney Diseases, DK56338 to HE-S and MAM; the Division of Cancer Epidemiology and Genetics, National Cancer Institute, CA125123 to CKO and MAM and the National Institute of Diabetes and Digestive and Kidney Diseases, DK097748 to CEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antizar-Ladislao B, 2008, ENVIRON INT, V34, P292, DOI 10.1016/j.envint.2007.09.005; Baker AH, 2015, CHEM RES TOXICOL, V28, P1156, DOI 10.1021/tx500433r; Bertuloso BD, 2015, TOXICOL LETT, V235, P45, DOI 10.1016/j.toxlet.2015.03.009; Bombrun M, 2017, CYTOM PART A, V91A, P1068, DOI 10.1002/cyto.a.23265; Brtko J, 2015, TOXICOL LETT, V234, P50, DOI 10.1016/j.toxlet.2015.02.009; Cave MC, 2016, BBA-GENE REGUL MECH, V1859, P1083, DOI 10.1016/j.bbagrm.2016.03.002; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Foulds Charles E, 2010, Mol Endocrinol, V24, P1090, DOI 10.1210/me.2009-0427; Foulds C, 2017, NAT REV ENDOCRINOL, V13, P445, DOI 10.1038/nrendo.2017.42; Grandjean P, 2015, ENDOCRINOLOGY, V156, P3408, DOI 10.1210/EN.2015-1350; Grondin M, 2007, TOXICOL APPL PHARM, V222, P57, DOI 10.1016/j.taap.2007.03.028; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; Hart SN, 2010, DRUG METAB DISPOS, V38, P988, DOI 10.1124/dmd.109.031831; Hartig SM, 2011, J CELL BIOL, V192, P55, DOI 10.1083/jcb.201004026; Heindel JJ, 2019, ANNU REV PHARMACOL, V59, P89, DOI 10.1146/annurev-pharmtox-010818-021304; Heindel JJ, 2017, REPROD TOXICOL, V68, P3, DOI 10.1016/j.reprotox.2016.10.001; Hiebl V, 2018, BIOTECHNOL ADV, V36, P1657, DOI 10.1016/j.biotechadv.2018.03.003; Hunakova L, 2016, TUMOR BIOL, V37, P6701, DOI 10.1007/s13277-015-4524-6; Janesick A, 2011, J STEROID BIOCHEM, V127, P4, DOI 10.1016/j.jsbmb.2011.01.005; Janesick AS, 2016, ENVIRON HEALTH PERSP, V124, P1214, DOI 10.1289/ehp.1510352; Kannan K, 1999, ENVIRON SCI TECHNOL, V33, P1776, DOI 10.1021/es990011w; Kirchner S, 2010, MOL ENDOCRINOL, V24, P526, DOI 10.1210/me.2009-0261; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; Lee MK, 2019, BASIC CLIN PHARMACOL, V125, P44, DOI 10.1111/bcpt.13214; Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06807; Li X, 2011, J STEROID BIOCHEM, V127, P9, DOI 10.1016/j.jsbmb.2011.03.012; Marques VB, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00101; Muscogiuri G, 2017, ARCH TOXICOL, V91, P3469, DOI 10.1007/s00204-017-2071-1; Nielsen JB, 2002, ENVIRON RES, V88, P129, DOI 10.1006/enrs.2001.4321; Orjalo AV, 2016, METHODS MOL BIOL, V1402, P119, DOI 10.1007/978-1-4939-3378-5_10; Osburn DL, 2001, MOL CELL BIOL, V21, P4909, DOI 10.1128/MCB.21.15.4909-4918.2001; de Araujo JFP, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00064; Rantakokko P, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-45; Richard AM, 2016, CHEM RES TOXICOL, V29, P1225, DOI 10.1021/acs.chemrestox.6b00135; Shoucri BM, 2018, ENDOCRINOLOGY, V159, P2863, DOI 10.1210/en.2018-00056; Shoucri BM, 2017, ENDOCRINOLOGY, V158, P3109, DOI 10.1210/en.2017-00348; Sifakis S, 2017, ENVIRON TOXICOL PHAR, V51, P56, DOI 10.1016/j.etap.2017.02.024; Stossi F, 2016, ONCOTARGET, V7, P16962, DOI 10.18632/oncotarget.7655; Takahashi S, 1999, ENVIRON POLLUT, V106, P213, DOI 10.1016/S0269-7491(99)00068-8; Uray IP, 2012, MOL PHARMACOL, V81, P228, DOI 10.1124/mol.111.072967; Yanik SC, 2011, TOXICOL SCI, V122, P476, DOI 10.1093/toxsci/kfr140; Zhou M, 2016, FOOD CHEM TOXICOL, V97, P316, DOI 10.1016/j.fct.2016.09.027; Zuo ZH, 2011, ENVIRON TOXICOL, V26, P79, DOI 10.1002/tox.20531	44	7	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224405	10.1371/journal.pone.0224405	http://dx.doi.org/10.1371/journal.pone.0224405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710612	Green Published, gold			2022-12-26	WOS:000532699900009
J	Panga, V; Kallor, AA; Nair, A; Harshen, S; Raghunathan, S				Panga, Venugopal; Kallor, Ashwin Adrian; Nair, Arunima; Harshen, Shilpa; Raghunathan, Srivatsan			Mitochondrial dysfunction in rheumatoid arthritis: A comprehensive analysis by integrating gene expression, protein-protein interactions and gene ontology data	PLOS ONE			English	Article							SYNOVIAL-FLUID; REACTIVE OXYGEN; LIPID-PEROXIDATION; OXIDATIVE STRESS; NITRIC-OXIDE; MONOAMINE-OXIDASE; DEGRADATION; APOPTOSIS; DAMAGE; SERUM	Several studies have reported mitochondrial dysfunction in rheumatoid arthritis (RA). Many nuclear DNA (nDNA) encoded proteins translocate to mitochondria, but their participation in the dysfunction of this cell organelle during RA is quite unclear. In this study, we have carried out an integrative analysis of gene expression, protein-protein interactions (PPI) and gene ontology data. The analysis has identified potential implications of the nDNA encoded proteins in RA mitochondrial dysfunction. Firstly, by analysing six synovial microarray datasets of RA patients and healthy controls obtained from the gene expression omnibus (GEO) database, we found differentially expressed nDNA genes that encode mitochondrial proteins. We uncovered some of the roles of these genes in RA mitochondrial dysfunction using literature search and gene ontology analysis. Secondly, by employing gene co-expression from microarrays and collating reliable PPI from seven databases, we created the first mitochondrial PPI network that is specific to the RA synovial joint tissue. Further, we identified hubs of this network, and moreover, by integrating gene expression and network analysis, we found differentially expressed neighbours of the hub proteins. The results demonstrate that nDNA encoded proteins are (i) crucial for the elevation of mitochondrial reactive oxygen species (ROS) and (ii) involved in membrane potential, transport processes, metabolism and intrinsic apoptosis during RA. Additionally, we proposed a model relating to mitochondrial dysfunction and inflammation in the disease. Our analysis presents a novel perspective on the roles of nDNA encoded proteins in mitochondrial dysfunction, especially in apoptosis, oxidative stress-related processes and their relation to inflammation in RA. These findings provide a plethora of information for further research.	[Panga, Venugopal; Kallor, Ashwin Adrian; Nair, Arunima; Harshen, Shilpa; Raghunathan, Srivatsan] Inst Bioinformat & Appl Biotechnol IBAB, Bengaluru, Karnataka, India; [Panga, Venugopal; Harshen, Shilpa] Manipal Acad Higher Educ, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Raghunathan, S (corresponding author), Inst Bioinformat & Appl Biotechnol IBAB, Bengaluru, Karnataka, India.	srivatsan@ibab.ac.in		Harshan, Shilpa/0000-0002-5244-2375	Institute of Bioinformatics and Applied Biotechnology (IBAB); Council of Scientific and Industrial Research (CSIR), Government of India (GoI) [09/1086(0001)/2012-EMR-1]; Department of Biotechnology, GoI [BTPR12422/MED/31/287/2014]	Institute of Bioinformatics and Applied Biotechnology (IBAB); Council of Scientific and Industrial Research (CSIR), Government of India (GoI)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, GoI	We thank the department of Information Technology, Biotechnology and Science & Technology (IT, BT and S&T), Government of Karnataka, India for infrastructure support. VP received fellowships from the Institute of Bioinformatics and Applied Biotechnology (IBAB) as well as from the Council of Scientific and Industrial Research (CSIR), Government of India (GoI) (File No. 09/1086(0001)/2012-EMR-1), URL: http://www.csirhrdg.res.in/.SR is a faculty at IBAB. This project was partially supported by a grant from the Department of Biotechnology, GoI (BTPR12422/MED/31/287/2014, URL: http://www.dbtindia.nic.in/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Auman JT, 2008, EUR J CANCER, V44, P1754, DOI 10.1016/j.ejca.2008.05.010; Bae SC, 2003, J AM COLL NUTR, V22, P311, DOI 10.1080/07315724.2003.10719309; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BASHIR S, 1993, ANN RHEUM DIS, V52, P659, DOI 10.1136/ard.52.9.659; Bauerova K, 1999, GEN PHYSIOL BIOPHYS, V18, P15; Bick AG, 2017, P NATL ACAD SCI USA, V114, pE9096, DOI 10.1073/pnas.1711303114; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; BROMLEY M, 1984, ARTHRITIS RHEUM, V27, P857, DOI 10.1002/art.1780270804; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cerhan JR, 2003, AM J EPIDEMIOL, V157, P345, DOI 10.1093/aje/kwf205; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; DABBAGH AJ, 1993, ANN RHEUM DIS, V52, P67, DOI 10.1136/ard.52.1.67; Dai L, 2000, FREE RADICAL RES, V32, P479, DOI 10.1080/10715760000300481; Dai N, 2015, CELL METAB, V21, P609, DOI 10.1016/j.cmet.2015.03.006; Dantzer R, 2011, PSYCHONEUROENDOCRINO, V36, P426, DOI 10.1016/j.psyneuen.2010.09.012; Del Rey MJ, 2010, ARTHRITIS RHEUM-US, V62, P3584, DOI 10.1002/art.27750; Dey P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161306; Ducreux J, 2014, ARTHRITIS RHEUMATOL, V66, P15, DOI 10.1002/art.38202; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Fassone E, 2010, HUM MOL GENET, V19, P4837, DOI 10.1093/hmg/ddq414; Fearon U, 2016, NAT REV RHEUMATOL, V12, P385, DOI 10.1038/nrrheum.2016.69; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; GROOTVELD M, 1991, BIOCHEM J, V273, P459, DOI 10.1042/bj2730459; Gupta V, 2015, J NEUROCHEM, V134, P21, DOI 10.1111/jnc.13099; Hagfors L, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-5; Hajizadeh S, 2003, ARTHRITIS RES THER, V5, pR234, DOI 10.1186/ar787; Hartmann B, 2016, ELIFE, V5, DOI 10.7554/eLife.16078; HELIOVAARA M, 1994, ANN RHEUM DIS, V53, P51, DOI 10.1136/ard.53.1.51; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Huber R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2485; Jang D, 1998, FREE RADICAL BIO MED, V24, P1511, DOI 10.1016/S0891-5849(97)00459-0; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kamer KJ, 2014, EMBO REP, V15, P299, DOI 10.1002/embr.201337946; Kaur H, 2012, J BIOL CHEM, V287, P8920, DOI 10.1074/jbc.M111.327411; Kennedy A, 2011, ARTHRITIS RHEUM-US, V63, P923, DOI 10.1002/art.30221; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kolodziej L, 2012, IUBMB LIFE, V64, P983, DOI 10.1002/iub.1092; Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005; Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054; Lemarechal H, 2006, CLIN CHIM ACTA, V372, P147, DOI 10.1016/j.cca.2006.04.002; Li HL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/953462; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; MARKLUND SL, 1986, ANN RHEUM DIS, V45, P847, DOI 10.1136/ard.45.10.847; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Medina-Gomez G, 2012, BEST PRACT RES CL EN, V26, P791, DOI 10.1016/j.beem.2012.06.002; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P393, DOI 10.1038/icb.2013.15; Mulherin DM, 1996, ANN RHEUM DIS, V55, P837, DOI 10.1136/ard.55.11.837; Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407; Ng CT, 2010, ANN RHEUM DIS, V69, P1389, DOI 10.1136/ard.2009.119776; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Olofsson Maria Haegg, 2008, BMC Chemical Biology, V8, P2, DOI 10.1186/1472-6769-8-2; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003; Ouyang J, 2013, ONCOL REP, V29, P79, DOI 10.3892/or.2012.2101; Ozturk HS, 1999, RHEUMATOL INT, V19, P35, DOI 10.1007/s002960050097; Pagano G, 2013, FREE RADICAL RES, V47, P71, DOI 10.3109/10715762.2012.748904; Palao G, 2006, ARTHRITIS RHEUM-US, V54, P1473, DOI 10.1002/art.21768; Panga V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199530; Paredes S, 2002, J RHEUMATOL, V29, P2271; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qin SF, 2001, BIOCHEMISTRY-US, V40, P8085, DOI 10.1021/bi0100788; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rosebeck S, 2008, APOPTOSIS, V13, P562, DOI 10.1007/s10495-008-0190-0; ROWLEY D, 1984, CLIN SCI, V66, P691, DOI 10.1042/cs0660691; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Sawamukai N, 2007, J IMMUNOL, V179, P6479, DOI 10.4049/jimmunol.179.10.6479; Schroecksnadel K, 2003, J RHEUMATOL, V30, P1935; Shannon CP, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3460-1; Smith Malcolm D, 2011, Open Rheumatol J, V5, P100, DOI 10.2174/1874312901105010100; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; Sun C, 2017, CELL IMMUNOL, V315, P27, DOI 10.1016/j.cellimm.2016.10.007; Sun ZY, 2019, HEREDITAS, V156, DOI 10.1186/s41065-019-0091-y; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Taysi S, 2002, RHEUMATOL INT, V21, P200, DOI 10.1007/s00296-001-0163-x; Tominaga M, 2006, J NEUROCHEM, V96, P292, DOI 10.1111/j.1471-4159.2005.03554.x; Toro-Dominguez D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0489-x; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; VAINIO U, 1970, ANN RHEUM DIS, V29, P434, DOI 10.1136/ard.29.4.434; van't Hof RJ, 2000, RHEUMATOLOGY, V39, P1004, DOI 10.1093/rheumatology/39.9.1004; Vishnivetskaya GB, 2007, AGGRESSIVE BEHAV, V33, P1, DOI 10.1002/ab.20161; Wall VZ, 2017, J LIPID RES, V58, P1174, DOI 10.1194/jlr.M076489; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Woetzel D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4526; Zhang C, 2019, CHIN MED-UK, V14, DOI 10.1186/s13020-019-0247-8; Zhou WZ, 2018, J CANCER RES THER, V14, pS1024, DOI 10.4103/0973-1482.189250; ZHU N, 2018, MEDICINE, V97, DOI DOI 10.1097/MD.0000000000010997	101	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224632	10.1371/journal.pone.0224632	http://dx.doi.org/10.1371/journal.pone.0224632			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703070	Green Published, gold			2022-12-26	WOS:000532697200018
J	Maeda, S; Yamaguchi, M; Maeda, K; Kobayashi, N; Izumi, N; Nagai, M; Obayashi, T; Ohashi, W; Katsuno, T; Nobata, H; Ito, Y				Maeda, Sayaka; Yamaguchi, Makoto; Maeda, Kunihiro; Kobayashi, Naoto; Izumi, Naoki; Nagai, Masaaki; Obayashi, Takaaki; Ohashi, Wataru; Katsuno, Takayuki; Nobata, Hironobu; Ito, Yasuhiko			Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients	PLOS ONE			English	Article							BACTERIAL OVERGROWTH; ACID SUPPRESSANTS; GUT MICROBIOTA; ASSOCIATION; PHARMACOKINETICS; COLONOSCOPY; INFECTION	Peritonitis is a major and the most significant complication of peritoneal dialysis (PD). Although some predictors of peritonitis in PD patients are known, the association between proton pump inhibitor (PPI) use and peritonitis has not been characterized. Here, we examined whether PPI use is a risk factor for the development of peritonitis, based on a single-center retrospective analysis of 230 consecutive Japanese PD patients at Narita Memorial Hospital. We assessed the association between PPI use and subsequent first episode of peritonitis using multivariate Cox proportional hazards models, following adjustment for clinically relevant factors. The median follow-up period was 36 months (interquartile range, 19-57 months). In total, 86 patients (37.4%) developed peritonitis. Analysis with multivariate Cox proportional hazards models revealed the following significant predictors of peritonitis: PPI use (adjusted hazard ratio [HR] = 1.72, 95% confidence interval [CI]: 1.11-2.66; P = 0.016) and low serum albumin level (per g/dl adjusted HR = 0.59, 95% CI: 0.39-0.90; P = 0.014). Thus, PPI use was independently associated with PD-related peritonitis. The results suggest that nephrology physicians should exercise caution when prescribing PPIs for PD patients.	[Maeda, Sayaka; Maeda, Kunihiro; Kobayashi, Naoto; Izumi, Naoki; Nagai, Masaaki; Obayashi, Takaaki] Narita Mem Hosp, Dept Nephrol, Toyohashi, Aichi, Japan; [Yamaguchi, Makoto; Katsuno, Takayuki; Nobata, Hironobu; Ito, Yasuhiko] Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan; [Ohashi, Wataru] Aichi Med Univ, Clin Res Ctr, Div Biostat, Nagakute, Aichi, Japan	Aichi Medical University; Aichi Medical University	Ito, Y (corresponding author), Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan.	yasuito@aichi-med-u.ac.jp						Brooks AW, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006842; Chang CS, 1998, HEPATOLOGY, V28, P1187, DOI 10.1002/hep.510280504; Chang SS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000944; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23075; Cho Y, 2014, AM J KIDNEY DIS, V64, P278, DOI 10.1053/j.ajkd.2014.02.025; Ciz M, 2013, BRIT J PHARMACOL, V170, P17, DOI 10.1111/bph.12107; Deshpande A, 2012, CLIN GASTROENTEROL H, V10, P225, DOI 10.1016/j.cgh.2011.09.030; Frei R, 2013, J ALLERGY CLIN IMMUN, V132, P194, DOI 10.1016/j.jaci.2013.01.013; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Jump RLP, 2007, ANTIMICROB AGENTS CH, V51, P2883, DOI 10.1128/AAC.01443-06; Keane WF, 1996, PERITON DIALYSIS INT, V16, P557; Keane WF, 1999, J CLIN PHARMACOL, V39, P927, DOI 10.1177/00912709922008542; Kwon JE, 2014, WORLD J GASTROENTERO, V20, P8187, DOI 10.3748/wjg.v20.i25.8187; Li PKT, 2016, PERITON DIALYSIS INT, V36, P481, DOI 10.3747/pdi.2016.00078; Machuca Eduardo, 2005, Adv Perit Dial, V21, P60; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Min YW, 2014, ALIMENT PHARM THER, V40, P695, DOI 10.1111/apt.12875; Perez-Fontan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148806; Poortvliet W, 2010, NETH J MED, V68, P377; Prasad N, 2007, PERITON DIALYSIS INT, V27, P42; SICA DA, 1987, EUR J CLIN PHARMACOL, V32, P587, DOI 10.1007/BF02455993; Takagi T, 2018, J CLIN BIOCHEM NUTR, V62, P100, DOI 10.3164/jcbn.17-78; Takahashi Y, 2006, J GASTROEN HEPATOL, V21, P1664, DOI 10.1111/j.1440-1746.2006.04270.x; Thorens J, 1996, GUT, V39, P54, DOI 10.1136/gut.39.1.54; Troidle L, 2003, AM J KIDNEY DIS, V42, P350, DOI 10.1016/S0272-6386(03)00661-9; van Diepen ATN, 2012, CLIN J AM SOC NEPHRO, V7, P1266, DOI 10.2215/CJN.00980112; Voinescu CG, 2002, INT J ARTIF ORGANS, V25, P249, DOI 10.1177/039139880202500402; Wang Q, 2003, AM J KIDNEY DIS, V41, P664, DOI 10.1053/ajkd.2003.50128; Yip T, 2007, PERITON DIALYSIS INT, V27, P560; Zhong HJ, 2019, J CLIN PHARM THER, V44, P209, DOI 10.1111/jcpt.12769	30	8	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224859	10.1371/journal.pone.0224859	http://dx.doi.org/10.1371/journal.pone.0224859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697753	Green Published, gold			2022-12-26	WOS:000532694400071
J	Kim, JI; Kang, BH				Kim, Jae-Il; Kang, Bong-Hui			Decreased retinal thickness in patients with Alzheimer's disease is correlated with disease severity	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PROGRESSION; DIAGNOSIS	Background and purpose The loss of retinal ganglion cells observed in Alzheimer's disease (AD) may be attributable to a neurodegeneration of the neuro-retinal structure. Amnestic mild cognitive impairment (aMCI) has been considered a prodromal stage of AD. We evaluated retinal thicknesses in patients with aMCI and AD compared to healthy controls using spectral-domain optical coherence tomography (OCT) to investigate whether changes in retinal thickness are correlated with the clinical severity of dementia. Methods Patients with aMCI (n = 14), mild to moderate AD (n = 7), severe AD (n = 9), and age-matched controls (n = 17) underwent neuro-ophthalmologic examinations. Global deterioration scale (GDS), clinical dementia rating (CDR), and mini-mental status examination (MMSE) were used to evaluate the clinical overall severity of dementia. The thicknesses of the peripapillary retinal nerve fiber layer (RNFL), total macula, and macular ganglion cell-inner plexiform layer (GC-IPL) were measured using Cirrus HD-OCT. Results The severe AD group had overall significantly thinner GC-IPL, total macula, and peripapillary RNFL compared to the controls (p < 0.05). In the mild to moderate AD group, the total macula, average RNFL, and superior RNFL thickness were each significantly reduced compared to controls (p < 0.05). The aMCI group had reduced total macula, average RNFL, and inferior RNFL thickness, but there were no significant differences compared to the controls. The GDS and CDR scores had a negative correlation with the thickness of the GC-IPL and the total macula. The MMSE scores had a positive correlation with both the total macular and average RNFL thickness, when adjusted for age (p < 0.05). Conclusions This study confirmed that retinal thickness is decreased in AD patients. There is a correlation between reduced retinal thickness and the clinical severity of dementia.	[Kim, Jae-Il; Kang, Bong-Hui] Dankook Univ, Dankook Univ Hosp, Dept Neurol, Coll Med, Cheonan, South Korea	Dankook University; Dankook University Hospital	Kang, BH (corresponding author), Dankook Univ, Dankook Univ Hosp, Dept Neurol, Coll Med, Cheonan, South Korea.	debora79@hanmail.net		Kang, Bong-hui/0000-0001-6852-9507	Dankook University	Dankook University	This research was supported by the research fund of Dankook University in 2017.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Ascaso FJ, 2014, J NEUROL, V261, P1522, DOI 10.1007/s00415-014-7374-z; Blanks JC, 1996, NEUROBIOL AGING, V17, P385, DOI 10.1016/0197-4580(96)00009-7; Coppola G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134750; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; Greenberg Benjamin M, 2010, Ther Adv Neurol Disord, V3, P153, DOI 10.1177/1756285610368890; Guo L, 2010, CURR ALZHEIMER RES, V7, P3, DOI 10.2174/156720510790274491; Jack CR, 2008, BRAIN, V131, P665, DOI 10.1093/brain/awm336; Jicha GA, 2006, ARCH NEUROL-CHICAGO, V63, P674, DOI 10.1001/archneur.63.5.674; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; 강봉희, 2013, [Journal of the Korean Neurological Association, 대한신경과학회지], V31, P173; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Lashley T, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.031781; Lee Jong Yeon, 2012, Korean J Ophthalmol, V26, P163, DOI 10.3341/kjo.2012.26.3.163; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nouri-Mahdavi K, 2013, AM J OPHTHALMOL, V156, P1297, DOI 10.1016/j.ajo.2013.08.001; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Sheehan B, 2012, THER ADV NEUROL DISO, V5, P349, DOI 10.1177/1756285612455733; Thomson Kelsey L, 2015, Alzheimers Dement (Amst), V1, P136, DOI 10.1016/j.dadm.2015.03.001; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Whitwell JL, 2008, NEUROLOGY, V70, P512, DOI 10.1212/01.wnl.0000280575.77437.a2; Wostyn P, 2009, BRIT J OPHTHALMOL, V93, P1557, DOI 10.1136/bjo.2008.148064	23	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224180	10.1371/journal.pone.0224180	http://dx.doi.org/10.1371/journal.pone.0224180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689310	Green Published, Green Submitted, gold			2022-12-26	WOS:000532680100014
J	Tetteh, J; Kogi, R; Yawson, AO; Mensah, G; Biritwum, R; Yawson, AE				Tetteh, John; Kogi, Robert; Yawson, Anita Ohenewa; Mensah, George; Biritwum, Richard; Yawson, Alfred Edwin			Effect of self-rated health status on functioning difficulties among older adults in Ghana: Coarsened exact matching method of analysis of the World Health Organization's study on global AGEing and adult health, Wave 2	PLOS ONE			English	Article							LIFE; ASSOCIATION; DECLINE; WOMEN; AGE	Background Functional difficulty assessment has been proven as a key factor in the health evaluation of adults. Previous studies have shown a reduction in health and functional difficulties with increasing age. This analysis was conducted to quantify the effect of poor self-rated health on functional difficulty among older adults in Ghana. Method This analysis was based on the World Health Organization Study on Global AGEing and Adult Health in Ghana for older adults 50 years and above. Fifteen standard functioning difficulty tools were extracted and used for the analysis. Three predictive models with the Coarsened Exact Matching method involving Negative Binomial, Logistics and Ordered logistic regression were performed using Stata 14. Results Overall, the prevalence of poor Self-rated health was 34.9% and that of functional difficulties among older adults in Ghana was 69.4%. Female sex, increasing age, being separated, having no religious affiliation, not currently working and being underweight were associated with and significantly influence poor Self-rated health [AOR(95%CI)p-value = 1.41(1.08-1.83)0.011, 3.85(2.62-5.64)0.000, 1.45(1.08-1.94)0.013, 2.62(1.68-4.07)0.000, 2.4(1.85-3.12)0.000 and 1.39(1.06-1.81)0.017 respectively]. In addition, poor Self-rated health and geographical location (rural vs. urban)significantly influence functioning difficulties among older adults in Ghana as predicted by the three models [Negative Binomial: PR(95%CI) = 1.62(1.43-1.82), Binary logistic: AOR(95%CI) = 3.67(2.79-4.81) and ordered logistic: AOR (95%CI) = 2.53(1.14-2.03)]. Conclusion Poor SRH is more pronounced among older adult females in Ghana. Some determinants of poor SRH include; age, geographical location (urban vs. rural), marital status, religion, and employment status. This provides pointers to important socio-demographic determinants with implications on the social function of older adults in line with the theme of the national aging policy of 2010, `ageing with security and dignity' and ultimately in the national quest to achieve the Sustainable Development Goals by 2030.	[Tetteh, John; Mensah, George; Biritwum, Richard; Yawson, Alfred Edwin] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth, Accra, Ghana; [Tetteh, John] Korle Bu Teaching Hosp, Natl Cardiothorac Ctr, Accra, Ghana; [Tetteh, John; Kogi, Robert] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana; [Yawson, Anita Ohenewa] Korle Bu Teaching Hosp, Dept Anesthesia, Accra, Ghana; [Yawson, Alfred Edwin] Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Accra, Ghana	University of Ghana; University of Ghana	Yawson, AE (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth, Accra, Ghana.; Yawson, AE (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Accra, Ghana.	aeyawson@ug.edu.gh	Kogi, Robert/ABA-2609-2021; Tetteh, John/AEU-3066-2022	Kogi, Robert/0000-0001-9158-597X; Tetteh, John/0000-0002-1986-4103				Ahs A, 2006, EUR J PUBLIC HEALTH, V16, P294, DOI 10.1093/eurpub/cki165; Akyol Y, 2010, TURK J RHEUMATOL, V25, P165, DOI 10.5152/tjr.2010.23; Borim FSA, 2014, REV SAUDE PUBL, V48, P714, DOI 10.1590/S0034-8910.2014048005243; Arnadottir SA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-670; Asfar T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-177; Baernholdt M, 2012, J RURAL HEALTH, V28, P339, DOI 10.1111/j.1748-0361.2011.00403.x; Bardage Carola, 2005, Eur J Ageing, V2, P149, DOI 10.1007/s10433-005-0032-7; Biritwum R, 2013, STUDY GLOBAL AGEING, P113; Biritwum R.B., 2015, GHANA STUDY GLOBAL A, DOI [10.13140/RG.2.1.4653.4564., DOI 10.13140/RG.2.1.4653.4564]; Blomstedt Y, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.8488; Cau BM, 2016, BMC PUBLIC HEALTH, V16, P20, DOI [10.1186/s12889-015-2680-7, DOI 10.1186/S12889-015-2680-7]; Cesari Matteo, 2008, BMC Geriatr, V8, P34, DOI 10.1186/1471-2318-8-34; Chan YY, 2015, BMC PUBLIC HEALTH, P1, DOI [10.1186/1471-2458-15-1, DOI 10.1186/1471-2458-15-1]; Chola L, 2013, ASS NEIGHBOURHOOD IN, DOI [10.1371/journal.pone.0071085, DOI 10.1371/JOURNAL.PONE.0071085]; Chola L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071085; Christian LM, 2013, ANN BEHAV MED, V46, P295, DOI 10.1007/s12160-013-9521-7; Colon-Emeric CS, 2013, AM FAM PHYSICIAN, V88, P388; Coume M, 2014, CAH ANNEE GERONTOL, V6, P90, DOI 10.1007/s12612-014-0376-8; Dangi A, 2016, FACTORS ASS SELF RAT; Debpuur C, 2010, GLOBAL HEALTH ACTION, V3, P54, DOI 10.3402/gha.v3i0.2151; Duboz P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184416; Fonta CL, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0560-y; Fuentes-Ramirez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170704; Golini N, 2016, SOC INDIC RES, V128, P321, DOI 10.1007/s11205-015-1033-3; Guarcello MA, 2017, TECHNOL KNOWL LEARN, V22, P335, DOI 10.1007/s10758-017-9317-0; Gyasi RM, 2018, ARCH GERONTOL GERIAT, V77, P174, DOI 10.1016/j.archger.2018.05.010; Hardy MA, 2014, J HEALTH SOC BEHAV, V55, P320, DOI 10.1177/0022146514541446; Hoeymans N, 1997, SOC SCI MED, V45, P1527, DOI 10.1016/S0277-9536(97)00089-0; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Ibraheem A B, 2014, Ann Ib Postgrad Med, V12, P31; Imai K, 2008, OBESITY, V16, P402, DOI 10.1038/oby.2007.70; Jann B, 2004, ALPHAWGT STATA MODUL; Jung Mi Sook, 2019, Osong Public Health Res Perspect, V10, P93, DOI 10.24171/j.phrp.2019.10.2.08; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lau YK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1601-0; Lim WY, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-184; Lindstrom M, 2009, HEALTH POLICY, V93, P172, DOI 10.1016/j.healthpol.2009.05.010; Lollar DJ, 2012, PEDIATRICS, V129, pE714, DOI 10.1542/peds.2011-0780; Macia E, 2012, EUR J AGEING, V9, P243, DOI 10.1007/s10433-012-0227-7; Ocampo JM, 2010, COLOMB MEDICA, V41, P275; Mavaddat N, 2011, J EPIDEMIOL COMMUN H, V65, P800, DOI 10.1136/jech.2009.090845; Mora P, 2008, ANN BEHAV MED, V36, P292, DOI 10.1007/s12160-008-9065-4; Muennig P, 2017, INT J EPIDEMIOL, V46, P1239, DOI 10.1093/ije/dyw290; Naseer M, 2016, EUR J CLIN NUTR, V70, P399, DOI 10.1038/ejcn.2015.196; Nielsen TH, 2016, HEALTH ECON, V25, P497, DOI 10.1002/hec.3167; Ocampoose M, 2010, SELF RATED HLTH IMPO; Ogunyemi AO, 2018, NIGER POSTGRAD MED J, V25, P73, DOI 10.4103/npmj.npmj_14_18; Ogwumike OO, 2016, WOMEN HEALTH, V56, P487, DOI 10.1080/03630242.2015.1101735; Olawa BD, 2020, AGING MENT HEALTH, V24, P15, DOI 10.1080/13607863.2018.1506748; Onadja Y, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-15; Paterson HdH, 2010, INT J BEHAV NUTR PHY, V7, P190; Saevareid HI, 2007, AGING MENT HEALTH, V11, P658, DOI 10.1080/13607860701368513; Satefano MI, 2009, CEM COARSENED EXACT; Schnittker J, 2005, MILBANK Q, V83, P397, DOI 10.1111/j.1468-0009.2005.00407.x; Seculi E, 2001, Gac Sanit, V15, P217; Smith PM, 2010, J CLIN EPIDEMIOL, V63, P412, DOI 10.1016/j.jclinepi.2009.08.015; Spalter T, 2014, GERONTOLOGIST, V54, P919, DOI 10.1093/geront/gnt084; St-Onge MP, 2005, CURR OPIN CLIN NUTR, V8, P523; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; WHO, 2013, HLTH STAT INF SYST S; WHO, 2017, HLTH SIT TREND ASS E; WHO, 2010, FREQ ASK QUEST WHAT; Zarini GG, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/315042	63	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224327	10.1371/journal.pone.0224327	http://dx.doi.org/10.1371/journal.pone.0224327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1BP	31689325	Green Published, gold			2022-12-26	WOS:000532680100018
J	Maeda, N; Maruhashi, T; Sugiura, D; Shimizu, K; Okazaki, IM; Okazaki, T				Maeda, Natsumi; Maruhashi, Takumi; Sugiura, Daisuke; Shimizu, Kenji; Okazaki, II-mi; Okazaki, Taku			Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; glucocorticoid; immunosuppression; immunology; T cell; T cell receptor (TCR); cytokine induction; coreceptor; immune checkpoint; PD-1	PD-1 EXPRESSION; RECEPTOR PD-1; ACTIVATION; EXHAUSTION; RESISTANCE; RESPONSES; PATHWAYS	The inhibitory co-receptor programmed cell death 1 (PD-1, Pdcd1) plays critical roles in the regulation of autoimmunity, anticancer immunity, and immunity against infections. Immunotherapies targeting PD-1 have revolutionized cancer management and instigated various trials of improved cancer immunotherapies. Moreover, extensive trials are underway to potentiate PD-1 function to suppress harmful immune responses. Here we found that both natural and synthetic glucocorticoids (GCs) up-regulate PD-1 on T cells without altering the expression levels of other co-receptors and cell surface molecules. GC-induced up-regulation of PD-1 depended on transactivation of PD-1 transcription mediated through the glucocorticoid receptor. We further found that a GC response element 2525 bp upstream of the transcription start site of Pdcd1 is responsible for GC-mediated transactivation. We also observed that in vivo administration of GCs significantly up-regulates PD-1 expression on tumor-infiltrating T cells. By analyzing T cells differing in PD-1 expression, we directly demonstrated that the amount of PD-1 on the cell surface correlates with its inhibitory effect. Accordingly, GCs potentiated the capacity of PD-1 to inhibit T cell activation, suggesting that this PD-1-mediated inhibition contributes, at least in part, to the anti-inflammatory and immunosuppressive effects of GCs. In light of the critical roles of PD-1 in the regulation of autoimmunity, we expect that the potentiation of PD-1 activity may offer a promising therapeutic strategy for managing inflammatory and autoimmune diseases. Our current findings provide a rationale for strategies seeking to enhance the inhibitory effect of PD-1 by increasing its expression level.	[Maeda, Natsumi; Maruhashi, Takumi; Sugiura, Daisuke; Shimizu, Kenji; Okazaki, II-mi; Okazaki, Taku] Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, 3-18-15 Kuramoto, Tokushima 7708503, Japan; [Maruhashi, Takumi; Sugiura, Daisuke; Shimizu, Kenji; Okazaki, II-mi; Okazaki, Taku] Univ Tokyo, Inst Quantitat Biosci, Lab Mol Immunol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan	Tokushima University; University of Tokyo	Okazaki, T (corresponding author), Tokushima Univ, Inst Adv Med Sci, Div Immune Regulat, 3-18-15 Kuramoto, Tokushima 7708503, Japan.; Okazaki, T (corresponding author), Univ Tokyo, Inst Quantitat Biosci, Lab Mol Immunol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	tokazaki@iam.u-tokyo.ac.jp		Maruhashi, Takumi/0000-0003-2944-1611; Okazaki, Il-mi/0000-0001-8644-0100; Okazaki, Taku/0000-0003-4790-1925; Sugiura, Daisuke/0000-0002-3865-3889	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development [JP18am0301007]; Japan Society for the Promotion of Science [JP18H05417, JP19H01029, 19K16694]; Katsunuma scholarship; Yoshimitsu Otsuka scholarship	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Katsunuma scholarship; Yoshimitsu Otsuka scholarship(Otsuka Pharmaceutical)	This work was supported in part by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency, Basic Science and Platform Technology Program for Innovative Biological Medicine of the Japan Agency for Medical Research and Development (JP18am0301007) and Grants-in-Aid by the Japan Society for the Promotion of Science JP18H05417, JP19H01029, and 19K16694. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Katsunuma and Yoshimitsu Otsuka scholarships.	Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boldizsar F, 2010, IMMUNOBIOLOGY, V215, P521, DOI 10.1016/j.imbio.2009.10.003; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Giles AJ, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0371-5; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Maeda TK, 2019, J BIOL CHEM, V294, P6017, DOI 10.1074/jbc.RA119.007455; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0; Maruhashi T, 2018, NAT IMMUNOL, V19, P1415, DOI 10.1038/s41590-018-0217-9; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; Mizuno R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00630; Mizuno R, 2019, BIOCHEM BIOPH RES CO, V511, P491, DOI 10.1016/j.bbrc.2019.02.004; MOSER M, 1995, EUR J IMMUNOL, V25, P2818, DOI 10.1002/eji.1830251016; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Petrillo MG, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-35; Piemonti L, 1999, J IMMUNOL, V162, P6473; Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]; Quatrini L, 2018, NAT IMMUNOL, V19, P954, DOI 10.1038/s41590-018-0185-0; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rocamora-Reverte L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00472; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Sugiura D, 2019, SCIENCE, V364, P558, DOI 10.1126/science.aav7062; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Tsitoura DC, 2004, J CLIN INVEST, V113, P619, DOI 10.1172/JCI200418975; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Xia M, 1999, CELL MOL LIFE SCI, V55, P1649, DOI 10.1007/s000180050403; Xiao G, 2012, P NATL ACAD SCI USA, V109, P15419, DOI 10.1073/pnas.1206370109; Xing KL, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0103-2	39	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19896	19906		10.1074/jbc.RA119.010379	http://dx.doi.org/10.1074/jbc.RA119.010379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31723031	Green Published, hybrid			2022-12-26	WOS:000505005800007
J	Yoon, JH; Choudhury, JR; Prakash, L; Prakash, S				Yoon, Jung-Hoon; Choudhury, Jayati Roy; Prakash, Louise; Prakash, Satya			Translesion synthesis DNA polymerases eta, iota, and nu promote mutagenic replication through the anticancer nucleoside cytarabine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translesion synthesis; cytarabine; AraC; acute myeloid leukemia; AraC mutagenesis	ERROR-FREE REPLICATION; ACUTE MYELOID-LEUKEMIA; NUCLEOTIDE INCORPORATION; THYMINE GLYCOL; BYPASS; YEAST; ZETA; MECHANISM; LESION; REV1	Cytarabine (AraC) is the mainstay for the treatment of acute myeloid leukemia (AML). Although complete remission is observed in a large proportion of patients, relapse occurs in almost all the cases. The chemotherapeutic action of AraC derives from its ability to inhibit DNA synthesis by the replicative polymerases (Pols); the replicative Pols can insert AraCTP at the 3'-terminus of the nascent DNA strand, but they are blocked at extending synthesis from AraC. By extending synthesis from the 3'-terminal AraC and by replicating through AraC that becomes incorporated into DNA, translesion synthesis ( TLS) DNA Pols could reduce the effectiveness of AraC in chemotherapy. Here we identify the TLS Pols required for replicating through the AraC templating residue and determine their error-proneness. We provide evidence that TLS makes a consequential contribution to the replication of AraC damaged DNA, that TLS through AraC is conducted by three different pathways dependent upon Pol., Pol., and Pol., respectively, and that TLS by all these Pols incurs considerable mutagenesis. The prominent role of TLS in promoting proficient and mutagenic replication through AraC suggests that TLS inhibition in AML patients would increase the effectiveness of AraC chemotherapy; and by reducing mutation formation, TLS inhibition may dampen the emergence of drug resistant tumors and thereby the high incidence of relapse in AraC treated patients.	[Yoon, Jung-Hoon; Choudhury, Jayati Roy; Prakash, Louise; Prakash, Satya] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Choudhury, Jayati Roy] NASA, Johnson Space Ctr, Human Hlth & Performance Directorate, 2101 Nasa Pkwy, Houston, TX 77058 USA	University of Texas System; University of Texas Medical Branch Galveston; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Prakash, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	saprakas@utmb.edu		Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NIH [CA200575]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH Grant CA200575. We thank Robert Johnson for help with preparation of this manuscript.	American Cancer Society, 2018, CANC FACTS FIG 2018; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Conde J, 2015, J BIOL CHEM, V290, P29794, DOI 10.1074/jbc.M115.693010; Cooper T. M, 2011, PRINCIPLES PRACTICE, P566; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fordham SE, 2015, LEUKEMIA, V29, P491, DOI 10.1038/leu.2014.284; Garg M, 2015, BLOOD, V126, P2491, DOI 10.1182/blood-2015-05-646240; Grant S, 1998, ADV CANCER RES, V72, P197; Greif PA, 2018, CLIN CANCER RES, V24, P1716, DOI 10.1158/1078-0432.CCR-17-2344; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HARRINGTON C, 1995, J BIOL CHEM, V270, P26664, DOI 10.1074/jbc.270.44.26664; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kadia TM, 2015, CL LYMPH MYELOM LEUK, V15, P139, DOI 10.1016/j.clml.2014.08.006; Kunz JB, 2015, HAEMATOLOGICA, V100, P1442, DOI 10.3324/haematol.2015.129692; Lichtman MA, 2013, BLOOD CELL MOL DIS, V50, P119, DOI 10.1016/j.bcmd.2012.10.005; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Magina KN, 2017, BLOOD, V130, P946, DOI 10.1182/blood-2017-04-777722; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; MIKITA T, 1988, BIOCHEMISTRY-US, V27, P4698, DOI 10.1021/bi00413a018; Nair DT, 2008, STRUCTURE, V16, P239, DOI 10.1016/j.str.2007.12.009; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Perrino Fred W., 1999, Cell Biochemistry and Biophysics, V30, P331, DOI 10.1007/BF02738118; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rechkoblit O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30796-w; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Swan MK, 2009, J MOL BIOL, V390, P699, DOI 10.1016/j.jmb.2009.05.026; Walter RB, 2015, LEUKEMIA, V29, P312, DOI 10.1038/leu.2014.242; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004; Washington MT, 2003, MOL CELL BIOL, V23, P8316, DOI 10.1128/MCB.23.22.8316-8322.2003; Yoon JH, 2019, GENE DEV, V33, P282, DOI 10.1101/gad.320531.118; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Yoon JH, 2018, J BIOL CHEM, V293, P2949, DOI 10.1074/jbc.RA117.000962; Yoon JH, 2017, J BIOL CHEM, V292, P18682, DOI 10.1074/jbc.M117.808659; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	44	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19048	19054		10.1074/jbc.RA119.011381	http://dx.doi.org/10.1074/jbc.RA119.011381			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31685662	hybrid, Green Published			2022-12-26	WOS:000516527800009
J	Zhou, JW; Fang, LR; Yang, ZX; Xu, SG; Lv, MT; Sun, Z; Chen, JY; Wang, D; Gao, J; Xiao, SB				Zhou, Junwei; Fang, Liurong; Yang, Zhixiang; Xu, Shangen; Lv, Mengting; Sun, Zheng; Chen, Jiyao; Wang, Dang; Gao, Jun; Xiao, Shaobo			Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach	FASEB JOURNAL			English	Article						biosensor; catalytic residue; molecular dynamics; molecular mechanism	PORCINE EPIDEMIC DIARRHEA; RESPIRATORY SYNDROME CORONAVIRUS; PARTICLE MESH EWALD; SUBSTRATE RECOGNITION; MOLECULAR-DYNAMICS; DRUG-RESISTANCE; MAIN PROTEINASE; POTENT INHIBITORS; NS3/4A INHIBITORS; A VIRUS	Coronaviruses (CoVs) infect humans and multiple other animal species, causing highly prevalent and severe diseases. 3C-like proteases (3CL(pro)s) from CoVs (also called main proteases) are essential for viral replication and are also involved in polyprotein cleavage and immune regulation, making them attractive and effective targets for the development of antiviral drugs. Herein, the 3CL(pro) from the porcine epidemic diarrhea virus, an enteropathogenic CoV, was used as a model to identify novel crucial residues for enzyme activity. First, we established a rapid, sensitive, and efficient luciferase-based biosensor to monitor the activity of PDEV 3CL(pro) in vivo. Using this luciferase biosensor, along with confirming the well-known catalytic residues (His41 and Cys144), we identified 4 novel proteolytically inactivated mutants of PDEV 3CL(pro), which was also confirmed in mammalian cells by biochemical experiments. Our molecular dynamics (MD) simulations showed that the hydrogen bonding interactions occurring within and outside of the protease's active site and the dynamic fluctuations of the substrate, especially the van der Waals contacts, were drastically altered, a situation related to the loss of 3CL(pro) activity. These data suggest that changing the intermolecular dynamics in protein-substrate complexes eliminates the mechanism underlying the protease activity. The discovery of novel crucial residues for enzyme activity in the binding pocket could potentially provide more druggable sites for the design of protease inhibitors. In addition, our in-depth study of the dynamic substrate's envelope model using MD simulations is an approach that could augment the discovery of new inhibitors against 3CL(pro) in CoVs and other viral 3C proteases.	[Zhou, Junwei; Fang, Liurong; Yang, Zhixiang; Xu, Shangen; Lv, Mengting; Sun, Zheng; Chen, Jiyao; Wang, Dang; Xiao, Shaobo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Gao, Jun] Huazhong Agr Univ, Coll Informat, Agr Bioinformat Key Lab Hubei Prov, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China; [Zhou, Junwei; Fang, Liurong; Yang, Zhixiang; Xu, Shangen; Lv, Mengting; Sun, Zheng; Chen, Jiyao; Wang, Dang; Xiao, Shaobo] Cooperat Innovat Ctr Sustainable Pig Prod, Key Lab Prevent Vet Med Hubei Prov, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Gao, J (corresponding author), Huazhong Agr Univ, Coll Informat, Agr Bioinformat Key Lab Hubei Prov, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.; Xiao, SB (corresponding author), Huazhong Agr Univ, Coll Vet Med, Lab Anim Virol, 1 Shi Zi Shan St, Wuhan 430070, Hubei, Peoples R China.	gaojun@mail.hzau.edu.cn; vet@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188	National Key Research and Development Program of China [2016YFD0500103, 2017YFB0203405]; National Natural Science Foundation of China [21873034, 31672569, 31672566]; Natural Science Foundation of Hubei Province [2017CFA059]; Special Project for Technology Innovation of Hubei Province [2017ABA138]; Fundamental Research Funds for the Central Universities [2662016PY070, 2662018JC027, 2015RC008]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Special Project for Technology Innovation of Hubei Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Key Research and Development Program of China (2016YFD0500103 and 2017YFB0203405), the National Natural Science Foundation of China (21873034, 31672569, and 31672566), the Natural Science Foundation of Hubei Province (2017CFA059), the Special Project for Technology Innovation of Hubei Province (2017ABA138), and the Fundamental Research Funds for the Central Universities (2662016PY070, 2662018JC027, and 2015RC008). The authors declare no conflicts of interest.	Ali A, 2013, ACS CHEM BIOL, V8, P1469, DOI 10.1021/cb400100g; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; Anand K, 2005, BIRK ADV INFECT DIS, P173; Bacha U, 2004, BIOCHEMISTRY-US, V43, P4906, DOI 10.1021/bi0361766; Blanchard JE, 2004, CHEM BIOL, V11, P1445, DOI 10.1016/j.chembiol.2004.08.011; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Case D., 2015, AMBER, V14; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; Colell EA, 2018, NUCLEIC ACIDS RES, V46, pW323, DOI 10.1093/nar/gky419; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Deeks SG, 1997, JAMA-J AM MED ASSOC, V277, P145, DOI 10.1001/jama.277.2.145; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Galban S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066248; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Holmes KV, 1996, FIELDS VIROLOGY, P1075; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Jain RP, 2004, J MED CHEM, V47, P6113, DOI 10.1021/jm0494873; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kao RY, 2004, CHEM BIOL, V11, P1293, DOI 10.1016/j.chembiol.2004.07.013; Kilianski A, 2013, J VIROL, V87, P11955, DOI 10.1128/JVI.02105-13; Kim Y, 2012, J VIROL, V86, P11754, DOI 10.1128/JVI.01348-12; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Kweon CH, 1999, VACCINE, V17, P2546, DOI 10.1016/S0264-410X(99)00059-6; Lai M.M.C., 2001, FIELDS VIROLOGY, P1163; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Liu C, 2015, J VIROL, V89, P6121, DOI 10.1128/JVI.00430-15; Matthew AN, 2018, STRUCTURE, V26, P1360, DOI 10.1016/j.str.2018.07.004; Matthew AN, 2017, J MED CHEM, V60, P5699, DOI 10.1021/acs.jmedchem.7b00426; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Ozen A, 2013, J CHEM THEORY COMPUT, V9, P5693, DOI 10.1021/ct400603p; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Pereira H., 1989, CORONAVIRIDAE ANDREW, P42; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ragland DA, 2014, J AM CHEM SOC, V136, P11956, DOI 10.1021/ja504096m; Romano KP, 2011, J VIROL, V85, P6106, DOI 10.1128/JVI.00377-11; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Soumana DI, 2016, J AM CHEM SOC, V138, P11850, DOI 10.1021/jacs.6b06454; Soumana DI, 2016, ACS CHEM BIOL, V11, P900, DOI 10.1021/acschembio.5b00647; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Tanner JA, 2005, CHEM BIOL, V12, P303, DOI 10.1016/j.chembiol.2005.01.006; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Wang D, 2016, J VIROL, V90, P2090, DOI 10.1128/JVI.02514-15; Wigdal Susan S, 2008, Curr Chem Genomics, V2, P16, DOI 10.2174/1875397300802010016; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Yang HT, 2005, PLOS BIOL, V3, P1742, DOI 10.1371/journal.pbio.0030324; Ye G, 2016, VIROLOGY, V494, P225, DOI 10.1016/j.virol.2016.04.018; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zhou JW, 2017, BIOCHEM BIOPH RES CO, V488, P621, DOI 10.1016/j.bbrc.2017.05.063; Zhu XY, 2017, J VIROL, V91, DOI [10.1128/JVI.00003-17, 10.1128/jvi.00003-17]	61	29	31	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14575	14587		10.1096/fj.201901624RR	http://dx.doi.org/10.1096/fj.201901624RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690127				2022-12-26	WOS:000507466100116
J	Andrews, T; Neher, DA; Weicht, TR; Barlow, JW				Andrews, Tucker; Neher, Deborah A.; Weicht, Thomas R.; Barlow, John W.			Mammary microbiome of lactating organic dairy cows varies by time, tissue site, and infection status	PLOS ONE			English	Article							TEAT SKIN; SAMPLING TECHNIQUE; BACTERIAL COUNTS; MASTITIS; MILK; IDENTIFICATION; POPULATIONS; CATTLE	Infections of the cow udder leading to mastitis and reducing milk quality are a critical challenge facing all dairy farmers. Mastitis may be linked to the ecological disruption of an endogenous mammary microbial community, suggesting an ecosystems approach to management and prevention of this disease. The teat end skin represents a first point of host contact with mastitis pathogens and may offer an opportunity for microbially mediated resistance to infection, yet we know little about the microbial community of teat end skin or its potential interaction with the microbial community of intramammary milk of organic dairy cattle. High-throughput sequencing of marker genes for bacterial and fungal communities was used to characterize the skin and milk microbiome of cows with both a healthy and infected gland (i.e., udder quarter) and to assess the sharing of microbial DNA between these tissue habitat sites. The mammary microbiome varied among cows, through time, and between skin and milk. Microbiomes of milk from healthy and infected quarters reflected a diverse group of microbial DNA sequences, though milk had far fewer operational taxonomic units (OTUs) than skin. Milk microbiomes of infected quarters were generally more variable than healthy quarters and were frequently dominated by a single OTU; teat end skin microbiomes were relatively similar between healthy and infected quarters. Commonly occurring genera that were shared between skin and milk of infected glands included Staphylococcus spp. bacteria and Debaryomyces spp. fungi. Commonly occurring genera that were shared between skin and milk of healthy glands included bacteria SMB53 (Clostridiaceae) and Penicillium spp. fungi. Results support an ecological interpretation of the mammary gland and the notion that mastitis can be described as a dysbiosis, an imbalance of the healthy mammary gland microbiome.	[Andrews, Tucker; Neher, Deborah A.; Weicht, Thomas R.] Univ Vermont, Dept Plant & Soil Sci, Burlington, VT 05405 USA; [Barlow, John W.] Univ Vermont, Dept Anim & Vet Sci, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Barlow, JW (corresponding author), Univ Vermont, Dept Anim & Vet Sci, Burlington, VT 05405 USA.	John.Barlow@uvm.edu			University of Vermont College of Agriculture and Life Sciences Dairy Center of Excellence [VT-H02203]	University of Vermont College of Agriculture and Life Sciences Dairy Center of Excellence	This study was supported by a University of Vermont College of Agriculture and Life Sciences Dairy Center of Excellence (https://www.uvm.edu/cals/dce/) competitive USDA HATCH experiment station award (VT-H02203) received by JB and DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins P.R., 2017, LAB HDB BOVINE MASTI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; Bonsaglia ECR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08790-5; Braem G, 2012, VET MICROBIOL, V157, P383, DOI 10.1016/j.vetmic.2011.12.031; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Culhane AC, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-59; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; Derakhshani H, 2018, J DAIRY SCI, V101, P10605, DOI 10.3168/jds.2018-14860; Detilleux JC, 2004, J DAIRY SCI, V87, P3716, DOI 10.3168/jds.S0022-0302(04)73510-9; Doyle CJ, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02694-16, 10.1128/aem.02694-16]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson JB, 2015, ENVIRON SCI TECHNOL, V49, P2675, DOI 10.1021/es503845j; Falentin H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00480; Friman M, 2017, VET J, V226, P57, DOI 10.1016/j.tvjl.2017.07.003; Ganda EK, 2016, SCI REP-UK, V6, DOI 10.1038/srep37565; Gill JJ, 2006, FEMS MICROBIOL ECOL, V56, P471, DOI 10.1111/j.1574-6941.2006.00091.x; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hiitio H, 2016, J DAIRY SCI, V99, P6532, DOI 10.3168/jds.2015-10811; HOGAN JS, 1989, J DAIRY SCI, V72, P250, DOI 10.3168/jds.S0022-0302(89)79103-7; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kuang Y, 2009, BIOCHEM ENG J, V45, P76, DOI 10.1016/j.bej.2009.02.010; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Metzger SA, 2018, J DAIRY SCI, V101, P6346, DOI 10.3168/jds.2017-14212; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Oikonomou G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085904; Oikonomou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047671; Oksanen J., 2019, R PACKAGE VERSION; Pereira ABD, 2013, J DAIRY SCI, V96, P7340, DOI 10.3168/jds.2013-6690; Rainard P, 2017, VET RES, V48, DOI 10.1186/s13567-017-0429-2; Rowbotham RF, 2016, J DAIRY SCI, V99, P6594, DOI 10.3168/jds.2015-10674; Ruegg PL, 2009, J ANIM SCI, V87, P43, DOI 10.2527/jas.2008-1217; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; van Baarlen P, 2013, CURR OPIN MICROBIOL, V16, P270, DOI 10.1016/j.mib.2013.07.001; Vanderhaeghen W, 2015, VET J, V203, P44, DOI 10.1016/j.tvjl.2014.11.001; Verdier-Metz I, 2012, APPL ENVIRON MICROB, V78, P326, DOI 10.1128/AEM.06229-11; WOODWARD WD, 1988, VET MICROBIOL, V17, P357, DOI 10.1016/0378-1135(88)90049-1	43	21	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225001	10.1371/journal.pone.0225001	http://dx.doi.org/10.1371/journal.pone.0225001			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725757	gold, Green Published			2022-12-26	WOS:000532764500041
J	Kaireit, TF; Huisinga, C; Peperhove, M; Wacker, F; Ringe, KI				Kaireit, Till F.; Huisinga, Carolin; Peperhove, Matti; Wacker, Frank; Ringe, Kristina, I			Evaluation of neutral oral contrast agents for assessment of the small bowel at abdominal staging CT	PLOS ONE			English	Article							CROHNS-DISEASE; POLYETHYLENE-GLYCOL; COMPUTED-TOMOGRAPHY; ENTEROGRAPHY; DISTENSION; WATER	Background Although neutral oral contrast agents are widely in use, a consensus regarding a standardized protocol in abdominal staging CT does not exist. Purpose To test the null hypothesis that there is no quantitative or qualitative difference between water and mannitol for evaluation of the small bowel at abdominal staging CT. Material and methods 180 patients prospectively underwent abdominal staging CT with oral administration of either 1 liter mannitol solution (n = 88) or water (n = 92). Intestinal distension was measured in 6 different segments of the small intestine. In addition, two radiologists separately evaluated diagnostic image quality with regards to luminal distension (three-point scale) in each segment and the possibility to rule out a possible underlying pathology. Quantitative and qualitative results were compared (Mann-Whitney test). Results Quantitatively, intestinal distension was comparable in all segments (p> 0.05), except for the horizontal duodenum (p = 0.019). The mean luminal diameter over all intestinal segments was 19.0 mm (18.1-19.9 mm) for the water group and 18.4 mm (17.5-19.2 mm) for the mannitol group, respectively. Qualitatively, ratings were comparable for the first three segments, while distal segments were rated better using mannitol. Side effects were only observed using mannitol (n = 26; 29.5%). Conclusions Orally administered water and mannitol solution for evaluation of the small bowel at abdominal staging CT in clinical routine resulted in comparable results for the quantitative, but not for the qualitative analysis. Looking more differentiated at the overall performance, water has advantages in terms of patient comfort, side effects and costs, and can therefore be regarded as noninferior to mannitol in this specific patient group.	[Kaireit, Till F.; Huisinga, Carolin; Peperhove, Matti; Wacker, Frank; Ringe, Kristina, I] Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany	Hannover Medical School	Kaireit, TF (corresponding author), Hannover Med Sch, Dept Diagnost & Intervent Radiol, Hannover, Germany.	kaireit.till@mh-hannover.de						ANGELELLI G, 1987, AM J ROENTGENOL, V149, P1084, DOI 10.2214/ajr.149.5.1084; Diederichs G, 2007, ROFO-FORTSCHR RONTG, V179, P1061, DOI 10.1055/s-2007-963278; Guimaraes LS, 2010, INFLAMM BOWEL DIS, V16, P226, DOI 10.1002/ibd.21025; Hara AK, 2008, AM J ROENTGENOL, V190, P1512, DOI 10.2214/AJR.07.2877; Harieaswar S, 2009, RADIOLOGY, V250, P246, DOI 10.1148/radiol.2493080353; Hebert JJ, 2006, AM J ROENTGENOL, V187, P1188, DOI 10.2214/AJR.05.1073; Hebert JJ, 2006, ABDOM IMAGING, V31, P48, DOI 10.1007/s00261-005-0350-4; Kammerer S, 2015, EUR RADIOL, V25, P669, DOI 10.1007/s00330-014-3446-9; Kong DG, 2012, ACTA CARDIOL, V67, P565, DOI 10.1080/AC.67.5.2174131; Laghi Andrea, 2002, Top Magn Reson Imaging, V13, P389, DOI 10.1097/00002142-200212000-00003; Lauenstein TC, 2003, RADIOLOGY, V228, P279, DOI 10.1148/radiol.2281020161; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Megibow AJ, 2006, RADIOLOGY, V238, P87, DOI 10.1148/radiol.2381041985; Minordi LM, 2011, BRIT J RADIOL, V84, P112, DOI 10.1259/bjr/71649888; Paparo F, 2013, EUR J RADIOL, V82, pE1, DOI 10.1016/j.ejrad.2012.08.021; Patak MA, 2001, LANCET, V358, P987, DOI 10.1016/S0140-6736(01)06127-X; Paulsen SR, 2006, RADIOGRAPHICS, V26, P641, DOI 10.1148/rg.263055162; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Reittner P, 2002, EUR RADIOL, V12, P2253, DOI 10.1007/s00330-002-1361-y; Schunk K, 1999, ROFO-FORTSCHR RONTG, V170, P338; Shankar KR, 1999, BRIT J SURG, V86, P1073, DOI 10.1046/j.1365-2168.1999.01192.x; Wittenberg J, 2002, RADIOGRAPHICS, V22, P1093, DOI 10.1148/radiographics.22.5.g02se201093; Wold PB, 2003, RADIOLOGY, V229, P275, DOI 10.1148/radiol.2291020877; World Health Organization, 2016, INT STAT CLASS DIS R, V10th	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225160	10.1371/journal.pone.0225160	http://dx.doi.org/10.1371/journal.pone.0225160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725763	Green Published, gold			2022-12-26	WOS:000532764500061
J	Bruni, A; Giaj-Levra, N; Ciammella, P; Maragna, V; Ferrari, K; Bonti, V; Grossi, F; Greco, S; Graco, C; Borghetti, P; Franceschini, D; Capelletto, E; Perna, M; Banna, G; Vagge, S; Baldini, E; Bria, E; Botti, A; Tiseo, M; Paci, M; Taraborrelli, M; Poletti, V; Granone, P; Ricardi, U; Novello, S; Scotti, V				Bruni, Alessio; Giaj-Levra, Niccolo; Ciammella, Patrizia; Maragna, Virginia; Ferrari, Katia; Bonti, Viola; Grossi, Francesco; Greco, Stefania; Graco, Carlo; Borghetti, Paolo; Franceschini, Davide; Capelletto, Enrica; Perna, Marco; Banna, Giuseppe; Vagge, Stefano; Baldini, Editta; Bria, Emilio; Botti, Andrea; Tiseo, Marcello; Paci, Massimiliano; Taraborrelli, Maria; Poletti, Venerino; Granone, Pierluigi; Ricardi, Umberto; Novello, Silvia; Scotti, Vieri			Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach	PLOS ONE			English	Article							ENDOBRONCHIAL ULTRASOUND; INDUCTION CHEMOTHERAPY; PHASE-III; RADIOTHERAPY; CONCURRENT; RADIATION; BIOPSY	Concurrent chemotherapy and radiotherapy (cCRT) is considered the standard treatment of locally advanced non-small cell lung cancer (LA-NSCLC). Unfortunately, management is still heterogeneous across different specialists. A multidisciplinary approach is needed in this setting due to recent, promising results obtained by consolidative immunotherapy. The aim of this survey is to assess current LA-NSCLC management in Italy. From January to April 2018, a 15-question survey focusing on diagnostic/therapeutic LA-NSCLC management was sent to 1,478 e-mail addresses that belonged to pneumologists, thoracic surgeons, and radiation and medical oncologists. 421 answers were analyzed: 176 radiation oncologists, 86 medical oncologists, 92 pneumologists, 64 thoracic surgeons and 3 other specialists. More than a half of the respondents had been practicing for >10 years after completing residency training. Some discrepancies were observed in clinical LA-NSCLC management: the lack of a regularly planned multidisciplinary tumor board, the use of upfront surgery in multistation stage IIIA, and territorial diffusion of cCRT in unresectable LA-NSCLC. Our analysis demonstrated good compliance with international guidelines in the diagnostic workup of LA-NSCLC. We observed a relationship between high clinical experience and good clinical practice. A multidisciplinary approach is mandatory for managing LA-NSCLC.	[Bruni, Alessio] Univ Hosp Modena, Dept Oncol & Hematol, Radiotherapy Unit, Modena, Italy; [Giaj-Levra, Niccolo] IRCCS Sacro Cuore Don Calabria Hosp, Adv Radiat Oncol, Verona, Italy; [Ciammella, Patrizia] AUSL IRCCS, Radiat Therapy Unit, Dept Oncol & Adv Technol, Reggio Emilia, Italy; [Maragna, Virginia; Perna, Marco; Scotti, Vieri] Careggi Univ Hosp, Dept Oncol, Radiat Therapy Unit, Florence, Italy; [Ferrari, Katia; Bonti, Viola] Careggi Univ Hosp, Sect Resp Med, Florence, Italy; [Grossi, Francesco] UOC Oncol Med Fdn & RCCS Ca Granda Osped Maggiore, Milan, Italy; [Greco, Stefania] San Camillo Forlanini Hosp, UOSD Oncol Pneumol, Rome, Italy; [Graco, Carlo] Campus Biomed Univ, Dept Radiat Oncol, Rome, Italy; [Borghetti, Paolo] Univ & Spedali Civili, Radiat Oncol Dept, Brescia, Italy; [Franceschini, Davide] Humanitas Canc Ctr & Res Hosp, Dept Radiotherapy & Radiosurg, Milan, Italy; [Capelletto, Enrica; Novello, Silvia] Univ Turin, Oncol Dept, AOU San Luigi, Orbassano, TO, Italy; [Banna, Giuseppe] Osped Cannizzaro, Oncol Dept, Catania, Italy; [Vagge, Stefano] Azienda Osped Univ San Martino Genova IST, Dept Radiat Oncol, Ist Nazl Ric Canc, Genoa, Italy; [Baldini, Editta] UOC Oncol Med Osped San Luca, Lucca, Italy; [Bria, Emilio] IRCCS Univ Cattolica Sacro Cuore, UOC Oncol Med, Comprehens Canc Ctr, Fdn Policlin Univ A Gemelli, Rome, Italy; [Botti, Andrea] AUSL IRCCS, Med Phys Unit, Dept Oncol & Adv Technol, Reggio Emilia, Italy; [Tiseo, Marcello] Univ Parma, Dept Med & Surg, Parma, Italy; [Tiseo, Marcello] Univ Hosp Parma, Med Oncol Unit, Parma, Italy; [Paci, Massimiliano] Azienda USL IRCCS Reggio Emilia, Div Thorac Surg, Reggio Emilia, Italy; [Taraborrelli, Maria] Univ G dAnnunzio, SS Annunziata Hosp, Radiotherapy Unit, Chieti, Italy; [Poletti, Venerino] Osped GB Morgagni, Dept Dis Thorax, Forli, I, Italy; [Poletti, Venerino] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Aarhus, Denmark; [Granone, Pierluigi] Catholic Univ, Dept Gen Thorac Surg, Rome, Italy; [Ricardi, Umberto] Univ Turin, Dept Oncol, Turin, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; IRCCS Sacro Cuore Don Calabria; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; Azienda Ospedaliera San Camillo-Forlanini; University Campus Bio-Medico - Rome Italy; Hospital Spedali Civili Brescia; University of Turin; University of Genoa; IRCCS AOU San Martino IST; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Parma; University of Parma; University Hospital of Parma; G d'Annunzio University of Chieti-Pescara; Aarhus University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Turin	Bruni, A (corresponding author), Univ Hosp Modena, Dept Oncol & Hematol, Radiotherapy Unit, Modena, Italy.	brunialessio@virgilio.it	Vagge, Stefano/AAF-2633-2021; Franceschini, Davide/AAB-3871-2019; Grossi, Francesco/AAL-5024-2021; novello, silvia/K-6335-2016; Ciammella, Patrizia/AAB-4222-2021	Vagge, Stefano/0000-0002-8212-7069; Franceschini, Davide/0000-0003-1142-2439; Grossi, Francesco/0000-0001-8412-3136; Ciammella, Patrizia/0000-0003-4315-1645; , Niccolo/0000-0002-4328-0319; Banna, Giuseppe Luigi/0000-0003-0764-3650; Perna, Marco/0000-0003-4427-273X; Bruni, Alessio/0000-0003-1068-5958				Adams K, 2009, THORAX, V64, P757, DOI 10.1136/thx.2008.109868; Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; ALBERTI W, 1995, BRIT MED J, V311, P899; Antonia SJ, 2018, NEW ENGL J MED, V379, P2342, DOI 10.1056/NEJMoa1809697; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Bilfinger TV, 2018, CLIN LUNG CANCER, V19, P346, DOI 10.1016/j.cllc.2018.01.006; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; Campbell BA, 2015, RESPIROLOGY, V20, P192, DOI 10.1111/resp.12459; Chandra S, 2012, RESP CARE, V57, P384, DOI 10.4187/respcare.01274; Crawford SM, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1904; De Leyn P, 2014, EUR J CARDIO-THORAC, V45, P787, DOI 10.1093/ejcts/ezu028; DILLMAN RO, 1990, NEW ENGL J MED, V323, P940, DOI 10.1056/NEJM199010043231403; Eberhardt WEE, 2015, J CLIN ONCOL, V33, P4194, DOI 10.1200/JCO.2015.62.6812; Glatzer M, 2016, EUR RESPIR REV, V25, DOI 10.1183/16000617.0053-2015; O'Rourke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002140.pub3; Pless M, 2015, LANCET, V386, P1049, DOI 10.1016/S0140-6736(15)60294-X; Postmus PE, 2017, ANN ONCOL, V28, P1, DOI 10.1093/annonc/mdx222	18	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224027	10.1371/journal.pone.0224027	http://dx.doi.org/10.1371/journal.pone.0224027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721773	Green Published, gold			2022-12-26	WOS:000532720700010
J	Mussie, KM; Yimer, SA; Manyazewal, T; Gradmann, C				Mussie, Kirubel Manyazewal; Yimer, Solomon Abebe; Manyazewal, Tsegahun; Gradmann, Christoph			Exploring local realities: Perceptions and experiences of healthcare workers on the management and control of drug-resistant tuberculosis in Addis Ababa, Ethiopia	PLOS ONE			English	Article							TB; POVERTY	Background Drug-resistant tuberculosis (DR-TB) remains a major health security threat worldwide. The effectiveness of implementation of DR-TB control strategies has been a subject of research and controversy. In resource-limited settings, using conventional medicine as the only framework to explain DR-TB gives a rather incomplete picture of the disease. This study intended to explore the perceptions and experiences of healthcare workers on the management and control of DR-TB in Addis Ababa, Ethiopia. Methods The study employed a qualitative methodology with an inductive approach and a thematic analysis. It involved in-depth interviews with healthcare workers providing clinical services to DR-TB patients in 10 public healthcare facilities in Addis Ababa, Ethiopia. Results A total of 18 healthcare workers participated until data saturation, which included 12 clinical nurses, four health officers and two medical laboratory technicians. The findings show that healthcare workers perceive DR-TB as a growing public health threat in Ethiopia, due to factors such as poverty, poor nutrition, crowded settings, healthcare worker and general public awareness of DR-TB, lack of good governance and culture. Conclusion The perspectives drawn from the healthcare workers shed more light on the image of DR-TB in a developing country context. It has been shown that understanding DR-TB is not confined to what can be drawn from the sphere of biomedicine. There are also interconnected barriers, which predict a dystopia in the epidemiology of DR-TB. Bringing DR-TB under control requires taking a step back from an overwhelming focus on the biomedical facets of the disease, and employ critical thinking on the wider social and structural forces as equally important targets.	[Mussie, Kirubel Manyazewal; Gradmann, Christoph] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Yimer, Solomon Abebe] Univ Oslo, Dept Microbiol, Unit Genome Dynam, Oslo, Norway; [Yimer, Solomon Abebe] Coalit Epidem Preparedness Innovat, Oslo, Norway; [Manyazewal, Tsegahun] Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa, Addis Ababa, Ethiopia	University of Oslo; University of Oslo; Addis Ababa University	Mussie, KM (corresponding author), Univ Oslo, Inst Hlth & Soc, Oslo, Norway.	k.m.mussie@studmed.uio.no	Mussie, Kirubel/ABE-1500-2020; Manyazewal, Tsegahun/ABA-2390-2021	Mussie, Kirubel/0000-0002-9313-1186; Manyazewal, Tsegahun/0000-0002-8360-7574	Institute of Health and Society, University of Oslo, Norway; U.S. National Institutes of Health (NIH)/Fogarty International Center Global Infectious Diseases grant [D43TW009127]; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER	Institute of Health and Society, University of Oslo, Norway; U.S. National Institutes of Health (NIH)/Fogarty International Center Global Infectious Diseases grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported in part by the Institute of Health and Society, University of Oslo, Norway (author Kirubel Manyazewal Mussie) and the U.S. National Institutes of Health (NIH)/Fogarty International Center Global Infectious Diseases grant D43TW009127 (author Dr. Tsegahun Manyazewal).	Alipanah N, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002595; Ayalew A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3459-0; Bjerrum S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-6; Carter DJ, 2018, LANCET GLOB HEALTH, V6, pE514, DOI 10.1016/S2214-109X(18)30195-5; Chandra S, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-3; Cox H, 2018, LANCET INFECT DIS, V18, pE282, DOI 10.1016/S1473-3099(18)30104-X; Dara M, 2018, INT J TUBERC LUNG D, V22, P592, DOI 10.5588/ijtld.18.0279; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Dimitrova B, 2006, HEALTH POLICY PLANN, V21, P265, DOI 10.1093/heapol/czl014; Eshetie S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2323-y; Falzon D, 2017, EUROPEAN RESP J, V49; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; Farmer P.E, 2001, INFECT INEQUALITIES; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Floyd K, 2018, LANCET RESP MED, V6, P299, DOI 10.1016/S2213-2600(18)30057-2; GALTUNG J, 1969, J PEACE RES, P167; Gebreegziabher Senedu B, 2016, Tuberc Res Treat, V2016, P2036234, DOI 10.1155/2016/2036234; Getnet F, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2133-3; Gizaw GD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0062-3; Gradmann C, 2017, ROUT HIST, P378; Hicks RM, 2014, INT J TUBERC LUNG D, V18, P1074, DOI 10.5588/ijtld.14.0231; Isara AR, 2015, NIGER J CLIN PRACT, V18, P664, DOI 10.4103/1119-3077.154212; Kenyon Tom, 2018, Health Aff (Millwood), V37, P1536, DOI 10.1377/hlthaff.2018.0894; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Kielmann K, 2010, INTRO QUALITATIVE RE; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Liamputtong P., 2018, THEMATIC ANAL, P257; Lienhardt C, 2018, LANCET RESP MED, V6, P242, DOI 10.1016/S2213-2600(18)30050-X; Malotle MM, 2017, PUBLIC HEALTH ACTION, V7, P258, DOI 10.5588/pha.17.0070; Mangum B, 2016, SOCIOCULTURAL EPIDEM; Manyazewal T, 2017, AM J CLIN PATHOL, V147, P285, DOI [10.1093/AJCP/AQX002, 10.1093/ajcp/aqx002]; Manyazewal T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012582; Noe A, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0344-8; Qian X, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0106-1; Sagbakken M, 2010, TUBERCULOSIS GLOBAL; Saunders MJ, 2016, LANCET INFECT DIS, V16, P395, DOI 10.1016/S1473-3099(15)00434-X; Sharma A, 2017, LANCET INFECT DIS, V17, P707, DOI 10.1016/S1473-3099(17)30247-5; Shete PB, 2018, LANCET GLOB HEALTH, V6, pE1272, DOI 10.1016/S2214-109X(18)30378-4; Shin SS, 2018, INT J TUBERC LUNG D, V22, P366, DOI 10.5588/ijtld.17.0376; SPENCE DPS, 1993, BRIT MED J, V307, P759, DOI 10.1136/bmj.307.6907.759; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2015, END TB STRAT GLOB ST; World Health Organization, 2015, FRM ENG ALL HLTH CAR; World Health Organization, 2016, TUBERCULOSIS; Zegeye A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210422; Zinatsa F, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3083-0	48	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224277	10.1371/journal.pone.0224277	http://dx.doi.org/10.1371/journal.pone.0224277			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1QS	31721767	gold, Green Published			2022-12-26	WOS:000532720700017
J	Sousa, JM; Vergara, M; Pulido, F; Antolin, GS; Hijona, L; Carnicer, F; Rincon, D; Salmeron, J; Mateos-Munoz, B; Jou, A; Polo-Lorduy, B; Rubin, A; Escarda, A; Aguilar, P; Aldamiz-Echevarria, T; Garcia-Buey, L; Carrion, JA; Hernandez-Guerra, M; Chimeno-Hernandez, S; Espinosa, N; Morillas, RM; Andrade, RJ; Delgado, M; Gallego, A; Magaz, M; Moreno-Planas, JM; Estebanez, A; Rico, M; Menendez, F; Sampedro, B; Morano, L; Izquierdo, S; Zozaya, JM; Rodriguez, M; Moran-Sanchez, S; Lorente, S; Martin-Granizo, I; Von-Wichmann, MA; Delgado, M; Manzanares, A				Manuel Sousa, Jose; Vergara, Mercedes; Pulido, Federico; Sanchez Antolin, Gloria; Hijona, Lander; Carnicer, Fernando; Rincon, Diego; Salmeron, Javier; Mateos-Munoz, Beatriz; Jou, Antoni; Polo-Lorduy, Benjamin; Rubin, Angel; Escarda, Ana; Aguilar, Patricia; Aldamiz-Echevarria, Teresa; Garcia-Buey, Luisa; Carrion, Jose A.; Hernandez-Guerra, Manuel; Chimeno-Hernandez, Sonia; Espinosa, Nuria; Morillas, Rosa Ma; Andrade, Raul J.; Delgado, Manuel; Gallego, Adolfo; Magaz, Marta; Maria Moreno-Planas, Jose; Estebanez, Angel; Rico, Mikel; Menendez, Fernando; Sampedro, Blanca; Morano, Luis; Izquierdo, Sonia; Manuel Zozaya, Jose; Rodriguez, Manuel; Moran-Sanchez, Senador; Lorente, Sara; Martin-Granizo, Ignacio; Angel Von-Wichmann, Miguel; Delgado, Marcial; Manzanares, Amanda			Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r +/- dasabuvir +/- ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; GENOTYPE 1; INFECTION; ABT-450/R-OMBITASVIR; HCV; OMBITASVIR/PARITAPREVIR/RITONAVIR; PREVALENCE; RITONAVIR; SAFETY	Aim We describe the effectiveness and safety of the interferon-free regimen ombitasvir/paritaprevir/ritonavir plus dasabuvir with or without ribavirin (OBV/PTV/r +/- DSV +/- RBV) in a nationwide representative sample of the hepatitis C virus (HCV) monoinfected and human immunodeficiency virus-1/hepatitis C virus (HIV/HCV) coinfected population in Spain. Material and methods Data were collected from patients infected with HCV genotypes 1 or 4, with or without HIV-1 coinfection, treated with OBV/PTV/r +/- DSV +/- RBV at 61 Spanish sites within the initial implementation year of the first government-driven "National HCV plan." Effectiveness was assessed by sustained virologic response at post-treatment week 12 (SVR12) and compared between monoinfected and coinfected patients using a non-inferiority margin of 5% and a 90% confidence interval (CI). Sociodemographic and clinical characteristics or patients and adverse events (AEs) were also recorded. Results Overall, 2,408 patients were included in the intention-to-treat analysis: 386 (16%) were patients with HIV/HCV. Patient selection reflected the real distribution of patients treated in each participating region in Spain. From the total population, 96.6% (95% CI, 95.8-97.3%) achieved SVR12. Noninferiority of SVR12 in coinfected patients was met, with a difference between monoinfected and coinfected patients of -2.2% (90% CI, -4.5% - 0.2%). Only genotype 4 was associated with non-response to OBV/PTV/r +/- DSV +/- RBV treatment (p < 0.001) in the multivariate analysis. Overall, 286 patients (11.9%) presented AEs potentially related to OBV/PTV/r +/- DSV, whereas 347 (29.0%) presented AEs potentially related to ribavirin and 61 (5.1%) interrupted ribavirin. Conclusions Our results confirm that OBV/PTV/r +/- DSV +/- RBV is effective and generally well tolerated in a representative sample of the HCV monoinfected and HCV/HIV coinfected population in Spain within the experience of a national strategic plan to tackle HCV.	[Manuel Sousa, Jose] Hosp Univ Virgen del Rocio, Hepatol Dept, Seville, Spain; [Vergara, Mercedes] Parc Tauli Sabadell Hosp Univ, Digest Dis Dept, Hepatol Unit, Barcelona, Spain; [Vergara, Mercedes] Inst Carlos III, CIBERehd, Madrid, Spain; [Pulido, Federico] Univ Complutense Madrid UCM, HIV Unit, Imas12, Hosp Univ 12 Octubre, Madrid, Spain; [Sanchez Antolin, Gloria] Hosp Univ Rio Hortega, Hepatol Dept, Valladolid, Spain; [Hijona, Lander] Hosp Univ Araba, Hepatol Dept, Vitoria, Alava, Spain; [Carnicer, Fernando] Hosp Gen Univ Alicante, Hepatol Dept, Alicante, Spain; [Rincon, Diego] Hosp Gen Univ Gregorio Maranon, Hepatol Dept, CIBERehd, Madrid, Spain; [Rincon, Diego] UCM, Madrid, Spain; [Salmeron, Javier] Complejo Hosp Univ Granada, Hepatol Dept, Granada, Spain; [Mateos-Munoz, Beatriz] Hosp Univ Ramon y Cajal, Hepatol Dept, Madrid, Spain; [Jou, Antoni] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Internal Med Dept, HIV Clin Unit, Barcelona, Spain; [Jou, Antoni] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio Lluita SIDA, Barcelona, Spain; [Polo-Lorduy, Benjamin] Hosp Univ Fdn Jimenez Diaz, Hepatol Dept, Madrid, Spain; [Rubin, Angel] Hosp Univ & Politecn La Fe, Hepatol Dept, Valencia, Spain; [Escarda, Ana] Hosp Univ Son Espases, Hepatol Dept, Palma De Mallorca, Spain; [Aguilar, Patricia] Cordoba Univ, Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Digest Syst Clin Unit, Cordoba, Spain; [Aldamiz-Echevarria, Teresa] Hosp Gen Univ Gregorio Maranon IiSGM, Infect Dis HIV, Madrid, Spain; [Garcia-Buey, Luisa] Hosp Univ La Princesa, Hepatol Dept, Madrid, Spain; [Carrion, Jose A.] UAB Univ Autonoma Barcelona Barcelona, Hosp del Mar, IMIM Hosp del Mar Med Res Inst, Gastroenterol Dept,Liver Sect, Barcelona, Spain; [Hernandez-Guerra, Manuel] Hosp Univ Canarias, Hepatol Dept, San Cristobal la Laguna, Santa Cruz De T, Spain; [Chimeno-Hernandez, Sonia] Hosp Arnau Vilanova, Hepatol Dept, Valencia, Spain; [Espinosa, Nuria] Univ Seville, Inst Biomed Seville IBiS, Clin Unit Infect Dis Microbiol & Prevent Med, CSIC,Infect Dis Res Grp, Seville, Spain; [Morillas, Rosa Ma] Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Liver Sect, IGTP, Barcelona, Spain; [Morillas, Rosa Ma] CIBEREHD, Barcelona, Spain; [Andrade, Raul J.] Univ Malaga, Hosp Univ Virgen de la Victoria, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed Malaga IBIMA,Unidad Gest Clin, Malaga, Spain; [Delgado, Manuel] Complejo Hosp Univ A Coruna, Hepatol Dept, La Coruna, Spain; [Gallego, Adolfo] Hosp Santa Creu & Sant Pau, Hepatol Dept, Barcelona, Spain; [Magaz, Marta] Hosp Univ Puerta de Hierro Majadahonda, Hepatol Dept, Madrid, Spain; [Maria Moreno-Planas, Jose] Complejo Hosp Univ Albacete, Digest Syst Dept, Albacete, Spain; [Estebanez, Angel] Hosp Univ Marques de Valdecilla, Hepatol Dept, Santander, Cantabria, Spain; [Rico, Mikel] Hosp Univ La Paz, Infect Dis Unit, Madrid, Spain; [Menendez, Fernando] Hosp Univ Basurto, Hepatol Dept, Bilbao, Vizcaya, Spain; [Sampedro, Blanca] Hosp Galdakao, Hepatol Dept, Galdakao, Vizcaya, Spain; [Morano, Luis] Hosp Univ Alvaro Cunqueiro, Infect Dis Unit, Vigo, Pontevedra, Spain; [Izquierdo, Sonia] Hosp Clin San Carlos, Hepatol Dept, Madrid, Spain; [Manuel Zozaya, Jose] Complejo Hosp Navarra, Hepatol Dept, Pamplona, Navarra, Spain; [Rodriguez, Manuel] Hosp Univ Cent Asturias, Div Gastroenterol & Hepatol, Liver Unit, Oviedo, Asturias, Spain; [Moran-Sanchez, Senador] Hosp Gen Univ Santa Lucia, Hepatol Dept, Murcia, Spain; [Lorente, Sara] Hosp Clin Univ Lozano Blesa, Hepatol Dept, Zaragoza, Spain; [Martin-Granizo, Ignacio] Hosp Univ Alvaro Cunqueiro, Dept Gastroenterol, Vigo, Pontevedra, Spain; [Angel Von-Wichmann, Miguel] Hosp Univ Donostia, Infect Dis Unit, Donostia San Sebastian, Gipuzkoa, Spain; [Delgado, Marcial] Hosp Reg Univ Malaga, Infect Dis Unit, Malaga, Spain; [Manzanares, Amanda] AbbVie Spain SLU, Madrid, Spain	Virgen del Rocio University Hospital; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Hospital del Rio Hortega; University Hospital of Araba; General University Hospital of Alicante; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; General University Gregorio Maranon Hospital; Complutense University of Madrid; University of Granada; Hospital Universitario Ramon y Cajal; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Hospital Universitari i Politecnic La Fe; Hospital Universitari Son Espases; Hospital de La Princesa; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de Malaga; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital of Santa Creu i Sant Pau; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario La Paz; Basurto Hospital; Galdakao Hospital; Hospital Clinico San Carlos; Servicio Navarro de Salud - Osasunbidea; Central University Hospital Asturias; Lozano Blesa University Clinical Hospital; AbbVie	Manzanares, A (corresponding author), AbbVie Spain SLU, Madrid, Spain.	amanda.manzanaresgarcia@abbvie.com	Pulido, Federico/B-8417-2009; Carrión, Jose A. A/GPW-5566-2022; Carrion, Jose A/M-2086-2017; Sanchez Antolin, Gloria/GPS-8021-2022; Rodriguez, Manuel/AAH-9936-2020	Pulido, Federico/0000-0002-7414-8812; Carrión, Jose A. A/0000-0001-7191-6081; Carrion, Jose A/0000-0001-7191-6081; Sanchez Antolin, Gloria/0000-0003-2108-4971; Rodriguez, Manuel/0000-0001-5763-7668; Espinosa, Nuria/0000-0003-2249-2352; , IIS Galicia Sur/0000-0003-3812-7413; Moreno-Planas, Jose Maria/0000-0002-7263-1595; Polo Lorduy, Benjamin/0000-0003-4845-3001; Vergara, Mercedes/0000-0002-6971-8657; Magaz, Marta/0000-0002-9787-1739; Gallego, Adolfo/0000-0002-8423-6787; Morano Amado, Luis Enrique/0000-0002-0560-3260; Hernandez-Guerra, Manuel/0000-0002-3478-9981; MORAN SANCHEZ, SENADOR/0000-0003-3745-8253	AbbVie	AbbVie(AbbVie)	The design, study conduct, and financial support for the study were provided by AbbVie (https://www.abbvie.com/).AbbVie participated in the interpretation of data, review, and approval of the manuscript. Medical writing and editing services were provided by Medical Statistics Consulting (MSC) and funded by AbbVie.	Abad S, 2017, AM J NEPHROL, V45, P267, DOI 10.1159/000454819; Fernandez DA, 2018, GASTROENT HEPAT-BARC, V41, P2, DOI 10.1016/j.gastrohep.2017.09.004; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; [Anonymous], 2017, GUIAS AEEH SEIMC MAN; Berenguer J, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw059; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bruguera M, 2006, MED CLIN-BARCELONA, V127, P113, DOI 10.1157/13090276; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; European Medicines Agency (EMA), 2015, EPAR PROD INF VIEK; European Medicines Agency (EMA), 2015, EPAR PROD INF EXV; Feld JJ, 2016, J HEPATOL, V64, P301, DOI 10.1016/j.jhep.2015.10.005; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2017, SAFETY EFFECTIVENESS; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Flisiak R, 2018, J VIRAL HEPATITIS, V25, P1298, DOI 10.1111/jvh.12945; Fried MD, 2014, SAFETY ABT 450 RITON; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Lavin AC, 2017, J HEPATOL, V66, pS272, DOI 10.1016/S0168-8278(17)30857-7; Calleja JL, 2017, J HEPATOL, V66, P1138, DOI 10.1016/j.jhep.2017.01.028; Montes ML, 2017, AIDS, V31, P1253, DOI 10.1097/QAD.0000000000001465; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Rockstroh JK, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx154; Rockstroh JK, 2015, LANCET HIV, V2, pE319, DOI 10.1016/S2352-3018(15)00114-9; Rodes Teixidor J, 2015, STRATEGIC PLAN TACKL; Wedemeyer H, 2017, J VIRAL HEPATITIS, V24, P936, DOI 10.1111/jvh.12722; Welzel TM, 2017, J VIRAL HEPATITIS, V24, P840, DOI 10.1111/jvh.12708; World Health Organization, 2018, HEP C; Wyles D, 2017, J INFECT DIS, V215, P599, DOI 10.1093/infdis/jiw597; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225061	10.1371/journal.pone.0225061	http://dx.doi.org/10.1371/journal.pone.0225061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714950	Green Published, gold			2022-12-26	WOS:000532710400025
J	Clark, DB; Ferraz, A; Clark, DA; Kellner, JR; Letcher, SG; Saatchi, S				Clark, David B.; Ferraz, Antonio; Clark, Deborah A.; Kellner, James R.; Letcher, Susan G.; Saatchi, Sassan			Diversity, distribution and dynamics of large trees across an old-growth lowland tropical rain forest landscape	PLOS ONE			English	Article							CARBON STORAGE; SCALE DISTRIBUTIONS; EMERGENT TREES; LA-SELVA; MORTALITY; BIOMASS; DROUGHT; PREDICTION; ECOLOGY; DECLINE	Large trees, here defined as >= 60 cm trunk diameter, are the most massive organisms in tropical rain forest, and are important in forest structure, dynamics and carbon cycling. The status of large trees in tropical forest is unclear, with both increasing and decreasing trends reported. We sampled across an old-growth tropical rain forest landscape at the La Selva Biological Station in Costa Rica to study the distribution and performance of large trees and their contribution to forest structure and dynamics. We censused all large trees in 238 0.50 ha plots, and also identified and measured all stems >= 10 cm diameter in 18 0.50 ha plots annually for 20 years (1997-2017). We assessed abundance, species diversity, and crown conditions of large trees in relation to soil type and topography, measured the contribution of large trees to stand structure, productivity, and dynamics, and analyzed the decadal population trends of large trees. Large trees accounted for 2.5% of stems and similar to 25% of mean basal area and Estimated Above-Ground Biomass, and produced similar to 10% of the estimated wood production. Crown exposure increased with stem diameter but predictability was low. Large tree density was about twice as high on more-fertile flat sites compared to less fertile sites on slopes and plateaus. Density of large trees increased 27% over the study interval, but the increase was restricted to the flat more-fertile sites. Mortality and recruitment differed between large trees and smaller stems, and strongly suggested that large tree density was affected by past climatic disturbances such as large El Nino events. Our results generally do not support the hypothesis of increasing biomass and turnover rates in tropical forest. We suggest that additional landscape-scale studies of large trees are needed to determine the generality of disturbance legacies in tropical forest study sites.	[Clark, David B.; Clark, Deborah A.] Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA; [Ferraz, Antonio; Saatchi, Sassan] CALTECH, NASA, Jet Prop Lab, Pasadena, CA 91125 USA; [Kellner, James R.] Brown Univ, Inst Brown Environm & Soc, Providence, RI 02912 USA; [Kellner, James R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Letcher, Susan G.] Coll Atlantic, Plant Biol, Bar Harbor, ME USA	University of Missouri System; University of Missouri Saint Louis; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University; Brown University	Clark, DB (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	dbclark50@yahoo.com	Saatchi, Sassan/AAQ-2649-2021	Letcher, Susan/0000-0002-9475-7674	U.S. National Science Foundation [1357177, 1357097, 1147367]; U.S. National Aeronautics and Space Agency (NASA) Terrestrial Ecology grant [TE08-0037]; NASA [16-ESUSPI16-0015]	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Aeronautics and Space Agency (NASA) Terrestrial Ecology grant; NASA(National Aeronautics & Space Administration (NASA))	Funding was provided by U.S. National Science Foundation grants 1357177 (DBC, DAC), 1357097 (JRK), and 1147367 (DAC, SGL), and by U.S. National Aeronautics and Space Agency (NASA) Terrestrial Ecology grant TE08-0037 (SS, AF, DBC). This work was partially carried out at the Jet Propulsion Laboratory, California Institute of Technology, and University of California Los Angeles, under a contract by NASA (16-ESUSPI16-0015) (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleixo I, 2019, NAT CLIM CHANGE, V9, P384, DOI 10.1038/s41558-019-0458-0; [Anonymous], 2004, TROPICAL FOREST DIVE; Balzotti CS, 2017, ECOGRAPHY, V40, P829, DOI 10.1111/ecog.02062; Bastin JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13156; Bastin JF, 2018, GLOBAL ECOL BIOGEOGR, V27, P1366, DOI 10.1111/geb.12803; Bennett AC, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.139, 10.1038/nplants.2015.139]; Bradford M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208377; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; BROWN S, 1992, INTERCIENCIA, V17, P8; Brown S, 1997, 134 FAO; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; CLARK DA, 1995, ECOLOGY, V76, P2581, DOI 10.2307/2265829; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clark DB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183819; Clark DB, 1996, J TROP ECOL, V12, P735, DOI 10.1017/S0266467400009937; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Clark DB, 2004, ECOL LETT, V7, P52, DOI 10.1046/j.1461-0248.2003.00547.x; Clark DB, 2004, ECOL APPL, V14, P61, DOI 10.1890/02-5120; Clark DB, 1996, FOREST ECOL MANAG, V80, P235, DOI 10.1016/0378-1127(95)03607-5; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Ferraz A, 2016, REMOTE SENS ENVIRON, V183, P318, DOI 10.1016/j.rse.2016.05.028; Fichtler E, 2003, BIOTROPICA, V35, P306, DOI 10.1111/j.1744-7429.2003.tb00585.x; Gomes E. P. C., 2003, Braz. J. Biol., V63, P47, DOI 10.1590/S1519-69842003000100007; Hartshorn GS, 1988, TROPICAL RAINFORESTS, P281; Hubbell SP, 2013, ECOL EVOL, V3, P3263, DOI 10.1002/ece3.705; Kellner J. R., 2009, Ecology, V90, P3274, DOI 10.1890/09-0254.1; Kellner JR, 2018, P NATL ACAD SCI USA, V115, P11268, DOI 10.1073/pnas.1800353115; Kellner JR, 2017, ECOLOGY, V98, P1700, DOI 10.1002/ecy.1847; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lindenmayer DB, 2017, BIOL REV, V92, P1434, DOI 10.1111/brv.12290; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lutz JA, 2018, GLOBAL ECOL BIOGEOGR, V27, P849, DOI 10.1111/geb.12747; Marra DM, 2018, GLOBAL CHANGE BIOL, V24, P5867, DOI 10.1111/gcb.14457; McDowell N, 2018, NEW PHYTOL, V219, P851, DOI 10.1111/nph.15027; Meakem V, 2018, NEW PHYTOL, V219, P947, DOI 10.1111/nph.14633; Meyer V, 2018, BIOGEOSCIENCES, V15, P3377, DOI 10.5194/bg-15-3377-2018; Murphy HT, 2013, J ECOL, V101, P1589, DOI 10.1111/1365-2745.12163; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Pennisi E, 2019, SCIENCE, V365, P962, DOI 10.1126/science.365.6457.962; Phillips OL, 2019, SURV GEOPHYS, V40, P913, DOI 10.1007/s10712-019-09540-0; Phillips OL, 2016, ECOL STUD-ANAL SYNTH, V227, P191, DOI 10.1007/978-3-662-49902-3_10; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Ploton P, 2017, REMOTE SENS ENVIRON, V200, P140, DOI 10.1016/j.rse.2017.08.001; Porder S, 2006, ECOLOGY, V87, P594, DOI 10.1890/05-0394; Rutishauser E, 2010, J VEG SCI, V21, P672, DOI 10.1111/j.1654-1103.2010.01175.x; Sheil D, 1996, J ECOL, V84, P91, DOI 10.2307/2261703; Sheil D, 2017, FUNCT ECOL, V31, P568, DOI 10.1111/1365-2435.12775; Silva CE, 2013, GLOBAL CHANGE BIOL, V19, P3423, DOI 10.1111/gcb.12312; Sist P, 2014, FOREST ECOL MANAG, V318, P103, DOI 10.1016/j.foreco.2014.01.005; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Soininen A., 2011, TERRASCAN USERS GUID; Sollins Phillip, 1994, P34; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Thomas RQ, 2013, ECOLOGY, V94, P920, DOI 10.1890/12-0939.1; VITOUSEK PM, 1987, BIOTROPICA, V19, P167, DOI 10.2307/2388740; Yang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05668-6; Zar J. H., 1996, BIOSTATISTICAL ANAL	64	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224896	10.1371/journal.pone.0224896	http://dx.doi.org/10.1371/journal.pone.0224896			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ8JF	31710643	Green Published, gold			2022-12-26	WOS:000499184100001
J	Itiola, AJ; Goga, AE; Ramokolo, V				Itiola, Ademola Joshua; Goga, Ameena Ebrahim; Ramokolo, Vundli			Trends and predictors of mother-to-child transmission of HIV in an era of protocol changes: Findings from two large health facilities in North East Nigeria	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; PREVENTION; PROGRAM; CHALLENGES	Background Research studies have demonstrated a reduction in the risk of mother-to-child transmission of HIV (MTCT) to less than 2%, or 5% in non-breastfeeding and breastfeeding populations, respectively, with antiretroviral interventions. However, the risk of MTCT in routine health-facility settings, where service delivery is usually sub-optimal needs monitoring. Method We conducted a retrospective review of data from 2008-2014, in two health facilities in Adamawa State, Nigeria. Descriptive statistics were used to estimate overall MTCT rate and MTCT rate by year, and period of prevention of mother-to-child transmission of HIV (PMTCT) protocol implementation. We conducted simple and multiple logistic-regression analyses, to identify predictors of MTCT. Results Data from 1,651 mother-to-infant pairs, with HIV deoxyribonucleic acid (DNA) polymerasechain reaction (PCR) test results from 2008 (n = 49), 2009 (n = 246), 2010 (n = 280), 2011 (n = 335), 2012 (n = 290), 2013 (n = 225) and 2014 (n = 226) were analysed. The overall MTCT rate among HIV exposed infants (HEIs) was 9.7% (95% CI 8.3% - 11.1%) at a median age of 8 weeks (IQR = 6-20). The MTCT rate decreased from 14.3% (4.4%-24.2%) in 2008 to 4.9% (2.1%-7.7%) in 2014 (p = 0.016). The MTCT rate was the lowest (5.4% [3.7% - 7.0%]) when all pregnant women living with HIV received triple antiretroviral therapy, as treatment or prophylaxis (ARVT/P). Using the pooled data, we found that infant age, breastfeeding option, antiretroviral regimen and year were predictors of MTCT. The adjusted odds of MTCT were significantly higher, when neither mother nor HEI received ARVT/P (Adjusted odds ratio (AOR) 26.4 [14.0-49.8], and lower amongst infants born in 2012, compared with those born in 2008 (AOR 0.2 [0.0-1.0]). Conclusion The MTCT rate declined significantly between 2008 and 2014 in these two routine health-facility settings in Nigeria. Our study suggests that ARVT/P yields the lowest MTCT. Thus, efforts to scale up lifelong ARVT/P (Option B+) in Nigeria should be accelerated.	[Itiola, Ademola Joshua] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Goga, Ameena Ebrahim; Ramokolo, Vundli] South African Med Res Council, Hlth Syst Res Unit, Pretoria, South Africa; [Goga, Ameena Ebrahim] South African Med Res Council, HIV Prevent Res Unit, Pretoria, South Africa; [Goga, Ameena Ebrahim] Univ Pretoria, Dept Paediat, Pretoria, South Africa	University of the Western Cape; South African Medical Research Council; South African Medical Research Council; University of Pretoria	Itiola, AJ (corresponding author), Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa.	ademola.itiola@gmail.com			School of Public Health, University of the Western Cape, Robert Sobukwe Road, Bellville, Cape Town, South Africa; South African Medical Research Council, Pretoria, South Africa	School of Public Health, University of the Western Cape, Robert Sobukwe Road, Bellville, Cape Town, South Africa; South African Medical Research Council, Pretoria, South Africa	The School of Public Health, University of the Western Cape, Robert Sobukwe Road, Bellville, Cape Town, South Africa provided funding for the professional language editing of the manuscript while South African Medical Research Council, Pretoria, South Africa funded the publication of the manuscript.	Afe AJ, 2011, HIV AIDS REV, V10, P14, DOI 10.1016/j.hivar.2011.02.001; Agboghoroma CO, 2015, J HIV HUMAN REPROD, V3, P7; Aliyu M. H., 2014, JAIDS, Journal of Acquired Immune Deficiency Syndromes, V67, pe19, DOI 10.1097/QAI.0000000000000215; Anoje C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-184; [Anonymous], 2017, STATA; [Anonymous], ANN INDIAN PSYCHIAT, V1, P51, DOI [10.4103/aip.aip_13_17, DOI 10.4103/AIP.AIP_13_17, DOI 10.4103/2321-9157.116527]; Audu R, 2015, AIDS RES HUM RETROV, V31, P433, DOI [10.1089/aid.2014.0159, 10.1089/AID.2014.0159]; Azcoaga-Lorenzo A, 2011, AIDS CARE, V23, P274, DOI 10.1080/09540121.2010.507750; Chama C, 2007, J OBSTET GYNAECOL, V27, P134, DOI 10.1080/01443610601113854; Chama CM, 2010, J OBSTET GYNAECOL, V30, P362, DOI 10.3109/01443611003672104; Chukwuemeka Iregbu Kenneth, 2014, Niger Med J, V55, P204, DOI 10.4103/0300-1652.132039; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Erekaha SC, 2018, SAHARA J-J SOC ASP H, V15, P128, DOI 10.1080/17290376.2018.1527245; Esene H., 2012, Journal of Medicine and Biomedical Research, V11, P105; Ezegbe Chigozie, 2012, Afr J Reprod Health, V16, P23; Federal Ministry of Health, 2007, NAT GUID PREV MOTH C; Federal Ministry of Health Nigeria, 2016, NAT GUID HIV PREV TR; Goga A, 2012, EVALUATION EFFECTIVE; Goga AE, 2016, HIGHEST RISK MOTHER; Ikechebelu J I, 2011, Niger J Med, V20, P421; Inalegwu Auchi, 2016, World J Virol, V5, P73, DOI 10.5501/wjv.v5.i2.73; Isah AM., 2016, J AIDS HIV RES, V8, P114; Kalu S, 2014, J AIDS CLIN RES, V5, P1; Khamofu H, 2015, J HIV HUMAN REPROD, V3, P34; Lussiana C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036381; Ministry of Health, 2014, NAT GUID PREV MOTH C; Myrtil Martine Pamphile, 2018, J Int Assoc Provid AIDS Care, V17, p2325958218774037, DOI 10.1177/2325958218774037; National Agency for the Control of AIDS, 2014, PMTCT DEM CREAT ACC; National Agency for the Control of AIDS, 2019, REV NAT HIV AIDS STR; Newell ML, 2001, B WORLD HEALTH ORGAN, V79, P1138; Nkwo PO, 2012, ANN MED HEALTH SCI R, V2, P56, DOI 10.4103/2141-9248.96940; Okafor II, 2014, ANN MED HEALTH SCI R, V4, P615, DOI 10.4103/2141-9248.139344; Sagay AS, 2015, CURR HIV RES, V13, P193, DOI 10.2174/1570162X1303150506182534; State Ministry of Health, 2018, AN STAT STRAT HLTH D; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2021, YOUNG PEOPL HIV; UNAIDS, 2016, GLOB PLAN EL NEW HIV; UNAIDS, 2018, COUNTR FACTSH NIG; Wise J, 2001, BRIT MED J, V322, P511; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2016, GUID UPD HIV INF FEE	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224670	10.1371/journal.pone.0224670	http://dx.doi.org/10.1371/journal.pone.0224670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710613	Green Published, gold			2022-12-26	WOS:000532699900015
J	Kaderka, R; Bulantova, J; Heneberg, P; Rezac, M				Kaderka, Radan; Bulantova, Jana; Heneberg, Petr; Rezac, Milan			Urticating setae of tarantulas (Araneae: Theraphosidae): Morphology, revision of typology and terminology and implications for taxonomy	PLOS ONE			English	Article							GENUS; MYGALOMORPHAE; SIMON; HAIRS; REVALIDATION; APHONOPELMA; IDENTITY; POCOCK; GENERA; SILK	Tarantula urticating setae are modified setae located on the abdomen or pedipalps, which represent an effective defensive mechanism against vertebrate or invertebrate predators and intruders. They are also useful taxonomic tools as morphological characters facilitating the classification of New World theraphosid spiders. In the present study, the morphology of urticating setae was studied on 144 taxa of New World theraphosids, including ontogenetic stages in chosen species, except for species with urticating setae of type VII. The typology of urticating setae was revised, and types I, III and IV were redescribed. The urticating setae in spiders with type I setae, which were originally among type III or were considered setae of intermediate morphology between types I and III, are newly considered to be ontogenetic derivatives of type I and are described as subtypes. Setae of intermediate morphology between that of body setae and type II urticating setae that were found in Iridopelma hirsutum and Antillena rickwesti may provide another evidence that type II urticating setae evolved from body setae. It is supposed that the fusion of barbs with the shaft may lead to the morphology of type II setae. As the type II setae of Aviculariinae evolved independently to the UrS of Theraphosinae and both subfamilies represent two non-sister groups, this should explain the differences in the morphology of body setae in Aviculariinae and Theraphosinae. The terminology of "barbs" and "reversed barbs" was revised and redefined, newly emphasizing the real direction of barbs.	[Kaderka, Radan] Mendel Univ Brno, Fac Forestry & Wood Technol, Brno, Czech Republic; [Bulantova, Jana] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Heneberg, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Rezac, Milan] Crop Res Inst, Biodivers Lab, Prague, Czech Republic	Mendel University in Brno; Charles University Prague; Charles University Prague; Czech Crop Research Institute (CRI)	Kaderka, R (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Brno, Czech Republic.	radan.kaderka@seznam.cz	Řezáč, Milan/ABE-8186-2020; Heneberg, Petr/C-1881-2012; Bulantová, Jana/M-5239-2017	Heneberg, Petr/0000-0002-0703-951X; Kaderka, Radan/0000-0003-3624-2143; Rezac, Milan/0000-0003-4373-7064	Ministry of Agriculture of the Czech Republic [MZe RO0416]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	MR. was supported by Financial Support of Ministry of Agriculture of the Czech Republic (grant MZe RO0416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, WORLD SPID CAT VERS; Bertani R, 2000, J ARACHNOL, V28, P29, DOI 10.1636/0161-8202(2000)028[0029:MPBAHF]2.0.CO;2; Bertani R, 1996, ZOOL ANZ, V234, P161; Bertani R, 1999, ACT 2 ENC AR CON SUL, P61; Bertani Rogerio, 2003, Bulletin of the British Arachnological Society, V12, P395; Bertani Rogerio, 2003, Zootaxa, V362, P1; Bertani Rogerio, 2001, Arquivos de Zoologia (Sao Paulo), V36, P265; Bertani R, 2011, ZOOTAXA, P1; Bertani R, 2013, ZOOLOGIA-CURITIBA, V30, P403, DOI 10.1590/S1984-46702013000400006; Bertani R, 2013, AN ACAD BRAS CIENC, V85, P235, DOI 10.1590/S0001-37652013005000007; Bertani R, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.230.3500; Clerc C., 1757, ARANEI SVECICI DESCR; Cooke J.A.L., 1972, American Museum Novitates, VNo. 2498, P1; Foelix R. F, 2011, BIOL SPIDERS; Fukushima CS, 2008, J ARACHNOL, V36, P402, DOI 10.1636/CA07-108.1; Fukushima CS, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.659.10717; Fukushima CS, 2005, ZOOTAXA, P1; Gabriel Ray, 2014, Journal of the British Tarantula Society, V29, P146; Gabriel Ray, 2016, Arachnology, V17, P61; Gallon RC, 2005, ZOOTAXA, P45; Gallon Richard C., 2003, Bulletin of the British Arachnological Society, V12, P405; Gargiulo FD, 2018, EUR J TAXON, V457, P1, DOI 10.5852/ejt.2018.457; Husser M, 2018, ZOOKEYS, P59, DOI 10.3897/zookeys.784.26521; Indicatti RP, 2008, ZOOTAXA, P21, DOI 10.11646/zootaxa.1814.1.2; Kaderka Radan, 2016, Revista Iberica de Aracnologia, V28, P121; Kaderka Radan, 2015, Rev. peru biol., V22, P275, DOI 10.15381/rpb.v22i3.11432; Kaderka R, 2016, J NAT HIST, V50, P393, DOI 10.1080/00222933.2015.1076082; Guadanucci JPL, 2017, ZOOSYSTEMA, V39, P263, DOI 10.5252/z2017n2a5; Locht Arturo, 2008, Boletin de la SEA, V43, P45; Longhorn SJ, 2011, REV IBERICA ARACHNOL, V19, P157; Luddecke T, 2018, MOL PHYLOGENET EVOL, V119, P63, DOI 10.1016/j.ympev.2017.10.015; Marshall S.D., 1990, Bulletin of the British Arachnological Society, V8, P122; MARSHALL SD, 1990, J ARACHNOL, V18, P143; Mendoza JI, 2016, EUR J TAXON, V232, P1, DOI 10.5852/ejt.2016.232; Marroquin JIM, 2014, ZOOL J LINN SOC-LOND, V170, P634, DOI 10.1111/zoj.12112; Mendoza Marroquin Jorge Ivan, 2012, Arthropoda Scientia, V2, P2; Miglio LT, 2013, IHERINGIA SER ZOOL, V103, P185, DOI 10.1590/S0073-47212013000200013; Ortiz David, 2008, Boletin de la SEA, V42, P107; Perafan C, 2016, ZOOKEYS, P89, DOI 10.3897/zookeys.601.7704; Perafan C, 2015, ZOOTAXA, V4033, P529, DOI 10.11646/zootaxa.4033.4.4; Perafan C, 2014, J NAT HIST, V48, P2389, DOI 10.1080/00222933.2014.902142; Perafan C, 2014, ZOOKEYS, P117, DOI 10.3897/zookeys.404.6243; Perez-Miles F, 1998, J ARACHNOL, V26, P120; Perez-Miles F, 2002, J ARACHNOL, V30, P316, DOI 10.1636/0161-8202(2002)030[0316:TOOAUH]2.0.CO;2; Perez-Miles F, 2008, ZOOTAXA, P54; Perez-Miles Fernando, 2019, Arachnology, V18, P150, DOI 10.13156/arac.2018.18.2.150; Perez-Miles Fernando, 1996, Mygalomorph, V1, P33; Perez-Miles F, 2010, J ARACHNOL, V38, P104, DOI 10.1636/A07-60.1; Perez-Miles Fernando, 2003, Bulletin of the British Arachnological Society, V12, P365; Pocock R. I., 1897, Proceedings of the Zoological Society of London, P724; Pocock RI., 1892, ANN MAGAZINE NATURAL, V10, P303; PRENTICE TR, 1992, J ARACHNOL, V20, P189; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Samm Robert, 2010, Tarantulas of the World, V142, P35; Schmidt G., 1993, VOGELSPINNEN VORKOMM; Schmidt G., 2003, VOGELSPINNEN HOHENWA; Schmidt G, 2001, ARACHNOLOGISCHE MAGA, V9, P1; Schmidt Guenter, 2005, Tarantulas of the World, V112, P3; SIMON E, 1873, MEMOIRES SOC ROYALE, V5, P1; Tesmoingt Marc, 2002, Tarantulas of the World, V76, P3; Thorell T., 1870, NOVA ACTA REGIAE SOC, V7, P109; Turner SP, 2018, SYST BIODIVERS, V16, P89, DOI 10.1080/14772000.2017.1346719; VALENCIO DA, 1969, NATURE, V223, P1353, DOI 10.1038/2231353a0; West RC, 2008, ZOOTAXA, P35; Yamamoto FU, 2007, REV BRAS ZOOL, V24, P971, DOI 10.1590/S0101-81752007000400013; Yamamoto FU, 2012, ZOOTAXA, P1; Zakharov Boris, 2015, Arachnologische Mitteilungen, P34, DOI 10.5431/aramit4904	67	6	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224384	10.1371/journal.pone.0224384	http://dx.doi.org/10.1371/journal.pone.0224384			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX6DZ	31710616	Green Published, gold			2022-12-26	WOS:000521971100001
J	McLeay, LJ; Doubell, MJ; Linnane, AJ				McLeay, Lachlan J.; Doubell, Mark J.; Linnane, Adrian J.			Spatial and temporal variations in female size at maturity of a Southern Rock Lobster (Jasus edwardsii) population: A likely response to climate change	PLOS ONE			English	Article							PALINURUS-ELEPHAS FABRICIUS; SEA-SURFACE-TEMPERATURE; SEXUAL-MATURITY; HOMARUS-AMERICANUS; PANULIRUS-CYGNUS; GROWTH-RATES; FISH ASSEMBLAGE; RECRUITMENT; AUSTRALIA; PATTERNS	The size at which sexual maturity is reached is a key population parameter used to guide the setting of minimum legal size limits in fisheries. Understanding spatial and temporal variations in size at maturity is fundamental to management because the relationship between size at maturity and minimum legal size limits affects the fraction of the mature population biomass that is harvested, and resulting egg production, larval settlement and recruitment. This study measured the size at maturity of female Southern Rock Lobster (Jasus edwardsii) across South Australia between 1991 and 2015 in relation to known oceanographic characteristics, surface and subsurface temperature data, and relative changes in lobster abundance. There was pronounced north to south spatial variation in estimates of size at maturity. Larger average size at maturity was recorded in warmer north-western areas of the fishery relative to the cooler waters of the south-east. Estimates of size at maturity also differed over 25 years across the fishery. However, the nature of temporal responses varied spatially, and were more consistent with variations in surface and subsurface water temperature at local-scales than changes in lobster density. In the well-mixed waters of the northwestern, western and south-eastern parts of the fishery, relatively high rates of increase in sea-surface temperature and size at maturity were recorded since 1991, indicating that size at maturity may be responding to ocean warming associated with global climate change. In more central parts of the fishery, contrasting temporal signals in sea-surface temperature (positive) and bottom temperature (negative) indicated increases in upwelling strength over the study period, and formation of a bottom cold pool below a warm surface layer, with corresponding decreases in size at maturity recorded. The spatio-temporal changes in size at maturity measured in this study highlight the need for oceanographic information to be integrated into future stock assessment models to enhance harvest strategy development, allow timely adaptive management decisions and increase the resilience of fisheries to the impacts of climate change.	[McLeay, Lachlan J.; Doubell, Mark J.; Linnane, Adrian J.] South Australian Res & Dev Inst Aquat Sci, Adelaide, SA, Australia		McLeay, LJ (corresponding author), South Australian Res & Dev Inst Aquat Sci, Adelaide, SA, Australia.	Lachlan.McLeay@sa.gov.au		McLeay, Lachlan/0000-0002-3518-8248	Australian Government	Australian Government(Australian GovernmentCGIAR)	We are grateful to the numerous industry members, state Government staff and volunteers that have assisted with collecting biological and fisheries data over the years. In particular we would like to thank Peter Hawthorne, Andrew Hogg and Doug Graske for their efforts collecting catch sampling data and Kylie Odgers (South Australian Research and Development Institute (SARDI)) for her assistance with entering catch and effort information relevant to the South Australian Rock Lobster Fishery. We also thank Jonathan Carroll (SARDI) for advice relating to R statistical procedures, and Ana Redondo Rodriguez (SARDI) for her assistance with downloading sea-surface temperature data that was sourced from the Integrated Marine Observing System (IMOS) (http://imos.org.au/) through the Australian Ocean Data Network (https://portal.aodn.org.au/).IMOS is a national collaborative research infrastructure, supported by the Australian Government.	Allen Micheal S., 2000, North American Journal of Fisheries Management, V20, P672, DOI 10.1577/1548-8675(2000)020<0672:DFPRTA>2.3.CO;2; ANNALA JH, 1980, NEW ZEAL J MAR FRESH, V14, P217, DOI 10.1080/00288330.1980.9515864; Asch RG, 2015, P NATL ACAD SCI USA, V112, pE4065, DOI 10.1073/pnas.1421946112; Baird ME, 2003, UNPUB; Bakun A, 2015, CURR CLIM CHANGE REP, V1, P85, DOI 10.1007/s40641-015-0008-4; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BEYERS CJD, 1987, S AFR J MARINE SCI, V5, P513, DOI 10.2989/025776187784522216; Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caputi N, 2010, CAN J FISH AQUAT SCI, V67, P85, DOI 10.1139/F09-167; Chandrapavan A, 2009, NEW ZEAL J MAR FRESH, V43, P537, DOI 10.1080/00288330909510020; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2012, AQUAT CONSERV, V22, P368, DOI 10.1002/aqc.2248; Chiswell SM, 2005, NEW ZEAL J MAR FRESH, V39, P1157, DOI 10.1080/00288330.2005.9517382; CHITTLEBOROUGH RG, 1975, AUST J MAR FRESH RES, V26, P177, DOI 10.1071/MF9750177; Cirano M, 2004, J PHYS OCEANOGR, V34, P668, DOI 10.1175/2509.1; de Lestang S, 2018, B MAR SCI, V94, P1055, DOI 10.5343/bms.2017.1100; Doubell MJ, 2018, DEEP-SEA RES PT II, V157, P27, DOI 10.1016/j.dsr2.2018.08.007; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Econsearch, 2018, EC IND COMM FISH S A; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Engelhard GH, 2014, GLOBAL CHANGE BIOL, V20, P2473, DOI 10.1111/gcb.12513; Feenstra J, 2019, NEW ZEAL J MAR FRESH, V53, P292, DOI 10.1080/00288330.2018.1556166; FIELDER D. R., 1964, AUSTRALIAN J MAR FRESHWATER RES, V15, P77; Froese R, 2008, FISH RES, V92, P231, DOI 10.1016/j.fishres.2008.01.005; Gardner C, 2005, SCI MAR, V69, P123, DOI 10.3989/scimar.2005.69n1123; Gardner C, 2003, B MAR SCI, V73, P653; Gardner C, 2006, SCI MAR, V70, P423, DOI 10.3989/scimar.2006.70n3423; Goni R, 2003, FISH RES, V65, P295, DOI 10.1016/j.fishres.2003.09.021; Goni R, 2003, MAR BIOL, V143, P583, DOI 10.1007/s00227-003-1097-5; Haarr ML, 2018, CAN J FISH AQUAT SCI, V75, P908, DOI 10.1139/cjfas-2016-0434; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Hartmann K, 2013, FISHERY ASSESSMENT R; Hartnoll RG, 2001, HYDROBIOLOGIA, V449, P111, DOI 10.1023/A:1017597104367; Helidoniotis F, 2014, NEW ZEAL J MAR FRESH, V48, P70, DOI 10.1080/00288330.2013.843574; Herzfeld M, 1997, PROG OCEANOGR, V39, P1, DOI 10.1016/S0079-6611(97)00010-4; Hinojosa IA, 2017, FISH OCEANOGR, V26, P49, DOI 10.1111/fog.12185; Hobday AJ, 2008, REPORT DEP CLIMATE C; Hobday DK, 1997, MAR FRESHWATER RES, V48, P1009, DOI 10.1071/MF97143; Johnston D, 2008, AQUACULTURE, V279, P77, DOI 10.1016/j.aquaculture.2008.03.048; Kaempf J, 2004, GEOPHYS RES LETT, V31; Landers DF, 2001, MAR FRESHWATER RES, V52, P1283, DOI 10.1071/MF01045; Le Bris A, 2017, FISH RES, V186, P397, DOI 10.1016/j.fishres.2016.09.008; LEWIS RK, 1981, AUST J MAR FRESH RES, V32, P843; Lewis RK., 1981, 88 S AUSTR; Linnane A, 2005, NEW ZEAL J MAR FRESH, V39, P335, DOI 10.1080/00288330.2005.9517314; Linnane A, 2018, SARDI RES REPORT SER, V988; Linnane A, 2016, SARDI RES REPORT SER, V908; Linnane A, 2018, SARDI RES REPORT SER, V989; Linnane AJ, 2008, J MAR BIOL ASSOC UK, V88, P583, DOI 10.1017/S0025315408001021; Linnane A, 2019, FISH RES, V219, DOI 10.1016/j.fishres.2019.105308; Linnane A, 2014, ICES J MAR SCI, V71, P528, DOI 10.1093/icesjms/fst176; Linnane A, 2011, FISH RES, V111, P1, DOI 10.1016/j.fishres.2011.06.006; Linnane A, 2010, FISH RES, V105, P163, DOI 10.1016/j.fishres.2010.04.001; Linnane A, 2009, FISH RES, V96, P238, DOI 10.1016/j.fishres.2008.11.008; Linnane A, 2009, NEW ZEAL J MAR FRESH, V43, P475, DOI 10.1080/00288330909510016; Little SA, 2005, J CRUSTACEAN BIOL, V25, P585, DOI 10.1651/C-2552.1; Lough J. M., 2012, MARINE CLIMATE CHANG; MacDiarmid Alison B., 2006, P45, DOI 10.1002/9780470995969.ch2; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; McClatchie S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002699; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; McMahan MD, 2016, MAR ECOL PROG SER, V557, P177, DOI 10.3354/meps11854; Melville-Smith R, 2006, MAR BIOL, V150, P183, DOI 10.1007/s00227-006-0349-6; Middleton JF, 2012, J MARINE SYST, V91, P34, DOI 10.1016/j.jmarsys.2011.09.006; Middleton JF, 2007, PROG OCEANOGR, V75, P1, DOI 10.1016/j.pocean.2007.07.001; Middleton JF, 2014, J GEOPHYS RES-OCEANS, V119, P2539, DOI 10.1002/2013JC009420; Olsen AM, 2006, T ROY SOC SOUTH AUST, V130, P113, DOI 10.1080/3721426.2006.10887054; Patterson H, 2016, FISHERY STATUS REPOR, V2016; Pecl G., 2009, REPORT AUSTR GOVT DE; Pecl GT, 2011, 2009070 I MAR ANT ST; Peterman RM, 2004, ICES J MAR SCI, V61, P1331, DOI 10.1016/j.icesjms.2004.08.017; Phillips B. F., 2000, SPINY LOBSTERS FISHE, P45; POLLOCK DE, 1993, ICES J MAR SCI, V50, P9, DOI 10.1006/jmsc.1993.1002; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Punt AE, 1997, MAR FRESHWATER RES, V48, P967, DOI 10.1071/MF97070; ROCHFORD DJ, 1986, AUST J MAR FRESH RES, V37, P1; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Stewardson C, 2016, STATUS AUSTR FISH ST, V2016; Stobart B, 2016, MAR FRESHWATER RES, V67, P612, DOI 10.1071/MF14340; Tsikliras AC, 2014, REV FISH BIOL FISHER, V24, P219, DOI 10.1007/s11160-013-9330-x; van Ruth PD, 2018, DEEP-SEA RES PT II, V157, P36, DOI 10.1016/j.dsr2.2018.09.008; Villacorta-Rath C, 2018, MOL ECOL, V27, P54, DOI 10.1111/mec.14427; WENNER AM, 1974, CAN J ZOOL, V52, P1095, DOI 10.1139/z74-147	84	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0225144	10.1371/journal.pone.0225144	http://dx.doi.org/10.1371/journal.pone.0225144			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710648	Green Published, gold			2022-12-26	WOS:000532699900043
J	Mendes, FC; Paciencia, I; Ferreira, AC; Martins, C; Rufo, JC; Silva, D; Cunha, P; Farraia, M; Moreira, P; Delgado, L; Soares, ML; Moreira, A				Mendes, Francisca Castro; Paciencia, Ines; Ferreira, Antonio Carlos; Martins, Carla; Rufo, Joao Cavaleiro; Silva, Diana; Cunha, Pedro; Farraia, Mariana; Moreira, Pedro; Delgado, Luis; Soares, Miguel Luz; Moreira, Andre			Development and validation of exhaled breath condensate microRNAs to identify and endotype asthma in children	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CHILDHOOD ASTHMA; EXPRESSION; PHENOTYPES; AIRWAYS; IDENTIFICATION; BIOMARKERS; CELLS	Detection and quantification of microRNAs (miRNAs) in exhaled breath condensate (EBC) has been poorly explored. Therefore we aimed to assess miRNAs in EBC as potential biomarkers to diagnose and endotype asthma in school aged children. In a cross sectional, nested case control study, all the asthmatic children (n = 71) and a random sample of controls (n = 115), aged 7 to 12 years, attending 71 classrooms from 20 local schools were selected and arbitrarily allocated to the development or validation set. Participants underwent skin-prick testing, spirometry with bronchodilation, had exhaled level of nitric oxide determined and EBC collected. Based on previous studies eleven miRNAs were chosen and analyzed in EBC by reverse transcription-quantitative real-time PCR. Principal component analysis was applied to identify miRNAs profiles and associations were estimated using regression models. In the development set (n = 89) two clusters of miRNAs were identified. After adjustments, cluster 1 and three of its clustered miRNAs, miR-126-3p, miR-133a-3p and miR-145-5p were positively associated with asthma. Moreover miR-21-5p was negatively associated with symptomatic asthma and positively associated with positive bronchodilation without symptoms. An association was also found between miR-126-3p, cluster 2 and one of its clustered miRNA, miR-146-5p, with higher FEF25-75 reversibility. These findings were confirmed in the validation set (n = 97) where two identical clusters of miRNAs were identified. Additional significant associations were observed between miR155-5p with symptomatic asthma, negative bronchodilation with symptoms and positive bronchodilation without symptoms. We showed that microRNAs can be measured in EBC of children and may be used as potential biomarkers of asthma, assisting asthma endotype establishment.	[Mendes, Francisca Castro; Paciencia, Ines; Rufo, Joao Cavaleiro; Silva, Diana; Delgado, Luis; Moreira, Andre] Univ Porto, Fac Med, Dept Patol, Serv Imunol Basica & Clin, Porto, Portugal; [Mendes, Francisca Castro; Paciencia, Ines; Rufo, Joao Cavaleiro; Farraia, Mariana; Moreira, Pedro; Moreira, Andre] Univ Porto, Inst Saude Publ, EPIUnit, Porto, Portugal; [Paciencia, Ines; Rufo, Joao Cavaleiro] Inst Sci & Innovat Mech Engn & Ind Management & N, Porto, Portugal; [Ferreira, Antonio Carlos; Soares, Miguel Luz] Univ Porto, Fac Med, Lab Apoio Invest Med Mol LAIMM, Porto, Portugal; [Ferreira, Antonio Carlos; Soares, Miguel Luz] Univ Porto, Fac Med, Ctr Invest Med CIM, Dept Biomed,Unidade Biol Expt, Porto, Portugal; [Ferreira, Antonio Carlos; Soares, Miguel Luz] Inst Biol Mol & Celular IBMC, Pain Grp, Porto, Portugal; [Ferreira, Antonio Carlos; Soares, Miguel Luz] Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal; [Martins, Carla; Silva, Diana; Delgado, Luis; Moreira, Andre] Ctr Hosp Sao Joao, Serv Imunoalergol, Porto, Portugal; [Cunha, Pedro; Moreira, Pedro; Moreira, Andre] Univ Porto, Fac Ciencias Nutr & Alimentacao, Porto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Sao Joao Hospital; Universidade do Porto	Mendes, FC (corresponding author), Univ Porto, Fac Med, Dept Patol, Serv Imunol Basica & Clin, Porto, Portugal.; Mendes, FC (corresponding author), Univ Porto, Inst Saude Publ, EPIUnit, Porto, Portugal.	francisca_castromendes@hotmail.com	Soares, Miguel/M-1968-2019; Rufo, João Cavaleiro/K-7994-2013; Delgado, Luis/L-8035-2013; Farraia, Mariana/AAZ-7594-2021; Moreira, Pedro/U-3034-2019; Silva, Diana/ABC-4233-2021; Moreira, André/AAH-9683-2020	Soares, Miguel/0000-0002-1812-6117; Rufo, João Cavaleiro/0000-0003-1175-242X; Delgado, Luis/0000-0003-2375-9071; Moreira, Pedro/0000-0002-7035-7799; Silva, Diana/0000-0002-0656-7206; Moreira, André/0000-0002-7294-9296; Paciencia, Ines/0000-0001-5762-7814; Castro Mendes, Francisca/0000-0002-2400-8408; Farraia, Mariana/0000-0002-4959-0975; Ferreira, Antonio Carlos/0000-0001-7645-8024	Fundacao para a Ciencia e Tecnologia [NORTE-01-0145-FEDER000010, EXALAR 21 02/SAICT/2017, 30193, SFRH/BD/144563/2019]; Programa Operacional Regional do Norte (NORTE2020), through Fundo Europeu de Desenvolvimento Regional (FEDER); EXALAR 21 project - FEDER/FNR; Fulbright Portugal	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Regional do Norte (NORTE2020), through Fundo Europeu de Desenvolvimento Regional (FEDER); EXALAR 21 project - FEDER/FNR; Fulbright Portugal	Authors gratefully acknowledge the funding by Fundacao para a Ciencia e Tecnologia through the Project NORTE-01-0145-FEDER000010 - Health, Comfort and Energy in the Built Environment (HEBE), cofinanced by Programa Operacional Regional do Norte (NORTE2020), through Fundo Europeu de Desenvolvimento Regional (FEDER) and EXALAR 21 project financed by FEDER/FNR and by Fundacao para a Ciencia e Tecnologia (EXALAR 21 02/SAICT/2017 - Project no 30193). FCM kindly acknowledges the scholarship SFRH/BD/144563/2019 SFRH/BD/144563/2019 granted by Fundacao para a Ciencia e Tecnologia, as well as the Fulbright Research Grant 2019/2020 granted by Fulbright Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Carlsen KCL, 2011, BREATHE, V8, P38, DOI 10.1183/20734735.004611; Carraro S, 2013, ALLERGY, V68, P110, DOI 10.1111/all.12063; Cruickshank-Quinn C, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0538-5; Depner M, 2014, AM J RESP CRIT CARE, V189, P129, DOI 10.1164/rccm.201307-1198OC; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Fan LX, 2016, EXP LUNG RES, V42, P417, DOI 10.1080/01902148.2016.1256452; Forno E, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00115; Gahleitner F, 2013, BIOANALYSIS, V5, P2239, DOI 10.4155/bio.13.184; Hammad RHM, 2018, INNATE IMMUN-LONDON, V24, P171, DOI 10.1177/1753425918763521; Heffler E, 2017, AM J RESP CELL MOL, V57, P642, DOI 10.1165/rcmb.2016-0231TR; Trinh HKT, 2017, MOL DIAGN THER, V21, P547, DOI 10.1007/s40291-017-0280-1; Jardim MJ, 2012, AM J RESP CELL MOL, V47, P536, DOI 10.1165/rcmb.2011-0160OC; Karam RA, 2019, CLIN BIOCH; Kuczmarski R J, 2000, Adv Data, P1; Lacedonia D, 2017, INT J CHRONIC OBSTR, V12, P1811, DOI 10.2147/COPD.S130616; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Liu F, 2012, MOL MED REP, V6, P1178, DOI 10.3892/mmr.2012.1030; Liu J, 2007, RESPIRATION, V74, P142, DOI 10.1159/000094238; Loureiro CC, 2015, REV PORT PNEUMOL; Lu TX, 2018, J ALLERGY CLIN IMMUN, V141, P1202, DOI 10.1016/j.jaci.2017.08.034; Maes T, 2016, J ALLERGY CLIN IMMUN, V137, P1433, DOI 10.1016/j.jaci.2016.02.018; Maitra S, 2008, APPL MULTIVAR STAT M, V79, P79; Malmhall C, 2017, SCAND J IMMUNOL, V85, P300, DOI 10.1111/sji.12535; Maniscalco M, 2017, J ALLERGY CLIN IMMUN, V139, P1536, DOI 10.1016/j.jaci.2016.08.038; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; McGeachie MJ, 2017, J ALLERGY CLIN IMMUN, V140, P598, DOI 10.1016/j.jaci.2017.01.023; Milger K, 2017, ALLERGY, V72, P1962, DOI 10.1111/all.13205; Montuschi Paolo, 2007, Ther Adv Respir Dis, V1, P5, DOI 10.1177/1753465807082373; Nejad C, 2018, FEBS J, V285, P3695, DOI 10.1111/febs.14482; Ong J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39873-0; Panganiban RP, 2016, J ALLERGY CLIN IMMUN, V137, P1423, DOI 10.1016/j.jaci.2016.01.029; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Papi M, 2018, NANO TODAY, V21, P14, DOI 10.1016/j.nantod.2018.03.001; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Peel AM, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa5a8a; Pinkerton M, 2013, J ALLERGY CLIN IMMUN, V132, P217, DOI 10.1016/j.jaci.2013.03.006; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Qin HB, 2012, INFLAMMATION, V35, P1595, DOI 10.1007/s10753-012-9474-1; Rebane A, 2013, J ALLERGY CLIN IMMUN, V132, P15, DOI 10.1016/j.jaci.2013.04.011; Rijavec M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06103; Rodrigo-Munoz JM, 2019, ALLERGY, V74, P507, DOI 10.1111/all.13570; Rufo JC, 2019, ALLERGY, V74, P527, DOI 10.1111/all.13596; Rufo JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193848; Sastre B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00826; Silva D, 2019, PEDIAT ALLERG IMM-UK, V30, P708, DOI 10.1111/pai.13111; Sinha A, 2013, J ALLERGY CLIN IMMUN, V132, P219, DOI 10.1016/j.jaci.2013.03.035; Solberg OD, 2012, AM J RESP CRIT CARE, V186, P965, DOI 10.1164/rccm.201201-0027OC; Spycher BD, 2010, CLIN EXP ALLERGY, V40, P1130, DOI 10.1111/j.1365-2222.2010.03541.x; Suojalehto H, 2014, INT ARCH ALLERGY IMM, V163, P168, DOI 10.1159/000358486; Takaku Y, 2016, ALLERGOL INT, V65, pS65, DOI 10.1016/j.alit.2016.05.007; Williams AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005889; Wu XB, 2014, INT J CLIN EXP MED, V7, P1307; Yang X, 2001, INT J HEAT MASS TRAN, V44, P1803, DOI 10.1016/S0017-9310(00)00227-1; Zhou H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101773	55	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224983	10.1371/journal.pone.0224983	http://dx.doi.org/10.1371/journal.pone.0224983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703106	Green Published, gold			2022-12-26	WOS:000532697200034
J	Peto, L; Fawcett, NJ; Crook, DW; Peto, TEA; Llewelyn, MJ; Walker, AS				Peto, Leon; Fawcett, Nicola J.; Crook, Derrick W.; Peto, Tim E. A.; Llewelyn, Martin J.; Walker, A. Sarah			Selective culture enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin resistant Enterobacteriaceae	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; COLONIZATION; MICROBIOTA; GROWTH; STOOL	Metagenomic sequencing of fecal DNA can usefully characterise an individual's intestinal resistome but is limited by its inability to detect important pathogens that may be present at low abundance, such as carbapenemase or extended-spectrum beta-lactamase producing Enterobacteriaceae. Here we aimed to develop a hybrid protocol to improve detection of resistance genes in Enterobacteriaceae by using a short period of culture enrichment prior to sequencing of DNA extracted directly from the enriched sample. Volunteer feces were spiked with carbapenemase-producing Enterobacteriaceae and incubated in selective broth culture for 6 hours before sequencing. Different DNA extraction methods were compared, including a plasmid extraction protocol to increase the detection of plasmid-associated resistance genes. Although enrichment prior to sequencing increased the detection of carbapenemase genes, the differing growth characteristics of the spike organisms precluded accurate quantification of their concentration prior to culture. Plasmid extraction increased detection of resistance genes present on plasmids, but the effects were heterogeneous and dependent on plasmid size. Our results demonstrate methods of improving the limit of detection of selected resistance mechanisms in a fecal resistome assay, but they also highlight the difficulties in using these techniques for accurate quantification and should inform future efforts to achieve this goal.	[Peto, Leon; Fawcett, Nicola J.; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah] John Radcliffe Hosp, Natl Inst Hlth Res NIHR Hlth Protect Res Unit Hea, Oxford, England; [Peto, Leon; Fawcett, Nicola J.; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah] Univ Oxford, Nuffield Dept Med, Oxford, England; [Crook, Derrick W.] Publ Hlth England, Natl Infect Serv, London, England; [Llewelyn, Martin J.] Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Brighton, E Sussex, England; [Llewelyn, Martin J.] Brighton & Sussex Univ Hosp NHS Trust, Dept Microbiol & Infect, Brighton, E Sussex, England	University of Oxford; University of Oxford; Public Health England; University of Brighton; University of Sussex; Brighton and Sussex University Hospitals NHS Trust; University of Brighton	Peto, L (corresponding author), John Radcliffe Hosp, Natl Inst Hlth Res NIHR Hlth Protect Res Unit Hea, Oxford, England.; Peto, L (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	leon.peto@ndm.ox.ac.uk	Llewelyn, Martin/A-7194-2011; Walker, Sarah/HDM-8717-2022	Llewelyn, Martin/0000-0002-6811-1124; Fawcett, Nicola/0000-0001-7477-6504; Crook, Derrick/0000-0002-0590-2850	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford; Public Health England (PHE) [HPRU-2012-10041]; NIHR Oxford Biomedical Research Centre; Medical Research Council UK Clinical Research Training Fellowship; MRC [MR/M003736/1] Funding Source: UKRI	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford; Public Health England (PHE); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council UK Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England (PHE) [HPRU-2012-10041], the NIHR Oxford Biomedical Research Centre, and a Medical Research Council UK Clinical Research Training Fellowship to NJF. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or PHE. DWC and TEAP are NIHR Senior Investigators. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen H, 2016, J CLIN MICROBIOL, V54, P1804, DOI 10.1128/JCM.02638-15; Arredondo-Alonso S, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000128; Blane B, 2016, DIAGN MICR INFEC DIS, V84, P181, DOI 10.1016/j.diagmicrobio.2015.11.008; Buelow E, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0309-z; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Donskey CJ, 2006, CLIN INFECT DIS, V43, pS62, DOI 10.1086/504481; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; GIBBONS RJ, 1967, J BACTERIOL, V93, P510, DOI 10.1128/JB.93.1.510-512.1967; Grall N, 2017, INT J ANTIMICROB AG, V50, P81, DOI 10.1016/j.ijantimicag.2017.02.018; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Lanza VF, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0387-y; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Noyes NR, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0361-8; Penders J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00087; Raymond F, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0669-7; Ruppe E, 2018, CLIN MICROBIOL INFEC, V24, P3, DOI 10.1016/j.cmi.2017.09.017; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sheppard AE, 2016, ANTIMICROB AGENTS CH, V60, P3767, DOI 10.1128/AAC.00464-16; Stoesser N, 2014, ANTIMICROB AGENTS CH, V58, P7347, DOI 10.1128/AAC.03900-14; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; WANG CH, 1978, J BACTERIOL, V136, P969, DOI 10.1128/JB.136.3.969-975.1978; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0222831	10.1371/journal.pone.0222831	http://dx.doi.org/10.1371/journal.pone.0222831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703058	Green Accepted, Green Published, gold			2022-12-26	WOS:000532697200002
J	da Silva, RG; Rosa-Santos, TM; Franca, SD; Kottapalli, P; Kottapalli, KR; Zingaretti, SM				da Silva, Renan Goncalves; Rosa-Santos, Thiago Mateus; Franca, Suzelei de Castro; Kottapalli, Pratibha; Kottapalli, Kameswara Rao; Zingaretti, Sonia Marli			Microtranscriptome analysis of sugarcane cultivars in response to aluminum stress	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; ARABIDOPSIS; GENES; IDENTIFICATION; TOXICITY; PLANTS; ROLES	Although several metallic elements are required for plant growth, excessive amounts of aluminum ions (Al3+) can result in the inhibition of root growth, thus triggering water and nutrient deficiencies. Plants under stress undergo gene expression changes in specific genes or post-transcriptional gene regulators, such as miRNAs, that can lead to stress tolerance. In this study, we investigated the miRNAs involved in the response of sugarcane to aluminum stress. Four miRNA libraries were generated using sugarcane roots of one tolerant and one sensitive sugarcane cultivar grown under aluminum stress and used to identify the miRNAs involved in the sugarcane aluminum toxicity response. The contrast in field phenotypes of sugarcane cultivars in the field during aluminum stress was reflected in the micro-transcriptome expression profiles. We identified 394 differentially expressed miRNAs in both cultivars, 104 of which were tolerant cultivar-specific, 116 were sensitive cultivar-specific, and 87 of which were common among cultivars. In addition, 52% of differentially expressed miRNAs were upregulated in the tolerant cultivar while the majority of differentially expressed miRNAs in the sensitive cultivar were downregulated. Real-time quantitative polymerase chain reaction was used to validate the expression levels of differentially expressed miRNAs. We also attempted to identify target genes of miRNAs of interest. Our results show that selected differentially expressed miRNAs of aluminum-stressed sugarcane cultivars play roles in signaling, root development, and lateral root formation. These genes thus may be important for aluminum tolerance in sugarcane and could be used in breeding programs to develop tolerant cultivars.	[da Silva, Renan Goncalves; Rosa-Santos, Thiago Mateus] Sao Paulo State Univ, Sch Agr & Vet Sci, UNESP, Jaboticabal, SP, Brazil; [Rosa-Santos, Thiago Mateus; Franca, Suzelei de Castro; Zingaretti, Sonia Marli] Univ Ribeirao Preto, Dept Biotechnol, Ribeirao Preto, SP, Brazil; [Kottapalli, Pratibha; Kottapalli, Kameswara Rao] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA	Universidade Estadual Paulista; Universidade de Ribeirao Preto; Texas Tech University System; Texas Tech University	Zingaretti, SM (corresponding author), Univ Ribeirao Preto, Dept Biotechnol, Ribeirao Preto, SP, Brazil.	szingaretti@unaerp.br	zingaretti, sonia marli/AAE-4433-2022; da Silva, Renan Gonçalves/AAX-9127-2020; Rosa-Santos, Thiago Mateus/AAE-8987-2022; zingaretti, sonia m/C-1123-2013	zingaretti, sonia marli/0000-0001-6755-4153; da Silva, Renan Gonçalves/0000-0002-7726-8203; Rosa-Santos, Thiago Mateus/0000-0002-8120-8158; zingaretti, sonia m/0000-0001-6755-4153	FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/19667-8, 2015/50451-4]; CNPQ Conselho Nacional de Pesquisa scholarship [153785/2014-4]; CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [001]	FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ Conselho Nacional de Pesquisa scholarship; CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo For financial support process number 2014/19667-8 and 2015/50451-4, www.fapesp.br to SMZ; CNPQ Conselho Nacional de Pesquisa scholarship award process number - 153785/2014-4 www.cnpq.br, to TMR; and CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Financial code 001, www.capes.gov.br to RGS.	Ballen-Taborda C, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/857986; BENNET R J, 1991, Plant and Soil, V134, P153; Bhalerao S. A., 2013, Journal of Applicable Chemistry, V2, P447; Blamey FPC, 2001, PLANT NUTRIENT ACQUISITION, P201; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Chen L, 2012, PLANTA, V235, P375, DOI 10.1007/s00425-011-1514-9; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Dantas ACD, 2001, PESQUI AGROPECU BRAS, V36, P615; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Doncheva S, 2005, J EXP BOT, V56, P1213, DOI 10.1093/jxb/eri115; Dreyer BH, 2019, ANN PLANT REV ONLINE, V2, P933, DOI 10.1002/9781119312994.apr0705; Drummond RD, 2001, GENET MOL BIOL, V24, P221, DOI 10.1590/S1415-47572001000100029; Gentile A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00058; Gentile A, 2013, PLANTA, V237, P783, DOI 10.1007/s00425-012-1795-7; Gielen H, 2012, INT J MOL SCI, V13, P15826, DOI 10.3390/ijms131215826; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gupta OP, 2014, PLANT MOL BIOL, V84, P1, DOI 10.1007/s11103-013-0120-6; He HY, 2014, PLANT CELL REP, V33, P831, DOI 10.1007/s00299-014-1565-z; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Lima JC, 2011, GENET MOL RES, V10, P2817, DOI 10.4238/2011.November.10.4; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nidhi Gupta, 2013, American Journal of Plant Sciences, V4, P21; OECD/Food and Agriculture Organization of the United Nations, 2015, OECD FAO AGR OUTL 20, DOI [10.1787/agr_2015-en, DOI 10.1787/AGR_2015-EN]; Outlook Fiesp, 2013, OUTL FIESP 2023 PROJ; Perez-Quintero AL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-29; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Shao HB, 2008, INT J BIOL SCI, V4, P8; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Silva IR, 2000, PLANT PHYSIOL, V123, P543, DOI 10.1104/pp.123.2.543; Sun FL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-142; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Thiebaut F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-290; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Vitorello Victor Alexandre, 2005, Braz. J. Plant Physiol., V17, P129, DOI 10.1590/S1677-04202005000100011; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Watt DA, 2003, J EXP BOT, V54, P1163, DOI 10.1093/jxb/erg128; Wu LY, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4953-x; Xue T, 2017, PLANT SCI, V262, P182, DOI 10.1016/j.plantsci.2017.06.008; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003; Zhao YF, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1171-7; Zhou JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117507; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083	48	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0217806	10.1371/journal.pone.0217806	http://dx.doi.org/10.1371/journal.pone.0217806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697688	Green Published, gold			2022-12-26	WOS:000532694400004
J	Vasylkivska, M; Jureckova, K; Branska, B; Sedlar, K; Kolek, J; Provaznik, I; Patakova, P				Vasylkivska, Maryna; Jureckova, Katerina; Branska, Barbora; Sedlar, Karel; Kolek, Jan; Provaznik, Ivo; Patakova, Petra			Transcriptional analysis of amino acid, metal ion, vitamin and carbohydrate uptake in butanol-producing Clostridium beijerinckii NRRL B-598	PLOS ONE			English	Article							PHOSPHOTRANSFERASE SYSTEM; GENE-EXPRESSION; NUTRITIONAL-REQUIREMENTS; ETHANOL FERMENTATION; HYDROGEN-PRODUCTION; ACETOBUTYLICUM; SPORULATION; METABOLISM; SEQUENCE; GLUCOSE	In-depth knowledge of cell metabolism and nutrient uptake mechanisms can lead to the development of a tool for improving acetone-butanol- ethanol (ABE) fermentation performance and help to overcome bottlenecks in the process, such as the high cost of substrates and low production rates. Over 300 genes potentially encoding transport of amino acids, metal ions, vitamins and carbohydrates were identified in the genome of the butanol-producing strain Clostridium beijerinckii NRRL B-598, based on similarity searches in protein function databases. Transcriptomic data of the genes were obtained during ABE fermentation by RNA-Seq experiments and covered acidogenesis, solventogenesis and sporulation. The physiological roles of the selected 81 actively expressed transport genes were established on the basis of their expression profiles at particular stages of ABE fermentation. This article describes how genes encoding the uptake of glucose, iron, riboflavin, glutamine, methionine and other nutrients take part in growth, production and stress responses of C. beijerinckii NRRL B-598. These data increase our knowledge of transport mechanisms in solventogenic Clostridium and may be used in the selection of individual genes for further research.	[Vasylkivska, Maryna; Branska, Barbora; Kolek, Jan; Patakova, Petra] Univ Chem & Technol Prague, Dept Biotechnol, Prague, Czech Republic; [Jureckova, Katerina; Sedlar, Karel; Provaznik, Ivo] Brno Univ Technol, Dept Biomed Engn, Brno, Czech Republic	University of Chemistry & Technology, Prague; Brno University of Technology	Vasylkivska, M (corresponding author), Univ Chem & Technol Prague, Dept Biotechnol, Prague, Czech Republic.	vasylkim@vscht.com	Provaznik, Ivo/F-4121-2012; Sedlar, Karel/K-1120-2014; Jureckova, Katerina/AAC-2736-2019; Branska, Barbora/G-6429-2019; Vasylkivska, Maryna/AAE-6124-2019; Patakova, Petra/B-6404-2018	Provaznik, Ivo/0000-0002-3422-7938; Sedlar, Karel/0000-0002-8269-4020; Jureckova, Katerina/0000-0001-5143-9521; Branska, Barbora/0000-0001-6536-7063; Vasylkivska, Maryna/0000-0003-4148-8930; Patakova, Petra/0000-0002-9410-4454	Czech Science Foundation GACR [GACR 17-00551S]; program "Projects of Large Research, Development, and Innovations Infrastructures" [LM2015042, LM2015085]; NCMG research infrastructure - MEYS CR [LM2015091]	Czech Science Foundation GACR(Grant Agency of the Czech Republic); program "Projects of Large Research, Development, and Innovations Infrastructures"; NCMG research infrastructure - MEYS CR	This work was supported by project grant GACR 17-00551S, The Czech Science Foundation GACR (https://gacr.cz) to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the CESNET LM2015042 and the CERIT Scientific Cloud LM2015085 for providing computational resources under the program "Projects of Large Research, Development, and Innovations Infrastructures". We acknowledge the CF Genomics of CEITEC, which is supported by the NCMG research infrastructure (LM2015091 funded by MEYS CR), for their support in obtaining the scientific data presented in this paper.	Al Makishah NH, 2013, APPL ENVIRON MICROB, V79, P6712, DOI 10.1128/AEM.01866-13; Algayyim SJM, 2018, RENEW SUST ENERG REV, V82, P1195, DOI 10.1016/j.rser.2017.09.082; Alsaker KV, 2010, BIOTECHNOL BIOENG, V105, P1131, DOI 10.1002/bit.22628; Alsaker KV, 2005, J BACTERIOL, V187, P7103, DOI 10.1128/JB.187.20.7103-7118.2005; Amador-Noguez D, 2011, APPL ENVIRON MICROB, V77, P7984, DOI 10.1128/AEM.05374-11; Bao MD, 2013, FUEL, V112, P38, DOI 10.1016/j.fuel.2013.04.063; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Byrne F. P., 2016, SUSTAINABLE CHEM PRO, V4, P7, DOI [10.1186/s40508-016-0051, DOI 10.1186/S40508-016-0051-Z]; Chin HL, 2003, BIOTECHNOL PROGR, V19, P383, DOI 10.1021/bp0200604; Crossley RA, 2007, APPL ENVIRON MICROB, V73, P7819, DOI 10.1128/AEM.01919-07; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durre P, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.TBS-0010-2012; EISENSTADT E, 1972, J BACTERIOL, V112, P264, DOI 10.1128/JB.112.1.264-267.1972; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Heluane H, 2011, APPL ENVIRON MICROB, V77, P4473, DOI 10.1128/AEM.00116-11; Henson MA, 2016, IFAC PAPERSONLINE, V49, P153, DOI 10.1016/j.ifacol.2016.12.118; Honicke D, 2012, NEW BIOTECHNOL, V29, P485, DOI 10.1016/j.nbt.2012.01.001; Jaehme M, 2015, BBA-GEN SUBJECTS, V1850, P565, DOI 10.1016/j.bbagen.2014.05.006; Jiao SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38818; Kolek J, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw031; Kolek J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0436-y; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Larocque M, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0117-z; Li TG, 2014, BIORESOURCE TECHNOL, V155, P220, DOI 10.1016/j.biortech.2013.12.089; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao ZP, 2018, APPL MICROBIOL BIOT, V102, P8107, DOI 10.1007/s00253-018-9208-x; LONG S, 1983, APPL ENVIRON MICROB, V45, P1389, DOI 10.1128/AEM.45.4.1389-1393.1983; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo HZ, 2017, BIOCHEM ENG J, V118, P132, DOI 10.1016/j.bej.2016.12.003; Luo HZ, 2016, BIORESOURCE TECHNOL, V200, P111, DOI 10.1016/j.biortech.2015.09.116; Luo HZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141160; Maret W, 2014, BINDING TRANSPORT ST, DOI [10.1039/9781849739979, DOI 10.1039/9781849739979]; Mascal M, 2012, BIOFUEL BIOPROD BIOR, V6, P483, DOI 10.1002/bbb.1328; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Mitchell WJ, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-1981-4; Mitchell WJ, 2015, J MOL MICROB BIOTECH, V25, P129, DOI 10.1159/000375125; Mitchell WJ, 1998, ADV MICROB PHYSIOL, V39, P31; Neumann-Schaal M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0614-2; Nguyen NPT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05661-z; Paredes CJ, 2004, NUCLEIC ACIDS RES, V32, P1973, DOI 10.1093/nar/gkh509; Patakova P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37679-0; Patakova P, 2009, CZECH J FOOD SCI, V27, P276, DOI 10.17221/106/2009-CJFS; Poudel S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0697-5; Prat D, 2013, ORG PROCESS RES DEV, V17, P1517, DOI 10.1021/op4002565; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reeve BWP, 2016, J APPL MICROBIOL, V120, P1271, DOI 10.1111/jam.13067; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2032, DOI 10.1093/nar/gkn046; Saxena J, 2012, WORLD J MICROB BIOT, V28, P1553, DOI 10.1007/s11274-011-0959-0; Sedlar K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4805-8; Sedlar K, 2017, J BIOTECHNOL, V244, P1, DOI 10.1016/j.jbiotec.2017.01.003; Sedlar K, 2015, J BIOTECHNOL, V214, P113, DOI 10.1016/j.jbiotec.2015.09.022; Seo SO, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201700182; Serio AW, 2006, J BACTERIOL, V188, P6396, DOI 10.1128/JB.00249-06; Servinsky MD, 2010, MICROBIOL-SGM, V156, P3478, DOI 10.1099/mic.0.037085-0; Shi YX, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S9; Shi Z, 2008, APPL ENVIRON MICROB, V74, P7709, DOI 10.1128/AEM.01948-08; Shukla G, 2015, WORLD J ENG, V12, P383, DOI 10.1260/1708-5284.12.4.383; SONI BK, 1987, APPL MICROBIOL BIOT, V25, P317; Storari M, 2016, FOOD MICROBIOL, V59, P213, DOI 10.1016/j.fm.2016.05.013; Sun Z, 2015, MOL MICROBIOL, V95, P576, DOI 10.1111/mmi.12894; Tangney M, 2007, APPL MICROBIOL BIOT, V74, P398, DOI 10.1007/s00253-006-0679-9; von Canstein H, 2008, APPL ENVIRON MICROB, V74, P615, DOI 10.1128/AEM.01387-07; Wang Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-138; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-102; Winzer K, 1997, MICROBIOL-UK, V143, P3279, DOI 10.1099/00221287-143-10-3279; Worst DJ, 1998, J BACTERIOL, V180, P1473, DOI 10.1128/JB.180.6.1473-1479.1998; Wu H, 2017, INT J HYDROGEN ENERG, V42, P6547, DOI 10.1016/j.ijhydene.2017.02.094; Wu YD, 2016, BIOTECHNOL BIOPROC E, V21, P60, DOI 10.1007/s12257-015-0583-1; Wu YD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16598; Wu YD, 2013, J BIOTECHNOL, V165, P18, DOI 10.1016/j.jbiotec.2013.02.009; Xing WR, 2018, CHEM ENG J, V333, P712, DOI 10.1016/j.cej.2017.09.176; Yang YP, 2016, METAB ENG, V35, P121, DOI 10.1016/j.ymben.2016.02.006; Zhang L, 2012, J BACTERIOL, V194, P1055, DOI 10.1128/JB.06241-11; Zhang Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-66; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78; Zhao X, 2012, INT J HYDROGEN ENERG, V37, P13711, DOI 10.1016/j.ijhydene.2012.02.144	79	10	10	8	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224560	10.1371/journal.pone.0224560	http://dx.doi.org/10.1371/journal.pone.0224560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697692	Green Published, gold			2022-12-26	WOS:000532694400031
J	Tan, KM; Faierstein, GB; Xu, PX; Barbosa, RMR; Buss, GK; Leal, WS				Tan, Kaiming; Faierstein, Gabriel B.; Xu, Pingxi; Barbosa, Rosangela M. R.; Buss, Garrison K.; Leal, Walter S.			A popular Indian clove-based mosquito repellent is less effective against Culex quinquefasciatus and Aedes aegypti than DEET	PLOS ONE			English	Article							ESSENTIAL OIL; CHEMICAL-COMPOSITION	Insect repellents are widely used as the first line of defense against mosquito bites and transmission of disease-causing agents. However, the cost of daily applications of even the most affordable and the gold standard of insect repellents, DEET, is still high for low-income populations where repellents are needed the most. An Indian clove-based homemade recipe has been presented as a panacea. We analyzed this homemade repellent and confirmed by behavioral measurements and odorant receptor responses that eugenol is the active ingredient in this formulation. Prepared as advertised, this homemade repellent is ineffective, whereas 5x more concentrated extracts from the brand most enriched in eugenol showed moderate repellency activity against Culex quinquefasciatus and Aedes aegypti. DEET showed higher performance when compared to the 5x concentrated formulation and is available in the same market at a lower price than the cost of the ingredients to prepare the homemade formulation.	[Tan, Kaiming; Xu, Pingxi; Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Faierstein, Gabriel B.; Barbosa, Rosangela M. R.; Buss, Garrison K.] Fundacao Oswaldo Cruz FIOCRUZ PE, Dept Entomol, Inst Aggeu Magalhaes, Recife, PE, Brazil; [Buss, Garrison K.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of California System; University of California Davis; Fundacao Oswaldo Cruz; Stanford University	Leal, WS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; Barbosa, Rosângela/AAC-3339-2020	Barbosa, Rosângela/0000-0002-1171-598X; Leal Filho, Walter/0000-0002-1241-5225; Faierstein, Gabriel/0000-0002-1663-7642	National Institute of Allergy and Infectious Diseases [R01AI095514, R21AI128931]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095514, R21AI128931] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	W.S.L. was supported by R01AI095514 and R21AI128931, National Institute of Allergy and Infectious Diseases. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affonso RS, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4096; Alquezar B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06119-w; Bougherra HH, 2015, IND CROP PROD, V63, P249, DOI 10.1016/j.indcrop.2014.09.048; Brady OJ, 2020, ANNU REV ENTOMOL, V65, P191, DOI 10.1146/annurev-ento-011019-024918; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dennis EJ, 2019, CURR BIOL, V29, P1551, DOI 10.1016/j.cub.2019.04.004; EPA, 2010, PROD PERF TEST GUID; Fontes G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-272; Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0; Leal HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18406-7; Leal WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42826; Leal WS, 2014, CURR OPIN INSECT SCI, V6, P93, DOI 10.1016/j.cois.2014.10.007; Lee KG, 2001, FOOD CHEM, V74, P443, DOI 10.1016/S0308-8146(01)00161-3; Lu WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189243; Miot HA, 2011, REV SOC BRAS MED TRO, V44, P793, DOI 10.1590/S0037-86822011000600030; Mogi-Mirin-Fire-Department, 2017, REP CAS MOSQ DENG; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Nchoutpouen E, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007229; Pawar VC, 2006, MYCOSES, V49, P316, DOI 10.1111/j.1439-0507.2006.01241.x; Prashar A, 2006, CELL PROLIFERAT, V39, P241, DOI 10.1111/j.1365-2184.2006.00384.x; Satyal P, 2019, PARASITOL RES, V118, P733, DOI 10.1007/s00436-019-06212-1; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Tabanca N, 2013, J AGR FOOD CHEM, V61, P8573, DOI 10.1021/jf402182h; Who, 2009, GUID EFF TEST MOSQ R, P1; WHO, DENG SEV DENG 2019; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111; Xu PX, 2013, J INSECT PHYSIOL, V59, P961, DOI 10.1016/j.jinsphys.2013.07.004	28	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224810	10.1371/journal.pone.0224810	http://dx.doi.org/10.1371/journal.pone.0224810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689339	Green Published, Green Submitted, gold			2022-12-26	WOS:000532680100044
J	Makou, E; Bailey, RG; Johnston, H; Parkin, JD; Hulme, AN; Hahner, G; Barlow, PN				Makou, Elisavet; Bailey, Richard G.; Johnston, Heather; Parkin, John D.; Hulme, Alison N.; Hahner, Georg; Barlow, Paul N.			Combining SPR with atomic-force microscopy enables single-molecule insights into activation and suppression of the complement cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						surface plasmon resonance (SPR); atomic force microscopy (AFM); complement system; protein-protein interaction; protein conformation; inflammation; single-molecule biophysics; C3b; factor H; immune response; molecular stretching; self-assembling monolayer; single-molecule analysis	FACTOR-H; ALTERNATIVE PATHWAY; BINDING-SITES; HOST RECOGNITION; APOPTOTIC CELLS; C3B; REGULATOR; COMPONENT; DISEASE; MODULES	Activation and suppression of the complement system compete on every serum-exposed surface, host or foreign. Potentially harmful outcomes of this competition depend on surface molecules through mechanisms that remain incompletely understood. Combining surface plasmon resonance (SPR) with atomic force microscopy (AFM), here we studied two complement system proteins at the single-molecule level: C3b, the proteolytically activated form of C3, and factor H (FH), the surface-sensing C3b-binding complement regulator. We used SPR to monitor complement initiation occurring through a positive-feedback loop wherein surface-deposited C3b participates in convertases that cleave C3, thereby depositing more C3b. Over multiple cycles of flowing factor B, factor D, and C3 over the SPR chip, we amplified C3b from ?20 to ?220 molecules??m(?2). AFM revealed C3b clusters of up to 20 molecules and solitary C3b molecules deposited up to 200 nm away from the clusters. A force of 0.17 ? 0.02 nanonewtons was needed to pull a single FH molecule, anchored to the AFM probe, from its complex with surface-attached C3b. The extent to which FH molecules stretched before detachment varied widely among complexes. Performing force-distance measurements with FH(D1119G), a variant lacking one of the C3b-binding sites and causing atypical hemolytic uremic syndrome, we found that it detached more uniformly and easily. In further SPR experiments, K-D values between FH and C3b on a custom-made chip surface were 5-fold tighter than on commercial chips and similar to those on erythrocytes. These results suggest that the chemistry at the surface on which FH acts drives conformational adjustments that are functionally critical.	[Makou, Elisavet; Johnston, Heather; Hulme, Alison N.; Barlow, Paul N.] Univ Edinburgh, EaStChem Sch Chem, Joseph Black Chem Bldg, Edinburgh EH9 3FJ, Midlothian, Scotland; [Bailey, Richard G.; Parkin, John D.; Hahner, Georg] Univ St Andrews, EaStChem Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Barlow, Paul N.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JY, Midlothian, Scotland	University of Edinburgh; University of St Andrews; University of Edinburgh	Barlow, PN (corresponding author), Univ Edinburgh, EaStChem Sch Chem, Joseph Black Chem Bldg, Edinburgh EH9 3FJ, Midlothian, Scotland.; Hahner, G (corresponding author), Univ St Andrews, EaStChem Sch Chem, St Andrews KY16 9ST, Fife, Scotland.	gh23@st-andrews.ac.uk; Paul.Barlow@ed.ac.uk		Hulme, Alison/0000-0002-4619-1506; Bailey, Richard/0000-0001-7367-766X	Leverhulme Trust [RPG-2015-109]	Leverhulme Trust(Leverhulme Trust)	This work was supported by Leverhulme Trust Grant RPG-2015-109. The authors declare that they have no conflicts of interest with the contents of this article.	Achila D, 2015, BIOCHEM J, V465, P325, DOI 10.1042/BJ20141069; Amarilyo G, 2010, EUR J IMMUNOL, V40, P699, DOI 10.1002/eji.200838951; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Blatt AZ, 2016, IMMUNOL REV, V274, P172, DOI 10.1111/imr.12466; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Chen ZA, 2016, MOL CELL PROTEOMICS, V15, P2730, DOI 10.1074/mcp.M115.056473; COCHRANE CG, 1968, J EXP MED, V127, P371, DOI 10.1084/jem.127.2.371; Dave S, 2004, INDIAN J MED RES, V119, P66; DISCIPIO RG, 1981, BIOCHEM J, V199, P485, DOI 10.1042/bj1990485; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; FISHELSON Z, 1984, J IMMUNOL, V132, P1430; de Jorge EG, 2018, MOL IMMUNOL, V102, P42, DOI 10.1016/j.molimm.2018.06.011; Harder MJ, 2016, J IMMUNOL, V196, P866, DOI 10.4049/jimmunol.1501919; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; Harris CL, 2018, MOL IMMUNOL, V102, P89, DOI 10.1016/j.molimm.2018.06.008; Harris CL, 2012, TRENDS IMMUNOL, V33, P513, DOI 10.1016/j.it.2012.06.001; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Herbert AP, 2015, J IMMUNOL, V195, P4986, DOI 10.4049/jimmunol.1501388; Hovingh ES, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02004; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jokiranta TS, 2001, INT IMMUNOPHARMACOL, V1, P495, DOI 10.1016/S1567-5769(00)00042-4; Kassa E, 2019, EXPERT OPIN BIOL TH, V19, P335, DOI 10.1080/14712598.2019.1575358; KAZATCHKINE MD, 1979, J IMMUNOL, V122, P75; Kerr H, 2017, J BIOL CHEM, V292, P13345, DOI 10.1074/jbc.M117.795088; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Lachmann PJ, 2018, IMMUNOBIOLOGY, V223, P519, DOI 10.1016/j.imbio.2018.02.001; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; LAW SKA, 1981, BIOCHEMISTRY-US, V20, P7457, DOI 10.1021/bi00529a020; LEVINE RP, 1990, CURR TOP MICROBIOL, V153, P73; Loyet KM, 2012, INVEST OPHTH VIS SCI, V53, P6628, DOI 10.1167/iovs.12-9587; Makou E, 2013, BIOCHEMISTRY-US, V52, P3949, DOI 10.1021/bi4003452; Makou E, 2012, J MOL BIOL, V424, P295, DOI 10.1016/j.jmb.2012.09.013; MARDINEY MR, 1968, AM J PATHOL, V53, P253; Martin M, 2016, IMMUNOL REV, V274, P218, DOI 10.1111/imr.12462; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Meri S, 2016, FEBS LETT, V590, P2418, DOI 10.1002/1873-3468.12284; Morgan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032187; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Muller-Eberhard H J, 1968, Adv Immunol, V8, P1, DOI 10.1016/S0065-2776(08)60464-2; MULLEREBERHARD HJ, 1967, J EXP MED, V125, P359, DOI 10.1084/jem.125.2.359; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Osborne AJ, 2018, J BIOL CHEM, V293, P17166, DOI 10.1074/jbc.RA118.004767; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; PANGBURN MK, 1983, J IMMUNOL, V131, P1930; Park DH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01007; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; Perkins SJ, 2010, ADV EXP MED BIOL, V703, P25, DOI 10.1007/978-1-4419-5635-4_3; PODACK ER, 1980, J EXP MED, V151, P301, DOI 10.1084/jem.151.2.301; Pouw RB, 2019, BLOOD ADV, V3, P621, DOI 10.1182/bloodadvances.2018025692; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Schmidt CQ, 2016, IMMUNOL REV, V274, P152, DOI 10.1111/imr.12475; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; TACK BF, 1976, BIOCHEMISTRY-US, V15, P4513, DOI 10.1021/bi00665a028; Tortajada A, 2009, HUM MOL GENET, V18, P3452, DOI 10.1093/hmg/ddp289; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Warwick A, 2014, J CLIN MED, V3, P1234, DOI 10.3390/jcm3041234; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	73	1	1	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20148	20163		10.1074/jbc.RA119.010913	http://dx.doi.org/10.1074/jbc.RA119.010913			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31719147	Green Published, hybrid			2022-12-26	WOS:000505005800026
J	Johnson, D; Zhu, L; Landim-Vieira, M; Pinto, JR; Chalovich, JM				Johnson, Dylan; Zhu, Li; Landim-Vieira, Maicon; Pinto, Jose Renato; Chalovich, Joseph M.			Basic residues within the cardiac troponin T C terminus are required for full inhibition of muscle contraction and limit activation by calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tropomyosin; muscle physiology; fluorescence resonance energy transfer (FRET); cardiac muscle; troponin; ATPase activity; cross-bridge kinetics; high Ala; high activation TnT (HAHA TnT); states of actin; troponin T (TnT)	RABBIT SKELETAL-MUSCLE; MYOSIN SUBFRAGMENT-1; ATPASE ACTIVITY; RESTRICTIVE CARDIOMYOPATHY; COOPERATIVE BINDING; REGULATORY PROTEINS; CA2+ SENSITIVITY; ENERGY-TRANSFER; INACTIVE STATE; F-ACTIN	Striated muscle is activated by myosin- and actin-linked processes, with the latter being regulated through changes in the position of tropomyosin relative to the actin surface. The C-terminal region of cardiac troponin T (TnT), a tropomyosin-associated protein, is required for full TnT inactivation at low Ca2+ and for limiting its activation at saturating Ca2+. Here, we investigated whether basic residues in this TnT region are involved in these activities, whether the TnT C terminus undergoes Ca2+-dependent conformational changes, and whether these residues affect cardiac muscle contraction. We generated a human cardiac TnT variant in which we replaced seven C-terminal Lys and Arg residues with Ala and added a Cys residue at either position 289 or 275 to affix a fluorescent probe. At pCa 3.7, actin filaments containing high-alanine TnT had an elevated ATPase rate like that obtained when the last TnT 14 residues were deleted. Acrylodan-tropomyosin fluorescence changes and S1-actin binding kinetics revealed that at pCa 8, the high-alanine TnT-containing filaments did not enter the first inactive state. FRET analyses indicated that the C-terminal TnT region approached Cys-190 of tropomyosin as actin filaments transitioned to the inactive B state; that transition was abolished with high-alanine TnT. High-alanine TnT-containing cardiac muscle preparations had increased Ca2+ sensitivity of both steady-state isometric force and sinusoidal stiffness as well as increased maximum steady-state isometric force and sinusoidal stiffness. We conclude that C-terminal basic residues in cardiac TnT are critical for the regulation of cardiac muscle contraction.	[Johnson, Dylan; Zhu, Li; Chalovich, Joseph M.] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, 600 Moye Blvd, Greenville, NC 27834 USA; [Landim-Vieira, Maicon; Pinto, Jose Renato] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Johnson, Dylan] Univ North Florida, 1 UNF Dr, Jacksonville, FL 32224 USA	University of North Carolina; East Carolina University; State University System of Florida; Florida State University; State University System of Florida; University of North Florida	Chalovich, JM (corresponding author), East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, 600 Moye Blvd, Greenville, NC 27834 USA.	chalovichj@ecu.edu	; Pinto, Jose R/H-2631-2017	Chalovich, Joseph/0000-0002-1243-4055; Landim-Vieira, Maicon/0000-0002-6696-8888; Pinto, Jose R/0000-0001-9092-4976	Brody School of Medicine at East Carolina University; National Institutes of Health [AR035216, HL128683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128683] Funding Source: NIH RePORTER	Brody School of Medicine at East Carolina University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Brody School of Medicine at East Carolina University as well as National Institutes of Health Grants AR035216 (to J. M. C.) and HL128683 (to J. R. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baxley T, 2017, BIOCHEMISTRY-US, V56, P2928, DOI 10.1021/acs.biochem.6b01092; Borrego-Diaz E, 2010, BIOPHYS J, V98, P2601, DOI 10.1016/j.bpj.2010.02.030; BRENNER SL, 1983, J BIOL CHEM, V258, P5013; Brouwer AM, 2011, PURE APPL CHEM, V83, P2213, DOI 10.1351/PAC-REP-10-09-31; Burhop J, 2001, J BIOL CHEM, V276, P20788, DOI 10.1074/jbc.M101110200; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; Chalovich JM, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00377; Chalovich JM, 2012, J MUSCLE RES CELL M, V33, P493, DOI 10.1007/s10974-012-9305-x; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; EBASHI S, 1973, COLD SPRING HARB SYM, V37, P215, DOI 10.1101/SQB.1973.037.01.031; EISENBERG E, 1970, NATURE, V228, P1092, DOI 10.1038/2281092a0; Franklin AJ, 2012, BIOPHYS J, V102, P2536, DOI 10.1016/j.bpj.2012.04.037; Gafurov B, 2004, BIOCHEMISTRY-US, V43, P15276, DOI 10.1021/bi048646h; Gonzalez-Martinez D, 2018, J MOL CELL CARDIOL, V123, P26, DOI 10.1016/j.yjmcc.2018.08.015; GREASER ML, 1971, J BIOL CHEM, V246, P4226; HASELGROVE JC, 1973, J MOL BIOL, V77, P549, DOI 10.1016/0022-2836(73)90222-2; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; Hibbs RE, 2004, J BIOL CHEM, V279, P28483, DOI 10.1074/jbc.M403713200; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1981, BIOPHYS J, V35, P99, DOI 10.1016/S0006-3495(81)84777-7; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Johnson D, 2018, BIOPHYS J, V115, P702, DOI 10.1016/j.bpj.2018.06.028; KIELLEY WW, 1960, BIOCHIM BIOPHYS ACTA, V41, P401; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Mathur MC, 2008, BIOPHYS J, V94, P542, DOI 10.1529/biophysj.107.113944; Mathur MC, 2009, BIOPHYS J, V96, P2237, DOI 10.1016/j.bpj.2008.12.3909; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; McNamara James W, 2015, Biophys Rev, V7, P5, DOI 10.1007/s12551-014-0151-5; MIKI M, 1986, BIOCHIM BIOPHYS ACTA, V871, P137, DOI 10.1016/0167-4838(86)90166-4; MORRIS EP, 1984, BIOCHEMISTRY-US, V23, P2214, DOI 10.1021/bi00305a018; PEARLSTONE JR, 1985, CAN J BIOCHEM CELL B, V63, P212, DOI 10.1139/o85-030; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Pinto JR, 2011, J BIOL CHEM, V286, P20901, DOI 10.1074/jbc.M111.234336; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SPUDICH JA, 1972, J MOL BIOL, V72, P619, DOI 10.1016/0022-2836(72)90180-5; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STEINBERG IZ, 1971, ANNU REV BIOCHEM, V40, P83, DOI 10.1146/annurev.bi.40.070171.000503; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TANOKURA M, 1983, J BIOCHEM, V93, P331, DOI 10.1093/oxfordjournals.jbchem.a134185; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WILKINSON JM, 1972, BIOCHEM J, V127, P215, DOI 10.1042/bj1270215; Yengo CM, 2010, CURR OPIN PHARMACOL, V10, P731, DOI 10.1016/j.coph.2010.09.013; Zot HG, 2016, ARCH BIOCHEM BIOPHYS, V601, P97, DOI 10.1016/j.abb.2016.03.011	48	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19535	19545		10.1074/jbc.RA119.010966	http://dx.doi.org/10.1074/jbc.RA119.010966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31712308	hybrid, Green Published			2022-12-26	WOS:000504093200008
J	Fan, WL; Zheng, J; Kong, WZ; Cui, LM; Aishanjiang, M; Yi, QZ; Wang, M; Cang, XH; Tang, XW; Chen, Y; Mo, JQ; Sondheimer, N; Ge, WZ; Guan, MX				Fan, Wenlu; Zheng, Jing; Kong, Wanzhong; Cui, Limei; Aishanjiang, Maerhaba; Yi, Qiuzi; Wang, Min; Cang, Xiaohui; Tang, Xiaowen; Chen, Ye; Mo, Jun Qin; Sondheimer, Neal; Ge, Wanzhong; Guan, Min-Xin			Contribution of a mitochondrial tyrosyl-tRNA synthetase mutation to the phenotypic expression of the deafness-associated tRNA(Ser(UCN)) 7511A > G mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hearing loss; mitochondrial tRNA; mutation; tyrosyl-tRNA synthetase 2 (YARS2); pathophysiology; oxidative stress; tRNA(Ser(UCN)); maternally transmitted deafness; genetic disorder	12S RIBOSOMAL-RNA; NON-SYNDROMIC DEAFNESS; T7511C MUTATION; HEARING-LOSS; DNA MUTATION; SENSORINEURAL DEAFNESS; M(1)G37 MODIFICATION; BIOCHEMICAL-EVIDENCE; NUCLEAR MODIFIER; OXIDATIVE STRESS	Nuclear modifier genes have been proposed to modify the phenotypic expression of mitochondrial DNA mutations. Using a targeted exome sequencing approach, here we found that the p.191Gly>Val mutation in mitochondrial tyrosyl-tRNA synthetase 2 (YARS2) interacts with the tRNA(Ser(UCN)) 7511A>G mutation in causing deafness. Strikingly, members of a Chinese family bearing both YARS2 p.191Gly>Val and m.7511A>G mutations displayed much higher penetrance of deafness than those pedigrees carrying only the m.7511A>G mutation. The m.7511A>G mutation changed the A4:U69 base pairing to G4:U69 pairing at the aminoacyl acceptor stem of tRNA(Ser(UCN)) and perturbed tRNA(Ser(UCN)) structure and function, including an increased melting temperature, altered conformation, instability, and aberrant aminoacylation of mutant tRNA. Using lymphoblastoid cell lines derived from symptomatic and asymptomatic members of these Chinese families and control subjects, we show that cell lines harboring only the m.7511A>G or p.191Gly>Val mutation revealed relatively mild defects in tRNA(Ser(UCN)) or tRNA(Tyr) metabolism, respectively. However, cell lines harboring both m.7511A>G and p.191Gly>Val mutations displayed more severe defective aminoacylations and lower tRNA(Ser(UCN)) and tRNA(Tyr) levels, aberrant aminoacylation, and lower levels of other tRNAs, including tRNA(Thr), tRNALys, tRNA(Leu(UUR)), and tRNA(Ser(AGY)), than those in the cell lines carrying only the m.7511A>G or p.191Gly>Val mutation. Furthermore, mutant cell lines harboring both m.7511A>G and p.191Gly>Val mutations exhibited greater decreases in the levels of mitochondrial translation, respiration, and mitochondrial ATP and membrane potentials, along with increased production of reactive oxygen species. Our findings provide molecular-level insights into the pathophysiology of maternally transmitted deafness arising from the synergy between tRNA(Ser(UCN)) and mitochondrial YARS mutations.	[Fan, Wenlu; Zheng, Jing; Cui, Limei; Aishanjiang, Maerhaba; Yi, Qiuzi; Cang, Xiaohui; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Childrens Hosp, Sch Med, Div Med Genet & Genom, Hangzhou 310058, Zhejiang, Peoples R China; [Fan, Wenlu; Zheng, Jing; Cui, Limei; Aishanjiang, Maerhaba; Yi, Qiuzi; Cang, Xiaohui; Chen, Ye; Ge, Wanzhong; Guan, Min-Xin] Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Fan, Wenlu; Kong, Wanzhong; Wang, Min; Tang, Xiaowen] Wenzhou Med Univ, Attardi Inst Biomed, Sch Life Sci & Lab Med, Wenzhou 325600, Zhejiang, Peoples R China; [Mo, Jun Qin] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Dept Pathol, San Diego, CA 92123 USA; [Sondheimer, Neal] Univ Toronto, Sch Med, Dept Mol Genet, Toronto, ON M5G 0A4, Canada; [Sondheimer, Neal] Hosp Sick Children, Toronto, ON M5G 0A4, Canada; [Guan, Min-Xin] Zhejiang Univ, Key Lab Reprod Genet, Minist Educ PRC, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ & Univ Toronto, Joint Inst Genet & Genome Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Zhejiang University	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Dept Genet, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn	; Chen, Ye/D-1164-2015	Sondheimer, Neal/0000-0001-9982-5712; Chen, Ye/0000-0003-3671-2504; Guan, Min-Xin/0000-0001-5067-6736; Ge, Wanzhong/0000-0003-1334-2723	Ministry of Science and Technology of Zhejiang Province [2018C03026]; National Key Technologies RAMP;D Program from the Ministry of Science and Technology of China [2014CB541704]; National Natural Science Foundation of China [81330024, 31671305, 81470685]	Ministry of Science and Technology of Zhejiang Province; National Key Technologies RAMP;D Program from the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are grateful to patients and their family members for their participation. This work was supported by the Grant 2018C03026 from Ministry of Science and Technology of Zhejiang Province, the National Key Technologies R&D Program Grant 2014CB541704 from the Ministry of Science and Technology of China (to M.X.G.) and Grants 81330024, 31671305 and 81470685 from the National Natural Science Foundation of China (to M. X. G., Y.C., and J. Z., respectively).	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Boczonadi V, 2018, ESSAYS BIOCHEM, V62, P321, DOI 10.1042/EBC20170103; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Ceriani F, 2016, P NATL ACAD SCI USA, V113, pE7194, DOI 10.1073/pnas.1616061113; Chapiro E, 2002, EUR J HUM GENET, V10, P851, DOI 10.1038/sj.ejhg.5200894; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; Chong YE, 2018, P NATL ACAD SCI USA, V115, P7527, DOI 10.1073/pnas.1807109115; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; KING MP, 1993, J BIOL CHEM, V268, P10228; Kuncha SK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02204-w; Lenhard B, 1999, NUCLEIC ACIDS RES, V27, P721, DOI 10.1093/nar/27.3.721; Li RH, 2005, BIOCHEM BIOPH RES CO, V328, P32, DOI 10.1016/j.bbrc.2004.12.140; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Lovato MA, 2001, EMBO J, V20, P4846, DOI 10.1093/emboj/20.17.4846; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Naganuma M, 2014, NATURE, V510, P507, DOI 10.1038/nature13440; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6; Schwartzentruber J, 2014, HUM MUTAT, V35, P1285, DOI 10.1002/humu.22629; Simon M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005097; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Steiner RE, 2019, IUBMB LIFE, V71, P1150, DOI 10.1002/iub.2080; Sue CM, 1999, NEUROLOGY, V52, P1905, DOI 10.1212/WNL.52.9.1905; Sun LT, 2016, J AM CHEM SOC, V138, P12948, DOI 10.1021/jacs.6b07121; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219; Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107; Zhang QH, 2018, NUCLEIC ACIDS RES, V46, P10930, DOI 10.1093/nar/gky758; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zhao XX, 2019, NUCLEIC ACIDS RES, V47, P10340, DOI 10.1093/nar/gkz742; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317; Zhou M, 2017, J BIOL CHEM, V292, P13934, DOI 10.1074/jbc.M117.787028; Zhou XL, 2017, HUM MUTAT, V38, P1740, DOI 10.1002/humu.23335	69	13	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19292	19305		10.1074/jbc.RA119.010598	http://dx.doi.org/10.1074/jbc.RA119.010598			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31685661	hybrid, Green Published			2022-12-26	WOS:000516527800028
J	Peng, Y; Wang, ZX; Wang, ZQ; Yu, F; Li, JW; Wong, JM				Peng, Yu; Wang, Zhenxing; Wang, Zhiqiang; Yu, Fang; Li, Jiwen; Wong, Jiemin			SUMOylation down-regulates rDNA transcription by repressing expression of upstream-binding factor and proto-oncogene c-Myc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small ubiquitin-like modifier (SUMO); UBC9; PIAS; rDNA transcription; RNA polymerase I; upstream-binding factor (UBF); c-Myc; gene regulation; ribosome biogenesis	RIBOSOMAL-RNA GENES; POLYMERASE I TRANSCRIPTION; SUMO MODIFICATION; UBIQUITIN; NUCLEOLIN; SYSTEM; DNA	Ribosome biogenesis is critical for proliferating cells and requires the coordinated activities of three eukaryotic RNA polymerases. We recently showed that the small ubiquitin-like modifier (SUMO) system controls the global level of RNA polymerase II (Pol II)-controlled transcription in mammalian cells by regulating cyclin-dependent kinase 9 (CDK9) activity. Here, we present evidence that the SUMO system also plays a critical role in the control of Pol I transcription. Using an siRNA-based knockdown approach, we found that multiple SUMO E3 ligases of the protein inhibitor of activated STAT (PIAS) family are involved in SUMO-mediated repression of rDNA gene transcription. We demonstrate that endogenous SUMO represses rDNA transcription primarily by repressing upstream-binding factor (UBF) and proto-oncogene c-Myc (c-Myc) expression and that ectopic overexpression of SUMO-associated enzymes additionally represses rDNA transcription via c-Myc SUMOylation and its subsequent degradation. The results of our study reveal a critical role of SUMOylation in the control of rDNA transcription, uncover the underlying mechanisms involved, and indicate that the SUMO system coordinates Pol I- and Pol II-mediated transcription in mammalian cells.	[Peng, Yu; Wang, Zhenxing; Wang, Zhiqiang; Yu, Fang; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Fengxian Dist Cent Hosp, ECNU Joint Ctr Translat Med, Inst Biomed Sci,Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Peng, Yu; Wang, Zhenxing; Wang, Zhiqiang; Yu, Fang; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Yu, Fang] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Wong, Jiemin] State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China	East China Normal University; East China Normal University; State University System of Florida; University of Florida	Li, JW; Wong, JM (corresponding author), East China Normal Univ, Fengxian Dist Cent Hosp, ECNU Joint Ctr Translat Med, Inst Biomed Sci,Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.; Li, JW; Wong, JM (corresponding author), East China Normal Univ, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.; Wong, JM (corresponding author), State Key Lab Oncogene & Related Genes, Shanghai, Peoples R China.	jwli@bio.ecnu.edu.cn; jmweng@bio.ecnu.edu.cn		Wong, Jiemin/0000-0002-5311-842X; Yu, Fang/0000-0001-9010-9461	Ministry of Science and Technology of China [2017YFA054201]; National Natural Science Foundation of China [31730048, 81530078, 31571325]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr. Cheng-Ming Chiang (University of Texas Southwestern Medical Center) for critical reading of the manuscript. We also thank members of Wong's lab for valuable discussion. This study is supported by grants from the Ministry of Science and Technology of China (2017YFA054201 to J.W.) and the National Natural Science Foundation of China (31730048, 81530078 and 31571325 to J.W.).	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Chymkowitch P, 2017, P NATL ACAD SCI USA, V114, P1039, DOI 10.1073/pnas.1615093114; Chymkowitch P, 2015, BIOESSAYS, V37, P1095, DOI 10.1002/bies.201500065; Cong R, 2014, NUCLEIC ACIDS RES, V42, P181, DOI 10.1093/nar/gkt863; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Diesch J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-43; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gonzalez-Prieto R, 2015, CELL CYCLE, V14, P1859, DOI 10.1080/15384101.2015.1040965; Goodfellow Sarah J, 2013, Subcell Biochem, V61, P211, DOI 10.1007/978-94-007-4525-4_10; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grummt I, 2013, BBA-GENE REGUL MECH, V1829, P393, DOI 10.1016/j.bbagrm.2012.10.004; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kusnadi EP, 2015, GENE, V556, P27, DOI 10.1016/j.gene.2014.11.010; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; Liang J, 2017, GENE DEV, V31, P802, DOI 10.1101/gad.296145.117; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ouyang J, 2009, EPIGENETICS-US, V4, P440, DOI 10.4161/epi.4.7.9807; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Rohira AD, 2013, J BIOL CHEM, V288, P19288, DOI 10.1074/jbc.M113.473744; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schneider DA, 2012, GENE, V493, P176, DOI 10.1016/j.gene.2011.08.006; Shi G, 2014, J BIOL CHEM, P29700; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Sun XX, 2018, P NATL ACAD SCI USA, V115, P10983, DOI 10.1073/pnas.1802932115; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Yang Xiang-Jiao, 2013, F1000Prime Rep, V5, P45, DOI 10.12703/P5-45; Yu F, 2018, CELL RES, V28, P670, DOI 10.1038/s41422-018-0023-9; Zhang DY, 2015, J BIOL CHEM, V290, P4784, DOI 10.1074/jbc.M114.598219	43	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19155	19166		10.1074/jbc.RA119.010624	http://dx.doi.org/10.1074/jbc.RA119.010624			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694914	hybrid, Green Published			2022-12-26	WOS:000516527800017
J	Zuo, XF; Kwon, SH; Janech, MG; Dang, YJ; Lauzon, SD; Fogelgren, B; Polgar, N; Lipschutz, JH				Zuo, Xiaofeng; Kwon, Sang-Ho; Janech, Michael G.; Dang, Yujing; Lauzon, Steven D.; Fogelgren, Ben; Polgar, Noemi; Lipschutz, Joshua H.			Primary cilia and the exocyst are linked to urinary extracellular vesicle production and content	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular vesicle; exocyst; GTPase; protein trafficking; exocyst complex; component 5 (EXOC5); ADP ribosylation factor 6 (ARF6); EPS8 like 2 (EPS8L2); primary cilia; ciliopathy	POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIOGENESIS; PKD1 GENE; PROTEIN; COMPLEX; MEMBRANE; ENCODES; SEC10; CDC42; INTERACTS	The recently proposed idea of "urocrine signaling" hypothesizes that small secreted extracellular vesicles (EVs) contain proteins that transmit signals to distant cells. However, the role of renal primary cilia in EV production and content is unclear. We previously showed that the exocyst, a highly conserved trafficking complex, is necessary for ciliogenesis; that it is present in human urinary EVs; that knockdown (KD) of exocyst complex component 5 (EXOC5), a central exocyst component, results in very short or absent cilia; and that human EXOC5 overexpression results in longer cilia. Here, we show that compared with control Madin-Darby canine kidney (MDCK) cells, EXOC5 overexpression increases and KD decreases EV numbers. Proteomic analyses of isolated EVs from EXOC5 control, KD, and EXOC5-overexpressing MDCK cells revealed significant alterations in protein composition. Using immunoblotting to specifically examine the expression levels of ADP ribosylation factor 6 (ARF6) and EPS8 like 2 (EPS8L2) in EVs, we found that EXOC5 KD increases ARF6 levels and decreases EPS8L2 levels, and that EXOC5 overexpression increases EPS8L2. Knockout of intraflagellar transport 88 (IFT88) confirmed that the changes in EV number/content were due to cilia loss: similar to EXOC5, the IFT88 loss resulted in very short or absent cilia, decreased EV numbers, increased EV ARF6 levels and decreased Eps8L2 levels compared with IFT88-rescued EVs. Compared with control animals, urine from proximal tubule-specific EXOC5-KO mice contained fewer EVs and had increased ARF6 levels. These results indicate that perturbations in exocyst and primary cilia affect EV number and protein content.	[Zuo, Xiaofeng; Dang, Yujing; Lipschutz, Joshua H.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Kwon, Sang-Ho] Augusta Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Janech, Michael G.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Lauzon, Steven D.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Fogelgren, Ben; Polgar, Noemi] Univ Hawaii Manoa, Dept Anat Biochem & Physiol, Honolulu, HI 96813 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; University System of Georgia; Augusta University; College of Charleston; Medical University of South Carolina; University of Hawaii System; University of Hawaii Manoa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Lipschutz, JH (corresponding author), Med Univ South Carolina, Med, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.; Lipschutz, JH (corresponding author), Med Univ South Carolina, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.	Lipschut@musc.edu	Lauzon, Steve/ABC-3727-2020	Lauzon, Steve/0000-0002-4911-0636; Polgar, Noemi/0000-0002-8400-162X; Kwon, Sang-Ho/0000-0001-9074-4641	NCATS NIH HHS [UL1 TR001450] Funding Source: Medline; NIDDK NIH HHS [R01 DK117308, R01 DK120510, P30 DK074038] Funding Source: Medline; NIGMS NIH HHS [P20 GM103457, P30 GM131944, P20 GM113134] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK120510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113134] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baek JI, 2016, J BIOL CHEM, V291, P8632, DOI 10.1074/jbc.M115.688663; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Camici M, 2008, BIOMARK MED, V2, P613, DOI 10.2217/17520363.2.6.613; Chacon-Heszele MF, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12116; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Choi SY, 2015, INVEST OPHTH VIS SCI, V56, P3361, DOI 10.1167/iovs.14-15692; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; DeLay BD, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00143; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Fogelgren B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129346; Fogelgren B, 2014, AM J PHYSIOL-RENAL, V307, pF1334, DOI 10.1152/ajprenal.00032.2014; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Grantham JJ, 2001, CURR OPIN NEPHROL HY, V10, P533, DOI 10.1097/00041552-200107000-00008; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hogan MC, 2014, KIDNEY INT, V85, P1225, DOI 10.1038/ki.2013.422; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Hurd TW, 2011, NEPHRON EXP NEPHROL, V118, pE9, DOI 10.1159/000320888; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; Leon IR, 2013, MOL CELL PROTEOMICS, V12, P2992, DOI 10.1074/mcp.M112.025585; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Lobo GP, 2017, J BIOL CHEM, V292, P14814, DOI 10.1074/jbc.M117.795674; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mallegol J, 2007, GASTROENTEROLOGY, V132, P1866, DOI 10.1053/j.gastro.2007.02.043; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Polgar N, 2015, AM J PHYSIOL-CELL PH, V309, pC190, DOI 10.1152/ajpcell.00011.2015; Polzin A, 2002, MOL CELL BIOL, V22, P1714, DOI 10.1128/MCB.22.6.1714-1722.2002; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Toikkanen JH, 2003, J BIOL CHEM, V278, P20946, DOI 10.1074/jbc.M213111200; USRDS, 2016, INC PREV PAT CHAR TR, V2; Wang J, 2014, CURR BIOL, V24, P519, DOI 10.1016/j.cub.2014.01.002; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; Wood CR, 2013, CURR BIOL, V23, P906, DOI 10.1016/j.cub.2013.04.019; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zuo XF, 2019, J BIOL CHEM, V294, P6710, DOI 10.1074/jbc.RA118.006527; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	65	9	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19099	19110		10.1074/jbc.RA119.009297	http://dx.doi.org/10.1074/jbc.RA119.009297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694916	hybrid, Green Published			2022-12-26	WOS:000516527800013
J	Huang, S; Benben, A; Green, R; Cheranda, N; Lee, G; Joseph, B; Keaveney, S; Wang, YQ				Huang, Shan; Benben, Alex; Green, Robert; Cheranda, Nina; Lee, Grace; Joseph, Benita; Keaveney, Shannon; Wang, Yuqi			Phosphorylation of the G? protein Gpa2 promotes protein kinase A signaling in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; protein phosphorylation; posttranslational modification (PTM); yeast; PKA; sporulation; protein kinase; cellular localization; glycogen synthase kinase; Gpa2; nutrient signaling	HETEROTRIMERIC G-PROTEIN; COUPLED RECEPTOR GPR1; ALPHA-SUBUNIT; PHOSPHOLIPASE-C; PSEUDOHYPHAL DIFFERENTIATION; N-MYRISTOYLATION; GLOBAL ANALYSIS; CAMP PATHWAY; PHOS-TAG; ACTIVATION	Heterotrimeric G proteins are important molecular switches that facilitate transmission of a variety of signals from the outside to the inside of cells. G proteins are highly conserved, enabling study of their regulatory mechanisms in model organisms such as the budding yeast Saccharomyces cerevisiae. Gpa2 is a yeast G? protein that functions in the nutrient signaling pathway. Using Phos-tag, a highly specific phosphate binding tag for separating phosphorylated proteins, we found that Gpa2 undergoes phosphorylation and that its level of phosphorylation is markedly increased upon nitrogen starvation. We also observed that phosphorylation of Gpa2 depends on glycogen synthase kinase (GSK). Disrupting GSK activity diminishes Gpa2 phosphorylation levels in vivo, and the purified GSK isoforms Mck1 and Ygk3 are capable of phosphorylating Gpa2 in vitro. Functionally, phosphorylation enhanced plasma membrane localization of Gpa2 and promoted nitrogen starvation?induced activation of protein kinase A. Together, the findings of our study reveal a mechanism by which GSK- and nutrient-dependent phosphorylation regulates subcellular localization of Gpa2 and its ability to activate downstream signaling.	[Huang, Shan; Benben, Alex; Green, Robert; Cheranda, Nina; Lee, Grace; Joseph, Benita; Keaveney, Shannon; Wang, Yuqi] St Louis Univ, Dept Biol, 3507 Laclede Ave, St Louis, MO 63103 USA	Saint Louis University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 3507 Laclede Ave, St Louis, MO 63103 USA.	yuqi.wang@slu.edu		Benben, Alex/0000-0003-4982-920X	NIGMS, National Institutes of Health [R15GM128047-01]; Knoedler undergraduate research funds from Saint Louis University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM128047] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Knoedler undergraduate research funds from Saint Louis University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R15GM128047-01 (to Y. W.) and Knoedler undergraduate research funds from Saint Louis University (to A. B., S. K., and B. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansari K, 1999, J BIOL CHEM, V274, P30052, DOI 10.1074/jbc.274.42.30052; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Demczuk A, 2008, EUKARYOT CELL, V7, P967, DOI 10.1128/EC.00438-07; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Donzeau M, 1999, MOL CELL BIOL, V19, P6110; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Flick JS, 1998, GENETICS, V148, P33; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Heng BC, 2013, BIOTECHNOL ADV, V31, P1676, DOI 10.1016/j.biotechadv.2013.08.017; Horinouchi T, 2016, METHODS MOL BIOL, V1397, P267, DOI 10.1007/978-1-4939-3353-2_18; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jin X, 2016, J BIOL CHEM, V291, P16231, DOI 10.1074/jbc.M115.713206; Kinoshita E, 2016, PROTEOMICS, V16, P1825, DOI 10.1002/pmic.201500494; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Li Y, 2013, J BIOL CHEM, V288, P11358, DOI 10.1074/jbc.M112.449751; Lo IC, 2015, DEV CELL, V33, P189, DOI 10.1016/j.devcel.2015.02.009; Lombardi MS, 2002, CRIT REV IMMUNOL, V22, P141; Lorenz MC, 2000, GENETICS, V154, P609; MITCHELL AP, 1990, MOL CELL BIOL, V10, P2104, DOI 10.1128/MCB.10.5.2104; Nazarko VY, 2008, CELL BIOL INT, V32, P502, DOI 10.1016/j.cellbi.2007.11.001; NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533; Peeters T, 2006, P NATL ACAD SCI USA, V103, P13034, DOI 10.1073/pnas.0509644103; Pereira J, 2009, YEAST, V26, P641, DOI 10.1002/yea.1711; Portela P, 2002, J BIOL CHEM, V277, P30477, DOI 10.1074/jbc.M201094200; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sato M, 2013, CIRC J, V77, P2455, DOI 10.1253/circj.CJ-13-0705; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; STONE DE, 1991, GENE DEV, V5, P1969, DOI 10.1101/gad.5.11.1969; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Weissgerber TL, 2017, J BIOL CHEM, V292, P20592, DOI 10.1074/jbc.RA117.000147; Xiao Y, 2000, MOL CELL BIOL, V20, P5447, DOI 10.1128/MCB.20.15.5447-5453.2000; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; YOSHIDA M, 1990, MOL GEN GENET, V221, P176, DOI 10.1007/BF00261718; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zhang P, 2015, LIFE SCI, V129, P35, DOI 10.1016/j.lfs.2015.02.029	44	3	3	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2019	294	49					18836	18845		10.1074/jbc.RA119.009609	http://dx.doi.org/10.1074/jbc.RA119.009609			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KD1GB	31690628	Green Published, hybrid			2022-12-26	WOS:000507618800027
J	Veech, RL; King, MT; Pawlosky, R; Bradshaw, PC; Curtis, W				Veech, Richard L.; King, M. Todd; Pawlosky, Robert; Bradshaw, Patrick C.; Curtis, William			Relationship between inorganic ion distribution, resting membrane potential, and the Delta G ' of ATP hydrolysis: a new paradigm	FASEB JOURNAL			English	Review						Gibbs-Donnan equilibrium; sodium-potassium ATPase; free energy; thermodynamics of ion transport; intravenous fluid therapies	NERVE; CELLS; LIVER	Cell membrane potential and inorganic ion distributions are currently viewed from a kinetic electric paradigm, which ignores thermodynamics. The resting membrane potential is viewed as a diffusion potential. The 9 major inorganic ions found in blood plasma (Ca2+, Na+, Mg2+, H+, Cl-, HCO3-, H2PO4-, and HPO42-) are distributed unequally across the plasma membrane. This unequal distribution requires the energy of ATP hydrolysis through the action of the Na+-K+ ATPase. The cell resting membrane potential in each of 3 different tissues with widely different resting membrane potentials has been shown to be equal to the Nernst equilibrium potential of the most permeant inorganic ion. The energy of the measured distribution of the 9 major inorganic ions between extra- and intracellular phases was essentially equal to the independently measured energy of ATP hydrolysis, showing that the distribution of these 9 major ions was in near-equilibrium with the Delta G ' of ATP. Therefore, thermodynamics does appear to play an essential role in the determination of the cell resting membrane potential and the inorganic ion distribution across the plasma membrane.	[Veech, Richard L.; King, M. Todd; Pawlosky, Robert] NIAAA, Lab Metab Control, NIH, 5625 Fishers Ln,Bldg 5625FL Room 2S-28, Rockville, MD 20852 USA; [Bradshaw, Patrick C.; Curtis, William] East Tennessee State Univ, Coll Med, Dept Biomed Sci, Johnson City, TN USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); East Tennessee State University	Veech, RL (corresponding author), NIAAA, Lab Metab Control, NIH, 5625 Fishers Ln,Bldg 5625FL Room 2S-28, Rockville, MD 20852 USA.	rveech@mail.nih.gov	Bradshaw, Patrick C./AAR-9189-2020	Bradshaw, Patrick C./0000-0002-4591-6798; Curtis, William/0000-0002-9434-2794				Alvarez O, 2017, J GEN PHYSIOL, V149, P911, DOI 10.1085/jgp.201711839; Donnan FG, 1924, CHEM REV, V1, P73, DOI 10.1021/cr60001a003; Gibbs J. W., 1876, T CONNECTICUT ACADEM, V3, P108, DOI DOI 10.2475/AJS.S3-16.96.441; HODGKIN AL, 1951, BIOL REV, V26, P339, DOI 10.1111/j.1469-185X.1951.tb01204.x; Hodgkin AL, 1939, NATURE, V144, P710, DOI 10.1038/144710a0; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; KLEBER AG, 1983, CIRC RES, V52, P442, DOI 10.1161/01.RES.52.4.442; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; MASUDA T, 1990, J BIOL CHEM, V265, P20321; MURPHY WP, 1952, J LAB CLIN MED, V40, P436; Nernst W., 1888, Z F PHYS CHEM, V2U, P613, DOI 10.1515/zpch- 1888-0274.; SKOU JC, 1965, PHYSIOL REV, V45, P596, DOI 10.1152/physrev.1965.45.3.596; Veech RL, 2019, IUBMB LIFE, V71, P565, DOI 10.1002/iub.1997; VEECH RL, 1986, AM J CLIN NUTR, V44, P519, DOI 10.1093/ajcn/44.4.519; Veech RL, 1995, INTEGR PHYS BEH SCI, V30, P283, DOI 10.1007/BF02691602; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; VEECH RL, 1994, ALCOHOL CLIN EXP RES, V18, P1040, DOI 10.1111/j.1530-0277.1994.tb00081.x; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WONDERGEM R, 1980, J CELL PHYSIOL, V102, P193, DOI 10.1002/jcp.1041020210	19	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13126	13130		10.1096/fj.201901942R	http://dx.doi.org/10.1096/fj.201901942R			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690124	Bronze, Green Published			2022-12-26	WOS:000507466100008
J	Wang, YJ; Wei, SM; Song, HH; Zhang, XJ; Wang, WJ; Du, N; Song, TC; Liang, H; Chen, XJ; Wang, YJ				Wang, Yingjie; Wei, Sumei; Song, Honghua; Zhang, Xuejie; Wang, Wenjuan; Du, Nan; Song, Tiancheng; Liang, Hao; Chen, Xiaojun; Wang, Yongjun			Macrophage migration inhibitory factor derived from spinal cord is involved in activation of macrophages following gecko tail amputation	FASEB JOURNAL			English	Article						MIF; nerve; regeneration; immune cells; reptile	FACTOR MIF; CELL-MIGRATION; REGENERATION; EXPRESSION; CYTOKINE; PATHWAY; PROTEIN; REPAIR; VITRO; CD44	Macrophages and their initiation of acute inflammation have been defined to be functionally important in tissue repair and regeneration. In injury-induced production of macrophage migration inhibitory factor (MIF), which has been described as a pleiotropic protein that participates in multiple cellular and biologic processes, it is unknown whether it is involved in the regulation of macrophage events during the epimorphic regeneration. In the model of gecko tail amputation, the protein levels of gecko MIF (gMIF) have been determined to be significantly increased in the nerve cells of the spinal cord in association with the recruitment of macrophages to the lesion site. gMIF has been shown to interact with the CD74 receptor to promote the migration of macrophages through activation of Ras homolog gene family member A and to trigger inflammatory responses through MAPK signaling pathways. The determination of microsphere phagocytosis also indicated that gMIF could enhance macrophage phagocytosis. gMIF-mediated recruitment and activation of macrophages have been found to be necessary for gecko tail regeneration, as evidenced by the depletion of macrophages using clodronate liposomes. The results present a novel function of MIF during the epimorphic regeneration, which is beneficial for insights into its pleiotropic property.	[Wang, Yingjie; Wei, Sumei; Song, Honghua; Zhang, Xuejie; Wang, Wenjuan; Du, Nan; Song, Tiancheng; Liang, Hao; Chen, Xiaojun; Wang, Yongjun] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu & Minist Educ, 19 Qixiu Rd, Nantong 226001, Peoples R China	Nantong University	Wang, YJ (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat Jiangsu & Minist Educ, 19 Qixiu Rd, Nantong 226001, Peoples R China.	wyjbs@ntu.edu.cn		Wang, Yongjun/0000-0001-5040-8926	National Natural Science Foundation of China [31471011, 31871211, 31640042, 31702022]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the National Natural Science Foundation of China (31471011, 31871211, 31640042, and 31702022) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors declare no conflicts of interest.	Alibardi L, 2014, PROG HISTOCHEM CYTO, V48, P143, DOI 10.1016/j.proghi.2013.12.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Burland T G, 2000, Methods Mol Biol, V132, P71; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chalimoniuk M, 2006, NEUROSCIENCE, V139, P1117, DOI 10.1016/j.neuroscience.2005.12.056; Chazaud B, 2014, IMMUNOBIOLOGY, V219, P172, DOI 10.1016/j.imbio.2013.09.001; Crichlow GV, 2009, BIOCHEMISTRY-US, V48, P132, DOI 10.1021/bi8014423; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Dong YY, 2013, J BIOL CHEM, V288, P18204, DOI 10.1074/jbc.M113.463810; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Harrison RA, 2009, BIOCHEM BIOPH RES CO, V390, P171, DOI 10.1016/j.bbrc.2009.09.112; Heit Bryan, 2003, Sci STKE, V2003, pPL5, DOI 10.1126/stke.2003.170.pl5; Koda M, 2004, ACTA NEUROPATHOL, V108, P31, DOI 10.1007/s00401-004-0853-z; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Lan HY, 1997, J EXP MED, V185, P1455, DOI 10.1084/jem.185.8.1455; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leyton-Jaimes MF, 2018, EXP NEUROL, V301, P83, DOI 10.1016/j.expneurol.2017.06.021; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10033; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lue HQ, 2011, CELL SIGNAL, V23, P135, DOI 10.1016/j.cellsig.2010.08.013; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Nguyen-Chi M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0751-2; Nguyen-Chi M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.374; Nishio Y, 2009, ACTA NEUROPATHOL, V117, P321, DOI 10.1007/s00401-008-0476-x; Ogata A, 1998, NEUROSCI LETT, V246, P173, DOI 10.1016/S0304-3940(98)00203-1; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Schrans-Stassen BHGJ, 2005, ANTIOXID REDOX SIGN, V7, P1211, DOI 10.1089/ars.2005.7.1211; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Simkin J, 2017, DEVELOPMENT, V144, P3907, DOI 10.1242/dev.150086; Simkin J, 2017, ELIFE, V6, DOI 10.7554/eLife.24623; Slack JMW, 2017, EMBO REP, V18, P1497, DOI 10.15252/embr.201643795; Su HT, 2017, INFLAMM RES, V66, P209, DOI 10.1007/s00011-016-0995-1; Wang YJ, 2012, INT J BIOCHEM CELL B, V44, P2288, DOI 10.1016/j.biocel.2012.09.011; Yoo SA, 2016, P NATL ACAD SCI USA, V113, pE7917, DOI 10.1073/pnas.1612717113; Yun MH, 2015, ELIFE, V4, DOI 10.7554/eLife.05505; Zhang S, 2014, FASEB J, V28, P4394, DOI 10.1096/fj.14-253625	47	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14798	14810		10.1096/fj.201801966RRR	http://dx.doi.org/10.1096/fj.201801966RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689136	Bronze			2022-12-26	WOS:000507466100133
J	Colamesta, V; Tamburrano, A; Barbara, A; Gentili, A; La Milia, DI; Berloco, F; Cicchetti, A; Piacentini, D; Galluzzi, R; Mastrodonato, SR; Cambieri, A; Ricciardi, W; Laurenti, P				Colamesta, Vittoria; Tamburrano, Andrea; Barbara, Andrea; Gentili, Andrea; La Milia, Daniele Ignazio; Berloco, Filippo; Cicchetti, Americo; Piacentini, Daniele; Galluzzi, Roberta; Mastrodonato, Sergio Riccardo; Cambieri, Andrea; Ricciardi, Walter; Laurenti, Patrizia			Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; PREVALENCE	Flu vaccination, as well as being effective to prevent seasonal influenza, decreases staff illness and absenteeism and reduces costs resulting from loss of productivity. Despite the effectiveness of flu vaccination, the seasonal coverage among healthcare workers is usually low. The aim of this retrospective observational study was to analyze the vaccination coverage rate among all employees (healthcare workers and administrative staff) of a large teaching hospital in Rome during the 2017-2018 influenza season, to perform a cost-consequence analysis of influenza vaccination (by evaluating the absenteeism due to illness in the epidemic period), and to assess the impact of vaccination in terms of both costs and sick days. The flu vaccination coverage rate was 9.8% among 4631 healthcare workers and 852 administrative employees. The human capital approach estimated a loss of productivity equal to 297.06 (sic) for each vaccinated worker and 517.22 (sic) for each unvaccinated worker (cost-outcome ratio: 120.07 (sic)/sick day). Applying the friction cost method, a loss of productivity equal to 237.65 (sic) for each vaccinated worker and 413.78 (sic) for each unvaccinated worker (cost-outcome ratio: 104.19 (sic)/sick day) was found. These results confirm the benefits of the flu vaccination for the society and the company. This allowed the management to grant one hour of permission to the flu-vaccinated workers in the following annual vaccination campaign (2018-2019).	[Colamesta, Vittoria; Tamburrano, Andrea; Barbara, Andrea; Gentili, Andrea; Ricciardi, Walter; Laurenti, Patrizia] Univ Cattolica Sacro Cuore, Sect Hyg, Inst Publ Hlth, Rome, Italy; [Colamesta, Vittoria] UOC Direz Sanitaria S Spirito & Nuovo Regina Marg, Local Hlth Unit ASL RM1, Rome, Italy; [La Milia, Daniele Ignazio; Berloco, Filippo; Cambieri, Andrea] Fdn Policlin Univ A Gemelli IRCCS, Hosp Hlth Management, Rome, Italy; [Cicchetti, Americo] Univ Cattolica Sacro Cuore, Postgrad Sch Hlth Econ & Management ALTEMS, Rome, Italy; [Piacentini, Daniele; Galluzzi, Roberta; Mastrodonato, Sergio Riccardo] Fdn Policlin Univ A Gemelli IRCCS, Human Resources Management, Rome, Italy; [Ricciardi, Walter; Laurenti, Patrizia] Fdn Policlin Univ A Gemelli IRCCS, Dept Woman & Child Hlth & Publ Hlth, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Tamburrano, A (corresponding author), Univ Cattolica Sacro Cuore, Sect Hyg, Inst Publ Hlth, Rome, Italy.	andrea.tamburrano01@icatt.it	Tamburrano, Andrea/AAD-8632-2019; Ricciardi, Walter/AAB-2056-2019; Cicchetti, Americo/AAP-9403-2021; LAURENTI, Patrizia/AAB-8268-2022; Berloco, Filippo/W-3749-2019; Barbara, Andrea/J-3954-2018	Tamburrano, Andrea/0000-0001-9903-2624; Ricciardi, Walter/0000-0002-5655-688X; LAURENTI, Patrizia/0000-0002-8532-0593; Berloco, Filippo/0000-0001-5752-0064; Cicchetti, Americo/0000-0002-4633-9195; Barbara, Andrea/0000-0001-5321-4537				Alicino C, 2015, HUM VACC IMMUNOTHER, V11, P95, DOI 10.4161/hv.34362; ALTEMS (Alta Scuola di Economia e Management dei Sistemi Sanitari), 2017, IMP EC FISC VACC AD; Amodio E, 2014, J HOSP INFECT, V86, P182, DOI 10.1016/j.jhin.2014.01.005; Amodio E, 2010, EPIDEMIOL BIOSTAT PU, V7, P311; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2012, GLOB ACT PLAN INFL V; [Anonymous], 2019, ARANAGENZIA; [Anonymous], 2005, WKLY EPIDEMIOL REC; [Anonymous], 2005, NOMENCLATORE TARIFFA; Barbara A, 2017, EUR J PUBLIC HLTH S3, V27, DOI [10.1093/eurpub/ckx187.380, DOI 10.1093/EURPUB/CKX187.380]; Barbara A, 2019, HUM VACC IMMUNOTHER, V15, P967, DOI 10.1080/21645515.2018.1556076; Capri S, 2018, HUM VACC IMMUNOTHER, V14, P1331, DOI 10.1080/21645515.2018.1438792; CDC, AC DET FREQ ASK QUES; Cella M. T., 2005, MED LAVORO; Corsaro A, 2017, MED SCI MONITOR, V23, P4574, DOI 10.12659/MSM.903009; ECDC, 2018, SEAS INFL VACC; Eichner M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2399-4; Esposito S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-422; Gazzetta Ufficiale della Repubblica Italiana, 2013, GAZZETTA UFFICIALE R; Gianino M. M., 2009, EPIDEMIOLOGIA PREVEN; Gianino MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182510; Gjini E, 2016, EPIDEMICS-NETH, V14, P71, DOI 10.1016/j.epidem.2015.11.001; Hammond G. W., 1984, CANADIAN MED ASS J; Karafillakis E, 2016, VACCINE, V34, P5013, DOI 10.1016/j.vaccine.2016.08.029; Kheiraoui F, 2015, QIJPH, V4; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; La Torre G, 2011, HUM VACCINES, V7, P728, DOI 10.4161/hv.7.7.15413; Mannocci A, 2010, REV HEALTH CARE, V1, P27, DOI 10.7175/rhc.v1i1.15; Mauskopf JA, 1998, PHARMACOECONOMICS, V13, P277, DOI 10.2165/00019053-199813030-00002; Mereckiene J., 2018, SEASONAL INFLUENZA V; Ministero della Salute, 2017, PIAN NAZ PREV VACC 2; Nguyen-Van-Tam J, 1999, INFECT CONT HOSP EP, V20, P691, DOI 10.1086/501568; Pradas-Velasco R, 2008, PHARMACOECONOMICS, V26, P45, DOI 10.2165/00019053-200826010-00005; Who.int, 2018, INFL SEAS; World Health Organization, 2019, VACCINES; Yassi A, 1991, Can J Infect Dis, V2, P101	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225326	10.1371/journal.pone.0225326	http://dx.doi.org/10.1371/journal.pone.0225326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725788	Green Published, gold			2022-12-26	WOS:000532764500077
J	Ryt-Hansen, P; Pedersen, AG; Larsen, I; Krog, JS; Kristensen, CS; Larsen, LE				Ryt-Hansen, Pia; Pedersen, Anders Gorm; Larsen, Inge; Krog, Jesper Schak; Kristensen, Charlotte Sonne; Larsen, Lars Erik			Acute Influenza A virus outbreak in an enzootic infected sow herd: Impact on viral dynamics, genetic and antigenic variability and effect of maternally derived antibodies and vaccination	PLOS ONE			English	Article							RESPIRATORY-DISEASE; IMMUNE-RESPONSES; SWINE; HEMAGGLUTININ; EVOLUTION; INFERENCE; PIGLETS; PIGS	Influenza A virus (IAV) is a highly contagious pathogen in pigs. Swine IAV (swIAV) infection causes respiratory disease and is thereby a challenge for animal health, animal welfare and the production economy. In Europe, the most widespread strategy for controlling swIAV is implementation of sow vaccination programs, to secure delivery of protective maternally derived antibodies (MDAs) to the newborn piglets. In this study we report a unique case, where a persistently swIAV (A/sw/Denmark/P5U4/2016(H1N1)) infected herd experienced an acute outbreak with a new swIAV subtype (A/sw/Denmark/HB4280U1/2017(H1N2)) and subsequently decided to implement a mass sow vaccination program. Clinical registrations, nasal swabs and blood samples were collected from four different batches of pigs before and after vaccination. Virus isolation, sequencing of the virus strain and hemagglutinin inhibition (HI) tests were performed on samples collected before and during the outbreak and after implementation of mass sow vaccination. After implementation of the sow mass vaccination, the time of infection was delayed and the viral load significantly decreased. An increased number of pigs, however, tested positive at two consecutive sampling times indicating prolonged shedding. In addition, a significantly smaller proportion of the 10-12 weeks old pigs were seropositive by the end of the study, indicating an impaired induction of antibodies against swIAV in the presence of MDAs. Sequencing of the herd strains revealed major differences in the hemagglutinin gene of the strain isolated before- and during the acute outbreak despite that, the two strains belonged to the same HA lineage. The HI tests confirmed a limited degree of cross-reaction between the two strains. Furthermore, the sequencing results of the hemagglutinin gene obtained before and after implementation of mass sow vaccination revealed an increased substitution rate and an increase in positively selected sites in the globular head of the hemagglutinin after vaccination.	[Ryt-Hansen, Pia; Krog, Jesper Schak; Larsen, Lars Erik] Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark; [Pedersen, Anders Gorm] Tech Univ, Dept Hlth Technol, Sect Bioinformat, Lyngby, Denmark; [Larsen, Inge; Larsen, Lars Erik] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg C, Denmark; [Kristensen, Charlotte Sonne] Danish Pig Res Ctr, SEGES, Aarhus N, Denmark	Technical University of Denmark; Technical University of Denmark; University of Copenhagen	Ryt-Hansen, P (corresponding author), Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark.	pryt@vet.dtu.dk	Larsen, Lars Erik/G-3827-2015	Larsen, Lars Erik/0000-0003-0730-5555; Pedersen, Anders Gorm/0000-0001-9650-8965; Larsen, Inge/0000-0003-4575-2241				Allerson MW, 2014, TRANSBOUND EMERG DIS, V61, P490, DOI 10.1111/tbed.12053; [Anonymous], 2017, VET RES, V48, P63, DOI [10.1186/s13567-017-, DOI 10.1186/S13567-017-]; Babon JAB, 2009, HUM IMMUNOL, V70, P711, DOI 10.1016/j.humimm.2009.06.004; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Bouckaert R., 2016, BEAST 2 SOFTWARE PLA; BROWN IH, 1993, VET REC, V132, P598, DOI 10.1136/vr.132.24.598; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cador C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163672; Cador C, 2016, VET RES, V47, DOI 10.1186/s13567-016-0365-6; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chamba Pardo FO, 2017, FRONT VET SCI, V4; Corzo CA, 2014, TRANSBOUND EMERG DIS, V61, P28, DOI 10.1111/j.1865-1682.2012.01367.x; Deblanc C, 2018, VET MICROBIOL, V216, P142, DOI 10.1016/j.vetmic.2018.01.019; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Diaz A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11272-3; Diaz A, 2017, J VIROL, V91, DOI 10.1128/JVI.00745-17; Edgar RC, 2013, MUSCLE MULTIPLE SEQU; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Ferreira JB, 2017, VET RES, V48, DOI 10.1186/s13567-017-0466-x; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Goldman N., 1994, MOL BIOL EVOL, V11; Goulding J, 2011, J INFECT DIS, V204, P1086, DOI 10.1093/infdis/jir467; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Holmes EC, 2013, CURR OPIN VIROL, V3, P180, DOI 10.1016/j.coviro.2012.12.003; IDT Biologika GmbH, ANN SUMM PROD CHAR R, P1; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jung Y, 2005, J COMP PATHOL, V132, P179, DOI 10.1016/j.jcpa.2004.09.008; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Krog JS, 2016, OVERVAGNING INFLUENZ; Loeffen WLA, 2009, VET MICROBIOL, V137, P45, DOI 10.1016/j.vetmic.2009.01.004; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Matsuzaki Y, 2014, J VIROL, V88, P12364, DOI 10.1128/JVI.01381-14; Nagy A, 2010, ARCH VIROL, V155, P665, DOI 10.1007/s00705-010-0636-x; National Center for Biotechnology Information, BAS LOC AL SEARCH TO; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Rajao DS, 2016, VIROLOGY, V491, P79, DOI 10.1016/j.virol.2016.01.015; RAMBAUT A, 2006, FIGTREE; RAMBAUT A, 2018, SYST BIOL, V67, P901, DOI [10.1093/sysbio/syy032, DOI 10.1093/SYSBIO/SYY032, DOI 10.1093/SYSBI0/SYY032]; Renshaw H., 1975, AM J VET RES, V36; RENSHAW HW, 1975, AM J VET RES, V36, P5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rose N, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-72; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; Ryt-Hansen P, 2019, RES VET SCI, V127, P47, DOI 10.1016/j.rvsc.2019.10.015; Ryt-Hansen P, 2019, VET RES, V50, DOI 10.1186/s13567-019-0655-x; Salmon H, 2009, DEV COMP IMMUNOL, V33, P384, DOI 10.1016/j.dci.2008.07.007; Scholtissek C, 1995, VIRUS GENES, V11, P209, DOI 10.1007/BF01728660; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Simon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115815; Simon-Grife M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-24; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Van Reeth K, 2013, CURR TOP MICROBIOL, V370, P173, DOI 10.1007/82_2012_266; Vincent AL, 2017, VET MICROBIOL, V206, P35, DOI 10.1016/j.vetmic.2016.11.026; Watson SJ, 2015, J VIROL, V89, P9920, DOI 10.1128/JVI.00840-15; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; Yang HL, 2012, EMERG INFECT DIS, V18, P1144, DOI 10.3201/eid1807.120009; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	62	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224854	10.1371/journal.pone.0224854	http://dx.doi.org/10.1371/journal.pone.0224854			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725751	Green Published, gold			2022-12-26	WOS:000532764500033
J	Wu, Z; Zhang, X; Hei, ZH; Hou, LY				Wu, Zhen; Zhang, Xu; Hei, Zhihui; Hou, Liyun			Identifying candidate diagnostic markers for early stage of non-small cell lung cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; THERAPEUTIC TARGET; FANCONI-ANEMIA; CENP-F; EXPRESSION; OVEREXPRESSION; PROTEIN; GENES; PATHWAY; CYCLE	We performed a series of bioinformatics analysis on a set of important gene expression data with 76 samples in early stage of non-small cell lung cancer, including 40 adenocarcinoma samples, 16 squamous cell carcinoma samples and 20 normal samples. In order to identify the specific markers for diagnosis, we compared the two subtypes with the normal samples respectively to determine the gene expression characteristics. Through the multi-dimensional scaling classification, we found that the samples were clustered well according to the disease cases. Based on the classification results and using empirical Bayes moderation and treat method, 486 important genes associated with the disease were identified. We constructed gene functions and gene pathways to verify our result and explain the pathogenicity factor and process. We generated a protein-protein interaction network based on the mutual interaction between the selected genes and found that the top thirteen hub genes were highly associated with lung cancer or some other cancers including five newly found genes through our method. The results of this study indicated that contrast on the gene expression between different subtypes and normal samples provides important information for the detection of non-small cell lung cancer and helps exploration of the disease pathogenesis.	[Wu, Zhen; Zhang, Xu; Hou, Liyun] Southwest Univ, Sch Math & Stat, Chongqing 400715, Peoples R China; [Hei, Zhihui] Chongqing Ninth Peoples Hosp, Dept Pediat Respirat, Chongqing 400700, Peoples R China	Southwest University - China	Zhang, X (corresponding author), Southwest Univ, Sch Math & Stat, Chongqing 400715, Peoples R China.	zhangxu1107@163.com	Hou, Liyun/HHD-2768-2022; He, Zhihui/B-1932-2018	He, Zhihui/0000-0002-4979-2550	National Science Foundation of China [11701471]; Basic Science and Frontier Technology Research Project of Chongqing [cstc2017jcyjAX0476]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Science and Frontier Technology Research Project of Chongqing	Xu Zhang has received the award No.11701471 from the National Science Foundation of China (http://www.nsfc.gov.cn/) and cstc2017jcyjAX0476 from Basic Science and Frontier Technology Research Project of Chongqing (http://kjj.cq.gov.cn).The funders did not play a role in this study.	Caputi M, 2005, J CELL PHYSIOL, V205, P319, DOI 10.1002/jcp.20424; Chen HL, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2259; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Deguchi A, 2005, CANCER RES, V65, P2330; Duan WR, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00368; Fimia GM, 2001, J CELL SCI, V114, P1971; Guo YL, 2010, J MED GENET, V47, P616, DOI 10.1136/jmg.2009.074252; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2019, MED SCI MONITOR, V25, P4333, DOI 10.12659/MSM.916962; Huang H, 2015, INT J CLIN EXP PATHO, V8, P11537; Kato T, 2012, J SURG ONCOL, V106, P423, DOI 10.1002/jso.23109; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kuo WY, 2015, ONCOTARGET, V6, P8663, DOI 10.18632/oncotarget.3536; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Li SC, 2018, CANCER MANAG RES, V10, P3383, DOI 10.2147/CMAR.S173941; Li Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34160-w; Liang B, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0829-6; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Liu WW, 2017, INT J MOL MED, V40, P731, DOI 10.3892/ijmm.2017.3079; Martucci D, 2004, STUD HEALTH TECHNOL, V102, P108; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Park JY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.152; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schneider MA, 2017, INT J ONCOL, V50, P365, DOI 10.3892/ijo.2017.3834; Shigeishi H, 2001, PATHOBIOLOGY, V69, P24, DOI 10.1159/000048754; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soria JC, 2000, CANCER RES, V60, P4000; Spira A, 2004, NEW ENGL J MED, V350, P2009; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tam TY, 2018, MONOGR RES NOTES MAT, P91; Tang Q, 2018, ONCOL LETT, V16, P2344, DOI 10.3892/ol.2018.8882; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022	46	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225080	10.1371/journal.pone.0225080	http://dx.doi.org/10.1371/journal.pone.0225080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ9HP	31726467	Green Published, gold			2022-12-26	WOS:000523570600001
J	Pouliot, GP; Degar, J; Hinze, L; Kochupurakkal, B; Vo, CD; Burns, MA; Moreau, L; Ganesa, C; Roderick, J; Peirs, S; Menten, B; Loh, ML; Hunger, SP; Silverman, LB; Harris, MH; Stevenson, KE; Weinstock, DM; Weng, AP; Van Vlierberghe, P; D'Andrea, AD; Gutierrez, A				Pouliot, Gayle P.; Degar, James; Hinze, Laura; Kochupurakkal, Bose; Vo, Chau D.; Burns, Melissa A.; Moreau, Lisa; Ganesa, Chirag; Roderick, Justine; Peirs, Sofie; Menten, Bjorn; Loh, Mignon L.; Hunger, Stephen P.; Silverman, Lewis B.; Harris, Marian H.; Stevenson, Kristen E.; Weinstock, David M.; Weng, Andrew P.; Van Vlierberghe, Pieter; D'Andrea, Alan D.; Gutierrez, Alejandro			Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia	PLOS ONE			English	Article							DNA-REPAIR DEFECT; POLY(ADP-RIBOSE) POLYMERASE; HOMOLOGOUS RECOMBINATION; SUSCEPTIBILITY GENE; GENOMIC LANDSCAPE; ANEMIA GENE; CANCER; BREAST; IDENTIFICATION; INACTIVATION	BRCA2 (also known as FANCD1) is a core component of the Fanconi pathway and suppresses transformation of immature T-cells in mice. However, the contribution of Fanconi-BRCA pathway deficiency to human T-cell acute lymphoblastic leukemia (T-ALL) remains undefined. We identified point mutations in 9 (23%) of 40 human T-ALL cases analyzed, with variant allele fractions consistent with heterozygous mutations early in tumor evolution. Two of these mutations were present in remission bone marrow specimens, suggesting germline alterations. BRCA2 was the most commonly mutated gene. The identified Fanconi-BRCA mutations encode hypomorphic or null alleles, as evidenced by their inability to fully rescue Fanconi-deficient cells from chromosome breakage, cytotoxicity and/or G2/M arrest upon treatment with DNA cross-linking agents. Disabling the tumor suppressor activity of the Fanconi-BRCA pathway is generally thought to require biallelic gene mutations. However, all mutations identified were monoallelic, and most cases appeared to retain expression of the wild-type allele. Using isogenic T-ALL cells, we found that BRCA2 haploinsufficiency induces selective hypersensitivity to ATR inhibition, in vitro and in vivo. These findings implicate Fanconi-BRCA pathway haploinsufficiency in the molecular pathogenesis of T-ALL, and provide a therapeutic rationale for inhibition of ATR or other druggable effectors of homologous recombination.	[Pouliot, Gayle P.; Degar, James; Hinze, Laura; Vo, Chau D.; Burns, Melissa A.; Moreau, Lisa; Silverman, Lewis B.; D'Andrea, Alan D.; Gutierrez, Alejandro] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Pouliot, Gayle P.; Burns, Melissa A.; Silverman, Lewis B.; Gutierrez, Alejandro] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kochupurakkal, Bose; Moreau, Lisa; Ganesa, Chirag; D'Andrea, Alan D.] Dana Farber Canc Inst, Ctr DNA Damage & Repair, Boston, MA 02115 USA; [Kochupurakkal, Bose; Moreau, Lisa; Ganesa, Chirag; D'Andrea, Alan D.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Roderick, Justine] Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Peirs, Sofie; Menten, Bjorn; Van Vlierberghe, Pieter] Univ Ghent, Dept Biomol Med, Ghent, Belgium; [Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Harris, Marian H.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Stevenson, Kristen E.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Weinstock, David M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Weng, Andrew P.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Pouliot, Gayle P.] AstraZeneca, Waltham, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Massachusetts System; University of Massachusetts Worcester; Ghent University; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; British Columbia Cancer Agency; AstraZeneca	Gutierrez, A (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Gutierrez, A (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	alejandro.gutierrez@childrens.harvard.edu	Menten, Björn/B-3072-2013; Van Vlierberghe, Pieter/G-8894-2013	Loh, Mignon/0000-0003-4099-4700; Van Vlierberghe, Pieter/0000-0001-9063-7205; Degar, James/0000-0002-5387-9069	NIH [R01 CA193651]; Boston Children's Hospital Translational Research Program; William Lawrence and Blanche Hughes Foundation; COG Chair's grant [U10 CA98543]; COG Statistical Center [U10 CA98413]; COG Specimen Banking [U24 CA114766]; COG Operations Center [U10 CA180886]; COG Statistics and Data Center [U10 CA180899]; Research Foundation Flanders (FWO); Ghent University Special Research Fund (BOF); Flemish cancer society Stand Up To Cancer (KOTK); Boston Children's Hospital; NATIONAL CANCER INSTITUTE [U10CA180886, U10CA180899, R01CA193651] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital Translational Research Program; William Lawrence and Blanche Hughes Foundation; COG Chair's grant; COG Statistical Center; COG Specimen Banking; COG Operations Center; COG Statistics and Data Center; Research Foundation Flanders (FWO)(FWO); Ghent University Special Research Fund (BOF)(Ghent University); Flemish cancer society Stand Up To Cancer (KOTK); Boston Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R01 CA193651, the Boston Children's Hospital Translational Research Program, and the William Lawrence and Blanche Hughes Foundation. The Children's Oncology Group work was supported by U10 CA98543 (COG Chair's grant), U10 CA98413 (COG Statistical Center), U24 CA114766 (COG Specimen Banking), U10 CA180886 (COG Operations Center), and U10 CA180899 (COG Statistics and Data Center). S.P.H. is the Jeffrey E. Perelman Distinguished Chair in the Department of Pediatrics, Children's Hospital of Philadelphia. P.V.V. and S.P. were supported by grants from the Research Foundation Flanders (FWO), the Ghent University Special Research Fund (BOF) and the Flemish cancer society Stand Up To Cancer (KOTK). A.G. is supported by an Investigatorship at Boston Children's Hospital. AstraZeneca provided AZD6738.	Alter BP, 2014, BEST PRACT RES CL HA, V27, P214, DOI 10.1016/j.beha.2014.10.002; Aries IM, 2018, J EXP MED, V215, P3094, DOI 10.1084/jem.20180570; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Federico MB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005792; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Borriello A, 2007, LEUKEMIA, V21, P72, DOI 10.1038/sj.leu.2404468; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48; Cerabona D, 2016, EXP HEMATOL, V44, P352, DOI 10.1016/j.exphem.2016.01.009; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; Dunn J, 2006, CANCER RES, V66, P11140, DOI 10.1158/0008-5472.CAN-06-0563; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foote KM, 2018, J MED CHEM, V61, P9889, DOI 10.1021/acs.jmedchem.8b01187; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; Friedman LS, 1998, CANCER RES, V58, P1338; Frousios K, 2013, GENOMICS, V102, P223, DOI 10.1016/j.ygeno.2013.06.005; Girardi T, 2017, BLOOD, V129, P1113, DOI 10.1182/blood-2016-10-706465; Goldsby RE, 1999, J PEDIAT HEMATOL ONC, V21, P240, DOI 10.1097/00043426-199905000-00014; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; Hirano S, 2005, EMBO J, V24, P418, DOI 10.1038/sj.emboj.7600534; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kiiski JI, 2014, P NATL ACAD SCI USA, V111, P15172, DOI 10.1073/pnas.1407909111; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu Y, 2017, NAT GENET, V49, P1211, DOI 10.1038/ng.3909; Madubata CJ, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0032-5; Maung KZY, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0090-7; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Naf D, 1998, MOL CELL BIOL, V18, P5952; Neidhardt G, 2017, JAMA ONCOL, V3, P1245, DOI 10.1001/jamaoncol.2016.5592; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Obermeier K, 2016, ONCOGENE, V35, P3796, DOI 10.1038/onc.2015.448; Pathania S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6496; Pulsipher M, 1998, MOL MED, V4, P468, DOI 10.1007/BF03401752; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rischewski JR, 2000, KLIN PADIATR, V212, P174, DOI 10.1055/s-2000-9673; Sanchez-Martin M, 2017, BLOOD, V129, P1124, DOI 10.1182/blood-2016-09-692582; Sawyer SL, 2015, CANCER DISCOV, V5, P135, DOI 10.1158/2159-8290.CD-14-1156; Sholl LM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87062; Skoulidis F, 2010, CANCER CELL, V18, P499, DOI 10.1016/j.ccr.2010.10.015; Smetsers S, 2012, FAM CANCER, V11, P661, DOI 10.1007/s10689-012-9553-3; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Svojgr K, 2016, EUR J MED GENET, V59, P152, DOI 10.1016/j.ejmg.2015.11.013; Tate JG, 2018, NUCL ACIDS RES; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Townsend EC, 2016, CANCER CELL, V29, P574, DOI 10.1016/j.ccell.2016.03.008; Tubbs A, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.002; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Yaeger R, 2018, CANCER CELL, V33, P125, DOI 10.1016/j.ccell.2017.12.004; 1999, JNCI J NATL CANCER I, V91, P1310	63	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0221288	10.1371/journal.pone.0221288	http://dx.doi.org/10.1371/journal.pone.0221288			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721781	Green Submitted, Green Published, gold			2022-12-26	WOS:000532720700004
J	Feng, SW; Kong, DC; Ding, WH; Ru, ZG; Li, G; Niu, LY				Feng, Suwei; Kong, Dechuan; Ding, Weihua; Ru, Zhengang; Li, Gan; Niu, Liyuan			A novel wheat lodging resistance evaluation method and device based on the thrust force of the stalks	PLOS ONE			English	Article							CULTIVARS; STEM	Wind speed is the most essential factor causing wheat lodging. Accurate understanding of the wind speed characteristics at near-surface layer of wheat fields and its effect on lodging is the basis of objective evaluation of wheat lodging resistance. In this paper, the characteristics of wind speed at the near-surface layer of wheat fields and their impact on lodging were studied. A new device was proposed for directly measuring the critical thrust force of wheat population lodging resistance in the field based on the black box method. A novel wheat stem lodging resistance evaluation method/model was established based on the critical thrust force of wheat population stem lodging and the wind speed characteristics of field near-surface layer. The method used the lodging critical wind speed as the index of wheat lodging resistance, which was verified by wind tunnel and field experiment. The results showed that there was a significant positive correlation between the critical wind speed of wheat lodging resistance and its critical thrust force. The values of wheat canopy apparent roughness length, wind attack angle, ventilation coefficient and other wind field characteristics had important effects on the calculation of wheat lodging resistance critical wind speed. The method can eliminate bias when calculating wheat lodging resistance by considering only one or a few indicators and the results of field lodging evaluation were consistent with those of field lodging survey. The method is simple and can be used to assess the lodging resistance of wheat, select extension regions for wheat varieties, and evaluate lodging factors in the field.	[Feng, Suwei; Ding, Weihua; Ru, Zhengang; Li, Gan; Niu, Liyuan] Henan Inst Sci & Technol, Wheat Ctr, Xinxiang, Henan, Peoples R China; [Feng, Suwei; Ding, Weihua; Ru, Zhengang; Li, Gan; Niu, Liyuan] Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Henan, Peoples R China; [Kong, Dechuan] Henan Inst Sci & Technol, Coll Artificial Intelligence, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology; Henan Institute of Science & Technology; Henan Institute of Science & Technology	Niu, LY (corresponding author), Henan Inst Sci & Technol, Wheat Ctr, Xinxiang, Henan, Peoples R China.; Niu, LY (corresponding author), Henan Inst Sci & Technol, Coll Life Sci & Technol, Xinxiang, Henan, Peoples R China.	nly1962@163.com			National Natural Science Foundation of China [31371525]; High-Level Personnel Research Project of Henan Institute of Science and Technology [2011002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-Level Personnel Research Project of Henan Institute of Science and Technology	This work was supported by the National Natural Science Foundation of China (No. 31371525) (http://www.nsfc.gov.cn/) and the High-Level Personnel Research Project of Henan Institute of Science and Technology (No. 2011002) (http://www.hist.edu.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acreche MM, 2011, FIELD CROP RES, V122, P40, DOI 10.1016/j.fcr.2011.02.004; Baker CJ, 1998, J THEOR BIOL, V194, P587, DOI 10.1006/jtbi.1998.0778; Berry PM, 2007, EUPHYTICA, V154, P165, DOI 10.1007/s10681-006-9284-3; Berry PM, 2004, ADV AGRON, V84, P217, DOI 10.1016/S0065-2113(04)84005-7; Berry PM, 2003, AGR FOREST METEOROL, V119, P167, DOI 10.1016/S0168-1923(03)00139-4; Berry PM, 2003, FIELD CROP RES, V80, P111, DOI 10.1016/S0378-4290(02)00174-0; CROOK MJ, 1995, J EXP BOT, V46, P931, DOI 10.1093/jxb/46.8.931; [冯素伟 Feng Suwei], 2015, [华北农学报, Acta Agriculturae Boreali-Sinica], V30, P69; [冯素伟 Feng Suwei], 2015, [麦类作物学报, Journal of Triticeae Crops], V35, P334; [冯素伟 Feng Suwei], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P57; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Guo C. H., 2010, AGR ENG, V26, P151; Guo QQ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040640; Guo QQ, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18061852; Guo YuMing, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P14; Harasim E, 2016, ROM AGRIC RES, V33, P205; Huang W, 2018, CROP MAGAZINE, V185, P19; Kelbert AJ, 2004, EUPHYTICA, V136, P211, DOI 10.1023/B:EUPH.0000030668.62653.0d; Kelbert AJ, 2004, PLANT BREEDING, V123, P349, DOI 10.1111/j.1439-0523.2004.00976.x; LIU HP, 2012, SHANDONG AGR SCI, V44, P55; Liu S, 1989, METEOROLOGICAL MONTH, V15, P8; Mao Yuhao, 2006, Acta Meteorologica Sinica, V64, P325; MURPHY H. C., 1958, AGRON JOUR, V50, P609; Niu LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157677; Niu LY, 2012, FIELD CROP RES, V139, P1, DOI 10.1016/j.fcr.2012.10.014; Peng DL, 2014, FIELD CROP RES, V157, P1, DOI 10.1016/j.fcr.2013.11.015; Sterling A, 2003, AGR FOREST METEOROL, V119, P149, DOI 10.1016/S0168-1923(03)00140-0; Su H.B, 1994, CHINESE J ATMOSPHERI, V18, P739, DOI [10.3878/j.issn.1006-9895.1994.06.11, DOI 10.3878/J.ISSN.1006-9895.1994.06.11]; Sulaiman NF, 2015, EFFECTS SOIL PHYS CO; Wang Dan, 2016, Yingyong Shengtai Xuebao, V27, P1496, DOI 10.13287/j.1001-9332.201605.039; Wang Y., 1997, J TRITICEAE CROPS, V17, P28; Wong D, 1982, ACTA METEOROLOGY, V40, P335; Xiao ShiHe, 2002, Agricultural Sciences in China, V1, P280; Xiao Y. G., 2015, FRONT AGRIC SCI ENG, V2, P168, DOI [DOI 10.15302/J-FASE-2015061, 10.15302/J-FASE-2015061]; [徐安 XU An], 2010, [空气动力学学报, Acta Aerodynamica Sinica], V28, P23; Yang S., 2006, CHINA MEASUREMENT TE, V32, P47; [杨振 YANG Zhen], 2007, [热带气象学报, Journal of Tropical Meteorology], V23, P413; [姚金保 Yao Jinbao], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P208; Zhang H, 1998, ATMOS SCI SINICA, V22, P11; Zhang MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187543; Zhong Y., 2009, AGR CLIMATOLOGY, P411; Zhu XinKai, 2006, Journal of Triticeae Crops, V26, P87	42	3	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224732	10.1371/journal.pone.0224732	http://dx.doi.org/10.1371/journal.pone.0224732			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714911	gold, Green Published			2022-12-26	WOS:000532710400011
J	Singh, H; Nugent, Z; Walkty, A; Yu, BN; Lix, LM; Targownik, LE; Bernstein, CN; Witt, J				Singh, Harminder; Nugent, Zoann; Walkty, A.; Yu, B. Nancy; Lix, Lisa M.; Targownik, Laura E.; Bernstein, Charles N.; Witt, Julia			Direct cost of health care for individuals with community associated Clostridium difficile infections: A population-based cohort study	PLOS ONE			English	Article							ADMINISTRATIVE DATA; DIAGNOSIS; EPIDEMIOLOGY; DISEASE; UPDATE; SURVEILLANCE; PREVALENCE; VANCOMYCIN; CARRIAGE; DIARRHEA	Background Even though the incidence of community-acquired Clostridium difficile infection (CDI) is reported to be increasing, few studies have reported on the healthcare costs of community-acquired CDI. We estimated cost of care for individuals with community-associated CDI and compared with that for matched controls without CDI in the time period of six months before to one year after CDI. Methods All individuals in the province of Manitoba, diagnosed with CDI between July 2005 and March 2015 were matched up to 4 individuals without CDI. Health care utilization and direct costs resulting from hospitalizations, physician reimbursement claims and prescriptions were determined from the population based provincial databases. Quantile regressions were performed to determine predictors of cost of individuals with community associated CDI. Results Of all CDIs, 30-40% in each period of the study had community-associated CDI; of which 12% were recurrent CDIs. The incremental median and 90th percentile cost of care for individuals with community-associated CDI was $800 and $16,000 respectively in the six months after CDI diagnosis. After adjustment for age, co-morbidities, sex, socioeconomic status and magnitude of health care utilization prior to CDI, the median incremental cost for recurrent CDI was $1,812 and that for a subsequent episode of CDI was $3,139 compared to those with a single community-associated CDI episode. The median cost for a prescription of Vancomycin was $316 (IQR 209-489). Conclusions Health care costs of an episode of community-associated CDI have been much more than the cost of antibiotic treatment. Our study provides population-based data for formal cost effectiveness analysis for use of newer treatments for community-associated CDI.	[Singh, Harminder; Nugent, Zoann; Targownik, Laura E.; Bernstein, Charles N.] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada; [Singh, Harminder; Walkty, A.; Targownik, Laura E.; Bernstein, Charles N.] Univ Manitoba, Max Rady Coll Med, Dept Internal Med, Winnipeg, MB, Canada; [Singh, Harminder; Nugent, Zoann] CancerCare Manitoba, Res Inst, Winnipeg, MB, Canada; [Singh, Harminder; Yu, B. Nancy; Lix, Lisa M.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Yu, B. Nancy] Manitoba Hlth Seniors & Act Living, Publ Hlth Branch, Winnipeg, MB, Canada; [Witt, Julia] Univ Manitoba, Dept Econ, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation; University of Manitoba; University of Manitoba	Singh, H (corresponding author), Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada.; Singh, H (corresponding author), Univ Manitoba, Max Rady Coll Med, Dept Internal Med, Winnipeg, MB, Canada.; Singh, H (corresponding author), CancerCare Manitoba, Res Inst, Winnipeg, MB, Canada.; Singh, H (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.	Harminder.singh@umanitoba.ca	Singh, Harminder/E-1848-2012; Targownik, Laura/ABD-2427-2021	Singh, Harminder/0000-0002-0024-5855; Targownik, Laura/0000-0002-4366-9076; Singh, Harminder/0000-0002-9354-2356	Merck Investigator Studies Program	Merck Investigator Studies Program	Supported by a research grant from the Merck Investigator Studies Program to HS. The opinions expressed in this paper are those of the authors. The study sponsor had no role in study design, the collection, analysis, and interpretation of data, the writing of the report; and the decision to submit the manuscript for publication.	Alfa MJ, 2002, DIAGN MICR INFEC DIS, V43, P257, DOI 10.1016/S0732-8893(02)00413-3; Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Chateau D, 2012, CAN J PUBLIC HEALTH, V103, pS23, DOI 10.1007/BF03403825; Choi KB, 2019, J HOSP INFECT, V102, P141, DOI 10.1016/j.jhin.2019.01.019; Dubberke ER, 2011, CLIN INFECT DIS, V53, P20, DOI 10.1093/cid/cir246; Dupont HL, 2013, CLIN GASTROENTEROL H, V11, P1216, DOI 10.1016/j.cgh.2013.03.016; Gabriel L, 2014, J HOSP INFECT, V88, P12, DOI 10.1016/j.jhin.2014.04.011; Galdys AL, 2014, J CLIN MICROBIOL, V52, P2406, DOI 10.1128/JCM.00222-14; Goto M, 2014, CLIN INFECT DIS, V58, P688, DOI 10.1093/cid/cit737; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kozyrskyj AL, 1998, ANN PHARMACOTHER, V32, P1152, DOI 10.1345/aph.18117; Lambert PJ, 2009, INFECT CONT HOSP EP, V30, P945, DOI 10.1086/605719; Le Monnier A, 2014, MED MALADIES INFECT, V44, P354, DOI 10.1016/j.medmal.2014.04.002; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Levy AR, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv076; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Mallard S, 2019, J HOSP INFECT, V102, P135, DOI 10.1016/j.jhin.2019.01.020; Manitoba Health HLaS, 2015, MAN HLTH HLTH LIV SE; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McDonald LC, 2018, CLIN INFECT DIS, V66, pE1, DOI [10.1093/cid/cix1085, 10.1093/cid/ciy149]; Nanwa N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172410; Nanwa N, 2015, AM J GASTROENTEROL, V110, P511, DOI 10.1038/ajg.2015.48; Pak TR, 2017, INFECT CONT HOSP EP, V38, P1478, DOI 10.1017/ice.2017.214; Phatharacharukul P, 2015, DIGEST DIS SCI, V60, P2913, DOI 10.1007/s10620-015-3714-9; Le P, 2018, INFECT CONT HOSP EP, V39, P412, DOI 10.1017/ice.2017.303; Piper Marc S, 2017, Curr Treat Options Gastroenterol, V15, P460, DOI 10.1007/s11938-017-0151-1; Qu HQ, 2014, DIABETES RES CLIN PR, V105, P285, DOI 10.1016/j.diabres.2014.06.002; Rea MC, 2012, J CLIN MICROBIOL, V50, P867, DOI 10.1128/JCM.05176-11; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Robinson JR, 1997, MED CARE, V35, P932, DOI 10.1097/00005650-199709000-00006; Rodrigues R, 2017, INFECT CONT HOSP EP, V38, P196, DOI 10.1017/ice.2016.246; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Singh H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171266; Stevens VW, 2017, JAMA INTERN MED, V177, P546, DOI 10.1001/jamainternmed.2016.9045; To KB, 2014, SURG INFECT, V15, P490, DOI 10.1089/sur.2013.186; Walkty A, 2013, J CLIN MICROBIOL, V51, P1152, DOI 10.1128/JCM.03203-12	36	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224609	10.1371/journal.pone.0224609	http://dx.doi.org/10.1371/journal.pone.0224609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703080	Green Published, gold			2022-12-26	WOS:000532697200016
J	Brawanski, N; Kashefiolasl, S; Won, SY; Tritt, S; Berkefeld, J; Senft, C; Seifert, V; Konczalla, J				Brawanski, Nina; Kashefiolasl, Sepide; Won, Sae-Yeon; Tritt, Stephanie; Berkefeld, Joachim; Senft, Christian; Seifert, Volker; Konczalla, Juergen			Does aneurysm side influence the infarction side and patients' outcome after subarachnoid hemorrhage?	PLOS ONE			English	Article							STROKE REHABILITATION; CEREBRAL INFARCTION; ISCHEMIC-STROKE; PREDICTORS; LOCATION; VASOSPASM; ADMISSION; DEATH	Background The prognostic factors and outcome of aneurysms appear to be dependent on its locations. Therefore, we compared left- and right- sided aneurysms in patients with aneurysmal subarachnoid hemorrhage (SAH) in terms of differences in outcome and prognostic factors. Methods Patients with SAH were entered into a prospectively collected database. A total of 509 patients with aneurysmal subarachnoid hemorrhage were retrospectively selected and stratified in two groups depending on side of ruptured aneurysm (right n = 284 vs. left n = 225). Midline aneurysms of the basilar and anterior communicating arteries were excluded from the analysis. Outcomes were assessed using the modified Rankin Scale (mRS; favorable (mRS 0-2) vs. unfavorable (mRS 3-6)) six months after SAH. Results We did not identify any differences in outcome depending on left- and right-sided ruptured aneurysms. In both groups, the significant negative predictive factors included clinical admission status (WFNS IV+V), Fisher 3- bleeding pattern in CT, the occurrence of delayed cerebral ischemia (DCI), early hydrocephalus and later shunt-dependence. The side of the ruptured aneurysm does not seem to influence patients' outcome. Interestingly, the aneurysm side predicts the side of infarction, with a significant influence on patients' outcome in case of left-sided infarctions. In addition, the in multivariate analysis side of aneurysm was an independent predictor for the side of cerebral infarctions. Conclusion The side of the ruptured aneurysms (right or left) did not influence patients' outcome. However, the aneurysm-side predicts the side of delayed infarctions and outcome appear to be worse in patients with left-sided infarctions.	[Brawanski, Nina; Kashefiolasl, Sepide; Won, Sae-Yeon; Senft, Christian; Seifert, Volker; Konczalla, Juergen] Goethe Univ Hosp, Dept Neurosurg, Frankfurt, Germany; [Tritt, Stephanie; Berkefeld, Joachim] Goethe Univ Hosp, Inst Neuroradiol, Frankfurt, Germany; [Tritt, Stephanie] Helios HSK Wiesbaden, Inst Neuroradiol, Wiesbaden, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Brawanski, N (corresponding author), Goethe Univ Hosp, Dept Neurosurg, Frankfurt, Germany.	Nina.Brawanski@kgu.de	Konczalla, Juergen/AAJ-8528-2021; Brawanski, Nina/AAL-7455-2020; Senft, Christian/F-4252-2010; Won, Sae-Yeon/AAK-3408-2020; Won, Sae-Yeon/AFQ-0295-2022	Brawanski, Nina/0000-0003-1502-4980; Senft, Christian/0000-0003-1288-6913; Konczalla, Juergen/0000-0001-9771-7806				Abla AA, 2014, J NEUROSURG, V120, P391, DOI 10.3171/2013.10.JNS13419; ALEXANDER MP, 1994, STROKE, V25, P128, DOI 10.1161/01.STR.25.1.128; CIFU DX, 1994, ARCH PHYS MED REHAB, V75, pS56; CUTTING J, 1978, J NEUROL NEUROSUR PS, V41, P548, DOI 10.1136/jnnp.41.6.548; FULLERTON KJ, 1986, LANCET, V1, P430; HECAEN H, 1962, Cah Coll Med Hop Paris, V3, P259; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Konczalla J, 2016, WORLD NEUROSURG; Konczalla J, 2016, J NEUROSURG, V124, P1731, DOI 10.3171/2015.5.JNS15161; Konczalla J, 2016, WORLD NEUROSURG, V88, P488, DOI 10.1016/j.wneu.2015.10.033; Konczalla J, 2015, NEUROSURGERY, V76, P540, DOI 10.1227/NEU.0000000000000672; Lagares A, 2001, ACTA NEUROCHIR, V143, P665, DOI 10.1007/s007010170044; LEHMANN JF, 1975, ARCH PHYS MED REHAB, V56, P383; Macciocchi SN, 1998, ARCH PHYS MED REHAB, V79, P1255, DOI 10.1016/S0003-9993(98)90271-4; Naidech AM, 2009, NEUROSURGERY, V64, P1052, DOI 10.1227/01.NEU.0000343543.43180.9C; Neidert MC, 2018, NEUROSURGERY, V83, P1286, DOI 10.1093/neuros/nyx609; Pegoli M, 2015, J NEUROSURG, V122, P414, DOI 10.3171/2014.10.JNS14290; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Rosenberg NF, 2013, NEUROCRIT CARE, V19, P293, DOI 10.1007/s12028-013-9869-3; Schaapsmeerders P, 2015, HUM BRAIN MAPP, V36, P2432, DOI 10.1002/hbm.22782; Sposato LA, 2016, STROKE, V47, P2959, DOI 10.1161/STROKEAHA.116.014928; Starnoni D, 2019, WORLD NEUROSURG, V130, pE743, DOI 10.1016/j.wneu.2019.06.213; Stienen MN, 2019, NEUROSURGERY, V84, P1124, DOI 10.1093/neuros/nyy155; Stienen MN, 2018, STROKE, V49, P3081, DOI 10.1161/STROKEAHA.118.022808; Stienen MN, 2018, STROKE, V49, P333, DOI 10.1161/STROKEAHA.117.019328; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; Sundseth J, 2015, NEUROCRIT CARE, V22, P6, DOI 10.1007/s12028-014-0056-y; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wong GKC, 2015, STROKE, V46, P3099, DOI 10.1161/STROKEAHA.115.010844; Zumofen DW, 2018, NEUROSURG REV, V41, P1059, DOI 10.1007/s10143-018-0952-2	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224013	10.1371/journal.pone.0224013	http://dx.doi.org/10.1371/journal.pone.0224013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY3IY	31697715	Green Published, gold			2022-12-26	WOS:000504313300001
J	Dickinson, E; Harrison, M; Parker, M; Dickinson, M; Donarski, J; Charlton, A; Nolan, R; Rafat, A; Gschwend, F; Hallett, J; Wakefield, M; Wilson, J				Dickinson, Elizabeth; Harrison, Mark; Parker, Marc; Dickinson, Michael; Donarski, James; Charlton, Adrian; Nolan, Rosie; Rafat, Aida; Gschwend, Florence; Hallett, Jason; Wakefield, Maureen; Wilson, Julie			From waste to food: Optimising the breakdown of oil palm waste to provide substrate for insects farmed as animal feed	PLOS ONE			English	Article							EMPTY FRUIT BUNCHES; IONIC LIQUID; EFFICIENT; BIOMASS; LIGNIN; DIGESTION; BIOGAS	Waste biomass from the palm oil industry is currently burned as a means of disposal and solutions are required to reduce the environmental impact. Whilst some waste biomass can be recycled to provide green energy such as biogas, this investigation aimed to optimise experimental conditions for recycling palm waste into substrate for insects, farmed as a sustainable high-protein animal feed. NMR spectroscopy and LC-HRMS were used to analyse the composition of palm empty fruit bunches (EFB) under experimental conditions optimised to produce nutritious substrate rather than biogas. Statistical pattern recognition techniques were used to investigate differences in composition for various combinations of pre-processing and anaerobic digestion (AD) methods. Pre-processing methods included steaming, pressure cooking, composting, microwaving, and breaking down the EFB using ionic liquids. AD conditions which were modified in combination with pre-processing methods were ratios of EFB:digestate and pH. Results show that the selection of pre-processing method affects the breakdown of the palm waste and subsequently the substrate composition and biogas production. Although large-scale insect feeding trials will be required to determine nutritional content, we found that conditions can be optimised to recycle palm waste for the production of substrate for insect rearing. Pre-processing EFB using ionic liquid before AD at pH6 with a 2:1 digestate:EFB ratio were found to be the best combination of experimental conditions.	[Dickinson, Elizabeth; Wilson, Julie] Univ York, Dept Math, York, N Yorkshire, England; [Harrison, Mark; Parker, Marc; Dickinson, Michael; Donarski, James; Charlton, Adrian; Wakefield, Maureen] Fera Sci Ltd, York, N Yorkshire, England; [Nolan, Rosie] Biorenewables Dev Ctr Ltd, York, N Yorkshire, England; [Rafat, Aida; Gschwend, Florence; Hallett, Jason] Imperial Coll London, Dept Chem Engn, London, England	University of York - UK; Food & Environment Research Agency; Imperial College London	Dickinson, E; Wilson, J (corresponding author), Univ York, Dept Math, York, N Yorkshire, England.	elizabeth.dickinson@york.ac.uk; julie.wilson@york.ac.uk	Hallett, Jason/A-3281-2012	Hallett, Jason/0000-0003-3431-2371; Dickinson, Elizabeth/0000-0001-8961-3230	EPSRC Impact Acceleration Award (IAA); Daphne Jackson Trust Fellowship - RSC; Douglas Bomford Trust; Department of Chemical Engineering, Imperial College; Fera Science Ltd, on an EPSRC IAA Researcher Mobility Grant; EPSRC; Daphne Jackson Trust; Department of Engineering, Imperial College; BBSRC	EPSRC Impact Acceleration Award (IAA)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Daphne Jackson Trust Fellowship - RSC; Douglas Bomford Trust; Department of Chemical Engineering, Imperial College; Fera Science Ltd, on an EPSRC IAA Researcher Mobility Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Daphne Jackson Trust; Department of Engineering, Imperial College; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by EPSRC Impact Acceleration Award (IAA) funding awarded to JW. ED was supported in part by a Daphne Jackson Trust Fellowship funded by the RSC and BBSRC. ED would also like to thank The Douglas Bomford Trust for funding analytical experiments to identify to the constituents of the waste biomass. AR was supported by a studentship from the Department of Chemical Engineering, Imperial College. This research was done in collaboration with scientists at commercial companies Fera Science Ltd and Biorenewables Development Centre Ltd (BDC). These commercial companies provided support in the form of salaries for authors MP, MH, MD, JD, MW, AC, and RN but did not provide any other means of funding. Anaerobic digestion services and biogas data collection was carried out at BDC. NMR and LC-MS data were collected by ED at Fera Science Ltd, on an EPSRC IAA Researcher Mobility Grant. The companies did not have any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors from commercial companies are articulated in the 'author contributions' section. The funders (Daphne Jackson Trust, EPSRC and Department of Engineering, Imperial College) provided support in the form of salaries for authors ED and AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abdullah N., 2013, BIOMASS NOW SUSTAINA; Avraham T, 2005, PLANT BIOTECHNOL J, V3, P71, DOI 10.1111/j.1467-7652.2004.00102.x; Aziz M, 2017, APPL THERM ENG, V114, P1378, DOI 10.1016/j.applthermaleng.2016.11.031; Brandt A, 2013, GREEN CHEM, V15, P550, DOI 10.1039/c2gc36364j; Brandt-Talbot A, 2017, GREEN CHEM, V19, P3078, DOI 10.1039/c7gc00705a; Bruni E, 2010, BIORESOURCE TECHNOL, V101, P7668, DOI 10.1016/j.biortech.2010.04.064; DEFRA, 2011, ANAEROBIC DIGESTION; EINARSSON H, 1983, J AGR FOOD CHEM, V31, P1043, DOI 10.1021/jf00119a031; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Evans R, 2017, ISME J, V11, P1680, DOI 10.1038/ismej.2017.22; Gschwend FJV, 2018, GREEN CHEM, V20, P3486, DOI [10.1039/c8gc00837j, 10.1039/C8GC00837J]; Hamzah N, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11041060; Kamahara H, 2010, BIOMASS BIOENERG, V34, P1818, DOI 10.1016/j.biombioe.2010.07.014; Kamimura N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44422; Kumaran P, 2016, RENEW SUST ENERG REV, V56, P929, DOI 10.1016/j.rser.2015.11.069; Li HQ, 2016, BIORESOURCE TECHNOL, V199, P34, DOI 10.1016/j.biortech.2015.08.099; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Mohammad N, 2012, RESOUR CONSERV RECY, V58, P69, DOI 10.1016/j.resconrec.2011.10.009; Mohammed MAA, 2012, BIORESOURCE TECHNOL, V110, P628, DOI 10.1016/j.biortech.2012.01.056; O-Thong S, 2012, APPL ENERG, V93, P648, DOI 10.1016/j.apenergy.2011.12.092; Purschke B, 2017, FOOD ADDIT CONTAM A, V34, P1410, DOI 10.1080/19440049.2017.1299946; Rusilowicz M, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0972-2; Salek RM, 2013, GIGASCIENCE, V2, DOI [10.1186/2047-217X-2-13, 10.1186/2047-217X-2-8]; Schleucher J, GEN ENHANCEMENT SCHE; Siddiquee Shafiquzzaman, 2017, Biotechnol Rep (Amst), V13, P1, DOI 10.1016/j.btre.2016.11.001; Simoneit BRT, 1999, ATMOS ENVIRON, V33, P173, DOI 10.1016/S1352-2310(98)00145-9; Suksong W, 2016, BIORESOURCE TECHNOL, V214, P166, DOI 10.1016/j.biortech.2016.04.077; Teh HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061344; Thi PTP, 2010, WATER RES, V44, P352, DOI 10.1016/j.watres.2009.09.030; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Varanasi P, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-14; Villar JC, 2001, WOOD SCI TECHNOL, V35, P245, DOI 10.1007/s002260100089; Wehrens R, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1015-8; Yiin CL, 2018, CLEAN TECHNOL ENVIR, V20, P1917, DOI 10.1007/s10098-018-1590-7; Yuan TQ, 2011, J AGR FOOD CHEM, V59, P10604, DOI 10.1021/jf2031549; Yue F, IDENTIFICATION 4 O 5; Zeng JJ, 2013, J AGR FOOD CHEM, V61, P10848, DOI 10.1021/jf4030486	37	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224771	10.1371/journal.pone.0224771	http://dx.doi.org/10.1371/journal.pone.0224771			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697740	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000532694400060
J	Walker, SC; Duong, M; Hayes, C; Berliner, L; Leve, LD; Atkins, DC; Herting, JR; Bishop, AS; Valencia, E				Walker, Sarah C.; Duong, Mylien; Hayes, Christopher; Berliner, Lucy; Leve, Leslie D.; Atkins, David C.; Herting, Jerald R.; Bishop, Asia S.; Valencia, Esteban			A tailored cognitive behavioral program for juvenile justice-referred females at risk of substance use and delinquency: A pilot quasi-experimental trial	PLOS ONE			English	Article							GENDER-DIFFERENCES; ALCOHOL-USE; FAMILY CONFLICT; USE DISORDERS; BASE-LINE; DRUG-USE; INTERVENTION; VIOLENCE; ASSOCIATION; EMPOWERMENT	This pilot quasi-experimental trial tested a gender-responsive cognitive behavioral group intervention with 87 court-involved female adolescents (5 juvenile courts) who were at indicated risk for substance use disorder. Participants in the intervention (n = 57) received twice weekly group sessions for 10 weeks (20 sessions) focused on building emotional, thought and behavior regulation skills and generalizing these skills to relationally-based scenarios (GOAL: Girls Only Active Learning). Youth in the control condition (n = 30) received services as usual, which included non-gender-specific aggression management training, individual counseling and no services. The GOAL program was found to be acceptable to youth and parents and feasible to implement within a juvenile court setting using skilled facilitators. Compared to services as usual, the program significantly and meaningfully reduced self-reported delinquent behavior (beta = 0.84, p < 0.05) over 6 months, and exhibited trend level effects for reduced substance use (beta = 0.40, p = 0.07). The program had mixed or no effects on family conflict and emotion regulation skills. These findings are discussed in light of treatment mechanisms and gender-responsive services.	[Walker, Sarah C.; Duong, Mylien; Atkins, David C.; Valencia, Esteban] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Hayes, Christopher] Snohomish Cty Juvenile Court, Everett, WA USA; [Berliner, Lucy] Harborview Ctr Sexual Assault & Trauma, Seattle, WA USA; [Leve, Leslie D.] Univ Oregon, Coll Educ, Eugene, OR 97403 USA; [Herting, Jerald R.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Bishop, Asia S.] Univ Washington, Dept Social Work, Seattle, WA 98195 USA; [Valencia, Esteban] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Oregon; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Walker, SC (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	secwalkr@uw.edu		Walker, Sarah/0000-0003-2298-7451; Leve, Leslie/0000-0003-3061-4524	National Institute of Drug Abuse [R21 DA037455]	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This study was funded by the National Institute of Drug Abuse (www.drugabuse.gov) to S.C.W. (R21 DA037455). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid L., 2015, FED PROBAT, V79, P11; Batchelder A, 2016, AIDS CARE, P1, DOI [10.1097/00004583-200101000-00020, DOI 10.1097/00004583-200101000-00020]; Boles SM, 2003, AGGRESS VIOLENT BEH, V8, P155, DOI 10.1016/S1359-1789(01)00057-X; BOTVIN GJ, 1990, J CONSULT CLIN PSYCH, V58, P437, DOI 10.1037/0022-006X.58.4.437; Butters JE, 2004, DRUG-EDUC PREV POLIC, V11, P381, DOI 10.1080/09687630410001704437; Carim-Todd L, 2013, DRUG ALCOHOL DEPEN, V132, P399, DOI 10.1016/j.drugalcdep.2013.04.014; Castillo-Gualda R, 2017, J RES ADOLESCENCE, P1; Catalano RF, 1996, J DRUG ISSUES, V26, P429, DOI 10.1177/002204269602600207; Cauffman E, 2008, J RES ADOLESCENCE, V18, P699, DOI 10.1111/j.1532-7795.2008.00577.x; Chan GCK, 2013, J STUD ALCOHOL DRUGS, V74, P396, DOI 10.15288/jsad.2013.74.396; Chassin L, 2004, J ABNORM PSYCHOL, V113, P483, DOI 10.1037/0021-843X.113.4.483; Chiesa A, 2014, SUBST USE MISUSE, V49, P492, DOI 10.3109/10826084.2013.770027; Coccaro EF, 2016, J PSYCHIATR RES, V81, P127, DOI 10.1016/j.jpsychires.2016.06.011; Corte C, 2010, J CHILD ADOLES SUBST, V19, P406, DOI 10.1080/1067828X.2010.515882; Dembo R, 2016, J CHILD ADOLES SUBST, V25, P458, DOI 10.1080/1067828X.2015.1103344; Eggert LL, 1996, J DRUG EDUC, V26, P101, DOI 10.2190/EQ6J-D4GH-K4YD-XRJB; Fagan AA, 2007, PREV SCI, V8, P115, DOI 10.1007/s11121-006-0062-1; Fagan AA, 2014, CRIM JUSTICE BEHAV, V41, P1057, DOI 10.1177/0093854814539801; Friedman AS, 2002, J CHILD ADOLES SUBST, V11, P43, DOI 10.1300/J029v11n04_03; GLICK B, 1987, J COUNS DEV, V65, P356, DOI 10.1002/j.1556-6676.1987.tb00730.x; GOLDSTEIN AP, 1994, SIMULAT GAMING, V25, P9, DOI 10.1177/1046878194251003; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Gratz KL, 2004, DIFFICULTIES EMOTION; Hallion LS, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00539; Hamilton Z, 2015, TECHNICAL REPORT; Hawkins JD, 1992, COMMUNITIES CARE ACT; Henggeler SW, 1996, J ADOLESCENCE, V19, P47, DOI 10.1006/jado.1996.0005; Hubbard DJ, 2008, CRIME DELINQUENCY, V54, P225, DOI 10.1177/0011128706296733; Johnston L.D., 1980, MONITORING FUTURE QU; Kerrigan D, 2017, JAIDS-J ACQ IMM DEF, V74, pS60, DOI 10.1097/qai.0000000000001203; Kissen M, 2009, B MENNINGER CLIN, V73, P34, DOI 10.1521/bumc.2009.73.1.34; Kort-Butler LA, 2009, J YOUTH ADOLESCENCE, V38, P122, DOI 10.1007/s10964-008-9291-x; Kuklinski MR, 2015, J EXP CRIMINOL, V11, P165, DOI 10.1007/s11292-014-9226-3; Langton CM, 2012, CRIM JUSTICE BEHAV, V39, P748; Lee CYS, 2008, PREV SCI, V9, P215, DOI 10.1007/s11121-008-0097-6; Leve LD, 2015, CLIN CHILD FAM PSYCH, V18, P252, DOI 10.1007/s10567-015-0186-6; Linehan M M, 1993, NIDA Res Monogr, V137, P201; Lipsey MW, 2009, VICTIMS OFFENDERS, V4, P124, DOI 10.1080/15564880802612573; Marlatt GA, 2007, SOUTH MED J, V100, P451, DOI 10.1097/SMJ.0b013e3180381416; McNeish D, 2017, J APPL STAT, V44, P24, DOI 10.1080/02664763.2016.1158246; Merikangas KR, 2012, HUM GENET, V131, P779, DOI 10.1007/s00439-012-1168-0; Mizock L, 2019, PSYCHIATR REHABIL J, V42, P3, DOI 10.1037/prj0000313; Morrison K, 2005, HEALTH COMMUN, V18, P237, DOI 10.1207/s15327027hc1803_3; Nadel MR, 2018, J RES CRIME DELINQ, V55, P278, DOI 10.1177/0022427817751571; Oesterle S, 2015, AM J COMMUN PSYCHOL, V56, P217, DOI 10.1007/s10464-015-9749-4; Porter M, 2016, AGR ECON-BLACKWELL, V47, P235, DOI 10.1111/agec.12225; Rocca CH, 2009, INT J EPIDEMIOL, V38, P577, DOI 10.1093/ije/dyn226; Rohde P, 2001, J AM ACAD CHILD PSY, V40, P83, DOI 10.1097/00004583-200101000-00020; Sanetti LMH, 2009, SCHOOL PSYCHOL REV, V38, P445; Schminkey DL, 2016, RES NURS HEALTH, V39, P286, DOI 10.1002/nur.21724; Schubert CA, 2011, J AM ACAD CHILD PSY, V50, P925, DOI 10.1016/j.jaac.2011.06.006; Schwalbe CS, 2012, CRIM JUSTICE BEHAV, V39, P185, DOI 10.1177/0093854811430185; Schwartz K, 2017, J OFFENDER REHABIL, V56, P20, DOI 10.1080/10509674.2016.1257532; Sharp C, 2006, J CHILD PSYCHOL PSYC, V47, P143, DOI 10.1111/j.1469-7610.2005.01464.x; Skeer MR, 2011, J ADOLESCENT HEALTH, V49, P187, DOI 10.1016/j.jadohealth.2010.12.003; Smith P, 2012, J CRIME JUSTICE, V35, P189, DOI 10.1080/0735648X.2012.674826; Stark L, 2018, J ADOLESCENT HEALTH, V62, pS15, DOI 10.1016/j.jadohealth.2017.06.014; Sternberg KJ, 2006, DEV REV, V26, P89, DOI 10.1016/j.dr.2005.12.001; Sudak D. M., 2016, TEACHING SUPERVISING; Taylor CA, 2008, J INTERPERS VIOLENCE, V23, P1618, DOI 10.1177/0886260508314323; Trenz RC, 2016, SUBST USE MISUSE, V51, P1716, DOI 10.1080/10826084.2016.1197260; Vaughn MG, 2004, RES SOCIAL WORK PRAC, V14, P325, DOI 10.1177/1049731504265834; Weisz JR, 2006, AM PSYCHOL, V61, P644, DOI 10.1037/0003-066X.61.6.644; Williams JF, 2015, PEDIATRICS, V136, pE1395, DOI 10.1542/peds.2015-3113; Zahn M, 2010, CAUSES CORRELATES GI, DOI [10.1097/QAI.0000000000001203, DOI 10.1097/QAI.0000000000001203]; Zimmer-Gembeck MJ, 2013, INFANT CHILD DEV, V22, P480, DOI 10.1002/icd.1804	66	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224363	10.1371/journal.pone.0224363	http://dx.doi.org/10.1371/journal.pone.0224363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697698	Green Published, gold			2022-12-26	WOS:000532694400024
J	Zhu, J; Hu, D; Yin, YQ; Zhu, ZB; Wang, N; Wang, B				Zhu, Jing; Hu, Dan; Yin, Yueqi; Zhu, Zhibin; Wang, Ning; Wang, Bei			HIV prevalence and correlated factors among male clients of female sex workers in a border region of China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RISK BEHAVIORS; YUNNAN PROVINCE; DRUG-USE; POPULATION; EPIDEMIC; CITY	Objectives To assess the prevalence of human immunodeficiency virus (HIV) infection and the correlated risk factors among male clients of female sex workers (FSWs) in a Chinese-Vietnamese border region in Yunnan Province, China. Methods A cross-sectional survey was conducted between 2014 and 2015 in Hekou County, Yunnan Province, China. Convenience sampling and snowball sampling methods were used to recruit male clients for a questionnaire survey to collect information on demographics, sexual behavior, and drug use. Blood and urine samples were collected for testing of HIV/sexually transmitted infections (STIs) and drug use. Multivariate logistic regression was used to examine factors correlated with HIV infection. Results Of 776 respondents who participated in the study, 721 (92.91%) were Chinese and 55 (7.09%) were Vietnamese. Overall HIV prevalence in male clients of FSWs was 2.06%, 128 (16.49%) were infected with HSV-2, and five (0.64%) tested syphilis-positive. Two-thirds (68.81%) of respondents reported always using condoms with FSWs, and 89.05% reported condom use in the last episode of commercial sex. Male clients from Vietnam were significantly more likely to take morphine (9.09%) compared with Chinese male clients of FSWs. Age >= 50 years (OR: 8.11, 95%CI: 1.26-52.16) and morphine positivity (OR: 7.35, 95% CI: 1.42-38.06) were associated with HIV infection in the multivariate logistic regression model. Conclusion The relatively high proportion of male clients of FSWs who have numerous sexual partners and use condoms less frequently make them serve as important bridges for HIV transmission from FSWs to the low-risk general population. The positive association between morphine positivity and HIV infection confirmed illegal drug use as another important route for acquiring HIV infection in addition to sexual transmission, indicating that innovative interventions addressing both drug use and risky sexual behaviors are greatly required for male clients. Respondents aged >= 50 years have a higher risk of HIV infection, which emphasizes that older male clients of FSWs should be focused in future HIV prevention interventions in the border regions of China.	[Zhu, Jing; Yin, Yueqi; Wang, Bei] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Med Stat, Key Lab Environm Med & Engn,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Hu, Dan] Nanjing Med Univ, Dept Hlth Policy & Management, Nanjing, Jiangsu, Peoples R China; [Zhu, Zhibin] Hekou Ctr Dis Control & Prevent, Hekou, Yunnan, Peoples R China; [Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Southeast University - China; Nanjing Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, B (corresponding author), Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Med Stat, Key Lab Environm Med & Engn,Minist Educ, Nanjing, Jiangsu, Peoples R China.	wangbeilxb@163.com		Wang, Bei/0000-0002-5232-0933	Mega-Projects of National Science Research for the 12th Five-Year Plan [2012ZX10001-001]	Mega-Projects of National Science Research for the 12th Five-Year Plan	This work was supported by Mega-Projects of National Science Research for the 12th Five-Year Plan (2012ZX10001-001). URLs: http://www.nmp.gov.cn/Ning Wang received this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to the health officials and outreach workers at CDC in Hekou County. Thanks also give to the physicians of the Hekou County People's Hospital. They did much work on the data collection and laboratory testing.	Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; CHEN YC, 2016, MEDICINE, V95; China National Center for AIDS/STD Control and Prevention Chinese CDC, 2016, CHINESE J AIDS STD, V22, P311, DOI [10.13419/j.cnki.aids.2016.05.01, DOI 10.13419/J.CNKI.AIDS.2016.05.01]; Goldenberg SM, 2010, SEX TRANSM DIS, V37, P319, DOI 10.1097/OLQ.0b013e3181c5334f; Hail-Jares K, 2016, DRUG ALCOHOL DEPEN, V161, P42, DOI 10.1016/j.drugalcdep.2016.01.026; Han LF, 2016, SEX TRANSM INFECT, V92, P309, DOI 10.1136/sextrans-2015-052173; Hekou Bureau of Statistics, 2008, HEK YAO AUT COUNT AL; Huang YY, 2012, GLOB PUBLIC HEALTH, V7, P509, DOI 10.1080/17441692.2012.657663; Huang ZJ, 2011, AIDS CARE, V23, P45, DOI 10.1080/09540121.2010.507759; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Jin X, 2010, JAIDS-J ACQ IMM DEF, V53, P131, DOI 10.1097/QAI.0b013e3181b3552a; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; McLaughlin MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071394; NCAIDS NCSTD China CDC, 2016, CHIN J AIDS STD, V22, P585; Nguyen NT, 2009, AIDS BEHAV, V13, P881, DOI 10.1007/s10461-008-9463-4; Pan S, 2013, J INFECT DIS S5, pS1211; Reilly KH, 2012, SEX TRANSM DIS, V39, P750, DOI 10.1097/OLQ.0b013e31825f7af7; Wang H, 2009, SEX TRANSM INFECT, V85, P290, DOI 10.1136/sti.2008.033100; Wang HB, 2012, SEX TRANSM DIS, V39, P835, DOI 10.1097/OLQ.0b013e318266b241; Wang HB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-198; Wang JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129430; Xu JJ, 2012, INT J STD AIDS, V23, P670, DOI 10.1258/ijsa.2009.009128; Xu JJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003535; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Xu JJ, 2011, SEX TRANSM DIS, V38, P89, DOI 10.1097/OLQ.0b013e3181f0bc5e; Yao Y, 2012, INT J STD AIDS, V23, P698, DOI 10.1258/ijsa.2012.011346; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Zang CP, 2011, CHINESE MED J-PEKING, V124, P1890, DOI 10.3760/cma.j.issn.0366-6999.2011.12.022; Zhang C, 2014, SEX TRANSM INFECT, V90, P230, DOI 10.1136/sextrans-2013-051275; Zhu J, 2018, INT J STD AIDS, V29, P424, DOI 10.1177/0956462417730258	30	4	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0225072	10.1371/journal.pone.0225072	http://dx.doi.org/10.1371/journal.pone.0225072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697754	Green Published, gold			2022-12-26	WOS:000532694400093
J	Biella, P; Tommasi, N; Akter, A; Guzzetti, L; Klecka, J; Sandionigi, A; Labra, M; Galimberti, A				Biella, Paolo; Tommasi, Nicola; Akter, Asma; Guzzetti, Lorenzo; Klecka, Jan; Sandionigi, Anna; Labra, Massimo; Galimberti, Andrea			Foraging strategies are maintained despite workforce reduction: A multidisciplinary survey on the pollen collected by a social pollinator	PLOS ONE			English	Article							BOMBUS-TERRESTRIS; BUMBLEBEES; BEES; HYMENOPTERA; DISCOVERY; EXPANSION; HONEYBEE; ECOLOGY; DENSITY; QUALITY	The way pollinators gather resources may play a key role for buffering their population declines. Social pollinators like bumblebees could adjust their foraging after significant work-force reductions to keep provisions to the colony optimal, especially in terms of pollen diversity and quantity. To test what effects a workforce reduction causes on the foraging for pollen, commercially-acquired colonies of the bumblebee Bombus terrestris were allowed to forage in the field and they were experimentally manipulated by removing half the number of workers. For each bumblebee, the pollen pellets were taxonomically identified with DNA metabarcoding of the ITS2 region followed by a statistical filtering based on ROC curves to filter out underrepresented OTUs. Video cameras and network analyses were employed to investigate changes in foraging strategies and behaviour. After filtering out the false-positives, HTS metabarcoding yielded a high plant diversity in the pollen pellets; for plant identity and pollen quantity traits no differences emerged between samples from treated and from control colonies, suggesting that plant choice was influenced mainly by external factors such as the plant phenology. The colonies responded to the removal of 50% of their workers by increasing the foraging activity of the remaining workers, while only negligible changes were found in diet breadth and indices describing the structure of the pollen transport network. Therefore, a consistency in the bumblebees' feeding strategies emerges in the short term despite the lowered workforce.	[Biella, Paolo; Tommasi, Nicola; Guzzetti, Lorenzo; Klecka, Jan; Sandionigi, Anna; Labra, Massimo; Galimberti, Andrea] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Biella, Paolo; Akter, Asma] Univ South Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Biella, Paolo; Akter, Asma] Czech Acad Sci, Inst Entomol, Biol Ctr, Ceske Budejovice, Czech Republic	University of Milano-Bicocca; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Galimberti, A (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	andrea.galimberti@unimib.it	Klecka, Jan/H-7874-2014; Sandionigi, Anna/H-8815-2016; Galimberti, Andrea/ABF-7019-2020; Biella, Paolo/AAZ-5886-2020; Akter, Asma/AAE-2499-2021	Klecka, Jan/0000-0003-0633-3896; Sandionigi, Anna/0000-0002-5257-0027; Galimberti, Andrea/0000-0003-3140-3024; Biella, Paolo/0000-0003-2297-006X; Akter, Asma/0000-0002-6336-2768; Guzzetti, Lorenzo/0000-0002-7265-0796	Czech Science Foundation [GP14-10035P, GJ17-24795Y]; University of South Bohemia [GA JU 152/2016/P]; Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR [CUP: H42F16002450001]	Czech Science Foundation(Grant Agency of the Czech Republic); University of South Bohemia; Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Czech Science Foundation awarded to JK (projects GP14-10035P and GJ17-24795Y), by the University of South Bohemia awarded to AA (grant GA JU 152/2016/P), by the Ministero dell'Istruzione, dell'Universita e della Ricerca - MIUR awarded to ML (project Sistemi Alimentari e Sviluppo Sostenibile - tra ricerca e processi internazionali e africani; CUP: H42F16002450001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckett SJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.140536; Bell KL, 2019, MOL ECOL, V28, P431, DOI 10.1111/mec.14840; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Biella P, 2017, COMMUNITY ECOL, V18, P1, DOI 10.1556/168.2017.18.1.1; Biella P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43553-4; Biella P, 2017, J INSECT CONSERV, V21, P357, DOI 10.1007/s10841-017-9983-1; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bocci G, 2015, METHODS ECOL EVOL, V6, P347, DOI 10.1111/2041-210X.12327; Bolnick DI, 2001, NATURE, V410, P463, DOI 10.1038/35068555; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Bruno A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44350; Buri P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085635; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Dormann C.F., 2008, R NEWS, V8, P8; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Farine DR, 2017, METHODS ECOL EVOL, V8, P1309, DOI 10.1111/2041-210X.12772; Fassetti F, 2017, SPRINGERBRIEF COMPUT, P1, DOI 10.1007/978-3-319-63477-7; Filipiak M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183236; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Galimberti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109363; Genissel A, 2002, ENTOMOL EXP APPL, V104, P329, DOI 10.1023/A:1021279220995; Geslin B, 2014, ECOL ENTOMOL, V39, P334, DOI 10.1111/een.12106; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Gresty CEA, 2018, ECOL EVOL, V8, P7574, DOI 10.1002/ece3.4234; Hagbery J, 2012, NATURWISSENSCHAFTEN, V99, P821, DOI 10.1007/s00114-012-0964-7; Isbell F, 2013, ECOL LETT, V16, P454, DOI 10.1111/ele.12066; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Jandt JM, 2016, CURR OPIN INSECT SCI, V15, P40, DOI 10.1016/j.cois.2016.02.012; Jandt JM, 2014, ANIM BEHAV, V87, P97, DOI 10.1016/j.anbehav.2013.10.017; Jandt JM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1829, DOI 10.1007/s00265-009-0810-x; Jeanson R, 2014, BIOL REV, V89, P671, DOI 10.1111/brv.12074; Jha S, 2015, MOL ECOL, V24, P993, DOI 10.1111/mec.13090; Kaiser-Bunbury CN, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv076; Kaluza BF, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1758; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Leadbeater E, 2014, BEHAV ECOL SOCIOBIOL, V68, P1145, DOI 10.1007/s00265-014-1725-8; Leonhardt SD, 2012, APIDOLOGIE, V43, P449, DOI 10.1007/s13592-011-0112-y; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Lindstrom SAM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1641; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; Lucas A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23103-0; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maurizio A., 1969, TRACHTPFLANZENBUCH N; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mezzasalma V., 2017, PLANT GENE, V9, P1, DOI DOI 10.1016/j.plgene.2016.11.001; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; MULLER CB, 1992, FUNCT ECOL, V6, P48, DOI 10.2307/2389770; Norfolk O, 2018, DIVERS DISTRIB, V24, P705, DOI 10.1111/ddi.12715; Nutz S, 2011, ANAL BIOANAL CHEM, V401, P717, DOI 10.1007/s00216-011-5089-x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Osgathorpe LM, 2011, ECOL ECON, V70, P1162, DOI 10.1016/j.ecolecon.2011.01.010; PENDREL BA, 1981, BEHAV ECOL SOCIOBIOL, V8, P71, DOI 10.1007/BF00300817; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Poisot T, 2012, METHODS ECOL EVOL, V3, P537, DOI 10.1111/j.2041-210X.2011.00174.x; POMEROY N, 1979, Journal of the Kansas Entomological Society, V52, P215; Pornon A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16785-5; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ruedenauer FA, 2016, BEHAV ECOL SOCIOBIOL, V70, P1209, DOI 10.1007/s00265-016-2129-8; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Saifuddin M, 2014, ENVIRON ENTOMOL, V43, P393, DOI 10.1603/EN13261; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Sickel W, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0051-y; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Tasei JN, 2008, APIDOLOGIE, V39, P397, DOI 10.1051/apido:2008017; Teper Dariusz, 2004, Journal of Apicultural Science, V48, P75; Tosi S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1711; Tur C, 2015, OIKOS, V124, P581, DOI 10.1111/oik.01668; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van Hoorde A, 1996, BIJENPLANTENGIDS KON; Van Laere O, 1971, Apidologie, V2, P197, DOI 10.1051/apido:19710205; Vanderplanck M, 2014, APIDOLOGIE, V45, P192, DOI 10.1007/s13592-013-0239-0; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269; Williams NM, 1998, BEHAV ECOL, V9, P612, DOI 10.1093/beheco/9.6.612; Willmer PG, 2017, ARTHROPOD-PLANT INTE, V11, P411, DOI 10.1007/s11829-017-9528-2	85	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224037	10.1371/journal.pone.0224037	http://dx.doi.org/10.1371/journal.pone.0224037			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LA1OD	31693676	Green Published, Green Submitted, gold			2022-12-26	WOS:000523723400001
J	Salim, H; Lee, PY; Sazlina, SG; Ching, SM; Mawardi, M; Shamsuddin, NH; Ali, H; Adibah, HI; Tan, NC				Salim, Hani; Lee, Ping Yein; Sazlina, Shariff Ghazali; Ching, Siew Mooi; Mawardi, Maliza; Shamsuddin, Nurainul Hana; Ali, Hanifatiyah; Adibah, Hanim Ismail; Tan, Ngiap Chuan			The self-care profiles and its determinants among adults with hypertension in primary health care clinics in Selangor, Malaysia	PLOS ONE			English	Article							AFRICAN-AMERICAN; CHRONIC DISEASE; BLOOD-PRESSURE; MANAGEMENT; INTERVENTIONS; TOOL	Introduction Self-care has been shown to improve clinical outcome of hypertension. Gauging the level of self-care among patients with hypertension enables the design of their personalized care plans. This study aimed to determine the self-care profiles and its determinants among patients with hypertension in the Malaysian primary care setting. Methods This was a cross sectional study conducted between 1 October 2016-30 April 2017 in three primary care clinics in the state of Selangor, Malaysia. All adults aged 18 years and above with hypertension for at least 6 months were recruited with a systematic random sampling of 1:2 ratio. The participants were assisted in the administration of the structured questionnaire, which included socio-demographic information, medical information and the Hypertension Self-Care Profile (HTN SCP) tool. Statistical analysis was done using SPSS version 20.0. Multiple linear regression was performed to determine the determinants for self-care. Results The mean age of the participants was 59.5 (SD10.2) years old. There were more women (52.5%) and most were Malays (44.0%) follow by Chinese (34%) and Indians (21%). Majority (84.2%) had secondary or primary school level of education. A third (30.7%) had a family history of hypertension. The mean total HTN-SCP score was 124.2 (SD 22.8) out of 180. The significant determinants that influenced the HTN-SCP scores included being men (B4.5, P-value0.008), Chinese ethnicity (B-14.7, P-value<0.001), primary level education/no formal school education level (B-15.7, P-value<0.001), secondary level education (B-9.2, P-value<0.001) and family history of hypertension (B 4.4, P-value 0.014). Conclusions The overall hypertension self-care profile among patients in this multi-ethnic country was moderate. Being men, Chinese, lower education level and without family history of hypertension were associated with lower hypertension self-care profile score. Healthcare intervention programmes to address self-care should target this group of patients.	[Salim, Hani; Lee, Ping Yein; Sazlina, Shariff Ghazali; Ching, Siew Mooi; Mawardi, Maliza; Shamsuddin, Nurainul Hana; Ali, Hanifatiyah; Adibah, Hanim Ismail] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia; [Tan, Ngiap Chuan] SingHlth Polyclin, Jalan Bukit Merah Connect One, Singapore, Singapore; [Tan, Ngiap Chuan] SingHlth Duke NUS Family Med Acad Clin Programme, Jalan Bukit Merah Connect One, Singapore, Singapore	Universiti Putra Malaysia	Lee, PY (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia.	yein@upm.edu.my	MEDIC, NURAINUL HANA BINTI SHAMSUDDIN //AAY-6897-2021; Lee, Ping Yein/C-1923-2012; Ismail, Adibah Hanim/B-8293-2019; Ching, Siew Mooi/I-5817-2013	MEDIC, NURAINUL HANA BINTI SHAMSUDDIN //0000-0001-8326-0024; Lee, Ping Yein/0000-0002-0912-6043; Ismail, Adibah Hanim/0000-0002-6904-375X; Ching, Siew Mooi/0000-0002-4425-7989	Malaysian Hypertension Society [MSH RG/2017/HSS]	Malaysian Hypertension Society	Funding of this work was supported by the Malaysian Hypertension Society research Grant No.: MSH RG/2017/HSS. All authors are investigators under this research grant. The funder was not involve in the study design, data collection, analysis, preparation of manuscript or decision to publish this manuscript.	Andrulis DP, 2007, AM J HEALTH BEHAV, V31, pS122; Azar Tol, 2012, J EDU HLTH PROMOT, V1, P19; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bosch-Capblanch X, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004808.pub3; Britt E, 2004, PATIENT EDUC COUNS, V53, P147, DOI 10.1016/S0738-3991(03)00141-1; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Choong Y O, 2015, E P INT C SOC SCI RE; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Ebrahim S., 1998, HLTH TECHNOL ASSESS, V2; Fan AZ, 2010, PREV MED, V50, P138, DOI 10.1016/j.ypmed.2009.12.007; Glynn LG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub4; Hamilton DF, 2015, BONE JOINT RES, V4, P152, DOI 10.1302/2046-3758.49.2000571; Han HR, 2014, J CARDIOVASC NURS, V29, pE11, DOI 10.1097/JCN.0b013e3182a3fd46; Han HR, 2014, J CARDIOVASC NURS, V29, P55, DOI 10.1097/JCN.0b013e3182775fd1; Hu H, 2013, INT J ANTENN PROPAG, V2013, DOI 10.1155/2013/416096; Institute for Public Health, 2015, NAT HLTH MORB SURV N, V2, P17; Koh YLE, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002955; Lemeshow S., 1990, TITLE ADEQUACY SAMPL; Lin PH, 2007, J AM DIET ASSOC, V107, P1541, DOI 10.1016/j.jada.2007.06.019; Malaysia MoH, 2015, CLIN PRACTICE GUIDEL, V5th; McLean G, 2016, J HYPERTENS, V34, P600, DOI 10.1097/HJH.0000000000000859; Ministry of Health Malaysia, 2015, NAT HLTH MORB SURV 2; Ministry of Health Malaysia, 2004, CLIN PRACT GUID MAN; Ministry of Health Malaysia, 2013, CLIN PRACTICE GUIDEL; Neminqani D.M., 2013, INT J SCI RES, V12, P1705; Ngoh SHA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008568; Orem DE, 1985, CONCEPTS PRACTICE, V3; Resnick B, 2009, J CARDIOVASC NURS, V24, P352, DOI 10.1097/JCN.0b013e3181ac0301; Schroeder K, 2004, ARCH INTERN MED, V164, P722, DOI 10.1001/archinte.164.7.722; Seow KC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016152; Tahereh Etesamifard, 2014, J BIOL TODAYS WORLD, V3, P275; Tan AKG, 2011, METAB SYNDR RELAT D, V9, P441, DOI 10.1089/met.2011.0031; Taylor SJ., 2014, HEALTH SERV DELIVERY, DOI [10.3310/hsdr02530, DOI 10.3310/HSDR02530]; Verberk WJ, 2011, BLOOD PRESS MONIT, V16, P149, DOI 10.1097/MBP.0b013e328346e092; Warren-Findlow J, 2012, J COMMUN HEALTH, V37, P15, DOI 10.1007/s10900-011-9410-6; WHO, 2013, WHO GLOB BRIEF HYP; WHO, MENS HLTH GAP MEN MU; Zinat Motlagh Sayed Fazel, 2016, IRAN RED CRESCENT ME, V18	38	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224649	10.1371/journal.pone.0224649	http://dx.doi.org/10.1371/journal.pone.0224649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693677	Green Published, gold			2022-12-26	WOS:000532690100033
J	Gurjar, SA; Wheeler, JX; Wadhwa, M; Thorpe, R; Kimber, I; Derrick, JP; Dearman, RJ; Metcalfe, C				Gurjar, Shalom A.; Wheeler, Jun X.; Wadhwa, Meenu; Thorpe, Robin; Kimber, Ian; Derrick, Jeremy P.; Dearman, Rebecca J.; Metcalfe, Clive			The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; thioredoxin (Trx); monoclonal antibody; redox regulation; disulfide; antibody-dependent cellular cytotoxicity (ADCC); biotherapeutic; functional effects; safety and efficacy; disulfide bond; complement-dependent cytotoxicity (CDC)	HUMAN-IGG; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; IN-VITRO; TRASTUZUMAB; COMPLEX; BINDING; CELLS; FLEXIBILITY; MECHANISMS	Therapeutic mAbs are used to manage a wide range of cancers and autoimmune disorders. However, mAb-based treatments are not always successful, highlighting the need for a better understanding of the factors influencing mAb efficacy. Increased levels of oxidative stress associated with several diseases are counteracted by the activities of various oxidoreductase enzymes, such as thioredoxin (Trx), which also reduces allosteric disulfide bonds in proteins, including mAbs. Here, using an array of in vitro assays, we explored the functional effects of Trx-mediated reduction on the mechanisms of action of six therapeutic mAbs. We found that Trx reduces the interchain disulfide bonds of the mAbs, after which they remain intact but have altered function. In general, this reduction increased antigen-binding capacity, resulting in, for example, enhanced tumor necrosis factor (TNF) neutralization by two anti-TNF mAbs. Conversely, Trx reduction decreased the antiproliferative activity of an anti-tyrosine kinase-type cell-surface receptor HER2 mAb. In all of the mAbs, Fc receptor binding was abrogated by Trx activity, with significant loss in both complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) activity of the mAbs tested. We also confirmed that without alkylation, Trx-reduced interchain disulfide bonds reoxidize, and ADCC activity is restored. In summary, Trx-mediated reduction has a substantial impact on the functional effects of an mAb, including variable effects on antigen binding and Fc function, with the potential to significantly impact mAb efficacy in vivo.	[Gurjar, Shalom A.; Wadhwa, Meenu; Thorpe, Robin; Metcalfe, Clive] Natl Inst Biol Stand & Controls, Div Biotherapeut, Blanche Lane South Mimms, Potters Bar EN6 3QG, Herts, England; [Wheeler, Jun X.] Natl Inst Biol Stand & Controls, Div Technol Dev & Infrastruct, Blanche Lane South Mimms, Potters Bar EN6 3QG, Herts, England; [Kimber, Ian; Derrick, Jeremy P.; Dearman, Rebecca J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Lydia Becker Inst Immunol & Inflammat, Fac Biol Med & Hlth,Sch Biol Sci, Manchester M13 9PT, Lancs, England; [Gurjar, Shalom A.] Oxford Genet, Medawar Ctr, Oxford Sci Pk,1 Robert Robinson Ave, Oxford OX4 4HG, England	National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; University of Manchester	Metcalfe, C (corresponding author), Natl Inst Biol Stand & Controls, Blanche Lane South Mimms, Potters Bar EN6 3QG, Herts, England.	clive.metcalfe@nibsc.org		Wadhwa, Meenu/0000-0002-2331-1093; Metcalfe, Clive/0000-0002-7856-8574	National Institute for Health Research (NIHR) Policy Research Programme (National Institute for Biological Standards and Control (NIBSC) Regulatory Science Research Unit)	National Institute for Health Research (NIHR) Policy Research Programme (National Institute for Biological Standards and Control (NIBSC) Regulatory Science Research Unit)	This paper is based on independent research commissioned and funded by the National Institute for Health Research (NIHR) Policy Research Programme (National Institute for Biological Standards and Control (NIBSC) Regulatory Science Research Unit). The views expressed in the publication are those of the author(s) and not necessarily those of the National Health Service (NHS), the NIHR, the Department of Health, "arms-length" bodies, or other government departments. The authors declare that they have no conflicts of interest with the contents of this article.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Banerji S, 2016, J BIOL CHEM, V291, P25004, DOI 10.1074/jbc.M116.736926; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Burkitt W, 2010, PROTEIN SCI, V19, P826, DOI 10.1002/pro.362; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Ceccarelli J, 2008, INT J CANCER, V123, P1770, DOI 10.1002/ijc.23709; Curbo S, 2009, BIOCHEM BIOPH RES CO, V390, P1272, DOI 10.1016/j.bbrc.2009.10.134; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; ERICSON ML, 1992, LYMPHOKINE CYTOK RES, V11, P201; Frenzel A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00217; Gurjar SA, 2017, J PHARMACEUT BIOMED, V143, P188, DOI 10.1016/j.jpba.2017.06.004; Heim K, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.69; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Hu S, 2013, J BIOL CHEM, V288, P27059, DOI 10.1074/jbc.M113.491530; Hutterer KM, 2013, MABS-AUSTIN, V5, P608, DOI 10.4161/mabs.24725; Irani V, 2015, MOL IMMUNOL, V67, P171, DOI 10.1016/j.molimm.2015.03.255; Janeway C. J., 2001, IMMUNOBIOLOGY IMMUNE, P93; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Karlenius Therese Christina, 2010, Cancers (Basel), V2, P209, DOI 10.3390/cancers2020209; Kellett-Clarke H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138137; Kim SJ, 2005, CLIN CANCER RES, V11, P8425, DOI 10.1158/1078-0432.CCR-05-0449; Kohno T, 2007, J INVEST DERM SYMP P, V12, P5, DOI 10.1038/sj.jidsymp.5650034; Krayukhina E, 2017, MABS-AUSTIN, V9, P664, DOI 10.1080/19420862.2017.1297909; Lan KH, 2005, ANN NY ACAD SCI, V1059, P70, DOI 10.1196/annals.1339.026; Lawrence DA, 1996, J LEUKOCYTE BIOL, V60, P611, DOI 10.1002/jlb.60.5.611; Liang SY, 2013, J BIOL CHEM, V288, P13799, DOI 10.1074/jbc.M112.433961; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lu TB, 2018, CLIN RHEUMATOL, V37, P117, DOI 10.1007/s10067-017-3832-1; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Metcalfe C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110036; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Nahta Rita, 2012, ISRN Oncol, V2012, P428062, DOI 10.5402/2012/428062; PACE CN, 1988, J BIOL CHEM, V263, P11820; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; PALMER JL, 1963, J BIOL CHEM, V238, P2393; Pellom ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081134; Perdriger A, 2009, BIOL-TARGETS THER, V3, P183; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Rezvani AR, 2011, BEST PRACT RES CL HA, V24, P203, DOI 10.1016/j.beha.2011.02.009; Roux KH, 1997, J IMMUNOL, V159, P3372; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Saphire EO, 2003, ADV EXP MED BIOL, V535, P55; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Sherrod SD, 2012, J PROTEOME RES, V11, P3467, DOI 10.1021/pr201240a; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stegmann M, 2013, EUR J IMMUNOL, V43, P15, DOI 10.1002/eji.201242849; Suzuki M, 2016, J BIOCHEM, V159, P67, DOI 10.1093/jb/mvv074; Suzuki M, 2013, BIOCHEM BIOPH RES CO, V436, P519, DOI 10.1016/j.bbrc.2013.05.137; Trexler-Schmidt M, 2010, BIOTECHNOL BIOENG, V106, P452, DOI 10.1002/bit.22699; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Xie ZJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002543; Zhang AM, 2014, ANAL CHEM, V86, P3468, DOI 10.1021/ac404130a	57	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19616	19634		10.1074/jbc.RA119.010637	http://dx.doi.org/10.1074/jbc.RA119.010637			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31727737	hybrid, Green Published			2022-12-26	WOS:000504093200014
J	Su, LJ; Jiang, XF; Yang, C; Zhang, JH; Chen, B; Li, YM; Yao, SJ; Xie, Q; Gomez, H; Murugan, R; Peng, ZY				Su, Lianjiu; Jiang, Xiaofang; Yang, Cheng; Zhang, Jiahao; Chen, Bo; Li, Yiming; Yao, Shijie; Xie, Qin; Gomez, Hernando; Murugan, Raghavan; Peng, Zhiyong			Pannexin 1 mediates ferroptosis that contributes to renal ischemia/reperfusion injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ferroptosis; lipid peroxidation; panx1; ischemia/reperfusion; kidney injury; ROS; cell death; MAPK signaling	ACUTE KIDNEY INJURY; CELL-DEATH; IRON; METABOLISM; GLUTATHIONE; CYCLE; EXPRESSION; TRANSPORT; PATHWAYS; FORM	Renal ischemia/reperfusion injury (IRI) is a significant challenge in perioperative medicine and is related to oxidative programmed cell death. However, the role of ferroptosis, a newly discovered form of oxidative cell death, has not been evaluated widely. Pannexin 1 (PANX1), an ATP-releasing pathway family protein, has pro-apoptotic effects during kidney injury. Here, we demonstrate that PANX1 deletion protects against renal IRI by regulating ferroptotic cell death. Panx1-knockout mice subjected to renal IRI had decreased plasma creatinine, malondialdehyde (MDA) levels in kidney tissues, and tubular cell death (visible as decreased TUNEL-positive renal tubular cells) compared with wildtype (WT) mice. In cultured human kidney 2 (HK-2) cells, silenced Panx1 expression significantly attenuated ferroptotic lipid peroxidation and iron accumulation induced by the ferroptosis inducer erastin. Moreover, the Panx1 silencing significantly modulated ferroptosis-related protein expression. Furthermore, Panx1 deletion induced the expression of a cytoprotective chaperone, heme oxygenase-1 (HO-1), and inhibited ferroptinophagy via the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway. In summary, Panx1 deletion protects against renal IRI by attenuating MAPK/ERK activation in a ferroptotic pathway. Our findings provide critical insights into the role of PANX1 in ferroptotic cell death and highlight a potential therapeutic target for the management of acute kidney injury (AKI) during the perioperative period.	[Su, Lianjiu; Jiang, Xiaofang; Yang, Cheng; Zhang, Jiahao; Chen, Bo; Li, Yiming; Yao, Shijie; Xie, Qin; Peng, Zhiyong] Wuhan Univ, Zhongnan Hosp, Dept Crit Care Med, Wuhan 430071, Hubei, Peoples R China; [Gomez, Hernando; Murugan, Raghavan; Peng, Zhiyong] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Ctr Crit Nephrol, Pittsburgh, PA 15223 USA	Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Peng, ZY (corresponding author), Wuhan Univ, Zhongnan Hosp, Crit Care Med, Wuhan 430000, Hubei, Peoples R China.	pengzy5@hotmail.com	Su, Lianjiu/AAA-2545-2022; Gomez, Hernando/ABB-4589-2020	Su, Lianjiu/0000-0001-6822-6602; 	National Natural Science Foundation of China [81560131]; Hubei Province Key Projects [WJ2017Z008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Key Projects	This project was supported by grant from National Natural Science Foundation of China [ZP, 81560131] and Hubei Province Key Projects [Z.P. WJ2017Z008]	Abdalkader M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00466; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Bauckman KA, 2016, AUTOPHAGY, V12, P850, DOI 10.1080/15548627.2016.1160176; Bond SR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00058; Chang LC, 2018, CANCER LETT, V416, P124, DOI 10.1016/j.canlet.2017.12.025; Cheloni G, 2013, CYTOM PART A, V83, P952, DOI 10.1002/cyto.a.22338; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Do Van B, 2016, NEUROBIOL DIS, V94, P169, DOI 10.1016/j.nbd.2016.05.011; Doll S, 2017, IUBMB LIFE, V69, P423, DOI 10.1002/iub.1616; Draganov D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16222; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Gentle ME, 2013, J AM SOC NEPHROL, V24, P787, DOI 10.1681/ASN.2012101024; Gu X, 2019, AM J TRANSL RES, V11, P3850; ISHII T, 1981, J BIOL CHEM, V256, P2387; Jankowski J, 2018, J AM SOC NEPHROL, V29, P1887, DOI 10.1681/ASN.2017121306; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/nchembio.2238, 10.1038/NCHEMBIO.2238]; Li YM, 2019, BBA-MOL BASIS DIS, V1865, P558, DOI 10.1016/j.bbadis.2018.10.041; Lin L, 2018, MOL MED REP, V18, P3027, DOI 10.3892/mmr.2018.9282; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Makarenkova HP, 2018, J INFLAMM RES, V11, P273, DOI 10.2147/JIR.S128401; Mancias JD, 2015, ELIFE, V4, DOI 10.7554/eLife.10308; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Meng XM, 2018, LAB INVEST, V98, P63, DOI 10.1038/labinvest.2017.120; Nissen JD, 2017, GLIA, V65, P474, DOI 10.1002/glia.23105; Prus E, 2008, CYTOM PART A, V73A, P22, DOI 10.1002/cyto.a.20491; Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151; Sang Q, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8731; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Su LJ, 2018, BRIT J ANAESTH, V121, P350, DOI 10.1016/j.bja.2018.02.069; Su X, 2019, THERANOSTICS, V9, P4461, DOI 10.7150/thno.35219; Sun MZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06946-z; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; Sun Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0794-4; Visarius TM, 1996, BIOCHEM PHARMACOL, V52, P259, DOI 10.1016/0006-2952(96)00203-1; Wang L, 2019, CELL DEATH DIFFER; Wang YH, 2019, AM J PHYSIOL-CELL PH, V317, pC68, DOI 10.1152/ajpcell.00117.2018; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Xu J, 2018, J CELL PHYSIOL, V233, P2075, DOI 10.1002/jcp.25906; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; ZAGER RA, 1995, KIDNEY INT, V48, P1624, DOI 10.1038/ki.1995.457	45	84	88	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19395	19404		10.1074/jbc.RA119.010949	http://dx.doi.org/10.1074/jbc.RA119.010949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694915	hybrid, Green Published			2022-12-26	WOS:000516527800035
J	Pang, ZD; Wang, Y; Wang, XJ; She, G; Ma, XZ; Song, Z; Zhao, LM; Wang, HF; Lai, BC; Gou, W; Du, XJ; Deng, XL				Pang, Zheng-Da; Wang, Yan; Wang, Xiao-Jing; She, Gang; Ma, Xiao-Zhen; Song, Zheng; Zhao, Li-Mei; Wang, Hui-Fang; Lai, Bao-Chang; Gou, Wei; Du, Xiao-Jun; Deng, Xiu-Ling			K(Ca)3.1 channel mediates inflammatory signaling of pancreatic beta cells and progression of type 2 diabetes mellitus	FASEB JOURNAL			English	Article						pancreatic islet beta cells; inflammation; nuclear factor-kappa B	ACTIVATED POTASSIUM CHANNEL; K+ CHANNEL; KAPPA-B; GLUCOSE; INHIBITOR; CHEMOKINE; BLOCKADE; PROTEIN; KCA3.1; RISK	Chronic islet inflammation is associated with development of type 2 diabetes mellitus (T2DM). Intermediate-conductance calcium-activated K+ (K(Ca)3.1) channel plays an important role in inflammatory diseases. However, the role and regulation of K(Ca)3.1 in pancreatic beta cells in progression of T2DM remain unclarified. In the present study, we evaluated the effect of the specific K(Ca)3.1 channel blocker 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34) on diabetic phenotype in the db/db model. In diabetic mice, blockade of K(Ca)3.1 significantly improved glucose tolerance, enhanced secretion of postprandial insulin level, and reduced loss of beta-cell mass through attenuating the expression and secretion of inflammatory mediators. Furthermore, in cultured pancreatic 13 cells, exposure to high levels of glucose or palmitic acid significantly increased expression and current density of the K(Ca)3.1 channel as well as secretion of proinflammatory chemokines, and the effects were similarly reversed by preincubation with TRAM-34 or a NF-kappa B inhibitor pyrrolidinedithiocarbamate. Additionally, expression of K(Ca)3.1 in pancreas islet cells was up-regulated by activation of NF-kappa B with IL-1 beta stimulation. In summary, up-regulated K(Ca)3.1 due to activation of NF-kappa B pathway leads to pancreatic inflammation via expression and secretion of chemokines and cytokines by pancreatic beta cells, thereby facilitating progression of T2DM.	[Pang, Zheng-Da; Wang, Yan; Wang, Xiao-Jing; She, Gang; Ma, Xiao-Zhen; Song, Zheng; Zhao, Li-Mei; Du, Xiao-Jun; Deng, Xiu-Ling] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Hlth Sci Ctr, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Lai, Bao-Chang; Deng, Xiu-Ling] Xi An Jiao Tong Univ, Sch Basic Med Sci, Cardiovasc Res Ctr, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Gou, Wei] Xi An Jiao Tong Univ, Sch Basic Med Sci, Basic Expt Teaching Ctr, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Wang, Hui-Fang] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian Guangren Hosp, Dept Pathol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Deng, XL (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Hlth Sci Ctr, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	dengxl@mail.xjtu.edu.cn			National Natural Science Foundation of China [81600656, 81570214, 81370191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 81600656, 81570214, and 81370191). The authors declare no conflicts of interest.	Basu S, 2019, LANCET DIABETES ENDO, V7, P25, DOI 10.1016/S2213-8587(18)30303-6; Burke SJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE715, DOI 10.1152/ajpendo.00153.2015; Burke SJ, 2015, BIOMOLECULES, V5, P1020, DOI 10.3390/biom5021020; Di L, 2010, J BIOL CHEM, V285, P38765, DOI 10.1074/jbc.M110.168070; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Drews G, 2009, ISLETS, V1, P148, DOI 10.4161/isl.1.2.9056; Dufer M, 2009, DIABETES, V58, P1835, DOI 10.2337/db08-1324; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Ma XZ, 2018, EXP CELL RES, V369, P208, DOI 10.1016/j.yexcr.2018.05.020; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Maedler K, 2017, J CLIN INVEST, V127, P1589, DOI 10.1172/JCI92172; Marchetti P, 2016, DIABETOLOGIA, V59, P668, DOI 10.1007/s00125-016-3875-x; Ortis F, 2012, FEBS LETT, V586, P984, DOI 10.1016/j.febslet.2012.02.021; Pang ZD, 2014, P NATL ACAD SCI USA, V111, pE1256, DOI 10.1073/pnas.1322009111; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Ripsin CM, 2009, AM FAM PHYSICIAN, V79, P29; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Schumann DM, 2007, P NATL ACAD SCI USA, V104, P2861, DOI 10.1073/pnas.0611487104; She G, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010418; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Tamarina NA, 2003, DIABETES, V52, P2000, DOI 10.2337/diabetes.52.8.2000; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Westwell-Roper CY, 2015, DIABETOLOGIA, V58, P575, DOI 10.1007/s00125-014-3447-x; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Zhao LM, 2015, PFLUG ARCH EUR J PHY, V467, P2275, DOI 10.1007/s00424-015-1694-4	37	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14760	14771		10.1096/fj.201901329RR	http://dx.doi.org/10.1096/fj.201901329RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690106	Bronze			2022-12-26	WOS:000507466100130
J	Zhu, JJ; Ramanathan, P; Bishop, EA; O'Donnell, V; Gladue, DP; Borca, MV				Zhu, James J.; Ramanathan, Palaniappan; Bishop, Elizabeth A.; O'Donnell, Vivian; Gladue, Douglas P.; Borca, Manuel, V			Mechanisms of African swine fever virus pathogenesis and immune evasion inferred from gene expression changes in infected swine macrophages	PLOS ONE			English	Article							T-CELL; LYMPHOCYTE APOPTOSIS; HOST-DEFENSE; BONE-MARROW; CYTOKINES; RECEPTOR; TNF; AUTOPHAGY; PATHOLOGY; LIGAND	African swine fever (ASF) is a swine disease caused by a large, structurally complex, double-stranded DNA virus, African swine fever virus (ASFV). In domestic pigs, acute infection by highly virulent ASF viruses causes hemorrhagic fever and death. Previous work has suggested that ASFV pathogenesis is primarily mediated by host cytokines produced by infected monocytes and macrophages. To better understand molecular mechanisms mediating virus pathogenesis and immune evasion, we used transcriptome analysis to identify gene expression changes after ASFV infection in ex vivo swine macrophages. Our results suggest that the cytokines of TNF family including FASLG, LTA, LTB, TNF, TNFSF4, TNFSF10, TNFSF13B and TNFSF18 are the major causative cytokine factors in ASF pathogenesis via inducing apoptosis. Other up-regulated proinflammatory cytokines (IL17F and interferons) and down-regulated anti-inflammatory cytokine (IL10) may also significantly contribute to ASF pathogenesis and cause excessive tissue inflammatory responses. The differential expression of genes also indicates that ASFV could evade both the innate and adaptive immune responses by (i) inhibiting MHC Class II antigen processing and presentation, (ii) avoiding CD8+ T effector cells and neutrophil extracellular traps via decreasing expression of neutrophil/CD8+ T effector cell-recruiting chemokines, (iii) suppressing M1 activation of macrophages, (iv) inducing immune suppressive cytokines, and (v) inhibiting the processes of macrophage autophagy and apoptosis. These results provide novel information to further investigate and better understand the mechanism of pathogenesis and immune evasion of this devastating swine disease.	[Zhu, James J.; Bishop, Elizabeth A.; Gladue, Douglas P.; Borca, Manuel, V] USDA ARS, FADRU, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA; [Ramanathan, Palaniappan] Oak Ridge Inst Sci & Educ ORISE, Oak Ridge, TN USA; [O'Donnell, Vivian] USDA, APHIS, Plum Isl Anim Dis Ctr, Orient, NY USA; [Ramanathan, Palaniappan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Department of Agriculture (USDA); University of Texas System; University of Texas Medical Branch Galveston	Zhu, JJ; Borca, MV (corresponding author), USDA ARS, FADRU, Plum Isl Anim Dis Ctr, Orient, NY 11957 USA.	james.zhu@ars.usda.gov; manuel.borca@ars.usda.gov	O'Donnell, Vivian/ACY-4611-2022; Gladue, Douglas/P-6280-2018; Ramanathan, Palaniappan/B-1062-2012	Gladue, Douglas/0000-0002-7894-0233; Ramanathan, Palaniappan/0000-0001-8121-7647	U.S. Department of Homeland Security [HSHQDC-11-X-00077, HSHQPM-12-X-00005]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-11-X-00077, HSHQPM-12-X-00005]	U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MB received funding from U.S. Department of Homeland Security under Award Numbers HSHQDC-11-X-00077 and HSHQPM-12-X-00005.; This research was partially supported through an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Numbers HSHQDC-11-X-00077 and HSHQPM-12-X-00005. We wish to specially thank Melanie Prarat for editing the manuscript.	Afonso CL, 2004, J VIROL, V78, P1858, DOI 10.1128/JVI.78.4.1858-1864.2004; Alonso C, 2013, VIRUS RES, V173, P42, DOI 10.1016/j.virusres.2012.12.006; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Antonelli A, 2014, AUTOIMMUN REV, V13, P272, DOI 10.1016/j.autrev.2013.10.010; Apelbaum A, 2013, MOL CELL BIOL, V33, P800, DOI 10.1128/MCB.01430-12; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Basler CF, 2017, SEMIN IMMUNOPATHOL, V39, P551, DOI 10.1007/s00281-017-0637-x; Basters A, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180250; Bekisz J, 2010, PHARMACEUTICALS, V3, P994, DOI 10.3390/ph3040994; Blome S, 2013, VIRUS RES, V173, P122, DOI 10.1016/j.virusres.2012.10.026; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bohlson SS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00402; Borca MV, 2018, VIRUS RES, V249, P116, DOI 10.1016/j.virusres.2018.03.017; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chen HH, 2017, CELL MOL IMMUNOL, V14, P736, DOI 10.1038/cmi.2017.44; Correia S, 2013, VIRUS RES, V173, P87, DOI 10.1016/j.virusres.2012.10.013; Croft M, 2017, NAT REV RHEUMATOL, V13, P217, DOI 10.1038/nrrheum.2017.22; del Moral MG, 1999, J VIROL, V73, P2173; Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020; Duncan SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02431; Dwivedi P, 2017, EXP HEMATOL, V46, P9, DOI 10.1016/j.exphem.2016.10.008; Gomez-Villamandos JC, 2013, VIRUS RES, V173, P140, DOI 10.1016/j.virusres.2013.01.017; GomezVillamandos JC, 1997, VET PATHOL, V34, P97, DOI 10.1177/030098589703400202; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Hamidi T, 2013, AUTOPHAGY, V9, P95, DOI 10.4161/auto.22258; Hamidzadeh K, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00074; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hurtado C, 2011, ARCH VIROL, V156, P219, DOI 10.1007/s00705-010-0846-2; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Jaing C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10186-4; Juhas U, 2015, POSTEP HIG MED DOSW, V69, P496, DOI 10.5604/17322693.1150133; Karalyan Z, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-18; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Krug PW, 2015, J VIROL, V89, P2324, DOI 10.1128/JVI.03250-14; Li QS, 2016, J IMMUNOL, V197, P962, DOI 10.4049/jimmunol.1502615; MALMQUIST WA, 1960, AM J VET RES, V21, P104; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Agraz-Cibrian JM, 2017, VIRUS RES, V228, P124, DOI 10.1016/j.virusres.2016.11.033; Messaoudi I, 2015, CURR OPIN IMMUNOL, V36, P38, DOI 10.1016/j.coi.2015.06.003; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Moriyama M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.4; Munz C, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100288; Munz C, 2016, IMMUNOL REV, V272, P17, DOI 10.1111/imr.12422; RamiroIbanez F, 1996, J GEN VIROL, V77, P2209, DOI 10.1099/0022-1317-77-9-2209; Roe MFE, 2004, CLIN EXP IMMUNOL, V137, P139, DOI 10.1111/j.1365-2249.2004.02512.x; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Salguero FJ, 2005, J COMP PATHOL, V132, P289, DOI 10.1016/j.jcpa.2004.11.004; Salguero FJ, 2002, VET IMMUNOL IMMUNOP, V90, P11, DOI 10.1016/S0165-2427(02)00225-8; Sanchez EG, 2013, VIRUS RES, V173, P58, DOI 10.1016/j.virusres.2012.10.025; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Silk RN, 2007, J GEN VIROL, V88, P411, DOI 10.1099/vir.0.82358-0; Tamura RE, 2012, CURR MOL MED, V12, P634; Teijaro JR, 2017, SEMIN IMMUNOPATHOL, V39, P501, DOI 10.1007/s00281-017-0640-2; VIAL T, 1994, DRUG SAFETY, V10, P115, DOI 10.2165/00002018-199410020-00003; Wack A, 2011, CURR OPIN VIROL, V1, P184, DOI 10.1016/j.coviro.2011.05.015; WARDLEY RC, 1977, ARCH VIROL, V55, P327, DOI 10.1007/BF01315054; WARDLEY RC, 1979, ARCH VIROL, V61, P217, DOI 10.1007/BF01318056; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Whittall JTD, 1997, IMMUNOLOGY, V91, P444, DOI 10.1046/j.1365-2567.1997.00272.x; Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134; Zhang FQ, 2006, J VIROL, V80, P10514, DOI 10.1128/JVI.00485-06; Zhao Y, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1004983; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004; Zhu JF, 2018, J CELL MOL MED, V22, P3353, DOI 10.1111/jcmm.13610; Zsak L, 1996, J VIROL, V70, P8865, DOI 10.1128/JVI.70.12.8865-8871.1996	68	38	44	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0223955	10.1371/journal.pone.0223955	http://dx.doi.org/10.1371/journal.pone.0223955			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725732	gold, Green Published			2022-12-26	WOS:000532764500012
J	Wakahara, T; Shiraogawa, A				Wakahara, Taku; Shiraogawa, Ayumu			Effects of neuromuscular electrical stimulation training on muscle size in collegiate track and field athletes	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; SUBCUTANEOUS FAT; STRENGTH; FIBER; MUSCULARITY; ACTIVATION; PARAMETERS; ENDURANCE; YOUNG	The purpose of this study was to examine the effects of neuromuscular electrical stimulation training for 12 weeks on the abdominal muscle size in trained athletes. Male collegiate track and field athletes participated in the present study and were randomly allocated to either training or control groups. Eleven participants of the training group completed a 60-session training program over a 12-week period (23 min/session, 5 days/week) involving neuromuscular electrical stimulation (mostly 20 Hz) for the abdominal muscles in addition to their usual training for the own events. The participants of the control group (n = 13) continued their usual training. Before and after the intervention period, cross-sectional areas of the rectus abdominis and abdominal oblique muscles (the internal and external obliques and trans versus abdominis) and subcutaneous fat thickness were measured with magnetic resonance and ultrasound imaging. There were no significant changes in cross-sectional area of the rectus abdominis or abdominal oblique muscles or in subcutaneous fat thickness in the training or control groups after the intervention period. The change in cross-sectional area of the rectus abdominis in each participant was not significantly correlated with pre-training cross-sectional area and neither was the mean value of fat thickness at pre- and post-training. These results suggest that low-frequency (20 Hz) neuromuscular electrical stimulation training for 12 weeks is ineffective in inducing hypertrophy of the abdominal muscles in trained athletes, even when they have a thin layer of subcutaneous fat.	[Wakahara, Taku; Shiraogawa, Ayumu] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan; [Wakahara, Taku] Waseda Univ, Human Performance Lab, Tokorozawa, Saitama, Japan	Doshisha University; Waseda University	Wakahara, T (corresponding author), Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan.; Wakahara, T (corresponding author), Waseda Univ, Human Performance Lab, Tokorozawa, Saitama, Japan.	twakahar@mail.doshisha.ac.jp		Wakahara, Taku/0000-0001-6864-7706	MTG Co., Ltd.	MTG Co., Ltd.	This study received funding from MTG Co., Ltd. (https://www.mtg.gr.jp/en/) to TW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2000, MED SCI SPORT EXER, V32, P1125, DOI 10.1097/00005768-200006000-00014; ABE T, 1994, AM J HUM BIOL, V6, P161, DOI 10.1002/ajhb.1310060204; ALON G, 1987, Journal of Orthopaedic and Sports Physical Therapy, V8, P567; CABRIC M, 1988, EUR J APPL PHYSIOL, V57, P1, DOI 10.1007/BF00691229; DELITTO A, 1989, INT J SPORTS MED, V10, P187, DOI 10.1055/s-2007-1024898; ERIKSSON E, 1981, INT J SPORTS MED, V2, P18, DOI 10.1055/s-2008-1034578; Filipovic A, 2012, J STRENGTH COND RES, V26, P2600, DOI 10.1519/JSC.0b013e31823f2cd1; Filipovic A, 2011, J STRENGTH COND RES, V25, P3218, DOI 10.1519/JSC.0b013e318212e3ce; Gondin J, 2005, MED SCI SPORT EXER, V37, P1291, DOI 10.1249/01.mss.0000175090.49048.41; Gondin J, 2006, J NEUROPHYSIOL, V95, P3328, DOI 10.1152/jn.01002.2005; Gondin J, 2011, J APPL PHYSIOL, V110, P433, DOI 10.1152/japplphysiol.00914.2010; HAKKINEN K, 1987, EUR J APPL PHYSIOL O, V56, P419, DOI 10.1007/BF00417769; Hortobagyi T, 2011, EUR J APPL PHYSIOL, V111, P2439, DOI 10.1007/s00421-011-2012-2; Kanehisa H, 2004, EUR J APPL PHYSIOL, V91, P534, DOI 10.1007/s00421-003-1034-9; Kikuchi N, 2016, J STRENGTH COND RES, V30, P2318, DOI 10.1519/JSC.0000000000001315; KIM CK, 1995, AVIAT SPACE ENVIR MD, V66, P251; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; Kubo J, 2007, J STRENGTH COND RES, V21, P1251; Maffiuletti NA, 2002, J APPL PHYSIOL, V92, P1383, DOI 10.1152/japplphysiol.00884.2001; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; MARTIN L, 1993, EUR J APPL PHYSIOL O, V67, P457, DOI 10.1007/BF00376463; Natsume T, 2018, EUR J APPL PHYSIOL, V118, P1339, DOI 10.1007/s00421-018-3866-3; Nishikawa Y, 2019, J ELECTROMYOGR KINES, V45, P46, DOI 10.1016/j.jelekin.2019.02.007; Perez M, 2002, PFLUG ARCH EUR J PHY, V443, P866, DOI 10.1007/s00424-001-0769-6; Petrofsky J, 2008, MED ENG PHYS, V30, P1168, DOI 10.1016/j.medengphy.2008.02.009; Putman CT, 2004, EUR J APPL PHYSIOL, V92, P376, DOI 10.1007/s00421-004-1104-7; RUTHER CL, 1995, J STRENGTH COND RES, V9, P155; Schoenfeld B, 2016, SCI DEV MUSCLE HYPER, P105; Sillen MJH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069391; Singer K P, 1986, Aust J Physiother, V32, P31, DOI 10.1016/S0004-9514(14)60641-3; Stevenson SW, 2001, MED SCI SPORT EXER, V33, P1304, DOI 10.1097/00005768-200108000-00010; STPIERRE D, 1986, J SPORT MED PHYS FIT, V26, P60; Takai Yohei, 2017, Sports Med Int Open, V1, pE147, DOI 10.1055/s-0043-115377; Tanaka NI, 2013, INT J SPORTS MED, V34, P56, DOI 10.1055/s-0032-1316316; Tanaka Noriko I., 2007, Journal of Physiological Anthropology, V26, P527, DOI 10.2114/jpa2.26.527; Theriault R, 1996, EUR J APPL PHYSIOL, V74, P311, DOI 10.1007/s004210050080	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224881	10.1371/journal.pone.0224881	http://dx.doi.org/10.1371/journal.pone.0224881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721812	gold, Green Published			2022-12-26	WOS:000532720700034
J	Mendes, CP; Koprowski, J				Mendes, Calebe Pereira; Koprowski, John			Does caching strategy vary with microclimate in endangered Mt. Graham red squirrels?	PLOS ONE			English	Article							HOARDING BEHAVIOR; TAMIASCIURUS; PERISHABILITY	Food hoarding is a common behavior used by a variety of animals to cope with periods of low food availability. At the retreating edge of species' distribution, the stressful environment and unfavourable climate conditions may impose severe costs on hoarding behavior. Since relict populations are hotspots for evolution and adaptation, and considering that food hoarding behavior has a strong evolutionary basis, we decided to evaluate the occurrence of behavioral variability in the amount of food cached by the endangered Mount Graham red squirrel (Tamiasciurus fremonti grahamensis). We tested the variation in cache size in response to microclimate, soil relief, vegetation, food availability and squirrel sex. The number of pits excavated by squirrels to cache cones was used as a proxy of cache size and was affected by mountain slope aspect and density of trees. More pits were excavated in the northeast facing slopes. The density of trees negatively affects the cache volume on southwest slopes, but not on northeast slopes. The sex of the resident squirrel also affects the number of pits in the squirrel midden, with males excavating 47% more pits than females. Males and females also presented different responses to the mountain slope aspect, with females excavating more pits on northeastern slopes than on southwestern slopes, whereas male cache size did not vary with the slope aspect. Finally, the squirrel's caching behavior did not vary in response to midden microclimate variation, a result with possible implications for the survival of the Mt Graham red squirrels, given the predicted temperature increases in the region due to climate change.	[Mendes, Calebe Pereira] Univ Estadual Paulista Julio Mesquite Filho UNESP, Inst Biociencias, Lab Biol Conservacao, Rio Claro, SP, Brazil; [Koprowski, John] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA	University of Arizona	Mendes, CP (corresponding author), Univ Estadual Paulista Julio Mesquite Filho UNESP, Inst Biociencias, Lab Biol Conservacao, Rio Claro, SP, Brazil.	calebepm3@hotmail.com		Pereira Mendes, Calebe/0000-0003-1323-3287; Koprowski, John/0000-0003-1406-9853	CAPEs (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [BEX 0659/15-0]	CAPEs (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work received a studentship from CAPEs (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - https://www.capes.gov.br), process number: BEX 0659/15-0 to CPM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudu S, 2016, WATER SCI ENG, V9, P265, DOI 10.1016/j.wse.2016.07.002; Agostinelli C., 2011, R PACKAGE CIRCULAR C; Akima H., 2020, AKIMA INTERPOLATION; Archibald DW, 2013, J MAMMAL, V94, P761, DOI 10.1644/12-MAMM-A-213.1; Bolker B., 2017, BBMLE TOOLS GEN MAXI; Burnham KP, 2003, MODEL SELECTION MULT; Correa-Metrio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081958; Courbaud B, 2003, AGR FOREST METEOROL, V116, P1, DOI 10.1016/S0168-1923(02)00254-X; Cox PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036299; Edenhofer O., 2014, CONTRIBUTION WORKING; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; FINLEY RB, 1969, MISCELLANEOUS PUBLIC, V51, P233; GENDRON RP, 1995, AM NAT, V145, P948, DOI 10.1086/285778; Goldstein EA, 2017, BIOL CONSERV, V205, P52, DOI 10.1016/j.biocon.2016.11.017; Granillo KA, 2009, LAST REFUGE MT GRAHA; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; GURNELL J, 1984, ANIM BEHAV, V32, P1119, DOI 10.1016/S0003-3472(84)80228-6; HadjChikh LZ, 1996, ANIM BEHAV, V52, P941, DOI 10.1006/anbe.1996.0242; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hendricks Paul, 2015, Northwestern Naturalist, V96, P240; Hope AG, 2016, MOL PHYLOGENET EVOL, V100, P170, DOI 10.1016/j.ympev.2016.04.014; HURLY TA, 1990, BEHAV ECOL SOCIOBIOL, V26, P91; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Koprowski JL, 2013, USDA P, P53; Koprowski JL, 2015, GRAHAM RED SQUIRREL; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lemon J., 2006, R R NEWS; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pewsey A., 2013, CIRCULAR STAT R, DOI [10.1080/09332480.2015.1016851, DOI 10.1080/09332480.2015.1016851]; Preston SD, 2009, J MAMMAL, V90, P787, DOI 10.1644/08-MAMM-A-254.1; R Development Core Team, 2016, R LANG ENV STAT COMP; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Schauffert CA, 2002, SOUTHWEST NAT, V47, P498, DOI 10.2307/3672515; SMITH AA, 1994, J WILDLIFE MANAGE, V58, P437, DOI 10.2307/3809314; SMITH CC, 1970, ECOL MONOGR, V40, P349, DOI 10.2307/1942287; Sutton A.O., 2016, CLIM CHANGE RESPONSE, V3, P12, DOI [10.1186/s40665-016-0025-0, DOI 10.1186/S40665-016-0025-0]; Tamura N, 1999, ANIM BEHAV, V58, P635, DOI 10.1006/anbe.1999.1163; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Waite TA, 2006, P R SOC B, V273, P2809, DOI 10.1098/rspb.2006.3667; Warshall P, 1995, USDA ROCKY, V264, P6; Wong BBM, 2015, BEHAV ECOL, V26, P665, DOI 10.1093/beheco/aru183	46	1	1	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224947	10.1371/journal.pone.0224947	http://dx.doi.org/10.1371/journal.pone.0224947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714949	gold, Green Published			2022-12-26	WOS:000532710400020
J	Cheng, CH; Zhong, YM; Wang, Q; Cai, ZM; Wang, DD; Li, CM				Cheng, Chunhong; Zhong, Yuanmei; Wang, Qing; Cai, Zhaoming; Wang, Diandong; Li, Changman			Genome-wide identification and gene expression analysis of SOS family genes in tuber mustard (Brassica juncea var. tumida)	PLOS ONE			English	Article							OVERLY SENSITIVE PATHWAY; ARABIDOPSIS-THALIANA; SALT TOLERANCE; STRESS TOLERANCE; RESPONSIVE GENES; PROTEIN; PROMOTER; ENCODES; SEQUENCE; ELEMENTS	The Salt Overly Sensitive (SOS) pathway in Arabidopsis thaliana plays important roles in maintaining appropriate ion homeostasis in the cytoplasm and regulating plant tolerance to salinity. However, little is known about the details regarding SOS family genes in the tuber mustard crop (Brassica juncea var. tumida). Here, 12 BjSOS family genes were identified in the B. juncea var. tumida genome including two homologous genes of SOS1, one and three homologs of SOS2 and SOS3, two homologs of SOS4, two homologs of SOS5 and two homologs of SOS6, respectively. The results of conserved motif analysis showed that these SOS homologs contained similar protein structures. By analyzing the cis-elements in the promoters of those BjSOS genes, several hormone- and stress-related cis-elements were found. The results of gene expression analysis showed that the homologous genes were induced by abiotic stress and pathogen. These findings indicate that BjSOS genes play crucial roles in the plant response to biotic and abiotic stresses. This study provides valuable information for further investigations of BjSOS genes in tuber mustard.	[Cheng, Chunhong; Zhong, Yuanmei; Wang, Qing; Cai, Zhaoming; Wang, Diandong; Li, Changman] Yangtze Normal Univ, Sch Adv Agr & Bioengn, Chongqing, Peoples R China	Yangtze Normal University	Li, CM (corresponding author), Yangtze Normal Univ, Sch Adv Agr & Bioengn, Chongqing, Peoples R China.	cmlyznu@163.com			National Natural Science Foundation of China [31701451, 31770407]; Chongqing technology innovation and application demonstration project [cstc2018jscxmsyb0152]; Chongqing Basic Research and Frontier Exploration Project [cstc2018jcyjAX0628]; Science and Technology Research Program of Chongqing Municipal Education Commission [KJQN201801434]; Yangtze Normal University Startup Foundation [2017KYQD151, 2017KYQD152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing technology innovation and application demonstration project; Chongqing Basic Research and Frontier Exploration Project; Science and Technology Research Program of Chongqing Municipal Education Commission; Yangtze Normal University Startup Foundation	This work was supported by The National Natural Science Foundation of China (Program Nos. 31701451 and 31770407), Zhaoming Cai and Diandong Wang; Chongqing technology innovation and application demonstration project (social livelihood) (Program No. cstc2018jscxmsyb0152), Changman Li; Chongqing Basic Research and Frontier Exploration Project (Program No. cstc2018jcyjAX0628), the Science and Technology Research Program of Chongqing Municipal Education Commission (Grant No. KJQN201801434), Chunhong Cheng; and Yangtze Normal University Startup Foundation for Dr. Scientific Research (Program Nos. 2017KYQD151 and 2017KYQD152), Zhaoming Cai and Chunhong Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Cai ZM, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020165; Chakraborty K, 2012, PLANT PHYSIOL BIOCH, V51, P90, DOI 10.1016/j.plaphy.2011.10.001; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chen JJ, 2018, PLANT SCI, V270, P257, DOI 10.1016/j.plantsci.2018.02.017; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Di FF, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030156; Dunn MA, 1998, PLANT MOL BIOL, V38, P551, DOI 10.1023/A:1006098132352; Feki K, 2015, J APPL GENET, V56, P15, DOI 10.1007/s13353-014-0228-7; Gong DM, 2004, PLANT PHYSIOL, V134, P919, DOI 10.1104/pp.103.037440; Goyal E, 2013, BIOL PLANTARUM, V57, P465, DOI 10.1007/s10535-013-0309-1; Kaur C, 2015, MOL BIOL REP, V42, P1139, DOI 10.1007/s11033-015-3851-4; Kumar G, 2009, J PLANT PHYSIOL, V166, P507, DOI 10.1016/j.jplph.2008.08.001; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; Mena M, 2002, PLANT PHYSIOL, V130, P111, DOI 10.1104/pp.005561; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Nutan KK, 2018, CURR GENOMICS, V19, P60, DOI 10.2174/1389202918666170228133621; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Sathee L, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1910-z; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Shi HZ, 2002, PLANT PHYSIOL, V129, P585, DOI 10.1104/pp.001982; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang RJ, 2010, PLANT MOL BIOL, V74, P367, DOI 10.1007/s11103-010-9680-x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657; Zhu JH, 2010, PLANT J, V63, P128, DOI 10.1111/j.1365-313X.2010.04227.x; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	35	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224672	10.1371/journal.pone.0224672	http://dx.doi.org/10.1371/journal.pone.0224672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710609	gold, Green Published			2022-12-26	WOS:000532699900016
J	Lentz, TA; Harman, JS; Marlow, NM; Beneciuk, JM; Fillingim, RB; George, SZ				Lentz, Trevor A.; Harman, Jeffrey S.; Marlow, Nicole M.; Beneciuk, Jason M.; Fillingim, Roger B.; George, Steven Z.			Factors associated with persistently high-cost health care utilization for musculoskeletal pain	PLOS ONE			English	Article							LOW-BACK-PAIN; SUPER-UTILIZERS; OLDER-ADULTS; POPULATION; EXPENDITURES; COMORBIDITY; OUTCOMES; OSTEOARTHRITIS; DEPRESSION; MANAGEMENT	Background Musculoskeletal pain conditions incur high costs and produce significant personal and public health consequences, including disability and opioid-related mortality. Persistence of high-cost health care utilization for musculoskeletal pain may help identify system inefficiencies that could limit value of care. The objective of this study was to identify factors associated with persistent high-cost utilization among individuals seeking health care for musculoskeletal pain. Methods This was a retrospective cohort study of Medical Expenditure Panel Survey data (2008-2013) that included a non-institutionalized, population-based sample of individuals seeking health care for a musculoskeletal pain condition (n = 12,985). Expenditures associated with musculoskeletal pain conditions over two consecutive years were analyzed from prescribed medicine, office-based medical provider visits, outpatient department visits, emergency room visits, inpatient hospital stays, and home health visits. Persistent high-cost utilization was defined as being in the top 15th percentile for annual musculoskeletal pain-related expenditures over 2 consecutive years. We used multinomial regression to determine which modifiable and non-modifiable sociodemographic, health, and pain-related variables were associated with persistent high-cost utilization. Results Approximately 35% of direct costs for musculoskeletal pain were concentrated among the 4% defined as persistent high-cost utilizers. Non-modifiable variables associated with expenditure group classification included age, race, poverty level, geographic region, insurance status, diagnosis type and total number of musculoskeletal pain diagnoses. Modifiable variables associated with increased risk of high expenditure classification were higher number of missed work days, greater pain interference, and higher use of prescription medication for pain, while higher self-reported physical and mental health were associated with lower risk of high expenditure classification. Conclusions Health care delivery models that prospectively identify these potentially modifiable factors may improve the costs and value of care for individuals with musculoskeletal pain prone to risk for high-cost care episodes.	[Lentz, Trevor A.; George, Steven Z.] Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA; [Lentz, Trevor A.; George, Steven Z.] Duke Univ, Dept Orthopaed Surg, Durham, NC 27708 USA; [Harman, Jeffrey S.] Florida State Univ, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA; [Marlow, Nicole M.] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA; [Beneciuk, Jason M.] Univ Florida, Brooks Rehabil, Dept Phys Therapy, Coll Publ Hlth & Hlth Profess Res Collaborat, Gainesville, FL USA; [Fillingim, Roger B.] Univ Florida, Pain Res & Intervent Ctr Excellence, Gainesville, FL USA	Duke University; Duke University; State University System of Florida; Florida State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lentz, TA (corresponding author), Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA.; Lentz, TA (corresponding author), Duke Univ, Dept Orthopaed Surg, Durham, NC 27708 USA.	trevor.lentz@duke.edu		George, Steven/0000-0003-4988-9421	Foundation for Physical Therapy Promotion of Doctoral Studies I II Awards; National Institutes of Health (NIH) Rehabilitation Research Career Development Program [K12-HD055929]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055929] Funding Source: NIH RePORTER	Foundation for Physical Therapy Promotion of Doctoral Studies I II Awards; National Institutes of Health (NIH) Rehabilitation Research Career Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Foundation for Physical Therapy (https://foundation4pt.org) Promotion of Doctoral Studies I & II Awards to TAL; and the National Institutes of Health (NIH) Rehabilitation Research Career Development Program (https://www.nichd.nih.gov) K12-HD055929 to JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2019, MMWR Morb Mortal Wkly Rep, V68, P409, DOI 10.15585/mmwr.mm6817a7; [Anonymous], 2000, SAS SYSTEM REGRESSIO; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Blackwell DL., 2014, SERIES 10 DATA NATL, V1, P1; Briggs AM, 2016, GERONTOLOGIST, V56, pS243, DOI 10.1093/geront/gnw002; Cahana A, 2013, PAIN MED, V14, P36, DOI 10.1111/pme.12013; Charlson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112479; Chechulin Yuriy, 2014, Healthc Policy, V9, P68; Cohen J., 1997, SAMPLE DESIGN MED EX; Cohen S, 2009, TESTING SURVEY ATTRI; Colla CH, 2018, HEALTH SERV RES, V53, P730, DOI 10.1111/1475-6773.12665; Coughlan D, 2014, VALUE HEALTH, V17, P90, DOI 10.1016/j.jval.2013.10.004; Cross MJ, 2006, RHEUMATOLOGY, V45, P92, DOI 10.1093/rheumatology/kei114; Cullen KL, 2018, J OCCUP REHABIL, V28, P1, DOI 10.1007/s10926-016-9690-x; de Oliveira C, 2016, HEALTH AFFAIR, V35, P36, DOI 10.1377/hlthaff.2015.0278; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Elliott MN, 2008, HEALTH SERV RES, V43, P833, DOI 10.1111/j.1475-6773.2007.00820.x; Emeche U, 2015, ANN FAM MED, V13, P6, DOI 10.1370/afm.1746; Figueroa JF, 2018, ANN INTERN MED, V169, P528, DOI 10.7326/M18-0085; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Fujii T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193208; Garfinkel S A, 1988, Health Care Financ Rev, V9, P41; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gatchel RJ, 2018, J PAIN, V19, P837, DOI 10.1016/j.jpain.2018.02.015; Guilcher SJT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149179; Gurung T, 2015, PHYSIOTHERAPY, V101, P243, DOI 10.1016/j.physio.2015.01.006; Harris LJ, 2016, J EMERG MED, V50, pE203, DOI 10.1016/j.jemermed.2015.09.002; Hart DL, 2011, PHYS THER, V91, P1812, DOI 10.2522/ptj.20100377; Heslop L, 2005, HEALTH SERV MANAG RE, V18, P232, DOI 10.1258/095148405774518633; HORNERJOHNSON W, 1999, HLTH SERV RES, V0049, P01980, DOI DOI 10.1111/1475-6773.12195; Karjalainen K, 2003, SPINE, V28, P2634, DOI 10.1097/01.BRS.0000099097.61495.2E; Kelsall HL, 2014, PAIN, V155, P685, DOI 10.1016/j.pain.2013.12.025; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Leininger LJ, 2015, MED CARE, V53, P729, DOI 10.1097/MLR.0000000000000391; Lentz TA, 2017, PHYS THER, V97, P354, DOI 10.2522/ptj.20160167; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Maeng DD, 2015, PAIN RES MANAG, V20, P234, DOI 10.1155/2015/862702; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Merkesdal S, 2005, INT J REHABIL RES, V28, P119, DOI 10.1097/00004356-200506000-00004; Mitchell EM, 2001, CONCENTRATION HLTH E; Nyman JA, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.5.194; Otani Koichiro, 2009, Health Mark Q, V26, P198, DOI 10.1080/07359680903263599; Prochaska JJ, 2012, INT J METH PSYCH RES, V21, P88, DOI 10.1002/mpr.1349; Ritzwoller DP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-72; Rosella LC, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0532-2; Roydhouse JK, 2018, HEALTH SERV RES, V53, P3809, DOI 10.1111/1475-6773.12980; Roydhouse JK, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-017-0823-5; Rundell SD, 2017, ARCH PHYS MED REHAB, V98, P43, DOI 10.1016/j.apmr.2016.06.022; Sennehed CP, 2018, PAIN, V159, P1456, DOI 10.1097/j.pain.0000000000001216; Thomas E, 2004, PAIN, V110, P361, DOI 10.1016/j.pain.2004.04.017; Thorn BE, 2018, ANN INTERN MED, V168, P471, DOI 10.7326/M17-0972; Traeger AC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002019; *US BUR LAB STAT, BLS MEAS PRIC CHANG; Von Korff M, 2016, J PAIN, V17, P1068, DOI 10.1016/j.jpain.2016.06.009; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	58	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0225125	10.1371/journal.pone.0225125	http://dx.doi.org/10.1371/journal.pone.0225125			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710655	Green Published, gold			2022-12-26	WOS:000532699900041
J	Griffin, LD				Griffin, Lewis D.			Reconciling the statistics of spectral reflectance and colour	PLOS ONE			English	Article								The spectral reflectance function of a surface specifies the fraction of the illumination reflected by it at each wavelength. Jointly with the illumination spectral density, this function determines the apparent colour of the surface. Models for the distribution of spectral reflectance functions in the natural environment are considered. The realism of the models is assessed in terms of the individual reflectance functions they generate, and in terms of the overall distribution of colours which they give rise to. Both realism assessments are made in comparison to empirical datasets. Previously described models (PCA- and fourier-based) of reflectance function statistics are evaluated, as are improved versions; and also a novel model, which synthesizes reflectance functions as a sum of sigmoid functions. Key model features for realism are identified. The new sigmoid-sum model is shown to be the most realistic, generating reflectance functions that are hard to distinguish from real ones, and accounting for the majority of colours found in natural images with the exception of an abundance of vegetation green and sky blue.	[Griffin, Lewis D.] UCL, Comp Sci, London, England	University of London; University College London	Griffin, LD (corresponding author), UCL, Comp Sci, London, England.	L.Griffin@cs.ucl.ac.uk		Griffin, Lewis/0000-0001-6286-2018				Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Anderson M, 1996, FOURTH COLOR IMAGING CONFERENCE: COLOR SCIENCE, SYSTEMS AND APPLICATIONS, P238; Berlin B., 1969, BASIC COLOR TERMS TH; Born M., 2013, PRINCIPLES OPTICS EL; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chatterjee S, 2003, NATURE, V426, P668, DOI 10.1038/nature02163; Conway BR, 2010, J NEUROSCI, V30, P14955, DOI 10.1523/JNEUROSCI.4348-10.2010; Coxeter H. S. M., 1961, INTRO GEOMETRY; Fairman HS, 2004, COLOR RES APPL, V29, P104, DOI 10.1002/col.10230; Fechner G., 1965, ELEMENTS PSYCHOPHYSI; FINLAYSON GD, 1994, J OPT SOC AM A, V11, P1553, DOI 10.1364/JOSAA.11.001553; Foss CE, 1944, J OPT SOC AM, V34, P361, DOI 10.1364/JOSA.34.000361; Foster DH, 2003, TRENDS COGN SCI, V7, P439, DOI 10.1016/j.tics.2003.08.002; Gegenfurtner K.R., 2001, COLOR VISION GENES P; Griffin LD, 2006, J R SOC INTERFACE, V3, P71, DOI 10.1098/rsif.2005.0076; Griffin LD, 2001, COLOR RES APPL, V26, P151, DOI 10.1002/1520-6378(200104)26:2<151::AID-COL1006>3.0.CO;2-G; Griffin LD, 1999, J OPT SOC AM A, V16, P2825, DOI 10.1364/JOSAA.16.002825; Griffin LD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216296; Hebart MN, THINGS DATABASE 1 85; Kelley K, 1955, 553 NBS, P553; Koenderink J., 1990, SOLID SHAPE; Koenderink J, 2017, I-PERCEPTION, V8, P1, DOI 10.1177/2041669517733484; Koenderink JJ, 2010, J OPT SOC AM A, V27, P206, DOI 10.1364/JOSAA.27.000206; KOENDERINK JJ, 1987, J OPT SOC AM A, V4, P1314, DOI 10.1364/JOSAA.4.001314; Kohonen O, 2006, COLOR RES APPL, V31, P381, DOI 10.1002/col.20244; Louwerse MM, 2008, PSYCHON B REV, V15, P838, DOI 10.3758/PBR.15.4.838; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; MCCOOL SF, 2007, PNWGTR705 USDA FOR S; Mylonas D, 2010, COL IM C; Nascimento SMC, 2002, J OPT SOC AM A, V19, P1484, DOI 10.1364/JOSAA.19.001484; NAYAR SK, 1991, IEEE T PATTERN ANAL, V13, P611, DOI 10.1109/34.85654; Ohta N, 2005, COLORIMETRY: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1002/0470094745; Olkkonen M, 2009, J VISION, V9, DOI 10.1167/9.12.6; Oyster CW., 1999, HUMAN EYE STRUCTURE; Popper K, 1979, 3 WORLDS; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stockman A., 2010, COLOR VISION MECH; VRHEL MJ, 1994, COLOR RES APPL, V19, P4, DOI 10.1111/j.1520-6378.1994.tb00053.x; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; Webster MA, 2007, NETWORK-COMP NEURAL, V18, P213, DOI 10.1080/09548980701654405; Zeki S., 1999, INNER VISION EXPLORA; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0223069	10.1371/journal.pone.0223069	http://dx.doi.org/10.1371/journal.pone.0223069			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703060	gold, Green Published			2022-12-26	WOS:000532697200003
J	Youssif, KA; Haggag, EG; Elshamy, AM; Rabeh, MA; Gabr, NM; Seleem, A; Salem, MA; Hussein, AS; Krischke, M; Mueller, MJ; Abdelmohsen, UR				Youssif, Khayrya A.; Haggag, Eman G.; Elshamy, Ali M.; Rabeh, Mohamed A.; Gabr, Nagwan M.; Seleem, Amany; Salem, M. Alaraby; Hussein, Ahmed S.; Krischke, Markus; Mueller, Martin J.; Abdelmohsen, Usama Ramadan			Anti-Alzheimer potential, metabolomic profiling and molecular docking of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea aqueous extracts	PLOS ONE			English	Article							DRUG-DELIVERY	The green synthesis of silver nanoparticles (SNPs) using plant extracts is an eco-friendly method. It is a single step and offers several advantages such as time reducing, cost-effective and environmental non-toxic. Silver nanoparticles are a type of Noble metal nanoparticles and it has tremendous applications in the field of diagnostics, therapeutics, antimicrobial activity, anticancer and neurodegenerative diseases. In the present work, the aqueous extracts of aerial parts of Lampranthus coccineus and Malephora lutea F. Aizoaceae were successfully used for the synthesis of silver nanoparticles. The formation of silver nanoparticles was early detected by a color change from pale yellow to reddish-brown color and was further confirmed by transmission electron microscope (TEM), UV-visible spectroscopy, Fourier transform infrared (FTIR) spectroscopy, dynamic light scattering (DLS), X-ray diffraction (XRD), and energy-dispersive X-ray diffraction (EDX). The TEM analysis of showed spherical nanoparticles with a mean size between 12.86 nm and 28.19 nm and the UV-visible spectroscopy showed lambda(max) of 417 nm, which confirms the presence of nanoparticles. The neuroprotective potential of SNPs was evaluated by assessing the antioxidant and cholinesterase inhibitory activity. Metabolomic profiling was performed on methanolic extracts of L. coccineus and M. lutea and resulted in the identification of 12 compounds, then docking was performed to investigate the possible interaction between the identified compounds and human acetylcholinesterase, butyrylcholinesterase, and glutathione transferase receptor, which are associated with the progress of Alzheimer's disease. Overall our SNPs highlighted its promising potential in terms of anticholinesterase and antioxidant activity as plant-based anti-Alzheimer drug and against oxidative stress.	[Youssif, Khayrya A.; Rabeh, Mohamed A.] Modern Univ Technol & Informat, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt; [Haggag, Eman G.; Gabr, Nagwan M.] Helwan Univ, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt; [Elshamy, Ali M.; Rabeh, Mohamed A.] Cairo Univ, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt; [Seleem, Amany] Natl Res Ctr, Dept Pharmacol, Cairo, Egypt; [Salem, M. Alaraby; Hussein, Ahmed S.] October Univ Modern Sci & Arts MSA, Dept Pharmaceut Chem, Cairo, Egypt; [Krischke, Markus; Mueller, Martin J.] Univ Wurzburg, Bioctr, Julius von Sachs Inst Biosci, Pharmaceut Biol, Wurzburg, Germany; [Abdelmohsen, Usama Ramadan] Minia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya, Egypt; [Abdelmohsen, Usama Ramadan] Deraya Univ, Fac Pharm, Dept Pharmacognosy, New Minia City, Minia, Egypt	Egyptian Knowledge Bank (EKB); Helwan University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA); University of Wurzburg; Egyptian Knowledge Bank (EKB); Minia University; Deraya University	Mueller, MJ (corresponding author), Univ Wurzburg, Bioctr, Julius von Sachs Inst Biosci, Pharmaceut Biol, Wurzburg, Germany.; Abdelmohsen, UR (corresponding author), Minia Univ, Fac Pharm, Dept Pharmacognosy, Al Minya, Egypt.; Abdelmohsen, UR (corresponding author), Deraya Univ, Fac Pharm, Dept Pharmacognosy, New Minia City, Minia, Egypt.	martin.mueller@biozentrum.uni-wuerzburg.de; Usama.ramadan@mu.edu.eg	Haggag, Eman G./F-4540-2017; Gabr, Nagwan/AAV-5866-2021; Abdelmohsen, Usama Ramadan/AAX-9874-2020	Abdelmohsen, Usama Ramadan/0000-0002-1014-6922	German Research Foundation (DFG); University of Wurzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing.	Abdelghany TM, 2018, BIONANOSCIENCE, V8, P5, DOI 10.1007/s12668-017-0413-3; Abdelhafez OH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202362; Abdelmohsen UR, 2014, MAR DRUGS, V12, P1220, DOI 10.3390/md12031220; Ahmed AA, 2018, TURK J BIOL, V42, P54, DOI 10.3906/biy-1710-2; Baruwati B, 2009, GREEN CHEM, V11, P926, DOI 10.1039/b902184a; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bootz A, 2004, EUR J PHARM BIOPHARM, V57, P369, DOI 10.1016/S0939-6411(03)00193-0; Carradori D, 2018, NANOMED-NANOTECHNOL, V14, P609, DOI 10.1016/j.nano.2017.12.006; Chandran SP, 2006, BIOTECHNOL PROGR, V22, P577, DOI 10.1021/bp0501423; Das S, 2013, COLLOID SURFACE B, V107, P27, DOI 10.1016/j.colsurfb.2013.01.061; Donda M. R., 2013, International Journal of Current Science, P1; Donda M.R., 2013, INT J CURR SCI, V7, P1; Erjaee Hoda, 2017, Advances in Natural Sciences: Nanoscience & Nanotechnology, V8, DOI 10.1088/2043-6254/aa690b; Evanoff DD, 2005, CHEMPHYSCHEM, V6, P1221, DOI 10.1002/cphc.200500113; Forough Mehrdad, 2010, Turkish Journal of Engineering and Environmental Sciences, V34, P281, DOI 10.3906/muh-1005-30; GALLE P, 1980, ACTA NEUROPATHOL, V49, P245, DOI 10.1007/BF00707114; Gardea-Torresdey JL, 2003, LANGMUIR, V19, P1357, DOI 10.1021/la020835i; Gour A, 2019, ARTIF CELL NANOMED B, V47, P844, DOI 10.1080/21691401.2019.1577878; Gurudeeban S, 2010, INVENT RAPID ETHNOPH, V1, P112; Hajipour MJ, 2017, TRENDS BIOTECHNOL, V35, P937, DOI 10.1016/j.tibtech.2017.06.002; Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104; Khan FA, 2016, J NANOMATER, V2016, P1, DOI 10.1155/2016/8026843; Kumar, 2017, J NANOMED NANOTECHNO, V08, DOI [DOI 10.4172/2157-7439.1000452, 10.4172/2157-7439.1000452]; Leela A, 2008, AFR J BIOTECHNOL, V7, P3162; Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g; Loureiro JA, 2016, COLLOID SURFACE B, V145, P8, DOI 10.1016/j.colsurfb.2016.04.041; Mani A., 2012, INT J BIO PHARM RES, V3, P631; Manikandan A., 2015, J NANOMED NANOTECHNO, V6, P1, DOI [DOI 10.4172/2157-7439.1000268, 10.4172/2157-7439.1000268]; Mohan S. C., 2014, Research Journal of Microbiology, V9, P142, DOI 10.3923/jm.2014.142.150; Moosa A., 2015, INT J CURR ENG TECHN, V5, P3233; Murthy YLN, 2010, J MAGN MAGN MATER, V322, P2071, DOI 10.1016/j.jmmm.2010.01.036; Nalwa H., 2007, HDB NANOSTRUCTURED B, V2; Nazim A, 2011, INSCIENCES J, V1, P169, DOI DOI 10.5640/INSC.0104169; Naziroglu M, 2017, EXPERT REV CLIN PHAR, V10, P773, DOI 10.1080/17512433.2017.1324781; Obaid AY., 2015, RES J MICROBIOL, V3, P119; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Paulkumar K, 2014, SCI WORLD J, DOI 10.1155/2014/829894; Ragab D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095313; Raheem DJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38940-w; Rajendran R., 2015, INT J PHARM PHARM SC, V7, P288; RATH M, 2014, INT J PLANT ANIM ENV, V4, P137; Saraiva C, 2016, J CONTROL RELEASE, V235, P34, DOI 10.1016/j.jconrel.2016.05.044; Sathaye, 2017, J MED PLANTS STUDIES, V5, P358; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003; Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002; Shawkey AM., 2013, ADV LIFE SCI TECHNOL, V13, P60; Shivaji S, 2011, PROCESS BIOCHEM, V46, P1800, DOI 10.1016/j.procbio.2011.06.008; Smuleac V, 2011, CHEMSUSCHEM, V4, P1773, DOI 10.1002/cssc.201100211; Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6; Tang R. C., 2017, ADV NAT SCI-NANOSCI, V8, P1, DOI DOI 10.1088/2043-6254/AA5983; Thirumurugan A., 2010, Der Pharma Chemica, V2, P279; Tripathy A, 2010, J NANOPART RES, V12, P237, DOI 10.1007/s11051-009-9602-5; Zheng XY, 2017, INT J PHARMACEUT, V525, P237, DOI 10.1016/j.ijpharm.2017.04.033	55	26	26	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0223781	10.1371/journal.pone.0223781	http://dx.doi.org/10.1371/journal.pone.0223781			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693694	gold, Green Published			2022-12-26	WOS:000532690100012
J	Nuell, S; Illera-Dominguez, V; Carmona, G; Alomar, X; Padulles, JM; Lloret, M; Cadefau, JA				Nuell, Sergi; Illera-Dominguez, Victor; Carmona, Gerard; Alomar, Xavier; Maria Padulles, Josep; Lloret, Mario; Aureli Cadefau, Joan			Sex differences in thigh muscle volumes, sprint performance and mechanical properties in national-level sprinters	PLOS ONE			English	Article							RUNNING PERFORMANCE; MASS; MEN	The purpose of this study was to determine and compare thigh muscle volumes (MVs), and sprint mechanical properties and performance between male and female national-level sprinters. We also studied possible relationships between thigh MVs and sprint performance. Nine male and eight female national-level sprinters participated in the study. T1-weighted magnetic resonance images of the thighs were obtained to determine MVs of quadriceps, hamstrings and adductors. Sprint performance was measured as the time to cover 40 and 80 m. Instantaneous sprint velocity was measured by radar to obtain theoretical maximum force (F-0), theoretical maximum velocity (V-0) and maximum power (Pmax). When MVs were normalized by height-mass, males showed larger hamstrings (13.5%, ES = 1.26, P < 0.05) compared with females, while quadriceps and adductors showed no statistically significant differences. Males were extremely faster than females in 40 m (14%, ES = 6.68, P < 0.001) and in 80 m (15%, ES = 5.01, P < 0.001. Males also showed increased sprint mechanical properties, with larger F-0 (19%, ES = 1.98, P < 0.01), much larger P-max (46%, ES = 3.76, P < 0.001), and extremely larger V-0 (23%, ES = 6.97, P < 0.001). With the pooled data, hamstring and adductor MVs correlated strongly (r = -0.685, P < 0.01) and moderately (r = -0.530, P < 0.05), respectively, with sprint performance; while quadriceps showed no association. The sex-stratified analysis showed weaker associations compared with pooled data, most likely due to small sample size. In conclusion, males were faster than females and showed larger MVs, especially in hamstrings. Moreover, regarding the thigh muscles, hamstrings MV seems the most related with sprint performance as previously proposed.	[Nuell, Sergi; Illera-Dominguez, Victor; Maria Padulles, Josep; Lloret, Mario; Aureli Cadefau, Joan] Univ Barcelona, Inst Nacl Educ Fis Catalunya INEFC, Barcelona, Spain; [Carmona, Gerard] Futbol Club Barcelona FCB, Barcelona, Spain; [Alomar, Xavier] Creu Blanca, Barcelona, Spain	University of Barcelona	Cadefau, JA (corresponding author), Univ Barcelona, Inst Nacl Educ Fis Catalunya INEFC, Barcelona, Spain.	jcadefau@gencat.cat	Carmona, Gerard/D-9267-2016; Cadefau, Joan Aureli/G-2906-2016; Illera-Domínguez, Víctor/AAF-2681-2021; Cadefau, Joan AurelI/M-7934-2018; Padullés, Josep M/AAB-2723-2019	Carmona, Gerard/0000-0001-5458-058X; Cadefau, Joan Aureli/0000-0001-6020-189X; Illera-Domínguez, Víctor/0000-0002-3521-2332; Cadefau, Joan AurelI/0000-0001-6020-189X; Padullés, Josep M/0000-0002-0531-7459; Nuell Turon, Sergi/0000-0002-0772-8534	Institut Nacional d'Educacio Fisica de Catalunya (INEFC); AGAUR [2017SGR741]; MICIN (AEI/FEDER, UE) [DEP2016-80085-R]; Institut Nacional d'Educacio Fisica de Catalunya (INEFC) [PINEFC2016]; MECD [FPU14/03006]	Institut Nacional d'Educacio Fisica de Catalunya (INEFC); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); MICIN (AEI/FEDER, UE); Institut Nacional d'Educacio Fisica de Catalunya (INEFC); MECD	This research was funded by Institut Nacional d'Educacio Fisica de Catalunya (INEFC); AGAUR (via the award 2017SGR741) and MICIN (via the award DEP2016-80085-R (AEI/FEDER, UE)). SN is the recipient of a predoctoral fellowship from Institut Nacional d'Educacio Fisica de Catalunya (INEFC) (PINEFC2016). VID received a predoctoral fellowship from the MECD (FPU14/03006). Additionally, Futbol Club Barcelona (FCB), Barcelona, Spain, (https://www.fcbarcelona.com/en/) provided support in the form of salary for GC. CreuBlanca (https://www.creu-blanca.es/) provided support in the form of salary for author XA. The funders id not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Brughelli M, 2011, J STRENGTH COND RES, V25, P933, DOI 10.1519/JSC.0b013e3181c64308; Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; Damas F, 2016, EUR J APPL PHYSIOL, V116, P49, DOI 10.1007/s00421-015-3243-4; Douglas J, 2018, J STRENGTH COND RES, V32, P1562, DOI 10.1519/JSC.0000000000002245; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Ema R, 2018, MED SCI SPORT EXER, V50, P2085, DOI 10.1249/MSS.0000000000001678; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Handsfield GG, 2017, SCAND J MED SCI SPOR, V27, P1050, DOI 10.1111/sms.12723; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Illera-Dominguez V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01265; Lenhard W., 2016, PSYCHOMETRICA, DOI [10.13140/RG.2.2.17823.92329, DOI 10.13140/RG.2.1.3478.4245, DOI 10.13140/RG.2.2.17823.92329]; Liljedahl ME, 1996, EUR J APPL PHYSIOL O, V74, P375, DOI 10.1007/s004210050089; Miyake Y, 2017, EUR J APPL PHYSIOL, V117, P533, DOI 10.1007/s00421-017-3557-5; Morin JB, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00404; Morin JB, 2012, EUR J APPL PHYSIOL, V112, P3921, DOI 10.1007/s00421-012-2379-8; Nagahara R, 2017, J SPORT MED PHYS FIT, V57, P1572, DOI 10.23736/S0022-4707.16.06622-6; Neumann DA, 2010, J ORTHOP SPORT PHYS, V40, P82, DOI 10.2519/jospt.2010.3025; Nordez A, 2009, J MAGN RESON IMAGING, V30, P1116, DOI 10.1002/jmri.21867; Nuell S, 2020, EUR J SPORT SCI, V20, P793, DOI 10.1080/17461391.2019.1668063; Okada J., 2011, INT J SPORT HLTH SCI, V9, P1, DOI [https://doi.org/10.5432/ijshs.20100018, DOI 10.5432/IJSHS.20100018, 10.5432/ijshs.20100018]; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; Ransdell LB., 1999, WOMEN SPORT PHYS ACT, V8, P55, DOI DOI 10.1123/WSPAJ.8.1.55; Samozino P, 2016, SCAND J MED SCI SPOR, V26, P648, DOI 10.1111/sms.12490; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; Slawinski J, 2017, SCAND J MED SCI SPOR, V27, P45, DOI 10.1111/sms.12627; Sugisaki N, 2018, INT J SPORT PHYSIOL, V13, P214, DOI 10.1123/ijspp.2016-0703; Tottori N, 2018, PEDIATR EXERC SCI, V30, P117, DOI 10.1123/pes.2016-0226; Weyand PG, 2005, J EXP BIOL, V208, P2625, DOI 10.1242/jeb.01609; Wiemann K., 1995, NEW STUD ATHLET, V10, P29; WITHERS RT, 1987, EUR J APPL PHYSIOL O, V56, P191, DOI 10.1007/BF00640643	32	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224862	10.1371/journal.pone.0224862	http://dx.doi.org/10.1371/journal.pone.0224862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689336	gold, Green Published			2022-12-26	WOS:000532680100045
J	Cheng, R; Billet, S; Liu, CX; Haldar, S; Choudhury, D; Tripathi, M; Hav, M; Merchant, A; Hu, T; Huang, HY; Zhou, HM; Bhowmick, NA				Cheng, Ran; Billet, Sandrine; Liu, Chuanxia; Haldar, Subhash; Choudhury, Diptiman; Tripathi, Manisha; Hav, Monirath; Merchant, Akil; Hu, Tao; Huang, Haiyun; Zhou, Hongmei; Bhowmick, Neil A.			Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells	ONCOGENE			English	Article							T-CELLS; IL-1-BETA; CORRELATE; DISEASE; MICE; IL-1	Periodontal diseases can lead to chronic inflammation affecting the integrity of the tooth supporting tissues. Recently, a striking association has been made between periodontal diseases and primary cancers in the absence of a mechanistic understanding. Here we address the effect of periodontal inflammation (PI) on tumor progression, metastasis, and possible underlining mechanisms. We show that an experimental model of PI in mice can promote lymph node (LN) micrometastasis, as well as head and neck metastasis of 4T1 breast cancer cells, both in early and late stages of cancer progression. The cervical LNs had a greater tumor burden and infiltration of MDSC and M2 macrophages compared with LNs at other sites. Pyroptosis and the resultant IL-1 beta production were detected in patients with PI, mirrored in mouse models. Anakinra, IL-1 receptor antagonist, limited metastasis, and MDSC recruitment at early stages of tumor progression, but failed to reverse established metastatic tumors. PI and the resulting production of IL-1 beta was found to promote CCL5, CXCL12, CCL2, and CXCL5 expression. These chemokines recruit MDSC and macrophages, finally enabling the generation of a premetastatic niche in the inflammatory site. These findings support the idea that periodontal inflammation promotes metastasis of breast cancer by recruiting MDSC in part by pyroptosis-induced IL-1 beta generation and downstream CCL2, CCL5, and CXCL5 signaling in the early steps of metastasis. These studies define the role for IL-1 beta in the metastatic progression of breast cancer and highlight the need to control PI, a pervasive inflammatory condition in older patients.	[Cheng, Ran; Liu, Chuanxia; Zhou, Hongmei] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Cheng, Ran; Billet, Sandrine; Liu, Chuanxia; Haldar, Subhash; Choudhury, Diptiman; Tripathi, Manisha; Hav, Monirath; Merchant, Akil; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Hu, Tao] Sichuan Univ, West China Hosp Stomatol, Dept Prevent Dent, Chengdu, Sichuan, Peoples R China; [Huang, Haiyun] Sichuan Univ, West China Hosp Stomatol, Dept Periodontol, Chengdu, Sichuan, Peoples R China; [Bhowmick, Neil A.] Greater Los Angeles Vet Adm, Dept Res, Los Angeles, CA 90073 USA	Sichuan University; Cedars Sinai Medical Center; Sichuan University; Sichuan University	Zhou, HM (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.; Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.; Bhowmick, NA (corresponding author), Greater Los Angeles Vet Adm, Dept Res, Los Angeles, CA 90073 USA.	zhouhm@scu.edu.cn; Neil.Bhowmick@cshs.org		Haldar, Subhash/0000-0002-1230-1770; , Ran/0000-0001-5590-3395; Zhou, Hongmei/0000-0003-2985-3536; Choudhury, Diptiman/0000-0003-1080-4558	National Cancer Institute [R01CA108646, P01CA098912]; Veterans Administration [BX001040]; National Nature Science Foundation of China [81772898, 81272962]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration(US Department of Veterans Affairs); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Cancer Institute (R01CA108646, P01CA098912) and Veterans Administration (BX001040) to NAB and the National Nature Science Foundation of China (No. 81772898 and 81272962) to HZ.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Achberger S, 2014, MOL IMMUNOL, V58, P182, DOI 10.1016/j.molimm.2013.11.018; Bar D, 2004, FASEB J, V18, P161, DOI 10.1096/fj.03-0483fje; Bode KA, 2009, J IMMUNOL, V182, P2176, DOI 10.4049/jimmunol.0802560; Casella G, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0596-5; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Cheng R, 2018, BBA-MOL BASIS DIS, V1864, P226, DOI 10.1016/j.bbadis.2017.10.025; Cheng R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00474; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; Correa Pelayo, 2011, US Gastroenterol Hepatol Rev, V7, P59; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gholizadeh P, 2017, BIOMED PHARMACOTHER, V89, P918, DOI 10.1016/j.biopha.2017.02.102; Gomes FIF, 2016, J ORAL MAXILLOFAC RE, V7, pe2; Guo BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36107; Haldar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39257; Haldar S, 2015, J BIOL CHEM, V290, P6574, DOI 10.1074/jbc.M114.617886; Han Y W, 2014, Adv Dent Res, V26, P47, DOI 10.1177/0022034514528334; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Huang A, 2013, CANCER IMMUNOL IMMUN, V62, P1439, DOI 10.1007/s00262-013-1450-6; Huang GN, 2017, TOXICOL APPL PHARM, V332, P138, DOI 10.1016/j.taap.2017.04.009; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kruger M, 2013, CASE REP DENT, V2013, DOI 10.1155/2013/262410; Kshirsagar AV, 2005, AM J KIDNEY DIS, V45, P650, DOI 10.1053/j.ajkd.2004.12.009; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Linden G, 2007, J CLIN PERIODONTOL, V34, P461, DOI 10.1111/j.1600-051X.2007.01075.x; Lukens JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00315; Moergel M, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-39; Mora J, 2016, BIOL CHEM, V397, P1125, DOI 10.1515/hsz-2016-0215; Nagy KN, 1998, ORAL ONCOL, V34, P304, DOI 10.1016/S1368-8375(98)80012-2; Pendyala Gowri, 2013, Dent Res J (Isfahan), V10, P704; Ray A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00052; Saijo Y, 2002, J IMMUNOL, V169, P469, DOI 10.4049/jimmunol.169.1.469; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Schapiro D, 2017, NAT METHODS, V14, P873, DOI [10.1038/NMETH.4391, 10.1038/nmeth.4391]; Schugar RC, 2018, ADIPOCYTE, V7, P49, DOI 10.1080/21623945.2017.1398295; Song XP, 2003, J IMMUNOL, V171, P6448, DOI 10.4049/jimmunol.171.12.6448; Su LK, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00213-17; Thi HTH, 2017, J CANCER PREV, V22, P62, DOI 10.15430/JCP.2017.22.2.62; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Yao QW, 2014, TUMOR BIOL, V35, P7073, DOI 10.1007/s13277-014-1951-8; Yokoyama M, 2011, J PERIODONTAL RES, V46, P464, DOI 10.1111/j.1600-0765.2011.01362.x; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yu JP, 2013, J IMMUNOL, V190, P3783, DOI 10.4049/jimmunol.1201449; Zeng XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079017; Zhang Y, 2013, CELL RES, V23, P394, DOI 10.1038/cr.2012.178	48	34	35	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	7					1543	1556		10.1038/s41388-019-1084-z	http://dx.doi.org/10.1038/s41388-019-1084-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KL2WP	31685946	Green Published, hybrid			2022-12-26	WOS:000513289600011
J	Xu, YQ; Du, XM; Turner, N; Brown, AJ; Yang, HY				Xu, Yanqing; Du, Ximing; Turner, Nigel; Brown, Andrew J.; Yang, Hongyuan			Enhanced acyl-CoA: cholesterol acyltransferase activity increases cholesterol levels on the lipid droplet surface and impairs adipocyte function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ACAT1; ACAT2; SOAT1; SOAT2; cholesterol; esterification; adipocytes; lipid droplets; adipogenesis; lipolysis; caveolin 1	INSIG-DEPENDENT UBIQUITINATION; BINDING PROTEIN; ADIPOSE-TISSUE; ACAT2; DEGRADATION; STEROL; EXPRESSION; COENZYME; ACCUMULATION; RECEPTOR	Cholesterol plays essential structural and signaling roles in mammalian cells, but too much cholesterol can cause cytotoxicity. Acyl-CoA: cholesterol acyltransferases 1 and 2 (ACAT1/2) convert cholesterol into its storage form, cholesteryl esters, regulating a key step in cellular cholesterol homeostasis. Adipose tissue can store > 50% of whole-body cholesterol. Interestingly, however, almost no ACAT activity is present in adipose tissue and most adipose cholesterol is stored in its free form. We therefore hypothesized that increased cholesterol esterification may have detrimental effects on adipose tissue function. Here, using several approaches, including protein overexpression, quantitative RT-PCR, immunofluorescence, and various biochemical assays, we found that ACAT1 expression is significantly increased in the adipose tissue of the ob/ob mice. We further demonstrated that ACAT1/2 overexpression partially inhibited the differentiation of 3T3-L1 preadipocytes. In mature adipocytes, increased ACAT activity reduced the size of lipid droplets (LDs) and inhibited lipolysis and insulin signaling. Paradoxically, the amount of free cholesterol increased on the surface of LDs in ACAT1/2 overexpressing adipocytes, accompanied by increased LD localization of caveolin-1. Moreover, cholesterol depletion in adipocytes by treating the cells with cholesterol-deficient media or beta-cyclodextrins induced changes in cholesterol distribution that were similar to those caused by ACAT1/2 overexpression. Our results suggest that ACAT1/2 overexpression increases the level of free cholesterol on the LD surface, thereby impeding adipocyte function. These findings provide detailed insights into the role of free cholesterol in LD and adipocyte function and suggest that ACAT inhibitors have potential utility for managing disorders associated with extreme obesity.	[Xu, Yanqing; Du, Ximing; Brown, Andrew J.; Yang, Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Turner, Nigel] Univ New South Wales, Sch Med Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Brown, AJ; Yang, HY (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au; h.rob.yang@unsw.edu.au	Yang, Hongyuan/AAR-1326-2020; Turner, Nigel/H-7176-2013	Yang, Hongyuan/0000-0002-8482-6031; Turner, Nigel/0000-0002-0119-9328	National Health and Medical Research Council (NHMRC) of Australia [1141939, 1144726]; NHMRC Senior Research Fellowship [1058237]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	We thank the Biomedical Imaging Facility at the UNSW Mark Wainwright Analytical Centre, Australia. This work is supported by project grants from the National Health and Medical Research Council (NHMRC) of Australia (1141939, and 1144726). H.Y. is supported by an NHMRC Senior Research Fellowship (1058237).	Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Farese RV, 1998, CURR OPIN LIPIDOL, V9, P119, DOI 10.1097/00041433-199804000-00007; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5; Gao MM, 2019, PROG LIPID RES, V75, DOI 10.1016/j.plipres.2019.100989; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guo DQ, 2016, ACTA BIOCH BIOPH SIN, V48, P990, DOI 10.1093/abbs/gmw095; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hudak Carolyn S, 2013, Front Endocrinol (Lausanne), V4, P79, DOI 10.3389/fendo.2013.00079; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Koivuniemi A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002299; KRAUSE BR, 1984, J LIPID RES, V25, P97; Krishna A, 2019, BIOPHYS J, V116, P69, DOI 10.1016/j.bpj.2018.11.3127; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Lam YY, 2011, OBES RES CLIN PRACT, V5, pE43, DOI 10.1016/j.orcp.2010.12.002; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Le Lay S, 2004, BIOCHEM SOC T, V32, P103, DOI 10.1042/BST0320103; Lee RG, 2000, J LIPID RES, V41, P1991; LITTLE MTE, 1992, AM J PHYSIOL, V262, pG599, DOI 10.1152/ajpgi.1992.262.4.G599; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Mesmin B, 2016, BBA-MOL CELL BIOL L, V1861, P940, DOI 10.1016/j.bbalip.2016.02.024; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nguyen TM, 2012, J LIPID RES, V53, P95, DOI 10.1194/jlr.M018820; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Prattes S, 2000, J CELL SCI, V113, P2977; Qin L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030429; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Sakashita N, 2000, AM J PATHOL, V156, P227, DOI 10.1016/S0002-9440(10)64723-2; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sun L, 2003, J LIPID RES, V44, P1877, DOI 10.1194/jlr.M300084-JLR200; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Temel RE, 2007, J LIPID RES, V48, P1618, DOI 10.1194/jlr.M700109-JLR200; Walther TC, 2017, ANNU REV CELL DEV BI, V33, P491, DOI 10.1146/annurev-cellbio-100616-060608; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Wang MY, 2016, BBA-MOL CELL BIOL L, V1861, P410, DOI 10.1016/j.bbalip.2016.02.018; Wang YJ, 2017, NAT CELL BIOL, V19, P808, DOI 10.1038/ncb3551; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wong LH, 2017, TRENDS BIOCHEM SCI, V42, P516, DOI 10.1016/j.tibs.2017.05.001; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Zhang J, 2012, J LIPID RES, V53, P1144, DOI 10.1194/jlr.M024356; Zhu YY, 2018, J LIPID RES, V59, P820, DOI 10.1194/jlr.M081745	61	24	25	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19306	19321		10.1074/jbc.RA119.011160	http://dx.doi.org/10.1074/jbc.RA119.011160			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31727739	hybrid, Green Published			2022-12-26	WOS:000516527800029
J	Bannister, S				Bannister, Scott			Distinct varieties of aesthetic chills in response to multimedia	PLOS ONE			English	Article							MUSIC; EMOTIONS; EMPATHY; BRAIN; EXPERIENCE; NOSTALGIA; WARMTH; STATES	The experience of aesthetic chills, often defined as a subjective response accompanied by goosebumps, shivers and tingling sensations, is a phenomenon often utilized to indicate moments of peak pleasure and emotional arousal in psychological research. However, little is currently understood about how to conceptualize the experience, particularly in terms of whether chills are general markers of intense pleasure and emotion, or instead a collection of distinct phenomenological experiences. To address this, a web-study was designed using images, videos, music videos, texts and music excerpts (from both an online forum dedicated to chills-eliciting stimuli and previous musical chills study), to explore variations across chills experience in terms of bodily and emotional responses reported. Results suggest that across participants (N = 179), three distinct chills categories could be identified: warm chills (chills co-occurring with smiling, warmth, feeling relaxed, stimulated and happy), cold chills (chills co-occurring with frowning, cold, sadness and anger), and moving chills (chills co-occurring with tears, feeling a lump in the throat, emotional intensity, and feelings of affection, tenderness and being moved). Warm chills were linked to stimuli expressing social communion and love; cold chills were elicited by stimuli portraying entities in distress, and support from one to another; moving chills were elicited by most stimuli, but their incidence were also predicted by ratings of trait empathy. Findings are discussed in terms of being moved, the importance of differing induction mechanisms such as shared experience and empathic concern, and the implications of distinct chills categories for both individual differences and inconsistencies in the existing aesthetic chills literature.	[Bannister, Scott] Univ Durham, Dept Mus, Durham, County Durham, England	Durham University	Bannister, S (corresponding author), Univ Durham, Dept Mus, Durham, County Durham, England.	scott.c.bannister@durham.ac.uk		Bannister, Scott/0000-0003-4905-0511	Arts and Humanities Research Council [AH/L503927/1]	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	' This research was funded by an Arts and Humanities Research Council (https://ahrc.ukri.org) doctoral studentship awarded to SB (Grant number AH/L503927/1), through the Northern Bridge Doctoral Training Partnership (http://www.northernbridge.ac.uk).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algoe SB, 2009, J POSIT PSYCHOL, V4, P105, DOI 10.1080/17439760802650519; Aucouturier JJ, 2017, COGNITION, V161, P94, DOI 10.1016/j.cognition.2017.01.019; Bannister S., 2018, DISTINCT VARIETIES A, DOI [10.7910/DVN/YFRSXW, DOI 10.7910/DVN/YFRSXW]; Bannister S, 2020, PSYCHOL MUSIC, V48, P297, DOI 10.1177/0305735618798024; Bannister S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02046; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BATSON CD, 1990, AM PSYCHOL, V45, P336, DOI 10.1037/0003-066X.45.3.336; Becker J., 2004, DEEP LISTENING MUSIC; Benedek M, 2011, BIOL PSYCHOL, V86, P320, DOI 10.1016/j.biopsycho.2010.12.012; Besson M, 2005, J EXPT PSYCHOL HUMAN, V21, P1278; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Braun S, 2015, PSYCHOL REP, V117, P735, DOI 10.2466/08.02.PR0.117c23z6; BRIESE E, 1991, PHYSIOL BEHAV, V49, P1153, DOI 10.1016/0031-9384(91)90343-M; Colver MC, 2016, PSYCHOL MUSIC, V44, P413, DOI 10.1177/0305735615572358; Cova F., 2017, PALGRAVE HDB AFFECT, P347, DOI [DOI 10.1007/978-3-319-63303-9_13, https://doi.org/10.1007/978-3-319-63303-9_13]; Cova F, 2014, PHILOS STUD, V169, P447, DOI 10.1007/s11098-013-0192-9; Craig DG, 2005, MUSIC SCI, V9, P273, DOI 10.1177/102986490500900207; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Corte K, 2007, PSYCHOL BELG, V47, P235, DOI 10.5334/pb-47-4-235; DEWIED M, 1995, POETICS, V23, P91, DOI 10.1016/0304-422X(94)00010-4; Eeroia T, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01176; Egermann H, 2013, MUSIC PERCEPT, V31, P139, DOI 10.1525/MP.2013.31.2.139; Fiske AP, 2019, EMOT REV, V11, P74, DOI 10.1177/1754073917723167; Fiske AP, 2004, RELATIONAL MODELS THEORY: CONTEMPORARY OVERVIEW, P61; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Gabrielsson Alf, 2011, STRONG EXPERIENCES M; Gernot G, 2018, COGN PROCESS, V19, P147, DOI 10.1007/s10339-017-0800-2; GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126; Greenacre M., 2007, CORRES ANAL PRACTICE, DOI [10.1201/9781420011234, DOI 10.1201/9781420011234]; Grewe O, 2007, MUSIC PERCEPT, V24, P297, DOI 10.1525/MP.2007.24.3.297; Grewe O, 2011, PSYCHOL MUSIC, V39, P220, DOI 10.1177/0305735610362950; Guhn M, 2007, MUSIC PERCEPT, V24, P473, DOI 10.1525/MP.2007.24.5.473; Haidt J, 2003, FLOURISHING: POSITIVE PSYCHOLOGY AND THE LIFE WELL-LIVED, P275, DOI 10.1037/10594-012; HALPERN DL, 1986, PERCEPT PSYCHOPHYS, V39, P77, DOI 10.3758/BF03211488; Hanich J, 2014, PSYCHOL AESTHET CREA, V8, P130, DOI 10.1037/a0035690; Huron D., 2010, HDB MUSIC EMOTION TH, P575, DOI DOI 10.1093/ACPROF:OSO/9780199230143.003.0021; Huron David, 2006, SWEET ANTICIPATION M; IJzerman H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00464; Ijzerman H, 2012, ACTA PSYCHOL, V140, P283, DOI 10.1016/j.actpsy.2012.05.002; Inagaki TK, 2013, PSYCHOL SCI, V24, P2272, DOI 10.1177/0956797613492773; Inbody J, 2015, SOCIOL RELIG, V76, P337, DOI 10.1093/socrel/srv032; Johnson-Laird PhilipN., 1989, COGNITION EMOTION, V3, P81, DOI [10.1080/02699938908408075, DOI 10.1080/02699938908408075]; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Koelsch S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002631; Kuehnast M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01242; Laeng B, 2016, CONSCIOUS COGN, V44, P161, DOI 10.1016/j.concog.2016.07.009; Le Roux B., 2010, MULTIPLE CORRES ANAL; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Levinson Jerrold, 2006, CONTEMPLATING ART ES; Margulis EH, 2017, MUSIC PERCEPT, V35, P235, DOI 10.1525/MP.2017.35.2.235; Maruskin LA, 2012, J PERS SOC PSYCHOL, V103, P135, DOI 10.1037/a0028117; McCrae RR, 2007, MOTIV EMOTION, V31, P5, DOI 10.1007/s11031-007-9053-1; Melanie Takahashi, 2003, J RITUAL STUDIES, V17, P72; Menninghaus W, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X17000309; Menninghaus W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128451; Merkle EC, 2016, PSYCHOL METHODS, V21, P151, DOI 10.1037/met0000038; Miu AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030618; Nagel F, 2008, MUSIC SCI, V12, P101, DOI 10.1177/102986490801200106; Nummenmaa L, 2018, P NATL ACAD SCI USA, V115, P9198, DOI 10.1073/pnas.1807390115; Nusbaum EC, 2011, SOC PSYCHOL PERS SCI, V2, P199, DOI 10.1177/1948550610386810; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Pelowski M, 2017, PHYS LIFE REV, V21, P80, DOI 10.1016/j.plrev.2017.02.003; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Robinson J, 2012, MUSIC THEOR SPECTRUM, V34, P71, DOI 10.1525/mts.2012.34.2.71; SACHS ME, 2016, SOC COGN AFFECT NEUR, V11, P884, DOI DOI 10.1093/SCAN/NSW009; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schoeller F., 2015, HUMAN SOCIAL STUDIES, V4, P26, DOI [10.1515/hssr-2015-0022, DOI 10.1515/HSSR-2015-0022]; Schoeller F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01093; Schubert TW, 2018, COGNITION EMOTION, V32, P174, DOI 10.1080/02699931.2016.1268998; Schutter DJLG, 2012, MOTIV EMOTION, V36, P46, DOI 10.1007/s11031-011-9237-6; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Stefan H, 2003, EPILEPSY BEHAV, V4, P65, DOI 10.1016/S1525-5050(02)00644-3; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; Tokaji A, 2003, JPN PSYCHOL RES, V45, P235, DOI 10.1111/1468-5884.00226; Vuoskoski JK, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00439; Vuoskoski JK, 2012, PSYCHOL AESTHET CREA, V6, P204, DOI 10.1037/a0026937; Wassiliwizky E, 2017, SOC COGN AFFECT NEUR, V12, P1229, DOI 10.1093/scan/nsx069; Wassiliwizky E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00041; Wassiliwizky E, 2015, PSYCHOL AESTHET CREA, V9, P405, DOI 10.1037/aca0000023; Wildschut T, 2006, J PERS SOC PSYCHOL, V91, P975, DOI 10.1037/0022-3514.91.5.975; Wildschut T, 2010, J PERS SOC PSYCHOL, V98, P573, DOI 10.1037/a0017597; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494; Zickfeld JH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00723	88	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224974	10.1371/journal.pone.0224974	http://dx.doi.org/10.1371/journal.pone.0224974			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2HK	31725733	Green Published, gold, Green Accepted			2022-12-26	WOS:000532764500037
J	Alvite, G; Riera, X; Cancela, S; Paulino, M; Esteves, A				Alvite, Gabriela; Riera, Ximena; Cancela, Saira; Paulino, Margot; Esteves, Adriana			Bioinformatic analysis of a novel Echinococcus granulosus nuclear receptor with two DNA binding domains	PLOS ONE			English	Article							HORMONE-RECEPTOR; SCHISTOSOMA-MANSONI; LIGAND-BINDING; LOCALIZATION; SEQUENCE; GENE; RXR; IDENTIFICATION; SUMOYLATION; EVOLUTION	Nuclear receptors are ligand-activated transcription factors capable of regulating the expression of complex gene networks. The family includes seven subfamilies of proteins with a wide phylogenetic distribution. A novel subfamily with two DNA-binding domains (2DBDs) has been reported in Schistosoma mansoni (Platyhelminth, Trematoda). This work describes the cDNA cloning and bioinformatics analysis of Eg2DBD alpha, a 2DBD nuclear receptor isoform from the parasite Echinococcus granulosus (Platyhelminth, Cestoda). The Eg2DBD alpha gene coding domain structure was analysed. Although two additional 2DBD nuclear receptors are reported in the parasite database GeneDB, they are unlikely to be expressed in the larval stage. Phylogenetic relationships between these atypical proteins from different cestodes are also analysed including S. mansoni 2DBD nuclear receptors. The presence of two DNA binding domains confers particular interest to these nuclear receptors, not only concerning their function but to the development of new antihelminthic drugs.	[Alvite, Gabriela; Riera, Ximena; Cancela, Saira; Esteves, Adriana] Univ Republica, Fac Chem, Biochem Sect, Montevideo, Uruguay; [Paulino, Margot] Univ Republica, Fac Chem, Dept Expt & Teoria Mat, Ctr Bioinformat, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Esteves, A (corresponding author), Univ Republica, Fac Chem, Biochem Sect, Montevideo, Uruguay.	aesteves@fcien.edu.uy			Sectoral Commission for Scientific Research [C206-348]; National Agency for Research and Innovation [ANIIFCE 2017_1_136527]	Sectoral Commission for Scientific Research; National Agency for Research and Innovation	This work was financially supported by the Sectoral Commission for Scientific Research (Grant No C206-348) (UdelaR) and the National Agency for Research and Innovation (Grant ANIIFCE 2017_1_136527), http://www.anii.org.uy/.The author responsible for the project is Gabriela Alvite. The funders only accepted the project, they did not participated in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvite G, 2016, EXP PARASITOL, V164, P1, DOI 10.1016/j.exppara.2016.02.002; Auwerx J, 1999, CELL, V97, P161; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brelivet Y, 2004, EMBO REP, V5, P423, DOI 10.1038/sj.embor.7400119; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Nicolao MC, 2014, ANTIMICROB AGENTS CH, V58, P5146, DOI 10.1128/AAC.02113-13; de Mendonca RL, 2002, EUR J BIOCHEM, V269, P5700, DOI 10.1046/j.1432-1033.2002.03287.x; de Mendonca RL, 2000, EUR J BIOCHEM, V267, P3208, DOI 10.1046/j.1432-1327.2000.01344.x; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293; Escobedo G, 2004, J PARASITOL, V90, P1235, DOI 10.1645/GE-297R; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; ESTEVES A, 1993, MOL BIOCHEM PARASIT, V58, P215, DOI 10.1016/0166-6851(93)90043-W; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Forster S, 2011, J CELL BIOCHEM, V112, P1630, DOI 10.1002/jcb.23073; Freebern WJ, 1999, GENE, V233, P33, DOI 10.1016/S0378-1119(99)00161-4; Freebern WJ, 1999, J BIOL CHEM, V274, P4577, DOI 10.1074/jbc.274.8.4577; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Gibilisco L, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006464; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; JENSEN EV, 1962, PERSPECT BIOL MED, V6, P47; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; LAUDET V, 1995, CURR BIOL, V5, P124, DOI 10.1016/S0960-9822(95)00031-5; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Liu S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00929; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Melvin VS, 2002, J BIOL CHEM, V277, P25115, DOI 10.1074/jbc.M110400200; Milburn D, 1998, PROTEIN ENG, V11, P855, DOI 10.1093/protein/11.10.855; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pakharukova MY, 2014, MOL BIOCHEM PARASIT, V194, P64, DOI 10.1016/j.molbiopara.2014.04.009; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pawlak M, 2012, CURR TOP MED CHEM, V12, P486, DOI 10.2174/156802612799436641; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Pourcet B, 2010, J BIOL CHEM, V285, P5983, DOI 10.1074/jbc.M109.078311; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thompson R.C.A., 1995, ECHINOCOCCUS HYDATID; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2017, J CLIN INVEST, V127, P1165, DOI 10.1172/JCI88890; Weikum ER, 2018, PROTEIN SCI, V27, P1876, DOI 10.1002/pro.3496; Wu WJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-27; Wu WJ, 2011, MOL CELL ENDOCRINOL, V334, P56, DOI 10.1016/j.mce.2010.06.011; Wu WJ, 2006, GENE, V366, P303, DOI 10.1016/j.gene.2005.09.013; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yang M, 2017, PARASITE, V24, DOI 10.1051/parasite/2017037; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x	61	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224703	10.1371/journal.pone.0224703	http://dx.doi.org/10.1371/journal.pone.0224703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710619	Green Published, gold			2022-12-26	WOS:000532699900017
J	Li, HH; Dong, ZJ; Ma, C; Tian, XB; Xiang, ZG; Xia, Q; Ma, PT; Liu, WX				Li, Huanhuan; Dong, Zhenjie; Ma, Chao; Tian, Xiubin; Xiang, Zhiguo; Xia, Qing; Ma, Pengtao; Liu, Wenxuan			Discovery of powdery mildew resistance gene candidates from Aegilops biuncialis chromosome 2M(b) based on transcriptome sequencing	PLOS ONE			English	Article							ADDITION LINE; STRIPE RUST; WHEAT; IDENTIFICATION; MARKERS; TOLERANCE; BARLEY	Powdery mildew is one of the most widespread diseases of wheat. The development and deployment of resistant varieties are one of the most economical and effective methods to manage this disease. Our previous study showed that the gene(s) at 2M(b) in Chinese Spring (CS)-Aegilops biuncialis 2M(b) disomic addition line TA7733 conferred a high level of resistance to powdery mildew of wheat. In this study, resistance spectrum of TA7733 was assayed by using 15 Blumeria graminis f. sp. tritici (Bgt) isolates prevalent in different regions of China. The result indicated that TA7733 was highly resistant to all tested Bgt isolates and the gene(s) on chromosome 2M(b) conferred broad-spectrum resistance to powdery mildew. In order to characterize mechanism of powdery mildew resistance by identifying candidates R-genes derived from Ae. biuncialis chromosome 2M(b) and develop 2M(b)-specific molecular markers, we performed RNA-seq analysis on TA7733 and CS. In total we identified 7,278 unigenes that showed specific expression in TA7733 pre and post Bgt-infection when compared to CS. Of these 7,278 unigenes, 295 were annotated as putative resistance (R) genes. Comparatively analysis of R-gene sequences from TA7733 and CS and integration CS Ref Seq v1.0 were used to develop R-gene specific primers. Of 295 R-genes we identified 53 R-genes were specific to 2M(b) and could be involved in powdery mildew resistance. Functional annotation of majority of the 53 R-genes encoded nucleotide binding leucine rich repeat (NLR) protein. The broad-spectrum resistance to powdery mildew in TA7733 and availability of 2M(b)-derived putative candidate R-gene specific molecular markers identified in this study will lay foundations for transferring powdery mildew resistance from 2M(b) to common wheat by inducing CS-Ae. biuncialis homoeologous recombination. Our study also provides useful candidates for further isolation and cloning of powdery mildew resistance gene(s) from Ae. biuncialis chromosome 2M(b).	[Li, Huanhuan; Dong, Zhenjie; Ma, Chao; Tian, Xiubin; Xia, Qing; Liu, Wenxuan] Henan Agr Univ, Coll Life Sci, Zhengzhou, Henan, Peoples R China; [Xiang, Zhiguo] Henan Acad Agr Sci, Wheat Res Ctr, Zhengzhou, Henan, Peoples R China; [Ma, Pengtao] Yantai Univ, Coll Life Sci, Yantai, Shandong, Peoples R China	Henan Agricultural University; Henan Academy of Agricultural Sciences; Yantai University	Liu, WX (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou, Henan, Peoples R China.	wxliu2003@hotmail.com		Liu, Wenxuan/0000-0003-1227-0991	National Natural Science Foundation of China [31801361, 31571658]; Scientific and Technological Research Project of Henan Province of China [192102110011]; Henan Province Special Major Science and Technology Project [161100110400]; State Key Laboratory of Wheat and Maize Crop Science at Henan Agricultural University, China [39990022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Research Project of Henan Province of China; Henan Province Special Major Science and Technology Project; State Key Laboratory of Wheat and Maize Crop Science at Henan Agricultural University, China	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31801361 to HL and Grant No. 31571658 to WL), the Scientific and Technological Research Project of Henan Province of China (Grant No. 192102110011 to HL), the Henan Province Special Major Science and Technology Project (Grant No. 161100110400 to WL) and the State Key Laboratory of Wheat and Maize Crop Science at Henan Agricultural University, China (Grant No. 39990022 to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaeva ED, 2004, PLANT SYST EVOL, V246, P45, DOI 10.1007/s00606-003-0072-4; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; DAMANIA A B, 1990, Journal of Genetics and Breeding, V44, P97; DIMOV A, 1993, RUST POWDERY MILDEW, P165; Du P, 2017, GENOME, V60, P93, DOI 10.1139/gen-2016-0095; Du WL, 2014, PLANTA, V239, P97, DOI 10.1007/s00425-013-1957-2; Farkas A, 2014, GENOME, V57, P61, DOI 10.1139/gen-2013-0204; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; GRIFFEY CA, 1993, PLANT DIS, V77, P618, DOI 10.1094/PD-77-0618; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Hao YB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150717, 10.1371/journal.pone.0163147]; He HG, 2018, MOL PLANT, V11, P879, DOI 10.1016/j.molp.2018.03.004; Huang J, 2012, MOL BREEDING, V30, P1737, DOI 10.1007/s11032-012-9757-0; Huang XY, 2018, THEOR APPL GENET, V131, P1967, DOI 10.1007/s00122-018-3126-2; Hurni S, 2013, PLANT J, V76, P957, DOI 10.1111/tpj.12345; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; KING IP, 1993, THEOR APPL GENET, V86, P895, DOI 10.1007/BF00211038; Li GQ, 2018, THEOR APPL GENET, V131, P2775, DOI 10.1007/s00122-018-3199-y; Li GQ, 2009, THEOR APPL GENET, V119, P531, DOI 10.1007/s00122-009-1061-y; Li HH, 2017, THEOR APPL GENET, V130, P109, DOI 10.1007/s00122-016-2797-9; Li QQ, 2016, GENE, V590, P5, DOI 10.1016/j.gene.2016.06.005; Li SJ, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5630-4; Li SJ, 2017, THEOR APPL GENET, V130, P2057, DOI 10.1007/s00122-017-2942-0; Li WT, 2017, CELL, V170, P114, DOI 10.1016/j.cell.2017.06.008; Liu WX, 2017, THEOR APPL GENET, V130, P841, DOI 10.1007/s00122-017-2855-y; Ma PT, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0403-5; Ma PT, 2014, EUPHYTICA, V200, P149, DOI 10.1007/s10681-014-1178-1; MAKKOUK KM, 1994, CAN J PLANT SCI, V74, P631, DOI 10.4141/cjps94-113; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Molnar I, 2004, FUNCT PLANT BIOL, V31, P1149, DOI 10.1071/FP03143; Morgounov A, 2012, EUR J PLANT PATHOL, V132, P323, DOI 10.1007/s10658-011-9879-y; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Resta P, 1996, AM J BOT, V83, P1556, DOI 10.2307/2445829; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; Sanchez-Martin J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1082-1; Schneider A, 2005, GENOME, V48, P1070, DOI 10.1139/G05-062; Schneider A, 2012, CZECH J GENET PLANT, V48, P169, DOI 10.17221/45/2012-CJGPB; Song LQ, 2016, THEOR APPL GENET, V129, P1023, DOI 10.1007/s00122-016-2680-8; Summers RW, 2013, PLANT PATHOL, V62, P115, DOI 10.1111/ppa.12165; Tan GX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00428; Wang DF, 2016, FUNCT INTEGR GENOMIC, V16, P115, DOI 10.1007/s10142-015-0471-y; Wang KY, 2018, THEOR APPL GENET, V131, P13, DOI 10.1007/s00122-017-2982-5; Wang ZZ, 2015, THEOR APPL GENET, V128, P365, DOI 10.1007/s00122-014-2436-2; Xia Qing, 2018, Journal of Henan Agricultural Sciences, V47, P64; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Xiao MG, 2013, THEOR APPL GENET, V126, P1397, DOI 10.1007/s00122-013-2060-6; Xing LP, 2018, MOL PLANT, V11, P874, DOI 10.1016/j.molp.2018.02.013; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Zhang DY, 2019, CROP J, V7, P761, DOI 10.1016/j.cj.2019.03.003; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051106; Zhang H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-898; Zhang RQ, 2018, THEOR APPL GENET, V131, P2613, DOI 10.1007/s00122-018-3176-5; Zhao Hui, 2013, Journal of Food, Agriculture & Environment, V11, P1046; Zhou JP, 2014, GENET MOL RES, V13, P660, DOI 10.4238/2014.January.28.11; Zhuang LF, 2011, MOL BREEDING, V27, P455, DOI 10.1007/s11032-010-9443-z; Zou SH, 2018, NEW PHYTOL, V218, P298, DOI 10.1111/nph.14964	58	9	9	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0220089	10.1371/journal.pone.0220089	http://dx.doi.org/10.1371/journal.pone.0220089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LD8IR	31710598	Green Submitted, Green Published, gold			2022-12-26	WOS:000526271900001
J	Berges, N; Nawaz, MS; Dahl, TB; Hagen, L; Bjoras, M; Laerdahl, JK; Alseth, I				Berges, Natalia; Nawaz, Meh Sameen; Dahl, Tuva Borresdatter; Hagen, Lars; Bjoras, Magnar; Laerdahl, Jon K.; Alseth, Ingrun			Complex alternative splicing of human Endonuclease V mRNA, but evidence for only a single protein isoform	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA; INOSINE; PURIFICATION; ENZYME; GENE	Endonuclease V (ENDOV) is a ribonuclease with affinity for inosine which is the deamination product of adenosine. The genomes of most organisms, including human, encode ENDOV homologs, yet knowledge about in vivo functions and gene regulation is sparse. To contribute in this field, we analyzed mRNA and protein expression of human ENDOV (hEN-DOV). Analyses of public sequence databases revealed numerous hENDOV transcript variants suggesting extensive alternative splicing. Many of the transcripts lacked one or more exons corresponding to conserved regions of the ENDOV core domain, suggesting that these transcripts do not encode for active proteins. Three complete transcripts were found with open reading frames encoding 282, 308 and 309 amino acids, respectively. Recombinant hENDOV 308 and hENDOV 309 share the same cleavage activity as hENDOV 282 which is the variant that has been used in previous studies of hENDOV. However, hENDOV 309 binds inosine-containing RNA with stronger affinity than the other isoforms. Overexpressed GFP-fused isoforms were found in cytoplasm, nucleoli and arsenite induced stress granules in human cells as previously reported for hENDOV 282. RT-qPCR analysis of the 3'-termini showed that hENDOV 308 and hENDOV 309 transcripts are more abundant than hENDOV 282 transcripts in immortalized cell lines, but not in primary cells, suggesting that cells regulate hENDOV mRNA expression. In spite of the presence of all three full-length transcripts, mass spectrometry analyses identified peptides corresponding to the hENDOV 309 isoform only. This result suggests that further studies of human ENDOV should rather encompass the hENDOV 309 isoform.	[Berges, Natalia; Nawaz, Meh Sameen; Dahl, Tuva Borresdatter; Bjoras, Magnar; Laerdahl, Jon K.; Alseth, Ingrun] Oslo Univ Hosp, Dept Microbiol, Rikshosp, Oslo, Norway; [Berges, Natalia; Nawaz, Meh Sameen; Dahl, Tuva Borresdatter; Bjoras, Magnar; Laerdahl, Jon K.; Alseth, Ingrun] Univ Oslo, Oslo, Norway; [Dahl, Tuva Borresdatter] Oslo Univ Hosp, Res Inst Internal Med, Rikshosp, Oslo, Norway; [Dahl, Tuva Borresdatter] Univ Oslo, Inst Clin Med, Oslo, Norway; [Hagen, Lars; Bjoras, Magnar] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Hagen, Lars] Norwegian Univ Sci & Technol, PROMEC Core Facil Prote & Mod, Trondheim, Norway; [Hagen, Lars] Cent Norway Reg Hlth Author, Trondheim, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Alseth, I (corresponding author), Oslo Univ Hosp, Dept Microbiol, Rikshosp, Oslo, Norway.; Alseth, I (corresponding author), Univ Oslo, Oslo, Norway.	ingrun.alseth@rr-research.no		Dahl, Tuva/0000-0001-7818-9411; Laerdahl, Jon Kristen/0000-0002-0826-9464	Norwegian Cancer Society [5739724]; Norwegian Research Council [250474]; Health Authority South East [2017088]	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Health Authority South East	This study was supported by grants to IA from The Norwegian Cancer Society (Grant number 5739724), The Norwegian Research Council (Grant number 250474) and Health Authority South East (Grant number 2017088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alseth I, 2014, CURR OPIN GENET DEV, V26, P116, DOI 10.1016/j.gde.2014.07.008; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; BRONSON DL, 1980, CANCER RES, V40, P2500; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Dalhus B, 2009, NAT STRUCT MOL BIOL, V16, P138, DOI 10.1038/nsmb.1538; DANG CV, 1989, J BIOL CHEM, V264, P18019; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; Dixit S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00104; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; Feng H, 2005, BIOCHEMISTRY-US, V44, P11486, DOI 10.1021/bi050837c; Fladeby C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047466; Garcia-Caballero D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08910-1; Guo GM, 1997, J BACTERIOL, V179, P310, DOI 10.1128/jb.179.2.310-316.1997; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kim JI, 2016, FEBS LETT, V590, P4354, DOI 10.1002/1873-3468.12470; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mannion N, 2015, BIOMOLECULES, V5, P2338, DOI 10.3390/biom5042338; Martin RM, 2015, NUCLEUS-PHILA, V6, P314, DOI 10.1080/19491034.2015.1079680; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mi RJ, 2012, MUTAT RES-FUND MOL M, V735, P12, DOI 10.1016/j.mrfmmm.2012.05.003; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; Nawaz MS, 2016, J BIOL CHEM, V291, P21786, DOI 10.1074/jbc.M116.730911; Nawaz MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24979; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; Pettersen HS, 2015, DNA REPAIR, V25, P60, DOI 10.1016/j.dnarep.2014.11.006; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Rodriguez JM, 2018, NUCLEIC ACIDS RES, V46, pD213, DOI 10.1093/nar/gkx997; Schouten KA, 1999, MUTAT RES-DNA REPAIR, V435, P245, DOI 10.1016/S0921-8777(99)00049-X; Stastna M, 2012, PROTEOMICS, V12, P2937, DOI 10.1002/pmic.201200161; Vik ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3271; YAO M, 1994, J BIOL CHEM, V269, P16260; Yasui M, 2008, J MOL BIOL, V377, P1015, DOI 10.1016/j.jmb.2008.01.033; Zhang ZM, 2014, ACTA CRYSTALLOGR D, V70, P2286, DOI 10.1107/S139900471401356X	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225081	10.1371/journal.pone.0225081	http://dx.doi.org/10.1371/journal.pone.0225081			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703097	gold, Green Published			2022-12-26	WOS:000532697200045
J	Kozik, AJ; Nakatsu, CH; Chun, H; Jones-Hall, YL				Kozik, Ariangela J.; Nakatsu, Cindy H.; Chun, Hyonho; Jones-Hall, Yava L.			Comparison of the fecal, cecal, and mucus microbiome in male and female mice after TNBS-induced colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; IMMUNE-RESPONSES; SEX-DIFFERENCES; MOUSE MODELS; CHALLENGES; MUCOSAL; ONSET; HOST	Crohn's Disease and Ulcerative Colitis are chronic, inflammatory conditions of the digestive tract, collectively known as Inflammatory Bowel Disease (IBD). The combined influence of lifestyle factors, genetics, and the gut microbiome contribute to IBD pathogenesis. Studies of the gut microbiome have shown significant differences in its composition between healthy individuals and those with IBD. Due to the high inter-individual microbiome variation seen in humans, mouse models of IBD are often used to investigate potential IBD mechanisms and their interplay between host, microbial, and environmental factors. While fecal samples are the predominant material used for microbial community analysis, they may not be the ideal sample to use for analysis of the microbiome of mice with experimental colitis, such as that induced by 2, 4, 6 trinitrobenzesulfonic acid (TNBS). As TNBS is administered intrarectally to induce colitis and inflammation is confined to the colon in this model, we hypothesized that the microbiome of the colonic mucus would most closely correlate with TNBS colitis severity. Based on our previous research, we also hypothesized that sex would be associated with both disease severity and microbial differences in mice with chronic TNBS colitis. We examined and compared the fecal, cecal content, and colonic mucus microbiota of 8-week old male and female C57BL/6J wild-type mice prior to and after the induction of TNBS colitis via 16S rRNA gene sequencing. We found that the colonic mucus microbiome was more closely correlated with disease severity than were alterations in the fecal and cecal microbiomes. We also found that the microbiomes of the feces, cecum, and mucus were distinct, but found no significant differences that were associated with sex in either compartment. Our findings highlight the importance of sampling colonic mucus in TNBS-induced colitis. Moreover, consideration of the differential impact of sex on the microbiome across mouse strains may be critical for the appropriate application of TNBS colitis models and robust comparisons across studies in the future.	[Kozik, Ariangela J.; Jones-Hall, Yava L.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Kozik, Ariangela J.; Nakatsu, Cindy H.; Jones-Hall, Yava L.] Purdue Univ, Interdisciplinary Life Sci, W Lafayette, IN 47907 USA; [Nakatsu, Cindy H.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Chun, Hyonho] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Kozik, Ariangela J.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Jones-Hall, Yava L.] Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Boston University; University of Michigan System; University of Michigan; Texas A&M University System; Texas A&M University College Station	Jones-Hall, YL (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.; Jones-Hall, YL (corresponding author), Purdue Univ, Interdisciplinary Life Sci, W Lafayette, IN 47907 USA.; Jones-Hall, YL (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	yavajh@tamu.edu	Kozik, Ariangela/AAV-2395-2021	Kozik, Ariangela/0000-0003-2322-4085; Jones-Hall, Yava/0000-0003-4030-9830				Alrafas HR, 2019, J LEUKOCYTE BIOL, V106, P467, DOI 10.1002/JLB.3A1218-476RR; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Asfaha S, 1999, AM J PHYSIOL-GASTR L, V276, pG703, DOI 10.1152/ajpgi.1999.276.3.G703; Bernbom N, 2006, J MICROBIOL METH, V66, P87, DOI 10.1016/j.mimet.2005.10.014; Brotman RM, 2014, VACCINE, V32, P1543, DOI 10.1016/j.vaccine.2013.10.010; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Devoss J, 2014, TOXICOL PATHOL, V42, P99, DOI 10.1177/0192623313509729; Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Ek WE, 2014, ANN GASTROENTEROL, V27, P294; Elderman M, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0186-6; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014; Figliuolo VR, 2017, LIFE SCI, V189, P29, DOI 10.1016/j.lfs.2017.09.014; Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00754; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Glymenaki M, 2017, INFLAMM BOWEL DIS, V23, P912, DOI 10.1097/MIB.0000000000001118; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Guo FF, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00156; Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090; Hofma BR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199394; Hugenholtz F, 2018, CELL MOL LIFE SCI, V75, P149, DOI 10.1007/s00018-017-2693-8; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263; Jones-Hall YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119441; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kozik AJ, 2017, EXP MOL PATHOL, V103, P311, DOI 10.1016/j.yexmp.2017.11.014; Lane ER, 2017, J INFLAMM RES, V10, P63, DOI 10.2147/JIR.S116088; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; Levy AN, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819836893; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Li PY, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00028; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Lo Presti A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01655; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mandal S, 2015, MICROB ECOL HLTH DIS, V26; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; Merritt AM, 2002, DIGEST DIS SCI, V47, P879, DOI 10.1023/A:1014720923611; Moen B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155402; Ananthakrishnan Ashwin N, 2013, Gastroenterol Hepatol (N Y), V9, P367; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nishida A, 2018, CLIN J GASTROENTEROL, V11, P1, DOI 10.1007/s12328-017-0813-5; Parfrey LW, 2012, CLIN MICROBIOL INFEC, V18, P5, DOI 10.1111/j.1469-0691.2012.03861.x; Pascal V., 2017, GUT, DOI [10.1136/gutjnl-2016-313235, DOI 10.1136/GUTJNL-2016-313235]; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; Sartor RB, 2015, NAT REV GASTRO HEPAT, V12, P253, DOI 10.1038/nrgastro.2015.46; Suzuki TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163720; Swindle MM, 1998, SCAND J LAB ANIM SCI, V25, P11; Tang MS, 2015, GUT MICROBES, V6, P48, DOI 10.1080/19490976.2014.1000080; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Verma R, 2010, J CLIN MICROBIOL, V48, P4279, DOI 10.1128/JCM.01360-10; Vermeire S, 2016, J CROHNS COLITIS, V10, P387, DOI 10.1093/ecco-jcc/jjv203; Wang YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013607; Wardill HR, 2019, INFLAMM BOWEL DIS, V25, P1196, DOI 10.1093/ibd/izz011; Watt E, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0207-9; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xiao Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03161-6; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4; Zhang S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00202	66	32	33	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225079	10.1371/journal.pone.0225079	http://dx.doi.org/10.1371/journal.pone.0225079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703107	Green Published, gold			2022-12-26	WOS:000532697200044
J	Wong, BKY; Murry, JB; Ramakrishnan, R; He, F; Balasa, A; Stinnett, GR; Pedersen, SE; Pautler, RG; Van den Veyver, IB				Wong, Bibiana K. Y.; Murry, Jaclyn B.; Ramakrishnan, Rajesh; He, Fang; Balasa, Alfred; Stinnett, Gary R.; Pedersen, Steen E.; Pautler, Robia G.; Van den Veyver, Ignatia B.			Maternal stress in Shank3(ex4-9) mice increases pup-directed care and alters brain white matter in male offspring	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; PRENATAL STRESS; SOCIAL IMPAIRMENT; CHILDREN; BEHAVIOR; SHANK3; PREGNANCY; CONNECTIVITY; HIPPOCAMPAL; EXPOSURE	Gene-environment interactions contribute to the risk for Autism Spectrum Disorder (ASD). Among environmental factors, prenatal exposure to stress may increase the risk for ASD. To examine if there is an interaction between exposure to maternal stress and reduced dosage or loss of Shank3, wild-type (WT), heterozygous (HET) and homozygous (HOM) female mice carrying a deletion of exons four through nine of Shank3 (Shank3(ex4-9)) were exposed to chronic unpredictable mild stress (CUMS) from prior to conception throughout gestation. This study examined maternal care of these dams and the white matter microstructure in the brains of their adult male offspring. Overall, our findings suggest that maternal exposure to CUMS increased pup-directed care for dams of all three genotypes. Compared to WT and HET dams, HOM dams also exhibited increased maternal care behaviors with increased time spent in the nest and reduced cage exploration, regardless of exposure to CUMS. Diffusion tensor imaging showed higher mean fractional anisotropy in the hippocampal stratum radiatum of WT and HOM male offspring from dams exposed to CUMS and HOM offspring from unexposed dams, compared to WT male offspring from unexposed dams. These data support that CUMS in Shank3-mutant dams results in subtle maternal care alterations and long-lasting changes in the white matter of the hippocampus of their offspring.	[Wong, Bibiana K. Y.; Ramakrishnan, Rajesh; He, Fang; Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Wong, Bibiana K. Y.; Ramakrishnan, Rajesh; Van den Veyver, Ignatia B.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Murry, Jaclyn B.; Van den Veyver, Ignatia B.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Balasa, Alfred] Baylor Coll Med, Dept Pediat, Sect Pediat Neurol & Dev Neurosci, Houston, TX 77030 USA; [Stinnett, Gary R.; Pedersen, Steen E.; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wong, Bibiana K. Y.] Noldus Informat Technol Inc, Leesburg, VA USA; [Murry, Jaclyn B.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Ramakrishnan, Rajesh] Univ St Thomas, Dept Biol, Houston, TX 77006 USA; [He, Fang] Guangzhou Med Hosp, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Stinnett, Gary R.] Georgia Inst Technol, Dept Med Phys, Atlanta, GA 30332 USA; [Pedersen, Steen E.] Ross Univ, Dept Med Fdn, Sch Med, Miramar, FL USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Los Angeles; University of Saint Thomas; University System of Georgia; Georgia Institute of Technology	Van den Veyver, IB (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.; Van den Veyver, IB (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Van den Veyver, IB (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	iveyver@bcm.edu	Van den Veyver, Ignatia B/AAF-4510-2021	Van den Veyver, Ignatia B/0000-0002-0651-5924; Murry, Jaclyn/0000-0002-9879-427X; Pedersen, Steen E./0000-0001-8755-8899; Ramakrishnan, Rajesh/0000-0001-8841-570X	Burroughs Wellcome Fund (BWF)-The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the University of Texas Health Science Center at Houston (BWF) [1008200]; National Institute of General Medical Sciences (NIGMS) [T32GM008307]; National Center for Research Resources (NCRR) [C06RR029965]; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (IDDRC); Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD) [1U54HD083092-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	Burroughs Wellcome Fund (BWF)-The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the University of Texas Health Science Center at Houston (BWF); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (IDDRC); Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JBM was supported by a training fellowship from the Burroughs Wellcome Fund (BWF)-The Houston Laboratory and Population Science Training Program in Gene-Environment Interaction of the University of Texas Health Science Center at Houston (BWF Grant No.1008200) and by a T32GM008307 from the National Institute of General Medical Sciences (NIGMS). The project described was also supported by Grant Number C06RR029965 from the National Center for Research Resources (NCRR). This work was also supported by the neurobehavioral core of the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (IDDRC) supported by award 1U54HD083092-04 from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD). The content is solely the responsibility of the authors and does not represent the official views of the BWF and the NIGMS, NCRR and NICHD of the National Institutes of Health. We note that while BKYW is a current employee of Noldus Information Technology Inc., she was not affiliated with Noldus Information Technology Inc. in any shape or form during the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Allen Marilee C, 2002, Semin Neonatol, V7, P211, DOI 10.1053/siny.2002.0108; Ameis SH, 2015, CORTEX, V62, P158, DOI 10.1016/j.cortex.2014.10.014; American Psychiatric Association, 2013, DSM 5 TASK FORC DIAG, V5th; Beery AK, 2015, NEUROBIOL STRESS, V1, P116, DOI 10.1016/j.ynstr.2014.10.004; Betancur C, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-17; Beversdorf DQ, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0945-4; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Bitner BR, 2012, MAGN RESON INSIGHTS, V5, P1, DOI 10.4137/MRI.S9352; Boersma GJ, 2015, NEUROBIOL STRESS, V1, P100, DOI 10.1016/j.ynstr.2014.10.006; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Chaste Pauline, 2012, Dialogues Clin Neurosci, V14, P281; Chourbaji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019218; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1; Class QA, 2014, PSYCHOL MED, V44, P71, DOI 10.1017/S0033291713000780; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; DiPietro JA, 2006, CHILD DEV, V77, P573, DOI 10.1111/j.1467-8624.2006.00891.x; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Geisheker MR, 2017, NAT NEUROSCI, V20, P1043, DOI 10.1038/nn.4589; Gordon I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35054; Kinney DK, 2008, NEUROSCI BIOBEHAV R, V32, P1519, DOI 10.1016/j.neubiorev.2008.06.004; Kouser M, 2013, J NEUROSCI, V33, P18448, DOI 10.1523/JNEUROSCI.3017-13.2013; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Macbeth AH, 2010, BEHAV NEUROSCI, V124, P677, DOI 10.1037/a0020799; Maes JHR, 2011, J CLIN EXP NEUROPSYC, V33, P210, DOI 10.1080/13803395.2010.501327; MAESTRIPIERI D, 1991, BEHAV NEUROSCI, V105, P663, DOI 10.1037/0735-7044.105.5.663; Mak-Fan KM, 2013, AUTISM, V17, P541, DOI 10.1177/1362361312442596; Martin-Sanchez A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00197; Meek LR, 2001, PHYSIOL BEHAV, V72, P473, DOI 10.1016/S0031-9384(00)00431-5; MEIJER A, 1985, ACTA PSYCHIAT SCAND, V72, P505, DOI 10.1111/j.1600-0447.1985.tb02647.x; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Nacher J, 2004, NEUROSCIENCE, V126, P503, DOI 10.1016/j.neuroscience.2004.03.038; Negron-Oyarzo I, 2015, CEREB CORTEX, V25, P3132, DOI 10.1093/cercor/bhu108; Noriuchi M, 2010, BRAIN RES, V1362, P141, DOI 10.1016/j.brainres.2010.09.051; Pardon MC, 2000, BIOL PSYCHIAT, V47, P858, DOI 10.1016/S0006-3223(99)00253-X; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Rai D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038893; Roberts AL, 2016, AUTISM, V20, P26, DOI 10.1177/1362361314566049; Ronald A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00223; Sarkar S, 2014, WORLD J BIOL PSYCHIA, V15, P346, DOI 10.3109/15622975.2014.903336; Sharma S, 2016, ANNU REV PSYCHOL, V67, P239, DOI 10.1146/annurev-psych-122414-033408; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Uchino S, 2013, BRAIN DEV-JPN, V35, P106, DOI 10.1016/j.braindev.2012.05.013; Uppal N, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0036-x; Van Bogaert MJV, 2006, GENES BRAIN BEHAV, V5, P139, DOI 10.1111/j.1601-183X.2005.00143.x; van Rooij D, 2018, AM J PSYCHIAT, V175, P359, DOI 10.1176/appi.ajp.2017.17010100; Varghese M, 2017, ACTA NEUROPATHOL, V134, P537, DOI 10.1007/s00401-017-1736-4; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Walder DJ, 2014, PSYCHIAT RES, V219, P353, DOI 10.1016/j.psychres.2014.04.034; Wang XM, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-30; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Wang ZS, 2011, NEUROPSYCHOPHARMACOL, V36, P772, DOI 10.1038/npp.2010.211; WARD AJ, 1990, CHILD PSYCHIAT HUM D, V20, P279, DOI 10.1007/BF00706020; Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z; Whitehead NS, 2003, J PSYCHOSOM OBST GYN, V24, P77, DOI 10.3109/01674820309042805; Woods SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.041; Zhou Y, 2016, NEURON, V89, P147, DOI 10.1016/j.neuron.2015.11.023; Zoghbi Huda Y, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a009886	60	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224876	10.1371/journal.pone.0224876	http://dx.doi.org/10.1371/journal.pone.0224876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703095	Green Published, gold			2022-12-26	WOS:000532697200028
J	Mawatari, M; Saito, R; Hibino, A; Kondo, H; Yagami, R; Odagiri, T; Tanabe, I; Shobugawa, Y				Mawatari, Momoko; Saito, Reiko; Hibino, Akinobu; Kondo, Hiroki; Yagami, Ren; Odagiri, Takashi; Tanabe, Ikumi; Shobugawa, Yugo		Japanese Influenza Collaborative S	Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza	PLOS ONE			English	Article							CLINICAL EFFECTIVENESS; VIRUS-INFECTION; OSELTAMIVIR RESISTANCE; A(H1N1)PDM09 VIRUS; CHILDREN; ZANAMIVIR; LANINAMIVIR; PERAMIVIR; ADULTS; MULTICENTER	Background Neuraminidase inhibitors (NAIs) effectively treat influenza. The clinical effectiveness of four NAIs (oseltamivir, zanamivir, laninamivir, and peramivir) was evaluated against influenza A/ H1N1pdm09, A/H3N2, and B viruses. Additionally, fever duration in patients infected with oseltamivir-resistant influenza A/H1N1pdm09 with the H275Y mutation was evaluated. Methods Patients aged < 20 years who visited outpatient clinics in Japan with influenza-like illnesses were enrolled during 4 influenza seasons from 2012/2013 to 2015/2016. After obtaining informed consent, patients who tested positive for influenza with rapid tests received one of the four NAIs. Patients recorded their body temperature daily for 8 days from the first visit. The influenza strain was identified using real-time polymerase chain reaction. Univariate and multivariable analyses were used to evaluate factors influencing fever duration. In children aged <= 5 years treated with oseltamivir, fever duration in oseltamivir-resistant A/H1N1pdm09-infected patients was compared to that in oseltamivir-sensitive A/H1N1pdm09-infected patients. Results Of the 1,368 patients analyzed, 297 (21.7%), 683 (49.9%), and 388 (28.4%) were infected with influenza A/H1N1pdm09, A/H3N2, and B, respectively. In multivariable analysis factors associated with significantly prolonged fever duration included: treatment with laninamivir (hazard ratio [HR]: 0.78, p = 0.006, compared to oseltamivir), influenza B (HR: 0.58, p<0.001, compared to influenza A/H1N1pdm09), and a higher body temperature at the clinic visit (HR: 0.87 per degree Celsius, p<0.001). Increasing age was associated with a significantly shorter duration of fever (HR: 1.31 for 6-9 years old, p<0.001; and HR: 1.65 for 10-19 years old, p<0.001, respectively, compared to 0-5 years old). Following treatment with oseltamivir, fever duration was significantly longer for oseltamivir-resistant A/H1N1pdm09-infected patients (n = 5) than for oseltamivir-sensitive A/H1N1pdm09 infected patients (n = 111) (mean, 89 versus 40 hours, p<0.001). Conclusions Our results revealed characteristic information on the effectiveness of the four NAIs and also on oseltamivir-resistant viruses that may affect patients' clinical care.	[Mawatari, Momoko; Saito, Reiko; Hibino, Akinobu; Kondo, Hiroki; Yagami, Ren; Odagiri, Takashi; Tanabe, Ikumi; Shobugawa, Yugo] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata, Japan; [Odagiri, Takashi] Iwate Med Univ, Sch Med, Dept Microbiol, Div Infect Dis & Immunol, Morioka, Iwate, Japan	Niigata University; Iwate Medical University	Mawatari, M (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth Publ Hlth, Niigata, Japan.	mawatamo@gmail.com			JSPS Core-to-core Program, B.Asia-Africa Science Platforms, Kakenhi; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Japan Agency for Medical Research and Development (AMED) [15fm0108009h0001]	JSPS Core-to-core Program, B.Asia-Africa Science Platforms, Kakenhi; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	RS was supported by JSPS Core-to-core Program, B.Asia-Africa Science Platforms, Kakenhi (Grants-in-Aid for Scientific Research), sourced from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Japan Agency for Medical Research and Development (AMED) (15fm0108009h0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Boivin G, 2002, ANTIVIR RES, V54, P143, DOI 10.1016/S0166-3542(01)00219-4; Burnham AJ, 2013, ANTIVIR RES, V100, P520, DOI 10.1016/j.antiviral.2013.08.023; Dapat IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036455; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hayden FG, 2019, CURR OPIN INFECT DIS, V32, P176, DOI 10.1097/QCO.0000000000000532; Hayden FG, 2018, NEW ENGL J MED, V379, P913, DOI 10.1056/NEJMoa1716197; Hibino A, 2017, VIRUS GENES, V53, P89, DOI 10.1007/s11262-016-1396-9; Hikita T, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/834181; Hirotsu N, 2018, EXPERT REV ANTI-INFE, V16, P173, DOI 10.1080/14787210.2018.1421945; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Ishiguro N, 2018, J INFECT CHEMOTHER, V24, P449, DOI 10.1016/j.jiac.2018.01.013; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Kakuya F, 2015, PEDIATR INT, V57, P888, DOI 10.1111/ped.12658; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawai N, 2005, CLIN INFECT DIS, V40, P1309, DOI 10.1086/429241; Kawai N, 2008, J INFECTION, V56, P51, DOI 10.1016/j.jinf.2007.09.002; Kawai N, 2006, CLIN INFECT DIS, V43, P439, DOI 10.1086/505868; Kawai N, 2009, J INFECTION, V59, P207, DOI 10.1016/j.jinf.2009.07.002; Kawai N, 2009, CLIN INFECT DIS, V48, P996, DOI 10.1086/597360; Kondo H, 2016, TOHOKU J EXP MED, V238, P113, DOI 10.1620/tjem.238.113; Koseki N, 2014, INFLUENZA OTHER RESP, V8, P151, DOI 10.1111/irv.12147; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Lina B, 2018, INFLUENZA OTHER RESP, V12, P267, DOI 10.1111/irv.12534; Matsuzaki Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-53; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Munoz Flor M, 2003, Paediatr Respir Rev, V4, P99, DOI 10.1016/S1526-0542(03)00027-7; Murakami Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146520; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Sato M, 2008, TOHOKU J EXP MED, V214, P113, DOI 10.1620/tjem.214.113; Shobugawa Y, 2012, J INFECT CHEMOTHER, V18, P858, DOI 10.1007/s10156-012-0428-1; Sugaya N, 2008, CLIN INFECT DIS, V47, P339, DOI 10.1086/589748; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Sugaya N, 2015, ANTIVIR THER, V20, P49, DOI 10.3851/IMP2798; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; Suzuki E, 2008, J MED VIROL, V80, P1065, DOI 10.1002/jmv.21144; Suzuki Y, 2011, J CLIN MICROBIOL, V49, P125, DOI 10.1128/JCM.01401-10; Takashita E, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.1.20666; Takemoto Y, 2013, CHEMOTHERAPY, V59, P373, DOI 10.1159/000362436; Tochino Y, 2017, J GEN FAM MED, V18, P386, DOI 10.1002/jgf2.109; Valetto G, 2003, PROC INT CONF SOFTW, P262, DOI 10.1109/ICSE.2003.1201206; Wang B, 2012, EUROSURVEILLANCE, V17, P12; Yoshi Naoko, 2016, Osaka City Med J, V62, P29; Zaraket Hassan, 2016, Curr Treat Options Infect Dis, V8, P311, DOI 10.1007/s40506-016-0085-5; Zaraket H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00262	47	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224683	10.1371/journal.pone.0224683	http://dx.doi.org/10.1371/journal.pone.0224683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697721	Green Published, gold, Green Submitted			2022-12-26	WOS:000532694400042
J	Oiki, S; Nakamichi, Y; Maruyama, Y; Mikami, B; Murata, K; Hashimoto, W				Oiki, Sayoko; Nakamichi, Yusuke; Maruyama, Yukie; Mikami, Bunzo; Murata, Kousaku; Hashimoto, Wataru			Streptococcal phosphotransferase system imports unsaturated hyaluronan disaccharide derived from host extracellular matrices	PLOS ONE			English	Article							CHONDROITIN SULFATE-C; ESCHERICHIA-COLI; GLUCURONYL HYDROLASE; MANNOSE TRANSPORTER; PHOSPHOENOLPYRUVATE; GLYCOSAMINOGLYCANS; DEGRADATION; SPECIFICITY; PNEUMONIAE; METABOLISM	Certain bacterial species target the polysaccharide glycosaminoglycans (GAGs) of animal extracellular matrices for colonization and/or infection. GAGs such as hyaluronan and chondroitin sulfate consist of repeating disaccharide units of uronate and amino sugar residues, and are depolymerized to unsaturated disaccharides by bacterial extracellular or cell-surface polysaccharide lyase. The disaccharides are degraded and metabolized by cytoplasmic enzymes such as unsaturated glucuronyl hydrolase, isomerase, and reductase. The genes encoding these enzymes are assembled to form a GAG genetic cluster. Here, we demonstrate the Streptococcus agalactiae phosphotransferase system (PTS) for import of unsaturated hyaluronan disaccharide. S. agalactiae NEM316 was found to depolymerize and assimilate hyaluronan, whereas its mutant with a disruption in the PTS genes included in the GAG cluster was unable to grow on hyaluronan, while retaining the ability to depolymerize hyaluronan. Using toluene-treated wild-type cells, the PTS activity for import of unsaturated hyaluronan disaccharide was significantly higher than that observed in the absence of the substrate. In contrast, the PTS mutant was unable to import unsaturated hyaluronan disaccharide, indicating that the corresponding PTS is the only importer of fragmented hyaluronan, which is suitable for PTS to phosphorylate the substrate at the C-6 position. This is distinct from Streptobacillus moniliformis ATP-binding cassette transporter for import of sulfated and non-sulfated fragmented GAGs without substrate modification. The three-dimensional structure of streptococcal EIIA, one of the PTS components, was found to contain a Rossman-fold motif by X-ray crystallization. Docking of EIIA with another component EIIB by modeling provided structural insights into the phosphate transfer mechanism. This study is the first to identify the substrate (unsaturated hyaluronan disaccharide) recognized and imported by the streptococcal PTS. The PTS and ABC transporter for import of GAGs shed light on bacterial clever colonization/infection system targeting various animal polysaccharides.	[Oiki, Sayoko; Nakamichi, Yusuke; Hashimoto, Wataru] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Basic & Appl Mol Biotechnol, Uji, Kyoto, Japan; [Maruyama, Yukie; Murata, Kousaku] Setsunan Univ, Fac Sci & Engn, Dept Life Sci, Lab Food Microbiol, Neyagawa, Osaka, Japan; [Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Appl Struct Biol, Uji, Kyoto, Japan	Kyoto University; Setsunan University; Kyoto University	Hashimoto, W (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Basic & Appl Mol Biotechnol, Uji, Kyoto, Japan.	whasimot@kais.kyoto-u.ac.jp	Nakamichi, Yusuke/H-1221-2018; Nakamichi, Yusuke/Y-2830-2019	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Yakult Bioscience Foundation; JASRI [2016B2574, 2012A1317]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yakult Bioscience Foundation; JASRI	This work was supported in part by Grants-in-Aid Scientific Research from the Japan Society for the Promotion of Science (to W. H.), and the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and Research Grant (to W. H.) from Yakult Bioscience Foundation.; We thank Dr. Daisuke Takamatsu, National Agriculture and Food Research Organization, for kindly supplying a thermosensitive suicide vector, pSET4s. We thank Ms. Ai Matsunami for her excellent technical assistance. We thank Drs. S. Baba and N. Mizuno of the Japan Synchrotron Radiation Research Institute (JASRI) for their kind help in data collection. Diffraction data were collected at the BL38B1 line of SPring-8 (Hyogo, Japan) with the approval of JASRI (Projects 2012A1317 and 2016B2574). The authors would like to thank Enago (www.enago.com) for the English language review.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker JR, 1997, BIOCHEM J, V327, P65, DOI 10.1042/bj3270065; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DeLano WL, 2002, PYMOL MOL GRAPHICS S, DOI [10.1042/bj3270065, DOI 10.1042/BJ3270065]; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; EDELSTAM GAB, 1991, J HISTOCHEM CYTOCHEM, V39, P1131, DOI 10.1177/39.8.1856461; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Foot M, 2005, J PHARMACEUT BIOMED, V38, P397, DOI 10.1016/j.jpba.2005.01.026; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Franz CMAP, 2011, INT J FOOD MICROBIOL, V151, P125, DOI 10.1016/j.ijfoodmicro.2011.08.014; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu J, 2008, J BIOL CHEM, V283, P11024, DOI 10.1074/jbc.M800312200; Ibberson CB, 2014, INFECT IMMUN, V82, P4253, DOI 10.1128/IAI.01710-14; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; Jedrzejas MJ, 2007, CELL MOL LIFE SCI, V64, P2799, DOI 10.1007/s00018-007-7125-8; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kamhi E, 2013, BIOL REV, V88, P928, DOI 10.1111/brv.12034; Karamanos NK, 2018, CHEM REV, V118, P9152, DOI 10.1021/acs.chemrev.8b00354; Kawai K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28886-w; KORNBERG HL, 1972, BIOCHEM J, V128, P1339, DOI 10.1042/bj1281339; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuivanen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26329; Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.010; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Maruyama Y, 2015, J BIOL CHEM, V290, P6281, DOI 10.1074/jbc.M114.604546; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; MATHEWS MB, 1961, BIOCHIM BIOPHYS ACTA, V53, P509, DOI 10.1016/0006-3002(61)90209-8; Moye ZD, 2014, APPL ENVIRON MICROB, V80, P5053, DOI 10.1128/AEM.00820-14; Nakamichi Y, 2011, J BIOL CHEM, V286, P6262, DOI 10.1074/jbc.M110.182618; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oiki S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16801-8; Oiki S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00917-y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson MJ, 1996, MED MICROBIOLOGY, DOI [10.1128/IAI.05756-11, DOI 10.1128/IAI.05756-11]; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; Prydz K, 2000, J CELL SCI, V113, P193; RICCI ML, 1994, FEMS MICROBIOL LETT, V119, P47; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; SAIER MH, 1977, BACTERIOL REV, V41, P856, DOI 10.1128/MMBR.41.4.856-871.1977; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287; Shafeeq S, 2011, MICROBIOL-SGM, V157, P2854, DOI 10.1099/mic.0.051359-0; SIMONI RD, 1967, P NATL ACAD SCI USA, V58, P1963, DOI 10.1073/pnas.58.5.1963; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang ZF, 2014, INFECT IMMUN, V82, P2615, DOI 10.1128/IAI.00022-14; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200	56	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224753	10.1371/journal.pone.0224753	http://dx.doi.org/10.1371/journal.pone.0224753			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697725	Green Published, gold, Green Submitted			2022-12-26	WOS:000532694400057
J	Sabater, JR; Sackner, MA; Adams, JA; Abraham, WM				Sabater, Juan R.; Sackner, Marvin A.; Adams, Jose A.; Abraham, William M.			Whole body periodic acceleration in normal and reduced mucociliary clearance of conscious sheep	PLOS ONE			English	Article							NITRIC-OXIDE; CYSTIC-FIBROSIS; NEUTROPHIL ELASTASE; THERAPY; PATHWAY	The purpose of this investigation was to ascertain whether nitric oxide (NO) released into the circulation by a noninvasive technology called whole body periodic acceleration (WBPA) could increase mucociliary clearance (MCC). It was based on observations by others that nitric oxide donor drugs increase ciliary beat frequency of nasal epithelium without increasing mucociliary clearance. Tracheal mucous velocity (TMV), a reflection of MCC, was measured in sheep after 1-hour treatment of WBPA and repeated after pretreatment with the NO synthase inhibitor, L-NAME to demonstrated action of NO. Aerosolized human neutrophil elastase (HNE) was administered to sheep to suppress TMV as might occur in cystic fibrosis and other inflammatory lung diseases. WBPA increased TMV to a peak of 136% of baseline 1h after intervention, an effect blocked by L-NAME. HNE reduced TMV to 55% of baseline but slowing was reversed by WBPA, protection lost in the presence of L-NAME. NO released into the circulation from eNOS by WBPA can acutely access airway epithelium for improving MCC slowed in cystic fibrosis and other inflammatory lung diseases as a means of enhancing host defense against pathogens.	[Sabater, Juan R.; Sackner, Marvin A.; Abraham, William M.] Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA; [Sackner, Marvin A.] Mt Sinai Med Ctr, Dept Med, Miami Beach, FL 33140 USA; [Adams, Jose A.] Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA	Mount Sinai Medical Center; Mount Sinai Medical Center; Mount Sinai Medical Center	Adams, JA (corresponding author), Mt Sinai Med Ctr, Div Neonatol, Miami Beach, FL 33140 USA.	tony-adams@msmc.com	Adams, Jose Antonio/ABC-2699-2021	Adams, Jose Antonio/0000-0002-9401-2226	Department of Research and Division of Neonatology	Department of Research and Division of Neonatology	This study was funded via internal research funds from the Department of Research and Division of Neonatology.	Abraham WM, 2006, AM J RESP CRIT CARE, V174, P743, DOI 10.1164/rccm.200601-048OC; Adams JA, 2005, J APPL PHYSIOL, V98, P1083, DOI 10.1152/japplphysiol.00662.2004; Adams JA, 2003, ANN BIOMED ENG, V31, P1337, DOI 10.1114/1.1623486; AMITANI R, 1991, AM J RESP CELL MOL, V4, P26, DOI 10.1165/ajrcmb/4.1.26; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Chowienczyk PJ, 1999, J AM COLL CARDIOL, V34, P2007, DOI 10.1016/S0735-1097(99)00441-6; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Fischer BM, 2002, AM J RESP CELL MOL, V26, P447, DOI 10.1165/ajrcmb.26.4.4473; Hirsh AJ, 2004, J PHARMACOL EXP THER, V311, P929, DOI 10.1124/jpet.104.071886; Howlin RP, 2017, MOL THER, V25, P2104, DOI 10.1016/j.ymthe.2017.06.021; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; Li DC, 2000, AM J RESP CELL MOL, V23, P175, DOI 10.1165/ajrcmb.23.2.4022; MESSINA MS, 1991, AM REV RESPIR DIS, V143, P993, DOI 10.1164/ajrccm/143.5_Pt_1.993; O'Riordan TG, 1998, J APPL PHYSIOL, V85, P1086, DOI 10.1152/jappl.1998.85.3.1086; ORIORDAN TG, 1992, AM REV RESPIR DIS, V146, P598, DOI 10.1164/ajrccm/146.3.598; ORiordan TG, 1997, AM J RESP CRIT CARE, V155, P1522, DOI 10.1164/ajrccm.155.5.9154852; Sabater JR, 1999, J APPL PHYSIOL, V87, P2191, DOI 10.1152/jappl.1999.87.6.2191; Sabater PR, 2005, CHEST, V128, P3743, DOI 10.1378/chest.128.5.3743; Sackner MA, 2005, CHEST, V127, P30, DOI 10.1378/chest.127.1.30; SACKNER MA, 1975, CHEST, V68, P774, DOI 10.1378/chest.68.6.774; SACKNER MA, 1976, CHEST, V69, P593, DOI 10.1378/chest.69.5.593; Sackner MA, 2019, EUR J APPL PHYSIOL, V119, P201, DOI 10.1007/s00421-018-4016-7; Scott DW, 2017, AM J RESP CRIT CARE, V196, P734, DOI 10.1164/rccm.201612-2445OC; SMALDONE GC, 1993, CHEST, V103, P1390, DOI 10.1378/chest.103.5.1390; Wright CD, 1999, J PHARMACOL EXP THER, V289, P1007; Wyatt TA, 2015, CELLS-BASEL, V4, P315, DOI 10.3390/cells4030315	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224764	10.1371/journal.pone.0224764	http://dx.doi.org/10.1371/journal.pone.0224764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697733	Green Published, gold, Green Submitted			2022-12-26	WOS:000532694400058
J	Aguilar, D; Lemonnier, N; Koppelman, GH; Melen, E; Oliva, B; Pinart, M; Guerra, S; Bousquet, J; Anto, JM				Aguilar, Daniel; Lemonnier, Nathanael; Koppelman, Gerard H.; Melen, Erik; Oliva, Baldo; Pinart, Mariona; Guerra, Stefano; Bousquet, Jean; Anto, Josep M.			Understanding allergic multimorbidity within the non-eosinophilic interactome	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; TOLL-LIKE RECEPTORS; GENE-EXPRESSION; DISEASE; ASTHMA; ASSOCIATION; RHINITIS; NETWORK; CELLS; MECHANISMS	Background The mechanisms explaining multimorbidity between asthma, dermatitis and rhinitis (allergic multimorbidity) are not well known. We investigated these mechanisms and their specificity in distinct cell types by means of an interactome-based analysis of expression data. Methods Genes associated to the diseases were identified using data mining approaches, and their multimorbidity mechanisms in distinct cell types were characterized by means of an in silico analysis of the topology of the human interactome. Results We characterized specific pathomechanisms for multimorbidities between asthma, dermatitis and rhinitis for distinct emergent non-eosinophilic cell types. We observed differential roles for cytokine signaling, TLR-mediated signaling and metabolic pathways for multimorbidities across distinct cell types. Furthermore, we also identified individual genes potentially associated to multimorbidity mechanisms. Conclusions Our results support the existence of differentiated multimorbidity mechanisms between asthma, dermatitis and rhinitis at cell type level, as well as mechanisms common to distinct cell types. These results will help understanding the biology underlying allergic multimorbidity, assisting in the design of new clinical studies.	[Aguilar, Daniel] Inst Salud Carlos III, Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Barcelona, Spain; [Aguilar, Daniel; Pinart, Mariona; Guerra, Stefano; Anto, Josep M.] Barcelona Inst Global Hlth, ISGlobal, Barcelona, Spain; [Aguilar, Daniel] 6AM Data Min, Barcelona, Spain; [Lemonnier, Nathanael] Univ Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Inst Adv Biosci, Site Sante,Allee Alpes, La Tronche, France; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Melen, Erik] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Oliva, Baldo] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Programme Biomed Informat, Struct Bioinformat Grp, Barcelona, Spain; [Guerra, Stefano] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ USA; [Bousquet, Jean] Hop Arnaud de Villeneuve Univ Hosp, Montpellier, France; [Bousquet, Jean] Univ Med Berlin, Charite, Berlin, Germany; [Bousquet, Jean] Humboldt Univ, Berlin, Germany; [Bousquet, Jean] Berlin Inst Hlth, Comprehens Allergy Ctr, Dept Dermatol & Allergy, Berlin, Germany	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; ISGlobal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Groningen; University of Groningen; Karolinska Institutet; Pompeu Fabra University; University of Arizona; Universite de Montpellier; CHU de Montpellier; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Berlin Institute of Health	Aguilar, D (corresponding author), Inst Salud Carlos III, Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Barcelona, Spain.; Aguilar, D (corresponding author), Barcelona Inst Global Hlth, ISGlobal, Barcelona, Spain.; Aguilar, D (corresponding author), 6AM Data Min, Barcelona, Spain.	daniel.aguilar@ciberehd.org	Lemonnier, Nathanael/K-5393-2016; Pinart Gilberga, Mariona/GLS-8842-2022	Lemonnier, Nathanael/0000-0002-3994-8697; Pinart Gilberga, Mariona/0000-0002-8223-1325; Bousquet, Jean/0000-0002-4061-4766; Koppelman, Gerard/0000-0001-8567-3252	Mechanisms of the Development of ALLergy (MeDALL), within the EU under the Health Cooperation Work Programme of the Seventh Framework programme [261357]; European Research Council [757919]; Swedish Research Council; French National Research Agency [ANR-15-IDEX-02]	Mechanisms of the Development of ALLergy (MeDALL), within the EU under the Health Cooperation Work Programme of the Seventh Framework programme; European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); French National Research Agency(French National Research Agency (ANR))	This work was supported by Mechanisms of the Development of ALLergy (MeDALL), a collaborative project done within the EU under the Health Cooperation Work Programme of the Seventh Framework programme (grant agreement number 261357). EM is supported by grants from the European Research Council (no 757919) and the Swedish Research Council. NL is a recipient of a postdoctoral fellowship from the French National Research Agency in the framework of the "Investissements d'avenir" program (ANR-15-IDEX-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 6AM Data Mining provided support in the form of a salary for DA, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguilar D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179125; Amberger Joanna S, 2017, Curr Protoc Bioinformatics, V58, DOI 10.1002/cpbi.27; Aryan Z, 2015, CURR OPIN ALLERGY CL, V15, P568, DOI 10.1097/ACI.0000000000000212; Atkins D, 2017, PEDIAT ALLERG IMM-UK, V28, P312, DOI 10.1111/pai.12715; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barshir R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003632; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezginov A, 2013, MOL BIOL EVOL, V30, P332, DOI 10.1093/molbev/mss218; Boulay ME, 2003, CURR OPIN ALLERGY CL, V3, P51, DOI 10.1097/01.all.0000053268.39029.19; Bousquet J, 2011, ALLERGY, V66, P596, DOI 10.1111/j.1398-9995.2010.02534.x; Cavalli G, 2015, RHEUMATOLOGY, V54, P2134, DOI 10.1093/rheumatology/kev269; Celestin J, 2012, CURR ALLERGY ASTHM R, V12, P18, DOI 10.1007/s11882-011-0240-5; Compalati E, 2010, EXPERT REV CLIN IMMU, V6, P413, DOI [10.1586/ECI.10.15, 10.1586/eci.10.15]; Cornish AJ, 2018, BIOINFORMATICS, V34, P2087, DOI 10.1093/bioinformatics/bty028; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Davis AP, 2019, NUCLEIC ACIDS RES, V47, pD948, DOI 10.1093/nar/gky868; Davis BP, 2016, ANNU REV PATHOL-MECH, V11, P365, DOI 10.1146/annurev-pathol-012615-044241; Delacour H, 2016, ANN BIOL CLIN-PARIS, V74, P279, DOI 10.1684/abc.2016.1141; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Engreitz JM, 2010, J BIOMED INFORM, V43, P932, DOI 10.1016/j.jbi.2010.07.001; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Faisal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113053; Fajt ML, 2015, J ALLERGY CLIN IMMUN, V135, P299, DOI 10.1016/j.jaci.2014.12.1871; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Furuta GT, 2014, ANN ALLERG ASTHMA IM, V113, P3, DOI 10.1016/j.anai.2014.04.002; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Garcia-Aymerich J, 2015, ALLERGY, V70, P973, DOI 10.1111/all.12640; Ghiassian SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27414; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Gill P, 2015, J ALLERGY CLIN IMMUN, V135, P1424, DOI 10.1016/j.jaci.2015.04.019; Gillis J, 2014, J PROTEOMICS, V100, P44, DOI 10.1016/j.jprot.2014.01.020; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goh KI, 2012, BRIEF FUNCT GENOMICS, V11, P533, DOI 10.1093/bfgp/els032; Gomez-Cabrero D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1291-3; Grapov D, 2015, BIOINFORMATICS, V31, P2757, DOI 10.1093/bioinformatics/btv194; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Guney E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094686; Guney E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043557; Incorvaia C, 2018, J Biol Regul Homeost Agents, V32, P67; Isik Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep17417; Kald B, 1996, DIGESTION, V57, P472, DOI 10.1159/000201376; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim TH, 2010, CLIN EXP ALLERGY, V40, P1742, DOI 10.1111/j.1365-2222.2010.03612.x; Kingo K, 2008, GENES IMMUN, V9, P445, DOI 10.1038/gene.2008.36; Kita H, 2013, INT ARCH ALLERGY IMM, V161, P3, DOI 10.1159/000350662; Kitsak M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35241; Ko Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39433; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Krause K, 2012, CURR OPIN ALLERGY CL, V12, P477, DOI 10.1097/ACI.0b013e3283574d0c; Kryuchkova-Mostacci N, 2017, BRIEF BIOINFORM, V18, P205, DOI 10.1093/bib/bbw008; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee WI, 2013, IMMUNOBIOLOGY, V218, P192, DOI 10.1016/j.imbio.2012.04.002; Lehne B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020133; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Lun SWM, 2009, J CLIN IMMUNOL, V29, P330, DOI 10.1007/s10875-008-9269-1; MALEFYT RD, 1991, J EXP MED, V174, P915; McCormack T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054945; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Nelms BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1062-5; Nhu QM, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00128; Nilsson D, 2014, ALLERGY, V69, P1506, DOI 10.1111/all.12495; Nishimura D., 2001, BIOCARTA BIOTECH SOF, V2; Nishimura Y, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-11; Nombela I, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006910; Ogris C, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw849; Oka A, 2017, J ALLER CL IMM-PRACT, V5, P160, DOI 10.1016/j.jaip.2016.08.002; Olze H, 2011, CURR OPIN ALLERGY CL, V11, P457, DOI 10.1097/ACI.0b013e32834a9764; Pan KH, 2005, P NATL ACAD SCI USA, V102, P8961, DOI 10.1073/pnas.0502674102; Pandey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088889; Panzer R, 2014, EXP DERMATOL, V23, P364, DOI 10.1111/exd.12383; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Pasanen A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41653; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Poddighe D, 2018, RESP MED, V141, P94, DOI 10.1016/j.rmed.2018.06.016; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; Radman M, 2015, ALLERGOL IMMUNOPATH, V43, P416, DOI 10.1016/j.aller.2014.04.006; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Reeves SR, 2016, J HISTOCHEM CYTOCHEM, V64, P364, DOI 10.1369/0022155416642989; Renkonen J, 2015, APMIS, V123, P716, DOI 10.1111/apm.12408; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Riba M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24647; Rubio-Perez C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04939-4; Ruscitti P, 2018, REV RECENT CLIN TRIA, V13, P210, DOI 10.2174/1574887113666180314102651; Santolini M, 2018, P NATL ACAD SCI USA, V115, pE6375, DOI 10.1073/pnas.1720589115; Schaefer MH, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00260; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Sharma A, 2015, HUM MOL GENET, V24, P3005, DOI 10.1093/hmg/ddv001; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Sonawane AR, 2017, CELL REP, V21, P1077, DOI 10.1016/j.celrep.2017.10.001; Sorensen T., 1948, BIOL SKAR, V5, P1; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Stephenson EL, 2018, BRAIN, V141, DOI 10.1093/brain/awy033; Stoney R, 2018, NPJ SYST BIOL APPL, V4, DOI 10.1038/s41540-018-0055-2; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Thomson NC, 2016, THER ADV RESPIR DIS, V10, P211, DOI 10.1177/1753465816632638; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Travers J, 1998, ARCH DERMATOL RES, V290, P569, DOI 10.1007/s004030050353; Vidal M, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6030; Wang K, 2010, CELL, V142, P351, DOI 10.1016/j.cell.2010.07.025; Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Wise SK, 2018, INT FORUM ALLERGY RH, V8, P108, DOI 10.1002/alr.22073; Yii ACA, 2018, ALLERGY, V73, P1964, DOI 10.1111/all.13496; Yu S, 2014, J ALLERGY CLIN IMMUN, V133, P943, DOI 10.1016/j.jaci.2014.02.015; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80; Zissler UM, 2016, MUCOSAL IMMUNOL, V9, P917, DOI 10.1038/mi.2015.110; Zivkovic AR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/274607	119	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224448	10.1371/journal.pone.0224448	http://dx.doi.org/10.1371/journal.pone.0224448			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693680	Green Published, gold			2022-12-26	WOS:000532690100026
J	Kim, MS; Park, HJ; Lee, SY; Kim, JN				Kim, Myung Sub; Park, Hee Jin; Lee, So Yeon; Kim, Ji Na			Association between ossification of the posterior longitudinal ligament and ossification of the nuchal ligament in the cervical spine	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR-BETA; DIFFERENTIATION; MYELOPATHY; ANATOMY; CELLS; DISH	Objectives To investigate the association between ossification of the posterior longitudinal ligament (OPLL) and ossification of the nuchal ligament (ONL) in terms of incidence and size. Methods This retrospective study evaluated 297 patients who underwent CT of the cervical spine (C-spine). Two radiologists worked in consensus. The incidence of OPLL from patients with and without ONL was compared using Chi Square tests. The mean lengths of ONL from patients with and without OPLL were compared using Student t-test. The correlations between the length of ONL and the presence of OPLL and between the length of ONL and the length of OPLL were analyzed with Pearson correlations. Results We found that OPLL occurred more frequently in patients with ONL than in patients without ONL (odd ratio = 2.524, p = 0.037); however, the mean length of ONL did not differ significantly patients with and without OPLL (p = 0.874). We found no significant correlation between the length of ONL and the length of OPLL (p = 0.233). Conclusion The presence of ONL was associated with the presence of OPLL. The length of OPLL and ONL showed no correlation.	[Kim, Myung Sub; Park, Hee Jin; Lee, So Yeon; Kim, Ji Na] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiol, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Park, HJ (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiol, Sch Med, Seoul, South Korea.	parkhiji@gmail.com		Lee, So-Yeon/0000-0002-0109-0998				CHAZAL J, 1985, J BIOMECH, V18, P167, DOI 10.1016/0021-9290(85)90202-7; Choi BW, 2011, ASIAN SPINE J, V5, P267, DOI 10.4184/asj.2011.5.4.267; Cohen J., 1998, STAT POWER ANAL BEHA; Ehara S, 1998, EUR J RADIOL, V27, P196, DOI 10.1016/S0720-048X(97)00164-2; Fujimori T, 2015, SPINE, V40, pE394, DOI 10.1097/BRS.0000000000000791; Furukawa K, 2006, J PHARMACOL SCI, V100, P201, DOI 10.1254/jphs.FMJ05004X4; Guo QF, 2011, EUR SPINE J, V20, pS195, DOI 10.1007/s00586-010-1538-z; HIRAI N, 1995, J SPINAL DISORD, V8, P337; Inaba K, 1996, IN VIVO, V10, P445; Kadri PAS, 2007, NEUROSURGERY, V61, P301, DOI 10.1227/01.neu.0000303985.65117.ea; KAWAGUCHI H, 1992, SPINE, V17, pS33; Kim DG, 2015, J KOREAN NEUROSURG S, V58, P442, DOI 10.3340/jkns.2015.58.5.442; Kon T, 1997, CALCIFIED TISSUE INT, V60, P291, DOI 10.1007/s002239900231; Li H, 2008, SPINE, V33, P2394, DOI 10.1097/BRS.0b013e3181838fe5; Mercer SR, 2003, CLIN ANAT, V16, P484, DOI 10.1002/ca.10121; Mitchell BS, 1998, J MANIP PHYSIOL THER, V21, P145; Sasai K, 2000, J SPINAL DISORD, V13, P26, DOI 10.1097/00002517-200002000-00005; Shingyouchi Y, 1996, SPINE, V21, P2474, DOI 10.1097/00007632-199611010-00013; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; Tsai YL, 2012, KAOHSIUNG J MED SCI, V28, P538, DOI 10.1016/j.kjms.2012.04.016; Tsukahara S, 2005, SPINE, V30, P2321, DOI 10.1097/01.brs.0000182318.47343.6d; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; Wang HL, 2014, SPINE, V39, pE7, DOI 10.1097/BRS.0000000000000037; Wang MY, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10277; Wang PN, 1999, SPINE, V24, P142, DOI 10.1097/00007632-199901150-00010; Xu P, 2011, MED HYPOTHESES, V76, P908, DOI 10.1016/j.mehy.2011.03.006; Yamamoto Y, 2002, SPINE, V27, P1852, DOI 10.1097/00007632-200209010-00009; Yoshii T, 2019, J ORTHOP SCI, V24, P35, DOI 10.1016/j.jos.2018.08.009	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224729	10.1371/journal.pone.0224729	http://dx.doi.org/10.1371/journal.pone.0224729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693687	gold, Green Published			2022-12-26	WOS:000532690100038
J	Fischenich, A; Hots, J; Verhey, J; Oberfeld, D				Fischenich, Alexander; Hots, Jan; Verhey, Jesko; Oberfeld, Daniel			Temporal weights in loudness: Investigation of the effects of background noise and sound level	PLOS ONE			English	Article							TIME-VARYING SOUNDS; NERVE-FIBERS; MODEL	Previous research has consistently shown that for sounds varying in intensity over time, the beginning of the sound is of higher importance for the perception of loudness than later parts (primacy effect). However, in all previous studies, the target sounds were presented in quiet, and at a fixed average sound level. In the present study, temporal loudness weights for a time-varying narrowband noise were investigated in the presence of a continuous bandpass-filtered background noise and the average sound levels of the target stimuli were varied across a range of 60 dB. Pronounced primacy effects were observed in all conditions and there were no significant differences between the temporal weights observed in the conditions in quiet and in background noise. Within the conditions in background noise, there was a significant effect of the sound level on the pattern of weights, which was mainly caused by a slight trend for increased weights at the end of the sounds ("recency effect") in the condition with lower average level. No such effect was observed for the in-quiet conditions. Taken together, the observed primacy effect is largely independent of masking as well as of sound level. Compatible with this conclusion, the observed primacy effects in quiet and in background noise can be well described by an exponential decay function using parameters based on previous studies. Simulations using a model for the partial loudness of timevarying sounds in background noise showed that the model does not predict the observed temporal loudness weights.	[Fischenich, Alexander; Oberfeld, Daniel] Johannes Gutenberg Univ Mainz, Dept Psychol, Mainz, Germany; [Hots, Jan; Verhey, Jesko] Otto von Guericke Univ, Dept Expt Audiol, Magdeburg, Germany	Johannes Gutenberg University of Mainz; Otto von Guericke University	Fischenich, A (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychol, Mainz, Germany.	alexander.fischenich@uni-mainz.de		Oberfeld, Daniel/0000-0002-6710-3309; Verhey, Jesko/0000-0002-2742-9187	Deutsche Forschungsgemeinschaft [OB346/6-1, VE373/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by Deutsche Forschungsgemeinschaft (OB346/6-1 to DO and VE373/2-1 to JV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, 3898 ISO; [Anonymous], 1998, 6031811998 IEC; Bronfman ZZ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004667; Chalupper J, 2002, ACTA ACUST UNITED AC, V88, P378; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dittrich K, 2009, J ACOUST SOC AM, V126, P3168, DOI 10.1121/1.3238233; Fastl H., 2007, PSYCHOACOUSTICS FACT, V3rd; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P193, DOI 10.1113/jphysiol.1978.sp012228; Glasberg BR, 2005, J AUDIO ENG SOC, V53, P906; Glasberg BR, 2002, J AUDIO ENG SOC, V50, P331; Glasberg BR, 2006, J ACOUST SOC AM, V120, P585, DOI 10.1121/1.2214151; Graham F. K., 1991, HDB COGNITIVE PSYCHO, P251; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Jesteadt W, 2011, SPRINGER HANDB AUDIT, V37, P109, DOI 10.1007/978-1-4419-6712-1_5; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kiang NYS, 1965, DISCHARGE PATTERNS S; Koelewijn T, 2009, J EXP PSYCHOL HUMAN, V35, P1303, DOI 10.1037/a0013901; Kohlrausch A, 1997, ACUSTICA, V83, P659; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Moore BCJ, 2016, TRENDS HEARING, V20; Moore BCJ, 2018, J ACOUST SOC AM, V143, P1504, DOI 10.1121/1.5027246; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; NOMOTO M, 1964, J NEUROPHYSIOL, V27, P768, DOI 10.1152/jn.1964.27.5.768; Oberfeld D, 2008, CAN J EXP PSYCHOL, V62, P24, DOI 10.1037/1196-1961.62.1.24; Oberfeld D, 2018, J ACOUST SOC AM, V144, pEL119, DOI 10.1121/1.5049895; Oberfeld D, 2018, J ACOUST SOC AM, V143, P943, DOI 10.1121/1.5023686; Oberfeld D, 2011, ATTEN PERCEPT PSYCHO, V73, P189, DOI 10.3758/s13414-010-0011-8; Pavlov IP, 2010, ANN NEUROSCI, V17, P136, DOI 10.5214/ans.0972-7531.1017309; Pedersen B, 2008, J ACOUST SOC AM, V123, P963, DOI 10.1121/1.2822883; Rennies J, 2013, P M AC, V19; Rennies J, 2015, ACTA ACUST UNITED AC, V101, P1145, DOI 10.3813/AAA.918907; Ruz M., 2002, PSICOLOGICA, V23, P283, DOI DOI 10.1080/09084282.2010.547774; Scharf B, 1978, HDB PERCEPTION, VIV, P187; Sechenov IM, 1965, REFLEXES BRAIN; SIMMONS AM, 1992, J ACOUST SOC AM, V91, P2831, DOI 10.1121/1.402964; Tsetsos K, 2012, FRONTIERS NEUROSCIEN, V6; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; YATES GK, 1985, HEARING RES, V17, P1, DOI 10.1016/0378-5955(85)90124-8	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0223075	10.1371/journal.pone.0223075	http://dx.doi.org/10.1371/journal.pone.0223075			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689327	Green Published, gold			2022-12-26	WOS:000532680100006
J	Irwin, MJ; Gupta, R; Gao, XZ; Cahill, KB; Chu, FX; Cote, RH				Irwin, Michael J.; Gupta, Richa; Gao, Xiong-Zhuo; Cahill, Karyn B.; Chu, Feixia; Cote, Rick H.			The molecular architecture of photoreceptor phosphodiesterase 6 (PDE6) with activated G protein elucidates the mechanism of visual excitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphodiesterases; G protein; phototransduction; allosteric regulation; mass spectrometry (MS); protein cross-linking; photoreceptor; integrative structural modeling; PDE6; transducin	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; INHIBITORY GAMMA-SUBUNIT; TRANSDUCIN ALPHA-SUBUNIT; CGMP-PHOSPHODIESTERASE; BINDING-SITES; TERMINAL REGION; GAF DOMAINS; IDENTIFICATION; GMP; PURIFICATION	Photoreceptor phosphodiesterase 6 (PDE6) is the central effector of the visual excitation pathway in both rod and cone photoreceptors, and PDE6 mutations that alter PDE6 structure or regulation can result in several human retinal diseases. The rod PDE6 holoenzyme consists of two catalytic subunits (P??) whose activity is suppressed in the dark by binding of two inhibitory ?-subunits (P?). Upon photoactivation of rhodopsin, the heterotrimeric G protein (transducin) is activated, resulting in binding of the activated transducin ?-subunit (Gt(?)) to PDE6, displacement of P? from the PDE6 active site, and enzyme activation. Although the biochemistry of this pathway is understood, a lack of detailed structural information about the PDE6 activation mechanism hampers efforts to develop therapeutic interventions for managing PDE6-associated retinal diseases. To address this gap, here we used a cross-linking MS-based approach to create a model of the entire interaction surface of P? with the regulatory and catalytic domains of P?? in its nonactivated state. Following reconstitution of PDE6 and activated Gt(?) with liposomes and identification of cross-links between Gt(?) and PDE6 subunits, we determined that the PDE6?Gt(?) protein complex consists of two Gt(?)-binding sites per holoenzyme. Each Gt(?) interacts with the catalytic domains of both catalytic subunits and induces major changes in the interaction sites of the P? subunit with the catalytic subunits. These results provide the first structural model for the activated state of the transducin?PDE6 complex during visual excitation, enhancing our understanding of the molecular etiology of inherited retinal diseases.	[Irwin, Michael J.; Gupta, Richa; Gao, Xiong-Zhuo; Cahill, Karyn B.; Chu, Feixia; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA; [Gao, Xiong-Zhuo] Biogen, 5000 Davis Dr, Res Triangle Pk, NC 27709 USA; [Cahill, Karyn B.] Envirologix Inc, 500 Riverside Ind Pkwy, Portland, ME 04103 USA	University System Of New Hampshire; University of New Hampshire; Biogen	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick/G-3363-2013	Cote, Rick/0000-0002-1573-6526	NEI, National Institutes of Health [R01 EY05798]; NIGMS, National Institutes of Health [P20 GM113131]; National Science Foundation [CLF 1307367]; NICHD, National Institutes of Health [R01 HD093783]; University of New Hampshire Collaborative Research Excellence grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD093783] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113131] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of New Hampshire Collaborative Research Excellence grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NEI, National Institutes of Health Grant R01 EY05798 (to R. H. C.), NIGMS, National Institutes of Health Grant P20 GM113131 (to R. H. C.), National Science Foundation Grant CLF 1307367 (to F. C.), NICHD, National Institutes of Health Grant R01 HD093783 (to F. C.), and University of New Hampshire Collaborative Research Excellence grant (to R. H. C. and F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alkhammash HI, 2015, PHYS CHEM CHEM PHYS, V17, P15547, DOI 10.1039/c4cp05882h; ANANT JS, 1992, J BIOL CHEM, V267, P687; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; Baillie GS, 2019, NAT REV DRUG DISCOV, V18, P770, DOI 10.1038/s41573-019-0033-4; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; Chu FX, 2019, J MOL BIOL, V431, P3677, DOI 10.1016/j.jmb.2019.07.035; Chu FX, 2018, METHODS, V144, P53, DOI 10.1016/j.ymeth.2018.05.023; Chu FX, 2010, MOL CELL PROTEOMICS, V9, P25, DOI 10.1074/mcp.M800555-MCP200; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2000, METHOD ENZYMOL, V315, P646; CUNNICK J, 1994, BIOCHEM J, V297, P87, DOI 10.1042/bj2970087; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Granovsky AE, 2001, BIOCHEMISTRY-US, V40, P13209, DOI 10.1021/bi011127j; Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200; Gulati S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4322; Guo LW, 2008, CURR PROTEIN PEPT SC, V9, P611, DOI 10.2174/138920308786733930; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lamb TD, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180076; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; Maryam A, 2019, COMPUT STRUCT BIOTEC, V17, P378, DOI 10.1016/j.csbj.2019.03.004; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; Milano SK, 2018, J BIOL CHEM, V293, P17941, DOI 10.1074/jbc.RA118.003746; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; Natochin M, 1998, J BIOL CHEM, V273, P21808, DOI 10.1074/jbc.273.34.21808; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Omar F, 2019, P NATL ACAD SCI USA, V116, P13320, DOI 10.1073/pnas.1822113116; Pentia Dana C., 2005, V307, P125; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Power M, 2020, PROG RETIN EYE RES, V74, DOI 10.1016/j.preteyeres.2019.07.005; Qi C, 2019, SCIENCE, V364, P389, DOI 10.1126/science.aav0778; Qureshi BM, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180075; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SLEPAK VZ, 1995, J BIOL CHEM, V270, P14319, DOI 10.1074/jbc.270.24.14319; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Szabo V, 2007, HUM MUTAT, V28, P741, DOI 10.1002/humu.9499; Ting T. D., 1993, PHOTORECEPTOR CELLS, P180; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Wang X, 2019, J BIOL CHEM, V294, P8351, DOI 10.1074/jbc.RA119.007520; Webb B, 2014, METHODS MOL BIOL, V1091, P277, DOI 10.1007/978-1-62703-691-7_20; Wensel Theodore G., 2005, V307, P289; Zeng-Elmore X, 2014, J MOL BIOL, V426, P3713, DOI 10.1016/j.jmb.2014.07.033; Zhang XJ, 2012, J BIOL CHEM, V287, P26312, DOI 10.1074/jbc.M112.377333; Zhang XJ, 2010, J BIOL CHEM, V285, P4455, DOI 10.1074/jbc.M109.057406; Zhang ZX, 2015, J BIOL CHEM, V290, P17131, DOI 10.1074/jbc.A115.647636; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	62	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19486	19497		10.1074/jbc.RA119.011002	http://dx.doi.org/10.1074/jbc.RA119.011002			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31690623	Green Published, hybrid			2022-12-26	WOS:000504093200004
J	Chen, YC; Sood, C; Francis, AC; Melikyan, GB; Dickson, RM				Chen, Yen-Cheng; Sood, Chetan; Francis, Ashwanth C.; Melikyan, Gregory B.; Dickson, Robert M.			Facile autofluorescence suppression enabling tracking of single viruses in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microscopy; Human Immunodeficiency Virus (HIV); membrane fusion; autofluorescence; optical modulation; photoswitchable fluorescent proteins; single virus tracking; synchronously amplified fluorescence image recovery (SAFIRe); live cell imaging	GREEN FLUORESCENT PROTEIN; IMAGING MICROSCOPY; CONTRAST; DISCRIMINATION; FLUOROPHORES; REDUCTION; FUSION; NADH; HIV; GFP	Live cell fluorescence imaging is the method of choice for studying dynamic processes, such as nuclear transport, vesicular trafficking, and virus entry and egress. However, endogenous cellular autofluorescence masks useful fluorescence signal, limiting the ability to reliably visualize low-abundance fluorescent proteins. Here, we employed synchronously amplified fluorescence image recovery (SAFIRe), which optically alters ground versus photophysical dark state populations within fluorescent proteins to modulate and selectively detect their background-free emission. Using a photoswitchable rsFastLime green fluorescent protein combined with a simple illumination and image-processing scheme, we demonstrate the utility of this approach for suppressing undesirable, unmodulatable fluorescence background. Significantly, we adapted this technique to different commercial wide-field and spinning-disk confocal microscopes, obtaining > 10-fold improvements in signal to background. SAFIRe allowed visualization of rsFastLime targeted to mitochondria by efficiently suppressing endogenous autofluorescence or overexpressed cytosolic unmodulatable EGFP. Suppression of the overlapping EGFP signal provided a means to perform multiplexed imaging of rsFastLime and spectrally overlapping fluorophores. Importantly, we used SAFIRe to reliably visualize and track single rsFastLime-labeled HIV-1 particles in living cells exhibiting high and uneven autofluorescence signals. Time-lapse SAFIRe imaging can be performed for an extended period of time to visualize HIV-1 entry into cells. SAFIRe should be broadly applicable for imaging live cell dynamics with commercial microscopes, even in strongly autofluorescent cells or cells expressing spectrally overlapping fluorescent proteins.	[Chen, Yen-Cheng; Dickson, Robert M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Chen, Yen-Cheng; Sood, Chetan; Francis, Ashwanth C.; Melikyan, Gregory B.] Emory Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Sood, Chetan] NanoView Biosci, Boston, MA 02135 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Children's Healthcare of Atlanta (CHOA)	Dickson, RM (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Melikyan, GB (corresponding author), Emory Sch Med, Dept Pediat, Atlanta, GA 30322 USA.; Melikyan, GB (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.	gmeliki@emory.edu; dickson@chemistry.gatech.edu	Francis, Ashwanth Christopher/N-5730-2018	Francis, Ashwanth Christopher/0000-0002-8663-2038; Chen, Yen-Cheng/0000-0001-5909-293X	NIH [R21EB020371, R01 AI1504535, R01 AI129862]; Vasser-Woolley foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vasser-Woolley foundation	The authors gratefully acknowledge the gift of the initial rsFastLime plasmid from C.J. Fahrni (Georgia Tech) and David Kabat (OHSU) for kindly providing CF3 cells. We also appreciate helpful discussions by Mariana Marin and other members of Melikyan laboratory. This work was supported by NIH R21EB020371 (RMD), the Vasser-Woolley foundation (RMD), the NIH R01 AI1504535 (GBM) and R01 AI129862 (GBM).	Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chen YC, 2017, J PHYS CHEM LETT, V8, P733, DOI 10.1021/acs.jpclett.6b02816; Chen YC, 2015, J AM CHEM SOC, V137, P12764, DOI 10.1021/jacs.5b07871; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Francis AC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005709; Francis AC, 2014, AIDS RES HUM RETROV, V30, P717, DOI [10.1089/aid.2013.0277, 10.1089/AID.2013.0277]; Gatzogiannis E, 2011, J PHYS CHEM LETT, V2, P461, DOI 10.1021/jz2000134; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3326; Guo JQ, 2010, AGR ISSUES POLICIES, P1; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Hsiang JC, 2014, ACCOUNTS CHEM RES, V47, P1545, DOI 10.1021/ar400325y; Hulme AE, 2015, J VIROL, V89, P5350, DOI 10.1128/JVI.00476-15; Icha J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700003; Jablonski AE, 2013, J AM CHEM SOC, V135, P16410, DOI 10.1021/ja405459b; Jablonski AE, 2012, J PHYS CHEM LETT, V3, P3585, DOI 10.1021/jz3016414; Knight AW, 2001, BIOPHOTONICS INT, V8, P42; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee SK, 2012, J BIOL CHEM, V287, P40867, DOI 10.1074/jbc.R112.399444; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Mansfield JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032458; Marriott G, 2008, P NATL ACAD SCI USA, V105, P17789, DOI 10.1073/pnas.0808882105; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Neumann M, 2002, J HISTOCHEM CYTOCHEM, V50, P437, DOI 10.1177/002215540205000315; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Querard J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00847-3; Querard J, 2015, ANGEW CHEM INT EDIT, V54, P2633, DOI 10.1002/anie.201408985; Rich RM, 2013, ANAL BIOANAL CHEM, V405, P2065, DOI 10.1007/s00216-012-6623-1; Richards CI, 2010, J PHYS CHEM B, V114, P660, DOI 10.1021/jp909167j; Richards CI, 2009, J AM CHEM SOC, V131, P4619, DOI 10.1021/ja809785s; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Sood C, 2017, J BIOL CHEM, V292, P20196, DOI 10.1074/jbc.M117.818088; Sood C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148944; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401; Suddala KC, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007532; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Yan YL, 2011, BIOCHEM J, V433, P411, DOI 10.1042/BJ20100992; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	51	4	4	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19111	19118		10.1074/jbc.RA119.010268	http://dx.doi.org/10.1074/jbc.RA119.010268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694918	Green Published, hybrid			2022-12-26	WOS:000516527800014
J	Fabi, S; Weber, LA; Leuthold, H				Fabi, Sarah; Weber, Lydia Anna; Leuthold, Hartmut			Empathic concern and personal distress depend on situational but not dispositional factors	PLOS ONE			English	Article							NEGATIVE AFFECT; PERSPECTIVE-TAKING; PAIN; EMOTIONALITY; BEHAVIOR	Empathic concern and personal distress are empathic responses that may result when observing someone in discomfort. Even though these empathic responses have received much attention in past research, it is still unclear which conditions contribute to their respective experience. Hence, the main goal of this study was to examine if dispositional empathic traits or rather situational variables are more likely to evoke empathic concern and personal distress and how the two empathic responses influence motor responses. We presented pictures of persons in psychological, physical, or no pain with matched descriptions of situations that promoted an other-focused state. Approach-avoidance movements were demanded by a subsequently presented tone. While psychological pain led to more empathic concern, physical pain led to higher ratings of personal distress. Linear mixed-effects modelling analysis further revealed that situational factors, such as the type of pain but also the affect experienced by the participants before the experiment predicted the two empathic responses, whereas dispositional empathic traits had no significant influence. In addition, the more intensely the empathic responses were experienced, the faster were movements initiated, presumably reflecting an effect of arousal. Overall, the present study advances our understanding of empathic responses to people in need and provides novel methodological tools to effectively manipulate and analyze empathic concern and personal distress in future research.	[Fabi, Sarah; Leuthold, Hartmut] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Weber, Lydia Anna] Univ Tubingen, Univ Klinikum Tubingen, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Fabi, S (corresponding author), Univ Tubingen, Dept Psychol, Tubingen, Germany.	sarah.fabi@uni-tuebingen.de			postgraduate fellowship of the state Baden-Wurttemberg; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tubingen	postgraduate fellowship of the state Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	Sarah Fabi was supported by a postgraduate fellowship of the state Baden-Wurttemberg. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baez S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179336; Banissy MJ, 2012, NEUROIMAGE, V62, P2034, DOI 10.1016/j.neuroimage.2012.05.081; Bates D., 2019, LME4 LINEAR MIXED EF; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; BATSON CD, 1983, J PERS SOC PSYCHOL, V45, P706, DOI 10.1037//0022-3514.45.3.706; BATSON CD, 1991, J PERS SOC PSYCHOL, V61, P413, DOI 10.1037/0022-3514.61.3.413; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; Batson CD, 1976, EFFECTS FALSE UNPUB; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Champely S., 2018, PACKAGE PWR; Cheetham Marcus, 2009, Front Hum Neurosci, V3, P29, DOI 10.3389/neuro.09.029.2009; Cohen J.E., 1988, STAT POWER ANAL BEHA; COKE JS, 1978, J PERS SOC PSYCHOL, V36, P752, DOI 10.1037/0022-3514.36.7.752; DAVIS MH, 1983, J PERS, V51, P167, DOI 10.1111/j.1467-6494.1983.tb00860.x; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Decety J, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P199; EISENBERG N, 1994, J PERS SOC PSYCHOL, V66, P776, DOI 10.1037/0022-3514.66.4.776; Eisenberg N, 1996, DEV PSYCHOL, V32, P195, DOI 10.1037/0012-1649.32.2.195; Eisenberg N., 1991, HDB MORAL BEHAV DEV, P63; Eklund J, 2009, SCAND J PSYCHOL, V50, P65, DOI 10.1111/j.1467-9450.2008.00673.x; Elsenberg N, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P71; Fabi S, 2018, NEUROPSYCHOLOGIA, V114, P143, DOI 10.1016/j.neuropsychologia.2018.04.024; Fabi S, 2017, SOC NEUROSCI-UK, V12, P701, DOI 10.1080/17470919.2016.1238009; FeldmanHall O, 2015, NEUROIMAGE, V105, P347, DOI 10.1016/j.neuroimage.2014.10.043; Hall JA, 2019, J SOC PSYCHOL, V159, P225, DOI 10.1080/00224545.2018.1477442; Hu KS, 2015, PSYCHOL RES-PSYCH FO, V79, P1054, DOI 10.1007/s00426-014-0634-9; Hu Y, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00024; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jordan MR, 2016, EMOTION, V16, P1107, DOI 10.1037/emo0000228; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kanske P, 2016, SOC COGN AFFECT NEUR, V11, P1383, DOI 10.1093/scan/nsw052; Kleiner M, 2007, PERCEPTION, V36, P14; Krieglmeyer R, 2013, EMOT REV, V5, P280, DOI 10.1177/1754073913477501; Krieglmeyer R, 2010, PSYCHOL SCI, V21, P607, DOI 10.1177/0956797610365131; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lang P.J, 1999, INT AFFECTIVE PICTUR, P2; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Light SN, 2015, BIOL PSYCHOL, V104, P116, DOI 10.1016/j.biopsycho.2014.11.015; Lopez-Perez B, 2014, SOC SCI J, V51, P676, DOI 10.1016/j.soscij.2014.08.001; Mella N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00501; Melloni M, 2014, COGN AFFECT BEHAV NE, V14, P407, DOI 10.3758/s13415-013-0205-3; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Morelli SA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00160; Morrison I, 2007, COGNITION, V104, P407, DOI 10.1016/j.cognition.2006.07.006; Myszkowski N, 2017, PSYCHIAT RES, V255, P292, DOI 10.1016/j.psychres.2017.05.047; Paulus C., 2009, SAARBRUCKER PERSONLI; Preston SD, 2012, EMOT REV, V4, P24, DOI 10.1177/1754073911421378; SANDERS AF, 1983, ACTA PSYCHOL, V53, P61, DOI 10.1016/0001-6918(83)90016-1; Sheng F, 2012, NEUROIMAGE, V61, P786, DOI 10.1016/j.neuroimage.2012.04.028; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wondra JD, 2015, PSYCHOL REV, V122, P411, DOI 10.1037/a0039252; WU MX, 2015, SCI REP-UK, V5, DOI DOI 10.1038/SREP10001; Zaki J, 2014, PSYCHOL BULL, V140, P1608, DOI 10.1037/a0037679; Zickfeld JH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00723	62	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225102	10.1371/journal.pone.0225102	http://dx.doi.org/10.1371/journal.pone.0225102			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2HK	31725812	gold, Green Published			2022-12-26	WOS:000532764500053
J	Kim, MS; Jeong, HY; Cho, KH; Oh, SW; Byun, SJ; Woo, SJ; Yang, HK; Hwang, JM; Park, KH; Kim, CK; Park, SJ				Kim, Min Seok; Jeong, Han Yeong; Cho, Kwan Hyuk; Oh, Seung Won; Byun, Seong Jun; Woo, Se Joon; Yang, Hee Kyung; Hwang, Jeong Min; Park, Kyu Hyung; Kim, Chi Kyung; Park, Sang Jun			Nonarteritic anterior ischemic optic neuropathy is associated with cerebral small vessel disease	PLOS ONE			English	Article							INCREASED RISK; BRAIN; PATHOGENESIS; MICROBLEEDS; STROKE	We investigated the presence of cerebral small vessel disease (SVD) in patients with nonarteritic anterior ischemic optic neuropathy (NAION) compared to control subjects without NAION to identify the association between NAION and cerebral SVD. We retrospectively reviewed the cases of 63 patients with NAION and 2749 control subjects without any neurologic and ocular diseases including NAION who underwent careful medical interviews, ophthalmic examinations, and magnetic resonance imaging (MRI) studies of the brain. We assessed and compared the degree of cerebral SVD on the MRIs. The patients with NAION presented with cerebral SVD more frequently than controls (68% versus 37%, respectively, p<0.001), which was also observed after adjusting for age, sex, comorbid conditions including hypertension, diabetes, and dyslipidemia, and smoking using the standardized mortality ratio (68% vs. 37%, p<0.001). A multivariate logistic regression analysis showed that the odds of cerebral SVD were 4.86 (95% CI, 2.10 to 11.24, p<0.001) times higher in patients with NAION than in the controls. We found that there was an association between cerebral SVD and NAION even after adjusting for age, sex, and medical histories. Clinicians should consider brain MRI scans in patients with NAION to prevent neurological impairment after cerebral SVD.	[Kim, Min Seok; Byun, Seong Jun; Woo, Se Joon; Yang, Hee Kyung; Hwang, Jeong Min; Park, Kyu Hyung; Park, Sang Jun] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea; [Jeong, Han Yeong] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Cho, Kwan Hyuk] Moons Eye Clin, Retina Ctr, Suwon, South Korea; [Oh, Seung Won] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Family Med, Seoul, South Korea; [Byun, Seong Jun] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Kim, Chi Kyung] Korea Univ, Guro Hosp, Dept Neurol, Seoul, South Korea; [Kim, Chi Kyung] Korea Univ, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Park, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Bundang Hosp, Seongnam, South Korea.; Kim, CK (corresponding author), Korea Univ, Guro Hosp, Dept Neurol, Seoul, South Korea.; Kim, CK (corresponding author), Korea Univ, Coll Med, Seoul, South Korea.	ckkim7@korea.ac.kr; sangjunpark@snu.ac.kr	Kim, Chi Kyung/AAR-9819-2020; Oh, Seung-Won/GLS-0494-2022		Busan Sungmo Eye Hospital; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2019M3E5D1A01068991]	Busan Sungmo Eye Hospital; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This study was supported by the Busan Sungmo Eye Hospital 2016 Sodam scholarship committee, and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2019M3E5D1A01068991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyropoulou MI, 2007, EUR RADIOL, V17, P1669, DOI 10.1007/s00330-006-0506-9; Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; ARNOLD AC, 1995, J NEURO-OPHTHALMOL, V15, P158; ARNOLD AC, 1994, AM J OPHTHALMOL, V117, P222, DOI 10.1016/S0002-9394(14)73080-6; Braun H, 2013, LANCET NEUROL, V12, P735, DOI 10.1016/S1474-4422(13)70148-0; Chen PH, 2012, CNS NEUROSCI THER, V18, P452, DOI 10.1111/j.1755-5949.2011.00292.x; Cho KH, 2017, INVEST OPHTH VIS SCI, V58, pBIO82, DOI 10.1167/iovs.17-21413; Cho KH, 2016, INVEST OPHTH VIS SCI, V57, P5818, DOI 10.1167/iovs.16-20106; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Fanning JP, 2014, STROKE, V45, P3461, DOI 10.1161/STROKEAHA.114.005919; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Hasanreisoglu M, 2013, NEUROEPIDEMIOLOGY, V40, P220, DOI 10.1159/000342155; Hayreh SS, 2017, AM J OPHTHALMOL, V175, P213, DOI 10.1016/j.ajo.2016.12.010; HAYREH SS, 1994, AM J OPHTHALMOL, V118, P766, DOI 10.1016/S0002-9394(14)72557-7; Kaup M, 2006, BRIT J OPHTHALMOL, V90, P1350, DOI 10.1136/bjo.2006.093559; Kerr NM, 2009, J CLIN NEUROSCI, V16, P994, DOI 10.1016/j.jocn.2009.04.002; Kim CK, 2011, CLIN NEUROL NEUROSUR, V113, P177, DOI 10.1016/j.clineuro.2010.10.013; Lee YC, 2016, AM J OPHTHALMOL, V170, P183, DOI 10.1016/j.ajo.2016.08.006; Miller NR, 2015, EYE, V29, P65, DOI 10.1038/eye.2014.144; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Sacco S, 2006, NEUROLOGY, V66, P1335, DOI 10.1212/01.wnl.0000210457.89798.0e; Shi YL, 2016, STROKE VASC NEUROL, V1, P83, DOI 10.1136/svn-2016-000035; van Norden AGW, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-29; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7	25	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225322	10.1371/journal.pone.0225322	http://dx.doi.org/10.1371/journal.pone.0225322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725805	gold, Green Published			2022-12-26	WOS:000532764500076
J	Anderson, ME; Mavica, J; Shackleford, L; Flis, I; Fochler, S; Basu, S; Alphey, L				Anderson, Michelle E.; Mavica, Jessica; Shackleford, Lewis; Flis, Ilona; Fochler, Sophia; Basu, Sanjay; Alphey, Luke			CRISPR/Cas9 gene editing in the West Nile Virus vector, Culex quinquefasciatus Say	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; TRANSFORMATION; DIPTERA; AEDES; DROSOPHILA; DISEASE	Culex quinquefasciatus Say is an opportunistic blood feeder with a wide geographic distribution which is also a major vector for a range of diseases of both animals and humans. CRISPR/Cas technologies have been applied to a wide variety of organisms for both applied and basic research purposes. CRISPR/Cas methods open new possibilities for genetic research in non-model organisms of public health importance. In this work we have adapted microinjection techniques commonly used in other mosquito species to Culex quinquefasciatus, and have shown these to be effective at generating homozygous knock-out mutations of a target gene in one generation. This is the first description of the kmo gene and mutant phenotype in this species.	[Anderson, Michelle E.; Mavica, Jessica; Shackleford, Lewis; Flis, Ilona; Fochler, Sophia; Basu, Sanjay; Alphey, Luke] Pirbright Inst, Arthropod Genet, Woking, Surrey, England; [Flis, Ilona] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Fochler, Sophia] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Glasgow; University of Oxford	Alphey, L (corresponding author), Pirbright Inst, Arthropod Genet, Woking, Surrey, England.	luke.alphey@pirbright.ac.uk	; Flis, Ilona/K-2577-2013	Anderson, Michelle/0000-0003-1510-2942; Basu, Sanjay/0000-0003-2098-7423; Flis, Ilona/0000-0003-4869-557X; Alphey, Luke/0000-0002-2916-3802	DARPA's Safe Genes program [N66001-17-2-4054]; Wellcome Trust [200171/Z/15/Z]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/I/00007033, BBS/E/I/00007038, BBS/E/I/00007039]; BBSRC [BBS/E/I/00007038, BBS/E/I/00007039, BBS/E/I/00007033] Funding Source: UKRI	DARPA's Safe Genes program; Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MEA, JM, LS, SF and LA were supported through an award from DARPA's Safe Genes program to MIT N66001-17-2-4054 (https://www.darpa.mil/program/safe-genes).The views, opinions and/or findings expressed are those of the author and should not be interpreted as representing the official views or policies of the U.S. Government. SB was supported by Wellcome Trust Collaborative Award 200171/Z/15/Z (https://wellcome.ac.uk/funding/schemes/collaborativ-eawards-science) to LA. This project was supported through strategic funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC) to The Pirbright Institute BBS/E/I/00007033, BBS/E/I/00007038 and BBS/E/I/00007039 (https://bbsrc.ukri.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822; Allen ML, 2004, PARASITOL INT, V53, P307, DOI 10.1016/j.parint.2004.04.002; Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701; Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Delannay C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199615; Eckermann KN, 2018, INSECT BIOCHEM MOLEC, V98, P16, DOI 10.1016/j.ibmb.2018.04.001; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Farasat I, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004724; Fotakis EA, 2017, ACTA TROP, V174, P29, DOI 10.1016/j.actatropica.2017.06.005; Fuchs Silke, 2013, Methods Mol Biol, V923, P601; Gregory M, 2016, INSECT MOL BIOL, V25, P259, DOI 10.1111/imb.12220; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Han Q, 2003, INSECT MOL BIOL, V12, P483, DOI 10.1046/j.1365-2583.2003.00433.x; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Itokawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24652; Jones CM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-78; Li M, METHODS GENERATION H; Li M, 2017, JOVE-J VIS EXP, DOI 10.3791/56990; Liu MJ, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00691; Lura T, 2012, J MED ENTOMOL, V49, P687, DOI 10.1603/ME11177; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Oberhofer G, 2019, P NATL ACAD SCI USA, V116, P6250, DOI 10.1073/pnas.1816928116; Sharma A, 2017, SCIENCE, V356, P642, DOI 10.1126/science.aam5498; Shen MW, 2018, NATURE, V563, P646, DOI 10.1038/s41586-018-0686-x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Yamamoto DS, 2018, TRANSGENIC RES, V27, P51, DOI 10.1007/s11248-018-0057-2	30	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224857	10.1371/journal.pone.0224857	http://dx.doi.org/10.1371/journal.pone.0224857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714905	gold, Green Published			2022-12-26	WOS:000532710400017
J	Ryu, J; Vincent, PFY; Ziogas, NK; Xu, LY; Sadeghpour, S; Curtin, J; Alexandris, AS; Stewart, N; Sima, R; du Lac, S; Glowatzki, E; Koliatsos, VE				Ryu, Jiwon; Vincent, Philippe F. Y.; Ziogas, Nikolaos K.; Xu, Leyan; Sadeghpour, Shirin; Curtin, John; Alexandris, Athanasios S.; Stewart, Nicholas; Sima, Richard; du Lac, Sascha; Glowatzki, Elisabeth; Koliatsos, Vassilis E.			Optogenetically transduced human ES cell-derived neural progenitors and their neuronal progenies: Phenotypic characterization and responses to optical stimulation	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SPINAL-CORD; GABAERGIC INTERNEURONS; FUNCTIONAL MATURATION; VOLITIONAL CONTROL; MOTOR-NEURONS; DISEASE; GRAFTS; DIFFERENTIATE; RATS	Optogenetically engineered human neural progenitors (hNPs) are viewed as promising tools in regenerative neuroscience because they allow the testing of the ability of hNPs to integrate within nervous system of an appropriate host not only structurally, but also functionally based on the responses of their differentiated progenies to light. Here, we transduced H9 embryonic stem cell-derived hNPs with a lentivirus harboring human channel rhodopsin (hChR2) and differentiated them into a forebrain lineage. We extensively characterized the fate and optogenetic functionality of hChR2-hNPs in vitro with electrophysiology and immunocytochemistry. We also explored whether the in vivo phenotype of ChR2-hNPs conforms to in vitro observations by grafting them into the frontal neocortex of rodents and analyzing their survival and neuronal differentiation. Human ChR2-hNPs acquired neuronal phenotypes (TUJ1, MAP2, SMI-312, and synapsin 1 immunoreactivity) in vitro after an average of 70 days of coculturing with CD1 astrocytes and progressively displayed both inhibitory and excitatory neurotransmitter signatures by immunocytochemistry and whole-cell patch clamp recording. Three months after transplantation into motor cortex of naive or injured mice, 60-70% of hChR2-hNPs at the transplantation site expressed TUJ1 and had neuronal cytologies, whereas 60% of cells also expressed ChR2. Transplant-derived neurons extended axons through major commissural and descending tracts and issued synaptophysin(+) terminals in the claustrum, endopiriform area, and corresponding insular and piriform cortices. There was no apparent difference in engraftment, differentiation, or connectivity patterns between injured and sham subjects. Same trends were observed in a second rodent host, i.e. rat, where we employed longer survival times and found that the majority of grafted hChR2-hNPs differentiated into GABAergic neurons that established dense terminal fields and innervated mostly dendritic profiles in host cortical neurons. In physiological experiments, human ChR2(+) neurons in culture generated spontaneous action potentials (APs) 100-170 days into differentiation and their firing activity was consistently driven by optical stimulation. Stimulation generated glutamatergic and GABAergic postsynaptic activity in neighboring ChR2(-) cells, evidence that hChR2-hNP-derived neurons had established functional synaptic connections with other neurons in culture. Light stimulation of hChR2-hNP transplants in vivo generated complicated results, in part because of the variable response of the transplants themselves. Our findings show that we can successfully derive hNPs with optogenetic properties that are fully transferrable to their differentiated neuronal progenies. We also show that these progenies have substantial neurotransmitter plasticity in vitro, whereas in vivo they mostly differentiate into inhibitory GABAergic neurons. Furthermore, neurons derived from hNPs have the capacity of establishing functional synapses with postsynaptic neurons in vitro, but this outcome is technically challenging to explore in vivo. We propose that optogenetically endowed hNPs hold great promise as tools to explore de novo circuit formation in the brain and, in the future, perhaps launch a new generation of neuromodulatory therapies.	[Ryu, Jiwon; Ziogas, Nikolaos K.; Xu, Leyan; Sadeghpour, Shirin; Curtin, John; Alexandris, Athanasios S.; Stewart, Nicholas; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Vincent, Philippe F. Y.; Sima, Richard; du Lac, Sascha; Glowatzki, Elisabeth] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Koliatsos, VE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.; Koliatsos, VE (corresponding author), Johns Hopkins Univ, Sch Med, Div Neuropathol, Baltimore, MD 21205 USA.; Koliatsos, VE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.	koliat@jhmi.edu	Vincent, Philippe/AAE-8642-2019	Vincent, Philippe/0000-0001-7712-7198; Ryu, Jiwon/0000-0003-0251-7858; Sima, Richard/0000-0001-7902-2728; Glowatzki, Elisabeth/0000-0003-3135-658X; Alexandris, Athanasios/0000-0002-5324-8355	MSCRF [TEDCO 2015-MSCRFI-1718 (RFA-MD-15-1)]; EMBO [ALTF240-2016]; Hearing Health Foundation; NIDCD [R01DC006476, R01DC012957]; Cordelia Corporation; John Mitchell, Jr. Trust; David M. Rubenstein Fund for Hearing Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012957] Funding Source: NIH RePORTER	MSCRF; EMBO(European Molecular Biology Organization (EMBO)); Hearing Health Foundation; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Cordelia Corporation; John Mitchell, Jr. Trust; David M. Rubenstein Fund for Hearing Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The project was supported by MSCRF TEDCO 2015-MSCRFI-1718 (RFA-MD-15-1) to VEK, EMBO ALTF240-2016 and Hearing Health Foundation grant to PFYV and grants (NIDCD R01DC006476 and R01DC012957, the Cordelia Corporation, the John Mitchell, Jr. Trust, the David M. Rubenstein Fund for Hearing Research) to EG.	Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Avaliani N, 2014, STEM CELLS, V32, P3088, DOI 10.1002/stem.1823; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Byers B, 2015, NEUROIMAGE, V114, P328, DOI 10.1016/j.neuroimage.2015.03.079; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Colasante G, 2015, CELL STEM CELL, V17, P719, DOI 10.1016/j.stem.2015.09.002; Colombres M, 2008, J CELL PHYSIOL, V216, P805, DOI 10.1002/jcp.21465; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Cunningham M, 2014, CELL STEM CELL, V15, P559, DOI 10.1016/j.stem.2014.10.006; Daadi MM, 2016, CELL TRANSPLANT, V25, P1371, DOI 10.3727/096368915X688533; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fandel TM, 2016, CELL STEM CELL, V19, P544, DOI 10.1016/j.stem.2016.08.020; Faravelli I, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt476; FRYSINGER RC, 1986, EXP NEUROL, V94, P247, DOI 10.1016/0014-4886(86)90100-7; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Han SSW, 2002, EXP NEUROL, V177, P360, DOI 10.1006/exnr.2002.7995; Herrero JL, 2018, J NEUROPHYSIOL, V119, P145, DOI 10.1152/jn.00551.2017; Jensen MB, 2013, J STROKE CEREBROVASC, V22, P304, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.008; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Koliatsos VE, 2015, REGEN MED, V10, P917, DOI 10.2217/rme.15.62; KOLIATSOS VE, 1994, J COMP NEUROL, V345, P510, DOI 10.1002/cne.903450404; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Ladewig J, 2008, STEM CELLS, V26, P1705, DOI 10.1634/stemcells.2008-0007; Mahairaki V, 2014, STEM CELLS DEV, V23, P2996, DOI 10.1089/scd.2013.0511; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Nasonkin I, 2009, STEM CELLS, V27, P2414, DOI 10.1002/stem.177; Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005; Niclis JC, 2017, STEM CELL TRANSL MED, V6, P1547, DOI 10.1002/sctm.16-0198; Pattinson KTS, 2009, J NEUROSCI, V29, P8177, DOI 10.1523/JNEUROSCI.1375-09.2009; Pina-Crespo JC, 2012, J NEUROSCI, V32, P15837, DOI 10.1523/JNEUROSCI.3735-12.2012; Prakash N, 1996, NATURE, V381, P702, DOI 10.1038/381702a0; Rosen AD, 2001, BBA-BIOMEMBRANES, V1511, P391, DOI 10.1016/S0005-2736(01)00301-7; Schildge S, 2013, JVISEXP; Snyder EY, GRAFTING IMMORTALIZE, P742, DOI [10.1016/0959-4388(94)90018-3, DOI 10.1016/0959-4388(94)90018-3]; Song J, 2007, NEUROSCI LETT, V423, P58, DOI 10.1016/j.neulet.2007.05.066; Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124; Stroh A, 2011, STEM CELLS, V29, P78, DOI 10.1002/stem.558; Tornero D, 2017, BRAIN, V140, P692, DOI 10.1093/brain/aww347; Vedyasova OA, 2005, B EXP BIOL MED+, V140, P265, DOI 10.1007/s10517-005-0462-4; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; Wyatt TJ, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/207230; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Xu L, 2015, CHIN CONTR CONF, P2093, DOI 10.1109/ChiCC.2015.7259957; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yang F, 2014, ELIFE, V3, DOI 10.7554/eLife.03255; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	59	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224846	10.1371/journal.pone.0224846	http://dx.doi.org/10.1371/journal.pone.0224846			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710637	Green Published, gold			2022-12-26	WOS:000532699900023
J	Bai, B; Meng, J; Mao, FY; Zhang, ZQ; Wang, YQ				Bai, Bin; Meng, Jin; Mao, Fang-Yuan; Zhang, Zhao-Qun; Wang, Yuan Qing			A new early Eocene deperetellid tapiroid illuminates the origin of Deperetellidae and the pattern of premolar molarization in Perissodactyla	PLOS ONE			English	Article							TOOTH ENAMEL; MAMMALIA; MIDDLE; CLASSIFICATION; PHYLOGENY	Deperetellidae is a clade of peculiar, Asian endemic tapiroids from the early and middle Eocene. The previously published material mainly comprises maxillae, mandibles, and some postcranial elements. However, the absence of cranial materials and primitive representatives of the deperetellids obscures their phylogenetic relationships within Tapiroidea. Furthermore, derived deperetellids have completely molarized premolars, but the pattern of their evolution remains unclear. Here, we report a nearly complete skull and some carpals of a new basal deperetellid tapiroid, Irenolophus qii gen. et sp. nov., from the late early Eocene of the Erlian Basin, Inner Mongolia, China. We suggest that deperetellids (along with Tapiridae) probably also arose from some basal `helaletids', based on the reduced, flat, lingually depressed metacones on the upper molars, the trend towards the bilophodonty on the lower molars, and a shallow narial notch with the premaxilla in contact with the nasal. The molarization of the premolars in Deperetellidae from Irenolophus through Teleolophus to Deperetella was initiated and gradually enhanced by the separation between the paraconule and the protocone. That pattern differs from the protocone-hypocone separation in helaletids, tapirids, and most rhinoceroses, and the metaconule-derived pseudohypocone in amynodontids. However, the specific relationship of deperetellids within Tapiroidea and the roles of different patterns of premolar molarization in perissodactyl evolution need further and comprehensive study.	[Bai, Bin; Meng, Jin; Mao, Fang-Yuan; Zhang, Zhao-Qun; Wang, Yuan Qing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Bai, Bin; Mao, Fang-Yuan; Zhang, Zhao-Qun; Wang, Yuan Qing] CAS Ctr Excellence Life & Paleoenviroment, Beijing, Peoples R China; [Bai, Bin] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Peoples R China; [Meng, Jin; Mao, Fang-Yuan] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Meng, Jin] CUNY, Grad Ctr, Earth & Environm Sci, New York, NY 10016 USA; [Zhang, Zhao-Qun; Wang, Yuan Qing] Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; American Museum of Natural History (AMNH); City University of New York (CUNY) System; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, B; Meng, J; Wang, YQ (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.; Bai, B; Wang, YQ (corresponding author), CAS Ctr Excellence Life & Paleoenviroment, Beijing, Peoples R China.; Bai, B (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Peoples R China.; Meng, J (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.; Meng, J (corresponding author), CUNY, Grad Ctr, Earth & Environm Sci, New York, NY 10016 USA.; Wang, YQ (corresponding author), Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing, Peoples R China.	baibin@ivpp.ac.cn; jmeng@amnh.org; wangyuanqing@ivpp.ac.cn	Bai, Bin/D-6898-2013	Bai, Bin/0000-0003-4394-8689	Strategic Priority Research Program of Chinese Academy of Sciences [XDB26000000]; National Natural Science Foundation of China [41672014, 41572021, 41472003]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [163103]; Youth Innovation Promotion Association, CAS [2017101]; Special Fund for Fossil Excavation and Preparation, CAS; Division of Paleontology, American Museum of Natural History	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences); Youth Innovation Promotion Association, CAS; Special Fund for Fossil Excavation and Preparation, CAS; Division of Paleontology, American Museum of Natural History	This work was funded by the Strategic Priority Research Program of Chinese Academy of Sciences (XDB26000000 to ZQZ), the National Natural Science Foundation of China (41672014 to BB, 41572021 to YQW, 41472003 to ZQZ), State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (163103 to BB), Youth Innovation Promotion Association, CAS (2017101 to BB), the Special Fund for Fossil Excavation and Preparation, CAS, and Frick Funds from the Division of Paleontology, American Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averianov AO, 2005, GEODIVERSITAS, V27, P221; Bai B., 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0110806; Bai Bin, 2018, VERTEBRATA PALASIATICA, V56, P193, DOI 10.19615/j.cnki.1000-3118.171214; Bai B, 2017, AM MUS NOVIT, P1; BOYDE A, 1986, ZOOL J LINN SOC-LOND, V87, P181, DOI 10.1111/j.1096-3642.1986.tb01336.x; BUTLER PM, 1952, P ZOOL SOC LOND, V121, P819; Colbert Matthew W., 2005, Palaeontologia Electronica, V8, P1; Dashzeveg D, 1997, ZOOL J LINN SOC-LOND, V120, P105; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; Gheerbrant E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157556; Granger W, 1908, B AM MUS NAT HIST, V24, P221; Gromova V, 1962, OSNOVY PALEONTOLOGII, P1; Harjunmaa E, 2014, NATURE, V512, P44, DOI 10.1038/nature13613; Holbrook LT, 1999, CLADISTICS, V15, P331, DOI 10.1111/j.1096-0031.1999.tb00270.x; Holbrook L, 2015, J MAMM EVOL, V22, P259, DOI 10.1007/s10914-014-9276-3; HOOKER JJ, 1989, EVOLUTION PERISSODAC, P00079; HUNTER JP, 1995, P NATL ACAD SCI USA, V92, P10718, DOI 10.1073/pnas.92.23.10718; Jernvall J, 2000, YEARB PHYS ANTHROPOL, V43, P171; Ladeveze S, 2010, J VERTEBR PALEONTOL, V30, P1559, DOI 10.1080/02724634.2010.501440; Mao Fang-Yuan, 2017, VERTEBRATA PALASIATICA, V55, P347, DOI 10.19615/j.cnki.1000-3118.170923; Matthew WD, 1925, AM MUSEUM NOVITATES, V199, P1; Matthews W. D., 1925, American Museum Novitates, V196, P1; Meng J, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)526[1:NSDFTE]2.0.CO;2; Osborn H. F., 1923, American Museum Novitates, V91, P1; Prothero D. R., 2005, EVOLUTION N AM RHINO; QI T, 1987, Annals of Carnegie Museum, V56, P1; Qiu Z-X., 2007, PALAEONT SIN C, V29, P1; Radinsky L., 1963, Bulletin of the Peabody Museum, VNo. 17, P1; Radinsky LB., 1967, AM MUS NOVIT, V2316, P1; RADINSKY LEONARD B., 1965, BULL MUS COMP ZOOL HARVARD UNIV, V134, P69; RADINSKY LEONARD B., 1965, BULL AMER MUS NAT HIST, V129, P181; RENSBERGER JM, 1980, PALEOBIOLOGY, V6, P477, DOI 10.1017/S009483730000364X; Rensberger John M., 2004, Bulletin of Carnegie Museum of Natural History, V36, P199, DOI 10.2992/0145-9058(2004)36[199:EFTEMF]2.0.CO;2; Reshetov VY, 1977, J PALAEONTOL SOC IND, V20, P41; Schlaikjer E, 1937, B MUS COMP ZOOL HARV, V80, P229; Scott W. B., 1941, T AM PHILOS SOC, V28, P747, DOI [10.2307/, DOI 10.2307/]; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Smith Thierry, 2015, PALAEOVERTEBRATA, V39, pe5, DOI 10.18563/pv.39.2.e5; [孙勃 SUN Bo], 2009, [地层学杂志, Journal of Stratigraphy], V33, P62; TONG YS, 1984, VERTEBRAT PALASIATIC, V22, P269; Tsubamoto T, 2005, ACTA PALAEONTOL POL, V50, P117; Tsubamoto T, 2012, J FOSSIL RES, V44, P78; von Koenigswald W, 2011, ACTA PALAEONTOL POL, V56, P11, DOI 10.4202/app.2010.0021; [王元青 Wang Yuanqing], 2012, [古脊椎动物学报, Vertebrata Palasiatica], V50, P181; Wilson JA, 1981, PEARCE SELLARDS SERI, V33, P1; Wood HE, 1933, B AM MUS NAT HIST, V67, P181; Wood HE, 1945, T AM PHILOS SOC, V34, P249; You Yuzhu, 1977, Vertebrata Palasiatica, V15, P46; Zdansky O., 1930, PALAEONTOL SINICA, V6, P5	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225045	10.1371/journal.pone.0225045	http://dx.doi.org/10.1371/journal.pone.0225045			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703104	Green Published, gold			2022-12-26	WOS:000532697200040
J	Brockway, HM; Kallapur, SG; Buhimschi, IA; Buhimschi, CS; Ackerman, WE; Muglia, LJ; Jones, HN				Brockway, Heather M.; Kallapur, Suhas G.; Buhimschi, Irina A.; Buhimschi, Catalin S.; Ackerman, William E.; Muglia, Louis J.; Jones, Helen N.			Unique transcriptomic landscapes identified in idiopathic spontaneous and infection related preterm births compared to normal term births	PLOS ONE			English	Article							COMPLEMENT-SYSTEM; PREGNANCY; ACTIVATION; TROPHOBLAST; TELOMERES; PLACENTA; PROTEIN; GENES; DNA	Preterm birth (PTB) is leading contributor to infant death in the United States and globally, yet the underlying mechanistic causes are not well understood. Histopathological studies of preterm birth suggest advanced villous maturity may have a role in idiopathic spontaneous preterm birth (isPTB). To better understand pathological and molecular basis of isPTB, we compared placental villous transcriptomes from carefully phenotyped cohorts of PTB due to infection or isPTB between 28-36 weeks gestation and healthy term placentas. Transcriptomic analyses revealed a unique expression signature for isPTB distinct from the agematched controls that were delivered prematurely due to infection. This signature included the upregulation of three IGF binding proteins (IGFBP1, IGFBP2, and IGFBP6), supporting a role for aberrant IGF signaling in isPTB. However, within the isPTB expression signature, we detected secondary signature of inflammatory markers including TNC, C3, CFH, and C1R, which have been associated with placental maturity. In contrast, the expression signature of the gestational age-matched infected samples included upregulation of proliferative genes along with cell cycling and mitosis pathways. Together, these data suggest an isPTB molecular signature of placental hypermaturity, likely contributing to the premature activation of inflammatory pathways associated with birth and providing a molecular basis for idiopathic spontaneous birth.	[Brockway, Heather M.; Muglia, Louis J.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Ctr Preterm Birth, Cincinnati, OH 45221 USA; [Brockway, Heather M.; Muglia, Louis J.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Kallapur, Suhas G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol, Los Angeles, CA 90095 USA; [Kallapur, Suhas G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dev Biol, Los Angeles, CA 90095 USA; [Buhimschi, Irina A.; Buhimschi, Catalin S.; Ackerman, William E.] Univ Illinois, Coll Med, Dept Obstet & Gynecol, Chicago, IL 60612 USA; [Jones, Helen N.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Ctr Fetal & Placental Res, Cincinnati, OH USA; [Jones, Helen N.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Brockway, HM (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Ctr Preterm Birth, Cincinnati, OH 45221 USA.; Brockway, HM (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	BrockwayHM@gmail.com	Buhimschi, Irina/AAY-6619-2021; Ackerman, William Edward/GRS-5804-2022	Ackerman, William Edward/0000-0001-7366-3903	March of Dimes Prematurity Research Center Ohio Collaborative Funding [07/136/18]; Bill and Melinda Gates Foundation [OPP1113966, 11/14-10/17]; Eunice Kennedy Shriver National Institute of Child and Health & Human Development of the National Institutes of Health [R01HD091527]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD098389, R01HD091527, R21HD090856] Funding Source: NIH RePORTER	March of Dimes Prematurity Research Center Ohio Collaborative Funding(March of Dimes); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Eunice Kennedy Shriver National Institute of Child and Health & Human Development of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants to LJM from the March of Dimes Prematurity Research Center Ohio Collaborative Funding 07/136/18, The Bill and Melinda Gates Foundation: Systems Biology Approaches to Birth Timing and Prematurity OPP1113966 Funding 11/14-10/17, and the Eunice Kennedy Shriver National Institute of Child and Health & Human Development of the National Institutes of Health Award Number R01HD091527. While the funders provided salary support for the above authors, they had no further role in the study design, data collection and analyses, decision to publish or preparation of this manuscript.	Ackerman WE, 2016, PLACENTA, V44, P23, DOI 10.1016/j.placenta.2016.05.010; Adrews S., 2010, FASTQC QUALITY CONTR; Allsopp R, 2007, PLACENTA, V28, P324, DOI 10.1016/j.placenta.2006.04.003; [Anonymous], 2017, Obstet Gynecol, V129, P967, DOI 10.1097/AOG.0000000000002042; AOG, 2013, OBSTET ANESTHESIA DI, V33, P193, DOI [10.1097/01.aoa.0000436305.40425.86, DOI 10.1097/01.AOA.0000436305.40425.86]; Bach LA, 2018, J MOL ENDOCRINOL, V61, pT11, DOI 10.1530/JME-17-0254; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Buhimschi IA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002049; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066; Chua CY, 2016, ONCOGENE, V35, P738, DOI 10.1038/onc.2015.131; Derzsy Z, 2010, MOL IMMUNOL, V47, P1500, DOI 10.1016/j.molimm.2010.01.021; Diaz P, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121798; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Forbes K, 2010, J ENDOCRINOL, V207, P1, DOI 10.1677/JOE-10-0174; Fowden AL, 2011, PROG BIOPHYS MOL BIO, V106, P281, DOI 10.1016/j.pbiomolbio.2010.11.005; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Gardosi J, 2018, AM J OBSTET GYNECOL, V218, pS609, DOI 10.1016/j.ajog.2017.12.011; Girardi G, 2006, MOL IMMUNOL, V43, P68, DOI 10.1016/j.molimm.2005.06.017; Hart SN, 2013, J COMPUT BIOL, V20, P970, DOI 10.1089/cmb.2012.0283; Ilekis JV, 2016, AM J OBSTET GYNECOL, V215, pS1, DOI 10.1016/j.ajog.2016.03.001; Iosef C, 2010, CELL SIGNAL, V22, P1033, DOI 10.1016/j.cellsig.2010.02.006; Jansson N, 2013, J CLIN ENDOCR METAB, V98, P105, DOI 10.1210/jc.2012-2667; Jones HN, 2015, PLACENTA, V36, P1078, DOI 10.1016/j.placenta.2015.08.003; Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC; Kruger F., 2012, TRIMGALORE TOOL AUTO; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li YC, 2014, INT J DEV BIOL, V58, P239, DOI 10.1387/ijdb.130341mp; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lynch AM, 2011, OBSTET GYNECOL, V117, P75, DOI 10.1097/AOG.0b013e3181fc3afa; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Midwood KS, 2016, J CELL SCI, V129, P4321, DOI 10.1242/jcs.190546; Monangi NK, 2015, SEMIN PERINATOL, V39, P574, DOI 10.1053/j.semperi.2015.09.005; Morgan TK, 2016, AM J PERINAT, V33, P258, DOI 10.1055/s-0035-1570379; Morgan TK, 2013, J MATERN-FETAL NEO M, V26, P647, DOI 10.3109/14767058.2012.746297; Muller C, 2005, DOUBLE LIFE KU PROTE, DOI [10.4161/cc.4.3.1565, DOI 10.4161/CC.4.3.1565]; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nijman TAJ, 2016, PLACENTA, V48, P56, DOI 10.1016/j.placenta.2016.10.006; Pei Y, 2017, HYPERMETHYLATION CHR; Phillippe M, 2015, REPROD SCI, V22, P1186, DOI 10.1177/1933719115592714; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; Rathore S, 2011, COMP STUDY TRACE ELE; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Skarzynska E, 2018, J TRACE ELEM MED BIO, V46, P83, DOI 10.1016/j.jtemb.2017.11.015; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Stampone E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041055; Yu LJ, 2015, PLACENTA, V36, P581, DOI 10.1016/j.placenta.2015.02.013; Zhang JW, 2016, AGEING RES REV, V25, P55, DOI 10.1016/j.arr.2015.11.006	51	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225062	10.1371/journal.pone.0225062	http://dx.doi.org/10.1371/journal.pone.0225062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703110	gold, Green Published			2022-12-26	WOS:000532697200041
J	Lares, MR				Lares, Monica R.			Synthesis, purification and crystallization of a putative critical bulge of HAR1 RNA	PLOS ONE			English	Article								Non-coding RNAs have raised a lot of interest because of their capabilities to perform enzymatic reactions and regulate gene expression in various ways. Human Accelerated Region 1 (HAR1) has been identified during the search for highly conserved regions in mammalian genomes, over one hundred base pairs long, and with high rates of substitution in the human genome. Its potential for coding for a protein is very minimal. However, the HAR1 transcript has been computationally predicted to have a stable secondary structure. Previous structure-probing experiments have suggested that the majority of differences between human and chimp constructs are in helices, designated C and D. For this reason, a 47nt construct consisting of the C and D helices along with two additional C-G pairs was synthesized, purified, and crystallized, and its x-ray structure is reported in this study. The final structure is an artificial dimer, with a bulge that forms different conformations on each monomer. This bulge has been observed in predicted secondary structures, footprinting assays, enzymatic degradation assays, NMR studies, in silico studies, and in this crystalized dimer structure. It is proposed that the HAR1 transcript is a non-coding RNA that interacts with an unknown binding partner responsible for brain development through this inherent structural motif of bulged adenosines.	[Lares, Monica R.] Sonoma State Univ, Chem Dept, Rohnert Pk, CA 94928 USA	California State University System; Sonoma State University	Lares, MR (corresponding author), Sonoma State Univ, Chem Dept, Rohnert Pk, CA 94928 USA.	lares@sonoma.edu						Beniaminov A, 2008, RNA, V14, P1270, DOI 10.1261/rna.1054608; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Costa MBW, 2018, J THEOR BIOL, V438, P143, DOI 10.1016/j.jtbi.2017.11.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ennifar E, 1999, STRUCTURE, V7, P1439, DOI 10.1016/S0969-2126(00)80033-7; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PEATTIE DA, 1981, P NATL ACAD SCI-BIOL, V78, P7331, DOI 10.1073/pnas.78.12.7331; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Rakic P, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P30; Robertson MP, 2008, ACTA CRYSTALLOGR D, V64, P738, DOI 10.1107/S0907444908011578; WU HN, 1987, BIOCHEMISTRY-US, V26, P8221, DOI 10.1021/bi00399a030; Ziegeler M, 2012, CHEMBIOCHEM, V13, P2100, DOI 10.1002/cbic.201200401	16	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225029	10.1371/journal.pone.0225029	http://dx.doi.org/10.1371/journal.pone.0225029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703109	Green Published, gold, Green Submitted			2022-12-26	WOS:000532697200038
J	Parra-Tabla, V; Angulo-Perez, D; Albor, C; Campos-Navarrete, MJ; Tun-Garrido, J; Sosenski, P; Alonso, C; Ashman, TL; Arceo-Gomez, G				Parra-Tabla, Victor; Angulo-Perez, Diego; Albor, Cristopher; Jose Campos-Navarrete, Maria; Tun-Garrido, Juan; Sosenski, Paula; Alonso, Conchita; Ashman, Tia-Lynn; Arceo-Gomez, Gerardo			The role of alien species on plant-floral visitor network structure in invaded communities	PLOS ONE			English	Article							POLLINATION NETWORKS; INVASIVE PLANTS; MUTUALISTIC NETWORKS; REPRODUCTIVE SUCCESS; IMPACTS; TRAITS; BIODIVERSITY; INTEGRATION; ARCHITECTURE; METAANALYSIS	The interactions between pairs of native and alien plants via shared use of pollinators have been widely studied. Community level studies however, are necessary in order to fully understand the factors and mechanisms that facilitate successful plant invasion, but these are still scarce. Specifically, few community level studies have considered how differences in invasion level (alien flower abundance), and degree of floral trait similarity between native and invasive species, mediate effects on native plant-pollinator communities. Here, we evaluated the role of alien species on overall plant-floral visitor network structure, and on species-level network parameters, across nine invaded coastal communities distributed along 205 km in Yucatan, Mexico that vary in alien species richness and flower abundance. We further assessed the potential the role of alien plant species on plant-floral visitor network structure and robustness via computational simulation of native and invasive plant extinction scenarios. We did not find significant differences between native and alien species in their functional floral phenotypes or in their visitation rate and pollinator community composition in these invaded sites. Variation in the proportion of alien plant species and flower abundance across sites did not influence plant-pollinator network structure. Species-level network parameters (i.e., normalized degree and nestedness contribution) did not differ between native and alien species. Furthermore, our simulation analyses revealed that alien species are functionally equivalent to native species and contribute equally to network structure and robustness. Overall, our results suggest that high levels of floral trait similarity and pollinator use overlap may help facilitate the integration of alien species into native plant-pollinator networks. As a result, alien species may also play a similar role than that of natives in the structure and stability of native plant and pollinator communities in the studied coastal sand dune ecosystem.	[Parra-Tabla, Victor; Angulo-Perez, Diego; Albor, Cristopher; Sosenski, Paula] Univ Autonoma Yucatan, Dept Ecol Trop, Campus Ciencias Biol & Agr, Merida, Yucatan, Mexico; [Jose Campos-Navarrete, Maria] Tecnol Nacl Mexico, Div Estudios Posgrad & Invest, Inst Tecnol Tizimin, Tizimin, Yucatan, Mexico; [Tun-Garrido, Juan] Univ Autonoma Yucatan, Dept Bot, Campus Ciencias Biol & Agr, Merida, Yucatan, Mexico; [Alonso, Conchita] CSIC, Estn Biol Donana, Seville, Spain; [Ashman, Tia-Lynn] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Arceo-Gomez, Gerardo] East Tennessee State Univ, Dept Biol Sci, Johnson City, TN USA	Universidad Autonoma de Yucatan; Universidad Autonoma de Yucatan; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; East Tennessee State University	Parra-Tabla, V (corresponding author), Univ Autonoma Yucatan, Dept Ecol Trop, Campus Ciencias Biol & Agr, Merida, Yucatan, Mexico.	victor.parratabla@gmail.com	Angulo, Diego F./B-3152-2015; Alonso, Conchita/L-6957-2014; Sosenski, Paula/AAX-6612-2020	Angulo, Diego F./0000-0002-5678-4946; Alonso, Conchita/0000-0002-7418-3204; Parra-Tabla, Victor/0000-0001-5920-0881	Consejo Nacional de Ciencia y Tecnologia [248406]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	VPT received grant 248406 from the Consejo Nacional de Ciencia y Tecnologia.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Albor C, 2019, J ECOL, V107, P2167, DOI 10.1111/1365-2745.13183; Albrecht M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0773; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2012, LANG ENV STAT COMP; [Anonymous], 2006, SAS MIXED MODELS; Arceo-Gomez G, 2016, J ECOL, V104, P1003, DOI 10.1111/1365-2745.12586; Barajas DC, 2018, THESIS; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bjerknes AL, 2007, BIOL CONSERV, V138, P1, DOI 10.1016/j.biocon.2007.04.015; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Caruso CM, 2000, EVOLUTION, V54, P1546, DOI 10.1111/j.0014-3820.2000.tb00700.x; Carvalheiro LG, 2014, ECOL LETT, V17, P1389, DOI 10.1111/ele.12342; Charlebois JA, 2017, ECOL LETT, V20, P1479, DOI 10.1111/ele.12831; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Colwell RK, 2009, ESTIMATES STAT ESTIM; Marquitti FMD, 2014, ECOGRAPHY, V37, P221, DOI 10.1111/j.1600-0587.2013.00506.x; Del Vecchio S, 2015, BIODIVERS CONSERV, V24, P371, DOI 10.1007/s10531-014-0814-3; Dormann C.F., 2008, R NEWS, V8, P8; Emer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143532; ESPEJEL I, 1987, J BIOGEOGR, V14, P499, DOI 10.2307/2844877; Gibson MR, 2012, J ECOL, V100, P1216, DOI 10.1111/j.1365-2745.2012.02004.x; Gomez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016143; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Hanula JL, 2011, INSECT CONSERV DIVER, V4, P275, DOI 10.1111/j.1752-4598.2011.00131.x; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Johnson AL, 2019, NEW PHYTOL, V221, P142, DOI 10.1111/nph.15366; Campos-Navarrete MJ, 2013, ARTHROPOD-PLANT INTE, V7, P607, DOI 10.1007/s11829-013-9280-1; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kantsa A, 2017, NAT ECOL EVOL, V1, P1502, DOI 10.1038/s41559-017-0298-0; Koski MH, 2015, ARTHROPOD-PLANT INTE, V9, P9, DOI 10.1007/s11829-014-9353-9; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Maruyama PK, 2016, DIVERS DISTRIB, V22, P672, DOI 10.1111/ddi.12434; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Minnaar C, 2019, ANN BOT-LONDON, V123, P225, DOI 10.1093/aob/mcy167; Miranda F., 1959, VEGETACION PENINSULA; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Padron B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006275; ParraTabla V, 2018, PLANT ECOL DIVERS; Powell KI, 2011, BIOL INVASIONS, V13, P905, DOI 10.1007/s10530-010-9878-5; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; PR, 2005, ANINHADO 1 0; Russo L, 2016, DIVERS DISTRIB, V22, P189, DOI 10.1111/ddi.12397; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; *SAS I INC, 2002, SAS VERS 9 1; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Stout JC, 2017, FUNCT ECOL, V31, P38, DOI 10.1111/1365-2435.12751; Thijs KW, 2012, BIOL INVASIONS, V14, P355, DOI 10.1007/s10530-011-0067-y; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Traveset A, 2018, OIKOS, V127, P45, DOI 10.1111/oik.04154; Traveset A, 2014, ANNU REV ECOL EVOL S, V45, P89, DOI 10.1146/annurev-ecolsys-120213-091857; Tylianakis JM, 2017, ANNU REV ECOL EVOL S, V48, P25, DOI 10.1146/annurev-ecolsys-110316-022821; Valdovinos FS, 2009, OIKOS, V118, P1190, DOI 10.1111/j.1600-0706.2009.17364.x; Valtonen A, 2006, BIOL CONSERV, V133, P389, DOI 10.1016/j.biocon.2006.06.015; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2009, P ROY SOC B-BIOL SCI, V276, P3887, DOI 10.1098/rspb.2009.1076; Zhao YH, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0080-1	67	10	10	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0218227	10.1371/journal.pone.0218227	http://dx.doi.org/10.1371/journal.pone.0218227			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703061	gold, Green Published, Green Submitted			2022-12-26	WOS:000532697200001
J	Al-Bulushi, S; Manjunatha, BM; Bathgate, R; Rickard, JP; de Graaf, SP				Al-Bulushi, Samir; Manjunatha, Bodhaganahalli M.; Bathgate, Roslyn; Rickard, Jessica P.; de Graaf, Simon P.			Artificial insemination with fresh, liquid stored and frozen thawed semen in dromedary camels	PLOS ONE			English	Article							FOLLICULAR WAVE; COLLECTION; FERTILITY	\This study was conducted to evaluate various factors affecting fertility following insemination of dromedary camels. In experiment 1, camels were either bred by natural mating (NM) or inseminated in the body of uterus with whole, split (50:50) or 1 mL of undiluted ejaculate. In experiment 2, camels were inseminated with fresh diluted semen either in the body of the uterus or tip of the uterine horn and at either the time of ovulation induction (0 h), 24 or 30 h later. In experiment 3, camels were inseminated at the tip of the uterine horn with different doses of fresh diluted semen (75, 150 or 300 x 10(6) motile spermatozoa) or with 150 x 10(6) motile spermatozoa diluted with different extenders (Green buffer, Optixcell or Triladyl). In experiment 4, camels were inseminated in the tip of the uterine horn with diluted (Triladyl or Optixcell) liquid-stored semen or diluted (Triladyl) frozen-thawed semen consisting of either 300 or 500 x 10(6) motile spermatozoa. The pregnancy rate in camels bred by NM was similar to camels inseminated with whole undiluted ejaculates whereas insemination with 1 mL undiluted ejaculate resulted in lower pregnancy compared to whole and split undiluted ejaculates (P < 0.05). Deposition of semen in the uterine body resulted in lower pregnancy rates compared to deposition in the tip of the horn (35.3% versus 72.2%, P < 0.05) but insemination at the time of ovulation induction and 24 h later resulted in higher pregnancy rate to camels inseminated at 30 h after induction (68.4 and 70.0% versus 23.5%; P < 0.05). Artificial insemination with 75 x 10(6) motile spermatozoa resulted in lower pregnancy rates compared to 150 and 300 x 10(6) motile spermatozoa doses (40.9% versus 65.2 and 70.0%, respectively) and pregnancy rate was not affected by extenders. Insemination of chilled motile spermatozoa stored in either Triladyl or Optixcell resulted in similar pregnancy rates, regardless of insemination dose, although an upward trend with increasing sperm number was apparent (Triladyl; 11.1% versus 21.1% and Optixcell; 5.9% versus 12.5%, for 300 x 10(6) and 500 x 10(6) groups, respectively; P > 0.05). No pregnancies were obtained with frozen thawed semen. In conclusion, this study demonstrated that the success of camel AI is highly dependent on sperm dose, location of semen deposition, timing of insemination and semen type. Further studies are required to determine the reason for the compromised fertility of preserved semen despite apparent high in vitro quality.	[Al-Bulushi, Samir; Rickard, Jessica P.; de Graaf, Simon P.] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [Al-Bulushi, Samir; Manjunatha, Bodhaganahalli M.] Anim Res Ctr, Directorate Gen Vet Serv, Royal Court Affairs, Muscat, Oman; [Bathgate, Roslyn] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney	Al-Bulushi, S (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.; Al-Bulushi, S (corresponding author), Anim Res Ctr, Directorate Gen Vet Serv, Royal Court Affairs, Muscat, Oman.	samir-albulushi@hotmail.com	Al-Bulushi, Samir/AAQ-6008-2020	Bathgate, Roslyn/0000-0002-7922-5610; de Graaf, Simon/0000-0002-0870-4219				AKBAR SJ, 2018, INT J ANIM SCI, V2, P1018; Al-Bulushi S, 2018, ANIM REPROD SCI, V197, P145, DOI 10.1016/j.anireprosci.2018.08.022; Al-Bulushi S, 2016, ANIMAL REPROD SCI; Anouassi, 1997, THERIOGENOLOGY CAMEL, P413; Anouassi A., 1992, Proceedings of the First International Camel Conference, Dubai, 2nd-6th February 1992., P175; Anouassi A., 2010, CLIN THERIOGENOL, V2, P391; CALDERON W, 1968, REV FAC MED VET, V22, P19; Deen A, 2003, ANIM REPROD SCI, V77, P223, DOI 10.1016/S0378-4320(03)00040-X; El-Hassanein E., 2003, RECENT ADV CAMEL REP, P0203; Elliot F., 1961, INT ZOO YB, V3, P94; Evans G, 1987, SALAMONS ARTIFICIAL, P93; Giuliano SM, 2012, ANIM REPROD SCI, V131, P204, DOI 10.1016/j.anireprosci.2012.03.010; Kershaw-Young CM, 2013, ANIM REPROD SCI, V138, P261, DOI 10.1016/j.anireprosci.2013.02.005; Manjunatha BM, 2018, THERIOGENOLOGY, V119, P208, DOI 10.1016/j.theriogenology.2018.07.001; Manjunatha BM, 2015, ANIM REPROD SCI, V160, P23, DOI 10.1016/j.anireprosci.2015.06.023; Manjunatha BM, 2015, REPROD BIOL, V15, P188, DOI 10.1016/j.repbio.2015.06.002; Medan MS, 2008, J REPROD DEVELOP, V54, P84, DOI 10.1262/jrd.19124; Morton K. M., 2013, Journal of Camelid Science, V6, P49; Morton KM, 2011, REPROD DOMEST ANIM, V46, P554, DOI 10.1111/j.1439-0531.2010.01678.x; Musa B, 1992, 1 INT CAM C NEWM UK; Sieme H, 1990, P WORKSH IS IT POSS; Skidmore J, 2006, P 1 C INT SOC CAM RE; Skidmore JA, 2006, THERIOGENOLOGY, V66, P292, DOI 10.1016/j.theriogenology.2005.11.013; Skidmore JA, 2013, ANIM REPROD SCI, V136, P178, DOI 10.1016/j.anireprosci.2012.10.008; Skidmore J. A., 2000, RECENT ADV CAMELID R; Skidmore JA, 2018, ANIM REPROD SCI, V194, P11, DOI 10.1016/j.anireprosci.2018.03.013; Vaughan J, 2003, ARTIFICIAL INSEMINAT, V1, P60; Waheed MM, 2010, J CAMEL PRACT RES, V17, P217; Zhao X, 1996, 1 CHIN INT ANN M AGR; Ziapour S, 2014, ANIM REPROD SCI, V151, P15, DOI 10.1016/j.anireprosci.2014.09.016	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224992	10.1371/journal.pone.0224992	http://dx.doi.org/10.1371/journal.pone.0224992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697770	Green Published, gold			2022-12-26	WOS:000532694400089
J	Das, L; Azmoon, P; Banki, MA; Mantuano, E; Gonias, SL				Das, Lipsa; Azmoon, Pardis; Banki, Michael A.; Mantuano, Elisabetta; Gonias, Steven L.			Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-2-MACROGLOBULIN RECEPTOR; CUTTING EDGE; RECOGNITION; NOD2; LIPOPOLYSACCHARIDE; EXPRESSION; PROTEIN; PEPTIDOGLYCAN; BINDING	Tissue-type plasminogen activator (tPA) is a major activator of fibrinolysis, which also attenuates the pro-inflammatory activity of lipopolysaccharide (LPS) in bone marrow-derived macrophages (BMDMs) and in vivo in mice. The activity of tPA as an LPS response modifier is independent of its proteinase activity and instead, dependent on the N-methyl-D-aspartate Receptor (NMDA-R), which is expressed by BMDMs. The major Toll-like receptor (TLR) for LPS is TLR4. Herein, we show that enzymatically-inactive (EI) tPA blocks the response of mouse BMDMs to selective TLR2 and TLR9 agonists, rapidly reversing I kappa B alpha phosphorylation and inhibiting expression of TNF alpha, CCL2, interleukin-1 beta, and interleukin-6. The activity of EI-tPA was replicated by activated alpha(2)-macroglobulin, which like EI-tPA, signals through an NMDA-R-dependent pathway. EI-tPA failed to inhibit cytokine expression by BMDMs in response to agonists that target the Pattern Recognition Receptors (PRRs), NOD1 and NOD2, providing evidence for specificity in the function of EI-tPA. Macrophages isolated from the peritoneal space (PMs), without adding eliciting agents, expressed decreased levels of cell-surface NMDA-R compared with BMDMs. These cells were unresponsive to EI-tPA in the presence of LPS. However, when PMs were treated with CSF-1, the abundance of cell-surface NMDA-R increased and the ability of EI-tPA to neutralize the response to LPS was established. We conclude that the anti-inflammatory activity of EI-tPA is selective for TLRs but not all PRRs. The ability of macrophages to respond to EI-tPA depends on the availability of cell surface NMDA-R, which may be macrophage differentiation-state dependent.	[Das, Lipsa; Azmoon, Pardis; Banki, Michael A.; Mantuano, Elisabetta; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	sgonias@ucsd.edu		Banki, Michael/0000-0002-8910-4695; Azmoon, Pardis/0000-0002-1512-5581; DAS, LIPSA/0000-0002-6896-4776	National Institutes of Health [R01 HL136395]; NIH [R01 NS097590]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work was provided by National Institutes of Health grant R01 HL136395 to S.L.G. S.L.G. also was supported by NIH grant R01 NS097590. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Assouvie A, 2018, METHODS MOL BIOL, V1784, P29, DOI 10.1007/978-1-4939-7837-3_3; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; BU GJ, 1993, J BIOL CHEM, V268, P13002; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; HUSSAINI IM, 1990, J BIOL CHEM, V265, P19441; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jones CV, 2013, ORGANOGENESIS, V9, P249, DOI 10.4161/org.25676; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Keck S, 2010, J IMMUNOL, V184, P5809, DOI 10.4049/jimmunol.0901423; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Latz E, 2004, J ENDOTOXIN RES, V10, P406, DOI 10.1179/096805104225006525; Lee YS, 2013, FREE RADICAL RES, V47, P422, DOI 10.3109/10715762.2013.784965; Mantuano E, 2017, BLOOD, V130, P1364, DOI 10.1182/blood-2017-04-780205; Mantuano E, 2016, P NATL ACAD SCI USA, V113, P1369, DOI 10.1073/pnas.1515480113; Mantuano E, 2015, J CELL SCI, V128, P3478, DOI 10.1242/jcs.173765; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; METCALF D, 1971, IMMUNOLOGY, V21, P427; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Schneewind O, 2014, J BACTERIOL, V196, P1133, DOI 10.1128/JB.01155-13; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shang LH, 2010, NITRIC OXIDE-BIOL CH, V23, P327, DOI 10.1016/j.niox.2010.09.004; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Zalfa C, 2019, J LEUKOCYTE BIOL, V105, P729, DOI 10.1002/JLB.3A0818-329RRR; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224738	10.1371/journal.pone.0224738	http://dx.doi.org/10.1371/journal.pone.0224738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LJ8EN	31697716	Green Published, Green Submitted, gold			2022-12-26	WOS:000530393800001
J	Shao, Q; Hu, L; Qin, H; Liu, YR; Tang, X; Lei, AP; Wang, JX				Shao, Qing; Hu, Lang; Qin, Huan; Liu, Yerong; Tang, Xing; Lei, Anping; Wang, Jiangxin			Metabolomic response of Euglena gracilis and its bleached mutant strain to light	PLOS ONE			English	Article							AMINOLEVULINIC-ACID SYNTHASE; PHOSPHOENOLPYRUVATE-CARBOXYKINASE; CHLOROPLAST; BIOSYNTHESIS; BIOGENESIS; ACCUMULATION; CARBOXYLASE; TOLERANCE; LIPIDS; CELLS	Euglena, a new superfood on the market, is a nutrient-rich, green single-celled microorganism that features the characteristics of both plant and animal. When cultivated under different conditions, Euglena produces different bioactive nutrients. Interestingly, Euglena is the only known microorganism whose chloroplasts are easy to lose under stress and become permanently bleached. We applied gas chromatography-mass spectrometry (GC-MS) to determine the metabolomes of wild-type (WT) Euglena gracilis and its bleached mutant OflB2 under light stimulation. We found a significant metabolic difference between WT and OflB2 cells in response to light. An increase of membrane components (phospholipids and acylamides) was observed in WT, while a decrease of some stimulant metabolites was detected in OflB2. These metabolomic changes after light stimulation are of great significance to the development of Euglena chloroplasts and their communications with the nucleus.	[Shao, Qing; Qin, Huan; Liu, Yerong; Tang, Xing; Lei, Anping; Wang, Jiangxin] Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen Engn Lab Marine Algal Biotechnol,Guangdo, Shenzhen, Peoples R China; [Hu, Lang] Hubei Engn Univ, Coll Life Sci & Technol, Xiaogan, Peoples R China	Shenzhen University; Hubei Engineering University	Lei, AP; Wang, JX (corresponding author), Shenzhen Univ, Coll Life Sci & Oceanog, Shenzhen Key Lab Marine Bioresource & Ecoenvironm, Shenzhen Engn Lab Marine Algal Biotechnol,Guangdo, Shenzhen, Peoples R China.	bioaplei@szu.edu.cn; jxwang@szu.edu.cn	Shao, Qinglong/AAZ-1682-2020; WANG, Jiangxin/AFE-8446-2022	Shao, Qinglong/0000-0003-1636-7045; WANG, Jiangxin/0000-0002-9917-067X; Hu, Lang/0000-0002-4032-1621	National Natural Science Foundation of China [31670116]; Guangdong Innovation Research Team Fund [2014ZT05S078]; Shenzhen Grant Plan for Science Technology [JCYJ20160308095910917, JCYJ20170818100339597]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovation Research Team Fund; Shenzhen Grant Plan for Science Technology	This work was supported by National Natural Science Foundation of China (31670116 to AL), the Guangdong Innovation Research Team Fund (2014ZT05S078 to JW), and the Shenzhen Grant Plan for Science & Technology (JCYJ20160308095910917, JCYJ20170818100339597, both to JW). They are used for the design of the study, data collection, data analysis and manuscript writing, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEALE SI, 1981, P NATL ACAD SCI-BIOL, V78, P1666, DOI 10.1073/pnas.78.3.1666; BOVARNIC.JG, 1974, J GEN MICROBIOL, V83, P63, DOI 10.1099/00221287-83-1-63; Buetow DE, 1982, BIOL EUGLENA, VIII, P254; CALVAYRAC R, 1981, PLANTA, V153, P6, DOI 10.1007/BF00385311; DOCKERTY A, 1979, PLANT PHYSIOL, V63, P468, DOI 10.1104/pp.63.3.468; EBERLY SL, 1986, ARCH BIOCHEM BIOPHYS, V245, P338, DOI 10.1016/0003-9861(86)90224-9; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; FOLEY T, 1982, PLANT PHYSIOL, V70, P219, DOI 10.1104/pp.70.1.219; FREYSSINET G, 1984, PLANT PHYSIOL, V75, P850, DOI 10.1104/pp.75.3.850; Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; HEIZMANN P, 1981, BIOCHIM BIOPHYS ACTA, V653, P412, DOI 10.1016/0005-2787(81)90197-0; Ito T, 2013, J BIOSCI BIOENG, V116, P408, DOI 10.1016/j.jbiosc.2013.03.019; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KARN RC, 1973, J PROTOZOOL, V20, P316, DOI 10.1111/j.1550-7408.1973.tb00886.x; Kobayashi K, 2016, SUBCELL BIOCHEM, V86, P103, DOI 10.1007/978-3-319-25979-6_5; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; MIYATAKE K, 1984, AGR BIOL CHEM TOKYO, V48, P2139, DOI 10.1080/00021369.1984.10866462; MONROY AF, 1986, PLANT PHYSIOL, V80, P618, DOI 10.1104/pp.80.3.618; MONROY AF, 1987, PLANT SCI, V51, P61, DOI 10.1016/0168-9452(87)90221-4; Ogbonna JC, 1998, J APPL PHYCOL, V10, P67, DOI 10.1023/A:1008011201437; PINEAU B, 1982, PLANTA, V156, P117, DOI 10.1007/BF00395426; PONSGENSCHMIDT E, 1988, PLANT PHYSIOL, V86, P457, DOI 10.1104/pp.86.2.457; Pribil M, 2014, J EXP BOT, V65, P1955, DOI 10.1093/jxb/eru090; Rast A, 2015, BBA-BIOENERGETICS, V1847, P821, DOI 10.1016/j.bbabio.2015.01.007; Ritter A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-116; SCHANTZ R, 1975, PLANT SCI LETT, V5, P313, DOI 10.1016/0304-4211(75)90059-0; Schwartzbach SD, 2017, BIOCH CELL MOL BIOL, P289; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tanoue R, 2014, FEBS LETT, V588, P1680, DOI 10.1016/j.febslet.2014.03.010; Wang Jiang-xin, 2002, Acta Hydrobiologica Sinica, V26, P175; Wang JX, 2004, PROG NAT SCI, V3, P21; Wang YX, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0151-y; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; Zeng M, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0279-4; Zhang WL, 2014, MOL BIOSYST, V10, P149, DOI 10.1039/c3mb70425d; Zhang ZH, 2013, J ETHNOPHARMACOL, V149, P303, DOI 10.1016/j.jep.2013.06.039	40	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224926	10.1371/journal.pone.0224926	http://dx.doi.org/10.1371/journal.pone.0224926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697795	gold, Green Published			2022-12-26	WOS:000532694400080
J	Asadgol, Z; Mohammadi, H; Kermani, M; Badirzadeh, A; Gholami, M				Asadgol, Zahra; Mohammadi, Hamed; Kermani, Majid; Badirzadeh, Alireza; Gholami, Mitra			The effect of climate change on cholera disease: The road ahead using artificial neural network	PLOS ONE			English	Article							INFECTIOUS-DISEASES; RAINFALL; TEMPERATURE; IMPACT	Climate change has been described to raise outbreaks of water-born infectious diseases and increases public health concerns. This study aimed at finding out these impacts on cholera infections by using Artificial Neural Networks (ANNs) from 2021 to 2050. Daily data for cholera infection cases in Qom city, which is located in the center of Iran, were analyzed from 1998 to 2016. To determine the best lag time and combination of inputs, Gamma Test (GT) was applied. General circulation model outputs were utilized to project future climate pattern under two scenarios of Representative Concentration Pathway (RCP2.6 and RCP8.5). Statistical downscaling was done to produce high-resolution synthetic time series weather dataset. ANNs were applied for simulating the impact of climate change on cholera. The observed climate variables including maximum and minimum temperatures and precipitation were tagged as predictors in ANNs. Cholera cases were considered as the target outcome variable. Projected future (2020-2050) climate in previous step was carried out to assess future cholera incidence. A seasonal trend in cholera infection was seen. Our results elucidated that the best lag time was 21 days. According to the results of downscaling tool, future climate in the study area by 2050 will be warmer and wetter. Simulation of cholera cases indicated that there is a clear trend of increasing cholera cases under the worst scenario (RCP8.5) by the year 2050 and the highest cholera cases observe in warmer months. The precipitation was recognized as the most effective input variable by sensitivity analysis. We observed a significant correlation between low precipitation and cholera infection. There is a strong evidence to show that cholera disease is correlated with environment variables, as low precipitation and high temperatures in warmer months could provide the swifter bacterial replication. These conditions in Iran, especially in the central parts, may raise the cholera infection rates. Furthermore, ANNs is an executive tool to simulate the impact of climate change on cholera to estimate the future trend of cholera incidence for adopting protective measures in endemic areas.	[Asadgol, Zahra; Kermani, Majid; Gholami, Mitra] Iran Univ Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Tehran, Iran; [Mohammadi, Hamed] Zanjan Univ Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Zanjan, Iran; [Kermani, Majid; Gholami, Mitra] Iran Univ Med Sci, Res Ctr Environm Hlth Technol, Tehran, Iran; [Badirzadeh, Alireza] Iran Univ Med Sci, Sch Med, Dept Parasitol & Mycol, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Gholami, M (corresponding author), Iran Univ Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Tehran, Iran.; Mohammadi, H (corresponding author), Zanjan Univ Med Sci, Sch Publ Hlth, Dept Environm Hlth Engn, Zanjan, Iran.; Gholami, M (corresponding author), Iran Univ Med Sci, Res Ctr Environm Hlth Technol, Tehran, Iran.	ham19@zums.ac.ir; gholamim@iums.ac.ir	Kermani, Majid/I-8352-2016; Gholami, Mitra/F-9490-2014; Mohammadi, Hemed/D-9669-2017	Kermani, Majid/0000-0003-1668-2942; Mohammadi, Hemed/0000-0002-6472-7167	Iran National Science Foundation [96001762]	Iran National Science Foundation(Iran National Science Foundation (INSF))	This work was financially supported by the Iran National Science Foundation Grant number 96001762 to Mitra Gholami. This article has been extracted from the Ph.D. thesis written by Zahra Asadgol in the Department of Environmental Health Engineering, School of Public Health at Iran University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acherjee B, 2011, APPL SOFT COMPUT, V11, P2548, DOI 10.1016/j.asoc.2010.10.005; Akanda AS, 2012, B WORLD HEALTH ORGAN, V90, P243, DOI 10.2471/BLT.11.092189; [Anonymous], 1885, HIST CHOLERA INDIA 1; [Anonymous], 2018, WEEKLY EPIDEMIOLOGIC; [Anonymous], 2002, GLOB CLIM CHANG HUM, DOI DOI 10.1023/A:1019621231796; ARBOGAST T, 2017, PLOS NEGLECT TROP D, V13, DOI DOI 10.1371/JOURNAL.PNTD.5245; Bandyopadhyay S, 2012, APPL GEOGR, V33, P63, DOI 10.1016/j.apgeog.2011.07.017; Bryden JL, 1871, EPIDEMIC CONNECTION; Bryden JL, 1870, REPORT GEN ASPECTS E; Chowdhury FR, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0185-1; Chuzhanova NA, 1998, BIOINFORMATICS, V14, P139, DOI 10.1093/bioinformatics/14.2.139; de Magny GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044577; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Dibike YB, 2005, J HYDROL, V307, P145, DOI 10.1016/j.jhydrol.2004.10.012; Emch M, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-31; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Haris AA, 2010, EVALUATION LARS WG G; Hashizume M, 2008, EPIDEMIOLOGY, V19, P103, DOI 10.1097/EDE.0b013e31815c09ea; Hashizume M, 2010, EPIDEMIOLOGY, V21, P706, DOI 10.1097/EDE.0b013e3181e5b053; Jones AJ, 1998, WINGAMMA USER GUIDE; Koncar N, 1997, OPTIMISATION METHODO; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; Martinez ME, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007327; Mendelsohn J, 2008, INT J HYG ENVIR HEAL, V211, P156, DOI 10.1016/j.ijheh.2006.12.002; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Moghaddamnia A, 2009, ADV WATER RESOUR, V32, P88, DOI 10.1016/j.advwatres.2008.10.005; Mohammadi H, 2018, HEALTH SCOPE, V7, DOI 10.5812/jhealthscope.57786; Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467; Nasr-Azadani F, 2017, ADV WATER RESOUR, V108, P332, DOI 10.1016/j.advwatres.2016.11.018; Nasr-Azadani F, 2015, CLIM RES, V64, P257, DOI 10.3354/cr01310; Olago D, 2007, AMBIO, V36, P350, DOI 10.1579/0044-7447(2007)36[350:CSAHFA]2.0.CO;2; Sedas VTP, 2007, J INFECT DEV COUNTR, V1, P224, DOI 10.3855/jidc.359; Pascual M, 2008, CLIM RES, V36, P131, DOI 10.3354/cr00730; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Penna MLF, 2004, REV SAUDE PUBL, V38, P351, DOI 10.1590/S0034-89102004000300003; Pezeshki Z, 2016, INT J ENTERIC PATHOG, V4, P1; Piri J, 2009, J HYDROL ENG, V14, P803, DOI 10.1061/(ASCE)HE.1943-5584.0000056; Ramirez IJ, 2015, GEOJOURNAL, V80, P129, DOI 10.1007/s10708-014-9541-2; Ruiz-Moreno D, 2007, ECOHEALTH, V4, P52, DOI 10.1007/s10393-006-0079-8; Semenov MA, 2010, CLIM RES, V41, P1, DOI 10.3354/cr00836; Semenza JC, 2012, ENVIRON HEALTH PERSP, V120, P385, DOI 10.1289/ehp.1103805; Tonnang HEZ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-111; Tsui APM, 1999, SMOOTH DATA MODELLIN; Wang YM, 2015, APPL SOFT COMPUT, V35, P280, DOI 10.1016/j.asoc.2015.05.047; WHO, 2008, PROT HLTH CLIM CHANG; Yomwan P, 2015, GEOMAT NAT HAZ RISK, V6, P289, DOI 10.1080/19475705.2013.853325; Yue YJ, 2014, WORLD J MICROB BIOT, V30, P1797, DOI 10.1007/s11274-014-1604-5	49	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224813	10.1371/journal.pone.0224813	http://dx.doi.org/10.1371/journal.pone.0224813			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693708	Green Published, gold			2022-12-26	WOS:000532690100043
J	Loss, SR; Lao, S; Eckles, JW; Anderson, AW; Blair, RB; Turner, RJ				Loss, Scott R.; Lao, Sirena; Eckles, Joanna W.; Anderson, Abigail W.; Blair, Robert B.; Turner, Reed J.			Factors influencing bird-building collisions in the downtown area of a major North American city	PLOS ONE			English	Article							WINDOW COLLISIONS; MORTALITY; LIGHT; RISK	Bird-building collisions are the largest source of avian collision mortality in North America. Despite a growing literature on bird-building collisions, little research has been conducted in downtown areas of major cities, and no studies have included stadiums, which can be extremely large, often have extensive glass surfaces and lighting, and therefore may cause many bird collisions. Further, few studies have assessed the role of nighttime lighting in increasing collisions, despite the often-cited importance of this factor, or considered collision correlates for different seasons and bird species. We conducted bird collision monitoring over four migration seasons at 21 buildings, including a large multi-use stadium, in downtown Minneapolis, Minnesota, USA. We used a rigorous survey methodology to quantify among-building variation in collisions and assess how building features (e.g., glass area, lighting, vegetation) influence total collision fatalities, fatalities for separate seasons and species, and numbers of species colliding. Four buildings, including the stadium, caused a high proportion of all collisions and drove positive effects of glass area and amount of surrounding vegetation on most collision variables. Excluding these buildings from analyses resulted in slightly different collision predictors, suggesting that factors leading some buildings to cause high numbers of collisions are not the exact same factors causing variation among more typical buildings. We also found variation in collision correlates between spring and fall migration and among bird species, that factors influencing collision fatalities also influence numbers of species colliding, and that the proportion, and potentially area, of glass lighted at night are associated with collisions. Thus, reducing bird collisions at large buildings, including stadiums, should be achievable by reducing glass area (or treating existing glass), reducing light emission at night, and prioritizing mitigation efforts for glass surfaces near vegetated areas and/or avoiding use of vegetation near glass.	[Loss, Scott R.; Lao, Sirena] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Eckles, Joanna W.; Turner, Reed J.] Audubon Minnesota, St Paul, MN USA; [Anderson, Abigail W.; Blair, Robert B.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Eckles, Joanna W.] Univ Minnesota, Coll Vet Med, Raptor Ctr, St Paul, MN 55108 USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Loss, SR (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.	scott.loss@okstate.edu	Blair, Robert Brown/GYQ-5874-2022; Lao, Sirena/G-3588-2017	Lao, Sirena/0000-0003-2907-7266; Loss, Scott/0000-0002-8753-2995	Minnesota Sports Facilities Authority; Minnesota Vikings Football, LLC	Minnesota Sports Facilities Authority; Minnesota Vikings Football, LLC	SRL, JWE, and RBB received funding for this research from the Minnesota Sports Facilities Authority (https://www.msfa.com/) and Minnesota Vikings Football, LLC (https://www.vikings.com/). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Borden W. Calvin, 2010, Ohio Journal of Science, V110, P44; Bracey AM, 2016, WILSON J ORNITHOL, V128, P355, DOI 10.1676/wils-128-02-355-367.1; Calvert AM, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00581-080211; Cusa M, 2015, URBAN ECOSYST, V18, P1427, DOI 10.1007/s11252-015-0459-3; Dalthorp D, 2018, US GEOL SURV TECH ME, P13, DOI [10.3133/tm7a2, DOI 10.3133/TM7A2, 10.3133/tm7A2]; Evans Ogden LJ, SUMMARY REPORT BIRD; Gelb Yigal, 2006, Kingbird, V56, P190; Gelb Y, 2009, NORTHEAST NAT, V16, P455, DOI 10.1656/045.016.n312; Hager SB, 2008, WILSON J ORNITHOL, V120, P550, DOI 10.1676/07-075.1; Hager SB, 2017, BIOL CONSERV, V212, P209, DOI 10.1016/j.biocon.2017.06.014; Hager SB, 2014, PEERJ, V2, DOI 10.7717/peerj.460; Hager SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053371; Hager SB, 2012, J FIELD ORNITHOL, V83, P203, DOI 10.1111/j.1557-9263.2012.00370.x; Hasham A., 2013, STAR; Hastad O, 2014, PEERJ, V2, DOI 10.7717/peerj.621; Homayoun TZ, 2016, URBAN ECOSYST, V19, P1579, DOI 10.1007/s11252-015-0437-9; Host TK, 2016, TWIN CITIES METROPOL; Johnson B., 2012, FINANCE COMMERC 1211; Kahle LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144600; KLEM D, 1990, J FIELD ORNITHOL, V61, P115; Klem D, 2004, WILSON BULL, V116, P69, DOI 10.1676/0043-5643(2004)116[0069:EOWAFP]2.0.CO;2; Klem D, 2009, WILSON J ORNITHOL, V121, P126, DOI 10.1676/08-068.1; Kummer JA, 2016, AVIAN CONSERV ECOL, V11, DOI 10.5751/ACE-00927-110212; Kummer JA, 2016, CONDOR, V118, P624, DOI 10.1650/CONDOR-16-26.1; Kummer JA, 2015, AVIAN CONSERV ECOL, V10, DOI 10.5751/ACE-00787-100206; Longcore T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034025; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; MACHTANS CS, 2013, AVIAN CONSERV ECOL, V8, DOI DOI 10.5751/ACE-00568-080206; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; McLaren JD, 2018, ECOL LETT, V21, P356, DOI 10.1111/ele.12902; Nichols KS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201558; Nichols KS, 2018, THESIS; Parkins KL, 2016, NORTHEAST NAT, V22, P84; Porter C., 2014, WALL STREET J; R Core Team, 2018, R LANG ENV STAT COMP; Riding CS, 2018, ECOL APPL, V28, P2119, DOI 10.1002/eap.1800; Sabo AM, 2016, PEERJ, V4, DOI 10.7717/peerj.2170; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider RM, 2018, PEERJ, V6, DOI 10.7717/peerj.4562; Smallwood KS, 2010, J WILDLIFE MANAGE, V74, P1089, DOI 10.2193/2009-266; Stevens BS, 2011, J WILDLIFE MANAGE, V75, P437, DOI 10.1002/jwmg.53; TAYLOR WK, 1986, J FIELD ORNITHOL, V57, P142; United States Environmental Protection Agency, EC N AM; Van Doren BM, 2017, P NATL ACAD SCI USA, V114, P11175, DOI 10.1073/pnas.1708574114; Winger BM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0364; Wittig TW, 2017, AVIAN CONSERV ECOL, V12, DOI [10.5751/ACE-01014-120117, 10.5751/ace-01014-120117]; Zink Robert M., 2010, Loon, V82, P34	50	18	18	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224164	10.1371/journal.pone.0224164	http://dx.doi.org/10.1371/journal.pone.0224164			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693699	Green Published, gold			2022-12-26	WOS:000532690100015
J	Marcon, A; Mladenoff, DJ; Grignolio, S; Apollonio, M				Marcon, Andrea; Mladenoff, David J.; Grignolio, Stefano; Apollonio, Marco			Effects of forest management and roe deer impact on a mountain forest development in the Italian Apennines: A modelling approach using LANDIS-II	PLOS ONE			English	Article							LANDSCAPE SIMULATION-MODEL; WHITE-TAILED DEER; CLIMATE-CHANGE; UNGULATE HERBIVORY; TURKEY OAK; VEGETATION; DYNAMICS; GROWTH; BIOMASS; TREES	Forest development is a complex phenomenon which, for the number of actors involved and the response time expressed by forests, is difficult to understand and explore. Forests in Italy, as in several areas of Europe, are experiencing intensive management and recently, an increasing impact by ungulates. The effects on forest development of these two disturbances combined are difficult to predict, and consequently to be properly managed. We used a forest landscape change model, LANDIS-II, to simulate forest development as driven by forestry practices and roe deer impact for 200 years in a mountain forest of the Italian Apennines. We found that each disturbance alters forest tree species richness, forest type abundance and distribution, and forest structure. When considered combined, the two disturbances show additive behavior, enhancing or moderating each other's effects. Forest management has a negative effect on tree species richness. We expected roe deer to have a negative effect on harvest yields, but this result was significant only for two of seven harvesting treatments. On the other hand, roe deer presence had a positive effect on tree species richness. All the simulation scenarios returned some extent of forest loss. The amount of the forest loss is lowest in the scenario without disturbances, and greatest when both disturbances are considered. However, the two disturbances combined, with the magnitude modelled in our simulations, have relatively low effects on the forest dynamics we analyzed in our study area. LANDIS-II was an effective approach for simulating combined management and ungulate driven trends of forest development, and to help understand the dynamics that lay behind it.	[Marcon, Andrea; Grignolio, Stefano; Apollonio, Marco] Univ Sassari, Dept Vet Med, Sassari, Italy; [Mladenoff, David J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Russell Labs, Madison, WI USA	University of Sassari; University of Wisconsin System; University of Wisconsin Madison	Marcon, A (corresponding author), Univ Sassari, Dept Vet Med, Sassari, Italy.	amarcon.work@gmail.com	Grignolio, Stefano/AAS-2988-2020; Marcon, Andrea/AAI-8138-2020	Grignolio, Stefano/0000-0002-0786-2004; Marcon, Andrea/0000-0003-3434-1279	Arezzo Province, A.T.C. 3 Arezzo, Casa Stabbi study center, Center for Research and Silviculture (CRASEL), University of Sassari [466]; Autonomous Region of Sardinia "P.O.R. F.S.E. 2014-2020 -Asse prioritario III "Istruzione e formazione" -Obiettivo tematico 10"; University of WisconsinMadison	Arezzo Province, A.T.C. 3 Arezzo, Casa Stabbi study center, Center for Research and Silviculture (CRASEL), University of Sassari; Autonomous Region of Sardinia "P.O.R. F.S.E. 2014-2020 -Asse prioritario III "Istruzione e formazione" -Obiettivo tematico 10"; University of WisconsinMadison	This work was supported by Arezzo Province, A.T.C. 3 Arezzo, Casa Stabbi study center, Center for Research and Silviculture (CRASEL), University of Sassari, within the project "Valutazione del disturbo arrecato alla vegetazione da popolazioni di capriolo di differente densita" -G. P. n. 466, 08.22.2011. SG had the support of the fund granted by the Autonomous Region of Sardinia "P.O.R. F.S.E. 2014-2020 -Asse prioritario III "Istruzione e formazione" -Obiettivo tematico 10". The University of WisconsinMadison funded the hosting of AM in the Mladenoff lab.	Aber JD, 1995, CLIM RES, V5, P207, DOI 10.3354/cr005207; Apollonio M., 2010, EUROPEAN UNGULATES T; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Bernetti G., 1995, SELVICOLTURA SPECIAL; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; BRZEZIECKI B, 1994, FOREST ECOL MANAG, V69, P167, DOI 10.1016/0378-1127(94)90227-5; Bugmann HKM, 1994, THESIS, DOI [10.3929/ethz-a-000946508, DOI 10.3929/ETHZ-A-000946508]; Burnham K P, 2003, MODEL SELECT MULTIMO; Busing RT, 1997, OIKOS, V78, P562, DOI 10.2307/3545618; Chianucci F., 2015, ANN SILVIC RES, V39, P32, DOI DOI 10.12899/ASR-945; Chollet S, 2013, FOREST ECOL MANAG, V289, P470, DOI 10.1016/j.foreco.2012.10.043; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Coulson T., 1999, BIODIVERS CONSERV, V8, P1719; Cutini A, 2011, ANN FOREST SCI, V68, P667, DOI 10.1007/s13595-011-0072-4; Cutini Andrea, 2009, Annali dell'Istituto Sperimentale per la Selvicoltura, V36, P79; de Bruijn A, 2014, ECOL MODEL, V287, P44, DOI 10.1016/j.ecolmodel.2014.05.004; De Marinis AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222150; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Fernandes PM, 2008, FOREST ECOL MANAG, V256, P246, DOI 10.1016/j.foreco.2008.04.032; Fyllas NM, 2007, ECOL MODEL, V204, P439, DOI 10.1016/j.ecolmodel.2007.02.006; Garcia J., 2004, THESIS; Gerhardt P, 2013, FOREST ECOL MANAG, V310, P173, DOI 10.1016/j.foreco.2013.08.030; Gill RMA, 2010, FORESTRY, V83, P53, DOI 10.1093/forestry/cpp031; Gough L, 1998, ECOLOGY, V79, P1586, DOI 10.1890/0012-9658(1998)079[1586:HEOPSD]2.0.CO;2; Grime J.P., 1988, COMP PLANT ECOLOGY F, P58; Gustafson EJ, 2000, CAN J FOREST RES, V30, P32, DOI 10.1139/cjfr-30-1-32; Gustafson EJ, 2010, ECOL APPL, V20, P700, DOI 10.1890/08-1693.1; HANNAH L, 1995, BIODIVERS CONSERV, V4, P128, DOI 10.1007/BF00137781; Henne PD, 2013, LANDSCAPE ECOL, V28, P819, DOI 10.1007/s10980-012-9782-8; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Hurley PM, 2012, BIOL CONSERV, V146, P62, DOI 10.1016/j.biocon.2011.10.034; Husheer SW, 2003, FOREST ECOL MANAG, V181, P99, DOI 10.1016/S0378-1127(03)00120-8; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; JACCARD S, 2010, FOREST ECOL MANAG, V260, P429, DOI [10.1016/j.foreco.2010.04.031, DOI 10.1016/J.FORECO.2010.04.031]; Johann E, 2004, BIOLOGICAL RESOURCES AND MIGRATION, P73; Jorritsma ITM, 1999, FOREST ECOL MANAG, V120, P23, DOI 10.1016/S0378-1127(98)00540-4; Joys AC, 2004, FOREST ECOL MANAG, V202, P23, DOI 10.1016/j.foreco.2004.06.035; Kaji K, 2000, WILDLIFE SOC B, V28, P699; Kaji K, 2004, J WILDLIFE MANAGE, V68, P889, DOI 10.2193/0022-541X(2004)068[0889:IOACSD]2.0.CO;2; Karam SL, 2013, ECOL MODEL, V250, P45, DOI 10.1016/j.ecolmodel.2012.10.016; Katona K, 2013, BIODIVERS CONSERV, V22, P1167, DOI 10.1007/s10531-013-0490-8; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kaufman L., 1990, FINDING GROUPS DATA, P68, DOI [10.1002/9780470316801.ch2, DOI 10.1002/9780470316801.CH2]; Kramer K, 2006, FOREST ECOL MANAG, V226, P238, DOI 10.1016/j.foreco.2006.01.037; Lischke H, 2006, ECOL MODEL, V199, P409, DOI 10.1016/j.ecolmodel.2005.11.046; Maechler M., 2019, CLUSTER CLUSTER ANAL; Miller J.H., 1990, SILVICS N AM, P461; Mladenoff D, 2012, GIS ENV MODELING PRO; Mladenoff D. J., 1999, Spatial modeling of forest landscape change: approaches and applications. Papers presented at a symposium in Albuquerque, New Mexico, USA, 1997., P125; Mladenoff D. J., 1999, SPATIAL MODELING FOR; Mladenoff DJ, 2004, ECOL MODEL, V180, P7, DOI 10.1016/j.ecolmodel.2004.03.016; Moore NP, 1999, BIOL CONSERV, V87, P255, DOI 10.1016/S0006-3207(98)00055-X; Newton AC, 2011, BIOL CONSERV, V144, P1949, DOI 10.1016/j.biocon.2011.03.026; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; O'Brien EA, 2003, FORESTRY, V76, P3, DOI 10.1093/forestry/76.1.3; Paula S., 2009, ECOLOGY, V90, P1420, DOI DOI 10.1890/08-1309.1; Perea R, 2014, FOREST ECOL MANAG, V312, P47, DOI 10.1016/j.foreco.2013.10.022; Putman RJ, 2012, GRAZING TEMPERATE EC; R Core Team, 2013, R LANG ENV STAT COMP; Reimoser F, 1996, FOREST ECOL MANAG, V88, P107, DOI 10.1016/S0378-1127(96)03816-9; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scheller RM, 2005, GLOBAL CHANGE BIOL, V11, P307, DOI 10.1111/j.1365-2486.2005.00906.x; Scheller RM, 2004, ECOL MODEL, V180, P211, DOI 10.1016/j.ecolmodel.2004.01.022; Scheller RM, 2007, LANDSCAPE ECOL, V22, P491, DOI 10.1007/s10980-006-9048-4; Scheller RM, 2007, ECOL MODEL, V201, P409, DOI 10.1016/j.ecolmodel.2006.10.009; Schippers P, 2014, ECOL COMPLEX, V17, P20, DOI 10.1016/j.ecocom.2013.07.002; Schumacher S, 2006, LANDSCAPE ECOL, V21, P539, DOI 10.1007/s10980-005-2165-7; Seidl R, 2011, ECOL MODEL, V222, P903, DOI 10.1016/j.ecolmodel.2010.09.040; Shang ZB, 2012, ECOL MODEL, V229, P50, DOI 10.1016/j.ecolmodel.2011.08.014; Shelton AL, 2014, FOREST ECOL MANAG, V320, P39, DOI 10.1016/j.foreco.2014.02.026; SZMIDT A, 1975, Acta Theriologica, V20, P255; Verdu M, 2002, EVOLUTION, V56, P1352, DOI 10.1111/j.0014-3820.2002.tb01449.x; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; Ward AI, 2004, FOREST ECOL MANAG, V191, P301, DOI 10.1016/j.foreco.2003.12.018; Ward BC, 2004, THESIS; Weisberg PJ, 2003, FOREST ECOL MANAG, V181, P1, DOI 10.1016/S0378-1127(03)00123-3; White MA, 2012, FOREST ECOL MANAG, V269, P222, DOI 10.1016/j.foreco.2011.12.043; Xu C, 2009, GLOBAL CHANGE BIOL, V15, P116, DOI 10.1111/j.1365-2486.2008.01705.x	79	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224788	10.1371/journal.pone.0224788	http://dx.doi.org/10.1371/journal.pone.0224788			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693689	Green Published, gold			2022-12-26	WOS:000532690100040
J	Shon, EJ; Townsend, AL				Shon, En-Jung; Townsend, Aloen Louise			Predictors of never having a mammogram among Chinese, Vietnamese, and Korean immigrant women in the US	PLOS ONE			English	Article							CANCER SCREENING BEHAVIORS; BREAST-CANCER; HEALTH-CARE; AMERICAN WOMEN; ASIAN WOMEN; DISPARITIES; BARRIERS; BELIEFS; ACCESS; RATES	Background Breast cancer is the most common cancer among Asian women in the U.S. The first objective was to investigate predictors (including ethnicity) of never having a mammogram in middle-aged and older Chinese, Vietnamese, and Korean immigrant women (main effects). The second objective was to explore whether relationships between predictors and never having a mammogram varied across the three groups (moderation effects of ethnicity). Methods Merged (2005-2007-2009-2011) California Health Interview Survey data were utilized. Unweighted sample was 3,710 Asian women ages 40 years and older (Chinese = 1,389; Vietnamese = 1,094; Korean = 1,227). Replicate weighted total sample size was 1,710,233 (Chinese = 940,000; Vietnamese = 410,000; Korean = 360,000). Replicate-weighted multivariate logistic regression was applied. Interaction effects (moderator role of ethnicity) were also examined, using multivariate logistic regression, for the second objective. Results For the first objective, odds of never having a mammogram were higher for women who were Korean (Ref = Vietnamese), unmarried, or a non-U.S. citizen. Odds were lower in women ages 50-59 or 60-69 (Ref = 70-85). Regarding the second objective, only for Chinese women, odds of never having a mammogram were lower as the number of physician visits got higher. Conclusion Culturally-sensitive outreach and services should be developed to target higher-risk groups. Patient-centered healthcare strategies tailored for the three groups could be effective. For Chinese women, in particular, regular information sessions or education programs could be provided for enhancing their physician visits.	[Shon, En-Jung] Miami Univ, Dept Family Sci & Social Work, Oxford, OH 45056 USA; [Townsend, Aloen Louise] Case Western Reserve Univ, Jack Joseph & Morton Mandel Sch Appl Social Sci, Cleveland, OH 44106 USA	Miami University; Case Western Reserve University	Shon, EJ (corresponding author), Miami Univ, Dept Family Sci & Social Work, Oxford, OH 45056 USA.	shone@miamioh.edu						American Cancer Society, 2017, CANC PREV EARL DET F; Andersen R., 2005, MILBANK Q, V83, DOI [10.1111/j.1468-0009.2005.00428.x, DOI 10.1111/J.1468-0009.2005.00428.X]; Andersen R.M., 2011, CHANGING US HLTH CAR; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Artiga S, 2017, HLTH COVERAGE CARE I; Asian Breast Cancer Project, 2013, BREAST CANC FACTS AS; Berkman LF, 2000, SOC WORK HEALTH CARE, V31, P3, DOI 10.1300/J010v31n02_02; Bloom JR, 2001, SOC SCI MED, V53, P1513, DOI 10.1016/S0277-9536(00)00440-8; Brown KC, 2009, J RURAL HEALTH, V25, P167, DOI 10.1111/j.1748-0361.2009.00213.x; California Health Interview Survey (CHIS), 2012, CHIS 2011 2012 METH; Carter EA, 2011, EXPANDED FAMILY LIFE; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Eun Y, 2009, J GERONTOL NURS, V35, P40, DOI 10.3928/00989134-20090731-09; Flach SD, 2004, J GEN INTERN MED, V19, P1019, DOI 10.1111/j.1525-1497.2004.30395.x; Flaskerud JH, 1999, NURS CLIN N AM, V34, P359; Frisbie WP, 2001, AM J EPIDEMIOL, V153, P372, DOI 10.1093/aje/153.4.372; Gehlert S, 2011, HANDBOOK OF AFRICAN AMERICAN HEALTH: SOCIAL AND BEHAVIORAL INTERVENTIONS, P165, DOI 10.1007/978-1-4419-9616-9_11; Gomez SL, 2010, AM J PUBLIC HEALTH, V100, P861, DOI 10.2105/AJPH.2009.176651; Gomez SL, 2010, AM J PUBLIC HEALTH, V100, pS125, DOI 10.2105/AJPH.2009.163931; Gorin SS, 2005, PREV MED, V40, P515, DOI 10.1016/j.ypmed.2004.09.031; Gradyoct D., 2015, NY TIMES; Grin T, 2012, FOREIGN BORN ASIA 20; Hoeffel EM., 2012, ASIAN POPULATION 201; Isaacs S, 2013, PRIM HEALTH CARE RES, V14, P63, DOI 10.1017/S1463423612000229; Jackson SL, 2003, CAN J PUBLIC HEALTH, V94, P275, DOI 10.1007/BF03403605; Kandula NR, 2006, CANCER-AM CANCER SOC, V107, P184, DOI 10.1002/cncr.21968; Kandula NR, SA; Kim W, 2010, SOC WORK PUBLIC HLTH, V25, P286, DOI 10.1080/19371910903240704; Klabunde Carrie N., 2012, Morbidity and Mortality Weekly Report, V61, P41; KOCH GG, 1975, INT STAT REV, V43, P59, DOI 10.2307/1402660; Le TD, 2014, J COMMUN HEALTH, V39, P248, DOI 10.1007/s10900-013-9776-8; Lee Eunice E, 2006, J Immigr Minor Health, V8, P223, DOI 10.1007/s10903-006-9326-2; Lee HJ, 2009, J ADV NURS, V65, P2574, DOI 10.1111/j.1365-2648.2009.05155.x; Lee HY, 2015, J TRANSCULT NURS, V26, P450, DOI 10.1177/1043659614526457; Lee HY, 2010, J WOMENS HEALTH, V19, P1877, DOI 10.1089/jwh.2009.1783; Lee JY, 2010, HEALTH PLACE, V16, P108, DOI 10.1016/j.healthplace.2009.09.003; Lee M, 1996, HLTH ED Q S, V23, pS76; Lee SM, 2014, J COMMUN HEALTH, V39, P201, DOI 10.1007/s10900-013-9763-0; Lee YS, 2012, HEALTH CARE WOMEN IN, V33, P422, DOI 10.1080/07399332.2011.603869; Lee-Lin F, 2007, JOGNN-J OBST GYN NEO, V36, P212, DOI [10.1111/J.1552-6909.2007.00141.x, 10.1111/j.1552-6909.2007.00141.x]; Lee-Lin F, 2012, JOGNN-J OBST GYN NEO, V41, P627, DOI 10.1111/j.1552-6909.2012.01348.x; Leng J, 2012, SUPPORT CARE CANCER, V20, P3221, DOI 10.1007/s00520-012-1464-1; Ma GX, 2012, INT J WOMENS HEALTH, V4, P235, DOI 10.2147/IJWH.S30738; Ma GX, 2009, AM J HEALTH BEHAV, V33, P650; Magai C, 2008, HEALTH EDUC BEHAV, V35, P835, DOI 10.1177/1090198107303281; Martinez O, 2017, MOMENTO, P36, DOI 10.15446/mo.n55.66143; Maxwell AE, 1998, WOMEN HEALTH, V27, P89, DOI 10.1300/J013v27n03_07; Maxwell AE, 2000, AM J PREV MED, V18, P62, DOI 10.1016/S0749-3797(99)00110-5; McPhee SJ, 1997, CANCER DETECT PREV, V21, P510; Myers HF, 2003, ACCULTURATION ADV TH; National Cancer Institute, 2017, TRENDS FEM BREAST CA; National Comprehensive Cancer Network (NCCN), 2016, NCCN CLIN PRACTICE G; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Pew Research Center, 2013, RIS AS AM; Ryu SY, 2013, WOMEN HEALTH ISS, V23, pE403, DOI 10.1016/j.whi.2013.08.005; Sadler Georgia Robins, 2003, Int J Equity Health, V2, P12, DOI 10.1186/1475-9276-2-12; Simon MA, 2017, J GERONTOL A-BIOL, V72, pS32, DOI 10.1093/gerona/glw247; Simon MA, 2014, J GERONTOL A-BIOL, V69, pS46, DOI 10.1093/gerona/glu174; Swenson SL, 2004, J GEN INTERN MED, V19, P1069, DOI 10.1111/j.1525-1497.2004.30384.x; Tang TS, 2000, PREV MED, V31, P575, DOI 10.1006/pmed.2000.0753; Taplin SH, 2004, JNCI-J NATL CANCER I, V96, P1518, DOI 10.1093/jnci/djh284; The Stata Corporation, 2019, STAT US GUID; Tsuchida J, 2015, CANCER MED-US, V4, P1136, DOI 10.1002/cam4.468; Tu SP, 2003, CANCER, V97, P1293, DOI 10.1002/cncr.11169; Wang JH, 2009, CANCER-AM CANCER SOC, V115, P4828, DOI 10.1002/cncr.24517; WOLTER KM, 2003, INTRO VARIANCE ESTIM; Wu TY, 2006, CANCER DETECT PREV, V30, P58, DOI 10.1016/j.cdp.2005.06.013; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Yi J. K., 2002, INT Q COMMUNITY HLTH, V21, P41; Yi J. K., 1994, J WOMENS HEALTH, V3, P205; Yu ESH, 2001, CANCER PRACT, V9, P81, DOI 10.1046/j.1523-5394.2001.009002081.x; Zuvekas SH, 2003, HEALTH AFFAIR, V22, P139, DOI 10.1377/hlthaff.22.2.139	73	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224505	10.1371/journal.pone.0224505	http://dx.doi.org/10.1371/journal.pone.0224505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1FJ	31693678	gold, Green Published			2022-12-26	WOS:000532690100027
J	Tapia, F; Wohlfarth, D; Sandig, V; Jordan, I; Genzel, Y; Reichl, U				Tapia, Felipe; Wohlfarth, Daniel; Sandig, Volker; Jordan, Ingo; Genzel, Yvonne; Reichl, Udo			Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect"	PLOS ONE			English	Article							DEFECTIVE INTERFERING PARTICLES; REPLICATION	Continuous cell culture-based influenza vaccine production could significantly reduce footprint and manufacturing costs compared to current batch processing. However, yields of influenza virus in continuous mode can be affected by oscillations in virus titers caused by periodic accumulation of defective interfering particles. The generation of such particles has also been observed previously in cascades of continuous stirred tank reactors (CSTRs) and is known as the "von Magnus effect". To improve virus yields and to avoid these oscillations, we have developed a novel continuous tubular bioreactor system for influenza A virus production. It was built using a 500 mL CSTR for cell growth linked to a 105 m long tubular plugflow bioreactor (PFBR). Virus propagation took place only in the PFBR with a nominal residence time of 20 h and a production capacity of 0.2 mL/min. The bioreactor was first tested with suspension MDCK cells at different multiplicities of infection (MOI), and then with suspension avian AGE1.CR.pIX cells at a fixed nominal MOI of 0.02. Maximum hemagglutinin (HA) titers of 2.4 and 1.6 log(10)(HA units/100 mu L) for suspension MDCK cells and AGE1.CR. pIX cells, respectively, were obtained. Flow cytometric analysis demonstrated that 100% infected cells with batch-like HA titers can be obtained at a MOI of at least 0.1. Stable HA and TCID50 titers over 18 days of production were confirmed using the AGE1.CR.pIX cell line, and PCR analysis demonstrated stable production of full-length genome. The contamination level of segments with deletions (potentially defective interfering particles), already present in the virus seed, was low and did not increase. Control experiments using batch and semi-continuous cultures confirmed these findings. A comparison showed that influenza virus production can be achieved with the tubular bioreactor system in about half the time with a space-time-yield up to two times higher than for typical batch cultures. In summary, a novel continuous tubular bioreactor system for cell culture-based influenza virus production was developed. One main advantage, an essentially single-passage amplification of viruses, should enable efficient production of vaccines as well as vectors for gene and cancer therapy.	[Tapia, Felipe; Wohlfarth, Daniel; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Sandig, Volker; Jordan, Ingo] ProBioGen AG, Berlin, Germany; [Reichl, Udo] Otto von Guericke Univ, Chair Bioproc Engn, Magdeburg, Germany	Max Planck Society; Otto von Guericke University	Tapia, F (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.	tapia@mpi-magdeburg.mpg.de		Jordan, Ingo/0000-0003-2711-7252; Tapia Delgado, Felipe/0000-0002-8470-2047	International Max Planck Research School of the Max Planck Society	International Max Planck Research School of the Max Planck Society	This work was supported by the International Max Planck Research School of the Max Planck Society to FT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. More info in https://www.mpi-magdeburg.mpg.de/imprs.	Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Buckland B, 2014, VACCINE, V32, P5496, DOI 10.1016/j.vaccine.2014.07.074; Ersu CB, 2008, ENVIRON TECHNOL, V29, P225, DOI 10.1080/09593330802029012; Frensing T, 2016, APPL MICROBIOL BIOT, V100, P7181, DOI 10.1007/s00253-016-7542-4; Frensing T, 2014, APPL MICROBIOL BIOT, V98, P8999, DOI 10.1007/s00253-014-5933-y; Frensing T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072288; Genzel Y., 2007, ANIMAL CELL BIOTECHN, P457, DOI [DOI 10.1007/978-1-59745-399-8_21, 10.1007/978-1-59745-399-8_21]; Genzel Y, 2014, VACCINE, V32, P2770, DOI 10.1016/j.vaccine.2014.02.016; Giri L, 2012, J GEN VIROL, V93, P389, DOI 10.1099/vir.0.036566-0; GORI GB, 1965, APPL MICROBIOL, V13, P909, DOI 10.1128/AEM.13.6.909-917.1965; Ingham J, 2007, INTRO MODELLING COMP; Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002; Konstantinov KB, 2015, J PHARM SCI-US, V104, P813, DOI 10.1002/jps.24268; Levenspiel O., 1962, CHEM REACTION ENG; Lohr V, 2010, VACCINE, V28, P6256, DOI 10.1016/j.vaccine.2010.07.004; Lohr V., 2014, THESIS; McLean KA, 2016, VACCINE, V34, P5410, DOI 10.1016/j.vaccine.2016.08.019; Molina E, 2001, J BIOTECHNOL, V92, P113, DOI 10.1016/S0168-1656(01)00353-4; MOSER A, 1991, BIOTECHNOL BIOENG, V37, P1054, DOI 10.1002/bit.260371111; Perdue ML, 2011, EXPERT REV VACCINES, V10, P1183, DOI [10.1586/erv.11.82, 10.1586/ERV.11.82]; Peschel B, 2013, VACCINE, V31, P5693, DOI 10.1016/j.vaccine.2013.09.051; ROTH F, 1994, BERL MUNCH TIERARZTL, V107, P123; Santek B, 2006, CHEM BIOCHEM ENG Q, V20, P389; Stettler M, 2007, BIOTECHNOL PROGR, V23, P1340, DOI 10.1021/bp070219i; Tapia F, Patent application WO, Patent No. [2017190790, 2017190790A1WO]; Tapia F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182553; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; World Health Organization Note, 2014, INFL VIR INF HUM	28	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224317	10.1371/journal.pone.0224317	http://dx.doi.org/10.1371/journal.pone.0224317			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689309	Green Published, gold			2022-12-26	WOS:000532680100017
J	Ames, S; Andring, JT; McKenna, R; Becker, HM				Ames, Samantha; Andring, Jacob T.; McKenna, Robert; Becker, Holger M.			CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells	ONCOGENE			English	Article							CARBONIC-ANHYDRASE IX; APPARENT DIFFUSION-COEFFICIENT; XENOPUS-LAEVIS OOCYTES; IMMUNOGLOBULIN SUPERFAMILY; TRANSMEMBRANE HELICES; LACTATE TRANSPORTER; ANCILLARY PROTEIN; PLASMA-MEMBRANE; BASIGIN CD147; EXPRESSION	Tumor cells rely on glycolysis to meet their elevated demand for energy. Thereby they produce significant amounts of lactate and protons, which are exported via monocarboxylate transporters (MCTs), supporting the formation of an acidic microenvironment. The present study demonstrates that carbonic anhydrase IX (CAIX), one of the major acid/base regulators in cancer cells, forms a protein complex with MCT1 and MCT4 in tissue samples from human breast cancer patients, but not healthy breast tissue. Formation of this transport metabolon requires binding of CAIX to the Ig1 domain of the MCT1/4 chaperon CD147 and is required for CAIX-mediated facilitation of MCT1/4 activity. Application of an antibody, directed against the CD147-Ig1 domain, displaces CAIX from the transporter and suppresses CAIX-mediated facilitation of proton-coupled lactate transport. In cancer cells, this "metabolon disruption" results in a decrease in lactate transport, reduced glycolysis, and ultimately reduced cell proliferation. Taken together, the study shows that carbonic anhydrases form transport metabolons with acid/base transporters in human tumor tissue and that these interactions can be exploited to interfere with tumor metabolism and proliferation.	[Ames, Samantha; Becker, Holger M.] Univ Kaiserslautern TUK, Dept Biol, Div Gen Zool, D-67653 Kaiserslautern, Germany; [Andring, Jacob T.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Becker, Holger M.] Univ Vet Med Hannover, Inst Physiol Chem, D-30559 Hannover, Germany	State University System of Florida; University of Florida; University of Veterinary Medicine Hannover, Foundation	Becker, HM (corresponding author), Univ Kaiserslautern TUK, Dept Biol, Div Gen Zool, D-67653 Kaiserslautern, Germany.	Holger.Becker@tiho-hannover.de	Becker, Holger/AAB-4322-2020		Deutsche Forschungsgemeinschaft [BE 4310/6-1]; Research Initiative BioComp; Lotto-Stiftung Rheinland-Pfalz; FAZIT Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Initiative BioComp; Lotto-Stiftung Rheinland-Pfalz; FAZIT Stiftung	We thank Heike Kanapin, Sandra Pfeiffer, HansPeter Schneider, and Patrick Pattar for technical assistance. The work was funded by the Deutsche Forschungsgemeinschaft (to H.M.B.; BE 4310/6-1), the Research Initiative BioComp (to H.M.B), and by stipends from the Lotto-Stiftung Rheinland-Pfalz and the FAZIT Stiftung (to S.A.).	Adams A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-538; Adelroth P, 2004, BBA-BIOENERGETICS, V1655, P102, DOI 10.1016/j.bbabio.2003.10.018; Alvarez BV, 2005, EMBO J, V24, P2499, DOI 10.1038/sj.emboj.7600736; Ames Samantha, 2018, Oncotarget, V9, P27940, DOI 10.18632/oncotarget.25371; Bane AL, 2014, ANN ONCOL, V25, P992, DOI 10.1093/annonc/mdu090; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2014, NEUROMETHODS, V90, P25, DOI 10.1007/978-1-4939-1059-5_2; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Beketic-Oreskovic L, 2011, PATHOL ONCOL RES, V17, P593, DOI 10.1007/s12253-010-9355-6; Belli P, 2015, RADIOL MED, V120, P268, DOI 10.1007/s11547-014-0442-8; Benjamin D, 2018, CELL REP, V25, P3047, DOI 10.1016/j.celrep.2018.11.043; Bonen A, 2000, MED SCI SPORT EXER, V32, P778, DOI 10.1097/00005768-200004000-00010; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CL, 2010, VIRCHOWS ARCH, V457, P53, DOI 10.1007/s00428-010-0938-0; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Choi JH, 2018, ANN NUCL MED, V32, P389, DOI 10.1007/s12149-018-1259-7; Choi J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3472; Choi J, 2013, PATHOBIOLOGY, V80, P41, DOI 10.1159/000339513; Cipolla V, 2014, EUR J RADIOL, V83, P2144, DOI 10.1016/j.ejrad.2014.09.015; Currie MJ, 2013, HUM PATHOL, V44, P402, DOI 10.1016/j.humpath.2012.06.004; Debernardi R, 2003, J NEUROSCI RES, V73, P141, DOI 10.1002/jnr.10660; Deitmer JW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00291; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forero-Quintero LS, 2019, J BIOL CHEM, V294, P593, DOI 10.1074/jbc.RA118.005536; FOSSUM S, 1991, EUR J IMMUNOL, V21, P671, DOI 10.1002/eji.1830210320; Friedman R, 2005, BIOPHYS J, V89, P768, DOI 10.1529/biophysj.105.058917; Guan X, 2019, AAPS J, V21, DOI 10.1208/s12248-018-0279-5; Guan XW, 2019, AAPS J, V21, DOI 10.1208/s12248-018-0261-2; Gutman M, 2006, PHOTOCH PHOTOBIO SCI, V5, P531, DOI 10.1039/b515887g; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hiremath SA, 2019, MATH BIOSCI ENG, V16, P320, DOI 10.3934/mbe.2019016; Innocenti A, 2009, BIOORG MED CHEM LETT, V19, P5825, DOI 10.1016/j.bmcl.2009.08.088; Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861; Jamali S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13605; Johnson JM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00027; Kim S, 2013, J BREAST CANCER, V16, P146, DOI 10.4048/jbc.2013.16.2.146; Klier M, 2011, J BIOL CHEM, V286, P27781, DOI 10.1074/jbc.M111.255331; Kuang YH, 2018, HONG KONG MED J, V24, P252, DOI 10.12809/hkmj176865; Kwon JE, 2013, TUMOR BIOL, V34, P115, DOI 10.1007/s13277-012-0518-9; Liu M, 2018, J CLIN PATHOL, V71, P1007, DOI 10.1136/jclinpath-2018-205342; Luz MCD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040170; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; Mboge MY, 2019, BIOCHEM J, V476, P1497, DOI 10.1042/BCJ20190177; Muramatsu T, 2016, J BIOCHEM, V159, P481, DOI 10.1093/jb/mvv127; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Noor SI, 2018, ELIFE, V7, DOI 10.7554/eLife.35176; Noor SI, 2017, FEBS J, V284, P149, DOI 10.1111/febs.13964; Noor SI, 2015, J BIOL CHEM, V290, P4476, DOI 10.1074/jbc.M114.624577; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Ozretic P, 2018, INT J BIOL MARKER, V33, P109, DOI 10.5301/ijbm.5000291; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pastorek J, 2015, SEMIN CANCER BIOL, V31, P52, DOI 10.1016/j.semcancer.2014.08.002; Pastorekova S, 2004, CANC THER, V2, P245; Pinard MA, 2015, ACTA CRYSTALLOGR F, V71, P1352, DOI 10.1107/S2053230X1501239X; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; Pinheiro C, 2010, HISTOPATHOLOGY, V56, P860, DOI 10.1111/j.1365-2559.2010.03560.x; Renner K, 2019, CELL REP, V29, P135, DOI 10.1016/j.celrep.2019.08.068; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; Supuran CT, 2017, METABOLITES, V7, DOI 10.3390/metabo7030048; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Swietach P, 2019, CANCER METAST REV, V38, P5, DOI 10.1007/s10555-018-09778-x; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Vermeulen JF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-240; Walter M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078056; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200; Wykoff CC, 2000, CANCER RES, V60, P7075; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zat'ovicova M, 2003, J IMMUNOL METHODS, V282, P117, DOI 10.1016/j.jim.2003.08.011	81	21	22	0	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1710	1723		10.1038/s41388-019-1098-6	http://dx.doi.org/10.1038/s41388-019-1098-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31723238	Green Submitted			2022-12-26	WOS:000514923000007
J	Reynolds, HM; Zhang, LP; Tran, DT; Ten Hagen, KG				Reynolds, Hayley M.; Zhang, Liping; Tran, Duy T.; Ten Hagen, Kelly G.			Tango1 coordinates the formation of endoplasmic reticulum/Golgi docking sites to mediate secretory granule formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mucin; glycoprotein secretion; secretion; Golgi; COPII; Drosophila; endoplasmic reticulum (ER); MIA SH3 domain ER export Factor 3 (MIA3); O-glycosylation; salivary gland; secretory granules; Tango1	DROSOPHILA; BIOGENESIS; GLAND; MODEL	Regulated secretion is a conserved process occurring across diverse cells and tissues. Current models suggest that the conserved cargo receptor Tango1 mediates the packaging of collagen into large coat protein complex II (COPII) vesicles that move from the endoplasmic reticulum (ER) to the Golgi apparatus. However, how Tango1 regulates the formation of COPII carriers and influences the secretion of other cargo remains unknown. Here, through high-resolution imaging of Tango1, COPII, Golgi, and secretory cargo (mucins) in Drosophila larval salivary glands, we found that Tango1 forms ring-like structures that mediate the formation of COPII rings rather than vesicles. These COPII rings act as docking sites for the cis-Golgi. Moreover, we observed nascent secretory mucins emerging from the Golgi side of these Tango1?COPII?Golgi complexes, suggesting that these structures represent functional docking sites/fusion points between the ER exit sites and the Golgi. Loss of Tango1 disrupted the formation of COPII rings, the association of COPII with the cis-Golgi, mucin O-glycosylation, and secretory granule biosynthesis. Additionally, we identified a Tango1 self-association domain that is essential for formation of this structure. Our results provide evidence that Tango1 organizes an interaction site where secretory cargo is efficiently transferred from the ER to Golgi and then to secretory vesicles. These findings may explain how the loss of Tango1 can influence Golgi/ER morphology and affect the secretion of diverse proteins across many tissues.	[Reynolds, Hayley M.; Zhang, Liping; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Sect, NIH, Bethesda, MD 20892 USA; [Tran, Duy T.] NIDCR, NIDCR Imaging Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov		Reynolds, Hayley/0000-0002-3077-5603	Intramural Research Program of the NIDCR, National Institutes of Health [Z01-DE000713]; NIDCR [DE000750-01]	Intramural Research Program of the NIDCR, National Institutes of Health; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Grant Z01-DE000713 from the Intramural Research Program of the NIDCR, National Institutes of Health (to K. G. T. H.). This work was also supported in part by NIDCR Imaging Core Grant DE000750-01 (to D. T. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Biyasheva A, 2001, DEV BIOL, V231, P234, DOI 10.1006/dbio.2000.0126; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Burgess J, 2012, DEVELOPMENT, V139, P3040, DOI 10.1242/dev.077644; Burgess J, 2011, MOL BIOL CELL, V22, P2094, DOI 10.1091/mbc.E11-01-0054; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; Heifetz Y, 2010, THERIOGENOLOGY, V73, P723, DOI 10.1016/j.theriogenology.2009.11.001; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ji S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05978-9; Ke HM, 2018, J GENET GENOMICS, V45, P299, DOI 10.1016/j.jgg.2018.05.002; KORGE G, 1977, DEV BIOL, V58, P339, DOI 10.1016/0012-1606(77)90096-3; Kurokawa K, 2019, J BIOCHEM, V165, P109, DOI 10.1093/jb/mvy080; Lerner DW, 2013, DEV CELL, V24, P159, DOI 10.1016/j.devcel.2012.12.005; Liu M, 2017, J CELL BIOL, V216, P1035, DOI 10.1083/jcb.201611088; Ma WF, 2016, P NATL ACAD SCI USA, V113, P10061, DOI 10.1073/pnas.1605916113; Maeda M, 2017, J CELL BIOL, V216, P1731, DOI 10.1083/jcb.201703084; McCaughey J, 2019, J CELL BIOL, V218, P929, DOI 10.1083/jcb.201806035; McCaughey J, 2018, HISTOCHEM CELL BIOL, V150, P119, DOI 10.1007/s00418-018-1689-2; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Petley-Ragan LM, 2016, J NEUROSCI, V36, P1151, DOI 10.1523/JNEUROSCI.1797-15.2016; Raote I, 2018, ELIFE, V7, DOI 10.7554/eLife.32723; Raote I, 2017, J CELL BIOL, V216, P901, DOI 10.1083/jcb.201608080; Rios-Barrera LD, 2017, P NATL ACAD SCI USA, V114, pE10389, DOI 10.1073/pnas.1711408114; Rousso T, 2016, NAT CELL BIOL, V18, P181, DOI 10.1038/ncb3288; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Santos AJM, 2016, J CELL BIOL, V213, P343, DOI 10.1083/jcb.201603072; Schnakenberg Sandra L, 2012, Spermatogenesis, V2, P224; Syed ZA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002850; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; Tran DT, 2017, J CELL SCI, V130, P1355, DOI 10.1242/jcs.193425; Tran DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10098; Wilson DG, 2011, J CELL BIOL, V194, P347, DOI 10.1083/jcb.2010071621942c; Yuan L, 2018, P NATL ACAD SCI USA, V115, pE12255, DOI 10.1073/pnas.1814810115; Zanetti G, 2013, ELIFE, V2, DOI 10.7554/eLife.00951; Zhang LP, 2017, J BIOL CHEM, V292, P21231, DOI 10.1074/jbc.M117.809848; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111	40	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19498	19510		10.1074/jbc.RA119.011063	http://dx.doi.org/10.1074/jbc.RA119.011063			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31690624	hybrid, Green Published			2022-12-26	WOS:000504093200005
J	Grifoll-Romero, L; Sainz-Polo, MA; Albesa-Jove, D; Guerin, ME; Biarnes, X; Planas, A				Grifoll-Romero, Laia; Angela Sainz-Polo, Maria; Albesa-Jove, David; Guerin, Marcelo E.; Biarnes, Xevi; Planas, Antoni			Structure-function relationships underlying the dual N-acetylmuramic and N-acetylglucosamine specificities of the bacterial peptidoglycan deacetylase PdaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Peptidoglycan; cell wall; bacterial pathogenesis; crystal structure; ligand-docking simulations; deacetylase; specificity; chitooligosaccharides; N-acetylglucosamine; N-acetylmuramic acid	POLYSACCHARIDE DEACETYLASES; CARBOHYDRATE ESTERASE; BACILLUS-CEREUS; CELL-SHAPE; LACTAM; STABILITY; VIRULENCE; SOFTWARE; RESIDUES; HOMOLOG	Bacillus subtilis PdaC (BsPdaC) is a membrane-bound, multidomain peptidoglycan N-deacetylase acting on N-acetylmuramic (MurNAc) residues and conferring lysozyme resistance to modified cell wall peptidoglycans. BsPdaC contains a C-terminal family 4 carbohydrate esterase (CE4) catalytic domain, but unlike other MurNAc deacetylases, BsPdaC also has GlcNAc deacetylase activity on chitooligosaccharides (COSs), characteristic of chitin deacetylases. To uncover the molecular basis of this dual activity, here we determined the X-ray structure of the BsPdaC CE4 domain at 1.54 angstrom resolution and analyzed its mode of action on COS substrates. We found that the minimal substrate is GlcNAc(3) and that activity increases with the degree of glycan polymerization. COS deacetylation kinetics revealed that BsPdaC operates by a multiple-chain mechanism starting at the internal GlcNAc units and leading to deacetylation of all but the reducing-end GlcNAc residues. Interestingly, BsPdaC shares higher sequence similarity with the peptidoglycan GlcNAc deacetylase SpPgdaA than with other MurNAc deacetylases. Therefore, we used ligand-docking simulations to analyze the dual GlcNAc- and MurNAc-binding specificities of BsPdaC and compared them with those of SpPgdA and BsPdaA, representing peptidoglycan deacetylases highly specific for GlcNAc or MurNAc residues, respectively. BsPdaC retains the conserved Asp-His-His metal-binding triad characteristic of CE4 enzymes acting on GlcNAc residues, differing from MurNAc deacetylases that lack the metal-coordinating Asp residue. BsPdaC contains short loops similar to those in SpPgdA, resulting in an open binding cleft that can accommodate polymeric substrates. We propose that PdaC is the first member of a new subclass of peptidoglycan MurNAc deacetylases.	[Grifoll-Romero, Laia; Biarnes, Xevi; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Lab Biochem, Barcelona 08017, Spain; [Angela Sainz-Polo, Maria; Albesa-Jove, David; Guerin, Marcelo E.] CIC bioGUNE, Struct Biol Unit, Bizkaia Technol Pk,Ed 801A, Derio 48160, Spain; [Albesa-Jove, David; Guerin, Marcelo E.] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain	Universitat Ramon Llull; Institut Quimic de Sarria; CIC bioGUNE; Basque Foundation for Science	Planas, A (corresponding author), Inst Quim Sarria, Via Augusta 390, Barcelona 08017, Spain.	antoni.planas@iqs.edu	PLANAS, ANTONI/I-4803-2015; Albesa-Jové, David/O-3822-2019; Albesa-Jové, David/F-5683-2016; Guerin, Marcelo/N-7245-2016	PLANAS, ANTONI/0000-0001-7073-3320; Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Guerin, Marcelo/0000-0001-9524-3184	Severo Ochoa Excellence Accreditation from MINECO, Spain. [SEV-2016-0644]; AGAUR from the Generalitat de Catalunya [2017SGR-727]; IQS; MINECO under the "Juan de la Cierva Postdoctoral program" [FJCI-2015-25725];  [BFU2016-77427-C2-1-R];  [BFU2016-77427-C2-2-R];  [BFU2017-92223-EXP]	Severo Ochoa Excellence Accreditation from MINECO, Spain.; AGAUR from the Generalitat de Catalunya; IQS; MINECO under the "Juan de la Cierva Postdoctoral program"; ; ; 	Work supported by grants BFU2016-77427-C2-1-R (to A.P.), BFU2016-77427-C2-2-R (to M.E.G.), BFU2017-92223-EXP (to M.E.G.) and Severo Ochoa Excellence Accreditation SEV-2016-0644 (to M.E.G.) from MINECO, Spain., and AGAUR grant 2017SGR-727 (to A. P.) from the Generalitat de Catalunya. We gratefully acknowledge Diamond Light Source (proposal mx15304), ALBA and iNEXT (proposal numbers 1618/2538) for granting access to synchrotron radiation facilities. Laia Grifoll acknowledges a predoctoral contract from IQS, and Maria Angela Sainz-Polo acknowledges a postdoctoral contract from MINECO under the "Juan de la Cierva Postdoctoral program" (FJCI-2015-25725). We thank Dr. Hugo Aragunde for the sequencing of deacetylated COS and Prof. Bruno Moerschbacher and Dr. Stefan Cord-Landwehr, University of Munster, for his advice on MS/MS sequencing analysis. Montserrat Murcia is acknowledged for performing some of the docking simulations.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Aragunde H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020412; ARAKI Y, 1971, BIOCHEM BIOPH RES CO, V42, P691, DOI 10.1016/0006-291X(71)90543-2; Arnaouteli S, 2015, J BIOL CHEM, V290, P13465, DOI 10.1074/jbc.M115.640029; Balomenou S, 2018, BIOORGAN MED CHEM, V26, P3845, DOI 10.1016/j.bmc.2018.06.045; Balomenou S, 2013, MOL MICROBIOL, V87, P867, DOI 10.1111/mmi.12137; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cord-Landwehr S, 2017, ANAL CHEM, V89, P2893, DOI 10.1021/acs.analchem.6b04183; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2004, J BIOCHEM, V136, P283, DOI 10.1093/jb/mvh151; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Giastas P, 2018, BIOCHEMISTRY-US, V57, P753, DOI 10.1021/acs.biochem.7b00919; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; Grifoll-Romero L, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10040352; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOHN M, 1993, P NATL ACAD SCI USA, V90, P625, DOI 10.1073/pnas.90.2.625; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobayashi K, 2012, J BIOL CHEM, V287, P9765, DOI 10.1074/jbc.M111.329490; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnyk JE, 2015, J AM CHEM SOC, V137, P6987, DOI 10.1021/jacs.5b01607; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Bui NK, 2011, BIOCHEM PHARMACOL, V82, P43, DOI 10.1016/j.bcp.2011.03.028; Oberbarnscheidt L, 2007, PROTEINS, V66, P250, DOI 10.1002/prot.21217; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popham DL, 1996, P NATL ACAD SCI USA, V93, P15405, DOI 10.1073/pnas.93.26.15405; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf AJ, 2018, NAT REV IMMUNOL, V18, P243, DOI 10.1038/nri.2017.136; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	47	9	9	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19066	19080		10.1074/jbc.RA119.009510	http://dx.doi.org/10.1074/jbc.RA119.009510			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31690626	Green Published, hybrid			2022-12-26	WOS:000516527800011
J	Liu, W; Zhou, Y; Liang, R; Zhang, Y				Liu, Wei; Zhou, Yi; Liang, Rui; Zhang, Yue			Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits	FASEB JOURNAL			English	Article						diabetes mellitus; hippocampus; apoptosis	NEURONAL APOPTOSIS; CDK5; P38; DEMENTIA; NEUROTOXICITY; MECHANISMS; RELEVANCE; ACTIVATOR; DECLINE; PATHWAY	Cognitive deficit is a prevalent and underestimated complication of diabetes, and the underlying cellular and molecular mechanisms are not well understood. Aberrant activity of cyclin-dependent kinase (Cdk)5 is implicated in a number of neurodegenerative diseases. The present study examined the role of Cdk5 in the progression of diabetes-related cognitive deficits. We showed that the Cdk5 protein expression and kinase activity were significantly increased in diabetic mice at 16 wk. In primary cultured hippocampal neurons exposed to 30 mM glucose, Cdk5 protein and kinase activity were also elevated in a time-dependent manner. Moreover, the high glucose exposure led to an aberrant Cdk5 activation due to its activator p25 that was cleaved from p35 by calpain. Both in diabetic mice and in cultured hippocampal neurons exposed to high glucose, inhibition of Cdk5 activity with roscovitine (Ros) or short hairpin RNA (shRNA) decreased the protein levels of cleaved caspase-3 and the ratio of Bax and Bcl-2. The apoptotic rate detected by TUNEL in vivo or Annexin V and propidium iodide staining for flow cytometry in vitro also had obvious reduction. In addition, high glucose exposure resulted in the increase of phosphorylated (phospho)-MAPK kinase (MKK)6, phospho-p38, and c-Jun, which were rescued by Ros or Cdk5 shRNA. It is more important that the cognitive deficits of diabetic mice were also effectively alleviated by Ros. These results indicate that aberrant Cdk5 activity triggered hippocampal neuron apoptosis by activating MKK6/p38 MAPK cascade in hyperglycemia. Inhibition of Cdk5 overactivation attenuates neuronal apoptosis and cognitive deficits and contributes to the relief of diabetic neurotoxicity in the brain.	[Liu, Wei; Liang, Rui] Hebei Med Univ, Hosp 2, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Zhou, Yi] Hebei Med Univ, Hosp 2, Dept Clin Diagnost, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yue] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhang, Y (corresponding author), Hebei Med Univ, Dept Clin Diagnost, 361 Zhongshan East Rd, Shijiazhuang, Hebei, Peoples R China.	zhyue515@126.com			National Natural Science Foundation of China [81770720]; China Postdoctoral Science Foundation Project [2016M591403]; Natural Science Fundation of Hebei Province [H2019206549, H2019206550]; Key Project of Scientific and Technological Research of Hebei Province [ZD2018003]; People's Livelihood Science and Technology Project of Hebei Province [19277784D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Project(China Postdoctoral Science Foundation); Natural Science Fundation of Hebei Province; Key Project of Scientific and Technological Research of Hebei Province; People's Livelihood Science and Technology Project of Hebei Province	This work was supported by the National Natural Science Foundation of China (81770720), the China Postdoctoral Science Foundation Project (2016M591403), the Natural Science Fundation of Hebei Province (H2019206549 and H2019206550), the Key Project of Scientific and Technological Research of Hebei Province (ZD2018003), and the People's Livelihood Science and Technology Project of Hebei Province (19277784D). The authors declare no conflicts of interest.	Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Bahar-Fuchs A, 2020, J GERONTOL A-BIOL, V75, P747, DOI 10.1093/gerona/glz073; BEER K, 2017, COCHRANE DB SYST REV, V7, DOI DOI 10.1038/S41598-017-15014-3; Biessels GJ, 2018, NAT REV ENDOCRINOL, V14, P591, DOI 10.1038/s41574-018-0048-7; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Chang KH, 2010, J NEUROCHEM, V113, P1221, DOI 10.1111/j.1471-4159.2010.06687.x; Corre I, 2017, ONCOTARGET, V8, P55684, DOI 10.18632/oncotarget.18264; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cukierman-Yaffe T, 2014, DIABETES-METAB RES, V30, P341, DOI 10.1002/dmrr.2507; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Eriksson JG, 2019, J ENDOCRINOL, V242, pT95, DOI 10.1530/JOE-18-0680; Hamdane Malika, 2007, Biotechnology Journal, V2, P967, DOI 10.1002/biot.200700059; Hardigan T, 2016, CLIN SCI, V130, P1807, DOI 10.1042/CS20160397; Harding JL, 2019, DIABETOLOGIA, V62, P3, DOI 10.1007/s00125-018-4711-2; Hasegawa Y, 2018, J ALZHEIMERS DIS, V61, P259, DOI 10.3233/JAD-170645; Jia WP, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3158; Kawauchi T, 2014, DEV GROWTH DIFFER, V56, P335, DOI 10.1111/dgd.12138; Kesavapany Sashi, 2007, Biotechnology Journal, V2, P978, DOI 10.1002/biot.200700057; Kheiri G, 2019, REV NEUROSCIENCE, V30, P9, DOI 10.1515/revneuro-2018-0008; Kong FJ, 2018, CLIN SCI, V132, P111, DOI 10.1042/CS20171432; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Lee JK, 2017, MOLECULES, V22, DOI 10.3390/molecules22081287; Li W, 2017, J ALZHEIMERS DIS, V57, P29, DOI 10.3233/JAD-161250; Liu SL, 2016, MOL NEUROBIOL, V53, P4328, DOI 10.1007/s12035-015-9369-x; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Martins RN, 2017, J ALZHEIMERS DIS, V59, P389, DOI 10.3233/JAD-170309; Matioli Maria Niures Pimentel dos Santos, 2017, Dement. neuropsychol., V11, P406, DOI 10.1590/1980-57642016dn11-040010; Moran C, 2017, J ALZHEIMERS DIS, V59, P405, DOI 10.3233/JAD-161166; Mushtaq G, 2016, CURR PHARM DESIGN, V22, P527, DOI 10.2174/1381612822666151124235028; Ojo O, 2015, INT J ENV RES PUB HE, V12, P8281, DOI 10.3390/ijerph120708281; Reno CM, 2013, AM J PHYSIOL-ENDOC M, V304, pE1331, DOI 10.1152/ajpendo.00084.2013; Shah K, 2017, MOL NEUROBIOL, V54, P2255, DOI 10.1007/s12035-016-9792-7; Simo R, 2017, ACTA DIABETOL, V54, P417, DOI 10.1007/s00592-017-0970-5; Wang NN, 2018, LIFE SCI, V212, P194, DOI 10.1016/j.lfs.2018.09.035; Wang WY, 2014, NEUROPHARMACOLOGY, V77, P90, DOI 10.1016/j.neuropharm.2013.09.006; Wilkaniec A, 2016, J NEUROCHEM, V136, P222, DOI 10.1111/jnc.13365; Xourgia E, 2019, WORLD J DIABETES, V10, P169, DOI 10.4239/wjd.v10.i3.169; Young PR, 2013, J BIOMOL SCREEN, V18, P1156, DOI 10.1177/1087057113497401; Yu JL, 2019, J CELL PHYSIOL, V234, P10655, DOI 10.1002/jcp.27746; Zhang HM, 2017, TOXICOL LETT, V277, P41, DOI 10.1016/j.toxlet.2017.05.027; Zhang J, 2008, CELL CYCLE, V7, P3487, DOI 10.4161/cc.7.22.7045; Zhu XW, 2001, J NEUROCHEM, V79, P311, DOI 10.1046/j.1471-4159.2001.00597.x	43	6	6	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14506	14515		10.1096/fj.201901292R	http://dx.doi.org/10.1096/fj.201901292R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689375	Bronze			2022-12-26	WOS:000507466100111
J	McKinney, ML; Gladstone, NS; Lentz, JG; Jackson, FA				McKinney, Michael L.; Gladstone, Nicholas S.; Lentz, Jillian G.; Jackson, Faith A.			Land snail dispersal, abundance and diversity on green roofs	PLOS ONE			English	Article							HABITAT; BIODIVERSITY; COMMUNITIES; FORESTS	We present the first major systematic study of land snail diversity on green roofs. We surveyed 27 green roofs and the adjacent ground habitat in six major cities in the southeastern United States. We found a total of 18 species of land snails, with three considered to be non-native or invasive species. The majority of land snails encountered in surveys are widespread, generalist species, typically adapted to open habitats. Twelve of the land snails encountered are "greenhouse" species that are very commonly transported via the horticultural trade. Therefore, we infer that at least some land snail species are introduced to green roofs via initial green roof installation and associated landscaping. The major determinants of snail species richness and abundance are the size of each roof and the quality of green roof maintenance regime.	[McKinney, Michael L.; Lentz, Jillian G.; Jackson, Faith A.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Gladstone, Nicholas S.] Southern Illinois Univ, Dept Zool, Carbondale, IL USA	University of Tennessee System; University of Tennessee Knoxville; Southern Illinois University System; Southern Illinois University	McKinney, ML (corresponding author), Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA.	mmckinne@utk.edu	mckinney, michael/AAK-6958-2021; Gladstone, Nicholas/ABI-6569-2020	mckinney, michael/0000-0001-6390-1795; Gladstone, Nicholas/0000-0001-5799-9992				Barbato D, 2017, URBAN ECOSYST, V20, P919, DOI 10.1007/s11252-017-0643-8; Barton K, 2020, MUMIN MULTIMODEL INF; Bergey EA, 2019, URBAN ECOSYST, V22, P325, DOI 10.1007/s11252-018-0815-1; Bergey EA, 2014, BIOL INVASIONS, V16, P1441, DOI 10.1007/s10530-013-0581-1; Braaker S, 2014, ECOLOGY, V95, P1010, DOI 10.1890/13-0705.1; Burch JB, 1962, KNOW E LAND SNAILS, pB87; CASCONE S, 2019, SUSTAINABILITY BASEL, V0011, DOI DOI 10.3390/SU11113020; Cowie RH, 2008, INT J PEST MANAGE, V54, P267, DOI 10.1080/09670870802403986; Dourson D.C., 2010, KENTUCKYS LAND SNAIL; Fernandez-Canero R, 2010, J ANIM VET ADV, V9, P2041; Harp DA, 2015, HORTTECHNOLOGY, V25, P221, DOI 10.21273/HORTTECH.25.2.221; Hodges MN, 2018, URBAN ECOSYST, V21, P721, DOI 10.1007/s11252-018-0746-x; Horsak M, 2016, BIOL INVASIONS, V18, P3547, DOI 10.1007/s10530-016-1247-6; Hubricht L, 1985, DISTRIBUTIONS NATIVE; Joimel S, 2018, ECOL ENG, V111, P117, DOI 10.1016/j.ecoleng.2017.12.002; Kappes H, 2014, POL J ECOL, V62, P739, DOI 10.3161/104.062.0416; Kirchenbaur T, 2017, FOREST ECOL MANAG, V396, P85, DOI 10.1016/j.foreco.2017.03.034; Kratschmer S, 2018, URBAN ECOSYST, V21, P429, DOI 10.1007/s11252-017-0726-6; Kyro K, 2018, URBAN FOR URBAN GREE, V29, P122, DOI 10.1016/j.ufug.2017.11.009; Liew TS, 2008, ZOOSYMPOSIA, V1, P271, DOI 10.11646/zoosymposia.1.1.16; Lososova Z, 2011, J BIOGEOGR, V38, P1152, DOI 10.1111/j.1365-2699.2011.02475.x; MacIvor JS, 2015, ECOL STUD-ANAL SYNTH, V223, P333, DOI 10.1007/978-3-319-14983-7_14; MacIvor JS, 2011, URBAN ECOSYST, V14, P225, DOI 10.1007/s11252-010-0149-0; Pall-Gergely Barna, 2014, Memoranda Societatis pro Fauna et Flora Fennica, V90, P13; Petremand G, 2018, URBAN ECOSYST, V21, P119, DOI 10.1007/s11252-017-0697-7; Pilsbry H., 1948, ACAD NATURAL SCI PHI, V2; R Core Team, 2021, R LANGUAGE ENV STAT; Rees W. J., 1965, Proceedings of the Malacological Society of London, V36, P269; Venables WN., 2002, MODERN APPL STAT S 4; Wada S, 2012, J BIOGEOGR, V39, P69, DOI 10.1111/j.1365-2699.2011.02559.x; Williams NSG, 2014, J APPL ECOL, V51, P1643, DOI 10.1111/1365-2664.12333; Yildirim S, 2018, INT J ADV APPL SCI, V5, P87, DOI 10.21833/ijaas.2018.10.012	32	5	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0221135	10.1371/journal.pone.0221135	http://dx.doi.org/10.1371/journal.pone.0221135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725718	Green Published, gold, Green Submitted			2022-12-26	WOS:000532764500005
J	Kebede, A; Beyene, D; Yenew, B; Diriba, G; Mehamd, Z; Alemu, A; Amare, M; Ameni, G				Kebede, Abebaw; Beyene, Dereje; Yenew, Bazezew; Diriba, Getu; Mehamd, Zemedu; Alemu, Ayinalem; Amare, Misikr; Ameni, Gobena			Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PERFORMANCE	Introduction In Ethiopia, >300 GeneXpert instruments have been deployed for tuberculosis (TB) testing using the Xpert MTB/RIF cartridge. Implementing quality indicators is necessary for monitoring and evaluating the quality of Xpert MTB/RIF diagnostic services. Objective To assess the use of quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia and to compare the findings with the predefined targets described in the literature. Methods Clinical specimens collected from patients with suspected TB were subjected to Xpert MTB/RIF testing at the National TB Reference Laboratory (NTRL) between January and December 2018. Data were collected from GeneXpert software and Laboratory Information System (LIS) databases. Quality indicators were calculated and analyzed. Bivariate and multivariate analyses were performed using SPSS software version 20 (SPSS Inc., Chicago, Illinois, USA). Results Of the 2515 specimens tested, 2274 (90.4%) had successful test results; 18.2% were positive for Mycobacterium tuberculosis (MTB). Among MTB positives (n = 413), 4.8% and 1.0% were rifampicin (RIF)-resistant and RIF-indeterminate cases, respectively. Unsuccessful results were 241 (9.6%); 8.9% of the total number of tests were errors, 0.04% had invalid results and 0.6% 'no result'. The most frequent error was probe check failure (error 5007). Instrument module A4, B2, B3, C3, and D3 (p<0.05) and tester experience (p<0.05) had a statistically significant association with errors in multivariate analysis. Additional 42 MTB cases (9.2% of the total cases) were detected among unsuccessful results by follow-up tests. Sixty-four percent of the initial test results were released within the turnaround time (TAT) <= 24 hours. Conclusion Most of the quality indicators for the Xpert MTB/RIF molecular assay were maintained within the targets. However, the error rate and TAT were out of the targets. Defective modules and lacking experience were the factors affecting successful test outcomes.	[Kebede, Abebaw; Yenew, Bazezew; Diriba, Getu; Mehamd, Zemedu; Alemu, Ayinalem; Amare, Misikr] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Kebede, Abebaw; Beyene, Dereje] Addis Ababa Univ, Coll Nat & Computat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Ameni, Gobena] Addis Ababa Univ, Aklilu Lemma Inst Pathol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Kebede, A (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.; Kebede, A (corresponding author), Addis Ababa Univ, Coll Nat & Computat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.	jkabebaw@gmail.com	Tessema, Bazezew Yenew/AAO-4148-2020; Ameni, Gobena/AAR-4201-2020	Ameni, Gobena/0000-0003-3987-0671; Alemu Shitie, Ayinalem/0000-0001-5307-8774; Kebede, Abebaw/0000-0002-6154-7275	FIC NIH HHS [D43 TW009127] Funding Source: Medline	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Agizew T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183237; Agonafir Mulualem, 2018, J Clin Tuberc Other Mycobact Dis, V12, P48, DOI 10.1016/j.jctube.2018.06.007; AKANE A, 1994, J FORENSIC SCI, V39, P362; Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; [Anonymous], 2012, 151892012 ISO; [Anonymous], 2012, GEN DX SYST OP MAN S; Ardizzoni E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144656; Arega B, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3943-1; Assefa D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3716-x; Berhe G, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-448; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Bodmer T, 2012, JOVE-J VIS EXP, DOI 10.3791/3547; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; Datiko DG, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6620-9; Derbie A, 2016, ETHIOP J HEALTH DEV, V30, P60; Eshetie Setegn, 2016, Int J Mycobacteriol, V5 Suppl 1, pS119, DOI 10.1016/j.ijmyco.2016.09.022; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; FMOH, 2018, NAT GUID TB TB LEPR; FMOH, 2014, IMPL GUID GEN MTD RI; Foundation for Innovative New Diagnostics, 2011, PERF XPERT MTB RIF V; Gelalcha AG, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2701-5; Geleta DA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0566-6; Gidado M, 2018, PUBLIC HEALTH ACTION, V8, P2, DOI 10.5588/pha.17.0080; Global Laboratory Initiative, 2017, PRACT GUID TB LAB ST; Jaleta KN, 2017, INFECT DRUG RESIST, V10, P185, DOI 10.2147/IDR.S135935; Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417; Maronna Aila, 2017, J. Bras. Patol. Med. Lab., V53, P165, DOI 10.5935/1676-2444.20170028; McCarthy KD, 2008, INT J TUBERC LUNG D, V12, P1015; Mulu Wondemagegn, 2017, BMC Res Notes, V10, P8, DOI 10.1186/s13104-016-2328-4; Mustapha G., 2015, SAARC Journal of Tuberculosis, Lung Diseases and HIV/AIDS, V12, P1; Selvakumar N, 2012, INT J MYCOBACT, V1, P185, DOI 10.1016/j.ijmyco.2012.09.004; Shiferaw MB, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4077-2; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2014, XOERT MTB RIF IMPL M; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM	37	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225205	10.1371/journal.pone.0225205	http://dx.doi.org/10.1371/journal.pone.0225205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714934	gold, Green Published			2022-12-26	WOS:000532710400036
J	Zhao, JF; Yu, AL; Du, YW; Wang, GH; Li, YF; Zhao, GY; Wang, XD; Zhang, WZ; Cheng, K; Liu, X; Wang, ZH; Wang, YW				Zhao, Jinfeng; Yu, Aili; Du, Yanwei; Wang, Gaohong; Li, Yanfang; Zhao, Genyou; Wang, Xiangdong; Zhang, Wenzhong; Cheng, Kai; Liu, Xin; Wang, Zhenhua; Wang, Yuwen			Foxtail millet (Setaria italica (L.) P. Beauv) CIPKs are responsive to ABA and abiotic stresses	PLOS ONE			English	Article							INTERACTING PROTEIN-KINASE; B-LIKE PROTEINS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR RESPONSES; PLANT-RESPONSES; GENOME SEQUENCE; CALCIUM SENSORS; GENE; CBL; TOLERANCE	CBL-interacting protein kinases (CIPKs) have been shown to regulate a variety of environmental stress-related signalling pathways in plants. Foxtail millet (Setaria italica (L.) P. Beauv) is known worldwide as a relatively stress-tolerant C4 crop species. Although the foxtail millet genome sequence has been released, little is known about the functions of CIPKs in foxtail millet. Therefore, a systematic genome-wide analysis of CIPK genes in foxtail millet was performed. In total, 35 CIPK members were identified in foxtail millet and divided into four subgroups (I to IV) on the basis of their phylogenetic relationships. Phylogenetic and gene structure analyses clearly divided all SiCIPKs into intron-poor and intron-rich clades. Cis-element analysis subsequently indicated that these SiCIPKs may be involved in responses to abiotic stimuli, hormones, and light signalling during plant growth and development, and stress-induced expression profile analysis revealed that all the SiCIPKs are involved in various stress signalling pathways. These results suggest that the CIPK genes in foxtail millet exhibit the basic characteristics of CIPK family members and play important roles in response to abiotic stresses. The results of this study will contribute to future functional characterization of abiotic stress responses mediated by CIPKs in foxtail millet.	[Zhao, Jinfeng; Yu, Aili; Du, Yanwei; Wang, Gaohong; Li, Yanfang; Zhao, Genyou; Zhang, Wenzhong; Cheng, Kai; Liu, Xin; Wang, Zhenhua; Wang, Yuwen] Shanxi Acad Agr Sci, Millet Res Inst, Shanxi Key Lab Genet Resources & Breeding Minor C, Changzhi, Shanxi, Peoples R China; [Wang, Xiangdong] Tangshan Acad Agr Sci, Tangshan, Hebei, Peoples R China	Shanxi Agricultural University	Zhao, JF; Yu, AL (corresponding author), Shanxi Acad Agr Sci, Millet Res Inst, Shanxi Key Lab Genet Resources & Breeding Minor C, Changzhi, Shanxi, Peoples R China.	zhaojfmail@126.com; yuailimail@126.com	li, yan/GTI-4638-2022		China Agricultural Research System [CARS-06-13.5-A23]; Project Plan of Shanxi Academy of Agricultural Sciences [YGG17021, YCX2018206]	China Agricultural Research System; Project Plan of Shanxi Academy of Agricultural Sciences	This work was supported by China Agricultural Research System (CARS-06-13.5-A23) and The Project Plan of Shanxi Academy of Agricultural Sciences (YGG17021 and YCX2018206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdula SE, 2016, PLANT MOL BIOL REP, V34, P501, DOI 10.1007/s11105-015-0939-x; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Albrecht V, 2001, EMBO J, V20, P1051, DOI 10.1093/emboj/20.5.1051; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bajaj S, 1999, MOL BREEDING, V5, P493, DOI 10.1023/A:1009660413133; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Chaves-Sanjuan A, 2014, P NATL ACAD SCI USA, V111, pE4532, DOI 10.1073/pnas.1407610111; Chen XF, 2011, J GENET GENOMICS, V38, P77, DOI 10.1016/j.jcg.2011.01.005; Cui XY, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1306-5; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Gao P, 2008, PLANT PHYSIOL BIOCH, V46, P935, DOI 10.1016/j.plaphy.2008.05.001; Guo YL, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1122-z; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He LR, 2013, BIOCHEM BIOPH RES CO, V435, P209, DOI 10.1016/j.bbrc.2013.04.080; Holmberg N, 1998, TRENDS PLANT SCI, V3, P61, DOI 10.1016/S1360-1385(97)01163-1; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu DG, 2012, PLANT CELL REP, V31, P713, DOI 10.1007/s00299-011-1189-5; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Hu W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00914; Huang CL, 2011, PLANT SCI, V181, P57, DOI 10.1016/j.plantsci.2011.03.011; Jia XP, 2016, J ANIM PLANT SCI, V26, P1526; Kanwar P, 2014, CELL CALCIUM, V56, P81, DOI 10.1016/j.ceca.2014.05.003; Kleist TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00187; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li LB, 2010, AGR SCI CHINA, V9, P19, DOI 10.1016/S1671-2927(09)60063-8; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan S, 2009, CURR OPIN PLANT BIOL, V12, P339, DOI 10.1016/j.pbi.2009.05.003; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mo CY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00269; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2013, CURR SCI INDIA, V105, P155; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Pan WH, 2018, RICE, V11, DOI 10.1186/s12284-018-0242-1; Pandey GK, 2015, PLANT PHYSIOL, V169, P780, DOI 10.1104/pp.15.00623; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Sheng LX, 2018, APPL BIOCHEM BIOTECH, V184, P63, DOI 10.1007/s12010-017-2530-4; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Sun T, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0657-4; Tai FJ, 2016, PLANT CELL TISS ORG, V124, P459, DOI 10.1007/s11240-015-0906-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01361; Tang RJ, 2015, P NATL ACAD SCI USA, V112, P3134, DOI 10.1073/pnas.1420944112; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Wang RK, 2012, PLANT MOL BIOL, V79, P123, DOI 10.1007/s11103-012-9899-9; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xi Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00978; Xiang Y, 2007, PLANT PHYSIOL, V144, P1416, DOI 10.1104/pp.107.101295; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Xu YY, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1784-0; Yan Y, 2018, PLANT CELL REP, V37, P887, DOI 10.1007/s00299-018-2276-7; Yang WQ, 2008, J GENET GENOMICS, V35, P531, DOI 10.1016/S1673-8527(08)60073-9; Yu QY, 2014, PLANT CELL REP, V33, P203, DOI 10.1007/s00299-013-1507-1; Yu YH, 2007, PLANT GROWTH REGUL, V52, P101, DOI 10.1007/s10725-007-9165-3; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang HF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-8; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang YM, 2017, PLANT MOL BIOL REP, V35, P634, DOI 10.1007/s11105-017-1051-1; Zhao JF, 2009, PLANT MOL BIOL, V69, P661, DOI 10.1007/s11103-008-9445-y; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu KK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28225	71	9	12	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225091	10.1371/journal.pone.0225091	http://dx.doi.org/10.1371/journal.pone.0225091			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714948	Green Published, gold			2022-12-26	WOS:000532710400027
J	Nozaki, H; Matsuzaki, R; Kashindye, BB; Ezekiel, CN; Shaban, S; Kawachi, M; Aibara, M; Nikaido, M				Nozaki, Hisayoshi; Matsuzaki, Ryo; Kashindye, Benedicto Boniphace; Ezekiel, Charles Nyarongo; Shaban, Sophia; Kawachi, Masanobu; Aibara, Mitsuto; Nikaido, Masato			Morphology, phylogeny, and taxonomy of two species of colonial volvocine green algae from Lake Victoria, Tanzania	PLOS ONE			English	Article							NOV VOLVOCACEAE; CHLOROPHYCEAE; EUDORINA; PLEODORINA; REPRODUCTION; EVOLUTION	The biodiversity and taxonomy of colonial volvocine green algae are important in ancient lakes in tropical regions. However, few taxonomic studies of these algae have been conducted in African ancient lakes. Here, we describe two species of colonial volvocine green algae in cultures originating from water samples from Lake Victoria, an ancient lake in Africa. One was identified as an undescribed morphological species of Eudorina; E. compacta sp. nov. This new species can be distinguished from other Eudorina species by its compactly arranged vegetative cells that form a hollow ellipsoidal colony. The other was identified as Colemanosphaera charkowiensis. The genus Colemanosphaera is new to Africa.	[Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Matsuzaki, Ryo; Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Matsuzaki, Ryo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kashindye, Benedicto Boniphace; Ezekiel, Charles Nyarongo; Shaban, Sophia] Tanzania Fisheries Res Inst TAFIRI, Mwanza, Tanzania; [Aibara, Mitsuto; Nikaido, Masato] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan	University of Tokyo; National Institute for Environmental Studies - Japan; University of Tsukuba; Tokyo Institute of Technology	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan.	nozaki@bs.s.u-tokyo.ac.jp		Nozaki, Hisayoshi/0000-0002-9308-4498; Matsuzaki, Ryo/0000-0002-8989-5933	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [16H02518, 17H04606]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	This study was supported by a Grants-inAid for Scientific Research (grant numbers 16H02518 for HN and 17H04606 for MN) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coleman AW, 2014, PHYCOLOGIA, V53, P423, DOI 10.2216/14-015.1; Coleman AW, 2002, AM J BOT, V89, P1523, DOI 10.3732/ajb.89.9.1523; Cristescu ME, 2010, MOL ECOL, V19, P4837, DOI 10.1111/j.1365-294X.2010.04832.x; Ettl H, 1983, SUSSWASSERFLORA MITT, V9; Fabry S, 1999, J MOL EVOL, V48, P94, DOI 10.1007/PL00006449; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FULTON AB, 1978, DEV BIOL, V64, P224, DOI 10.1016/0012-1606(78)90074-X; GOLDSTEIN M, 1964, J PROTOZOOL, V11, P317, DOI 10.1111/j.1550-7408.1964.tb01762.x; Hamaji T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0019-5; Hanschen ER, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11370; Hu YX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01351; Isaka N, 2012, J PHYCOL, V48, P759, DOI 10.1111/j.1529-8817.2012.01142.x; Kawachi M., 2013, MCC NIES LIST STRAIN; Kimbara R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221632; Kulikovskiy Maxim S., 2015, V26, P10; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Martens K, 1997, TRENDS ECOL EVOL, V12, P177, DOI 10.1016/S0169-5347(97)01039-2; McCracken MD, 1970, ARCH PROTISTENKD, V112, P262; Nakada T., 2015, FRESHWATER ALGAE N A, V2, P265, DOI [DOI 10.1016/B978-0-12-385876-4.00006-2, 10.1016/B978-0-12-385876-4.00006-2]; NOZAKI H, 1992, PHYCOLOGIA, V31, P529, DOI 10.2216/i0031-8884-31-6-529.1; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; NOZAKI H, 1991, PHYCOLOGIA, V30, P449, DOI 10.2216/i0031-8884-30-5-449.1; NOZAKI H, 1989, PHYCOLOGIA, V28, P252, DOI 10.2216/i0031-8884-28-2-252.1; NOZAKI H, 1983, BOT MAG TOKYO, V96, P103, DOI 10.1007/BF02491095; Nozaki H, 2001, EUR J PHYCOL, V36, P23, DOI 10.1080/09670260110001735158; Nozaki H, 1994, PHOTOMICROGRAPHS FRE, V3, P22; Nozaki H, 2019, PHYCOLOGIA, V58, P192, DOI 10.1080/00318884.2018.1540238; Nozaki H, 2017, PHYCOLOGIA, V56, P469, DOI 10.2216/17-3.1; Nozaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142632; Nozaki H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-37; Pringsheim E.G., 1946, PURE CULTURES ALGAE; RICH FLORENCE, 1933, ANN S AFRICAN MUS, V16, P427; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Smith Gilbert M., 1944, TRANS AMER MICROSC SOC, V63, P265, DOI 10.2307/3223302; STARR RC, 1980, P NATL ACAD SCI-BIOL, V77, P1025, DOI 10.1073/pnas.77.2.1025; West G. S., 1910, J QUECETT MICROSC 2, V11, P99; Yamada TK, 2008, EUR J PHYCOL, V43, P317, DOI 10.1080/09670260701763484	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224269	10.1371/journal.pone.0224269	http://dx.doi.org/10.1371/journal.pone.0224269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710621	gold, Green Published			2022-12-26	WOS:000532699900007
J	Irwin, RM; Bonassar, LJ; Cohen, I; Matuska, AM; Commins, J; Cole, B; Fortier, LA				Irwin, Rebecca M.; Bonassar, Lawrence J.; Cohen, Itai; Matuska, Andrea M.; Commins, Jacqueline; Cole, Brian; Fortier, Lisa A.			The clot thickens: Autologous and allogeneic fibrin sealants are mechanically equivalent in an ex vivo model of cartilage repair	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO; ARTICULAR-CARTILAGE; SCAFFOLD; GLUE; THROMBELASTOGRAPHY; MICROFRACTURE; BIOCARTILAGE; INTEGRATION; DEPENDENCE	Fibrin sealants are commonly used in cartilage repair surgeries to adhere cells or grafts into a cartilage defect. Both autologous and commercial allogeneic fibrin sealants are used in cartilage repair surgeries, yet there are no studies characterizing and comparing the mechanical properties of fibrin sealants from all-autologous sources. The objectives of this study were to investigate (i) the effect of fibrinogen and thrombin sources on failure mechanics of sealants, and (ii) how sealants affect the adhesion of particulated cartilage graft material (BioCartilage) to surrounding cartilage under physiological loading. Allogeneic thrombin and fibrinogen were purchased (Tisseel), and autologous sources were prepared from platelet-rich plasma (PRP) and platelet-poor plasma (PPP) generated from human blood. To compare failure characteristics, sealants were sandwiched between cartilage explants and pulled to failure. The effect of sealant on the adhesion of BioCartilage graft to cartilage was determined by quantifying microscale strains at the graft-cartilage interface using an in vitro cartilage defect model subjected to shear loading at physiological strains well below failure thresholds. Fibrinogen sources were not equivalent; PRP fibrinogen created sealants that were more brittle, failed at lower strains, and resulted in sustained higher strains through the graft-cartilage interface depth compared to PPP and allogeneic sources. PPP clotted slower compared to PRP, suggesting PPP may percolate deeper into the repair to provide more stability through the tissue depth. There was no difference in bulk failure properties or microscale strains at the graft-cartilage interface between the purely autologous sealant (autologous thrombin + PPP fibrinogen) and the commercial allogeneic sealant. Clinical Significance: All-autologous fibrin sealants fabricated with PPP have comparable adhesion strength as commercial allogeneic sealants in vitro, whereas PRP creates an inferior allautologous sealant that sustains higher strains through the graft-cartilage interface depth.	[Irwin, Rebecca M.; Bonassar, Lawrence J.; Commins, Jacqueline] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY USA; [Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Cohen, Itai] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Matuska, Andrea M.] Arthrex Inc, Res & Dev, Naples, FL USA; [Cole, Brian] Rush Univ, Med Ctr, Midwest Orthoped Rush, Chicago, IL 60612 USA; [Fortier, Lisa A.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Rush University; Cornell University	Fortier, LA (corresponding author), Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA.	laf4@cornell.edu		Matuska, Andrea/0000-0001-9751-7986; Irwin, Rebecca/0000-0001-6549-9912	Graduate Assistance in Areas of National Need (GAANN) [P200A150273]; National Institute of Health Research Project Grant Program [5R01AR071394-02]; National Science Foundation Civil, Mechanical, and Manufacturing Innovation (CMMI) [1536463]; Arthrex Inc.; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071394] Funding Source: NIH RePORTER	Graduate Assistance in Areas of National Need (GAANN)(US Department of Education); National Institute of Health Research Project Grant Program; National Science Foundation Civil, Mechanical, and Manufacturing Innovation (CMMI); Arthrex Inc.; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was partially funded by the Graduate Assistance in Areas of National Need (GAANN) Fellowship grant number P200A150273 (https://www2.ed.gov/programs/gaann/index.html) to RI. This research was partially funded through the National Institute of Health Research Project Grant Program grant number 5R01AR071394-02 (https://grants.nih.gov/grants/funding/r01.htm), the National Science Foundation Civil, Mechanical, and Manufacturing Innovation (CMMI) grant 1536463 (https://www.nsf.gov/div/index.jsp?div= CMMI), and by Arthrex Inc. The sponsor Arthrex played the following roles in this study. A.M is a full time employee of Arthrex Inc and contributed to fibrin sealant fabrication, discussion of results, and commented on manuscript. B.C. and L.F. are both consultants for Arthrex Inc. B.C. participated in planning of shear loading experiments and editing of manuscript. L.F. supervised all experiments, participated in planning of all experiments, interpretation of data, and writing and editing of manuscript.	Azadani AN, 2009, ANN THORAC SURG, V87, P1154, DOI 10.1016/j.athoracsur.2008.12.072; Baxter Healthcare Corporation, 2013, TISS FIBR SEAL PACK; Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X; Blaber J, 2015, EXP MECH, V55, P1105, DOI 10.1007/s11340-015-0009-1; Bonnevie ED, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216702; Bonnevie ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143415; Buckley MR, 2008, J BIOMECH, V41, P2430, DOI 10.1016/j.jbiomech.2008.05.021; Buckley MR, 2010, J BIOMECH, V43, P796, DOI 10.1016/j.jbiomech.2009.10.012; Castillo TN, 2011, AM J SPORT MED, V39, P266, DOI 10.1177/0363546510387517; Chan DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19220; Choi NY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-103; Christensen BB, 2015, CARTILAGE, V6, P166, DOI 10.1177/1947603515580983; Cravens MG, 2017, CLIN BIOMECH, V49, P34, DOI 10.1016/j.clinbiomech.2017.08.004; Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045; Dickneite G, 2003, THROMB RES, V112, P73, DOI 10.1016/j.thromres.2003.10.010; Epstein KL, 2011, J VET INTERN MED, V25, P307, DOI 10.1111/j.1939-1676.2010.0673.x; Epstein KL, 2009, J VET EMERG CRIT CAR, V19, P96, DOI 10.1111/j.1476-4431.2008.00381.x; Farr J, 2014, AM J SPORT MED, V42, P1417, DOI 10.1177/0363546514528671; Fortier LA, 1998, AM J VET RES, V59, P514; Fortier LA, 2016, AM J SPORT MED, V44, P2366, DOI 10.1177/0363546516648644; GAFFNEY PJ, 1992, THROMB HAEMOSTASIS, V68, P428; Glidden PF, 2000, CLIN APPL THROMB-HEM, V6, P226, DOI 10.1177/107602960000600408; Goodrich LR, 2016, J BONE JOINT SURG AM, V98, P23, DOI 10.2106/JBJS.O.00407; Gugerell A, 2014, WOUND REPAIR REGEN, V22, P740, DOI 10.1111/wrr.12234; Hale BW, 2012, AM J VET RES, V73, P313, DOI 10.2460/ajvr.73.2.313; Hanson AJ, 2002, J BIOMED MATER RES, V61, P474, DOI 10.1002/jbm.10196; Henak CR, 2016, J BIOMECH, V49, P3320, DOI 10.1016/j.jbiomech.2016.08.016; Herberhold C, 1999, J BIOMECH, V32, P1287, DOI 10.1016/S0021-9290(99)00130-X; Hickerson WL, 2011, BLOOD COAGUL FIBRIN, V22, P19, DOI 10.1097/MBC.0b013e32833fcbfb; Hirahara AM, 2015, SPORTS MED ARTHROSC, V23, P143, DOI 10.1097/JSA.0000000000000071; Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587; Hohendorff B, 2009, J FOOT ANKLE SURG, V48, P439, DOI 10.1053/j.jfas.2009.04.005; Hunter CJ, 2004, TISSUE ENG, V10, P736, DOI 10.1089/1076327041348310; Isaacs JE, 2008, J HAND SURG-AM, V33A, P893, DOI 10.1016/j.jhsa.2008.02.009; Johnson TS, 2004, TISSUE ENG, V10, P1308, DOI 10.1089/1076327042500445; Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04; Lacaze L, 2012, J SURG RES, V176, P455, DOI 10.1016/j.jss.2011.11.1017; Lamsa T, 2008, PANCREAS, V36, P261, DOI 10.1097/MPA.0b013e31816714a2; Man D, 2001, PLAST RECONSTR SURG, V107, P229, DOI 10.1097/00006534-200101000-00037; McCormick F, 2014, ARTHROSCOPY, V30, P222, DOI 10.1016/j.arthro.2013.11.001; Meppelink AM, 2016, TISSUE ENG PT A, V22, P962, DOI [10.1089/ten.TEA.2015.0577, 10.1089/ten.tea.2015.0577]; Middendorf JM, 2017, J BIOMECH, V64, P77, DOI 10.1016/j.jbiomech.2017.09.007; Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947; Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151; Peretti GM, 1999, TISSUE ENG, V5, P317, DOI 10.1089/ten.1999.5.317; Qureshi AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007627; Rees M, 1996, BRIT J SURG, V83, P1526, DOI 10.1002/bjs.1800831110; Salamanna F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846045; Sameem M, 2011, PLAST RECONSTR SURG, V127, P2381, DOI 10.1097/PRS.0b013e3182131cf5; Scotti C, 2010, KNEE SURG SPORT TR A, V18, P1400, DOI 10.1007/s00167-009-1014-7; Spotnitz William D, 2014, ISRN Surg, V2014, P203943, DOI 10.1155/2014/203943; Triplett DA, 1981, PROCEDURES COAGULATI, P38; Verra WC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200804; Wang KC, 2017, ARTHROSC TEC, V6, pE1613, DOI 10.1016/j.eats.2017.06.018	54	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224756	10.1371/journal.pone.0224756	http://dx.doi.org/10.1371/journal.pone.0224756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703078	Green Published, gold			2022-12-26	WOS:000532697200021
J	Dayton, L; Gicquelais, RE; Tobin, K; Davey-Rothwell, M; Falade-Nwulia, O; Kong, XR; Fingerhood, M; Jones, AA; Latkin, C				Dayton, Lauren; Gicquelais, Rachel E.; Tobin, Karin; Davey-Rothwell, Melissa; Falade-Nwulia, Oluwaseun; Kong, Xiangrong; Fingerhood, Michael; Jones, Abenaa A.; Latkin, Carl			More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD	PLOS ONE			English	Article							OPIOID OVERDOSE DEATHS; DRUG OVERDOSE; INTRANASAL; EDUCATION; HEROIN; TRENDS; TRIAL; CARE	Background Fatal opioid overdose is a pressing public health concern in the United States. Addressing barriers and augmenting facilitators to take-home naloxone (THN) access and administration could expand program reach in preventing fatal overdoses. Methods THN access (i.e., being prescribed or receiving THN) was assessed in a Baltimore, Maryland-based sample of 577 people who use opioids (PWUO) and had a history of injecting drugs. A sub-analysis examined correlates of THN administration among those with THN access and who witnessed an overdose (N = 345). Logistic generalized estimating equations with robust standard errors were used to identify facilitators and barriers to accessing and using THN. Results The majority of PWUO (66%) reported THN access. In the multivariable model, decreased THN access was associated with the fear that a person may become aggressive after being revived with THN (aOR: 0.55, 95% CI: 0.35-0.85), police threaten people at an overdose event (aOR: 0.68, 95% CI: 0.36-1.00), and insufficient overdose training (aOR: 0.43, 95% CI: 0.28-0.68). Enrollment in medication-assisted treatment, personally experiencing an overdose, and graduating from high school were associated with higher access. About half (49%) of PWUO with THN access and who had witnessed an overdose reported having administered THN. THN use was positively associated with "often" or "always" carrying THN (aOR: 3.47, 95% CI: 1.99-6.06), witnessing more overdoses (aOR:5.18, 95% CI: 2.22-12.07), experiencing recent homelessness, and injecting in the past year. THN use was reduced among participants who did not feel that they had sufficient overdose training (aOR: 0.56, 95% CI: 0.32-0.96). Conclusion THN programs must bolster confidence in administering THN and address barriers to use, such as fear of a THN recipient becoming aggressive. Normative change around carrying THN is an important component in an overdose prevention strategy.	[Dayton, Lauren; Tobin, Karin; Davey-Rothwell, Melissa; Jones, Abenaa A.; Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Gicquelais, Rachel E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Falade-Nwulia, Oluwaseun] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Kong, Xiangrong] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Fingerhood, Michael] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Fingerhood, Michael] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dayton, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.	ldayton2@jhu.edu		Gicquelais, Rachel/0000-0002-7022-6385; Jones, Abenaa/0000-0002-0819-4941; Dayton, Lauren/0000-0002-1400-3670	National Institutes of Health [DA022961, DA040488, AI102623, K23DA041294]; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA041294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health grants DA022961(CL), DA040488(CL), AI102623(REG), and K23DA041294(OFN) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenian P, 2018, NEUROPHARMACOLOGY, V134, P121, DOI 10.1016/j.neuropharm.2017.10.016; Buajordet I, 2004, EUR J EMERG MED, V11, P19, DOI 10.1097/00063110-200402000-00004; Centers for Disease Control and Prevention, 2018, 2018 ANN SURV REP DR; Centers for Disease Control and Prevention, UND CAUS DEATH 1999; Clarke SFJ, 2005, EMERG MED J, V22, P612, DOI 10.1136/emj.2003.009613; Davis CS, 2015, J LAW MED ETHICS, V43, P19, DOI 10.1111/jlme.12208; Drug Enforcement Administration: Strategic Intelligence Section, 2018, FENT REM MOST SIGN S; Dunn KE, 2017, DRUG ALCOHOL DEPEN, V173, pS39, DOI 10.1016/j.drugalcdep.2016.12.003; Fischer B, 2018, PREV MED, V107, P109, DOI 10.1016/j.ypmed.2017.11.001; GADDIS GM, 1992, ANN PHARMACOTHER, V26, P196, DOI 10.1177/106002809202600211; Gomes T, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0217; Heavey SC, 2018, INT J DRUG POLICY, V51, P27, DOI 10.1016/j.drugpo.2017.09.015; KANTAK KM, 1986, PSYCHOPHARMACOLOGY, V90, P451; Kelly AM, 2005, MED J AUSTRALIA, V182, P24, DOI 10.5694/j.1326-5377.2005.tb06550.x; Kenney SR, 2018, J SUBST ABUSE TREAT, V84, P17, DOI 10.1016/j.jsat.2017.10.008; Khatiwoda Prasana, 2018, N C Med J, V79, P149, DOI 10.18043/ncm.79.3.149; Ko SJ, 2008, PROF PSYCHOL-RES PR, V39, P396, DOI 10.1037/0735-7028.39.4.396; Latkin CA, 2019, SUBST USE MISUSE, V0, P1; Latkin CA, 2018, SUBST ABUS, V39, P384, DOI 10.1080/08897077.2018.1439801; Martins SS, 2015, AM J PUBLIC HEALTH, V105, pE29, DOI 10.2105/AJPH.2015.302843; McDonald R, 2016, ADDICTION, V111, P1177, DOI 10.1111/add.13326; Muskett C, 2014, INT J MENT HEALTH NU, V23, P51, DOI 10.1111/inm.12012; National Safety Council, 2017, NSC MOT VEH FAT EST; Neale J, 2015, ADDICTION, V110, P1644, DOI 10.1111/add.13027; Ogeil RP, 2018, INT J DRUG POLICY, V55, P8, DOI 10.1016/j.drugpo.2017.12.020; Robinson A, 2014, AM J HEALTH-SYST PH, V71, P2129, DOI 10.2146/ajhp130798; Rook EJ, 2006, BASIC CLIN PHARMACOL, V98, P86, DOI 10.1111/j.1742-7843.2006.pto_233.x; Roxburgh A, 2017, DRUG ALCOHOL DEPEN, V179, P291, DOI 10.1016/j.drugalcdep.2017.07.018; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; StataCorp, 2014, STAT STAT SOFTW REL; Strang, 2000, Int J Drug Policy, V11, P437, DOI 10.1016/S0955-3959(00)00070-0; Tobin KE, 2005, ADDICTION, V100, P397, DOI 10.1111/j.1360-0443.2005.00975.x; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; World Health Organization, 2014, SUBST US COMM MAN OP	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224686	10.1371/journal.pone.0224686	http://dx.doi.org/10.1371/journal.pone.0224686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697736	Green Published, gold			2022-12-26	WOS:000532694400043
J	Hattenrath-Lehmann, TK; Jankowiak, J; Koch, F; Gobler, CJ				Hattenrath-Lehmann, Theresa K.; Jankowiak, Jennifer; Koch, Florian; Gobler, Christopher J.			Prokaryotic and eukaryotic microbiomes associated with blooms of the ichthyotoxic dinoflagellate Cochlodinium (Margalefidinium) polykrikoides in New York, USA, estuaries	PLOS ONE			English	Article							RED TIDE DINOFLAGELLATE; ALEXANDRIUM-TAMARENSE; COMMUNITY COMPOSITION; LONG-ISLAND; DINOPHYCEAE; BACTERIAL; GYMNODINIALES; PARASITISM; DIVERSITY; DYNAMICS	While harmful algal blooms caused by the ichthyotoxic dinoflagellate, Cochlodinium (Margalefidinium) polykrikoides, are allelopathic and may have unique associations with bacteria, a comprehensive assessment of the planktonic communities associated with these blooms has been lacking. Here, we used high-throughput amplicon sequencing to assess size fractionated (0.2 and 5 mu m) bacterial (16S) and phytoplankton assemblages (18S) associated with blooms of C. polykrikoides during recurrent blooms in NY, USA. Over a three-year period, samples were collected inside ('patch') and outside ('non-patch') dense accumulations of C. polykrikoides to assess the microbiome associated with these blooms. Eukaryotic plankton communities of blooms had significantly lower diversity than non-bloom samples, and non-bloom samples hosted 30 eukaryotic operational taxonomic units (OTUs) not found within blooms, suggesting they may have been allelopathically excluded from blooms. Differential abundance analyses revealed that C. polykrikoides blooms were significantly enriched in dinoflagellates (p<0.001) and the experimental enrichment of C. polykrikoides led to a significant increase in the relative abundance of eight genera of dinoflagellates but a significant decline in other eukaryotic plankton. Amoebophrya co-dominated both within- and near- C. polykrikoides blooms and was more abundant in bloom patches. The core bacterial microbiome of the >0.2 mu m fraction of blooms was dominated by an uncultured bacterium from the SAR11 clade, while the >5 mu m size fraction was co-dominated by an uncultured bacterium from Rhodobacteraceae and Coraliomargarita. Two bacterial lineages within the >0.2 mu m fraction, as well as the Gammaproteobacterium, Halioglobus, from the >5 mu m fraction were unique to the microbiome of blooms, while there were 154 bacterial OTUs only found in non-bloom waters. Collectively, these findings reveal the unique composition and potential function of eukaryotic and prokaryotic communities associated with C. polykrikoides blooms.	[Hattenrath-Lehmann, Theresa K.; Jankowiak, Jennifer; Koch, Florian; Gobler, Christopher J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11968 USA; [Jankowiak, Jennifer] New York State Dept Hlth, Wadsworth Ctr, Empire State Plaza, Albany, NY USA; [Koch, Florian] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Marine Biogeosci, Bremerhaven, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; Wadsworth Center; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Southampton, NY 11968 USA.	christopher.gobler@stonybrook.edu		Koch, Florian/0000-0001-7107-4160	Chicago Community Trust; Rauch Foundation	Chicago Community Trust; Rauch Foundation	We are grateful for financial support from the Chicago Community Trust and the Rauch Foundation to CJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barbera P, 2019, SYST BIOL, V68, P365, DOI 10.1093/sysbio/syy054; Borcard D., 2018, NUMERICAL ECOLOGY R, DOI DOI 10.1016/j.foreco.2007.07.028; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; Coats DW, 1996, AQUAT MICROB ECOL, V11, P1, DOI 10.3354/ame011001; Czech L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217050; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Dempster EL, 1999, BIOTECHNIQUES, V27, P66, DOI 10.2144/99271bm13; Doblin MA, 1999, J EXP MAR BIOL ECOL, V236, P33, DOI 10.1016/S0022-0981(98)00193-2; Douglas G.M., 2020, PICURUST2 IMPROVED E, DOI [10.1101/672295, 672295, 10.1101/672295, DOI 10.1101/672295]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elifantz H, 2005, APPL ENVIRON MICROB, V71, P7799, DOI 10.1128/AEM.71.12.7799-7805.2005; Fistarol GO, 2003, MAR ECOL PROG SER, V255, P115, DOI 10.3354/meps255115; Garces E, 2007, AQUAT MICROB ECOL, V46, P55, DOI 10.3354/ame046055; Gobler CJ, 2008, HARMFUL ALGAE, V7, P293, DOI 10.1016/j.hal.2007.12.006; Gobler CJ, 2012, HARMFUL ALGAE, V17, P64, DOI 10.1016/j.hal.2012.03.001; Gobler CJ, 2004, HARMFUL ALGAE, V3, P471, DOI 10.1016/j.hal.2004.06.013; Griffith AW, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0340; Guannel ML, 2011, AQUAT MICROB ECOL, V64, P117, DOI 10.3354/ame01513; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Hasegawa Y, 2007, ENVIRON MICROBIOL, V9, P3108, DOI 10.1111/j.1462-2920.2007.01421.x; Hattenrath-Lehmann TK, 2017, HARMFUL ALGAE, V68, P17, DOI 10.1016/j.hal.2017.07.003; Hattenrath-Lehmann TK, 2016, APPL ENVIRON MICROB, V82, P1114, DOI 10.1128/AEM.03457-15; Hattenrath-Lehmann TK, 2011, HARMFUL ALGAE, V11, P106, DOI 10.1016/j.hal.2011.08.005; Heal KR, 2017, P NATL ACAD SCI USA, V114, P364, DOI 10.1073/pnas.1608462114; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Huang SJ, 2012, ISME J, V6, P285, DOI 10.1038/ismej.2011.106; Jankowiak J, 2019, LIMNOLOGY OCEANOGRAP; Jasti S, 2005, APPL ENVIRON MICROB, V71, P3483, DOI 10.1128/AEM.71.7.3483-3494.2005; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Jeong HJ, 2005, AQUAT MICROB ECOL, V41, P131, DOI 10.3354/ame041131; Jeong HJ, 2004, J EUKARYOT MICROBIOL, V51, P563, DOI 10.1111/j.1550-7408.2004.tb00292.x; Jiang XD, 2010, OECOLOGIA, V164, P1133, DOI 10.1007/s00442-010-1744-8; Jiang XD, 2010, LIMNOL OCEANOGR, V55, P1643, DOI 10.4319/lo.2010.55.4.1643; Jousset A, 2017, ISME J, V11, P853, DOI 10.1038/ismej.2016.174; Jung SW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25345-4; Kim CS, 1999, J PLANKTON RES, V21, P2105, DOI 10.1093/plankt/21.11.2105; Kim H.G., 1998, HARMFUL ALGAL BLOOMS; Kim MJ, 2008, J APPL PHYCOL, V20, P1069, DOI 10.1007/s10811-008-9312-x; Kim S, 2014, J EUKARYOT MICROBIOL, V61, P173, DOI 10.1111/jeu.12097; Kirchman DL, 2016, ANNU REV MAR SCI, V8, P285, DOI 10.1146/annurev-marine-122414-033938; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koch F, 2014, HARMFUL ALGAE, V33, P41, DOI 10.1016/j.hal.2014.01.003; Koch F, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00363; Kudela RM, 2012, HARMFUL ALGAE, V14, P71, DOI 10.1016/j.hal.2011.10.015; Landa M, 2016, ISME J, V10, P39, DOI 10.1038/ismej.2015.105; Lee BK, 2008, J MICROBIOL, V46, P274, DOI 10.1007/s12275-007-0238-9; Lee Jong-Soo, 1996, Journal of the Korean Fisheries Society, V29, P165; Li JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15488; Li Z, 2015, J PHYCOL, V51, P204, DOI 10.1111/jpy.12252; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Louca S, 2018, BIOINFORMATICS, V34, P1053, DOI 10.1093/bioinformatics/btx701; Margalef R., 1961, INVEST PESQ, V18, P76; Marshall Harold G., 2005, Oceanological and Hydrobiological Studies, V34, P35; Matsuoka K, 2008, HARMFUL ALGAE, V7, P261, DOI 10.1016/j.hal.2007.12.002; McMurdie PJ, 2015, BIOINFORMATICS, V31, P282, DOI 10.1093/bioinformatics/btu616; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Metfies K, 2016, OCEAN SCI, V12, P1237, DOI 10.5194/os-12-1237-2016; Mulholland MR, 2009, ESTUAR COAST, V32, P734, DOI 10.1007/s12237-009-9169-5; Nuzzi Robert, 2004, Harmful Algae News, V27, P10; Oh JI, 2011, BIOTECHNOL BIOPROC E, V16, P1124, DOI 10.1007/s12257-011-0232-2; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Park BS, 2019, HARMFUL ALGAE, V84, P119, DOI 10.1016/j.hal.2019.02.001; Park BS, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12474; Park BS, 2015, HARMFUL ALGAE, V48, P44, DOI 10.1016/j.hal.2015.07.004; Park MG, 2013, HARMFUL ALGAE, V30, pS62, DOI 10.1016/j.hal.2013.10.007; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Phlips EJ, 2011, HARMFUL ALGAE, V10, P277, DOI 10.1016/j.hal.2010.11.001; Poulson KL, 2010, MAR ECOL PROG SER, V416, P69, DOI 10.3354/meps08788; Prince EK, 2008, P ROY SOC B-BIOL SCI, V275, P2733, DOI 10.1098/rspb.2008.0760; Rheuban JE, 2016, BIOGEOSCIENCES, V13, P253, DOI 10.5194/bg-13-253-2016; Richlen ML, 2010, HARMFUL ALGAE, V9, P163, DOI 10.1016/j.hal.2009.08.013; Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI USA, V109, P14041, DOI 10.1073/pnas.1208755109; Seong KA, 2006, MAR ECOL PROG SER, V322, P85, DOI 10.3354/meps322085; Shin H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23634-6; Sison-Mangus MP, 2014, ISME J, V8, P63, DOI 10.1038/ismej.2013.138; Stern R, 2018, J PLANKTON RES, V40, P519, DOI 10.1093/plankt/fby035; Tang YZ, 2012, HARMFUL ALGAE, V20, P71, DOI 10.1016/j.hal.2012.08.001; Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107; Tang YZ, 2010, MAR ECOL PROG SER, V406, P19, DOI 10.3354/meps08537; Tang YZ, 2009, HARMFUL ALGAE, V8, P454, DOI 10.1016/j.hal.2008.10.001; Thangaraj P, 2017, BIOCHEM SYST ECOL, V70, P29, DOI 10.1016/j.bse.2016.10.021; Tomas CR, 2008, HARMFUL ALGAE, V7, P308, DOI 10.1016/j.hal.2007.12.005; Verity PG, 2010, HARMFUL ALGAE, V9, P144, DOI 10.1016/j.hal.2009.08.009; Weissbach A, 2010, HARMFUL ALGAE, V10, P9, DOI 10.1016/j.hal.2010.05.007; Whyte JNCI, 2001, PHYCOLOGIA, V40, P298, DOI 10.2216/i0031-8884-40-3-298.1; Wichels A, 2004, HELGOLAND MAR RES, V58, P93, DOI 10.1007/s10152-004-0174-6; Xiao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106510; Yang CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08476; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zhou J, 2018, FRONTIERS MICROBIOLO, V9	97	11	12	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0223067	10.1371/journal.pone.0223067	http://dx.doi.org/10.1371/journal.pone.0223067			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697694	Green Submitted, gold, Green Published			2022-12-26	WOS:000532694400010
J	Madden, M; Morris, S; Stewart, D; Atkin, K; Gough, B; McCambridge, J				Madden, Mary; Morris, Stephanie; Stewart, Duncan; Atkin, Karl; Gough, Brendan; McCambridge, Jim			Conceptualising alcohol consumption in relation to long-term health conditions: Exploring risk in interviewee accounts of drinking and taking medications	PLOS ONE			English	Article							LAY EPIDEMIOLOGY; MEDICINES; ADHERENCE; BURDEN; CARE	Background Alcohol use is a major contributor to the burden of disease, including long-term non-communicable diseases. Alcohol can also interact with and counter the effects of medications. This study addresses how people with long term conditions, who take multiple medications, experience and understand their alcohol use. The study objective is to explore how people conceptualise the risks posed to their own health from their concurrent alcohol and medicines use. Methods and findings Semi-structured interviews were conducted with a sample of 24 people in the North of England taking medication for long term conditions who drank alcohol twice a week or more often. Transcripts were analysed using a modified framework method with a constructionist thematic analysis. Alcohol was consumed recreationally and to aid with symptoms of sleeplessness, stress and pain. Interviewees were concerned about the felt effects of concurrent alcohol and medicines use and sought ways to minimise the negative effects. Interviewees associated their own drinking with short-term reward, pleasure and relief. Risky drinking was located elsewhere, in the drinking of others. People made experiential, embodied sense of health harms and did not seem aware of, or convinced by, (or in some cases appeared resigned to) future harms to their own health from alcohol use. The study has limitations common to exploratory qualitative studies. Conclusions Health risk communication should be better informed about how people with long-term health conditions perceive health outcomes over time, and how they adopt experience-based safety strategies in contexts in which alcohol consumption is heavily promoted and weakly regulated, whilst medicines adherence is expected. Supporting people to make active and informed connections between medicines, alcohol and potential personal health harms requires more than a one-way style of risk communication if it is to be perceived as opening up rather than restricting choice.	[Madden, Mary; Morris, Stephanie; Stewart, Duncan; Atkin, Karl; McCambridge, Jim] Univ York, Dept Hlth Sci, Seebohm Rowntree Bldg, York, N Yorkshire, England; [Gough, Brendan] Leeds Beckett Univ, Sch Social Sci, Leeds, W Yorkshire, England	University of York - UK; Leeds Beckett University	Madden, M (corresponding author), Univ York, Dept Hlth Sci, Seebohm Rowntree Bldg, York, N Yorkshire, England.	mary.madden@york.ac.uk	Stewart, Duncan/GZL-1637-2022	Stewart, Duncan/0000-0001-7355-4280; Madden, Mary/0000-0001-5749-2665; Morris, Steph/0000-0002-9005-4680; McCambridge, Jim/0000-0002-5461-7001	National Institute for Health Research (NIHR) [RP-PG-0216-20002]	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This research was funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research (RP-PG-0216-20002). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to the interviewees and the patient and public involvement group who advised on the study. This research was funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research (RP-PG-0216-20002).	Ahmed H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3996; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1111/j.1530-0277.1998.tb03991.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Britten N., 2008, MEDICINES SOC PATIEN; Bryson CL, 2008, J GEN INTERN MED, V23, P346; Bush J, 2009, RES SOC ADMIN PHARM, V5, P305, DOI 10.1016/j.sapharm.2009.01.003; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; Department for Communities and Local Government, 2015, ENGLISH INDICES DEPR; Duerden M., 2013, POLYPHARMACY MED OPT; Edwards G, 2000, WORLDS FAVOURITE DRU; Ewbank L, 2018, RISING COST MEDICINE; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94, 10.1016/S0140-6736(18)31310-2]; Grodensky CA, 2012, J STUD ALCOHOL DRUGS, V73, P899, DOI 10.15288/jsad.2012.73.899; Haighton C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205956; Holton AE, 2017, BMC GERIATR, P17; Holton AE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017453; Hui M, 2017, RHEUMATOLOGY, V56, P1056, DOI 10.1093/rheumatology/kex150; Khadjesari Z, 2019, J PUBLIC HEALTH-UK, V41, pE185, DOI 10.1093/pubmed/fdy067; Kypri K, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3944; Ling J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-892; Lovatt M, 2015, ADDICTION, V110, P1912, DOI 10.1111/add.13072; Madden M, 2019, RES SOCIAL ADM PHARM; Mahler C, 2010, J EVAL CLIN PRACT, V16, P574, DOI 10.1111/j.1365-2753.2009.01169.x; Moriarty HJ, 2012, FAM PRACT, V29, P213, DOI 10.1093/fampra/cmr082; Morris S, 2019, DRUG ALCOHOL REV, V38, P561, DOI 10.1111/dar.12960; Muhlack E, 2018, BMC PUBLIC HEALTH, P18; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; PSNC, 2018, NEW MED SERV NMS PHA; PSNC, MURS BAS 2018; Public Health England, 2019, DEP WITHDR ASS SOM P; Quirk A, 2016, DRUG ALCOHOL DEPEN, V161, P36, DOI 10.1016/j.drugalcdep.2016.01.023; Rapley T, 2006, SOC SCI MED, V63, P2418, DOI 10.1016/j.socscimed.2006.05.025; Rathbone AP, 2017, RES SOC ADMIN PHARM, V13, P403, DOI 10.1016/j.sapharm.2016.06.004; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Scambler G, 2010, NEW DIRECTIONS SOCIO; Stein Michael D, 2005, Subst Abus, V26, P1, DOI 10.1300/J465v26n01_01; Teuscher U, 2011, PSYCHOL REC, V61, P613, DOI 10.1007/BF03395780; The National Institute for Health and Care Excellence (NICE), 2010, ALC US DIS PREV; UK Department of Health, 2016, UK CHIEF MED OFF LOW; Webster A, 2009, SCI CULT-UK, V18, P233, DOI 10.1080/09505430902885631; Wilson GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071792; World Health Organization, 2012, WHOEMPMAR20123	45	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224706	10.1371/journal.pone.0224706	http://dx.doi.org/10.1371/journal.pone.0224706			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697723	Green Accepted, Green Published, gold			2022-12-26	WOS:000532694400045
J	Vabalas, A; Gowen, E; Poliakoff, E; Casson, AJ				Vabalas, Andrius; Gowen, Emma; Poliakoff, Ellen; Casson, Alexander J.			Machine learning algorithm validation with a limited sample size	PLOS ONE			English	Article							SELECTION; CLASSIFICATION	Advances in neuroimaging, genomic, motion tracking, eye-tracking and many other technology-based data collection methods have led to a torrent of high dimensional datasets, which commonly have a small number of samples because of the intrinsic high cost of data collection involving human participants. High dimensional data with a small number of samples is of critical importance for identifying biomarkers and conducting feasibility and pilot work, however it can lead to biased machine learning (ML) performance estimates. Our review of studies which have applied ML to predict autistic from non-autistic individuals showed that small sample size is associated with higher reported classification accuracy. Thus, we have investigated whether this bias could be caused by the use of validation methods which do not sufficiently control overfitting. Our simulations show that K-fold Cross-Validation (CV) produces strongly biased performance estimates with small sample sizes, and the bias is still evident with sample size of 1000. Nested CV and train/test split approaches produce robust and unbiased performance estimates regardless of sample size. We also show that feature selection if performed on pooled training and testing data is contributing to bias considerably more than parameter tuning. In addition, the contribution to bias by data dimensionality, hyper-parameter space and number of CV folds was explored, and validation methods were compared with discriminable data. The results suggest how to design robust testing methodologies when working with small datasets and how to interpret the results of other studies based on what validation method was used.	[Vabalas, Andrius; Casson, Alexander J.] Univ Manchester, Sch Elect & Elect Engn, Mat Devices & Syst Div, Manchester, Lancs, England; [Gowen, Emma; Poliakoff, Ellen] Univ Manchester, Sch Biol Sci, Manchester, Lancs, England	University of Manchester; University of Manchester	Vabalas, A (corresponding author), Univ Manchester, Sch Elect & Elect Engn, Mat Devices & Syst Div, Manchester, Lancs, England.	andrius.vabalas@manchester.ac.uk		Casson, Alex/0000-0003-1408-1190	UK Engineering and Physical Sciences Research Council; University of Manchester [EP/m507969/1]; University of Manchester; EPSRC [1830965] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Manchester; University of Manchester; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EG, EP and AJC hold academic positions at the University of Manchester. AV was supported by the UK Engineering and Physical Sciences Research Council (website: https://epsrc.ukri.org/) and its Doctoral Training Partnership with the University of Manchester (ref.: EP/m507969/1). The funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional internal or external funding received for this study.; A. Vabalas is supported by the UK Engineering and Physical Sciences Research Council and its Doctoral Training Partnership with the University of Manchester.	Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Beleites C, 2013, ANAL CHIM ACTA, V760, P25, DOI 10.1016/j.aca.2012.11.007; Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; Bone D, 2015, J AUTISM DEV DISORD, V45, P1121, DOI 10.1007/s10803-014-2268-6; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Combrisson E, 2015, J NEUROSCI METH, V250, P126, DOI 10.1016/j.jneumeth.2015.01.010; Dernoncourt D, 2014, COMPUT STAT DATA AN, V71, P681, DOI 10.1016/j.csda.2013.07.012; Devos O, 2009, CHEMOMETR INTELL LAB, V96, P27, DOI 10.1016/j.chemolab.2008.11.005; Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Hua JP, 2005, BIOINFORMATICS, V21, P1509, DOI 10.1093/bioinformatics/bti171; Hyde KK, 2019, REV J AUTISM DEV DIS, V6, P128, DOI 10.1007/s40489-019-00158-x; Jain A.K., 1982, HDB STAT, P835, DOI 10.1016/S0169-7161(82)02042-2; KANAL L, 1971, PATTERN RECOGN, V3, P225, DOI 10.1016/0031-3203(71)90013-6; Kassraian-Fard P, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00177; Krstajic D, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-10; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Mukherjee S, 2003, J COMPUT BIOL, V10, P119, DOI 10.1089/106652703321825928; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; RAUDYS SJ, 1991, IEEE T PATTERN ANAL, V13, P252, DOI 10.1109/34.75512; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Varoquaux G, 2018, NEUROIMAGE, V180, P68, DOI 10.1016/j.neuroimage.2017.06.061; Varoquaux G, 2017, NEUROIMAGE, V145, P166, DOI 10.1016/j.neuroimage.2016.10.038	29	330	331	18	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224365	10.1371/journal.pone.0224365	http://dx.doi.org/10.1371/journal.pone.0224365			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697686	Green Published, gold			2022-12-26	WOS:000532694400025
J	Mansoor, S; Ahmed, N; Sharma, V; Jan, S; Nabi, SU; Mir, JI; Mir, MA; Masoodi, KZ				Mansoor, Sheikh; Ahmed, Nazeer; Sharma, Vikas; Jan, Sumira; Nabi, Sajad Un; Mir, Javid, I; Mir, Mudasir A.; Masoodi, Khalid Z.			Elucidating genetic variability and population structure in Venturia inaequalis associated with apple scab diseaseusing SSR markers	PLOS ONE			English	Article							COLLETOTRICHUM-GLOEOSPORIOIDES; ORIGIN	Apple scab caused by Venturia inaequalis Cooke (Wint.) is one the important diseases of trade and industrial significance in apple. In present study variability studies in pathogen isolates were studied, which is one of the most important factors for devising management studies of scab disease in apple. Genetic diversity of 30 Venturia inaequalis isolates from 12 districts of two geographical distinct regions of Jammu and Kashmir was calculated based on the allele frequencies of 28 SSR markers and the internal transcribed spacer (ITS) region of the ribosomal DNA. The ITS based characterized sequences were submitted to NCBI Gen Bank and accession numbers were sanctioned. Dendrogram showed that all the accessions formed 2 main clusters with various degree of sub clustering within the clusters. Analysis based on SSR study reveals that the heterozygosity ranged from 0.0 and 0.5, with an average value of 0.39. The expected heterozygosis or gene diversity (He) ranged from 0.0 to 0.50 with an average of 0.40. The Fst value ranges from 0 to 0.6 with an average of 0.194. Diversity within each population (HS) values ranging from 0.26 to 0.33. Average differentiation among populations (GST) was 0.11 and populations were isolated by significant distance (r(2) = 0.50, P < 0.01). From the AMOVA analysis, 25% of variation was observed among population, 9% among individuals and 66% within individuals observed in the population. Structure analysis grouped isolates into two populations. Principle coordinate analysis explained variation of 36.6% in population 1, 14.30% in population 2 and 13.10% in population 3(Admixture) with 64.07% as overall cumulative percentage of variation. This indicates that extensive short-distance gene flow occurs in Kashmir region that dispersal over longer distances also appears to occur frequently enough to prevent differentiation due to genetic drift. Also it is evident that Jammu and Kashmir most likely has V. inaequalissubpopulations linked to diverse climatic conditions of the Jammu region compared to the mountainous inland Kashmir region. The results of present study would help to understand the genetic diversity of V. inaequalis from Jammu and Kashmir that would lead in the development of more effective management strategies and development of new resistant cultivars through marker-assisted selection.	[Mansoor, Sheikh; Sharma, Vikas] Sher E Kashmir Univ Agr Sci & Technol Jammu, Div Biochem, Srinagar, Jammu & Kashmir, India; [Ahmed, Nazeer; Mir, Mudasir A.; Masoodi, Khalid Z.] Sher E Kashmir Univ Agr Sci & Technol SKUAST K, Div Plant Biotechnol, Transcript Lab, Srinagar, Jammu & Kashmir, India; [Jan, Sumira; Nabi, Sajad Un; Mir, Javid, I] ICAR Cent Inst Temperate Hort, Srinagar, Jammu & Kashmir, India	Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu); Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Temperate Horticulture	Masoodi, KZ (corresponding author), Sher E Kashmir Univ Agr Sci & Technol SKUAST K, Div Plant Biotechnol, Transcript Lab, Srinagar, Jammu & Kashmir, India.	masoodikz@skuastkashmir.ac.in	Masoodi, Khalid Z/F-1787-2015; Mansoor, Sheikh/AAK-1432-2020; Masoodi, KhalidZ./ABG-5492-2021; Mir, Javid/GLT-6517-2022	Masoodi, Khalid Z/0000-0002-4889-5558; Mansoor, Sheikh/0000-0003-1902-4611; Masoodi, KhalidZ./0000-0002-4889-5558; Ahmed, Dr. Nazeer/0000-0002-2884-4788	SERB project, Science and Engineering Research Board, Department of Science and Technology, Government of India [EMR/2016/005598, SERB-2016/ECR0000025]	SERB project, Science and Engineering Research Board, Department of Science and Technology, Government of India	This work was supported by SERB project: EMR/2016/005598 and SERB-2016/ECR0000025, Science and Engineering Research Board, Department of Science and Technology, Government of India, www.serb.gov.in/, to KZM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAHAKOON PW, 1994, PHYSIOL MOL PLANT P, V44, P93, DOI 10.1016/S0885-5765(05)80104-3; BERBEE ML, 1992, MOL BIOL EVOL, V9, P278; Bhat TA., 2017, POTENTIAL PROSPECTS; Birch JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186259; Bowen JK, 2011, MOL PLANT PATHOL, V12, P105, DOI 10.1111/j.1364-3703.2010.00656.x; BROWN AHD, 1980, GENETICS, V96, P523; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49, P391, DOI 10.1146/annurev-phyto-072910-095339; Cooke BM, 2006, EPIDEMIOLOGY PLANT D; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebrahimi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167415; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferree DC., 2003, CAB INT 2003 APPLES; Frantz A, 2006, J EVOLUTION BIOL, V19, P392, DOI 10.1111/j.1420-9101.2005.01025.x; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Grimova L, 2016, PHYTOPATHOL MEDITERR, V55, P1, DOI 10.14601/Phytopathol_Mediterr-16295; Guerin F, 2004, MOL ECOL NOTES, V4, P268, DOI 10.1111/j.1471-8286.2004.00637.x; Guerin F, 2004, PHYTOPATHOLOGY, V94, P364, DOI 10.1094/PHYTO.2004.94.4.364; Guerin F, 2007, FUNGAL GENET BIOL, V44, P284, DOI 10.1016/j.fgb.2006.10.005; Iwen PC, 2002, MED MYCOL, V40, P87, DOI 10.1080/mmy.40.1.87.109; Kodsueb R, 2006, MYCOLOGIA, V98, P571, DOI 10.3852/mycologia.98.4.571; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LIYANAGE HD, 1992, PHYTOPATHOLOGY, V82, P1371, DOI 10.1094/Phyto-82-1371; MacHardy W.E, 1996, APPLE SCAB BIOL EPID; McDonald BA, 1997, PHYTOPATHOLOGY, V87, P448, DOI 10.1094/PHYTO.1997.87.4.448; Monje LD, 2013, SYST PARASITOL, V86, P43, DOI 10.1007/s11230-013-9428-5; Muneer A. S., 2017, INT J CHEM STUDIES, V5, p1107.1113; Nabi SU, 2018, PHYTOPARASITICA, V46, P705, DOI 10.1007/s12600-018-0701-7; Padder B. A., 2011, Asian Journal of Plant Pathology, V5, P75, DOI 10.3923/ajppaj.2011.75.83; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X, 2006, JACQUEMOUD COLLET J; Pritchard JK, 2000, GENETICS, V155, P945; Sarkate A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36237-y; Shafi S.M., 2019, ECON MICROBIOL, V15, P1; Sivanesan A., TAXONOMY PATHOLOGY V; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Tenzer I, 1999, PHYTOPATHOLOGY, V89, P748, DOI 10.1094/PHYTO.1999.89.9.748; Xu XM, 2008, PLANT DIS, V92, P247, DOI 10.1094/PDIS-92-2-0247; Xu XM, 2013, EUR J PLANT PATHOL, V135, P97, DOI 10.1007/s10658-012-0068-4; Yeh F., POPGENE 32V 1 31 MIC; Zhang L., 2010, GENETIC DIVERSITY TE	42	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224300	10.1371/journal.pone.0224300	http://dx.doi.org/10.1371/journal.pone.0224300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693681	Green Published, gold			2022-12-26	WOS:000532690100021
J	Gao, J; Peng, H; Chen, FB; Liu, Y; Chen, BW; Li, WB				Gao, Jian; Peng, Hua; Chen, Fabo; Liu, Yi; Chen, Baowei; Li, Wenbo			Genome-wide identification and characterization, phylogenetic comparison and expression profiles of SPL transcription factor family in B. juncea (Cruciferae)	PLOS ONE			English	Article							ARABIDOPSIS; ORGANIZATION; GENES	SQUAMOSA promoter-binding protein-like (SPL), as plant specific transcription factors, is involved in many plant growth and development processes. However, there is less systematical study for SPL transcription factor in B. juncea (Cruciferae). Here, a total of 59 SPL genes classified into eight phylogenetic groups were identified in B. juncea, highly conserved within each ortholog were also found based on gene structure, conserved motif, as well as clustering level. In addition, clustering of SPL domain showed that two zinc finger-like structures and NLS segments were identified in almost of BjuSPLs. Analyzed of putative cis-elements for BjuSPLs demonstrated that SPL transcription factors were involved in adverse environmental changes, such as light, plant stresses and phytohormones response. Expression analysis showed that differentially expressed SPL genes were identified in flower and stem development of Cruciferae; such as BjuSPL3a-B, BjuSPL2b_B and BjuSPL2c_A were significantly expressed in flower; BjuSPL 3b_B and BjuSPL10a_A were significantly expressed in stem node (VP: vegetative period). Moreover, 28 of the 59 BjuSPLs were found involved in their posttranscriptional regulation targeted by miR156. We demonstrated that miR156 negatively regulated BjuSPL10a_ A and BjuSPL3b_B to act for stem development in B. juncea.	[Gao, Jian; Chen, Fabo; Liu, Yi; Chen, Baowei; Li, Wenbo] Yangtze Normal Univ, Dept Life Sci & Technol, Chongqing, Peoples R China; [Gao, Jian; Chen, Fabo; Li, Wenbo] Yangtze Normal Univ, Ctr Green Dev & Collaborat Innovat Wuling Mt Reg, Chongqing, Peoples R China; [Peng, Hua] Sichuan Tourism Coll, Chengdu, Sichuan, Peoples R China	Yangtze Normal University; Yangtze Normal University; Sichuan Tourism University	Li, WB (corresponding author), Yangtze Normal Univ, Dept Life Sci & Technol, Chongqing, Peoples R China.; Li, WB (corresponding author), Yangtze Normal Univ, Ctr Green Dev & Collaborat Innovat Wuling Mt Reg, Chongqing, Peoples R China.	liverb@163.com	Li, Wenbo/AAP-2905-2021	Li, Wenbo/0000-0003-2407-1017				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chao LM, 2017, MOL PLANT, V10, P735, DOI 10.1016/j.molp.2017.03.010; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Silva GFFE, 2014, PLANT J, V78, P604, DOI 10.1111/tpj.12493; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gao J, 2015, J PLANT BIOL, V58, P211, DOI 10.1007/s12374-014-0572-5; Garcia-Molina A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0231-5; George C, 2007, NAT GENET, V39, P544, DOI [10.1038/ng2001, DOI 10.1038/NG2001]; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hou HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059358; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jung JH, 2012, PLANT J, V69, P577, DOI 10.1111/j.1365-313X.2011.04813.x; Kavas M, 2017, COMPUT BIOL CHEM, V67, P131, DOI 10.1016/j.compbiolchem.2017.01.001; Kong XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-433; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li CL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-131; Liu N, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0969-z; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Stief A, 2014, PLANT CELL, V26, P1792, DOI 10.1105/tpc.114.123851; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; Tan HW, 2015, GENOME, V58, P463, DOI 10.1139/gen-2015-0074; Tripathi RK, 2017, DEV GENES EVOL, V227, P101, DOI 10.1007/s00427-017-0574-7; Wang H, 2015, MOL PLANT, V8, P677, DOI 10.1016/j.molp.2015.01.008; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pW78, DOI 10.1093/nar/gkv487; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xing SP, 2013, PLANT J, V75, P566, DOI 10.1111/tpj.12221; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Xu ML, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006263; Yang JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-231; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Yu N, 2015, PLANT J, V83, P673, DOI 10.1111/tpj.12919; Zhang Y, 2007, PLANT MOL BIOL, V63, P429, DOI 10.1007/s11103-006-9099-6	41	1	1	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224704	10.1371/journal.pone.0224704	http://dx.doi.org/10.1371/journal.pone.0224704			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689304	gold, Green Published			2022-12-26	WOS:000532680100040
J	Sendra, L; Herrero, MJ; Montalva, EM; Noguera, I; Orbis, F; Diaz, A; Fernandez-Delgado, R; Lopez-Andujar, R; Alino, SF				Sendra, Luis; Jose Herrero, Maria; Maria Montalva, Eva; Noguera, Inmaculada; Orbis, Francisco; Diaz, Ana; Fernandez-Delgado, Rafael; Lopez-Andujar, Rafael; Alino, Salvador F.			Efficacy of interleukin 10 gene hydrofection in pig liver vascular isolated 'in vivo' by surgical procedure with interest in liver transplantation	PLOS ONE			English	Article							REGULATORY T-CELLS; RESTING DENDRITIC CELLS; KUPFFER CELLS; TOLERANCE; RESPONSES; IL-10; LIPOPOLYSACCHARIDE; INDUCTION; FOXP3; MICE	Aim Liver transplantation is the only curative strategy for final stage liver diseases. Despite the great advances achieved during the last 20 years, the recipient immune response after transplantation is not entirely controlled. This results in high rates of acute cell rejection and, approximately, 10% of early mortality. Therapeutic treatment could be improved by efficiently transfecting genes that encode natural immunosuppressant proteins, employing safe procedures that could be transferred to clinical setting. In this sense, interleukin 10 plays a central role in immune tolerance response by acting at different levels. Methods hIL10 gene was hydrofected by retrograde hydrodynamic injection in pig liver with complete vascular exclusion mediated by an 'in vivo' surgical procedure. Levels of IL10 DNA, RNA and protein were determined within liver tissue 1 and 10 days after the injection and, more frequently, also the interleukin-10 protein in peripheral blood. Results The procedure was safe for the animals and neither hemodynamic parameters nor liver function determinations showed relevant alterations. The hIL10 hydrofection in watertight liver mediated efficient gene transfer and this was transcribed and translated to protein, achieving up to 110 pg/ml of IL10 in peripheral blood. This value is close to that considered able to reduce the activity of TNF alpha by half (IL10 IC50 for TNF alpha = 124 pg/ml). Conclusions Results of this work suggest that IL10 liver hydrofection with vascular exclusion in vivo is a safe and transferable procedure that mediates plasma protein levels with potential clinical interest in immune modulation after transplantation.	[Sendra, Luis; Jose Herrero, Maria; Alino, Salvador F.] Inst Invest Sanitaria La Fe, Pharmacogenet Unit, Valencia, Spain; [Sendra, Luis; Jose Herrero, Maria; Alino, Salvador F.] Univ Valencia, Dept Pharmacol, Gene Therapy Unit, Valencia, Spain; [Maria Montalva, Eva; Lopez-Andujar, Rafael] Inst Invest Sanitaria La Fe, Unit Expt Hepatol & Liver Transplantat, Valencia, Spain; [Maria Montalva, Eva; Orbis, Francisco; Lopez-Andujar, Rafael] Hosp Univ & Politecn La Fe, HPB Surg & Transplant Unit, Valencia, Spain; [Noguera, Inmaculada; Diaz, Ana] Univ Valencia, Cent Serv Expt Support, SCSIE, Valencia, Spain; [Fernandez-Delgado, Rafael] Univ Valencia, Dept Pediat Obstet & Gynecol, Pediat Unit, Valencia, Spain; [Alino, Salvador F.] Hosp Univ & Politecn La Fe, Clin Pharmacol Unit, Valencia, Spain	University of Valencia; Hospital Universitari i Politecnic La Fe; University of Valencia; University of Valencia; Hospital Universitari i Politecnic La Fe	Herrero, MJ (corresponding author), Inst Invest Sanitaria La Fe, Pharmacogenet Unit, Valencia, Spain.; Herrero, MJ (corresponding author), Univ Valencia, Dept Pharmacol, Gene Therapy Unit, Valencia, Spain.	maria.jose.herrero@uv.es	Montalva, Eva/ABH-7902-2020; Lopéz-Andujar, Rafael/ABH-7793-2020; Herrero, Maria Jose/M-1649-2014	Montalva, Eva/0000-0002-8563-1340; Lopéz-Andujar, Rafael/0000-0001-8946-4343; Diaz Cuevas, Ana/0000-0002-5396-4466; Herrero, Maria Jose/0000-0002-6042-4185; Sendra Gisbert, Luis/0000-0003-3176-9763; Alino Pellicer, Salvador Francisco/0000-0002-7830-8713	Spanish Ministry of Economy and Competitiveness [SAF2011-27002]; Fundacion Mutua Madrilena [2017/0483]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	This research was funded by the Spanish Ministry of Economy and Competitiveness (SAF2011-27002) to SFA and the Fundacion Mutua Madrilena (2017/0483) to RLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B J. A., 2002, MOL BIOL CELL; Breous E, 2009, HEPATOLOGY, V50, P612, DOI 10.1002/hep.23043; Buelens C, 1997, EUR J IMMUNOL, V27, P1848, DOI 10.1002/eji.1830270805; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Hirschfield GM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1670; Ireland SJ, 2015, CYTOKINE, V73, P236, DOI 10.1016/j.cyto.2015.01.009; Kamimura K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107203; Kamimura K, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.52; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Khanna A, 2000, J IMMUNOL, V164, P1346, DOI 10.4049/jimmunol.164.3.1346; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; Knolle PA, 1998, CLIN EXP IMMUNOL, V114, P427; Kudo S, 1997, J EXP MED, V185, P777, DOI 10.1084/jem.185.4.777; Matsuno K, 1996, J EXP MED, V183, P1865, DOI 10.1084/jem.183.4.1865; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1; Rifle G, 2004, TRANSPLANTATION, V77, pS5, DOI 10.1097/01.TP.0000107184.18562.FC; Seldon Paul M., 1998, Cell Biochemistry and Biophysics, V29, P179, DOI 10.1007/BF02737835; Gisbert LS, 2017, LIVER TRANSPLANT, V23, P50, DOI 10.1002/lt.24667; Sendra L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163898; Sendra L, 2016, EUR RADIOL, V26, P95, DOI 10.1007/s00330-015-3792-2; Tedesco D, 2018, LIVER TRANSPLANT, V24, P89, DOI 10.1002/lt.24873; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tsoulfas G, 2006, J SURG RES, V135, P242, DOI 10.1016/j.jss.2006.04.020; Zhang GY, 2009, CURR OPIN ORGAN TRAN, V14, P40, DOI 10.1097/MOT.0b013e32831da83c; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224568	10.1371/journal.pone.0224568	http://dx.doi.org/10.1371/journal.pone.0224568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689315	gold, Green Published			2022-12-26	WOS:000532680100030
J	Westre, B; Giske, A; Guttormsen, H; Sorbye, SW; Skjeldestad, FE				Westre, Bjorn; Giske, Anita; Guttormsen, Hilde; Sorbye, Sveinung Wergeland; Skjeldestad, Finn Egil			Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+in young Norwegian women-A cohort study	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE DISTRIBUTION; CANCER; RISK; HISTORY; POPULATION; PREVENTION; REGRESSION; INFECTION; LESIONS; TRENDS	Within 2021, Norway intends to complete implementation of HPV DNA-based primary screening for cervical cancer for women 34-69 years, while continue cytology-based screening for women 25-33 years. Over the recent years, the incidence of cervical cancer has increased by 30% among women younger than 40 years. In this subset of women, nearly 30% were diagnosed with a normal smear, as most recent smear, prior the cancer diagnosis. This observation demands quality control of normal smears. The aim of this study was to assess increase in program sensitivity of CIN2+ after follow-up of women with false negative Pap-smears testing positive for a 3-type (-16, -18, -45) HPV mRNA test in a cohort design over one screening interval. 521 women, aged 23-39 years, and no prior history of CIN1+ or HSIL, with an ASC-US or worse smear (ASC-US+) and 1444 women with normal screening cytology comprised the study cohorts. The positivity rate for the 3-type HPV mRNA was 1.9% (28/1444). Rescreening revealed 23 women with ASC-US, two women with LSIL, two women with ASC-H, and one woman with AGUS. If the HPV mRNApositivity rate and histology findings from samples rescreened were applied to all women with normal cytology, an estimated increase in screening sensitivity of 16.4% (95% CI:15.3-17.5) for CIN2+ and 17.3% (95% CI:16.2-18.4) for CIN3+ were achieved. By rescreening less than 2% of women with normal cytology positive for a 3-type HPV mRNA test, we achieved a significant increase in screening program sensitivity.	[Westre, Bjorn; Giske, Anita; Guttormsen, Hilde] More & Romsdal Hlth Trust, Alesund Hosp, Dept Pathol, Alesund, Norway; [Sorbye, Sveinung Wergeland] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Skjeldestad, Finn Egil] UiT Arctic Univ Norway, Res Grp Epidemiol Chron Dis, Dept Community Med, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Skjeldestad, FE (corresponding author), UiT Arctic Univ Norway, Res Grp Epidemiol Chron Dis, Dept Community Med, Tromso, Norway.	eskjelde@online.no	Sorbye, Sveinung Wergeland/AAE-7208-2020	Sorbye, Sveinung Wergeland/0000-0002-8250-3992; Skjeldestad, Finn Egil/0000-0001-9875-4991				Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Arbyn M, 2014, J PATHOL, V234, P431, DOI 10.1002/path.4424; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Castanon A, 2013, BRIT J CANCER, V109, P35, DOI 10.1038/bjc.2013.322; Castanon A, 2012, CYTOPATHOLOGY, V23, P13, DOI 10.1111/j.1365-2303.2011.00948.x; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Herbert A, 2010, BJOG-INT J OBSTET GY, V117, P736, DOI 10.1111/j.1471-0528.2010.02511.x; Ho GYF, 2011, J LOW GENIT TRACT DI, V15, P268, DOI 10.1097/LGT.0b013e3182216fef; Holl K, 2015, INT J CANCER, V137, P2858, DOI 10.1002/ijc.29651; Ibanez R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/605375; Kirschner B, 2011, GYNECOL ONCOL, V120, P68, DOI 10.1016/j.ygyno.2010.09.021; Kitchener HC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18230; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Lonnberg S, 2015, INT J CANCER, V137, P1758, DOI 10.1002/ijc.29541; Lonnberg S, 2012, CANCER EPIDEM BIOMAR, V21, P1354, DOI 10.1158/1055-9965.EPI-12-0162; Moscicki AB, 2010, OBSTET GYNECOL, V116, P1373, DOI 10.1097/AOG.0b013e3181fe777f; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Naber SK, 2016, CANCER CAUSE CONTROL, V27, P569, DOI 10.1007/s10552-016-0732-7; Nygard M, 2012, OKNING FOREKOMST LIV; Nygard M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003460; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Pedersen K, 2015, KOSTNADER MASSEUNDER; Powell N, 2013, J CLIN VIROL, V58, P571, DOI 10.1016/j.jcv.2013.08.020; Rebolj M, 2015, EUR J CANCER, V51, P1456, DOI 10.1016/j.ejca.2015.04.012; Ronco Guglielmo, 2015, Epidemiol Prev, V39, P77; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Skare GB, 2018, NORWEGIAN CERVICAL C; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Sorbye SW, 2017, BMC CLIN PATHOL, V17, DOI 10.1186/s12907-017-0058-8; Tjalma WA, 2013, INT J CANCER, V132, P854, DOI 10.1002/ijc.27713; Trottier H, 2009, CANCER EPIDEM BIOMAR, V18, P854, DOI 10.1158/1055-9965.EPI-08-1012; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0221546	10.1371/journal.pone.0221546	http://dx.doi.org/10.1371/journal.pone.0221546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689301	Green Published, gold			2022-12-26	WOS:000532680100004
J	Gao, XL; Tian, WJ; Liu, BF; Wu, JY; Xie, W; Shen, Q				Gao, Xue-Ling; Tian, Wen-Jia; Liu, Bofeng; Wu, Jingyi; Xie, Wei; Shen, Qin			High-mobility group nucleosomal binding domain 2 protects against microcephaly by maintaining global chromatin accessibility during corticogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neural stem cell (NSC); neurogenesis; neurodevelopment; neurological disease; chromatin remodeling; chromatin assembly and disassembly; HMGN proteins; microcephaly; neural stem cells	TRANSCRIPTION FACTOR KLF7; PROTEINS; CELLS; DIFFERENTIATION; NEUROGENESIS; TRANSITIONS; PREVALENCE; EXPRESSION; LANDSCAPE; NEOCORTEX	The surface area of the human cerebral cortex undergoes dramatic expansion during late fetal development, leading to cortical folding, an evolutionary feature not present in rodents. Microcephaly is a neurodevelopmental disorder defined by an abnormally small brain, and many gene mutations have been found to be associated with primary microcephaly. However, mouse models generated by ablating primary microcephaly-associated genes often fail to recapitulate the severe loss of cortical surface area observed in individuals with this pathology. Here, we show that a mouse model with deficient expression of high-mobility group nucleosomal binding domain 2 (HMGN2) manifests microcephaly with reduced cortical surface area and almost normal radial corticogenesis, with a pattern of incomplete penetrance. We revealed that altered cleavage plane and mitotic delay of ventricular radial glia may explain the rising ratio of intermediate progenitor cells to radial glia and the displacement of neural progenitor cells in microcephalic mutant mice. These led to decreased self-renewal of the radial glia and reduction in lateral expansion. Furthermore, we found that HMGN2 protected corticogenesis by maintaining global chromatin accessibility mainly at promoter regions, thereby ensuring the correct regulation of the transcriptome. Our findings underscore the importance of the regulation of chromatin structure in cortical development and highlight a mouse model with critical insights into the etiology of microcephaly.	[Gao, Xue-Ling] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Gao, Xue-Ling; Tian, Wen-Jia; Shen, Qin] Tongji Univ, Key Lab Spine & Spinal Cord Injury Repair & Regen, Minist Educ, Tongji Hosp,Sch Life Sci & Technol, Shanghai 200065, Peoples R China; [Gao, Xue-Ling; Tian, Wen-Jia; Shen, Qin] Tongji Univ, Sch Life Sci & Technol, Minist Educ, Frontier Sci Ctr Stem Cell Res, Shanghai 200092, Peoples R China; [Tian, Wen-Jia; Liu, Bofeng; Wu, Jingyi; Xie, Wei] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Bofeng; Wu, Jingyi; Xie, Wei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Ctr Stem Cell Biol & Regenerat Med, Beijing 100084, Peoples R China; [Shen, Qin] Tongji Univ, Brain & Spinal Cord Clin Res Ctr, Shanghai 200092, Peoples R China; [Wu, Jingyi] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Wu, Jingyi] Harvard Med Sch, Boston, MA 02114 USA; [Wu, Jingyi] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Peking University; Tongji University; Tongji University; Tsinghua University; Tsinghua University; Tongji University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Shen, Q (corresponding author), Tongji Univ, Key Lab Spine & Spinal Cord Injury Repair & Regen, Minist Educ, Tongji Hosp,Sch Life Sci & Technol, Shanghai 200065, Peoples R China.; Shen, Q (corresponding author), Tongji Univ, Sch Life Sci & Technol, Minist Educ, Frontier Sci Ctr Stem Cell Res, Shanghai 200092, Peoples R China.; Shen, Q (corresponding author), Tongji Univ, Brain & Spinal Cord Clin Res Ctr, Shanghai 200092, Peoples R China.	shenqin@tongji.edu.cn			National Science Foundation of China [31671068]; Ministry of Science and Technology of China [2019YFA0110102]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Science Foundation of China Grant 31671068 and Ministry of Science and Technology of China Grant 2019YFA0110102. The authors declare that they have no conflicts of interest with the contents of this article.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bhattacharya A, 2003, CANCER RES, V63, P8167; Brown SDM, 2018, NAT REV GENET, V19, P357, DOI 10.1038/s41576-018-0005-2; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen FY, 2012, J NEUROSCI METH, V207, P172, DOI 10.1016/j.jneumeth.2012.03.016; Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885; de la Torre-Ubieta L, 2018, CELL, V172, P289, DOI 10.1016/j.cell.2017.12.014; Deng T, 2017, NUCLEIC ACIDS RES, V45, P3031, DOI 10.1093/nar/gkw1222; Deng T, 2015, GENOME RES, V25, P1295, DOI 10.1101/gr.192229.115; Desir J, 2008, AM J MED GENET A, V146A, P1439, DOI 10.1002/ajmg.a.32312; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dupuis N, 2015, HUM MOL GENET, V24, P2771, DOI 10.1093/hmg/ddv038; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hu XL, 2017, NEURON, V95, P309, DOI 10.1016/j.neuron.2017.06.047; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831; Jayaraman D, 2016, NEURON, V92, P813, DOI 10.1016/j.neuron.2016.09.056; Johnson MB, 2018, NATURE, V556, P370, DOI 10.1038/s41586-018-0035-0; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Kajimura D, 2007, GENE, V388, P34, DOI 10.1016/j.gene.2006.09.027; Kishi Y, 2012, NAT NEUROSCI, V15, P1127, DOI 10.1038/nn.3165; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kugler JE, 2012, BBA-GENE REGUL MECH, V1819, P652, DOI 10.1016/j.bbagrm.2012.01.013; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04122-x; Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003; Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006; Moon BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02720-9; Mounier A, 2015, J NEUROSCI, V35, P11862, DOI 10.1523/JNEUROSCI.1001-15.2015; NEW JS, 1986, J HETEROCYCLIC CHEM, V23, P545, DOI 10.1002/jhet.5570230247; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ochocinska MJ, 2009, MECH DEVELOP, V126, P128, DOI 10.1016/j.mod.2008.11.009; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Ozturk N, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00005; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Ramasamy SK, 2010, MOL CELL BIOL, V30, P1946, DOI 10.1128/MCB.01419-09; Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Singh S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00062; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Yamanaka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4354; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zhu N, 2010, BBA-GENE REGUL MECH, V1799, P74, DOI 10.1016/j.bbagrm.2009.11.006	62	7	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2020	295	2					468	480		10.1074/jbc.RA119.010616	http://dx.doi.org/10.1074/jbc.RA119.010616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KC7SS	31699896	Green Published, hybrid			2022-12-26	WOS:000507373600017
J	Carrera, LC; Victoria, C; Ramirez, JL; Jackman, C; Calzada, JE; Torres, R				Carrera, Lorenzo Caceres; Victoria, Carlos; Ramirez, Jose L.; Jackman, Carmela; Calzada, Jose E.; Torres, Rolando			Study of the epidemiological behavior of malaria in the Darien Region, Panama. 2015-2017	PLOS ONE			English	Article							ANTIMALARIAL-DRUG RESISTANCE; WESTERN AMAZON REGION; PLASMODIUM-VIVAX; AUTOCHTHONOUS MALARIA; HYPOENDEMIC MALARIA; DIPTERA-CULICIDAE; CLIMATE-CHANGE; SAO-PAULO; TRANSMISSION; FALCIPARUM	Background Malaria is endemic in Darien and an assessment of the different factors affecting its epidemiology is crucial for the development of adequate strategies of surveillance, prevention, and disease control. The objective of this study was to determine the main characteristics of the epidemiological behavior of malaria in the Darien region. Methods This research was comprised of a retrospective analysis to determine the incidence and malaria distribution in the Darien region from 2015 to 2017. We evaluated malaria indicators, disease distribution, incidence (by age group and sex), diagnostic methods, treatment, and control measures. In addition, we examined the cross-border migration activity and its possible contribution to the maintenance and distribution of malaria. Results During the period of 2015-2017, we examined 41,141 thick blood smear samples, out of which 501 tested positive for malaria. Plasmodium vivax was responsible for 92.2% of those infections. Males comprised 62.7% of the total diagnosed cases. Meanwhile, a similar percentage, 62.7%, of the total cases were registered in economically active ages. The more frequent symptoms included fever (99.4%) and chills (97.4%), with 53.1% of cases registering between 2,000 and 6,000 parasites/mu l of blood. The annual parasitic incidence (API) average was 3.0/1,000 inhabitants, while the slide positivity rate (SPR) was 1.2% and the annual blood examination rate (ABER) 22.5%. In Darien there is a constant internal and cross-border migration movement between Panama and Colombia. Malaria control measures consisted of the active and passive search of suspected cases and of the application of vector control measures. Conclusion This study provides an additional perspective on malaria epidemiology in Darien. Additional efforts are required to intensify malaria surveillance and to achieve an effective control, eventually moving closer to the objective of malaria elimination. At the same time, there is a need for more eco-epidemiological, entomological and migratory studies to determine how these factors contribute to the patterns of maintenance and dissemination of malaria.	[Carrera, Lorenzo Caceres; Torres, Rolando] Gorgas Mem Inst Hlth Studies, Dept Med Entomol, Panama City, Panama; [Victoria, Carlos] Minist Hlth, Malaria Program, Panama City, Panama; [Ramirez, Jose L.] ARS, Crop Bioprotect Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL USA; [Jackman, Carmela] Minist Hlth, Epidemiol Dept Darien Reg, Panama City, Panama; [Calzada, Jose E.] Gorgas Mem Inst Hlth Studies, Direcct Res & Technol Dev, Panama City, Panama	Instituto Conmemorativo Gorgas de Estudios de la Salud; Ministerio de Salud de la Republica de Panama; United States Department of Agriculture (USDA); Ministerio de Salud de la Republica de Panama; Instituto Conmemorativo Gorgas de Estudios de la Salud	Carrera, LC (corresponding author), Gorgas Mem Inst Hlth Studies, Dept Med Entomol, Panama City, Panama.	lcaceres@gorgas.gob.pa		Caceres Carrera, Lorenzo/0000-0002-2025-6893	Ministry of Economy and Finance (MEF)	Ministry of Economy and Finance (MEF)	LCC was assigned and administered the funds assigned by the Ministry of Economy and Finance (MEF). No grant was received for the authors. www.mef.gob.pa.The MEF did not play any role in the design of the study, collection and analysis of data and the decision to publish or prepare the manuscript.	Adeola AM, 2016, TROP MED INT HEALTH, V21, P675, DOI 10.1111/tmi.12680; Afrane YA, 2006, AM J TROP MED HYG, V74, P772, DOI 10.4269/ajtmh.2006.74.772; Marques GRAM, 2008, REV SOC BRAS MED TRO, V41, P386, DOI 10.1590/S0037-86822008000400012; Hurtado LA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2235-3; [Anonymous], ESSENTIAL MALARIOLOG; [Anonymous], 1980, ESSENTIAL MALARIOLOG; [Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; [Anonymous], 2012, MAN SEV MAL PRACT HD; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; AULT SK, 1989, DEMOGRAPHY VECTOR BO, P283; Autoridad Nacional del Ambiente, 2010, ATL AMB REP PAN PRIM; Awab GR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-105; Baird JK, 2016, AM J TROP MED HYG, V95, P35, DOI 10.4269/ajtmh.16-0171; Baird JK, 2012, ADV PARASIT, V80, P203, DOI 10.1016/B978-0-12-397900-1.00004-9; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Benavides-Melo JA, 2015, CURARE, V2, P33, DOI [10.16925/cu.v2i2.1185, DOI 10.16925/CU.V2I2.1185]; Blair-Trujillo S, 2007, BILL M GATES FDN MAL; Bruce-Chwatt L J, 1968, East Afr Med J, V45, P266; Cabrera OL, 2012, B MAL SALUD AMB; Caceres L, 2012, BIOMEDICA, V32, P557, DOI [10.1590/S0120-41572012000400011, 10.7705/biomedica.v32i4.773]; Caceres L, 2011, BIOMEDICA, V31, P419, DOI 10.1590/S0120-41572011000300014; Calzada JE, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0987-6; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; Campuzano Zuluaga G, 2010, MED LAB, V16, P311; Castillo CS, 1991, PRINCIPIOS EPIDEMIOL; Collins WE, 2002, J PARASITOL, V88, P295, DOI 10.1645/0022-3395(2002)088[0295:EIOAFW]2.0.CO;2; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; Coutin Marie Gisele, 2010, Rev Cubana Salud Pública, V36, P95, DOI 10.1590/s0864-34662010000100010; Couto RD, 2010, REV SOC BRAS MED TRO, V43, P52, DOI 10.1590/S0037-86822010000100012; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; D'Acremont V, 2007, BMJ-BRIT MED J, V334, P403, DOI [10.1136/bmj.39073.496829.AE, DOI 10.1136/BMJ.39073.496829.AE]; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Escalante AA, 2015, AM J TROP MED HYG, V93, P79, DOI 10.4269/ajtmh.15-0005; Ferreira IM, 2012, CIENC SAUDE COLETIVA, V17, P2415, DOI 10.1590/S1413-81232012000900022; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; Galappaththy GNL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004389.pub2; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hernandez M, 2016, BIOMEDICA, V36, P98, DOI 10.7705/biomedica.v36i0.2934; Hurtado LA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.27; Ibor U. W., 2017, Science World Journal, V12, P19; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-97; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Krisher LK, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1630-x; Lainhart W, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004718; Le PVV, 2019, PLOS ONE, V6, P14, DOI [10.1371/J.241545, DOI 10.1371/J.241545]; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Loaiza JR, 2008, J MED ENTOMOL, V45, P841, DOI 10.1603/0022-2585(2008)45[841:SCADOA]2.0.CO;2; Loaiza J, 2009, AM J TROP MED HYG, V81, P23, DOI 10.4269/ajtmh.2009.81.23; Lopez FJ, 1988, PUBLICACION CIENTIFI, V512, P196; Lopez-Beltran C, 2013, HIST CIENC SAUDE-MAN, V20, P388, DOI 10.1590/S0104-597020130002000002; Lorenz C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0934-6; Lynch CA, 2015, TROP MED INT HEALTH, V20, P773, DOI 10.1111/tmi.12480; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0; Marques MM, 2014, ANTIMICROB AGENTS CH, V58, P342, DOI 10.1128/AAC.02279-12; McKenzie FE, 2002, J PARASITOL, V88, P521, DOI 10.1645/0022-3395(2002)088[0521:PVBSD]2.0.CO;2; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Ministerio de Salud de Panama, 2005, SIT SALN PAN, P174; Ministerio de Salud de Panama, 2011, MAN NORM PROC MAL, P172; Ministerio de Salud de Panama, INF TECN SIT MAL PAN, P37; Naing C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003071; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Ochoa Johanna, 2006, Biomed., V26, P278; Olliaro PL, 1995, B WORLD HEALTH ORGAN, V73, P565; Onyango EA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1600-3; Organizacion Panamericana de la Salud, 2017, INF SIT MAL AM 2014, P106; Paaijmans KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055777; Rodriguez JCP, 2011, MEM I OSWALDO CRUZ, V106, P114, DOI 10.1590/S0074-02762011000900015; Pan American Health Organization, 2013, SIT MAL REG AM 2000, P5; Pan American Health Organization, 2012, INF SIT PAL AM 2011, P3; Pan American Health Organization, 2016, WASH D C PLAN ACC EL; PETERS DH, 1992, LANCET, V339, P690, DOI 10.1016/0140-6736(92)90860-6; Pindolia DK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-169; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; PROTHERO RM, 1977, INT J EPIDEMIOL, V6, P259, DOI 10.1093/ije/6.3.259; Ramal C, 2008, REV PERU EPIDEMIOL, V12, P1; Reiter Bernd, 2012, AFRODESCENDANTS IDEN, DOI [10.14321/j.ctt7zt80g, DOI 10.14321/J.CTT7ZT80G]; Rodríguez U Claudia, 2007, Rev. perú. med. exp. salud publica, V24, P35; Rodriguez-Morales AJ, 2004, VARIABILIDAD CLIMATI, V2, P26; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-56; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Samudio F, 2005, AM J TROP MED HYG, V73, P839, DOI 10.4269/ajtmh.2005.73.839; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; SEVILLACASAS E, 1993, SOC SCI MED, V37, P1155, DOI 10.1016/0277-9536(93)90255-3; SHUTE GT, 1973, B WORLD HEALTH ORGAN, V48, P591; SIVIGILA, 2016, B EP SEM SEM EP NUM; Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040; Staalsoe T, 1998, PARASITOL TODAY, V14, P177, DOI 10.1016/S0169-4758(98)01228-9; Takala-Harrison S, 2015, ANN NY ACAD SCI, V1342, P62, DOI 10.1111/nyas.12766; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Tatem AJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-218; VENTER N, 2017, PARASITE VECTOR, V10, P48654, DOI DOI 10.1186/J.24524; White NJ, 2012, ADV PARASIT, V80, P113, DOI 10.1016/B978-0-12-397900-1.00002-5; Whittaker M, 2012, MALARIA J S1, V11, pP101; WHO, 2018, WORLD MAL REP 2018; *WHO, 1996, ASS THER EFF ANT DRU; World Health Organization, 2016, GLOB MAL PROGR; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2017, WORLD MAL REP WORLD; World Health Organization, 2015, GUID TREATM MAL, V3, P303; World Health Organization, 2015, GLOB TECHNN STRAT MA; World Health Organization (WHO), 2016, GLOB DIF EHLTH MAK U; Zuluaga-Idarraga L, 2016, ANTIMICROB AGENTS CH, V60, P4610, DOI 10.1128/AAC.00186-16; 2010, WORLD MAL REP 2010, P1; 2013, WORLD MAL REP 2013, P1	112	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224508	10.1371/journal.pone.0224508	http://dx.doi.org/10.1371/journal.pone.0224508			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730618	gold, Green Published			2022-12-26	WOS:000532809500004
J	Bauknight, DK; Osinski, V; Dasa, SSK; Nguyen, AT; Marshall, MA; Hartman, J; Harms, M; O'Mahony, G; Boucher, J; Klibanov, AL; McNamara, CA; Kelly, KA				Bauknight, Dustin K.; Osinski, Victoria; Dasa, Siva Sai Krishna; Nguyen, Anh T.; Marshall, Melissa A.; Hartman, Julia; Harms, Matthew; O'Mahony, Gavin; Boucher, Jeremie; Klibanov, Alexander L.; McNamara, Coleen A.; Kelly, Kimberly A.			Importance of thorough tissue and cellular level characterization of targeted drugs in the evaluation of pharmacodynamic effects	PLOS ONE			English	Article							RECEPTOR-ALPHA/GAMMA AGONIST; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; B-LYMPHOCYTES; PPAR-ALPHA; TESAGLITAZAR; MACROPHAGES; PROHIBITIN; LIPOSOMES	Targeted nanoparticle delivery is a promising strategy for increasing efficacy and limiting side effects of therapeutics. When designing a targeted liposomal formulation, the in vivo biodistribution of the particles must be characterized to determine the value of the targeting approach. Peroxisome proliferator-activated receptor (PPAR) agonists effectively treat metabolic syndrome by decreasing dyslipidemia and insulin resistance but side effects have limited their use, making them a class of compounds that could benefit from targeted liposomal delivery. The adipose targeting sequence peptide (ATS) could fit this role, as it has been shown to bind to adipose tissue endothelium and induce weight loss when delivered conjugated to a pro-apoptotic peptide. To date, however, a full assessment of ATS in vivo biodistribution has not been reported, leaving important unanswered questions regarding the exact mechanisms whereby ATS targeting enhances therapeutic efficacy. We designed this study to evaluate the biodistribution of ATS-conjugated liposomes loaded with the PPAR alpha/gamma dual agonist tesaglitazar in leptin-deficient ob/ob mice. The ATS-liposome biodistribution in adipose tissue and other organs was examined at the cellular and tissue level using microscopy, flow cytometry, and fluorescent molecular tomography. Changes in metabolic parameters and gene expression were measured by target and off-target tissue responses to the treatment. Unexpectedly, ATS targeting did not increase liposomal uptake in adipose relative to other tissues, but did increase uptake in the kidneys. Targeting also did not significantly alter metabolic parameters. Analysis of the liposome cellular distribution in the stromal vascular fraction with flow cytometry revealed high uptake by multiple cell types. Our findings highlight the need for thorough study of in vivo biodistribution when evaluating a targeted therapy.	[Bauknight, Dustin K.; Dasa, Siva Sai Krishna; Hartman, Julia; Klibanov, Alexander L.; Kelly, Kimberly A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA; [Bauknight, Dustin K.; Dasa, Siva Sai Krishna; Kelly, Kimberly A.] Univ Virginia, Canc Ctr, Charlottesville, VA 22903 USA; [Osinski, Victoria; Nguyen, Anh T.; Marshall, Melissa A.; Hartman, Julia; Klibanov, Alexander L.; McNamara, Coleen A.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA; [Osinski, Victoria] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Harms, Matthew; O'Mahony, Gavin; Boucher, Jeremie] AstraZeneca, BioPharmaceut R&D, Res & Early Dev Cardiovasc Renal & Metab CVRM, Gothenburg, Sweden; [Boucher, Jeremie] Univ Gothenburg, Lundberg Lab Diabet Res, Gothenburg, Sweden; [Boucher, Jeremie] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden; [Klibanov, Alexander L.; McNamara, Coleen A.] Univ Virginia, Dept Med, Div Cardiovasc Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; AstraZeneca; University of Gothenburg; University of Gothenburg; University of Virginia	Kelly, KA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.; Kelly, KA (corresponding author), Univ Virginia, Canc Ctr, Charlottesville, VA 22903 USA.	kak3x@virginia.edu	Osinski, Victoria/AGX-7982-2022; Nguyen, Anh/GQQ-3393-2022; Osinski, Victoria/AAU-5839-2020	Osinski, Victoria/0000-0002-8969-8454	AstraZeneca/UVA Strategic Alliance; NATIONAL CANCER INSTITUTE [R01CA168712, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055798] Funding Source: NIH RePORTER	AstraZeneca/UVA Strategic Alliance(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the AstraZeneca/UVA Strategic Alliance to CAM, KAK & ALK. Authors HM, GO, and JB are employees of AstraZeneca. The funder provided support in the form of salaries for authors HM, GO, and JB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Competing interests:	Ande SR, 2016, TRENDS ENDOCRIN MET, V27, P531, DOI 10.1016/j.tem.2016.05.003; Bailey Clifford J, 2007, Diab Vasc Dis Res, V4, P161; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Barnhart KF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002621; Bays Harold, 2007, Diab Vasc Dis Res, V4, P181; Beech JR, 2013, CURR PHARM DESIGN, V19, P6560; Bu L, 2013, AAPS J, V15, P1001, DOI 10.1208/s12248-013-9501-7; Bulbake U, 2017, PHARMACEUTICS, V9, DOI 10.3390/pharmaceutics9020012; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; Dasa SSK, 2017, NANOMED-NANOTECHNOL, V13, P2565, DOI 10.1016/j.nano.2017.07.005; Dasa SSK, 2015, J CONTROL RELEASE, V220, P556, DOI 10.1016/j.jconrel.2015.06.017; Fagerberg B, 2005, DIABETOLOGIA, V48, P1716, DOI 10.1007/s00125-005-1846-8; Feng B, 2011, PLOS ONE, V6, P1, DOI DOI 10.1371/J0URNAL.P0NE.0024358; Glassman PM, 2019, J PHARMACOL EXP THER, V370, P570, DOI 10.1124/jpet.119.257113; Goldstein BJ, 2006, CURR MED RES OPIN, V22, P2575, DOI 10.1185/030079906X154169; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Hamren B, 2012, J CLIN PHARMACOL, V52, P1317, DOI 10.1177/0091270011416937; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hossen MN, 2012, J CONTROL RELEASE, V163, P101, DOI 10.1016/j.jconrel.2012.09.002; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; Kajimoto K, 2010, J IMMUNOL METHODS, V357, P43, DOI 10.1016/j.jim.2010.03.011; Kim DH, 2010, DIABETES, V59, P907, DOI 10.2337/db09-1141; Kiss-Toth E, 2008, PPAR RES, V2008, DOI 10.1155/2008/183108; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kulkarni JA, 2019, NANOSCALE, V11, P9023, DOI 10.1039/c9nr02004g; Ljung B, 2002, J LIPID RES, V43, P1855, DOI 10.1194/jlr.M200127-JLR200; McDonnell ME, 2012, OBESITY, V20, P1372, DOI 10.1038/oby.2012.54; Murakami K, 2007, EUR J PHARMACOL, V561, P206, DOI 10.1016/j.ejphar.2006.12.037; Oakes ND, 2005, AM J PHYSIOL-REG I, V289, pR938, DOI 10.1152/ajpregu.00252.2005; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Penas F, 2015, BBA-MOL BASIS DIS, V1852, P893, DOI 10.1016/j.bbadis.2014.12.019; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ramakrishnan VM, 2018, TISSUE ENG PART B-RE, V24, P289, DOI [10.1089/ten.teb.2017.0061, 10.1089/ten.TEB.2017.0061]; Rizos CV, 2009, EXPERT OPIN DRUG SAF, V8, P15, DOI [10.1517/14740330802597821 , 10.1517/14740330802597821]; Ruan XZ, 2008, AM J PHYSIOL-RENAL, V294, pF1032, DOI 10.1152/ajprenal.00152.2007; Salameh A, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86351; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Schuster H, 2008, ATHEROSCLEROSIS, V197, P355, DOI 10.1016/j.atherosclerosis.2007.05.029; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; STOCKINGER H, 1990, J IMMUNOL, V145, P3889; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Tonstad S, 2007, METABOLISM, V56, P1285, DOI 10.1016/j.metabol.2007.05.003; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang YJ, 2014, BBA-MOL CELL RES, V1843, P1393, DOI 10.1016/j.bbamcr.2014.04.005; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Won YW, 2014, NAT MATER, V13, P1157, DOI [10.1038/nmat4092, 10.1038/NMAT4092]; Working P. K., 1994, Journal of Liposome Research, V4, P667, DOI 10.3109/08982109409037065; Xue Y, 2016, P NATL ACAD SCI USA, V113, P5552, DOI 10.1073/pnas.1603840113; Zhang HJ, 2016, ONCOTARGETS THER, V9, P3001, DOI 10.2147/OTT.S105587	54	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224917	10.1371/journal.pone.0224917	http://dx.doi.org/10.1371/journal.pone.0224917			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725756	Green Published, gold			2022-12-26	WOS:000532764500034
J	Kil, LP; Vaneman, J; van der Lubbe, JEM; Czapska-Casey, D; Tolboom, JTBM; Roozendaal, R; Zahn, RC; Kuipers, H; Solforosi, L				Kil, Laurens P.; Vaneman, Joost; van der Lubbe, Joan E. M.; Czapska-Casey, Dominika; Tolboom, Jeroen T. B. M.; Roozendaal, Ramon; Zahn, Roland C.; Kuipers, Harmjan; Solforosi, Laura			Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice	PLOS ONE			English	Article							MEMORY B; NEUTRALIZING ANTIBODIES; HEMAGGLUTININ-STEM; SEASONAL INFLUENZA; CENTER SELECTION; CELL; VIRUS; ANTIGEN	Correlates of protection (CoP) are invaluable for iterative vaccine design studies, especially in pursuit of complex vaccines such as a universal influenza vaccine (UFV) where a single antigen is optimized to elicit broad protection against many viral antigenic variants. Since broadly protective antibodies against influenza virus often exhibit mutational evidence of prolonged diversification, we studied germinal center (GC) kinetics in hemagglutinin (HA) immunized mice. Here we report that as early as 4 days after secondary immunization, the expansion of HA-specific GC B cells inversely correlated to protection against influenza virus challenge, induced by the antigen. In contrast, follicular T helper (TFH) cells did not expand differently after boost vaccination, suggestive of a B-cell intrinsic difference in activation and differentiation inferred by protective antigen properties. Importantly, differences in antigen dose only affected GC B-cell frequencies after primary immunization. The absence of accompanying differences in total anti-HA or epitope-specific antibody levels induced by vaccines of different efficacy suggests that the GC B-cell response upon revaccination represents an early and unique marker of protection that may significantly accelerate the pre-clinical phase of vaccine development.	[Kil, Laurens P.; Vaneman, Joost; van der Lubbe, Joan E. M.; Czapska-Casey, Dominika; Tolboom, Jeroen T. B. M.; Roozendaal, Ramon; Zahn, Roland C.; Kuipers, Harmjan; Solforosi, Laura] Janssen Vaccines & Prevent BV, Pharmaceut Co Johnson & Johnson, Leiden, Netherlands; [Kil, Laurens P.] Genmab, Dept Translat Res, Utrecht, Netherlands	Johnson & Johnson; Genmab	Solforosi, L (corresponding author), Janssen Vaccines & Prevent BV, Pharmaceut Co Johnson & Johnson, Leiden, Netherlands.	lsolforo@its.jnj.com	Zahn, Roland/ABE-8779-2021	Solforosi, Laura/0000-0003-3786-6468	Janssen Vaccines & Prevention B.V., a pharmaceutical company of Johnson Johnson	Janssen Vaccines & Prevention B.V., a pharmaceutical company of Johnson Johnson	All the authors that contributed to this manuscript are/were employees of Janssen Vaccines & Prevention B.V., a pharmaceutical company of Johnson & Johnson. Janssen Vaccines & Prevention B.V. provided support in the form of salaries for authors [L.P.K., J.V., J.E.M. vdL., D.C.-C., J.T.B.M.T., R.R., R.C.Z., H.K. and L. S.] and reagents to perform the experiments. The content of the current manuscript has exclusively scientific purposes. The specific roles of the authors are articulated in the 'author contributions' section.	Adachi Y, 2015, J EXP MED, V212, P1709, DOI 10.1084/jem.20142284; Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; Cho A, 2016, CURR OPIN VIROL, V17, P110, DOI 10.1016/j.coviro.2016.03.002; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113; Henry C, 2018, TRENDS IMMUNOL, V39, P70, DOI 10.1016/j.it.2017.08.003; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Koutsakos M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8405; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Maamary J, 2017, P NATL ACAD SCI USA, V114, P10172, DOI 10.1073/pnas.1707950114; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nair N, 2013, IMMUN INFLAMM DIS, V1, P3, DOI 10.1002/iid3.3; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Paules CI, 2018, NEW ENGL J MED, V378, P7, DOI 10.1056/NEJMp1714916; Paules CI, 2017, IMMUNITY, V47, P599, DOI 10.1016/j.immuni.2017.09.007; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; SALK JE, 1945, AM J HYG, V42, P57, DOI 10.1093/oxfordjournals.aje.a119025; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Tan HX, 2019, J CLIN INVEST, V129, P850, DOI 10.1172/JCI123366; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; van der Lubbe JEM, 2018, F1000RES, P1; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225063	10.1371/journal.pone.0225063	http://dx.doi.org/10.1371/journal.pone.0225063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725776	gold, Green Published			2022-12-26	WOS:000532764500046
J	Liao, F; Chen, HN; Xie, JL; Zhan, SF; Pan, P; Lao, ZZ; Fan, YH; Lin, LP; Lai, YN; Lin, SF; Wu, JG; Liu, XH; Li, G				Liao, Feng; Chen, Huini; Xie, Jieliang; Zhan, Shaofeng; Pan, Pan; Lao, Zizhao; Fan, Yaohua; Lin, Lupin; Lai, Yanni; Lin, Shuangfeng; Wu, Jianguo; Liu, Xiaohong; Li, Geng			Molecular epidemiological characteristics of dengue virus carried by 34 patients in Guangzhou in 2018	PLOS ONE			English	Article							OUTBREAK	Dengue fever is a major worldwide public health problem that, as estimated by the WHO, causes epidemics in over 100 countries, resulting in hundreds of millions of dengue virus (DENV) infections every year. In China, dengue fever mainly occurs in coastal areas. Recurring dengue outbreaks were reported by Guangdong Province almost every year since the first epidemic in 1978. DENV infections persisted in Guangzhou in consecutive years since 2000, with the dengue epidemic reaching a historical peak in 2014. Because Guangzhou is one of the largest cities for opening up in China, understanding the epidemiological characteristics of dengue fever in the city can hopefully provide a significant basis for developing effective dengue prevention strategies. In this study, a total of 34 DENV strains, including 29 DENV-1 strains and 5 DENV-2 strains, were isolated from a blood samples drawn from patients who were diagnosed with dengue fever by hospitals in Guangzhou during 2018. To explore the epidemiological characteristics of dengue fever, the envelope (E) gene obtained from the isolates was amplified for phylogenetic analysis. The results from the phylogenetic analysis showed that DENV in Guangzhou was mainly imported from Southeast Asian countries. Additionally, propagation paths based on phylogeographical analysis suggested potential local dengue transmission in Guangzhou.	[Liao, Feng; Liu, Xiaohong; Li, Geng] Guangzhou Univ Chinese Med, Lab Anim Ctr, Guangzhou, Peoples R China; [Chen, Huini; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Guangzhou, Peoples R China; [Xie, Jieliang] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Peoples R China; [Zhan, Shaofeng; Fan, Yaohua; Lai, Yanni; Lin, Shuangfeng] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Peoples R China; [Pan, Pan] WuHan Univ, Coll Life Sci, Wuhan, Hubei, Peoples R China; [Lao, Zizhao] Guangzhou Univ Chinese Med, Math Engn Acad Chinese Med, Guangzhou, Peoples R China; [Lin, Lupin] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China	Guangzhou University of Chinese Medicine; Jinan University; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Wuhan University; Guangzhou University of Chinese Medicine; Guangzhou Medical University	Li, G (corresponding author), Guangzhou Univ Chinese Med, Lab Anim Ctr, Guangzhou, Peoples R China.	lg@gzucm.edu.cn		Wu, Jianguo/0000-0002-8326-2895	National Nature Science Foundation of China [81803813, 81973549]; Science & Technology Planning Project of Guangzhou [201804010029]; State Key Laboratory of Natural Medicines [SKLNMKF201906]; Key Research Projects of GZUCM First-class universities and Top Disciplines [A1AFD018191A17]; Science & Technology Planning Project of Guangdong Province Office of Education [2018KCXTD007, 2014GKXM032]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Planning Project of Guangzhou; State Key Laboratory of Natural Medicines; Key Research Projects of GZUCM First-class universities and Top Disciplines; Science & Technology Planning Project of Guangdong Province Office of Education	This work was supported by 81803813, to Li G, from National Nature Science Foundation of China; 201804010029, to Li G, from Science & Technology Planning Project of Guangzhou; SKLNMKF201906, to Li G, from The Open Project of State Key Laboratory of Natural Medicines; A1AFD018191A17, to Liu XH, from Key Research Projects of GZUCM First-class universities and Top Disciplines; 2018KCXTD007, to Liu XH, from Science & Technology Planning Project of Guangdong Province Office of Education; 2014GKXM032, to Lai XP, from Science & Technology Planning Project of Guangdong Province Office of Education; 81973549, to Li G, from National Nature Science Foundation of China.	[Anonymous], 2009, DENG GUID DIAGN TREA; Ayres DL, 2012, BEAGLE APPL PROGRAMM; Chen P, 2018, VIROL SIN, V33, P394, DOI 10.1007/s12250-018-0056-8; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endy TP, 2010, CURR TOP MICROBIOL, V338, P1, DOI 10.1007/978-3-642-02215-9_1; Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317; Guo XX, 2007, J MED ENTOMOL, V44, P492, DOI 10.1603/0022-2585(2007)44[492:SARODV]2.0.CO;2; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ko HY, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006827; Lai SJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006743; Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li G, 2017, VIROL SIN, V32, P63, DOI 10.1007/s12250-016-3872-8; Li MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166211; Lin Y, 2019, INT J INFECT DIS, V79, P152, DOI 10.1016/j.ijid.2018.11.370; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Niu C, 2020, VECTOR-BORNE ZOONOT, V20, P143, DOI 10.1089/vbz.2019.2477; Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Sang SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003808; Sang SW, 2015, INFECT GENET EVOL, V32, P178, DOI 10.1016/j.meegid.2015.03.005; Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tong MX, 2019, J INFECT PUBLIC HEAL, V12, P388, DOI 10.1016/j.jiph.2018.12.010; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662; Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548	33	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224676	10.1371/journal.pone.0224676	http://dx.doi.org/10.1371/journal.pone.0224676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725752	Green Published, gold			2022-12-26	WOS:000532764500024
J	Nagati, JS; Xu, M; Garcia, T; Comerford, SA; Hammer, RE; Garcia, JA				Nagati, Jason S.; Xu, Min; Garcia, Trent; Comerford, Sarah A.; Hammer, Robert E.; Garcia, Joseph A.			A substitution mutation in a conserved domain of mammalian acetate-dependent acetyl CoA synthetase 2 results in destabilized protein and impaired HIF-2 signaling	PLOS ONE			English	Article							HISTONE ACETYLATION; CRYSTAL-STRUCTURE; BINDING; TRANSCRIPTION; ENZYME	The response to environmental stresses by eukaryotic organisms includes activation of protective biological mechanisms, orchestrated in part by transcriptional regulators. The tri-member Hypoxia Inducible Factor (HIF) family of DNA-binding transcription factors include HIF-2, which is activated under conditions of oxygen or glucose deprivation. Although oxygen-dependent protein degradation is a key mechanism by which HIF-1 and HIF-2 activity is regulated, HIF-2 is also influenced substantially by the coupled action of acetylation and deacetylation. The acetylation/deacetylation process that HIF-2 undergoes employs a specific acetyltransferase and deacetylase. Likewise, the supply of the acetyl donor, acetyl CoA, used for HIF-2 acetylation originates from a specific acetyl CoA generator, acetate-dependent acetyl CoA synthetase 2 (Acss2). Although Acss2 is predominantly cytosolic, a subset of the Acss2 cellular pool is enriched in the nucleus following oxygen or glucose deprivation. Prevention of nuclear localization by a directed mutation in a putative nuclear localization signal in Acss2 abrogates HIF-2 acetylation and blunts HIF-2 dependent signaling as well as flank tumor growth for knockdown/rescue cancer cells expressing ectopic Acss2. In this study, we report generation of a novel mouse strain using CRISPR/Cas9 mutagenesis that express this mutant Acss2 allele in the mouse germline. The homozygous mutant mice have impaired induction of the canonical HIF-2 target gene erythropoietin and blunted recovery from acute anemia. Surprisingly, Acss2 protein levels are dramatically reduced in these mutant mice. Functional studies investigating the basis for this phenotype reveal multiple protein instability domains in the Acss2 carboxy terminus. The findings described herein may be of relevance in the regulation of native Acss2 protein as well as for humans carrying missense mutations in these domains.	[Nagati, Jason S.; Garcia, Trent; Garcia, Joseph A.] Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA; [Xu, Min] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Comerford, Sarah A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Garcia, Joseph A.] James J Peters VA Med Ctr, Dept Res, New York, NY 10029 USA	Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Garcia, JA (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10032 USA.; Garcia, JA (corresponding author), James J Peters VA Med Ctr, Dept Res, New York, NY 10029 USA.	jag2369@cumc.columbia.edu		Garcia, Joseph/0000-0002-5621-7538; Hammer, Robert E./0000-0001-5487-7551; Comerford, Sarah Ann/0000-0002-7452-7759; Nagati, Jason/0000-0002-4507-6581	United States Department of Veterans Affairs [I01BX000446]; United States National Institutes of Health [HL108104, HL130142, P309DK079328]	United States Department of Veterans Affairs(US Department of Veterans Affairs); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by funds provided by the United States Department of Veterans Affairs (I01BX000446 - JG) and the United States National Institutes of Health (HL108104, HL130142 -JG; P309DK079328 - O'Brien Kidney Research Core Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulusu V, 2017, CELL REP, V18, P647, DOI 10.1016/j.celrep.2016.12.055; Chen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190241; Chen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116515; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Costantini LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8670; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Gao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11960; Geffen Y, 2016, MOL CELL, V63, P1055, DOI 10.1016/j.molcel.2016.08.005; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Li XJ, 2017, MOL CELL, V66, P684, DOI 10.1016/j.molcel.2017.04.026; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Mews P, 2017, NATURE, V546, P381, DOI 10.1038/nature22405; Nam YJ, 2014, DEVELOPMENT, V141, P4267, DOI 10.1242/dev.114025; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Starai VJ, 2005, J BIOL CHEM, V280, P26200, DOI 10.1074/jbc.M504863200; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225105	10.1371/journal.pone.0225105	http://dx.doi.org/10.1371/journal.pone.0225105			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725783	Green Submitted, Green Published, gold			2022-12-26	WOS:000532764500054
J	Park, SW; Jang, HJ; Kim, M; Kwag, J				Park, Sahn Woo; Jang, Hyun Jae; Kim, Mincheol; Kwag, Jeehyun			Spatiotemporally random and diverse grid cell spike patterns contribute to the transformation of grid cell to place cell in a neural network model	PLOS ONE			English	Article							MEDIAL ENTORHINAL CORTEX; THETA-PHASE PRECESSION; SPATIAL REPRESENTATION; PYRAMIDAL CELLS; CA1; FIELDS; OSCILLATIONS; MAP; ORGANIZATION; HIPPOCAMPUS	The medial entorhinal cortex and the hippocampus are brain regions specialized in spatial information processing. While an animal navigates around an environment, grid cells in the medial entorhinal cortex spike at multiple discrete locations, forming hexagonal grid patterns, and each grid cell is spatiotemporally dynamic with a different grid size, spacing, and orientation. In contrast, place cells in the hippocampus spike when an animal is at one or more specific locations, called a "place field". While an animal traverses through a place field, the place cell's spike phases relative to the hippocampal theta-frequency oscillation advance in phase, known as the "spike phase precession" phenomenon and each spike encodes the specific location within the place field. Interestingly, the medial entorhinal cortical grid cells and the hippocampal place cells are only one excitatory synapse apart. However, how the spatiotemporally dynamic multi-peaked grid cell activities are transformed into hippocampal place cell activities with spike phase precession phenomenon is yet unknown. To address this question, we construct an anatomically and physiologically realistic neural network model comprised of 10,000 grid cell models, each with a spatiotemporally dynamic grid patterns and a place cell model connected by excitatory synapses. Using this neural network model, we show that grid cells' spike activities with spatiotemporally random and diverse grid orientation, spacing, and phases as inputs to place cell are able to generate a place field with spike phase precession. These results indicate that spatiotemporally random and diverse grid cell spike activities are essential for the formation of place cell activity observed in vivo.	[Park, Sahn Woo; Jang, Hyun Jae; Kim, Mincheol; Kwag, Jeehyun] Korea Univ, Dept Brain & Cognit Engn, Neural Computat Lab, Seoul, South Korea	Korea University	Kwag, J (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Neural Computat Lab, Seoul, South Korea.	jkwag@korea.ac.kr		Jang, Hyun Jae/0000-0002-3245-6681	National Research Foundation (NRF) - Korean government (MSIT) [NRF-2013R1A1A2053280, NRF-2016R1A1A05921614, NRF-2015M3C7A1028790, NRF-2019M3E5D2A01058328]; Korea University	National Research Foundation (NRF) - Korean government (MSIT); Korea University	This study was supported by the Basic Science Research Program (NRF-2013R1A1A2053280, NRF-2016R1A1A05921614), the Brain Research Program (NRF-2015M3C7A1028790) and the Brain Convergence Research Program (NRF-2019M3E5D2A01058328) through the National Research Foundation (NRF) funded by the Korean government (MSIT) to JK. HJJ was supported by a Korea University Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Azizi AH, 2014, HIPPOCAMPUS, V24, P912, DOI 10.1002/hipo.22306; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Castro L, 2014, BIOL CYBERN, V108, P133, DOI 10.1007/s00422-013-0581-3; Chapman CA, 1999, J NEUROSCI, V19, P8637; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; de Boor C., 2001, APPL MATH SCI, V27; Dragoi G, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00046; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Fernandez-Ruiz A, 2017, NEURON, V93, P1213, DOI 10.1016/j.neuron.2017.02.017; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hales JB, 2014, CELL REP, V9, P893, DOI 10.1016/j.celrep.2014.10.009; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Hayman RM, 2008, HIPPOCAMPUS, V18, P1301, DOI 10.1002/hipo.20513; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Hussaini SA, 2011, NEURON, V72, P643, DOI 10.1016/j.neuron.2011.09.007; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jaramillo J, 2014, J NEUROSCI, V34, P7715, DOI 10.1523/JNEUROSCI.5136-13.2014; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kanter BR, 2017, NEURON, V93, P1480, DOI 10.1016/j.neuron.2017.03.001; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kwag J, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0604; Lyttle D, 2013, HIPPOCAMPUS, V23, P729, DOI 10.1002/hipo.22132; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Magee JC, 1998, J NEUROSCI, V18, P7613; Masurkar AV, 2017, CELL REP, V18, P148, DOI 10.1016/j.celrep.2016.12.012; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Miao CL, 2015, NEURON, V88, P590, DOI 10.1016/j.neuron.2015.09.051; Molter C, 2008, NEURAL NETWORKS, V21, P303, DOI 10.1016/j.neunet.2007.12.032; Moser EI, 2014, NAT REV NEUROSCI, V15, P466, DOI 10.1038/nrn3766; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Otmakhova NA, 2005, J NEUROPHYSIOL, V94, P1413, DOI 10.1152/jn.00217.2005; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Park E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022349; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; Rapp PR, 2002, CEREB CORTEX, V12, P1171, DOI 10.1093/cercor/12.11.1171; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Rueckemann JW, 2016, HIPPOCAMPUS, V26, P246, DOI 10.1002/hipo.22519; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Schlesiger MI, 2015, NAT NEUROSCI, V18, P1123, DOI 10.1038/nn.4056; Shah MM, 2011, J PHYSIOL-LONDON, V589, P6029, DOI 10.1113/jphysiol.2011.220913; Si B, 2009, COGN NEURODYNAMICS, V3, P177, DOI 10.1007/s11571-009-9079-z; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Sterratt DC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002545; Tropp J, 2005, HIPPOCAMPUS, V15, P154, DOI 10.1002/hipo.20042; Van Cauter T, 2008, EUR J NEUROSCI, V27, P1933, DOI 10.1111/j.1460-9568.2008.06158.x; Yamaguchi Y, 2002, J NEUROPHYSIOL, V87, P2629, DOI 10.1152/jn.2002.87.6.2629; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; Zhang S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00222; Zhao R, 2016, CELL REP, V16, P793, DOI 10.1016/j.celrep.2016.06.032; Zilli EA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000573	68	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225100	10.1371/journal.pone.0225100	http://dx.doi.org/10.1371/journal.pone.0225100			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725775	Green Published, gold			2022-12-26	WOS:000532764500052
J	Sogunle, E; Masukume, G; Nelson, G				Sogunle, Eniola; Masukume, Gwinyai; Nelson, Gill			The association between caesarean section delivery and later life obesity in 21-24 year olds in an Urban South African birth cohort	PLOS ONE			English	Article							OFFSPRING OVERWEIGHT; EARLY ADULTHOOD; GUT MICROBIOTA; RISK; ADOLESCENCE; CHILDHOOD; CHILDREN; WEIGHT; MODE	Background Obesity is an important public health problem and rates have reached epidemic proportions in many countries. Studies have explored the association between infants delivered by caesarean section and their later life risk of obesity, in many countries outside Africa. As a result of the increasing caesarean section and obesity rates in South Africa, we investigated the association in this country. Methods This was a retrospective analysis of data that were collected from a prospective South African birth cohort (Birth to Twenty Plus), established in 1990. A total of 889 young adults aged 21-24 years were included in the analysis. Poisson regression models were fitted to assess the association between mode of delivery and early adulthood obesity. Results Of the 889 young adults, 106 (11.9%) were obese while 72 (8.1%) were delivered by caesarean section; of which 14 (19.4%) were obese. Caesarean section delivery was significantly associated with obesity in young adults after adjusting for potential confounders like young adults' sex and birth weight, mothers' parity, and education (incidence rate ratio 1.64, 95% CI 1.01-2.68, p = 0.045). Conclusion The association of caesarean section with early adulthood obesity should be interpreted with caution because data on certain key confounding factors such as mothers' pre-pregnancy body mass index and gestational diabetes were not available. Further research from Africa, with larger sample sizes and databases with useful linking of maternal and infant data, should be conducted.	[Sogunle, Eniola; Masukume, Gwinyai; Nelson, Gill] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa	University of Witwatersrand	Sogunle, E (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	eniolasogunle@yahoo.com	Nelson, Gill/AAC-3074-2020	Nelson, Gill/0000-0001-7815-3718; Sogunle, Eniola/0000-0002-7776-993X; Masukume, Gwinyai/0000-0002-9251-0264				Aiken CE, 2014, OBSTET GYNECOL, V123, P796, DOI 10.1097/AOG.0000000000000188; [Anonymous], 2000, WHO TECHN REP SER; Barros AJD, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4165-3; Barros FC, 2012, AM J CLIN NUTR, V95, P465, DOI 10.3945/ajcn.111.026401; Bernardi JR, 2015, AM J CLIN NUTR, V102, P295, DOI 10.3945/ajcn.114.105205; Biasucci G, 2008, J NUTR, V138, p1796S, DOI 10.1093/jn/138.9.1796S; Canavan TP, 2004, OBSTET GYNECOL SURV, V59, P678, DOI 10.1097/01.ogx.0000137611.26772.2d; Choi KH, 2008, AM J PUBLIC HEALTH, V98, P1841, DOI 10.2105/AJPH.2007.113050; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Cois Annibale, 2015, BMC Obes, V2, P42, DOI 10.1186/s40608-015-0072-2; Darmasseelane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087896; Dayi C, 2016, S AFRICAN HLTH REV H; de Mutsert R, 2014, AM J EPIDEMIOL, V179, P1353, DOI 10.1093/aje/kwu052; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA; Filipovic J., 2014, INSIDE WAR NATURAL B; Flemming K, 2013, ARCH DIS CHILD, V98, P526, DOI 10.1136/archdischild-2012-303459; Fuemmeler BF, 2009, OBESITY FACTS, V2, P179, DOI 10.1159/000220605; Goldani HAS, 2011, AM J CLIN NUTR, V93, P1344, DOI 10.3945/ajcn.110.010033; Goldani MZ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-104; Hansen S, 2018, INT J OBESITY, V42, P15, DOI 10.1038/ijo.2017.175; Horta BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074301; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Lee ACC, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3677; Li X, 2014, ELECT MEASUREMENT TE, V37, P1, DOI DOI 10.3906/B0T-1210-44; Mamun AA, 2013, OBSTET GYNECOL, V122, P1176, DOI 10.1097/AOG.0000000000000016; Masukume G, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025051; Mears Katrina, 2004, J Obstet Gynaecol, V24, P129; Mesquita DN, 2013, COHORT STUDY, V8, DOI [10.1371/journal.pone.0066827, DOI 10.1371/JOURNAL.PONE.0066827]; Micklesfield LK, 2013, CARDIOVASC J AFR, V24, P369, DOI 10.5830/CVJA-2013-069; Mueller NT, 2017, INT J OBESITY, V41, P497, DOI 10.1038/ijo.2016.219; Neovius K, 2010, INT J OBESITY, V34, P75, DOI 10.1038/ijo.2009.178; Niemeier HM, 2006, J ADOLESCENT HEALTH, V39, P842, DOI 10.1016/j.jadohealth.2006.07.001; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Plough AC, 2017, OBSTET GYNECOL, V130, P358, DOI 10.1097/AOG.0000000000002128; Redden M., 2017, GUARDIAN; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; RICHTER LM, 1995, PAEDIATR PERINAT EP, V9, P109, DOI 10.1111/j.1365-3016.1995.tb00124.x; Richter RB, 2011, ELECTRON J COMB, V18; Rodriguez JM, 2015, MICROBIAL ECOLOGY HL, V26; Rubin D. B., 2004, MULTIPLE IMPUTATION; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Seitzman RL, 2008, AM J EPIDEMIOL, V167, P1217, DOI 10.1093/aje/kwn024; Sifferlin A., 2015, C SECTIONS SHOULD ON; Stevens J, 2012, J ADOLESCENT HEALTH, V50, P221, DOI 10.1016/j.jadohealth.2011.06.006; Sutharsan R, 2015, CLIN OBES, V5, P293, DOI 10.1111/cob.12114; Timlin MT, 2007, NUTR REV, V65, P268, DOI 10.1111/j.1753-4887.2007.tb00304.x; Tun HM, 2018, JAMA PEDIATR, V172, P368, DOI 10.1001/jamapediatrics.2017.5535; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; van der Merwe MT, 2012, SAMJ S AFR MED J, V102, P289, DOI 10.7196/SAMJ.5543; Wampach L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07631-x; Wengreen HJ, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-32; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Yuan C, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2385; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	56	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0221379	10.1371/journal.pone.0221379	http://dx.doi.org/10.1371/journal.pone.0221379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2HK	31725725	Green Submitted, Green Published, gold			2022-12-26	WOS:000532764500006
J	Walker, FM; Tobin, A; Simmons, NB; Sobek, CJ; Sanchez, DE; Chambers, CL; Fofanov, VY				Walker, Faith M.; Tobin, Abby; Simmons, Nancy B.; Sobek, Colin J.; Sanchez, Daniel E.; Chambers, Carol L.; Fofanov, Viacheslav Y.			A fecal sequel: Testing the limits of a genetic assay for bat species identification	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; DNA; PERSISTENCE; LAMANAI; PELLETS; SEARCH	DNA metabarcoding assays are powerful tools for delving into the DNA in wildlife feces, giving unprecedented ability to detect species, understand natural history, and identify pathogens for a range of applications in management, conservation, and research. Next-generation sequencing technology is developing rapidly, which makes it especially important that predictability and reproducibility of DNA metabarcoding assays are explored together with the post-depositional ecology of the target taxon's fecal DNA. Here, we defined the constraints of an assay called 'Species from Feces' used by government agencies, research groups, and non-governmental organizations to identify bat species from guano. We tested assay sensitivity by examining how time and humidity affect the ability to recover and successfully sequence DNA in guano, assessing whether a fecal pellet from a rare bat species could be detected in a background of feces from other bat species, and evaluating the efficacy of Species from Feces as a survey tool for bat roosts in temperate and tropical areas. We found that the assay performs well with feces over two years old in dry, cool environments, and fails by 12 months at 100% relative humidity. We also found that it reliably identifies rare DNA, has great utility for surveying roosts in temperate and tropical regions, and detects more bat species than do visual surveys. We attribute the success of Species from Feces to characteristics of the assay paired with application in taxa that are particularly well-suited for fecal DNA survival. In a time of rapid evolution of DNA metabarcoding approaches and their use with feces, this study illustrates the strengths and limitations of applied assays.	[Walker, Faith M.; Tobin, Abby; Sobek, Colin J.; Sanchez, Daniel E.; Chambers, Carol L.] No Arizona Univ, Sch Forestry, Bat Ecol & Genet Lab, Flagstaff, AZ 86011 USA; [Walker, Faith M.; Sobek, Colin J.; Sanchez, Daniel E.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA; [Simmons, Nancy B.] Amer Museum Nat Hist, Dept Mammal, Div Vertebrate Zool3, New York, NY 10024 USA; [Fofanov, Viacheslav Y.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA	Northern Arizona University; Northern Arizona University; American Museum of Natural History (AMNH); Northern Arizona University	Walker, FM (corresponding author), No Arizona Univ, Sch Forestry, Bat Ecol & Genet Lab, Flagstaff, AZ 86011 USA.; Walker, FM (corresponding author), No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA.	Faith.Walker@nau.edu	Chambers, Carol L/GXV-9460-2022	Walker, Faith/0000-0001-8435-4452; Sobek, Colin/0000-0002-0885-0435	Northern Arizona University through the Arizona Technology & Research Initiative Fund; Taxonomic Mammalogy Fund of the American Museum of Natural History; Bat Conservation International [1002263]; U.S. Bureau of Land Management [1002263]; Arizona's Technology and Research Initiative Fund	Northern Arizona University through the Arizona Technology & Research Initiative Fund; Taxonomic Mammalogy Fund of the American Museum of Natural History; Bat Conservation International; U.S. Bureau of Land Management; Arizona's Technology and Research Initiative Fund	This work was supported by Northern Arizona University (www.nau.edu) through the Arizona Technology & Research Initiative Fund (FMW) and by the Taxonomic Mammalogy Fund of the American Museum of Natural History (NBS; www.amnh.org).We also received funding from Bat Conservation International (1002263; CLC, FMW; www.batcon.org), and the U.S. Bureau of Land Management (1002263; CLC, FMW). Computational analyses were run on Northern Arizona University's Monsoon computing cluster, funded by Arizona's Technology and Research Initiative Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ando H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32845-w; Batovska J, 2018, MOL ECOL RESOUR, V18, P32, DOI 10.1111/1755-0998.12682; Becker DJ, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0089; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bobrowiec PED, 2015, J MAMMAL, V96, P54, DOI 10.1093/jmammal/gyu002; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brigham R. Mark, 2018, Caribbean Naturalist, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cassey P, 2006, BIOSCIENCE, V56, P958, DOI 10.1641/0006-3568(2006)56[958:RARIE]2.0.CO;2; Colman RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126626; Divoll TJ, 2018, MOL ECOL RESOUR, V18, P590, DOI 10.1111/1755-0998.12770; Drakulovski P, 2013, EXP PARASITOL, V135, P257, DOI 10.1016/j.exppara.2013.07.002; Eckert KA, 2006, INT J PRIMATOL, V27, P227, DOI 10.1007/s10764-005-9010-3; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elbrecht V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130324; Fenton MB, 2001, J TROP ECOL, V17, P511, DOI 10.1017/S0266467401001389; Fofanov VY, 2018, ECOL EVOL, V8, P5563, DOI 10.1002/ece3.4084; HARESTAD AS, 1987, J WILDLIFE MANAGE, V51, P33, DOI 10.2307/3801624; Heim O, 2019, ACTA ETHOL, V22, P223, DOI 10.1007/s10211-019-00319-5; Herrera JP, 2018, ACTA CHIROPTEROL, V20, P147, DOI 10.3161/15081109ACC2018.20.1.011; Kaunisto KM, 2017, ECOL EVOL, V7, P8588, DOI 10.1002/ece3.3404; Kerley GIH, 2018, OECOLOGIA, V188, P107, DOI 10.1007/s00442-018-4203-6; King SRB, 2018, ECOL EVOL, V8, P4053, DOI 10.1002/ece3.3956; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; LAMBERT JDH, 1978, TURRIALBA, V28, P33; Langwig KE, 2015, EMERG INFECT DIS, V21, P1023, DOI 10.3201/eid2106.150123; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lucchini V, 2002, MOL ECOL, V11, P857, DOI 10.1046/j.1365-294X.2002.01489.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maudet C, 2004, MOL ECOL NOTES, V4, P772, DOI 10.1111/j.1471-8286.2004.00787.x; McInnes JC, 2017, METHODS ECOL EVOL, V8, P192, DOI 10.1111/2041-210X.12677; Meier L, 2001, P BAT CONS MIN TECHN; Michalski F, 2011, MOL ECOL RESOUR, V11, P862, DOI 10.1111/j.1755-0998.2011.03031.x; Murphy MA, 2007, CONSERV GENET, V8, P1219, DOI 10.1007/s10592-006-9264-0; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Panasci M, 2011, J WILDLIFE MANAGE, V75, P1616, DOI 10.1002/jwmg.221; Poole KG, 2011, J WILDLIFE MANAGE, V75, P1527, DOI 10.1002/jwmg.184; RAMSEY FL, 1997, STAT SLEUTH; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Tobin A, 2018, J WILDLIFE MANAGE, V82, P1345, DOI 10.1002/jwmg.21498; Vesterinen EJ, 2018, ECOL EVOL, V8, P10914, DOI 10.1002/ece3.4559; Vynne C, 2012, ANIM CONSERV, V15, P184, DOI 10.1111/j.1469-1795.2011.00503.x; Walker FM, 2009, MOL ECOL RESOUR, V9, P720, DOI 10.1111/j.1755-0998.2009.02582.x; Walker FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162342; Walker FM, 2016, SPECIES FECES; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224969	10.1371/journal.pone.0224969	http://dx.doi.org/10.1371/journal.pone.0224969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725795	gold, Green Published			2022-12-26	WOS:000532764500036
J	Arai, T; Atsukawa, M; Tsubota, A; Kawano, T; Koeda, M; Yoshida, Y; Tanabe, T; Okubo, T; Hayama, K; Iwashita, A; Itokawa, N; Kondo, C; Kaneko, K; Kawamoto, C; Hatori, T; Emoto, N; Iio, E; Tanake, Y; Iwakiri, K				Arai, Taeang; Atsukawa, Masanori; Tsubota, Akihito; Kawano, Tadamichi; Koeda, Mai; Yoshida, Yuji; Tanabe, Tomohide; Okubo, Tomomi; Hayama, Korenobu; Iwashita, Ai; Itokawa, Norio; Kondo, Chisa; Kaneko, Keiko; Kawamoto, Chiaki; Hatori, Tsutomu; Emoto, Naoya; Iio, Etsuko; Tanake, Yasuhito; Iwakiri, Katsuhiko			Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ARTERIAL STIFFNESS; FIBROSIS STAGE; HISTOLOGICAL SEVERITY; CLINICAL-PRACTICE; AORTIC STIFFNESS; RISK-FACTOR; NAFLD; PNPLA3; MARKER	Although the presence of nonalcoholic fatty liver disease (NAFLD) is known to be related to subclinical atherosclerosis, the relationship between the severity of NAFLD and subclinical atherosclerosis is not clear. This study aimed to clarify the factors related to subclinical arteriosclerosis, including the histopathological severity of the disease and PNPLA3 gene polymorphisms, in NAFLD patients. We measured brachial-ankle pulse wave velocity (baPWV) as an index of arterial stiffness in 153 biopsy-proven NAFLD patients. The baPWV values were significantly higher in the advanced fibrosis group than in the less advanced group (median, 1679 cm/s vs 1489 cm/s; p = 5.49x10(-4)). Multiple logistic regression analysis revealed that older age (>= 55 years) (p = 8.57x10(-3); OR = 3.03), hypertension (p = 1.05x10(-3); OR = 3.46), and advanced fibrosis (p = 9.22x10(-3); OR = 2.94) were independently linked to baPWV >= 1600 cm/s. NAFLD patients were categorized into low-risk group (number of risk factors = 0), intermediate-risk group (= 1), and high-risk group (>= 2) based on their risk factors, including older age, hypertension, and biopsy-confirmed advanced fibrosis. The prevalence of baPWV >= 1600 cm/s was 7.1% (3/42) in the low-risk group, 30.8% (12/39) in the intermediate-risk group, and 63.9% (46/72) in the high-risk group. Noninvasive liver fibrosis markers and scores, including the FIB-4 index, NAFLD fibrosis score, hyaluronic acid, Wisteria floribunda agglutinin positive Mac-2-binding protein, and type IV collagen 7s, were feasible substitutes for invasive liver biopsy. Older age, hypertension, and advanced fibrosis are independently related to arterial stiffness, and a combination of these three factors may predict risk of arteriosclerosis in NAFLD patients.	[Arai, Taeang; Atsukawa, Masanori; Kawano, Tadamichi; Tanabe, Tomohide; Hayama, Korenobu; Iwashita, Ai; Kondo, Chisa; Kaneko, Keiko; Kawamoto, Chiaki; Iwakiri, Katsuhiko] Nippon Med Sch, Div Gastroenterol & Hepatol, Tokyo, Japan; [Tsubota, Akihito] Jikei Univ, Res Ctr Med Sci, Core Res Facil Basic Sci, Sch Med, Tokyo, Japan; [Koeda, Mai; Yoshida, Yuji; Okubo, Tomomi; Itokawa, Norio] Nippon Med Sch, Div Gastroenterol, Chiba Hokusoh Hosp, Inzai, Japan; [Hatori, Tsutomu] Nippon Med Sch, Div Pathol, Chiba Hokusoh Hosp, Inzai, Japan; [Emoto, Naoya] Nippon Med Sch, Div Endocrinol, Chiba Hokusoh Hosp, Inzai, Japan; [Iio, Etsuko; Tanake, Yasuhito] Nagoya City Univ, Dept Virol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Iio, Etsuko; Tanake, Yasuhito] Nagoya City Univ, Liver Unit, Grad Sch Med Sci, Nagoya, Aichi, Japan	Nippon Medical School; Jikei University; Nippon Medical School; Nippon Medical School; Nippon Medical School; Nagoya City University; Nagoya City University	Atsukawa, M (corresponding author), Nippon Med Sch, Div Gastroenterol & Hepatol, Tokyo, Japan.	momogachi@yahoo.co.jp	Emoto, Naoya/AAX-8320-2021	Emoto, Naoya/0000-0003-2026-4057; Tanaka, Yasuhito/0000-0002-2473-6966				Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Atsukawa M, 2018, HEPATOL RES, V48, P424, DOI 10.1111/hepr.13046; Bugianesi E, 2016, J HEPATOL, V65, P643, DOI 10.1016/j.jhep.2016.05.038; Chen Y, 2015, ATHEROSCLEROSIS, V241, P145, DOI 10.1016/j.atherosclerosis.2015.05.002; Di Costanzo A, 2017, ATHEROSCLEROSIS, V257, P232, DOI 10.1016/j.atherosclerosis.2016.12.018; Fargion S, 2014, WORLD J GASTROENTERO, V20, P13306, DOI 10.3748/wjg.v20.i37.13306; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gummesson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202666; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Hashimoto E, 2011, J GASTROENTEROL, V46, P63, DOI 10.1007/s00535-010-0311-8; Huang RC, 2013, HEPATOLOGY, V58, P1306, DOI 10.1002/hep.26495; Huang Y, 2012, ARTERIOSCL THROM VAS, V32, P2321, DOI 10.1161/ATVBAHA.112.252957; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kim HJ, 2009, DIABETES RES CLIN PR, V85, P30, DOI 10.1016/j.diabres.2009.03.013; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koo BK, 2018, J GASTROEN HEPATOL, V33, P1277, DOI 10.1111/jgh.14056; Le MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173499; Lee YJ, 2012, DIGEST DIS SCI, V57, P196, DOI 10.1007/s10620-011-1819-3; Leite NC, 2016, LIVER INT, V36, P977, DOI 10.1111/liv.12994; Li N, 2015, NUTR METAB CARDIOVAS, V25, P218, DOI 10.1016/j.numecd.2014.10.002; Lonardo A, 2017, DIGEST LIVER DIS, V49, P471, DOI 10.1016/j.dld.2017.01.147; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Ogawa Y, 2018, J GASTROEN HEPATOL, V33, P1795, DOI 10.1111/jgh.14156; Oni ET, 2013, ATHEROSCLEROSIS, V230, P258, DOI 10.1016/j.atherosclerosis.2013.07.052; Ozturk K, 2015, ATHEROSCLEROSIS, V240, P380, DOI 10.1016/j.atherosclerosis.2015.04.009; Petta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074089; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Salvi P, 2010, J HYPERTENS, V28, P1699, DOI 10.1097/HJH.0b013e32833a7de6; Seko Y, 2017, HEPATOL RES, V47, P1083, DOI 10.1111/hepr.12840; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Sunbul M, 2014, ATHEROSCLEROSIS, V237, P490, DOI 10.1016/j.atherosclerosis.2014.10.004; Suzuki A, 2005, LIVER INT, V25, P779, DOI 10.1111/j.1478-3231.2005.01064.x; Taniai M, 2018, HEPATOL RES, V48, P947, DOI 10.1111/hepr.13203; Targher G, 2006, DIABETES CARE, V29, P1325, DOI 10.2337/dc06-0135; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P517, DOI 10.5551/jat.15792; Tomiyama H, 2016, J ATHEROSCLER THROMB, V23, P128, DOI 10.5551/jat.32979; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Yambe M, 2004, HYPERTENS RES, V27, P625, DOI 10.1291/hypres.27.625; Yoneda M, 2007, J GASTROENTEROL, V42, P375, DOI 10.1007/s00535-007-2014-3; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhou YY, 2018, HEPATOL COMMUN, V2, P376, DOI 10.1002/hep4.1155	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224184	10.1371/journal.pone.0224184	http://dx.doi.org/10.1371/journal.pone.0224184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721770	gold, Green Published			2022-12-26	WOS:000532720700012
J	Axelsen, JB; Andersen, S; Sun, XQ; Ringgaard, S; Hyldebrandt, JA; Kurakula, K; Goumans, MJ; de Man, FS; Nielsen-Kudsk, JE; Bogaard, HJ; Andersen, A				Axelsen, Julie Birkmose; Andersen, Stine; Sun, Xiao-Qing; Ringgaard, Steffen; Hyldebrandt, Janus Adler; Kurakula, Kondababu; Goumans, Marie-Jose; de Man, Frances S.; Nielsen-Kudsk, Jens Erik; Bogaard, Harm-Jan; Andersen, Asger			Effects of 6-mercaptopurine in pressure overload induced right heart failure	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; NUCLEAR RECEPTOR NUR77; RIGHT-VENTRICULAR HYPERTROPHY; LONG-TERM SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; DILATED CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; LYSYL OXIDASE; APOPTOSIS; METAANALYSIS	Background Several antineoplastic drugs have been proposed as new compounds for pulmonary arterial hypertension treatment but many have cardiotoxic side effects. The chemotherapeutic agent 6-mercaptopurine may have an effect in treatment of pulmonary arterial hypertension but at the same time, its effects on the afterload adaption of the right ventricle is unpredictable due to interaction with multiple downstream signalling pathways in the cardiomyocytes. We investigated the direct cardiac effects of 6-mercaptopurine in rats with isolated right heart failure caused by pulmonary trunk banding (PTB). Methods Male Wistar rat weanlings (112 +/- 2 g) were randomized to sham operation (sham, n = 10) or PTB. The PTB animals were randomized to placebo (PTB-control, n = 10) and 6-mercaptopurine (7.5 mg/kg/day) groups with treatment start before the PTB procedure (PTB-prevention, n = 10) or two weeks after (PTB-reversal, n = 10). Right ventricular effects were evaluated by echocardiography, cardiac MRI, invasive pressure-volume measurements, and histological and molecular analyses. Results PTB increased right ventricular afterload and caused right ventricular hypertrophy and failure. 6-mercaptopurine did not improve right ventricular function nor reduce right ventricular remodelling in both prevention and reversal studies compared with placebo-treated rats. Conclusion Treatment with 6-mercaptopurine did not have any beneficial or detrimental effects on right ventricular function or remodelling. Our data suggest that treatment of pulmonary arterial hypertension with 6-mercaptopurine is not harmful to the failing right ventricle.	[Axelsen, Julie Birkmose; Andersen, Stine; Nielsen-Kudsk, Jens Erik; Andersen, Asger] Aarhus Univ Hosp, Dept Cardiol Res, Aarhus, Denmark; [Sun, Xiao-Qing; de Man, Frances S.; Bogaard, Harm-Jan] Vrije Univ Amsterdam Med Ctr, Dept Pulmonol, Amsterdam, Netherlands; [Ringgaard, Steffen] Aarhus Univ Hosp, MR Ctr, Aarhus, Denmark; [Hyldebrandt, Janus Adler] Aarhus Univ Hosp, Dept Anesthesiol & Intens Care, Aarhus, Denmark; [Kurakula, Kondababu; Goumans, Marie-Jose] Leiden Univ, Med Ctr, Dept Cell & Chem Biol, Leiden, Netherlands	Aarhus University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Aarhus University; Aarhus University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Andersen, A (corresponding author), Aarhus Univ Hosp, Dept Cardiol Res, Aarhus, Denmark.	asger.andersen@clin.au.dk	Goumans, Marie Jose/U-1455-2019; Goumans, Marie-José/AAG-4994-2021	Goumans, Marie Jose/0000-0001-9344-6746; Bogaard, Harm Jan/0000-0001-5371-0346; Axelsen, Julie Birkmose/0000-0002-1221-0115; Kurakula, Konda Babu/0000-0002-9830-6344; Handoko-de Man, Frances/0000-0002-5776-7793; Adler Hyldebrandt, Janus/0000-0001-8318-0323	Aarhus Universitets forskningsfond; Helga og Peter Kornings Fond [274023-9]; Ingenior August Frederik Wedell Erichsens Legat [13655]; Fonden til laegevidenskabens fremme [17-L-0099]; Simon Spies Fonden; Danish Medical Research Grant [2017-1064/96]; Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development; Royal Netherlands Academy of Sciences Grant [2012-08]; Dutch Lung Foundation (Longfonds) [5.2.17.198J0]	Aarhus Universitets forskningsfond; Helga og Peter Kornings Fond; Ingenior August Frederik Wedell Erichsens Legat; Fonden til laegevidenskabens fremme; Simon Spies Fonden; Danish Medical Research Grant; Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences Grant; Dutch Lung Foundation (Longfonds)	JBA was generously supported by Aarhus Universitets forskningsfond (http://auff.au.dk/), Helga og Peter Kornings Fond grant 274023-9 (https://health.au.dk/om-health/fonde-og-legater-ved-health/helga-og-peter-kornings-fond/), Ingenior August Frederik Wedell Erichsens Legat grant 13655, Fonden til laegevidenskabens fremme grant 17-L-0099 (https://www.apmollerfonde.dk/ansoegning/laegefonden/), Simon Spies Fonden (http://spiesfonden.dk/), and The Danish Medical Research Grant 2017-1064/96 (https://www.laeger.dk/laegeforeningens-forskningsfond).We acknowledge support from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development, and the Royal Netherlands Academy of Sciences Grant 2012-08 awarded to the Phaedra consortium (http://www.phaedraresearch.nl) (XQS, KK, MJG, FSDM, HJB). We also acknowledge support for KK by the Dutch Lung Foundation (Longfonds) grant number-5.2.17.198J0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarbakke J, 1997, TRENDS PHARMACOL SCI, V18, P3, DOI 10.1016/S0165-6147(96)01007-3; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Andersen S, 2018, JOVE-J VIS EXP, DOI 10.3791/58050; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Borgdorff MAJ, 2015, HEART FAIL REV, V20, P475, DOI 10.1007/s10741-015-9479-6; Braun MU, 2003, CARDIOVASC RES, V59, P658, DOI 10.1016/S0008-6363(03)00470-X; CAMARGO PR, 1995, PEDIATR CARDIOL, V16, P61, DOI 10.1007/BF00796819; Cartledge JE, 2015, CARDIOVASC RES, V105, P260, DOI 10.1093/cvr/cvu264; Cheng TC, 2018, AM J PHYSIOL-HEART C, V315, pH699, DOI 10.1152/ajpheart.00047.2018; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Cuffari C, 1996, GUT, V39, P401, DOI 10.1136/gut.39.3.401; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Egemnazarov B, 2018, MATRIX BIOL, V68-69, P507, DOI 10.1016/j.matbio.2018.01.010; Esfandiary A, 2019, CARDIOVASC RES, V115, P1217, DOI 10.1093/cvr/cvz049; Frustaci A, 2006, MODERN PATHOL, V19, P755, DOI 10.1038/modpathol.3800594; Frustaci A, 2009, EUR HEART J, V30, P1995, DOI 10.1093/eurheartj/ehp249; Fujiu K, 2014, J MOL CELL CARDIOL, V70, P64, DOI 10.1016/j.yjmcc.2014.01.013; Gao XF, 2017, PATIENT PREFER ADHER, V11, P871, DOI 10.2147/PPA.S133288; Handoko ML, 2010, EUR RESPIR REV, V19, P72, DOI 10.1183/09059180.00007109; Handoko ML, 2009, CIRCULATION, V120, P42, DOI 10.1161/CIRCULATIONAHA.108.829713; Huang HY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0543-5; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Ibrahim YF, 2017, J PHARMACOL EXP THER, V363, P20, DOI 10.1124/jpet.117.239921; Innocenti F, 1999, CANCER CHEMOTH PHARM, V43, P133, DOI 10.1007/s002800050873; Kane GC, 2011, CHEST, V139, P1285, DOI 10.1378/chest.10-1293; Kurakula K, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02400-2018; LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605; Lopez BA, 2013, CARDIOVASC RES, V99, P111, DOI 10.1093/cvr/cvt100; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; Lu C, 2016, J CARDIOVASC MED, V17, P631, DOI 10.2459/JCM.0000000000000134; Marinkovic G, 2014, J IMMUNOL, V192, P4370, DOI 10.4049/jimmunol.1302527; Medzikovic L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15404; Mendes-Ferreira P, 2016, AM J PHYSIOL-HEART C, V311, pH85, DOI 10.1152/ajpheart.00089.2016; Nagaya N, 2000, CIRCULATION, V102, P865; Okada M, 2009, J PHARMACOL SCI, V111, P193, DOI 10.1254/jphs.09112FP; Ordentlich P, 2003, J BIOL CHEM, V278, P24791, DOI 10.1074/jbc.M302167200; Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306; Pires NMM, 2007, CIRCULATION, V115, P493, DOI 10.1161/CIRCULATIONAHA.106.626838; Rain S, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002636; Schultz JG, 2016, CARDIOL YOUNG, V26, P451, DOI 10.1017/S1047951115000402; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Stepnowska E, 2017, ADV CLIN EXP MED, V26, P549, DOI 10.17219/acem/61855; Sun XQ, 2017, EUR RESPIR J, V50, DOI 10.1183/1393003.congress-2017.OA4660; Sun XQ, 2017, CARDIOVASC RES, V113, P1441, DOI 10.1093/cvr/cvx159; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709; van de Veerdonk MC, 2015, CHEST, V147, P1063, DOI 10.1378/chest.14-0701; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Vonk-Noordegraaf A, 2013, J AM COLL CARDIOL, V62, pD22, DOI 10.1016/j.jacc.2013.10.027; Wang RH, 2013, EMBO MOL MED, V5, P137, DOI 10.1002/emmm.201201369; Wang XH, 2016, CARDIOVASC RES, V110, P188, DOI 10.1093/cvr/cvw047; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; Wojnicz R, 2001, CIRCULATION, V104, P39, DOI 10.1161/01.CIR.104.1.39; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Yan GJ, 2015, MOL CELL BIOL, V35, P3312, DOI 10.1128/MCB.00229-15; Yoo YG, 2007, ONCOGENE, V26, P3823, DOI 10.1038/sj.onc.1210149; Yoshida K, J CARDIAC FAILURE, V22, pS198; You XH, 2018, J BIOL CHEM, V293, P14001, DOI 10.1074/jbc.RA118.003099; Zheng JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094732; Zhou H, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0682-1; Zungu-Edmondson M, 2016, CARDIOVASC RES, V110, P30, DOI 10.1093/cvr/cvw014	64	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225122	10.1371/journal.pone.0225122	http://dx.doi.org/10.1371/journal.pone.0225122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714926	Green Published, gold			2022-12-26	WOS:000532710400031
J	Lindheimer, JB; Cook, DB; Klein-Adams, JC; Qian, W; Hill, HZ; Lange, G; Ndirangu, DS; Wylie, GR; Falvo, MJ				Lindheimer, Jacob B.; Cook, Dane B.; Klein-Adams, Jacquelyn C.; Qian, Wei; Hill, Helene Z.; Lange, Gudrun; Ndirangu, Duncan S.; Wylie, Glenn R.; Falvo, Michael J.			Veterans with Gulf War Illness exhibit distinct respiratory patterns during maximal cardiopulmonary exercise	PLOS ONE			English	Article							VENTILATORY RESPONSE; INCREMENTAL EXERCISE; PERCEIVED EXERTION; PAIN; PREVALENCE; FIBROMYALGIA; CHALLENGE; FREQUENCY; SYMPTOMS; TIME	Introduction The components of minute ventilation, respiratory frequency and tidal volume, appear differentially regulated and thereby afford unique insight into the ventilatory response to exercise. However, respiratory frequency and tidal volume are infrequently reported, and have not previously been considered among military veterans with Gulf War Illness. Our purpose was to evaluate respiratory frequency and tidal volume in response to a maximal cardiopulmonary exercise test in individuals with and without Gulf War Illness. Materials and methods 20 cases with Gulf War Illness and 14 controls participated in this study and performed maximal cardiopulmonary exercise test on a cycle ergometer. Ventilatory variables (minute ventilation, respiratory frequency and tidal volume) were obtained and normalized to peak exercise capacity. Using mixed-design analysis of variance models, with group and time as factors, we analyzed exercise ventilatory patterns for the entire sample and for 11 subjects from each group matched for race, age, sex, and height. Results Despite similar minute ventilation (p = 0.57, eta(2)(p) = 0.01), tidal volume was greater (p = 0.02, eta(2)(p) = 0.16) and respiratory frequency was lower (p = 0.004, eta(2)(p) = 0.24) in Veterans with Gulf War Illness than controls. The findings for respiratory frequency remained significant in the matched subgroup (p = 0.004, eta(2)(p) = 0.35). Conclusion In our sample, veterans with Gulf War Illness adopt a unique exercise ventilatory pattern characterized by reduced respiratory frequency, despite similar ventilation relative to controls. Although the mechanism(s) by which this pattern is achieved remains unresolved, our findings suggest that the components of ventilation should be considered when evaluating clinical conditions with unexplained exertional symptoms.	[Lindheimer, Jacob B.; Klein-Adams, Jacquelyn C.; Qian, Wei; Ndirangu, Duncan S.; Wylie, Glenn R.; Falvo, Michael J.] War Related Illness & Injury Study Ctr, Dept Vet Affairs New Jersey Hlth Care Syst, E Orange, NJ 07018 USA; [Lindheimer, Jacob B.; Cook, Dane B.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA; [Lindheimer, Jacob B.; Cook, Dane B.] Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA; [Qian, Wei; Hill, Helene Z.; Falvo, Michael J.] Univ Med & Dent New Jersey, Rutgers Biomed & Hlth Sci, Newark, NJ USA; [Lange, Gudrun] Mt Sinai Beth Israel, Dept Neurol, New York, NY USA; [Wylie, Glenn R.] Kessler Fdn, W Orange, NJ USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; Rutgers State University New Brunswick; Rutgers State University Medical Center; Kessler Institute for Rehabilitation	Lindheimer, JB (corresponding author), War Related Illness & Injury Study Ctr, Dept Vet Affairs New Jersey Hlth Care Syst, E Orange, NJ 07018 USA.; Lindheimer, JB (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.; Lindheimer, JB (corresponding author), Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA.	Lindheimer@wisc.edu	Qian, Wei/B-8231-2013; Lindheimer, Jacob/O-7935-2016	Lindheimer, Jacob/0000-0002-1581-3210; Falvo, Michael/0000-0001-9348-6676	Department of Veterans Affairs Office of Research Development; Clinical Science Research Development [1I21CX000797, 1K2CX001679]; Veterans Affairs [IK2CX001679] Funding Source: NIH RePORTER	Department of Veterans Affairs Office of Research Development(US Department of Veterans Affairs); Clinical Science Research Development; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Office of Research & Development; Clinical Science Research & Development: 1I21CX000797 (MJF), 1K2CX001679 (JBL), www.research.va.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARON EA, 1992, J APPL PHYSIOL, V72, P1810, DOI 10.1152/jappl.1992.72.5.1810; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bell HJ, 2006, RESP PHYSIOL NEUROBI, V152, P128, DOI 10.1016/j.resp.2005.07.008; Broderick G, 2013, BRAIN BEHAV IMMUN, V28, P159, DOI 10.1016/j.bbi.2012.11.007; Broderick G, 2011, BRAIN BEHAV IMMUN, V25, P302, DOI 10.1016/j.bbi.2010.10.011; Busch V, 2012, PAIN MED, V13, P215, DOI 10.1111/j.1526-4637.2011.01243.x; Chalaye P, 2009, PAIN MED, V10, P1334, DOI 10.1111/j.1526-4637.2009.00681.x; Cook DB, 2006, ARTHRITIS RHEUM-US, V54, P3351, DOI 10.1002/art.22124; Cook DB, 2010, J PAIN, V11, P764, DOI 10.1016/j.jpain.2009.11.010; Cook DB, 2003, MED SCI SPORT EXER, V35, P569, DOI 10.1249/01.MSS.0000058438.25278.33; Donta ST, 2003, JAMA-J AM MED ASSOC, V289, P1396, DOI 10.1001/jama.289.11.1396; Falvo MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1124; Forster HV, 2011, CONTROL BREATHING EX; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Grant JA, 2009, PSYCHOSOM MED, V71, P106, DOI 10.1097/PSY.0b013e31818f52ee; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HIRSCH JA, 1982, J APPL PHYSIOL, V53, P1281, DOI 10.1152/jappl.1982.53.5.1281; Inbar O, 2001, MED SCI SPORT EXER, V33, P1463, DOI 10.1097/00005768-200109000-00007; IOM (Institute of Medicine), 2014, CHRON MULT ILLN GULF; Karlinsky JB, 2004, ARCH INTERN MED, V164, P2488, DOI 10.1001/archinte.164.22.2488; Kelsall HL, 2004, THORAX, V59, P897, DOI 10.1136/thx.2003.017103; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lindheimer JB, 2017, FATIGUE, V5, P69, DOI 10.1080/21641846.2017.1321166; Loe H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113884; MARTIN PA, 1993, J PHYSIOL-LONDON, V470, P601, DOI 10.1113/jphysiol.1993.sp019877; Medinger AE, 1998, CHEST, V113, P612, DOI 10.1378/chest.113.3.612; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nagelkirk PR, 2003, MIL MED, V168, P750; Neder JA, 2003, EUR RESPIR J, V21, P530, DOI 10.1183/09031936.03.00045402; Nicolo A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00922; Nicolo A, 2017, EXP PHYSIOL, V102, P934, DOI 10.1113/EP086352; Nicolo A, 2016, J SPORT SCI, V34, P1199, DOI 10.1080/02640414.2015.1102315; Nicolo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094990; PIANOSI P, 1991, AM REV RESPIR DIS, V143, P226, DOI 10.1164/ajrccm/143.2.226; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Rayhan RU, 2013, AM J TRANSL RES, V5, P212; Sanudo B, 2009, CLIN EXP RHEUMATOL, V27, pS62; Sheel AW, 2012, COMPR PHYSIOL, V2, P1093, DOI 10.1002/cphy.c100046; Smylie AL, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-29; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Tanner DA, 2014, RESP PHYSIOL NEUROBI, V191, P9, DOI 10.1016/j.resp.2013.10.011; Thornton JM, 2001, J PHYSIOL-LONDON, V533, P823, DOI 10.1111/j.1469-7793.2001.00823.x; Tipton MJ, 2017, J PHYSL; Turk DC, 2004, J PAIN, V5, P483, DOI 10.1016/j.jpain.2004.08.002; Turner DL, 2004, EUR J APPL PHYSIOL, V93, P333, DOI 10.1007/s00421-004-1194-2; Turner DL, 2002, RESP PHYSIOL NEUROBI, V132, P159, DOI 10.1016/S1569-9048(02)00075-7; Whistler T, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-12; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wood HE, 2003, J PHYSIOL-LONDON, V553, P967, DOI 10.1113/jphysiol.2003.047597; Zautra AJ, 2010, PAIN, V149, P12, DOI 10.1016/j.pain.2009.10.001	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224833	10.1371/journal.pone.0224833	http://dx.doi.org/10.1371/journal.pone.0224833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714907	Green Published, gold			2022-12-26	WOS:000532710400015
J	Takai, S; Watanabe, Y; Sanematsu, K; Yoshida, R; Margolskee, RF; Jiang, PH; Atsuta, I; Koyano, K; Ninomiya, Y; Shigemura, N				Takai, Shingo; Watanabe, Yu; Sanematsu, Keisuke; Yoshida, Ryusuke; Margolskee, Robert F.; Jiang, Peihua; Atsuta, Ikiru; Koyano, Kiyoshi; Ninomiya, Yuzo; Shigemura, Noriatsu			Effects of insulin signaling on mouse taste cell proliferation	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; SINGLE LGR5; STEM-CELLS; MTOR; EXPRESSION; COMPLEX; WNT	Expression of insulin and its receptor (IR) in rodent taste cells has been proposed, but exactly which types of taste cells express IR and the function of insulin signaling in taste organ have yet to be determined. In this study, we analyzed expression of IR mRNA and protein in mouse taste bud cells in vivo and explored its function ex vivo in organoids, using RT-PCR, immunohistochemistry, and quantitative PCR. In mouse taste tissue, IR was expressed broadly in taste buds, including in type II and III taste cells. With using 3-D taste bud organoids, we found insulin in the culture medium significantly decreased the number of taste cell and mRNA expression levels of many taste cell genes, including nucleoside triphosphate diphosphohydrolase-2 (NTPDase2), Tas1R3 (T1R3), gustducin, carbonic anhydrase 4 (CA4), glucose transporter-8 (GLUT8), and sodium-glucose cotransporter-1 (SGLT1) in a concentration-dependent manner. Rapamycin, an inhibitor of mechanistic target of rapamycin (mTOR) signaling, diminished insulin's effects and increase taste cell generation. Altogether, circulating insulin might be an important regulator of taste cell growth and/or proliferation via activation of the mTOR pathway.	[Takai, Shingo; Watanabe, Yu; Sanematsu, Keisuke; Shigemura, Noriatsu] Kyushu Univ, Fac Dent Sci, Sect Oral Neurosci, Fukuoka, Japan; [Takai, Shingo; Margolskee, Robert F.; Jiang, Peihua; Ninomiya, Yuzo] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Watanabe, Yu; Atsuta, Ikiru; Koyano, Kiyoshi] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Removable Prosthodont, Fukuoka, Japan; [Yoshida, Ryusuke] Okayama Univ, Grad Sch Med, Dept Oral Physiol Dent & Pharmaceut Sci, Okayama, Japan; [Ninomiya, Yuzo; Shigemura, Noriatsu] Kyushu Univ, Res & Dev Ctr Five Sense Devices Taste & Odor Sen, Div Sensory Physiol, Fukuoka, Japan	Kyushu University; Monell Chemical Senses Center; Kyushu University; Okayama University; Kyushu University	Takai, S; Shigemura, N (corresponding author), Kyushu Univ, Fac Dent Sci, Sect Oral Neurosci, Fukuoka, Japan.; Takai, S (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.; Shigemura, N (corresponding author), Kyushu Univ, Res & Dev Ctr Five Sense Devices Taste & Odor Sen, Div Sensory Physiol, Fukuoka, Japan.	takashin@dent.kyushu-u.ac.jp; shigemura@dent.kyushu-u.ac.jp		Shigemura, Noriatsu/0000-0002-3061-6362; Takai, Shingo/0000-0002-4623-908X; Yoshida, Ryusuke/0000-0001-7584-9437; Margolskee, Robert/0000-0002-9572-2887	Japan Society for the Promotion of Science [17K17938, 15H02571, 15K11044, S2605]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI 17K17938 (S.T.), 15H02571 (Y.N.), and 15K11044 (N.S.) from the Scientific Research and Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (S2605) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Baquero AF, 2011, AM J PHYSIOL-CELL PH, V300, pC860, DOI 10.1152/ajpcell.00318.2010; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Biggs BT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148315; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Doyle ME, 2018, ENDOCRINOLOGY, V159, P3331, DOI 10.1210/en.2018-00534; Gondivkar SM, 2009, ORAL SURG ORAL MED O, V108, P876, DOI 10.1016/j.tripleo.2009.08.015; Hamamichi R, 2006, NEUROSCIENCE, V141, P2129, DOI 10.1016/j.neuroscience.2006.05.061; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; LAWSON WB, 1979, PSYCHOSOM MED, V41, P219, DOI 10.1097/00006842-197905000-00005; Liebl DJ, 1999, DEV BIOL, V213, P378, DOI 10.1006/dbio.1999.9385; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; Lu WJ, 2018, P NATL ACAD SCI USA, V115, pE200, DOI 10.1073/pnas.1719109115; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Morgan-Bathke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113183; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Perros P, 1996, DIABETES CARE, V19, P768, DOI 10.2337/diacare.19.7.768; Petersen CI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002098; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren WW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04099-5; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Suzuki Y, 2005, J COMP NEUROL, V482, P74, DOI 10.1002/cne.20379; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Yoon MS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111176; ZHANG CX, 1995, DIFFERENTIATION, V59, P155, DOI 10.1046/j.1432-0436.1995.5930155.x; Zhou YQ, 2006, DEV BIOL, V297, P198, DOI 10.1016/j.ydbio.2006.05.022; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225190	10.1371/journal.pone.0225190	http://dx.doi.org/10.1371/journal.pone.0225190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714935	Green Published, gold			2022-12-26	WOS:000532710400035
J	Cesa-Luna, C; Munoz-Rojas, J; Saab-Rincon, G; Baez, A; Morales-Garcia, YE; Juarez-Gonzalez, VR; Quintero-Hernandez, V				Cesa-Luna, Catherine; Munoz-Rojas, Jesus; Saab-Rincon, Gloria; Baez, Antonino; Elizabeth Morales-Garcia, Yolanda; Rivelino Juarez-Gonzalez, Victor; Quintero-Hernandez, Veronica			Structural characterization of scorpion peptides and their bactericidal activity against clinical isolates of multidrug-resistant bacteria	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; ANTIMICROBIAL PEPTIDES; VENOM PEPTIDES; FUNCTIONAL-CHARACTERIZATION; BIOLOGICAL-ACTIVITY; ANTIBACTERIAL; PURIFICATION; COMPONENTS; ISCT	Scorpion venom peptides represent a novel source of antimicrobial peptides (AMPs) with broad-spectrum activity. In this study, we determined the minimum bactericidal concentration (MBC) of three scorpion AMPs, Uy234, Uy17, and Uy192, which are found in the venomous glands of the Urodacus yaschenkoi scorpion, against the clinical isolates of multidrug-resistant (MDR) bacteria. In addition, we tested the activity of a consensus AMP designed in our laboratory based on some previously reported IsCT-type (cytotoxic linear peptide) AMPs with the aim of obtaining higher antimicrobial activity. All peptides tested showed high antimicrobial activity against MDR clinical isolates, with the highest activity against beta-hemolytic Streptococcus strains. The hemolytic activity was determined against human red blood cells and was significantly lower than that of previously reported AMPs. The alpha-helical structure of the four AMPs was confirmed by circular dichroism (CD). These results suggest that the four peptides can be valuable tools for the design and development of AMPs for use in the inhibition of MDR pathogenic bacteria. A clear index of synergism and additivity was found for the combination of QnCs-BUAP + Uy234, which makes these peptides the most promising candidates against pathogenic bacteria.	[Cesa-Luna, Catherine; Munoz-Rojas, Jesus; Baez, Antonino; Elizabeth Morales-Garcia, Yolanda; Quintero-Hernandez, Veronica] Benemerita Univ Autonoma Puebla BUAP, Ctr Invest Ciencias Microbiol CICM, Inst Ciencias IC, Lab Ecol Mol Microbiana LEMM,Ecol & Survival Micr, Puebla, Puebla, Mexico; [Saab-Rincon, Gloria] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca, Morelos, Mexico; [Elizabeth Morales-Garcia, Yolanda] BUAP, Fac Ciencias Biol, Biotecnol, Puebla, Mexico; [Rivelino Juarez-Gonzalez, Victor] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca, Morelos, Mexico; [Quintero-Hernandez, Veronica] BUAP, IC, CICM, CONACYT ESMG,LEMM, Puebla, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla	Quintero-Hernandez, V (corresponding author), Benemerita Univ Autonoma Puebla BUAP, Ctr Invest Ciencias Microbiol CICM, Inst Ciencias IC, Lab Ecol Mol Microbiana LEMM,Ecol & Survival Micr, Puebla, Puebla, Mexico.; Juarez-Gonzalez, VR (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca, Morelos, Mexico.; Quintero-Hernandez, V (corresponding author), BUAP, IC, CICM, CONACYT ESMG,LEMM, Puebla, Puebla, Mexico.	rivelino@ibt.unam.mx; vquinterohe@conacyt.mx	Saab-RIncon, Gloria/AFO-4892-2022; Morales-García, Yolanda Elizabeth/AAU-5882-2020; Muñoz-Rojas, Jesús/B-9786-2019; Cesa, Catherine/AAV-1113-2020; Baez, Antonino/T-6638-2017	Saab-RIncon, Gloria/0000-0002-5251-1000; Morales-García, Yolanda Elizabeth/0000-0003-0376-034X; Muñoz-Rojas, Jesús/0000-0002-1151-9778; Cesa, Catherine/0000-0003-2482-1316; Baez, Antonino/0000-0001-8453-3178; Quintero-Hernandez, Veronica/0000-0002-1856-8134	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [538125/294272]; Apoyo Redes del Programa para el Desarrollo Profesional Docente (PRODEP): 2015-2018 [CA-262]; Direccion de Innovacion y Transferencia de Conocimiento (DITCo) [2016-3, 2016-4]; Vicerrectoria de Investigacion y Estudios de Posgrado-Benemerita Universidad Autonoma de Puebla (VIEP-BUAP) [COL525704-VIEP2018, 100524554-VIEP2018, 100425788VIEP2018]; CONACYT	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Apoyo Redes del Programa para el Desarrollo Profesional Docente (PRODEP): 2015-2018; Direccion de Innovacion y Transferencia de Conocimiento (DITCo); Vicerrectoria de Investigacion y Estudios de Posgrado-Benemerita Universidad Autonoma de Puebla (VIEP-BUAP); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by JMR: Consejo Nacional de Ciencia y Tecnologia (CONACYT): 538125/294272; JMR: Apoyo Redes del Programa para el Desarrollo Profesional Docente (PRODEP): 2015-2018: CA-262; JMR: Direccion de Innovacion y Transferencia de Conocimiento (DITCo): 2016-3; 2016-4; Vicerrectoria de Investigacion y Estudios de Posgrado-Benemerita Universidad Autonoma de Puebla (VIEP-BUAP): VQH:COL525704-VIEP2018; AB:100524554-VIEP2018; JMR:100425788VIEP2018. We are grateful to CONACYT for the fellowship awarded to Catherine Cesa-Luna.	Almaaytah A, 2018, MOLECULES, V23, DOI 10.3390/molecules23071603; Almaaytah A, 2018, INFECT DRUG RESIST, V11, P835, DOI 10.2147/IDR.S166236; Almaaytah A, 2017, INFECT DRUG RESIST, V10, P1, DOI 10.2147/IDR.S118877; Almaaytah A, 2014, PEPTIDES, V51, P35, DOI 10.1016/j.peptides.2013.10.021; Antimicrobial M, 2002, NATURE, DOI [10.1145/122514.122517, DOI 10.1145/122514.122517]; BAUMANN G, 1974, Journal of Supramolecular Structure, V2, P538, DOI 10.1002/jss.400020504; Bea RD, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6030013; Cao LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040135; Cao W, 2005, PROTEIN EXPRES PURIF, V40, P404, DOI 10.1016/j.pep.2004.12.007; Castro-Gonzalez R, 2011, PLANT SOIL, V345, P155, DOI 10.1007/s11104-011-0768-0; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Corral-Lugo A, 2012, COLOMB BIOTECNOLOGIC; Corzo G, 2001, BIOCHEM J, V359, P35, DOI 10.1042/0264-6021:3590035; Dai L, 2002, BIOCHEM BIOPH RES CO, V293, P1514, DOI 10.1016/S0006-291X(02)00423-0; Dai L, 2001, BIOCHEM BIOPH RES CO, V286, P820, DOI 10.1006/bbrc.2001.5472; Dennison S R., 2012, PROTEIN PEPTIDE LETT, DOI [10.2174/092986612800494110, DOI 10.2174/092986612800494110]; Dennison SR, 2009, MOL CELL BIOCHEM, V332, P43, DOI 10.1007/s11010-009-0172-8; Epand RM, 2009, MOL BIOSYST, V5, P580, DOI 10.1039/b900278m; Estrada-de los Santos P, 2016, ANN MICROBIOL, V66, P1303, DOI 10.1007/s13213-015-1183-1; Fan Z, 2011, ANTIMICROB AGENTS CH, V55, P5220, DOI 10.1128/AAC.00369-11; Gao B, 2018, AMINO ACIDS, V50, P1025, DOI 10.1007/s00726-018-2580-0; Guangsheng Liu, 2018, International Journal of Mining and Mineral Engineering, V9, P1; Guo XX, 2013, BIOCHIMIE, V95, P1784, DOI 10.1016/j.biochi.2013.06.003; Hall CW, 2017, FEMS MICROBIOL REV, V41, P276, DOI [10.1093/femsre/fux010, 10.1093/femsre/f]; Harrison PL, 2014, TOXICON, V88, P115, DOI 10.1016/j.toxicon.2014.06.006; Hernandez-Aponte CA, 2011, TOXICON, V57, P84, DOI 10.1016/j.toxicon.2010.10.008; Kim MK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19434-7; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; LI ZY, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.00975389; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Luna-Ramirez K, 2017, TOXINS, V9, DOI 10.3390/toxins9010022; Luna-Ramirez K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127883; Luna-Ramirez K, 2014, BBA-BIOMEMBRANES, V1838, P2140, DOI 10.1016/j.bbamem.2013.10.022; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Marques-Neto LM, 2018, TOXINS, V10, DOI 10.3390/toxins10060219; Moerman L, 2002, EUR J BIOCHEM, V269, P4799, DOI 10.1046/j.1432-1033.2002.03177.x; Mura M, 2016, EUR BIOPHYS J BIOPHY, V45, P195, DOI 10.1007/s00249-015-1094-x; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nie Y, 2012, PEPTIDES, V38, P389, DOI 10.1016/j.peptides.2012.09.012; Ortiz E, 2015, TOXICON, V93, P125, DOI 10.1016/j.toxicon.2014.11.233; Parente AMS, 2018, TOXINS, V10, DOI 10.3390/toxins10040161; Pedron CN, 2019, BIOORG CHEM, V90, DOI 10.1016/j.bioorg.2019.103038; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P9482, DOI 10.1021/bi00154a022; Pushpanathan Muthuirulan, 2013, Int J Pept, V2013, P675391, DOI 10.1155/2013/675391; Quintero-Hernandez V, 2017, ALIANZAS TENDENCIAS, V2, P10; Ramirez-Carreto S, 2015, PEPTIDES, V73, P51, DOI 10.1016/j.peptides.2015.08.014; Ramirez-Carreto S, 2012, PEPTIDES, V34, P290, DOI 10.1016/j.peptides.2012.02.002; Rossolini GM, 2015, J SIENA ACAD SCI, V7, DOI DOI 10.4081/jsas.2015.6409; Samy RP, 2017, BIOCHEM PHARMACOL, V134, P127, DOI 10.1016/j.bcp.2017.03.005; Sforca ML, 2004, BIOCHEMISTRY-US, V43, P5608, DOI 10.1021/bi0360915; Somay Dogan T, 2018, TURK J BIOL, V42, P490, DOI 10.3906/biy-1804-35; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stromstedt AAA, 2010, CURRENT OPINION COLL, DOI [10.1016/j.cocis.2009.06.002, DOI 10.1016/J.COCIS.2009.06.002]; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Torres-Larios A, 2000, EUR J BIOCHEM, V267, P5023, DOI 10.1046/j.1432-1327.2000.01556.x; Travkova OG, 2017, ADV COLLOID INTERFAC, V247, P521, DOI 10.1016/j.cis.2017.06.001; Trentini MM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00273; Walkenhorst WF, 2014, BBA-BIOMEMBRANES, V1838, P2234, DOI 10.1016/j.bbamem.2014.05.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu SF, 2014, PEPTIDES, V53, P30, DOI 10.1016/j.peptides.2013.12.012; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899	61	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0222438	10.1371/journal.pone.0222438	http://dx.doi.org/10.1371/journal.pone.0222438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710627	Green Published, Green Submitted, gold			2022-12-26	WOS:000532699900002
J	Ladrera, R; Belmarid, O; Tomas, R; Prat, N; Canedo-Arguelles, M				Ladrera, Ruben; Belmarid, Oscar; Tomas, Rafael; Prat, Narcis; Canedo-Argueelles, Miguel			Agricultural impacts on streams near Nitrate Vulnerable Zones: A case study in the Ebro basin, Northern Spain	PLOS ONE			English	Article							FINE SEDIMENT; INVERTEBRATE COMMUNITIES; MACROINVERTEBRATE COMMUNITIES; MULTIPLE STRESSORS; BIOLOGICAL TRAITS; ECOSYSTEMS; POLLUTION; RESPONSES; OXYGEN; IMPLEMENTATION	Agricultural intensification during the last century has caused river degradation across Europe. From the wide range of stressors derived from agricultural activities that impact rivers, diffuse agricultural pollution has received most of the attention from managers and scientists. The aim of this study was to determine the main stressors exerted by intensive agriculture on streams around Nitrate Vulnerable Zones (NVZs), which are areas of land that drain into waters polluted by nitrates according to the European Nitrate Directive (91/ 676/EEC). The study area was located in the NW of La Rioja (Northern Spain), which has some of the highest nitrate concentrations within the Ebro basin. The relationships between 40 environmental variables and the taxonomic and functional characteristics of the macroinvertebrate assemblages (which are useful indicators of water quality) were analyzed in 11 stream reaches differentially affected by upstream agricultural activity. The streams affected by a greater percentage of agricultural land cover in the surrounding catchment had significantly higher nitrate concentrations than the remaining sites. However, hydromorphological alteration (i.e. channel simplification, riparian forest and habitat degradation), which is closely linked to agricultural practices, was the main factor affecting macroinvertebrate assemblages. We suggest that "good agricultural practices" should be implemented in streams affected by NVZs to reverse stream degradation, in concordance with the European Water Framework Directive (WFD).	[Ladrera, Ruben; Tomas, Rafael] Univ La Rioja, Food & Agr Dept, Sci & Technol Complex, Logrono, La Rioja, Spain; [Belmarid, Oscar] IRTA, Marine & Continental Waters Program, St Carles De La Rapita, Catalonia, Spain; [Prat, Narcis; Canedo-Argueelles, Miguel] Univ Barcelona, Inst Recerca Aigua IdRA, Dept Biol Evolut Ecol & Ciencies Ambientals, Freshwater Ecol Hydrol & Management Grp FEHM, Catalonia, Spain	Universidad de La Rioja; IRTA; University of Barcelona	Canedo-Arguelles, M (corresponding author), Univ Barcelona, Inst Recerca Aigua IdRA, Dept Biol Evolut Ecol & Ciencies Ambientals, Freshwater Ecol Hydrol & Management Grp FEHM, Catalonia, Spain.	mcanedo.fem@gmail.com	Ladrera, Rubén/AAE-5460-2019; Cañedo-Argüelles, Miguel/L-6365-2014	Ladrera, Rubén/0000-0002-5172-3271; Cañedo-Argüelles, Miguel/0000-0003-3864-7451; Tomas-Las-Heras, Rafael/0000-0002-8496-7280; Belmar, Oscar/0000-0003-2988-2572	Institute of Studies of La Rioja; Spanish Ministerio de Economia [CTM2017-89295-P]; Industria y Competitividad - Agencia Estatal de Investigacion; European Regional Development Fund (ERDF)	Institute of Studies of La Rioja; Spanish Ministerio de Economia(Spanish Government); Industria y Competitividad - Agencia Estatal de Investigacion; European Regional Development Fund (ERDF)(European Commission)	This study received funding from the Institute of Studies of La Rioja, which did not play a role at any point in the research or publication process. Miguel Canedo-Arguelles was supported by the MECODISPER project (CTM2017-89295-P) funded by the Spanish Ministerio de Economia, Industria y Competitividad - Agencia Estatal de Investigacion and cofunded by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alba-Tercedor J., 2002, LIMNETICA, V21, P175; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Anderson MJ, 2008, PRIMER PERMANOVA GUI; [Anonymous], 2015, EST OBJ MED MAS AG F; Arauzo M, 2011, J HYDROL, V411, P155, DOI 10.1016/j.jhydrol.2011.10.004; Arauzo M, 2013, AGR ECOSYST ENVIRON, V179, P94, DOI 10.1016/j.agee.2013.07.013; ASTM, 1995, STANDARD METHODS EXA; Beermann AJ, 2018, SCI TOTAL ENVIRON, V610, P961, DOI 10.1016/j.scitotenv.2017.08.084; Belmar O, 2019, FRESHWATER BIOL, V64, DOI 10.1111/fwb.13289; Birk S, 2012, ECOL INDIC, V18, P31, DOI 10.1016/j.ecolind.2011.10.009; Bogan MT, 2015, FRESHWATER BIOL, V60, P2547, DOI 10.1111/fwb.12522; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; Bonada Nuria, 2002, Limnetica, V21, P13; Brown LE, 2019, GLOBAL CHANGE BIOL, V25, P602, DOI 10.1111/gcb.14516; Burdon FJ, BIORXIV2018329623; Burdon FJ, 2013, ECOL APPL, V23, P1036, DOI 10.1890/12-1190.1; Camargo JA, 2005, CHEMOSPHERE, V58, P1255, DOI 10.1016/j.chemosphere.2004.10.044; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Cheng SY, 2002, AQUAT TOXICOL, V61, P181, DOI 10.1016/S0166-445X(02)00053-X; CHEVENET F, 1994, FRESHWATER BIOL, V31, P295, DOI 10.1111/j.1365-2427.1994.tb01742.x; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Doledec S, 2006, J N AM BENTHOL SOC, V25, P44, DOI 10.1899/0887-3593(2006)25[44:COSAFA]2.0.CO;2; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ector L., 2005, P7; Elliott J. Malcolm, 2008, Freshwater Reviews, V1, P189, DOI 10.1608/FRJ-1.2.4; Estevez E, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0022; Finlay JC, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00071.1; Flavio HM, 2017, SCI TOTAL ENVIRON, V596, P378, DOI 10.1016/j.scitotenv.2017.04.057; Genito D, 2002, J FRESHWATER ECOL, V17, P109, DOI 10.1080/02705060.2002.9663874; Gieswein A, 2019, SCI TOTAL ENVIRON, V652, P1290, DOI 10.1016/j.scitotenv.2018.10.180; Gorley C.K., 2006, GETTING STARTED PRIM; Haas MB, 2017, J ENVIRON MANAGE, V196, P347, DOI 10.1016/j.jenvman.2017.02.060; Harding JS, 1999, FRESHWATER BIOL, V42, P345, DOI 10.1046/j.1365-2427.1999.444470.x; Hauer F. Richard, 1996, P339; Hevia V, 2017, ECOL EVOL, V7, P831, DOI 10.1002/ece3.2692; Houlden V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203000; Howden NJK, 2011, J ENVIRON MONITOR, V13, P514, DOI 10.1039/c0em00722f; IPBES, 2019, REP WORKSH VIS SCEN; Jacobsen D, 2003, FRESHWATER BIOL, V48, P2025, DOI 10.1046/j.1365-2427.2003.01140.x; Jensen FB, 1996, AQUAT TOXICOL, V34, P95, DOI 10.1016/0166-445X(95)00030-8; Jones JI, 2012, RIVER RES APPL, V28, P1055, DOI 10.1002/rra.1516; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Kay P, 2012, J HYDROL, V422, P10, DOI 10.1016/j.jhydrol.2011.12.005; Lange K, 2014, FRESHWATER BIOL, V59, P2431, DOI 10.1111/fwb.12437; Larsen S, 2009, FRESHWATER BIOL, V54, P203, DOI 10.1111/j.1365-2427.2008.02093.x; Liess A, 2012, FRESHW SCI, V31, P813, DOI 10.1899/11-019.1; Magbanua FS, 2013, FRESHWATER BIOL, V58, P1729, DOI 10.1111/fwb.12163; Magbanua FS, 2010, J APPL ECOL, V47, P1014, DOI 10.1111/j.1365-2664.2010.01859.x; Menduia J, 1984, B GEOL MIN, V95, P35; Mondy CP, 2016, SCI TOTAL ENVIRON, V572, P196, DOI 10.1016/j.scitotenv.2016.07.227; Moore AA, 2005, ECOL APPL, V15, P1169, DOI 10.1890/04-1484; Munne A, AQUAT CONSERV MAR FR, V13, P147; Munne A, 2009, THESIS; Munne A, 2009, HYDROBIOLOGIA, V628, P203, DOI 10.1007/s10750-009-9757-1; Murphy JF, 2017, RIVER RES APPL, V33, P1606, DOI 10.1002/rra.3194; Pardo Isabel, 2002, Limnetica, V21, P115; Pearson CE, 2016, J APPL ECOL, V53, P408, DOI 10.1111/1365-2664.12586; Piggott JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049873; Piscart C, 2009, ENVIRON POLLUT, V157, P1011, DOI 10.1016/j.envpol.2008.10.010; Rabeni CF, 2005, AQUAT SCI, V67, P395, DOI 10.1007/s00027-005-0793-2; Rixen T, 2010, J ENVIRON MANAGE, V91, P1730, DOI 10.1016/j.jenvman.2010.03.009; Martin JAR, 2006, ENVIRON POLLUT, V144, P1001, DOI 10.1016/j.envpol.2006.01.045; Sanchez-Morales M, 2018, SCI TOTAL ENVIRON, V642, P937, DOI 10.1016/j.scitotenv.2018.06.132; Schmera D, 2017, HYDROBIOLOGIA, V787, P27, DOI 10.1007/s10750-016-2974-5; Shields FD, 2006, J AM WATER RESOUR AS, V42, P25, DOI 10.1111/j.1752-1688.2006.tb03820.x; Song MY, 2009, AQUAT ECOL, V43, P999, DOI 10.1007/s10452-008-9218-3; Statzner B, 2004, ECOGRAPHY, V27, P470, DOI 10.1111/j.0906-7590.2004.03836.x; Statzner B, 2007, BIODIVERS CONSERV, V16, P3609, DOI 10.1007/s10531-007-9150-1; Statzner B, 2012, GEOMORPHOLOGY, V157, P49, DOI 10.1016/j.geomorph.2011.03.022; Tachet H, 2006, INVERTEBRES EAU DOUC; Usseglio-Polatera P, 2000, FRESHWATER BIOL, V43, P175, DOI 10.1046/j.1365-2427.2000.00535.x; Voulvoulis N, 2017, SCI TOTAL ENVIRON, V575, P358, DOI 10.1016/j.scitotenv.2016.09.228; Wagenhoff A, 2012, J APPL ECOL, V49, P892, DOI 10.1111/j.1365-2664.2012.02162.x; Weatherhead EK, 2009, LAND USE POLICY, V26, pS243, DOI 10.1016/j.landusepol.2009.08.007; Worrall F, 2009, J HYDROL, V370, P21, DOI 10.1016/j.jhydrol.2009.02.036	77	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0218582	10.1371/journal.pone.0218582	http://dx.doi.org/10.1371/journal.pone.0218582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV5GZ	31703059	Green Published, gold, Green Submitted			2022-12-26	WOS:000520512400001
J	Luketich, AM; Papuga, SA; Crimmins, MA				Luketich, Anthony M.; Papuga, Shirley A.; Crimmins, Michael A.			Ecohydrology of urban trees under passive and active irrigation in a semiarid city	PLOS ONE			English	Article							STREET TREES; LOS-ANGELES; WATER-USE; PRECIPITATION; ECOSYSTEMS; DYNAMICS; CLIMATE; BENEFITS; PULSES; FOREST	The infiltration of stormwater runoff for use by urban trees is a major co-benefit of green infrastructure for desert cities with limited water resources. However, the effects of this passive irrigation versus regular, controlled moisture inputs, or active irrigation, is largely unquantified. We monitored the ecohydrology of urban mesquite trees (Prosopis spp.) under these contrasting irrigation regimes in semiarid Tucson, AZ. Measurements included soil moisture, sap velocity, canopy greenness, and leaf-area index. We expected both irrigation types to provide additional deep (> 20 cm) soil moisture compared to natural conditions, and that trees would depend on this deep moisture for transpiration and phenological activity. Results show that active irrigation supported higher soil moisture throughout the study than passive irrigation. Passive irrigation only provided additional deep moisture when green infrastructure features received impervious runoff from a city street. Sap velocity and greenness were similar under both irrigation types, outside of isolated periods of time. These differences occurred during the extremely wet summer 2017 when passively irrigated trees exhibited a greenness peak, and the dry conditions of spring when actively irrigated trees had higher sap flow and relative greenness. Finally, it was not determined that deep soil moisture had a stronger relationship with mesquite productivity than shallow moisture, but both relationships were stronger in the spring, before summer rains. This study aims to contribute empirical observations of green infrastructure performance for urban watershed management.	[Luketich, Anthony M.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Luketich, Anthony M.; Papuga, Shirley A.; Crimmins, Michael A.] Univ Arizona, Dept Environm Sci, Tucson, AZ 85721 USA; [Papuga, Shirley A.] Wayne State Univ, Dept Geol, Detroit, MI USA	University of New Mexico; University of Arizona; Wayne State University	Luketich, AM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.; Luketich, AM (corresponding author), Univ Arizona, Dept Environm Sci, Tucson, AZ 85721 USA.	luketich.anthony@gmail.com	Papuga, Shirley/J-7026-2013	Papuga, Shirley/0000-0002-7226-0640	NSF CNH award [1518376]	NSF CNH award	SP received funding from NSF CNH award 1518376. https://www.nsf.gov/awardsearch/showAward?AWD_ID=1518376.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berland A, 2017, LANDSCAPE URBAN PLAN, V162, P167, DOI 10.1016/j.landurbplan.2017.02.017; Buyantuyev A, 2009, J ARID ENVIRON, V73, P512, DOI 10.1016/j.jaridenv.2008.12.015; CABLE DR, 1977, J RANGE MANAGE, V30, P4, DOI 10.2307/3897324; Cavanaugh ML, 2011, ECOHYDROLOGY, V4, P671, DOI 10.1002/eco.157; Census Bureau US, 2010, 2010 CENS POP HOUS 2; Crum SM, 2017, J APPL METEOROL CLIM, V56, P2531, DOI 10.1175/JAMC-D-17-0054.1; Demuzere M, 2014, J ENVIRON MANAGE, V146, P107, DOI 10.1016/j.jenvman.2014.07.025; Ebrahimian A, 2019, SCI TOTAL ENVIRON, V688, P797, DOI 10.1016/j.scitotenv.2019.06.256; Fravolini A, 2005, OECOLOGIA, V144, P618, DOI 10.1007/s00442-005-0078-4; Gebert LL, 2019, URBAN FOR URBAN GREE, V40, P152, DOI 10.1016/j.ufug.2018.07.017; Grey V, 2018, J HYDROL, V565, P400, DOI 10.1016/j.jhydrol.2018.08.038; Grey V, 2018, LANDSCAPE URBAN PLAN, V178, P122, DOI 10.1016/j.landurbplan.2018.06.002; Houdeshel D, 2014, J IRRIG DRAIN ENG, V140, DOI 10.1061/(ASCE)IR.1943-4774.0000663; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Jenerette GD, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044001; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Kauffman AT, 2017, STORMWATER IRRIGATIO; Keenan TF, 2014, ECOL APPL, V24, P1478, DOI 10.1890/13-0652.1; Kettler TA, 2001, SOIL SCI SOC AM J, V65, P849, DOI 10.2136/sssaj2001.653849x; Kurc SA, 2010, J ARID ENVIRON, V74, P585, DOI 10.1016/j.jaridenv.2009.10.003; Kurc SA, 2004, WATER RESOUR RES, V40, DOI 10.1029/2004WR003068; Kurc SA, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005011; Lancaster B, 2006, RAINWATER HARVESTING, V1; LEVITT DG, 1995, J AM SOC HORTIC SCI, V120, P409, DOI 10.21273/JASHS.120.3.409; Lu P, 2004, ACTA BOT SIN, V46, P631; McCarthy Heather R., 2010, Urban Ecosystems, V13, P393, DOI 10.1007/s11252-010-0127-6; Mizunuma T, 2013, FUNCT ECOL, V27, P196, DOI 10.1111/1365-2435.12026; Mullaney J, 2015, LANDSCAPE URBAN PLAN, V134, P157, DOI 10.1016/j.landurbplan.2014.10.013; Nolan RH, 2018, J ARID ENVIRON, V153, P1, DOI 10.1016/j.jaridenv.2018.01.003; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Ogle K, 2004, OECOLOGIA, V141, P282, DOI 10.1007/s00442-004-1507-5; Pataki DE, 2011, ECOL APPL, V21, P661, DOI 10.1890/09-1717.1; Pettit NE, 2018, HYDROL PROCESS, V32, P1502, DOI 10.1002/hyp.11510; Pincetl S, 2013, GEOJOURNAL, V78, P475, DOI 10.1007/s10708-012-9446-x; Potts DL, 2008, ECOLOGY, V89, P2900, DOI 10.1890/07-1177.1; Richardson AD, 2007, OECOLOGIA, V152, P323, DOI 10.1007/s00442-006-0657-z; Rodriguez-Iturbe I, 2000, WATER RESOUR RES, V36, P3, DOI 10.1029/1999WR900210; Sanchez-Mejia ZM, 2014, WATER RESOUR RES, V50, P306, DOI 10.1002/2013WR014135; Scharenbroch BC, 2016, J ENVIRON QUAL, V45, P199, DOI 10.2134/jeq2015.01.0060; Schuch U, 2017, STUDY IRRIGATION REQ; Schuch UK, 2007, MESQUITE PALO VERDE; Scott RL, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000900; Scott RL, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006149; Sheppard PR, 2002, CLIM RES, V21, P219, DOI 10.3354/cr021219; Shields C, 2015, WATER RESOUR RES, V51, P302, DOI 10.1002/2014WR016108; Smith WK, 2018, GEOPHYS RES LETT, V45, P748, DOI 10.1002/2017GL075922; Szota C, 2019, LANDSCAPE URBAN PLAN, V182, P144, DOI 10.1016/j.landurbplan.2018.10.021; Szutu DJ, 2019, WATER RESOUR RES, V55, P5679, DOI 10.1029/2018WR023990; Toomey M, 2015, ECOL APPL, V25, P99, DOI 10.1890/14-0005.1; US Department of Commerce NNWS, NO AR MONS SEAS; Villegas JC, 2010, VADOSE ZONE J, V9, P537, DOI 10.2136/vzj2009.0032; Yang HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01260-y; Yang JC, 2017, LANDSCAPE URBAN PLAN, V167, P339, DOI 10.1016/j.landurbplan.2017.07.014; Yang JC, 2015, ENERG BUILDINGS, V107, P335, DOI 10.1016/j.enbuild.2015.08.045; Zhao QS, 2018, URBAN SCI, V2, DOI 10.3390/urbansci2010004; Zipper SC, 2017, GEOPHYS RES LETT, V44, P873, DOI 10.1002/2016GL072190	56	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224804	10.1371/journal.pone.0224804	http://dx.doi.org/10.1371/journal.pone.0224804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1HV	31703086	gold, Green Published			2022-12-26	WOS:000532697200024
J	Gaffar, SMA; Chisti, MJ; Mahfuz, M; Ahmed, T				Gaffar, S. M. Abdul; Chisti, Mohammod Jobayer; Mahfuz, Mustafa; Ahmed, Tahmeed			Impact of negative tuberculin skin test on growth among disadvantaged Bangladeshi children	PLOS ONE			English	Article							ENTEROPATHOGENS; UNDERNUTRITION; MALNUTRITION; ASSOCIATION; COHORT	Millions of children are suffering from tuberculosis (TB) worldwide and often end-up with fatal outcome especially in resource-poor settings. Tuberculin skin test (TST) is a conventionally used diagnostic test, less sensitive but highly specific for the diagnosis of clinical TB especially in undernourished children. However, we do not have any data on the role of TST positivity among the children who received nutritional intervention. Our aim was to examine the growth differences between TST-positive and TST-negative undernourished children aged 12 to 18 months who received nutritional intervention prospectively for 90 feeding days. Our further aim was to explore the determinants of TST positivity at enrollment. TB screening as one of the secondary causes of malnutrition was performed on 243 stunted [length for age Z score (LAZ) <-2 standard deviations] or at-risk of stunting (LAZ score between <-1 and-2 standard deviations) children in a community-based intervention study designed to improve their growth parameters. Differences of growth between TST-positives (n = 29) and TST-negatives (n = 214) were compared using paired samples t-test and multivariable linear regression from anthropometric data collected before and after nutritional intervention. Multivariable logistic regression was used to find out possible predictors of TST positivity using baseline sociodemographic data. Of the 243 children screened, 29 (11.9%) were TST-positive and 11 (4.5%) had clinically diagnosed pulmonary TB. Statistically significant improvement of LAZ and weight for age Z-score (WAZ) were observed among the TST-negative participants at the end of intervention period (p = 0.03 for LAZ and p = 0.01 for WAZ). However, we did not find any association between TST status and response to nutritional intervention in our multivariable linear regression models. Our study findings demonstrated a positive impact of nutritional intervention on growth parameters among TST-negative participants.	[Gaffar, S. M. Abdul; Chisti, Mohammod Jobayer; Mahfuz, Mustafa; Ahmed, Tahmeed] Int Ctr Diarrhoea Dis Res, Nutr & Clin Serv Div NCSD, Bangladesh Icddr B, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Gaffar, SMA (corresponding author), Int Ctr Diarrhoea Dis Res, Nutr & Clin Serv Div NCSD, Bangladesh Icddr B, Dhaka, Bangladesh.	gaffar@icddrb.org	Mahfuz, Mustafa/H-5923-2017	Mahfuz, Mustafa/0000-0002-4090-785X; Gaffar, Dr. S.M. Abdul/0000-0001-5625-1966	Bill and Melinda Gates Foundation under its Global Health Program [OPP1136751]	Bill and Melinda Gates Foundation under its Global Health Program	Tahmeed Ahmed received research funding from the Bill and Melinda Gates Foundation under its Global Health Program (Project investment id is OPP1136751). The funding agency had no role in study design, data collection and interpretation, or the decision to submit the manuscript for publication. https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2015/11/OPP1136751.	Ahmed T, 2014, CLIN INFECT DIS, V59, pS280, DOI 10.1093/cid/ciu458; BLACK RE, 1984, PEDIATRICS, V73, P799; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chisti Mohammod Jobayer, 2017, Glob Pediatr Health, V4, p2333794X16686871, DOI 10.1177/2333794X16686871; Dodd P. J., 2014, LANCET, V8, pe453, DOI DOI 10.1016/S2214-109X(14)70245-1; Dodd PJ, 2017, LANCET GLOB HEALTH, V5, pE898, DOI [10.1016/S2214-109X(17)30289-9, 10.1016/s2214-109x(17)30289-9]; Gustafson P, 2007, EPIDEMIOLOGY, V18, P340, DOI 10.1097/01.ede.0000259987.46912.2b; Hill PC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000068; HLAING T, 1993, PARASITOLOGY, V107, pS125, DOI 10.1017/S0031182000075557; Hoa NB, 2013, INT J TUBERC LUNG D, V17, P738, DOI 10.5588/ijtld.12.0200; Hossain S, 2013, INT J TUBERC LUNG D, V17, P1267, DOI 10.5588/ijtld.13.0114; Mahfuz M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017768; Martin SJ, 2019, J DIET SUPPL, V16, P602, DOI 10.1080/19390211.2018.1472165; Martinez L, 2018, LANCET CHILD ADOLESC, V2, P46, DOI 10.1016/S2352-4642(17)30149-9; Martinez L, 2017, AM J EPIDEMIOL, V185, P1327, DOI 10.1093/aje/kwx025; MARTORELL R, 1975, AM J DIS CHILD, V129, P1296, DOI 10.1001/archpedi.1975.02120480022007; Acosta AM, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000370; National Tuberculosis Control Programme (NTP) Bangladesh World Health Organization (WHO), 2016, NAT GUID MAN TUB CHI; Oshikoya KA, 2018, ARCH DIS CHILD, V103, P1101, DOI 10.1136/archdischild-2018-314972; Platts-Mills JA, 2017, AM J CLIN NUTR, V105, P1132, DOI 10.3945/ajcn.116.138800; ROSE DN, 1995, J GEN INTERN MED, V10, P635, DOI 10.1007/BF02602749; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224752	10.1371/journal.pone.0224752	http://dx.doi.org/10.1371/journal.pone.0224752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697726	Green Published, gold			2022-12-26	WOS:000532694400056
J	Klass, M; Faoro, V; Carpentier, A				Klass, Malgorzata; Faoro, Vitalie; Carpentier, Alain			Assessment of energy expenditure during high intensity cycling and running using a heart rate and activity monitor in young active adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MOTION SENSOR; EXERCISE; ACCELEROMETRY; ACTIHEART; VALIDITY; RELIABILITY; VALIDATION	Objective Although high intensity physical activities may represent a great proportion of the total energy expenditure in active people, only sparse studies have investigated the accuracy of wearable monitors to assess activity related energy expenditure (AEE) during high intensity exercises. Therefore, the purpose of the present study was to investigate the accuracy of the Actiheart, a light portable monitor estimating AEE based on heart rate (HR) and activity counts (ACT), during two popular activities (running and cycling) performed at high intensities. The benefit of an individual calibration of the HR-AEE relationship established during a preliminary maximal test was also evaluated. Methods AEE was estimated in eighteen active adults (4 women and 14 men; 25 +/- 4 yr) with indirect calorimetry using a respiratory gas analysis system (reference method) and the Actiheart during 5-min running and cycling at 60, 75 and 85% of maximal oxygen uptake (VO(2)max) previously determined during a maximal test performed on a treadmill or cycle ergometer. For the Actiheart, AEE was estimated either using the group or individual calibrated equations available in the dedicated software, and their respective HR, ACT or combined HR/ACT algorithms. Results When the HR algorithm was used for cycling and the HR or HR/ACT algorithms for running, AEE measured by the Actiheart increased proportionally to exercise intensity from 60 to 85% VO(2)max (P< 0.001). Compared to indirect calorimetry, the Actiheart group calibrated equations slightly to moderately underestimated (3 to 20%) AEE for the three exercise intensities (P< 0.001). Accuracy of AEE estimation was greatly improved by individual calibration of the HR-AEE relationship (underestimation below 5% and intraclass correlation coefficient [ICC]: 0.79-0.93) compared to group calibration (ICC: 0.64-0.79). Conclusion The Actiheart enables to assess AEE during high intensity running and cycling when the appropriate algorithm is applied. Since an underestimation was present for group calibration, an individual and sport-specific calibration should be performed when a high accuracy is required.	[Klass, Malgorzata; Carpentier, Alain] Univ Libre Bruxelles ULB, Lab Biometry & Exercise Nutr, Brussels, Belgium; [Faoro, Vitalie] Univ Libre Bruxelles ULB, Cardiopulm Exercise Lab, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Klass, M (corresponding author), Univ Libre Bruxelles ULB, Lab Biometry & Exercise Nutr, Brussels, Belgium.	mklass@ulb.ac.be		Klass, Malgorzata/0000-0003-1317-5945	University Foundation of Belgium	University Foundation of Belgium	The authors would like to thank Jean-Charles Suaud and Romain Frayssinet for their help in data collection. This paper is published with the support of the University Foundation of Belgium.	ANDREWS RB, 1971, AM J CLIN NUTR, V24, P1139; Barreira T, 2009, INT J EXER SCI, V2, P60; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Brage S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137206; Brychta R, 2010, IEEE ENG MED BIOL, V29, P42, DOI 10.1109/MEMB.2009.935463; Chowdhury EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171720; Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Deschenes MR, 2006, MED SCI SPORT EXER, V38, P1304, DOI 10.1249/01.mss.0000227316.93351.56; Drenowatz C, 2011, EUR J APPL PHYSIOL, V111, P883, DOI 10.1007/s00421-010-1695-0; Gastin PB, 2018, J SCI MED SPORT, V21, P291, DOI 10.1016/j.jsams.2017.07.022; Hiilloskorpi H, 1999, INT J SPORTS MED, V20, P438; Hiilloskorpi HK, 2003, INT J SPORTS MED, V24, P332; Isacco L, 2012, SPORTS MED, V42, P327, DOI 10.2165/11598900-000000000-00000; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Kendall B, 2018, J SPORTS SCI, V4, P1, DOI [DOI 10.1080/02640414.2018.1481723, 10.1080/02640414.2018.1481723]; Koehler K, 2013, EUR J SPORT SCI, V13, P31, DOI 10.1080/17461391.2011.586439; Koehler K, 2011, MED SCI SPORT EXER, V43, P1328, DOI 10.1249/MSS.0b013e31820750f5; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lam YY, 2016, MOL METAB, V5, P1057, DOI 10.1016/j.molmet.2016.09.005; Luke A, 1997, MED SCI SPORT EXER, V29, P144, DOI 10.1097/00005768-199701000-00021; Nichols JF, 2010, INT J SPORT NUTR EXE, V20, P487, DOI 10.1123/ijsnem.20.6.487; O'Driscoll R, 2020, BRIT J SPORT MED, V54, P332, DOI 10.1136/bjsports-2018-099643; Rousset S, 2015, EUR J SPORT SCI, V15, P391, DOI 10.1080/17461391.2014.949309; Santos DA, 2014, J SCI MED SPORT, V17, P387, DOI 10.1016/j.jsams.2013.09.006; Schneller MB, 2015, SENSORS-BASEL, V15, P6133, DOI 10.3390/s150306133; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Spierer DK, 2011, EUR J APPL PHYSIOL, V111, P659, DOI 10.1007/s00421-010-1672-7; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Strath SJ, 2001, MED SCI SPORT EXER, V33, P2118, DOI 10.1097/00005768-200112000-00022; Thompson D, 2006, J NUTR, V136, P1037, DOI 10.1093/jn/136.4.1037; van Hoye K, 2014, J STRENGTH COND RES, V28, P2806, DOI 10.1519/JSC.0b013e3182a1f836; Villars C, 2012, J APPL PHYSIOL, V113, P1763, DOI 10.1152/japplphysiol.01413.2011; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp KR, 2003, P NUTR SOC, V62, P645, DOI 10.1079/PNS2003279	38	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224948	10.1371/journal.pone.0224948	http://dx.doi.org/10.1371/journal.pone.0224948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697742	Green Published, gold			2022-12-26	WOS:000532694400084
J	Prudencio, CB; Rudge, MVC; Pinheiro, FA; Sartorao , CI; Nunes, SK; Pedroni, CR; Junginger, B; Barbosa, AMP				Prudencio, Caroline B.; Rudge, Marilza V. C.; Pinheiro, Fabiane A.; Sartorao Filho, Carlos, I; Nunes, Sthefanie K.; Pedroni, Cristiane R.; Junginger, Baerbel; Barbosa, Angelica M. P.			Negative impact of gestational diabetes mellitus on progress of pelvic floor muscle electromyography activity: Cohort study	PLOS ONE			English	Article							WOMEN; ULTRASOUND; NEUROPATHY	Background and objective Pelvic floor muscles are involved in postural stability, in maintenance intra-abdominal pressure, and on mechanical support for pelvic organ. Gestational Diabetes Mellitus' (GDM) pregnancies complicated by fetal macrosomia, large placenta and polyhydramnios contribute for abrupt and intense increase in maternal intra-abdominal pressure. Our objective was analyze the impact of GDM on pelvic floor muscle (PFM) electromyography (EMG) activity progress from 24-30 to 36-38 weeks of gestation. We conducted a prospective cohort study. PFM EMG was performed in nulliparous or primiparous women with one previous elective cesarean delivery and with or not GDM diagnosed by the American Diabetes Association criteria. A careful explanation of the muscle anatomy and functionality of the PFM was given before EMG assessment. The outcome measures were PFM recruitment and progress from 24-30 to 36-38 weeks of gestation analyzed by the normalized root mean square (RMS) during rest-activity, fast and hold pelvic floor muscle contraction. Results Fifty-two pregnant women were assigned to 2 groups: the GDM (n = 26) and normoglycemic (NG) (n = 26). The demographic and obstetric data showed homogeneity between the groups. PFM activity progress was decreased in rest-activity (P = 0.042) and hold contraction (P = 0.044) at 36-38 weeks of gestation in the GDM group relative to that in the NG group. Conclusion GDM group showed a progressive decrease in EMG-PFM activity during rest-activity and hold contractions from 24-30 to 36-38 weeks of gestation.	[Prudencio, Caroline B.; Rudge, Marilza V. C.; Pinheiro, Fabiane A.; Sartorao Filho, Carlos, I; Nunes, Sthefanie K.; Barbosa, Angelica M. P.] Sao Paulo State Univ Unesp, Dept Gynecol & Obstet, Botucatu Med Sch, UNESP,Univ Estadual Paulista, Botucatu, SP, Brazil; [Pedroni, Cristiane R.; Barbosa, Angelica M. P.] Sao Paulo State Univ Unesp, Dept Physiotherapy & Occupat Therapy, Sch Philosophy & Sci, UNESP,Univ Estadual Paulista, Marilia, SP, Brazil; [Junginger, Baerbel] Charite, Gynecol Dept, Berlin, Germany	Universidade Estadual Paulista; Universidade Estadual Paulista; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Prudencio, CB (corresponding author), Sao Paulo State Univ Unesp, Dept Gynecol & Obstet, Botucatu Med Sch, UNESP,Univ Estadual Paulista, Botucatu, SP, Brazil.	caroline_baldini@hotmail.com	Filho, Carlos Izaias Sartorão/ABB-2588-2021; Sartorao-Filho, Carlos izaias/AAQ-3078-2021; Baldini Prudencio, Caroline/A-7915-2016; junginger, baerbel/AAM-3990-2021; PEDRONI, CRISTIANE/H-7043-2018; Mercia Pascon Barbosa, Angelica/E-4220-2016	Filho, Carlos Izaias Sartorão/0000-0003-4710-3392; Baldini Prudencio, Caroline/0000-0002-2070-3606; Affonso Pinheiro, Fabiane/0000-0002-2223-7522; PEDRONI, CRISTIANE/0000-0001-6907-3345; Mercia Pascon Barbosa, Angelica/0000-0003-0817-9511	Brazilian Federal Agency for Support and Evaluation of graduate Education/SD (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES/DS); Sao Paulo Research Foundation [2016/01743-5]	Brazilian Federal Agency for Support and Evaluation of graduate Education/SD (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES/DS); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work received a scholarship from Brazilian Federal Agency for Support and Evaluation of graduate Education/SD (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES/DS to CBP. MVCR recevied financial assistance to develop the project from Sao Paulo Research Foundation protocol number 2016/01743-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2016, J APPL PHYSIOL, V121, P1, DOI 10.1152/japplphysiol.00733.2015; Allen MD, 2015, J APPL PHYSIOL, V118, P1014, DOI 10.1152/japplphysiol.00441.2014; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Vassimon FIA, 2016, INT UROGYNECOL J, V27, P587, DOI 10.1007/s00192-015-2865-8; Batista RLA, 2011, BRAZ J PHYS THER, V15, P386, DOI 10.1590/S1413-35552011005000026; Boyle KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106872; Cermenati G, 2012, J LIPID RES, V53, P300, DOI 10.1194/jlr.M021188; Chin HY, 2012, INT UROGYNECOL J, V23, P1631, DOI 10.1007/s00192-012-1773-4; Rudge MVC, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.05.014; Dipla K, 2017, DIABETOLOGIA, V60, P192, DOI 10.1007/s00125-016-4129-7; Enoka RM, 2015, J APPL PHYSIOL, V119, P1516, DOI 10.1152/japplphysiol.00280.2015; Farrar D, 2016, INT J WOMENS HEALTH, V8, P519, DOI 10.2147/IJWH.S102117; Friedman S, 2012, OBSTET GYNECOL, V120, P1021, DOI [http://10.1097/AOG.0b013e318265de39, 10.1097/AOG.0b013e318265de39]; Glazer HI, 2000, GLAZER INTRAPELVIC S; Hacad CR, 2015, APPL PSYCHOPHYS BIOF, V40, P9, DOI 10.1007/s10484-015-9271-3; Harvey MA, 2008, ACTA OBSTET GYN SCAN, V87, P1315, DOI 10.1080/00016340802460321; Haylen BT, 2016, INT UROGYNECOL J, V27, P655, DOI 10.1007/s00192-016-3003-y; Henderson JW, 2013, FEMALE PELVIC MED RE, V19, P8, DOI 10.1097/SPV.0b013e31827ab9d0; Hilton TN, 2008, PHYS THER, V88, P1336, DOI 10.2522/ptj.20080079; Hoffman B, 2013, OBSTET WILLIAMS; Kuwabara S, 2002, INTERNAL MED, V41, P360, DOI 10.2169/internalmedicine.41.360; Resende APM, 2012, INT UROGYNECOL J, V23, P1041, DOI 10.1007/s00192-012-1702-6; Marini G, 2011, UROGYNAECOLOGIA, V25, DOI [10.4081/uij.2011.e9, DOI 10.4081/UIJ.2011.E9]; Marshall P, 2003, J ELECTROMYOGR KINES, V13, P477, DOI 10.1016/S1050-6411(03)00027-0; Merletti R, 2014, RECOMMENDATIONS SENS; Micussi MT, 2015, DIABETES METAB SYNDR, V409, DOI [10.2147/DMSO.S85816, DOI 10.2147/DMSO.S85816]; Ortenblad N, 2011, J PHYSIOL-LONDON, V589, P711, DOI 10.1113/jphysiol.2010.195982; Barbosa AMP, 2011, CLINICS, V66, P1341, DOI 10.1590/S1807-59322011000800006; Piculo F, 2014, INT UROGYNECOL J, V25, P403, DOI 10.1007/s00192-013-2218-4; Rusu L, 2009, ROM J MORPHOL EMBRYO, V50, P283; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; de Oliveira DCS, 2012, REV BRAS MED ESPORTE, V18, P261, DOI 10.1590/S1517-86922012000400009; Smith MD, 2007, INT UROGYNECOL J, V18, P901, DOI 10.1007/s00192-006-0259-7; Turrina A, 2013, J BODYW MOV THER, V17, P95, DOI 10.1016/j.jbmt.2012.06.001; Volloyhaug I, 2016, ULTRASOUND OBST GYN, V47, P768, DOI 10.1002/uog.15731	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0223261	10.1371/journal.pone.0223261	http://dx.doi.org/10.1371/journal.pone.0223261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697712	gold, Green Published, Green Submitted			2022-12-26	WOS:000532694400013
J	Shaked, D; Sunderaraman, P; Piscitello, J; Cines, S; Hale, C; Devanand, D; Karlawish, J; Cosentino, S				Shaked, Danielle; Sunderaraman, Preeti; Piscitello, Jennifer; Cines, Sarah; Hale, Christiane; Devanand, Davangere; Karlawish, Jason; Cosentino, Stephanie			Modification of everyday activities and its association with self-awareness in cognitively diverse older adults	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HEALTH LITERACY; IMPAIRMENT; DEMENTIA; DEFICITS; MCI; ANOSOGNOSIA; PERFORMANCE; PREDICTORS; FRAILTY	Cognitive impairment (CI) in older adults is frequently accompanied by difficulty performing complex everyday activities (e.g., managing finances). However, it is unclear if and how older adults with CI modify their activities (i.e., Do individuals continue, monitor, seek help with, change their approach to, or stop different activities?). In the current study, we examined if older adults with CI are concerned about their ability to carry out complex activities, if and how they modify activities based on their concern, and the factors associated with activity modification. We hypothesized that older adults with CI will more frequently be concerned about, and modify, everyday activities than cognitively healthy (HE) older adults, and that higher awareness of memory loss in the CI group would relate to more frequent modification. The sample included 81 older adults (51 HEs; mean age 70.02 (7.34) and 30 CI; mean age 75.97 (8.12)). Compared to HEs, the CI group reported having more concern about, F(3,77) = 5.50, p = 0.02, and modifying a greater number of activities, F(3,77) = 5.02, p = 0.03. Medication management (30%) and completing taxes (33.3%) were among the most frequently modified activities for the CI and HE groups, respectively. In the CI group, higher memory awareness was associated with more concern (r =.53, p =.005) and activity modification (r = 0.55, p =.003). Findings provide novel information about how cognitively diverse older adults navigate complex activities in daily life. We propose a preliminary theoretical model by which self-awareness may influence navigation of everyday activities in the context of CI.	[Shaked, Danielle; Sunderaraman, Preeti; Piscitello, Jennifer; Cines, Sarah; Hale, Christiane; Devanand, Davangere; Cosentino, Stephanie] Columbia Univ, Med Ctr, Cognit Neurosci Div, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Shaked, Danielle] Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21228 USA; [Sunderaraman, Preeti; Hale, Christiane; Cosentino, Stephanie] Columbia Univ, Gertrude H Sergievsky Ctr, Med Ctr, New York, NY 10027 USA; [Sunderaraman, Preeti; Devanand, Davangere; Cosentino, Stephanie] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA; [Devanand, Davangere] Columbia Univ, Dept Psychiat, Med Ctr, Div Geriatr Psychiat, New York, NY USA; [Devanand, Davangere] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Karlawish, Jason] Univ Penn, Hlth Brain Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA	Columbia University; University System of Maryland; University of Maryland Baltimore County; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; University of Pennsylvania; Pennsylvania Medicine	Cosentino, S (corresponding author), Columbia Univ, Med Ctr, Cognit Neurosci Div, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; Cosentino, S (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Med Ctr, New York, NY 10027 USA.; Cosentino, S (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10027 USA.	sc2460@cumc.columbia.edu	Sunderaraman, Preeti/AAJ-1247-2020	Sunderaraman, Preeti/0000-0001-6011-8412; Piscitello, Jennifer/0000-0003-3033-504X	Marilyn S. Ware Alzheimer Program at the University of Pennsylvania; Paul B. Beeson Career Development Award in Aging [K23 AG032899]; Ruth L. Kirschstein Predoctoral Individual National Research Service Award [F32AG053035, R01 AG17761, R01 AG007370, P50 AG008702]; NATIONAL INSTITUTE ON AGING [P30AG010124, F32AG053035, P50AG008702, R01AG007370] Funding Source: NIH RePORTER	Marilyn S. Ware Alzheimer Program at the University of Pennsylvania; Paul B. Beeson Career Development Award in Aging; Ruth L. Kirschstein Predoctoral Individual National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Marilyn S. Ware Alzheimer Program at the University of Pennsylvania (PI: Karlawish), the Paul B. Beeson Career Development Award in Aging (K23 AG032899: PI Cosentino), the Ruth L. Kirschstein Predoctoral Individual National Research Service Award (F32AG053035: PI: Sunderaraman), R01 AG17761 (PI: Devanand), R01 AG007370 (PI: Stern), P50 AG008702 (PI: Small).	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Avila J, 2015, GEROPSYCH, V28, P191, DOI 10.1024/1662-9647/a000136; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Boron JB, 2013, GERIATR NURS, V34, P395, DOI 10.1016/j.gerinurse.2013.05.010; Buckley RF, 2015, J ALZHEIMERS DIS, V48, pS125, DOI 10.3233/JAD-150095; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clare L, 2004, BRIT J CLIN PSYCHOL, V43, P177, DOI 10.1348/014466504323088042; Cosentino S, 2005, J INT NEUROPSYCH SOC, V11, P910, DOI 10.1017/S1355617705050964; Cosentino S, 2011, INT J ALZHEIMERS DIS; Cosentino S, 2007, CORTEX, V43, P1004, DOI 10.1016/S0010-9452(08)70697-X; Cosentino Stephanie, 2011, Int J Alzheimers Dis, V2011, P483897, DOI 10.4061/2011/483897; Cotrell V, 1999, ALZ DIS ASSOC DIS, V13, P151, DOI 10.1097/00002093-199907000-00007; Dean KJ, 2013, EXPLORING HEALTHCARE; Devanand DP, 1997, J AM GERIATR SOC, V45, P321, DOI 10.1111/j.1532-5415.1997.tb00947.x; Farias ST, 2006, ALZ DIS ASSOC DIS, V20, P217, DOI 10.1097/01.wad.0000213849.51495.d9; Farias ST, 2013, PSYCHOL AGING, V28, P1070, DOI 10.1037/a0034069; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Galeone F, 2011, INT J GERIATR PSYCH, V26, P695, DOI 10.1002/gps.2583; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jutten Roos J, 2017, Alzheimers Dement (Amst), V8, P26, DOI 10.1016/j.dadm.2017.03.002; Kelleher M, 2015, INT J GERIATRIC PSYC; Koren D, 2004, SCHIZOPHR RES, V70, P195, DOI 10.1016/j.schres.2004.02.004; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; LAWTON MP, 1971, J AM GERIATR SOC, V19, P465, DOI 10.1111/j.1532-5415.1971.tb01206.x; Lindbergh CA, 2016, NEUROPSYCHOL REV, V26, P129, DOI 10.1007/s11065-016-9321-5; Maki Y, 2012, AM J ALZHEIMERS DIS, V27, P339, DOI 10.1177/1533317512452039; Manini T, 2007, J GERONTOL A-BIOL, V62, P616, DOI 10.1093/gerona/62.6.616; Martin RC, 2019, ARCH CLIN NEUROPSYCH, V34, P152, DOI 10.1093/arclin/acy030; Mattis S, 1988, DEMENTIA RATING SCAL; Mograbi DC, 2012, NEUROPSYCHOLOGIA, V50, P2075, DOI 10.1016/j.neuropsychologia.2012.05.008; Morris JC, 1993, NEUROLOGY; Morris RG, 2004, COGN NEUROPSYCHOL, P275; Nobili F, 2010, J ALZHEIMERS DIS, V22, P993, DOI 10.3233/JAD-2010-100423; Onor M L, 2006, Am J Alzheimers Dis Other Demen, V21, P333, DOI 10.1177/1533317506292454; Orellano E, 2012, AM J OCCUP THER, V66, P292, DOI 10.5014/ajot.2012.003053; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; REED BR, 1993, J CLIN EXP NEUROPSYC, V15, P231, DOI 10.1080/01688639308402560; Roberts JL, 2009, DEMENT GERIATR COGN, V28, P95, DOI 10.1159/000234911; Rosas-Salazar C, 2012, J ALLERGY CLIN IMMUN, V129, P935, DOI 10.1016/j.jaci.2012.01.040; Schmitter-Edgecombe M, 2014, ARCH CLIN NEUROPSYCH, V29, P776, DOI 10.1093/arclin/acu053; Starkstein SE, 2014, CORTEX, V61, P64, DOI 10.1016/j.cortex.2014.07.019; Stern Y, 2017, ALZHEIMERS DEMENT, V13, P20, DOI 10.1016/j.jalz.2016.04.004; Stites SD, 2018, ALZ DIS ASSOC DIS, V32, P276, DOI 10.1097/WAD.0000000000000262; Stites SD, 2017, J GERONTOL B-PSYCHOL, V72, P974, DOI 10.1093/geronb/gbx100; Tabert MH, 2002, NEUROLOGY, V58, P758, DOI 10.1212/WNL.58.5.758; Tremont G, 2011, INT J GERIATR PSYCH, V26, P299, DOI 10.1002/gps.2529; Turken U, 2003, AM J PSYCHIAT, V160, P1881, DOI 10.1176/appi.ajp.160.10.1881; Vogel A, 2004, DEMENT GERIATR COGN, V17, P181, DOI 10.1159/000076354; Walsh K. W., 1966, NEUROPSYCHOLOGY CLIN; Weintraub Sandra, 2018, Alzheimers Dement (N Y), V4, P64, DOI 10.1016/j.trci.2018.01.003; Zimmerman E.B., 2015, POPULATION HLTH BEHA, P347	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0222769	10.1371/journal.pone.0222769	http://dx.doi.org/10.1371/journal.pone.0222769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697690	Green Published, gold			2022-12-26	WOS:000532694400009
J	Matsugi, A; Yoshida, N; Nishishita, S; Okada, Y; Mori, N; Oku, K; Douchi, S; Hosomi, K; Saitoh, Y				Matsugi, Akiyoshi; Yoshida, Naoki; Nishishita, Satoru; Okada, Yohei; Mori, Nobuhiko; Oku, Kosuke; Douchi, Shinya; Hosomi, Koichi; Saitoh, Youichi			Cerebellum-mediated trainability of eye and head movements for dynamic gazing	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; VESTIBULOOCULAR REFLEX; COORDINATION; SACCADES; PURSUIT; TMS	Objective To investigate whether gaze stabilization exercises (GSEs) improve eye and head movements and whether low-frequency cerebellar repetitive transcranial magnetic stimulation (rTMS) inhibits GSE trainability. Methods 25 healthy adults (real rTMS, n = 12; sham rTMS, n = 13) were recruited. Real or sham rTMS was performed for 15 min (1 Hz, 900 stimulations). The center of the butterfly coil was set 1 cm below the inion in the real rTMS. Following stimulation, 10 trials of 1 min of a GSE were conducted at 1 min intervals. In the GSE, the subjects were instructed to stand upright and horizontally rotate their heads according to a beeping sound corresponding to 2 Hz and with a gaze point ahead of them. Electrooculograms were used to estimate the horizontal gaze direction of the right eye, and gyroscopic measurements were performed to estimate the horizontal head angular velocity during the GSE trials. The percentage change from the first trial of motion range of the eye and head was calculated for each measurement. The percent change of the eye/head range ratio was calculated to assess the synchronous changes of the eye and head movements as the exercise increased. Results Bayesian two-way analysis of variance showed that cerebellar rTMS affected the eye motion range and eye/head range ratio. A post hoc comparison (Bayesian t-test) showed evidence that the eye motion range and eye/head range ratio were reduced in the fifth, sixth, and seventh trials compared with the first trial sham stimulation condition. Conclusions GSEs can modulate eye movements with respect to head movements, and the cerebellum may be associated with eye-head coordination trainability for dynamic gazing during head movements.	[Matsugi, Akiyoshi; Oku, Kosuke] Shijonawate Gakuen Univ, Fac Rehabil, Daitou City, Osaka, Japan; [Yoshida, Naoki; Nishishita, Satoru] Tokuyukai Med Corp, Inst Rehabil Sci, Dept Res, Sakuranocho, Toyonaka, Osaka, Japan; [Yoshida, Naoki; Nishishita, Satoru] Kansai Rehabil Hosp, Dept Rehabil, Sakuranocho, Toyonaka, Osaka, Japan; [Okada, Yohei] Kio Univ, Fac Hlth Sci, Koryo, Nara, Japan; [Okada, Yohei] Kio Univ, Neurorehabil Res Ctr, Koryo, Nara, Japan; [Mori, Nobuhiko; Hosomi, Koichi; Saitoh, Youichi] Osaka Univ, Off Univ Ind Collaborat, Dept Neuromodulat & Neurosurg, Osaka, Japan; [Mori, Nobuhiko; Hosomi, Koichi; Saitoh, Youichi] Osaka Univ, Dept Neurosurg, Grad Sch Med, Osaka, Japan; [Douchi, Shinya] Natl Hosp Org Kyoto Med Ctr, Dept Rehabil, Husimi Ku, Kyoto, Kyoto, Japan	Osaka University; Osaka University	Matsugi, A (corresponding author), Shijonawate Gakuen Univ, Fac Rehabil, Daitou City, Osaka, Japan.	a-matsugi@reha.shijonawate-gakuen.ac.jp	Matsugi, Akiyoshi/AAV-7677-2020	Matsugi, Akiyoshi/0000-0002-3244-0874; Okada, Yohei/0000-0001-7860-3440; Mori, Nobuhiko/0000-0001-6537-6322; oku, kosuke/0000-0003-3917-406X	JSPS KAKENHI [JP17K01541]; Japan Agency for Medical Research and Development (AMED) [JP19dm0307007]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by JSPS KAKENHI Grant Number JP17K01541 and partially supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP19dm0307007. Tokuyukai Medical Corporation provided support in the form of salaries for authors N.Y. and S.N., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Fuka Nishitani, Ikumi Mitamura, and Kento Yamada contributed to the conduct of all experiments. We would like to thank all the volunteers for their participation. We would also like to thank Enago (www.enago.jp) for the English language editing. This work was supported by JSPS KAKENHI Grant Number JP17K01541 and partially supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP19dm0307007.	Barbara N, 2016, IEEE SYS MAN CYBERN, P1069, DOI 10.1109/SMC.2016.7844384; Bhardwaj V., 2014, INT J PHYSIOTHER RES, V2, P642; Boayue Nya Mehnwolo, 2018, F1000Res, V7, P704, DOI 10.12688/f1000research.15125.2; Dienes Z, 2018, ADDICTION, V113, P240, DOI 10.1111/add.14002; Fang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121035; Fierro B, 2007, EXP BRAIN RES, V176, P440, DOI 10.1007/s00221-006-0628-y; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Haarmeier T, 2010, CEREB CORTEX, V20, P2234, DOI 10.1093/cercor/bhp285; Hardwick RM, 2014, BRAIN STIMUL, V7, P643, DOI 10.1016/j.brs.2014.04.009; Hiraoka K, 2010, CEREBELLUM, V9, P454, DOI 10.1007/s12311-010-0187-4; Hobbs BP, 2008, J BIOPHARM STAT, V18, P54, DOI 10.1080/10543400701668266; Hoekstra R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195474; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; Jenkinson N, 2010, CEREBELLUM, V9, P548, DOI 10.1007/s12311-010-0193-6; Klomjai W, 2015, ANN PHYS REHABIL MED, V58, P208, DOI 10.1016/j.rehab.2015.05.005; Matsugi A, 2020, NEUROSCI RES, V150, P37, DOI 10.1016/j.neures.2019.01.012; Matsugi A, 2018, SOMATOSENS MOT RES, V35, P80, DOI 10.1080/08990220.2018.1465403; Matsugi A, 2018, NEUROREPORT, V29, P808, DOI 10.1097/WNR.0000000000001036; Matsugi A, 2017, NEUROREPORT, V28, P439, DOI 10.1097/WNR.0000000000000776; Matsugi A, 2014, NEUROREPORT, V25, P1375, DOI 10.1097/WNR.0000000000000275; Matsugi Akiyoshi, 2012, Indian J Physiol Pharmacol, V56, P193; Matsugi A, 2013, CEREBELLUM, V12, P147, DOI 10.1007/s12311-012-0402-6; MILES FA, 1980, J NEUROPHYSIOL, V43, P1406, DOI 10.1152/jn.1980.43.5.1406; Mitsutake T, 2017, NEUROREPORT, V28, P745, DOI 10.1097/WNR.0000000000000841; Morimoto H, 2011, GAIT POSTURE, V33, P600, DOI 10.1016/j.gaitpost.2011.01.016; Nagel M, 2003, J NEUROL SCI, V213, P35, DOI 10.1016/S0022-510X(03)00145-X; NODA H, 1986, J PHYSIOL-LONDON, V379, P39, DOI 10.1113/jphysiol.1986.sp016240; Panouilleres M, 2013, CEREBELLUM, V12, P557, DOI 10.1007/s12311-013-0463-1; Peter H., 1997, BIOMETRIKA, V84, P9; Popa T, 2010, BRAIN STIMUL, V3, P161, DOI 10.1016/j.brs.2009.10.001; Schmid R, 1988, Adv Otorhinolaryngol, V41, P89; Shinmei Y, 2002, J NEUROPHYSIOL, V87, P1836, DOI 10.1152/jn.00150.2001; Soetedjo R, 2019, J NEUROPHYSIOL, V121, P2153, DOI 10.1152/jn.00781.2018; Tanaka H, 2018, NEUROSCI RES, V133, P15, DOI 10.1016/j.neures.2017.11.004; Team J, 2019, JASP VERS 0 10 1; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; Ueta Yusuke, 2017, J Phys Ther Sci, V29, P1494, DOI 10.1589/jpts.29.1494; van Dun K, 2017, CEREBELLUM, V16, P695, DOI 10.1007/s12311-016-0840-7; van Ravenzwaaij D, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0699-7; Zangemeister WH, 2001, ACTA OTO-LARYNGOL, P140; Zaslavsky BG, 2013, BIOMETRICS, V69, P157, DOI 10.1111/j.1541-0420.2012.01806.x	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2019	14	11							e0224458	10.1371/journal.pone.0224458	http://dx.doi.org/10.1371/journal.pone.0224458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1AJ	31682634	Green Published, gold			2022-12-26	WOS:000532676800017
J	Kam, A; Loo, S; Fan, JS; Sze, SK; Yang, DW; Tam, JP				Kam, Antony; Loo, Shining; Fan, Jing-Song; Sze, Siu Kwan; Yang, Daiwen; Tam, James P.			Roseltide rT7 is a disulfide-rich, anionic, and cell-penetrating peptide that inhibits proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proteasome; cell-penetrating peptide (CPP); peptides; peptide chemical synthesis; enzyme inhibitor; protease inhibitor; structure-function; natural product; drug discovery; drug action; cystine-knot peptide; Hibiscus sabdariffa; plant peptide; proteasome inhibitor; roseltide rT7	NF-KAPPA-B; CRYSTAL-STRUCTURE; 20S PROTEASOME; KNOT; SYSTEM; ACTIVATION; EXPRESSION; PROTEIN; ICAM-1; EPOXOMICIN	Disulfide-rich plant peptides with molecular masses of 2?6 kDa represent an expanding class of peptidyl-type natural products with diverse functions. They are structurally compact, hyperstable, and underexplored as cell-penetrating agents that inhibit intracellular functions. Here, we report the discovery of an anionic, 34-residue peptide, the disulfide-rich roseltide rT7 from Hibiscus sabdariffa (of the Malvaceae family) that penetrates cells and inhibits their proteasomal activities. Combined proteomics and NMR spectroscopy revealed that roseltide rT7 is a cystine-knotted, six-cysteine hevein-like cysteine-rich peptide. A pair-wise comparison indicated that roseltide rT7 is >100-fold more stable against protease degradation than its S-alkylated analog. Confocal microscopy studies and cell-based assays disclosed that after roseltide rT7 penetrates cells, it causes accumulation of ubiquitinated proteins, inhibits human 20S proteasomes, reduces tumor necrosis factor-induced I?B? degradation, and decreases expression levels of intercellular adhesion molecule-1. Structure-activity studies revealed that roseltide rT7 uses a canonical substrate-binding mechanism for proteasomal inhibition enabled by an IIML motif embedded in its proline-rich and exceptionally long intercysteine loop 4. Taken together, our results provide mechanistic insights into a novel disulfide-rich, anionic, and cell-penetrating peptide, representing a potential lead for further development as a proteasomal inhibitor in anti-cancer or anti-inflammatory therapies.	[Kam, Antony; Loo, Shining; Sze, Siu Kwan; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Fan, Jing-Song; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	JPTam@ntu.edu.sg	Sze, Siu Kwan/AAO-3342-2020; Tam, James P/A-2176-2011; yang, daiwen/H-8408-2012; LOO, Shining/AAT-2864-2021	Sze, Siu Kwan/0000-0002-5652-1687; Tam, James P/0000-0003-4433-198X; yang, daiwen/0000-0002-6804-0071; LOO, Shining/0000-0002-2220-8297; Kam, Antony/0000-0003-2155-6887	Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC); AcRF Tier 3 funding [MOE2016-T3-1-003]	Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC)(Nanyang Technological University); AcRF Tier 3 funding	This work was supported in part by Nanyang Technological University Internal Funding-Synzymes and Natural Products (SYNC) and AcRF Tier 3 funding Grant MOE2016-T3-1-003. The authors declare that they have no conflicts of interest with the contents of this article.	Adams J, 2002, TRENDS MOL MED, V8, pS49, DOI 10.1016/S1471-4914(02)02315-8; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Basit A, 2006, AM J PHYSIOL-LUNG C, V291, pL200, DOI 10.1152/ajplung.00346.2005; Bax M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060581; Beck P, 2012, BIOL CHEM, V393, P1101, DOI 10.1515/hsz-2012-0212; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; Bundy RE, 2005, ANTIOXID REDOX SIGN, V7, P14, DOI 10.1089/ars.2005.7.14; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Gao XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35179; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; Grawert MA, 2012, CHEM COMMUN, V48, P1364, DOI 10.1039/c1cc15273d; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2002, CHEM BIOL, V9, P655, DOI 10.1016/S1074-5521(02)00144-8; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; HANADA M, 1992, J ANTIBIOT, V45, P1746, DOI 10.7164/antibiotics.45.1746; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; Holden NS, 2004, EUR J BIOCHEM, V271, P785, DOI 10.1111/j.1432-1033.2004.03982.x; Huber EM, 2015, J AM CHEM SOC, V137, P7835, DOI 10.1021/jacs.5b03688; Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068; Iyer S, 2011, FEBS J, V278, P4304, DOI 10.1111/j.1742-4658.2011.08350.x; Jha D, 2011, BIOCONJUGATE CHEM, V22, P319, DOI 10.1021/bc100045s; Ji YB, 2013, J AM CHEM SOC, V135, P11623, DOI 10.1021/ja405108p; Kam A, 2019, J BIOL CHEM, V294, P4000, DOI 10.1074/jbc.RA118.006693; Kam A, 2014, INT J CARDIOL, V171, P231, DOI 10.1016/j.ijcard.2013.12.020; Kim KB, 1999, BIOORG MED CHEM LETT, V9, P3335, DOI 10.1016/S0960-894X(99)00612-5; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Konno S, 2002, AM J RESP CELL MOL, V26, P594, DOI 10.1165/ajrcmb.26.5.4438; Kwon YT, 2017, TRENDS BIOCHEM SCI, V42, P873, DOI 10.1016/j.tibs.2017.09.002; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo SN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02162; Loo SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep39401; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Molesini B, 2017, BRIT J CLIN PHARMACO, V83, P63, DOI 10.1111/bcp.12932; Moore SJ, 2012, METHOD ENZYMOL, V503, P223, DOI 10.1016/B978-0-12-396962-0.00009-4; Northfield SE, 2014, EUR J MED CHEM, V77, P248, DOI 10.1016/j.ejmech.2014.03.011; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Pai P. P., 2017, TOXINS DRUG DISCOVER; Peraro L, 2018, ANGEW CHEM INT EDIT, V57, P11868, DOI 10.1002/anie.201801361; Pereira AR, 2012, CHEMBIOCHEM, V13, P810, DOI 10.1002/cbic.201200007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Nguyen QT, 2015, J BIOL CHEM, V290, P31138, DOI 10.1074/jbc.M115.654855; Riaz G, 2018, BIOMED PHARMACOTHER, V102, P575, DOI 10.1016/j.biopha.2018.03.023; Richardson Paul G, 2003, Cancer Control, V10, P361; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Silverman AP, 2011, J MOL RECOGNIT, V24, P127, DOI 10.1002/jmr.1036; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Tam JP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33894-x; Varshavsky A, 2017, ANNU REV BIOCHEM, V86, P123, DOI 10.1146/annurev-biochem-061516-044859; Winter MB, 2017, ELIFE, V6, DOI 10.7554/eLife.27364; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Yabe K, 2009, J BIOCHEM, V145, P217, DOI 10.1093/jb/mvn160; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	72	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19604	19615		10.1074/jbc.RA119.010796	http://dx.doi.org/10.1074/jbc.RA119.010796			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31727740	hybrid, Green Published			2022-12-26	WOS:000504093200013
J	Tripathi, A; Martinez, E; Obaidullah, AJ; Lete, MG; Lonnfors, M; Khan, D; Soni, KG; Mousley, CJ; Kellogg, GE; Bankaitis, VA				Tripathi, Ashutosh; Martinez, Elliott; Obaidullah, Ahmad J.; Lete, Marta G.; Lonnfors, Max; Khan, Danish; Soni, Krishnakant G.; Mousley, Carl J.; Kellogg, Glen E.; Bankaitis, Vytas A.			Functional Diversification of the Chemical Landscapes of Yeast Sec14-like Phosphatidylinositol Transfer Protein Lipid-Binding Cavities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidylinositol transfer proteins; phosphoinositide signaling; Sec14-domain; cavity mapping; squalene; sterols	SACCHAROMYCES-CEREVISIAE; POTENTIAL FUNCTIONS; METABOLISM; PHOSPHOINOSITIDES; PHOSPHOLIPIDS; BIOSYNTHESIS; DEGENERATION; PREDICTION; TRANSPORT; DOCKING	Phosphatidylinositol-transfer proteins (PITPs) are key regulators of lipid signaling in eukaryotic cells. These proteins both potentiate the activities of phosphatidylinositol (PtdIns) 4-OH kinases and help channel production of specific pools of PtdIns-4-phosphate (PtdIns4P) dedicated to specific biological outcomes. In this manner, PITPs represent a major contributor to the mechanisms by which the biological outcomes of phosphoinositide are diversified. The two-ligand priming model proposes that the engine by which Sec14-like PITPs potentiate PtdIns kinase activities is a heterotypic lipid exchange cycle where PtdIns is a common exchange substrate among the Sec14-like PITP family, but the second exchange ligand varies with the PITP. A major prediction of this model is that second-exchangeable ligand identity will vary from PITP to PITP. Thus, we used structural, computational and biochemical approaches to probe the diversities of the lipid-binding cavity microenvironments of the yeast Sec14-like PITPs. Using Sfh2 and Sfh3 as models, we demonstrate these represent PtdIns/squalene and PtdIns/ergosterol exchange proteins, respectively. The collective data report that yeast Sec14-like PITP lipid-binding pockets indeed define diverse chemical microenvironments that translate into differential ligand binding specificities across this protein family.	[Tripathi, Ashutosh; Lete, Marta G.; Lonnfors, Max; Soni, Krishnakant G.; Bankaitis, Vytas A.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Martinez, Elliott; Khan, Danish; Bankaitis, Vytas A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Obaidullah, Ahmad J.; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Obaidullah, Ahmad J.; Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23298 USA; [Lonnfors, Max] Abo Akad Univ, Fac Sci & Engn, Dept Biosci, FI-20520 Turku, Finland; [Mousley, Carl J.] Curtin Univ, Fac Hlth Sci, CHIRI, Sch Biomed Sci, Bentley, WA 6102, Australia; [Bankaitis, Vytas A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Obaidullah, Ahmad J.] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, POB 2457, Riyadh 11451, Saudi Arabia	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Virginia Commonwealth University; Virginia Commonwealth University; Abo Akademi University; Curtin University; Texas A&M University System; Texas A&M University College Station; King Saud University	Tripathi, A; Bankaitis, VA (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA.; Bankaitis, VA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.; Bankaitis, VA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	tripathi@tamu.edu; vytas@tamu.edu	Lete, Marta G/C-3960-2017; OBAIDULLAH, AHMAD J./GQI-4663-2022; KHAN, DANISH/AAN-2493-2021; OBAIDULLAH, AHMAD JOMAH/ABD-2825-2020	Lete, Marta G/0000-0002-9654-7881; OBAIDULLAH, AHMAD J./0000-0002-7532-6318; KHAN, DANISH/0000-0002-0650-3990; bankaitis, vytas/0000-0002-1654-6759; Mousley, Carl/0000-0002-0192-7030	National Institutes of Health [R35 GM131804]; Robert A. Welch Foundation [BE-0017]; Basque Government; Sigrid Juselius Foundation; King Saud University; Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM131804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Basque Government(Basque Government); Sigrid Juselius Foundation(Sigrid Juselius Foundation); King Saud University(King Saud University); Laboratory for Molecular Simulation and High Performance Research Computing at Texas AM University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R35 GM131804 from the National Institutes of Health and BE-0017 from the Robert A. Welch Foundation to VAB. MGL and ML were supported by postdoctoral fellowships from the Basque Government and the Sigrid Juselius Foundation, respectively. A. J. O. acknowledges King Saud University for support of his graduate studies at Virginia Commonwealth University. The Laboratory for Molecular Simulation and High Performance Research Computing at Texas A&M University provided software, support, and computer time. We thank Kaitlyn McGrath for help with lipid transfer assays, and Pentti Somerharju (Helsinki) and J. Peter Slotte (Turku) for their generous gifts of fluorescent lipids.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Alb JG, 2007, J LIPID RES, V48, P1857, DOI 10.1194/jlr.M700145-JLR200; Alb JG, 2003, J BIOL CHEM, V278, P33501, DOI 10.1074/jbc.M303591200; [Anonymous], 2018, MOL OP ENV MOE; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Cha MK, 2003, J BIOL CHEM, V278, P34952, DOI 10.1074/jbc.M301819200; Christen M, 2015, J STRUCT BIOL, V190, P261, DOI 10.1016/j.jsb.2015.05.001; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Desfougeres T, 2008, BIOCHEM J, V409, P299, DOI 10.1042/BJ20071028; Ghosh R, 2015, MOL BIOL CELL, V26, P1764, DOI 10.1091/mbc.E14-10-1475; Giansanti MG, 2006, CURR BIOL, V16, P195, DOI 10.1016/j.cub.2005.12.011; GORDESKY SE, 1973, BIOCHEM BIOPH RES CO, V50, P1027, DOI 10.1016/0006-291X(73)91509-X; Grabon A, 2015, BBA-MOL CELL BIOL L, V1851, P724, DOI 10.1016/j.bbalip.2014.12.011; GUPTA CM, 1977, P NATL ACAD SCI USA, V74, P4315, DOI 10.1073/pnas.74.10.4315; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hoffman CS, 2015, GENETICS, V201, P403, DOI 10.1534/genetics.115.181503; Holic R, 2014, BBA-MOL CELL BIOL L, V1841, P1483, DOI 10.1016/j.bbalip.2014.07.014; Huang J, 2018, DEV CELL, V44, P378, DOI 10.1016/j.devcel.2017.12.026; Huang J, 2016, MOL BIOL CELL, V27, P2317, DOI 10.1091/mbc.E16-04-0221; Ile KE, 2010, TRAFFIC, V11, P1151, DOI 10.1111/j.1600-0854.2010.01085.x; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Khan D, 2016, J LIPID RES, V57, P650, DOI 10.1194/jlr.M066381; Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989; Liebeschuetz JW, 2012, J COMPUT AID MOL DES, V26, P737, DOI 10.1007/s10822-012-9551-4; Milligan SC, 1997, J CELL BIOL, V139, P351, DOI 10.1083/jcb.139.2.351; Mousley CJ, 2012, CELL, V148, P702, DOI 10.1016/j.cell.2011.12.026; Nakase Y, 2001, MOL BIOL CELL, V12, P901, DOI 10.1091/mbc.12.4.901; Nile AH, 2010, CLIN LIPIDOL, V5, P867, DOI 10.2217/CLP.10.67; Regnacq M, 2002, FEMS MICROBIOL LETT, V216, P165, DOI 10.1016/S0378-1097(02)01034-0; Ren JH, 2014, MOL BIOL CELL, V25, P712, DOI 10.1091/mbc.E13-11-0634; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Routt SM, 2005, TRAFFIC, V6, P1157, DOI 10.1111/j.1600-0854.2005.00350.x; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schaaf G, 2011, MOL BIOL CELL, V22, P892, DOI 10.1091/mbc.E10-11-0903; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; SOMERHARJU P, 1982, CHEM PHYS LIPIDS, V30, P81, DOI 10.1016/0009-3084(82)90009-3; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Totrov M, 2001, BIOPOLYMERS, V60, P124, DOI 10.1002/1097-0282(2001)60:2<124::AID-BIP1008>3.0.CO;2-S; Tripathi A, 2011, METHODS MOL BIOL, V716, P39, DOI 10.1007/978-1-61779-012-6_3; Tripathi A, 2010, PROTEINS, V78, P825, DOI 10.1002/prot.22608; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Wu WI, 2000, J BIOL CHEM, V275, P14446, DOI 10.1074/jbc.275.19.14446; Yang H, 2013, FEBS LETT, V587, P1610, DOI 10.1016/j.febslet.2013.04.009	55	5	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19081	19098		10.1074/jbc.RA119.011153	http://dx.doi.org/10.1074/jbc.RA119.011153			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31690622	hybrid, Green Published			2022-12-26	WOS:000516527800012
J	Rodriguez, S; Stewart, AN; Lei, X; Cao, X; Little, HC; Fong, V; Sarver, DC; Wong, GW				Rodriguez, Susana; Stewart, Ashley N.; Lei, Xia; Cao, Xi; Little, Hannah C.; Fong, Vincent; Sarver, Dylan C.; Wong, G. William			PRADC1: a novel metabolic-responsive secretory protein that modulates physical activity and adiposity	FASEB JOURNAL			English	Article						lipid metabolism; obesity; diabetes; insulin resistance	TISSUE INFLAMMATION; WEIGHT-LOSS; OBESITY; FAT; GLUCOSE	Interorgan communication mediated by secreted proteins plays a pivotal role in metabolic homeostasis, yet the function of many circulating secretory proteins remains unknown. Here, we describe the function of protease -associated domain-containing 1 (PRADC1), an enigmatic secretory protein widely expressed in humans and mice. In metabolically active tissues (liver, muscle, fat, heart, and kidney), we showed that Pradc1 expression is significantly suppressed by refeeding and reduced in kidney and brown fat in the context of obesity. PRADC1 is dispensable for whole-body metabolism when mice are fed a low-fat diet. However, in obesity induced by high-fat feeding, PRADC1-deficient female mice have reduced weight gain and adiposity despite similar caloric intake. Decreased fat mass is attributed, in part, to increased metabolic rate, physical activity, and energy expenditure in these animals. Reduced adiposity in PRADC1-deficient mice, however, does not improve systemic glucose and lipid metabolism, insulin sensitivity, liver steatosis, or adipose inflammation. Thus, in PRADC1-deficient animals, decreased fat mass and enhanced physical activity are insufficient to confer a healthy metabolic phenotype in the context of an obesogenic diet. Our results shed light on the physiologic function of PRADC1 and the complex regulation of metabolic health.	[Rodriguez, Susana; Stewart, Ashley N.; Lei, Xia; Cao, Xi; Little, Hannah C.; Sarver, Dylan C.; Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA; [Rodriguez, Susana; Stewart, Ashley N.; Lei, Xia; Cao, Xi; Little, Hannah C.; Sarver, Dylan C.; Wong, G. William] Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA; [Fong, Vincent] Johns Hopkins Univ, Dept Med, Div Endocrinol, Baltimore, MD 21205 USA; [Cao, Xi] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Capital Medical University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.; Wong, GW (corresponding author), Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu			U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK084171]; American Diabetes Association [1-18-PMF-022]; Ford Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); Ford Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Susan Aja (Department of Neuroscience and Center for Metabolism and Obesity Research, Johns Hopkins University) for help with indirect calorimetry and Andrew Wolfe for help with multiplex quantification of thyroid hormones. This work was supported by a grant from the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (DK084171 to G.W.W.). S.R. was supported by a postdoctoral fellowship from the American Diabetes Association (1-18-PMF-022). A.N.S. was sup-ported by a predoctoral fellowship from the Ford Foundation. The authors declare no conflicts of interest.	Bradley David, 2012, Gastroenterology, V143, P897, DOI 10.1053/j.gastro.2012.07.114; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Lei X, 2017, J BIOL CHEM, V292, P14836, DOI [10.1074/jbc.m116.766808, 10.1074/jbc.M116.766808]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mauvais-Jarvis F, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0033-y; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Pandey A, 2015, DIABETES CARE, V38, P1494, DOI 10.2337/dc14-2378; Petersen PS, 2017, AM J PHYSIOL-ENDOC M, V312, pE309, DOI 10.1152/ajpendo.00344.2016; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rodriguez S, 2016, AM J PHYSIOL-ENDOC M, V311, pE678, DOI 10.1152/ajpendo.00087.2016; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varlamov Oleg, 2014, Front Endocrinol (Lausanne), V5, P241, DOI 10.3389/fendo.2014.00241; Vitola BE, 2009, OBESITY, V17, P1744, DOI 10.1038/oby.2009.171; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhou B, 2004, FEBS LETT, V576, P401, DOI 10.1016/j.febslet.2004.09.039	23	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14748	14759		10.1096/fj.201901279R	http://dx.doi.org/10.1096/fj.201901279R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689374	Bronze, Green Published			2022-12-26	WOS:000507466100129
J	Izquierdo-Lara, R; Chumbe, A; Calderon, K; Fernandez-Diaz, M; Vakharia, VN				Izquierdo-Lara, Ray; Chumbe, Ana; Calderon, Katherine; Fernandez-Diaz, Manolo; Vakharia, Vikram N.			Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design	PLOS ONE			English	Article							FUSION PROTEIN; GENETIC DIVERSITY; EXPRESSION; TROPISM; GENOME; DOMAIN	Although typical Newcastle disease virus (NDV) vaccines can prevent mortality, they are not effective in preventing viral shedding. To overcome this, genotype-matched vaccines have been proposed. To date, this approach has never been tested against genotype XII strains. In this study, we generated and assessed the protection against genotype XII challenge of two chimeric NDV vaccine strains (rLS1-XII-1 and rLS1-XII-2). The rLS1-XII-1 virus has the complete fusion protein (F) and the hemagglutinin-neuraminidase (HN) open reading frames replaced with those from genotype XII strain NDV/peacock/Peru/2011 (PP2011) in a recombinant LaSota (rLS1) backbone. In rLS1-XII-2 virus, cytoplasmic tails of F and HN proteins were restored to those of rLS1. In vitro evaluation showed that rLS1-XII-2 and the parental rLS1 strains replicate at higher efficiencies than rLS1-XII-1. In the first vaccine/challenge experiment, SPF chickens vaccinated with rLS1-XII-1 virus showed only 71.3% protection, whereas, rLS1 and rLS1-XII-2 vaccinated chickens were fully protected. In a second experiment, both rLS1-XII-2 and the commercial vaccine strain LaSota induced 100% protection. However, rLS1-XII-2 virus significantly reduced viral shedding, both in the number of shedding birds and in quantity of shed virus. In conclusion, we have developed a vaccine candidate capable of fully protecting chickens against genotype XII challenges. Furthermore, we have shown the importance of cytoplasmic tails in virus replication and vaccine competence.	[Izquierdo-Lara, Ray; Chumbe, Ana; Calderon, Katherine; Fernandez-Diaz, Manolo] FARVET SAC, Chincha Alta, Ica, Peru; [Izquierdo-Lara, Ray; Chumbe, Ana] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima, Peru; [Vakharia, Vikram N.] Univ Maryland Baltimore Cty, Inst Marine & Environm Technol, Baltimore, MD 21228 USA	Universidad Nacional Mayor de San Marcos; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University of Maryland Baltimore County	Izquierdo-Lara, R (corresponding author), FARVET SAC, Chincha Alta, Ica, Peru.; Izquierdo-Lara, R (corresponding author), Univ Nacl Mayor San Marcos, Sch Vet Med, Lima, Peru.	ray.izquierdo@unmsm.edu.pe		Izquierdo Lara, Ray William/0000-0001-9912-6970; Vakharia, Vikram/0000-0002-0955-3010; Calderon Mayo, Katherine Ivette/0000-0002-7461-8335	Peruvian Science and Technology Program (FINCyT) [ITAI-2-P-050-009-15]	Peruvian Science and Technology Program (FINCyT)	This study was partially funded by the Peruvian Science and Technology Program (FINCyT) contract no ITAI-2-P-050-009-15. There was no additional external funding received for this study.	Bian X, 2018, J BANK FINANC, V92, P1, DOI 10.1016/j.jbankfin.2018.04.006; Cho SH, 2008, CLIN VACCINE IMMUNOL, V15, P1572, DOI 10.1128/CVI.00156-08; Chumbe A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00792-15; Chumbe A, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0900-8; Chumbe A, 2017, AVIAN DIS, V61, P16, DOI 10.1637/11456-062016-Reg; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Diel DG, 2012, J CLIN MICROBIOL, V50, P378, DOI 10.1128/JCM.06018-11; Dolganiuc V, 2003, J VIROL, V77, P12968, DOI 10.1128/JVI.77.24.12968-12979.2003; Dortmans JCFM, 2012, VET MICROBIOL, V160, P17, DOI 10.1016/j.vetmic.2012.05.003; Hines Nichole L, 2012, Vet Med Int, V2012, P708216, DOI 10.1155/2012/708216; Hu ZL, 2011, AVIAN DIS, V55, P391, DOI 10.1637/9633-122410-Reg.1; Kai Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0366-5; Kim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074022; Kim SH, 2011, J VIROL, V85, P8582, DOI 10.1128/JVI.00652-11; Kim SH, 2009, J VIROL, V83, P10250, DOI 10.1128/JVI.01038-09; Kim SK, 2017, PLOS ONE, V12, P3; Liu HJ, 2018, VACCINE, V36, P3917, DOI 10.1016/j.vaccine.2018.05.074; Liu HL, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00129-12; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; OGASAWARA T, 1992, EMBO J, V11, P467, DOI 10.1002/j.1460-2075.1992.tb05076.x; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; Peeters BPH, 2000, ARCH VIROL, V145, P1829, DOI 10.1007/s007050070059; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Perozo F, 2008, AVIAN PATHOL, V37, P237, DOI 10.1080/03079450802043734; Samal S, 2013, J VIROL, V87, P10083, DOI 10.1128/JVI.01446-13; Snoeck CJ, 2013, J CLIN MICROBIOL, V51, P2250, DOI 10.1128/JCM.00684-13; Wajid A, 2018, TROP ANIM HEALTH PRO, V50, P1645, DOI 10.1007/s11250-018-1607-6; World Organization for Animal Health, 2012, TERR MAN; Xiao S, 2012, PLOS ONE, V12; Le XTK, 2018, ARCH VIROL, V163, P3125, DOI 10.1007/s00705-018-3961-0; Zhao H, 2003, J GEN VIROL, V84, P781, DOI 10.1099/vir.0.18884-0	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0209539	10.1371/journal.pone.0209539	http://dx.doi.org/10.1371/journal.pone.0209539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725727	Green Submitted, gold, Green Published			2022-12-26	WOS:000532764500001
J	Loux, SC; Dini, P; Ali, HES; Kalbfleisch, T; Ball, BA				Loux, Shavahn C.; Dini, Pouya; Ali, Hossam El-Sheikh; Kalbfleisch, Theodore; Ball, Barry A.			Characterization of the placental transcriptome through mid to late gestation in the mare	PLOS ONE			English	Article							ENDOMETRIAL CUP REACTION; GENE-EXPRESSION; PRETERM LABOR; INVASIVE TROPHOBLAST; ALPHA-FETOPROTEIN; FETAL INTERFACE; AMNIOTIC-FLUID; EQUINE; PREGNANCY; PLASMA	The placenta is a dynamic organ which undergoes extensive remodeling throughout pregnancy to support, protect and nourish the developing fetus. Despite the importance of the placenta, very little is known about its gene expression beyond very early pregnancy and post-partum. Therefore, we utilized RNA-sequencing to characterize the transcriptome from the fetal (chorioallantois) and maternal (endometrium) components of the placenta from mares throughout gestation (4, 6, 10, 11 m). Within the endometrium, 47% of genes changed throughout pregnancy, while in the chorioallantois, 29% of genes underwent significant changes in expression. Further bioinformatic analyses of both differentially expressed genes and highly expressed genes help reveal similarities and differences between tissues. Overall, the tissues were more similar than different, with similar to 95% of genes expressed in both tissues, and high similarities between the most highly expressed genes (9/20 conserved), as well as marked similarities between the PANTHER pathways identified. The most highly expressed genes fell under a few broad categories, including endocrine and immune-related transcripts, iron-binding proteins, extracellular matrix proteins, transport proteins and antioxidants. Serine protease inhibitors were particularly abundant, including SERPINA3, 6 and 14, as well as SPINK7 and 9. This paper also demonstrates the ability to effectively separate maternal and fetal components of the placenta, with only a minimal amount of chorioallantoic contamination in the endometrium (similar to 8%). This aspect of equine placentation is a boon for better understanding gestational physiology and allows the horse to be used in areas where a separation of fetal and maternal tissues is essential. Overall, these data represent the first large-scale characterization of placental gene expression in any species and include time points from multiple mid- to late-gestational stages, helping further our understanding of gestational physiology.	[Loux, Shavahn C.; Dini, Pouya; Ali, Hossam El-Sheikh; Kalbfleisch, Theodore; Ball, Barry A.] Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Lexington, KY 40506 USA; [Dini, Pouya] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Ali, Hossam El-Sheikh] Univ Mansoura, Fac Vet Med, Theriogenol Dept, Mansoura, Egypt	University of Kentucky; Ghent University; Egyptian Knowledge Bank (EKB); Mansoura University	Ball, BA (corresponding author), Univ Kentucky, Dept Vet Sci, Maxwell H Gluck Equine Res Ctr, Lexington, KY 40506 USA.	b.a.ball@uky.edu	Ali, Hossam El-Sheikh/A-2940-2012; Kalbfleisch, Theodore/AAN-5407-2021; Dini, Pouya/AAR-3722-2020	Ali, Hossam El-Sheikh/0000-0003-1677-488X; Dini, Pouya/0000-0001-5553-5967; Kalbfleisch, Theodore/0000-0002-2370-8189; Loux, Shavahn/0000-0001-5193-6675	Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners; Albert Clay Endowment	Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners; Albert Clay Endowment	This work was funded by the Kentucky Thoroughbred Association/Kentucky Thoroughbred Breeders and Owners and the Albert Clay Endowment. The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2009, PLACENTA, V30, P1005, DOI 10.1016/j.placenta.2009.09.007; Allen WRT, 2017, PLACENTA, V50, P53, DOI 10.1016/j.placenta.2016.12.024; ALLEN WR, 1982, J REPROD FERTIL, P57; ALLEN WR, 1973, ANAT REC, V177, P485, DOI 10.1002/ar.1091770403; Almeida J, 2011, REPRODUCTION, V141, P841, DOI 10.1530/REP-10-0499; Antczak DF, 2013, ANNU REV ANIM BIOSCI, V1, P419, DOI 10.1146/annurev-animal-031412-103703; Arthur G.H., 1969, J REPROD FERTIL S, V9, P45; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Brosnahan MM, 2012, J IMMUNOL, V188, P4181, DOI 10.4049/jimmunol.1103509; Bujold E, 2008, J MATERN-FETAL NEO M, V21, P697, DOI 10.1080/14767050802053289; BULMER JN, 1991, HUM REPROD, V6, P791, DOI 10.1093/oxfordjournals.humrep.a137430; Canisso IF, 2017, EQUINE VET J, V49, P244, DOI 10.1111/evj.12556; Canisso IF, 2015, ANIM REPROD SCI, V154, P48, DOI 10.1016/j.anireprosci.2014.12.019; Canisso IF, 2014, AM J REPROD IMMUNOL, V72, P376, DOI 10.1111/aji.12278; Conley AJ, 2016, THERIOGENOLOGY, V86, P355, DOI 10.1016/j.theriogenology.2016.04.049; Dini P, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5341-2; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DOUGLAS RH, 1975, J REPROD FERTIL, P503; GRUNIG G, 1995, PLACENTA, V16, P539, DOI 10.1016/S0143-4004(05)80005-0; HOLTAN DW, 1975, J REPROD FERTIL, P419; Iqbal K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113928; Kalbfleisch TS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0199-z; Kisielewska K, 2019, J ANIM SCI, V97, P851, DOI 10.1093/jas/sky458; Klein C, 2016, REPROD FERT DEVELOP, V28, P1712, DOI 10.1071/RD14489; Klein C, 2016, DOMEST ANIM ENDOCRIN, V56, pS212, DOI 10.1016/j.domaniend.2016.03.006; Klein C, 2016, THERIOGENOLOGY, V86, P451, DOI 10.1016/j.theriogenology.2016.04.061; KNOX RV, 1994, ENDOCRINOLOGY, V135, P2517, DOI 10.1210/en.135.6.2517; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Legacki EL, 2017, REPRODUCTION, V154, P445, DOI [10.1530/REP-17-0239, 10.1530/rep-17-0239]; Legacki EL, 2016, REPRODUCTION, V151, P421, DOI 10.1530/REP-15-0547; Loux SC, 2018, PLACENTA, V64, P71, DOI 10.1016/j.placenta.2018.03.004; Loux SC, 2017, REPRODUCTION, V153, P197, DOI 10.1530/REP-16-0396; Loux SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175045; Majewska M, 2017, FUNCT INTEGR GENOMIC, V17, P551, DOI 10.1007/s10142-017-0555-y; Marshall DE, 1996, J STEROID BIOCHEM, V59, P281, DOI 10.1016/S0960-0760(96)00115-X; Merkl M, 2010, BIOL REPROD, V83, P874, DOI 10.1095/biolreprod.110.085233; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; MITCHELL D, 1973, VET REC, V93, P365, DOI 10.1136/vr.93.13.365; Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001; Read JE, 2018, REPRODUCTION, V156, P313, DOI 10.1530/REP-18-0270; Reinholt BM, 2017, GEN COMP ENDOCR, V247, P174, DOI 10.1016/j.ygcen.2017.01.030; Romero R, 2008, J MATERN-FETAL NEO M, V21, P367, DOI 10.1080/14767050802045848; Romero R, 2014, AM J REPROD IMMUNOL, V71, P330, DOI 10.1111/aji.12189; ROSSDALE P, 1973, RES VET SCI, V15, P395, DOI 10.1016/S0034-5288(18)33820-7; Salomon C, 2017, PROG MOL BIOL TRANSL, V145, P163, DOI 10.1016/bs.pmbts.2016.12.006; SAMUEL CA, 1976, J REPROD FERTIL, V48, P257, DOI 10.1530/jrf.0.0480257; SAMUEL CA, 1975, J REPROD FERTIL, P575; Scaravaggi I, 2019, REPROD FERT DEVELOP, V31, P496, DOI 10.1071/RD18144; Silver M, 1976, Adv Exp Med Biol, V75, P731; Smits K, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136432; STEVEN DH, 1982, J REPROD FERTIL, P41; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Tong M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023028; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vincze B, 2015, THERIOGENOLOGY, V84, P1581, DOI 10.1016/j.theriogenology.2015.08.006; Wang X, 2013, P NATL ACAD SCI USA, V110, P10705, DOI 10.1073/pnas.1308998110; Wang X, 2012, GENOME RES, V22, P1855, DOI 10.1101/gr.138487.112; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Wu ZH, 2019, J INVEST DERMATOL, V139, P1135, DOI 10.1016/j.jid.2018.11.004; Yamanouchi K, 1997, MOL REPROD DEV, V47, P363, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;363::AID-MRD2&gt;3.0.CO;2-I; Zhang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158655	62	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224497	10.1371/journal.pone.0224497	http://dx.doi.org/10.1371/journal.pone.0224497			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725741	gold, Green Published			2022-12-26	WOS:000532764500017
J	Palomino, E; Lapez-Frutos, JM; Sotillo, M				Palomino, Elena; Maria Lopez-Frutos, Jose; Sotillo, Maria			Operation of cognitive memory inhibition in adults with Down syndrome: Effects of maintenance load and material	PLOS ONE			English	Article							WORKING-MEMORY; SHORT-TERM; RETROACTIVE INTERFERENCE; EXECUTIVE FUNCTION; CHILDREN; FACES; INDIVIDUALS; RECOGNITION; CAPACITY; WILLIAMS	Background Cognitive inhibition is one of the executive functions; this process over memory plays a fundamental role in recalling relevant information. The aims of this study were to understand the effects of maintenance load and stimuli on the operation of cognitive inhibition over memory in working memory tasks in adults with Down syndrome. Method The study included 36 individuals with Down syndrome (mean age = 33.44 years, standard deviation = 7.54 years, 50% women) and 36 individuals with neurotypical development (mean age = 33.55 years, standard deviation = 7.52 years, 50% women). The participants performed a working memory task in which they had to solve an interference problem during the maintenance phase. Results The Down syndrome group performed worse on cognitive inhibition over memory than the neurotypical development group. Both groups had lower recall with interference and under high-load conditions. In the neurotypical development group, memory was similar with both materials. The Down syndrome group performed better with non-social stimuli than with social stimuli. Conclusions Understanding the variables that influence cognitive inhibition over memory will help in planning effective interventions for people with Down syndrome. Considering the results, special importance should be placed on work with social stimuli, at least in individuals with Down syndrome.	[Palomino, Elena; Maria Lopez-Frutos, Jose; Sotillo, Maria] Autonomous Univ Madrid, Fac Psychol, Dept Basic Psychol, Madrid, Spain	Autonomous University of Madrid	Palomino, E (corresponding author), Autonomous Univ Madrid, Fac Psychol, Dept Basic Psychol, Madrid, Spain.	elena.palomino@inv.uam.es	Sotillo, Maria/N-4947-2014; Lopez Frutos, Jose Maria/E-1046-2012	Sotillo, Maria/0000-0002-9602-9216; Lopez Frutos, Jose Maria/0000-0001-6095-4736; Palomino Plaza, Elena/0000-0002-3455-4912	Autour des Williams [10.06.01.0050]	Autour des Williams	This work received funding from Autour des Williams, Code 10.06.01.0050 to JMLF and MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M. C., 2011, SUCCESSFUL REMEMBERI, P107; Annaz D, 2009, J EXP CHILD PSYCHOL, V102, P456, DOI 10.1016/j.jecp.2008.11.005; [Anonymous], 2000, HDB PSYCHIAT MEASURE; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; AZARI NP, 1994, BRAIN LANG, V46, P1, DOI 10.1006/brln.1994.1001; Baddeley A, 2007, J INTELL DISABIL RES, V51, P925, DOI 10.1111/j.1365-2788.2007.00979.x; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Belacchi C, 2014, RES DEV DISABIL, V35, P1027, DOI 10.1016/j.ridd.2014.01.036; Bezdjian S, 2009, BRIT J DEV PSYCHOL, V27, P365, DOI 10.1348/026151008X314919; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Carney DPJ, 2013, RES DEV DISABIL, V34, P46, DOI 10.1016/j.ridd.2012.07.013; Cavallini E, 2003, ARCH GERONTOL GERIAT, V37, P241, DOI 10.1016/S0167-4943(03)00063-3; Cebula KR, 2008, INT REV RES MENT RET, V35, P43, DOI 10.1016/S0074-7750(07)35002-7; Charbonnier L, 2016, APPETITE, V96, P166, DOI 10.1016/j.appet.2015.08.041; Cheung OS, 2010, J EXP PSYCHOL HUMAN, V36, P448, DOI 10.1037/a0016471; Clapp WC, 2010, CEREB CORTEX, V20, P859, DOI 10.1093/cercor/bhp150; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Cowan N, 2017, PSYCHON B REV, V24, P1158, DOI 10.3758/s13423-016-1191-6; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Danielsson H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01230; DAS JP, 1995, RES DEV DISABIL, V16, P11, DOI 10.1016/0891-4222(94)00032-5; DEFFENBACHER KA, 1981, J EXP PSYCHOL-HUM L, V7, P299, DOI 10.1037/0278-7393.7.4.299; Devenny DA, 2004, DEV NEUROPSYCHOL, V26, P691, DOI 10.1207/s15326942dn2603_3; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; DOBSON E, 1994, J PSYCHOL, V128, P315, DOI 10.1080/00223980.1994.9712735; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Esbensen AJ, 2008, AM J MENT RETARD, V113, P263, DOI 10.1352/0895-8017(2008)113[263:SACIHF]2.0.CO;2; Foroni F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00051; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Ghezzo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113111; Gilchrist AL, 2008, MEMORY, V16, P773, DOI 10.1080/09658210802261124; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hawkins BA, 2003, MENT RETARD, V41, P7, DOI 10.1352/0047-6765(2003)041<0007:ABACFO>2.0.CO;2; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Holland JW, 2009, FOOD SCI TECH-INT SE, P107; Jarrold C, 1997, Cogn Neuropsychiatry, V2, P101, DOI 10.1080/135468097396351; Jarrold C, 1999, NEUROPSYCHOLOGIA, V37, P637, DOI 10.1016/S0028-3932(98)00128-6; Lanfranchi S, 2004, AM J MENT RETARD, V109, P456, DOI 10.1352/0895-8017(2004)109<456:VAVWMD>2.0.CO;2; Lanfranchi S, 2009, CHILD NEUROPSYCHOL, V15, P397, DOI 10.1080/09297040902740652; Lustig C, 2001, J EXP PSYCHOL GEN, V130, P199, DOI 10.1037//0096-3445.130.2.199; May CP, 1999, MEM COGNITION, V27, P759, DOI 10.3758/BF03198529; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; O'Hearn K, 2009, BRAIN COGNITION, V69, P495, DOI 10.1016/j.bandc.2008.10.004; Oberauer K, 2018, PSYCHOL BULL, V144, P885, DOI 10.1037/bul0000153; Palomino E, SPAN J PSYCHOL; Patterson D, 2007, MENT RETARD DEV D R, V13, P199, DOI 10.1002/mrdd.20162; PEARLSON GD, 1990, AM J NEURORADIOL, V11, P811; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pitcairn TK, 2000, PERCEPTUAL-MOTOR BEHAVIOR IN DOWN SYNDROME, P123; Porter MA, 2007, NEUROPSYCHOLOGIA, V45, P2839, DOI 10.1016/j.neuropsychologia.2007.05.006; Psychology Software Tools, 2012, PSYCHOL SOFTWARE TOO; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Richler JJ, 2014, PSYCHOL BULL, V140, P1281, DOI 10.1037/a0037004; Roth M., 1998, CAMBRIDGE EXAMINATIO; Rowe J, 2006, BRIT J CLIN PSYCHOL, V45, P5, DOI 10.1348/014466505X29594; Solesio-Jofre E, 2012, J GERONTOL A-BIOL, V67, P565, DOI 10.1093/gerona/glr199; Solesio-Jofre E, 2011, BIOL PSYCHOL, V88, P72, DOI 10.1016/j.biopsycho.2011.06.011; Turk J, 1998, J INTELL DISABIL RES, V42, P490, DOI 10.1046/j.1365-2788.1998.4260490.x; WANG PP, 1994, J CLIN EXP NEUROPSYC, V16, P317, DOI 10.1080/01688639408402641; Wechsler D., 2003, WECHSLER MEMORY SCAL; Wechsler D., 2012, WAIS 4 KASIKIRJA; Williams KR, 2005, AM J MENT RETARD, V110, P378, DOI 10.1352/0895-8017(2005)110[378:ERBCWD]2.0.CO;2; Wishart JG, 2007, J INTELL DISABIL RES, V51, P996, DOI 10.1111/j.1365-2788.2007.01007.x; Wishart JG, 2007, J INTELL DISABIL RES, V51, P551, DOI 10.1111/j.1365-2788.2006.00947.x; Wishart JG, 2000, AM J MENT RETARD, V105, P466, DOI 10.1352/0895-8017(2000)105<0466:ROIAEI>2.0.CO;2; Yang YY, 2014, RES DEV DISABIL, V35, P1473, DOI 10.1016/j.ridd.2014.04.002; Zacks R. T., 2000, HDB AGING COGNITION, V2nd, P293, DOI DOI 10.3758/S13423-011-0086-9; Zigman WB, 2013, DEV DISABIL RES REV, V18, P51, DOI 10.1002/ddrr.1128	72	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225009	10.1371/journal.pone.0225009	http://dx.doi.org/10.1371/journal.pone.0225009			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2HK	31725777	Green Published, gold			2022-12-26	WOS:000532764500043
J	Hochhausen, N; Orschulik, J; Follmann, A; Santos, SA; Dohmeier, H; Leonhardt, S; Rossaint, R; Czaplik, M				Hochhausen, Nadine; Orschulik, Jakob; Follmann, Andreas; Santos, Susana Aguiar; Dohmeier, Henriette; Leonhardt, Steffen; Rossaint, Rolf; Czaplik, Michael			Comparison of two experimental ARDS models in pigs using electrical impedance tomography	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISTRESS; ANIMAL-MODELS; LUNG; MECHANISMS; OUTCOMES	Background Animal trials contribute to major achievements in medical science. The so-called lavage model is frequently used to evaluate ventilation strategies in acute respiratory distress syndrome (ARDS) using electrical impedance tomography (EIT). But, the lavage model itself might have systematic impacts on EIT parameters. Therefore, we established an additional experimental model, in which ARDS is caused by intravenously administered lipopolysaccharide (LPS). In this study, we want to examine if EIT measurements provide consistent results in both experimental models or whether the pathophysiology of the model influences the findings. Overall, we want to compare both experimental models regarding clinical parameters and EIT-derived indices, namely the global inhomogeneity (GI) index and the regional ventilation delay (RVD) index. Methods Nineteen pigs were included in this study, allocated to the control group (CO; n = 5), lavage group (LAV; n = 7) and LPS group (LPS; n = 7). After baseline measurements and the establishment of ARDS, assessment of respiratory mechanics, hemodynamics, gas exchange and EIT recordings were performed hourly over eight hours. Results In both experimental ARDS models, EIT measurements provided reliable results. But, the GI and the RVD index did not show consistent results as compared to the CO group. Initially, GI and RVD index were higher in the LAV group but not in the LPS group as compared to the CO group. This effect disappeared during the study. Furthermore, the GI index and the RVD index were higher in the LAV group compared to the LPS group in the beginning as well. This, once again, disappeared. Clinical lung injury parameters remained more stable when using LPS. Conclusion The two models showed quite different influences on the GI and RVD index. This implies, that the underlying pathophysiology affects EIT parameters and thus the findings. Hence, translation to EIT-guided clinical therapy in humans suffering from ARDS might be limited.	[Hochhausen, Nadine; Follmann, Andreas; Dohmeier, Henriette; Rossaint, Rolf; Czaplik, Michael] Rhein Westfal TH Aachen, Med Fac, Dept Anesthesiol, Aachen, Germany; [Orschulik, Jakob; Santos, Susana Aguiar; Leonhardt, Steffen] Rhein Westfal TH Aachen, Philips Chair Med Informat Technol, Aachen, Germany	RWTH Aachen University; Philips; Philips Healthcare; RWTH Aachen University	Hochhausen, N (corresponding author), Rhein Westfal TH Aachen, Med Fac, Dept Anesthesiol, Aachen, Germany.	nhochhausen@ukaachen.de	Leonhardt, Steffen/AAO-9082-2021	Leonhardt, Steffen/0000-0002-6898-6887	research grant ("Rotationsstelle") from the Medical Faculty of RWTH Aachen University, Germany; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [CZ 215/2-3, LE 817/20-3]	research grant ("Rotationsstelle") from the Medical Faculty of RWTH Aachen University, Germany; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG))	This work was funded by a research grant ("Rotationsstelle") from the Medical Faculty of RWTH Aachen University, Germany-NO to NH. The authors gratefully acknowledge financial support provided by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG) CZ 215/2-3, LE 817/20-3)-NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; ASHBAUGH DG, 1967, LANCET, V2, P319; Ballard-Croft C, 2012, ANN THORAC SURG, V93, P1331, DOI 10.1016/j.athoracsur.2011.06.107; Bannerman DD, 2003, AM J PHYSIOL-LUNG C, V284, pL899, DOI 10.1152/ajplung.00338.2002; Becher T, 2017, PHYSL MEAS; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blankman P, 2014, CRIT CARE, V18, DOI 10.1186/cc13866; Costa ELV, 2009, INTENS CARE MED, V35, P1132, DOI 10.1007/s00134-009-1447-y; Frerichs I, 2017, THORAX, V72, P83, DOI 10.1136/thoraxjnl-2016-208357; Gomez-Laberge C, 2013, PHYSIOL MEAS, V34, P163, DOI 10.1088/0967-3334/34/2/163; Hochhausen N, 2017, RESP CARE, V62, P340, DOI 10.4187/respcare.05060; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Lobo B, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.06; Lowhagen K, 2010, MINERVA ANESTESIOL, V76, P1024; Nanchal RS, 2018, F1000RESEARCH, V7; Reifferscheid F, 2011, RESPIROLOGY, V16, P523, DOI 10.1111/j.1440-1843.2011.01929.x; Rocco PRM, 2016, INTENS CARE MED, V42, P806, DOI 10.1007/s00134-016-4268-9; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Russ M, 2016, JOVE-J VIS EXP, DOI 10.3791/53610; Santos SA, 2018, RESP PHYSIOL NEUROBI, V254, P1, DOI 10.1016/j.resp.2018.03.016; Umbrello  M., 2016, INT J MOL SCI, V18; van Genderingen Huibert R, 2003, Intensive Care Med, V29, P233; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wrigge H, 2008, CRIT CARE MED, V36, P903, DOI 10.1097/CCM.0B013E3181652EDD; Zhao Y, 2010, INT J INNOV MANAG, V14, P1, DOI 10.1142/S1363919610002520; Zhao Z, 2009, IFMBE PROC, V22, P256; Zhao Zhanqi, 2014, BMC Res Notes, V7, P82, DOI 10.1186/1756-0500-7-82; Zhao ZQ, 2009, INTENS CARE MED, V35, P1900, DOI 10.1007/s00134-009-1589-y	29	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225218	10.1371/journal.pone.0225218	http://dx.doi.org/10.1371/journal.pone.0225218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721803	Green Published, gold			2022-12-26	WOS:000532720700046
J	Yuan, WH; Li, AFY; Hsu, HC; Hu, YS; Lee, RC				Yuan, Wei-Hsin; Li, Anna Fen-Yau; Hsu, Hui-Chen; Hu, Yong-Sin; Lee, Rheun-Chuan			Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CT; RESECTION; OUTCOMES	Objective Primary hepatic angiosarcoma (PHA) is extremely rare and most patients die within 12 months of diagnosis. The object of the study is to determine the association of initial clinical-radiological features and staging with outcomes in patients with PHA. Methods The medical records of adult patients with PHA were retrieved from an electronic medical record database and a pathology database and retrospectively reviewed. During 10 years, 22 eligible patients were included. Data extracted focused on the information before the first formal treatment with a pathological proof, including demographic characteristics, medical history, laboratory data, preliminary images, histopathological records, treatment, and follow-up survival period. Two radiologists blindly re-analyzed preliminary images of all 22 patients together and recorded tumor features and imaging stage based on the American Joint Committee on Cancer (AJCC) 8th edition tumor-node-metastasis (TNM) Staging System for hepatocellular carcinoma. A radiologist compiled the initial clinical data and preliminary image stage to analyze the association with patients' survival outcome. Results Higher aspartate aminotransferase (AST), higher total bilirubin (TB), lower albumin (ALB), longer prothrombin time (PT) and lower platelet count of serum relative to the normal reference range were more common in patients who survived. 90 days (all P < 0.05). Overall survival was much better in patients with single PHA than in those with other tumor patterns of multiple PHA (all P < 0.05). Overall survival determined by preliminary imaging showed significant differences between stage I and stage III (P = 0.044), stage I and stage IV (P = 0.011), and stage III and IV (P = 0.047). No patients were at stage II. Conclusions Initial serum levels of ALT, TB, ALB, and PT, platelet count, single mass in liver, and preliminary imaging staging could help predict survival outcomes of patients with PHA.	[Yuan, Wei-Hsin] Taipei Municipal Gan Dau Hosp, Div Radiol, Taipei Vet Gen Hosp, Taipei, Taiwan; [Yuan, Wei-Hsin; Li, Anna Fen-Yau; Hu, Yong-Sin; Lee, Rheun-Chuan] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Yuan, Wei-Hsin; Hu, Yong-Sin; Lee, Rheun-Chuan] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Li, Anna Fen-Yau] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan; [Hsu, Hui-Chen] Taiwan Adventist Hosp, Dept Med Imaging, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Yuan, WH (corresponding author), Taipei Municipal Gan Dau Hosp, Div Radiol, Taipei Vet Gen Hosp, Taipei, Taiwan.; Yuan, WH; Lee, RC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Yuan, WH; Lee, RC (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.	williamyuan.tw@gmail.com; rclee@vghtpe.gov.tw						Bruegel M, 2013, ABDOM IMAGING, V38, P745, DOI 10.1007/s00261-012-9967-2; Chaudhary P, 2015, EJSO-EUR J SURG ONC, V41, P1137, DOI 10.1016/j.ejso.2015.04.022; Chung YE, 2009, RADIOGRAPHICS, V29, P683, DOI 10.1148/rg.293085729; Dehal AN, 2018, J GASTROINTEST SURG, V22, P1764, DOI 10.1007/s11605-018-3777-y; Durand F, 2005, J HEPATOL, V42, pS100, DOI 10.1016/j.jhep.2004.11.015; Gaballah AH, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170039; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Huang IH, 2016, ONCOL LETT, V11, P3218, DOI 10.3892/ol.2016.4348; Huang NC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000816; Kalva SP, 2015, RADIOGRAPHICS, V35, P1618, DOI 10.1148/rg.2015140333; Kamath SM, 2015, J CANCER RES THER, V11, DOI 10.4103/0973-1482.146132; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kim HR, 2009, ANN ONCOL, V20, P780, DOI 10.1093/annonc/mdn702; Konstantinidis IT, 2018, J SURG ONCOL, V117, P886, DOI 10.1002/jso.24979; Koyama T, 2002, RADIOLOGY, V222, P667, DOI 10.1148/radiol.2223010877; Kuei A, 2015, WORLD J GASTROENTERO, V21, P8271, DOI 10.3748/wjg.v21.i27.8271; Lau EKC, 2019, J GASTROINTEST CANC, V50, P647, DOI 10.1007/s12029-018-0094-3; Lin YH, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0489-6; Ling WW, 2017, J MED ULTRASON, V44, P267, DOI 10.1007/s10396-016-0761-6; Murphy B J, 1989, Radiographics, V9, P307; Pan T, 2017, RADIOLOGY, V282, P259, DOI 10.1148/radiol.2016151807; Pickhardt PJ, 2015, EUR RADIOL, V25, P315, DOI 10.1007/s00330-014-3442-0; Pierce DB, 2018, AM J ROENTGENOL, V210, P175, DOI 10.2214/AJR.16.17573; Poon RTP, 2003, ANN SURG, V237, P376, DOI 10.1097/00000658-200303000-00012; Qiao Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-3996-3; Slebocki K, 2017, J COMPUT ASSIST TOMO, V41, P294, DOI 10.1097/RCT.0000000000000503; Wang HP, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008033; Weitz J, 2007, CANCER-AM CANCER SOC, V109, P1391, DOI 10.1002/cncr.22530; Wu CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004952; Zheng YW, 2014, J GASTROEN HEPATOL, V29, P906, DOI 10.1111/jgh.12506	30	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0225043	10.1371/journal.pone.0225043	http://dx.doi.org/10.1371/journal.pone.0225043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710641	gold, Green Published			2022-12-26	WOS:000532699900037
J	Cavaliere, E; Baulch, HM				Cavaliere, Emily; Baulch, Helen M.			Winter nitrification in ice-covered lakes	PLOS ONE			English	Article							NITROUS-OXIDE PRODUCTION; OXYGEN DEPLETION; COMMUNITY COMPOSITION; NITRIFYING BACTERIA; SURFACE WATERS; NITRATE UPTAKE; WASTE-WATER; DENITRIFICATION; RATES; AMMONIUM	With changes in ice cover duration, nutrient loading, and anoxia risk, it is important to understand the mechanisms that control nitrogen cycling and oxygen depletion in lakes through winter. Current understanding is largely limited to description of changes in chemistry, with few measurements of the processes driving winter changes, how they differ across lakes, and how they are impacted by under-ice conditions. Nitrification is a process which consumes oxygen and ammonium (NH4+), and supplies nitrate (NO3-). To date, nitrification has been measured under ice cover in only two lakes globally. Here, we used (NH4+)-N-15 enrichment to measure rates of pelagic nitrification in thirteen water bodies in two ecozones. Our work demonstrates ecologically important rates of nitrification can occur despite low water temperatures, impacting NH4+, NO3- and, most importantly, oxygen concentrations. However, high rates are not the norm. When, where and why is nitrification important in winter? We found that nitrification rates were highest in a eutrophic lake chain downstream of a wastewater treatment effluent (mean: 226.5 mu g N L-1 d(-1)), and in a semi-saline prairie lake (110.0 mu g N L-1 d(-1)). In the boreal shield, a eutrophic lake had nitrification rates exceeding those of an oligotrophic lake by 6-fold. Supplementing our results with literature data we found NH4+ concentrations were the strongest predictor of nitrification rates across lentic ecosystems in winter. Higher nitrification rates were associated with higher concentrations of NH4+, NO3- and nitrous oxide (N2O). While more work is required to understand the switch between high and low nitrification rates and strengthen our understanding of winter nitrogen cycling, this work demonstrates that high nitrification rates can occur in winter.	[Cavaliere, Emily; Baulch, Helen M.] Univ Saskatchewan, Sch Environm & Sustainabil, Global Inst Water Secur, Saskatoon, SK, Canada; [Cavaliere, Emily; Baulch, Helen M.] 11 Innovat Blvd, Saskatoon, SK, Canada	University of Saskatchewan; Global Institute for Water Security	Cavaliere, E (corresponding author), Univ Saskatchewan, Sch Environm & Sustainabil, Global Inst Water Secur, Saskatoon, SK, Canada.; Cavaliere, E (corresponding author), 11 Innovat Blvd, Saskatoon, SK, Canada.	emily.cavaliere@gmail.com		Baulch, Helen/0000-0001-9018-4998; Cavaliere, Emily/0000-0001-7456-6750	Natural Sciences and Engineering Research Council [418506201]; Global Institute for Water Security; University of Saskatchewan, School of Environment and Sustainability; NSERC; Environment Canada Science Horizons Program; Canada Excellence Research Chair Funding; Teacher-Scholar Doctoral Fellowship; School of Environment and Sustainability; University of Saskatchewan	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Global Institute for Water Security; University of Saskatchewan, School of Environment and Sustainability; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Environment Canada Science Horizons Program; Canada Excellence Research Chair Funding; Teacher-Scholar Doctoral Fellowship; School of Environment and Sustainability; University of Saskatchewan	The authors would like to acknowledge support of Natural Sciences and Engineering Research Council (HB; Discovery Grant - 418506201; http://www.nserc-crsng.gc.ca/), the Global Institute for Water Security (HB; https://www.usask.ca/water/), and the University of Saskatchewan, School of Environment and Sustainability (HB & EC; https://sens.usask.ca/) and the Teacher Scholar Doctoral Fellowship (EC; project. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.https://students.usask.ca/money/awards/graduateawards.php?award=301368GS04) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors would like to acknowledge support of NSERC (Discovery Grant to HMB), Environment Canada Science Horizons Program, the Global Institute for Water Security and Canada Excellence Research Chair Funding, the School of Environment and Sustainability, the University of Saskatchewan, and the Teacher-Scholar Doctoral Fellowship for funding this project. For their support and advice, we would like to thank Drs. Rebecca North, Angela Bedard-Haughn, John-Mark Davies, and Cherie Westbrook. We would like to thank the IISD-ELA-Ken Sandilands, for collection of the ELA water samples and chemistry data for us. Further, we would like to acknowledge the following individuals for their extensive technical assistance, particularly those that aided in field work that took place in the extreme cold of Saskatchewan winter: Bruce Johnson, Dell Bayne, Jay Bauer, Britni Brenna, Cameron Hoggarth, Erin Hillis, Victor Sit, Kim Gilmour, Navjot Kaur, Rosa Brannen, Dr. Michael Kehoe, Alyse Kambeitz, Dr. Lorne Doig, Katya Dobrovolskkava, Katy Nugent, Jeremy Kiss, Dr. Colin Whitfield, Sherry Olauson, Kate Wilson, Michelle Martel-Andre, Raea Gooding, Noel Galuschik, Zachary Keesey and all members of the Saskwatche Lab. The authors would like to acknowledge the useful and constructive feedback from anonymous reviewers that improved this work.	Allan RJ, 1980, SCI SERIES, V112; Allison FE, 1973, NITRIFICATION DEV SO, P230, DOI [10.1016/S0166-2481(08)70570-1, DOI 10.1016/S0166-2481(08)70570-1]; Andersson MGI, 2006, AQUAT MICROB ECOL, V42, P149, DOI 10.3354/ame042149; ARBABI M, 1974, WATER RESOUR RES, V10, P921, DOI 10.1029/WR010i005p00921; BARICA J, 1979, J FISH RES BOARD CAN, V36, P980, DOI 10.1139/f79-136; BARICA J, 1977, PROG WATER TECHNOL, V8, P313; Baulch HM, 2012, FRESHWATER BIOL, V57, P509, DOI 10.1111/j.1365-2427.2011.02720.x; BEDARD C, 1989, MICROBIOL REV, V53, P68; Bertilsson S, 2013, LIMNOL OCEANOGR, V58, P1998, DOI 10.4319/lo.2013.58.6.1998; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Canelhas MR, 2016, LIMNOL OCEANOGR, V61, pS78, DOI 10.1002/lno.10288; Carini SA, 2003, GEOMICROBIOL J, V20, P355, DOI 10.1080/01490450303900; Carini SA, 2010, CONT SHELF RES, V30, P1795, DOI 10.1016/j.csr.2010.08.001; Carini SA, 2008, LIMNOL OCEANOGR, V53, P2546, DOI 10.4319/lo.2008.53.6.2546; CARLUCCI AF, 1969, LIMNOL OCEANOGR, V14, P736, DOI 10.4319/lo.1969.14.5.0736; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; CATALAN J, 1992, CAN J FISH AQUAT SCI, V49, P945, DOI 10.1139/f92-105; Cavaliere E, 2018, BIOGEOCHEMISTRY, V137, P285, DOI 10.1007/s10533-018-0419-0; Cebron A, 2005, AQUAT MICROB ECOL, V41, P25, DOI 10.3354/ame041025; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Denfeld BA, 2018, LIMNOL OCEANOGR LETT, P1; Dodds WK, 2000, ECOSYSTEMS, V3, P574, DOI 10.1007/s100210000050; Ecological Stratification Working Group, 1995, NAT EC FRAM CAN; Elser JJ, 2002, HYDROBIOLOGIA, V481, P101, DOI 10.1023/A:1021217221004; Fair GM, 1939, SEWAGE WORKS J, V11, P445; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Frame CH, 2010, BIOGEOSCIENCES, V7, P2695, DOI 10.5194/bg-7-2695-2010; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Glibert PM, 2016, LIMNOL OCEANOGR, V61, P165, DOI 10.1002/lno.10203; GLIBERT PM, 1995, MAR ECOL PROG SER, V122, P27, DOI 10.3354/meps122027; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; Gribsholt B, 2005, LIMNOL OCEANOGR, V50, P1945, DOI 10.4319/lo.2005.50.6.1945; Gu BH, 2012, INT REV HYDROBIOL, V97, P233, DOI 10.1002/iroh.201111466; Guerrero MA, 1996, MAR ECOL PROG SER, V141, P183, DOI 10.3354/meps141183; Hampton SE, 2017, ECOL LETT, V20, P98, DOI 10.1111/ele.12699; Hosseini N, 2017, ENVIRON MODEL ASSESS, V22, P291, DOI 10.1007/s10666-016-9541-3; Hosseini N, 2017, WATER-SUI, V9, DOI 10.3390/w9030199; JORGENSEN KS, 1984, CAN J MICROBIOL, V30, P1073, DOI 10.1139/m84-167; Kehoe MJ, 2015, ENVIRON SCI TECHNOL, V49, P10984, DOI 10.1021/acs.est.5b00979; Kemp MJ, 2002, LIMNOL OCEANOGR, V47, P1380, DOI 10.4319/lo.2002.47.5.1380; KLINGENSMITH KM, 1983, APPL ENVIRON MICROB, V46, P1084, DOI 10.1128/AEM.46.5.1084-1092.1983; KNOWLES R, 1987, CAN J FISH AQUAT SCI, V44, P743, DOI 10.1139/f87-090; Leavitt PR, 2006, LIMNOL OCEANOGR, V51, P2262, DOI 10.4319/lo.2006.51.5.2262; Lewis WM, 2011, ENVIRON SCI TECHNOL, V45, P10300, DOI 10.1021/es202401p; Lomas MW, 1999, LIMNOL OCEANOGR, V44, P556, DOI 10.4319/lo.1999.44.3.0556; MAGNUSON JJ, 1985, ENVIRON BIOL FISH, V14, P241, DOI 10.1007/BF00002627; Masse S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213748; MATHIAS JA, 1980, CAN J FISH AQUAT SCI, V37, P185, DOI 10.1139/f80-024; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; Merbt SN, 2012, FEMS MICROBIOL LETT, V327, P41, DOI 10.1111/j.1574-6968.2011.02457.x; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Muller B, 2012, ENVIRON SCI TECHNOL, V46, P9964, DOI 10.1021/es301422r; O'Brien JM, 2007, BIOGEOCHEMISTRY, V84, P31, DOI 10.1007/s10533-007-9073-7; Pawlowicz R, 2008, LIMNOL OCEANOGR-METH, V6, P489, DOI 10.4319/lom.2008.6.489; Peng XF, 2016, J GEOPHYS RES-OCEANS, V121, P1667, DOI 10.1002/2015JC011455; Pernica P, 2017, INLAND WATERS, V7, P138, DOI 10.1080/20442041.2017.1296627; Pomeroy J. W., 2005, 1 U SASK CTR HYDR; Powers SM, 2017, LIMNOL OCEANOGR LETT, V2, P177, DOI 10.1002/lol2.10048; Powers SM, 2017, BIOGEOCHEMISTRY, V136, P119, DOI 10.1007/s10533-017-0382-1; R Core Team, 2021, R LANGUAGE ENV STAT; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Ribot M, 2012, FRESHW SCI, V31, P1057, DOI 10.1899/11-161.1; RYSGAARD S, 1994, LIMNOL OCEANOGR, V39, P1643, DOI 10.4319/lo.1994.39.7.1643; Saskatchewan Water Security Agency Agency SWS, 2015, SASK WAT SEC AG REG; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Sigman DM, 1997, MAR CHEM, V57, P227, DOI 10.1016/S0304-4203(97)00009-1; Small GE, 2013, LIMNOL OCEANOGR, V58, P276, DOI 10.4319/lo.2013.58.1.0276; Soued C, 2016, NAT GEOSCI, V9, P116, DOI 10.1038/NGEO2611; Souza AC, 2014, DEEP-SEA RES PT II, V102, P68, DOI 10.1016/j.dsr2.2013.12.017; Stark JM, 1996, BIOGEOCHEMISTRY, V35, P433, DOI 10.1007/BF02183035; Thamdrup B, 1998, AQUAT MICROB ECOL, V15, P191, DOI 10.3354/ame015191; van der Kamp G, 2008, CAN WATER RESOUR J, V33, P23, DOI 10.4296/cwrj3301023; Verpoorter C, 2014, GEOPHYS RES LETT, V41, P6396, DOI 10.1002/2014GL060641; WARD BB, 1987, DEEP-SEA RES, V34, P785, DOI 10.1016/0198-0149(87)90037-9; WARD BB, 1982, DEEP-SEA RES, V29, P247, DOI 10.1016/0198-0149(82)90112-1; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Young B, 2017, WATER RES, V111, P224, DOI 10.1016/j.watres.2016.12.050; Zeng J, 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Zhou HX, 2018, SCI TOTAL ENVIRON, V643, P225, DOI 10.1016/j.scitotenv.2018.06.100	84	12	13	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224864	10.1371/journal.pone.0224864	http://dx.doi.org/10.1371/journal.pone.0224864			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697768	gold, Green Published			2022-12-26	WOS:000532694400073
J	Mee , S; Bunney, BG; Fujimoto, K; Penner, J; Seward, G; Crowfoot, K; Bunney, WE; Reist, C				Mee, Steven; Bunney, Blynn G.; Fujimoto, Ken; Penner, John; Seward, Garrett; Crowfoot, Keeley; Bunney, William E.; Reist, Christopher			A study of psychological pain in substance use disorder and its relationship to treatment outcome	PLOS ONE			English	Article							MENTAL PAIN; PSYCHACHE; SUICIDALITY; DRUG	Substance Use Disorder (SUD) is a major public health concern affecting an estimated 22.5 million individuals in the United States. The primary aim of this study was to characterize psychological pain in a cohort of patients participating in outpatient treatment for SUD. A secondary aim was to determine the relationships between pre-treatment assessments of psychological pain, depression, anxiety and hopelessness with treatment retention time and completion rates. Data was analyzed from 289 patients enrolled in an outpatient community drug treatment clinic in Southern California, U.S. A previously determined threshold score on the Mee-Bunney Psychological Pain Assessment Scale (MBP) was utilized to group patients into high and low-moderate scoring subgroups. The higher pain group scored higher on measures of anxiety, hopelessness and depression compared to those in the low-moderate pain group. Additionally, patients scoring in the higher psychological pain group exhibited reduced retention times in treatment and more than two-fold increased odds of dropout relative to patients with lower pre-treatment levels of psychological pain. Among all assessments, the correlation between psychological pain and treatment retention time was strongest. To our knowledge, this is the first study to demonstrate that psychological pain is an important construct which correlates with relevant clinical outcomes in SUD. Furthermore, pre-treatment screening for psychological pain may help target higher-risk patients for clinical interventions aimed at improving treatment retention and completion rates.	[Mee, Steven; Penner, John; Seward, Garrett; Crowfoot, Keeley] Appl Innovat Psychiat, Los Alamitos, CA USA; [Bunney, Blynn G.; Bunney, William E.; Reist, Christopher] Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; [Fujimoto, Ken] Loyola Univ, Chicago, IL 60611 USA	University of California System; University of California Irvine; Loyola University Chicago	Reist, C (corresponding author), Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA.	creist@uci.edu						Andersson HW, 2018, SUBST ABUS-RES TREAT, V12, DOI 10.1177/1178221818760551; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Beck ATE N., J CONSULTING CLIN PS, V56, P893; Berlim MT, 2003, SUICIDE LIFE-THREAT, V33, P242, DOI 10.1521/suli.33.3.242.23220; Brorson HH, 2013, CLIN PSYCHOL REV, V33, P1010, DOI 10.1016/j.cpr.2013.07.007; Conejero I, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0893-z; Deane FP, 2012, J STUD ALCOHOL DRUGS, V73, P216, DOI 10.15288/jsad.2012.73.216; Decker KP, 2017, MIL MED, V182, DOI 10.7205/MILMED-D-15-00560; Guimaraes R, 2014, SOC PSYCH PSYCH EPID, V49, P405, DOI 10.1007/s00127-013-0751-6; Inserro A., 2018, FENTANYL DRIVING OVE; Koob GF, 2015, EUR J PHARMACOL, V753, P73, DOI 10.1016/j.ejphar.2014.11.044; Leenaars AA, 2010, SUICIDE LIFE-THREAT, V40, P476, DOI 10.1521/suli.2010.40.5.476; Linehan M, 1990, SCREENING SUCIDAL BE; Mee S, 2011, J PSYCHIATR RES, V45, P1504, DOI 10.1016/j.jpsychires.2011.06.011; Meerwijk EL, 2014, PSYCHOTHER PSYCHOSOM, V83, P62, DOI 10.1159/000348869; Meerwijk EL, 2013, BRAIN IMAGING BEHAV, V7, P245, DOI 10.1007/s11682-013-9234-3; National Institute on Drug Abuse, 2018, PRINC DRUG ADD TREAT, V3rd; National Institute on Drug Abuse (NIDA), 2018, PRINC DRUG ADD TREAT, VThird; Orbach I, 2003, ISR J PSYCHIATR REL, V40, P191; Orbach I, 2003, SUICIDE LIFE-THREAT, V33, P231, DOI 10.1521/suli.33.3.231.23213; Patterson AA, 2012, SUICIDE LIFE-THREAT, V42, P147, DOI 10.1111/j.1943-278X.2011.00078.x; Pompili M, 2008, SUICIDE LIFE-THREAT, V38, P116, DOI 10.1521/suli.2008.38.1.116; Reist C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177974; SAMHSA, 2016, TREATM EP DAT SETS T; SAMSHA, 2015, BEH HLTH BAR SUBST A; SHNEIDMAN ES, 1993, J NERV MENT DIS, V181, P145, DOI 10.1097/00005053-199303000-00001; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Soumani A, 2011, Psychiatriki, V22, P330; Stahler GJ, 2016, ADDICT BEHAV, V58, P129, DOI 10.1016/j.addbeh.2016.02.030; STARK MJ, 1992, CLIN PSYCHOL REV, V12, P93, DOI 10.1016/0272-7358(92)90092-M; Troister T, 2012, J CLIN PSYCHOL, V68, P1019, DOI 10.1002/jclp.21869; US Surgeon General R, 2016, FAC ADD AM FAC ADD S	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0216266	10.1371/journal.pone.0216266	http://dx.doi.org/10.1371/journal.pone.0216266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697679	gold, Green Published, Green Submitted			2022-12-26	WOS:000532694400003
J	Murphy, C; Poerio, G; Sormaz, M; Wang, HT; Vatansever, D; Allen, M; Margulies, DS; Jefferies, E; Smallwood, J				Murphy, Charlotte; Poerio, Giulia; Sormaz, Mladen; Wang, Hao-Ting; Vatansever, Deniz; Allen, Micah; Margulies, Daniel S.; Jefferies, Elizabeth; Smallwood, Jonathan			Hello, is that me you are looking for? A re-examination of the role of the DMN in social and self relevant aspects of off-task thought	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; EPISODIC MEMORY; MOTION ARTIFACT; MIND; EXPERIENCE; BRAIN; REPRESENTATION; DEACTIVATION; ORGANIZATION; STRATEGIES	Neural activity within the default mode network (DMN) is widely assumed to relate to processing during off-task states, however it remains unclear whether this association emerges from a shared role in self or social content that is common in these conditions. In the current study, we examine the possibility that the role of the DMN in ongoing thought emerges from contributions to specific features of off-task experience such as self-relevant or social content. A group of participants described their experiences while performing a laboratory task over a period of days. In a different session, neural activity was measured while participants performed Self/Other judgements (e.g., Does the word 'Honest' apply to you (Self condition) or Barack Obama (Other condition)). Despite the prominence of social and personal content in off-task reports, there was no association with neural activity during off-task trait adjective judgements. Instead, during both Self and Other judgements we found recruitment of caudal posterior cingulate cortex-a core DMN hub-was above baseline for individuals whose laboratory experiences were characterised as detailed. These data provide little support for a role of the DMN in self or other content in the off-task state and instead suggest a role in how on-going thought is represented.	[Murphy, Charlotte; Sormaz, Mladen; Wang, Hao-Ting; Vatansever, Deniz; Jefferies, Elizabeth; Smallwood, Jonathan] Univ York, Dept Psychol, York, N Yorkshire, England; [Poerio, Giulia] Univ Sheffield, Dept Psychol, Sheffield, S Yorkshire, England; [Allen, Micah] Univ Cambridge, Cambridge Psychiat, Cambridge, England; [Margulies, Daniel S.] ICM Hop Pitie Salpetriere, FRONTLAB, Paris, France	University of York - UK; University of Sheffield; University of Cambridge; UDICE-French Research Universities; Sorbonne Universite	Murphy, C (corresponding author), Univ York, Dept Psychol, York, N Yorkshire, England.	charlotte.murphy@york.ac.uk	Smallwood, Jonathan/ABE-8365-2020; Vatansever, Deniz/AAE-9766-2020	Vatansever, Deniz/0000-0002-2494-9945; Murphy, Charlotte/0000-0002-8992-8248; Wang, Hao-Ting/0000-0003-4078-2038; Poerio, Giulia/0000-0002-2343-5109; Allen, Micah/0000-0001-9399-4179	ERC; Volkswagen Foundation [Wandering Minds - 89440, 89439]; John Templeton Foundation [FLEXSEM-771863]	ERC(European Research Council (ERC)European Commission); Volkswagen Foundation(Volkswagen); John Templeton Foundation	This study was supported by awards to JS from the ERC (WANDERINGMINDS - 646927), the Volkswagen Foundation (Wandering Minds - 89440 and 89439) and the John Templeton Foundation, "Prospective Psychology Stage 2: A Research Competition". EJ was supported by grant FLEXSEM-771863 from the ERC.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Braga RM, 2015, NEUROSCIENTIST, V21, P540, DOI 10.1177/1073858415585730; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2013, TRENDS COGN SCI, V17, P648, DOI 10.1016/j.tics.2013.09.017; Bzdok D, 2015, NEUROIMAGE, V106, P55, DOI 10.1016/j.neuroimage.2014.11.009; Christoff K, 2016, NAT REV NEUROSCI, V17, P718, DOI 10.1038/nrn.2016.113; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Ciric R, 2017, NEUROIMAGE, V154, P174, DOI 10.1016/j.neuroimage.2017.03.020; Crittenden B, 2015, ELIFE, V4, DOI 10.7554/eLife.06481; Davey J, 2015, J NEUROSCI, V35, P15230, DOI 10.1523/JNEUROSCI.4705-14.2015; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gonzalez-Garcia C, 2018, ELIFE, V7, DOI 10.7554/eLife.36068; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Ho NSP, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116045; Hu CP, 2016, NEUROSCI BIOBEHAV R, V61, P197, DOI 10.1016/j.neubiorev.2015.12.003; Hulley SB., 2013, DESIGNING CLIN RES E, V4th ed., P79; Irish M, 2019, PSYCHOL RES-PSYCH FO, V83, P747, DOI 10.1007/s00426-018-1102-8; Kernbach JM, 2018, P NATL ACAD SCI USA, V115, P12295, DOI 10.1073/pnas.1804876115; Konishi M, 2017, COGNITION, V168, P16, DOI 10.1016/j.cognition.2017.06.006; Konishi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132209; Krieger-Redwood K, 2016, NEUROIMAGE, V141, P366, DOI 10.1016/j.neuroimage.2016.07.060; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mitchell J. P., 2015, J COGNITIVE NEUROSCI, V17, P1306, DOI [10.1162/, DOI 10.1162/]; Murphy C, 2019, NEUROIMAGE, V186, P487, DOI 10.1016/j.neuroimage.2018.11.009; Murphy C, 2018, NEUROIMAGE, V171, P393, DOI 10.1016/j.neuroimage.2018.01.017; O'Callaghan C, 2015, BRAIN COGNITION, V93, P1, DOI 10.1016/j.bandc.2014.11.001; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Quintana DS, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1761-4; Ramanan S, 2018, CORTEX, V106, P261, DOI 10.1016/j.cortex.2018.06.016; Richter FR, 2016, ELIFE, V5, DOI 10.7554/eLife.18260; Ruby FJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077554; Sanders JG, 2017, Q J EXP PSYCHOL, V70, P1053, DOI 10.1080/17470218.2016.1216573; Schooler JW, 2002, TRENDS COGN SCI, V6, P339, DOI 10.1016/S1364-6613(02)01949-6; Seli P, 2018, TRENDS COGN SCI, V22, P479, DOI 10.1016/j.tics.2018.03.010; Sestieri C, 2013, NEUROPSYCHOLOGIA, V51, P900, DOI 10.1016/j.neuropsychologia.2013.01.023; Smallwood J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152272; Smallwood J, 2015, ANNU REV PSYCHOL, V66, P487, DOI 10.1146/annurev-psych-010814-015331; Smallwood J, 2013, PSYCHOL BULL, V139, P519, DOI 10.1037/a0030010; Smallwood J, 2011, CONSCIOUS COGN, V20, P1120, DOI 10.1016/j.concog.2010.12.017; Song XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044423; Sormaz M, 2018, P NATL ACAD SCI USA, V115, P9318, DOI 10.1073/pnas.1721259115; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Stawarczyk D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016997; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vatansever D, 2017, P NATL ACAD SCI USA, V114, P12821, DOI 10.1073/pnas.1710521114; Wang HT, 2018, PSYCHOL SCI, V29, P56, DOI 10.1177/0956797617728727; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wong S, 2017, CORTEX, V91, P169, DOI 10.1016/j.cortex.2016.09.013; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	56	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0216182	10.1371/journal.pone.0216182	http://dx.doi.org/10.1371/journal.pone.0216182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697677	Green Published, gold, Green Accepted			2022-12-26	WOS:000532694400002
J	Stefaniak, M; Dmoch-Gajzlerska, E; Mazurkiewicz, B; Gajzlerska-Majewska, W				Stefaniak, Malgorzata; Dmoch-Gajzlerska, Ewa; Mazurkiewicz, Barbara; Gajzlerska-Majewska, Wanda			Maternal serum and cord blood leptin concentrations at delivery	PLOS ONE			English	Article							GESTATIONAL-AGE; PREGNANCY; OBESITY; BIRTH; ADIPONECTIN; OVERWEIGHT; ARTERIAL; WEIGHT; LIFE	Introduction Studies have demonstrated leptin involvement in the physiology and pathophysiology of pregnancy and suggest that leptin may be a prognostic marker for some complications of pregnancy although the association remains unclear. To date no studies have reported leptin reference intervals established in normal pregnancy, which could be used for interpreting the differences in leptin levels found in normal and pathological pregnancies. Objective To determine leptin concentrations at delivery, in maternal serum in normal pregnancy and in cord blood and to establish reference intervals for leptin. Material and methods The study was performed in 194 pregnant women without any comorbid health conditions. Leptin concentrations in maternal serum and in cord blood were measured by ELISA and subsequently analyzed by gestational age (weeks), maternal Body Mass Index (BMI), mode of delivery and infant gender and birth weight. For comparative analyses of normally distributed variables, parametric tests such as the Student-t were used to test the assumption of homogeneity or non-homogeneity of variance and a One-Way ANOVA when more than two groups were compared. The Pearson correlation coefficient was calculated to assess the correlation between normally distributed variables (p<0.05). The reference intervals for leptin were obtained by referring to the central 95% of laboratory test values. Results In normal pregnant women, the mean serum leptin concentration at delivery was 37.17 28.07 ng/mL and the established reference interval was 33.19-41.14 ng/mL. The mean leptin concentration in cord blood was 14.78 +/- 15.97 ng/mL and the established reference interval was 12.32-17.67 ng/mL. There was a statistically significant positive correlation between maternal serum and cord blood leptin concentrations (r = 0.37; p = 0.00). Mean leptin concentrations in cord blood increased with gestational age (p = 0.00). No statistically significant differences in maternal serum and cord blood leptin concentrations were found in regard to mode of delivery and neonatal gender. A statistically significant correlation was found between maternal serum leptin and third-trimester BMI (r = 0.22; p = 0.00), but there was no association between maternal BMI and cord blood leptin concentration. There was a statistically significant positive correlation between cord blood leptin concentration and birth weight (r = 0.23; p = 0.00). Conclusions Reference intervals for leptin in maternal serum and in cord blood established in normal pregnancy could be used in clinical practice for interpreting the differences in leptin concentrations found in normal pregnancy and in complications of pregnancy. The results indicate a strong association between maternal serum leptin levels and obesity and between cord blood leptin levels and birth weight.	[Stefaniak, Malgorzata; Dmoch-Gajzlerska, Ewa; Mazurkiewicz, Barbara] Med Univ Warsaw, Dept Obstet & Gynecol Didact, Fac Hlth Sci, Warsaw, Poland; [Gajzlerska-Majewska, Wanda] Med Univ Warsaw, Dept Obstet & Gynecol, Fac Med 1, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw	Stefaniak, M (corresponding author), Med Univ Warsaw, Dept Obstet & Gynecol Didact, Fac Hlth Sci, Warsaw, Poland.	malgorzata.stefaniak@wum.edu.pl	Stefaniak, Małgorzata/ABH-1735-2020; Dmoch-Gajzlerska, Ewa/V-4439-2018	Stefaniak, Małgorzata/0000-0002-0319-6067; Dmoch-Gajzlerska, Ewa/0000-0002-1244-6531	fund for scientific research and development projects selected on a highly competitive basis at the Faculty of Health Sciences, e Medical University of Warsaw [NZG/PM4/16]	fund for scientific research and development projects selected on a highly competitive basis at the Faculty of Health Sciences, e Medical University of Warsaw	The research was financed from the fund for scientific research and development projects selected on a highly competitive basis at the Faculty of Health Sciences, e Medical University of Warsaw (decision code: NZG/PM4/16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Atawi FS, 2004, SAUDI MED J, V25, P1617; [Anonymous], 2008, PERSPECTIVES J REFOR, V23, P3; Arendas K, 2008, J OBSTET GYNAECOL CA, V30, P477, DOI 10.1016/S1701-2163(16)32863-8; Butte NF, 1997, J CLIN ENDOCR METAB, V82, P1480; Carlhall S, 2018, ACTA OBSTET GYN SCAN, V97, P1248, DOI 10.1111/aogs.13380; Catov JM, 2007, AM J OBSTET GYNECOL, V196, p558e1; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Duan X. C., 2015, AM J PHYSIOL-HEART C, V308, pH603; Franco-Sena AB, 2015, CLIN ENDOCRINOL, V82, P127, DOI 10.1111/cen.12487; Garanty-Bogacka Barbara, 2003, Ginekol Pol, V74, P356; Gardosi J, 2009, BEST PRACT RES CL OB, V23, P741, DOI 10.1016/j.bpobgyn.2009.09.001; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Hardie L, 1997, CLIN ENDOCRINOL, V47, P101, DOI 10.1046/j.1365-2265.1997.2441017.x; Horovitz GL, 2010, DEFINING ESTABLISHIN, P30; Laml T, 2001, J SOC GYNECOL INVEST, V8, P43, DOI 10.1016/S1071-5576(00)00121-0; Lepercq J, 2001, J CLIN ENDOCR METAB, V86, P2409, DOI 10.1210/jc.86.6.2409; Logan CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149918; Mantzoros CS, 2009, PEDIATRICS, V123, P682, DOI 10.1542/peds.2008-0343; Marino-Ortega LA, 2015, INT J CLIN EXP MED, V8, P11260; Mellati AA, 2010, ARCH MED RES, V41, P26, DOI 10.1016/j.arcmed.2009.12.001; Misra VK, 2011, OBESITY, V19, P416, DOI 10.1038/oby.2010.172; Nuamah MA, 2004, ENDOCR J, V51, P177, DOI 10.1507/endocrj.51.177; Perez-Perez A, 2018, J CELL MOL MED, V22, P716, DOI 10.1111/jcmm.13369; Schubring C, 1998, HORM RES, V50, P276, DOI 10.1159/000023290; Schubring C, 1997, J CLIN ENDOCR METAB, V82, P1480, DOI 10.1210/jc.82.5.1480; Shroff MR, 2013, CLIN ENDOCRINOL, V78, P607, DOI 10.1111/cen.12029; Stang J, 2016, J ACAD NUTR DIET, V116, P677, DOI 10.1016/j.jand.2016.01.008; Su Pen-Hua, 2002, Acta Paediatrica Taiwanica, V43, P249; Tamura T, 1998, OBSTET GYNECOL, V91, P389, DOI 10.1016/S0029-7844(97)00670-4; Tessier DR, 2013, PLACENTA, V34, P205, DOI 10.1016/j.placenta.2012.11.035; Tsai PJ, 2004, CLIN ENDOCRINOL, V61, P88, DOI 10.1111/j.1365-2265.2004.02057.x; Valuniene M, 2007, MEDICINA-LITHUANIA, V43, P784, DOI 10.3390/medicina43100100; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Weyermann M, 2006, CLIN CHEM, V52, P2095, DOI 10.1373/clinchem.2006.071019; WHO, 2019, WHO WHO GLOB INFOBAS; Yoshimitsu N, 2000, OBSTET GYNECOL, V96, P342, DOI 10.1016/S0029-7844(00)00927-3	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224863	10.1371/journal.pone.0224863	http://dx.doi.org/10.1371/journal.pone.0224863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JO6FC	31697751	Green Published, gold			2022-12-26	WOS:000497672100001
J	Bajunirwe, F; Akakimpa, D; Tumwebaze, FP; Abongomera, G; Mugyenyi, PN; Kityo, CM				Bajunirwe, Francis; Akakimpa, Denis; Tumwebaze, Flora P.; Abongomera, George; Mugyenyi, Peter N.; Kityo, Cissy M.			Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study	PLOS ONE			English	Article							YOUNG-PEOPLE; SEXUAL-BEHAVIOR; MATERIAL DEPRIVATION; GENERAL-POPULATION; RISK BEHAVIOR; URBAN SLUMS; PREVENTION; TRENDS; PREVALENCE; INFECTION	Background In Uganda, the HIV epidemic is now mature and generalized. Recently, there have been reports of resurgence in the incidence of HIV after several years of successful control. The causes for this resurgence are not clear but suspected to be driven by structural factors that influence large groups of people rather than individuals. The aim of this study was to describe the structural drivers of the HIV epidemic in high prevalence regions and inform the next generation of interventions. Methodology We conducted a total of 35 focus group discussions in 11 districts in Uganda. Due to their high HIV prevalence, the districts had been selected to implement a donor supported program to scale up HIV prevention, care and treatment. Focus groups consisted of men and women including opinion leaders, civil servants including teachers, police officers, religious, political leaders, shop keepers, local residents and other ordinary persons from all walks of life. The qualitative data were transcribed and analyzed manually. Texts were coded using a coding scheme which was prepared ahead of time but emerging themes and codes were also allowed. Results Our data indicated there is persistence of several structural drivers and factors for HIV in rural Uganda. The structural drivers of HIV were divided into three categories: Gender issues, socio-cultural, and economic drivers. The specific drivers included several gender issues, stigma surrounding illness, traditional medical practices, urbanization, alcohol and substance abuse and poverty. New drivers arising from urbanization, easy access to mobile phone, internet and technological advancement have emerged. These drivers are intertwined within an existing culture, lifestyle and the mixture is influenced by modernization. Conclusion The traditional structural drivers of HIV have persisted since the emergence of the HIV epidemic in Uganda and new ones have emerged. All these drivers may require combined structural interventions that are culturally and locally adapted in order to tackle the resurgence in incidence of HIV in Uganda.	[Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Akakimpa, Denis; Tumwebaze, Flora P.; Abongomera, George; Mugyenyi, Peter N.; Kityo, Cissy M.] Joint Clin Res Ctr, Kampala, Uganda	Mbarara University of Science & Technology; Joint Clinic Research Center - United Arab Emirates	Bajunirwe, F (corresponding author), Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda.	fbaj@yahoo.com		Abongomera, George/0000-0001-8794-3674; Bajunirwe, Francis/0000-0002-1326-5230	Civil Society Fund	Civil Society Fund	The data collection was conducted as part of Strengthening Civil Society for Improved HIV/AIDS (SCIPHA) project funded by Civil Society Fund grant to JCRC (PI Professor Peter Mugyenyi). The funders had no role in the study design, data collection, analysis or preparation of this manuscript.	Abimanyi-Ochom J, 2011, AIDS CARE, V23, P1545, DOI 10.1080/09540121.2011.582477; Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; [Anonymous], 2012, DEM HLTH SURV; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Beattie TS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1623-7; Brawner BM, 2015, NURS RES, V64, P100, DOI 10.1097/NNR.0000000000000076; Chan BT, 2016, JAIDS-J ACQ IMM DEF, V72, P558, DOI 10.1097/QAI.0000000000001011; Chan BT, 2015, AIDS, V29, P83, DOI 10.1097/QAD.0000000000000495; Greif MJ, 2012, HEALTH PLACE, V18, P400, DOI 10.1016/j.healthplace.2011.12.008; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; Kamali A, 2016, SEX TRANSM INFECT, V92, P447, DOI 10.1136/sextrans-2015-052179; Kamndaya M, 2015, ROLE MAT DEPRIVATION, P1, DOI [10.1080/17441692.2015.1014393, DOI 10.1080/17441692.2015.1014393]; Kamndaya M, 2015, HEALTH PLACE, V33, P90, DOI 10.1016/j.healthplace.2015.03.001; Kamndaya M, 2014, J URBAN HEALTH, V91, P581, DOI 10.1007/s11524-013-9856-1; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Kunnuji M, 2014, CULT HEALTH SEX, V16, P727, DOI 10.1080/13691058.2014.894206; Kyegombe N, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19232; Kyegombe N, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.25082; Mabumba ED, 2007, TROP DOCT, V37, P229, DOI 10.1258/004947507782332955; Mall S, 2013, AIDS CARE, V25, P194, DOI 10.1080/09540121.2012.689810; Marshall BDL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-7; Mwanga JR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-957; Okeyo T M, 1994, Afr J Med Pract, V1, P20; Parkhurst JO, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19052; Perry B, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19010; Rujumba J., 2010, CONFL HEALTH, V4, P18, DOI [10.1186/1752-1505-4-18, DOI 10.1186/1752-1505-4-18]; Russell S, 2015, ANTIRETROVIRAL THERA, DOI [10.1111/1467-9566.12341, DOI 10.1111/1467-9566.12341]; Santelli JS, 2015, AIDS, V29, P211, DOI 10.1097/QAD.0000000000000533; Schuyler AC, 2017, GLOB PUBLIC HEALTH, V12, P1033, DOI 10.1080/17441692.2015.1074715; Seeley J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17397; Shafer LA, 2008, AIDS, V22, P1641, DOI 10.1097/QAD.0b013e32830a7502; Thamattoor U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131629; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Wagman JA, 2015, HEALTH CARE WOMEN IN, P1, DOI DOI 10.1080/07399332.2015; Wagman JA, 2015, LANCET GLOB HEALTH, V3, pE23, DOI 10.1016/S2214-109X(14)70344-4; Wight D, 2006, SOC SCI MED, V62, P987, DOI 10.1016/j.socscimed.2005.06.052	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0211084	10.1371/journal.pone.0211084	http://dx.doi.org/10.1371/journal.pone.0211084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1FJ	31693660	Green Published, Green Submitted, gold			2022-12-26	WOS:000532690100003
J	Christensen, S; Wolf, E; Altevers, J; Diaz-Cuervo, H				Christensen, Stefan; Wolf, Eva; Altevers, Julia; Diaz-Cuervo, Helena			Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; RISK; TENOFOVIR; AGE; INFECTION	People living with human immunodeficiency virus (PLHIV) are at high risk of developing non-HIV related comorbidities, particularly at older ages. In a retrospective claims database analysis, we compared PLHIV to a matched, non-HIV cohort to assess the prevalence of comorbidities and healthcare costs in PLHIV and the general non-HIV population in Germany. In total, 2,132 adult patients with HIV were identified in the InGef research database with HIV ICD-10 diagnosis within each year from 2011 to 2014. Of these, 1,969 could be matched to a control cohort of 3,938 individuals (1:2 ratio). Matching criteria included age, gender and socio-economic variables. The prevalence of acute renal disease (0.5% vs. 0.2%, p = 0.045), bone fractures due to osteoporosis (6.4% vs. 2.1%, p<0.001), chronic renal disease (4.3% vs. 2.4%, p<0.001), cardiovascular disease (12.8% vs. 10.4%, p = 0.006), Hepatitis B (5.9% vs. 0.3%, p<0.001) and Hepatitis C infection (8.8% vs. 0.3%, p<0.001) was significantly higher in PLHIV compared to the matched non-HIV cohort. Mean costs excluding costs for antiretroviral therapy (ART) were significantly higher in the HIV cohort (8,049(sic) vs. 3,658(sic), p<0.05). On average, PLHIV incurred excess costs of 16,441(sic) for ART, 2,747(sic) for pharmaceuticals excluding ART (p<0.05), 1,441(sic) for outpatient care (p<0.05) and 321(sic) for inpatient care (p<0.05). Devices and remedies' costs were significantly higher in the control cohort with excess costs of 113(sic) (p<0.05). Considering mean total costs, excluding ART, excess costs for PLHIV amounted to 8,049(sic) (p<0.05). This analysis demonstrated an increased comorbidity and economic burden of PLHIV compared to matched controls. Our findings suggest that HIV remains an area of high unmet medical need. To improve patient outcomes, adequate HIV management including regular monitoring, screening for comorbidities and optimal ART selection throughout the life course of PLHIV are of key importance.	[Christensen, Stefan] Ctr Interdisciplinary Med CIM Infect Dis, Munster, Germany; [Christensen, Stefan] Muenster Univ Hosp, Dept Gastroenterol & Hepatol, Munster, Germany; [Wolf, Eva] MUC Res, Munich, Germany; [Altevers, Julia] Xcenda GmbH, Hannover, Germany; [Diaz-Cuervo, Helena] Gilead Sci Europe, Greater London, England	University of Munster; Gilead Sciences	Altevers, J (corresponding author), Xcenda GmbH, Hannover, Germany.	julia.altevers@xcenda.de			Gilead Sciences Europe Ltd.	Gilead Sciences Europe Ltd.(Gilead Sciences)	This study was funded by Gilead Sciences Europe Ltd.	Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; [Anonymous], WORLD DRUG REP 2014; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Blackwell DL, 2014, VITAL HLTH STAT, V10; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Bundesinstitut fur Bau- Stadt-und Raumforschung (BBSR; Federal Institute for Research on Building Urban Affairs and Spatial Development), 2016, IND KART RAUM STADT; Centers for Disease Control and Prevention, 2016, 16 CDCP, V16; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Guaraldi G, 2013, CLINICOECONOMIC OUTC, V5, P481, DOI 10.2147/CEOR.S40607; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Kuhn J, 2006, GESUNDHEITSWESEN, V68, P551, DOI 10.1055/s-2006-926988; Latzitis N, 2011, GESUNDHEITSWESEN, V73, P217, DOI 10.1055/s-0030-1252035; Luther VP, 2007, CLIN GERIATR MED, V23, P567, DOI 10.1016/j.cger.2007.02.004; McComsey GA, 2018, AIDS, V32, P477, DOI 10.1097/QAD.0000000000001725; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Powderly WG, 2010, NON AIDS DEFINING IL, V3; Quiros-Roldan E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3804-4; Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Vance DE, 2010, AM J NURS, V110, P42, DOI 10.1097/01.NAJ.0000368952.80634.42; Vogel M, 2010, DTSCH ARZTEBL INT, V107, P507, DOI 10.3238/arztebl.2010.0507; von Gaudecker HM, 2004, REGIONALE MORTALITAT	26	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224279	10.1371/journal.pone.0224279	http://dx.doi.org/10.1371/journal.pone.0224279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693696	Green Published, gold			2022-12-26	WOS:000532690100020
J	Harikrishnan, V; Titus, AS; Cowling, RT; Kailasam, S				Harikrishnan, V; Titus, Allen Sam; Cowling, Randy T.; Kailasam, Shivakumar			Collagen receptor cross-talk determines ?-smooth muscle actin-dependent collagen gene expression in angiotensin II?stimulated cardiac fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; fibrosis; integrin; collagen; tyrosine-protein kinase (tyrosine kinase); cardiovascular disease; connective tissue; cardiac fibroblast; cardiac fibrosis; collagen type I; discoidin domain receptor 2; integrin-beta1; alpha-smooth muscle actin; tissue damage; gene regulation	INTEGRIN BETA-1; EXTRACELLULAR-MATRIX; AP-1; PROLIFERATION; MIGRATION; ADHESION; BETA-1-INTEGRIN; DIFFERENTIATION; TRANSCRIPTION; HYPERTENSION	Excessive collagen deposition by myofibroblasts during adverse cardiac remodeling leads to myocardial fibrosis that can compromise cardiac function. Unraveling the mechanisms underlying collagen gene expression in cardiac myofibroblasts is therefore an important clinical goal. The collagen receptors, discoidin domain receptor 2 (DDR2), a collagen-specific receptor tyrosine kinase, and integrin-?1, are reported to mediate tissue fibrosis. Here, we probed the role of DDR2?integrin-?1 cross-talk in the regulation of collagen ?1(I) gene expression in angiotensin II (Ang II)-stimulated cardiac fibroblasts. Results from gene silencing/overexpression approaches, electrophoretic mobility shift assays, and ChIP revealed that DDR2 acts via extracellular signal?regulated kinase 1/2 mitogen-activated protein kinase (ERK1/2 MAPK)-dependent transforming growth factor-?1 (TGF-?1) signaling to activate activator protein-1 (AP-1) that in turn transcriptionally enhances the expression of collagen-binding integrin-?1 in Ang II?stimulated cardiac fibroblasts. The DDR2?integrin-?1 link was also evident in spontaneously hypertensive rats and DDR2-knockout mice. Further, DDR2 acted via integrin-?1 to regulate ?-smooth muscle actin (?-SMA) and collagen type I expression in Ang II?exposed cardiac fibroblasts. Downstream of the DDR2?integrin-?1 axis, ?-SMA was found to regulate collagen ?1(I) gene expression via the Ca2+ channel, transient receptor potential cation channel subfamily C member 6 (TRPC6), and the profibrotic transcription factor, Yes-associated protein (YAP). This finding indicated that fibroblast-to-myofibroblast conversion is mechanistically coupled to collagen expression. The observation that collagen receptor cross-talk underlies ?-SMA?dependent collagen type I expression in cardiac fibroblasts expands our understanding of the complex mechanisms involved in collagen gene expression in the heart and may be relevant to cardiac fibrogenesis.	[Harikrishnan, V; Titus, Allen Sam; Kailasam, Shivakumar] Sree Chitra Tirunal Inst Med Sci & Technol, Div Cellular & Mol Cardiol, Trivandrum 695011, Kerala, India; [Cowling, Randy T.] Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA; [Harikrishnan, V] Govt India, Dept Biotechnol, Delhi, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); University of California System; University of California San Diego; Department of Biotechnology (DBT) India	Kailasam, S (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Cellular & Mol Cardiol, Trivandrum 695011, Kerala, India.	shivak@sctimst.ac.in	Titus, Allen/GSD-8138-2022	Titus, Allen/0000-0001-8149-3895	Department of Biotechnology, Government of India [BT/PR23486/BRB/10/1589/2017]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, Government of India, Research Grant BT/PR23486/BRB/10/1589/2017 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anupama V, 2016, J MOL CELL CARDIOL, V97, P295, DOI 10.1016/j.yjmcc.2016.05.010; BRILLA CG, 1993, EUR HEART J, V14, P57; Civitarese RA, 2016, AM J PHYSIOL-HEART C, V311, pH96, DOI 10.1152/ajpheart.00918.2015; Cowling RT, 2014, AM J PHYSIOL-HEART C, V307, pH773, DOI 10.1152/ajpheart.00142.2014; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Dokainish H, 2017, LANCET GLOB HEALTH, V5, pE665, DOI [10.1016/s2214-109x(17)30196-1, 10.1016/S2214-109X(17)30196-1]; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Follonier L, 2008, J CELL SCI, V121, P3305, DOI 10.1242/jcs.024521; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; George M, 2016, J MOL CELL CARDIOL, V90, P59, DOI 10.1016/j.yjmcc.2015.12.004; He XJ, 2017, P NATL ACAD SCI USA, V114, pE4582, DOI 10.1073/pnas.1621384114; Henderson NC, 2013, BBA-MOL BASIS DIS, V1832, P891, DOI 10.1016/j.bbadis.2012.10.005; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Israeli-Rosenberg S, 2014, CIRC RES, V114, P572, DOI 10.1161/CIRCRESAHA.114.301275; Jia SJ, 2018, AM J RESP CELL MOL, V59, P295, DOI 10.1165/rcmb.2017-0419OC; Jiang T, 2008, NEPHROLOGY, V13, P212, DOI 10.1111/j.1440-1797.2007.00913.x; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kaur H, 2016, CIRC RES, V118, P1906, DOI 10.1161/CIRCRESAHA.116.308643; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Krishnamurthy P, 2006, HEART, V92, P1309, DOI 10.1136/hrt.2005.071001; Kumaran C, 2002, AM J PHYSIOL-HEART C, V282, pH1855, DOI 10.1152/ajpheart.00747.2001; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lee HW, 2013, CLIN CANCER RES, V19, P5879, DOI 10.1158/1078-0432.CCR-13-1181; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Liu SX, 2013, J INVEST DERMATOL, V133, P899, DOI 10.1038/jid.2012.438; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Moore-Morris T, 2015, J MOL MED, V93, P823, DOI 10.1007/s00109-015-1314-y; Nichols TC, 1999, CIRC RES, V85, P1040; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Philip L, 2013, J MOL CELL CARDIOL, V62, P217, DOI 10.1016/j.yjmcc.2013.06.009; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Popov C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.71; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; Ren XS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43259; Rockey DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077166; Rog-Zielinska EA, 2016, TRENDS MOL MED, V22, P99, DOI 10.1016/j.molmed.2015.12.006; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Sopel MJ, 2011, LAB INVEST, V91, P565, DOI 10.1038/labinvest.2010.190; Soto-Ribeiro M, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224493; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Talior-Volodarsky I, 2012, CARDIOVASC RES, V96, P265, DOI 10.1093/cvr/cvs259; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Valiente-Alandi I, 2018, CIRCULATION, V138, P1236, DOI 10.1161/CIRCULATIONAHA.118.034609; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wernig G, 2017, P NATL ACAD SCI USA, V114, P4757, DOI 10.1073/pnas.1621375114; WOOD EJ, 1983, BIOCHEM EDUC, V11, P82, DOI 10.1016/0307-4412(83)90068-7; Wu SL, 2005, FREE RADICAL BIO MED, V39, P1601, DOI 10.1016/j.freeradbiomed.2005.08.006; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yeh YC, 2011, MOL BIOL CELL, V22, P940, DOI 10.1091/mbc.E10-08-0678; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zablocki D, 2013, ANTIOXID REDOX SIGN, V19, P1095, DOI 10.1089/ars.2012.4588; Zhang BY, 2016, J PHARMACOL SCI, V132, P171, DOI 10.1016/j.jphs.2016.05.008; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao XK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19276	60	24	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19723	19739		10.1074/jbc.RA119.009744	http://dx.doi.org/10.1074/jbc.RA119.009744			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31699892	Green Published, hybrid			2022-12-26	WOS:000504093200021
J	Singaravelu, R; Ahmed, N; Quan, C; Srinivasan, P; Ablenas, CJ; Roy, DG; Pezacki, JP				Singaravelu, Ragunath; Ahmed, Nadine; Quan, Curtis; Srinivasan, Prashanth; Ablenas, Christopher J.; Roy, Dominic G.; Pezacki, John Paul			A conserved miRNA-183 cluster regulates the innate antiviral response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); interferon; interferon regulatory factor (IRF); innate immunity; posttranscriptional regulation; antiviral signaling; IFN regulatory factor 3 (IRF3); miR-183 cluster; STAT1	MICRORNA; VIRUS; TRANSCRIPTION; ACTIVATION; EXPRESSION; TYROSINE; MIR-182; STAT1; TBK1; IRF3	Upon immune recognition of viruses, the mammalian innate immune response activates a complex signal transduction network to combat infection. This activation requires phosphorylation of key transcription factors regulating IFN production and signaling, including IFN regulatory factor 3 (IRF3) and STAT1. The mechanisms regulating these STAT1 and IRF3 phosphorylation events remain unclear. Here, using human and mouse cell lines along with gene microarrays, quantitative RT-PCR, viral infection and plaque assays, and reporter gene assays, we demonstrate that a microRNA cluster conserved among bilaterian animals, encoding miR-96, miR-182, and miR-183, regulates IFN signaling. In particular, we observed that the miR-183 cluster promotes IFN production and signaling, mediated by enhancing IRF3 and STAT1 phosphorylation. We also found that the miR-183 cluster activates the IFN pathway and inhibits vesicular stomatitis virus infection by directly targeting several negative regulators of IRF3 and STAT1 activities, including protein phosphatase 2A (PPP2CA) and tripartite motif?containing 27 (TRIM27). Overall, our work reveals an important role of the evolutionarily conserved miR-183 cluster in the regulation of mammalian innate immunity.	[Singaravelu, Ragunath; Roy, Dominic G.; Pezacki, John Paul] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Ahmed, Nadine; Quan, Curtis; Srinivasan, Prashanth; Ablenas, Christopher J.; Pezacki, John Paul] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa	Pezacki, JP (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.; Pezacki, JP (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada.	John.Pezacki@uottawa.ca		Srinivasan, Prashanth/0000-0002-4898-2205; Roy, Dominic/0000-0002-6044-0118	Natural Sciences and Engineering Research Council [298496]; Canadian Institutes of Health Research [136807]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Natural Sciences and Engineering Research Council Grant 298496 and Canadian Institutes of Health Research Grant 136807. University of Ottawa has filed a patent on the miR-183 cluster's immunomodulatory properties in the name of John Paul Pezacki and Ragunath Singaravelu.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen YM, 2015, INT J CLIN EXP MED, V8, P18462; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Donatelli SS, 2014, P NATL ACAD SCI USA, V111, P4203, DOI 10.1073/pnas.1319269111; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; El Sobky SA, 2016, IMMUNOL LETT, V169, P52, DOI 10.1016/j.imlet.2015.10.013; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Mitchell AM, 2015, MBIO, V6, DOI 10.1128/mBio.02510-14; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Oussaief L, 2015, J VIROL, V89, P12178, DOI 10.1128/JVI.01757-15; Powdrill MH, 2016, CURR OPIN VIROL, V19, P71, DOI 10.1016/j.coviro.2016.07.005; Shanker V, 2013, J VIRAL HEPATITIS, V20, P612, DOI 10.1111/jvh.12083; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Singaravelu R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18529-x; Singaravelu R, 2015, NAT CHEM BIOL, V11, P988, DOI 10.1038/nchembio.1940; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tremblay N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005772; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yu HS, 2014, J MOL MED, V92, P961, DOI 10.1007/s00109-014-1159-9; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108	36	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19785	19794		10.1074/jbc.RA119.010858	http://dx.doi.org/10.1074/jbc.RA119.010858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31694919	hybrid, Green Published			2022-12-26	WOS:000504093200025
J	Khan, SA; Chang, HT				Khan, Sabih Ahmad; Chang, Hsien-Tsung			Comparative analysis on Facebook post interaction using DNN, ELM and LSTM	PLOS ONE			English	Article							POPULARITY; ONLINE	This study presents a novel research approach to predict user interaction for social media post using machine learning algorithms. The posts are converted to vector form using word2vec and doc2vec model. These two methods are used to analyse the best approach for generating word embeddings. The generated word embeddings of post combined with other attributes like post published time, type of post and total interactions are used to train machine learning algorithms. Deep neural network (DNN), Extreme Learning Machine (ELM) and Long Short-Term Memory (LSTM) are used to compare the prediction of total interaction for a particular post. For word2vec, the word vectors are created using both continuous bag-of-words (CBOW) and skip-gram models. Also the pre-trained word vectors provided by google is used for the analysis. For doc2vec, the word embeddings are created using both the Distributed Memory model of Paragraph Vectors (PV-DM) and Distributed Bag of Words model of Paragraph Vectors (PV-DBOW). A word embedding is also created using PV-DBOW combined with skip-gram.	[Khan, Sabih Ahmad; Chang, Hsien-Tsung] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan 33302, Taiwan; [Chang, Hsien-Tsung] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan 33302, Taiwan	Chang Gung University; Chang Gung Memorial Hospital	Chang, HT (corresponding author), Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan 33302, Taiwan.; Chang, HT (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan 33302, Taiwan.	smallpig@widelab.org	Chang, Hsien-Tsung/E-7511-2012	Chang, Hsien-Tsung/0000-0003-4987-5943; Khan, Sabih Ahmad/0000-0003-3369-6529	Ministry of Science and Technology, Republic of China [MOST 108-2221-E-182-049 (NERPD2J0281)]; Chang Gung Memorial Hospital [CMRPD2J0021]	Ministry of Science and Technology, Republic of China; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Financial support furnished by the Ministry of Science and Technology, Republic of China, through Grant MOST 108-2221-E-182-049 (NERPD2J0281) and Chang Gung Memorial Hospital through Grant CMRPD2J0021 are gratefully acknowledged.	Agnihotri R, 2016, IND MARKET MANAG, V53, P172, DOI 10.1016/j.indmarman.2015.09.003; Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Ashley C, 2015, PSYCHOL MARKET, V32, P15, DOI 10.1002/mar.20761; Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Bianchi C, 2015, J BUS RES, V68, P2552, DOI 10.1016/j.jbusres.2015.06.026; Cha M., 2010, ICWSM, V10, P30, DOI DOI 10.1145/2897659.2897663; Chan C, 2012, LIBR MANAGE, V33, P479, DOI 10.1108/01435121211279849; Chang YT, 2015, J BUS RES, V68, P777, DOI 10.1016/j.jbusres.2014.11.027; Cvijikj I.P., 2011, PRIV SEC RISK TRUST, P810, DOI DOI 10.1109/PASSAT/SOCIALCOM.2011.21; Cvijikj IP, 2011, LECT NOTES COMPUT SC, V6984, P161, DOI 10.1007/978-3-642-24704-0_21; de Vries L, 2012, J INTERACT MARK, V26, P83, DOI 10.1016/j.intmar.2012.01.003; Garcia S., 2016, BIG DATA ANAL, V1, P9, DOI 10.1186/s41044-016-0014-0; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Glorot X., 2011, P 14 INT C ART INT S, P315; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; He W, 2015, INFORM MANAGE-AMSTER, V52, P801, DOI 10.1016/j.im.2015.04.006; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Jadaliha M, 2010, PROCEEDINGS OF THE ASME DYNAMIC SYSTEMS AND CONTROL CONFERENCE 2010, VOL 2, P623; Joulin Armand, 2016, ARXIV160701759; Khalid S, 2014, 2014 SCIENCE AND INFORMATION CONFERENCE (SAI), P372, DOI 10.1109/SAI.2014.6918213; Kingma DP., 2014, ADAM METHOD STOCHAST; Lau JH, 2016, ARXIV160705368 CORR; Le Q., 2014, 31 INT C MACH LEARN, P1188; Lee RJ, 2017, TRANSPORT RES A-POL, V100, P40, DOI 10.1016/j.tra.2017.03.001; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Liang PW, 2013, 2013 IEEE 14TH INTERNATIONAL CONFERENCE ON MOBILE DATA MANAGEMENT (MDM 2013), VOL 2, P91, DOI 10.1109/MDM.2013.73; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Moro S, 2016, J BUS RES, V69, P3341, DOI 10.1016/j.jbusres.2016.02.010; Myers Seth A., 2012, P 18 ACM SIGKDD INT, P33, DOI DOI 10.1145/2339530.2339540; Pappas IO, 2017, TELEMAT INFORM, V34, P730, DOI 10.1016/j.tele.2016.08.021; Peng KH, 2015, WIRELESS OPTIC COMM, P9, DOI 10.1109/WOCC.2015.7346106; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Pyle, 1999, DATA PREPARATION DAT; Rehurek R., 2010, P LREC 2010 WORKSH N; Rodriguez M. Gomez, 2010, P 16 ACM SIGKDD INT, P1019, DOI DOI 10.1145/1835804.1835933; Rong X., 2014, ARXIV14112738; Sabate F, 2014, EUR MANAG J, V32, P1001, DOI 10.1016/j.emj.2014.05.001; Schaidnagel M, 2015, DIGITAL ENTERPRISE C, P259; Sorzano COS, 2014, ARXIV14032877; Statista, 2022, MOST POP SOC NETW WO; Statista (The Statistics Portal),, 2018, NUMB MONTHL ACT FAC; Straton N, 2017, IEEE INT CONF BIG DA, P2772; Straton N, 2017, IEEE INT CONGR BIG, P89, DOI 10.1109/BigDataCongress.2017.21; Tang JX, 2016, IEEE T NEUR NET LEAR, V27, P809, DOI 10.1109/TNNLS.2015.2424995; Zadeh AH, 2014, DECIS SUPPORT SYST, V65, P59, DOI 10.1016/j.dss.2014.05.003; Zhang JX, 2016, IEEE ACM T NETWORK, V24, P2866, DOI 10.1109/TNET.2015.2494059	48	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224452	10.1371/journal.pone.0224452	http://dx.doi.org/10.1371/journal.pone.0224452			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1MV	31714918	gold, Green Published			2022-12-26	WOS:000532710400007
J	Pinkhardt, EH; Liu, HJ; Ma, D; Chen, J; Pachollek, A; Kunz, MS; Kassubek, J; Ludolph, AC; Huang, YN; Chen, HB; Landwehrmeyer, GB; Wang, ZX; Su, W				Pinkhardt, Elmar H.; Liu, Huijing; Ma, Di; Chen, Jing; Pachollek, Adrian; Kunz, Martin S.; Kassubek, Jan; Ludolph, Albert C.; Huang, Yining; Chen, Haibo; Landwehrmeyer, G. Bernhard; Wang, Zhaoxia; Su, Wen			Olfactory screening of Parkinson's Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin' Sticks 12-identification test	PLOS ONE			English	Article							ODOR IDENTIFICATION; DYSFUNCTION; DISCRIMINATION; VALIDATION; STAGE	Background Olfactory testing is a useful tool in the differential diagnosis of Parkinson's Disease (PD). Although fast and easy to use, the high intercultural variability of odor detection limits the world-wide use of the most common test sets. Objective The aim of this study was to test one of the most commonly used olfactory tests (Sniffin' Sticks 12-identification test) in an adapted version for a Chinese population of healthy subjects and PD patients. Methods For this purpose, cohorts of 39 Chinese and 41 German PD patients as well as 70 Chinese and 100 German healthy subjects have been examined both with the original and the adapted version of the Sniffin' Sticks test, the latter being designed according to the regional culture. Results The adapted Chinese version of the Sniffin' Sticks 12 identification test proved to discriminate Chinese PD patients from controls with a high specificity but relatively low sensitivity. Yet not all odor exchanges would have been necessary as the original odors including liquorice and coffee showed an equally high identification rate in the Chinese and German cohorts. Conclusions The results showed that the newly adapted test could be used as a screening test for PD related olfactory dysfunction in a Chinese population. However further investigation will be necessary to optimize the selection of odors for the Chinese version of the test	[Pinkhardt, Elmar H.; Pachollek, Adrian; Kunz, Martin S.; Kassubek, Jan; Ludolph, Albert C.; Landwehrmeyer, G. Bernhard] Ulm Univ, Dept Neurol, Ulm, Germany; [Liu, Huijing; Chen, Haibo; Su, Wen] Beijing Hosp, Natl Ctr Gerontol, Neurol Dept, Beijing, Peoples R China; [Ma, Di; Chen, Jing; Huang, Yining; Wang, Zhaoxia] Peking Univ, Dept Neurol, Hosp 1, Beijing, Peoples R China	Ulm University; Beijing Hospital; Peking University	Pinkhardt, EH (corresponding author), Ulm Univ, Dept Neurol, Ulm, Germany.; Su, W (corresponding author), Beijing Hosp, Natl Ctr Gerontol, Neurol Dept, Beijing, Peoples R China.	elmar.pinkhardt@uni-ulm.de; suwendy@126.com	Kassubek, Jan/GPX-0910-2022; Kassubek, Jan/F-2774-2015; Kassubek, Jan/O-1740-2019; Landwehrmeyer, Georg Bernhard/AHB-4443-2022	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Pinkhardt, Elmar/0000-0003-1579-3472	UULM-PUHSC-JointCenter	UULM-PUHSC-JointCenter	All authors were part of the study group that was funded by the UULM-PUHSC-JointCenter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antsov E, 2014, PARKINSONISM RELAT D, V20, P830, DOI 10.1016/j.parkreldis.2014.04.012; Berg D, 2018, J PARKINSON DIS, V8, pS19, DOI 10.3233/JPD-181457; Chen W, 2012, ALZHEIMERS RES THER, V1, P1; Chen W, 2012, J NEUROL SCI, V316, P47, DOI 10.1016/j.jns.2012.01.033; Chou KL, 2009, PARKINSONISM RELAT D, V15, P640, DOI 10.1016/j.parkreldis.2009.03.004; Doty RL, 2017, LANCET NEUROL, V16, P478, DOI 10.1016/S1474-4422(17)30123-0; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138; Feng G, 2019, CHEM SENSES, V44, P189, DOI 10.1093/chemse/bjz006; Fjaeldstad A, 2015, CLIN OTOLARYNGOL, V40, P545, DOI 10.1111/coa.12405; Hoover KC, 2015, CHEM SENSES, V40, P481, DOI 10.1093/chemse/bjv030; Hoover KC, 2010, AM J PHYS ANTHROPOL, P63, DOI 10.1002/ajpa.21441; HUANG SF, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0UMAL.P0NE.0160199; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Krismer F, 2017, PARKINSONISM RELAT D, V35, P36, DOI 10.1016/j.parkreldis.2016.11.010; Hernandez NL, 2015, NEUROLOGIA, V30, P496, DOI 10.1016/j.nrl.2014.03.010; Mahlknecht P, 2015, NEUROLOGY, V84, P654, DOI 10.1212/WNL.0000000000001265; Majid A, 2017, PERCEPTION, V46, P406, DOI 10.1177/0301006616688224; Neumann C, 2012, CLIN OTOLARYNGOL, V37, P23, DOI 10.1111/j.1749-4486.2012.02431.x; Postuma RB, 2016, LANCET NEUROL, V15, P546, DOI 10.1016/S1474-4422(16)00116-2; Ribeiro JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148937; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Rumiati RI, 2016, PSYCHON B REV, V23, P1043, DOI 10.3758/s13423-015-0908-2; Shu CH, 2008, EUR ARCH OTO-RHINO-L, V265, P787, DOI 10.1007/s00405-007-0551-2; Silveira-Moriyama L, 2010, MOVEMENT DISORD, V25, P570, DOI 10.1002/mds.22688; Silveira-Moriyama L, 2009, NEUROSCI LETT, V453, P77, DOI 10.1016/j.neulet.2009.02.006; Tekeli H, 2013, MED SCI MONITOR, V19, P1221, DOI 10.12659/MSM.889838	29	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224331	10.1371/journal.pone.0224331	http://dx.doi.org/10.1371/journal.pone.0224331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703081	gold, Green Published			2022-12-26	WOS:000532697200009
J	El Ashmawy, WR; Williams, DR; Gerry, AC; Champagne, JD; Lehenbauer, TW; Aly, SS				El Ashmawy, Wagdy R.; Williams, Deniece R.; Gerry, Alec C.; Champagne, John D.; Lehenbauer, Terry W.; Aly, Sharif S.			Risk factors affecting dairy cattle protective grouping behavior, commonly known as bunching, against Stomoxys calcitrans (L.) on California dairies	PLOS ONE			English	Article							STABLE FLIES DIPTERA; WEIGHT-GAIN; FEED-EFFICIENCY; HEAT-STRESS; FLY DIPTERA; MUSCIDAE; ABUNDANCE; TEMPERATURE; RESPONSES; PARASITES	Bunching is the term used to describe the protective aggregating behavior of cattle against the painful bites of stable flies (Stomoxys calcitrans), where cattle gather in a group with their heads to the center of the group and their tails to the outside to reduce stable fly attack. Both sexes of the stable fly feed on blood, and their painful bites negatively impact cattle health, productivity and welfare. A longitudinal study was conducted from April to July 2017 to estimate the stable fly activity on 20 California dairies (average herd size = 2466 +/- 1050), to determine stable fly activity that induced bunching, and to evaluate the association between management and environmental factors, and cattle bunching. Stable fly activity was recorded weekly using trap counts and leg counts. Data was analyzed using linear mixed models with odds ratio. Cattle bunching at the dairy level was predicted by mean trap counts of >= 150 flies/trap/week, while bunching at the pen level was predicted by mean leg counts > 1 fly/leg/cow or mean trap counts > 50 flies/trap/week for traps closest to the pen. Additional risk factors predicting cattle bunching at the dairy level were study week (May/June vs July), presence of crops adjacent to dairy > 2 sides, and feeding wet distillers grain. Additional risk factors predicting cattle bunching at the pen level were study week (May/June vs July), ambient temperature <= 30 degrees C, pen design (freestall vs open dry lot or bedded pack), production status (lactating/dry vs close-up), presence of crops surrounding cattle pens, feeding rations containing molasses. Cattle bunching was reduced at the pen level by relative humidity > 50%, and when the cattle pen was surrounded by other cattle pens or was bordered by a main road. At the dairy level, removal of manure along fence lines of cattle pens was protective against cattle bunching.	[El Ashmawy, Wagdy R.; Williams, Deniece R.; Champagne, John D.; Lehenbauer, Terry W.; Aly, Sharif S.] Univ Calif Davis, Vet Med Teaching & Res Ctr, Sch Vet Med, Tulare, CA 93274 USA; [El Ashmawy, Wagdy R.] Cairo Univ, Fac Vet Med, Dept Med & Infect Dis, Giza, Egypt; [Gerry, Alec C.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Lehenbauer, Terry W.; Aly, Sharif S.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; Egyptian Knowledge Bank (EKB); Cairo University; University of California System; University of California Riverside; University of California System; University of California Davis	Aly, SS (corresponding author), Univ Calif Davis, Vet Med Teaching & Res Ctr, Sch Vet Med, Tulare, CA 93274 USA.; Aly, SS (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	saly@ucdavis.edu	Aly, Sharif S./J-6586-2019; Elashmawy, Wagdy R/M-3263-2016; Williams, Deniece/AAD-6368-2020	Aly, Sharif S./0000-0003-0330-5013; Williams, Deniece/0000-0002-7534-732X; ElAshmawy, Wagdy/0000-0001-6466-1455; ElAshmawy, Wagdy/0000-0002-2167-2442	Center of Food Animal Health, School of Veterinary Medicine, University of California Davis (USDA NIFA) [CA-V-VME-4077-H]	Center of Food Animal Health, School of Veterinary Medicine, University of California Davis (USDA NIFA)	Funding for this study was provided by the Center of Food Animal Health, School of Veterinary Medicine, University of California Davis (USDA NIFA project number: CA-V-VME-4077-H, PI Aly). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRY IL, 1985, ENVIRON ENTOMOL, V14, P336, DOI 10.1093/ee/14.3.336; BERRY IL, 1986, ENVIRON ENTOMOL, V15, P706, DOI 10.1093/ee/15.3.706; BERRY IL, 1983, T ASAE, V26, P873; Bishopp FC., 1926, FARMERS B, V1097, P1; Broce AB, 1999, J KANSAS ENTOMOL SOC, V72, P60; BRUCE WN, 1958, J ECON ENTOMOL, V51, P269, DOI 10.1093/jee/51.3.269; BRUCE WN, 1947, J ECON ENTOMOL, V40, P530, DOI 10.1093/jee/40.4.530; BUSCHMAN LL, 1981, ENVIRON ENTOMOL, V10, P16, DOI 10.1093/ee/10.1.16; CAMPBELL JB, 1987, J ECON ENTOMOL, V80, P117, DOI 10.1093/jee/80.1.117; CAMPBELL JB, 1993, J AGR ENTOMOL, V10, P155; Catangui MA, 1997, J ECON ENTOMOL, V90, P6, DOI 10.1093/jee/90.1.6; Freeborn SB, 1928, J ECON ENTOMOL, V21, P494, DOI 10.1093/jee/21.3.494; Gerry AC, 2007, 8258 U CAL DIV AGR N; GRANETT P, 1956, J ECON ENTOMOL, V49, P465, DOI 10.1093/jee/49.4.465; Greene G.L., 1989, Miscellaneous Publications of the Entomological Society of America, P12; HART BL, 1992, J PARASITOL, V78, P256, DOI 10.2307/3283472; Lysyk TJ, 1998, J MED ENTOMOL, V35, P107, DOI 10.1093/jmedent/35.2.107; Mader TL, 2002, J ANIM SCI, V80, P2373; MEYER JA, 1983, J ECON ENTOMOL, V76, P103, DOI 10.1093/jee/76.1.103; MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011; Mullens BA, 2006, MED VET ENTOMOL, V20, P122, DOI 10.1111/j.1365-2915.2006.00608.x; Mullens BA, 2005, J MED ENTOMOL, V42, P705, DOI 10.1603/0022-2585(2005)042[0705:RBRASF]2.0.CO;2; MULLENS BA, 1987, J ECON ENTOMOL, V80, P1039, DOI 10.1093/jee/80.5.1039; SCHMIDTMANN ET, 1985, J ECON ENTOMOL, V78, P102, DOI 10.1093/jee/78.1.102; SCHMIDTMANN ET, 1982, APPL ANIM ETHOL, V8, P429, DOI 10.1016/0304-3762(82)90056-6; Showler Allan T., 2015, International Journal of Insect Science, V7, P19, DOI 10.4137/IJIS.S21647; SMITH CW, 1975, J NEW YORK ENTOMOL S, V83, P235; Taylor DB, 2008, ENVIRON ENTOMOL, V37, P625, DOI 10.1603/0046-225X(2008)37[625:SFIASF]2.0.CO;2; Taylor DB, 2012, J MED ENTOMOL, V49, P198, DOI 10.1603/ME10050; Vitela-Mendoza I, 2016, J DAIRY SCI, V99, P9912, DOI 10.3168/jds.2016-11484; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WARNES ML, 1987, MED VET ENTOMOL, V1, P53, DOI 10.1111/j.1365-2915.1987.tb00322.x; WIEMAN GA, 1992, J ECON ENTOMOL, V85, P1835, DOI 10.1093/jee/85.5.1835	33	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224987	10.1371/journal.pone.0224987	http://dx.doi.org/10.1371/journal.pone.0224987			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697765	Green Published, gold			2022-12-26	WOS:000532694400088
J	Izumida, T; Nakamura, Y; Ishikawa, S				Izumida, Toshihide; Nakamura, Yosikazu; Ishikawa, Shizukiyo			Impact of body mass index and metabolically unhealthy status on mortality in the Japanese general population: The JMS cohort study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; NORMAL-WEIGHT; MEN; HEALTHY; STROKE; WOMEN; OBESE; METAANALYSIS; ASSOCIATION; UNDERWEIGHT	This study aimed to investigate the associations of body mass index (BMI) and metabolically unhealthy weight with all-cause mortality, cardiovascular disease (CVD) mortality, and cancer mortality as well as the effect of age on the associations. This prospective study enrolled Japanese individuals in the general population. Participants were divided into eight phenotypes according to the BMI classification and metabolic status. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using a Cox regression hazard model. In total, 10,824 individuals with a mean age of 55.3 years were evaluated. During a mean follow-up of 18.4 years (198,776 person-years), 2,274 participants died. Among the metabolically unhealthy, the association between BMI and mortality was J-shaped after adjustment for various confounders (multivariable HR [95% CI] for all-cause mortality: underweight, 2.0 [1.5-2.7]; obesity 2.8 [2.1-3.6]). The association remained the same in metabolically unhealthy participants aged < 65 years and >= 65 years. The results were compatible in the analyses restricted to subjects who never smoked. Regardless of age, metabolically unhealthy underweight (MUHU) have approximately a 3-fold higher risk of CVD mortality, compared with metabolically healthy normal weight. Not only metabolically unhealthy obesity, but also MUHU was strongly associated with an increased risk of mortality. More attention should be given to the health issues of metabolically unhealthy participants without obesity, particularly those with MUHU.	[Izumida, Toshihide] Kamitaira Clin, Nanto, Toyama, Japan; [Nakamura, Yosikazu; Ishikawa, Shizukiyo] Jichi Med Univ, Ctr Community Med, Div Publ Hlth, Shimotsuke, Tochigi, Japan	Jichi Medical University	Ishikawa, S (corresponding author), Jichi Med Univ, Ctr Community Med, Div Publ Hlth, Shimotsuke, Tochigi, Japan.	i-shizu@jichi.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [13470096, 15390209, 18390198]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grant-inAid 13470096, 15390209, and 18390198 to SI (http://kaken.nii.ac.jp/en/) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the public health doctors, nurses, and officers in Iwaizumi, Yamato, Tako, Takasu, Sakuma, Wara, Kuze, Hokudan, Okawa, Sakugi, Ainoshima, and Akaike, Japan, for their help, support, and contributions.	Ahuja V, 2015, DIABETOLOGIA, V58, P265, DOI 10.1007/s00125-014-3414-6; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bea JW, 2017, J AM COLL CARDIOL, V70, P1438, DOI 10.1016/j.jacc.2017.07.742; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/S2213-8587(18)30288-2, 10.1016/s2213-8587(18)30288-2]; Caleyachetty R, 2017, J AM COLL CARDIOL, V70, P1429, DOI 10.1016/j.jacc.2017.07.763; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dehlendorff C, 2014, JAMA NEUROL, V71, P978, DOI 10.1001/jamaneurol.2014.1017; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gao BX, 2016, EUR J INTERN MED, V29, P46, DOI 10.1016/j.ejim.2015.11.020; Hirokawa K, 2006, EUR J EPIDEMIOL, V21, P641, DOI 10.1007/s10654-006-9049-2; Huang KY, 2016, ATHEROSCLEROSIS, V253, P94, DOI 10.1016/j.atherosclerosis.2016.08.042; Iacobini C, 2019, METABOLISM, V92, P51, DOI 10.1016/j.metabol.2018.11.009; Ishikawa Shizukiyo, 2002, J Epidemiol, V12, P408; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Lee SH, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.46; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Lundin H, 2012, EUR J CLIN NUTR, V66, P1050, DOI 10.1038/ejcn.2012.100; Nakao YM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190862; Ng TP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180818; Nordestgaard BG, 2016, CLIN CHEM, V62, P930, DOI 10.1373/clinchem.2016.258897; Ridker PM, 2004, CIRCULATION, V109, P2818, DOI 10.1161/01.CIR.0000132467.45278.59; Ruderman N, 1998, DIABETES, V47, P699, DOI 10.2337/diabetes.47.5.699; Saito I, 2009, CIRC J, V73, P878, DOI 10.1253/circj.CJ-08-1025; Scherbakov N, 2011, STROKE, V42, P3646, DOI 10.1161/STROKEAHA.111.619163; Stefan N, 2017, CELL METAB, V26, P292, DOI 10.1016/j.cmet.2017.07.008; Sundvall J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-63; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Winslow UC, 2015, INT J EPIDEMIOL, V44, P540, DOI 10.1093/ije/dyu276; Wu CL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095300, 10.1371/journal.pone.0102589]	36	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224802	10.1371/journal.pone.0224802	http://dx.doi.org/10.1371/journal.pone.0224802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697720	Green Published, Green Submitted, gold			2022-12-26	WOS:000532694400064
J	Dang, BT; Rahman, MA; Tran, SQ; Glenner, H				Binh Thuy Dang; Rahman, Muhammad Arifur; Sang Quang Tran; Glenner, Henrik			Genome-wide SNP analyses reveal population structure of Portunus pelagicus along Vietnam coastline	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; GENETIC DIVERSITY; READ ALIGNMENT; MEKONG DELTA; R PACKAGE; CD-HIT; CONSEQUENCES; SOFTWARE; LINNAEUS; LOCI	The blue swimming crab (Portunus pelagicus Linnaeus, 1758) is one of the commercially exploited crab fishery resources in Vietnam. This is the first study to provide a broad survey of genetic diversity, population structure and migration patterns of P. pelagicus along the Vietnamese coastline. The crab samples were collected from northern, central and southern Vietnam. Here, we used a panel of single nucleotide polymorphisms (SNPs) generated from restriction site-associated DNA sequencing (RADseq). After removing 32 outlier loci, 306 putatively neutral SNPs from 96 individuals were used to assess fine-scale population structure of blue swimming crab. The mean observed heterozygosity (Ho) and expected heterozygosity (He) per locus was 0.196 and 0.223, respectively. Pairwise Fst and hierarchical AMOVA supported significant differentiation of central and northern from southern populations (P<0.01). Population structure analyses revealed that P. pelagicus in the south is a separate fisheries unit from the north and center. Contemporary migration patterns supported high migration between northern and central populations and restricted genetic exchange within the southern population. In contrast, historic gene flow provides strong evidence for single panmictic population. The results are useful for understanding current status of P. pelagicus in the wild under an environment changing due to natural and anthropogenic stresses, with implications for fisheries management.	[Binh Thuy Dang; Rahman, Muhammad Arifur; Sang Quang Tran] Nha Trang Univ, Inst Biotechnol & Environm, Dept Biol, Nha Trang City, Vietnam; [Rahman, Muhammad Arifur] Nha Trang Univ, Dept Grad Studies, Nha Trang City, Vietnam; [Glenner, Henrik] Univ Bergen, Dept Biol Sci, Bergen, Norway	Nha Trang University; Nha Trang University; University of Bergen	Dang, BT (corresponding author), Nha Trang Univ, Inst Biotechnol & Environm, Dept Biol, Nha Trang City, Vietnam.; Glenner, H (corresponding author), Univ Bergen, Dept Biol Sci, Bergen, Norway.	binhdt@ntu.edu.vn; Henrik.Glenner@uib.no	Rahman, Muhammad/AAI-2518-2020	Quang Tran, Sang/0000-0002-9586-2433; Rahman, Muhammad Arifur/0000-0002-7666-8029	NORHED [QZA-0485 SRV-13/0010]	NORHED	This project was funded by NORHED under the framework of research project QZA-0485 SRV-13/0010 titled "Incorporating Climate Change into Ecosystem Approaches to Fisheries and Aquaculture Management in Sri Lanka and Vietnam".	Ackiss AS, 2019, J HERED, V110, P535, DOI 10.1093/jhered/esz016; Aglieri G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099647; Al-Breiki RD, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5044-8; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Banks R, 2009, ASSESSMENT REPORT VI; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli Peter, 2009, V17, P42; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger AM, 2017, CAN J FISH AQUAT SCI, V74, P1698, DOI 10.1139/cjfas-2017-0150; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bryars S, 1997, LARVAL DISPERSAL OF; Bryars SR, 2004, MAR FRESHWATER RES, V55, P809, DOI 10.1071/MF04045; Chai CJ, 2017, ZOOL STUD, V56, DOI 10.6620/ZS.2017.56-26; Chen CS, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007150; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Chong ZC, 2012, BIOINFORMATICS, V28, P2732, DOI 10.1093/bioinformatics/bts482; Cimmaruta R, 2003, OCEANOL ACTA, V26, P101, DOI 10.1016/S0399-1784(02)01234-3; Condie S, 2016, GLOBAL ECOL BIOGEOGR, V25, P1264, DOI 10.1111/geb.12485; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dang BT, 2019, CONSERV GENET, DOI [10.1007/s10592-019-01157-5, DOI 10.1007/S10592-019-01157-5]; Daniel F., 2003, GENETICS, V164, P1567; Delord C, 2018, METHODS ECOL EVOL, V9, P1959, DOI 10.1111/2041-210X.13034; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Ernawati T.R.I., 2017, BIODIVERSITAS J BIOL, V18, P1705, DOI [10.13057/biodiv/d180450, DOI 10.13057/BIODIV/D180451, DOI 10.13057/BIODIV/D180450]; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO, 2016, SPEC FACT SHEETS POR; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujaya Y., 2016, African Journal of Biotechnology, V15, P180; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gonzalez EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163052; Ha VV, 2015, STOCK FISHERY ASSESS; Ha VV, 2014, STOCK FISHERY ASSESS; Hamilton PB, 2016, FISH FISH, V17, P545, DOI 10.1111/faf.12125; Dao HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124568; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kangas MI, 2000, SYNOPSIS BIOL EXPLOI; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kembaren Duranta D., 2018, Biodiversitas, V19, P1326; Kemppainen P, 2015, MOL ECOL RESOUR, V15, P1031, DOI 10.1111/1755-0998.12369; Kenchington EL, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P235, DOI 10.1079/9780851996332.0235; Kerr LA, 2017, ICES J MAR SCI, V74, P1708, DOI 10.1093/icesjms/fsw188; Klinbunga S, 2010, GENET MOL RES, V9, P1615, DOI 10.4238/vol9-3gmr886; Klinbunga S, 2007, BIOCHEM GENET, V45, P725, DOI 10.1007/s10528-007-9110-1; Kritzer J. P., 2014, STOCK IDENTIFICATION, P29, DOI DOI 10.1016/B978-0-12-397003-9.00003-5; Kunsook Chutapa, 2014, Tropical Life Sciences Research, V25, P41; Lai JCY, 2010, RAFFLES B ZOOL, V58, P199; Lemopoulos A, 2019, ECOL EVOL, V9, P2106, DOI 10.1002/ece3.4905; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li HY, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-99; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Macale AMB, 2017, KUROSHIO SCI, V11, P54; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miao GD, 2017, CONSERV GENET RESOUR, V9, P549, DOI 10.1007/s12686-017-0720-6; Milligan BG, 2003, GENETICS, V163, P1153; Dam MT, 2014, PROC INT CONF ADV, P36, DOI 10.1109/ATC.2014.7043352; Moore JS, 2014, MOL ECOL, V23, P5680, DOI 10.1111/mec.12972; Morgan SG, 2009, ECOLOGY, V90, P3489, DOI 10.1890/08-1550.1; Munguia-Vega A, 2015, GLOB ECOL CONSERV, V4, P264, DOI 10.1016/j.gecco.2015.07.005; Nehemia A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182987; NEWBERG MH, 1994, J CELL BIOCHEM, P344; Hung NN, 2012, HYDROL PROCESS, V26, P674, DOI 10.1002/hyp.8183; Pasuya MF, 2016, GEOM GEOSP TECHN C, P8; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pew J, 2015, MOL ECOL RESOUR, V15, P557, DOI 10.1111/1755-0998.12323; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Puritz JB, 2014, PEERJ, V2, DOI 10.7717/peerj.431; Puritz JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1238; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Ren GJ, 2018, MITOCHONDRIAL DNA A, V29, P192, DOI 10.1080/24701394.2016.1261855; Riesgo A, 2019, BMC EVOLUTIONARY BIO, V19, P1, DOI [10.1186/s12862-018-1333-8, DOI 10.1186/S12862-018-1333-8]; Schmidt-Thome P, 2015, SPRINGER BRIEFS EART, P7, DOI [10.1007/978-3-319-12346-2, DOI 10.1007/978-3-319-12346-2]; Seafood Watch Consulting Researcher, 2018, BLUE SWIMM CRAB VIET; Sezmis E, 2004, THESIS; Sienes Persie Mark Q., 2014, Philippine Science Letters, V7, P317; Sundqvist L, 2016, ECOL EVOL, V6, P3461, DOI 10.1002/ece3.2096; Svane I, 2004, BLUE SWIMMER CRAB PO; Teske PR, 2016, SCI REP-UK, V6, DOI 10.1038/srep34205; Toonen RJ, 2013, PEERJ, V1, DOI 10.7717/peerj.203; Thanh TD, 2004, REG ENVIRON CHANGE, V4, P49, DOI 10.1007/s10113-003-0062-7; Tran TD, 2006, ROLE MANGROVE CORAL, P1; Truelove NK, 2017, CORAL REEFS, V36, P233, DOI 10.1007/s00338-016-1516-y; Tureli C, 2017, MEDITERR MAR SCI, V18, P424, DOI 10.12681/mms.13789; Van Ninh P, 2000, GEOSTROPHIC DRIFT CU, P365; VASEP, 2013, VIETN LEAD SUPPL FRE; Tri VK, 2012, ENVIRON SCI ENG, P49, DOI 10.1007/978-94-007-3962-8_3; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Waples RS, 2017, MOL ECOL, V26, P1211, DOI 10.1111/mec.14022; Yap ES, 2002, MOL ECOL NOTES, V2, P30, DOI 10.1046/j.1471-8278 .2001.00136.x; Yuhara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084720; Zairion, 2015, Indian Journal of Science and Technology, V8, P596	100	7	7	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224473	10.1371/journal.pone.0224473	http://dx.doi.org/10.1371/journal.pone.0224473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KK7ZA	31689298	Green Published, gold			2022-12-26	WOS:000512955400001
J	Marcucci, L; Bondi, M; Randazzo, G; Reggiani, C; Natali, AN; Pavan, PG				Marcucci, Lorenzo; Bondi, Michela; Randazzo, Giulia; Reggiani, Carlo; Natali, Arturo N.; Pavan, Piero G.			Fibre and extracellular matrix contributions to passive forces in human skeletal muscles: An experimental based constitutive law for numerical modelling of the passive element in the classical Hill-type three element model	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; LATERAL TRANSMISSION; TITIN ISOFORMS; TENSION; STIFFNESS; VELOCITY; COLLAGEN	The forces that allow body movement can be divided into active (generated by sarcomeric contractile proteins) and passive (sustained by intra-sarcomeric proteins, fibre cytoskeleton and extracellular matrix (ECM)). These are needed to transmit the active forces to the tendon and the skeleton. However, the relative contribution of the intra- and extra- sarcomeric components in transmitting the passive forces is still under debate. There is limited data in the literature about human muscle and so it is difficult to make predictions using multiscale models, imposing a purely phenomenological description for passive forces. In this paper, we apply a method for the experimental characterization of the passive properties of fibres and ECM to human biopsy and propose their clear separation in a Finite Element Model. Experimental data were collected on human single muscle fibres and bundles, taken from vastus lateralis muscle of elderly subjects. Both were progressively elongated to obtain two stress-strain curves which were fitted to exponential equations. The mechanical properties of the extracellular passive components in a bundle of fibres were deduced by the subtraction of the passive tension observed in single fibres from the passive tension observed in the bundle itself. Our results showed that modulus and tensile load bearing capability of ECM are higher than those of fibres and defined their quantitative characterization that can be used in macroscopic models to study their role in the transmission of forces in physiological and pathophysiological conditions.	[Marcucci, Lorenzo; Bondi, Michela; Randazzo, Giulia; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Marcucci, Lorenzo; Reggiani, Carlo; Natali, Arturo N.; Pavan, Piero G.] Univ Padua, Ctr Mech Biol Mat, Padua, Italy; [Reggiani, Carlo] Kinesiol Res Ctr, Garibaldijeva, Koper, Slovenia; [Natali, Arturo N.; Pavan, Piero G.] Univ Padua, Dept Ind Engn, Padua, Italy; [Pavan, Piero G.] Fdn Ist Ric Pediat Citta Speranza, Corso Stati Uniti 4, Padua, Italy	University of Padua; University of Padua; University of Padua; Fondazione Citta della Speranza	Marcucci, L (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.; Marcucci, L (corresponding author), Univ Padua, Ctr Mech Biol Mat, Padua, Italy.	lorenzo.marcucci@gmail.com	Marcucci, Lorenzo/AAD-5771-2020	Marcucci, Lorenzo/0000-0002-9542-4417	University of Padova under the MSCA SoE @UniPD programme (Acronym of the project: "Heart Fi-Re")	University of Padova under the MSCA SoE @UniPD programme (Acronym of the project: "Heart Fi-Re")	Lorenzo Marcucci's work is supported by the University of Padova under the MSCA SoE @UniPD programme (Acronym of the project: "Heart Fi-Re", funding: Euros 150.000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleiler C, 2019, J MECH BEHAV BIOMED, V97, P171, DOI 10.1016/j.jmbbm.2019.05.012; Blemker SS, 2005, J BIOMECH, V38, P657, DOI 10.1016/j.jbiomech.2004.04.009; Brown SHM, 2012, J ORTHOP RES, V30, P1321, DOI 10.1002/jor.22068; Brynnel A, 2018, ELIFE, V7, DOI 10.7554/eLife.40532; Chen XF, 2016, J BIOMECH, V49, P2989, DOI 10.1016/j.jbiomech.2016.07.013; Gao YX, 2008, ANN BIOMED ENG, V36, P1615, DOI 10.1007/s10439-008-9547-3; Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Gindre J, 2013, J MECH BEHAV BIOMED, V22, P84, DOI 10.1016/j.jmbbm.2013.02.007; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; He ZH, 2000, BIOPHYS J, V79, P945, DOI 10.1016/S0006-3495(00)76349-1; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HOROWITS R, 1992, BIOPHYS J, V61, P392, DOI 10.1016/S0006-3495(92)81845-3; Huijing PA, 1998, J EXP BIOL, V201, P683; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Hwang W, 2005, J APPL PHYSIOL, V98, P1328, DOI 10.1152/japplphysiol.00816.2004; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lieber RL, 2011, PHILOS T R SOC B, V366, P1466, DOI 10.1098/rstb.2010.0316; LIEBER RL, 1994, J NEUROPHYSIOL, V71, P874, DOI 10.1152/jn.1994.71.3.874; Lieber RL, 2003, MUSCLE NERVE, V28, P464, DOI 10.1002/mus.10446; Lu YT, 2010, J BIOMECH, V43, P2629, DOI 10.1016/j.jbiomech.2010.05.030; MAGID A, 1985, SCIENCE, V230, P1280, DOI 10.1126/science.4071053; Marcucci L, 2017, BIOMECH MODEL MECHAN, V16, P1833, DOI 10.1007/s10237-017-0922-6; METZGER JM, 1990, SCIENCE, V247, P1088, DOI 10.1126/science.2309121; Meyer G, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.182089; Meyer GA, 2011, J BIOMECH, V44, P771, DOI 10.1016/j.jbiomech.2010.10.044; Mijailovich SM, 2010, J APPL PHYSIOL, V109, P1500, DOI 10.1152/japplphysiol.00493.2010; Moore AZ, 2014, J AM GERIATR SOC, V62, P230, DOI 10.1111/jgs.12653; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Nocella M, 2014, AM J PHYSIOL-CELL PH, V307, pC1123, DOI 10.1152/ajpcell.00290.2014; Pato MPM, 2011, COMPUT METHOD BIOMEC, V14, P505, DOI 10.1080/10255842.2010.483683; Pisot R, 2016, J APPL PHYSIOL, V120, P922, DOI 10.1152/japplphysiol.00858.2015; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; Ramaswamy KS, 2011, J PHYSIOL-LONDON, V589, P1195, DOI 10.1113/jphysiol.2010.201921; Rehorn MR, 2014, J BIOMECH, V47, P687, DOI 10.1016/j.jbiomech.2013.11.044; Rejc E, 2018, J PHYSIOL-LONDON, V596, P647, DOI 10.1113/JP274772; Sharafi B, 2011, J BIOMECH, V44, P2031, DOI 10.1016/j.jbiomech.2011.04.038; Sharafi B, 2010, J BIOMECH, V43, P3207, DOI 10.1016/j.jbiomech.2010.07.020; Silldorff MD, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01315; Smith LR, 2014, AM J PHYSIOL-CELL PH, V306, pC889, DOI 10.1152/ajpcell.00383.2013; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Spyrou LA, 2017, J THEOR BIOL, V414, P50, DOI 10.1016/j.jtbi.2016.11.018; STREET SF, 1983, J CELL PHYSIOL, V114, P346, DOI 10.1002/jcp.1041140314; Tang CY, 2009, J BIOMECH, V42, P865, DOI 10.1016/j.jbiomech.2009.01.021; Tirrell TF, 2012, J EXP BIOL, V215, P2551, DOI 10.1242/jeb.069385; Virgilio KM, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0080; WANG K, 1991, P NATL ACAD SCI USA, V88, P7101, DOI 10.1073/pnas.88.16.7101; Ward SR, 2009, J BIOMECH, V42, P1384, DOI 10.1016/j.jbiomech.2008.09.042; Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014; Zhang GZ, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0132-y	50	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224232	10.1371/journal.pone.0224232	http://dx.doi.org/10.1371/journal.pone.0224232			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LD3RX	31689322	Green Published, gold			2022-12-26	WOS:000525950900001
J	Manoranjan, B; Chokshi, C; Venugopal, C; Subapanditha, M; Savage, N; Tatari, N; Provias, JP; Murty, NK; Moffat, J; Doble, BW; Singh, SK				Manoranjan, Branavan; Chokshi, Chirayu; Venugopal, Chitra; Subapanditha, Minomi; Savage, Neil; Tatari, Nazanin; Provias, John P.; Murty, Naresh K.; Moffat, Jason; Doble, Bradley W.; Singh, Sheila K.			A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells	ONCOGENE			English	Article							CANCER STEM-CELLS; BETA-CATENIN; NEURAL PROGENITORS; ACTIVATION; CD133; EXPRESSION; AKT; TRANSACTIVATION; DIFFERENTIATION; IDENTIFICATION	Mechanistic insight into signaling pathways downstream of surface receptors has been revolutionized with integrated cancer genomics. This has fostered current treatment modalities, namely immunotherapy, to capitalize on targeting key oncogenic signaling nodes downstream of a limited number of surface markers. Unfortunately, rudimentary mechanistic understanding of most other cell surface proteins has reduced the clinical utility of these markers. CD133 has reproducibly been shown to correlate with disease progression, recurrence, and poor overall survivorship in the malignant adult brain tumor, glioblastoma (GBM). Using several patient-derived CD133(high) and CD133(low) GBMs we describe intrinsic differences in determinants of stemness, which we owe to a CD133-AKT-Wnt signaling axis in which CD133 functions as a putative cell surface receptor for AKT-dependent Wnt activation. These findings may have implications for personalized oncology trials targeting PI3K/AKT or Wnt as both pathways may be activated independent of their canonical drivers, leading to treatment resistance and disease relapse.	[Manoranjan, Branavan] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON L8S 4K1, Canada; [Manoranjan, Branavan; Chokshi, Chirayu; Venugopal, Chitra; Subapanditha, Minomi; Savage, Neil; Tatari, Nazanin; Doble, Bradley W.; Singh, Sheila K.] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8S 4K1, Canada; [Manoranjan, Branavan; Chokshi, Chirayu; Tatari, Nazanin; Doble, Bradley W.; Singh, Sheila K.] McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada; [Provias, John P.] McMaster Univ, Dept Pathol, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada; [Murty, Naresh K.; Singh, Sheila K.] McMaster Univ, Fac Hlth Sci, Surg, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada; [Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto	Singh, SK (corresponding author), McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8S 4K1, Canada.; Singh, SK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.; Singh, SK (corresponding author), McMaster Univ, Fac Hlth Sci, Surg, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	ssingh@mcmaster.ca	Moffat, Jason/AAC-1110-2020; Singh, Sheila K/W-2799-2018; Doble, Bradley/L-7551-2016	Moffat, Jason/0000-0002-5663-8586; Singh, Sheila K/0000-0003-1272-5300; Doble, Bradley/0000-0002-0260-2983; Tatari, Nazanin/0000-0002-0003-6121	Canadian Institutes of Health Research Vanier Canada Graduate Scholarship; Neurosurgical Research and Education Foundation; American Association of Neurological surgeons, Pediatric Section; Ontario Institute for Cancer Research; McMaster University Department of Surgery	Canadian Institutes of Health Research Vanier Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Neurosurgical Research and Education Foundation; American Association of Neurological surgeons, Pediatric Section; Ontario Institute for Cancer Research; McMaster University Department of Surgery	B.M. is supported by a Canadian Institutes of Health Research Vanier Canada Graduate Scholarship. S.K.S. is supported by the Neurosurgical Research and Education Foundation and American Association of Neurological surgeons, Pediatric Section, the Ontario Institute for Cancer Research, and McMaster University Department of Surgery.	Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cox CV, 2009, BLOOD, V113, P3287, DOI 10.1182/blood-2008-04-154187; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hu BL, 2016, CELL, V167, P1281, DOI 10.1016/j.cell.2016.10.039; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Lan XY, 2017, NATURE, V549, P227, DOI 10.1038/nature23666; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Rheinbay E, 2013, CELL REP, V3, P1567, DOI 10.1016/j.celrep.2013.04.021; Rossi M, 2011, CANCER BIOL THER, V11, P753, DOI 10.4161/cbt.11.8.14894; Sastre-Perona A, 2016, ONCOTARGET, V7, P49435, DOI 10.18632/oncotarget.10356; Shibahara I, 2013, NEURO-ONCOLOGY, V15, P1151, DOI 10.1093/neuonc/not066; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Taal W, 2014, LANCET ONCOL, V15, P943, DOI 10.1016/S1470-2045(14)70314-6; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Uhrbom L, 2002, CANCER RES, V62, P5551; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei W, 2016, CANCER CELL, V29, P563, DOI 10.1016/j.ccell.2016.03.012; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Weller M, 2017, LANCET ONCOL, V18, P1373, DOI 10.1016/S1470-2045(17)30517-X; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang LY, 2010, PATHOL ONCOL RES, V16, P253, DOI 10.1007/s12253-009-9219-0; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	41	21	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	7					1590	1599		10.1038/s41388-019-1086-x	http://dx.doi.org/10.1038/s41388-019-1086-x			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KL2WP	31695152				2022-12-26	WOS:000513289600014
J	Emmanuel, JS; Sengupta, A; Gordon, ER; Noble, JT; Cruz-Vera, LR				Emmanuel, Jerusha Salome; Sengupta, Arnab; Gordon, Emily Roth; Noble, Joseph Thomas; Cruz-Vera, Luis Rogelio			The regulatory TnaC nascent peptide preferentially inhibits release factor 2-mediated hydrolysis of peptidyl-tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Regulatory nascent peptides; release factor; L-tryptophan; peptidyl transferase center; ribosomal arrest; gene regulation; translation termination; tnaC; GGQ tripeptide motif	TRYPTOPHANASE OPERON EXPRESSION; 23S RIBOSOMAL-RNA; ESCHERICHIA-COLI; GGQ MOTIF; TRANSLATION; TERMINATION; INDUCTION; CODON; RF2; NUCLEOTIDES	The tnaC regulatory gene from the tna operon of Escherichia coli controls the transcription of its own operon through an attenuation mechanism relying on the accumulation of arrested ribosomes during inhibition of its own translation termination. This free L-Trp dependent mechanism of inhibition of translation termination remains unclear. Here, we analyzed the inhibitory effects of L-Trp on the function of two known E. coli translation termination factors, RF1 and RF2. Using a series of reporter genes, we found that the in vivo L-Trp sensitivity of tnaC gene expression is influenced by the identity of its stop codon, with the UGA stop codon producing higher expression efficiency of the tnaA-lacZ gene construct than the UAG stop codon. in vitro TnaC-peptidyl-tRNA accumulation and toeprinting assays confirmed that in the presence of L-Trp, the UGA stop codon generates higher accumulation of both TnaC-peptidyl-tRNA and arrested ribosomes than does the UAG stop codon. RF-mediated hydrolysis assays corroborated that L-Trp blocks RF2 function more than that of RF1. Mutational analyses disclosed that amino acids substitutions at the 246 and 256 residue positions surrounding the RF2-GGQ functional motif reduce L-Trp dependent expression of the tnaC(UGA) tnaA-lacZ construct and the ability of L-Trp to inhibit RF2-mediated cleavage of the TnaC-peptidyl-tRNA. Altogether, our results indicate that L-Trp preferentially blocks RF2 activity during translation termination of the tnaC gene. This inhibition depends on the identities of amino acid residues surrounding the RF2-GGQ functional motif.	[Emmanuel, Jerusha Salome; Sengupta, Arnab; Gordon, Emily Roth; Noble, Joseph Thomas; Cruz-Vera, Luis Rogelio] Univ Alabama, 301 Sparkman Dr, Huntsville, AL 35899 USA; [Sengupta, Arnab] North Carolina State Univ, Raleigh, NC 27695 USA; [Gordon, Emily Roth] HudsonAlpha Inst Biotechnol, Huntsville, AL USA	University of Alabama System; University of Alabama Huntsville; University of North Carolina; North Carolina State University; HudsonAlpha Institute for Biotechnology	Cruz-Vera, LR (corresponding author), Univ Alabama, 301 Sparkman Dr, Huntsville, AL 35899 USA.	luis.cruz-vera@uah.edu	Cruz-Vera, Luis Rogelio/AFV-2807-2022	Cruz-Vera, Luis Rogelio/0000-0002-4593-9957; Noble, Joseph/0000-0002-9261-4039; Emmanuel, Jerusha/0000-0002-8220-9558	Alabama Space Grant Consortium; National Science Foundation [MCB-1158271]; UAH RCEU program	Alabama Space Grant Consortium; National Science Foundation(National Science Foundation (NSF)); UAH RCEU program	We are grateful to Hani Zaher for the kind provision of the pETDuet plasmids and Karin Musier-Forsyth for provide us with L-PSA used in this study. We also thank Valerie Heurgue-Hamard for providing us with the VH1125 strain. Nora Vazquez-Laslop, Gabriel Guarneros, Frances Yap, and Tanya Sysoeva for their valuable critics regarding this version of the manuscript, and Yan Zhang and Carol Gross for their helpful discussion about their data on the expression of the tna operon under the expression of the RF2 A246 protein variant. We also want to thank previous anonymous reviewers for their observations that led us to improve the scientific content of this article. J. N. and L.R.C-V will like to tank the UAH RCEU program and Alabama Space Grant Consortium for supporting J.N. during the course of his work. This work was supported by National Science Foundation [MCB-1158271 to L.R.C-V].	Adio S, 2018, ELIFE, V7, DOI 10.7554/eLife.34252; Bischoff L, 2014, CELL REP, V9, P469, DOI 10.1016/j.celrep.2014.09.011; Burakovsky DE, 2010, RNA, V16, P1848, DOI 10.1261/rna.2185710; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; DEELEY MC, 1982, J BACTERIOL, V151, P942, DOI 10.1128/JB.151.2.942-951.1982; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; GOLLNICK P, 1990, J BACTERIOL, V172, P3100, DOI 10.1128/jb.172.6.3100-3107.1990; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Gong M, 2006, J BACTERIOL, V188, P1892, DOI 10.1128/JB.188.5.1892-1898.2006; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; Konan KV, 1999, J BACTERIOL, V181, P1530, DOI 10.1128/JB.181.5.1530-1536.1999; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Martinez AK, 2014, NUCLEIC ACIDS RES, V42, P1245, DOI 10.1093/nar/gkt923; Martinez AK, 2012, NUCLEIC ACIDS RES, V40, P2247, DOI 10.1093/nar/gkr1052; Mora L, 2007, J BIOL CHEM, V282, P35638, DOI 10.1074/jbc.M706076200; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierson WE, 2016, CELL REP, V17, P11, DOI 10.1016/j.celrep.2016.08.085; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sanbonmatsu KY, 2005, P NATL ACAD SCI USA, V102, P15854, DOI 10.1073/pnas.0503456102; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; STEWART V, 1986, J BACTERIOL, V167, P383, DOI 10.1128/jb.167.1.383-386.1986; STEWART V, 1985, J BACTERIOL, V164, P731, DOI 10.1128/JB.164.2.731-740.1985; Svidritskiy E, 2018, STRUCTURE, V26, P821, DOI 10.1016/j.str.2018.04.001; TIAN P, 2018, P NATL ACAD SCI US, V0115; Trappl K, 2016, J MOL BIOL, V428, P1333, DOI 10.1016/j.jmb.2016.01.021; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wood TK, 2011, TRENDS BIOTECHNOL, V29, P87, DOI 10.1016/j.tibtech.2010.11.001; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; Yang R, 2009, J BACTERIOL, V191, P3445, DOI 10.1128/JB.00096-09; YANOFSKY C, 1991, J BACTERIOL, V173, P6009, DOI 10.1128/jb.173.19.6009-6017.1991; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3	43	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19224	19235		10.1074/jbc.RA119.011313	http://dx.doi.org/10.1074/jbc.RA119.011313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31712310	Green Published, hybrid			2022-12-26	WOS:000516527800022
J	Dang, C; Han, B; Li, Q; Han, RR; Hao, JW				Dang, Chun; Han, Bin; Li, Qian; Han, Ranran; Hao, Junwei			Up-regulation of PGC-1 alpha in neurons protects against experimental autoimmune encephalomyelitis	FASEB JOURNAL			English	Article						neuronal apoptosis; EAE; ROS	MITOCHONDRIAL BIOGENESIS; NLRP3 INFLAMMASOME; TRANSCRIPTIONAL CONTROL; UNCOUPLING PROTEINS; DYSFUNCTION; ACTIVATION; EXPRESSION; NEURODEGENERATION; SUPPRESSION; RESPIRATION	Reactive oxygen species (ROS) generation and mitochondrial dysfunction are related to neuron loss in multiple sclerosis (MS). Although peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha) appears to play a key role in modulating levels of mitochondrial ROS, antioxidants, and uncoupling proteins (UCPs), and PGC-1 alpha expression is reduced in the neocortex of patients with MS, it is unclear what its role is in neurons and in the manifestation of clinical symptoms of MS. Here, we show in wild-type (WT) experimental autoimmune encephalomyelitis (EAE) mice that PGC-1 alpha is decreased 13 d after EAE induction followed by a steady decline up to 20 d. These changes were accompanied by parallel alterations in levels of superoxide dismutase 2, peroxiredoxin 3, thioredoxin 2, UCP4, and UCP5. In transgenic (TG) mice with neuron-specific overexpression of PGC-1 alpha (PGC-1 alpha(f/f)Eno2-Cre), clinical symptoms after EAE induction were delayed and less severe than in WT mice. The degrees of apoptotic neuron loss and demyelination were also less severe in PGC-1 alpha-TG mice. Overexpression of PGC-1 alpha in neuronal neuroblastoma spinal cord 34 cells subjected to EAE inflammatory conditions showed similar results to those obtained in vivo. RNA sequencing analysis showed that apoptotic processes were significantly enriched in the top 10 significant gene ontology (GO) terms of differentially expressed genes, and the apoptotic pathway was significantly enriched in Kyoto Encyclopedia of Genes and Genomes pathway analysis. Our findings indicate that up-regulation of neuronal PGC-1 alpha protected neurons from apoptosis in EAE. Manipulating PGC-1 alpha levels in MS may help stave off this devastating disease.	[Dang, Chun; Han, Ranran; Hao, Junwei] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurol, Gen Hosp, Tianjin 300052, Peoples R China; [Han, Bin] Qingdao Univ, Dept Neurol, Affiliated Hosp, Qingdao, Peoples R China; [Li, Qian] Harbin Med Univ, Dept Neurol, Affiliated Hosp 2, Harbin, Peoples R China	Tianjin Medical University; Qingdao University; Harbin Medical University	Hao, JW (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurol, Gen Hosp, Tianjin 300052, Peoples R China.	hjw@tmu.edu.cn	Dang, Chun/AAK-5524-2021	Dang, Chun/0000-0001-5023-6095	National Natural Science Foundation of China [81571600, 81322018, 81273287, 81100887, 81825008, 81870954]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81571600, 81322018,81273287, 81100887, 81825008, and 81870954). The authors declare no conflicts of interest.	Ahmed Z, 2002, AM J PATHOL, V161, P1577, DOI 10.1016/S0002-9440(10)64436-7; Akhtar RS, 2004, BBA-MOL CELL RES, V1644, P189, DOI 10.1016/j.bbamcr.2003.10.013; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Aviello G, 2017, BRIT J PHARMACOL, V174, P1704, DOI 10.1111/bph.13428; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; BENNUN A, 1982, J IMMUNOL, V128, P1450; Bittner S, 2014, JOVE-J VIS EXP, DOI 10.3791/51275; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Buttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197; Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Chernousova S, 2017, GENE THER, V24, P282, DOI 10.1038/gt.2017.13; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Council N. R, 2011, GUIDE CARE USE LAB A; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Diao L, 2014, SHOCK, V41, P138, DOI 10.1097/SHK.0000000000000075; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; Giatti S, 2012, J NEUROENDOCRINOL, V24, P851, DOI 10.1111/j.1365-2826.2012.02284.x; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hwang IK, 2010, FREE RADICAL BIO MED, V48, P1242, DOI 10.1016/j.freeradbiomed.2010.02.007; Jiang W, 2017, P NATL ACAD SCI USA, V114, pE6202, DOI 10.1073/pnas.1705491114; Kang YH, 2018, CELL REP, V22, P3493, DOI 10.1016/j.celrep.2018.02.071; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kupershmidt L, 2009, FASEB J, V23, P3766, DOI 10.1096/fj.09-130047; Li DJ, 2018, CELL REP, V22, P3574, DOI 10.1016/j.celrep.2018.03.011; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Loh KP, 2010, STROKE, V41, P2661, DOI 10.1161/STROKEAHA.110.589895; Mao GX, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/750963; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Marchev AS, 2017, ANN NY ACAD SCI, V1401, P114, DOI 10.1111/nyas.13407; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nakase T, 2007, NEUROPATHOLOGY, V27, P442, DOI 10.1111/j.1440-1789.2007.00815.x; Nijland PG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0170-2; Nimmagadda VK, 2013, J IMMUNOL, V190, P4595, DOI 10.4049/jimmunol.1202584; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Pandit A, 2009, J NEUROL SCI, V279, P14, DOI 10.1016/j.jns.2009.01.009; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Remels AHV, 2010, FASEB J, V24, P5052, DOI 10.1096/fj.09-150714; Rupprecht A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041406; Sattler MB, 2010, EXP NEUROL, V225, P40, DOI 10.1016/j.expneurol.2009.08.016; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Smorodchenko A, 2009, BBA-BIOMEMBRANES, V1788, P2309, DOI 10.1016/j.bbamem.2009.07.018; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Sweeney G, 2016, ANAT CELL BIOL, V49, P1, DOI 10.5115/acb.2016.49.1.1; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Vera-Ramirez L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04070-6; Vince JE, 2016, CELL MOL LIFE SCI, V73, P2349, DOI 10.1007/s00018-016-2205-2; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Witte ME, 2013, ACTA NEUROPATHOL, V125, P231, DOI 10.1007/s00401-012-1052-y; Witte ME, 2009, J PATHOL, V219, P193, DOI 10.1002/path.2582; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Ye XC, 2017, EXP NEUROL, V292, P46, DOI 10.1016/j.expneurol.2017.03.002	65	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14811	14824		10.1096/fj.201901149RR	http://dx.doi.org/10.1096/fj.201901149RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31718280				2022-12-26	WOS:000507466100134
J	Sakimoto, Y; Kida, H; Mitsushima, D				Sakimoto, Yuya; Kida, Hiroyuki; Mitsushima, Dai			Temporal dynamics of learning-promoted synaptic diversity in CA1 pyramidal neurons	FASEB JOURNAL			English	Article						AMPA receptor; glutamate; GABA(A) receptor; GABA; contextual learning	GABA(A) RECEPTOR PHOSPHORYLATION; GAMMA-AMINOBUTYRIC-ACID; LONG-TERM POTENTIATION; PROTEIN-KINASE; HOMEOSTATIC PLASTICITY; FUNCTIONAL MODULATION; ALZHEIMERS-DISEASE; SILENT SYNAPSES; AMPA RECEPTORS; DIRECT BINDING	Although contextual learning requires plasticity at both excitatory and inhibitory (E/I) synapses in cornu ammonis 1 (CA1) neurons, the temporal dynamics across the neuronal population are poorly understood. Using an inhibitory avoidance task, we analyzed the dynamic changes in learning-induced E/I synaptic plasticity. The training strengthened GABA(A) receptor mediated synapses within 1 min, peaked at 10 min, and lasted for over 60 min. The intracellular loop (Ser(408-409)) of GABAA receptor beta(3) subunit was also phosphorylated within 1 min of training. As the results of strengthening of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor- mediated synapses, CA1 pyramidal neurons exhibited broad diversity of E/I synaptic currents within 5 min. Moreover, presynaptic glutamate release probability at basal dendrites also increased within 5 min. To further quantify the diversified E/I synaptic currents, we calculated self-entropy (bit) for individual neurons. The neurons showed individual levels of the parameter, which rapidly increased within 1 min of training and maintained for over 60 min. These results suggest that learning-induced synaptic plasticity is critical immediately following encoding rather than during the retrieval phase of the learning. Understanding the temporal dynamics along with the quantification of synaptic diversity would be necessary to identify a failure point for learning-promoted plasticity in cognitive disorders.	[Sakimoto, Yuya; Kida, Hiroyuki; Mitsushima, Dai] Yamaguchi Univ, Grad Sch Med, Dept Physiol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan; [Mitsushima, Dai] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University	Mitsushima, D (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Physiol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	mitsu@yamaguchi-u.ac.jp	Skimoto, Yuya/GLU-9872-2022		Ministry of Education, Culture, Sports, Science, and Technology of Japan [16H05129, 19H03402, 25460314, 26115518]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank H. Tsurutani for technical support of Western blot, and R. Fujimoto for helpful comments (both from Yamaguchi University). This project was supported by Grants-in-Aid for Scientific Research B (Grants 16H05129 and 19H03402 to D. M.), Scientific Research C (Grant 25460314 to Y.S. and D.M.), and Scientific Research in Innovative Areas (Grant 26115518 to D.M.) from the the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare no conflicts of interest.	[Anonymous], 2017, J PHYSIOL SCI; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bonini JS, 2003, BEHAV PHARMACOL, V14, P161, DOI 10.1097/00008877-200303000-00008; Brandon NJ, 2002, J NEUROSCI, V22, P6353; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Bromer C, 2018, P NATL ACAD SCI USA, V115, pE2410, DOI 10.1073/pnas.1716189115; CASTELLANO C, 1990, BEHAV NEURAL BIOL, V54, P156, DOI 10.1016/0163-1047(90)91352-C; Choi JH, 2018, SCIENCE, V360, P430, DOI 10.1126/science.aas9204; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; de Luca E, 2017, NEURON, V95, P63, DOI 10.1016/j.neuron.2017.06.022; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hori T, 2012, NEURON, V76, P511, DOI 10.1016/j.neuron.2012.08.013; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Jaafari N, 2012, J NEUROSCI, V32, P11618, DOI 10.1523/JNEUROSCI.5068-11.2012; JERUSALINSKY D, 1992, BEHAV NEURAL BIOL, V58, P76, DOI 10.1016/0163-1047(92)90982-A; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Kida H, 2017, JOVE-J VIS EXP, DOI 10.3791/55876; Kida H, 2016, CEREB CORTEX, V26, P3494, DOI 10.1093/cercor/bhw134; Kim DH, 2012, NEUROPSYCHOPHARMACOL, V37, P422, DOI 10.1038/npp.2011.189; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kowalczyk S, 2013, EUR J NEUROSCI, V37, P544, DOI 10.1111/ejn.12078; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Lu H, 2010, NEURON, V67, P821, DOI 10.1016/j.neuron.2010.08.012; Luft T, 2004, NEUROBIOL LEARN MEM, V82, P52, DOI 10.1016/j.nlm.2004.03.002; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Martinez-Bellver S, 2017, J PHYSIOL-LONDON, V595, P1775, DOI 10.1113/JP272841; MCDONALD BJ, 1994, J BIOL CHEM, V269, P18111; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mele M, 2016, J NEUROCHEM, V139, P997, DOI 10.1111/jnc.13742; Mendez P, 2018, CELL REP, V22, P1451, DOI 10.1016/j.celrep.2018.01.025; MITSUSHIMA D, 1994, P NATL ACAD SCI USA, V91, P395, DOI 10.1073/pnas.91.1.395; Mitsushima D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3760; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Mitsushima D, 2009, J NEUROSCI, V29, P3808, DOI 10.1523/JNEUROSCI.5301-08.2009; Morris R, 2006, HIPPOCAMPUS BOOK, P581, DOI DOI 10.1093/ACPROF:OSO/9780195100273.003.0013; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petrini EM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00300; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Prange O, 1999, J NEUROSCI, V19, P6427; Pugh JR, 2005, BIOPHYS J, V88, P1740, DOI 10.1529/biophysj.104.055814; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ren SQ, 2013, EMBO J, V32, P1365, DOI 10.1038/emboj.2013.60; Renner MC, 2017, ELIFE, V6, DOI 10.7554/eLife.25462; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sakimoto Y, 2019, CEREB CORTEX, V29, P2183, DOI 10.1093/cercor/bhz022; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sheather SJ, 2004, STAT SCI, V19, P588, DOI 10.1214/088342304000000297; Silverman BW., 1986, DENSITY ESTIMATION S, V26, DOI 10.1201/9781315140919; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Takemoto K, 2017, NAT BIOTECHNOL, V35, P38, DOI 10.1038/nbt.3710; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Townsend M, 2016, J NEUROPHYSIOL, V116, P2663, DOI 10.1152/jn.00243.2016; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tretter V, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00023; Ulrich D, 2015, J NEUROSCI, V35, P9205, DOI 10.1523/JNEUROSCI.0950-15.2015; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	83	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14382	14393		10.1096/fj.201801893RRR	http://dx.doi.org/10.1096/fj.201801893RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31689120	Green Published, hybrid			2022-12-26	WOS:000507466100102
J	Mohammed, P; Linden, A; Reilly, M				Mohammed, Perry; Linden, Andrea; Reilly, Maura			Quantifying pediatric patient need for second- and third-line HIV treatment: A tool for decision-making in resource-limited settings	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY	As national HIV programs across the world mature and continue to scale up towards UNAIDS' 90-90-90 targets, it is increasingly important to accurately estimate HIV treatment needs in pediatric patient populations to prepare for anticipated increases in demand. This is particularly vital in sub-Saharan Africa, where the bulk of the global pediatric HIV burden remains concentrated, and for treatment-experienced populations, for which data are severely limited. This article discusses the conceptual framework behind and application of a five-year country-level quantification and decision-making tool aimed at providing national HIV programs and their partners with a better understanding of their evolving national HIV treatment and programming needs for second-and third-line pediatric populations. The conceptual framework of the algorithm which undergirds the tool is the patient pathway, along which key influencing factors that determine whether pediatric HIV patients are linked to care, remain in treatment, and are appropriately switched to later lines of treatment are accounted for quantitatively. Excel-based and arithmetic, the algorithm is designed to use available national, regional, and global data for factors impacting patient estimates including treatment coverage; routine viral load testing; viral load non-suppression; confirmed treatment failure; and patient loss to follow up-outcomes for which data are generally very limited in this patient population. The ultimate output of the tool is an estimate of the aggregate annual number of patients by treatment line. Given the limitations in available data for pediatric HIV, particularly for patients on second- and third-line treatments, this tool may help fill a data gap by providing a mechanism for policymakers to scenario plan, thus aiding resource allocation decisions for pediatric HIV program scale-up. The tool may be used to streamline national antiretroviral procurement of later lines of treatment, especially in resource-limited settings, and may also be used to add value to broader HIV policy and planning processes at the national level.	[Mohammed, Perry] Johnson & Johnson, Global Publ Hlth, High Wycombe, Herts, England; [Linden, Andrea; Reilly, Maura] Rabin Martin, New York, NY 10018 USA	Johnson & Johnson	Linden, A (corresponding author), Rabin Martin, New York, NY 10018 USA.	Andrea.Linden@rabinmartin.com			Johnson & Johnson Global Public Health; Johnson & Johnson and Rabin Martin	Johnson & Johnson Global Public Health; Johnson & Johnson and Rabin Martin	This work was supported exclusively by Johnson & Johnson Global Public Health. The authors did not receive separate funding for this work. Johnson & Johnson and Rabin Martin provided support in the form of salaries for authors PM and AL and MR, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	African Society for Laboratory Medicine (ASLM), 2014, LAB CHALL VIR LOAD I; Bastard M, 2016, PEDIATR INFECT DIS J, V35, P981, DOI 10.1097/INF.0000000000001213; Clinton Health Access Initiative (CHAI), 2017, SIMPL PED ARV FOR TO; Clinton Health Access Initiative (CHAI), 2015, STAT ANT DRUG MARK L; Corrigan B, 2018, PEDIATR INFECT DIS J, V37, P669, DOI 10.1097/INF.0000000000001843; Habiyambere V, 2016, WHO GLOBAL ARVS DIAG; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2019, COMM CTR DEF RIGHTS; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2019, AIDSINFO DAT; Lazarus Erica, 2017, Pediatr Infect Dis J, V36, P492, DOI 10.1097/INF.0000000000001481; Lecher S, 2016, MMWR-MORBID MORTAL W, V65, P1332, DOI 10.15585/mmwr.mm6547a2; Mahy M, 2017, AIDS, V31, pS13, DOI 10.1097/QAD.0000000000001306; Meintjes G, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0081-8; Moorhouse M, 2019, JAIDS-J ACQ IMM DEF, V80, P73, DOI 10.1097/QAI.0000000000001883; National AIDS & STI Control Programme (NASCOP), 2016, NAT ACT DASHB; National AIDS & STI Control Programme (NASCOP), 2019, VIR LOAD SYST; Penazzato M, 2014, AIDS, V28, pS445, DOI 10.1097/QAD.0000000000000481; PHMSA, 2019, DAT STAT; Saphonn V, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-7; UNICEF, 2017, CHILDREN AIDS STAT U; United States Centers for Disease Control and Prevention (CDC), 2015, STRAT ID LINK HIV IN; United States President's Emergency Plan for AIDS Relief (PEPFAR), 2018, KEN COUMNTR OP PLAN; United States President's Emergency Plan for AIDS Relief (PEPFAR) and Children's Investment Fund Foundation (CIFF), 2017, PROM PRACT LESS LEAR; WHO CDC Global Fund., 2017, GLOB FUND HIV DRUG R; World Health Organisation (WHO), 2017, GUID PUBL HLTH RESP; World Health Organization, 2017, GUID MAN ADV HIV DIS; Wynberg E, 2018, CLIN DRUG INVEST, V38, P231, DOI 10.1007/s40261-017-0605-1; Zwinkels D., 2012, WHO AMDS PARTN M GEN	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224226	10.1371/journal.pone.0224226	http://dx.doi.org/10.1371/journal.pone.0224226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725749	Green Published, gold			2022-12-26	WOS:000532764500014
J	de la Cruz-Pavia, I; Gervain, J; Vatikiotis-Bateson, E; Werker, JF				de la Cruz-Pavia, Irene; Gervain, Judit; Vatikiotis-Bateson, Eric; Werker, Janet F.			Finding phrases: On the role of co-verbal facial information in learning word order in infancy	PLOS ONE			English	Article							PROSODIC PROMINENCE; VISUAL INFORMATION; HEAD MOTION; SPEECH; PERCEPTION; ACQUISITION; INTEGRATION; GESTURE; LIPS	The input contains perceptually available cues, which might allow young infants to discover abstract properties of the target language. Thus, word frequency and prosodic prominence correlate systematically with basic word order in natural languages. Prelexical infants are sensitive to these frequency-based and prosodic cues, and use them to parse new input into phrases that follow the order characteristic of their native languages. Importantly, young infants readily integrate auditory and visual facial information while processing language. Here, we ask whether co-verbal visual information provided by talking faces also helps prelexical infants learn the word order of their native language in addition to word frequency and prosodic prominence. We created two structurally ambiguous artificial languages containing head nods produced by an animated avatar, aligned or misaligned with the frequency-based and prosodic information. During 4 minutes, two groups of 4- and 8-month-old infants were familiarized with the artificial language containing aligned auditory and visual cues, while two further groups were exposed to the misaligned language. Using a modified Head-turn Preference Procedure, we tested infants' preference for test items exhibiting the word order of the native language, French, vs. the opposite word order. At 4 months, infants had no preference, suggesting that 4-month-olds were not able to integrate the three available cues, or had not yet built a representation of word order. By contrast, 8-month-olds showed no preference when auditory and visual cues were aligned and a preference for the native word order when visual cues were misaligned. These results imply that infants at this age start to integrate the co-verbal visual and auditory cues.	[de la Cruz-Pavia, Irene; Gervain, Judit] Univ Paris 05, Sorbonne Paris Cite, Integrat Neurosci & Cognit Ctr, INCC UMR 8002, Paris, France; [de la Cruz-Pavia, Irene; Gervain, Judit] CNRS, INCC UMR 8002, Integrat Neurosci & Cognit Ctr, Paris, France; [de la Cruz-Pavia, Irene; Werker, Janet F.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Vatikiotis-Bateson, Eric] Univ British Columbia, Dept Linguist, Vancouver, BC, Canada	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of British Columbia; University of British Columbia	de la Cruz-Pavia, I (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Integrat Neurosci & Cognit Ctr, INCC UMR 8002, Paris, France.; de la Cruz-Pavia, I (corresponding author), CNRS, INCC UMR 8002, Integrat Neurosci & Cognit Ctr, Paris, France.	irene.de-la-cruz-pavia@parisdescartes.fr	de la Cruz-Pavía, Irene/Y-8191-2019	de la Cruz-Pavía, Irene/0000-0003-3425-0596; Gervain, Judit/0000-0002-2125-6369; Werker, Janet F./0000-0002-1168-9013	Marie Curie International Outgoing Fellowship within the EU [624972]; Natural Sciences and Engineering Research Council [RGPIN-2015-03967]; French Investissements d'Avenir - Labex EFL program [ANR-10-LABX-0083]; ANR [ANR-15-CE37-0009-01]; ERC [773202 ERC-2017-COG]	Marie Curie International Outgoing Fellowship within the EU; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); French Investissements d'Avenir - Labex EFL program(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission)	This research was supported by a Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development (2007-2013) under REA grant agreement no. [624972] awarded to ICP (https://ec.europa.eu/research/fp7/index_en.cfm), Natural Sciences and Engineering Research Council (RGPIN-2015-03967; http://www.nserccrsng.gc.ca/index_eng.asp) to J.F.W., as well as the French Investissements d'Avenir - Labex EFL program (ANR-10-LABX-0083; http://www.enseignementsup-recherche.gouv.fr/cid55551/investissements-d-avenir-projets-laboratoires-dexcellence-par-region-et-domaine.html), ANR grant (ANR-15-CE37-0009-01; http://www.agencenationale-recherche.fr/en/), and ERC Consolidator Grant (773202 ERC-2017-COG `BabyRhythm'; https://erc.europa.eu/funding/consolidator-grants) to J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Moubayed S, 2010, J MULTIMODAL USER IN, V3, P299, DOI 10.1007/s12193-010-0054-0; Bernard C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00451; Brown R., 1973, 1 LANGUAGE; Burnham D, 2004, DEV PSYCHOBIOL, V45, P204, DOI 10.1002/dev.20032; Cave C, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P2175, DOI 10.1109/ICSLP.1996.607235; Christophe A, 1997, LANG COGNITIVE PROC, V12, P585, DOI 10.1080/016909697386637; Christophe A, 2003, DEVELOPMENTAL SCI, V6, P211, DOI 10.1111/1467-7687.00273; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cunillera T, 2010, Q J EXP PSYCHOL, V63, P260, DOI 10.1080/17470210902888809; Danielson DK, 2017, COGNITIVE DEV, V42, P37, DOI 10.1016/j.cogdev.2017.02.004; de la Cruz-Pavia I, 2020, LANG ACQUIS, V27, P160, DOI 10.1080/10489223.2019.1659276; de la Cruz-Pavia I, 2020, LANG SPEECH, V63, P264, DOI 10.1177/0023830919842353; Dohen M., 2006, SPEECH PROSODY 2006, P221; Dohen M, 2009, LANG SPEECH, V52, P177, DOI 10.1177/0023830909103166; Dutoit T., 1997, INTRO TEXT TO SPEECH, DOI [DOI 10.1007/978-94-011-5730-8, 10.1007/978-94-011-5730-8]; Esteve-Gibert N, 2015, INFANT BEHAV DEV, V38, P126, DOI 10.1016/j.infbeh.2014.12.016; Gervain J, 2008, COGNITIVE PSYCHOL, V57, P56, DOI 10.1016/j.cogpsych.2007.12.001; Gervain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2430; Gonzalez-Gomez N, 2019, J EXP CHILD PSYCHOL, V178, P170, DOI 10.1016/j.jecp.2018.08.014; Granstrom B, 2005, SPEECH COMMUN, V46, P473, DOI 10.1016/j.specom.2005.02.017; Hollich G, 2005, CHILD DEV, V76, P598, DOI 10.1111/j.1467-8624.2005.00866.x; Ishi CT, 2014, SPEECH COMMUN, V57, P233, DOI 10.1016/j.specom.2013.06.008; Kim J, 2014, SPEECH COMMUN, V57, P317, DOI 10.1016/j.specom.2013.06.003; Krahmer E, 2007, J MEM LANG, V57, P396, DOI 10.1016/j.jml.2007.06.005; Kubicek C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089275; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Lewkowicz DJ, 1996, J EXP PSYCHOL HUMAN, V22, P1094, DOI 10.1037/0096-1523.22.5.1094; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Mitchel AD, 2014, LANG COGN NEUROSCI, V29, P771, DOI 10.1080/01690965.2013.791703; Mixdorff H, 2013, P AVSP; MORGAN JL, 1987, COGNITIVE PSYCHOL, V19, P498, DOI 10.1016/0010-0285(87)90017-X; MORGAN JL, 1995, CHILD DEV, V66, P911, DOI 10.2307/1131789; Morgan JL, 1996, SIGNAL TO SYNTAX: BOOTSTRAPPING FROM SPEECH TO GRAMMAR IN EARLY ACQUISITION, P1; Munhall KG, 2004, PSYCHOL SCI, V15, P133, DOI 10.1111/j.0963-7214.2004.01502010.x; NELSON DGK, 1995, INFANT BEHAV DEV, V18, P111; Nespor M., 2008, L L, V7, P1, DOI DOI 10.1418/28093; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Prieto P, 2015, J PHONETICS, V49, P41, DOI 10.1016/j.wocn.2014.10.005; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; Scarborough R, 2009, LANG SPEECH, V52, P135, DOI 10.1177/0023830909103165; Shaw K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126059; Swerts M, 2008, J PHONETICS, V36, P219, DOI 10.1016/j.wocn.2007.05.001; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; Thiessen ED, 2010, COGNITIVE SCI, V34, P1093, DOI 10.1111/j.1551-6709.2010.01118.x; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; Yehia HC, 2002, J PHONETICS, V30, P555, DOI 10.1006/jpho.2002.0165	47	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224786	10.1371/journal.pone.0224786	http://dx.doi.org/10.1371/journal.pone.0224786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710615	gold, Green Published			2022-12-26	WOS:000532699900019
J	Whitt, CE; Tauer, LW; Huson, H				Whitt, Christine E.; Tauer, Loren W.; Huson, Heather			Bull efficiency using dairy genetic traits	PLOS ONE			English	Article							PRODUCTIVITY GROWTH; ECONOMIC WEIGHTS; INDEX	Dairy bulls are evaluated using progeny data and genomic testing to determine the quantity of specific traits that they will pass to their daughters. Some bulls excel in some traits but not others. Specifying these various traits as outputs, with the single input of insemination, technical, revenue, allocative, and profit efficiency of bulls available for artificial insemination are estimated using Free Disposal Hull. Although bulls generally are highly technically efficient, because only high performing bull semen is offered for sale, bulls are less revenue, allocative and profit efficient. These efficiencies are relative to peer bulls and can be updated as new bulls become available.	[Whitt, Christine E.] USDA, ERS, Washington, DC 20250 USA; [Tauer, Loren W.] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Cornell SC Johnson Coll Business, Ithaca, NY USA; [Huson, Heather] Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14853 USA	United States Department of Agriculture (USDA); Cornell University; Cornell University	Whitt, CE (corresponding author), USDA, ERS, Washington, DC 20250 USA.	cs2292@cornell.edu		Huson, Heather/0000-0001-8299-0447				AMER P, 1995, AM J AGR ECON, V77, P1054, DOI 10.2307/1243829; AMER PR, 1992, ANIM PROD, V54, P341, DOI 10.1017/S0003356100020791; AMER PR, 1994, ANIM PROD, V58, P11, DOI 10.1017/S0003356100007029; Atsbeha DM, 2015, J PROD ANAL, V43, P403, DOI 10.1007/s11123-014-0412-0; Atsbeha DM, 2012, AM J AGR ECON, V94, P996, DOI 10.1093/ajae/aas033; BABCOCK BA, 1991, AM J AGR ECON, V73, P850, DOI 10.2307/1242837; Bogetoft P, 2011, BENCHMARKING DEA SFR; Brown G, 2001, RESOUR ENERGY ECON, V33, P355; Chavas JP, 2019, ENVIRON RESOUR ECON, V42, P109; Cole JB, 2007, J DAIRY SCI, V90, P2489, DOI 10.3168/jds.2006-436; Holstein Foundation, 2017, UND GEN; Jaenicke EC, 1999, AM J AGR ECON, V81, P881, DOI 10.2307/1244331; Kerr AW, 1984, W J AGR EC, V9, P14; Mareth T, 2017, INT J PRODUCT PERFOR, V66, P380, DOI 10.1108/IJPPM-09-2015-0131; Nalley LL, 2010, AGR ECON-BLACKWELL, V41, P453, DOI 10.1111/j.1574-0862.2010.00457.x; Pryce JE, 2012, J DAIRY SCI, V95, P377, DOI 10.3168/jds.2011-4254; Richards TJ, 1996, CANADIAN J AGR EC, V44, P1; SHANKS RD, 1979, J DAIRY SCI, V62, P1429, DOI 10.3168/jds.S0022-0302(79)83441-4; Simar L, 1998, MANAGE SCI, V44, P49, DOI 10.1287/mnsc.44.1.49; Tauer LW, 2001, APPL ECON LETT, V8, P295, DOI 10.1080/135048501750157422; VanRaden PM, NET MERIT MEASURE LI; Weigel K, 2010, HIGH PLAINS DAIR C	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0223436	10.1371/journal.pone.0223436	http://dx.doi.org/10.1371/journal.pone.0223436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710626	Green Published, gold			2022-12-26	WOS:000532699900004
J	Tran, BX; Dang, AK; Vu, GT; Tran, TT; Latkin, CA; Ho, CSH; Ho, RCM				Bach Xuan Tran; Anh Kim Dang; Giang Thu Vu; Tung Thanh Tran; Latkin, Carl A.; Ho, Cyrus S. H.; Ho, Roger C. M.			Patient satisfaction with HIV services in Vietnam: Status, service models and association with treatment outcome	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV/AIDS PATIENTS; QUALITY; CARE; QUESTIONNAIRE; EXPERIENCE; ADHERENCE; SURVIVAL	This study assessed the satisfaction of patients receiving antiretroviral treatment (ART) in Vietnam and its multilevel predictors. Cross-sectional data were collected from January to September 2013 in eight outpatient clinics in Hanoi and Nam Dinh provinces. Patient satisfaction was evaluated using the Satisfaction with HIV/AIDS Treatment Interview Scale. Multivariable Tobit regression was utilized to measure the associations between these factors and satisfaction with treatment services. Generalized Mixed-effect Regression model was used to estimate the effect of satisfaction with the quality of service on the change between the initial and the latest CD4 cell count. Among 1133 patients, most of them were completely satisfied with the 10 domains measured (65.5% to 82.5%). "Service quality and convenience" domain which was attributed by the waiting time and administrative procedure had the lowest score of complete satisfaction. Compared to central clinics, provincial clinics were negatively associated with the overall satisfaction (Coef = -0.58; 95%CI = -0.95;-0.21). Patients rating higher score in "Consultation, explanation, and guidance of health care workers", "Responsiveness of health care workers to patients' questions and requests" and "Perceived overall satisfaction with the quality of service" were related to improvement in immunological treatment outcomes. Our results revealed the high level of satisfaction among ART patients towards HIV care and treatment services, and this had a high correlation to treatment outcomes. Interventions should focus on reducing administrative procedures, providing sufficient guidance and comprehensive services which integrate physical with psychological care for improving the health outcome of the ART program.	[Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Bach Xuan Tran; Latkin, Carl A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Anh Kim Dang] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Giang Thu Vu; Tung Thanh Tran] Nguyen Tat Thanh Univ, Ctr Excellence Evidence Based Med, Ho Chi Minh City, Vietnam; [Ho, Cyrus S. H.] Natl Univ Singapore Hosp, Dept Psychol Med, Singapore, Singapore; [Ho, Roger C. M.] Nguyen Tat Thanh Univ, Ctr Excellence Behav Med, Ho Chi Minh City, Vietnam; [Ho, Roger C. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Ho, Roger C. M.] Natl Univ Singapore, Inst Hlth Innovat & Technol iHealthtech, Singapore, Singapore	Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Duy Tan University; Nguyen Tat Thanh University (NTTU); National University of Singapore; Nguyen Tat Thanh University (NTTU); National University of Singapore; National University of Singapore	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.; Tran, BX (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	bach.ipmph@gmail.com	Ho, Roger/ABD-8859-2021; Ho, Cyrus SH/AAN-9344-2020; Ho, Roger C./ABD-9061-2021	Ho, Cyrus SH/0000-0002-7092-9566; Ho, Roger C./0000-0001-9629-4493				Aiken Linda H, 2012, BMJ, V344, pe1717, DOI 10.1136/bmj.e1717; Tran BX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142644; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.19570, 10.3402/gha.v6i0.18619]; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046680; Baker T L, 1997, Health Mark Q, V15, P1; Control VAoHA, 2013, VIETN HIV AIDS EST P; Dang BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054729; Devnani M, 2012, AIDS CARE, V24, P100, DOI 10.1080/09540121.2011.592816; Dixit S, 2018, PATIENT SATISFACTION, V5, P8; FITZPATRICK R, 1991, BMJ-BRIT MED J, V302, P1129, DOI 10.1136/bmj.302.6785.1129; Flickinger TE, 2013, JAIDS-J ACQ IMM DEF, V63, P362, DOI 10.1097/QAI.0b013e318295b86a; Gupta D, 2014, SUPPORT CARE CANCER, V22, P129, DOI 10.1007/s00520-013-1956-7; Gupta D, 2013, J HEALTHC QUAL, V35, P37, DOI 10.1111/j.1945-1474.2012.00217.x; Hogan Beth, 2007, Health Mark Q, V24, P93, DOI 10.1080/07359680802125923; Karunamoorthi K, 2009, EUR REV MED PHARMACO, V13, P331; Kato M, 2014, CURR HIV-AIDS REP, V11, P487, DOI 10.1007/s11904-014-0235-7; Kato M, 2013, JAIDS-J ACQ IMM DEF, V63, pE142, DOI 10.1097/QAI.0b013e31829b535b; Land L, 2011, INT J STD AIDS, V22, P430, DOI 10.1258/ijsa.2011.010450; LARSEN DE, 1976, SOC SCI MED, V10, P29, DOI 10.1016/0037-7856(76)90136-0; Le Duc-Cuong., 2010, ASIAN PACIFIC J DIS, V4, P23, DOI DOI 10.7223/apjdm.4.23; Madden A, 2008, DRUG ALCOHOL REV, V27, P671, DOI 10.1080/09595230801935706; Ministry of Health, 2017, GUID HIV AIDS TREATM; Moore BR, 2010, AM J MED QUAL, V25, P384, DOI 10.1177/1062860610371974; Njilele AC, 2012, INT J CLIN PHARM-NET, V34, P98, DOI 10.1007/s11096-011-9596-9; Olakunde BO, 2015, ANN GLOB HEALTH, V81, P684, DOI 10.1016/j.aogh.2015.10.005; Perez-Salgado D, 2015, REV INVEST CLIN, V67, P80; Preau M, 2012, AIDS CARE, V24, P434, DOI 10.1080/09540121.2011.613909; Rathert C, 2011, HEALTH CARE MANAGE R, V36, P359, DOI 10.1097/HMR.0b013e318219cda1; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; South Korea Disease Control Headquarters, 2017, ANN REP HIV AIDS; Nguyen STT, 2018, NAGOYA J MED SCI, V80, P227, DOI 10.18999/nagjms.80.2.227; Surur AS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2714-1; Umeokonkwo CD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206499; UNAIDS, 2017, FACT SHEET GLOB HIV; UNAIDS, 2016, SNAPSH HIV INV; Vo BN, 2012, AIDS CARE, V24, P1442, DOI 10.1080/09540121.2011.652357; Wandeler G, 2016, CURR OPIN HIV AIDS, V11, P492, DOI 10.1097/COH.0000000000000298; Weingart SN, 2006, INT J QUAL HEALTH C, V18, P95, DOI 10.1093/intqhc/mzi087; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization United Nations Office on Drugs and Crime & UNAIDS, 2012, TECHN GUID COUNTR SE; Wouters E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-210; Wu AW, 2000, DIS MANAG HEALTH OUT, V7, P315, DOI 10.2165/00115677-200007060-00003; Xesfingi S, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1327-4	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0223723	10.1371/journal.pone.0223723	http://dx.doi.org/10.1371/journal.pone.0223723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1HV	31703089	Green Published, gold, Green Submitted			2022-12-26	WOS:000532697200005
J	Erhartova, D; Cahova, M; Dankova, H; Heczkova, M; Mikova, I; Sticova, E; Spicak, J; Seda, O; Trunecka, P				Erhartova, Denisa; Cahova, Monika; Dankova, Helena; Heczkova, Marie; Mikova, Irena; Sticova, Eva; Spicak, Julius; Seda, Ondrej; Trunecka, Pavel			Serum miR-33a is associated with steatosis and inflammation in patients with nonalcoholic fatty liver disease after liver transplantation	PLOS ONE			English	Article							CHOLESTEROL; STEATOHEPATITIS; PREVALENCE; MICRORNAS	Background & aims MiR-33a has emerged as a critical regulator of lipid homeostasis in the liver. Genetic deficiency of miR-33a aggravates liver steatosis in a preclinical model of non-alcoholic fatty liver disease (NAFLD), and relative expression of miR-33a is increased in the livers of patients with non-alcoholic steatohepatitis (NASH). It was unknown whether miR-33a is detectable in the serum of patients with NAFLD. We sought to determine whether circulating miR-33a is associated with histological hepatic steatosis, inflammation, ballooning or fibrosis, and whether it could be used as a serum marker in patients with NAFLD/NASH. Methods We analysed circulating miR-33a using quantitative PCR in 116 liver transplant recipients who underwent post-transplant protocol liver biopsy. Regression analysis was used to determine association of serum miR-33a with hepatic steatosis, inflammation, ballooning and fibrosis in liver biopsy. Results Liver graft steatosis and inflammation, but not ballooning or fibrosis, were significantly associated with serum miR-33a, dyslipidemia and insulin resistance markers on univariate analysis. Multivariate analysis showed that steatosis was independently associated with serum miR-33a, ALT, glycaemia and waist circumference, whereas inflammation was independently associated with miR-33a, HbA1 and serum triglyceride levels. Receiver operating characteristic analysis showed that exclusion of serum miR-33a from multivariate analysis resulted in non-significant reduction of prediction model accuracy of liver steatosis or inflammation. Conclusions Our data indicate that circulating miR-33a is an independent predictor of liver steatosis and inflammation in patients after liver transplantation. Although statistically significant, its contribution to the accuracy of prediction model employing readily available clinical and biochemical variables was limited in our cohort.	[Erhartova, Denisa; Mikova, Irena; Spicak, Julius; Trunecka, Pavel] Inst Clin & Expt Med, Dept Hepatogastroenterol, Prague, Czech Republic; [Erhartova, Denisa] Charles Univ Prague, Fac Med 1, Inst Physiol, Prague, Czech Republic; [Cahova, Monika; Dankova, Helena; Heczkova, Marie] Inst Clin & Expt Med, Expt Med Ctr, Prague, Czech Republic; [Sticova, Eva] Inst Clin & Expt Med, Clin & Transplant Pathol Ctr, Prague, Czech Republic; [Seda, Ondrej] Charles Univ Prague, Prague, Czech Republic; [Seda, Ondrej] Gen Univ Hosp Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Charles University Prague; General University Hospital Prague	Trunecka, P (corresponding author), Inst Clin & Expt Med, Dept Hepatogastroenterol, Prague, Czech Republic.	patr@ikem.cz	Cahova, Monika/Z-1568-2018	Cahova, Monika/0000-0003-2640-5084; Erhartova Kyselova, Denisa/0000-0001-6652-653X	Ministry of Health of the Czech Republic [15-26906A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This project was supported by Ministry of Health of the Czech Republic, grant number 15-26906A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castera L, 2019, GASTROENTEROLOGY, V156, P1264, DOI 10.1053/j.gastro.2018.12.036; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Diehl AM, 2018, NEW ENGL J MED, V378, P781; Dlouha D, 2019, DONOR PNPLA3 TM6SF2; Dumortier J, 2010, AM J GASTROENTEROL, V105, P613, DOI 10.1038/ajg.2009.717; Hejlova I, 2016, LIVER TRANSPLANT, V22, P644, DOI 10.1002/lt.24393; Horie T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3883; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li J, 2009, TRANSPL P, V41, P3560, DOI 10.1016/j.transproceed.2009.06.222; Liu CH, 2018, J HEPATOL, V69, P1335, DOI 10.1016/j.jhep.2018.08.008; Lopez-Riera M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28854-4; Marsman WA, 1996, TRANSPLANTATION, V62, P1246, DOI 10.1097/00007890-199611150-00011; McCormack L, 2007, ANN SURG, V246, P940, DOI 10.1097/SLA.0b013e31815c2a3f; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Narayanan P, 2019, TRANSPLANTATION, V103, pe14, DOI 10.1097/TP.0000000000002317; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Trunecka P, 2018, DIGEST LIVER DIS, V50, P490, DOI 10.1016/j.dld.2017.12.030; Vega-Badillo J, 2016, LIVER INT, V36, P1383, DOI 10.1111/liv.13109; Younossi ZM, 2019, TRANSPLANTATION, V103, P22, DOI 10.1097/TP.0000000000002484; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	24	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224820	10.1371/journal.pone.0224820	http://dx.doi.org/10.1371/journal.pone.0224820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LH1OW	31703079	Green Published, gold			2022-12-26	WOS:000528559700001
J	de Souza, W; de Abreu, LC; da Silva, LG; Bezerra, IMP				de Souza, Wesley; de Abreu, Luiz Carlos; da Silva, Leonardo Gomes; Pinheiro Bezerra, Italla Maria			Incidence of chronic kidney disease hospitalisations and mortality in Espirito Santo between 1996 to 2017	PLOS ONE			English	Article								Introduction Chronic kidney disease (CKD) has a set of clinical and laboratory abnormalities where renal function loss is noted. The high prevalence of comorbidity of people living with CKD, its economic impact and its prognosis have made it a public health problem, justifying the need to implement preventive measures. Objective To analyse the mortality and incidence of hospital admissions for CKD. Methods Ecological study with a time series design using secondary microdata of deaths and hospital admissions from patients with CKD from 1996 to 2017 in the State of Espi ' rito Santo, Brazil. Results The average mortality rate of CKD during the studied years was 2.92 per 100,000 inhabitants per year. During this period global mortality was a stationary phenomenon. In women, the trend of mortality from 2005 on increased 7,87% per year. Between 2008 and 2017, the average incidence hospital admissions due to CKD per year was 45.76 per 100,000 inhabitants. It was observed that the overall hospital admission increased by the equivalent of 6.23% per year. More than a half of mortality and hospitalisations correspond to male patients over 50 years of age. In terms of mortality, 32.99% corresponded to Caucasian patients, while 35.13% of hospitalisations were mixed race. Conclusion We found that age and gender are factors associated with deaths and hospitalisations for chronic kidney disease. While hospitalisation increases 6.23% per year, global mortality remains stationary. However, from 2005 onwards a trend towards increasing of 7.87%/ annual in mortality was observed in women.	[de Souza, Wesley; de Abreu, Luiz Carlos; Pinheiro Bezerra, Italla Maria] Escola Super Ciencias Santa Casa Misericordia Vit, Programa Mestrado Polit Publ & Desenvolvimento Lo, Vitoria, ES, Brazil; [de Abreu, Luiz Carlos; da Silva, Leonardo Gomes; Pinheiro Bezerra, Italla Maria] Escola Super Ciencias Santa Casa Misericordia Vit, Lab Escrita Cient, Vitoria, ES, Brazil; [de Abreu, Luiz Carlos; Pinheiro Bezerra, Italla Maria] Ctr Univ Sande ABC CUSABC, Lab Delineamento Estudos & Escrita Cient, Santo Andre, SP, Brazil; [de Abreu, Luiz Carlos] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Pinheiro Bezerra, Italla Maria] Univ Fed Acre, Bolsista Capes Brasil, Programa Mestrado Ciencias Saude Amazonia, Rio Branco, Acre, Brazil	Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; University of Limerick; Universidade Federal do Acre (UFAC)	de Abreu, LC (corresponding author), Escola Super Ciencias Santa Casa Misericordia Vit, Programa Mestrado Polit Publ & Desenvolvimento Lo, Vitoria, ES, Brazil.; de Abreu, LC (corresponding author), Escola Super Ciencias Santa Casa Misericordia Vit, Lab Escrita Cient, Vitoria, ES, Brazil.; de Abreu, LC (corresponding author), Ctr Univ Sande ABC CUSABC, Lab Delineamento Estudos & Escrita Cient, Santo Andre, SP, Brazil.; de Abreu, LC (corresponding author), Univ Limerick, Grad Entry Med Sch, Limerick, Ireland.	luiz.abreu@emescam.br	de Abreu, Luiz Carlos/AAL-8219-2021	de Abreu, Luiz Carlos/0000-0002-7618-2109; Gomes da Silva, Leonardo/0000-0002-1820-8075				Abreu LC, 2017, J HUM GROWTH DEV, V27, P258, DOI DOI 10.7322/jhgd.141485; Ahmad OB, 2001, AGE STANDARDIZATION, V31, DOI [10.1161/HYPERTENSIONAHA.114.04394, DOI 10.1161/HYPERTENSIONAHA.114.04394]; Antunes JLF, 2015, EPIDEMIOL E SERVICOS, DOI [10.5123/S1679-49742915000390024, DOI 10.5123/S1679-49742915000390024]; Bernardi Cesarino C, 2013, ACTA PAUL ENFERM; Brasil M da S, 2014, DIRETRIZES CLIN CUID, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; de Vries EF, 2016, NEPHRON, V133, P89, DOI 10.1159/000446548; Garcia-Garcia G, 2015, AM J NEPHROL, V41, P116, DOI 10.1159/000369843; Goes EF, 2013, SAUDE DEBATE, DOI [10.1590/S0103-11042013000400004, DOI 10.1590/S0103-11042013000400004]; Gouveia Denise Sbrissia e Silva, 2017, Braz. J. Nephrol., V39, P162, DOI 10.5935/0101-2800.20170019; Green JA, 2015, ADV CHRONIC KIDNEY D, V22, P24, DOI 10.1053/j.ackd.2014.07.004; Hemke AC, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-258; Herrera-Anazco Percy, 2015, J Bras Nefrol, V37, P192, DOI 10.5935/0101-2800.20150031; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Jain P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100831; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jha V, 2013, LANCET, DOI [10.1016/S0140-673(13)60687-X, DOI 10.1016/S0140-673(13)60687-X]; Kao CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177759; Kihal-Talantikite W, 2015, CLIN KIDNEY J, V8, P7, DOI 10.1093/ckj/sfu131; Magalhães Fernanda Guilhermino, 2015, Rev. bras. geriatr. gerontol., V18, P679, DOI 10.1590/1809-9823.2015.14132; Magalhaes LP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167895; Maria I, 2017, J HUM GROWTH DEV J H, DOI [10.7322/j.hgd.123189, DOI 10.7322/J.HGD.123189]; Marinovich S, 2012, NEFROLOGIA, V32, P79, DOI 10.3265/Nefrologia.pre2011.Nov.11110; Domingos MAM, 2017, SAO PAULO MED J, V135, P133, DOI 10.1590/1516-3180.2016.0272261116; Narres M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147329; Obrador GT, 2014, EPIDEMIOL CHRON, V7, P2014; Pinheiro Rejane Sobrino, 2002, Ciênc. saúde coletiva, V7, P687; Registro Brasileiro de Transplantes, 2018, DIM TRANSPL BRAS CAD; Goncalves GMR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203992; Scialla JJ, 2012, KIDNEY INT, V82, P106, DOI 10.1038/ki.2012.82; Sesso R, 2008, NEFROLOGIA; Shen YJ, 2017, ENDOCRINE, V55, P75, DOI 10.1007/s12020-016-1014-6; Silva JRM, 2017, THESIS; Sociedade Brasileira de Nefrologia (SBN), 2017, CENS 2016; Terra FS, 2007, THESIS; Tonelli M, 2014, KIDNEY INT, V85, P1269, DOI 10.1038/ki.2012.488; Wei XJ, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3610-z; World Health Organization, 2003, GLOBAL BURDEN DIS ST; Zetola VH, 2001, ARQ NEUROPSIQUIATR	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224889	10.1371/journal.pone.0224889	http://dx.doi.org/10.1371/journal.pone.0224889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697772	Green Published, gold			2022-12-26	WOS:000532694400077
J	Curry, JM; Besmer, DM; Erick, TK; Steuerwald, N; Das Roy, L; Grover, P; Rao, S; Nath, S; Ferrier, JW; Reid, RW; Mukherjee, P				Curry, Jennifer M.; Besmer, Dahlia M.; Erick, Timothy K.; Steuerwald, Nury; Das Roy, Lopamudra; Grover, Priyanka; Rao, Shanti; Nath, Sritama; Ferrier, Jacob W.; Reid, Robert W.; Mukherjee, Pinku			Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; INDOLEAMINE 2,3-DIOXYGENASE; METASTATIC BREAST; T-CELL; TRYPTOPHAN DEGRADATION; COX-2 INHIBITORS; MOUSE MODEL; EXPRESSION; GROWTH; CYCLOOXYGENASE-2	In recent years, vaccines against tumor antigens have shown potential for combating invasive cancers, including primary tumors and metastatic lesions. This is particularly pertinent for breast cancer, which is the second-leading cause of cancer-related death in women. MUC1 is a glycoprotein that is normally expressed on glandular epithelium, but is overexpressed and under-glycosylated in most human cancers, including the majority of breast cancers. This under-glycosylation exposes the MUC1 protein core on the tumor-associated form of the protein. We have previously shown that a vaccine consisting of MUC1 core peptides stimulates a tumor-specific immune response. However, this immune response is dampened by the immunosuppressive microenvironment within breast tumors. Thus, in the present study, we investigated the effectiveness of MUC1 vaccination in combination with four different drugs that inhibit different components of the COX pathway: indomethacin (COX-1 and COX-2 inhibitor), celecoxib (COX-2 inhibitor), 1-methyl tryptophan (indoleamine 2,3 dioxygenase inhibitor), and AH6809 (prostaglandin E2 receptor antagonist). These treatment regimens were explored for the treatment of orthotopic MUC1-expressing breast tumors in mice transgenic for human MUC1. We found that the combination of vaccine and indomethacin resulted in a significant reduction in tumor burden. Indomethacin did not increase tumor-specific immune responses over vaccine alone, but rather appeared to reduce the proliferation and increase apoptosis of tumor cells, thus rendering them susceptible to immune cell killing.	[Curry, Jennifer M.; Besmer, Dahlia M.; Erick, Timothy K.; Das Roy, Lopamudra; Grover, Priyanka; Rao, Shanti; Nath, Sritama; Mukherjee, Pinku] Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA; [Steuerwald, Nury] Carolinas Med Ctr, Mol Biol & Genom Lab, Charlotte, NC 28203 USA; [Ferrier, Jacob W.; Reid, Robert W.] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC USA; [Mukherjee, Pinku] OncoTAb Inc, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; Carolinas Medical Center; University of North Carolina; University of North Carolina Charlotte	Mukherjee, P (corresponding author), Univ North Carolina Charlotte, Dept Biol Sci, Charlotte, NC 28223 USA.; Mukherjee, P (corresponding author), OncoTAb Inc, Charlotte, NC 28223 USA.	pmukherj@uncc.edu		Simangan, Mon Erick/0000-0002-2480-245X; Reid, Robert/0000-0001-7125-7151; Ferrier, Jacob/0000-0002-4173-1040	Department of Defense Award [CDMRP BCRP 10578683]; Susan G. Komen Breast Cancer Foundation Research Grant [KG101475]; Irwin Belk Endowment from UNCC	Department of Defense Award(United States Department of Defense); Susan G. Komen Breast Cancer Foundation Research Grant(Susan G. Komen Breast Cancer Foundation); Irwin Belk Endowment from UNCC	This work was supported by Department of Defense Award (CDMRP BCRP 10578683), and by Susan G. Komen Breast Cancer Foundation Research Grant (KG101475). This work was also funded by Irwin Belk Endowment from UNCC. Pinku Mukherjee is the founder and Chief Scientific Officer (CSO) of OncoTAb, Inc., a startup company that owns patents and rights to the TAB004 antibody and markets the TAB004-based ELISA as a Laboratory Developed Test under the commercial name AgkuraTM Personal Score. OncoTAb, Inc. provided support in the form of salary for Pinku Mukherjee, but did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Antonia S, 2004, CURR OPIN IMMUNOL, V16, P130, DOI 10.1016/j.coi.2004.01.012; Apostolopoulos V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1505; Avigan D, 2004, CLIN CANCER RES, V10, P4699, DOI 10.1158/1078-0432.CCR-04-0347; Basu GD, 2005, BREAST CANCER RES, V7, pR422, DOI 10.1186/bcr1019; Basu GD, 2004, MOL CANCER RES, V2, P632; Bengtsson AK, 2002, CRIT REV IMMUNOL, V22, P201; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Burger AM, 2005, EUR J CANCER, V41, P1515, DOI 10.1016/j.ejca.2005.04.023; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chiba S, 2014, ELIFE, V3, DOI 10.7554/eLife.04177; Coelho AL, 2007, J IMMUNOL, V179, P5474, DOI 10.4049/jimmunol.179.8.5474; Croce MV, 2003, J HISTOCHEM CYTOCHEM, V51, P781, DOI 10.1177/002215540305100609; D Basu G, 2006, J IMMUNOL, V177, P2391, DOI 10.4049/jimmunol.177.4.2391; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Das Roy L, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3412; Das Roy L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-365; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Espinoza I, 2014, J CELL COMMUN SIGNAL, V8, P23, DOI 10.1007/s12079-013-0214-6; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Farmaki E, 2016, ONCOGENE, V35, P6309, DOI 10.1038/onc.2016.161; Fletcher M, 2015, CANCER RES, V75, P275, DOI 10.1158/0008-5472.CAN-14-1491; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Ghosh SK, 2013, CLIN BREAST CANCER, V13, P109, DOI 10.1016/j.clbc.2012.09.016; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Gun FD, 2012, MED ONCOL, V29, P466, DOI 10.1007/s12032-011-9873-4; Guo CQ, 2013, ADV CANCER RES, V119, P421, DOI 10.1016/B978-0-12-407190-2.00007-1; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Gupta RA, 2000, ANN NY ACAD SCI, V910, P196; Gurpinar E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00181; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Holen I, 2002, CANCER RES, V62, P1619; Huang YT, 2017, ONCOTARGET, V8, P9200, DOI 10.18632/oncotarget.13677; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Jendrossek V, 2013, CANCER LETT, V332, P313, DOI 10.1016/j.canlet.2011.01.012; Kwilas AR, 2015, ONCOTARGET, V6, P28194, DOI 10.18632/oncotarget.4442; Liou JY, 2007, CANCER RES, V67, P3185, DOI 10.1158/0008-5472.CAN-06-3431; Liu B, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0260-7; Mahmoodi M, 2012, PATHOL ONCOL RES, V18, P49, DOI 10.1007/s12253-011-9415-6; Marzec KA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/638526; Mazhar D, 2006, BRIT J CANCER, V94, P346, DOI 10.1038/sj.bjc.6602942; McCarthy K, 2009, ANTICANCER RES, V29, P3785; Miles D, 2011, ONCOLOGIST, V16, P1092, DOI 10.1634/theoncologist.2010-0307; Mirandola P, 2004, BLOOD, V104, P2418, DOI 10.1182/blood-2004-04-1294; Monnot GC, 2018, BREAST, V37, P187, DOI 10.1016/j.breast.2017.06.009; Moon YW, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0094-9; Moore LJ, 2016, TRANSL ONCOL, V9, P295, DOI 10.1016/j.tranon.2016.05.001; Mukherjee P, 2007, VACCINE, V25, P1607, DOI 10.1016/j.vaccine.2006.11.007; Mukherjee P, 2003, J IMMUNOTHER, V26, P47, DOI 10.1097/00002371-200301000-00006; Mukherjee P, 2001, GLYCOCONJUGATE J, V18, P931, DOI 10.1023/A:1022260711583; Mukherjee Pinku, 2004, Breast Dis, V20, P53; Mukherjee P, 2009, J IMMUNOL, V182, P216, DOI 10.4049/jimmunol.182.1.216; Muller AJ, 2005, EXPERT OPIN THER TAR, V9, P831, DOI 10.1517/14728222.9.4.831; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Nath S, 2015, PANCREAS, V44, P909, DOI 10.1097/MPA.0000000000000371; Nath S, 2014, TRENDS MOL MED, V20, P332, DOI 10.1016/j.molmed.2014.02.007; O'Kelly J, 2008, INT J ONCOL, V33, P59; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Popovic PJ, 2007, J NUTR, V137, p1681S, DOI 10.1093/jn/137.6.1681S; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Renema N, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160150; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Rowse GJ, 1998, CANCER RES, V58, P315; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Roy Lopamudra Das, 2017, Genes Cancer, V8, P536, DOI 10.18632/genesandcancer.134; Sheen-Chen SM, 2009, ANTICANCER RES, V29, P1131; Shiff SJ, 1999, J EXP MED, V190, P445, DOI 10.1084/jem.190.4.445; Shim JY, 2003, MODERN PATHOL, V16, P1199, DOI 10.1097/01.MP.0000097372.73582.CB; Siegel RL, 2018, CA-CANCER J CLIN, V68, P30; SIMPSONHERREN L, 1970, CANCER CHEMOTH REP 1, V54, P143; Siroy A, 2013, HUM PATHOL, V44, P2159, DOI 10.1016/j.humpath.2013.04.010; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Stergiou N, 2019, CANCER IMMUNOL RES, V7, P113, DOI 10.1158/2326-6066.CIR-18-0256; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vassilaros S, 2013, IMMUNOTHERAPY-UK, V5, P1177, DOI [10.2217/IMT.13.126, 10.2217/imt.13.126]; Wang ZQ, 2017, ONCOTARGET, V8, P12664, DOI 10.18632/oncotarget.8610; Wobser M, 2007, CANCER IMMUNOL IMMUN, V56, P1017, DOI 10.1007/s00262-006-0256-1; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Yu H, 1996, BRIT J CANCER, V74, P1242, DOI 10.1038/bjc.1996.523; Zaretsky JZ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-57; Zarghi A, 2011, IRAN J PHARM RES, V10, P655; Zha S, 2004, CANCER LETT, V215, P1, DOI 10.1016/j.canlet.2004.06.014; Zhang HY, 2019, VACCINE, V37, P2090, DOI 10.1016/j.vaccine.2019.02.055; Zhang XP, 1999, J EXP MED, V190, P451, DOI 10.1084/jem.190.4.451	96	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224309	10.1371/journal.pone.0224309	http://dx.doi.org/10.1371/journal.pone.0224309			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693710	Green Published, gold			2022-12-26	WOS:000532690100023
J	Humphrey, C; Veve, MP; Walker, B; Shorman, MA				Humphrey, Clayton; Veve, Michael P.; Walker, Brian; Shorman, Mahmoud A.			Long-term vancomycin use had low risk of ototoxicity	PLOS ONE			English	Article							HEARING-LOSS; TOXICITY; NEPHROTOXICITY	Background Vancomycin is a commonly used antibiotic with potent activity against Gram-positive organisms, but prolonged use and high doses can lead to toxicity. While vancomycin-associated nephrotoxicity is widely reported, few cases of ototoxicity have been described. The objective of this study was to determine the prevalence of negative changes in audiograms in patients receiving long-term intravenous (IV) vancomycin and to identify high-risk patients who need audiogram monitoring. Methods This was an IRB approved, cross-sectional study performed at an academic medical center from 1/2012-3/2019. Patients who were prescribed IV vancomycin for >= 14 days and had baseline and follow-up weekly audiometry were included. All data was extracted from the electronic medical record. The primary endpoint was worsening audiogram while on vancomycin. Descriptive and bivariate statistics were used to describe the patient population. Results 424 patients were screened for inclusion; 92 received at least two audiograms while on vancomycin. Fifty-three percent of patients were men, the median (IQR) patient age was 44 (34-58) years, and 8% of patients had an estimated Cockcroft-Gault creatinine clearance <= 30 mL/min or received hemodialysis. The median (IQR) vancomycin exposure up until the last recorded audiogram was 30 (17-42) days. Vancomycin indications were: 53 (58%) bone and joint infections, 17 (18%) infective endocarditis, 10 (11%) bacteremia, 12 (13%) other infections. Seven (8%) patients experienced a worsening change in hearing from baseline, two (2%) of them suffered mild loss, two (2%) had mild to moderate loss, and three (3%) developed moderate-to-severe hearing loss. In bivariate analyses, no variables were found to be associated with a worsening change in audiogram, including baseline abnormal audiogram, age >= 40 years, elevated serum vancomycin levels, or vancomycin doses > 4 grams/day. Conclusions The prevalence of negative changes in audiograms among patients receiving long-term intravenous vancomycin was low. The utility of routine audiogram testing in this population remains questionable except in high-risk patients; however, larger prospective studies with controls may be warranted to further explore the risk of ototoxicity.	[Humphrey, Clayton; Veve, Michael P.; Walker, Brian; Shorman, Mahmoud A.] Univ Tennessee, Grad Sch Med, Knoxville, TN 37920 USA; [Veve, Michael P.] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37920 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Shorman, MA (corresponding author), Univ Tennessee, Grad Sch Med, Knoxville, TN 37920 USA.	mshorman@utmck.edu	Shorman, Mahmoud/AAK-5917-2021	, Mahmoud/0000-0003-3371-5101; Veve, Michael/0000-0001-5967-5211				Alexander TH, 2013, OTOL NEUROTOL, V34, P1586, DOI 10.1097/MAO.0000000000000222; BAILIE GR, 1988, MED TOXICOL ADV DRUG, V3, P376, DOI 10.1007/BF03259891; Bamgbola O, 2016, THER ADV ENDOCRINOL, V7, P136, DOI 10.1177/2042018816638223; BRUMMETT RE, 1989, ANTIMICROB AGENTS CH, V33, P791, DOI 10.1128/AAC.33.6.791; CAMPBELL KCM, 1993, OTOLARYNG CLIN N AM, V26, P903; Elting LS, 1998, CANCER, V83, P2597, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2597::AID-CNCR27>3.0.CO;2-L; FARBER BB, 1984, EUR J CLIN MICROBIOL, V3, P1, DOI 10.1007/BF02032805; Forouzesh A, 2009, ANTIMICROB AGENTS CH, V53, P483, DOI 10.1128/AAC.01088-08; Hidayat LK, 2006, ARCH INTERN MED, V166, P2138, DOI 10.1001/archinte.166.19.2138; James C W, 2001, Proc (Bayl Univ Med Cent), V14, P189; KAVANAGH KT, 1983, LARYNGOSCOPE, V93, P649; Kirby WMM, 1981, REV INFECT DIS, DOI [10.1007/bf02032805, DOI 10.1007/BF02032805]; LACKNER TE, 1984, ARCH INTERN MED, V144, P419, DOI 10.1001/archinte.1984.00350140253045; Lanvers-Kaminsky C, 2017, CLIN PHARMACOL THER, V101, P491, DOI 10.1002/cpt.603; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P1330, DOI 10.1128/AAC.01602-07; Martin Jennifer H, 2010, Clin Biochem Rev, V31, P21; MELLOR JA, 1985, J ANTIMICROB CHEMOTH, V15, P773, DOI 10.1093/jac/15.6.773; Miner LJ, 2004, AM J PERINAT, V21, P433, DOI 10.1055/s-2004-835959; REYES MP, 1989, AM J OBSTET GYNECOL, V161, P977, DOI 10.1016/0002-9378(89)90766-7; Rybak LP, 2007, KIDNEY INT, V72, P931, DOI 10.1038/sj.ki.5002434; Rybak MJ, 2009, PHARMACOTHERAPY, V29, P1275, DOI 10.1592/phco.29.11.1275; Seng JJB, 2018, INT J CLIN PHARM-NET, V40, P977, DOI 10.1007/s11096-018-0670-4; Shields RK, 2009, ANTIMICROB AGENTS CH, V53, P4572, DOI 10.1128/AAC.00537-09; TRABER PG, 1981, ANN INTERN MED, V95, P458, DOI 10.7326/0003-4819-95-4-458; Trosman SJ, 2016, OTOLARYNG HEAD NECK, V154, P1068, DOI 10.1177/0194599816635144	26	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224561	10.1371/journal.pone.0224561	http://dx.doi.org/10.1371/journal.pone.0224561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693679	Green Published, gold			2022-12-26	WOS:000532690100029
J	Leon-Garcia, IV; Lasso, E				Leon-Garcia, Indira, V; Lasso, Eloisa			High heat tolerance in plants from the Andean highlands: Implications for paramos in a warmer world	PLOS ONE			English	Article							THERMAL TOLERANCE; CLIMATE-CHANGE; CHLOROPHYLL FLUORESCENCE; TEMPERATURE TOLERANCE; ESPELETIA-SCHULTZII; FICUS-INSIPIDA; TROPICAL TREE; ALPINE; DESERT; VULNERABILITY	Tropical plant species are expected to have high heat tolerance reflecting phenotypic adjustments to warm regions or their evolutionary adaptation history. However, tropical highland specialists adapted to the colder temperatures found in the highlands, where short and prostrated vegetation decouples plants from ambient conditions, could exhibit different upper thermal limits than those of their lowland counterparts. Here we evaluated leaf heat tolerance of 21 tropical alpine paramo species to determine: 1) whether species with restricted distribution (i.e., highland specialists) have lower heat tolerance and are more vulnerable to warming than species with widespread distribution; 2) whether different growth forms have different heat tolerance; and 3) whether species height (i.e., microhabitat) influences its heat tolerance. We quantified heat tolerance by evaluating T-50, which is the temperature that causes a reduction in 50% of initial F-v/F-m values and reflects an irreversible damage to the photosynthetic apparatus. Additionally, we estimated the thermal safety margins as the difference between T-50 and the maximum leaf temperature registered for the species. All species presented high T-50 values ranging between 45.4 degrees C and 53.9 degrees C, similar to those found for tropical lowland species. Heat tolerance was not correlated with species distributions or plant height, but showed a strong relationship with growth form, with rosettes having the highest heat tolerance. Thermal safety margins ranged from 12.1 to 31.0 degrees C. High heat tolerance and broad thermal safety margins suggest low vulnerability of paramo species to warming as long as plants are capable of regulating the leaf temperature within this threshold. Whether paramo plants would be able to regulate leaf temperature if drought episodes become more frequent and transpirational cooling is compromised is the next question that needs to be answered.	[Leon-Garcia, Indira, V; Lasso, Eloisa] Univ Andes, Dept Ciencias Biol, Bogota, Cundinamarca, Colombia; [Lasso, Eloisa] Smithsonian Trop Res Inst, Panama City, Panama	Universidad de los Andes (Colombia); Smithsonian Institution; Smithsonian Tropical Research Institute	Leon-Garcia, IV (corresponding author), Univ Andes, Dept Ciencias Biol, Bogota, Cundinamarca, Colombia.	iv.leon1135@uniandes.edu.co		Lasso, Eloisa/0000-0003-4586-8674	Patrimonio autonomo fondo nacional de financiamiento para la ciencia, la tecnologia y la innovacion Francisco Jose de Caldas Colciencias [120471451294]; Fondo de Investigaciones de la Facultad de Ciencias de la Universidad de los Andes, Convocatoria 2018-2019 para la Financiacion de Programas de Investigacion	Patrimonio autonomo fondo nacional de financiamiento para la ciencia, la tecnologia y la innovacion Francisco Jose de Caldas Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fondo de Investigaciones de la Facultad de Ciencias de la Universidad de los Andes, Convocatoria 2018-2019 para la Financiacion de Programas de Investigacion	Funding for this research comes from "Patrimonio autonomo fondo nacional de financiamiento para la ciencia, la tecnologia y la innovacion Francisco Jose de Caldas Colciencias", for the 714 convocation in 2015, grant number 120471451294 and from "Fondo de Investigaciones de la Facultad de Ciencias de la Universidad de los Andes, Convocatoria 2018-2019 para la Financiacion de Programas de Investigacion". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EP., 2011, CLIMATE CHANGE BIODI, P1, DOI DOI 10.13140/2.1.3718.4969; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Braun V, 2002, PHOTOSYNTHETICA, V40, P587, DOI 10.1023/A:1024312304995; Briceno VF, 2015, ALPINE BOT, V125, P59, DOI 10.1007/s00035-015-0155-1; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Buchner O, 2003, ARCT ANTARCT ALP RES, V35, P411, DOI 10.1657/1523-0430(2003)035[0411:VOHTIA]2.0.CO;2; Buchner O, 2017, ENVIRON EXP BOT, V133, P159, DOI 10.1016/j.envexpbot.2016.10.010; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Cavieres LA, 2000, ACTA OECOL, V21, P203, DOI 10.1016/S1146-609X(00)01077-8; Cavieres LA, 2007, ARCT ANTARCT ALP RES, V39, P229, DOI 10.1657/1523-0430(2007)39[229:MMOCPA]2.0.CO;2; Cuesta-Camacho F, 2012, POSIBLES EFECTOS CAL; Cunningham SC, 2006, TREE PHYSIOL, V26, P1435, DOI 10.1093/treephys/26.11.1435; Curtis EM, 2014, OECOLOGIA, V175, P1051, DOI 10.1007/s00442-014-2988-5; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dietrich L, 2014, ALPINE BOT, V124, P27, DOI 10.1007/s00035-014-0123-1; Ducruet JM, 2007, PHOTOSYNTH RES, V93, P159, DOI 10.1007/s11120-007-9132-x; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P3215, DOI 10.1111/j.1365-2486.2010.02197.x; Feeley KJ, 2015, FRONT BIOGEOGR, P7, DOI [10.21425/f57427602, DOI 10.21425/F57427602]; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Graae BJ, 2018, PERSPECT PLANT ECOL, V30, P41, DOI 10.1016/j.ppees.2017.09.008; Krause GH, 2013, J PLANT PHYSIOL, V170, P822, DOI 10.1016/j.jplph.2013.01.005; Krause GH, 2010, FUNCT PLANT BIOL, V37, P890, DOI 10.1071/FP10034; Hupp N, 2017, J VEG SCI, V28, P928, DOI 10.1111/jvs.12553; IPCC, 2014, CHANG 2014 SYNTH REP, DOI [10.1256/004316502320517344, DOI 10.1256/004316502320517344]; Kattan GH, 2004, J BIOGEOGR, V31, P1829, DOI 10.1111/j.1365-2699.2004.01109.x; Knight CA, 2003, NEW PHYTOL, V160, P337, DOI 10.1046/j.1469-8137.2003.00880.x; KORNER C, 1983, ACTA OECOL-OEC PLANT, V4, P117; Korner C., 2003, ALPINE PLANT LIFE, P344, DOI [10.1007/978-3-642-18970-8, DOI 10.1007/978-3-642-18970-8]; Korner C, 2018, PERSPECT PLANT ECOL, V30, P16, DOI 10.1016/j.ppees.2017.04.004; KRAUSE GH, 1984, PHOTOSYNTH RES, V5, P139, DOI 10.1007/BF00028527; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; Leon-Garcia I V., 2019, HEAT TOLERANCE PLANT, DOI [10.17504/protocols.io.29fgh3n, DOI 10.17504/PROTOCOLS.IO.29FGH3N]; Loik ME, 2000, FUNCT ECOL, V14, P166, DOI 10.1046/j.1365-2435.2000.00411.x; Marcante S, 2014, PLANT ECOL, V215, P747, DOI 10.1007/s11258-014-0361-8; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MEINZER F, 1985, ECOLOGY, V66, P512, DOI 10.2307/1940399; Mora MA, 2019, PLANT ECOL DIVERS, V12, P593, DOI 10.1080/17550874.2018.1507055; Neuner G, 2000, PLANT BIOLOGY, V2, P677, DOI 10.1055/s-2000-16635; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; O'Sullivan OS, 2017, GLOBAL CHANGE BIOL, V23, P209, DOI 10.1111/gcb.13477; Perez TM, 2016, SCIENCE, V351, P1392, DOI 10.1126/science.aaf3343; RADA F, 1987, J EXP BOT, V38, P491, DOI 10.1093/jxb/38.3.491; RADA F, 1985, PLANT CELL ENVIRON, V8, P501, DOI 10.1111/j.1365-3040.1985.tb01685.x; Ramirez LA, 2015, PLANT ECOL, V216, P213, DOI 10.1007/s11258-014-0429-5; Ramirez-Villegas J, 2014, J NAT CONSERV, V22, P391, DOI 10.1016/j.jnc.2014.03.007; Ruiz D, 2008, SCI TOTAL ENVIRON, V398, P122, DOI 10.1016/j.scitotenv.2008.02.038; Sastry A., 2017, SCI REP-UK, V7, P1, DOI DOI 10.1038/S41598-016-0028-X; Scherrer D, 2011, INT J BIOMETEOROL, V55, P645, DOI 10.1007/s00484-010-0364-7; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Slot M, 2019, PHOTOSYNTH RES, V141, P119, DOI 10.1007/s11120-018-0563-3; SMILLIE RM, 1979, AUST J PLANT PHYSIOL, V6, P135, DOI 10.1071/PP9790135; SMITH A P, 1974, Biotropica, V6, P263, DOI 10.2307/2989670; SMITH AP, 1979, BIOTROPICA, V11, P43, DOI 10.2307/2388171; SQUEO FA, 1991, OECOLOGIA, V86, P378, DOI 10.1007/BF00317604; Squeo FA, 1996, OECOLOGIA, V105, P552, DOI 10.1007/BF00330019; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; TURNIDGE C, 2009, ACTA OECOL, V35, P610, DOI [10.1016/j.actao.2009.05.009, DOI 10.1016/J.ACTAO.2009.05.009]; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Yuste JC, 2017, SOIL BIOL BIOCHEM, V110, P8, DOI 10.1016/j.soilbio.2017.02.016; Zhu LL, 2018, PLANT CELL ENVIRON, V41, P1251, DOI 10.1111/pce.13133	64	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224218	10.1371/journal.pone.0224218	http://dx.doi.org/10.1371/journal.pone.0224218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693675	Green Published, gold			2022-12-26	WOS:000532690100016
J	Salcedo, DL; Soto, LA; Paduan, JB				Salcedo, Diana L.; Soto, Luis A.; Paduan, Jennifer B.			Trophic structure of the macrofauna associated to deep-vents of the southern Gulf of California: Pescadero Basin and Pescadero Transform Fault	PLOS ONE			English	Article							STABLE-ISOTOPES; HYDROTHERMAL VENTS; FOOD WEBS; COMMUNITIES; SULFIDE; ECOLOGY; CARBON; FAUNA	Newly discovered hydrothermal systems in the Pescadero Basin (PB) and the neighboring Pescadero Transform Fault (PTF) at the mouth of the Gulf of California disclosed a diverse macrofauna assemblage. The trophic structure of both ecosystems was assessed using carbon (delta C-13), nitrogen (delta N-15), and sulfur (delta S-34) stable isotopes. The delta C-13 ranged from -40.8 to -12.1 parts per thousand, revealing diverse carbon sources and its assimilation via Calvin-Benson-Bassham and the reductive tricarboxylic acid cycles. The delta N-15 values were between -12.5 and 18.3 parts per thousand, corresponding to primary and secondary consumers. The delta S-34 values fluctuated from -36.2 to 15.1 parts per thousand, indicating the sulfide assimilation of biogenic, magmatic, and photosynthetic sources. In PB high-temperature vents, primary consumers including symbiont-bearing, bacterivores and filter-feeders predominated. The secondary consumers within the scavengers/detritivores and predator guilds were scarce. The siboglinid Oasisia aff alvinae dominated the macrofauna assemblage at PB, but rather than playing a trophic role, it provides a substrate to vent dwellers. In PTF low-temperature vents, only symbiont-bearing primary consumers were analyzed, displaying the lowest delta S-34 values. This assemblage was dominated by the coexisting siboglinids Lamellibrachia barhami and Escarpia spicata. delta S-34 values allowed to distinguish between PB and PTF vent communities, to exclude the presence of methanotrophic organisms, and the detection of photosynthetic organic matter input.	[Salcedo, Diana L.] Univ Nacl Autonoma Mexico, Posgrad Ciencias Mar & Limnol, Mexico City, DF, Mexico; [Soto, Luis A.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City, DF, Mexico; [Paduan, Jennifer B.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Monterey Bay Aquarium Research Institute	Salcedo, DL (corresponding author), Univ Nacl Autonoma Mexico, Posgrad Ciencias Mar & Limnol, Mexico City, DF, Mexico.; Soto, LA (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Mexico City, DF, Mexico.	dilesaor@gmail.com; lasg@cmarl.unam.mx		Salcedo, Diana/0000-0002-0309-0879	ICML; UNAM; CONACYT; David and Lucile Packard Foundation	ICML; UNAM(Universidad Nacional Autonoma de Mexico); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	Research funding was provided by ICML, UNAM (LAS), CONACYT (DLS), and David and Lucile Packard Foundation (JBP).	Beaulieu S.E., INTERRIDGE GLOBAL DA; Bouillon S, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 7: FUNCTIONING OF ECOSYSTEMS AT THE LAND-OCEAN INTERFACE, P143; Bourbonnais A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003863; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Clague DA, 2018, GEOCHEM GEOPHY GEOSY, V19, P807, DOI 10.1002/2017GC007348; Copley JTP, 1999, MAR ECOL-P S Z N I, V20, P291, DOI 10.1046/j.1439-0485.1999.2034076.x; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Erickson KL, 2009, DEEP-SEA RES PT II, V56, P1577, DOI 10.1016/j.dsr2.2009.05.002; Fabri MC, 2011, J MAR BIOL ASSOC UK, V91, P1, DOI 10.1017/S0025315410000731; FISHER CR, 1994, MAR ECOL PROG SER, V103, P45, DOI 10.3354/meps103045; Freytag JK, 2001, P NATL ACAD SCI USA, V98, P13408, DOI 10.1073/pnas.231589498; FRY B, 1983, NATURE, V306, P51, DOI 10.1038/306051a0; Goffredi S.K., 2017, P R SOC LON B, V284, P1; Govenar B, 2012, OCEANOGRAPHY, V25, P246, DOI 10.5670/oceanog.2012.23; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Kessler JD, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004822; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; KIM ES, 1989, GEOCHEM J, V23, P195, DOI 10.2343/geochemj.23.195; Krumins JA, 2013, BIOSCIENCE, V63, P35, DOI 10.1525/bio.2013.63.1.8; Lalli C, 1997, BIOGEOCHEMICAL OCEAN; Lavin M.F., 1997, CONTRIBUCIONES OCEAN, V3, P141; Lee RW, 1996, BIOL BULL, V190, P373, DOI 10.2307/1543030; Lelievre Y, 2018, BIOGEOSCIENCES, V15, P2629, DOI 10.5194/bg-15-2629-2018; MacAvoy SE, 2005, MAR ECOL PROG SER, V292, P51, DOI 10.3354/meps292051; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Mekhtiyeva V. L., 1976, GEOCHEM INT, V13, P82; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Middelburg JJ, 2014, BIOGEOSCIENCES, V11, P2357, DOI 10.5194/bg-11-2357-2014; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mizota Chitoshi, 2003, Japanese Journal of Benthology, V58, P56; Muller EM, 2016, SCI REP, V6, P1; Nelson D.C., 1995, DEEP SEA HYDROTHERMA, P125; Paduan JB, 2018, GEOCHEM GEOPHY GEOSY, V19, P4788, DOI 10.1029/2018GC007771; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Portail M, 2016, PLOS ONE, V11, P1, DOI [10.1371/journal.pone.0162263, DOI 10.1371/JOURNAL.PONE.0162263]; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Reid WDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065553; SAKAI H, 1978, EARTH PLANET SC LETT, V39, P151, DOI 10.1016/0012-821X(78)90151-6; Schuett C, 2007, HELGOLAND MAR RES, V61, P211, DOI 10.1007/s10152-007-0069-4; Soto LA, 2009, DEEP-SEA RES PT II, V56, P1675, DOI 10.1016/j.dsr2.2009.05.013; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Van Audenhaege L, 2019, DEEP-SEA RES PT I, V148, P88, DOI 10.1016/j.dsr.2019.04.018; VANDOVER CL, 1989, MAR BIOL, V102, P257, DOI 10.1007/BF00428287; VANDOVER CL, 1994, LIMNOL OCEANOGR, V39, P51, DOI 10.4319/lo.1994.39.1.0051; WELHAN JA, 1987, AAPG BULL, V71, P215; Windoffer R, 1997, BIOL BULL-US, V193, P381, DOI 10.2307/1542940; Yamanaka T, 2015, SUBSEAFLOOR BIOSPHER, P105, DOI DOI 10.1007/978-4-431-54865-2; Yorisue Takefumi, 2012, Plankton & Benthos Research, V7, P35	49	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224698	10.1371/journal.pone.0224698	http://dx.doi.org/10.1371/journal.pone.0224698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689305	Green Published, gold			2022-12-26	WOS:000532680100039
J	Guellec, J; Elbahnsi, A; Le Tertre, M; Uguen, K; Gourlaouen, I; Ferec, C; Ka, C; Callebaut, I; Le Gac, G				Guellec, Julie; Elbahnsi, Ahmad; Le Tertre, Marlene; Uguen, Kevin; Gourlaouen, Isabelle; Ferec, Claude; Ka, Chandran; Callebaut, Isabelle; Le Gac, Gerald			Molecular model of the ferroportin intracellular gate and implications for the human iron transport cycle and hemochromatosis type 4A	FASEB JOURNAL			English	Article						MFS transporters; gating residues; alternating access mechanism; molecular dynamics simulations; iron metabolism	SLC40A1 GENE; MUTATIONS; DISEASE; FAMILY; HYPERFERRITINEMIA; HEPCIDIN; CONSEQUENCES; MECHANISM; DIAGNOSIS; DYNAMICS	Ferroportin 1 (FPN1) is a major facilitator superfamily transporter that is essential for proper maintenance of human iron homeostasis at the systemic and cellular level. FPN1 dysfunction leads to the progressive accumulation of iron in reticuloendothelial cells, causing hemochromatosis type 4A (or ferroportin disease), an autosomal dominant disorder that displays large phenotypic heterogeneity. Although crystal structures have unveiled the outward- and inward-facing conformations of the bacterial homolog Bdellovibrio bacteriovorus Fpn (or Bd2019) and calcium has recently been identified as an essential cofactor, our molecular understanding of the iron transport mechanism remains incomplete. Here, we used a combination of molecular modeling, molecular dynamics simulations, and Ala site-directed mutagenesis, followed by complementary in vitro functional analyses, to explore the structural architecture of the human FPN1 intracellular gate. We reveal an interdomain network that involves 5 key amino acids and is likely very important for stability of the iron exporter facing the extracellular milieu. We also identify inter- and intradomain interactions that rely on the 2 Asp84 and Asn174 critical residues and do not exist in the bacterial homolog. These interactions are thought to play an important role in the modulation of conformational changes during the transport cycle. We interpret these results in the context of hemochromatosis type 4A, reinforcing the idea that different categories of loss-of-function mutations exist. Our findings provide an unprecedented view of the human FPN1 outward-facing structure and the particular function of the so-called "gating residues" in the mechanism of iron export.	[Guellec, Julie; Le Tertre, Marlene; Uguen, Kevin; Gourlaouen, Isabelle; Ferec, Claude; Ka, Chandran; Le Gac, Gerald] Univ Brest, Univ Bretagne Loire, Etab Francais Sang Bretagne, INSERM,UMR 1078,Inst Brestois Sante Agromatiere, Brest, France; [Guellec, Julie; Ferec, Claude] Assoc Gaetan Saleun, Brest, France; [Elbahnsi, Ahmad; Callebaut, Isabelle] Sorbonne Univ, Museum Natl Hist Nat, Inst Mineral Phys Mat & Cosmochim, UMR CNRS 7590,IMPMC, Paris, France; [Le Tertre, Marlene; Uguen, Kevin; Ferec, Claude; Ka, Chandran; Le Gac, Gerald] CHRU Brest, Hop Morvan, Serv Genet Med, Brest, France; [Ka, Chandran; Le Gac, Gerald] Lab Excellence Lab Excellence GR Ex, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); CHU Brest; Universite de Bretagne Occidentale	Le Gac, G (corresponding author), Ctr Hosp Reg Univ Brest, Hop Morvan, Lab Gent Mol & Histocompatibil, Bat 5Bis,2 Ave Foch, F-29200 Brest, France.	gerald.legac@univ-brest.fr	Le Gac, Gérald/AFQ-1679-2022; Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710; Elbahnsi, Ahmad/0000-0002-5356-2440	French Association "Vaincre La Mucoviscidose"; Grand Equipement National de Calcul Intensif (GENCI)/Centre Informatique National de l'Enseignement Superieur (CINES) [2017-A0020707206, 2018-A0040707206, 2019-A0060707206]; French Hospital Clinical Research Program (Progamme Hospitalier de Recherche Clinique 2009; Brest University Hospital) [UF0857]; Gaetan Saleun Association, and the Laboratory of Excellence (GR-Ex) [ANR-11-LABX0051]; Investissement D'avenir d'Excellence (IdEx) program "Investissements d'avenir" of the French National Research Agency [ANR-18-IDEX-0001]	French Association "Vaincre La Mucoviscidose"; Grand Equipement National de Calcul Intensif (GENCI)/Centre Informatique National de l'Enseignement Superieur (CINES); French Hospital Clinical Research Program (Progamme Hospitalier de Recherche Clinique 2009; Brest University Hospital); Gaetan Saleun Association, and the Laboratory of Excellence (GR-Ex); Investissement D'avenir d'Excellence (IdEx) program "Investissements d'avenir" of the French National Research Agency(French National Research Agency (ANR))	The authors thank George Gao and Alain R.M. Townsend (Weatherall Institute, Oxford University, Oxford, United Kingdom) for the generous gift of the CD8 expression vector. The protocol used for molecular dynamics simulation was developed during the research work on the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein, which was supported by the French Association "Vaincre La Mucoviscidose," and performed using High-Performance Computing (HPC) resources from Grand Equipement National de Calcul Intensif (GENCI)/Centre Informatique National de l'Enseignement Superieur (CINES) (Grants 2017-A0020707206, 2018-A0040707206, and 2019-A0060707206). This work was also supported by grants from the French Hospital Clinical Research Program (Progamme Hospitalier de Recherche Clinique 2009; Brest University Hospital; UF0857), the Gaetan Saleun Association, and the Laboratory of Excellence (GR-Ex) (ANR-11-LABX0051). The labex GR-Ex is funded by the Investissement D'avenir d'Excellence (IdEx) program "Investissements d'avenir" of the French National Research Agency (ANR-18-IDEX-0001). The authors declare no conflicts of interest.	Bach V, 2006, BLOOD CELL MOL DIS, V36, P41, DOI 10.1016/j.bcmd.2005.09.001; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Callebaut I, 2014, HUM MOL GENET, V23, P4479, DOI 10.1093/hmg/ddu160; Corradi V, 2019, CHEM REV, V119, P5775, DOI 10.1021/acs.chemrev.8b00451; Corradini E, 2005, BLOOD CELL MOL DIS, V35, P315, DOI 10.1016/j.bcmd.2005.07.010; Cunat S, 2007, CLIN CHEM, V53, P2060, DOI 10.1373/clinchem.2007.090605; De Domenico I, 2006, HAEMATOLOGICA, V91, P1092; Deshpande CN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05446-4; di Patti MCB, 2014, FEBS J, V281, P2851, DOI 10.1111/febs.12825; di Patti MCB, 2015, FEBS LETT, V589, P3829, DOI 10.1016/j.febslet.2015.11.025; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Fowler PW, 2015, STRUCTURE, V23, P290, DOI 10.1016/j.str.2014.12.012; Frazer DM, 2017, AM J CLIN NUTR, V105, P1255, DOI 10.3945/ajcn.117.158188; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Griffiths WJH, 2010, HEPATOLOGY, V51, P788, DOI 10.1002/hep.23377; Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y; Hattori A, 2012, PATHOL INT, V62, P612, DOI 10.1111/j.1440-1827.2012.02848.x; Heinz LP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25061-z; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hetet G, 2003, BLOOD, V102, P1904, DOI 10.1182/blood-2003-02-0439; Hoffmann B, 2018, CELL MOL LIFE SCI, V75, P3829, DOI 10.1007/s00018-018-2835-7; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jo S, 2017, J COMPUT CHEM, V38, P1114, DOI 10.1002/jcc.24660; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jouanolle AM, 2003, J HEPATOL, V39, P286, DOI 10.1016/S0168-8278(03)00148-X; Ka C, 2005, HUM GENET, V117, P467, DOI 10.1007/s00439-005-1307-y; Ka C, 2018, HAEMATOLOGICA, V103, P1796, DOI 10.3324/haematol.2018.189845; Kaneko Y, 2010, J GASTROENTEROL, V45, P1163, DOI 10.1007/s00535-010-0259-8; Koyama C, 2005, INTERNAL MED, V44, P990, DOI 10.2169/internalmedicine.44.990; Lamoureux G, 2006, J PHYS CHEM B, V110, P3308, DOI 10.1021/jp056043p; Latorraca NR, 2017, CELL, V169, P96, DOI 10.1016/j.cell.2017.03.010; Le Gac G, 2013, HUM MUTAT, V34, P1371, DOI 10.1002/humu.22369; Majore S, 2018, BBA-MOL BASIS DIS, V1864, P464, DOI 10.1016/j.bbadis.2017.11.006; Martens C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06704-1; Muehlenberg K, 2014, Z GASTROENTEROL, V52, P1075, DOI 10.1055/s-0034-1366809; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pelucchi S, 2008, CLIN GENET, V73, P171, DOI 10.1111/j.1399-0004.2007.00950.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pietrangelo A, 2017, HAEMATOLOGICA, V102, P1972, DOI 10.3324/haematol.2017.170720; Quistgaard EM, 2016, NAT REV MOL CELL BIO, V17, P123, DOI 10.1038/nrm.2015.25; Saja K, 2010, BRIT J HAEMATOL, V149, P914, DOI 10.1111/j.1365-2141.2010.08137.x; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Speletas M, 2008, BLOOD CELL MOL DIS, V40, P353, DOI 10.1016/j.bcmd.2007.09.011; Stelzl LS, 2014, J MOL BIOL, V426, P735, DOI 10.1016/j.jmb.2013.10.024; Taniguchi R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9545; Vlasveld LT, 2018, HAEMATOLOGICA, V103, P1753, DOI 10.3324/haematol.2018.203315; Wallace DF, 2017, AM J HEMATOL, V92, P1052, DOI 10.1002/ajh.24844; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Wang YW, 2017, INT J HEMATOL, V105, P521, DOI 10.1007/s12185-016-2150-8; Webb B, 2017, METHODS MOL BIOL, V1654, P39, DOI 10.1007/978-1-4939-7231-9_4; Yamashita T, 2014, CLIN J GASTROENTEROL, V7, P260, DOI 10.1007/s12328-014-0487-1	54	6	6	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14625	14635		10.1096/fj.201901857R	http://dx.doi.org/10.1096/fj.201901857R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690120	Green Submitted, Bronze			2022-12-26	WOS:000507466100120
J	Kumar, L; Greiner, R				Kumar, Luke; Greiner, Russell			Gene expression based survival prediction for cancer patients-A topic modeling approach	PLOS ONE			English	Article							BREAST-CANCER; REGRESSION	Cancer is one of the leading cause of death, worldwide. Many believe that genomic data will enable us to better predict the survival time of these patients, which will lead to better, more personalized treatment options and patient care. As standard survival prediction models have a hard time coping with the high-dimensionality of such gene expression data, many projects use some dimensionality reduction techniques to overcome this hurdle. We introduce a novel methodology, inspired by topic modeling from the natural language domain, to derive expressive features from the high-dimensional gene expression data. There, a document is represented as a mixture over a relatively small number of topics, where each topic corresponds to a distribution over the words; here, to accommodate the heterogeneity of a patient's cancer, we represent each patient (approximate to document) as a mixture over cancer-topics, where each cancer-topic is a mixture over gene expression values (approximate to words). This required some extensions to the standard LDA model-e.g., to accommodate the real-valued expression values-leading to our novel discretized Latent Dirichlet Allocation (dLDA) procedure. After using this dLDA to learn these cancer-topics, we can then express each patient as a distribution over a small number of cancer-topics, then use this low-dimensional "distribution vector" as input to a learning algorithm-here, we ran the recent survival prediction algorithm, MTLR, on this representation of the cancer dataset. We initially focus on the METABRIC dataset, which describes each of n = 1,981 breast cancer patients using the r = 49,576 gene expression values, from microarrays. Our results show that our approach (dLDA followed by MTLR) provides survival estimates that are more accurate than standard models, in terms of the standard Concordance measure. We then validate this "dLDA +MTLR" approach by running it on the n = 883 Pan-kidney (KIPAN) dataset, over r = 15,529 gene expression values-here using the mRNAseq modality-and find that it again achieves excellent results. In both cases, we also show that the resulting model is calibrated, using the recent "D-calibrated" measure. These successes, in two different cancer types and expression modalities, demonstrates the generality, and the effectiveness, of this approach. The dLDA+MTLR source code is available at https://github.com/nitsanluke/GELDA-Survival.	[Kumar, Luke; Greiner, Russell] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Kumar, Luke; Greiner, Russell] Amii, Edmonton, AB, Canada	University of Alberta	Greiner, R (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.; Greiner, R (corresponding author), Amii, Edmonton, AB, Canada.	rgreiner@ualberta.ca	Greiner, Russell/AAQ-4502-2020	Greiner, Russell/0000-0001-8327-934X; Kumar, Luke/0000-0002-5129-2598	Alberta Machine Intelligence Institute (Amii); NSERC	Alberta Machine Intelligence Institute (Amii); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work has been supported by the funding from Alberta Machine Intelligence Institute (Amii), and from NSERC.	Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; Andres A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193523; [Anonymous], 2016, ANA OV PAN KIDN COH; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bicego M, 2012, IEEE ACM T COMPUT BI, V9, P1831, DOI 10.1109/TCBB.2012.121; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Cheng WY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005974; COX DR, 1972, J R STAT SOC B, V34, P187; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson JA, 2012, ARXIV12025999; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Guinney J, 2017, LANCET ONCOL, V18, P132, DOI 10.1016/S1470-2045(16)30560-5; Haider Humza, 2018, ARXIV181111347; Hoffman M., 2010, ADV NEURAL INFORM PR, P856; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Hosmer DW, 2013, APPL LOGISTIC REGRES, V398; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Kalbfleisch J. D., 2011, STAT ANAL FAILURE TI, V360; Khan FM, 2008, IEEE DATA MINING, P863, DOI 10.1109/ICDM.2008.50; Liu L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3252-8; Margolin AA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006112; Masada T, 2012, INT C ADV DAT MIN AP; Mcauliffe J. D., 2008, ADV NEURAL INFORM PR, P121; MCCuLLAGH P., 1989, GEN LINEAR MODELS, V37; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Rogers S, 2005, IEEE ACM T COMPUT BI, V2, P143, DOI 10.1109/TCBB.2005.29; Simon N, 2011, J STAT SOFTW, V39, P1; Skinner J, 2017, FOUND SPORT MANAGE, P144; Steck H., 2008, ADV NEURAL INFORM PR, V20, P1209; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yousefi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11817-6; Yu C.N., 2011, ADV NEURAL INF PROCE, V24, P1845	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224446	10.1371/journal.pone.0224446	http://dx.doi.org/10.1371/journal.pone.0224446			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730620	Green Published, gold, Green Submitted			2022-12-26	WOS:000532809500003
J	Rey-Vinolas, S; Castano, O; Ruiz-Macarrilla, L; Llorens, X; Mora, JM; Engel, E; Mateos-Timoneda, MA				Rey-Vinolas, Sergi; Castano, Oscar; Ruiz-Macarrilla, Leonardo; Llorens, Xavier; Mora, Jose M.; Engel, Elisabeth; Mateos-Timoneda, Miguel A.			Development of a novel automatable fabrication method based on electrospinning co electrospraying for rotator cuff augmentation patches	PLOS ONE			English	Article							REPAIR INTEGRITY; TENDON; SCAFFOLDS; ORIENTATION; TOPOGRAPHY; NANOFIBERS; ALIGNMENT; BIOLOGY; FILMS	Rotator cuff tear is one of the most common shoulder diseases. Rotator cuff augmentation (RCA) is trying to solve the high retear failure percentage after the surgery procedures (20-90%). The ideal augmentation patch must provide a temporal mechanical support during the healing process. In this work, we proposed a simple method for the fabrication of synthetic RCA patches. This method combines the use of electrospraying to produce poly-Llactic-co-epsilon-caprolactone (PLC) films in an organogel form and electrospinning to produce poly(lactic) acid (PLA) nanofibers. The device consists in a combination of layers, creating a multilayered construct, enabling the possibility of tuning its mechanical properties and thickness. Besides, both techniques are simple to escalate for industrial production. A complete characterization has been performed to optimize the involved number of layers and production time of PLC films and PLA nanofibers fabrication, obtaining a final optimal configuration for RCA devices. Structural, mechanical and suture properties were evaluated. Also, the possibility of surface functionalization to improve the bioactivity of the scaffold was studied, adding aligned electrospun PLA nanofibers on the surface of the device to mimic the natural tendon topography. Surface modification was characterized by culturing adult normal human dermal fibroblasts. Lack of toxicity was detected for material presented, and cell alignment shape orientation guided by aligned fibers, mimicking tendon structure, was obtained. Cell proliferation and protein production were also evaluated.	[Rey-Vinolas, Sergi; Castano, Oscar; Engel, Elisabeth; Mateos-Timoneda, Miguel A.] Barcelona Inst Sci & Technol BIST, Inst Bioengn Catalonia IBEC, Biomat Regenerat Therapies, Barcelona, Spain; [Rey-Vinolas, Sergi; Castano, Oscar; Engel, Elisabeth; Mateos-Timoneda, Miguel A.] CIBER Bioingn Biomat & Nanomed CIBER BBN, Madrid, Spain; [Castano, Oscar] Univ Barcelona UB, Elect & Biomed Engn Dept, Barcelona, Spain; [Castano, Oscar] Univ Barcelona & N2UB, Inst Nanosci & Nanotechnol, Bioelect Unit, Barcelona, Spain; [Castano, Oscar] Univ Barcelona & N2UB, Inst Nanosci & Nanotechnol, Nanobioengn Lab, Barcelona, Spain; [Ruiz-Macarrilla, Leonardo] Hosp Badalona Germans Trias & Pujol, Serv COT, Badalona, Spain; [Llorens, Xavier; Mora, Jose M.] Fundacio Joan Costa Roma, Consorci Sanitari Terrassa, Terrassa, Spain; [Llorens, Xavier; Mora, Jose M.] Hosp Terrassa, Serv COT, Consorci Sanitari Terrassa, Terrassa, Spain; [Engel, Elisabeth; Mateos-Timoneda, Miguel A.] Tech Univ Catalonia UPC, Dept Mat Sci & Met Engn, EEBE Campus, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Germans Trias i Pujol; Universitat Politecnica de Catalunya	Engel, E; Mateos-Timoneda, MA (corresponding author), Barcelona Inst Sci & Technol BIST, Inst Bioengn Catalonia IBEC, Biomat Regenerat Therapies, Barcelona, Spain.; Engel, E; Mateos-Timoneda, MA (corresponding author), CIBER Bioingn Biomat & Nanomed CIBER BBN, Madrid, Spain.; Engel, E; Mateos-Timoneda, MA (corresponding author), Tech Univ Catalonia UPC, Dept Mat Sci & Met Engn, EEBE Campus, Barcelona, Spain.	eengel@ibecbarcelona.eu; mamateos@ibecbarcelona.eu	Engel, Elisabeth/AAU-6657-2021; Timoneda, Miguel Angel Mateos/D-4666-2014; Castano, Oscar/F-6725-2012	Engel, Elisabeth/0000-0003-4855-8874; Timoneda, Miguel Angel Mateos/0000-0001-7657-1414; Castano, Oscar/0000-0001-9212-784X; Rey Vinolas, Sergi/0000-0002-2128-7704	Obra Social La Caixa, (Tendon Tissue Engineering: A Helping Hand for Rotator Cuff Tears (BIOTENDON). RECERCAIXA 2013)	Obra Social La Caixa, (Tendon Tissue Engineering: A Helping Hand for Rotator Cuff Tears (BIOTENDON). RECERCAIXA 2013)	This study has been granted by The Obra Social La Caixa, (Tendon Tissue Engineering: A Helping Hand for Rotator Cuff Tears (BIOTENDON). RECERCAIXA 2013), a non-profit organization that funds research on health and social topics. Thus, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Z, 2014, BIOMATERIALS, V35, P4769, DOI 10.1016/j.biomaterials.2014.02.051; Alvarez Z, 2013, BIOMATERIALS, V34, P2221, DOI 10.1016/j.biomaterials.2012.12.001; Aurora A, 2012, J SHOULDER ELB SURG, V21, P1064, DOI 10.1016/j.jse.2011.05.014; Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021; Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012; Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005; Bock N, 2012, PROG POLYM SCI, V37, P1510, DOI 10.1016/j.progpolymsci.2012.03.002; Bodnar E, 2018, J AEROSOL SCI, V125, P93, DOI 10.1016/j.jaerosci.2018.04.012; Bosworth LA, 2013, J MATER SCI-MATER M, V24, P1605, DOI 10.1007/s10856-013-4911-8; Chainani A, 2016, TECH ORTHOP, V31, P91, DOI 10.1097/BTO.0000000000000168; Chaudhury S, 2012, J SHOULDER ELB SURG, V21, P1168, DOI 10.1016/j.jse.2011.08.045; Coons DA, 2006, SPORTS MED ARTHROSC, V14, P185, DOI 10.1097/00132585-200609000-00011; Derwin KA, 2006, J BONE JT SURG, P2665; Fee T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154806; Fehringer EV, 2008, J SHOULDER ELB SURG, V17, P881, DOI 10.1016/j.jse.2008.05.039; FRANCE EP, 1989, AM J SPORT MED, V17, P176, DOI 10.1177/036354658901700206; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; GAZIELLY DF, 1994, CLIN ORTHOP RELAT R, P43; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982, DOI 10.2106/00004623-199173070-00004; Hu XF, 2018, J MATER CHEM B, V6, P2274, DOI 10.1039/c7tb03247a; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008; Jung C, 2016, ARCH ORTHOP TRAUM SU, V136, P609, DOI 10.1007/s00402-016-2436-6; Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054; LaCroix AS, 2013, J APPL PHYSIOL, V115, P43, DOI 10.1152/japplphysiol.01449.2012; Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037; Liu S, 2013, BIOMATERIALS, V34, P4690, DOI 10.1016/j.biomaterials.2013.03.026; Mateos-Timoneda MA, 2014, J MATER SCI-MATER M, V25, P1781, DOI 10.1007/s10856-014-5199-z; McElvany MD, 2015, AM J SPORT MED, V43, P491, DOI 10.1177/0363546514529644; Patel S, 2016, ANN NY ACAD SCI, V1383, P97, DOI 10.1111/nyas.13267; Persano L, 2013, MACROMOL MATER ENG, V298, P504, DOI 10.1002/mame.201200290; Prabhath A, 2018, INT J PHARMACEUT, V544, P358, DOI 10.1016/j.ijpharm.2018.01.006; Punet X, 2017, POLYMER, V113, P81, DOI 10.1016/j.polymer.2017.02.056; Ratcliffe A, 2015, ANN BIOMED ENG, V43, P819, DOI 10.1007/s10439-015-1263-1; Ricchetti ET, 2012, J SHOULDER ELB SURG, V21, P251, DOI 10.1016/j.jse.2011.10.003; Sharma P, 2005, SURG-J R COLL SURG E, V3, P309, DOI 10.1016/S1479-666X(05)80109-X; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Teh TKH, 2013, TISSUE ENG PT A, V19, P1360, DOI [10.1089/ten.tea.2012.0279, 10.1089/ten.TEA.2012.0279]; Vitale MA, 2007, J SHOULDER ELB SURG, V16, P181, DOI 10.1016/j.jse.2006.06.013; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6; Wang WB, 2016, NANOMEDICINE-UK, V11, P1055, DOI 10.2217/nnm.16.24; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835; Yin Z, 2015, BIOMATERIALS, V44, P173, DOI 10.1016/j.biomaterials.2014.12.027; Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083; Yu M, 2017, MACROMOL MATER ENG, V302, DOI 10.1002/mame.201700002	49	2	2	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224661	10.1371/journal.pone.0224661	http://dx.doi.org/10.1371/journal.pone.0224661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725745	Green Published, gold			2022-12-26	WOS:000532764500023
J	Rohr, V; Berner, R; Lameu, EL; Popovych, OV; Yanchuk, S				Roehr, Vera; Berner, Rico; Lameu, Ewandson L.; Popovych, Oleksandr, V; Yanchuk, Serhiy			Frequency cluster formation and slow oscillations in neural populations with plasticity	PLOS ONE			English	Article							TIMING-DEPENDENT PLASTICITY; HIERARCHICAL ORGANIZATION; FUNCTIONAL CONNECTIVITY; NETWORKS; DYNAMICS; MODEL; STIMULATION; REFLECTS	We report the phenomenon of frequency clustering in a network of Hodgkin-Huxley neurons with spike timing-dependent plasticity. The clustering leads to a splitting of a neural population into a few groups synchronized at different frequencies. In this regime, the amplitude of the mean field undergoes low-frequency modulations, which may contribute to the mechanism of the emergence of slow oscillations of neural activity observed in spectral power of local field potentials or electroencephalographic signals at high frequencies. In addition to numerical simulations of such multi-clusters, we investigate the mechanisms of the observed phenomena using the simplest case of two clusters. In particular, we propose a phenomenological model which describes the dynamics of two clusters taking into account the adaptation of coupling weights. We also determine the set of plasticity functions (update rules), which lead to multi-clustering.	[Roehr, Vera] Tech Univ Berlin, Neurotechnol Grp, Berlin, Germany; [Berner, Rico] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Berner, Rico; Yanchuk, Serhiy] Tech Univ Berlin, Inst Math, Berlin, Germany; [Lameu, Ewandson L.] Natl Inst Space Res INPE, Sao Jose Dos Campos, SP, Brazil; [Lameu, Ewandson L.] Humboldt Univ, Inst Phys, Berlin, Germany; [Popovych, Oleksandr, V] Inst Neurosci & Med Brain & Behav INM 7, Res Ctr Julich, Julich, Germany; [Popovych, Oleksandr, V] Heinrich Heine Univ Dusseldorf, Inst Syst Neurosci, Med Fac, Dusseldorf, Germany	Technical University of Berlin; Technical University of Berlin; Technical University of Berlin; Instituto Nacional de Pesquisas Espaciais (INPE); Humboldt University of Berlin; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Rohr, V (corresponding author), Tech Univ Berlin, Neurotechnol Grp, Berlin, Germany.	v.roehr@tu-berlin.de	Berner, Rico/AAW-5721-2020; Yanchuk, Serhiy/C-5679-2011; Popovych, Oleksandr/H-8738-2013	Berner, Rico/0000-0003-4821-3366; Yanchuk, Serhiy/0000-0003-1628-9569; Popovych, Oleksandr/0000-0001-9994-1764	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [384950143, 411803875, 308748074]; European Union [826421]; Sao Paulo Research Foundation (processes FAPESP) [2016/23398-8, 2017/13502-5]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); European Union(European Commission); Sao Paulo Research Foundation (processes FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	VR, SY and RB acknowledge the financial support by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) -Project 384950143, Project 411803875 and Project 308748074. OVP acknowledges the support by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement 826421 (VirtualBrainCloud). ELL acknowledges the financial support by the Sao Paulo Research Foundation (processes FAPESP 2016/23398-8 and 2017/13502-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Alvarado-Rojas C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04545; Ashourvan A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215520; Ashwin P, 2015, CHAOS, V25, DOI 10.1063/1.4905197; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Berner R., SIAM J APPL DYN SYST; Berner R, CHAOS; Betzel RF, 2017, NETW NEUROSCI, V1, P42, DOI [10.1162/NETN_a_00002, 10.1162/netn_a_00002]; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bick C, 2016, NONLINEARITY, V29, P1468, DOI 10.1088/0951-7715/29/5/1468; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bolt T, 2017, HUM BRAIN MAPP, V38, P1992, DOI 10.1002/hbm.23500; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; Cateau H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051909; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; GUCKENHEIMER J, 1975, J MATH BIOL, V1, P259, DOI 10.1007/BF01273747; HANSEL D, 1993, EUROPHYS LETT, V23, P367, DOI 10.1209/0295-5075/23/5/011; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HODGKIN AL, 1990, B MATH BIOL, V52, P25, DOI 10.1007/BF02459568; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Hoppensteadt FC, 1996, BIOL CYBERN, V75, P129, DOI 10.1007/s004220050280; Kasatkin DV, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.062211; Kepecs A, 2002, BIOL CYBERN, V87, P446, DOI 10.1007/s00422-002-0358-6; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Lohse C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003712; Lucken L, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032210; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Maistrenko YL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066207; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Marrelec G, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005031; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Ponce-Alvarez A, 2015, PLOS COMPUT BIOL, V11, DOI [10.1007/978-1-4757-3484-3, DOI 10.1007/978-1-4757-3484-3]; Popovych OV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117205; Popovych OV, 2013, SCI REP-UK, V3, DOI 10.1038/srep02926; Rubin J, 2001, PHYS REV LETT, V86, P364, DOI 10.1103/PhysRevLett.86.364; Seliger P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041906; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tass PA, 2006, BIOL CYBERN, V94, P58, DOI 10.1007/s00422-005-0028-6; Tass PA, 2012, BIOL CYBERN, V106, P27, DOI 10.1007/s00422-012-0479-5; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Winfree A., 2001, GEOMETRY BIOL TIME, V2, DOI [10.1007/978-1-4757-3484-3, DOI 10.1007/978-1-4757-3484-3]; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Zhou Y, 2018, CEREB CORTEX, V28, P726, DOI 10.1093/cercor/bhx307	57	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225094	10.1371/journal.pone.0225094	http://dx.doi.org/10.1371/journal.pone.0225094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725782	Green Published, gold, Green Submitted			2022-12-26	WOS:000532764500051
J	Randall, DA; Patterson, JA; Gallimore, F; Morris, JM; McGee, TM; Ford, JB				Randall, Deborah A.; Patterson, Jillian A.; Gallimore, Felicity; Morris, Jonathan M.; McGee, Therese M.; Ford, Jane B.		Obstetric Transfusion Steering Grp	The association between haemoglobin levels in the first 20 weeks of pregnancy and pregnancy outcomes	PLOS ONE			English	Article							PATIENT BLOOD MANAGEMENT; MATERNAL HEMOGLOBIN; IRON-DEFICIENCY; ANEMIA; DELIVERY; WOMEN; RISK; HEMORRHAGE; BIRTH	Background Low haemoglobin has been linked to adverse pregnancy outcomes. Our study aimed to assess the association of haemoglobin (Hb) in the first 20 weeks of pregnancy, and restoration of low Hb levels, with pregnancy outcomes in Australia. Methods Clinical data for singleton pregnancies from two tertiary public hospitals in New South Wales were extracted for 2011-2015. The relationship between the lowest Hb result in the first 20 weeks of pregnancy and adverse outcomes was determined using adjusted Poisson regression. Those with Hb <110 g/L were classified into 'restored' and 'not restored' based on Hb results from 21 weeks onwards, and risk of adverse outcomes explored with adjusted Poisson regression. Results Of 31,906 singleton pregnancies, 4.0% had Hb <110 and 10.2% had >140 g/L at <20 weeks. Women with low Hb had significantly higher risks of postpartum haemorrhage, transfusion, preterm birth, very low birthweight, and having a baby transferred to higher care or stillbirth. High Hb was also associated with higher risks of preterm, very low birthweight, and transfer to higher care/stillbirth. Transfusion was the only outcome where risk decreased with increasing Hb. Risk of transfusion was significantly lower in the 'restored' group compared with the 'not restored' group (OR 0.39, 95% CI 0.22-0.70), but restoration of Hb did not significantly affect the other outcomes measured. Conclusions Women with both low and high Hb in the first 20 weeks of pregnancy had higher risks of adverse outcomes than those with normal Hb. Restoring Hb after 20 weeks did not improve most adverse outcome rates but did reduce risk of transfusion.	[Randall, Deborah A.; Patterson, Jillian A.; Gallimore, Felicity; Morris, Jonathan M.; Ford, Jane B.] Univ Sydney, Northern Clin Sch, Women & Babies Res, St Leonards, NSW, Australia; [Randall, Deborah A.; Patterson, Jillian A.; Gallimore, Felicity; Morris, Jonathan M.; Ford, Jane B.] Kolling Inst, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia; [McGee, Therese M.] Westmead Hosp, Womens & Newborn Hlth, Westmead, NSW, Australia; [McGee, Therese M.] Univ Sydney, Sydney, NSW, Australia	University of Sydney; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Sydney	Randall, DA (corresponding author), Univ Sydney, Northern Clin Sch, Women & Babies Res, St Leonards, NSW, Australia.; Randall, DA (corresponding author), Kolling Inst, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia.	deborah.randall@sydney.edu.au	Peek, Michael/D-5991-2016	Peek, Michael/0000-0001-6055-5129	Australian National Blood Authority Pilot Project	Australian National Blood Authority Pilot Project	The study was funded by the Australian National Blood Authority Pilot Project funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Australian Bureau of Statistics, 2018, CENSUS POPULATION HO; Center for Disease Control and Prevention (CDC), 1998, REC PREV CONTR IR DE; Chatterjee R, 2016, CLIN NUTR, V35, P741, DOI 10.1016/j.clnu.2015.05.014; Department of Health, 2018, CLIN PRACTICE GUIDEL; Dewey KG, 2017, AM J CLIN NUTR, V106, p1694S, DOI 10.3945/ajcn.117.156075; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Drukker L, 2015, TRANSFUSION, V55, P2799, DOI 10.1111/trf.13252; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Gonzales Gustavo F, 2012, ISRN Obstet Gynecol, V2012, P368571, DOI 10.5402/2012/368571; Gonzales GF, 2009, AM J PHYSIOL-REG I, V297, pR1477, DOI 10.1152/ajpregu.00275.2009; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Isbister JP, 2013, BEST PRACT RES-CLIN, V27, P69, DOI 10.1016/j.bpa.2013.02.002; Kavle JA, 2008, J HEALTH POPUL NUTR, V26, P232; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Milman N, 2008, ANN HEMATOL, V87, P949, DOI 10.1007/s00277-008-0518-4; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; Munoz M, 2018, TRANSFUSION MED, V28, P22, DOI 10.1111/tme.12443; MURPHY JF, 1986, LANCET, V1, P992; National Blood Authority, 2015, PAT BLOOD MAN GUID M; Owiredu WKBA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0805-3; Patterson JA, 2014, OBSTET GYNECOL, V123, P126, DOI 10.1097/AOG.0000000000000054; Pena-Rosas Juan Pablo, 2015, Cochrane Database Syst Rev, pCD009997, DOI [10.1002/14651858.CD009997, 10.1002/14651858.CD009997.pub2]; Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2014, 25 RANZCOG; Scheil W, 2017, PREGNANCY OUTCOME S; Sinha P, 2008, J OBSTET GYNAECOL, V28, P377, DOI 10.1080/01443610802091487; SNOMED International, 2018, WHAT IS SNOM CT 2018; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Vahanian SA, 2015, AM J OBSTET GYNECOL, V213, pS78, DOI 10.1016/j.ajog.2015.05.058; WHO, 2011, WHO TECH REP SER, V959, P1; World Health Organization, 1992, INT STAT CLASS DIS R	32	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225123	10.1371/journal.pone.0225123	http://dx.doi.org/10.1371/journal.pone.0225123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721799	gold, Green Published			2022-12-26	WOS:000532720700038
J	Bernardina, GRD; Monnet, T; Cerveri, P; Silvatti, AP				Bernardina, Gustavo R. D.; Monnet, Tony; Cerveri, Pietro; Silvatti, Amanda P.			Moving system with action sport cameras: 3D kinematics of the walking and running in a large volume	PLOS ONE			English	Article							MOTION CAPTURE; ACCURACY; CALIBRATION	Traditionally, motion analysis in clinical laboratories using optoelectronic systems (MOCAP) is performed in acquisition volumes of limited size. Given the complexity and cost of MOCAP in larger volumes, action sports cameras (ASC) represent an alternative approach in which the cameras move along with the subject during the movement task. Thus, this study aims to compare ASC against a traditional MOCAP in the perspective of reconstructing walking and running movements in large spatial volumes, which extend over the common laboratory setup. The two systems, consisting of four cameras each, were closely mounted on a custom carrying structure endowed with wheels. Two different acquisition setups, namely steady and moving conditions, were taken into account. A devoted calibration procedure, using the same protocol for the two systems, enabled the reconstruction of surface markers, placed on voluntary subjects, during the two acquisition setups. The comparison was quantitatively expressed in terms of three-dimensional (3D) marker reconstruction and kinematic computation quality. The quality of the marker reconstruction quality was quantified by means of the mean absolute error (MAE) of intermarker distance and two-stick angle. The kinematic computation quality was quantified by means of the measure of the knee angle reconstruction during walking and running trials. In order to evaluate the camera system and moving camera effects, we used a Wilcoxon rank sum test and a Kruskal Wallis test (post-hoc Tukey), respectively. The Spearman correlation coefficient (rho) and the Wilcoxon rank sum test were applied to compare the kinematic data obtained by the two camera systems. We found small ASC MAE values (< 2.6mm and 1.3 degrees), but they were significantly bigger than the MOCAP (< 0.7mm and 0.6 degrees). However, for the human movement no significant differences were found between kinematic variables in walking and running acquisitions (p>0.05), and the motion patterns of the right-left knee angles between both systems were very similar (rho>0.90, p<0.05). These results highlighted the promising results of a system that uses ASC based on the procedure of mobile cameras to follow the movement of the subject, allowing a less constrained movement in the direction in which the structure moves, compared to the traditional laboratory setup.	[Bernardina, Gustavo R. D.] Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil; [Monnet, Tony] Univ Poitiers, Dept Biomech & Robot, PPRIME Inst, CNRS,ENSMA,UPR 3346, Poitiers, France; [Cerveri, Pietro] Politecn Milan, Eletron Informat & Bioengn Dept, Milan, Italy; [Silvatti, Amanda P.] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil	Universidade Federal de Minas Gerais; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Ecole Nationale Superieure de Mecanique et d'Aerotechnique (ISAE-ENSMA); Universite de Poitiers; Polytechnic University of Milan; Universidade Federal de Vicosa	Bernardina, GRD (corresponding author), Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil.	gustavordalla@gmail.com		Monnet, Tony/0000-0003-2942-2437	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Counsel of Technological and Scientific Development) [481391/2013-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazilian Federal Agency for Support and Evaluation of Graduation Education) [2011/10-7, 08/2014]; Fundacao de Amparo a Pesquisa de Minas Gerais (Minas Gerais Research Foundation) [PEE-00596-14, 12040/2017]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Counsel of Technological and Scientific Development); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazilian Federal Agency for Support and Evaluation of Graduation Education); Fundacao de Amparo a Pesquisa de Minas Gerais (Minas Gerais Research Foundation)	APS received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Counsel of Technological and Scientific Development) (www.cnpq.br) through Award Numbers 481391/2013-4. GRDB and this study received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazilian Federal Agency for Support and Evaluation of Graduation Education) (www.capes.gov.br) through Award Numbers 2011/10-7 and 08/2014. APS and GRDB received funding from Fundacao de Amparo a Pesquisa de Minas Gerais (Minas Gerais Research Foundation) (www.fapemig.br) through Award Number PEE-00596-14 and 12040/2017. The funders had no role in study/design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Begon M, 2009, J BIOMECH, V42, P2649, DOI 10.1016/j.jbiomech.2009.08.020; Bernardina GRD, 2017, J BIOMECH, V51, P77, DOI 10.1016/j.jbiomech.2016.11.068; Bernardina GRD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160490; Bini RR, 2010, SPORT BIOMECH, V9, P223, DOI 10.1080/14763141.2010.540672; Cerveri P, 2001, IEEE T EVOLUT COMPUT, V5, P271, DOI 10.1109/4235.930315; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colloud Floren, 2008, Journal of Biomechanics, V41, DOI 10.1016/S0021-9290(08)70057-5; Dalla Bernardina GR, 2019, J APPL BIOMECH, V35, P80, DOI 10.1123/jab.2017-0101; Eichelberger P, 2016, J BIOMECH, V49, P2085, DOI 10.1016/j.jbiomech.2016.05.007; Fantozzi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138105; Field A.P., 2020, DISCOVERING STAT USI, V4th; Fong DTP, 2010, SENSORS-BASEL, V10, P11556, DOI 10.3390/s101211556; Mirek E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00102; Nez A, 2016, MED ENG PHYS, V38, P1289, DOI 10.1016/j.medengphy.2016.08.004; Pietraszewski B, 2012, ACTA BIOENG BIOMECH, V14, P9, DOI 10.5277/abb120302; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Silvatti AP, 2013, COMPUT METHOD BIOMEC, V16, P1240, DOI 10.1080/10255842.2012.664637; Silvatti AP, 2012, J BIOMECH, V45, P1112, DOI 10.1016/j.jbiomech.2012.01.004; Sinclair J, 2013, J HUM KINET, V39, P25, DOI 10.2478/hukin-2013-0065; Sinclair J, 2013, SPORT BIOMECH, V12, P272, DOI 10.1080/14763141.2012.759614; Steer RR, 2006, J SPORT SCI MED, V5, P52; van der Kruk E, 2018, EUR J SPORT SCI, V18, P806, DOI 10.1080/17461391.2018.1463397	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224182	10.1371/journal.pone.0224182	http://dx.doi.org/10.1371/journal.pone.0224182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714919	Green Published, gold			2022-12-26	WOS:000532710400005
J	Qiang, J; Khamis, OAM; Jiang, HJ; Cao, ZM; He, J; Tao, YF; Xu, P; Bao, JW				Qiang, Jun; Khamis, Omyia Ahmed Mohamed; Jiang, Huo Jin; Cao, Zhe Ming; He, Jie; Tao, Yi Fan; Xu, Pao; Bao, Jin Wen			Effects of dietary supplementation with apple peel powder on the growth, blood and liver parameters, and transcriptome of genetically improved farmed tilapia (GIFT, Oreochromis niloticus)	PLOS ONE			English	Article							FACTOR-II; HEPATIC STEATOSIS; BY-PRODUCTS; EXPRESSION; PERFORMANCE; MICE; GENE; TRITERPENOIDS; ACCUMULATION; RESISTANCE	High-density aquaculture and nutritional imbalances may promote fatty liver in genetically improved farmed tilapia (GIFT, Oreochromis niloticus), thus reducing the gains achieved by breeding. In this study, apple peel powder (APP) was used as a feed additive for GIFT. A control group (fed on a diet without APP) and five groups fed on diets supplemented with APP (at 0.05%, 0.1%, 0.2%, 0.4%, or 0.8% of the diet, by weight) were established to investigate the effects of APP on GIFT growth performance and physiological parameters, and on gene expression as determined by transcriptomic analysis. Dietary supplementation with APP at 0.2% promoted GIFT growth, reduced total cholesterol and triacylglycerol levels in the serum and liver, and decreased alanine aminotransferase and aspartate aminotransferase activities in the serum. Gene expression profiles in the liver were compared among the control, 0.2% APP, and 0.8% APP groups, and differentially expressed genes among these groups were identified. Annotation analyses using tools at the Gene Ontology and Kyoto Encyclopedia of Genes and Genomes databases showed that the differentially expressed genes were mainly involved in the regulation of immunity and fat metabolism. The results showed that excessive supplementation with APP in the diet significantly inhibited the expression of insulin-like growth factor 2 and liver-type fatty acid-binding protein, and stimulated the expression of fatty acid desaturase 2, heat shock protein 90 beta family member 1, and nuclear factor kappa B. This resulted in disordered lipid metabolism and increased proinflammatory reactions, which in turn caused liver damage. Therefore, APP has good potential as an environmentally friendly feed additive for GIFT at levels of 0.1%-0.2% in the diet, but excessive amounts can have adverse effects.	[Qiang, Jun; Khamis, Omyia Ahmed Mohamed; Cao, Zhe Ming; He, Jie; Tao, Yi Fan; Xu, Pao; Bao, Jin Wen] Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China; [Jiang, Huo Jin] Beijing Yujing Biotechnol Co Ltd, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Qiang, J; Xu, P (corresponding author), Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China.	qiangj@ffrc.cn; Xup@ffrc.cn			Natural Science Foundation of Jiangsu Province, China [BK20181137]; Central Public-Interest Scientific Institution Basal Research Fund, Freshwater Fisheries Research Center, CAFS [2019JBFC01]; Cooperative Development Project of Freshwater Fisheries Research Center [2019502700]; Beijing Yujing Biotechnology Co., Ltd. [2019502700]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Central Public-Interest Scientific Institution Basal Research Fund, Freshwater Fisheries Research Center, CAFS; Cooperative Development Project of Freshwater Fisheries Research Center; Beijing Yujing Biotechnology Co., Ltd.	This work was supported by the Natural Science Foundation of Jiangsu Province, China (No. BK20181137); the Central Public-Interest Scientific Institution Basal Research Fund, Freshwater Fisheries Research Center, CAFS (No. 2019JBFC01); and the Cooperative Development Project of Freshwater Fisheries Research Center and Beijing Yujing Biotechnology Co., Ltd. (No. 2019502700). The funder [Beijing Yujing Biotechnology Co., Ltd.] provided support in the form of salaries for author [HJJ; JWB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baolige, 2018, Animal Husbandry and Feed Science (Inner Mongolia), V39, P1; Cao LanXiu, 2009, Journal of the Fourth Military Medical University, V30, P2129; Dai ZR, 2015, AM J PHYSIOL-ENDOC M, V308, pE849, DOI 10.1152/ajpendo.00540.2014; Denis MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053725; Djilas S, 2009, CHEM IND CHEM ENG Q, V15, P191, DOI 10.2298/CICEQ0904191D; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; Ferguson LR, 2007, MUTAT RES-FUND MOL M, V623, P14, DOI 10.1016/j.mrfmmm.2007.03.014; Gabriel NN, 2015, FISH SHELLFISH IMMUN, V44, P504, DOI 10.1016/j.fsi.2015.03.002; Galanakis CM, 2012, TRENDS FOOD SCI TECH, V26, P68, DOI 10.1016/j.tifs.2012.03.003; Gimeno RE, 2005, CURR OPIN PHARMACOL, V5, P122, DOI 10.1016/j.coph.2005.01.006; Gorinstein S, 2001, J AGR FOOD CHEM, V49, P952, DOI 10.1021/jf000947k; Gou GengWu, 2016, Journal of Fisheries of China, V40, P1309; He X, 2008, J AGR FOOD CHEM, V56, P9905, DOI 10.1021/jf8015255; Henriquez C, 2010, J FOOD SCI, V75, pH172, DOI 10.1111/j.1750-3841.2010.01700.x; Hill DJ, 2000, ENDOCRINOLOGY, V141, P1151, DOI 10.1210/en.141.3.1151; Huang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16132; Jia R, 2019, FISH SHELLFISH IMMUN, V93, P395, DOI 10.1016/j.fsi.2019.07.080; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lamberson WR, 1996, J ANIM SCI, V74, P1753; Leccese A, 2009, NEW ZEAL J CROP HORT, V37, P71, DOI 10.1080/01140670909510251; Li H, 2011, CHEM J CHINESE U, V32, P28; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; [李珊 Li Shan], 2018, [食品工业科技, Science & Technology of Food Industry], V39, P301; Li X, 2016, INFLAMMATION, V39, P96, DOI 10.1007/s10753-015-0227-9; Lin M, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-19; Martin GG, 2006, AM J PHYSIOL-GASTR L, V290, pG36, DOI 10.1152/ajpgi.00510.2004; Mock TS, 2019, AQUACULTURE, V501, P191, DOI 10.1016/j.aquaculture.2018.11.012; Mueller D, 2013, FOOD CHEM, V139, P339, DOI 10.1016/j.foodchem.2013.01.101; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Ni PJ, 2016, FISH SHELLFISH IMMUN, V55, P28, DOI 10.1016/j.fsi.2016.03.163; Njemini R, 2007, BIOGERONTOLOGY, V8, P353, DOI 10.1007/s10522-006-9078-y; Noritaka S, 2003, CANC LETT, V192, P25, DOI 10.1016/s0304-3835(02)00684-5; Nouri M. K., 2011, Middle East Journal of Scientific Research, V9, P744; O'Shea N, 2012, INNOV FOOD SCI EMERG, V16, P1, DOI 10.1016/j.ifset.2012.06.002; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Qiang J, 2019, FISH SHELLFISH IMMUN, V92, P395, DOI 10.1016/j.fsi.2019.06.026; Qiang J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01422; Qiang J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00998; Qiang J, 2017, AQUAC RES, V48, P2827, DOI 10.1111/are.13117; Qiang Jun, 2015, Chinese Journal of Animal Nutrition, V27, P1769; Qin SF, 2011, EXP EYE RES, V93, P889, DOI 10.1016/j.exer.2011.10.002; Qin YX, 2011, J COMMUNITY MED, V9, P11; Reardon HT, 2013, PROSTAG LEUKOTR ESS, V88, P15, DOI 10.1016/j.plefa.2012.02.003; Sakai M, 1999, AQUACULTURE, V172, P63, DOI 10.1016/S0044-8486(98)00436-0; Spencer GSG, 1996, POULTRY SCI, V75, P388, DOI 10.3382/ps.0750388; Tang YW, 2017, FOOD CHEM FUNCT ANAL, V2, P164; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang SQ, 2014, AQUACULTURE, V434, P57, DOI 10.1016/j.aquaculture.2014.07.016; Wang XQ, 2018, PHARM CLIN CHINESE M, V3, P46; Wolfe KL, 2003, J AGR FOOD CHEM, V51, P1676, DOI 10.1021/jf025916z; Xie XW, 2017, BIOMED PHARMACOTHER, V86, P694, DOI 10.1016/j.biopha.2016.12.066; [徐奇友 Xu Qiyou], 2012, [东北农业大学学报, Journal of Northeast Agricultural University], V43, P118; Yin GJ, 2009, FISH SHELLFISH IMMUN, V26, P140, DOI 10.1016/j.fsi.2008.08.015; Zhang GS, 2016, SCI REP-UK, V6, DOI 10.1038/srep22907; Zhao MG, 2018, J CHINA PHARM UNIV, V49, P333, DOI 10.11665/j.issn.1000-5048.20180312; Zhu JL, 2010, WORLD CHINESE J DIGE, V18, P1525; 韩正康, 1999, [畜牧与兽医, Animal Husbandry ＆ Veterinary Medicine], V31, P1	60	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224995	10.1371/journal.pone.0224995	http://dx.doi.org/10.1371/journal.pone.0224995			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714944	Green Published, gold			2022-12-26	WOS:000532710400023
J	Dong, CJ; Wang, LL; Li, Q; Shang, QM				Dong, Chun-Juan; Wang, Ling-Ling; Li, Qian; Shang, Qing-Mao			Bacterial communities in the rhizosphere, phyllosphere and endosphere of tomato plants	PLOS ONE			English	Article							MICROBIOTA; DIVERSITY; ENDOPHYTES; INSIGHTS; COLONIZATION; REVEALS; STRAIN; ROOTS	Plants harbor diverse bacterial communities, which play crucial roles in plant health and growth, in their rhizosphere, phyllosphere and endosphere. Tomato is an important model for studying plant-microbe interactions, but comparison of its associated bacterial community is still lacking. In this study, using Illumina sequencing of 16S rRNA amplicons, we characterized and compared the bacterial size and community from rootzone soil as well as the rhizosphere, phyllosphere and endosphere of roots, stems, leaves, fruits and seeds of tomato plants that were grown in greenhouse conditions. Habitat (soil, phyllospheric, and endophytic) structured the community. The bacterial communities from the soil-type samples (rootzone soil and rhizosphere) showed the highest richness and diversity. The lowest bacterial diversity occurred in the phyllospheric samples, while the lowest richness occurred in the endosphere. Among the endophytic samples, both bacterial diversity and richness varied in different tissues, with the highest values in roots. The most abundant phyla in the tomato-associated community was Proteobacteria, with the exception of the seeds and jelly, where both Proteobacteria and Firmicutes were dominant. At the genus level, the sequences of Pseudomonas and Acinetobacter were prevalent in the rhizosphere, and in the phyllosphere, more than 97% of the sequences were assigned to Acinetobacter. For the endophytes, Acinetobacter, Enterobacter, and Pseudomonas were the abundant genera in the roots, stems and leaves. In the fruits, the bacterial endophytes varied in different compartments, with Enterobacter being enriched in the pericarp and seeds, Acinetobacter in the placenta, and Weissella in the jelly. The present data provide a comprehensive description of the tomato-associated bacterial community and will be useful for better understanding plant-microbe interactions and selecting suitable bacterial taxa for tomato production.	[Dong, Chun-Juan; Wang, Ling-Ling; Li, Qian; Shang, Qing-Mao] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Hort Crop Biol & Germplasm Innovat, Minist Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Dong, CJ; Shang, QM (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Hort Crop Biol & Germplasm Innovat, Minist Agr, Beijing, Peoples R China.	dongchunjuan@caas.cn; dcj04@tsinghua.org.cn			National Key Research and Development Program of China [2016YED0201003]; China Agriculture Research System [CARS-25]; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAASASTIP-IVFCAAS)	National Key Research and Development Program of China; China Agriculture Research System; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAASASTIP-IVFCAAS)	This work was supported by grants from the National Key Research and Development Program of China (No. 2016YED0201003), the China Agriculture Research System (CARS-25), and the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAASASTIP-IVFCAAS). CD and QS's work were supported by these funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal I, 2019, MICROBIOL RES, V221, P36, DOI 10.1016/j.micres.2019.02.001; Allard SM, 2016, SCI TOTAL ENVIRON, V573, P555, DOI 10.1016/j.scitotenv.2016.08.157; Amari M, 2013, APPL MICROBIOL BIOT, V97, P5413, DOI 10.1007/s00253-012-4447-8; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Andreote FD, 2017, CURR OPIN MICROBIOL, V37, P29, DOI 10.1016/j.mib.2017.03.011; Backer R, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01473; Bai YL, 2018, PLANT J, V93, P781, DOI 10.1111/tpj.13800; Bakker MG, 2012, PLANT SOIL, V360, P1, DOI 10.1007/s11104-012-1361-x; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Brader G, 2017, ANNU REV PHYTOPATHOL, V55, P61, DOI 10.1146/annurev-phyto-080516-035641; Bringel F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00486; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Compant S, 2008, FEMS MICROBIOL ECOL, V63, P84, DOI 10.1111/j.1574-6941.2007.00410.x; Czajkowski R, 2010, PHYTOPATHOLOGY, V100, P134, DOI 10.1094/PHYTO-100-2-0134; de Lamo FJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02977; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Halpern M, 2013, INT J SYST EVOL MICR, V63, P4259, DOI 10.1099/ijs.0.052217-0; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Himani Chaturvedi, 2016, Journal of Plant Pathology and Microbiology, V7, P376; Karlova R, 2014, J EXP BOT, V65, P4527, DOI 10.1093/jxb/eru316; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Lee SA, 2016, J MICROBIOL, V54, P823, DOI 10.1007/s12275-016-6410-3; Lindow SE, 2002, CURR OPIN BIOTECH, V13, P238, DOI 10.1016/S0958-1669(02)00313-0; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V153, P351, DOI 10.1016/j.ijfoodmicro.2011.11.026; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magnucka EG, 2015, MICROBIOL RES, V181, P112, DOI 10.1016/j.micres.2015.04.005; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marquez-Santacruz HA, 2010, GENET MOL RES, V9, P2372, DOI 10.4238/vol9-4gmr921; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mori H, 2014, DNA RES, V21, P217, DOI 10.1093/dnares/dst052; Muller T, 2014, FEMS MICROBIOL ECOL, V87, P2, DOI 10.1111/1574-6941.12198; Ottesen AR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-114; Porter NT, 2018, TRENDS MICROBIOL, V26, P966, DOI 10.1016/j.tim.2018.08.005; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rastogi G, 2013, FEMS MICROBIOL LETT, V348, P1, DOI 10.1111/1574-6968.12225; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Raza W, 2017, CRIT REV BIOTECHNOL, V37, P202, DOI 10.3109/07388551.2015.1130683; Rezki S, 2016, PEERJ, V4, DOI 10.7717/peerj.1923; Romero FM, 2016, RES MICROBIOL, V167, P222, DOI 10.1016/j.resmic.2015.11.001; Romero FM, 2014, FEMS MICROBIOL LETT, V351, P187, DOI 10.1111/1574-6968.12377; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Singh R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01767; Singh VK, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0896-1; Tian BY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17087; Tian XY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02288; Toju H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38344-2; Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wang WF, 2016, MICROBIOL RES, V188, P1, DOI 10.1016/j.micres.2016.04.009; Yashiro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037131; Zhao JT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01286	56	70	71	11	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0223847	10.1371/journal.pone.0223847	http://dx.doi.org/10.1371/journal.pone.0223847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703074	gold, Green Published			2022-12-26	WOS:000532697200008
J	Liu, LM; Koo, YM; Akwitti, C; Russell, T; Gay, E; Laskowitz, DT; Yun, Y				Liu, Lumei; Koo, Youngmi; Akwitti, Chukwuma; Russell, Teal; Gay, Elaine; Laskowitz, Daniel T.; Yun, Yeoheung			Three-dimensional (3D) brain microphysiological system for organophosphates and neurochemical agent toxicity screening	PLOS ONE			English	Article							INDUCED APOPTOSIS; PBPK/PD MODEL; CHLORPYRIFOS; DEXTROMETHORPHAN; INHIBITION; ACETYLCHOLINESTERASE; NEUROTOXICITY; INSECTICIDES; MECHANISMS; NEURONS	We investigated a potential use of a 3D tetraculture brain microphysiological system (BMPS) for neurotoxic chemical agent screening. This platform consists of neuronal tissue with extracellular matrix (ECM)-embedded neuroblastoma cells, microglia, and astrocytes, and vascular tissue with dynamic flow and membrane-free culture of the endothelial layer. We tested the broader applicability of this model, focusing on organophosphates (OPs) Malathion (MT), Parathion (PT), and Chlorpyrifos (CPF), and chemicals that interact with GABA and/or opioid receptor systems, including Muscimol (MUS), Dextromethorphan (DXM), and Ethanol (EtOH). We validated the BMPS platform by measuring the neurotoxic effects on barrier integrity, acetylcholinesterase (AChE) inhibition, viability, and residual OP concentration. The results show that OPs penetrated the model blood brain barrier (BBB) and inhibited AChE activity. DXM, MUS, and EtOH also penetrated the BBB and induced moderate toxicity. The results correlate well with available in vivo data. In addition, simulation results from an in silico physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) model that we generated show good agreement with in vivo and in vitro data. In conclusion, this paper demonstrates the potential utility of a membrane-free tetraculture BMPS that can recapitulate brain complexity as a cost-effective alternative to animal models.	[Liu, Lumei; Koo, Youngmi; Akwitti, Chukwuma; Russell, Teal; Yun, Yeoheung] North Carolina Agr & Tech State Univ, Dept Chem Biol & Bio Engn, FIT BEST Lab, Greensboro, NC 27411 USA; [Gay, Elaine] RTI Int, Ctr Drug Discovery, Res Triangle Pk, NC USA; [Laskowitz, Daniel T.] Duke Univ, Brain Injury Translat Res Ctr, Dept Neurol, Durham, NC USA; [Laskowitz, Daniel T.] Duke Univ, Brain Injury Translat Res Ctr, Dept Anesthesiol, Durham, NC USA; [Laskowitz, Daniel T.] Duke Univ, Brain Injury Translat Res Ctr, Dept Neurobiol, Durham, NC USA	University of North Carolina; North Carolina A&T State University; Research Triangle Institute; Duke University; Duke University; Duke University	Liu, LM; Yun, Y (corresponding author), North Carolina Agr & Tech State Univ, Dept Chem Biol & Bio Engn, FIT BEST Lab, Greensboro, NC 27411 USA.	yyun@ncat.edu			U.S. Department of Defense through the MSRDC Consortium (DTRA) at North Carolina A & T State University [D01 W911SR14-2-0001-0010]; U.S. Department of Defense through the MSRDC Consortium (ECBC) at North Carolina A & T State University [D01 W911SR14-2-0001-0010]; NIH NIGMS [ISC3GM113728]; NSF EAGER Grant [1649243]	U.S. Department of Defense through the MSRDC Consortium (DTRA) at North Carolina A & T State University; U.S. Department of Defense through the MSRDC Consortium (ECBC) at North Carolina A & T State University; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF EAGER Grant(National Science Foundation (NSF))	This work was supported by U.S. Department of Defense contact #D01 W911SR14-2-0001-0010 awarded through the MSRDC Consortium (DTRA and ECBC) at North Carolina A & T State University, NIH NIGMS grant (ISC3GM113728, https://www.nigms.nih.gov/Research/Pages/default.aspx; YY is the recipient), NSF EAGER Grant (1649243, https://www.nsf.gov/awardsearch/showAward?AWD_ID=1649243; YY is the recipient). These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the `author contributions' section.	[Anonymous], 2012, EVARREST FIBRIN SEAL; Ariwodola OJ, 2004, J NEUROSCI, V24, P10679, DOI 10.1523/JNEUROSCI.1768-04.2004; Budavari S., 1989, MERCK INDEX ENCY CHE; Carlson K, 2000, TOXICOL APPL PHARM, V168, P102, DOI 10.1006/taap.2000.8997; Chen C-L, 2018, ANTIMICROBIAL AGENTS; Echave M, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-111; Eto M., 2018, ORGANOPHOSPHORUS PES; GEARHART JM, 1990, TOXICOL APPL PHARM, V106, P295, DOI 10.1016/0041-008X(90)90249-T; GEARHART JM, 1994, ENVIRON HEALTH PERSP, V102, P51, DOI 10.1289/ehp.94102s1151; Hawkins B. T., 2016, APPL IN VITRO TOXICO, V2, P223; Hole G., 2014, 8 THINGS YOU NEED KN; Itzhak BRaB, 2015, ARCH OTOLARYNGOL, V1; Jo SH, 2007, OTOLARYNG HEAD NECK, V137, P454, DOI 10.1016/j.otohns.2006.09.020; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; Kashyap MP, 2013, STEM CELLS DEV, V22, P224, DOI 10.1089/scd.2012.0220; Koo Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20876-2; KOZIOL FS, 1982, J ECON ENTOMOL, V75, P28, DOI 10.1093/jee/75.1.28; Larson TA, 2013, P NATL ACAD SCI USA; Lenz DE, 2010, CHEM-BIOL INTERACT, V187, P249, DOI 10.1016/j.cbi.2010.05.014; Liu YX, 2003, J PHARMACOL EXP THER, V305, P212, DOI 10.1124/jpet.102.043166; Mozet C, 2012, EUR ARCH OTO-RHINO-L, V269, P2247, DOI 10.1007/s00405-011-1904-4; Nesheim O, 1982, PESTICIDE APPLICATOR; Park JH, 2015, NEUROTOXICOLOGY, V51, P145, DOI 10.1016/j.neuro.2015.10.008; Poet TS, 2014, XENOBIOTICA, V44, P868, DOI 10.3109/00498254.2014.918295; Rahman NA, 2016, BRAIN RES, V1642, P532, DOI 10.1016/j.brainres.2016.04.024; Rush T, 2010, NEUROSCIENCE, V166, P899, DOI 10.1016/j.neuroscience.2010.01.025; Slotkin TA, 2006, ENVIRON HEALTH PERSP, V114, P746, DOI 10.1289/ehp.8828; Slotkin TA, 2011, REPROD TOXICOL, V31, P297, DOI 10.1016/j.reprotox.2010.07.012; Tateno M, 2008, PSYCHIAT INVEST, V5, P21, DOI 10.4306/pi.2008.5.1.21; Tiffany-Castiglioni E, 1999, TOXICOL SCI, V51, P178, DOI 10.1093/toxsci/51.2.178; Timchalk C, 2002, TOXICOL SCI, V66, P34, DOI 10.1093/toxsci/66.1.34; vandenPol AN, 1996, J NEUROSCI, V16, P4283; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Wevers NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep38856; Yi Y, 2015, TRENDS BIOTECHNOL, V33, P762, DOI 10.1016/j.tibtech.2015.09.007; Ziemann U, 1998, NEUROLOGY, V51, P1320, DOI 10.1212/WNL.51.5.1320	36	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224657	10.1371/journal.pone.0224657	http://dx.doi.org/10.1371/journal.pone.0224657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703066	Green Published, gold			2022-12-26	WOS:000532697200019
J	Stefanovic, M; Djan, M; Velickovic, N; Beukovic, D; Lavadinovic, V; Zhelev, CD; Demirbas, Y; Paule, L; Gedeon, CI; Mamuris, Z; Posautz, A; Beiglbock, C; Kubber-Heiss, A; Suchentrunk, F				Stefanovic, Milomir; Djan, Mihajla; Velickovic, Nevena; Beukovic, Dejan; Lavadinovic, Vukan; Zhelev, Chavdar Dinev; Demirbas, Yasin; Paule, Ladislav; Gedeon, Csongor Istvan; Mamuris, Zissis; Posautz, Annika; Beiglbock, Christoph; Kuebber-Heiss, Anna; Suchentrunk, Franz			Positive selection and precipitation effects on the mitochondrial NADH dehydrogenase subunit 6 gene in brown hares (Lepus europaeus) under a phylogeographic perspective	PLOS ONE			English	Article							POPULATION-GENETICS; PALLAS; DIFFERENTIATION; VARIABILITY; DIVERSITY; EVOLUTION; PATTERNS; CLIMATE; MODEL	Previous studies in hares and jackrabbits have indicated that positive selection has shaped the genetic diversity of mitochondrial genes involved in oxidative phosphorylation, which may affect cellular energy production and cause regional adaptation to different environmental (climatic) pressures. In the present study, we sequenced the NADH dehydrogenase subunit 6 (MT-ND6) gene of 267 brown hares (L. europaeus) from Europe and Asia Minor and tested for positive selection and adaptations acting on amino acid sequences (protein variants). Molecular diversity indices and spatial clustering were assessed by DnaSP, Network, and Geneland, while the presence of selection signals was tested by codeml in PAML, and by using the Datamonkey Adaptive Evolution web server. The SPSS software was used to run multinomial regression models to test for possible effects of climate parameters on the currently obtained protein variants. Fifty-eight haplotypes were revealed with a haplotype diversity of 0.817, coding for 17 different protein variants. The MT-ND6 phylogeographic pattern as determined by the nucleotide sequences followed the earlier found model based on the neutrally evolving D-loop sequences, and reflected the earlier found phylogeographic Late Pleistocene scenario. Based on several selection tests, only one codon position consistently proved to be under positive selection. It did occur exclusively in the evolutionarily younger hares from Europe and it gave rise to several protein variants from the southeastern and south-central Balkans. The occurrence of several of those variants was significantly favored under certain precipitation conditions, as proved by our multinomial regression models. Possibly, the great altitudinal variation in the Balkans may have lead to bigger changes in precipitation across that region and this may have imposed an evolutionarily novel selective pressure on the protein variants and could have led to regional adaptation.	[Stefanovic, Milomir; Djan, Mihajla; Velickovic, Nevena] Univ Novi Sad, Fac Sci, Dept Biol & Ecol, Novi Sad, Serbia; [Beukovic, Dejan] Univ Novi Sad, Fac Agr, Novi Sad, Serbia; [Lavadinovic, Vukan] Univ Belgrade, Fac Forestry, Belgrade, Serbia; [Zhelev, Chavdar Dinev] Southwestern State Forest Enterprise Blagoevgrad, Blagoevgrad, Bulgaria; [Demirbas, Yasin] Kirikkale Univ, Fac Sci & Arts, Kirikkale, Turkey; [Paule, Ladislav] Tech Univ, Fac Forestry, Zvolen, Slovakia; [Gedeon, Csongor Istvan] Hungarian Acad Sci, Inst Soil Sci & Agr Chem, Budapest, Hungary; [Mamuris, Zissis] Univ Thessaly, Dept Biochem & Biotechnol, Larrisa, Greece; [Posautz, Annika; Beiglbock, Christoph; Kuebber-Heiss, Anna; Suchentrunk, Franz] Univ Vet Med Vienna, Res Inst Wildlife Ecol, Vienna, Austria	University of Novi Sad; University of Novi Sad; University of Belgrade; Kirikkale University; Technical University Zvolen; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Thessaly; University of Veterinary Medicine Vienna	Stefanovic, M (corresponding author), Univ Novi Sad, Fac Sci, Dept Biol & Ecol, Novi Sad, Serbia.	milomir.stefanovic@dbe.uns.ac.rs	Mamuris, Zissis/AAN-2576-2021; Velickovic, Nevena/ABG-4787-2020; Gedeon, Csongor Istvan/D-7665-2011	Velickovic, Nevena/0000-0003-0797-269X; Gedeon, Csongor Istvan/0000-0003-4027-2409; Beukovic, Dejan/0000-0003-1431-0475; Stefanovic, Milomir/0000-0001-6294-3782	Ministry of Education, Science and Technological Development, Republic of Serbia [43002]; Provincial Secretariat for Science and Technological Development [0601 78/37-316]; Wildlife Research - Franz Suchentrunk [1/2017]	Ministry of Education, Science and Technological Development, Republic of Serbia; Provincial Secretariat for Science and Technological Development; Wildlife Research - Franz Suchentrunk	This work was financially supported by the Ministry of Education, Science and Technological Development, Republic of Serbia Grant No. 43002, project title "Biosensing technology and global system for long-term research and integrated management of ecosystems"; and the Provincial Secretariat for Science and Technological Development Grant No. 0601 78/37-316, project title "Evaluation of ecological networks in AP Vojvodina as support for nature conservation". Partial financial support was provided by Wildlife Research - Franz Suchentrunk (project No. 1/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2013, GENETICA, V141, P23, DOI 10.1007/s10709-013-9703-z; Ashrafzadeh MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204653; Avise JC, 2012, MOL MARKERS NATURAL; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Ballard JWO, 2010, MOL ECOL, V19, P1523, DOI 10.1111/j.1365-294X.2010.04594.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Balloux F, 2009, P ROY SOC B-BIOL SCI, V276, P3447, DOI 10.1098/rspb.2009.0752; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Ben Slimen H, 2008, BIOCHEM SYST ECOL, V36, P22, DOI 10.1016/j.bse.2007.06.014; Ben Slimen H, 2018, J ZOOL SYST EVOL RES, V56, P428, DOI 10.1111/jzs.12204; Ben Slimen H, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0896-0; Consuegra S, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0138-0; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Demirbas Y, 2019, MAMM BIOL, V94, P77, DOI 10.1016/j.mambio.2018.09.005; Djan M, 2017, HYSTRIX, V28, P186, DOI 10.4404/hystrix-28.2-12202; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Fickel J, 2005, J WILDLIFE MANAGE, V69, P760, DOI 10.2193/0022-541X(2005)069[0760:GSOPOE]2.0.CO;2; Fickel J, 2008, EUR J WILDLIFE RES, V54, P495, DOI 10.1007/s10344-008-0175-x; Flux J, 1990, STATUS SURVEY CONSER, V4, P61; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Garvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024127; Giannoulis T, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1354-y; Gu P, 2016, MITOCHONDRIAL DNA A, V27, P455, DOI 10.3109/19401736.2014.900667; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARTL GB, 1993, ACTA THERIOL, V38, P33, DOI 10.4098/AT.arch.93-41; HOLT I, 2003, GENETICS MITOCHONDRI; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V34, P55, DOI 10.1016/j.ympev.2004.09.007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 1996, GENETICS, V143, P537; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mamuris Z, 2002, BIOCHEM GENET, V40, P323, DOI 10.1023/A:1020260819629; Manolopoulou I, 2016, ARXIV160401617; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Melo-Ferreira J, 2014, GENOME BIOL EVOL, V6, P886, DOI 10.1093/gbe/evu059; Morales HE, 2015, MOL ECOL, V24, P2820, DOI 10.1111/mec.13203; Ning T, 2010, GENET MOL RES, V9, P144, DOI 10.4238/vol9-1gmr705; Pickarski N, 2015, PALAEOGEOGR PALAEOCL, V435, P145, DOI 10.1016/j.palaeo.2015.06.015; Russell DW, 2001, MOL CLONING LAB MANU; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Sert H, 2005, MAMM BIOL, V70, P171, DOI 10.1016/j.mambio.2004.10.003; Sert H, 2009, MAMM BIOL, V74, P286, DOI 10.1016/j.mambio.2008.05.008; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Stamatis C, 2009, J BIOGEOGR, V36, P515, DOI 10.1111/j.1365-2699.2008.02013.x; Strzala T, 2008, ELECT J POLISH AGR U, V11; Suchentrunk F, 2003, BIOCHEM GENET, V41, P127, DOI 10.1023/A:1023354709392; Suchentrunk F, 2000, ACTA THERIOL, V45, P1; Vapa L, 2007, ACTA ZOOL ACAD SCI H, V53, P75; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu L, 2011, MITOCHONDRION, V11, P497, DOI 10.1016/j.mito.2011.01.004; Yuan Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1349-z; Zagwijn WH, 1996, QUATERNARY SCI REV, V15, P451, DOI 10.1016/0277-3791(96)00011-X; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhelev C., 2015, THESIS	57	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224902	10.1371/journal.pone.0224902	http://dx.doi.org/10.1371/journal.pone.0224902			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KL7GR	31703111	Green Published, gold, Green Submitted			2022-12-26	WOS:000513587800001
J	Doghri, Y; Chetaneau, F; Rhimi, M; Kriaa, A; Lalanne, V; Thorin, C; Maguin, E; Mallem, MY; Desfontis, JC				Doghri, Yosra; Chetaneau, Fabien; Rhimi, Moez; Kriaa, Aicha; Lalanne, Valerie; Thorin, Chantal; Maguin, Emmanuelle; Mallem, M. Yassine; Desfontis, Jean-Claude			Sildenafil citrate long-term treatment effects on cardiovascular reactivity in a SHR experimental model of metabolic syndrome	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; DIET-INDUCED OBESITY; GUT MICROBIOTA; HIGH-FAT; ENDOTHELIAL DYSFUNCTION; VASORELAXATION; RESISTANCE; AORTA	Much evidence indicates that metabolic syndrome is strongly correlated with a decrease in nitric oxide and an increase in oxidative stress leading to cardiovascular alterations. In recent years, gut microbiota has emerged as a new contributor to the metabolic syndrome establishment and associated cardiovascular diseases, but the underlying mechanisms remain unclear. We hypothesized that a positive modulation of cyclic guanosine monophosphate (cGMP) pathway, through phosphodiesterase type 5 (PDE5) inhibition could prevent cardiovascular alterations and gut dysbiosis that may be associated to metabolic syndrome. Spontaneously hypertensive rats (SHR) were randomly divided into 4 groups: control, cafeteria diet (CD) and sildenafil citrate treated groups (5mg/kg per os) were given either a CD or a standard chow diet for 10 weeks. Body weight, arterial blood pressure and glucose tolerance test were monitored. At the 10th week, cardiac inotropy and coronary perfusion pressure were evaluated on isolated heart according to Langendorff method. Cumulative concentration response curves to phenylephrine and acetylcholine were determined on thoracic aorta rings for vascular reactivity evaluation. Faecal samples were collected for the gut microbiota analysis. Compared to the control group, CD-fed rats showed a significant increase in body weight gain, arterial blood pressure and were glucose intolerant. This group showed also a decrease in beta-adrenoceptor-induced cardiac inotropy and coronary vasodilation. Gut microbiota analysis revealed a significant reduction in the abundance of Lactobocillus spp in cafeteria diet-fed rats when compared to the control ones. Sildenafil citrate long-term treatment decreased weight gain and arterial blood pressure, improved coronary vasodilation and reduced a 1-adrenoceptor-induced vasoconstriction in CD group. However, it did not reverse gut dysbiosis induced by chronic CD feeding. These results suggest that cGMP pathway targeting may be a potential therapeutic strategy for the management of the metabolic syndrome and associated cardiovascular disorders.	[Doghri, Yosra; Chetaneau, Fabien; Lalanne, Valerie; Thorin, Chantal; Mallem, M. Yassine; Desfontis, Jean-Claude] Oniris, Coll Vet Med Food Sci & Engn, Atlanpole La Chantrerie, UPSP NP3 2017 B6146,Nutr Pathophysiol & Pharmacol, Route Gachet,5 BP, Nantes, France; [Rhimi, Moez; Kriaa, Aicha; Maguin, Emmanuelle] Univ Paris Saclay, UMR Micalis 1319, INRA, AgroParisTech,Microbiota Interact Human & Anim Te, Jouy En Josas, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Doghri, Y (corresponding author), Oniris, Coll Vet Med Food Sci & Engn, Atlanpole La Chantrerie, UPSP NP3 2017 B6146,Nutr Pathophysiol & Pharmacol, Route Gachet,5 BP, Nantes, France.	yosra.doghri@oniris-nantes.fr	Desfontis, Jean-Claude/AAA-1623-2022	RHIMI, Moez/0000-0001-8067-6526; Desfontis, Jean-Claude/0000-0002-1124-7979; MALLEM, yassine/0000-0001-5867-580X				Ahirwar AK, 2015, HORM MOL BIOL CLIN I, V24, P131, DOI 10.1515/hmbci-2015-0039; Andric SA, 2010, AM J PHYSIOL-ENDOC M, V299, pE544, DOI 10.1152/ajpendo.00337.2010; Arshad N, 2013, WIRES SYST BIOL MED, V5, P409, DOI 10.1002/wsbm.1223; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenyiova A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2502843; Bleau C, 2015, DIABETES-METAB RES, V31, P545, DOI 10.1002/dmrr.2617; Bortolin RC, 2018, INT J OBESITY, V42, P525, DOI 10.1038/ijo.2017.225; Brandt N, 2010, AM J PHYSIOL-ENDOC M, V299, pE215, DOI 10.1152/ajpendo.00098.2010; Buglioni A, 2016, ANNU REV MED, V67, P229, DOI 10.1146/annurev-med-052914-091923; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; del Bas JM, 2018, INT J OBESITY, V42, P746, DOI 10.1038/ijo.2017.284; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Festi D, 2014, WORLD J GASTROENTERO, V20, P16079, DOI 10.3748/wjg.v20.i43.16079; Goldstein I, 2016, J SEX MED, V13, P852, DOI 10.1016/j.jsxm.2016.02.166; Graham DA, 2004, J APPL PHYSIOL, V96, P2088, DOI 10.1152/japplphysiol.01252.2003; He MQ, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0183-1; Ho JE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001001; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Jiang C, 2015, CRIT CARE MED, V43, pE241, DOI 10.1097/CCM.0000000000000999; Johann K, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0026-0; Kanso H, 2014, INT DAIRY J, V39, P113, DOI 10.1016/j.idairyj.2014.05.004; Kim JA, 2015, AM J PHYSIOL-ENDOC M, V309, pE767, DOI 10.1152/ajpendo.00369.2015; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931; Lima-Leopoldo AP, 2011, ARQ BRAS CARDIOL, V97, P232, DOI 10.1590/S0066-782X2011005000061; Lorkowska B, 2006, J PHARMACOL EXP THER, V317, P1019, DOI 10.1124/jpet.105.098798; Lunardi CN, 2007, VASC PHARMACOL, V47, P139, DOI 10.1016/j.vph.2007.05.003; Mergia E, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0646-5; Miesel A, 2010, ANN NUTR METAB, V56, P127, DOI 10.1159/000278748; Moreno-Fernandez S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101502; MORENOINDIAS I, 2014, FRONT MICROBIOL, V5, DOI DOI 10.1016/J.351.325; Nevelsteen I, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-51; Okubo H, 2018, CURR MED CHEM, V25, P984, DOI 10.2174/0929867324666171009121702; Rehakova R, 2016, PHYSIOL RES, V65, pS401, DOI 10.33549/physiolres.933440; Rengo Giuseppe, 2014, Front Physiol, V5, P356, DOI 10.3389/fphys.2014.00356; Rentoukas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035739; Round J, 2018, STUD COMICS, V9, P3, DOI 10.1386/stic.9.1.3_2; Ryu SY, 2018, WORLD J MENS HEALTH, V36, P41, DOI 10.5534/wjmh.17028; Sauvaget F, 2010, EUR J PHARMACOL, V644, P169, DOI 10.1016/j.ejphar.2010.07.003; SCHIRNER M, 1993, BRIT J PHARMACOL, V109, P900, DOI 10.1111/j.1476-5381.1993.tb13704.x; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Tanida M, 2008, OBES RES CLIN PRACT, V2, P159, DOI 10.1016/j.orcp.2008.04.003; Teixeira-da-Silva JJ, 2019, LIFE SCI, V225, P29, DOI 10.1016/j.lfs.2019.03.074; Thorin C, 2010, J PHARM PHARMACOL, V62, P339, DOI 10.1211/jpp.62.03.0008; Velasquez MT, 2018, METAB SYNDR RELAT D, V16, P321, DOI 10.1089/met.2017.0163; Weiss R, 2013, ANN NY ACAD SCI, V1281, P123, DOI 10.1111/nyas.12030; Wong SK, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0123-9; Yaguas K, 2010, AM J NEPHROL, V31, P283, DOI 10.1159/000279307; Yang T, 2015, HYPERTENSION, V65, P1331, DOI 10.1161/HYPERTENSIONAHA.115.05315; Yu J, 2016, PHYSIOL RES, V65, P209, DOI 10.33549/physiolres.933007	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0223914	10.1371/journal.pone.0223914	http://dx.doi.org/10.1371/journal.pone.0223914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697707	gold, Green Published			2022-12-26	WOS:000532694400015
J	Prinja, S; Jagnoor, J; Sharma, D; Aggarwal, S; Katoch, S; Lakshmi, PVM; Ivers, R				Prinja, Shankar; Jagnoor, Jagnoor; Sharma, Deepshikha; Aggarwal, Sameer; Katoch, Swati; Lakshmi, P. V. M.; Ivers, Rebecca			Out-of-pocket expenditure and catastrophic health expenditure for hospitalization due to injuries in public sector hospitals in North India	PLOS ONE			English	Article							GLOBAL BURDEN; SYSTEMATIC ANALYSIS; LIFE EXPECTANCY; ECONOMIC BURDEN; TRAUMA CARE; COST; INSURANCE; DISEASE; STATE	Background Injuries are a major public health problem, resulting in high health care demand and economic burden. They result in loss of disability adjusted life years (DALYs) and high out-of-pocket expenditure. However, there is little evidence on the economic burden of injuries in India. We undertook this study to report out-of-pocket expenditure and the prevalence of catastrophic health expenditure for injuries related hospitalizations in public sector hospitals in North India. Further, we also evaluate the determinants of catastrophic health expenditure. Methods and analysis A prospective observational study was conducted. Participants were recruited from three hospitals for all injury cases. Data were collected via face-to-face baseline interviews and follow-up interviews over the phone at 1, 2, 4 and 12 months post-injury. Prevalence of catastrophic health expenditure (more than 30% of consumption expenditure) and impoverishment (International dollar 1.90) were estimated. Results Road traffic injuries (57%) were the leading cause of injury. Direct out-of-pocket expenditure for hospitalizations was INR 16,768 (USD 263) while indirect productivity loss was INR 8,164 (USD 128). The prevalence of catastrophic expenditure was 22.2% with 12.2% slipping below poverty line. Prevalence of catastrophic health expenditure and impoverishment was higher and significantly associated with poorest quintile, tertiary care hospital and increased duration of hospitalization (p < 0.001). Conclusion The economic impact of injuries is notably high both in terms of out-of-pocket expenditure and productivity loss. A high proportion of households experienced catastrophic expenditure and impoverishment following an injury, highlighting need for programs to prevent injuries.	[Prinja, Shankar; Sharma, Deepshikha; Aggarwal, Sameer; Katoch, Swati; Lakshmi, P. V. M.] Post Grad Inst Med Educ & Res, Chandigarh, India; [Jagnoor, Jagnoor] George Inst Global Hlth, New Delhi, India; [Jagnoor, Jagnoor; Ivers, Rebecca] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; George Institute for Global Health; University of Sydney	Prinja, S (corresponding author), Post Grad Inst Med Educ & Res, Chandigarh, India.	shankarprinja@gmail.com		jagnoor, Jagnoor/0000-0002-5276-9095; Ivers, Rebecca/0000-0003-3448-662X	Road Traffic Injury Resource Network	Road Traffic Injury Resource Network	The study was funded by the Road Traffic Injury Resource Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge The Road Traffic Injury Resource Network for providing the funding for undertaking this study.	Aeron-Thomas A, 2004, PPR010 TRANSP RES LA; Alvarez-Hernandez E, 2012, REUMATOL CLIN, V8, P168, DOI [10.1016/j.reumae.2012.06.018, 10.1016/j.reuma.2012.05.002]; [Anonymous], 2014, 71 SOC CONS SURV; Banerjee A, 2013, ACM IEEE INT CONF CY, P71, DOI 10.1109/ICCPS.2013.6604001; Brinda EM, 2015, J EPIDEMIOL COMMUN H, V69, P489, DOI 10.1136/jech-2014-204960; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Chatterjee P, 2018, LANCET, V392, P997, DOI 10.1016/S0140-6736(18)32284-0; Dror DM, 2008, INDIAN J MED RES, V127, P347; Engelgau M, 2012, EC IMPACT NONCOMMUNI; Gopalakrishnan S, 2012, J Family Med Prim Care, V1, P144, DOI 10.4103/2249-4863.104987; Greene H., 2003, ECONOMETRIC ANAL; Gururaj G, 2008, NATL MED J INDIA, V21, P14; Nguyen H, 2013, INJURY, V44, P684, DOI 10.1016/j.injury.2012.05.006; Nguyen H, 2013, INJURY PREV, V19, P79, DOI 10.1136/injuryprev-2011-040293; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Jagnoor J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008884; Jan S, 2016, B WORLD HEALTH ORGAN, V94, P193, DOI 10.2471/BLT.15.158303; Joshipura MK, 2008, WORLD J SURG, V32, P1613, DOI 10.1007/s00268-008-9634-5; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Kumar GA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-285; Mohan Dinesh, 2004, ROAD AHEAD TRAFFIC I; NSSO, 2001, CONC DEF US NSS; OECD, 1982, OECD LIST SOC IND; OECD [Organisation for Economic Co-operation and Development], 2001, MEAS PROD OECD MAN M; Papola T. S., 2017, ILO ASIA PACIFIC WOR, V178; Prinja S, 2016, FINAL REPORT 2016 EV; Prinja S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170996; Prinja S, 2015, LANCET, V385, P57, DOI 10.1016/S0140-6736(15)60852-2; Prinja S, 2012, INDIAN J MED RES, V136, P421; Reddy G M M, 2009, Indian J Med Sci, V63, P549; Rice D P, 1985, Health Care Financ Rev, V7, P61; Rocha-Garcia A, 2003, SALUD PUBLICA MEXICO, V45, P285, DOI 10.1590/S0036-36342003000400007; Scott K., LIVING STANDARDS MEA; Sharma D, 2017, INDIAN J MED RES, V146, P759, DOI 10.4103/ijmr.IJMR_2003_15; Van Beeck EF, 2007, J TRAUMA, V62, P534, DOI 10.1097/TA.0b013e31802e70c7; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wesson HKH, 2014, HEALTH POLICY PLANN, V29, P795, DOI 10.1093/heapol/czt064; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2014, INJ VIOL FACTS	42	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224721	10.1371/journal.pone.0224721	http://dx.doi.org/10.1371/journal.pone.0224721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697781	Green Published, gold			2022-12-26	WOS:000532694400050
J	Zoellner, H; Chami, B; Kelly, E; Moore, MAS				Zoellner, Hans; Chami, Belal; Kelly, Elizabeth; Moore, Malcolm A. S.			Increased cell size, structural complexity and migration of cancer cells acquiring fibroblast organelles by cell-projection pumping	PLOS ONE			English	Article							TUNNELING NANOTUBES; INTERCELLULAR COMMUNICATION; MEMBRANE NANOTUBES; STEM-CELLS; EXOSOMES	We recently described a hydrodynamic mechanism for cytoplasmic transfer between cells, termed cell-projection pumping (CPP). Earlier image analysis related altered SAOS-2 osteosarcoma cell morphology, to what we now recognize as CPP uptake of fibroblast cytoplasm. We here examine SAOS-2 phenotype following co-culture with human dermal fibroblasts (HDF) in which organelles were pre-labelled with a fluorescent lipophilic marker. Fluorescence activated cell sorting (FACS) analysis was performed of HDF and SAOS-2, cultured either alone or together. FACS forward scatter is proportionate to cell size, and increased for SAOS-2 with high levels of HDF fluorescence uptake (p < 0.004). FACS side scatter is proportionate to internal cell complexity, and increased in SAOS-2 with increasing uptake of HDF fluorescence (p < 0.004), consistent with uptake of HDF organelles. Scratch migration assays revealed that HDF migrated more quickly than SAOS-2 in both isolated cell culture, and following co-culture (p < 0.004). Notably, SAOS-2 with high levels of HDF labelling migrated faster compared with SAOS-2 with low HDF labelling (p < 0.008). A slight and unconvincing reduction in SAOS-2 proliferation was seen (p < 0.02). Similar results were obtained in single additional experiments with A673 and H312 cancer cells. Forward and side scatter results suggest organellar transfer by CPP increases cancer cell morphological diversity. This may contribute to histological pleomorphism relevant to cancer diagnosis and prognosis. Also, increased migration of sub-populations of cancer cells with high CPP organellar uptake, may contribute to invasion and metastasis in-vivo. We thus suggest relevance of CPP to cancer diagnosis and progression.	[Zoellner, Hans; Chami, Belal; Kelly, Elizabeth] Univ Sydney, Westmead Hosp, Fac Med & Hlth,Sch Dent, Cellular & Mol Pathol Res Unit,Oral Pathol & Oral, Westmead, NSW, Australia; [Zoellner, Hans; Moore, Malcolm A. S.] Mem Sloan Kettering Canc Ctr, Cell Biol, 1275 York Ave, New York, NY 10021 USA	University of Sydney; Memorial Sloan Kettering Cancer Center	Zoellner, H (corresponding author), Univ Sydney, Westmead Hosp, Fac Med & Hlth,Sch Dent, Cellular & Mol Pathol Res Unit,Oral Pathol & Oral, Westmead, NSW, Australia.; Zoellner, H (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol, 1275 York Ave, New York, NY 10021 USA.	hans.zoellner@sydney.edu.au	Zoellner, Hans/GWQ-7168-2022	Zoellner, Hans/0000-0003-4804-2464	Memorial Sloan Kettering Cancer Center [MSKCC P30 CA008748]; Australian Dental Research Fund; Australian Dental Industry Association; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Memorial Sloan Kettering Cancer Center; Australian Dental Research Fund; Australian Dental Industry Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Memorial Sloan Kettering Cancer Center, including via MSKCC P30 CA008748 Cancer Center Support Grant; (https://www.mskcc.org) to MASM and supported by the Australian Dental Research Fund and Australian Dental Industry Association (https://www.ada.org.au/AusDentResearchFoundation/ADRF-Home) to HZ. An anonymous donor supported the laboratory to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Memorial Sloan Kettering Cancer Center, including via MSKCC P30 CA008748 Cancer Center Support Grant, as well as the Australian Dental Research Fund and Australian Dental Industry Association for their support of this work. We also thank an anonymous donor for their generous contribution.	Ady JW, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00400; Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Ariazi J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00333; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; David M., 2011, THESIS; David MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101202; David MS, 2013, CYTOKINE, V62, P48, DOI 10.1016/j.cyto.2013.02.028; David MS, 2012, J PATHOL, V228, P495, DOI 10.1002/path.4063; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; GARRIGUES J, 1994, J CELL BIOL, V125, P129, DOI 10.1083/jcb.125.1.129; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Gerdes HH, 2013, MECH DEVELOP, V130, P381, DOI 10.1016/j.mod.2012.11.006; Guescini M, 2012, EXP CELL RES, V318, P603, DOI 10.1016/j.yexcr.2012.01.005; Hanna SJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223321; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Jaroszeski MJ, 1999, MOL BIOTECHNOL, V11, P37, DOI 10.1007/BF02789175; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Kumar V, 2014, ROBBINS COTRAN PATHO; Lou Emil, 2012, Commun Integr Biol, V5, P399, DOI 10.4161/cib.20569; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Morton MC, 2018, CELL REP, V23, P78, DOI 10.1016/j.celrep.2018.03.037; Nakamura K, 2017, MOL CANCER RES, V15, P78, DOI 10.1158/1541-7786.MCR-16-0191; OLIVER MH, 1989, J CELL SCI, V92, P513; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Samaeekia R, 2018, INVEST OPHTH VIS SCI, V59, P5194, DOI 10.1167/iovs.18-24803; Sinclair KA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0354-8; Thayanithy V, 2014, EXP CELL RES, V323, P178, DOI 10.1016/j.yexcr.2014.01.014; Vallabhaneni KC, 2012, STEM CELLS DEV, V21, P3104, DOI 10.1089/scd.2011.0691; Wu HH, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0560-z; Zheng HC, 2017, ONCOTARGET, V8, P59950, DOI 10.18632/oncotarget.19048; Zoellner H, 2019, BIORXIV, DOI [10.1101/531798, DOI 10.1101/531798]	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224800	10.1371/journal.pone.0224800	http://dx.doi.org/10.1371/journal.pone.0224800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697757	Green Published, Green Submitted, gold			2022-12-26	WOS:000532694400063
J	Ma, XD; Wang, QQ; Li, YW; Tan, P; Wu, HY; Wang, PR; Dong, X; Hong, L; Meng, GY				Ma, Xiaodan; Wang, Qianqian; Li, Yuwen; Tan, Pan; Wu, Haiyan; Wang, Pengran; Dong, Xue; Hong, Liang; Meng, Guoyu			How BamA recruits OMP substrates via poly-POTRAs domain	FASEB JOURNAL			English	Article						beta-barrel assembly machinery; OMP recruitment; lipopartners; fishing mechanism	OUTER-MEMBRANE PROTEINS; BARREL ASSEMBLY MACHINERY; CRYSTAL-STRUCTURE; ESSENTIAL COMPONENT; ESCHERICHIA-COLI; YAET COMPLEX; BIOGENESIS; DYNAMICS; ANTIGEN; TRANSLOCATION	Almost all the outer membrane proteins (OMPs) fold into an invariant beta-barrel fold via the polypeptide-transport-associated (POTRA) motif and beta-barrel assembly machinery (BAM). However, whether and how poly-POTRAs interact with OMPs remain largely unknown. Here, we have characterized the structures of Haemophilus influenzae poly-POTRAs via X-ray crystallography, small angle X-ray scattering, and molecular dynamics simulation. Unexpectedly, crystal packing reveals a putative OMP travel pathway spiraled by the conserved alpha 2-beta 2 edges in poly-POTRAs. Supportively, the structure-based mutations targeting the OMP binding sites significantly disrupt OMP biogenesis, resulting in severe cell growth defects. Another notable feature in H. influenzae POTRA structures is flexibility. As characterized by ELISA assays, poly-POTRAs could recruit OMP substrates in a step-wise manner. More importantly, the restriction of POTRA-POTRA linkage and flexibility significantly impairs the BamA function and causes cell growth defect. Altogether, these results suggest that the beta-strand augmentations and intrinsic flexibility are important factors for BamA-OMP recruitment.	[Ma, Xiaodan; Wang, Qianqian; Li, Yuwen; Wu, Haiyan; Wang, Pengran; Dong, Xue; Meng, Guoyu] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China; [Wang, Pengran] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Inst Translat Med, Shanghai, Peoples R China; [Tan, Pan; Hong, Liang] Shanghai Jiao Tong Univ, Sch Phys & Astron, Inst Translat Med, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Meng, GY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China.	guoyumeng@shsmu.edu.cn	li, yuwen/HGU-6435-2022; Li, yu/HHZ-5236-2022	Tan, Pan/0000-0003-2086-0940; Meng (meng), Guoyu (guo yu)/0000-0001-7904-2382	National Scientific Foundation of China [81970132, 81770142, 81800144, 31800642, 81370620, 81570120]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20152504]; Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institute of Higher Learning	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institute of Higher Learning	The authors thank the personnel of Beamlines BL17U1/18U1/19U1/19U2 Shanghai Synchrotron Radiation Facility/National Center for Protein Science Shanghai (SSRF/NCPSS) for help during data collection. The authors also thank Drs. Thomas J. Silhavy (Princeton University, Princeton, NJ, USA), Joseph W. St Geme III (University of Pennsylvania, Philadel-phia, PA, USA), and Yihua Huang (Institute of Biophysics, Chinese Academy of Sciences, Beijing, China) for their kind sharing of JCM166 cells. This work was supported by research Grants 81970132, 81770142, 81800144, 31800642, 81370620, and 81570120 from National Scientific Foundation of China, research Grant 20152504 from Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support, and the Program for Professor of Special Appointment (Eastern Scholar) at the Shanghai Institute of Higher Learning. The authors declare no conflicts of interest.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold T, 2010, J BIOL CHEM, V285, P18003, DOI 10.1074/jbc.M110.112516; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Bennion D, 2010, MOL MICROBIOL, V77, P1153, DOI 10.1111/j.1365-2958.2010.07280.x; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Delattre AS, 2011, MOL MICROBIOL, V81, P99, DOI 10.1111/j.1365-2958.2011.07680.x; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Garnett JA, 2012, CURR PROTEIN PEPT SC, V13, P739; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Grass S, 2015, J BACTERIOL, V197, P1769, DOI 10.1128/JB.00039-15; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Heinz E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00370; Heras B, 2014, P NATL ACAD SCI USA, V111, P457, DOI 10.1073/pnas.1311592111; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Inoue K, 2004, PLANT J, V39, P354, DOI 10.1111/j.1365-313X.2004.02135.x; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Loosmore SM, 1997, INFECT IMMUN, V65, P3701, DOI 10.1128/IAI.65.9.3701-3707.1997; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8452; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; MELCHIONNA S, 1993, MOL PHYS, V78, P533, DOI 10.1080/00268979300100371; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; Meng G, 2008, J MOL BIOL, V384, P824, DOI 10.1016/j.jmb.2008.09.085; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Noinaj N, 2015, METHODS MOL BIOL, V1329, P51, DOI 10.1007/978-1-4939-2871-2_4; Noinaj N, 2015, CURR OPIN STRUC BIOL, V31, P35, DOI 10.1016/j.sbi.2015.02.012; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; O'Neil PK, 2017, P NATL ACAD SCI USA, V114, pE4868, DOI 10.1073/pnas.1621179114; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Simmerman RF, 2014, INT REV CEL MOL BIO, V308, P1, DOI 10.1016/B978-0-12-800097-7.00001-4; Sinnige T, 2015, STRUCTURE, V23, P1317, DOI 10.1016/j.str.2015.04.014; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; THOMAS WR, 1990, INFECT IMMUN, V58, P1909, DOI 10.1128/IAI.58.6.1909-1913.1990; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vo JL, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600431; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yang YP, 1998, INFECT IMMUN, V66, P3349, DOI 10.1128/IAI.66.7.3349-3354.1998; Zavialov A, 2007, FEMS MICROBIOL REV, V31, P478, DOI 10.1111/j.1574-6976.2007.00075.x; Zeng LH, 2017, ELIFE, V6, DOI 10.7554/eLife.28619	67	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14690	14702		10.1096/fj.201900681RR	http://dx.doi.org/10.1096/fj.201900681RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31702961	Bronze			2022-12-26	WOS:000507466100125
J	DeMarshall, C; Oh, E; Kheirkhah, R; Sieber, F; Zetterberg, H; Blennow, K; Nagele, RG				DeMarshall, Cassandra; Oh, Esther; Kheirkhah, Rahil; Sieber, Frederick; Zetterberg, Henrik; Blennow, Kaj; Nagele, Robert G.			Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; CLINICAL UTILITY; EARLY-DIAGNOSIS; CSF BIOMARKERS; TAU PROTEINS; DISEASE; GUIDELINES; DISCOVERY; DECLINE	Post-operative delirium (POD) is the most common complication following major surgery in non-demented older (> 65 y/o) patients. Patients experiencing POD show increased risk for future cognitive decline, including mild cognitive impairment (MCI) and Alzheimer's disease (AD) and, conversely, patients with cognitive decline at surgery show increased risk for POD. Here, we demonstrate that a previously established panel of AD-driven MCI (ADMCI) autoantibody (aAB) biomarkers can be used to detect prodromal AD pre-surgically in individuals admitted into the hospital for hip fracture repair (HFR) surgery. Plasma from 39 STRIDE (STRIDE: A Strategy to Reduce the Incidence of Postoperative Delirium in Elderly Patients) HFR patients and sera from 25 age- and sex-matched non-demented and non-surgical controls were screened using human protein microarrays to measure expression of a panel of 44 previously identified MCI aAB biomarkers. The predictive classification accuracy of the aAB biomarker panel was evaluated using Random Forest (RF). The ADMCI aAB biomarkers successfully distinguished 21 STRIDE HFR patients (CDR = 0.5) from 25 matched nonsurgical controls with an overall accuracy of 91.3% (sensitivity = 95.2%; specificity = 88.0%). The ADMCI aAB panel also correctly identified six patients with preoperative CDR = 0 who later converted to CDR = 0.5 or > 1 at one-year follow-up. Lastly, the majority of cognitively normal (CDR = 0) STRIDE HFR subjects that were positive for CSF AD biomarkers based on the A/T/N classification system were likewise classified as ADMCI aAB-positive using the biomarker panel. Results suggest that pre-surgical detection of ADMCI aAB biomarkers can readily identify HFR patients with likely early-stage AD pathology using pre-surgery blood samples, opening up the potential for early, blood-based AD detection and improvements in peri- and postoperative patient management.	[DeMarshall, Cassandra; Nagele, Robert G.] Rowan Univ, Sch Osteopath Med, New Jersey Inst Successful Aging, Biomarker Discovery Ctr, Stratford, NJ 08084 USA; [DeMarshall, Cassandra; Nagele, Robert G.] Rowan Univ, Sch Osteopath Med, Dept Geriatr Gerontol, Stratford, NJ 08084 USA; [Oh, Esther] Johns Hopkins Univ, Sch Med, Dept Med Psychiat & Behav Sci, Pathol, Baltimore, MD USA; [Oh, Esther; Sieber, Frederick] Johns Hopkins Bayview Med Ctr, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21224 USA; [Kheirkhah, Rahil] Rowan Univ, Grad Sch Biomed Sci GSBS, Stratford, NJ USA; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England	Rowan University; Rowan University School of Osteopathic Medicine; Rowan University; Rowan University School of Osteopathic Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Rowan University; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; University of London; University College London	Nagele, RG (corresponding author), Rowan Univ, Sch Osteopath Med, New Jersey Inst Successful Aging, Biomarker Discovery Ctr, Stratford, NJ 08084 USA.; Nagele, RG (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Geriatr Gerontol, Stratford, NJ 08084 USA.	nagelero@rowan.edu						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2015, ALZHEIMERS DEMENT, V11, P58, DOI 10.1016/j.jalz.2014.02.004; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Casey David A, 2010, P T, V35, P208; Cheng Lesley, 2013, Frontiers in Genetics, V4, P150, DOI [10.3389/fgene.2013.00150, 10.3389/fimmu.2013.00388]; Cummings Jeffrey L, 2011, Alzheimers Dement, V7, pe13, DOI 10.1016/j.jalz.2010.06.004; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; DeMarshall C, 2017, J NEUROIMMUNOL, V309, P51, DOI 10.1016/j.jneuroim.2017.05.010; DeMarshall Cassandra A, 2016, Alzheimers Dement (Amst), V3, P51, DOI 10.1016/j.dadm.2016.03.002; DeMarshall CA, 2015, IMMUNOL LETT, V168, P80, DOI 10.1016/j.imlet.2015.09.010; Fagan AM, 2011, ARCH NEUROL-CHICAGO, V68, P1137, DOI 10.1001/archneurol.2011.105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Han M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032383; Hansson O, 2018, ALZHEIMERS DEMENT, V14, P1470, DOI 10.1016/j.jalz.2018.01.010; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Henriksen K, 2014, ALZHEIMERS DEMENT, V10, P115, DOI 10.1016/j.jalz.2013.01.013; Hulette CM, 1998, J NEUROPATH EXP NEUR, V57, P1168, DOI 10.1097/00005072-199812000-00009; Jack CR, 2016, NEUROLOGY, V87, P539, DOI 10.1212/WNL.0000000000002923; Jack CR, 2017, LANCET NEUROL, V16, P435, DOI 10.1016/S1474-4422(17)30077-7; Janelidze S, 2016, ANN CLIN TRANSL NEUR, V3, P154, DOI 10.1002/acn3.274; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kang JH, 2013, CLIN CHEM, V59, P903, DOI 10.1373/clinchem.2013.202937; Kiddle SJ, 2014, J ALZHEIMERS DIS, V38, P515, DOI 10.3233/JAD-130380; Li TJ, 2017, CLIN TRIALS, V14, P299, DOI 10.1177/1740774516687253; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Mattsson N, 2009, ANN NY ACAD SCI, V1180, P28, DOI 10.1111/j.1749-6632.2009.04944.x; Morris GP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0135-5; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Nagele E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023112; Nagele EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060726; O'Bryant SE, 2017, ALZHEIMERS DEMENT, V13, P45, DOI 10.1016/j.jalz.2016.09.014; O'Bryant SE, 2015, ALZHEIMERS DEMENT, V11, P549, DOI 10.1016/j.jalz.2014.08.099; O'Bryant SE, 2014, DEMENT GERIATR COGN, V37, P45, DOI 10.1159/000345605; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; Oh ES, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204695; Pase MP, 2019, JAMA NEUROL, V76, P598, DOI 10.1001/jamaneurol.2018.4666; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2009, CURR ALZHEIMER RES, V6, P324, DOI 10.2174/156720509788929237; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Sattlecker M, 2014, ALZHEIMERS DEMENT, V10, P724, DOI 10.1016/j.jalz.2013.09.016; Shahpasand-Kroner H, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0448-x; Sieber FE, 2018, JAMA SURG, V153, P987, DOI 10.1001/jamasurg.2018.2602; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Trojanowski JQ, 2011, PROG NEUROBIOL, V95, P491, DOI 10.1016/j.pneurobio.2011.07.004; van der Vlies AE, 2009, NEUROLOGY, V72, P1056, DOI 10.1212/01.wnl.0000345014.48839.71; Whitwell JL, 2012, ARCH NEUROL-CHICAGO, V69, P614, DOI 10.1001/archneurol.2011.3029	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0225178	10.1371/journal.pone.0225178	http://dx.doi.org/10.1371/journal.pone.0225178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730624	Green Published, gold			2022-12-26	WOS:000532809500028
J	Almadini, AM; Hassaballa, AA				Almadini, Abdulrahman Mohamed; Hassaballa, Abdalhaleem Abdalla			Depicting changes in land surface cover at Al-Hassa oasis of Saudi Arabia using remote sensing and GIS techniques	PLOS ONE			English	Article							ACCURACY; DISTRICT; GROWTH	This study assessed the spatial and temporal variations of land cover in the agricultural areas of the Al-Hassa oasis, Kingdom of Saudi Arabia (KSA). Change detection technique was applied in order to classify variations among different surface cover aspects, during three successive stages between 1985 and 2017 (i.e., 1985 to 1999 (14 years), 1999 to 2013 (14 years), and 2013 to 2017 (4 years)), using two scenarios. During the first stage, significant urban sprawl (i.e., 3,200 ha) occurred on bare lands within the old oasis, while only 590 ha of the oasis's vegetation area was occupied by urban cover. However, the final stage revealed rapid urban development (1,270 ha by 2017) within the oasis's vegetation region, while no urban sprawl occurred on bare lands (area of 1,900 ha, same as that in 1999-2013). Vegetation cover of around 1,000 ha changed to the bare soil class, in addition to the areas that were occupied by the urban class (1,700 ha in total). The study provides quantitative information on the influence of urban development on the spatial changes in vegetation cover of the oasis, especially during recent decades.	[Almadini, Abdulrahman Mohamed; Hassaballa, Abdalhaleem Abdalla] King Faisal Univ, Coll Agr & Food Sci, Environm & Agr Nat Resources Dept, Al Hasa, Saudi Arabia	King Faisal University	Hassaballa, AA (corresponding author), King Faisal Univ, Coll Agr & Food Sci, Environm & Agr Nat Resources Dept, Al Hasa, Saudi Arabia.	ahassaballa@kfu.edu.sa	Hassaballa, Abdalhaleem/AGG-0578-2022; Hassaballa, Abdalhaleem/AAB-7566-2022; Hassaballa, Abdalhaleem/AAV-4851-2021	Hassaballa, Abdalhaleem/0000-0001-5881-7273; 	Deanship of Scientific Research at King Faisal University [186152]	Deanship of Scientific Research at King Faisal University	The study is financially supported by the Deanship of Scientific Research at King Faisal University under Nasher Track (Grant No. 186152). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelatti H., 2017, RESOURCES ENV, V7, P69; Adler-Golden SM, 1999, PROC SPIE, V3753, P61, DOI 10.1117/12.366315; Afzan Buyadi Siti Nor, 2013, PROCEDIA SOCIAL BEHA, P516; Ahmad A., 2012, APPL MATH SCI, V6, P6425, DOI DOI 10.12988/AMS.2013.34214; Al Harbi K., 2003, DISCOVERING DETECTIN, P283; Al-Harbi KM, 2010, EGYPT J REMOTE SENS, V13, P37, DOI 10.1016/j.ejrs.2010.07.005; Al-Jabr M.A, 1984, THESIS U DURHAM DURH; Al-Shayaa MS, 2012, J ANIM PLANT SCI, V22, P239; Al-Tahir A.A.S., 1999, AL HASSA GEOGRAPHIC, V1st ed.; Al-Zara I, 2011, TRENDS APPL SCI RES, V6, P1; Albisher AA, 2010, EGYPTIAN J APPL SCI, V25, P19; Aldakheel Y., 2005, SCI J KING FAISAL U, V6, P1426; Alkuwaiti KA, 2002, C DEV WAT AGR RES RE; Almadini A.M., 2006, ALEXANDRIA SCI EXCHA, V27, P322; Almadini AM, 2012, AT2530KSA KACST; Almadini AM, 2007, 8089 KFU KSA DEANSH; Almutairi A, 2010, REMOTE SENS-BASEL, V2, P1508, DOI 10.3390/rs2061508; Alqarni S., 2018, Journal of Geographic Information System, V10, P659; Alqurashi Abdullah F., 2019, Geocarto International, V34, P78, DOI 10.1080/10106049.2017.1367423; [Anonymous], 1964, WESTF LOHRSTRASS 15, V2; Appiah DO, 2015, ISPRS INT J GEO-INF, V4, P1265, DOI 10.3390/ijgi4031265; Barakat A, 2019, EARTH SYST ENVIRON, V3, P113, DOI 10.1007/s41748-019-00088-y; Barbier EB, 2000, AGR ECON, V23, P299, DOI 10.1111/j.1574-0862.2000.tb00281.x; Bastiaanssen W, 2011, UTFSAU012 FAO HIDA; Belaid M., 2003, P 2 FIG REG C DEC 20, P2; Dewan AM, 2009, APPL GEOGR, V29, P390, DOI 10.1016/j.apgeog.2008.12.005; Doos BR, 2002, GLOBAL ENVIRON CHANG, V12, P303, DOI 10.1016/S0959-3780(02)00043-2; Elhadary Y.A., 2014, J GULF ARAB PENINS S, V155, P40; Erb KH, 2015, INT ENCY SOCIAL BEHA, P238; Gharaibeh E., 2011, INT, V2, P103, DOI DOI 10.5383/SWES.02.02.006; Grubler A, 1994, CHANGES LAND USE LAN, P287; Jat MK, 2008, INT J REMOTE SENS, V29, P543, DOI 10.1080/01431160701280983; Kasperson JX, 1996, ENVIRONMENT, V38, P4, DOI 10.1080/00139157.1996.9931008; Lambin E.F., 1999, LAND USE LAND COVER, V1st ed.; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Leichtweiss Institute, 1979, LBID PUBL; MAW Ministry of Agriculture and Water, 1984, WAT ATL SAUD AR PREP; Mubarak FA, 2004, HABITAT INT, V28, P567, DOI 10.1016/j.habitatint.2003.10.010; Municipality of Al-Ahsa, 2018, AL AHS CREAT CIT CRA; Qian LX, 2006, PEDOSPHERE, V16, P681, DOI 10.1016/S1002-0160(06)60103-3; Rahman A, 2012, AJAE, P1; Rajab Z.A., 1990, AL HASSA OASIS STUDY; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rawat JS, 2015, EGYPT J REMOTE SENS, V18, P77, DOI 10.1016/j.ejrs.2015.02.002; Salih A., 2018, J REMOTE SENS GIS, V7, P228, DOI [10.4172/2469-4134.1000228., DOI 10.4172/2469-4134.1000228]; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Trotter L, 2017, AIMS ENV SCI, P4; Trung NH, 2007, INT J GEOINFORMATICS, V3, P1; Valta-Hulkkonen K, 2004, INT J REMOTE SENSING, P25; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Young A, 1999, ENVIRON DEV SUSTAIN, V1, P3, DOI DOI 10.1023/A:1010055012699; Zeng N, 1999, SCIENCE, V286, P1537, DOI 10.1126/science.286.5444.1537	52	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0221115	10.1371/journal.pone.0221115	http://dx.doi.org/10.1371/journal.pone.0221115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2HK	31725716	Green Published, gold			2022-12-26	WOS:000532764500004
J	Fiorentini, M; Zenobi, S; Giorgini, E; Basili, D; Conti, C; Pro, C; Monaci, E; Orsini, R				Fiorentini, Marco; Zenobi, Stefano; Giorgini, Elisabetta; Basili, Danilo; Conti, Carla; Pro, Chiara; Monaci, Elga; Orsini, Roberto			Nitrogen and chlorophyll status determination in durum wheat as influenced by fertilization and soil management: Preliminary results	PLOS ONE			English	Article							NO-TILLAGE; CONSERVATION TILLAGE; NUTRITION INDEX; CEREAL SYSTEMS; USE EFFICIENCY; METER; STRATEGIES; READINGS; ROTATION; GROWTH	Handheld chlorophyll meters as Soil Plant Analysis Development (SPAD) have proven to be useful tools for rapid, no-destructive assessment of chlorophyll and nitrogen status in various crops. This method is used to diagnose the need of nitrogen fertilization to improve the efficiency of the agricultural system and to minimize nitrogen losses and deficiency. The objective of this study is to evaluate the effect of repeated conservative agriculture practices on the SPAD readings, leaves chlorophyll concentration and Nitrogen Nutrition Index (NNI) relationships in durum wheat under Mediterranean conditions. The experimental site is a part of a long-term-experiment established in 1994 and is still on-going where three tillage managements and three nitrogen fertilizer treatments were repeated in the same plots every year. We observed a linear relationship between the SPAD readings performed in the central and distal portion of the leaf (R-2 = 0.96). In fertilized durum wheat, we found all positive exponential relationships between SPAD readings, chlorophyll leaves concentration (R-2 = 0.85) and NNI (R-2 = 0.89). In the unfertilized treatment, the SPAD has a good attitude to estimate leaves chlorophyll concentration (R-2 = 0.74) and NNI (R-2 = 0.77) only in crop grow a soil with relative high content of soil organic matter and nitrogen availability, as observed in the no tilled plots. The results show that the SPAD can be used for a correct assessment of chlorophyll and nitrogen status in durum wheat but also to evaluate indirectly the content of soil organic matter and nitrogen availability during different growth stages of the crop cycle.	[Fiorentini, Marco; Zenobi, Stefano; Monaci, Elga; Orsini, Roberto] Marche Polytech Univ, Sect Agron & Crop Sci, Dept Agr Food & Environm Sci D3A, Ancona, Italy; [Giorgini, Elisabetta; Basili, Danilo; Conti, Carla; Pro, Chiara] Marche Polytech Univ, Sect Gen & Inorgan Chem, Dept Life & Environm Sci DISVA, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University	Orsini, R (corresponding author), Marche Polytech Univ, Sect Agron & Crop Sci, Dept Agr Food & Environm Sci D3A, Ancona, Italy.	r.orsini@univpm.it	Fiorentini, Marco/ABD-7060-2021; Giorgini, Elisabetta/AAU-3596-2021; Basili, Danilo/T-3088-2019	Fiorentini, Marco/0000-0002-1101-7313; Basili, Danilo/0000-0003-4830-7848; Pro, Chiara/0000-0002-1279-1976; GIORGINI, ELISABETTA/0000-0003-0503-5870; ORSINI, Roberto/0000-0002-1347-3566	Marche Region trough measure 16.1 Action 2 of the Rural Development Plan (PSR 2014/2020) "Precision agriculture: reduction of the environmental impact of production systems" [29000]	Marche Region trough measure 16.1 Action 2 of the Rural Development Plan (PSR 2014/2020) "Precision agriculture: reduction of the environmental impact of production systems"	Marche Polytechnic University, trough University Strategic Project (PSA 2017) "PFRLab: Setting of a Precision Farming Robotic Laboratory for cropping system sustainability and food safety and security" coordinated by Dr. Orsini Roberto, PhD and Marche Region trough measure 16.1 Action 2 of the Rural Development Plan (PSR 2014/2020) "Precision agriculture: reduction of the environmental impact of production systems" (project ID 29000) coordinated by Consorzio Agrario Adriatico Societa Cooperativa.	Abdelhamid MT, 2004, BIORESOURCE TECHNOL, V93, P183, DOI 10.1016/j.biortech.2003.10.012; Ali AM, 2015, PEDOSPHERE, V25, P72, DOI 10.1016/S1002-0160(14)60077-1; [Anonymous], 1997, DIAGNOSIS NITROGEN S; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Arregui LM, 2006, PLANT SOIL, V288, P57, DOI 10.1007/s11104-006-9064-9; Bodirsky BL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4858; BUCKEE GK, 1994, J I BREWING, V100, P57, DOI 10.1002/jib.1994.100.2.57; Busetto L, 2017, IEEE J-STARS, V10, P5423, DOI 10.1109/JSTARS.2017.2679159; De Sanctis G, 2012, EUR J AGRON, V40, P18, DOI 10.1016/j.eja.2012.02.002; Debaeke P, 2006, J PLANT NUTR, V29, P75, DOI 10.1080/01904160500416471; Duan YH, 2011, SOIL SCI SOC AM J, V75, P1562, DOI 10.2136/sssaj2010.0315; Dumas A, 1826, ANN CHIMIE, V33, P342; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; FAO, 2006, WORLD REF BAS SOIL R, P110; Farina R, 2011, SOIL TILL RES, V112, P36, DOI 10.1016/j.still.2010.11.002; GREENWOOD DJ, 1990, ANN BOT-LONDON, V66, P425, DOI 10.1093/oxfordjournals.aob.a088044; HEYNEKE E, 2017, FRONT PLANT SCI, V8, DOI DOI 10.3389/FPLS.2017.00020; Hirel B, 2011, SUSTAINABILITY-BASEL, V3, P1452, DOI 10.3390/su3091452; Huang SY, 2018, PEDOSPHERE, V28, P814, DOI 10.1016/S1002-0160(17)60392-8; Iocola I, 2017, EUR J AGRON, V90, P96, DOI 10.1016/j.eja.2017.07.011; Jemai I, 2013, SOIL TILL RES, V126, P26, DOI 10.1016/j.still.2012.07.008; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Lassaletta L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105011; Li HW, 2007, AUST J SOIL RES, V45, P344, DOI 10.1071/SR07003; Li T, 2015, GLOBAL CHANGE BIOL, V21, P1328, DOI 10.1111/gcb.12758; Lin FF, 2010, COMPUT ELECTRON AGR, V71, pS60, DOI 10.1016/j.compag.2009.09.006; Lopez-Bellido L, 2013, SOIL TILL RES, V130, P18, DOI 10.1016/j.still.2013.02.002; Lopez-Garrido R, 2011, SOIL USE MANAGE, V27, P177, DOI 10.1111/j.1475-2743.2011.00329.x; MCGINNIS L, 2007, AGR RES, V55, P8, DOI DOI 10.1016/j.still.2013.02.002; Moussa-Machraoui SB, 2010, SOIL TILL RES, V106, P247, DOI 10.1016/j.still.2009.10.009; Netto AT, 2005, SCI HORTIC-AMSTERDAM, V104, P199, DOI 10.1016/j.scienta.2004.08.013; Olfs HW, 2005, J PLANT NUTR SOIL SC, V168, P414, DOI 10.1002/jpln.200520526; Orsini R, 2019, IOP C SER EARTH ENV, V275, DOI 10.1088/1755-1315/275/1/012021; Paudel KP, 2006, RENEW AGR FOOD SYST, V21, P124, DOI 10.1079/RAF2005138; Prost L, 2007, AGRON SUSTAIN DEV, V27, P321, DOI 10.1051/agro:2007032; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Ravier C, 2018, NUTR CYCL AGROECOSYS, V110, P117, DOI 10.1007/s10705-017-9891-5; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Sadras VO, 2014, FIELD CROP RES, V164, P54, DOI 10.1016/j.fcr.2014.05.006; Samborski S, 2008, ACTA PHYSIOL PLANT, V30, P419, DOI 10.1007/s11738-008-0164-4; Samborski SM, 2009, AGRON J, V101, P800, DOI 10.2134/agronj2008.0162Rx; Seddaiu G, 2016, EUR J AGRON, V77, P166, DOI 10.1016/j.eja.2016.02.008; Stagnari F, 2009, SUSTAIN AGR REV, V1, P55, DOI 10.1007/978-1-4020-9654-9_5; Tsialtas JT, 2018, CROP PROT, V113, P48, DOI 10.1016/j.cropro.2018.07.008; Uddling J, 2007, PHOTOSYNTH RES, V91, P37, DOI 10.1007/s11120-006-9077-5; United Nations, 2017, WORLD POP PROSP 2017, DOI DOI 10.1017/CBO9781107415324.004; WOOD CW, 1993, P AG SOC NZ, V23, P1; Xie YX, 2007, PEDOSPHERE, V17, P200, DOI 10.1016/S1002-0160(07)60026-5; Yuan ZF, 2016, FIELD CROP RES, V185, P12, DOI 10.1016/j.fcr.2015.10.003; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhao SC, 2016, AGR ECOSYST ENVIRON, V216, P82, DOI 10.1016/j.agee.2015.09.028; Zhao X, 2017, EUR J AGRON, V84, P67, DOI 10.1016/j.eja.2016.11.009; Zheng HL, 2015, J INTEGR AGR, V14, P190, DOI 10.1016/S2095-3119(14)60925-4; Ziadi N, 2010, CROP SCI, V50, P2580, DOI 10.2135/cropsci2010.01.0032	54	17	18	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225126	10.1371/journal.pone.0225126	http://dx.doi.org/10.1371/journal.pone.0225126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725780	Green Published, gold			2022-12-26	WOS:000532764500058
J	Mugglin, C; Haas, AD; van Oosterhout, JJ; Msukwa, M; Tenthani, L; Estill, J; Egger, M; Keiser, O				Mugglin, Catrina; Haas, Andreas D.; van Oosterhout, Joep J.; Msukwa, Malango; Tenthani, Lyson; Estill, Janne; Egger, Matthias; Keiser, Olivia			Long-term retention on antiretroviral therapy among infants, children, adolescents and adults in Malawi: A cohort study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; FOLLOW-UP; TREATMENT PROGRAMS; DRUG-RESISTANCE; PATIENTS LOST; RISK-FACTORS; CARE; ADHERENCE; INTERVENTIONS; INITIATION	Objectives We examine long-term retention of adults, adolescents and children on antiretroviral therapy under different HIV treatment guidelines in Malawi. Design Prospective cohort study. Setting and participants Adults and children starting ART between 2005 and 2015 in 21 health facilities in southern Malawi. Methods We used survival analysis to assess retention at clinic level, Cox regression to examine risk factors for loss to follow up, and competing risk analysis to assess long-term outcomes of people on antiretroviral therapy (ART). Results We included 132,274 individuals in our analysis, totalling 270,256 person years of follow up (PYFU; median per patient 1.3, interquartile range (IQR) 0.26-3.1), 62% were female and the median age was 32 years. Retention on ART was lower in the first year on ART compared to subsequent years for all guideline periods and age groups. Infants (0-3 years), adolescents and young adults (15-24 years) were at highest risk of LTFU. Comparing the different calendar periods of ART initiation we found that retention improved initially, but remained stable thereafter. Conclusion Even though the number of patients and the burden on health care system increased substantially during the study period of rapid ART expansion, retention on ART improved in the early years of ART provision, but gains in retention were not maintained over 5 years on ART. Reducing high attrition in the first year of ART should remain a priority for ART programs, and so should addressing poor retention among adolescents, young adults and men.	[Mugglin, Catrina; Haas, Andreas D.; Tenthani, Lyson; Estill, Janne; Egger, Matthias; Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [van Oosterhout, Joep J.] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Msukwa, Malango] Baobab Hlth Trust, Lilongwe, Malawi; [Msukwa, Malango; Estill, Janne; Keiser, Olivia] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Tenthani, Lyson] I TECH Malawi, Lilongwe, Malawi	University of Bern; University of Malawi; University of Geneva	Mugglin, C (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	catrina.mugglin@ispm.unibe.ch	Haas, Andreas D./AAR-3187-2020	Haas, Andreas D./0000-0002-4849-181X; Mugglin, Catrina/0000-0001-7966-3939; Egger, Matthias/0000-0001-7462-5132	Bill and Melinda Gates Foundation [OPP1090200]; National Institute of Allergy And Infectious Diseases of the National Institutes of Health [U01AI069924]; Schweizerische Akademie der Medizinischen Wissenschaften (SAMW); Swiss National Science Foundation (SNF) [163878]; SNF Early Postdoc.Mobility Fellowship [P2BEP3_178602]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Schweizerische Akademie der Medizinischen Wissenschaften (SAMW); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF Early Postdoc.Mobility Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Bill and Melinda Gates Foundation (OPP1090200), and the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U01AI069924. CM was supported by a MD-PhD fellowship from Schweizerische Akademie der Medizinischen Wissenschaften (SAMW). OK was supported by a professorship grant from the Swiss National Science Foundation (SNF) (163878) and AH was partly supported by a SNF Early Postdoc.Mobility Fellowship (P2BEP3_178602). These funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of author's salaries and research material. We would like to thank all the participants of the study, and the staff who collected the data. The study was funded by the Bill and Melinda Gates Foundation (OPP1090200), and the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U01AI069924. CM was supported by a MD-PhD fellowship from Schweizerische Akademie der Medizinischen Wissenschaften (SAMW). OK was supported by professorship grant from the Swiss National Science Foundation (SNF)(163878) and AH was partly supported by a SNF Early Postdoc.Mobility Fellowship (P2BEP3_178602). These funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of author's salaries and research material.	Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Bucciardini R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136117; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fox MP, 2016, LANCET HIV, V3, pE554, DOI 10.1016/S2352-3018(16)30149-7; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Fox MP, 2015, AIDS, V29, P493, DOI 10.1097/QAD.0000000000000559; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; GRIMSRUD A, 2015, J INT AIDS SOC, V18, DOI DOI 10.7448/IAS.18.1; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Grimsrud AT, 2013, J CLIN EPIDEMIOL, V66, P1006, DOI 10.1016/j.jclinepi.2013.03.013; Gwynn RC, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0898-9; Haas AD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25084; Haas AD, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21947; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Harries AD, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3620-x; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Johnson LF, 2014, AM J EPIDEMIOL, V180, P1208, DOI 10.1093/aje/kwu295; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, 90 90 90 AMB TREATM, V40; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Koole Olivier, 2014, J Acquir Immune Defic Syndr, V67, pe27, DOI 10.1097/QAI.0000000000000252; Kranzer K, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21737; Lall P, 2015, J INT AIDS SOC, V18, P41, DOI 10.7448/IAS.18.2.19393; MacPherson P, 2015, TROP MED INT HEALTH, V20, P1015, DOI 10.1111/tmi.12517; Matyanga CMJ, 2016, PUBLIC HEALTH ACTION, V6, P97, DOI 10.5588/pha.15.0077; Meresse M, 2014, HIV MED, V15, P478, DOI 10.1111/hiv.12140; Mills EJ, 2014, LANCET HIV, V1, pE104, DOI 10.1016/S2352-3018(14)00003-4; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2016, PATIENT PREFER ADHER, V10, P683, DOI 10.2147/PPA.S100002; Okoboi S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20841; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tiruneh YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156619; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Yehia BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129376; Yehia BR, 2014, JAIDS-J ACQ IMM DEF, V65, P333, DOI 10.1097/QAI.0000000000000023; Zurcher K, 2017, TROP MED INT HEALTH, V22, P375, DOI 10.1111/tmi.12843	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224837	10.1371/journal.pone.0224837	http://dx.doi.org/10.1371/journal.pone.0224837			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725750	Green Published, gold, Green Submitted			2022-12-26	WOS:000532764500032
J	Gu, W; Zhang, AQ; Sun, HM; Gu, YC; Chao, JG; Tian, R; Duan, JA				Gu, Wei; Zhang, Aqin; Sun, Hongmei; Gu, Yuchen; Chao, Jianguo; Tian, Rong; Duan, Jin-Ao			Identifying resurrection genes through the differentially expressed genes between Selaginella tamariscina (Beauv.) spring and Selaginella moellendorffii Hieron under drought stress	PLOS ONE			English	Article							DESICCATION TOLERANCE; TRANSCRIPTION FACTOR; ENHANCES TOLERANCE; IMPROVES DROUGHT; ABIOTIC STRESSES; TOTAL FLAVONOIDS; RESPONSIVE GENE; SALT TOLERANCE; PROTEIN; TREHALOSE	Selaginella tamariscina (Beauv.) spring, a primitive vascular resurrection plant, can survive extreme drought and recover when water becomes available. To identify drought-inducible genes and to clarify the molecular mechanism of drought tolerance, a comparative transcriptional pattern analysis was conducted between S. tamariscina and Selaginella moellendorffii Hieron (drought sensitive). 133 drought related genes were identified, including 72 functional genes and 61 regulatory genes. And several drought responsive reactions, such as antioxidant activity, osmotic balance, cuticle defense and signal transduction were highlighted in S. tamariscina under drought. Notably, besides peroxidase, catalase and L-ascorbate oxidase genes, DEGs associated with phenylalanine metabolism and polyamine catabolism could be alternative ways to enhance antioxidant ability in S. tamariscina. DEGs related to soluble carbohydrate metabolism, late embryogenesis abundant protein (LEA) and aquaporin protein (AQP) confirmed that osmotic adjustment could resist drought during desiccation. DEGs involved in xyloglucan metabolic process, pectin metabolic process and cutin biosynthesis may also contribute to drought tolerance of S. tamariscina by cuticle defense. Drought-responsive genes encoding protein kinases, calcium sensors, transcription factors (TFs) and plant hormones also help to drought resistance of S. tamariscina. The preliminary validation experiments were performed and the results were consistent with our hypothetical integrated regulatory network. The results of this study provide candidate resurrection genes and an integrated regulatory network for further studies on the molecular mechanisms of stress tolerance in S. tamariscina.	[Gu, Wei; Zhang, Aqin; Sun, Hongmei; Gu, Yuchen; Chao, Jianguo; Tian, Rong; Duan, Jin-Ao] Nanjing Univ Chinese Med, Sch Pharm, Nanjing, Peoples R China; [Gu, Wei; Duan, Jin-Ao] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Nanjing, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Duan, JA (corresponding author), Nanjing Univ Chinese Med, Sch Pharm, Nanjing, Peoples R China.; Duan, JA (corresponding author), Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Nanjing, Peoples R China.	gw98826@163.com	Sun, Hongmei/CAF-0999-2022		Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization [ZDXM-HT-1-5, ZDXM-3-24]; Priority Academic Program Development of Jiangsu Higher Education Institutions [ysxk-2014]; 2017 Chinese Medicine Public Health Service Subvention Special "National traditional Chinese Medicine Resource Survey Project" [Caishe (2017) 66]; National Natural Science Foundation of China [81573520]	Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; Priority Academic Program Development of Jiangsu Higher Education Institutions; 2017 Chinese Medicine Public Health Service Subvention Special "National traditional Chinese Medicine Resource Survey Project"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization (Grant No. ZDXM-HT-1-5 and ZDXM-3-24), the Priority Academic Program Development of Jiangsu Higher Education Institutions (ysxk-2014) and 2017 Chinese Medicine Public Health Service Subvention Special "National traditional Chinese Medicine Resource Survey Project" (Caishe (2017) 66). JinAo Duan was the host of the above-mentioned four projects. This research was also supported by the National Natural Science Foundation of China(Grant No. 81573520) and Jianguo Chao was the host of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agduma Angelo Rellama, 2016, Trop Life Sci Res, V27, P37, DOI 10.21315/tlsr2016.27.2.4; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bhalothia P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00547; Bi HH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1033-3; Brown DB, 2012, J BIOL CHEM, V287, P935, DOI 10.1074/jbc.M111.311571; Carey RE, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-4; Cho SK, 2006, FEBS LETT, V580, P3136, DOI 10.1016/j.febslet.2006.04.062; Choi JY, 2011, PLANT CELL REP, V30, P867, DOI 10.1007/s00299-010-0989-3; Palacios IC, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5030064; Dilshad E, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0811-7; Furuki T, 2018, ADV EXP MED BIOL, V1081, P271, DOI 10.1007/978-981-13-1244-1_15; Gu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067818; Heo JK, 2017, MOLECULES, V22, DOI 10.3390/molecules22101590; Huang C, 2014, Z NATURFORSCH C, V69, P142, DOI 10.5560/ZNC.2013-0079; Im YJ, 2002, MOL CELLS, V13, P264; Islam MS, 2009, BMB REP, V42, P611, DOI 10.5483/BMBRep.2009.42.9.611; Ji T, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00499; Kour S, 2018, AN ACAD BRAS CIENC, V90, P1493, DOI 10.1590/0001-3765201820170632; KSOURI N, 2016, FRONT PLANT SCI, V7, DOI DOI 10.3389/FPLS.2015.01715; Kwon Y, 2007, PLANT J, V49, P184, DOI 10.1111/j.1365-313X.2006.02950.x; Dat LD, 2017, BIOORG MED CHEM LETT, V27, P524, DOI 10.1016/j.bmcl.2016.12.028; Lee SB, 2009, PLANT J, V60, P462, DOI 10.1111/j.1365-313X.2009.03973.x; Li J, 2015, BIOCHEM BIOPH RES CO, V459, P208, DOI 10.1016/j.bbrc.2015.02.052; Li KQ, 2017, PLANT BIOTECHNOL J, V15, P1186, DOI 10.1111/pbi.12708; Li XY, 2019, PLANT SIGNAL BEHAV, V14, DOI 10.1080/15592324.2019.1621089; Lin QF, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1986-5; Liu MS, 2008, PLANT CELL PHYSIOL, V49, P653, DOI 10.1093/pcp/pcn040; Liu X, 2019, GENE, V710, P210, DOI 10.1016/j.gene.2019.06.006; Lv X, 2018, J EXP BOT; Manishankar P, 2018, J EXP BOT; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Mehta RH, 2017, FUNCT INTEGR GENOMIC, V17, P1, DOI 10.1007/s10142-016-0523-y; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittal S, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00115; Munir S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31772; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Olsson C, 2016, J PHYS CHEM B, V120, P4723, DOI 10.1021/acs.jpcb.6b02517; Petersen KB, 2018, EVOLUTION, V72, P1080, DOI 10.1111/evo.13484; Phimchan P, 2014, J AGR FOOD CHEM, V62, P7057, DOI 10.1021/jf4051717; Pilati S, 2017, FRONT PLANT SCI, V8, P1, DOI 10.3389/fpls.2017.01093; Plancot B, 2019, CARBOHYD POLYM, V208, P180, DOI 10.1016/j.carbpol.2018.12.051; Rampino P, 2017, PLANT PHYSIOL BIOCH, V120, P223, DOI 10.1016/j.plaphy.2017.10.010; Rodriguez-Salazar J, 2009, FEMS MICROBIOL LETT, V296, P52, DOI 10.1111/j.1574-6968.2009.01614.x; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; SHARMA A, 2019, MOLECULES, V24; Vandelle E, 2018, PLANT PHYSIOL BIOCH, V129, P221, DOI 10.1016/j.plaphy.2018.06.003; Vilchez JI, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01577; Wang XC, 2017, PLANT PHYSIOL, V173, P944, DOI 10.1104/pp.16.01527; Wang XN, 2010, J PROTEOME RES, V9, P6561, DOI 10.1021/pr100767k; Weidenbach D, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2014.1003752; Wu FQ, 2015, J EXP BOT, V66, P271, DOI 10.1093/jxb/eru417; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Xu ZC, 2018, MOL PLANT, V11, P983, DOI 10.1016/j.molp.2018.05.003; Ye JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13988-8; Yobi A, 2013, MOL PLANT, V6, P369, DOI 10.1093/mp/sss155; Yobi A, 2012, PLANT J, V72, P983, DOI 10.1111/tpj.12008; Yuan LX, 2017, BIOL OPEN, V6, P1024, DOI 10.1242/bio.026534; Zanella M, 2016, J EXP BOT, V67, P1819, DOI 10.1093/jxb/erv572; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x; Zheng XK, 2013, J PHARM PHARMACOL, V65, P757, DOI 10.1111/jphp.12035; Zheng XK, 2011, J ETHNOPHARMACOL, V137, P662, DOI 10.1016/j.jep.2011.06.018; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439; Zhu Yan, 2017, BMC Genomics, V18, P1042, DOI 10.1186/s12864-016-3266-1	64	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224765	10.1371/journal.pone.0224765	http://dx.doi.org/10.1371/journal.pone.0224765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721818	gold, Green Published			2022-12-26	WOS:000532720700028
J	Song, BL; Li, YB; Sun, JW; Qi, YZ; Li, P; Li, YM; Gu, ZX				Song, Baolong; Li, Yibo; Sun, Jianwei; Qi, Yizhe; Li, Peng; Li, Yongming; Gu, Zexu			Computational fluid dynamics simulation of changes in the morphology and airflow dynamics of the upper airways in OSAHS patients after treatment with oral appliances	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; PRESSURE; CPAP; HYPOPNEA; MEN	Objectives To explore the changes of morphology and internal airflow in upper airways (UA) after the use of oral appliances (OAs) in patients with obstructive sleep apnea hypopnea syndrome (OSAHS), and investigate the mechanisms by which OAs function as a therapy for OSAHS. Methods Eight OSAHS patients (all male, aged 37-58, mean age 46.25) underwent CT scans before and after OA use. Then, computational fluid dynamics(CFD) models were built on the base of the CT scans using Mimics and ANSYS ICEM CFD software. The internal airflow of the upper airways was simulated using ANSYS-FLUENT and the results were analyzed using ANSYS-CFD-Post. The data were analyzed to identify the most important changes of biomechanical properties between patients with and without OA intervention. Upper airway morphology and the internal airflow changes were compared using t-tests and Spearman correlation coefficient analysis. Results The narrowest area of upper airways was found to be located in the lower bound of velopharynx, where the volume and pressure were statistically significantly increased (P<0.05) and the air velocity was statistically significantly decreased (P<0.05) in the presence of the 0A(P<0.05). After wearing OA, pharyngeal resistance was significantly decreased (P<0.05), from 290.63 to 186.25Pa/L, and the airflow resistance of the pharynx has reduced by 35.9%. Conclusion The enlargement of the upper airway after wearing the OA changed its airflow dynamics, which decreased the negative pressure and resistance in narrow areas of the upper airways. Thus, the collapsibility of the upper airways was reduced and patency was sustained.	[Song, Baolong; Sun, Jianwei; Qi, Yizhe; Li, Peng; Li, Yongming; Gu, Zexu] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian, Peoples R China; [Song, Baolong; Sun, Jianwei; Qi, Yizhe; Li, Peng; Li, Yongming; Gu, Zexu] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China; [Song, Baolong; Sun, Jianwei; Qi, Yizhe; Li, Peng; Li, Yongming; Gu, Zexu] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Shaanxi Clin Res Ctr Oral Dis, Xian, Peoples R China; [Li, Yibo] Changsha Stomatol Hosp, Dept Orthodont, Changsha, Hunan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Li, YM; Gu, ZX (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, State Key Lab Mil Stomatol, Xian, Peoples R China.; Li, YM; Gu, ZX (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Natl Clin Res Ctr Oral Dis, Xian, Peoples R China.; Li, YM; Gu, ZX (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Shaanxi Clin Res Ctr Oral Dis, Xian, Peoples R China.	liyongming@fmmu.edu.cn; zeki99@163.com	li, yong/HDN-3885-2022					Awad KM, 2012, AM J MED, V125, P485, DOI 10.1016/j.amjmed.2011.11.025; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; BERMAN EJ, 1991, CHEST, V100, P347, DOI 10.1378/chest.100.2.347; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; CARTWRIGHT RD, 1982, JAMA-J AM MED ASSOC, V248, P705, DOI 10.1001/jama.248.6.705; Engleman HM, 1996, CHEST, V109, P1470, DOI 10.1378/chest.109.6.1470; Ferretti GR, 2001, EUR RESPIR J, V18, P381, DOI 10.1183/09031936.01.00217701; FUJITA S, 1981, OTOLARYNG HEAD NECK, V89, P923, DOI 10.1177/019459988108900609; HAHN I, 1993, J APPL PHYSIOL, V75, P2273, DOI 10.1152/jappl.1993.75.5.2273; Haskell JA., 2009, SEMIN ORTHOD, V15, P132; Jeong SJ, 2007, MED ENG PHYS, V29, P637, DOI 10.1016/j.medengphy.2006.08.017; Katz IM, 1999, J AEROSOL SCI, V30, P173, DOI 10.1016/S0021-8502(98)00043-3; Keyhani K, 1995, J BIOMECH ENG-T ASME, V117, P429, DOI 10.1115/1.2794204; Kyung SH, 2005, ANGLE ORTHOD, V75, P15; LARSSON H, 1991, ACTA OTO-LARYNGOL, V111, P582, DOI 10.3109/00016489109138387; Luo XY, 2004, MED ENG PHYS, V26, P403, DOI 10.1016/j.medengphy.2004.02.008; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Malhotra A, 2002, AM J RESP CRIT CARE, V166, P1388, DOI 10.1164/rccm.2112072; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Naegele B, 1998, SLEEP, V21, P392, DOI 10.1093/sleep/21.4.392; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; RILEY RW, 1986, OTOLARYNG HEAD NECK, V94, P589; Sam K, 2006, RESP MED, V100, P897, DOI 10.1016/j.rmed.2005.08.019; SERIES F, 1993, ANN INTERN MED, V119, P449, DOI 10.7326/0003-4819-119-6-199309150-00001; SULLIVAN CE, 1981, LANCET, V1, P862; Weaver TE, 1997, SLEEP, V20, P278, DOI 10.1093/sleep/20.4.278; Wilhelmsson B, 1999, ACTA OTO-LARYNGOL, V119, P503; Yang C, 2003, OTOLARYNG CLIN N AM, V36, P409, DOI 10.1016/S0030-6665(03)00017-3; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	29	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0219642	10.1371/journal.pone.0219642	http://dx.doi.org/10.1371/journal.pone.0219642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721777	Green Submitted, Green Published, gold			2022-12-26	WOS:000532720700003
J	Hammond, MJ; Wang, TF; Cummins, SF				Hammond, Michael J.; Wang, Tianfang; Cummins, Scott F.			Characterisation of early metazoan secretion through associated signal peptidase complex subunits, prohormone convertases and carboxypeptidases of the marine sponge (Amphimedon queenslandica)	PLOS ONE			English	Article							EVOLUTION; SEQUENCE; TOPOLOGY; ORIGINS; GENOME	Efficient communication between cells requires the ability to process precursor proteins into their mature and biologically active forms, prior to secretion into the extracellular space. Eukaryotic cells achieve this via a suite of enzymes that involve a signal peptidase complex, prohormone convertases and carboxypeptidases. Using genome and transcriptome data of the demosponge Amphimedon queenslandica, a universal ancestor to metazoan multicellularity, we endeavour to bridge the evolution of precursor processing machinery from single-celled eukaryotic ancestors through to the complex multicellular organisms that compromise Metazoa. The precursor processing repertoire as defined in this study of A. queenslandica consists of 3 defined signal peptidase subunits, 6 prohormone convertases and 1 carboxypeptidase, with 2 putative duplicates identified for signal peptidase complex subunits. Analysis of their gene expression levels throughout the sponge development enabled us to predict levels of activity. Some A. queenslandica precursor processing components belong to established functional clades while others were identified as having novel, yet to be discovered roles. These findings have clarified the presence of precursor processing machinery in the poriferans, showing the necessary machinery for the removal of precursor sequences, a critical post-translational modification required by multicellular organisms, and further sets a foundation towards understanding the molecular mechanism for ancient protein processing.	[Hammond, Michael J.; Wang, Tianfang; Cummins, Scott F.] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia	University of the Sunshine Coast	Hammond, MJ (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia.	mjh042@student.usc.edu.au	Hammond, Michael/AAD-6296-2021; Wang, Tianfang/L-5192-2016	Hammond, Michael/0000-0001-7406-0717; Wang, Tianfang/0000-0002-4876-7767	Australian Research Council	Australian Research Council(Australian Research Council)	SFC received funding from an Australian Research Council grant. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aittomaki S, 2017, FASEB J, V31, P4770, DOI 10.1096/fj.201700296R; Antonin W, 2000, J BIOL CHEM, V275, P34068, DOI 10.1074/jbc.M006126200; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Conaco C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-209; DALBEY RE, 1992, TRENDS BIOCHEM SCI, V17, P474, DOI 10.1016/0968-0004(92)90492-R; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; Eddy Sean R, 2009, Genome Inform, V23, P205; Fang H, 1996, J BIOL CHEM, V271, P16460, DOI 10.1074/jbc.271.28.16460; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Guan JM, 2018, ARCH INSECT BIOCHEM, V97, DOI 10.1002/arch.21441; Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996; Ishikawa T, 1998, GENE, V215, P361, DOI 10.1016/S0378-1119(98)00270-4; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006; Kalinina E, 2006, J CELL BIOCHEM, V99, P770, DOI 10.1002/jcb.20972; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Leys SP, 2006, CAN J ZOOL, V84, P262, DOI 10.1139/Z05-170; Leys SP, 2005, CURR BIOL, V15, pR114, DOI 10.1016/j.cub.2005.02.005; LOH YP, 1985, J BIOL CHEM, V260, P7194; Lusson J, 1997, BIOCHEM J, V326, P737, DOI 10.1042/bj3260737; Luxmi R, 2018, PROTEOMES, V6, DOI 10.3390/proteomes6040036; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; Moreland RT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-316; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Pauls D, 2019, EUROPEAN J NEUROSCIE, V18; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poole CB, 2007, MOL BIOCHEM PARASIT, V155, P1, DOI 10.1016/j.molbiopara.2007.05.001; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rokas A, 2008, CURR OPIN GENET DEV, V18, P472, DOI 10.1016/j.gde.2008.09.004; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 2008, INT J BIOCH CELL BIO, V40; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; Thacker C, 2000, BIOESSAYS, V22, P545, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;545::AID-BIES7&gt;3.0.CO;2-F	45	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225227	10.1371/journal.pone.0225227	http://dx.doi.org/10.1371/journal.pone.0225227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714927	Green Published, gold			2022-12-26	WOS:000532710400038
J	Saleem, A; Bekele, A; Fitzpatrick, MB; Mahmoud, EA; Lin, AW; Velasco, HE; Rashed, MM				Saleem, Atif; Bekele, Alemayehu; Fitzpatrick, Megan B.; Mahmoud, Eiman A.; Lin, Athena W.; Velasco, H. Eduardo; Rashed, Mona M.			Knowledge and awareness of cervical cancer in Southwestern Ethiopia is lacking: A descriptive analysis	PLOS ONE			English	Article							COLLABORATIVE REANALYSIS; INDIVIDUAL DATA; WOMEN	Purpose Cervical cancer remains the second most common cancer and cancer-related death among women in Ethiopia. This is the first study, to our knowledge, describing the demographic, and clinicopathologic characteristics of cervical cancer cases in a mainly rural, Southwestern Ethiopian population with a low literacy rate to provide data on the cervical cancer burden and help guide future prevention and intervention efforts. Methods A descriptive analysis of 154 cervical cancer cases at the Jimma University Teaching Hospital in Southwestern Ethiopia from January 2008 -December 2010 was performed. Demographic and clinical characteristics were obtained from patient questionnaires and cervical punch biopsies were histologically examined. Results Of the 154 participants with a histopathologic diagnosis of cervical cancer, 95.36% had not heard of cervical cancer and 89.6% were locally advanced at the time of diagnosis. Moreover, 86.4% of participants were illiterate, and 62% lived in a rural area. Conclusion A majority of the 154 women with cervical cancer studied at the Jimma University Teaching Hospital in Southwestern Ethiopia were illiterate, had not heard of cervical cancer and had advanced disease at the time of diagnosis. Given the low rates of literacy and knowledge regarding cervical cancer in this population which has been shown to correlate with a decreased odds of undergoing screening, future interventions to address the cervical cancer burden here must include an effective educational component.	[Saleem, Atif; Fitzpatrick, Megan B.] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Bekele, Alemayehu] Jimma Univ, Coll Med, Jimma, Ethiopia; [Mahmoud, Eiman A.; Lin, Athena W.; Velasco, H. Eduardo] Touro Univ, Coll Osteopath Med, Dept Basic Sci, Vallejo, CA USA; [Rashed, Mona M.] Gen Org Teaching Hosp & Inst, Dept Pathol, Cairo, Egypt	Stanford University; Jimma University; Touro University California; Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI)	Saleem, A (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA.	asaleem@stanford.edu	Fitzpatrick, Megan/ABD-3483-2020; Ramogola-Masire, Doreen/AAP-2754-2020	Fitzpatrick, Megan/0000-0001-7040-8018; Ramogola-Masire, Doreen/0000-0001-9624-8366; MAHMOUD, EIMAN/0000-0003-2298-7101	Jimma University Teaching Hospital; Global Physicians Corps	Jimma University Teaching Hospital; Global Physicians Corps	This study was funded in terms of the materials (questionnaires, histopathological materials including microscopic slides/staining materials) by the Jimma University Teaching Hospital and by the Global Physicians Corps (http://globalphysicians.org/).	Abate S. M., 2015, GYNECOLOGY OBSTET TR, DOI [10.4172/2161-0932.S3, DOI 10.4172/2161-0932.S3]; Abiodun OA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-814; Adugna A, 2017, DEMOGRAPHY HLTH; Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Aweke YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181415; Bekele A, 2010, TROP MED INT HEALTH, V15, P890, DOI 10.1111/j.1365-3156.2010.02552.x; Bruni L, 2016, ICO INFORM CTR HPV C; Chigbu CO, 2017, INT J GYNECOL OBSTET, V137, P319, DOI 10.1002/ijgo.12150; CSA-Ethiopia IC, 2011, INT ETHIOPIA DEMOGRA; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Erku DA, 2017, GYNECOLOGIC ONCOLOGY, V4, P20, DOI [DOI 10.1186/S40661-017-0057-6, 10.1186/s40661-017-0057-6]; Federal Ministry of Health Ethiopia, 2015, NAT CANC CONTR PLAN; Geremew AB, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0471-1; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Jensen KE, 2013, BRIT J CANCER, V108, P234, DOI 10.1038/bjc.2012.513; Johnson LG, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0718-9; Kumar S, 2009, ARCH GYNECOL OBSTET, V280, P25, DOI 10.1007/s00404-008-0851-9; Maguire FB, 2016, CALIFORNIA CANC REPO; Mitiku I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163136; Moodley M, 2003, INT J GYNECOL CANCER, V13, P103, DOI 10.1136/ijgc-00009577-200303000-00001; Moodley M, 2009, EUR J GYNAECOL ONCOL, V30, P145; Olu-Eddo Adesuwa Noma, 2011, Nig Q J Hosp Med, V21, P149; Peirson L, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-35; Rates RS, SEER CANC STAT REV 1; Shiferaw N, 2016, GLOB HEALTH-SCI PRAC, V4, P87, DOI 10.9745/GHSP-D-15-00325; Tadesse SK, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0231-0; Teame H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191506; Tilahun M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-622; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	31	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0215117	10.1371/journal.pone.0215117	http://dx.doi.org/10.1371/journal.pone.0215117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714915	gold, Green Submitted, Green Published			2022-12-26	WOS:000532710400001
J	Kubota, M; Kakimoto, K; Nakagawa, T; Koubayashi, E; Nakazawa, K; Tawa, H; Hirata, Y; Okada, T; Kawakami, K; Asai, A; Hosomi, S; Takeuchi, T; Fukunishi, S; Inoue, T; Asahi, M; Higuchi, K				Kubota, Minori; Kakimoto, Kazuki; Nakagawa, Takatoshi; Koubayashi, Eiko; Nakazawa, Kei; Tawa, Hideki; Hirata, Yuki; Okada, Toshihiko; Kawakami, Ken; Asai, Akira; Hosomi, Shuhei; Takeuchi, Toshihisa; Fukunishi, Shinya; Inoue, Takuya; Asahi, Michio; Higuchi, Kazuhide			Autophagy deficiency exacerbates colitis through excessive oxidative stress and MAPK signaling pathway activation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; PANETH CELLS; ATG16L1; APOPTOSIS; INFLAMMATION; INDUCTION; MICE	Background and aim Autophagy is an essential process involved in the pathogenesis of inflammatory bowel disease (IBD). Although there are many data showing the roles of autophagy in intestinal epithelial cells (IECs), the mechanisms involved remain to be fully elucidated. We investigated the influence of autophagy in IECs on gastrointestinal tract inflammation. Methods Mice with conditional knockout of Atg5 in IECs (Atg5(flox/flox)/villin-Cre mice) were subjected to dextran sulfate sodium (DSS)-induced colitis and analyzed for colitis susceptibility. Additionally, we used Atg5-silenced rat IECs (IEC6shAtg5 cells) for in vitro assays. Results Sensitivity to DSS markedly increased in Atg5(flox/flox)/villin-Cre mice compared to that in wildtype mice. In IEC6shAtg5 cells, apoptosis was enhanced, and cell viability significantly decreased compared to IEC-6 cells. The expression of proinflammatory cytokines increased upon suppression of autophagy. Furthermore, silencing of Atg5 was associated with inflammation of IECs, activation of the mitogen-activated protein kinase (MAPK) signaling pathway by the intracellular reactive oxygen species accumulation, and NF-kappa B p65 phosphorylation. Conclusions Autophagy in IECs plays an essential role in the maintenance of intestinal homeostasis, and autophagy deficiency triggers inflammation. Development of methods targeting autophagy might be beneficial in the treatment of IBD.	[Kubota, Minori; Kakimoto, Kazuki; Koubayashi, Eiko; Nakazawa, Kei; Tawa, Hideki; Hirata, Yuki; Okada, Toshihiko; Kawakami, Ken; Asai, Akira; Takeuchi, Toshihisa; Fukunishi, Shinya; Inoue, Takuya; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Daigakumachi, Takatsuki, Osaka, Japan; [Nakagawa, Takatoshi; Asahi, Michio] Osaka Med Coll, Fac Med, Dept Pharmacol, Daigakumachi, Takatsuki, Osaka, Japan; [Hosomi, Shuhei] Osaka City Univ, Dept Gastroenterol, Grad Sch Med, Abeno Ku, Asahimachi, Osaka, Japan	Osaka Medical College; Osaka Medical College; Osaka Metropolitan University	Higuchi, K (corresponding author), Osaka Med Coll, Dept Internal Med 2, Daigakumachi, Takatsuki, Osaka, Japan.; Asahi, M (corresponding author), Osaka Med Coll, Fac Med, Dept Pharmacol, Daigakumachi, Takatsuki, Osaka, Japan.	masahi@osaka-meo.ac.jp; higuchi@osaka-med.ac.jp			OMC Internal Research Grant	OMC Internal Research Grant	This work was supported by funding from the OMC Internal Research Grant to MA, KH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Asano J, 2017, CELL REP, V20, P1050, DOI 10.1016/j.celrep.2017.07.019; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cabrera S, 2013, AUTOPHAGY, V9, P1188, DOI 10.4161/auto.24797; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Deretic V, 2008, DEV CELL, V15, P641, DOI 10.1016/j.devcel.2008.10.009; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harada S, 2015, J PHARMACOL EXP THER, V355, P353, DOI 10.1124/jpet.115.226431; Hausmann M, 2007, CLIN EXP IMMUNOL, V148, P373, DOI 10.1111/j.1365-2249.2007.03350.x; Hirata Y, 2018, J CLIN BIOCHEM NUTR, V62, P221, DOI 10.3164/jcbn.17-106; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Schulzke JD, 2006, ANN NY ACAD SCI, V1072, P288, DOI 10.1196/annals.1326.027; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Yano T, 2009, NAT IMMUNOL, V10, P134, DOI 10.1038/ni0209-134; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632	27	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225066	10.1371/journal.pone.0225066	http://dx.doi.org/10.1371/journal.pone.0225066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703091	Green Published, gold			2022-12-26	WOS:000532697200042
J	Brunetti, G; Navazio, AS; Giuliani, A; Giordano, A; Proli, EM; Antonelli, G; Raponi, G				Brunetti, Grazia; Navazio, Anna Sara; Giuliani, Alessandro; Giordano, Alessandra; Proli, Enrica Maria; Antonelli, Guido; Raponi, Giammarco			Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemiology, biofilm production, antifungal agents consumption and drug-susceptibility	PLOS ONE			English	Article							RISK-FACTORS; CLINICAL CHARACTERISTICS; PARAPSILOSIS; MORTALITY; CARE; SURVEILLANCE; PREDICTORS; MANAGEMENT; FUNGEMIA; IMPACT	Candida bloodstream infection (BSI) represents a growing infective problem frequently associated to biofilm production due to the utilization of intravascular devices. Candida species distribution (n = 612 strains), their biofilm production and hospital antifungal drug consumption were evaluated in different wards of a tertiary care academic hospital in Italy during the years 2011-2016. In the considered time window, an increasing number of Candida BSI (p = 0.005) and of biofilm producing strains were observed (p<0.0001). Although C. albicans was the species more frequently isolated in BSI with a major biofilm production, an increased involvement of non-albicans species was reported, particularly of C. parapsilosis that displayed a high frequency in catheter infections, and lower biofilm production compared to C. albicans. Although trends of biofilm production were substantially stable in time, a decreasing biofilm production by C. parapsilosis in the Intensive Care Unit (ICU) was observed (p = 0.0041). Principal component analysis displayed a change in antifungal drugs consumption driven by two mutually independent temporal trends, i.e. voriconazole use in the general medicine wards initially, and fluconazole use mainly in the ICU; these factors explain 68.9% and 25.7% of total variance respectively. Moreover, a significant trend (p = 0.003) in fluconazole use during the whole time period considered emerged, particularly in the ICU (p = 0.017), but also in the general medicine wards (p = 0.03). These trends paralleled with significant increase MIC90 of fluconazole (p = 0.05), particularly for C. parapsilosis in the ICU (p = 0.04), with a general and significant decreased trend of the MIC90 values of caspofungin (p = 0.04), and with significant increased MIC50 values for amphotericin B (p = 0.01) over the study period. In conclusion, drug utilization in our hospital turned out to be a putative influencing factor on the ecology of the species, on the increase in time of the biofilm producing strains and on the Candida antifungal susceptibility profile, thus influencing clinical management.	[Brunetti, Grazia; Giordano, Alessandra; Raponi, Giammarco] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Navazio, Anna Sara; Antonelli, Guido] Sapienza Univ Rome, Cenci Bolognetti Fdn, Lab Microbiol, Dept Mol Med, Rome, Italy; [Navazio, Anna Sara; Antonelli, Guido] Sapienza Univ Rome, Cenci Bolognetti Fdn, Pasteur Inst, Rome, Italy; [Giuliani, Alessandro] Ist Super Sanita, Dept Environm & Hlth, Rome, Italy; [Giordano, Alessandra; Antonelli, Guido; Raponi, Giammarco] Sapienza Univ Hosp Policlin Umberto I, Microbiol & Virol Unit, Rome, Italy; [Proli, Enrica Maria] Univ Hosp Policlin Umberto I, Hosp Pharm, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Sapienza University Rome; University Hospital Sapienza Rome	Raponi, G (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.; Raponi, G (corresponding author), Sapienza Univ Hosp Policlin Umberto I, Microbiol & Virol Unit, Rome, Italy.	giammarco.raponi@uniroma1.it	Raponi, Giammarco/AAL-2806-2021; Giuliani, Alessandro/K-7589-2016; Raponi, Giammarco/A-1806-2013	Raponi, Giammarco/0000-0002-9665-0811; Giuliani, Alessandro/0000-0002-4640-804X; ANTONELLI, Guido/0000-0002-2533-2939; Brunetti, Grazia/0000-0002-0037-3216				Bassetti M, 2007, DIAGN MICR INFEC DIS, V58, P325, DOI 10.1016/j.diagmicrobio.2007.01.005; Bassetti M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2497-3; Bitew A, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0607-z; Bonassoli LA, 2005, J HOSP INFECT, V59, P159, DOI 10.1016/j.jhin.2004.06.033; Brunetti G, 2017, ADV EXP MED BIOL, V973, P89, DOI 10.1007/5584_2016_196; Caggiano G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/256580; Chen PY, 2014, J MICROBIOL IMMUNOL, V47, P95, DOI 10.1016/j.jmii.2012.08.025; Clark TA, 2004, J CLIN MICROBIOL, V42, P4468, DOI 10.1128/JCM.42.10.4468-4472.2004; CLERI DJ, 1980, J INFECT DIS, V141, P781, DOI 10.1093/infdis/141.6.781; Cleveland AA, 2012, CLIN INFECT DIS, V55, P1352, DOI 10.1093/cid/cis697; Cortegiani A, 2019, INTENS CARE MED, V45, P512, DOI 10.1007/s00134-018-5363-x; Ghezzi MC, 2017, J MED MICROBIOL, V66, P990, DOI 10.1099/jmm.0.000505; Ghosh AK, 2015, CLIN MICROBIOL INFEC, V21, P372, DOI 10.1016/j.cmi.2014.11.009; Giuliani A, 2017, DRUG DISCOV TODAY, V22, P1069, DOI 10.1016/j.drudis.2017.01.005; Hajjeh RA, 2004, J CLIN MICROBIOL, V42, P1519, DOI 10.1128/JCM.42.4.1519-1527.2004; JOLICOEUR PIERRE, 1960, GROWTH, V24, P339; Kang SJ, 2017, J INFECTION, V75, P246, DOI 10.1016/j.jinf.2017.05.019; Koehler P, 2019, CLIN MICROBIOL INFEC; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0; Li WS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01196; Lindberg E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40280-8; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000; Marak MB, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/7495218; Marcos-Zambrano LJ, 2014, INT J MED MICROBIOL, V304, P1192, DOI 10.1016/j.ijmm.2014.08.012; Mencarini J, 2018, INFECTION, V46, P469, DOI 10.1007/s15010-018-1139-z; Milazzo L, 2014, MYCOPATHOLOGIA, V178, P227, DOI 10.1007/s11046-014-9786-9; Monroy-Perez E, 2016, CAN J INFECT DIS MED, V2016, DOI 10.1155/2016/5930489; Munoz P, 2018, CLIN MICROBIOL INFEC, V24, P1010, DOI 10.1016/j.cmi.2018.01.022; Nguyen MH, 1996, AM J MED, V100, P617, DOI 10.1016/S0002-9343(95)00010-0; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2019, OPEN FORUM INFECT DI, V6, pS79, DOI 10.1093/ofid/ofy358; Pinto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025712; Playford EG, 2010, J HOSP INFECT, V76, P46, DOI 10.1016/j.jhin.2010.01.022; Pristov KE, 2019, CLIN MICROBIOL INFEC; Rajendran R, 2016, CLIN MICROBIOL INFEC, V22, P87, DOI 10.1016/j.cmi.2015.09.018; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Retherford RD, 1993, STAT MODELS CAUSAL A, P119; Sakagami T, 2019, J INFECT CHEMOTHER, V25, P34, DOI 10.1016/j.jiac.2018.10.007; Sandini S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-106; Sherry L, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-182; Shin JH, 2002, J CLIN MICROBIOL, V40, P1244, DOI 10.1128/JCM.40.4.1244-1248.2002; Silva S, 2011, TRENDS MICROBIOL, V19, P241, DOI 10.1016/j.tim.2011.02.003; Soldini S, 2018, CLIN MICROBIOL INFEC, V24, P771, DOI 10.1016/j.cmi.2017.11.005; Toth R, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00111-18; Tumbarello M, 2007, J CLIN MICROBIOL, V45, P1843, DOI 10.1128/JCM.00131-07; Tumbarello Mario, 2012, PLoS One, V7, pe33705, DOI 10.1371/journal.pone.0033705; Vandeputte Patrick, 2012, Int J Microbiol, V2012, P713687, DOI 10.1155/2012/713687; World Health Organization, 2021, COLL CTR DRUG STAT M; Yang ZT, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-241; Zhang XB, 2012, JPN J INFECT DIS, V65, P510, DOI 10.7883/yoken.65.510	55	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224678	10.1371/journal.pone.0224678	http://dx.doi.org/10.1371/journal.pone.0224678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697722	Green Published, gold			2022-12-26	WOS:000532694400040
J	Craig, JM; Kim, LY; Tagliacollo, VA; Albert, JS				Craig, Jack M.; Kim, Lesley Y.; Tagliacollo, Victor A.; Albert, James S.			Phylogenetic revision of Gymnotidae (Teleostei: Gymnotiformes), with descriptions of six subgenera	PLOS ONE			English	Article							LOWLAND AMAZON BASIN; ELECTRIC FISH; OSTARIOPHYSI GYMNOTIFORMES; RIVER CAPTURE; LIFE-HISTORY; BRAZIL; CARAPO; RIO; KNIFEFISHES; SIGNATURE	The diversity of gymnotid electric fishes has been intensely studied over the past 25 years, with 35 species named since 1994, compared to 11 species in the previous 236 years. Substantial effort has also been applied in recent years to documenting gymnotid interrelationships, with seven systematic studies published using morphological and molecular datasets. Nevertheless, until now, all gymnotids have been assigned to one of just two supraspecific taxa, the subfamily Electrophorinae with one genus Electrophorus and three valid species and the subfamily Gymnotine also with one genus Gymnotus and 43 valid species. This simple classification has obscured the substantial phenotypic and lineage diversity within the subfamily Gymnotine and hampered ecological and evolutionary studies of gymnotid biology. Here we present the most well-resolved and taxon-complete phylogeny of the Gymnotidae to date, including materials from all but one of the valid species. This phylogeny was constructed using a five-gene molecular dataset and a 115-character morphological dataset, enabling the inclusion of several species for which molecular data are still lacking. This phylogeny was time-calibrated using biogeographical priors in the absence of a fossil record. The tree topology is similar to those of previous studies, recovering all the major clades previously recognized with informal names. We propose a new gymnotid classification including two subfamilies (Electrophorinae and Gymnotinae) and six subgenera within the genus Gymnotus. Each subgenus exhibits a distinctive biogeographic distribution, within which most species have allopatric distributions and the subgenera are diverged from one another by an estimated 5-35 million years. We further provide robust taxonomic diagnoses, descriptions and identification keys to all gymnotid subgenera and all but four species. This new taxonomy more equitably partitions species diversity among supra-specific taxa, employing the previously vacant subgenus and subfamily ranks. This new taxonomy renders known gymnotid diversity more accessible to study by highlighting the deep divergences (chronological, geographical, genetic and morphological) among its several clades.	[Craig, Jack M.; Kim, Lesley Y.; Albert, James S.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Tagliacollo, Victor A.] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil	University of Louisiana Lafayette; Universidade de Sao Paulo	Craig, JM (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.	jack.m.craig@gmail.com	Tagliacollo, Victor A/C-9798-2012	Tagliacollo, Victor A/0000-0003-1493-9409	United States National Science Foundation [DEB 0614334, 0741450, 1354511]	United States National Science Foundation(National Science Foundation (NSF))	This work was supported by United States National Science Foundation DEB 0614334, 0741450 and 1354511 to JSA.	Albert J. S., 2001, ICHTHYOL EXPLOR FRES, V12, P241; Albert JS, 2006, J S AM EARTH SCI, V21, P14, DOI 10.1016/j.jsames.2005.07.010; Albert JS, 2018, NEOTROP ICHTHYOL, V16, DOI 10.1590/1982-0224-20180033; Albert James S., 2003, Zootaxa, V287, P1; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Albert JS, 1999, COPEIA, P410; Albert JS, 1995, P BIOL SOC WASH, V108, P662; Albert JS, 2010, NAT KNOWL, V1, P1, DOI [10.1016/j.ympev.2015.11.007, DOI 10.1016/J.YMPEV.2015.11.007]; Albert JS, 2018, MOUNTAINS CLIMATE BI; Albert JS, 2001, MISC PUBL MUS ZOOL U; Albert JS., 2005, SYSTEM BIODIVERS, V4, P375, DOI DOI 10.1017/S1477200004001574; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1864, P ACAD NAT SCI PHILA, V20, P151; Antonelli A, 2018, PEERJ, V6, DOI 10.7717/peerj.5644; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Bennett DJ, 2018, LIFE-BASEL, V8, DOI 10.3390/life8020020; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BROWN PS, 1994, ENVIRON BIOL FISH, V41, P9; Burridge CP, 2006, EVOLUTION, V60, P1038; Campos-da-Paz Ricardo, 2002, Ichthyological Exploration of Freshwaters, V13, P185; CamposDaPaz R, 1996, COPEIA, P937; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cognato D, 2007, ICHTHYOL EXPLOR FRES, V18, P375; Correa SB, 2008, J FISH BIOL, V72, P629, DOI 10.1111/j.1095-8649.2007.01752.x; Craig JM, 2018, ZOOTAXA, V4413, P111, DOI 10.11646/zootaxa.4413.1.3; Craig JM, 2018, ZOOTAXA, V4379, P47, DOI 10.11646/zootaxa.4379.1.3; Craig JM, 2017, ZOOTAXA, V4318, P401, DOI 10.11646/zootaxa.4318.3.1; Crampton WGR, 2013, J EXP BIOL, V216, P2523, DOI 10.1242/jeb.083261; Crampton WGR, 2005, COPEIA, P82; Crampton WGR, 2004, COPEIA, P525; CRAMPTON WGR, 2003, ZOOTAXA, V348, P1, DOI DOI 10.11646/ZOOTAXA.348.1.1; Crampton William G.R., 2003, Zootaxa, V277, P1; Crampton WGR, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P165; Crampton WGR, 2008, NEOTROP ICHTHYOL, V6, P599, DOI 10.1590/S1679-62252008000400008; delleChiaje S, 1847, NUOVI ANN SCI NAT 1; Ellis MM, 1913, MEM CARNEGIE MUS, V6, P109, DOI DOI 10.5962/BHL.TITLE.12969; Fernandes FMC, 2005, ZOOTAXA, P1; Fronk AH, 2019, COPEIA, V107, P305, DOI 10.1643/CI-18-164; Giora J, 2016, ZOOTAXA, V4066, P581, DOI 10.11646/zootaxa.4066.5.6; Goloboff P, 2008, CLADISTICS, V24, P91; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hoedeman JJ, 1962, B AQUAT BIOL, V3, P53; Houttuyn M, 1764, NATUURLYKE HIST UITV; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; LaMONTE F. R., 1935, AMER MUS NOVITATES, V781, P1; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lehmberg ES, 2018, J BIOGEOGR, V45, P815, DOI 10.1111/jbi.13177; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Lovejoy NR, 2010, MOL PHYLOGENET EVOL, V54, P278, DOI 10.1016/j.ympev.2009.09.017; Lundberg John G., 1998, P13; Mago-Leccia F., 1994, ELECT FISHES CONTINE, V29; Maldonado-Ocampo JA, 2004, ZOOTAXA, P1; Maxime EL, 2014, COPEIA, P462, DOI 10.1643/CI-13-054; Maxime EL, 2011, COPEIA, P77, DOI 10.1643/CI-10-009; Maxime EL, 2009, NEOTROP ICHTHYOL, V7, P579, DOI 10.1590/S1679-62252009000400004; Milhomem SSR, 2012, J FISH BIOL, V80, P802, DOI 10.1111/j.1095-8649.2012.03219.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Rambaut A., 2018, FIGTREE TREE FIGURE; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rangel-Pereira FD, 2012, VERTEBR ZOOL, V62, P363; Rangel-Pereira FS, 2014, VERTEBR ZOOL, V64, P169; Richer-de-Forges MM, 2009, COPEIA, P538, DOI 10.1643/CI-07-103; Sanderson MJ, 2008, SYST BIOL, V57, P335, DOI 10.1080/10635150802158688; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tagliacollo VA, 2017, SYST BIOL, V66, P183, DOI 10.1093/sysbio/syv064; Tagliacollo VA, 2016, MOL PHYLOGENET EVOL, V95, P20, DOI 10.1016/j.ympev.2015.11.007; Tagliacollo VA, 2015, J BIOGEOGR, V42, P2349, DOI 10.1111/jbi.12594; Valenciennes A., VOYAGE AMERIQUE MERI; Van der Sleen P., 2017, FIELD GUIDE FISHES A; Vanin AS, 2017, ENVIRON BIOL FISH, V100, P69, DOI 10.1007/s10641-016-0556-z	74	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224599	10.1371/journal.pone.0224599	http://dx.doi.org/10.1371/journal.pone.0224599			112	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697735	Green Published, gold			2022-12-26	WOS:000532694400036
J	Hebert, JJ; Abraham, E; Wedderkopp, N; Bigney, E; Richardson, E; Darling, M; Hall, H; Fisher, CG; Rampersaud, YR; Thomas, KC; Jacobs, B; Johnson, M; Paquet, J; Attabib, N; Jarzem, P; Wai, EK; Rasoulinejad, P; Ahn, H; Nataraj, A; Stratton, A; Manson, N				Hebert, Jeffrey J.; Abraham, Edward; Wedderkopp, Niels; Bigney, Erin; Richardson, Eden; Darling, Mariah; Hall, Hamilton; Fisher, Charles G.; Rampersaud, Y. Raja; Thomas, Kenneth C.; Jacobs, Bradley; Johnson, Michael; Paquet, Jerome; Attabib, Najmedden; Jarzem, Peter; Wai, Eugene K.; Rasoulinejad, Parham; Ahn, Henry; Nataraj, Andrew; Stratton, Alexandra; Manson, Neil			Patients undergoing surgery for lumbar spinal stenosis experience unique courses of pain and disability: A group-based trajectory analysis	PLOS ONE			English	Article							LOW-BACK-PAIN; RATING-SCALE; THERAPY	Objective Identify patient subgroups defined by trajectories of pain and disability following surgery for degenerative lumbar spinal stenosis, and investigate the construct validity of the subgroups by evaluating for meaningful differences in clinical outcomes. Methods We recruited patients with degenerative lumbar spinal stenosis from 13 surgical spine centers who were deemed to be surgical candidates. Study outcomes (leg and back pain numeric rating scales, modified Oswestry disability index) were measured before surgery, and after 3, 12, and 24 months. Group-based trajectory models were developed to identify trajectory subgroups for leg pain, back pain, and pain-related disability. We examined for differences in the proportion of patients achieving minimum clinically important change in pain and disability (30%) and clinical success (50% reduction in disability or Oswestry score <= 22) 12 months from surgery. Results Data from 548 patients (mean[SD] age = 66.7[9.1] years; 46% female) were included. The models estimated 3 unique trajectories for leg pain (excellent outcome = 14.4%, good outcome = 49.5%, poor outcome = 36.1%), back pain (excellent outcome = 13.1%, good outcome = 45.0%, poor outcome = 41.9%), and disability (excellent outcome = 30.8%, fair outcome = 40.1%, poor outcome = 29.1%). The construct validity of the trajectory subgroups was confirmed by between-trajectory group differences in the proportion of patients meeting thresholds for minimum clinically important change and clinical success after 12 postoperative months (p <.001). Conclusion Subgroups of patients with degenerative lumbar spinal stenosis can be identified by their trajectories of pain and disability following surgery. Although most patients experienced important reductions in pain and disability, 29% to 42% of patients were classified as members of an outcome trajectory subgroup that experienced little to no benefit from surgery. These findings may inform appropriate expectation setting for patients and clinicians and highlight the need for better methods of treatment selection for patients with degenerative lumbar spinal stenosis.	[Hebert, Jeffrey J.] Univ New Brunswick, Fac Kinesiol, Fredericton, NB, Canada; [Hebert, Jeffrey J.] Murdoch Univ, Sch Psychol & Exercise Sci, Perth, WA, Australia; [Abraham, Edward; Bigney, Erin; Richardson, Eden; Darling, Mariah; Attabib, Najmedden; Manson, Neil] Canada East Spine Ctr, St John, NB, Canada; [Abraham, Edward; Manson, Neil] Horizon Hlth Network, Div Orthopaed Surg, Zone 2, St John, NB, Canada; [Abraham, Edward; Attabib, Najmedden; Manson, Neil] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Wedderkopp, Niels] Univ Southern Denmark, Dept Reg Hlth Res, Odense, Denmark; [Wedderkopp, Niels] Hosp Southwestern Jutland, Orthoped Dept, Esbjerg, Denmark; [Hall, Hamilton] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Fisher, Charles G.] Univ British Columbia, Blusson Spinal Cord Ctr, Dept Orthoped Surg, Combined Neurosurg & Orthoped Spine Program, Vancouver, BC, Canada; [Rampersaud, Y. Raja] Univ Toronto, Univ Hlth Network, Krembil Res Inst, Arthrit Program, Toronto, ON, Canada; [Thomas, Kenneth C.; Jacobs, Bradley] Univ Calgary, Foothills Med Ctr, Calgary, AB, Canada; [Jacobs, Bradley] Univ Calgary, Dept Clin Neurosci, Div Neurosurg Spine Program, Calgary, AB, Canada; [Johnson, Michael] Univ Manitoba, Dept Surg, Sect Orthoped & Neurosurg, Winnipeg, MB, Canada; [Paquet, Jerome] Univ Laval, Dept Surg, Div Neurosurg, CHU Quebec, Quebec City, PQ, Canada; [Attabib, Najmedden] Horizon Hlth Network, Zone 2, Div Neurosurg, St John, NB, Canada; [Jarzem, Peter] McGill Scoliosis & Spine Res Grp, Montreal, PQ, Canada; [Jarzem, Peter] McGill Univ, Div Orthopaed, Hlth Ctr, Montreal, PQ, Canada; [Wai, Eugene K.; Stratton, Alexandra] Univ Ottawa, Dept Surg, Ottawa, ON, Canada; [Rasoulinejad, Parham] Victoria Hosp, London Hlth Sci Ctr, London, ON, Canada; [Rasoulinejad, Parham] Western Univ, Schulich Sch Med, Dept Surg, Div Orthopaed Surg, London, ON, Canada; [Ahn, Henry] Univ Toronto, Spine Program, Toronto, ON, Canada; [Nataraj, Andrew] Univ Alberta Hosp, Fac Med & Dent, Dept Surg, Div Neurosurg, Edmonton, AB, Canada	University of New Brunswick; Murdoch University; Dalhousie University; University of Southern Denmark; University of Toronto; University of British Columbia; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Calgary; University of Calgary; University of Manitoba; Laval University; McGill University; University of Ottawa; London Health Sciences Centre; University of Victoria; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University of Alberta	Hebert, JJ (corresponding author), Univ New Brunswick, Fac Kinesiol, Fredericton, NB, Canada.; Hebert, JJ (corresponding author), Murdoch Univ, Sch Psychol & Exercise Sci, Perth, WA, Australia.	J.Hebert@unb.ca	Bigney, Erin/AAJ-3173-2021	Wedderkopp, Niels/0000-0002-9660-6618; Hebert, Jeffrey/0000-0002-6959-325X				Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Comer CM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-121; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Frankfurt S, 2016, COUNS PSYCHOL, V44, P622, DOI 10.1177/0011000016658097; Fritsch CG, 2017, EUR SPINE J, V26, P324, DOI 10.1007/s00586-016-4668-0; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; Fritz JM, 2009, SPINE, V34, P2803, DOI 10.1097/BRS.0b013e3181ae2bd4; Hebert JJ, 2015, BRIT J SPORT MED, V49, P100, DOI 10.1136/bjsports-2013-092402; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Krebs EE, 2007, J GEN INTERN MED, V22, P1453, DOI 10.1007/s11606-007-0321-2; Laursen B, 2006, MERRILL PALMER QUART, V52, P377, DOI 10.1353/mpq.2006.0029; Machado Gustavo C, 2016, Cochrane Database Syst Rev, V11, pCD012421; Malmivaara A, 2007, SPINE, V32, P1, DOI 10.1097/01.brs.0000251014.81875.6d; McCaffery M., 2008, PAIN CLIN MANUAL NUR; McGregor AH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009644.pub2; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Otani K, 2013, SCI WORLD J, DOI 10.1155/2013/590652; Tosteson ANA, 2008, ANN INTERN MED, V149, P845, DOI 10.7326/0003-4819-149-12-200812160-00003; van Hooff ML, 2016, SPINE J, V16, P1221, DOI 10.1016/j.spinee.2016.06.010; Weinstein JN, 2008, NEW ENGL J MED, V358, P794, DOI 10.1056/NEJMoa0707136; Zaina F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010264.pub2; Zelman DC, 2005, PAIN, V115, P29, DOI 10.1016/j.pain.2005.01.028	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224200	10.1371/journal.pone.0224200	http://dx.doi.org/10.1371/journal.pone.0224200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697714	Green Published, gold			2022-12-26	WOS:000532694400021
J	Zu, HY; Zhang, H; Yao, MH; Zhang, JY; Di, H; Zhang, L; Dong, L; Wang, ZH; Zhou, Y				Zu, Hongyue; Zhang, Hong; Yao, Minhao; Zhang, Jiayue; Di, Hong; Zhang, Lin; Dong, Ling; Wang, Zhenhua; Zhou, Yu			Molecular characteristics of segment 5, a unique fragment encoding two partially overlapping ORFs in the genome of rice black-streaked dwarf virus	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; GENETIC-VARIATION; RNA; RECOMBINATION; SELECTION; EXPRESSION; PROTEINS; DIVERSIFICATION; POPULATIONS; MECHANISMS	Rice black-streaked dwarf virus (RBSDV), a ds-RNA virus in Fijivirus genus with family Reoviridae, which is transmitted by the small brown planthopper, is responsible for incidence of maize rough dwarf disease (MRDD) and rice black-streaked dwarf disease (RBSDD). To understand the variation and evolution of S5, a unique fragment in the genome of RBSDV which encodes two partially overlapping ORFs (ORF5-1 and ORF5-2), we analyzed 127 sequences from maize and rice exhibiting symptoms of dwarfism. The nucleotide diversity of both ORF5-1 (pi = 0.039) and ORF5-2 (pi = 0.027) was higher than that of the overlapping region (pi = 0.011) (P < 0.05). ORF5-2 was under the greatest selection pressure based on codon bias analysis, and its activation was possibly influenced by the overlapping region. The recombinant fragments of three recombinant events (14NM23, 14BM20, and 14NM17) cross the overlapping region. Based on neighbor-joining tree analysis, the overlapping region could represent the evolutionary basis of the full-length S5, which was classified into three main groups. RBSDV populations were expanding and haplotype diversity resulted mainly from the overlapping region. The genetic differentiation of combinations (T127-B35, T127-J34, A58-B35, A58-J34, and B35-J34) reached significant or extremely significant levels. Gene flow was most frequent between subpopulations A58 and B35, with the smallest vertical bar Fst vertical bar (0.02930). We investigated interactions between 13 RBSDV proteins by two-hybrid screening assays and identified interactions between P5-1/P6, P6/P9-1, and P3/P6. We also observed self-interactive effects of P3, P6, P7-1, and P10. In short, we have proven that RBSDV populations were expanding and the overlapping region plays an important role in the genetic variation and evolution of RBSDV S5. Our results enable ongoing research into the evolutionary history of RBSDV-S5 with two partly overlapping ORFs.	[Zu, Hongyue; Zhang, Hong; Yao, Minhao; Zhang, Jiayue; Di, Hong; Zhang, Lin; Dong, Ling; Wang, Zhenhua; Zhou, Yu] Northeast Agr Univ, Key Lab Germplasm Enhancement Physiol & Ecol Food, Changjiang Rd, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Wang, ZH; Zhou, Y (corresponding author), Northeast Agr Univ, Key Lab Germplasm Enhancement Physiol & Ecol Food, Changjiang Rd, Harbin, Heilongjiang, Peoples R China.	zhenhuawang_2006@163.com; zhouyu0924@126.com	Di, Hong J/G-5583-2010	Zhou, Yu/0000-0002-9748-0914	China Postdoctoral Science Foundation [2017M611344]; National Natural Science Foundation of China [31801376]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project funded by China Postdoctoral Science Foundation (2018T110266), the National Natural Science Foundation of China (31801376) and China Postdoctoral Science Foundation (2017M611344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2011, PHYTOPATHOLOGY, V101, P1136, DOI 10.1094/PHYTO-01-11-0017; Azzam O, 2000, ARCH VIROL, V145, P1183, DOI 10.1007/s007050070118; Cardinale DJ, 2013, VIRUSES-BASEL, V5, P162, DOI 10.3390/v5010162; Carver Tim J, 2005, Appl Bioinformatics, V4, P151, DOI 10.2165/00822942-200504020-00010; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Chen WH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11334; Chiusano ML, 2 CODON POSITIONS GE, DOI [10.1016/s0378-1119(00)00521-7, DOI 10.1016/S0378-1119(00)00521-7]; Datta S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-156; DING SW, 1994, VIROLOGY, V198, P593, DOI 10.1006/viro.1994.1071; Du ZY, 2007, J GEN VIROL, V88, P2596, DOI 10.1099/vir.0.82927-0; Ge BB, 2014, ARCH VIROL, V159, P3197, DOI 10.1007/s00705-014-2180-6; Gupta SK, 2001, GENE, V273, P63, DOI 10.1016/S0378-1119(01)00576-5; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li J, 2015, ARCH VIROL, V160, P453, DOI 10.1007/s00705-014-2268-z; Li J, 2013, ARCH VIROL, V158, P1649, DOI 10.1007/s00705-013-1660-4; Li RG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21677-3; Li YQ, 2012, ARCH VIROL, V157, P1351, DOI 10.1007/s00705-012-1282-2; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu XY, 2015, ARCH VIROL, V160, P1211, DOI 10.1007/s00705-015-2382-6; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; MA HX, 2011, ZHONGHUA LIU XING BI, V34, P1213; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; McInerney JO, 1998, P NATL ACAD SCI USA, V95, P10698, DOI 10.1073/pnas.95.18.10698; Mertens P, 2004, VIRUS RES, V101, P3, DOI 10.1016/j.virusres.2003.12.002; Nouri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096582; Roossinck MJ, 1997, ANNU REV PHYTOPATHOL, V35, P191, DOI 10.1146/annurev.phyto.35.1.191; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salaipeth L, 2014, J GEN VIROL, V95, P740, DOI 10.1099/vir.0.058164-0; Seo JK, 2009, VIROLOGY, V393, P91, DOI 10.1016/j.virol.2009.07.007; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; Sun BJ, 2013, PHYTOPATHOLOGY, V103, P949, DOI 10.1094/PHYTO-01-13-0013-R; Supyani S, 2007, J GEN VIROL, V88, P342, DOI 10.1099/vir.0.82318-0; Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0; Walia JJ, 2014, PHYTOPATHOLOGY, V104, P108, DOI 10.1094/PHYTO-05-13-0145-R; Wei TY, 2009, J GEN VIROL, V90, P1025, DOI 10.1099/vir.0.006858-0; Weng JF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-98; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xie T, 1998, FEBS LETT, V434, P93; Xu QF, 2015, GENE, V572, P169, DOI 10.1016/j.gene.2015.07.008; Yang J, 2014, ARCH VIROL, V159, P307, DOI 10.1007/s00705-013-1832-2; Yin X, 2013, ARCH VIROL, V158, P2505, DOI 10.1007/s00705-013-1766-8; Zhang LD, 2005, CHINESE SCI BULL, V50, P305, DOI 10.1360/982004-731; Zhou Y, 2017, PLANT DIS, V101, P1588, DOI 10.1094/PDIS-12-16-1814-RE; Zhou Y, 2015, ARCH VIROL, V160, P1119, DOI 10.1007/s00705-014-2291-0	51	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224569	10.1371/journal.pone.0224569	http://dx.doi.org/10.1371/journal.pone.0224569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697693	Green Published, gold			2022-12-26	WOS:000532694400032
J	Li, XH; Lee, JH				Li, Xi-Hui; Lee, Joon-Hee			Quorum sensing-dependent post-secretional activation of extracellular proteases in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						quorum sensing; protease; metalloprotease; protein processing; protein secretion; protein?protein interaction; inhibition mechanism; microbial pathogenesis	ACTIVE-SITE HIS-223; PROTEIN SECRETION; LASA PROTEASE; ELASTASE; PROPEPTIDE; SYSTEM; IDENTIFICATION; PURIFICATION; SUBSTITUTION; SPECIFICITY	Pseudomonas aeruginosa secretes multiple proteases that are implicated in its pathogenesis, and most of them are regulated by quorum sensing (QS). In this study, we found that the activities of three major extracellular proteases, protease IV (PIV), elastase A (LasA), and elastase B (LasB), are reduced considerably when expressed in a QS mutant (MW1). PIV and LasA expressed in MW1 exhibited little activity, even when purified, and their activities were inhibited by noncleavage or binding of their propeptides. LasB was activated by a QS-dependent factor, indicating that, unlike what has been proposed previously, LasB is not autoactivated. When LasB was relieved from inhibition, it activated PIV, which then sequentially processed pro-LasA to mature LasA. When activated, LasB was not inhibited by exogenous addition of its propeptide, but LasA and PIV were inhibited by their propeptides, even after prior activation. These differences may be explained by the fact that LasB can degrade its own propeptide but PIV and LasA cannot. We also found that, although PIV is the preferred LasA-activating factor, LasB can also partially activate LasA. Overall, LasB, PIV, and LasA were activated postsecretionally in a cascading manner in which the initial activation of LasB was controlled tightly by QS at the protein level in addition to the well-known transcriptional control of these proteases by QS. Interestingly, human elastase also activated LasA, indicating that the activation cascade is triggered by host factors during infection. In summary, a QS-induced proteolytic cascade activates secreted proteases from P. aeruginosa.	[Li, Xi-Hui; Lee, Joon-Hee] Pusan Natl Univ, Coll Pharm, Dept Pharm, Busan 609735, South Korea	Pusan National University	Lee, JH (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Pharm, Busan 609735, South Korea.	joonhee@pusan.ac.kr			National Research Foundation of Korea - Korean government [NRF-2019R1A2C1010087]; National Research Foundation of Korea [2017M3A9E4078553]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea grant funded by the Korean government (NRF-2019R1A2C1010087). This work was also supported by a grant from the National Research Foundation of Korea (2017M3A9E4078553). The authors declare that they have no conflicts of interest with the contents of this article.	AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bradshaw JL, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00212-18, 10.1128/msphere.00212-18]; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; ChaponHerve V, 1997, MOL MICROBIOL, V24, P1169, DOI 10.1046/j.1365-2958.1997.4271794.x; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Dolly JO, 2006, EUR J NEUROL, V13, P1, DOI 10.1111/j.1468-1331.2006.01648.x; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gustin JK, 1996, J BACTERIOL, V178, P6608, DOI 10.1128/jb.178.22.6608-6617.1996; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoge R., 2010, CURR RES TECHNOL ED, P383; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kessler E, 1997, J BIOL CHEM, V272, P9884; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; KESSLER E, 1994, J BIOL CHEM, V269, P22726; Lee JH, 2006, MOL MICROBIOL, V59, P602, DOI 10.1111/j.1365-2958.2005.04960.x; MCIVER K, 1991, J BACTERIOL, V173, P7781, DOI 10.1128/jb.173.24.7781-7789.1991; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; MCIVER KS, 1993, J BACTERIOL, V175, P4008, DOI 10.1128/JB.175.13.4008-4015.1993; Oh J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03733-6; PARK S, 1995, MOL MICROBIOL, V16, P263, DOI 10.1111/j.1365-2958.1995.tb02298.x; Park SJ, 1998, ARCH BIOCHEM BIOPHYS, V357, P8, DOI 10.1006/abbi.1998.0787; Park SJ, 2014, MOL MICROBIOL, V94, P1298, DOI 10.1111/mmi.12830; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; RUST L, 1994, METHOD ENZYMOL, V235, P554; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	33	20	20	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19635	19644		10.1074/jbc.RA119.011047	http://dx.doi.org/10.1074/jbc.RA119.011047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31727738	hybrid, Green Published			2022-12-26	WOS:000504093200015
J	Carnevale, C; Manni, G; Roberti, G; Micera, A; Bruno, L; Cacciamani, A; Altafini, R; Quaranta, L; Agnifili, L; Tanga, L; Riva, I; Oddone, F				Carnevale, Carmela; Manni, Gianluca; Roberti, Gloria; Micera, Alessandra; Bruno, Luca; Cacciamani, Andrea; Altafini, Romeo; Quaranta, Luciano; Agnifili, Luca; Tanga, Lucia; Riva, Ivano; Oddone, Francesco			Human vitreous concentrations of citicoline following topical application of citicoline 2% ophthalmic solution	PLOS ONE			English	Article							NEUROPROTECTIVE ROLE; CORNEAL THICKNESS; EYE DROPS; PENETRATION; GLAUCOMA; PRECURSOR; DOPAMINE; DISEASE	Purpose To evaluate the presence and concentration of citicoline and its metabolites (choline, cytidine and uridine) in the vitreous body in human eyes after topical application of an ophthalmic solution of citicoline 2%, in vivo. Methods Twenty-one subjects affected by epiretinal membrane with surgical indication for pars-plana vitrectomy underwent treatment with 1 drop 3 times/day of a solution of citicoline 2%, 0.2% high molecular weight hyaluronic acid and 0.01% benzalkonium chloride (OMK1, Omikron Italia s.r.l., Rome, Italy) 14 days before surgery and 2 hours prior to surgery. Five additional patients served as controls and received an OMK1 vehicle solution without citicoline. The vitreous samples were taken at the beginning of the pars-plana vitrectomy and analyzed for qualitative/quantitative determination of vitreous concentration of citicoline and its metabolites by means of high performance liquid chromatography. Results The overall mean concentration of citicoline in patients treated with citicoline 2% solution was 406.72 +/- 52.99 mu g/mL, while the mean concentration of choline, cytidine and uridine was 180.88 +/- 41.49 mu g/mL, 44.45 +/- 10.19 mu g/mL and 330.41 +/- 75.8 mu g/mL, respectively. The concentration of citicoline in phakic eyes (n = 13, 366.61 +/- 129.61 mu g/mL) was lower compared to that found in pseudophakic eyes (n = 8, 435.89 +/- 131.42 mu g/mL) and the difference was not statistically significant. The concentration of citicoline in the control eyes was 45.66 +/- 26.36 mu g/mL, while the concentration of choline, cytidine and uridine were 17.21 +/- 9.93 mu g/mL, 6.24 +/- 3.6 mu g/mL and 172.80 +/- 99.76 mu g/mL, respectively. Conclusion Citicoline can reach the human vitreous in high concentration when administered in ophthalmic solution. This evidence contributes to the build-up of the pyramid of the evidences required for determining the role of citicoline administered in ophthalmic formulation in retinal and optic nerve neurodegenerative diseases.	[Carnevale, Carmela; Manni, Gianluca; Roberti, Gloria; Micera, Alessandra; Bruno, Luca; Cacciamani, Andrea; Tanga, Lucia; Riva, Ivano; Oddone, Francesco] IRCCS Fdn Bietti, Rome, Italy; [Manni, Gianluca] Univ Roma Tor Vergata, DSCMT, Rome, Italy; [Altafini, Romeo] Dolo Hosp, Ophthalmol Clin, Venice, Italy; [Quaranta, Luciano] Univ Pavia, IRCCS Fdn Policlin San Matteo, Sect Ophthalmol, Dept Surg & Clin Diagnost & Pediat Sci, Pavia, Italy; [Agnifili, Luca] Univ G dAnnunzio, Dept Med & Aging Sci, Ophthalmol Clin, Chieti, Italy	IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of Rome Tor Vergata; IRCCS Fondazione San Matteo; University of Pavia; G d'Annunzio University of Chieti-Pescara	Oddone, F (corresponding author), IRCCS Fdn Bietti, Rome, Italy.	odd1fr@gmail.com	Cacciamani, Andrea/AAB-2154-2021; Micera, Alessandra/J-3373-2013; Oddone, Francesco/K-8876-2016; Agnifili, Luca/AAC-6345-2022; Riva, Ivano/B-9860-2019	Cacciamani, Andrea/0000-0003-1793-9842; Oddone, Francesco/0000-0002-2504-0004; Riva, Ivano/0000-0002-7397-2260; quaranta, luciano/0000-0002-5462-1713; manni, gianluca/0000-0002-9006-8556	Fondazione Roma; Italian Ministry of Health; Istituto di Ricerca Neuroftalmologia (I.R.N.) s.r. l., Rome, Italy	Fondazione Roma(Fondazione RomaEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy); Istituto di Ricerca Neuroftalmologia (I.R.N.) s.r. l., Rome, Italy	The research for this paper was supported by Fondazione Roma and the Italian Ministry of Health. This study was also sponsored by Istituto di Ricerca Neuroftalmologia (I.R.N.) s.r. l., Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNOLI A, 1982, NEUROPSYCHOBIOLOGY, V8, P289, DOI 10.1159/000117914; Bogdanov P., 2018, INT J MOL SCI, V19; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Faiq MA, 2019, PROG RETIN EYE RES, V72, DOI 10.1016/j.preteyeres.2019.06.003; Fresina M, 2008, GRAEF ARCH CLIN EXP, V246, P143, DOI 10.1007/s00417-007-0621-6; Gareri P, 2017, J ALZHEIMERS DIS, V56, P557, DOI 10.3233/JAD-160808; Grieb P, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00073; Kaur IP, 2002, DRUG DEV IND PHARM, V28, P353, DOI 10.1081/DDC-120002997; Kent AR, 2001, OPHTHALMOLOGY, V108, P784, DOI 10.1016/S0161-6420(00)00654-0; MARTINET M, 1979, ARCH INT PHARMACOD T, V239, P52; Martinez-de-la-Casa JM, 2012, EYE, V26, P972, DOI 10.1038/eye.2012.74; Matteucci A, 2014, INT J MOL SCI, V15, P6286, DOI 10.3390/ijms15046286; Ottobelli L, 2013, OPHTHALMOLOGICA, V229, P219, DOI 10.1159/000350496; Parisi V, 2008, EUR J NEUROL, V15, P465, DOI 10.1111/j.1468-1331.2008.02099.x; Parisi V, 1999, OPHTHALMOLOGY, V106, P1126, DOI 10.1016/S0161-6420(99)90269-5; Parisi V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220435; Parisi V, 2015, GRAEF ARCH CLIN EXP, V253, P1327, DOI 10.1007/s00417-015-3044-9; Parisi V, 2008, PROG BRAIN RES, V173, P541, DOI 10.1016/S0079-6123(08)01137-0; Park CH, 2005, EXP EYE RES, V81, P350, DOI 10.1016/j.exer.2005.02.007; Porciatti V, 1998, CURR EYE RES, V17, P141, DOI 10.1076/ceyr.17.2.141.5606; Rejdak R, 2002, OPHTHALMIC RES, V34, P146, DOI 10.1159/000063658; Roberti G, 2015, INT J MOL SCI, V16, P28401, DOI 10.3390/ijms161226099; Roberti G, 2014, INDIAN J OPHTHALMOL, V62, P549, DOI 10.4103/0301-4738.133484; Secades J J, 2016, Rev Neurol, V63, pS1; Secades JJ, 2006, METHOD FIND EXP CLIN, V28, P1; Secades JJ, 2016, J STROKE CEREBROVASC, V25, P1984, DOI 10.1016/j.jstrokecerebrovasdis.2016.04.010; Spierer O, 2015, OPTOMETRY VISION SCI, V92, P1027, DOI 10.1097/OPX.0000000000000692; Takamura Y, 2015, J OCUL PHARMACOL TH, V31, P282, DOI 10.1089/jop.2015.0003; Wang L, 2007, BRAIN RES, V1133, P42, DOI 10.1016/j.brainres.2006.11.048; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224982	10.1371/journal.pone.0224982	http://dx.doi.org/10.1371/journal.pone.0224982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725734	Green Published, gold			2022-12-26	WOS:000532764500038
J	Sempa, JB; Rossouw, TM; Lesaffre, E; Nieuwoudt, M				Sempa, Joseph B.; Rossouw, Theresa M.; Lesaffre, Emmanuel; Nieuwoudt, Martin			Cumulative viral load as a predictor of CD4+T-cell response to antiretroviral therapy using Bayesian statistical models	PLOS ONE			English	Article							CELL COUNT RECOVERY; IMMUNE RECONSTITUTION; HIV-INFECTION; MORTALITY; VIRUS; DISTRIBUTIONS; CELLS/MM(3); INITIATION; GREATER; ADULTS	Introduction There are Challenges in statistically modelling immune responses to longitudinal HIV viral load exposure as a function of covariates. We define Bayesian Markov Chain Monte Carlo mixed effects models to incorporate priors and examine the effect of different distributional assumptions. We prospectively fit these models to an as-yet-unpublished data from the Tshwane District Hospital HIV treatment clinic in South Africa, to determine if cumulative log viral load, an indicator of long-term viral exposure, is a valid predictor of immune response. Methods Models are defined, to express 'slope', i.e. mean annual increase in CD4 counts, and 'asymptote', i.e. the odds of having a CD4 count >= 500 cells/mu L during antiretroviral treatment, as a function of covariates and random-effects. We compare the effect of using informative versus non-informative prior distributions on model parameters. Models with cubic splines or Skew-normal distributions are also compared using the conditional Deviance Information Criterion. Results The data of 750 patients are analyzed. Overall, models adjusting for cumulative log viral load provide a significantly better fit than those that do not. An increase in cumulative log viral load is associated with a decrease in CD4 count slope (19.6 cells/mu L (95% credible interval: 28.26, 10.93)) and a reduction in the odds of achieving a CD4 counts >= 500 cells/pL (0.42 (95% CI: 0.236, 0.730)) during 5 years of therapy. Using informative priors improves the cumulative log viral load estimate, and a skew-normal distribution for the random-intercept and measurement error results is a better fit compared to using classical Gaussian distributions. Discussion We demonstrate in an unpublished South African cohort that cumulative log viral load is a strong and significant predictor of both CD4 count slope and asymptote. We argue that Bayesian methods should be used more frequently for such data, given their flexibility to incorporate prior information and non-Gaussian distributions.	[Sempa, Joseph B.; Nieuwoudt, Martin] Stellenbosch Univ, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Natl Res Fdn NRF, South African Dept Sci & Technol DST, Stellenbosch, South Africa; [Rossouw, Theresa M.] Univ Pretoria, Inst Cellular & Mol Med, Dept Immunol, Pretoria, South Africa; [Lesaffre, Emmanuel] Katholieke Univ Leuven, Interuniv Inst Biostat & Stat Bioinformat, Leuven, Belgium; [Nieuwoudt, Martin] Stellenbosch Univ, Inst Biomed Engn IBE, Mech & Mechatron Engn, Western Cape, South Africa	Stellenbosch University; University of Pretoria; Hasselt University; KU Leuven; Stellenbosch University	Sempa, JB (corresponding author), Stellenbosch Univ, Ctr Excellence Epidemiol Modelling & Anal SACEMA, Natl Res Fdn NRF, South African Dept Sci & Technol DST, Stellenbosch, South Africa.	sempaj@sun.ac.za		Rossouw, Theresa/0000-0003-4066-922X; Nieuwoudt, Martin/0000-0002-6354-799X; Bukulu Sempa, Joseph/0000-0003-1062-0417	South African Department of Science and Technology/National Research Foundation - Stellenbosch University	South African Department of Science and Technology/National Research Foundation - Stellenbosch University	JBS is funded by South African Department of Science and Technology/National Research Foundation. MN is funded by Stellenbosch University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2012, BASIC IMMUNOLOGY FUN, DOI DOI 10.1007/978-1-62703-589-7_1; Abbas AK, 2012, BASIC IMMUNOLOGY FUN, DOI [10.1002/bmb.2004.494032069999, DOI 10.1002/BMB.2004.494032069999]; Anderegg N, 2018, CLIN INFECT DIS, V66, P893, DOI 10.1093/cid/cix915; Awoke T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168323; Boulle C, 2013, JAIDS-J ACQ IMM DEF, V62, P569, DOI 10.1097/QAI.0b013e318285f7b6; Castelnuovo B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/736938; Chen R, 2012, BAYESIAN INFERENCE M; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; De Beaudrap P, 2009, AM J TROP MED HYG, V80, P1047, DOI 10.4269/ajtmh.2009.80.1047; Easterbrook PJ, 2002, AIDS, V16, P1521, DOI 10.1097/00002030-200207260-00009; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fung ICH, 2012, JAIDS-J ACQ IMM DEF, V60, P5, DOI 10.1097/QAI.0b013e3182487a20; Gelman A., 2013, BAYESIAN DATA ANAL, DOI [10.1201/b16018, DOI 10.1007/S13398-014-0173-7.2]; Ghosh P, 2007, STAT MED, V26, P1255, DOI 10.1002/sim.2667; Gordon CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125248; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Grebe E, 2017, JAIDS-J ACQ IMM DEF, V76, P547, DOI [10.1097/QAI.0000000000001537, 10.1097/qai.0000000000001537]; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Grennan JT, 2012, J INFECT DIS, V205, P1230, DOI 10.1093/infdis/jis104; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Komarek A, 2008, COMPUT STAT DATA AN, V52, P3441, DOI 10.1016/j.csda.2007.10.024; Kulkarni H, 2011, JAIDS-J ACQ IMM DEF, V57, P387, DOI 10.1097/QAI.0b013e3182219113; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Lawrie D, 2009, SAMJ S AFR MED J, V99, P243; Lesaffre E., 2012, BAYESIAN BIOSTATISTI, DOI DOI 10.1002/9781119942412; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; Marconi VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017956; Maskew M, 2013, JAIDS-J ACQ IMM DEF, V63, P442, DOI 10.1097/QAI.0b013e3182969cc1; Nakanjako D, 2016, AIDS, V30, P1913, DOI 10.1097/QAD.0000000000001085; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Okoye AA, 2013, IMMUNOL REV, V254, P54, DOI 10.1111/imr.12066; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patrikar Seema, 2014, Med J Armed Forces India, V70, P134, DOI 10.1016/j.mjafi.2013.08.005; Pinzone MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/515962; Prague M, 2017, BIOMETRICS, V73, P294, DOI 10.1111/biom.12564; Quintero A, 2018, STAT MED, V37, P2440, DOI 10.1002/sim.7649; RABOUD JM, 1995, J ACQ IMMUN DEF SYND, V10, pS67; Reda AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058595; Reynolds SJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-381; Sahu SK, 2003, CAN J STAT, V31, P129, DOI 10.2307/3316064; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P254, DOI 10.1093/jac/dkt336; Sax PE, 2013, CLIN INFECT DIS, V56, P1344, DOI 10.1093/cid/cit008; Semeere AS, 2014, JAIDS-J ACQ IMM DEF, V67, P382, DOI 10.1097/QAI.0000000000000330; Sempa JB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171658; Sempa JB, 2016, AM J EPIDEMIOL, V184, P67, DOI 10.1093/aje/kwv303; Sempa JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073190; Sia D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3783-5; Siedner MJ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw032; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tanner MA, 1987, SOURCE J AM STAT ASS; VANROOD Y, 1991, CLIN EXP IMMUNOL, V86, P349; Verbeke G, 1996, J AM STAT ASSOC, V91, P217, DOI 10.2307/2291398; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Williams BG, 2006, J INFECT DIS, V194, P1450, DOI 10.1086/508206	59	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224723	10.1371/journal.pone.0224723	http://dx.doi.org/10.1371/journal.pone.0224723			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721805	Green Published, gold			2022-12-26	WOS:000532720700026
J	Wang, SN; Zhai, JC; Liu, WS; Xia, YL; Han, L; Li, HP				Wang, Sheng-Nan; Zhai, Jian-Cheng; Liu, Wei-Shi; Xia, Yan-Ling; Han, Lei; Li, He-Ping			Origins of Chinese reindeer (Rangifer tarandus) based on mitochondrial DNA analyses	PLOS ONE			English	Article							REFUGIA; PHYLOGEOGRAPHY; DOMESTICATION; CARIBOU; HISTORY	The most southern population of reindeer (Rangifer tarandus) inhabits northeastern China, but the migration route and origin of this population have not been confirmed. The sequences of mitochondrial DNA control regions from domestic and wild herds from Eurasia and China were analysed. The results showed that the Chinese reindeer population originated independently from north-central Russian domestic herds, belonging to a large reindeer population that was present across Beringia during the last glacial period. Some studies have reported that the Chinese reindeer population is closely related to wild forest reindeer herds in Russia. Our results, however, indicate that wild forest reindeer herds of southeastern Russia contributed little or nothing to the Chinese reindeer herd gene pool. Chinese reindeer herds have a much greater genetic similarity to more northerly distributed tundra-type herds that inhabit open areas. The present findings will be essential for future conservation planning for Chinese reindeer.	[Wang, Sheng-Nan; Zhai, Jian-Cheng; Liu, Wei-Shi; Xia, Yan-Ling; Han, Lei; Li, He-Ping] Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China	Northeast Forestry University - China	Li, HP (corresponding author), Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China.	lihepinghrb2002@nefu.edu.cn			Fundamental Research Funds for the Central Universities [2572017AA19, 2572016AA42]; State Forestry Administration of China (the Field Rescue and Breeding Program of Rare and Endangered Species)	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Forestry Administration of China (the Field Rescue and Breeding Program of Rare and Endangered Species)	This study was financially supported by the Fundamental Research Funds for the Central Universities (2572017AA19), (2572016AA42) and the State Forestry Administration of China (the Field Rescue and Breeding Program of Rare and Endangered Species). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson KA, 1991, ARCHAEOL ENV, V10, P1; Ball MC, 2010, CONSERV GENET, V11, P2131, DOI 10.1007/s10592-010-0099-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banfield A. W. F., 1961, REVISION REINDEER CA; Cosewic, 2011, DES UN CAR RANG TAR; Dalen L, 2005, BIOL J LINN SOC, V84, P79, DOI 10.1111/j.1095-8312.2005.00415.x; Eger JL, 2009, P CAR GEN REL WORKSH, P45; Fedorov VB, 2002, P ROY SOC B-BIOL SCI, V269, P2071, DOI 10.1098/rspb.2002.2126; Flagstad O, 2003, EVOLUTION, V57, P658; Galaty GJ, 1990, WORLD PASTORALISM, P255; Geist Valerius, 2003, Rangifer, P57; Gordon Bryan, 2003, Rangifer, P15; GUTHRIE R D, 1971, Quaternary Research (Orlando), V1, P474, DOI 10.1016/0033-5894(71)90060-3; Heal, 2005, ARCTIC CLIMATE IMPAC; Hedman S, 2003, BOPLATSER OFFERPLATS; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Holtmeier F-K., 2015, ANIMALS INFLUENCE LA; Jernsletten J.-L. L., 2002, SUSTAINABLE REINDEER; Klutsch CFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052661; Kofinas G, 2000, POLAR RES, V19, P3, DOI 10.1111/j.1751-8369.2000.tb00323.x; Kvie KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165237; Li HaiTao, 2004, Journal of Economic Animal, V8, P9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Mirov NT, 1945, AM ANTHROPOL, V47, P393, DOI 10.1525/aa.1945.47.3.02a00030; NELLEMAN G, 1961, FOLK, V3, P91; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Roed KH, 2008, P ROY SOC B-BIOL SCI, V275, P1849, DOI 10.1098/rspb.2008.0332; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Stammler F., 2010, GOOD EAT GOOD LIVE N; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; STORCK PL, 1994, AM ANTIQUITY, V59, P121, DOI 10.2307/3085506; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vainshtein S., 1980, NOMADS S SIBERIA PAS; Weckworth BV, 2012, MOL ECOL, V21, P3610, DOI 10.1111/j.1365-294X.2012.05621.x; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913; Yin R. X., 1999, CHINESE WILDLIFE, V20, P34; Zhai JC, 2017, ZOOL STUD, V56, DOI 10.6620/ZS.2017.56-11; Zhong Li-cheng, 2008, Jingji Dongwu Xuebao, V12, P46; Zigouris J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083837	43	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225037	10.1371/journal.pone.0225037	http://dx.doi.org/10.1371/journal.pone.0225037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV4NN	31721804	gold, Green Published			2022-12-26	WOS:000520459000001
J	Yu, N; Cui, HY; Chen, X; Chang, Y				Yu, Ning; Cui, Hongyan; Chen, Xu; Chang, Ying			Changes of serum pentraxin-3 and hypersensitive CRP levels during pregnancy and their relationship with gestational diabetes mellitus	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INSULIN SENSITIVITY; PREDICTION; INFLAMMATION	Objective To investigate the changes of inflammatory factors pentraxin 3 (PTX3) and hypersensitive C-reactive protein (hs-CRP) during pregnancy and their relationship with gestational diabetes mellitus (GDM). Methods The nested case-control study method was used. Eighty non-obese single-pregnant women diagnosed with GDM were included into the case group (GDM, n = 80), together with another eighty pregnant women with normal glucose tolerance were matched in the same period and divided into the control group (CON, n = 80), for detecting multiple biochemical indicators in different pregnancy stages by ELISA. Results The serum levels of PTX3 and hs-CRP in pregnant women increased with the increase of gestational age (p < 0.001, p < 0.001). The levels of PTX3 and hs-CRP in group GDM were significantly higher in the middle and late pregnancy stages than group CON (p < 0.01, p < 0.05; p < 0.05, p < 0.05). PTX3 was positively correlated with hs-CRP, body mass index (BMI), fasting plasma glucose (FPG), and homeostasis model assessment of insulin resistance (HOMAIR). Conclusions PTX3 and hs-CRP may be related to the pathogenesis of GDM, and they are significantly increased in the second trimester, which provides a new idea for early prevention and treatment of GDM and risk prediction of long-term cardiovascular diseases.	[Yu, Ning; Cui, Hongyan; Chen, Xu; Chang, Ying] Tianjin Cent Hosp Obstet & Gynecol, Dept Obstet, Tianjin Key Lab Human Dev & Reprod Regulat, Tianjin, Peoples R China		Cui, HY (corresponding author), Tianjin Cent Hosp Obstet & Gynecol, Dept Obstet, Tianjin Key Lab Human Dev & Reprod Regulat, Tianjin, Peoples R China.	hycuicn@126.com			Tianjin municipal health and family planning commission [2015KZ079]	Tianjin municipal health and family planning commission	This work was funded by Tianjin municipal health and family planning commission (2015KZ079).	Agrawal A, 2005, MOL IMMUNOL, V42, P927, DOI 10.1016/j.molimm.2004.09.028; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Dali-Youcef N, 2013, ANN MED, V45, P242, DOI 10.3109/07853890.2012.705015; Dongel I, 2019, PAK J MED SCI, V35, P464, DOI 10.12669/pjms.35.2.181; Grewal E, 2012, METABOLISM, V61, P715, DOI 10.1016/j.metabol.2011.10.009; Hamed S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2606-3; Kansu-Celik H, 2019, ARCH ENDOCRIN METAB, V63, P121, DOI 10.20945/2359-3997000000126; Kianpour M, 2019, IRAN J NURS MIDWIFE, V24, P360, DOI 10.4103/ijnmr.IJNMR_352_14; Lekva T, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0345-1; Li X, 2007, JNMU, V21, P382, DOI DOI 10.1016/S1007-4376(07)60083-5; Ozgu-Erdinc AS, 2015, J MATERN-FETAL NEO M, V28, P1957, DOI 10.3109/14767058.2014.973397; Rao MY, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/5101423; Sellers EAC, 2016, DIABETES CARE, V39, P2240, DOI 10.2337/dc16-1148; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tang Q, 2015, DRUG DISCOV THER, V9, P380, DOI 10.5582/ddt.2015.01207; Todoric J, 2013, EUR J CLIN INVEST, V43, P341, DOI 10.1111/eci.12051; Tosi F, 2014, EUR J ENDOCRINOL, V170, P401, DOI 10.1530/EJE-13-0761; Tunc-Ata M, 2017, J EXERC REHABIL, V13, P279, DOI 10.12965/jer.1734920.490; Williams S, 2012, MED PRIN PRACT, V21, P301, DOI 10.1159/000334480; Yildirim M, 2015, GYNECOL OBSTET INVES, V80, P223, DOI 10.1159/000373889; Zhao BH, 2018, J DIABETES INVEST, V9, P967, DOI 10.1111/jdi.12798; Zhou YJ, 2018, CELL PHYSIOL BIOCHEM, V51, P1119, DOI 10.1159/000495491	23	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224739	10.1371/journal.pone.0224739	http://dx.doi.org/10.1371/journal.pone.0224739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721795	Green Published, gold			2022-12-26	WOS:000532720700027
J	Murimi-Worstell, IB; Ballreich, JM; Seamans, MJ; Alexander, GC				Murimi-Worstell, Irene B.; Ballreich, Jeromie M.; Seamans, Marissa J.; Alexander, G. Caleb			Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs	PLOS ONE			English	Article								Despite the importance of pharmacopeial standards, little is known regarding their effect on drug competition. Such information is of particular relevance given the rising costs of prescription drugs and the focus of policy-makers and other stakeholders on addressing these costs. We examined 982 prescription drugs approved by U.S Food and Drug Administration since 1982 to examine the association between U.S. Pharmacopeia (USP) standards, generic entry and prescription costs. The presence of a USP drug product monograph was not associated with the time to the third generic entrant or with the likelihood of having a generic competitor. However, on average, drugs with USP drug product monographs had approximately fifty percent more generic manufacturers in the U.S. than their counterparts after accounting for factors such as market volume, age, route of administration and vintage. This greater competition was associated with an approximate savings of $6.22 billion in 2016, suggesting that USP drug product monographs may play an important role in promoting pharmaceutical competition and reducing prescription drug costs.	[Murimi-Worstell, Irene B.; Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Murimi-Worstell, Irene B.; Ballreich, Jeromie M.; Seamans, Marissa J.; Alexander, G. Caleb] Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD 21205 USA; [Ballreich, Jeromie M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Seamans, Marissa J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Alexander, G. Caleb] Johns Hopkins Med, Div Gen Internal Med, Dept Med, Baltimore, MD 21287 USA; [Murimi-Worstell, Irene B.] Massachusetts Coll Pharm & Hlth Sci, Program Pharmaceut Econ & Policy, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Alexander, GC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.; Alexander, GC (corresponding author), Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD 21205 USA.; Alexander, GC (corresponding author), Johns Hopkins Med, Div Gen Internal Med, Dept Med, Baltimore, MD 21287 USA.	galexan9@jhmi.edu		Ballreich, Jeromie/0000-0003-2564-4577	U.S. Pharmacopeia; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007292] Funding Source: NIH RePORTER	U.S. Pharmacopeia; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by a grant from U.S. Pharmacopeia, who participated in the design and conduct of the study, analysis and interpretation of the data, and review of the final manuscript, although the decision to submit the manuscript for publication was the authors' alone.	ANDERSON L, 1995, SPIRIT VOLUNTARISM L; [Anonymous], 2018, IQVIA I HEALTHCARE I; [Anonymous], 2018, US PHARM NAT FORM US; Association for Accessible Medicines, 2017, GEN DRUG ACC SAV US; Association for Accessible Medicines, CASE COMP 2019 GEN D; Bhattacharyya L, 2004, PHARM RES-DORDR, V21, P1725, DOI 10.1023/B:PHAM.0000045222.01170.4c; Butler Henry N., 2015, FLA L REV, V67, P977; Center for Drug Evaluation and Research US Food and Drug Administration, 2018, GOOD SUBM PRACT GUID; Dave CV, 2017, NEW ENGL J MED, V377, P2597, DOI 10.1056/NEJMc1711899; Derbyshire M., 2016, GENERICS BIOSIMILARS, V5, P45; DiJulio B, 2015, KAISER HLTH TRACKING; Erika Lietzan, 2016, FEDERALIST SOC REV, V17; Federal Trade Commission, 2010, PAY DEL DRUG CO PAYO; Heller W M, 1986, J Parenter Sci Technol, V40, P80; HELLER WM, 1970, J AMER MED ASSOC, V213, P576; Heyward J, 2018, J PHARM SCI; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Kovtun Y, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.768.768; Morton FS, 2017, ENABLING COMPETITION, V2; Sarpatwari A, 2014, NEW ENGL J MED, V370, P1476, DOI 10.1056/NEJMp1400488; The United States Pharmacopeial Convention, USP FDA WORK TOG PRO; U.S Food and Drug Administration, 2018, NAT DRUH COD DIR; US Food and Drug Administration, 2018, OR BOOK APPR DRUG PR; USP-NF, GEN NOT 4	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225109	10.1371/journal.pone.0225109	http://dx.doi.org/10.1371/journal.pone.0225109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714946	Green Published, gold			2022-12-26	WOS:000532710400030
J	Konecny, J; Hrselova, H; Bukovska, P; Hujslova, M; Jansa, J				Konecny, Jan; Hrselova, Hana; Bukovska, Petra; Hujslova, Martina; Jansa, Jan			Correlative evidence for co-regulation of phosphorus and carbon exchanges with symbiotic fungus in the arbuscular mycorrhizal Medicago truncatula	PLOS ONE			English	Article							PHOSPHATE TRANSPORTER GENE; RHIZOPHAGUS-IRREGULARIS; PLANT; ROOTS; SOIL; EXPRESSION; BIODIVERSITY; MEMBERS; IDENTIFICATION; COLONIZATION	Research efforts directed to elucidation of mechanisms behind trading of resources between the partners in the arbuscular mycorrhizal (AM) symbiosis have seen a considerable progress in the recent years. Yet, despite of the recent developments, some key questions still remain unanswered. For example, it is well established that the strictly biotrophic AM fungus releases phosphorus to- and receives carbon molecules from the plant symbiont, but the particular genes, and their products, responsible for facilitating this exchange, are still not fully described, nor are the principles and pathways of their regulation. Here, we made a de novo quest for genes involved in carbon transfer from the plant to the fungus using genome-wide gene expression array targeting whole root and whole shoot gene expression profiles of mycorrhizal and non-mycorrhizal Medicago truncatula plants grown in a glasshouse. Using physiological intervention of heavy shading (90% incoming light removed) and the correlation of expression levels of MtPT4, the mycorrhiza-inducible phosphate transporter operating at the symbiotic interface between the root cortical cells and the AM fungus, and our candidate genes, we demonstrate that several novel genes may be involved in resource tradings in the AM symbiosis established by M. truncatula. These include glucose-6-phosphate/phosphate translocator, polyol/monosaccharide transporter, DUR3-like, nucleotide-diphospho-sugar transferase or a putative membrane transporter. Besides, we also examined the expression of other M. truncatula phosphate transporters (MtPT1-3, MtPT5-6) to gain further insights in the balance between the "direct" and the "mycorrhizal" phosphate uptake pathways upon colonization of roots by the AM fungus, as affected by short-term carbon/energy deprivation. In addition, the role of the novel candidate genes in plant cell metabolism is discussed based on available literature.	[Konecny, Jan] Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic; [Konecny, Jan; Hrselova, Hana; Bukovska, Petra; Hujslova, Martina; Jansa, Jan] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Konecny, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic.; Konecny, J (corresponding author), Czech Acad Sci, Inst Microbiol, Prague, Czech Republic.	jan.konecny@natur.cuni.cz	Konečný, Jan/AAY-8576-2021; Hršelová, Hana/H-6340-2014; Bukovská, Petra/H-6658-2014; Jansa, Jan/H-3161-2014	Konečný, Jan/0000-0001-5975-6732; Hršelová, Hana/0000-0003-3546-2718; Jansa, Jan/0000-0002-0331-1774; Bukovska, Petra/0000-0003-4173-6244	Ministry of Education, Youth and Sports of the Czech Republic [LK11224, LO1417]; Faculty of Science, Charles University;  [RVO 61388971]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Science, Charles University; 	This work was supported by Ministry of Education, Youth and Sports of the Czech Republic (JJ, project LK11224) and by long-term development program RVO 61388971. The writing of manuscript and the funding of publishing fee were further supported by JK PhD scholarship (Faculty of Science, Charles University) and by project LO1417 provided by the Ministry of Education, Youth and Sports of the Czech Republic.	An JY, 2019, NEW PHYTOL, V224, P396, DOI 10.1111/nph.15975; Baier MC, 2010, PLANT PHYSIOL, V152, P1000, DOI 10.1104/pp.109.149898; Balestrini R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00237; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Bender SF, 2015, J APPL ECOL, V52, P228, DOI 10.1111/1365-2664.12351; Bernardo L, 2019, PLANT PHYSIOL BIOCH, V137, P203, DOI 10.1016/j.plaphy.2019.02.007; Bitterlich M, 2014, PLANT J, V78, P877, DOI 10.1111/tpj.12515; Bohner A, 2015, PLANT J, V81, P377, DOI 10.1111/tpj.12740; Brands M, 2018, PLANT J, V95, P219, DOI 10.1111/tpj.13943; Bravo A, 2017, NEW PHYTOL, V214, P1631, DOI 10.1111/nph.14533; Bravo A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.208, 10.1038/NPLANTS.2015.208]; Bukovska P, 2018, MYCORRHIZA, V28, P269, DOI 10.1007/s00572-018-0825-0; Calabrese S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00679; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Couillerot O, 2013, APPL MICROBIOL BIOT, V97, P4639, DOI 10.1007/s00253-012-4249-z; di Fossalunga AS, 2019, CHEM BIOL TECHNOL AG, V6, DOI 10.1186/s40538-019-0150-7; Doidy J, 2012, MOL PLANT, V5, P1346, DOI 10.1093/mp/sss079; Dreyer I, 2019, NEW PHYTOL, V222, P1043, DOI 10.1111/nph.15646; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia K, 2016, TRENDS PLANT SCI, V21, P937, DOI 10.1016/j.tplants.2016.07.010; Glassop D, 2005, PLANTA, V222, P688, DOI 10.1007/s00425-005-0015-0; Grunwald U, 2009, PLANTA, V229, P1023, DOI 10.1007/s00425-008-0877-z; Gryndler M, 2018, MYCORRHIZA, V28, P435, DOI 10.1007/s00572-018-0844-x; Gutjahr C, 2012, PLANT J, V69, P906, DOI 10.1111/j.1365-313X.2011.04842.x; HARLEY J L, 1987, New Phytologist, V105, P1, DOI 10.1111/j.1469-8137.1987.tb00674.x; Harrison MJ, 1996, PLANT J, V9, P491, DOI 10.1046/j.1365-313X.1996.09040491.x; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Hart MM, 2018, FUNCT ECOL, V32, P126, DOI 10.1111/1365-2435.12976; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; Hewitt E., 1966, SAND WATER CULTURE M, V187-237, P430; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; JAKOBSEN I, 1990, NEW PHYTOL, V115, P77, DOI 10.1111/j.1469-8137.1990.tb00924.x; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Jiang YN, 2017, SCIENCE, V356, P1172, DOI 10.1126/science.aam9970; Jin HR, 2012, SCI CHINA LIFE SCI, V55, P474, DOI 10.1007/s11427-012-4330-y; Kafle A, 2019, PLANT CELL ENVIRON, V42, P270, DOI 10.1111/pce.13359; Kammerer B, 1998, PLANT CELL, V10, P105, DOI 10.1105/tpc.10.1.105; Keymer A, 2018, CURR OPIN PLANT BIOL, V44, P137, DOI 10.1016/j.pbi.2018.04.005; Keymer A, 2017, ELIFE, V6, DOI [10.7554/eLife.29107, 10.7554/eLife.29107.001]; Kim SJ, 2017, MYCOBIOLOGY, V45, P20, DOI 10.5941/MYCO.2017.45.1.20; Klepek YS, 2010, J EXP BOT, V61, P537, DOI 10.1093/jxb/erp322; Konvalinkova T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00065; Lahmidi NA, 2016, PLANT PHYSIOL BIOCH, V107, P354, DOI 10.1016/j.plaphy.2016.06.023; Lendenmann M, 2011, MYCORRHIZA, V21, P689, DOI 10.1007/s00572-011-0371-5; Lin IW, 2014, NATURE, V508, P1, DOI 10.1038/nature13082; Liu GW, 2015, PLANTA, V241, P861, DOI 10.1007/s00425-014-2219-7; Liu JY, 2008, J BIOL CHEM, V283, P24673, DOI 10.1074/jbc.M802695200; Lohse S, 2005, PLANT PHYSIOL, V139, P329, DOI 10.1104/pp.105.061457; Luginbuehl LH, 2017, CURR BIOL, V27, pR952, DOI 10.1016/j.cub.2017.06.042; Maeda D, 2006, PLANT CELL PHYSIOL, V47, P807, DOI 10.1093/pcp/pcj069; Manck-Gotzenberger J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00487; Nagy R, 2005, PLANT J, V42, P236, DOI 10.1111/j.1365-313X.2005.02364.x; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; OHNO T, 1991, SOIL SCI SOC AM J, V55, P892, DOI 10.2136/sssaj1991.03615995005500030046x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Puschel D, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00390; Pumplin N, 2009, PLANT PHYSIOL, V151, P809, DOI 10.1104/pp.109.141879; R Core Team, 2018, R LANG ENV STAT COMP; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Raven JA, 2018, NEW PHYTOL, V217, P1420, DOI 10.1111/nph.14967; Rezacova V, 2017, MYCORRHIZA ECOPHYSIO, P1; Rezacova V, 2018, PLANT SOIL, V425, P441, DOI 10.1007/s11104-018-3606-9; Rezacova V, 2016, PEDOBIOLOGIA, V59, P179, DOI 10.1016/j.pedobi.2016.04.002; Rich MK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3988-8; Rich MK, 2017, TRENDS PLANT SCI, V22, P652, DOI 10.1016/j.tplants.2017.05.008; Richardson AE, 2011, PLANT SOIL, V349, P121, DOI 10.1007/s11104-011-0950-4; Sakiroglu M, 2017, THEOR APPL GENET, V130, P261, DOI 10.1007/s00122-016-2782-3; SALZER P, 1991, BOT ACTA, V104, P439, DOI 10.1111/j.1438-8677.1991.tb00256.x; Sameeullah M., 2016, MECH MOL INTERACTION, V2, P45; Schaarschmidt S, 2008, PLANT SIGNAL BEHAV, V3, P317, DOI 10.4161/psb.3.5.5307; Schott S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00912; SLA (Servicezentrum Landentwicklung und Agrarforderung), 2019, SCHLAEG 2019 HAUPTZ; Slavikova R, 2017, MYCORRHIZA, V27, P35, DOI 10.1007/s00572-016-0731-2; Smith SE, 2015, ANNU PLANT REV, V48, P409, DOI 10.1002/9781118958841.ch14; Smith SE, 2011, PLANT PHYSIOL, V156, P1050, DOI 10.1104/pp.111.174581; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Tan ZJ, 2012, PLANT MOL BIOL REP, V30, P1480, DOI 10.1007/s11105-012-0467-x; Tan ZJ, 2012, PLANT MOL BIOL REP, V30, P885, DOI 10.1007/s11105-011-0402-6; TANG HB, 2014, BMC GENOMICS, V15; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; van de Wiel CCM, 2016, EUPHYTICA, V207, P1, DOI 10.1007/s10681-015-1572-3; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wang ET, 2012, CURR BIOL, V22, P2242, DOI 10.1016/j.cub.2012.09.043; Wang WX, 2017, MOL PLANT, V10, P1147, DOI 10.1016/j.molp.2017.07.012; Wewer V, 2014, PLANT J, V79, P398, DOI 10.1111/tpj.12566; Wipf D, 2019, NEW PHYTOL, V223, P1127, DOI 10.1111/nph.15775; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901	94	7	8	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224938	10.1371/journal.pone.0224938	http://dx.doi.org/10.1371/journal.pone.0224938			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KC8BF	31710651	Green Published, gold, Green Submitted			2022-12-26	WOS:000507395800001
J	Chadchankar, J; Korboukh, V; Conway, LC; Wobst, HJ; Walker, CA; Doig, P; Jacobsen, SJ; Brandon, NJ; Moss, SJ; Wang, Q				Chadchankar, Jayashree; Korboukh, Victoria; Conway, Leslie C.; Wobst, Heike J.; Walker, Chandler A.; Doig, Peter; Jacobsen, Steve J.; Brandon, Nicholas J.; Moss, Stephen J.; Wang, Qi			Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells	PLOS ONE			English	Article							UCH37 DEUBIQUITINATING ENZYME; 26S PROTEASOME; STRUCTURAL-CHARACTERIZATION; DEGRADATION; INHIBITOR; UBP6; ACTIVATION; MUTATIONS; PROTECTS; BINDING	USP14 is a cysteine protease deubiquitinase associated with the proteasome and plays important catalytic and allosteric roles in proteasomal degradation. USP14 inhibition has been considered a therapeutic strategy for accelerating degradation of aggregation-prone proteins in neurodegenerative diseases and for inhibiting proteasome function to induce apoptotic cell death in cancers. Here we studied the effects of USP14 inhibition in mammalian cells using small molecule inhibitors and an inactive USP14 mutant C114A. Neither the inhibitors nor USP14 C114A showed consistent or significant effects on the level of TDP-43, tau or a-synuclein in HEK293T cells. However, USP14 C114A led to a robust accumulation of ubiquitinated proteins, which were isolated by ubiquitin immunoprecipitation and identified by mass spectrometry. Among these proteins we confirmed that ubiquitinated beta-catenin accumulated in the cells expressing USP14 C114A with immunoblotting and immunoprecipitation experiments. The proteasome binding domain of USP14 C114A is required for its effect on ubiquitinated proteins. UCHL5 is the other cysteine protease deubiquitinase associated with the proteasome. Interestingly, the inactive mutant of UCHL5 C88A also caused an accumulation of ubiquitinated proteins in HEK293T cells but did not affect beta-catenin, demonstrating USP14 but not UCHL5 has a specific effect on beta-catenin. We used ubiquitin immunoprecipitation and mass spectrometry to identify the accumulated ubiquitinated proteins in UCHL5 C88A expressing cells which are mostly distinct from those identified in USP14 C114A expressing cells. Among the identified proteins are well established proteasome substrates and proteasome subunits. Besides beta-catenin, we also verified with immunoblotting that UCHL5 C88A inhibits its own deubiquitination and USP14 C114A inhibits deubiquitination of two proteasomal subunits PSMC1 and PSMD4. Together our data suggest that USP14 and UCHL5 can deubiquitinate distinct substrates at the proteasome and regulate the ubiquitination of the proteasome itself which is tightly linked to its function.	[Chadchankar, Jayashree; Conway, Leslie C.] Tufts Univ, AstraZeneca Tufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA; [Korboukh, Victoria; Doig, Peter] AstraZeneca, Discovery Sci, BioPharmaceut R&D, Waltham, MA USA; [Wobst, Heike J.; Walker, Chandler A.; Jacobsen, Steve J.; Brandon, Nicholas J.; Moss, Stephen J.; Wang, Qi] AstraZeneca, Neurosci, BioPharmaceut R&D, Waltham, MA 02451 USA; [Moss, Stephen J.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	Tufts University; AstraZeneca; AstraZeneca; Tufts University; University of London; University College London	Wang, Q (corresponding author), AstraZeneca, Neurosci, BioPharmaceut R&D, Waltham, MA 02451 USA.	qi.wang@azneuro.com		Wang, Qi/0000-0002-5077-6304	AstraZeneca; National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke [NS051195, NS056359, NS081735, R21NS080064, NS087662]; NIH-National Institute of Mental Health [MH097446]; DOD [AR140209]	AstraZeneca(AstraZeneca); National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DOD(United States Department of Defense)	This work was supported by funding from AstraZeneca. VK, HW, CW, PD, SJ, NB, and QW are employed by AstraZeneca. JC and LC were supported by funding from AstraZeneca. SM is supported by funding from AstraZeneca and National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke Grants NS051195, NS056359, NS081735, R21NS080064 and NS087662; NIH-National Institute of Mental Health Grant MH097446, and DOD, AR140209. The funder AstraZeneca has roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Al-Shami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013654; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Aufderheide A, 2015, P NATL ACAD SCI USA, V112, P8626, DOI 10.1073/pnas.1510449112; Barmada SJ, 2014, NAT CHEM BIOL, V10, P677, DOI 10.1038/nchembio.1563; Bashore C, 2015, NAT STRUCT MOL BIOL, V22, P712, DOI 10.1038/nsmb.3075; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Boselli M, 2017, J BIOL CHEM, V292, P19209, DOI 10.1074/jbc.M117.815126; Burgie ES, 2012, PROTEINS, V80, P649, DOI 10.1002/prot.23147; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chesser AS, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00122; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; de Poot SAH, 2017, J MOL BIOL, V429, P3525, DOI 10.1016/j.jmb.2017.09.015; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Goitea VE, 2015, J BIOL CHEM, V290, P16403, DOI 10.1074/jbc.M114.626127; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hassiepen U, 2007, ANAL BIOCHEM, V371, P201, DOI 10.1016/j.ab.2007.07.034; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Homma T, 2015, SCI REP-UK, V5, DOI 10.1038/srep11028; Hyrskyluoto A, 2014, HUM MOL GENET, V23, P5928, DOI 10.1093/hmg/ddu317; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Jin YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047884; Kemp M, 2016, PROGR MED CHEM, V55, P149, DOI 10.1016/bs.pmch.2015.10.002; Kim HT, 2017, J BIOL CHEM, V292, P9830, DOI 10.1074/jbc.M116.763128; Kiprowska MJ, 2017, BBA-MOL BASIS DIS, V1863, P1157, DOI 10.1016/j.bbadis.2017.03.017; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kuo CL, 2017, P NATL ACAD SCI USA, V114, pE3404, DOI 10.1073/pnas.1701734114; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lee Byung-Hoon, 2012, Curr Protoc Chem Biol, V4, P311, DOI 10.1002/9780470559277.ch120078; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li J, 2011, CELL CYCLE, V10, P2946, DOI 10.4161/cc.10.17.15922; Liu B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07185-y; Luan B, 2016, P NATL ACAD SCI USA, V113, P2642, DOI 10.1073/pnas.1601561113; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Morrow ME, 2018, EMBO REP, V19, DOI 10.15252/embr.201745680; Ortuno Daniel, 2016, F1000Res, V5, P137, DOI 10.12688/f1000research.7800.2; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Randles L, 2016, J BIOL CHEM, V291, P8773, DOI 10.1074/jbc.M115.694588; Saeki Y, 2017, J BIOCHEM, V161, P113, DOI 10.1093/jb/mvw091; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Sell GL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00322; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stamos JL, 2013, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A007898; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep26979; Wang X, 2015, CHEM BIOL DRUG DES, V86, P1036, DOI 10.1111/cbdd.12571; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; Wobst HJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00046; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225145	10.1371/journal.pone.0225145	http://dx.doi.org/10.1371/journal.pone.0225145			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703099	Green Published, Green Submitted, gold			2022-12-26	WOS:000532697200046
J	Hao, WJ; Hu, CH; Huang, YB; Chen, YX				Hao, Wenjing; Hu, Cuihua; Huang, Yibing; Chen, Yuxin			Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; APOPTOSIS; PROSTATE	The apoptosis-inducing peptide kla (KLAKLAK)(2) possesses the ability to disrupt mitochondrial membranes and induce cancer cell apoptosis, but this peptide has a poor eukaryotic cell-penetrating potential. Thus, it requires the assistance of other peptides for effective translocation at micromolar concentrations. In this study, breast and lung cancer cells were treated by kla peptide co-administrated with membrane-active anticancer peptide HPRP-A1. HPRP-A1 assisted kla to enter cancer cells and localized on mitochondrial membranes to result in cytochrome C releasing and mitochondrial depolarization which ultimately induced apoptosis.The apoptosis rate was up to 65% and 45% on MCF-7 and A549 cell lines, respectively, induced by HPRP-A1 coadministration with kla group. The breast cancer model was constructed in mice, and the anticancer peptides were injected to observe the changes in cancer volume, andimmunohistochemical analysis was performed on the tissues and organs after the drug was administered. Both the weight and volume of tumor tissue were remarkable lower in HPRP-A1 with kla group compared with thosepeptidealonggroups. The results showed that the combined drug group effectively inhibited the growth of cancer and did not cause toxic damage to normal tissues, as well as exhibited significantly improvement on peptide anticancer activity in vitro and in vivo.	[Hao, Wenjing; Huang, Yibing; Chen, Yuxin] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun, Peoples R China; [Hao, Wenjing; Huang, Yibing; Chen, Yuxin] Jilin Univ, Sch Life Sci, Changchun, Peoples R China; [Hu, Cuihua] Changchun Univ Sci & Technol, Key Lab Cross Scale Micro & Nano Mfg, Minist Educ, Changchun, Peoples R China; [Hu, Cuihua] Changchun Univ Sci & Technol, Int Res Ctr Nano Handling & Mfg China, Changchun, Peoples R China; [Chen, Yuxin] JiangsuProteLight Pharmaceut & Biotechnol Co Ltd, Jiangyin, Peoples R China	Jilin University; Jilin University; Changchun University of Science & Technology; Changchun University of Science & Technology	Chen, YX (corresponding author), Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun, Peoples R China.; Chen, YX (corresponding author), Jilin Univ, Sch Life Sci, Changchun, Peoples R China.; Chen, YX (corresponding author), JiangsuProteLight Pharmaceut & Biotechnol Co Ltd, Jiangyin, Peoples R China.	chen_yuxin@jlu.edu.cn			National Major Science and Technology Projects of China [2017ZX09201001-004-005]; Natural Science Foundation of Jilin Province of China [20180101250JC]; "13th Five-Year" Science and Technology Project of Jilin Provincial Department of Education [JJKH20180178KJ]	National Major Science and Technology Projects of China; Natural Science Foundation of Jilin Province of China; "13th Five-Year" Science and Technology Project of Jilin Provincial Department of Education	This work was supported by the National Major Science and Technology Projects of China (2017ZX09201001-004-005 to YC), Natural Science Foundation of Jilin Province of China (20180101250JC to YH), and "13th Five-Year" Science and Technology Project of Jilin Provincial Department of Education (JJKH20180178KJ to YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. provided support in the form of a salary for author YC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrasiabi Z, 2013, TRANSIT METAL CHEM, V38, P665, DOI 10.1007/s11243-013-9735-3; Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; Bartsch I, 2012, BIOMATERIALS, V33, P6926, DOI 10.1016/j.biomaterials.2012.06.039; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chen RW, 2013, CANCER RES, V73, P1352, DOI 10.1158/0008-5472.CAN-12-1979; Chen Y, 2002, J PEPT RES, V59, P18, DOI 10.1046/j.1397-002x.2001.10994.x; Chen YX, 2006, CHEM BIOL DRUG DES, V67, P162, DOI 10.1111/j.1747-0285.2006.00349.x; Chobot V, 2014, MOLECULES, V19, P20023, DOI 10.3390/molecules191220023; Cieslewicz M, 2013, P NATL ACAD SCI USA, V110, P15919, DOI 10.1073/pnas.1312197110; De GJ, 2014, ONCOTARGET, V5, P7734, DOI 10.18632/oncotarget.2301; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Foillard S, 2008, CHEMBIOCHEM, V9, P2326, DOI 10.1002/cbic.200800327; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Guo ZR, 2017, J DRUG TARGET, V25, P715, DOI 10.1080/1061186X.2017.1322598; Hao XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138911; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Huang YB, 2015, MINI-REV MED CHEM, V15, P73, DOI 10.2174/1389557514666141107120954; Huang Y, 2017, ONCOL REP, V37, P2063, DOI 10.3892/or.2017.5440; Hyun S, 2014, BIOMACROMOLECULES, V15, P3746, DOI 10.1021/bm501026e; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Mai XT, 2015, J PEPT SCI, V21, P561, DOI 10.1002/psc.2767; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Rudolf E, 2006, CHEM-BIOL INTERACT, V162, P212, DOI 10.1016/j.cbi.2006.06.005; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Zhao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139578; Zhao J, 2015, ONCOTARGET, V6, P1769, DOI 10.18632/oncotarget.2754; Zhao LJ, 2013, SCI CHINA CHEM, V56, P1307, DOI 10.1007/s11426-013-4884-y	30	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0223738	10.1371/journal.pone.0223738	http://dx.doi.org/10.1371/journal.pone.0223738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703065	Green Published, gold			2022-12-26	WOS:000532697200006
J	Kato, S; Hirai, M; Ohkuma, M; Suzuki, K				Kato, Shingo; Hirai, Miho; Ohkuma, Moriya; Suzuki, Katsuhiko			Microbial metabolisms in an abyssal ferromanganese crust from the Takuyo-Daigo Seamount as revealed by metagenomics	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEON; DISSOLVED ORGANIC-CARBON; MANGANESE OXIDES; GEN. NOV.; COMPLETE NITRIFICATION; POTENTIAL MECHANISMS; MN(II) OXIDATION; HEME PEROXIDASES; GENOME; COMMUNITY	Rocky outcrops covered with thick Fe and Mn oxide coatings, which are known as ferromanganese (Fe-Mn) crusts, are commonly found on slopes of aged seamounts in bathyal and abyssal zones. Although the presence of diverse microorganisms on these Fe-Mn crusts has been reported, little is known about their metabolism. Here, we report the metabolic potential of the microbial community in an abyssal crust collected in the Takuyo-Daigo Seamount, in the north-western Pacific. We performed shotgun metagenomic sequencing of the Fe-Mn crust, and detected putative genes involved in dissolution and precipitation of Fe and Mn, nitrification, sulfur oxidation, carbon fixation, and decomposition of organics in the metagenome. In addition, four metagenome-assembled genomes (MAGs) of abundant members in the microbial community were recovered from the metagenome. The MAGs were affiliated with Thaumarchaeota, Alphaproteobacteria, and Gammaproteobacteria, and were distantly related to previously reported genomes/MAGs of cultured and uncultured species. Putative genes involved in the above reactions were also found in the crust MAGs. Our results suggest that crust microbial communities play a role in biogeochemical cycling of C, N, S, Fe, and Mn, and imply that they contribute to the growth of Fe-Mn crusts.	[Kato, Shingo; Suzuki, Katsuhiko] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Submarine Resources Res Ctr, Yokosuka, Kanagawa, Japan; [Kato, Shingo; Ohkuma, Moriya] RIKEN BioResource Res Ctr, Japan Collect Microorganisms JCM, Tsukuba, Ibaraki, Japan; [Hirai, Miho] JAMSTEC, Res & Dev Ctr Marine Biosci, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); RIKEN; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Kato, S (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Submarine Resources Res Ctr, Yokosuka, Kanagawa, Japan.; Kato, S (corresponding author), RIKEN BioResource Res Ctr, Japan Collect Microorganisms JCM, Tsukuba, Ibaraki, Japan.	skato@riken.jp	Suzuki, Katsuhiko/B-1143-2018	Suzuki, Katsuhiko/0000-0003-4266-5046; Kato, Shingo/0000-0002-4175-0532	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science(JSPS) [19H03310]; Ministry of Education,Culture,Sports,Science and Technology (MEXT)	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science(JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education,Culture,Sports,Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Cabinet Office, Government of Japan, through the Next-generation Technology for Ocean Resources Exploration (known as Zipangu-in-the-ocean project) in the Cross-ministerial Strategic Innovation Promotion Program (SIP) to SK and KS, and by a Grant-in-Aid for Scientific Research (B) (#19H03310) from the Japan Society for the Promotion of Science(JSPS), The Ministry of Education,Culture,Sports,Science and Technology (MEXT) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2012, P NATL ACAD SCI USA, V109, P17989, DOI 10.1073/pnas.1201914109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Andeer PF, 2015, ENVIRON MICROBIOL, V17, P3925, DOI 10.1111/1462-2920.12893; Anderson CR, 2009, APPL ENVIRON MICROB, V75, P4130, DOI 10.1128/AEM.02890-08; Baker BJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0077-6; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BARBER RT, 1968, NATURE, V220, P274, DOI 10.1038/220274a0; Barco RA, 2015, APPL ENVIRON MICROB, V81, P5927, DOI 10.1128/AEM.01374-15; Bayer B, 2016, ISME J, V10, P1051, DOI 10.1038/ismej.2015.200; Bienhold C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148016; Blothe M, 2015, ENVIRON SCI TECHNOL, V49, P7692, DOI 10.1021/es504930v; Bowers RM, 2017, NAT BIOTECHNOL, V35, P725, DOI 10.1038/nbt.3893; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Du ZJ, 2016, INT J SYST EVOL MICR, V66, P107, DOI 10.1099/ijsem.0.000683; Dyksma S, 2016, ISME J, V10, P1939, DOI [10.1038/ISMEJ.2015.257, 10.1038/ismej.2015.257]; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrlich HL, 1996, CHEM GEOL, V132, P5, DOI 10.1016/S0009-2541(96)00035-6; Eloe EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020388; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Garrison NL, 2016, PEERJ, V4, DOI 10.7717/peerj.1719; Geszvain K, 2012, BIOCHEM SOC T, V40, P1244, DOI 10.1042/BST20120229; Glasby G.P., 2006, MARINE GEOCHEMISTRY, DOI [10.1007/3-540-32144-6_11, DOI 10.1007/3-540-32144-6_11]; GOLDBERG ED, 1954, J GEOL, V62, P249, DOI 10.1086/626161; Goto KT, 2014, GEOCHIM COSMOCHIM AC, V146, P43, DOI 10.1016/j.gca.2014.10.003; Gruber-Vodicka H. R., 2019, BIORXIV, DOI [10.1101/521922, DOI 10.1101/521922]; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hein J.R., 2014, TREATISE GEOCHEMISTR, V13, P273, DOI [DOI 10.1016/B978-0-08-095975-7.01111-6, 10.1016/B978-0-08-095975-7.01111-6]; Hirai M, 2017, MICROBES ENVIRON, V32, P336, DOI 10.1264/jsme2.ME17132; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004957; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165; Kashiwabara T, 2014, GEOCHIM COSMOCHIM AC, V131, P150, DOI 10.1016/j.gca.2014.01.020; Kato S, 2018, MICROBES ENVIRON, V33, P366, DOI 10.1264/jsme2.ME18090; Kato S, 2018, ENVIRON MICROBIOL, V20, P862, DOI 10.1111/1462-2920.14032; Kato S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01265; Kato S, 2014, INT J SYST EVOL MICR, V64, P921, DOI 10.1099/ijs.0.058487-0; Kerou M, 2016, P NATL ACAD SCI USA, V113, pE7937, DOI 10.1073/pnas.1601212113; Kitzinger K, 2019, NAT MICROBIOL, V4, P234, DOI 10.1038/s41564-018-0316-2; Kleber M, 2015, ADV AGRON, V130, P1, DOI 10.1016/bs.agron.2014.10.005; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2017, ISME J, V11, P2399, DOI 10.1038/ismej.2017.113; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Koschinsky A, 1995, GEOCHIM COSMOCHIM AC, V59, P5113, DOI 10.1016/0016-7037(95)00358-4; Koschinsky A, 2017, ELEMENTS, V13, P177, DOI 10.2113/gselements.13.3.177; Lassak K, 2012, RES MICROBIOL, V163, P630, DOI 10.1016/j.resmic.2012.10.024; Leang C, 2003, J BACTERIOL, V185, P2096, DOI 10.1128/JB.185.7.2096-2103.2003; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Learman DR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00262; Lee MD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01470; Lehtovirta-Morley LE, 2016, APPL ENVIRON MICROB, V82, P2608, DOI 10.1128/AEM.04031-15; Lindh MV, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01696; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Mehta T, 2005, APPL ENVIRON MICROB, V71, P8634, DOI 10.1128/AEM.71.12.8634-8641.2005; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; Moreau JW, 2007, SCIENCE, V316, P1600, DOI 10.1126/science.1141064; Mosier AC, 2012, MICROB ECOL, V64, P955, DOI 10.1007/s00248-012-0075-1; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Mussmann M, 2017, ISME J, V11, P1276, DOI 10.1038/ismej.2016.185; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; NAKANISHI M, 1989, J GEOPHYS RES-SOLID, V94, P15437, DOI 10.1029/JB094iB11p15437; Nitahara S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173071; Nitahara S, 2011, FEMS MICROBIOL LETT, V321, P121, DOI 10.1111/j.1574-6968.2011.02323.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palatinszky M, 2015, NATURE, V524, P105, DOI 10.1038/nature14856; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pester M, 2014, ENVIRON MICROBIOL, V16, P3055, DOI 10.1111/1462-2920.12300; Qin W, 2017, INT J SYST EVOL MICR, V67, P5067, DOI 10.1099/ijsem.0.002416; Qin W, 2014, P NATL ACAD SCI USA, V111, P12504, DOI 10.1073/pnas.1324115111; Rees AP, 2006, DEEP-SEA RES PT II, V53, P1649, DOI 10.1016/j.dsr2.2006.05.008; Reese BK, 2018, GEOMICROBIOL J, V35, P468, DOI 10.1080/01490451.2017.1392649; Santoro AE, 2015, P NATL ACAD SCI USA, V112, P1173, DOI 10.1073/pnas.1416223112; Seah BKB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01451; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shiraishi F, 2016, EARTH PLANET SC LETT, V447, P10, DOI 10.1016/j.epsl.2016.04.021; Shulse CN, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.428; Singer E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01409; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SUNDA WG, 1994, NATURE, V367, P62, DOI 10.1038/367062a0; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Tolar BB, 2017, ENVIRON MICROBIOL, V19, P4838, DOI 10.1111/1462-2920.13457; Tully BJ, 2016, APPL ENVIRON MICROB, V82, P4232, DOI 10.1128/AEM.01023-16; Tully BJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00161; Usui A, 2017, ORE GEOL REV, V87, P71, DOI 10.1016/j.oregeorev.2016.09.032; van Kessel MAHJ, 2015, NATURE, V528, P555, DOI 10.1038/nature16459; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Widner B, 2013, ANAL CHEM, V85, P6661, DOI 10.1021/ac400351c; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418	101	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224888	10.1371/journal.pone.0224888	http://dx.doi.org/10.1371/journal.pone.0224888			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703093	gold, Green Published, Green Submitted			2022-12-26	WOS:000532697200029
J	Byun, SS; Lee, M; Hong, SK; Lee, H				Byun, Seok-Soo; Lee, Minseung; Hong, Sung Kyu; Lee, Hakmin			Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study	PLOS ONE			English	Article							NITRIC-OXIDE; RECEPTOR EXPRESSION; PROGNOSTIC VALUE; METASTASIS; MORTALITY	Background Ki-67 is known to be useful in estimating the fraction of proliferation tumor cells in various malignancies. We tried to investigate clinical association of Ki-67 (MIB-1) expression with the oncological outcomes in patients with localized prostate cancer (PCa) after the radical prostatectomy (RP). Materials and Methods We retrospectively analyzed the data of 1,561 patients who underwent RP for localized PCa. According to the propensity score having Ki-67 expression, 183 patients with positive Ki-67 expression were matched to 549 patients without Ki-67 expression. By using multivariate Cox-proportional hazards models and logistic regression tests, the prognostic value of each variable was tested. Results After propensity score matching, positive Ki-67 group showed significant worse clinical characteristics and pathologic outcomes than negative Ki-67 group. The multivariate analysis showed that the Ki-67 expression was significantly associated with several adverse pathologic outcomes including higher pathologic stage (p = 0.006), higher grade group (p = 0.005), seminal vesicle invasion (p = 0.036), and positive surgical margin (p = 0.025). The group with Ki-67 expression showed significant worse biochemical recurrence-free survival (p< 0.001) than negative Ki-67 group. Subsequent multivariate Cox analyses showed that Ki-67 was independent predictor for BCR after RP (HR 1.549, 95% CI 1.187-2.021, p = 0.001). Conclusion In our study, high Ki-67 expression was significantly related with adverse pathological and finally with worse biochemical recurrence-free survival. Further studies are needed to validate the prognostic value of Ki-67 more exactly in PCa patients.	[Byun, Seok-Soo; Lee, Minseung; Hong, Sung Kyu; Lee, Hakmin] Seoul Natl Univ, Dept Urol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU)	Lee, H (corresponding author), Seoul Natl Univ, Dept Urol, Bundang Hosp, Seongnam, South Korea.	65828@snubh.org			National Research Foundation of Korea (NRF) - Korean government (MSIP; Ministry of Science, ICT, and Future Planning) [NRF-2017R1C1B1009252]	National Research Foundation of Korea (NRF) - Korean government (MSIP; Ministry of Science, ICT, and Future Planning)	This study was supported in part by National Research Foundation of Korea (NRF) grant NRF-2017R1C1B1009252 (grant receiver: Hakmin Lee), funded by the Korean government (MSIP; Ministry of Science, ICT, and Future Planning). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt MC, 1996, J UROLOGY, V156, P1064, DOI 10.1016/S0022-5347(01)65703-3; Dall'Era MA, 2017, PROSTATE CANCER P D, V20, P1, DOI 10.1038/pcan.2016.51; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Fantony JJ, 2018, BIOMARK MED, V12, P727, DOI 10.2217/bmm-2017-0322; Fisher G, 2013, BRIT J CANCER, V108, P271, DOI 10.1038/bjc.2012.598; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Goltz D, 2015, PATHOLOGY, V47, P629, DOI 10.1097/PAT.0000000000000320; Greene FL, 2002, AJCC CANC STAGING MA, V6th, P309; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jadeski LC, 1999, AM J PATHOL, V155, P1381, DOI 10.1016/S0002-9440(10)65240-6; Kloppel G., 2017, VALUE KI 67 PROGNOST; Madu CO, 2010, J CANCER, V1, P150; Malhotra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020293; Nishimukai A, 2015, CLIN BREAST CANCER, V15, P204, DOI 10.1016/j.clbc.2014.12.007; Orucevic A, 1999, INT J CANCER, V81, P889, DOI 10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2; Pollack A, 2004, J CLIN ONCOL, V22, P2133, DOI 10.1200/JCO.2004.09.150; Saricanbaz I, 2014, ASIAN PAC J CANCER P, V15, P8215, DOI 10.7314/APJCP.2014.15.19.8215; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Thomsen LL, 1998, CANCER METAST REV, V17, P107, DOI 10.1023/A:1005912906436; Tretiakova MS, 2016, PROSTATE CANCER P D, V19, P264, DOI 10.1038/pcan.2016.12; Verhoven B, 2013, INT J RADIAT ONCOL, V86, P317, DOI 10.1016/j.ijrobp.2013.01.016; Warth A, 2014, BRIT J CANCER, V111, P1222, DOI 10.1038/bjc.2014.402; Zeng AL, 2015, ONCOTARGET, V6, P30232, DOI 10.18632/oncotarget.4920	25	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224671	10.1371/journal.pone.0224671	http://dx.doi.org/10.1371/journal.pone.0224671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697718	Green Published, gold			2022-12-26	WOS:000532694400039
J	Chen, JN; Cao, FB; Shan, SL; Yin, XH; Huang, M; Zou, YB				Chen, Jiana; Cao, Fangbo; Shan, Shuanglu; Yin, Xiaohong; Huang, Min; Zou, Yingbin			Grain filling of early-season rice cultivars grown under mechanical transplanting	PLOS ONE			English	Article							YIELD COMPONENTS; HYBRID RICE; DRY	High yields of mechanized intensive rice-based cropping systems, e.g. double-season cropping using early- and late-season rice, are important to ensure national food security in China. However, few studies addressing the relationship between grain weight and grain yield of early-season rice under machine-transplanted conditions. A field experiment was conducted to determine the critical grain-filling characteristics and related physiological aspects that contribute to high grain weight in machine-transplanted early-season rice. The results showed that grain yield was significantly positively correlated with grain weight but not with panicles per m(2), spikelets per panicle, and spikelet-filling percentage. Furthermore, this study demonstrated that there was a significant positive correlation between grain weight and mean grain-filling rate, which was significantly positively correlated with harvest index and grain cytokinin content. These results indicate that high grain-filling rate driven by good transport of assimilates to grains and strong grain sink strength is responsible for high grain weight in machine-transplanted early-season rice.	[Chen, Jiana; Cao, Fangbo; Shan, Shuanglu; Yin, Xiaohong; Huang, Min; Zou, Yingbin] Hunan Agr Univ, Coll Agron, Crop & Environm Res Ctr, Changsha, Peoples R China; [Yin, Xiaohong] Guangxi Acad Agr Sci, Rice Res Inst, Guangxi Key Lab Rice Genet & Breeding, Nanning, Peoples R China	Hunan Agricultural University; Guangxi Academy of Agricultural Sciences	Huang, M (corresponding author), Hunan Agr Univ, Coll Agron, Crop & Environm Res Ctr, Changsha, Peoples R China.	mhuang@hunau.edu.cn		Huang, Min/0000-0002-6944-8538	National Key R&D Program of China [2017YFD0301503]; Earmarked Fund for China Agriculture Research System [CARS-01]	National Key R&D Program of China; Earmarked Fund for China Agriculture Research System	This work was supported by the National Key R&D Program of China (2017YFD0301503) to MH and the Earmarked Fund for China Agriculture Research System (CARS-01) to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hongthong P, 2012, RES CROP, V13, P781; Huang M, 2011, J AGR SCI-CAMBRIDGE, V149, P487, DOI 10.1017/S0021859610001097; Huang M., 2009, World Applied Sciences Journal, V6, P674; Huang M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38883-2; Huang M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36572-0; Huang M, 2018, J INTEGR AGR, V17, P1299, DOI 10.1016/S2095-3119(17)61771-4; Huang M, 2018, FIELD CROP RES, V224, P22, DOI 10.1016/j.fcr.2018.05.001; Huang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158601; Huang M, 2011, AGR SCI CHINA, V10, P1537, DOI 10.1016/S1671-2927(11)60149-1; JONES DB, 1979, CROP SCI, V19, P641, DOI 10.2135/cropsci1979.0011183X001900050023x; Kung JKS, 2002, J COMP ECON, V30, P395, DOI 10.1006/jcec.2002.1780; Li QC, 2018, PLANT PHYSIOL BIOCH, V132, P652, DOI 10.1016/j.plaphy.2018.10.009; Liang JS, 2001, PHYSIOL PLANTARUM, V112, P470, DOI 10.1034/j.1399-3054.2001.1120403.x; National Bureau of Statistics of China, 2019, PLANT AR MAJ CROPS; [彭少兵 Peng ShaoBing], 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P845; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Shi WJ, 2013, NEW PHYTOL, V197, P825, DOI 10.1111/nph.12088; Sikder H. P., 1976, Indian Agriculturalist, V20, P133; Xia X, 2017, CHINA WORLD ECON, V25, P93, DOI 10.1111/cwe.12208; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112; Yang W, 2008, AGRON J, V100, P1390, DOI 10.2134/agronj2007.0356; YOSHIDA S, 1981, FUNDAMENTALS RICE CR, P601; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008; Zou YingBin, 2018, Acta Agronomica Sinica, V44, P791; Zou YingBin, 2011, Scientia Agricultura Sinica, V44, P254	27	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224935	10.1371/journal.pone.0224935	http://dx.doi.org/10.1371/journal.pone.0224935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697760	Green Published, gold, Green Submitted			2022-12-26	WOS:000532694400081
J	Pereira, CB; Dohmeier, H; Kunczik, J; Hochhausen, N; Tolba, R; Czaplik, M				Pereira, Carina Barbosa; Dohmeier, Henriette; Kunczik, Janosch; Hochhausen, Nadine; Tolba, Rene; Czaplik, Michael			Contactless monitoring of heart and respiratory rate in anesthetized pigs using infrared thermography	PLOS ONE			English	Article								Pig experiments have played an important role in medical breakthroughs during the last century. In fact, pigs are one of the major animal species used in translational research, surgical models and procedural training due to their anatomical and physiological similarities to humans. To ensure high bioethical standards in animal trials, new directives have been implemented, among others, to refine the procedures and minimize animals' stress and pain. This paper presents a contactless motion-based approach for monitoring cardiorespiratory signals (heart rate and respiratory rate) in anesthetized pigs using infrared thermography. Heart rate monitoring is estimated by measuring the vibrations (precordial motion) of the chest caused by the heartbeat. Respiratory rate, in turn, is computed by measuring the mechanical chest movements that accompany the respiratory cycle. To test the feasibility of this approach, thermal videos of 17 anesthetized pigs were acquired and analyzed. A high agreement between infrared thermography and a gold standard (electrocardiography and capnography-derived respiratory rate) was achieved. The mean absolute error averaged 3.43 +/- 3.05 bpm and 0.27 +/- 0.48 breaths/min for heart rate and respiratory rate, respectively. In sum, infrared thermography is capable of assessing cardiorespiratory signals in pigs. Future work should be conducted to evaluate infared thermography capability of capturing information for long term monitoring of research animals in a diverse set of facilities.	[Pereira, Carina Barbosa; Dohmeier, Henriette; Kunczik, Janosch; Hochhausen, Nadine; Czaplik, Michael] Rhein Westfal TH Aachen, Fac Med, Dept Anesthesiol, Aachen, Nrw, Germany; [Tolba, Rene] Rhein Westfal TH Aachen, Inst Lab Anim Sci & Expt Surg, Fac Med, Aachen, Nrw, Germany	RWTH Aachen University; RWTH Aachen University	Pereira, CB (corresponding author), Rhein Westfal TH Aachen, Fac Med, Dept Anesthesiol, Aachen, Nrw, Germany.	cpereira@ukaachen.de	Pereira, Carina B/M-6712-2015	Pereira, Carina B/0000-0003-1788-4562	German Research Foundation (DFG) [CZ 215/2-1, CZ 215/3-1, TO 542/5-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The initial animal trial was supported by the German Research Foundation (DFG); M.C. received the grant number CZ 215/2-1. The IRT analysis including image and signal processing in the framework of this paper was also funded by the German Research Foundation (DFG); M.C. and R.T. received the following grants CZ 215/3-1 and TO 542/5-1, respectively. Note that DFG is a self-governed organization financed by the German states and the federal government. URL: https://www.dfg.de/en/index.jsp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-93; [Anonymous], 1991, SCI MED ANIMALS; Blanik N., 2014, P 15 INT C BIOM ENG, P92, DOI DOI 10.1007/978-3-319-02913-9_; Eisenberg ME, 2020, J CLIN MONIT COMPUT, V34, P139, DOI 10.1007/s10877-018-0222-4; Exner C, 2007, ANIMAL EXPT RES EDS; Festing S, 2007, EMBO REP, V8, P526, DOI 10.1038/sj.embor.7400993; Garbey M, 2007, IEEE T BIO-MED ENG, V54, P1418, DOI 10.1109/TBME.2007.891930; Gonzalez-Sanchez C, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071052; Ison SH, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00108; Knobel RB, 2011, BIOL RES NURS, V13, P274, DOI 10.1177/1099800411403467; Martinez-Miro S, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0791-8; Mutlu K, 2018, J NEUROSCI METH, V301, P1, DOI 10.1016/j.jneumeth.2018.02.017; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pereira CB, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18113653; Pereira CB, 2014, BIOMED OPT EXPRESS, V5, P1075, DOI 10.1364/BOE.5.001075; Russell WMS., 1959, MED J AUSTRALIA; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Soerensen DD, 2014, COMPUT ELECTRON AGR, V109, P52, DOI 10.1016/j.compag.2014.09.003; Vainer BG, 2018, ANN BIOMED ENG, V46, P960, DOI 10.1007/s10439-018-2018-6; Varanini M, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P149, DOI 10.1109/CIC.2008.4748999; Zhao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071384	21	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224747	10.1371/journal.pone.0224747	http://dx.doi.org/10.1371/journal.pone.0224747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JO6EB	31693688	Green Published, gold			2022-12-26	WOS:000497669000001
J	Radzi, R; Muangmai, N; Broady, P; Omar, WMW; Lavoue, S; Convey, P; Merican, F				Radzi, Ranina; Muangmai, Narongrit; Broady, Paul; Omar, Wan Maznah Wan; Lavoue, Sebastien; Convey, Peter; Merican, Faradina			Nodosilinea signiensis sp. nov. (Leptolyngbyaceae, Synechococcales), a new terrestrial cyanobacterium isolated from mats collected on Signy Island, South Orkney Islands, Antarctica	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PHYLOGENETIC ANALYSES; POLYPHASIC APPROACH; DIVERSITY; 16S-23S; TAXA; CLASSIFICATION; SEQUENCE; ALGAE	Terrestrial cyanobacteria are very diverse and widely distributed in Antarctica, where they can form macroscopically visible biofilms on the surfaces of soils and rocks, and on benthic surfaces in fresh waters. We recently isolated several terrestrial cyanobacteria from soils collected on Signy Island, South Orkney Islands, Antarctica. Among them, we found a novel species of Nodosilinea, named here as Nodosilinea signiensis sp. nov. This new species is morphologically and genetically distinct from other described species. Morphological examination indicated that the new species is differentiated from others in the genus by cell size, cell shape, filament attenuation, sheath morphology and granulation. 16S rDNA phylogenetic analyses clearly confirmed that N. signiensis belongs to the genus Nodosilinea, but that it is genetically distinct from other known species of Nodosilinea. The D1-D1 helix of the 16S-23S ITS region of the new species was also different from previously described Nodosilinea species. This is the first detailed characterization of a member of the genus Nodosilinea from Antarctica as well as being a newly described species.	[Radzi, Ranina; Omar, Wan Maznah Wan; Lavoue, Sebastien; Merican, Faradina] Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia; [Muangmai, Narongrit] Kasetsart Univ, Fac Fisheries, Dept Fishery Biol, Bangkok, Thailand; [Broady, Paul] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Convey, Peter] British Antarctic Survey, Cambridge, England	Universiti Sains Malaysia; Kasetsart University; University of Canterbury; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Merican, F (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia.	faradina@usm.my	Merican, Faradina/F-6785-2019; Convey, Peter/AAV-5728-2020; Lavoue, Sebastien/H-7118-2012	Merican, Faradina/0000-0003-1441-0134; Convey, Peter/0000-0001-8497-9903; Lavoue, Sebastien/0000-0003-4798-6666	YPASM Berth Support; YPASM Fellowship [304/PBIOLOGI/650963]; RUI grant [1001/PBIOLOGI/811305]; Flagship grant [304/PBIOLOGI/650723/P131]; NERC; NERC [bas0100036] Funding Source: UKRI	YPASM Berth Support; YPASM Fellowship; RUI grant; Flagship grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study received funding support from YPASM Berth Support, YPASM Fellowship 304/PBIOLOGI/650963, RUI grant 1001/PBIOLOGI/811305 and Flagship grant 304/PBIOLOGI/650723/P131. Peter Convey is supported by NERC core funding to the BAS 'Biodiversity, Evolution and Adaptation' Team.; We thank Dr Japareng Lalung for collection of the original soil sample on Signy Island. British Antarctic Survey staff at Signy research station are thanked for logistical and other practical support. This paper also contributes to the international SCAR `State of the Antarctic Ecosystem' (AntEco) research programme. Peter Convey is supported by NERC core funding to the BAS `Biodiversity, Evolution and Adaptation' Team.	Abed RMM, 2002, ARCH MICROBIOL, V177, P361, DOI 10.1007/s00203-001-0390-2; Anagnostidis K, 2005, SUBWASSERFLORA MITTE, V19; Bolch CJS, 1996, J APPL PHYCOL, V8, P5, DOI 10.1007/BF02186215; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Brinkmann M, 2007, POLAR BIOL, V30, P1505, DOI 10.1007/s00300-007-0311-1; Brito A, 2017, MOL PHYLOGENET EVOL, V111, P18, DOI 10.1016/j.ympev.2017.03.006; Broady PA, 1979, TERRESTRIAL ALGAE SI; Castenholz RW, 1989, BERGEYS MANUAL SYSTE, V3, P1727; Cavacini P., 2001, POLAR BIOSCI, V14, P45, DOI DOI 10.15094/00006165; Costa MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23436; Dadheech PK, 2012, HYDROBIOLOGIA, V691, P269, DOI 10.1007/s10750-012-1080-6; DVORAK P, 2017, OLOMOUC, V17, P269, DOI DOI 10.5507/FOT.2017.017; Dvorak P, 2017, FOTTEA, V17, P269, DOI 10.5507/fot.2017.017; Dvorak P, 2014, PHYTOTAXA, V170, P24; Friedmann E I, 1988, Polarforschung, V58, P251; FRIEDMANN EI, 1982, SCIENCE, V215, P1045, DOI 10.1126/science.215.4536.1045; Gaydon DS, 2012, EUR J AGRON, V39, P35, DOI 10.1016/j.eja.2012.01.004; Heidari F, 2018, FOTTEA, V18, P137, DOI 10.5507/fot.2017.024; Jahodarova E, 2017, PHYTOTAXA, V326, P28, DOI 10.11646/phytotaxa.326.1.2; Jancusova M, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw100; Johansen JR, 2011, NOVA HEDWIGIA, V92, P283, DOI 10.1127/0029-5035/2011/0092-0283; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Komarek Jiri, 2007, Polish Polar Research, V28, P211; Komarek J, 2018, HYDROBIOLOGIA, V811, P7, DOI 10.1007/s10750-017-3379-9; Komarek J, 2016, EUR J PHYCOL, V51, P346, DOI 10.1080/09670262.2016.1163738; Komarek J, 2014, PRESLIA, V86, P295; Kongisser RA, 1925, METHODS STUDYING PHY; Li XC, 2016, PHYCOLOGIA, V55, P478, DOI 10.2216/15-149.1; Li ZK, 2007, PHYCOLOGIA, V46, P396, DOI 10.2216/06-89.1; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Vaz MGMV, 2015, INT J SYST EVOL MICR, V65, P298, DOI 10.1099/ijs.0.070110-0; Mares J, 2018, HYDROBIOLOGIA, V811, P19, DOI 10.1007/s10750-017-3373-2; Mataloni G, 2000, POLAR BIOL, V23, P205, DOI 10.1007/s003000050028; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; Miscoe L.H., 2016, BIBLIOTHECA PHYCOLOG, V120; Mueller DR, 2004, POLAR BIOL, V27, P66, DOI 10.1007/s00300-003-0580-2; Osorio-Santos K, 2014, EUR J PHYCOL, V49, P450, DOI 10.1080/09670262.2014.976843; Perkerson RB, 2011, J PHYCOL, V47, P1397, DOI 10.1111/j.1529-8817.2011.01077.x; Priscu JC, 1998, SCIENCE, V280, P2095, DOI 10.1126/science.280.5372.2095; Quesada A., 2012, ECOLOGY CYANOBACTERI, P387, DOI DOI 10.1007/978-94-007-3855-3_14; Rambaut A., 2009, FIGTREE VERSION 1 3; Rehakova K, 2007, PHYCOLOGIA, V46, P481, DOI 10.2216/06-92.1; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sciuto K, 2017, CRYPTOGAMIE ALGOL, V38, P285, DOI 10.7872/crya/v38.iss4.2017.285; Sciuto K, 2016, MOL PHYLOGENET EVOL, V105, P15, DOI 10.1016/j.ympev.2016.08.010; Song GF, 2015, PHYTOTAXA, V224, P72, DOI 10.11646/phytotaxa.224.1.5; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoyanov P, 2014, EBOS13748; Taton A, 2011, POLAR BIOL, V34, P181, DOI 10.1007/s00300-010-0868-y; Taton A, 2003, APPL ENVIRON MICROB, V69, P5157, DOI 10.1128/AEM.69.9.5157-5169.2003; Turicchia S, 2009, NOVA HEDWIGIA, V89, P165, DOI 10.1127/0029-5035/2009/0089-0165; Vaccarino MA, 2012, J PHYCOL, V48, P1178, DOI 10.1111/j.1529-8817.2012.01203.x; Vazquez-Martinez J, 2018, PHYTOTAXA, V334, P167, DOI 10.11646/phytotaxa.334.2.6; Vishnivetskaya Tatiana A., 2009, V16, P73; Wynn-Williams D. D., 1988, POLARFORSCHUNG, V58, P239; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Zammit G, 2012, EUR J PHYCOL, V47, P341, DOI 10.1080/09670262.2012.717106; Zimba PV, 2017, J PHYCOL, V53, P188, DOI 10.1111/jpy.12490	63	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2019	14	11							e0224395	10.1371/journal.pone.0224395	http://dx.doi.org/10.1371/journal.pone.0224395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1AJ	31682631	gold, Green Published, Green Accepted			2022-12-26	WOS:000532676800015
J	Komazin, G; Maybin, M; Woodard, RW; Scior, T; Schwudke, D; Schombel, U; Gisch, N; Mamat, U; Meredith, TC				Komazin, Gloria; Maybin, Michael; Woodard, Ronald W.; Scior, Thomas; Schwudke, Dominik; Schombel, Ursula; Gisch, Nicolas; Mamat, Uwe; Meredith, Timothy C.			Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endotoxin; lipopolysaccharide (LPS); metabolic endotoxemia; intestinal alkaline phosphatase; Toll-like receptor (TLR); lipid A; systemic inflammation; metabolic syndrome; gut microbiome; intestinal flora	ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; ACID-DEFICIENT MUTANT; LIPID-A PRECURSORS; SALMONELLA-TYPHIMURIUM; DEACYLATED LIPOPOLYSACCHARIDE; ENTEROCYTE MICROVILLUS; METABOLIC ENDOTOXEMIA; POLYMYXIN RESISTANCE; CRYSTAL-STRUCTURE; GUT MICROBIOTA	Lipopolysaccharide (LPS) from the Gram-negative bacterial outer membrane potently activates the human innate immune system. LPS is recognized by the Toll-like receptor 4/myeloid differentiation factor-2 (TLR4/MD2) complex, leading to the release of pro-inflammatory cytokines. Alkaline phosphatase (AP) is currently being investigated as an anti-inflammatory agent for detoxifying LPS through dephosphorylating lipid A, thus providing a potential treatment for managing both acute (sepsis) and chronic (metabolic endotoxemia) pathologies wherein aberrant TLR4/MD2 activation has been implicated. Endogenous LPS preparations are chemically heterogeneous, and little is known regarding the LPS chemotype substrate range of AP. Here, we investigated the activity of AP on a panel of structurally defined LPS chemotypes isolated from Escherichia coli and demonstrate that calf intestinal AP (cIAP) has only minimal activity against unmodified enteric LPS chemotypes. Inorganic phosphate was only released from a subset of LPS chemotypes harboring spontaneously labile phosphoethanolamine (PEtN) modifications connected through phosphoanhydride bonds. We demonstrate that the spontaneously hydrolyzed O-phosphorylethanolamine is the actual substrate for AP. We found that the 1- and 4'-lipid A phosphate groups critical in TLR4/MD2 signaling become susceptible to hydrolysis only after de-O-acylation of ester linked primary acyl chains on lipid A. Furthermore, PEtN modifications on lipid A specifically enhanced hTLR4 agonist activity of underacylated LPS preparations. Computational binding models are proposed to explain the limitation of AP substrate specificity imposed by the acylation state of lipid A, and the mechanism of PEtN in enhancing hTLR4/MD2 signaling.	[Komazin, Gloria; Maybin, Michael; Meredith, Timothy C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Woodard, Ronald W.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Scior, Thomas] Benemerita Univ Autonoma Puebla, Fac Ciencias Quim, Puebla 72000, Mexico; [Schwudke, Dominik; Schombel, Ursula; Gisch, Nicolas] Leibniz Lung Ctr, Res Ctr Borstel, Bioanalyt Chem Prior Res Area Infect, D-23845 Borstel, Germany; [Mamat, Uwe] Leibniz Lung Ctr, Res Ctr Borstel, Cellular Microbiol, Prior Res Area Infect, D-23845 Borstel, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; Benemerita Universidad Autonoma de Puebla; Forschungszentrum Borstel; Forschungszentrum Borstel	Meredith, TC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	txm50@psu.edu	Thomas, alias Tom Scior/AAM-9189-2020; Schwudke, Dominik/B-3478-2013; Meredith, Timothy/X-2713-2019	Thomas, alias Tom Scior/0000-0003-2196-2682; Schwudke, Dominik/0000-0002-1379-9451; Meredith, Timothy/0000-0002-1901-6841; Gisch, Nicolas/0000-0003-3260-5269	National Institutes of Health Grants NAID [R21 AI138152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI138152] Funding Source: NIH RePORTER	National Institutes of Health Grants NAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants NAID R21 AI138152 (to TCM). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bentala H, 2002, SHOCK, V18, P561, DOI 10.1097/00024382-200212000-00013; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bilski J, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9074601; Moreira APB, 2012, NUTR HOSP, V27, P382, DOI [10.1590/S0212-16112012000200007, 10.3305/nh.2012.27.2.5543]; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Buchet R, 2013, METHODS MOL BIOL, V1053, P27, DOI 10.1007/978-1-62703-562-0_3; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Chen HD, 2013, ANNU REV MICROBIOL, V67, P83, DOI 10.1146/annurev-micro-092412-155751; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cullen TW, 2013, INFECT IMMUN, V81, P430, DOI 10.1128/IAI.01046-12; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; DALNOGARE AR, 1990, J IMMUNOL, V144, P1404; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Duseja A, 2014, CLIN LIVER DIS, V18, P59, DOI 10.1016/j.cld.2013.09.002; Esparza GA, 2012, INNATE IMMUN-LONDON, V18, P478, DOI 10.1177/1753425911422723; Faas MM, 2017, MOL ASPECTS MED, V55, P9, DOI 10.1016/j.mam.2017.01.002; Fawley J, 2016, J SURG RES, V202, P225, DOI 10.1016/j.jss.2015.12.008; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; Ghosh K, 2013, J STRUCT BIOL, V184, P182, DOI 10.1016/j.jsb.2013.09.017; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Gorelik A, 2018, P NATL ACAD SCI USA, V115, pE896, DOI 10.1073/pnas.1719834115; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Gregg KA, 2017, MBIO, V8, DOI [10.1128/mBio.00492-17, 10.1128/mbio.00492-17]; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HALL CL, 1983, P NATL ACAD SCI-BIOL, V80, P6671, DOI 10.1073/pnas.80.21.6671; HARKNESS DR, 1968, ARCH BIOCHEM BIOPHYS, V126, P513, DOI 10.1016/0003-9861(68)90436-0; Henderson JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50623; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HULETT FM, 1991, J BIOL CHEM, V266, P1077; JANSSON PE, 1981, EUR J BIOCHEM, V115, P571; John CM, 2012, INFECT IMMUN, V80, P4014, DOI 10.1128/IAI.00506-12; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kiffer-Moreira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089374; Klein G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020356; Klein G, 2013, J BIOL CHEM, V288, P8111, DOI 10.1074/jbc.M112.445981; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Kutschera A, 2019, SCIENCE, V364, P178, DOI 10.1126/science.aau1279; Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; LEHRER S, 1972, INFECT IMMUN, V6, P928, DOI 10.1128/IAI.6.6.928-933.1972; Linder CH, 2009, BONE, V45, P987, DOI 10.1016/j.bone.2009.07.009; Liu MF, 2010, J IMMUNOL, V185, P6974, DOI 10.4049/jimmunol.1000953; LOPPNOW H, 1989, J IMMUNOL, V142, P3229; Maldonado RF, 2016, FEMS MICROBIOL REV, V40, P480, DOI 10.1093/femsre/fuw007; Malo MS, 2010, GUT, V59, P1476, DOI 10.1136/gut.2010.211706; Malo MS, 2014, AM J PHYSIOL-GASTR L, V306, pG826, DOI 10.1152/ajpgi.00357.2013; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; McClure R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00386; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; Meng JM, 2011, J IMMUNOL, V187, P3683, DOI 10.4049/jimmunol.1101397; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Merighi M, 2005, J BACTERIOL, V187, P7407, DOI 10.1128/JB.187.21.7407-7416.2005; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Moreno-Indias I, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00190; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Moss AK, 2013, AM J PHYSIOL-GASTR L, V304, pG597, DOI 10.1152/ajpgi.00455.2012; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Neves AL, 2013, J MOL ENDOCRINOL, V51, pR51, DOI 10.1530/JME-13-0079; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ouchi N, 2012, NAGOYA J MED SCI, V74, P19; Packiam M, 2014, INFECT IMMUN, V82, P2170, DOI 10.1128/IAI.01504-14; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Peters E, 2015, BRIT J PHARMACOL, V172, P4932, DOI 10.1111/bph.13261; Pettengill M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175936; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piya MK, 2013, CURR OPIN LIPIDOL, V24, P78, DOI 10.1097/MOL.0b013e32835b4431; Poelstra K, 1997, AM J PATHOL, V151, P1163; POHLMAN TH, 1987, J EXP MED, V165, P1393, DOI 10.1084/jem.165.5.1393; Rader BA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00897; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; Ranf S, 2015, NAT IMMUNOL, V16, P426, DOI 10.1038/ni.3124; Renzi F, 2016, INFECT IMMUN, V84, P550, DOI 10.1128/IAI.01006-15; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; RICK PD, 1977, J BIOL CHEM, V252, P4904; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; ROSNER MR, 1979, J BIOL CHEM, V254, P5906; Schromm AB, 1998, J IMMUNOL, V161, P5464; Scior T, 2007, DRUG DESIGN RES PERS, P675; Scior T, 2013, COMPUT STRUCT BIOTEC, V5, DOI 10.5936/csbj.201302012; Shifrin DA, 2012, CURR BIOL, V22, P627, DOI 10.1016/j.cub.2012.02.022; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; STRAIN SM, 1983, J BIOL CHEM, V258, P2906; STRAIN SM, 1985, J BIOL CHEM, V260, P6089; Sunden F, 2016, J AM CHEM SOC, V138, P14273, DOI 10.1021/jacs.6b06186; Thompson M., 2004, ACS M PHIL PA; Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tuin A, 2006, AM J PHYSIOL-GASTR L, V290, pG377, DOI 10.1152/ajpgi.00147.2005; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; WANG MH, 1991, INFECT IMMUN, V59, P4655, DOI 10.1128/IAI.59.12.4655-4664.1991; White KA, 1999, J BIOL CHEM, V274, P31391, DOI 10.1074/jbc.274.44.31391; Yang WH, 2018, CELL HOST MICROBE, V24, P500, DOI 10.1016/j.chom.2018.09.011; Yang Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00314; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Zariri A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36575; Zariri A, 2015, EXPERT REV VACCINES, V14, P861, DOI 10.1586/14760584.2015.1026808; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	120	7	8	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19405	19423		10.1074/jbc.RA119.010836	http://dx.doi.org/10.1074/jbc.RA119.010836			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31704704	Green Published, hybrid			2022-12-26	WOS:000516527800036
J	Miller, MS; Douglass, J; Hwang, MS; Skora, AD; Murphy, M; Papadopoulos, N; Kinzler, KW; Vogelstein, B; Zhou, SB; Gabelli, SB				Miller, Michelle S.; Douglass, Jacqueline; Hwang, Michael S.; Skora, Andrew D.; Murphy, Michael; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Zhou, Shibin; Gabelli, Sandra B.			An engineered antibody fragment targeting mutant beta-catenin via major histocompatibility complex I neoantigen presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; ANTI-P185HER2 ANTIBODY; NEURAL-NETWORKS; CANCER; GENERATION; MUTATIONS; THERAPY; PEPTIDE; CELLS	Mutations in CTNNB1, the gene encoding beta-catenin, are common in colon and liver cancers, the most frequent mutation affecting Ser-45 in beta-catenin. Peptides derived from WT beta-catenin have previously been shown to be presented on the cell surface as part of major histocompatibility complex (MHC) class I, suggesting an opportunity for targeting this common driver gene mutation with antibody-based therapies. Here, crystal structures of both the WT and S45F mutant peptide bound to HLA-A*03:01 at 2.20 and 2.45 angstrom resolutions, respectively, confirmed the accessibility of the phenylalanine residue for antibody recognition. Phage display was then used to identify single-chain variable fragment clones that selectively bind the S45F mutant peptide presented in HLA-A*03:01 and have minimal WT or other off-target binding. Following the initial characterization of five clones, we selected a single clone, E10, for further investigation. We developed a computational model of the binding of E10 to the mutant peptide-bound HLA-A3, incorporating data from affinity maturation as initial validation. In the future, our model may be used to design clones with maintained specificity and higher affinity. Such derivatives could be adapted into either cell-based (CAR-T) or protein-based (bispecific T-cell engagers) therapies to target cancer cells harboring the S45F mutation in CTNNB1.	[Miller, Michelle S.; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Douglass, Jacqueline; Hwang, Michael S.; Skora, Andrew D.; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Zhou, Shibin] Johns Hopkins Univ, Sch Med, Ludwig Ctr, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21287 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [Murphy, Michael] GE Healthcare Life Sci, Marlborough, MA 01752 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Skora, Andrew D.] Eli Lilly & Co, Lilly Biotechnol Ctr, San Diego, CA 92121 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; General Electric; Johns Hopkins University; Eli Lilly	Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	gabelli@jhmi.edu	; Gabelli, Sandra/A-3705-2008	Miller, Michelle/0000-0003-1972-4503; Gabelli, Sandra/0000-0003-1205-5204	Lustgarten Foundation; BKI Cancer Genetics and Genomics Research Program; United States Department of Defense Grant [CDMRP BC151831]; National Institutes of Health [CA062924, P30 CA006973]; Virginia and D. K. Ludwig Fund for Cancer Research; Commonwealth Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER	Lustgarten Foundation; BKI Cancer Genetics and Genomics Research Program; United States Department of Defense Grant(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and D. K. Ludwig Fund for Cancer Research; Commonwealth Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Lustgarten Foundation (to B. V.), the BKI Cancer Genetics and Genomics Research Program (to B. V.), United States Department of Defense Grant CDMRP BC151831 (to S. B. G.), and National Institutes of Health Grants CA062924 (to S. B. G.), P30 CA006973 (to B. V.), The Virginia and D. K. Ludwig Fund for Cancer Research (to B. V. and K. W. K.) and the Commonwealth Fund (to S. Z.). B. V., K. W. K., and N. P. are founders of, hold equity in, and are consultants to Thrive Earlier Detection and Personal Genome Diagnostics. K. W. K. and N. P. are on the Board of Directors of Thrive Earlier Detection. S. Z. is a founder of, holds equity in, and serves as a consultant to Personal Genome Diagnostics, holds equity in Thrive Earlier Detection, and has a research agreement with BioMed Valley Discoveries. K. W. K and B. V. are consultants to Sysmex, Eisai, and CAGE Pharma and hold equity in CAGE Pharma. B. V. is also a consultant to Nexus, and K. W. K., B. V., S. Z., and N. P. are consultants to and hold equity in NeoPhore. Sysmex, Qiagen, Invitae, Personal Genome Diagnostics, PapGene, Thrive Earlier Detection, BioMed Valley Discoveries, Pierce Biotechnology, Horizon Discovery, Life Technologies, as well as other companies, have licensed previously described technologies from Johns Hopkins University. B. V., K. W. K., S. Z., and N. P. are inventors on some of these technologies. Licenses to these technologies are or will be associated with equity or royalty payments to the inventors as well as to Johns Hopkins University. Patent applications on the work described in this paper have or may be filed by Johns Hopkins University. The terms of all these arrangements are being managed by Johns Hopkins University in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman J. D, 2003, CURR PROTOC IMMUNOL; ANDERSON KS, 1993, J IMMUNOL, V151, P3407; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Catrow JL, 2015, J MED CHEM, V58, P4678, DOI 10.1021/acs.jmedchem.5b00223; Chen HJ, 2012, BIOCHEM PHARMACOL, V84, P1143, DOI 10.1016/j.bcp.2012.08.011; Cui C, 2018, TRENDS BIOCHEM SCI, V43, P623, DOI 10.1016/j.tibs.2018.06.003; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; Dietrich L, 2017, CELL CHEM BIOL, V24, P958, DOI 10.1016/j.chembiol.2017.06.013; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang L, 2016, CANCER RES, V76, P891, DOI 10.1158/0008-5472.CAN-15-1519; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Fiskus W, 2015, LEUKEMIA, V29, P1267, DOI 10.1038/leu.2014.340; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Granados DP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4600; Grossmann TN, 2012, P NATL ACAD SCI USA, V109, P17942, DOI 10.1073/pnas.1208396109; Hagen T, 2002, BIOCHEM BIOPH RES CO, V294, P324, DOI 10.1016/S0006-291X(02)00485-0; Hahne G, 2013, BIOORGAN MED CHEM, V21, P4020, DOI 10.1016/j.bmc.2013.02.050; Hsieh TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19156; Huang Z, 2014, ACS CHEM BIOL, V9, P193, DOI 10.1021/cb400795x; Hwang SY, 2016, CELL REP, V16, P28, DOI 10.1016/j.celrep.2016.05.071; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaleli NE, 2019, PROTEINS, V87, P607, DOI 10.1002/prot.25685; Kandel RA, 2018, CANCER TREAT REV, V66, P74, DOI 10.1016/j.ctrv.2018.04.005; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Kasper B, 2016, ANN SURG ONCOL, V23, P1924, DOI 10.1245/s10434-016-5132-4; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laumont CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10238; Lazar AJF, 2008, AM J PATHOL, V173, P1518, DOI 10.2353/ajpath.2008.080475; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Trufero JM, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0474-0; McMahon RM, 2011, ACTA CRYSTALLOGR D, V67, P447, DOI 10.1107/S0907444911007888; Mirabelli-Primdahl L, 1999, CANCER RES, V59, P3346; Monga SP, 2015, GASTROENTEROLOGY, V148, P1294, DOI 10.1053/j.gastro.2015.02.056; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; O'Toole SA, 2013, J CLIN PATHOL, V66, P530, DOI 10.1136/jclinpath-2012-201361; Perna F, 2017, CANCER CELL, V32, P506, DOI 10.1016/j.ccell.2017.09.004; Sankar K, 2018, PROTEINS, V86, P1147, DOI 10.1002/prot.25594; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schneider JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06845-3; Shin SH, 2017, EBIOMEDICINE, V25, P22, DOI 10.1016/j.ebiom.2017.09.029; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Skora AD, 2015, P NATL ACAD SCI USA, V112, P9967, DOI 10.1073/pnas.1511996112; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thomas AM, 2004, J EXP MED, V200, P297, DOI 10.1084/jem.20031435; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Trosset JY, 2006, PROTEINS, V64, P60, DOI 10.1002/prot.20955; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; Wang Xiaolei, 2015, Biochem Biophys Rep, V3, P169; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu BX, 2013, ACS CHEM BIOL, V8, P524, DOI 10.1021/cb300564v; Yu J, 2015, GUT, V64, P636, DOI 10.1136/gutjnl-2013-306620; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zhang SH, 2011, MOL IMMUNOL, V49, P395, DOI 10.1016/j.molimm.2011.08.015; Zhu K, 2014, PROTEINS, V82, P1646, DOI 10.1002/prot.24551	71	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19322	19334		10.1074/jbc.RA119.010251	http://dx.doi.org/10.1074/jbc.RA119.010251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31690625	Green Published, hybrid			2022-12-26	WOS:000516527800030
J	Hu, SQ; Ma, R; Wang, H				Hu, Siquan; Ma, Ruixiong; Wang, Haiou			An improved deep learning method for predicting DNA-binding proteins based on contextual features in amino acid sequences	PLOS ONE			English	Article							RIBOSOMAL-RNA-BINDING; SECONDARY STRUCTURE	As the number of known proteins has expanded, how to accurately identify DNA binding proteins has become a significant biological challenge. At present, various computational methods have been proposed to recognize DNA-binding proteins from only amino acid sequences, such as SVM, DNABP and CNN-RNN. However, these methods do not consider the context in amino acid sequences, which makes it difficult for them to adequately capture sequence features. In this study, a new method that coordinates a bidirectional long-term memory recurrent neural network and a convolutional neural network, called CNN-BiLSTM, is proposed to identify DNA binding proteins. The CNN-BiLSTM model can explore the potential contextual relationships of amino acid sequences and obtain more features than can traditional models. The experimental results show that the CNN-BiLSTM achieves a validation set prediction accuracy of 96.5%-7.8% higher than that of SVM, 9.6% higher than that of DNABP and 3.7% higher than that of CNN-RNN. After testing on 20,000 independent samples provided by UniProt that were not involved in model training, the accuracy of CNN-BiLSTM reached 94.5%-12% higher than that of SVM, 4.9% higher than that of DNABP and 4% higher than that of CNN-RNN. We visualized and compared the model training process of CNN-BiLSTM with that of CNN-RNN and found that the former is capable of better generalization from the training dataset, showing that CNN-BiLSTM has a wider range of adaptations to protein sequences. On the test set, CNN-BiLSTM has better credibility because its predicted scores are closer to the sample labels than are those of CNN-RNN. Therefore, the proposed CNN-BiLSTM is a more powerful method for identifying DNA-binding proteins.	[Hu, Siquan; Ma, Ruixiong] Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Beijing, Peoples R China; [Hu, Siquan] Sichuan Jiuzhou Video Technol Co Ltd, Mianyang, Sichuan, Peoples R China; [Wang, Haiou] Univ Sci & Technol Beijing, Sch Chem & Biol Engn, Beijing, Peoples R China	University of Science & Technology Beijing; University of Science & Technology Beijing	Hu, SQ (corresponding author), Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Beijing, Peoples R China.; Hu, SQ (corresponding author), Sichuan Jiuzhou Video Technol Co Ltd, Mianyang, Sichuan, Peoples R China.	husiquan@ustb.edu.cn			Sichuan Science and Technology Program, P.R. China [2018GZDZX0034]; Sichuan Jiuzhou Video Technology Co., Ltd, Mianyang, China	Sichuan Science and Technology Program, P.R. China; Sichuan Jiuzhou Video Technology Co., Ltd, Mianyang, China	This work was supported by: (1) Sichuan Science and Technology Program (No. 2018GZDZX0034), P.R. China, author: Siquan Hu; (2) Sichuan Jiuzhou Video Technology Co., Ltd, Mianyang, China, author: Siquan Hu. The funders provided support in the form of salaries for author (SH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Adilina S, 2019, J THEOR BIOL, V460, P64, DOI 10.1016/j.jtbi.2018.10.027; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; BOWEN B, 1980, NUCLEIC ACIDS RES, V8, P1, DOI 10.1093/nar/8.1.1; Brown JB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-25; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chollet F., 2018, ASTROPHYSICS SOURCE; Chowdhury SY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14945-1; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Figliuzzi M, 2016, MOL BIOL EVOL, V33, P268, DOI 10.1093/molbev/msv211; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Hochreiter S, 1997, ADV NEUR IN, V9, P473; Huang Zhiheng, 2015, CORR; Hugh P, 2004, NUCLEIC ACIDS RES, V32, P4732, DOI [10.1093/nar/gkh803, DOI 10.1093/NAR/GKH803]; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Liu B., 2014, PLOS ONE, V9, P3, DOI DOI 10.1371/J0URNAL.P0NE.0106691; Liu XJ, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080394; Lou WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086703; Luscombe NM, 2000, GENOME BIOL, V1; Ma X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167345; Medsker L, 2001, RECURRENT NEURAL NET; Melamud O., 2016, P CONLL, P51; Motion GB, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv805; Pennington J., 2014, P 2014 C EMPIRICAL M, P1532, DOI DOI 10.3115/V1/D14-1162; Pichler Klemens, 2018, Curr Protoc Bioinformatics, V62, pe52, DOI 10.1002/cpbi.52; Qiu JF, 2016, EURASIP J ADV SIG PR, DOI 10.1186/s13634-016-0355-x; Qui YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188129; Rahman MS, 2018, J THEOR BIOL, V452, P22, DOI 10.1016/j.jtbi.2018.05.006; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Starosta AL, 2014, NUCLEIC ACIDS RES, V42, P10711, DOI 10.1093/nar/gku768; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; Wang P., 2015, ARXIV151100215; Wang YB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185587; Yan CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-262; Yaseen A, 2014, J CHEM INF MODEL, V54, P992, DOI 10.1021/ci400647u; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zeng HY, 2016, BIOINFORMATICS, V32, P121, DOI 10.1093/bioinformatics/btw255; Zhang Q, 2018, IEEE ACM T COMPUTATI; Zhang S, 2015, PACLIC, P73, DOI DOI 10.18653/V1/P16-2034; Zou CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-90	48	17	17	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225317	10.1371/journal.pone.0225317	http://dx.doi.org/10.1371/journal.pone.0225317			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725778	Green Published, gold			2022-12-26	WOS:000532764500075
J	Locke, DH; Polsky, C; Grove, JM; Groffman, PM; Nelson, KC; Larson, KL; Cavender-Bares, J; Heffernan, JB; Chowdhury, RR; Hobbie, SE; Bettez, ND; Hall, SJ; Neill, C; Ogden, L; O'Neil-Dunne, J				Locke, Dexter H.; Polsky, Colin; Grove, J. Morgan; Groffman, Peter M.; Nelson, Kristen C.; Larson, Kelli L.; Cavender-Bares, Jeannine; Heffernan, James B.; Chowdhury, Rinku Roy; Hobbie, Sarah E.; Bettez, Neil D.; Hall, Sharon J.; Neill, Christopher; Ogden, Laura; O'Neil-Dunne, Jarlath			Residential household yard care practices along urban-exurban gradients in six climatically-diverse US metropolitan areas	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; LAKE MENDOTA; MANAGEMENT; VEGETATION; ECOLOGY; NEIGHBORHOODS; PREDICTORS; PHOENIX; GARDENS; BOSTON	Residential land is expanding in the United States, and lawn now covers more area than the country's leading irrigated crop by area. Given that lawns are widespread across diverse climatic regions and there is rising concern about the environmental impacts associated with their management, there is a clear need to understand the geographic variation, drivers, and outcomes of common yard care practices. We hypothesized that 1) income, age, and the number of neighbors known by name will be positively associated with the odds of having irrigated, fertilized, or applied pesticides in the last year, 2) irrigation, fertilization, and pesticide application will vary quadratically with population density, with the highest odds in suburban areas, and 3) the odds of irrigating will vary by climate, but fertilization and pesticide application will not. We used multi-level models to systematically address nested spatial scales within and across six U.S. metropolitan areas-Boston, Baltimore, Miami, Minneapolis-St. Paul, Phoenix, and Los Angeles. We found significant variation in yard care practices at the household (the relationship with income was positive), urban-exurban gradient (the relationship with population density was an inverted U), and regional scales (city-tocity variation). A multi-level modeling framework was useful for discerning these scale dependent outcomes because this approach controls for autocorrelation at multiple spatial scales. Our findings may guide policies or programs seeking to mitigate the potentially deleterious outcomes associated with water use and chemical application, by identifying the subpopulations most likely to irrigate, fertilize, and/or apply pesticides.	[Locke, Dexter H.; Grove, J. Morgan] USDA Forest Serv, Baltimore Field Stn, Baltimore, MD 21228 USA; [Polsky, Colin] Florida Atlantic Univ, Ctr Environm Studies, Davie, FL USA; [Groffman, Peter M.] CUNY, Adv Sci Res Ctr, 85 St Nicholas Terrace, New York, NY 10021 USA; [Groffman, Peter M.] Brooklyn Coll, Dept Earth & Environm Sci, 85 St Nicholas Terrace, New York, NY USA; [Nelson, Kristen C.] Univ Minnesota, Dept Forest Resources, Minneapolis, MN 55455 USA; [Nelson, Kristen C.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, Minneapolis, MN 55455 USA; [Larson, Kelli L.] Arizona State Univ, Sch Geog Sci, Tempe, AZ USA; [Larson, Kelli L.] Arizona State Univ, Sch Urban Planning, Tempe, AZ USA; [Larson, Kelli L.] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA; [Cavender-Bares, Jeannine; Hobbie, Sarah E.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Heffernan, James B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Chowdhury, Rinku Roy] Grad Sch Geog, Worcester, MA USA; [Bettez, Neil D.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Hall, Sharon J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Neill, Christopher] Woods Hole Res Ctr, Falmouth, MA USA; [Ogden, Laura] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [O'Neil-Dunne, Jarlath] Univ Vermont, Spatial Anal Lab, Rubenstein Sch Environm & Nat Resources, Aiken Ctr, Burlington, VT USA	United States Department of Agriculture (USDA); United States Forest Service; State University System of Florida; Florida Atlantic University; City University of New York (CUNY) System; City University of New York (CUNY) System; Brooklyn College (CUNY); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Minnesota System; University of Minnesota Twin Cities; Duke University; Cary Institute of Ecosystem Studies; Arizona State University; Arizona State University-Tempe; Woods Hole Research Center; Dartmouth College; University of Vermont	Locke, DH (corresponding author), USDA Forest Serv, Baltimore Field Stn, Baltimore, MD 21228 USA.	dexter.locke@usda.gov	Cavender-Bares, Jeannine/K-5716-2013	Hall, Sharon/0000-0002-8859-6691; Locke, Dexter/0000-0003-2704-9720; Grove, J. Morgan/0000-0002-7803-074X; Cavender-Bares, Jeannine/0000-0003-3375-9630	Macro-Systems Biology Program (US NSF) [EF-1065548, EF-1065737, EF-1065740, EF-1065741, EF-1065772, EF-1065785, EF-1065831, EF-121238320]; NIFA McIntire-Stennis [1000343 MIN-42051]; NSF LTER for Baltimore [DEB-0423476, DEB-1027188]; Edna Bailey Sussman Foundation; Libby Fund Enhancement Award; Marion I. Wright `46 Travel Grant at Clark University; Warnock Foundation; USDA Forest Service Northern Research Station; Baltimore Field Station; Philadelphia Field Station; National Socio-Environmental Synthesis Center (SESYNC) under the National Science Foundation [DBI1052875]; NSF LTER program for Phoenix [BCS-1026865, DEB-0423704, DEB-9714833, DEB1637590, DEB-1832016]; NSF LTER program for Plum Island, Boston [OCE-1058747, 1238212]; NSF LTER program for Florida Coastal Everglades, Miami [DBI-0620409]; NSF LTER program for Cedar Creek, Minneapolis-St. Paul [DEB-0620652];  [DC-BC ULTRA-Ex NSF-DEB-0948947]	Macro-Systems Biology Program (US NSF); NIFA McIntire-Stennis; NSF LTER for Baltimore; Edna Bailey Sussman Foundation; Libby Fund Enhancement Award; Marion I. Wright `46 Travel Grant at Clark University; Warnock Foundation; USDA Forest Service Northern Research Station(United States Department of Agriculture (USDA)United States Forest Service); Baltimore Field Station; Philadelphia Field Station; National Socio-Environmental Synthesis Center (SESYNC) under the National Science Foundation; NSF LTER program for Phoenix; NSF LTER program for Plum Island, Boston; NSF LTER program for Florida Coastal Everglades, Miami; NSF LTER program for Cedar Creek, Minneapolis-St. Paul; 	This research is supported by the Macro-Systems Biology Program (US NSF) under Grants EF-1065548, -1065737, -1065740, -1065741, -1065772, -1065785, -1065831, and -121238320 and the NIFA McIntire-Stennis 1000343 MIN-42051. The work arose from research funded by grants from the NSF LTER program for Baltimore (DEB-0423476, DEB-1027188); Phoenix (BCS-1026865, DEB-0423704, DEB-9714833, DEB1637590, DEB-1832016); Plum Island, Boston (OCE-1058747 and 1238212); Cedar Creek, Minneapolis-St. Paul (DEB-0620652); and Florida Coastal Everglades, Miami (DBI-0620409). Edna Bailey Sussman Foundation, Libby Fund Enhancement Award and the Marion I. Wright `46 Travel Grant at Clark University, The Warnock Foundation, the USDA Forest Service Northern Research Station, Baltimore and Philadelphia Field Stations, and the DC-BC ULTRA-Ex NSF-DEB-0948947 also provided support. This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI1052875. Anonymous reviewers supplied constructive feedback that helped to improve this paper. The findings and opinions reported here do not necessarily reflect those of the funders of this research.	Aguinis H, 2013, J MANAGE, V39, P1490, DOI 10.1177/0149206313478188; Bates D, 2014, J STAT SOF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bennett EM, 1999, ECOSYSTEMS, V2, P69, DOI 10.1007/s100219900059; Bormann F. H., 2001, REDESIGNING AM LAWN; Carpenter Stephen R., 2006, P236; Carrico AR, 2013, ENVIRON BEHAV, V45, P427, DOI 10.1177/0013916511434637; Chowdhury R. R., 2011, CITIES ENV CATE, V4, P1, DOI 10.15365/cate.4162011; Claritas Inc, 2008, PRIZM SEGM NARR; Fraser JC, 2013, LANDSCAPE URBAN PLAN, V115, P30, DOI 10.1016/j.landurbplan.2013.02.013; Giner NM, 2013, LANDSCAPE URBAN PLAN, V111, P25, DOI 10.1016/j.landurbplan.2012.12.006; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grove JM, 2006, ECOSYSTEMS, V9, P578, DOI 10.1007/s10021-006-0116-z; Grove JM, 2014, ENVIRON MANAGE, V54, P402, DOI 10.1007/s00267-014-0310-2; Grove JM, 2006, SOC NATUR RESOUR, V19, P117, DOI 10.1080/08941920500394501; Harris EM, 2013, PROF GEOGR, V65, P345, DOI 10.1080/00330124.2012.681586; Harris EM, 2012, HUM ECOL, V40, P735, DOI 10.1007/s10745-012-9514-3; Hernke MT, 2011, ECOHEALTH, V8, P223, DOI 10.1007/s10393-011-0697-7; Hope D, 2006, SOC NATUR RESOUR, V19, P101, DOI 10.1080/08941920500394469; Hope D, 2003, P NATL ACAD SCI USA, V100, P8788, DOI 10.1073/pnas.1537557100; Jenkins VS, LAWN HIST AM OBSESSI; Kara EL, 2012, AQUAT SCI, V74, P241, DOI 10.1007/s00027-011-0215-6; Kuznetsova A., 2015, R PACKAGE VERSION PA; Larson K. L., 2014, CITIES ENV, V7, P6; Larson KL, 2009, ENVIRON MANAGE, V44, P921, DOI 10.1007/s00267-009-9353-1; Lepczyk CA, 2004, ENVIRON MANAGE, V33, P110, DOI 10.1007/s00267-003-0036-z; Locke D.H., 2016, J URBAN ECOL, V1, P1, DOI [10.1093/jue/juw006, DOI 10.1093/JUE/JUW006]; Locke DH, 2018, SOC NATUR RESOUR, V31, P1169, DOI 10.1080/08941920.2018.1481549; Locke DH, 2016, APPL SPAT ANAL POLIC, V9, P77, DOI 10.1007/s12061-014-9131-1; Marco A, 2008, CR BIOL, V331, P452, DOI 10.1016/j.crvi.2008.03.007; Martin CA, 2004, LANDSCAPE URBAN PLAN, V69, P355, DOI 10.1016/j.landurbplan.2003.10.034; Martini NF, 2015, ENVIRON BEHAV, V47, P158, DOI 10.1177/0013916513492418; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Nassauer JI, 2009, LANDSCAPE URBAN PLAN, V92, P282, DOI 10.1016/j.landurbplan.2009.05.010; ODUM WE, 1982, BIOSCIENCE, V32, P728, DOI 10.2307/1308718; Pham T-T-H, 2012, URBAN FOR URBAN GREE; Polsky C, 2014, P NATL ACAD SCI USA, V111, P4432, DOI 10.1073/pnas.1323995111; R Core Team, 2021, R LANGUAGE ENV STAT; Robbins P, 2003, ECON GEOGR, V79, P425; Robbins P, 2001, CITIES, V18, P369, DOI 10.1016/S0264-2751(01)00029-4; Robbins P., 2012, LAWN PEOPLE GRASSES; Robinson WS, 1950, AM SOCIOLOGICAL REV, V15; Scotts, 1998, SCOTSS LAWNC SPEC AN, P11; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Pham TTH, 2012, LANDSCAPE URBAN PLAN, V107, P214, DOI 10.1016/j.landurbplan.2012.06.002; Yabiku ST, 2008, ENVIRON BEHAV, V40, P382, DOI 10.1177/0013916507300359; Zhou WQ, 2009, SOC NATUR RESOUR, V22, P744, DOI 10.1080/08941920802074330	48	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0222630	10.1371/journal.pone.0222630	http://dx.doi.org/10.1371/journal.pone.0222630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1QS	31721782	gold, Green Published			2022-12-26	WOS:000532720700005
J	Medhin, LB; Achila, OO; Abrham, AT; Efrem, B; Hailu, K; Abraha, DM; Gilazghi, L; Meresie, A; Said, SM				Medhin, Lidia Biniam; Achila, Oliver Okoth; Abrham, Adiam Tesfamariam; Efrem, Biniam; Hailu, Kibrom; Abraha, Daniel Mebrahtu; Gilazghi, Luwam; Meresie, Alay; Said, Salih Mohammed			Incidence of colorectal cancer in Eritrea: Data from the National Health Laboratory, 2011-2017	PLOS ONE			English	Article							EPIDEMIOLOGY	Introduction Recent studies have reported a significant increase in the prevalence of colorectal cancer (CRC) in Sub-Saharan Africa (SSA). Further, several studies employing disparate modelling algorithms have projected a significant rise in the frequency of CRC cases in the region. However, lack of good quality data on multiple themes related to CRC including incidence, among others, continues to be a problem in the region. Therefore, this study was designed to collect data on the incidence of CRC in Eritrea. Methods We conducted a retrospective analysis using data captured between 2011 and 2017 at the National Health Laboratory (NHL) in Asmara, Eritrea. Results 241 colorectal cases were identified in the Eritrean National Health Laboratory (NHL) database between 2011 and 2017. In the final analysis we included 94 patients confirmed cases giving an average of 18.8 patients per annum. The average age Standard deviation (SD) was 57.62 17.14 with a male: female ratio of 58/36 (1: 1.61). The minimum and maximum age of the patients was 19 and 90 years, respectively. The rectum to colon ratio was 47/47 (1:1). The proportion of patients < 50 years in this cohort was significant. The age -standardized incidence rate (ASIR) in the study period was between 0.97 per 100 000 to 2.21 per 100 000. Similarly, the cumulative ASIR was 9.97 per 100 000. Analysis of trends did not reveal shifts over the study period (P<0.05). However, a strong correlation between incidence and age was established. Conclusion This study suggests that the incidence of CRC in Eritrea is relatively low. A significant number of patients were less than 50 years of age. Even then it's our opinion that this study may underestimate the incidence of CRC.	[Medhin, Lidia Biniam; Hailu, Kibrom] Natl Hlth Lab, Pathol, Asmera, Eritrea; [Achila, Oliver Okoth; Abrham, Adiam Tesfamariam; Efrem, Biniam] Orotta Sch Med & Hlth Sci, Clin Lab Sci, Asmera, Eritrea; [Abraha, Daniel Mebrahtu] Natl Hlth Lab, Hematol, Asmera, Eritrea; [Gilazghi, Luwam] Natl Hlth Lab, Immunoserol, Asmera, Eritrea; [Meresie, Alay] Natl Hlth Lab, Clin Chem, Asmera, Eritrea; [Said, Salih Mohammed] Natl Hlth Lab, Microbiol, Asmera, Eritrea		Medhin, LB (corresponding author), Natl Hlth Lab, Pathol, Asmera, Eritrea.	lidibinimed@gmail.com	Achila, Oliver O/M-9977-2017	MEDHIN, LIDIA/0000-0002-2438-5588				Anderson WF, 2003, CANCER METAST REV, V22, P67, DOI 10.1023/A:1022264002228; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Asombang AW, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.248.12464; Bray F, CA CANC J CLIN; Cronje L, 2009, S AFR J SCI, V105, P68, DOI 10.1590/s0038-23532009000100023; Davis DM, 2011, J AM COLL SURGEONS, V213, P352, DOI 10.1016/j.jamcollsurg.2011.04.033; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Giles WH., 2010, GLOB HEALTH PROMOT, V3-05; Graham Alice, 2012, J Glob Health, V2, P020404, DOI 10.7189/jogh.02.020204; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Hagos A, 2016, UK J PHARM BIOSCI, V4, P47, DOI DOI 10.20510/ukjpb/4/i5/118035; Irabor D, 2009, EUR J CANCER CARE, V18, P110, DOI 10.1111/j.1365-2354.2008.00982.x; Irabor DO, 2014, J CANCER RES CLIN, V2014, DOI [10.1155/2014/267190, DOI 10.1155/2014/267190]; Kolligs FT, 2016, VISC MED, V32, P158, DOI 10.1159/000446488; Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Marley AR, 2016, INT J MOL EPIDEMIOL, V7, P105; Meetoo Danny, 2008, Br J Nurs, V17, P1320; Moolla Z, 2014, WORLD J SURG, V38, P2466, DOI 10.1007/s00268-014-2595-y; Ngeow J, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv325; O'Keefe SJD, 2007, J NUTR, V137, p175S, DOI 10.1093/jn/137.1.175S; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Walker ARP, 2002, EUR J CANCER PREV, V11, P187, DOI 10.1097/00008469-200204000-00012; World Health Organization, 2000, INT CLASSIFICATION D	24	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224045	10.1371/journal.pone.0224045	http://dx.doi.org/10.1371/journal.pone.0224045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721763	Green Published, gold			2022-12-26	WOS:000532720700011
J	Koim-Puchowska, B; Klosowski, G; Mikulski, D; Menka, A				Koim-Puchowska, Beata; Klosowski, Grzegorz; Mikulski, Dawid; Menka, Aleksandra			Evaluation of various methods of selection of B. subtilis strains capable of secreting surface-active compounds	PLOS ONE			English	Article							ENHANCED OIL-RECOVERY; BACILLUS-SUBTILIS; BIOSURFACTANT PRODUCTION; LIPOPEPTIDE BIOSURFACTANT; ISOFORMS; REMOVAL; BIODEGRADATION; IDENTIFICATION; OPTIMIZATION; BACTERIAL	The aim of the study was the evaluation of a three-step method for the selection of bacterial strains capable of producing surfactin. The procedure consisted of the following steps: 1. blood agar test, 2. measurement of the surface tension (ST) of the medium using the du Nouy method before and after submerged culture, 3. qualitative and quantitative assessment of surfactin by HPLC. Forty five Bacillus subtilis natto strains producing haemolysis zones (>= 3mm) were selected. Nineten of them reduced ST of the medium to. 40 mN/m; in six cases, the reduction was as much as 50%. All indicated strains produced surfactin. Positive correlations (p < 0.5) between the percentage reduction of ST of the medium and surfactin concentration (r = 0.44), indicate that this parameter is determinant of the ability to synthesize this compound. The blood agar test has been shown to be useful only as a preselection criterion for surfactin producers (18 strains selected by this method reduced ST by only <= 30%). The proposed selection strategy proved effective and made it possible to select the BS15 strain that reduced the ST of the medium to 30.56 +/- 0.15 mN/m and simultaneously provided a high concentration of surfactin compared to other strains.	[Koim-Puchowska, Beata; Klosowski, Grzegorz; Mikulski, Dawid; Menka, Aleksandra] Kazimierz Wielki Univ, Dept Biotechnol, Bydgoszcz, Poland	Kazimierz Wielki University	Klosowski, G (corresponding author), Kazimierz Wielki Univ, Dept Biotechnol, Bydgoszcz, Poland.	klosowski@ukw.edu.pl	Koim-Puchowska, Beata/AAP-4361-2020; Mikulski, Dawid/AAS-5806-2020	Koim-Puchowska, Beata/0000-0002-0744-0231; Mikulski, Dawid/0000-0001-9989-3029; Klosowski, Grzegorz/0000-0002-4678-4512	 [008/RID/2018/19]		This study was funded by the Polish Minister of Science and Higher Education, under the program "Regional Initiative of Excellence" in 2019-2022 (Grant No. 008/RID/2018/19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2008, APPL BIOCHEM BIOTECH, V150, P289, DOI 10.1007/s12010-008-8153-z; Al-Bahry SN, 2013, INT BIODETER BIODEGR, V81, P141, DOI 10.1016/j.ibiod.2012.01.006; Al-Wahaibi Y, 2014, COLLOID SURFACE B, V114, P324, DOI 10.1016/j.colsurfb.2013.09.022; Alonso S, 2016, BIOCHEM ENG J, V110, P125, DOI 10.1016/j.bej.2016.02.006; Amani H, 2013, PETROL SCI TECHNOL, V31, P1249, DOI 10.1080/10916466.2010.542416; [Anonymous], 2016, ACMITE MARKET INTELL; Banat IM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00697; Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648; Bezza FA, 2015, BIOCHEM ENG J, V101, P168, DOI 10.1016/j.bej.2015.05.007; Bonmatin JM, 2003, COMB CHEM HIGH T SCR, V6, P541; Chaprao MJ, 2015, ELECTRON J BIOTECHN, V18, P471, DOI 10.1016/j.ejbt.2015.09.005; Chen WC, 2015, BIOCHEM ENG J, V103, P158, DOI 10.1016/j.bej.2015.07.009; COOPER DG, 1986, MICROBIOL SCI, V3, P145; COOPER DG, 1981, APPL ENVIRON MICROB, V42, P408, DOI 10.1128/AEM.42.3.408-412.1981; Czaczyk K., 2007, ZYWN-NAUK TECHNOL JA, V1, P140; Das K, 2007, PROCESS BIOCHEM, V42, P1191, DOI 10.1016/j.procbio.2007.05.011; de Faria AF, 2011, PROCESS BIOCHEM, V46, P1951, DOI 10.1016/j.procbio.2011.07.001; Dhiman R, 2016, RES J RECENT SCI, V5, P39; de Oliveira DWF, 2013, COLLOID SURFACE B, V101, P34, DOI 10.1016/j.colsurfb.2012.06.011; Gudina EJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00059; Gudina EJ, 2013, TRENDS PHARMACOL SCI, V34, P667, DOI 10.1016/j.tips.2013.10.002; Gurjar J, 2015, BIORESOURCE TECHNOL, V189, P243, DOI 10.1016/j.biortech.2015.04.013; Haddad NIA, 2008, PROTEIN PEPTIDE LETT, V15, P265, DOI 10.2174/092986608783744225; Hsieh FC, 2004, CURR MICROBIOL, V49, P186, DOI 10.1007/s00284-004-4314-7; Ilawe NV, 2018, PHYS CHEM CHEM PHYS, V20, P18158, DOI 10.1039/c8cp00691a; Ismail W, 2013, INT BIODETER BIODEGR, V84, P168, DOI 10.1016/j.ibiod.2012.04.017; Ivankovic T, 2010, ARH HIG RADA TOKSIKO, V61, P95, DOI 10.2478/10004-1254-61-2010-1943; Jackson SA, 2015, CURR OPIN BIOTECH, V33, P176, DOI 10.1016/j.copbio.2015.03.004; Jacques P, 2011, MICROBIOL MONOGR, V20, P57, DOI 10.1007/978-3-642-14490-5_3; Jajor P, 2016, J MOL STRUCT, V1126, P141, DOI 10.1016/j.molstruc.2016.02.014; Jha SS, 2016, BRAZ J MICROBIOL, V47, P955, DOI 10.1016/j.bjm.2016.07.006; Jokari S, 2013, INT J ENVIRON RES, V7, P851; Joshi S, 2008, BIORESOURCE TECHNOL, V99, P195, DOI 10.1016/j.biortech.2006.12.010; Knepper TP, 2003, COMPREHENSIVE ANAL C, P1; Lai CC, 2009, J HAZARD MATER, V167, P609, DOI 10.1016/j.jhazmat.2009.01.017; de Franca IWL, 2015, CATAL TODAY, V255, P10, DOI 10.1016/j.cattod.2015.01.046; Liu JF, 2015, INT J MOL SCI, V16, P4814, DOI 10.3390/ijms16034814; Liu JF, 2012, APPL BIOCHEM BIOTECH, V166, P2091, DOI 10.1007/s12010-012-9636-5; Liu Q, 2015, BIOCHEM ENG J, V93, P31, DOI 10.1016/j.bej.2014.08.023; Mubarak MQE, 2015, SAINS MALAYS, V44, P115, DOI 10.17576/jsm-2015-4401-16; Mukherjee S, 2006, TRENDS BIOTECHNOL, V24, P509, DOI 10.1016/j.tibtech.2006.09.005; MULLIGAN CN, 1984, J FERMENT TECHNOL, V62, P311; Nayak A, 2018, INT J ENVIRON SCI TE, P1, DOI DOI 10.1016/B978-0-323-48104-5.00001-9; Nicolas JP, 2003, BIOPHYS J, V85, P1377, DOI 10.1016/S0006-3495(03)74571-8; Nitschke M, 2006, BIORESOURCE TECHNOL, V97, P336, DOI 10.1016/j.biortech.2005.02.044; Nitschke M, 2004, APPL BIOCHEM BIOTECH, V112, P163, DOI 10.1385/ABAB:112:3:163; Pathak KV, 2014, 3 BIOTECH, V4, P41, DOI 10.1007/s13205-013-0119-3; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Ratledge C, 2006, BASIC BIOTECHNOLOGY, 3RD EDITION, P25; Razafindralambo H, 1998, J AGR FOOD CHEM, V46, P911, DOI 10.1021/jf970592d; Santos DKF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030401; Sarubbo, 2014, BIOTECHNOLOGY, V11, P1, DOI DOI 10.3390/IJMS150712523; Sen R, 2005, PROCESS BIOCHEM, V40, P2953, DOI 10.1016/j.procbio.2005.01.014; Shin KH, 2006, J HAZARD MATER, V137, P1831, DOI 10.1016/j.jhazmat.2006.05.025; Slivinski CT, 2012, PROCESS BIOCHEM, V47, P1848, DOI 10.1016/j.procbio.2012.06.014; Taskin M, 2011, J APPL MICROBIOL, V111, P826, DOI 10.1111/j.1365-2672.2011.05103.x; Vedaraman N, 2011, BRAZ J CHEM ENG, V28, P175, DOI 10.1590/S0104-66322011000200001; Vollenbroich D, 1997, BIOLOGICALS, V25, P289, DOI 10.1006/biol.1997.0099; Walter V, 2010, ADV EXP MED BIOL, V672, P1; Wang Q, 2018, PROCESS BIOCHEM, V70, P36, DOI 10.1016/j.procbio.2018.04.003; Wei YH, 2003, J BIOSCI BIOENG, V96, P174, DOI 10.1016/S1389-1723(03)90121-6; Wei YH, 2010, INT J MOL SCI, V11, P4526, DOI 10.3390/ijms11114526; Willenbacher J, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0145-0; Willenbacher J, 2014, APPL MICROBIOL BIOT, V98, P9623, DOI 10.1007/s00253-014-6010-2; Wu YS, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00761; Youssef NH, 2004, J MICROBIOL METH, V56, P339, DOI 10.1016/j.mimet.2003.11.001; Zhao F, 2017, J PETROL SCI ENG, V157, P124, DOI 10.1016/j.petrol.2017.07.022; Zhao Y, 2012, ANAL SCI, V28, P789, DOI 10.2116/analsci.28.789; Zhu Z, 2013, J ENVIRON MANAGE, V127, P96, DOI 10.1016/j.jenvman.2013.04.017	69	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225108	10.1371/journal.pone.0225108	http://dx.doi.org/10.1371/journal.pone.0225108			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31715626	Green Published, gold			2022-12-26	WOS:000532710400029
J	Sarrassat, S; Ganaba, R; Some, H; Cresswell, JA; Diallo, AH; Cousens, S; Filippi, V				Sarrassat, Sophie; Ganaba, Rasmane; Some, Henri; Cresswell, Jenny A.; Diallo, Abdoulaye H.; Cousens, Simon; Filippi, Veronique			Suboptimal infant and young child feeding practices in rural Boucle du Mouhoun, Burkina Faso: Findings from a cross-sectional population-based survey	PLOS ONE			English	Article							2-YEAR INTEGRATED AGRICULTURE; MODERATE ACUTE MALNUTRITION; RANDOMIZED CONTROLLED-TRIAL; BEHAVIOR-CHANGE; NUTRITION; PROGRAM; UNDERNUTRITION; EMPOWERMENT; INCREASES; ALIVE	Introduction In Burkina Faso in 2016, 27% and 8% of children under-5 were estimated to suffer from stunting and wasting respectively. Here, we report on infant and young child feeding (IYCF) practices in rural areas of the Boucle du Mouhoun region. Materials and methods A cross-sectional population-based survey was performed in 2017 in a representative sample of mothers of children aged 6 to 23 months. IYCF practices were assessed using 24-hour dietary recall. Logistic regression was used to identify predictors of IYCF practices. All analyses accounted for sampling stratification by child's age group and for data clustering. Results According to mothers' reports, 60% (95%CI 55, 65%) of children received the minimum meal frequency, but only 18% (95%CI 15, 22%) and 13% (95%CI 10, 16%) benefited from the minimum dietary diversity and the minimum acceptable diet respectively. Only 16% (95%CI 13, 20%) of mothers reported increasing breastfeeding or liquids and continued feeding during an episode of child illness. Knowledge of timely introduction of complementary foods and recommended feeding practices during an illness were low. Despite positive attitudes towards the introduction of key food groups, mother's perceived self-efficacy to provide children with these food groups every day was relatively low. Discussion Our findings highlight the need for interventions to improve mothers' knowledge and practices in relation to IYCF in the Boucle du Mouhoun region. Behaviour change communication strategies have the potential to improve IYCF indicators but should be tailored to the local context. The high attendance of health facilities for preventive well-baby consultations represents an opportunity for contact with caretakers that should be exploited for promotion and child growth monitoring.	[Sarrassat, Sophie; Cresswell, Jenny A.; Cousens, Simon; Filippi, Veronique] London Sch Hyg & Trop Med, Ctr Maternal Adolescent Reprod & Child Hlth, Dept Infect Dis Epidemiol, London, England; [Ganaba, Rasmane; Some, Henri] Africsante, Bobo Dioulasso, Burkina Faso; [Diallo, Abdoulaye H.] Ctr Muraz, Bobo Dioulasso, Burkina Faso	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz	Sarrassat, S (corresponding author), London Sch Hyg & Trop Med, Ctr Maternal Adolescent Reprod & Child Hlth, Dept Infect Dis Epidemiol, London, England.	sophie.sarrassat@lshtm.ac.uk		Sarrassat, Sophie/0000-0001-6872-6455; Cresswell, Jenny/0000-0002-9553-1132	Bill & Melinda Gates Foundation [OPP50838]; government of Canada; government of Ireland	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); government of Canada(CGIAR); government of Ireland	Alive & Thrive is funded by the Bill & Melinda Gates Foundation and the governments of Canada and Ireland and managed by FHI 360. This research was supported by funding from the Bill & Melinda Gates Foundation, Grant Number OPP50838.	[Anonymous], USAID OFFICE FOOD PE; Aubel J, 2012, MATERN CHILD NUTR, V8, P19, DOI 10.1111/j.1740-8709.2011.00333.x; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Cresswell JA, 2019, LANCET GLOB HEALTH, V7, pE357, DOI 10.1016/S2214-109X(18)30494-7; Cresswell JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179593; Food and Agriculture Organisation of the United Nations International Fund for Agricultural Development UNICEF World Food Programme and World Health Organisation, 2017, BUILD RES PEAC FOOD; Heckert J, 2019, SOC SCI MED, V233, P93, DOI 10.1016/j.socscimed.2019.05.016; Houngbe F, 2017, J NUTR, V147, P1410, DOI 10.3945/jn.117.247858; Jahan S, 2016, HUMAN DEV REPORT 201; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; Lassi ZS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S13; Menon P, 2016, J NUTR, V146, P2075, DOI 10.3945/jn.116.232314; Nikiema L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177839; Olney DK, 2016, J NUTR, V146, P1109, DOI 10.3945/jn.115.224261; Olney DK, 2015, J NUTR, V145, P1317, DOI 10.3945/jn.114.203539; Rawat R, 2017, J NUTR, V147, P670, DOI 10.3945/jn.116.243907; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Sanghvi T, 2016, MATERN CHILD NUTR, V12, P141, DOI 10.1111/mcn.12277; Tonguet-Papucci A, 2017, J NUTR, V147, P1418, DOI 10.3945/jn.116.244517; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; World Health Organization, 2008, DEF CONCL CONS M H 1; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224769	10.1371/journal.pone.0224769	http://dx.doi.org/10.1371/journal.pone.0224769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714910	Green Published, Green Accepted, gold			2022-12-26	WOS:000532710400013
J	Si, HB; Ma, P; Liang, QY; Yin, YJ; Wang, P; Zhang, Q; Wang, SF; Deng, HS				Si, Hongbin; Ma, Peng; Liang, Qiying; Yin, Youjie; Wang, Ping; Zhang, Qi; Wang, Saifei; Deng, Hansong			Overexpression of pink1 or parkin in indirect flight muscles promotes mitochondrial proteostasis and extends lifespan in Drosophila melanogaster	PLOS ONE			English	Article							MITOPHAGY; P62/SQSTM1; MECHANISMS; NEURONS; DISEASE	Dysfunctional mitochondria have been implicated in aging and age-related disorders such as Parkinson's diseases (PD). We previously showed that pink1 and parkin, two familial PD genes, function in a linear pathway to maintain mitochondrial integrity and function. Studies of mammalian cell lines also suggest that these genes regulate mitochondrial autophagy (mitophagy). Overexpressing Parkin promotes proteostasis and function of aged muscles both in fruit flies and mice, and recent studies also indicated that mitochondrial ubiquitination are accumulated in aged muscles. However, the underlying mechanisms for pink1 and parkin mediated mitophagy on longevity is not fully understood. Here, we found that mitochondrial ubiquitination increased in indirect flight muscles (IFMs) in an age-dependent manner. Overexpression of pink1 or parkin in IFMs can abolish mitochondrial ubiquitination, restore ATP level and extend lifespan, while blocking autophagy via ATG1 knock-down suppress these effects in aged IFMs. Taken together, these results show that pink1/parkin promotes mitophagy of mitochondrial ubiquitination in aged muscles and extend lifespan in an Atg1-dependent manner. Our study provides physiological evidence that mitophagy of mitochondrial ubiquitination mediated by PINK1/Parkin is crucial for muscle function and highlights the role of mitophagy in the pathogenesis of chronic diseases like PD.	[Si, Hongbin; Liang, Qiying] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Peoples R China; [Ma, Peng; Yin, Youjie; Wang, Ping; Zhang, Qi; Wang, Saifei; Deng, Hansong] Tongji Univ, Shanghai East Hosp, Sch Life Sci & Technol, Shanghai, Peoples R China	Guangxi University; Tongji University	Deng, HS (corresponding author), Tongji Univ, Shanghai East Hosp, Sch Life Sci & Technol, Shanghai, Peoples R China.	hdeng@tongji.edu.cn			National Key Research and Development Project [2018YFA0107100]	National Key Research and Development Project	This work was supported by a National Key Research and Development Project (2018YFA0107100) to HD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio R, 2019, CELL REP, V28, P1029, DOI 10.1016/j.celrep.2019.06.070; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cornelissen T, 2018, ELIFE, V7, DOI 10.7554/eLife.35878; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Khalil B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.581; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Leduc-Gaudet JP, 2019, J PHYSIOL-LONDON, V597, P1975, DOI 10.1113/JP277157; Ma P, 2018, MOL BIOL CELL, V29, P3082, DOI 10.1091/mbc.E18-04-0243; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013151; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958	30	15	17	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225214	10.1371/journal.pone.0225214	http://dx.doi.org/10.1371/journal.pone.0225214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LH3TJ	31714929	gold, Green Published			2022-12-26	WOS:000528709700001
J	Pagh, S; Pertoldi, C; Petersen, HH; Jensen, TH; Hansen, MS; Madsen, S; Kraft, DCE; Iversen, N; Roslev, P; Chriel, M				Pagh, Sussie; Pertoldi, Cino; Petersen, Heidi Huus; Jensen, Trine Hammer; Hansen, Mette Sif; Madsen, Sussi; Kraft, David Chr Evar; Iversen, Niels; Roslev, Peter; Chriel, Mariann			Methods for the identification of farm escapees in feral mink (Neovison vison) populations	PLOS ONE			English	Article							FOX VULPES-VULPES; AMERICAN MINK; BODY-SIZE; MUSTELA-VISON; DIMORPHISM; CONSEQUENCES; VACCINATION; INCREASE; IMPACTS; SPAIN	In Denmark, American mink (Neovison vison) have been bred for their fur since the mid-1920s. Mink escaping from farms may supply the feral population. Often, it is of biological and management interest to separate the population of feral mink (i.e. mink caught in the wild) in two groups: 1) mink born on farms i.e., escapees, and 2) mink born in the wild. In this study, two methods were used for separating feral mink into the two groups: a) Comparison of body length of farmed mink and feral mink, and b) Presence of a biomarker (tetracycline: an oral antibiotic used on mink farms). A total of 367 wild caught mink (from the mainland of Denmark and the island of Bornholm), and 147 mink from farms, collected during the period 2014-2018, were used for the analysis of body length. For the testing of tetracycline (TC) as a biomarker, 78 mink from farms where there was knowledge about TC treatment (with or without) were examined for fluorescent markings in the canine teeth. Results from both univariate analyses and Gaussian mixture model analysis demonstrated clear divisions between the mean body length (mean +/- S.E., range) of farmed males (52.1 cm +/- 0.4, 48-68) and farmed females (mean 44.0 +/- 0.2, 40-50), and between farmed mink and wild caught mink. Mixture analysis identified two groups within each sex of the wild caught mink, one assigned to farmed mink (born in captivity) and another group of smaller mink suspected of being born in the wild. On Bornholm, the mean (+/- SD, range) length of males born in the wild was 43.7cm (+/- 0.3, 36-57) and for females 37.5cm (+/- 0.3, 32-45). The mean length (+/- SD, range) of males born in the wild in the mainland of Denmark was 42.5cm (+/- 2.3, 36-46) and for females 36.1cm (+/- 1.0, 34-37). Among the feral mink from mainland Denmark, 28.4% of males and 21.6% of females were identified as escapees, while 0% of the males and 1% of the females were identified as escapees among the wild caught mink on Bornholm. Eight percent of mink from farms using tetracycline were false negatives, while no false positives were found among mink from farms not using TC. TC fluorescence was found in five of 217 mink caught in the wild equivalent to 22% escapees in mainland Denmark. No TC markings were found in mink caught in the wild on Bornholm. In conclusion, both methods a) the body length of mink, and b) fluorescent biomarkers in canine teeth are considered as useful tools to identifing mink that have escaped from farms.	[Pagh, Sussie; Pertoldi, Cino; Jensen, Trine Hammer; Iversen, Niels; Roslev, Peter] Aalborg Univ, Dept Chem & Biosci, Sect Biol & Environm Sci, Aalborg, Denmark; [Pertoldi, Cino; Jensen, Trine Hammer] Aalborg Zoo, Aalborg, Denmark; [Petersen, Heidi Huus; Hansen, Mette Sif; Chriel, Mariann] Tech Univ Denmark, Natl Vet Inst, Lyngby, Denmark; [Madsen, Sussi; Kraft, David Chr Evar] Univ Aarhus, Dept Dent & Oral Hlth, Aarhus, Denmark	Aalborg University; Technical University of Denmark; Aarhus University	Pagh, S (corresponding author), Aalborg Univ, Dept Chem & Biosci, Sect Biol & Environm Sci, Aalborg, Denmark.	sup@bio.aau.dk	Dietz, Rune/F-9154-2015; Pertoldi, Cino/I-1746-2012; Iversen, Niels/H-1544-2013	Dietz, Rune/0000-0001-9652-317X; Pertoldi, Cino/0000-0002-4644-8981; Iversen, Niels/0000-0002-5316-0425; Petersen, Heidi Huus/0000-0002-7208-7614; Kraft, David/0000-0002-2973-7546	Danish Environmental Environmental protection agency	Danish Environmental Environmental protection agency	The Danish Environmental Environmental protection agency, funded the study; however, the funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Baker PJ, 2004, BEHAV ECOL, V15, P766, DOI 10.1093/beheco/arh077; Banks PB, 2004, OIKOS, V105, P79; Bonesi L, 2007, BIOL CONSERV, V134, P470, DOI 10.1016/j.biocon.2006.09.006; Brzezinski M, 2018, J ZOOL, V304, P109, DOI 10.1111/jzo.12500; Brzezinski M, 2014, ECOTOXICOLOGY, V23, P767, DOI 10.1007/s10646-014-1213-y; Bugnon P, 2004, J VET MED B, V51, P433, DOI 10.1111/j.1439-0450.2004.00801.x; Christensen TK, VILDTUDBYTTESTATISTI; Clausen J., 2018, DANSK PELSAVL FAGBLA; DAYAN T, 1994, ECOLOGY, V75, P1063, DOI 10.2307/1939430; Garshelis DL, 1997, J WILDLIFE MANAGE, V61, P466, DOI 10.2307/3802605; Gortazar C, 2000, J ZOOL, V250, P335; Hammershoj M, 2004, ACTA THERIOL, V49, P337, DOI 10.1007/BF03192532; Hammershoj Mette, 2005, Journal for Nature Conservation (Jena), V13, P267, DOI 10.1016/j.jnc.2005.03.001; Hammershoj M, 2006, ECOGRAPHY, V29, P465, DOI 10.1111/j.2006.0906-7590.04492.x; KOLB HH, 1974, J ZOOL, V173, P253; LINDSTROM E, 1983, J ZOOL, V199, P117; Long JL, 2003, INTRO MAMMALS WORLD; Macdonald DW, 2002, ECOGRAPHY, V25, P295, DOI 10.1034/j.1600-0587.2002.250306.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; McLachlan GJ, 1998, LECT NOTES COMPUTER; Meiri S, 2005, ECOLOGY, V86, P1432, DOI 10.1890/04-1503; Meiri S, 2014, J ANIM ECOL, V83, P1302, DOI 10.1111/1365-2656.12248; Melero Y, 2014, OECOLOGIA, V174, P427, DOI 10.1007/s00442-013-2774-9; Melero Y, 2012, BIODIVERS CONSERV, V21, P1795, DOI 10.1007/s10531-012-0277-3; Melero Y, 2010, BIOL INVASIONS, V12, P3877, DOI 10.1007/s10530-010-9778-8; Naturstyrelsen, 2012, FORV MINL NEOV VIS D; Pagh Sussie, 2018, Zoology and Ecology, V28, P1, DOI 10.1080/21658005.2017.1409997; Pertoldi C, 2013, J ANIM SCI, V91, P2530, DOI 10.2527/jas.2012-6039; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Robardet E, 2012, J WILDLIFE DIS, V48, P858, DOI 10.7589/2011-07-205; SMAL CM, 1991, J ZOOL, V224, P233, DOI 10.1111/j.1469-7998.1991.tb04802.x; Tamlin AL, 2009, WILDLIFE BIOL, V15, P48; Williamson RA, 2015, ARCH ORAL DENT RES, V3, P1, DOI [10.7243/2053-5775-3-3, DOI 10.7243/2053-5775-3-3]; Yom-Tov Y, 2003, EVOL ECOL RES, V5, P1037; Yom-Tov Y, 2007, BIOL J LINN SOC, V90, P729, DOI 10.1111/j.1095-8312.2007.00761.x; Zalewski A, 2007, ACTA THERIOL, V52, P237, DOI 10.1007/BF03194220; Zalewski A, 2012, BIOL J LINN SOC, V105, P681, DOI 10.1111/j.1095-8312.2011.01811.x; Zschille J., 2004, DISTRIBUTION ECOLOGY, V37, P103; Zub K, 2011, J ANIM ECOL, V80, P259, DOI 10.1111/j.1365-2656.2010.01762.x	40	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224559	10.1371/journal.pone.0224559	http://dx.doi.org/10.1371/journal.pone.0224559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710608	Green Published, gold, Green Submitted			2022-12-26	WOS:000532699900011
J	Boquete, L; Lopez-Guillen, E; Vilades, E; Miguel-Jimenez, JM; Pablo, LE; De Santiago, L; del Castillo, MO; Alonso-Rodriguez, MC; Morla, EMS; Lopez-Dorado, A; Garcia-Martin, E				Boquete, L.; Lopez-Guillen, E.; Vilades, E.; Miguel-Jimenez, J. M.; Pablo, L. E.; De Santiago, L.; Ortiz del Castillo, M.; Alonso-Rodriguez, M. C.; Sanchez Morla, E. M.; Lopez-Dorado, A.; Garcia-Martin, E.			Diagnostic ability of multifocal electroretinogram in early multiple sclerosis using a new signal analysis method	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; DEGENERATION; BIOMARKER	Purpose To determine if a novel analysis method will increase the diagnostic value of the multifocal electroretinogram (mfERG) in diagnosing early-stage multiple sclerosis (MS). Methods We studied the mfERG signals of OD (Oculus Dexter) eyes of fifteen patients diagnosed with early-stage MS (in all cases < 12 months) and without a history of optic neuritis (ON) (F: M = 11:4), and those of six controls (F:M = 3:3). We obtained values of amplitude and latency of N1 and P1 waves, and a method to assess normalized root-mean-square error (F-NRMSE) between model signals and mfERG recordings was used. Responses of each eye were analysed at a global level, and by rings, quadrants and hemispheres. AUC (area under the ROC curve) is used as discriminant factor. Results The standard method of analysis obtains further discrimination between controls and MS in ring R3 (AUC = 0.82), analysing N1 waves amplitudes. In all of the retina analysis regions, F-NRMSE value shows a greater discriminating power than the standard method. The highest AUC value (AUC = 0.91) was in the superior temporal quadrant. Conclusion By analysing mfERG recordings and contrasting them with those of healthy controls it is possible to detect early-stage MS in patients without a previous history of ON.	[Boquete, L.; Lopez-Guillen, E.; Miguel-Jimenez, J. M.; De Santiago, L.; Ortiz del Castillo, M.; Lopez-Dorado, A.] Univ Alcala, Elect Dept, Biomed Engn Grp, Madrid, Spain; [Boquete, L.; Vilades, E.; Garcia-Martin, E.] RETICS Themat Networks Cooperat Res Hlth Ocular, Madrid, Spain; [Vilades, E.; Pablo, L. E.; Garcia-Martin, E.] Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain; [Vilades, E.; Pablo, L. E.; Garcia-Martin, E.] Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Innovat & Res Grp Miguel Servet Ophthalmol GIMSO, Zaragoza, Spain; [Alonso-Rodriguez, M. C.] Univ Alcala, Phys & Math Dept, Madrid, Spain; [Sanchez Morla, E. M.] 12 Octubre Hosp I 12, Inst Hlth Res, Madrid, Spain	Universidad de Alcala; Miguel Servet University Hospital; University of Zaragoza; Universidad de Alcala	Garcia-Martin, E (corresponding author), RETICS Themat Networks Cooperat Res Hlth Ocular, Madrid, Spain.; Garcia-Martin, E (corresponding author), Miguel Servet Univ Hosp, Ophthalmol Dept, Zaragoza, Spain.; Garcia-Martin, E (corresponding author), Univ Zaragoza, Aragon Inst Hlth Res IIS Aragon, Innovat & Res Grp Miguel Servet Ophthalmol GIMSO, Zaragoza, Spain.	egmvivax@yahoo.com	Boquete, Luciano/GXN-4674-2022; Alonso-Rodriguez, Maria Concepcion/B-9307-2016	Lopez-Guillen, Elena/0000-0002-8145-9045; GARCIA-MARTIN, ELENA/0000-0001-6258-2489; Ortiz del Castillo, Miguel/0000-0001-8431-3765; Alonso-Rodriguez, Maria Concepcion/0000-0003-2175-4162; Pablo, Luis/0000-0003-2389-8282	Carlos III Health Institute [PI17/01726]; RETICS Oftared [RD16/0008/020, RD16/0008/029];  [DPI2017-88438-R]	Carlos III Health Institute(Instituto de Salud Carlos III); RETICS Oftared; 	This work was supported by the Carlos III Health Institute [grant number PI17/01726, "Neuro-ophthalmological evaluation as a biomarker of diagnosis, monitoring and prognosis in multiple sclerosis", to EGM]; Secretary of State for Research, Development and Innovation [grant number DPI2017-88438-R (AEI/FEDER, UE) to LB] and RETICS Oftared, RD16/0008/020 to LB and RD16/0008/029 to EGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brusini P, 2018, EYE, V32, P113, DOI 10.1038/eye.2017.159; Canham LJW, 2015, MULT SCLER RELAT DIS, V4, P607, DOI 10.1016/j.msard.2015.07.009; Chan HHL, 2011, CLIN EXP OPTOM, V94, P247, DOI 10.1111/j.1444-0938.2010.00571.x; Garcia-Martin E, 2017, OPHTHALMOLOGY, V124, P688, DOI 10.1016/j.ophtha.2017.01.005; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P1705, DOI 10.1016/j.ophtha.2012.01.046; Garcia-Martin E, 2011, BRIT J OPHTHALMOL, V95, P1577, DOI 10.1136/bjo.2010.199232; Giffroy X, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0608-1; Gundogan FC, 2007, INVEST OPHTH VIS SCI, V48, P5773, DOI 10.1167/iovs.07-0834; Hanson JVM, 2018, INVEST OPHTH VIS SCI, V59, P549, DOI 10.1167/iovs.17-22821; Hardmeier M, 2017, MULT SCLER J, V23, P1309, DOI 10.1177/1352458517707265; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; Kaunzner UW, 2017, THER ADV NEUROL DISO, V10, DOI 10.1177/1756285617708911; Kretschmann U, 1998, VISION RES, V38, P3817, DOI 10.1016/S0042-6989(98)00071-6; Lai TYY, 2007, SURV OPHTHALMOL, V52, P61, DOI 10.1016/j.survophthal.2006.10.005; Mousa Mohammad F, 2014, Korean J Ophthalmol, V28, P49, DOI 10.3341/kjo.2014.28.1.49; Muller PL, 2016, J VISION, V16, DOI 10.1167/16.1.15; Neroev V. V., 2016, Human Physiology, V42, P879, DOI 10.1134/S0362119716080090; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Polo V, 2014, EYE, V28, P680, DOI 10.1038/eye.2014.51; Robson AG, 2018, DOC OPHTHALMOL, V136, P1, DOI 10.1007/s10633-017-9621-y; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; Satue M, 2018, CURR EYE RES, V43, P109, DOI 10.1080/02713683.2017.1370116; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224500	10.1371/journal.pone.0224500	http://dx.doi.org/10.1371/journal.pone.0224500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703082	Green Published, gold			2022-12-26	WOS:000532697200013
J	Mremi, A; Broadwater, G; Jackson, K; Amsi, P; Mbulwa, C; Hyslop, T; Ong, C; Hall, A				Mremi, Alex; Broadwater, Gloria; Jackson, Kahima; Amsi, Patrick; Mbulwa, Cosmas; Hyslop, Terry; Ong, Cecilia; Hall, Allison			Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes	PLOS ONE			English	Article							AFRICAN-AMERICAN; PROLIFERATION MARKERS; STATISTICS; SURVIVAL; TRENDS; EPIDEMIOLOGY; CHEMOTHERAPY; CARCINOMAS; FREQUENCY; ANCESTRY	Introduction Breast cancer is a major cause of morbidity and mortality for women in Sub-Saharan Africa and for black American women. There is evidence that the pathologic characteristics of breast cancers in both African women and black American women may differ from their counterparts of European ancestry. However, despite the great burden of disease, data on pathologic features of breast carcinoma in Sub-Saharan Africa is limited and often contradictory. This lack of information makes it difficult to prioritize resource use in efforts to improve breast cancer outcomes in the region. Methods We examined consecutive cases of breast cancer in Tanzanian women (n = 83), black American women (n = 120), and white American women (n = 120). Each case was assessed for tumor type, grade, mitotic count, ER and HER2 status, and tumor infiltrating lymphocyte involvement. Results The Tanzanian subjects were younger and had higher stage tumors than the subjects in either American group. Breast cancers in the Tanzanian and black American groups were more likely to be high grade (p = 0.008), to have a high mitotic rate (p< 0.0001), and to be ER-negative (p< 0.001) than the tumors in the white American group. Higher levels of tumor infiltrating lymphocyte involvement were seen among Tanzanian and black American subjects compared to white American subjects (p = 0.0001). Among all subjects, tumor infiltrating lymphocyte levels were higher in tumors with a high mitotic rate. Among Tanzanian and black American subjects, tumor infiltrating lymphocyte levels were higher in ER-negative tumors. These findings have implications for treatment priorities for breast cancer in Tanzania and other Sub-Saharan African countries.	[Mremi, Alex; Amsi, Patrick] Kilimanjaro Christian Med Univ Coll, Dept Pathol, Moshi, Tanzania; [Broadwater, Gloria; Hyslop, Terry] Duke Univ, Dept Biostat & Bioinformat, Med Ctr, Durham, NC USA; [Jackson, Kahima; Mbulwa, Cosmas] Bugando Med Ctr, Dept Pathol, Mwanza, Tanzania; [Ong, Cecilia] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Hall, Allison] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Mremi, A (corresponding author), Kilimanjaro Christian Med Univ Coll, Dept Pathol, Moshi, Tanzania.	alexmremi@kcmc.ac.tz	Mremi, Alex/AAQ-6399-2020	Mremi, Alex/0000-0001-7226-0168; Ong, Cecilia/0000-0003-0589-6427	Duke Global Health Institute; Duke Cancer Institute; Duke University Department of Pathology; Duke Cancer Institute through NIH [P30CA014236]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER	Duke Global Health Institute; Duke Cancer Institute; Duke University Department of Pathology; Duke Cancer Institute through NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Global Cancer Pilot Grant from the Duke Global Health Institute (https://globalhealth.duke.edu/) and the Duke Cancer Institute (http://dukecancerinstitute.org/), supporting AH, AM, KJ, CM, PA, departmental funds from the Duke University Department of Pathology, supporting AH, and the Duke Cancer Institute through NIH grant P30CA014236, supporting GB and TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadori D, 2014, BREAST CANCER RES TR, V145, P177, DOI 10.1007/s10549-014-2903-0; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chibon F, 2009, MODERN PATHOL, V22, P403, DOI 10.1038/modpathol.2008.195; Chokunonga E, 2013, INT J CANCER, V133, P721, DOI 10.1002/ijc.28063; Denkert C, 2018, LANCET ONCOL, V19, P40, DOI 10.1016/S1470-2045(17)30904-X; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; DeSantis CE, 2017, CA-CANCER J CLIN, V67, P439, DOI 10.3322/caac.21412; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P290, DOI 10.3322/caac.21340; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Dobon B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09996; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Eng A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001720; Freedman RA, 2009, J CLIN ONCOL, V27, P713, DOI 10.1200/JCO.2008.17.9234; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Haddad SA, 2016, CARCINOGENESIS, V37, P870, DOI 10.1093/carcin/bgw067; Huo DZ, 2017, JAMA ONCOL, V3, P1654, DOI 10.1001/jamaoncol.2017.0595; Huo DZ, 2016, HUM MOL GENET, V25, P4835, DOI 10.1093/hmg/ddw305; Jedy-Agba E, 2016, LANCET GLOB HEALTH, V4, pE923, DOI 10.1016/s2214-109x(16)30259-5; Jiagge E, 2016, ANN SURG ONCOL, V23, P3843, DOI 10.1245/s10434-016-5420-z; Joko-Fru WY, 2020, INT J CANCER, V146, P1208, DOI 10.1002/ijc.32406; Killelea BK, 2015, J CLIN ONCOL, V33, P4267, DOI 10.1200/JCO.2015.63.7801; Lee AHS, 2011, J CLIN PATHOL, V64, P490, DOI 10.1136/jcp.2011.089177; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; McCormack VA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3478; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Rambau Peter, 2014, BMC Res Notes, V7, P399, DOI 10.1186/1756-0500-7-399; Sail K, 2012, ETHNIC HEALTH, V17, P309, DOI 10.1080/13557858.2011.628011; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Sawe RT, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2204-6; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Vincent-Salomon A, 2004, EUR J CANCER, V40, P1502, DOI 10.1016/j.ejca.2004.03.014; Wabinga HR, 2014, INT J CANCER, V135, P432, DOI 10.1002/ijc.28661; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072; Williams DR, 2016, CANCER-AM CANCER SOC, V122, P2138, DOI 10.1002/cncr.29935	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224760	10.1371/journal.pone.0224760	http://dx.doi.org/10.1371/journal.pone.0224760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703083	Green Published, gold			2022-12-26	WOS:000532697200022
J	Tsai, CC; Chuang, SY; Hsieh, IC; Ho, LH; Chu, PH; Jeng, C				Tsai, Ching-Ching; Chuang, Shao-Yuan; Hsieh, I-Chang; Ho, Lun-Hui; Chu, Pao-Hsien; Jeng, Chii			The association between psychological distress and angina pectoris: A population-based study	PLOS ONE			English	Article							RISK-FACTORS; ROSE ANGINA; DEPRESSION; PREVALENCE; VALIDITY; DISEASE; ANXIETY; MEN; HOSTILITY; ISCHEMIA	Background Psychological distress is an undifferentiated combination of symptoms that may be related to the occurrence of angina pectoris (AP). However, few studies have investigated the relationship between psychological distress and AP, particularly in Asian populations. The purpose of this study was to examine the relationship between psychological distress and AP in Taiwanese adults. Methods We adopted a cross-sectional design to explore the data of the 2005-2008 Nutrition and Health Survey in Taiwan. In total, 2080 subjects (aged >= 19 years) responded to questionnaire interviews and underwent physical examinations. Each of the five dimensions of psychological distress (sleep disturbance, anxiety, hostility, depression, and feelings of inferiority) were scored (from 0-20) according to the Five-Item Brief Symptom Rating Scale (BSRS-5). A score >= 6 points indicated psychological distress. AP was evaluated using a modified Rose questionnaire. Findings In total, 102 subjects (3.6%) had AP, and 231 subjects (8.8%) had symptoms of psychological distress. After adjusting for the basic data, metabolism, and lifestyle covariates, the BSRS-5 total score was associated with AP (odds ratio [OR] = 1.2, 95% confidence interval [CI] = 1.13-1.26, p < 0.001). Subjects with psychological distress had a higher risk of AP (OR = 2.97, 95% CI = 1.76-4.99, p < 0.001). Conclusions The presence of AP is associated with psychological distress. Health care providers should therefore be aware of the impact of psychological distress on AP. Our study findings can serve as a reference for AP assessments. Large scale longitudinal studies are needed to confirm a causal relationship between psychological distress and AP.	[Tsai, Ching-Ching; Ho, Lun-Hui] Chang Gung Univ Sci & Technol, Coll Nursing, Dept Nursing, Taoyuan, Taiwan; [Tsai, Ching-Ching] Chang Gung Mem Hosp, Dept Cardiol, Linkou, Taiwan; [Chuang, Shao-Yuan] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Hsieh, I-Chang; Chu, Pao-Hsien] Chang Gung Mem Hosp, Heart Failure Ctr, Dept Cardiol, Linkou, Taiwan; [Hsieh, I-Chang; Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Ho, Lun-Hui] Chang Gung Mem Hosp, Dept Nursing, Linkou, Taiwan; [Jeng, Chii] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan	Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Taipei Medical University	Jeng, C (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.	chii@tmu.edu.tw	CHUANG, shao-yuan/ABB-4057-2020	CHUANG, shao-yuan/0000-0003-2138-4771; Jeng, Chii/0000-0002-8012-5780; Chu, Pao-Hsien/0000-0003-0361-6348	Ministry of Science and Technology, Taiwan, ROC [MOST 105-2314-B-255-008]	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by Grant MOST 105-2314-B-255-008 to CCT from the Ministry of Science and Technology, Taiwan, ROC. However, the funders had no role in study design, data collection, and analysis, decision to publish, or manuscript preparation.	Alonso JJ, 2015, REV ESP CARDIOL, V68, P691, DOI [10.1016/j.rec.2014.09.020, 10.1016/j.recesp.2014.09.019]; [Anonymous], 2020, ESC REPORT EUR HEART, DOI 10.1093/eurheartj/ehy913; Arnold SV, 2009, CIRCULATION, V120, P126, DOI 10.1161/CIRCULATIONAHA.108.806034; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Bastos MS, 2012, ARQ BRAS CARDIOL, V99, P1056, DOI 10.1590/S0066-782X2012001400012; Bekkouche NS, 2013, PSYCHOSOM MED, V75, P413, DOI 10.1097/PSY.0b013e31828c4cb4; Bridewell WB, 1997, PERS INDIV DIFFER, V22, P587, DOI 10.1016/S0191-8869(96)00224-3; Byles JE, 2014, DEPRESS ANXIETY, V31, P524, DOI 10.1002/da.22162; Carney RM, 2012, CURR PSYCHIAT REP, V14, P1, DOI 10.1007/s11920-011-0247-6; Chen HC, 2005, J FORMOS MED ASSOC, V104, P824; Choi DH, 2018, INT J CARDIOL, V251, P58, DOI 10.1016/j.ijcard.2017.10.060; Cohen BE, 2015, AM J HYPERTENS, V28, P1295, DOI 10.1093/ajh/hpv047; Coss-Adame Enrique, 2015, Gastroenterol Hepatol (N Y), V11, P759; Drapeau A, 2012, MENTAL ILLNESSES UND, P105, DOI DOI 10.5772/30872; Fiedorowicz JG, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0492-6; Gesualdo M, 2016, J CARDIOVASC MED, V17, P330, DOI 10.2459/JCM.0000000000000351; Graff-Iversen S, 2014, J EPIDEMIOL COMMUN H, V68, P754, DOI 10.1136/jech-2013-203642; Handberg EM, 2013, WOMENS HEALTH, V9, P479, DOI [10.2217/whe.13.50, 10.2217/WHE.13.50]; Health Promotion Administration of the Ministry of Health and Welfare, 2018, JUDGM CRIT MET SYNDR; Hemingway H, 2008, CIRCULATION, V117, P1526, DOI 10.1161/CIRCULATIONAHA.107.720953; Hernandez R, 2018, EMOT REV, V10, P18, DOI 10.1177/1754073917697824; Huaug SY., 1995, THESIS; Koyanagi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138261; Lee MB, 2003, J FORMOS MED ASSOC, V102, P687; Lin YC, 2004, J GERONTOL A-BIOL, V59, P161; Liyanage PLGC, 2013, GALLE MED J, V18, P12; Miller TQ, 1996, PSYCHOL BULL, V119, P322, DOI 10.1037/0033-2909.119.2.322; Mommersteeg PMC, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003387; Nicholson A, 2005, PSYCHOSOM MED, V67, P522, DOI 10.1097/01.psy.0000171159.86446.9e; Pan WH, 2004, SURVEY RES DATA ARCH; Pedersen SS, 2017, EUR J PREV CARDIOL, V24, P108, DOI 10.1177/2047487317703827; Pimple P, 2015, J PSYCHOSOM RES, V78, P433, DOI 10.1016/j.jpsychores.2015.02.007; Rahman Muhammad Aziz, 2013, Indian Heart J, V65, P30, DOI 10.1016/j.ihj.2012.09.008; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Shojaei M, 2013, JENTASHAPIR J HLTH R, V4, P477, DOI [10.1007/s10654-007-9200-8, DOI 10.1007/S10654-007-9200-8]; St-Jean K, 2005, J BEHAV MED, V28, P527, DOI 10.1007/s10865-005-9024-5; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Tu SH, 2011, ASIA PAC J CLIN NUTR, V20, P225; Willerson JT, 2015, CARDIOVASC MED-LOND, P365, DOI 10.1007/978-1-4471-2828-1_15; Wu CY, 2016, J FORMOS MED ASSOC, V115, P395, DOI 10.1016/j.jfma.2015.05.004; Yei NH, 2003, THESIS; Zaman MJS, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-50	42	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224451	10.1371/journal.pone.0224451	http://dx.doi.org/10.1371/journal.pone.0224451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1HV	31703084	Green Published, gold			2022-12-26	WOS:000532697200011
J	Mayburd, AL; Koivogui, M; Baranova, A				Mayburd, Anatoly L.; Koivogui, Mathilda; Baranova, Ancha			Pharmacological signatures of the reduced incidence and the progression of cognitive decline in ageing populations suggest the protective role of beneficial polypharmacy	PLOS ONE			English	Article							II RECEPTOR BLOCKERS; ALZHEIMERS-DISEASE; UNITED-STATES; DOUBLE-BLIND; MOUSE MODEL; DEMENTIA; BIOTIN; RISK; SUPPLEMENTATION; PREVALENCE	Preventive treatments for dementia are warranted. Here we show that utilization of certain combinations of prescription medications and supplements correlates with reduced rates of cognitive decline. More than 1,900 FDA-approved agents and supplements were collapsed into 53 mechanism-based groups and traced in electronic medical records (EMRs) for >50,000 patients. These mechanistic groups were aligned with the data presented in more than 300 clinical trials, then regression model was built to fit the signals from EMRs to clinical trial performance. While EMR signals of each single agents correlated with clinical performance relatively weakly, the signals produced by combinations of active compounds were highly correlated with the clinical trial performance (R = 0.93, p = 3.8 x10<^>-8). Higher ranking pharmacological modalities were traced in patient profiles as their combinations, producing protective complexity estimates reflecting degrees of exposure to beneficial polypharmacy. For each age strata, the higher was the protective complexity score, the lower was the prevalence of dementia, with maximized life-long effects for the highest regression score /diversity compositions. The connection was less strong in individuals already diagnosed with cognitive impairment. Confounder analysis confirmed an independent effect of protective complexity in multivariate context. A sub-cohort with lifelong odds of dementia decreased > 5-folds was identified; this sub-cohort should be studied in further details, including controlled clinical trials. In short, our study systematically explored combinatorial preventive treatment regimens for age-associated multi-morbidity, with an emphasis on neurodegeneration, and provided extensive evidence for their feasibility.	[Mayburd, Anatoly L.; Koivogui, Mathilda] Neurocombinatorix, Alexandria, VA 22303 USA; [Mayburd, Anatoly L.; Baranova, Ancha] George Mason Univ, Sch Syst Biol, Colgan Hall,MSN 3E1 George Mason Univ, Manassas, VA 20110 USA; [Baranova, Ancha] Res Ctr Med Genet, Moscow, Russia	George Mason University; Research Centre for Medical Genetics	Mayburd, AL (corresponding author), Neurocombinatorix, Alexandria, VA 22303 USA.; Mayburd, AL; Baranova, A (corresponding author), George Mason Univ, Sch Syst Biol, Colgan Hall,MSN 3E1 George Mason Univ, Manassas, VA 20110 USA.; Baranova, A (corresponding author), Res Ctr Med Genet, Moscow, Russia.	mail@inventomika.org; abaranov@gmu.edu		Mayburd, Anatoly/0000-0001-6281-0066				Aerts L, 2017, NEUROLOGY, V88, P2225, DOI 10.1212/WNL.0000000000004015; Akbari E, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00256; Anagnostouli M, 1999, ACTA NEUROL SCAND, V99, P387, DOI 10.1111/j.1600-0404.1999.tb07369.x; Andrieu S, 2015, LANCET NEUROL, V14, P926, DOI 10.1016/S1474-4422(15)00153-2; [Anonymous], 2019, UPDATED ALZHEIMERS S; [Anonymous], 2018, US, DOI 10.1136/annrheumdis-2014-206917, Patent No. [9,351,961. 51, 9351961]; [Anonymous], [No title captured]; [Anonymous], 2019, ALZHEIMERS DIS RELAT; [Anonymous], 2019, GLENN ISRAEL DETERMI; [Anonymous], 2019, OFFICE SUPPORT LINES; Appleby BS, 2013, DEMENT GERIATR COGN, V35, P1, DOI 10.1159/000345791; Bohlken J, 2018, J ALZHEIMERS DIS, P1; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; Bredesen DE, 2014, AGING-US, V6, P707, DOI 10.18632/aging.100690; Campbell JM, 2018, J ALZHEIMERS DIS, P1, DOI DOI 10.3233/JAD-189007; Carrasco L, 2017, ADV ALZH DIS, V5, P281, DOI 10.3233/978-1-61499-706-281; Cohen SH, 2018, J ALZHEIMERS DIS PAR, V8, DOI 10.4172/2161-0460.1000450; Dregan A, 2015, J ALZHEIMERS DIS, V46, P1039, DOI 10.3233/JAD-150171; Echouffo-Tcheugui JB, 2018, NEUROLOGY, V91, pE1961, DOI 10.1212/WNL.0000000000006549; El-Dessouki AM, 2017, MOL NEUROBIOL, V54, P5074, DOI 10.1007/s12035-016-0051-8; Fahy GM, 1999, AGING CELL, V54; Gibson EM, 2019, CELL, V176, P43, DOI 10.1016/j.cell.2018.10.049; Gold PE, 2014, BRAIN RES BULL, V105, P25, DOI 10.1016/j.brainresbull.2013.12.012; Gomm W, 2016, JAMA NEUROL, V73, P410, DOI 10.1001/jamaneurol.2015.4791; Goya RG, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1075-y; Grinde B, 2017, IMMUN AGEING, V14, DOI 10.1186/s12979-017-0102-7; Hammond BR, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00254; Hejl A, 2002, J NEUROL NEUROSUR PS, V73, P390, DOI 10.1136/jnnp.73.4.390; Hervas D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179283; Huang YM, 2015, BRIT J OPHTHALMOL, V99, P371, DOI 10.1136/bjophthalmol-2014-305503; Iskra R, 2018, HEALTHY AGEING LONG, V8, P133, DOI 10.1007/978-3-030-03742-0_5; Jacobs V, 2017, EXPERT REV CARDIOVAS, V15, P897, DOI 10.1080/14779072.2017.1411189; Jutley G, 2017, NEURODEGENER DIS MAN, V7, P157, DOI 10.2217/nmt-2017-0004; Kim MY, 2018, J ALZHEIMERS DIS, V63, P635, DOI 10.3233/JAD-170895; Kim SH, 2017, BRIT J PHARMACOL, V174, P4224, DOI 10.1111/bph.14030; Kirkland AE, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060730; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Kivipelto M, 2018, NATURE REV NEUROLOGY, P1; Kumar A, 2017, BIOMED PHARMACOTHER, V88, P698, DOI 10.1016/j.biopha.2017.01.059; Lages Lucas C, 2017, J Clin Transl Res, V2, P135; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Lee S. Y., 2019, MEDICINE, V98; Lehrer S, 2017, DISCOV MED, V24, P147; Liu CT, 2017, ONCOTARGET, V8, P79680, DOI 10.18632/oncotarget.19094; Lu N, 2016, ANN RHEUM DIS, V75, P547, DOI 10.1136/annrheumdis-2014-206917; Manzo Ciro, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5030082; Mayburd AL, INCREASED LIFESPAN I; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Mehta D, 2017, EXPERT OPIN INV DRUG, V26, P735, DOI 10.1080/13543784.2017.1323868; Mocchegiani E, 2018, HDB IMMUNOSENESCENCE, P1; Mok SA, 2018, NAT STRUCT MOL BIOL, V25, P384, DOI 10.1038/s41594-018-0057-1; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Park JH, 2016, ENVIRON TOXICOL PHAR, V42, P1, DOI 10.1016/j.etap.2015.12.014; Park SK, 2018, DRUG SAFETY, V41, P615, DOI 10.1007/s40264-018-0638-2; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Pourhoseingholi Mohamad Amin, 2012, Gastroenterol Hepatol Bed Bench, V5, P79; Ren X, 2019, BIOCH BIOPHYSICA ACT; Renzi-Hammond LM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111246; Riveron-Negrete L, 2017, MINI-REV MED CHEM, V17, P529, DOI 10.2174/1389557516666160923132611; Saavedra JM, 2017, PHARMACOL RES, V125, P91, DOI 10.1016/j.phrs.2017.06.017; Saavedra JM, 2016, CELL MOL NEUROBIOL, V36, P259, DOI 10.1007/s10571-015-0327-y; Sanborn V, 2018, CONT CLIN TRIAL COMM, V12, P192, DOI 10.1016/j.conctc.2018.11.006; Tai JJ, 2018, BRAIN RES, V1678, P64, DOI 10.1016/j.brainres.2017.10.012; Tarleton EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180067; Tourbah A, 2016, MULT SCLER J, V22, P1719, DOI 10.1177/1352458516667568; van Beers M, 2018, EXPERT REV RESP MED, V12, P1061, DOI 10.1080/17476348.2018.1533405; Walker V, 2019, BIORXIV; Weinstein G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212293; Wroolie T.E., 2017, PERS MED PSYCHIAT, V4-6, P7, DOI [10.1016/j.pmip., DOI 10.1016/J.PMIP]; Zaghrioui M, 2018, SOLID STATE SCI, V79, P1, DOI 10.1016/j.solidstatesciences.2018.03.003; Zhang Q, 2015, BRAIN RES, V1622, P361, DOI 10.1016/j.brainres.2015.07.010; Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282	73	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224315	10.1371/journal.pone.0224315	http://dx.doi.org/10.1371/journal.pone.0224315			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693707	gold, Green Published			2022-12-26	WOS:000532690100024
J	Nepal, V; Fabrizio, MC				Nepal, Vaskar; Fabrizio, Mary C.			High salinity tolerance of invasive blue catfish suggests potential for further range expansion in the Chesapeake Bay region	PLOS ONE			English	Article							FRESH-WATER FISHES; JUVENILE; SURVIVAL; STURGEON; COASTAL; TEMPERATURE; REGRESSION; TOXICITY; ONTOGENY	In estuaries, salinity is believed to limit the colonization of brackish water habitats by freshwater species. Blue catfish Ictalurus furcatus, recognized as a freshwater species, is an invasive species in tidal rivers of the Chesapeake Bay. Salinity tolerance of this species, though likely to determine its potential range expansion and dispersal in estuarine habitats, is not well-known. To address this issue, we subjected blue catfish to a short-term salinity tolerance experiment and found that this species tolerates salinities higher than most freshwater fishes and that larger blue catfish tolerate elevated salinities for longer periods compared with smaller individuals. Our results are supported by spatially extensive, long-term fisheries surveys in the Chesapeake Bay region, which revealed a gradual (1975-2017) down-estuary range expansion of blue catfish from tidal freshwater areas to habitats exceeding 10 psu [practical salinity units] and that large blue catfish (> 200 mm fork length) occur in salinities greater than 10 psu in Chesapeake Bay tributaries. Habitat suitability predictions based on our laboratory results indicate that blue catfish can use brackish habitats to colonize new river systems, particularly during wet months when salinity decreases throughout the tidal rivers of the Chesapeake Bay.	[Nepal, Vaskar; Fabrizio, Mary C.] Virginia Inst Marine Sci, William & Mary, Gloucester Point, VA 23062 USA	William & Mary; Virginia Institute of Marine Science	Nepal, V (corresponding author), Virginia Inst Marine Sci, William & Mary, Gloucester Point, VA 23062 USA.	vnepalkc@vims.edu		Fabrizio, Mary/0000-0002-6115-5490; Nepal, Vaskar/0000-0001-9155-7768	Virginia Sea Grant; Virginia Marine Resources Commission; Office of Academic Studies at the Virginia Institute of Marine Science, William Mary	Virginia Sea Grant; Virginia Marine Resources Commission; Office of Academic Studies at the Virginia Institute of Marine Science, William Mary	Financial assistance was provided by Virginia Sea Grant (VN), Virginia Marine Resources Commission (MCF), the Office of Academic Studies at the Virginia Institute of Marine Science, William & Mary (VN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN KO, 1971, PROG FISH CULT, V33, P135, DOI 10.1577/1548-8640(1971)33[135:NOTRST]2.0.CO;2; Allen PJ, 2011, J COMP PHYSIOL B, V181, P1045, DOI 10.1007/s00360-011-0592-0; Altinok I, 1998, COMP BIOCHEM PHYS A, V120, P609, DOI 10.1016/S1095-6433(98)10073-9; ANYANWU PE, 1991, AQUACULTURE, V99, P157, DOI 10.1016/0044-8486(91)90295-I; Beatty SJ, 2011, MAR FRESHWATER RES, V62, P91, DOI 10.1071/MF10100; Beecham RV, 2009, N AM J AQUACULT, V71, P348, DOI 10.1577/A08-034.1; Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Bringolf RB, 2005, T AM FISH SOC, V134, P927, DOI 10.1577/T04-195.1; BRION MA, 2013, PHILIPP J SCI, V142, P13; Brown J. Anne, 2007, V2, P401; Bunch AJ, 2018, NORTHEAST NAT, V25, P333, DOI 10.1656/045.025.0215; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; CHERVINSKI J, 1984, J FISH BIOL, V25, P147, DOI 10.1111/j.1095-8649.1984.tb04861.x; CLEMENS HOWARD P., 1955, TRANS AMER FISH SOC, V84, P97, DOI 10.1577/1548-8659(1954)84[97:TOBWFO]2.0.CO;2; COX DR, 1972, J R STAT SOC B, V34, P187; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Downie AT, 2016, CAN J ZOOL, V94, P677, DOI 10.1139/cjz-2016-0013; Du JB, 2015, J GEOPHYS RES-OCEANS, V120, P78, DOI 10.1002/2014JC010422; Fabrizio MC, 2018, ESTUAR COAST, V41, P827, DOI 10.1007/s12237-017-0307-1; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Fuller PL, 1999, NONINDIGENOUS FISHES; Gotelli NJ, 2008, PRIMER ECOLOGY, V4th; Gutierre SMM, 2016, HYDROBIOLOGIA, V777, P21, DOI 10.1007/s10750-016-2740-8; HAMILTON MA, 1977, ENVIRON SCI TECHNOL, V11, P714, DOI 10.1021/es60130a004; Hill RW, 2008, ANIMAL PHYSL; Horodysky AZ, 2015, REV FISH BIOL FISHER, V25, P425, DOI 10.1007/s11160-015-9393-y; ICTF (Invasive Catfishes Task Force), 2014, FIN REP SUST FISH GO; James KR, 2003, AUST J BOT, V51, P703, DOI 10.1071/BT02110; Kefford BJ, 2004, ENVIRON POLLUT, V129, P355, DOI 10.1016/j.envpol.2003.12.005; KENDALL ARTHUR W., 1968, CHESAPEAKE SCI, V9, P103, DOI 10.1007/BF02688385; KOENKER R, 1994, BIOMETRIKA, V81, P673; Kultz D, 2015, J EXP BIOL, V218, P1907, DOI 10.1242/jeb.118695; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Madon SP, 2002, MAR ECOL PROG SER, V243, P235, DOI 10.3354/meps243235; MCCORMICK SD, 1994, ESTUARIES, V17, P26, DOI 10.2307/1352332; MCENROE M, 1985, ENVIRON BIOL FISH, V14, P23, DOI 10.1007/BF00001573; Gutierre SMM, 2014, MAR FRESHWATER RES, V65, P425, DOI 10.1071/MF13161; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; NEWMAN MC, 1992, AQUAT TOXICOL, V23, P85, DOI 10.1016/0166-445X(92)90001-4; Paavola M, 2005, ESTUAR COAST SHELF S, V64, P738, DOI 10.1016/j.ecss.2005.03.021; Potter IC, 2015, FISH FISH, V16, P230, DOI 10.1111/faf.12050; Reay W.G., 2005, HURRICANE ISABEL PER, P135; Schloesser RW, 2011, AM FISH S S, V77, P369; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schmitt JD, 2019, ENVIRON BIOL FISH, V102, P443, DOI 10.1007/s10641-018-0783-6; Schofield PJ, 2009, ENVIRON BIOL FISH, V85, P51, DOI 10.1007/s10641-009-9456-9; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; TEBO L. B., 1964, PROGR FISH CULT, V26, P99, DOI 10.1577/1548-8640(1964)26[99:EOSCOT]2.0.CO;2; Tuckey TD, 2017, F104R21 VIRG I MAR S; Tuckey TD, 2017, MAR COAST FISH, V9, P564, DOI 10.1080/19425120.2017.1381207; Vetemaa M, 2005, J APPL ICHTHYOL, V21, P287, DOI 10.1111/j.1439-0426.2005.00680.x; WATANABE WO, 1985, AQUACULTURE, V48, P159, DOI 10.1016/0044-8486(85)90102-4	54	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224770	10.1371/journal.pone.0224770	http://dx.doi.org/10.1371/journal.pone.0224770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689331	Green Published, gold			2022-12-26	WOS:000532680100042
J	Yang, S; Kwak, S; Lee, JH; Kang, S; Lee, SP				Yang, Seokhun; Kwak, Soongu; Lee, Jeong-Hoon; Kang, Shinae; Lee, Seung-Pyo			Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; RISK-FACTOR; FOLLOW-UP; NAFLD; ASSOCIATION; IMPACT; HYPERTENSION; JAPANESE; COHORT	Aims The relationship between nonalcoholic fatty liver disease and incident metabolic syndrome in metabolically healthy subjects is unknown. We aimed to investigate whether nonalcoholic fatty liver disease is a predictor of future metabolic syndrome in metabolically healthy subjects. Materials and methods Subjects who underwent health evaluation at least twice between 2009 and 2015 from the National Health Insurance Service-National Sample Cohort in South Korea were included. Patients without obesity who had no metabolic syndrome components were finally analyzed (n = 28,880). The definition of nonalcoholic fatty liver disease was based on both the hepatic steatosis and fatty liver indices. The incidence of metabolic syndrome, prediabetes/type 2 diabetes, hypertension, and dyslipidemia was compared between the subjects with and without nonalcoholic fatty liver disease. Results The presence of nonalcoholic fatty liver disease was associated with a higher risk of incident metabolic syndrome, prediabetes/type 2 diabetes, hypertension, and dyslipidemia in the entire cohort (metabolic syndrome: adjusted hazard ratio, 2.10; 95% confidence interval, 1.18-3.71; prediabetes/type 2 diabetes: adjusted hazard ratio, 1.42; 95% confidence interval, 1.06-1.90; hypertension: adjusted hazard ratio, 2.36; 95% confidence interval, 1.35-4.12; dyslipidemia: adjusted hazard ratio, 1.49; 95% confidence interval, 1.07-2.06). A similar finding was observed in the age-, sex-, smoking status-, and body mass index-based 1:5 propensity score-matched cohort of 1,092 subjects (metabolic syndrome: adjusted hazard ratio, 3.56; 95% confidence interval, 1.79-7.07; prediabetes/type 2 diabetes: adjusted hazard ratio, 1.97; 95% confidence interval, 1.04-3.73; hypertension: adjusted hazard ratio, 2.57; 95% confidence interval, 1.35-4.88; dyslipidemia: adjusted hazard ratio, 1.61; 95% confidence interval, 1.12-2.32). Conclusions Nonalcoholic fatty liver disease is an early predictor of metabolic dysfunction even in metabolically healthy populations.	[Yang, Seokhun; Kwak, Soongu; Lee, Seung-Pyo] Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Yang, Seokhun; Kwak, Soongu; Lee, Jeong-Hoon; Lee, Seung-Pyo] Seoul Natl Univ Hosp, Cardiovasc Inst, Dept Internal Med, Seoul, South Korea; [Lee, Jeong-Hoon] Seoul Natl Univ Hosp, Div Gastroenterol, Dept Internal Med, Seoul, South Korea; [Kang, Shinae] Yonsei Univ, Dept Internal Med, Div Endocrinol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Yonsei University	Lee, SP (corresponding author), Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea.; Lee, JH; Lee, SP (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Inst, Dept Internal Med, Seoul, South Korea.; Lee, JH (corresponding author), Seoul Natl Univ Hosp, Div Gastroenterol, Dept Internal Med, Seoul, South Korea.; Kang, S (corresponding author), Yonsei Univ, Dept Internal Med, Div Endocrinol, Seoul, South Korea.	pindra@empal.com; shinae95@yuhs.ac; sproll1@snu.ac.kr	Yang, Seokhun/AAV-3033-2020	Yang, Seokhun/0000-0003-2078-3930; Kang, Shinae/0000-0002-9719-4774; Kwak, Soongu/0000-0002-1798-7441	Yuhan pharmaceuticals, Republic of Korea	Yuhan pharmaceuticals, Republic of Korea	This study was supported by an unrestricted grant from the Yuhan pharmaceuticals, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884; Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Artunc F, 2016, NAT REV NEPHROL, V12, P721, DOI 10.1038/nrneph.2016.145; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bonnet F, 2017, J HYPERTENS, V35, P493, DOI 10.1097/HJH.0000000000001204; Brown AE, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0755-4; Cali AMG, 2007, DIABETES CARE, V30, P3093, DOI 10.2337/dc07-1088; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Choi YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201308; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fedchuk L, 2014, ALIMENT PHARM THER, V40, P1209, DOI 10.1111/apt.12963; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hashimoto Y, 2017, ENDOCRINE, V57, P89, DOI 10.1007/s12020-017-1313-6; Kantartzis K, 2008, DIABETES CARE, V31, P366, DOI 10.2337/dc07-1558; Kikkawa K, 2015, CLIN CHIM ACTA, V438, P70, DOI 10.1016/j.cca.2014.07.017; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lau K, 2012, J HYPERTENS, V30, P1260, DOI 10.1097/HJH.0b013e3283536662; Lee E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209687; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Liu M, 2017, J CLIN ENDOCR METAB, V102, P1309, DOI 10.1210/jc.2016-3440; Lonardo A, 2019, HEPATOLOGY; Lonardo A, 2018, J HEPATOL, V68, P335, DOI 10.1016/j.jhep.2017.09.021; Lonardo A, 2017, DIGEST LIVER DIS, V49, P471, DOI 10.1016/j.dld.2017.01.147; Lonardo A, 2017, ATHEROSCLEROSIS, V257, P253, DOI 10.1016/j.atherosclerosis.2017.01.008; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Ma JT, 2017, J HEPATOL, V66, P390, DOI 10.1016/j.jhep.2016.09.022; Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Ortiz-Lopez C, 2012, DIABETES CARE, V35, P873, DOI 10.2337/dc11-1849; Park HE, 2016, J CLIN ENDOCR METAB, V101, P3134, DOI 10.1210/jc.2016-1525; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Ryoo JH, 2014, J GASTROEN HEPATOL, V29, P1926, DOI 10.1111/jgh.12643; Ryoo JH, 2013, ATHEROSCLEROSIS, V227, P398, DOI 10.1016/j.atherosclerosis.2013.01.002; Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593; Sung KC, 2014, J HEPATOL, V60, P1040, DOI 10.1016/j.jhep.2014.01.009; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x; Yamazaki H, 2015, DIABETES CARE, V38, P1673, DOI 10.2337/dc15-0140; Yang JD, 2017, CLIN GASTROENTEROL H, V15, P127, DOI 10.1016/j.cgh.2016.07.034; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4	46	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2019	14	11							e0224626	10.1371/journal.pone.0224626	http://dx.doi.org/10.1371/journal.pone.0224626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1AJ	31682638	Green Published, gold			2022-12-26	WOS:000532676800022
J	Zhang, WJ; Yang, Y; Dong, ZZ; Shi, Z; Zhang, JT				Zhang, Wenji; Yang, Yang; Dong, Zizheng; Shi, Zhi; Zhang, Jian-Ting			Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; FUNCTIONAL RESCUE; 4-PHENYLBUTYRATE THERAPY; CYSTIC-FIBROSIS; OLIGOMERIZATION; PROTEINS; DOMAIN; PURIFICATION; INHIBITION; EXPRESSION	ATP-binding cassette (ABC) subfamily G member 2 (ABCG2) belongs to the ABC transporter superfamily and has been implicated in multidrug resistance of cancers. Although the structure and function of ABCG2 have been extensively studied, little is known about its biogenesis and the regulation thereof. In this study, using mutagenesis and several biochemical analyses, we show that the positive charges in the vicinity of the RKR motif downstream of the ABC signature drive trafficking of nascent ABCG2 out of the endoplasmic reticulum (ER) onto plasma membranes. Substitutions of and naturally occurring single-nucleotide polymorphisms within these positively charged residues disabled the trafficking of ABCG2 out of the ER. A representative ABCG2 variant in which the RKR motif had been altered underwent increased ER stress?associated degradation. We also found that unlike WT ABCG2, genetic ABCG2 RKR variants have disrupted normal maturation and do not reduce accumulation of the anticancer drug mitoxantrone and no longer confer resistance to the drug. We conclude that the positive charges downstream of the ABC signature motif critically regulate ABCG2 trafficking and maturation. We propose that single-nucleotide polymorphisms of these residues reduce ABCG2 expression via ER stress?associated degradation pathway and may contribute to reduced cancer drug resistance, improving the success of cancer chemotherapy.	[Zhang, Wenji; Dong, Zizheng; Zhang, Jian-Ting] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Zhang, Wenji; Dong, Zizheng; Zhang, Jian-Ting] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA; [Zhang, Wenji; Yang, Yang; Shi, Zhi] Jinan Univ, Coll Life Sci & Technol, Dept Cell Biol, Guangzhou 510632, Guangdong, Peoples R China; [Zhang, Wenji; Yang, Yang; Shi, Zhi] Jinan Univ, Coll Life Sci & Technol, Guangdong Prov Key Lab Bioengn Med, Inst Biomed,Natl Engn Res Ctr Genet Med, Guangzhou 510632, Guangdong, Peoples R China; [Dong, Zizheng; Zhang, Jian-Ting] Univ Toledo, Coll Med & Life Sci, Dept Canc Biol, 3000 Arlington Ave, Toledo, OH 43614 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Jinan University; Jinan University; University System of Ohio; University of Toledo	Zhang, JT (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Canc Biol, 3000 Arlington Ave, Toledo, OH 43614 USA.; Shi, Z (corresponding author), Jinan Univ, Dept Cell Biol, 601 Huangpu Ave W, Guangzhou 510632, Guangdong, Peoples R China.	tshizhi@jnu.edu.cn; jianting.zhang@utoledo.edu		Shi, Zhi/0000-0002-8328-0305; Zhang, Wenji/0000-0003-1500-6627				Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8; Bakos E, 1997, BIOCHEM J, V323, P777, DOI 10.1042/bj3230777; Basseville A, 2012, CANCER RES, V72, P3642, DOI 10.1158/0008-5472.CAN-11-2008; Basseville Agnes, 2011, F1000 Biol Rep, V3, P23, DOI 10.3410/B3-23; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; Dong ZZ, 2013, J BIOL CHEM, V288, P27951, DOI 10.1074/jbc.M113.483164; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Henriksen U, 2005, J CELL SCI, V118, P1417, DOI 10.1242/jcs.01729; HOLMBERG SRM, 1990, CIRC RES, V67, P272, DOI 10.1161/01.RES.67.2.272; Hou YX, 2009, BIOCHEMISTRY-US, V48, P9122, DOI 10.1021/bi900675v; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Iram SH, 2014, BBA-BIOMEMBRANES, V1838, P756, DOI 10.1016/j.bbamem.2013.11.002; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Lee YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24013; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Liu XA, 2012, APOPTOSIS, V17, P1039, DOI 10.1007/s10495-012-0744-z; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Mo W, 2012, BIOCHEMISTRY-US, V51, P3634, DOI 10.1021/bi300301a; Mo Wei, 2012, Int J Biochem Mol Biol, V3, P1; Mo W, 2009, EXPERT OPIN DRUG MET, V5, P1049, DOI 10.1517/17425250903124371; Ni Zhanglin, 2010, Int J Biochem Mol Biol, V1, P1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Peng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015276; Peng H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005676; Peters LR, 2011, J IMMUNOL, V187, P919, DOI 10.4049/jimmunol.1100690; Pomozi V, 2017, J INVEST DERMATOL, V137, P595, DOI 10.1016/j.jid.2016.10.035; Qi Q, 2013, ONCOGENE, V32, P1030, DOI 10.1038/onc.2012.109; Qiu JG, 2015, ONCOTARGET, V6, P15494, DOI 10.18632/oncotarget.3820; Reddy SS, 2019, CHEM-BIOL INTERACT, V306, P70, DOI 10.1016/j.cbi.2019.04.009; Ren XQ, 2004, MOL PHARMACOL, V65, P1536, DOI 10.1124/mol.65.6.1536; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Shneider BL, 2016, J PEDIATR GASTR NUTR, V62, P424, DOI 10.1097/MPG.0000000000001082; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; Sorrenson B, 2013, J LIPID RES, V54, P55, DOI 10.1194/jlr.M027193; Stacchini A, 2012, CYTOM PART B-CLIN CY, V82B, P280, DOI [10.1002/cyto.b.21026, 10.1002/cyto.b.21034, 10.1002/cyto.b.21029, 10.1002/cyto.b.21036, 10.1002/cyto.b.21028]; Tamura A, 2006, MOL PHARMACOL, V70, P287, DOI 10.1124/mol.106.023556; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang WJ, 2018, BIOCHEM BIOPH RES CO, V503, P408, DOI 10.1016/j.bbrc.2018.06.157	50	4	4	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20222	20232		10.1074/jbc.RA119.008347	http://dx.doi.org/10.1074/jbc.RA119.008347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31719146	hybrid, Green Published			2022-12-26	WOS:000505005800032
J	Tachiyama, S; Chang, YJ; Muthuramalingam, M; Hu, B; Barta, ML; Picking, WL; Liu, J; Picking, WD				Tachiyama, Shoichi; Chang, Yunjie; Muthuramalingam, Meenakumari; Hu, Bo; Barta, Michael L.; Picking, Wendy L.; Liu, Jun; Picking, William D.			The cytoplasmic domain of MxiG interacts with MxiK and directs assembly of the sorting platform in the Shigella type III secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MxiG; MxiK; type III secretion; Shigella; sorting platform; protein-protein interactions; cryo-electron tomography; virulence factor; effector protein	STRUCTURAL INSIGHTS; PROTEIN SECRETION; FLAGELLAR MOTOR; VISUALIZATION; FLEXNERI; COMPLEX; EXPORT; RECONSTRUCTION; ARCHITECTURE; ATPASE	Many Gram-negative bacteria use type III secretion systems (T3SSs) to inject virulence effector proteins into eukaryotic cells. The T3SS apparatus (T3SA) is structurally conserved among diverse bacterial pathogens and consists of a cytoplasmic sorting platform, an envelope-spanning basal body, and an extracellular needle with tip complex. The sorting platform is essential for effector recognition and powering secretion. Studies using bacterial "minicells" have revealed an unprecedented level of structural detail of the sorting platform; however, many of the structure-function relationships within this complex remain enigmatic. Here, we report on improved cryo-electron tomographic approaches to enhance the resolution of the Shigella T3SA sorting platform (at <= 2nm resolution) done in concert with biochemical and genetic methods to define the sorting platform interactome and interactions with the T3SA inner-membrane ring (IR). We observed that the sorting platform consists of "pods" with six-fold symmetry that interact with the Spa47 ATPase via radial extensions comprising MxiN. Most importantly, MxiK maintained an interaction with the IR via specific interactions with the cytoplasmic domain of the IR protein MxiG (MxiGC), which is a noncanonical forkhead-associated domain, and that MxiK has an elongated structure that interacts with the IR via MxiGC. T4 lysozyme-mediated insertional mutagenesis of MxiK revealed its orientation within the sorting platform and enabled disruption of interactions with its binding partners, which abolished sorting platform assembly. Finally, a comparison with the homologous interactions in the Salmonella T3SS sorting platform revealed clear differences in th`eir IR-sorting platform interfaces that have possible mechanistic implications.	[Tachiyama, Shoichi; Picking, William D.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Chang, Yunjie; Liu, Jun] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06516 USA; [Chang, Yunjie; Liu, Jun] Yale Univ, Microbial Sci Inst, West Haven, CT 06516 USA; [Muthuramalingam, Meenakumari; Barta, Michael L.] Univ Kansas, Higuchi Biosci Ctr, Lawrence, KS 66047 USA; [Hu, Bo] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Picking, Wendy L.; Picking, William D.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA; [Barta, Michael L.] Catalent Pharma Solut, Kansas City, MO 64137 USA	University of Kansas; Yale University; Yale University; University of Kansas; University of Texas System; University of Texas Health Science Center Houston; University of Kansas	Picking, WD (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA.; Liu, J (corresponding author), Yale Univ, Dept Microbial Pathogenesis, New Haven, CT 06516 USA.	jliu@yale.edu; picking@ku.edu		Muthuramalingam, Meenakumari/0000-0001-5635-325X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123351] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI123351] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agulleiro JI, 2015, J STRUCT BIOL, V189, P147, DOI 10.1016/j.jsb.2014.11.009; ANDREWS GP, 1992, INFECT IMMUN, V60, P3287, DOI 10.1128/IAI.60.8.3287-3295.1992; Barison N, 2012, FASEB J, V26, P1717, DOI 10.1096/fj.11-197160; Barta ML, 2018, PROTEIN SCI, V27, P1392, DOI 10.1002/pro.3428; Barta ML, 2017, J BIOL CHEM, V292, P16677, DOI 10.1074/jbc.M117.802231; Bergeron JRC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003307; BI E, 1990, J BACTERIOL, V172, P5610, DOI 10.1128/jb.172.10.5610-5616.1990; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Burgess JL, 2016, J BIOL CHEM, V291, P25837, DOI 10.1074/jbc.M116.755256; Case HB, 2018, BIOCHEMISTRY-US, V57, P2266, DOI 10.1021/acs.biochem.8b00070; Cherradi Y, 2014, MICROBIOL-SGM, V160, P130, DOI 10.1099/mic.0.071712-0; Choudhari SP, 2013, PROTEIN SCI, V22, P666, DOI 10.1002/pro.2249; Dickenson NE, 2013, PROTEIN SCI, V22, P614, DOI 10.1002/pro.2245; Diepold A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15940; Diepold A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002039; Fernandez-Leiro R, 2017, ACTA CRYSTALLOGR D, V73, P496, DOI 10.1107/S2059798316019276; Galan JE, 2018, CELL, V172, P1306, DOI 10.1016/j.cell.2018.01.034; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Hu J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06298-8; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kotloff KL, 2018, LANCET, V391, P801, DOI 10.1016/S0140-6736(17)33296-8; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kuhlen L, 2018, NAT STRUCT MOL BIOL, V25, P583, DOI 10.1038/s41594-018-0086-9; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lee PC, 2015, TRENDS MICROBIOL, V23, P296, DOI 10.1016/j.tim.2015.01.012; Majewski DD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08477-7; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mattock E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00064; McDowell MA, 2011, J BIOL CHEM, V286, P30606, DOI 10.1074/jbc.M111.243865; Onodera NT, 2012, J BACTERIOL, V194, P3022, DOI 10.1128/JB.00393-12; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Portaliou AG, 2016, TRENDS BIOCHEM SCI, V41, P175, DOI 10.1016/j.tibs.2015.09.005; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; Winkler H, 2009, J STRUCT BIOL, V165, P64, DOI 10.1016/j.jsb.2008.10.004; Zhao YH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01434; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu SW, 2017, METHODS MOL BIOL, V1593, P229, DOI 10.1007/978-1-4939-6927-2_18	49	11	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19184	19196		10.1074/jbc.RA119.009125	http://dx.doi.org/10.1074/jbc.RA119.009125			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699894	Green Published, hybrid			2022-12-26	WOS:000516527800019
J	Sarayloo, F; Dionne-Laporte, A; Catoire, H; Rochefort, D; Houle, G; Ross, JP; Akcimen, F; Oliveira, RD; Turecki, G; Dion, PA; Rouleau, GA				Sarayloo, Faezeh; Dionne-Laporte, Alexandre; Catoire, Helene; Rochefort, Daniel; Houle, Gabrielle; Ross, Jay P.; Akcimen, Fulya; Oliveira, Rachel De Barros; Turecki, Gustavo; Dion, Patrick A.; Rouleau, Guy A.			Mineral absorption is an enriched pathway in a brain region of restless legs syndrome patients with reduced MEIS1 expression	PLOS ONE			English	Article							RNA-SEQ; SUSCEPTIBILITY LOCUS; IRON-DEFICIENCY; GENE; RISK; LINKAGE; IDENTIFICATION; MAPS	Restless legs syndrome is a common complex disorder with different genetic and environmental risk factors. Here we used human cell lines to conduct an RNA-Seq study and observed how the gene showing the most significant association with RLS, MEIS1, acts as a regulator of the expression of many other genes. Some of the genes affected by its expression level are linked to pathways previously reported to be associated with RLS. We found that in cells where MEIS1 expression was either increased or prevented, mineral absorption is the principal dysregulated pathway. The mineral absorption pathway genes, HMOX1 and VDR are involved in iron metabolism and response to vitamin D, respectively. This shows a strong functional link to the known RLS pathways. We observed the same enrichment of the mineral absorption pathway in postmortem brain tissues of RLS patients showing a reduced expression of MEIS1. The expression of genes encoding metallothioneins (MTs) was observed to be dysregulated across the RNA-Seq datasets generated from both human cells and tissues. MTs are highly relevant to RLS as they bind intracellular metals, protect against oxidative stress and interact with ferritins which manage iron level in the central nervous system. Overall, our study suggests that in a subset of RLS patients, the contribution of MEIS1 appears to be associated to its downstream regulation of genes that are more directly involved in pathways that are relevant to RLS. While MTs have been implicated in the pathogenesis of neurodegenerative diseases such as Parkinson's diseases, this is a first report to propose that they have a role in RLS.	[Sarayloo, Faezeh; Houle, Gabrielle; Ross, Jay P.; Akcimen, Fulya; Turecki, Gustavo] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Sarayloo, Faezeh; Dionne-Laporte, Alexandre; Catoire, Helene; Rochefort, Daniel; Houle, Gabrielle; Ross, Jay P.; Akcimen, Fulya; Oliveira, Rachel De Barros; Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Douglas Inst, Dept Psychiat, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Rouleau, GA (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.; Rouleau, GA (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	Guy.rouleau@mcgill.ca		Akcimen, Fulya/0000-0003-0931-5247; Ross, Jay/0000-0002-8183-2524	Canadian Institutes of Health Research (CIHR) [RN254517332736]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) RN254517332736 (to GAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2007, MOVEMENT DISORD, V22, pS440, DOI 10.1002/mds.21607; Balaban H, 2012, SLEEP MED, V13, P953, DOI 10.1016/j.sleep.2012.04.009; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bonati MT, 2003, BRAIN, V126, P1485, DOI 10.1093/brain/awg137; Bourgey M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz037; Cakir T, 2015, ACTA NEUROL BELG, V115, P623, DOI 10.1007/s13760-015-0474-4; Catoire H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30665-6; Catoire H, 2011, ANN NEUROL, V70, P170, DOI 10.1002/ana.22435; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen SH, 2004, AM J HUM GENET, V74, P876, DOI 10.1086/420772; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Desai AV, 2004, TWIN RES, V7, P589, DOI 10.1375/1369052042663841; Desautels A, 2001, AM J HUM GENET, V69, P1266, DOI 10.1086/324649; Dhawan V, 2006, POSTGRAD MED J, V82, P626, DOI 10.1136/pgmj.2006.045690; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Garcia-Borreguero D, 2016, SLEEP MED, V21, P1, DOI 10.1016/j.sleep.2016.01.017; Garcia-Martin E, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001448; Godau J, 2008, MOVEMENT DISORD, V23, P1184, DOI 10.1002/mds.22070; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jimenez-Jimenez FJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002125; Juarez-Rebollar D, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5828056; Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248; Kemlink D, 2008, NEUROGENETICS, V9, P75, DOI 10.1007/s10048-007-0113-1; Koo BB, 2016, TREMOR OTHER HYPERK, V6, DOI 10.7916/D83J3D2G; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Leierer J, 2016, NEPHROL DIAL TRANSPL, V31, P1444, DOI 10.1093/ndt/gfv451; Levchenko A, 2006, NEUROLOGY, V67, P900, DOI 10.1212/01.wnl.0000233991.20410.b6; Levchenko A, 2009, MOVEMENT DISORD, V24, P40, DOI 10.1002/mds.22263; Mahe EA, 2017, GENOME RES, V27, P947, DOI 10.1101/gr.211466.116; Miyazaki I, 2013, NEUROBIOL DIS, V59, P244, DOI 10.1016/j.nbd.2013.08.003; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Novak M, 2015, SEMIN NEPHROL, V35, P347, DOI 10.1016/j.semnephrol.2015.06.006; Ondo W, 2004, ARCH NEUROL-CHICAGO, V61, P1393, DOI 10.1001/archneur.61.9.1393; Orihuela R, 2011, CHEM COMMUN, V47, P12155, DOI 10.1039/c1cc14819b; Pichler I, 2006, AM J HUM GENET, V79, P716, DOI 10.1086/507875; ROBERTSON A, 1989, J NUTR, V119, P439, DOI 10.1093/jn/119.3.439; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Romero IG, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-42; Sarayloo F, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00935; Schormair B, 2017, LANCET NEUROL, V16, P898, DOI 10.1016/S1474-4422(17)30327-7; Schuierer S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3827-y; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trenkwalder C, 2016, NEUROLOGY, V86, P1336, DOI 10.1212/WNL.0000000000002542; Vasconcelos FF, 2016, CELL REP, V17, P469, DOI 10.1016/j.celrep.2016.09.024; Wali S, 2015, SLEEP BREATH, V19, P579, DOI 10.1007/s11325-014-1049-y; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winkelmann J, 2008, CURR NEUROL NEUROSCI, V8, P211, DOI 10.1007/s11910-008-0033-y; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Xiong L, 2007, NEUROLOGY, V68, P1631, DOI 10.1212/01.wnl.0000261016.90374.fd; Xiong L, 2009, HUM MOL GENET, V18, P1065, DOI 10.1093/hmg/ddn443; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001	55	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225186	10.1371/journal.pone.0225186	http://dx.doi.org/10.1371/journal.pone.0225186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725784	Green Published, gold			2022-12-26	WOS:000532764500065
J	Lin, MH; Yeh, CH; Mou, CH; Lin, YW; Chen, PC; Chang, YY; Sung, FC; Wang, JY				Lin, Ming-Hung; Yeh, Chung-Hsin; Mou, Chih-Hsin; Lin, Ya-Wen; Chen, Pei-Chun; Chang, Yin-Yi; Sung, Fung-Chang; Wang, Jong-Yi			Stroke risks in women with dysmenorrhea by age and stroke subtype	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EVENTS; PREVALENCE; ESTROGEN; HORMONES; DISEASE; HEALTH	Background Dysmenorrhea and stroke are health problems affecting women worldwide in their day-today lives; however, there is limited knowledge of the stroke risk in women with dysmenorrhea, and there have been no studies assessing the specific distribution of stroke subtypes. This case-control study assessed stroke subtypes by age and the role of comorbidities in women with dysmenorrhea. Methods and findings Data obtained between 1997 and 2013 from Taiwan's health insurance database identified 514 stroke cases and 31,201 non-stroke controls in women with dysmenorrhea aged 15-49 years. Proportional distributions of subtypes and odds ratios (ORs) of stroke associated with comorbidities by age and subtype were measured. We found that the stroke risk in dysmenorrheal patients increased with age, and that hypertension was nine-fold more prevalent in the stroke cases than in the controls and was associated with an adjusted OR of 4.53 (95% confidence interval (CI) = 3.46-5.92) for all stroke cases. Moreover, the proportion of hemorrhagic stroke was greater than that of ischemic stroke in younger dysmenorrheal patients between 15-24 years old (50.5% vs. 11.4%), whereas this was reversed in those aged 30-49 years old (16.1% vs. 21.0%). Overall, 25.3% of the stroke cases consisted of transient cerebral ischemia and 31.3% were other acute but ill-defined cerebrovascular diseases, in which the prevalence increased with age for both types of strokes. Hypertension was the comorbidity with the highest OR associated with each subtype stroke; diabetes, hyperlipidemia, arrhythmia, and thyroid disease were also comorbidities that were significantly associated with ill-defined cerebrovascular diseases. Conclusions The stroke type varies by age in dysmenorrheal patients, and hypertension is the most important comorbidity associated with all types of stroke; therefore, more attention for stroke prevention must be paid to women with dysmenorrhea, particularly when combined with comorbidities.	[Lin, Ming-Hung; Lin, Ya-Wen; Chen, Pei-Chun] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lin, Ming-Hung] Tajen Univ, Dept Coll Pharm & Hlth Care, Pingtung, Taiwan; [Yeh, Chung-Hsin] Yuan Rung Hosp, Dept Neurol, Changhua, Taiwan; [Yeh, Chung-Hsin] Da Yeh Univ, Coll Nursing & Hlth Sci, Dept Nursing, Changhua, Taiwan; [Yeh, Chung-Hsin] HungKuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan; [Mou, Chih-Hsin; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Ya-Wen] China Med Univ, Sch Nursing, Taichung, Taiwan; [Lin, Ya-Wen] China Med Univ, Grad Inst Nursing, Taichung, Taiwan; [Chang, Yin-Yi] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Sung, Fung-Chang; Wang, Jong-Yi] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan	China Medical University Taiwan; Da Yeh University; Hungkuang University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wang, JY (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	ericwang@mail.cmu.edu.tw	Lin, Ming Hung/ABH-4835-2020	Lin, Ming Hung/0000-0002-3128-7468; Wang, Jong-Yi/0000-0002-7798-826X	Ministry of Health and Welfare, Taiwan [MOHW108-TDU-B-212-133004]; China Medical University Hospital [DMR-108-024, DMR-108-111]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10701010021]; Taiwan Clinical Trial Consortium for Stroke [MOST 107-2321-B-039-004]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Ministry of Science and Technology, Taipei, Taiwan [MOST 108-2410-H-039-001]; China Medical University, Taichung, Taiwan [CMU108-MF-103, CMU107-S-18]	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; Taiwan Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Ministry of Science and Technology, Taipei, Taiwan; China Medical University, Taichung, Taiwan(China Medical University)	This study was supported in part by grants from the Ministry of Health and Welfare, Taiwan (MOHW108-TDU-B-212-133004), China Medical University Hospital (DMR-108-024 and DMR-108-111), Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10701010021), the Taiwan Clinical Trial Consortium for Stroke (MOST 107-2321-B-039-004), the Tseng-Lien Lin Foundation, Taichung, Taiwan, the Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan, the Ministry of Science and Technology, Taipei, Taiwan (Grant No. MOST 108-2410-H-039-001), and China Medical University, Taichung, Taiwan (Grant No. CMU108-MF-103 and CMU107-S-18).	Aiyagari V., 2016, HYPERTENSION STROKE; Andersohn F, 2006, STROKE, V37, P1725, DOI 10.1161/01.STR.0000226642.55207.94; Bally M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1909; Baron JA, 2008, LANCET, V372, P1756, DOI 10.1016/S0140-6736(08)61490-7; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Boehme AK, 2017, CIRC RES, V120, P472, DOI 10.1161/CIRCRESAHA.116.308398; Canonico M, 2016, STROKE, V47, P1734, DOI 10.1161/STROKEAHA.116.013052; Chen LC, 2006, J CLIN PHARM THER, V31, P565, DOI 10.1111/j.1365-2710.2006.00774.x; Chen PC, 2008, J PEDIATR-US, V152, P388, DOI 10.1016/j.jpeds.2007.08.003; Chung B, 2004, PEDIATRICS, V114, P206; DESANCTIS V, 2017, ACTA BIOMED, V87, P233; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; GIROUD M, 1995, J CLIN EPIDEMIOL, V48, P1343, DOI 10.1016/0895-4356(95)00039-9; Gislason GH, 2009, ARCH INTERN MED, V169, P141, DOI 10.1001/archinternmed.2008.525; Gordon CM, 2010, NEW ENGL J MED, V363, P365, DOI 10.1056/NEJMcp0912024; Habibi N, 2015, PAIN MANAG NURS, V16, P855, DOI 10.1016/j.pmn.2015.07.001; Harada T, 2013, YONAGO ACTA MED, V56, P81; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Ju H, 2014, EPIDEMIOL REV, V36, P104, DOI 10.1093/epirev/mxt009; Kische H, 2016, METABOLISM, V65, P1286, DOI 10.1016/j.metabol.2016.05.011; KLEIN JR, 1981, PEDIATRICS, V68, P661; Lai YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136634; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; Mu F, 2017, HYPERTENSION, V70, P59, DOI 10.1161/HYPERTENSIONAHA.117.09056; Park K, 2014, VASC HEALTH RISK MAN, V10, P25, DOI 10.2147/VHRM.S54159; Royal College of Obstetricians and Gynaecologists, 2012, GREEN TOP GUID 41; Schisterman EF, 2010, AM J EPIDEMIOL, V172, P430, DOI 10.1093/aje/kwq131; Sheikh HU, 2018, HEADACHE, V58, P5, DOI 10.1111/head.13229; Xu H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207929; Zanchetti A, 2014, J HYPERTENS, V32, P1888, DOI 10.1097/HJH.0000000000000254	30	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225221	10.1371/journal.pone.0225221	http://dx.doi.org/10.1371/journal.pone.0225221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714928	Green Published, gold			2022-12-26	WOS:000532710400037
J	Blassova, T; Tonar, Z; Tomasek, P; Hosek, P; Hollan, I; Treska, V; Molacek, J				Blassova, Tereza; Tonar, Zbynek; Tomasek, Petr; Hosek, Petr; Hollan, Ivana; Treska, Vladislav; Molacek, Jiri			Inflammatory cell infiltrates, hypoxia, vascularization, pentraxin 3 and osteoprotegerin in abdominal aortic aneurysms - A quantitative histological study	PLOS ONE			English	Article							CIRCULATING BIOMARKERS; ATHEROSCLEROSIS; CALCIFICATION; PROGRESSION; EXPRESSION; ASSOCIATION; ADVENTITIA	Information about the tissue characteristics of abdominal aortic aneurysms (AAAs), some of which may be reflected in the serum, can help to elucidate AAA pathogenesis and identify new AAA biomarkers. This information would be beneficial not only for diagnostics and follow-up but also for potential therapeutic intervention. Therefore, the aim of our study was to compare the expression of structural proteins, immune factors (T and B lymphocytes, macrophages, neutrophils and pentraxin 3 (PTX3)), osteoprotegerin (OPG), microvessels and hypoxic cells in AAA and nonaneurysmal aortic walls. We examined specimens collected during surgery for AAA repair (n = 39) and from the abdominal aortas of kidney donors without AAA (n = 8). Using histochemical and immunohistochemical methods, we quantified the areas positive for smooth muscle actin, desmin, elastin, collagen, OPG, CD3, CD20, MAC387, myeloperoxidase, PTX3, and hypoxia-inducible factor 1-alpha and the density of CD31-positive microvessels. AAA samples contained significantly less actin, desmin, elastin and OPG, more collagen, macrophages, neutrophils, T lymphocytes, B lymphocytes, hypoxic cells and PTX3, and a greater density of vasa vasorum (VV) than those in non-AAA samples. Hypoxia positively correlated with actin and negatively correlated with collagen. Microvascular density was related to inflammatory cell infiltrates, hypoxia, PTX3 expression and AAA diameter. The lower OPG expression in AAAs supports the notion of its protective role in AAA remodeling. AAA contained altered amounts of structural proteins, implying reduced vascular elasticity. PTX3 was upregulated in AAA and colocalized with inflammatory infiltrates. This evidence supports further evaluation of PTX3 as a candidate marker of AAA. The presence of aortic hypoxia, despite hypervascularization, suggests that hypoxia-induced neoangiogenesis may play a role in AAA pathogenesis. VV angiogenesis of the AAA wall increases its vulnerability.	[Blassova, Tereza; Tonar, Zbynek; Tomasek, Petr; Hosek, Petr] Charles Univ Prague, Dept Histol & Embryol, Fac Med Pilsen, Plzen, Czech Republic; [Blassova, Tereza; Tonar, Zbynek; Tomasek, Petr; Hosek, Petr] Charles Univ Prague, Biomed Ctr, Fac Med Pilsen, Plzen, Czech Republic; [Hollan, Ivana] Hosp Rheumat Dis, Lillehammer, Norway; [Hollan, Ivana] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Treska, Vladislav; Molacek, Jiri] Charles Univ Prague, Univ Hosp Pilsen, Fac Med Pilsen, Dept Vasc Surg, Plzen, Czech Republic	Charles University Prague; Charles University Prague; Harvard University; Brigham & Women's Hospital; Charles University Prague	Blassova, T (corresponding author), Charles Univ Prague, Dept Histol & Embryol, Fac Med Pilsen, Plzen, Czech Republic.; Blassova, T (corresponding author), Charles Univ Prague, Biomed Ctr, Fac Med Pilsen, Plzen, Czech Republic.	tereza.blassova@lfp.cuni.cz	Tonar, Zbynek/I-2728-2017; Molacek, Jiri/R-1994-2017	Tonar, Zbynek/0000-0002-7200-9894; Blassova, Tereza/0000-0001-7260-563X; Hosek, Petr/0000-0002-9359-4770; Molacek, Jiri/0000-0002-7445-0149	Ministry of Health of the Czech Republic [AZV 15-32727A]; National Sustainability Program I [LO1503]; Charles University Research Fund [Q39]; Ministry of Education, Youth and Sport of the Czech Republic [CZ.02.1.01/0.0/0.0/16_019/0000787, CZ.02.1.01/0.0/0.017_048/0007280]; European Regional Development Fund	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); National Sustainability Program I; Charles University Research Fund; Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission)	This work was mainly supported by the Ministry of Health of the Czech Republic, Project No. AZV 15-32727A. The study received additional support from the National Sustainability Program I No. LO1503, from the Charles University Research Fund -Progres Q39, by project No. CZ.02.1.01/0.0/0.0/16_019/0000787 "Fighting INfectious Diseases" and No. CZ.02.1.01/0.0/0.017_048/0007280 "Application of Modern Technologies in Medicine and Industry", awarded by the Ministry of Education, Youth and Sport of the Czech Republic, financed by European Regional Development Fund.	Arao K, 2015, HEART VESSELS, V30, P211, DOI 10.1007/s00380-014-0470-2; Armstrong PJ, 2002, J VASC SURG, V35, P346, DOI 10.1067/mva.2002.121071; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Billaud M, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00124; Bonacina F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/725102; Buda V, 2017, EUR HEART J, V38, P561; Bumdelger B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147088; Cabiati M, 2017, EUR HEART J, V38, P707; Callegari A, 2014, J VASC RES, V51, P118, DOI 10.1159/000358920; Docherty CK, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011628; Eberlova L, 2013, PATHOBIOLOGY, V80, P11, DOI 10.1159/000339304; Folsom AR, 2015, CIRCULATION, V132, P578, DOI 10.1161/CIRCULATIONAHA.115.016537; Fornai F, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0080-1; Gabel G, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006798; Henriksson AE, 2018, PROTEOMES, V6, DOI 10.3390/proteomes6040043; HOLMES DR, 1995, J VASC SURG, V21, P761, DOI 10.1016/S0741-5214(05)80007-2; Howard V, 2010, UNBIASED STEREOLOGY; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kinoshita M, 2018, J ATHEROSCLER THROMB, V25, P846, DOI 10.5551/jat.GL2017; Kocova J, 1970, Folia Morphol (Praha), V18, P293; Koole D, 2012, ARTERIOSCL THROM VAS, V32, P1497, DOI 10.1161/ATVBAHA.111.243592; Kuhnl A, 2017, DTSCH ARZTEBL INT, V114, P391, DOI 10.3238/arztebl.2017.0391; Liu H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007123; Molacek J, 2019, EPMA J, V10, P125, DOI 10.1007/s13167-019-00173-2; Moran CS, 2005, CIRCULATION, V111, P3119, DOI 10.1161/CIRCULATIONAHA.104.464727; Moris D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925840; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Mouton P.R., 2001, PRINCIPLES PRACTICES; Nakamura A, 2015, HEART VESSELS, V30, P752, DOI 10.1007/s00380-014-0553-0; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; Patel R, 2016, LANCET, V388, P2366, DOI 10.1016/S0140-6736(16)31135-7; Popescu MR, 2013, ROM J LEG MED, V21, P207, DOI 10.4323/rjlm.2013.207; Reeps C, 2009, PATHOBIOLOGY, V76, P243, DOI 10.1159/000228900; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Rodella LF, 2016, ACTA HISTOCHEM, V118, P256, DOI 10.1016/j.acthis.2016.01.007; Sawada H, 2014, CIRCULATION; Sawada H, 2015, INT J CARDIOL, V195, P281, DOI 10.1016/j.ijcard.2015.05.177; Tanaka H, 2017, JOVE-J VIS EXP, DOI 10.3791/55763; Tanaka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134386; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057398; Tonar Z, 2008, MICROSC RES TECHNIQ, V71, P760, DOI 10.1002/jemt.20619; Tonar Z, 2015, ANN ANAT, V201, P79, DOI 10.1016/j.aanat.2015.05.005; Tsai SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28612; Urbonavicius S, 2008, EUR J VASC ENDOVASC, V36, P273, DOI 10.1016/j.ejvs.2008.05.009; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Witter K, 2017, ANAT HISTOL EMBRYOL, V46, P110, DOI 10.1111/ahe.12239; Yigit S, 2013, EUR HEART J, V34, P566	48	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224818	10.1371/journal.pone.0224818	http://dx.doi.org/10.1371/journal.pone.0224818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ9IV	31703088	gold, Green Published			2022-12-26	WOS:000523573800001
J	Buchholz, F; Antonielli, L; Kostic, T; Sessitsch, A; Mitter, B				Buchholz, Franziska; Antonielli, Livio; Kostic, Tanja; Sessitsch, Angela; Mitter, Birgit			The bacterial community in potato is recruited from soil and partly inherited across generations	PLOS ONE			English	Article							RIBOSOMAL-RNA; TRANSGENIC POTATOES; SPROUT GROWTH; PLANTS; DIVERSITY; ROOT; TUBERS; COLONIZATION; MICROBIOME; ENDOPHYTES	Strong efforts have been made to understand the bacterial communities in potato plants and the rhizosphere. Research has focused on the effect of the environment and plant genotype on bacterial community structures and dynamics, while little is known about the origin and assembly of the bacterial community, especially in potato tubers. The tuber microbiota, however, may be of special interest as it could play an important role in crop quality, such as storage stability. Here, we used 16S rRNA gene amplicon sequencing to study the bacterial communities that colonize tubers of different potato cultivars commonly used in Austrian potato production over three generations and grown in different soils. Statistical analysis of sequencing data showed that the bacterial community of potato tubers has changed over generations and has become more similar to the soil bacterial community, while the impact of the potato cultivar on the bacterial assemblage has lost significance over time. The communities in different tuber parts did not differ significantly, while the soil bacterial community showed significant differences to the tuber microbiota composition. Additionally, the presence of OTUs in subsequent tuber generation points to vertical transmission of a subset of the tuber microbiota. Four OTUs were common to all tuber generations and all potato varieties. In summary, we conclude that the microbiota of potato tubers is recruited from the soil largely independent from the plant variety. Furthermore, the bacterial assemblage in potato tubers consists of bacteria transmitted from one tuber generation to the next and bacteria recruited from the soil.	[Buchholz, Franziska; Antonielli, Livio; Kostic, Tanja; Sessitsch, Angela; Mitter, Birgit] AIT Austrian Inst Technol GmbH, Ctr Hlth & Bioresources, Bioresources Unit, Tulin, Austria	Austrian Institute of Technology (AIT)	Mitter, B (corresponding author), AIT Austrian Inst Technol GmbH, Ctr Hlth & Bioresources, Bioresources Unit, Tulin, Austria.	birgit.mitter@ait.ac.at	Sessitsch, Angela/AAW-3191-2020	Sessitsch, Angela/0000-0003-0137-930X; Kostic, Tanja/0000-0003-4972-4141				Aulakh J., 2013, AGR APPL EC ASS 2013; Badri DV, 2013, J BIOL CHEM, V288, P4502, DOI 10.1074/jbc.M112.433300; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Bengtsson-Palme J, 2015, MOL ECOL RESOUR, V15, P1403, DOI 10.1111/1755-0998.12399; Bergna A, 2018, PHYTOBIOMES J, V2, P183, DOI 10.1094/PBIOMES-06-18-0029-R; Bonder MJ, 2012, BIOINFORMATICS, V28, P2891, DOI 10.1093/bioinformatics/bts552; Buchholz F, 2018, MICROB BIOTECHNOL, V11, P971, DOI 10.1111/1751-7915.13252; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carli C, 2010, POTATO RES, V53, P313, DOI 10.1007/s11540-010-9172-z; Carvalhais LC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00235; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chen W, RAM R AMPLICON SEQUE; Chung SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep39690; Dale F, 2014, BREEDING STORAGE; de Souza PM, 2010, BRAZ J MICROBIOL, V41, P850, DOI 10.1590/S1517-83822010000400004; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Furnkranz M, 2012, MICROB ECOL, V63, P418, DOI 10.1007/s00248-011-9942-4; Glassner H, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv074; Guyer A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01309; Hack H., 1993, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V45, P11; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Harrison PT, 2018, J CYST FIBROS, V17, P10, DOI 10.1016/j.jcf.2017.11.018; Hartmann A, 2011, PLANT PHYSIOL, V155, P776, DOI 10.1104/pp.110.168252; Hay R K M, 2006, PHYSL CROP YIELD, V2; Helias V, 2000, PLANT PATHOL, V49, P33, DOI 10.1046/j.1365-3059.2000.00431.x; HERVE M, 2019, RVAIDEMEMOIRE TESTIN; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2012, MICROB ECOL, V63, P460, DOI 10.1007/s00248-011-9930-8; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Kobayashi A, 2015, MICROBES ENVIRON, V30, P301, DOI 10.1264/jsme2.ME15109; Koiv V, 2015, SCI REP-UK, V5, DOI 10.1038/srep11606; Lahti L., TOOLS MICROBIOME ANA; Lakshmanan V, 2013, PLANT SIGNAL BEHAV, V8; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Liebe S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw004; Lottmann J, 2000, ADVANCES IN VERTICILLIUM: RESEARCH AND DISEASE MANAGEMENT, P264; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mitter EK, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00849, 10.3389/fmicb.2017.00011]; Nikolenko SI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S7; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paulson J, 2019, METAGENOMSEQ STAT AN; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pfeiffer S, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw242; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Pritchard S, 2012, RBC820004; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rasche F, 2006, FEMS MICROBIOL ECOL, V56, P219, DOI 10.1111/j.1574-6941.2005.00027.x; Rasche F, 2006, J APPL ECOL, V43, P555, DOI 10.1111/j.1365-2664.2006.01169.x; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Rezki S, 2018, PLANT SOIL, V422, P67, DOI 10.1007/s11104-017-3451-2; Rodriguez CE, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02708; Rognes T., 2015, VSEARCH VERSATILE OP; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Saary P, 2017, BIOINFORMATICS, V33, P2594, DOI 10.1093/bioinformatics/btx206; Samad A, 2017, ENVIRON MICROBIOL, V19, P1407, DOI 10.1111/1462-2920.13618; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Sessitsch A, 2004, CAN J MICROBIOL, V50, P239, DOI [10.1139/w03-118, 10.1139/W03-118]; Singh Brajesh, 2003, Indian Journal of Plant Physiology, V8, P141; Slininger PJ, 2003, BIOCONTROL SCI TECHN, V13, P477, DOI 10.1080/0958315031000140992; Someya N, 2013, MICROBES ENVIRON, V28, P295, DOI 10.1264/jsme2.ME13006; STURZ AV, 1995, PLANT SOIL, V175, P257, DOI 10.1007/BF00011362; Sturz AV, 1999, PLANT PATHOL, V48, P360, DOI 10.1046/j.1365-3059.1999.00351.x; Suttle JC, 2004, J PLANT PHYSIOL, V161, P157, DOI 10.1078/0176-1617-01222; Terry L, 2013, REV FACTORS AFFECTIN; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Vannier N, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0459-7; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Weinert N, 2010, FEMS MICROBIOL ECOL, V74, P114, DOI 10.1111/j.1574-6941.2010.00936.x; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Yi HS, 2015, BIOINFORMATICS, V31, P4000, DOI 10.1093/bioinformatics/btv501; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	77	18	19	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0223691	10.1371/journal.pone.0223691	http://dx.doi.org/10.1371/journal.pone.0223691			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703062	gold, Green Published			2022-12-26	WOS:000532697200004
J	Lin, L; Xia, XH; Liu, W; Wang, YM; Hua, ZY				Lin, Lu; Xia, Xuhua; Liu, Wei; Wang, Yongming; Hua, Ziyu			Clinical characteristics of neonatal fulminant necrotizing enterocolitis in a tertiary Children's hospital in the last 10 years	PLOS ONE			English	Article							PROCALCITONIN; OUTCOMES; SEPSIS; RISK	The aim of this retrospective study was to explore the risk factors and clinical characteristics related to neonatal fulminant necrotizing enterocolitis (NEC). From 1 November 2007 to 31 October 2017, 352 neonates who were diagnosed with NEC (Bell stage >=Pi B) and admitted to the Children's Hospital of Chongqing Medical University were enrolled. Among these patients, 112 (31.82%) cases fulfilled the definition of fulminant NEC, and 62.5% (70/112) of fulminant cases presented a poor prognosis. All the survivors in the fulminant NEC group underwent surgery. Those in the fulminant NEC group were more likely to have the following clinical features: sepsis preceding NEC (P< 0.001), abdominal distention (P<0.001), bowel sound disappearance (P = 0.001), leukopenia or neutropenia (P< 0.001), C-reactive protein (CRP) < 10 mg/L (P = 0.003), procalcitonin (PCT) < 2 mu g/ L (P< 0.001), pH <= 7.2 (P<0.001), and radiographic evidence of pneumoperitoneum (P< 0.001) or seroperitoneum on ultrasonography (P = 0.017). In conclusion, fulminant NEC is characterized by urgent onset and prompt deterioration, potentially resulting in death. The lack of unique characteristics makes it difficult to recognize by medical caregivers. Close observation, early detection and timely surgical intervention may improve the prognosis.	[Lin, Lu; Xia, Xuhua; Wang, Yongming; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Lin, Lu; Xia, Xuhua; Liu, Wei; Wang, Yongming; Hua, Ziyu] Natl Clin Res Ctr Child Hlth & Disorders, Chongqing, Peoples R China; [Lin, Lu; Xia, Xuhua; Liu, Wei; Wang, Yongming; Hua, Ziyu] China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China; [Liu, Wei] Chongqing Med Univ, Dept Gastrointestinal & Neonatal Surg, Childrens Hosp, Chongqing, Peoples R China; [Wang, Yongming] Chongqing Key Lab Child Hlth & Nutr, Chongqing, Peoples R China; [Hua, Ziyu] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Natl Clin Res Ctr Child Hlth & Disorders, Chongqing, Peoples R China.; Hua, ZY (corresponding author), China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China.; Hua, ZY (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.	h_ziyu@126.com	Lin, Lu/AAE-5954-2021		Clinical Research Project of Children's Hospital of Chongqing Medical University [YBXM 2019007]	Clinical Research Project of Children's Hospital of Chongqing Medical University	This study was supported by grants from the Clinical Research Project of Children's Hospital of Chongqing Medical University (YBXM 2019007). The funder had no role in study design, data collection and analysis, desision to publish, or preparation of the manuscript.	Alexander VN, 2011, J PEDIATR-US, V159, P392, DOI 10.1016/j.jpeds.2011.02.035; Bell SG, 2017, NEONATAL NETW, V36, P380, DOI 10.1891/0730-0832.36.6.380; Bhatia J, 2010, CHINESE MED J-PEKING, V123, P2759, DOI 10.3760/cma.j.issn.0366-6999.2010.20.002; Christensen RD, 2010, FETAL PEDIATR PATHOL, V29, P185, DOI 10.3109/15513815.2010.483874; COVERT RF, 1989, AM J PERINAT, V6, P455, DOI 10.1055/s-2007-999639; Gagliardi L, 2008, J PEDIATR GASTR NUTR, V47, P206, DOI 10.1097/MPG.0b013e318174e855; Gordon PV, 2011, J PERINATOL, V31, P149, DOI 10.1038/jp.2010.164; Hammond PJ, 2008, EUR J PEDIATR SURG, V18, P185, DOI 10.1055/s-2008-1038440; HUMMER P, 1986, LANGENBECK ARCH CHIR, V369, P673, DOI 10.1007/BF01274459; HUTTER JJ, 1976, J PEDIATR-US, V88, P1026, DOI 10.1016/S0022-3476(76)81069-4; Kling Pamela J, 2003, J Perinatol, V23, P523, DOI 10.1038/sj.jp.7210983; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; Lambert DK, 2012, J PERINATOL, V32, P194, DOI 10.1038/jp.2011.61; Lamy B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00697; Lee Jane S, 2003, Semin Neonatol, V8, P449, DOI 10.1016/S1084-2756(03)00123-4; Morgan JA, 2011, CURR OPIN INFECT DIS, V24, P183, DOI 10.1097/QCO.0b013e328345d5b5; Neu J, 2014, NEONATOLOGY, V106, P289, DOI 10.1159/000365130; Patel RM, 2016, JAMA-J AM MED ASSOC, V315, P889, DOI 10.1001/jama.2016.1204; Ron O, 2009, J PEDIATR SURG, V44, P749, DOI 10.1016/j.jpedsurg.2008.09.031; Ruan L, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2236-1; Silverman MA, 2017, GASTROENTEROL CLIN N, V46, P61, DOI 10.1016/j.gtc.2016.09.010; Voss M, 1998, PEDIATR SURG INT, V13, P576, DOI 10.1007/s003830050407; [王雪秋 Wang Xueqiu], 2018, [临床儿科杂志, Journal of Chinical Pediatrics], V36, P871; Yu ZB, 2010, SCAND J INFECT DIS, V42, P723, DOI 10.3109/00365548.2010.489906	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224880	10.1371/journal.pone.0224880	http://dx.doi.org/10.1371/journal.pone.0224880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KY2HO	31703096	Green Published, gold			2022-12-26	WOS:000522392700001
J	Scheich, S; Enssle, JC; Mucke, VT; Acker, F; Aspacher, L; Wolf, S; Wilke, AC; Weber, S; Brunnberg, U; Serve, H; Steffen, B				Scheich, Sebastian; Enssle, Julius C.; Muecke, Victoria T.; Acker, Fabian; Aspacher, Lukas; Wolf, Sebastian; Wilke, Anne C.; Weber, Sarah; Brunnberg, Uta; Serve, Hubert; Steffen, Bjoern			Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantation	PLOS ONE			English	Article							BODY-MASS INDEX; NON-HODGKINS; CONDITIONING CHEMOTHERAPY; MARROW-TRANSPLANTATION; CANCER DEVELOPMENT; AMERICAN SOCIETY; RISK; MORTALITY; METAANALYSIS; OVERWEIGHT	Autologous hematopoietic stem cell transplantation (auto-HSCT) provides a potentially curative treatment option for relapsed and refractory lymphomas. Obesity displays an emerging epidemic risk factor for global mortality and is associated with an increased mortality in cancer patients. To date, the impact of obesity on the outcome of lymphoma patients undergoing auto-HSCT is understudied. We conducted a retrospective single-center study assessing 119 lymphoma patients who underwent auto-HSCT. Overall survival (OS) served as the primary endpoint whereas progression free survival (PFS), cumulative incidence of non-relapse related mortality (NRM) and cumulative incidence of relapse were analyzed as secondary endpoints. Obese patients (Body mass index, BMI.30) had significantly lower OS (45.3% vs. 77.9%; p = 0.005) and PFS (29.8% vs. 67.2%; p<0.001) compared to nonobese patients at 48 months post-transplantation. The cumulative incidence of NRM displayed no significant differences while the cumulative incidence of relapse was significantly increased in patients with BMI >= 30 (66.2% vs. 21.5%; p< 0.001). Patients with a BMI< 25 and overweight patients (BMI 25-30; 76.1% vs. 80.9%; p = 0.585), showed no significant difference in OS, whereas patients with BMI.30 exhibited significant lower OS when compared to either of both groups (76.1% vs. 45.3%; p =.0.021 and 80.9% vs. 45.3%; p = 0.010). Furthermore, in a multivariate analysis, obesity was identified as an independent risk factor for death (Hazard ratio 2.231; 95% CI 1.024 to 4.860; p = 0.043). Further studies are needed to evaluate the reasons for the higher relapse rate causing higher mortality in obese patients.	[Scheich, Sebastian; Enssle, Julius C.; Acker, Fabian; Aspacher, Lukas; Wolf, Sebastian; Wilke, Anne C.; Weber, Sarah; Brunnberg, Uta; Serve, Hubert; Steffen, Bjoern] Univ Hosp Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany; [Muecke, Victoria T.] Univ Hosp Frankfurt, Dept Gastroenterol Hepatol Pulmonol & Endocrinol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Scheich, S (corresponding author), Univ Hosp Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany.	sebastian.scheich@kgu.de		Weber, Sarah/0000-0002-9624-1399; Acker, Fabian/0000-0002-6207-0237; Serve, Hubert/0000-0001-8472-5516				Apovian Caroline M, 2016, Am J Manag Care, V22, ps176; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Blijlevens N, 2008, J CLIN ONCOL, V26, P1519, DOI 10.1200/JCO.2007.13.6028; Bocquier A, 2015, PUBLIC HEALTH NUTR, V18, P2952, DOI 10.1017/S1368980014002912; Broccoli A, 2019, BRIT J HAEMATOL, V184, P93, DOI 10.1111/bjh.15639; Brunstein CG, 2019, BIOL BLOOD MARROW TR, V25, P480, DOI 10.1016/j.bbmt.2018.11.005; Bubalo J, 2014, BIOL BLOOD MARROW TR, V20, P600, DOI 10.1016/j.bbmt.2014.01.019; Caballero MD, 2003, ANN ONCOL, V14, P140, DOI 10.1093/annonc/mdg008; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chan DSM, 2014, ANN ONCOL, V25, P1901, DOI 10.1093/annonc/mdu042; Chan H, 2016, LEUKEMIA LYMPHOMA, V57, P2584, DOI 10.3109/10428194.2016.1151508; Costa LJ, 2008, BRIT J HAEMATOL, V143, P268, DOI 10.1111/j.1365-2141.2008.07342.x; Costa LJ, 2017, AM J HEMATOL, V92, P161, DOI 10.1002/ajh.24615; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dickson T M, 1999, Biol Blood Marrow Transplant, V5, P299, DOI 10.1016/S1083-8791(99)70005-4; Epperla N, 2019, BLOOD ADV, V3, P1661, DOI 10.1182/bloodadvances.2019000102; Field KM, 2008, J ONCOL PRACT, V4, P108, DOI 10.1200/JOP.0832001; Gonzalez-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34; Green B, 2004, BRIT J CLIN PHARMACO, V58, P119, DOI 10.1111/j.1365-2125.2004.02157.x; Griggs JJ, 2012, J CLIN ONCOL, V30, P1553, DOI 10.1200/JCO.2011.39.9436; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hitz F, 2015, ANN HEMATOL, V94, P1839, DOI 10.1007/s00277-015-2467-z; Hohloch K, 2018, BRIT J HAEMATOL, V180, P236, DOI 10.1111/bjh.15029; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Hutchings M, 2018, ANN ONCOL, V29, P1687, DOI 10.1093/annonc/mdy167; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Iyengar NM, 2015, ANNU REV MED, V66, P297, DOI 10.1146/annurev-med-050913-022228; Jain R, 2011, CLIN PHARMACOL THER, V90, P77, DOI 10.1038/clpt.2011.104; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Kuruvilla J, 2016, BLOOD, V127, P2093, DOI 10.1182/blood-2015-11-624320; Larsson SC, 2011, EUR J CANCER, V47, P2422, DOI 10.1016/j.ejca.2011.06.029; Lyman GH, 2013, NAT REV CLIN ONCOL, V10, DOI [10.1038/nrclinonc.2013.108-c2, 10.1038/nrclinonc.2013.108]; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgu013; Navarro WH, 2006, BIOL BLOOD MARROW TR, V12, P541, DOI 10.1016/j.bbmt.2005.12.033; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nikolousis E, 2010, ANN HEMATOL, V89, P1141, DOI 10.1007/s00277-010-1001-6; Pai MP, 2012, PHARMACOTHERAPY, V32, P856, DOI 10.1002/j.1875-9114.2012.01108.x; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Tarella C, 2000, BONE MARROW TRANSPL, V26, P1185, DOI 10.1038/sj.bmt.1702692; Wang YR, 2016, 2016 INT IEEE CONFERENCES ON UBIQUITOUS INTELLIGENCE & COMPUTING, ADVANCED & TRUSTED COMPUTING, SCALABLE COMPUTING AND COMMUNICATIONS, CLOUD AND BIG DATA COMPUTING, INTERNET OF PEOPLE, AND SMART WORLD CONGRESS (UIC/ATC/SCALCOM/CBDCOM/IOP/SMARTWORLD), P815, DOI [10.1109/UIC-ATC-ScalCom-CBDCom-IoP-SmartWorld.2016.75, 10.1109/UIC-ATC-ScalCom-CBDCom-IoP-SmartWorld.2016.0130]	48	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0225035	10.1371/journal.pone.0225035	http://dx.doi.org/10.1371/journal.pone.0225035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703102	Green Published, gold			2022-12-26	WOS:000532697200039
J	Gofrit, ON; Klein, BY; Cohen, IR; Ben-Hur, T; Greenblatt, CL; Bercovier, H				Gofrit, Ofer N.; Klein, Benjamin Y.; Cohen, Irun R.; Ben-Hur, Tamir; Greenblatt, Charles L.; Bercovier, Herve			Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients	PLOS ONE			English	Article							REGULATORY T-CELLS; RANDOMIZED-TRIAL; MOUSE MODEL; IMMUNIZATION; VACCINE; MILD	Background Alzheimer's disease (AD) affects one in ten people older than 65 years. Thus far, there is no cure or even disease-modifying treatment for this disease. The immune system is a major player in the pathogenesis of AD. Bacillus Calmette-Guerin (BCG), developed as a vaccine against tuberculosis, modulates the immune system and reduces recurrence of non-muscle invasive bladder cancer. Theoretical considerations suggested that treatment with BCG may decrease the risk of AD. We tested this hypothesis on a natural population of bladder cancer patients. Methods and findings After removing all bladder cancer patients presenting with AD or developing AD within oneyear following diagnosis of bladder cancer, we collected data on a total of 1371 patients (1134 males and 237 females) who were followed for at least one year after the diagnosis of bladder cancer. The mean age at diagnosis of bladder cancer was 68.1 years (SD 13.0). Adjuvant post-operative intra-vesical treatment with BCG was given to 878 (64%) of these patients. The median period post-operative follow-up was 8 years. During follow-up, 65 patients developed AD at a mean age of 84 years (SD 5.9), including 21 patients (2.4%) who had been treated with BCG and 44 patients (8.9%) who had not received BCG. Patients who had been treated with BCG manifested more than 4-fold less risk for AD than those not treated with BCG. The Cox proportional hazards regression model and the Kaplan-Meier analysis of AD free survival both indicated high significance: patients not treated with BCG had a significantly higher risk of developing AD compared to BCG treated patients (HR 4.778, 95%CI: 2.837-8.046, p = 4.08x10(-9) and Log Rank Chi-square 42.438, df = 1, p = 7.30x10(-11), respectively). Exposure to BCG did not modify the prevalence of Parkinson's disease, 1.9% in BCG treated patients and 1.6% in untreated (Fisher's Exact Test, p = 1). Conclusions Bladder cancer patients treated with BCG were significantly less likely to develop AD at any age than patients who were not so treated. This finding of a retrospective study suggests that BCG treatment might also reduce the incidence of AD in the general population. Confirmation of such effects of BCG in other retrospective studies would support prospective studies of BCG in AD.	[Gofrit, Ofer N.] Hadassah Hebrew Univ Med Ctr, Dept Urol, Jerusalem, Israel; [Klein, Benjamin Y.; Greenblatt, Charles L.; Bercovier, Herve] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Jerusalem, Israel; [Cohen, Irun R.] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Ben-Hur, Tamir] Hadassah Hebrew Univ Med Ctr, Dept Neurol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Hebrew University of Jerusalem	Gofrit, ON (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Urol, Jerusalem, Israel.; Bercovier, H (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Jerusalem, Israel.	ogofrit@gmail.com; hb@cc.huji.ac.il	Bercovier, Herve/AHC-6851-2022; Greenblatt, Chuck/ABC-8220-2021	Bercovier, Herve (hillel)/0000-0001-7297-3029; Gofrit, Ofer/0000-0001-8815-6488				Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Aarts S, 2014, EUR J GEN PRACT, V20, P61, DOI 10.3109/13814788.2013.818655; Baek H, 2016, ONCOTARGET, V7, P69347, DOI 10.18632/oncotarget.12469; Bauerl C, 2018, LETT APPL MICROBIOL, V66, P464, DOI 10.1111/lam.12882; Bajic P, 2019, UROLOGY, V126, P10, DOI 10.1016/j.urology.2018.12.034; Bowles EJA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179857; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Chamie K, 2011, CANCER-AM CANCER SOC, V117, P5392, DOI 10.1002/cncr.26198; Demetrius LA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0006; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Egan MF, 2019, NEW ENGL J MED, V380, P1408, DOI 10.1056/NEJMoa1812840; Gauthier S, 2016, LANCET, V388, P2873, DOI 10.1016/S0140-6736(16)31275-2; Gofrit ON, 2019, MED HYPOTHESES, V123, P95, DOI 10.1016/j.mehy.2019.01.007; Gofrit ON, 2018, BJU INT, V121, P627, DOI 10.1111/bju.14108; Harach T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41802; Honig LS, 2018, NEW ENGL J MED, V378, P321, DOI 10.1056/NEJMoa1705971; Jobke B, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002518; Kamat AM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0280-z; Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014; Lacan G, 2013, J NEUROSCI RES, V91, P1292, DOI 10.1002/jnr.23253; Lee JE, 2008, J IMMUNOL, V181, P6201, DOI 10.4049/jimmunol.181.9.6201; Li YY, 2018, RENAL FAILURE, V40, P280, DOI 10.1080/0886022X.2018.1456462; Monteiro-Maia R, 2014, MEM I OSWALDO CRUZ, V109, P838, DOI 10.1590/0074-0276140091; Moorlag SJCFM, 2019, CLIN MICROBIOL INFEC, V25, P1473, DOI 10.1016/j.cmi.2019.04.020; Musicco M, 2013, NEUROLOGY, V81, P322, DOI 10.1212/WNL.0b013e31829c5ec1; Nebel RA, 2018, ALZHEIMERS DEMENT, V14, P1171, DOI 10.1016/j.jalz.2018.04.008; Niu H, 2017, NEUROLOGIA, V32, P523, DOI 10.1016/j.nrl.2016.02.016; Ott BR, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00245; Prince M., 2016, WORLD ALZHEIMER REPO; Qi FF, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0808-7; Ristori G, 2014, NEUROLOGY, V82, P41, DOI 10.1212/01.wnl.0000438216.93319.ab; Spencer BA, 2013, J ONCOL PRACT, V9, P92, DOI 10.1200/JOP.2011.000480; Taniguchi K, 1999, CLIN EXP IMMUNOL, V115, P131; VanItallie TB, 2017, METABOLISM, V69, pS41, DOI 10.1016/j.metabol.2017.01.014; Zhu XY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009204; Zuo ZJ, 2017, NEUROBIOL DIS, V101, P27, DOI 10.1016/j.nbd.2017.02.001	36	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224433	10.1371/journal.pone.0224433	http://dx.doi.org/10.1371/journal.pone.0224433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697701	Green Published, gold			2022-12-26	WOS:000532694400027
J	Mallard, B; Leach, DN; Wohlmuth, H; Tiralongo, J				Mallard, Brody; Leach, David N.; Wohlmuth, Hans; Tiralongo, Joe			Synergistic immuno-modulatory activity in human macrophages of a medicinal mushroom formulation consisting of Reishi, Shiitake and Maitake	PLOS ONE			English	Article							NATURAL-PRODUCTS; GLUCAN	A key characteristic of mushroom polysaccharides that elicit an immunomodulatory response is that they are rich in beta-glucans and low in alpha-glucans. In this study we analysed nine commercially available preparations from three mushroom species, Reishi (Ganoderma lucidum), Shiitake (Lentinula edodes) and Maitake (Grifola frondosa), for beta- and alpha-glucan content. Based on beta- and alpha-glucan content we selected three extracts to combine into a formula and evaluated the ability of the individual extracts and formula to impact on the expression of cytokines IL-1 alpha, IL-6, IL-10 and TNF-alpha in human macrophages with and without LPS stimulation. The majority of mushroom extracts and the formula were found to be highly potent immuno-stimulators possessing EC50 values lower than 100 mu g/mL. Interestingly the mushroom formula had lower EC50 values in TNF-alpha expression from LPS stimulated macrophages compared to the individual extracts, suggesting a potential synergistic effect of the mushroom formula. A response additivity graph and curve-shift analysis illustrated that indeed the mushroom formula exhibited an immuno-stimulatory synergistic effect on the expression of the majority of cytokines evaluated in both LPS stimulated and non-stimulated human macrophages, with IL-10 having an antagonistic response. This study represents the first report of a synergistic immuno-modulatory response in human macrophages elicited from a mushroom formula rationally derived from beta- and alpha-glucan content.	[Mallard, Brody; Tiralongo, Joe] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia; [Leach, David N.; Wohlmuth, Hans] Integria Healthcare, Eight Mile Plains, Qld, Australia; [Leach, David N.; Wohlmuth, Hans] Western Sydney Univ, Natl Inst Complementary Med, Penrith, NSW, Australia; [Wohlmuth, Hans] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	Griffith University; Western Sydney University; University of Queensland	Tiralongo, J (corresponding author), Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia.	j.tiralongo@griffith.edu.au		Tiralongo, Joe/0000-0002-3529-6310; Leach, David/0000-0002-0682-0638	Integria Healthcare (Australia) Pty Ltd.	Integria Healthcare (Australia) Pty Ltd.	This research was sponsored by Integria Healthcare (Australia) Pty Ltd.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Bachiega TF, 2012, PHYTOTHER RES, V26, P1308, DOI 10.1002/ptr.3731; Barsanti L, 2011, NAT PROD REP, V28, P457, DOI 10.1039/c0np00018c; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Chen JZ, 2007, MYCOL RES, V111, P635, DOI 10.1016/j.mycres.2007.02.011; Cheng KC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-411; Chu K, 2002, J CLIN PHARM, V42; Elsayed EA, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/805841; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Guo L, 2009, INT IMMUNOPHARMACOL, V9, P1175, DOI 10.1016/j.intimp.2009.06.005; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Kirmaz C, 2005, EUR CYTOKINE NETW, V16, P128; Lindequist U, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/806180; Lull C, 2005, MEDIAT INFLAMM, P63, DOI 10.1155/MI.2005.63; McCleary BV, 2016, J AOAC INT, V99, P364, DOI 10.5740/jaoacint.15-0289; Meisel C, 1996, EUR J IMMUNOL, V26, P1580, DOI 10.1002/eji.1830260726; Menck K, 2014, JOVE-J VIS EXP, DOI 10.3791/51554; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Ramachandran C, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8379843; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Samuelsen ABC, 2014, MOL NUTR FOOD RES, V58, P183, DOI 10.1002/mnfr.201300338; Spelman K, 2006, ALTERN MED REV, V11, P128; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Tiralongo J, 2019, IMMUNOMODULATORY COM; Verma SP, 1997, BIOCHEM BIOPH RES CO, V233, P692, DOI 10.1006/bbrc.1997.6527; Vetvicka V., 2014, ANN TRANSLATIONAL ME, V2; Voronov E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00177; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wang ZW, 2008, LIFE SCI, V83, P293, DOI 10.1016/j.lfs.2008.06.017; Wasser Solomon P, 2014, Biomed J, V37, P345, DOI 10.4103/2319-4170.138318; Wismar R, 2010, ANN NY ACAD SCI, V1190, P70, DOI 10.1111/j.1749-6632.2009.05256.x	31	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224740	10.1371/journal.pone.0224740	http://dx.doi.org/10.1371/journal.pone.0224740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697749	gold, Green Published			2022-12-26	WOS:000532694400054
J	Cointet, E; Wielgosz-Collin, G; Bougaran, G; Rabesaotra, V; Goncalves, O; Meleder, V				Cointet, Eva; Wielgosz-Collin, Gaetane; Bougaran, Gael; Rabesaotra, Vony; Goncalves, Olivier; Meleder, Vona			Effects of light and nitrogen availability on photosynthetic efficiency and fatty acid content of three original benthic diatom strains	PLOS ONE			English	Article							TOTAL LIPID-CONTENT; PHAEODACTYLUM-TRICORNUTUM; BIOCHEMICAL-COMPOSITION; MARINE DIATOMS; ENVIRONMENTAL-FACTORS; SKELETONEMA-COSTATUM; SILICATE LIMITATION; GROWTH; MICROALGAE; TEMPERATURE	Microalgal biotechnology has gained considerable importance in recent decades. Applications range from simple biomass production for food and animal feed to valuable products for fuel, pharmaceuticals, health, biomolecules and materials relevant to nanotechnology. There are few reports of the exploration of wider microalgae biodiversity in the literature on high value microalgal compounds, however, because it is believed that there is little to be gained in terms of biomass productivity by examining new strains. Still, without diversity, innovation in biotechnology applications is currently limited. Using microalgal diversity is a very promising way to match species and processes for a specific biotechnological application. In this context, three benthic marine diatom strains (Entomoneis paludosa NCC18.2, Nitzschia alexandrine NCC33, and Staurosira sp NCC182) were selected for their lipid production and growth capacities. Using PAM fluorometry and FTIR spectroscopy, this study investigated the impact of nitrogen repletion and depletion as well as light intensity (30, 100, and 400 mu mol.photons.m(-2).s(-1)) on their growth, photosynthetic performance and macromolecular content, with the aim of improving the quality of their lipid composition. Results suggest that under high light and nitrogen limitation, the photosynthetic machinery is negatively impacted, leading cells to reduce their growth and accumulate lipids and/or carbohydrates. However, increasing lipid content under stressful conditions does not increase the production of lipids of interest: PUFA, ARA and EPA production decreases. Culture conditions to optimize production of such fatty acids in these three original strains led to a balance between economic and ecophysiological constraints: low light and no nitrogen limitation led to better photosynthetic capacities associated with energy savings, and hence a more profitable approach.	[Cointet, Eva; Wielgosz-Collin, Gaetane; Rabesaotra, Vony; Meleder, Vona] Univ Nantes, Lab Mer Mol Sante, Nantes, France; [Bougaran, Gael] PBA IFREMER, Nantes, France; [Goncalves, Olivier] Univ Nantes, GEPEA, Nantes, France	Nantes Universite; Ifremer; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite	Cointet, E (corresponding author), Univ Nantes, Lab Mer Mol Sante, Nantes, France.	eva.cointet@gmail.com		cointet, eva/0000-0003-3981-9569; Bougaran, Gael/0000-0002-3463-7590	Atlantic Microalgae research program (AMI) - Region Pays de la Loire; BIO-Tide project through the 2015-2016 BiodivERsA COFUND call for research proposals; BelSPO; FWO; ANR; SNSF	Atlantic Microalgae research program (AMI) - Region Pays de la Loire; BIO-Tide project through the 2015-2016 BiodivERsA COFUND call for research proposals; BelSPO(Belgian Federal Science Policy Office); FWO(FWO); ANR(French National Research Agency (ANR)); SNSF(Swiss National Science Foundation (SNSF))	This research was supported under the Atlantic Microalgae research program (AMI), funded by the Region Pays de la Loire, and the BIO-Tide project, itself funded through the 2015-2016 BiodivERsA COFUND call for research proposals, with the national funders BelSPO, FWO, ANR and SNSF.	ACKMAN RG, 1964, J FISH RES BOARD CAN, V21, P747, DOI 10.1139/f64-067; Alipanah L, 2015, J EXP BOT, V66, P6281, DOI 10.1093/jxb/erv340; Allen E., 1914, J MAR BIOL ASSOC UK, V10, P417, DOI DOI 10.1017/S0025315400008225; Amaro HM, 2011, APPL ENERG, V88, P3402, DOI 10.1016/j.apenergy.2010.12.014; Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; Aminot A., 2004, HYDROLOGIE ECOSYSTEM; Anning T, 2000, LIMNOL OCEANOGR, V45, P1807, DOI 10.4319/lo.2000.45.8.1807; Beardall J, 2001, AQUAT SCI, V63, P44, DOI 10.1007/PL00001344; Beardall J, 2001, AQUAT SCI, V63, P107, DOI 10.1007/PL00001342; Beer S, 1998, MAR ECOL PROG SER, V174, P293, DOI 10.3354/meps174293; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bondioli P, 2012, BIORESOURCE TECHNOL, V114, P567, DOI 10.1016/j.biortech.2012.02.123; Bougaran G, 2010, J THEOR BIOL, V265, P443, DOI 10.1016/j.jtbi.2010.04.018; BRAND LE, 1981, J EXP MAR BIOL ECOL, V50, P119, DOI 10.1016/0022-0981(81)90045-9; Brembu T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0406; Brown MR, 1996, J PHYCOL, V32, P64, DOI 10.1111/j.0022-3646.1996.00064.x; Bucciarelli E, 2003, LIMNOL OCEANOGR, V48, P2256, DOI 10.4319/lo.2003.48.6.2256; Cade-Menun BJ, 2010, MAR CHEM, V121, P27, DOI 10.1016/j.marchem.2010.03.002; Chen GQ, 2007, FOOD CHEM, V104, P1580, DOI 10.1016/j.foodchem.2007.03.008; Chen YC, 2012, FOOD CHEM, V131, P211, DOI 10.1016/j.foodchem.2011.08.062; CHUECAS L, 1969, J MAR BIOL ASSOC UK, V49, P97, DOI 10.1017/S0025315400046439; Coat R, 2014, BIOPROC BIOSYST ENG, V37, P2175, DOI 10.1007/s00449-014-1194-5; Cointet E, 2019, ALGAL RES, V39, DOI 10.1016/j.algal.2019.101425; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Cruz S, 2008, AQUAT BOT, V88, P256, DOI 10.1016/j.aquabot.2007.11.001; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; DAVIS CO, 1976, J PHYCOL, V12, P291, DOI 10.1111/j.1529-8817.1976.tb02847.x; Dean AP, 2010, BIORESOURCE TECHNOL, V101, P4499, DOI 10.1016/j.biortech.2010.01.065; Dempster TA, 1998, J PHYCOL, V34, P712, DOI 10.1046/j.1529-8817.1998.340712.x; DUBINSKY Z, 1974, OECOLOGIA, V16, P53, DOI 10.1007/BF00345087; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Gao YY, 2013, BIORESOURCE TECHNOL, V147, P484, DOI 10.1016/j.biortech.2013.08.066; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x; Goldman JC, 2003, LIMNOL OCEANOGR, V48, P1176, DOI 10.4319/lo.2003.48.3.1176; Griffiths MJ, 2012, J APPL PHYCOL, V24, P989, DOI 10.1007/s10811-011-9723-y; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Guiheneuf F, 2008, DIATOM RES, V23, P93; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; He QN, 2015, BIORESOURCE TECHNOL, V191, P219, DOI 10.1016/j.biortech.2015.05.021; Hildebrand M, 2012, BIOFUELS-UK, V3, P221, DOI 10.4155/bfs.11.157; Huete-Ortega M, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1061-8; Huntley ME, 2015, ALGAL RES, V10, P249, DOI 10.1016/j.algal.2015.04.016; Jauffrais T, 2015, J EXP MAR BIOL ECOL, V469, P83, DOI 10.1016/j.jembe.2015.04.014; Jiang HM, 2004, J PHYCOL, V40, P651, DOI 10.1111/j.1529-8817.2004.03112.x; Jiang YL, 2012, PLANT PHYSIOL BIOCH, V54, P70, DOI 10.1016/j.plaphy.2012.02.012; Joseph MM, 2017, BIOFUELS-UK, V8, P81, DOI 10.1080/17597269.2016.1204585; KATES M, 1966, BIOCHIM BIOPHYS ACTA, V116, P264, DOI 10.1016/0005-2760(66)90009-9; Koroleff F., 1970, INT COUNCIL EXPLORAT, P19; Lai JX, 2011, J EXP MAR BIOL ECOL, V405, P6, DOI 10.1016/j.jembe.2011.05.010; Leon ES, 2014, BIOPROC BIOSYST ENG, V37, P2371, DOI 10.1007/s00449-014-1215-4; Liu ZY, 2008, BIORESOURCE TECHNOL, V99, P4717, DOI 10.1016/j.biortech.2007.09.073; Mamaeva A, 2018, J APPL PHYCOL, V30, P2237, DOI 10.1007/s10811-018-1471-9; MCLACHLAN J, 1964, CAN J MICROBIOL, V10, P769, DOI 10.1139/m64-098; MORTENSEN SH, 1988, J EXP MAR BIOL ECOL, V122, P173, DOI 10.1016/0022-0981(88)90183-9; Napoleon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066423; Norici A, 2011, PLANT CELL ENVIRON, V34, P1666, DOI 10.1111/j.1365-3040.2011.02362.x; Ozkan A, 2012, BIORESOURCE TECHNOL, V114, P542, DOI 10.1016/j.biortech.2012.03.055; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pessoa MG, 2019, BIOTECHNOL ADV, V37, P319, DOI 10.1016/j.biotechadv.2019.01.007; PLUMLEY FG, 1989, P NATL ACAD SCI USA, V86, P2678, DOI 10.1073/pnas.86.8.2678; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Quigg A, 2003, PLANT CELL ENVIRON, V26, P693, DOI 10.1046/j.1365-3040.2003.01004.x; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Renaud SM, 1999, AQUACULTURE, V170, P147, DOI 10.1016/S0044-8486(98)00399-8; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P649, DOI 10.4319/lo.1981.26.4.0649; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; ROESSLER PG, 1988, J PHYCOL, V24, P394, DOI 10.1111/j.1529-8817.1988.tb00189.x; Roleda MY, 2013, BIORESOURCE TECHNOL, V129, P439, DOI 10.1016/j.biortech.2012.11.043; Sayanova O, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0407; Schaub I, 2017, POLAR BIOL, V40, P1425, DOI 10.1007/s00300-016-2067-y; Schultze LKP, 2015, ALGAL RES, V8, P37, DOI 10.1016/j.algal.2015.01.007; Shahidi F., 2007, MARINE NUTRACEUTICAL; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; Silva-Aciares FR, 2008, AQUACULT ENG, V38, P26, DOI 10.1016/j.aquaeng.2007.10.005; Solovchenko AE, 2008, J APPL PHYCOL, V20, P245, DOI 10.1007/s10811-007-9233-0; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; SRIHARAN S, 1990, APPL BIOCHEM BIOTECH, V24-5, P309, DOI 10.1007/BF02920255; Sunda WG, 2004, LIMNOL OCEANOGR, V49, P1742, DOI 10.4319/lo.2004.49.5.1742; Thi TYD, 2011, BIOMASS BIOENERG, V35, P2534, DOI 10.1016/j.biombioe.2011.02.021; Tian X, 2010, BIORESOURCE TECHNOL, V101, P977, DOI 10.1016/j.biortech.2009.09.007; TURPIN DH, 1991, J PHYCOL, V27, P14, DOI 10.1111/j.0022-3646.1991.00014.x; VARUM KM, 1984, J EXP MAR BIOL ECOL, V83, P13, DOI 10.1016/0022-0981(84)90114-X; VASSILIEV IR, 1994, PHOTOSYNTH RES, V42, P51, DOI 10.1007/BF00019058; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; VOLKMAN JK, 1980, PHYTOCHEMISTRY, V19, P1809, DOI 10.1016/S0031-9422(00)83818-2; White S, 2011, BIORESOURCE TECHNOL, V102, P1675, DOI 10.1016/j.biortech.2010.09.097; Wilhelm C, 2014, MAR GENOM, V16, P5, DOI 10.1016/j.margen.2013.12.003; Xia S, 2013, CHIN J OCEANOL LIMN, V31, P1163, DOI 10.1007/s00343-013-2092-4; Yi ZQ, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00017; YONGMANITCHAI W, 1991, APPL ENVIRON MICROB, V57, P419, DOI 10.1128/AEM.57.2.419-425.1991; Yu ET, 2009, J APPL PHYCOL, V21, P669, DOI 10.1007/s10811-008-9400-y; Zhao F., 2016, FUNDAM RENEW ENERGY, V6, P22; Zulu N.N., 2018, PROG LIPID RES	101	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224701	10.1371/journal.pone.0224701	http://dx.doi.org/10.1371/journal.pone.0224701			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31694047	Green Published, gold			2022-12-26	WOS:000532690100036
J	Shi, XX; Qiu, HP; Wang, JY; Zhang, Z; Wang, YL; Sun, GC				Shi, Xiao-Xiao; Qiu, Hai-Ping; Wang, Jiao-yu; Zhang, Zhen; Wang, Yan-Li; Sun, Guo-Chang			A handy method to remove bacterial contamination from fungal cultures	PLOS ONE			English	Article							ELIMINATION	Contamination control and removal are very important technical aspects of microbiological research. Bacterial contamination is very common in fungal cultures. Currently, the commonly used approach for inhibiting bacteria is antibiotic treatment; however, there are drawbacks to using antibiotics, including incomplete removal, limited antibacterial spectra, tendency toward recontamination, effects to fungal strains, and potential risks to the environment. Therefore, in the present work, we developed a new method for bacterial removal from fungi cultured on solid medium, the Cabin-Sequestering (CS) method, based on the different culture characteristics between fungi and bacteria. First, 3-5 mm round or square holes (the "cabin") are excavated on a solid medium plate. The fungal strain containing possible bacterial contamination is inoculated into the cabin. The cabin is then covered with a sterilized coverslip, followed by incubation at the appropriate temperature. After 7-10 days of culturing, fungal hyphae grow out along the edge of the coverslip; however, the contaminating bacteria cannot pass through the space formed between the medium and the coverslip and, thus, remain in the cabin. The newly grown fungal hyphae around the coverslip are re-inoculated into fresh culture plates, where they form bacteria-free fungal colonies. The CS method is easy handling, with a short experimental cycle and rare recontamination. When necessary, it can also be used in combination with antibiotics in bacterial removal operations.	[Shi, Xiao-Xiao; Qiu, Hai-Ping; Wang, Jiao-yu; Zhang, Zhen; Wang, Yan-Li; Sun, Guo-Chang] Zhejiang Acad Agr Sci, Inst Plant Protect Microbiol, State Key Lab Managing Biot & Chem Threats Qual &, Hangzhou, Peoples R China; [Shi, Xiao-Xiao] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang Normal University	Wang, JY; Sun, GC (corresponding author), Zhejiang Acad Agr Sci, Inst Plant Protect Microbiol, State Key Lab Managing Biot & Chem Threats Qual &, Hangzhou, Peoples R China.	wangjiaoyu78@sina.com; sunc01@sina.com			National Natural Science Foundation of China [31170136, 31470249]; State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products [2010DS700124-221804]; National Key Research and Development Program of China [2016YFD0300707]; Key Technology Research and Development Program of Zhejiang province [2019C02010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products; National Key Research and Development Program of China; Key Technology Research and Development Program of Zhejiang province	This work was funded by National Natural Science Foundation of China grant number 31170136 and 31470249 to JW; State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products grant number 2010DS700124-221804 to JW; National Key Research and Development Program of China grant number 2016YFD0300707; Key Technology Research and Development Program of Zhejiang province grant number 2019C02010.	Cai X H, 2003, CHIN J TROP AGR, V23, P40; Cother NJ, 2009, AUSTRALAS PLANT PATH, V38, P132, DOI 10.1071/AP08096; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Deng XM, 2004, JIANGXI FORESTRY SCI, V6, P33; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Ko SS, 2001, J PHYTOPATHOL, V149, P509, DOI 10.1046/j.1439-0434.2001.00662.x; Kritzinger EM, 1998, PLANT CELL TISS ORG, V52, P61, DOI 10.1023/A:1005937016338; LEIFERT C, 1992, PLANT CELL TISS ORG, V29, P153, DOI 10.1007/BF00033621; Machacek JE, 1934, PHYTOPATHOLOGY, V24, P301; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; REED BM, 1995, IN VITRO CELL DEV-PL, V31, P53, DOI 10.1007/BF02632228; ROBSON GD, 1987, J GEN MICROBIOL, V133, P361; Ryan MJ, 2004, MYCOL RES, V108, P1351, DOI 10.1017/S0953756204001650; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tang XaioQing, 1996, Acta Mycologica Sinica, V15, P188; Wang LB, 2007, LIAONING AGR SCI, V3, P69; Xiao YL, 2003, TECHNIQUES SUGAR FRE; Yang X, 2013, HORTIC SEED, V06; Zhang XM, 2009, MAR SCI, V11, P26; Zhou MY, 2016, EXP LAB MED, V34, P477	20	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224635	10.1371/journal.pone.0224635	http://dx.doi.org/10.1371/journal.pone.0224635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693673	Green Published, gold			2022-12-26	WOS:000532690100032
J	Decoene, T; De Maeseneire, SL; De Mey, M				Decoene, Thomas; De Maeseneire, Sofie L.; De Mey, Marjan			Modulating transcription through development of semi-synthetic yeast core promoters	PLOS ONE			English	Article							SHORT SYNTHETIC TERMINATORS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; RNA-POLYMERASE; CHROMOSOMAL INTEGRATION; PROTEIN EXPRESSION; INITIATION SITES; SEQUENCES; DESIGN; BIOLOGY	Altering gene expression regulation by promoter engineering is a very effective way to finetune heterologous pathways in eukaryotic hosts. Typically, pathway building approaches in yeast still use a limited set of long, native promoters. With the today's introduction of longer and more complex pathways, an expansion of this synthetic biology toolbox is necessary. In this study we elucidated the core promoter structure of the well-characterized yeast TEF1 promoter and determined the minimal length needed for sufficient protein expression. Furthermore, this minimal core promoter sequence was used for the creation of a promoter library covering different expression strengths. This resulted in a group of short, 69 bp promoters with an 8.0-fold expression range. One exemplar had a two and four times higher expression compared to the native CYC1 and ADH1 promoter, respectively. Additionally, as it was described that the protein expression range could be broadened by upstream activating sequences (UASs), we integrated earlier described single and multiple short, synthetic UASs in front of the strongest yeast core promoter. This approach resulted to further variation in protein expression and an overall promoter library spanning a 20-fold activity range and covering a length from 69 bp to maximally 129 bp. Furthermore, the robustness of this library was assessed on three alternative carbon sources besides glucose. As such, the suitability of short yeast core promoters for metabolic engineering applications on different media, either in an individual context or combined with UAS elements, was demonstrated.	[Decoene, Thomas; De Mey, Marjan] Univ Ghent, Ctr Synthet Biol CSB, Ghent, Belgium; [De Maeseneire, Sofie L.] Univ Ghent, Ctr Ind Biotechnol & Biocatalysis InBiobe, Ghent, Belgium	Ghent University; Ghent University	De Mey, M (corresponding author), Univ Ghent, Ctr Synthet Biol CSB, Ghent, Belgium.	marjan.demey@ugent.be	De Maeseneire, Sofie/ABG-3053-2020	De Maeseneire, Sofie/0000-0002-5314-1697; De Mey, Marjan/0000-0002-8134-9436	Institute for Innovation and Entrepreneurship in Flanders (Agentschap Innoveren Ondernemen) [131733]; BOF-IOP project "MLSB" of the Bijzonder Onderzoeksfonds [BOF16/IOP/040]; BioRoboost Project of the European Union [820699]	Institute for Innovation and Entrepreneurship in Flanders (Agentschap Innoveren Ondernemen); BOF-IOP project "MLSB" of the Bijzonder Onderzoeksfonds; BioRoboost Project of the European Union	The first author holds a PhD grant (131733) from the Institute for Innovation and Entrepreneurship in Flanders (Agentschap Innoveren & Ondernemen). This research was also supported by the BOF-IOP project "MLSB" (BOF16/IOP/040) of the Bijzonder Onderzoeksfonds and by the BioRoboost Project of the European Union (820699).	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; BENTON BM, 1990, MOL CELL BIOL, V10, P353, DOI 10.1128/MCB.10.1.353; Blazeck J, 2013, BIOTECHNOL J, V8, P46, DOI 10.1002/biot.201200120; Blazeck J, 2012, BIOTECHNOL BIOENG, V109, P2884, DOI 10.1002/bit.24552; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Bonde MT, 2016, NAT METHODS, V13, P233, DOI [10.1038/NMETH.3727, 10.1038/nmeth.3727]; Brachmann CB, 1998, YEAST, V14, P115; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; CHEN W, 1985, EMBO J, V4, P3273, DOI 10.1002/j.1460-2075.1985.tb04077.x; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Cuperus JT, 2017, GENOME RES, V27, P2015, DOI 10.1101/gr.224964.117; Curran KA, 2015, ACS SYNTH BIOL, V4, P824, DOI 10.1021/sb5003357; Curran KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5002; Curran KA, 2013, METAB ENG, V19, P88, DOI 10.1016/j.ymben.2013.07.001; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; Danino YM, 2015, BBA-GENE REGUL MECH, V1849, P1116, DOI 10.1016/j.bbagrm.2015.04.003; David F, 2016, ACS SYNTH BIOL, V5, P224, DOI 10.1021/acssynbio.5b00161; Decoene T, 2018, CRIT REV BIOTECHNOL, V38, P647, DOI 10.1080/07388551.2017.1380600; Decoene T, 2018, ACS SYNTH BIOL, V7, P622, DOI 10.1021/acssynbio.7b00366; Dower K, 2002, RNA, V8, P686, DOI 10.1017/S1355838202024068; Dvir S, 2013, P NATL ACAD SCI USA, V110, pE2792, DOI 10.1073/pnas.1222534110; Ede C, 2016, ACS SYNTH BIOL, V5, P395, DOI 10.1021/acssynbio.5b00266; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Jansen A, 2012, NUCLEIC ACIDS RES, V40, P3870, DOI 10.1093/nar/gkr1311; Jendresen CB, 2015, APPL ENVIRON MICROB, V81, P4458, DOI 10.1128/AEM.00405-15; Jensen NB, 2014, FEMS YEAST RES, V14, P238, DOI 10.1111/1567-1364.12118; Jullesson D, 2015, BIOTECHNOL ADV, V33, P1395, DOI 10.1016/j.biotechadv.2015.02.011; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li SJ, 2015, ACS SYNTH BIOL, V4, P1308, DOI 10.1021/acssynbio.5b00069; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Lian J., 2017, NATURE COMMUNICATION, V8, P1, DOI DOI 10.1038/S41467-016-0009-6; Lubliner S, 2015, GENOME RES, V25, P1008, DOI 10.1101/gr.188193.114; Lubliner S, 2013, NUCLEIC ACIDS RES, V41, P5569, DOI 10.1093/nar/gkt256; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; Machens F, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00063; MacPherson M, 2017, ACS SYNTH BIOL, V6, P130, DOI 10.1021/acssynbio.6b00165; McIsaac RS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1402; McIsaac RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1313; McMillan J, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz048; Mitchell LA, 2015, NUCLEIC ACIDS RES, V43, P6620, DOI 10.1093/nar/gkv466; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Nielsen J, 2016, CELL, V164, P1185, DOI 10.1016/j.cell.2016.02.004; Ottoz DSM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku616; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; Peng B, 2015, MICROB CELL FACT, P1; Petersen SD, 2018, NUCLEIC ACIDS RES, P1, DOI [10.1093/nar/gkx1156, DOI 10.1093/NAR/GKX1156]; Portela RMC, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700340; Portela RMC, 2017, ACS SYNTH BIOL, V6, P471, DOI 10.1021/acssynbio.6b00178; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Rantasalo A, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky558; Rantasalo A, 2018, ACS SYNTH BIOL, V7, P1573, DOI 10.1021/acssynbio.8b00076; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; Redden H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8810; Redden H, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12188; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Tuller T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-391; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Weenink T, 2017, BIORXIV, DOI [10.1101/137877, DOI 10.1101/137877]; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	72	13	13	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224476	10.1371/journal.pone.0224476	http://dx.doi.org/10.1371/journal.pone.0224476			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689317	Green Published, gold, Green Submitted			2022-12-26	WOS:000532680100024
J	Gibbs, DA; West, JM				Gibbs, David A.; West, Jordan M.			Resilience assessment of Puerto Rico's coral reefs to inform reef management	PLOS ONE			English	Article								Globally increasing sea surface temperatures threaten coral reefs, both directly and through interactions with local stressors. More resilient reefs have a higher likelihood of returning to a coral-dominated state following a disturbance, such as a mass bleaching event. To advance practical approaches to reef resilience assessments and aid resilience-based management of coral reefs, we conducted a resilience assessment for Puerto Rico's coral reefs, modified from methods used in other U.S. jurisdictions. We calculated relative resilience scores for 103 sites from an existing commonwealth-wide survey using eight resilience indicators-such as coral diversity, macroalgae percent cover, and herbivorous fish biomass and assessed which indicators most drove resilience. We found that sites of very different relative resilience were generally highly spatially intermixed, underscoring the importance and necessity of decision making and management at fine scales. In combination with information on levels of two localized stressors (fishing pressure and pollution exposure), we used the resilience indicators to assess which of seven potential management actions could be used at each site to maintain or improve resilience. Fishery management was the management action that applied to the most sites. Furthermore, we combined sites' resilience scores with projected ocean warming to assign sites to vulnerability categories. Island-wide or community-level managers can use the actions and vulnerability information as a starting point for resilience-based management of their reefs. This assessment differs from many previous ones because we tested how much information could be yielded by a "desktop" assessment using freely-available, existing data rather than from a customized, resilience-focused field survey. The available data still permitted analyses comparable to previous assessments, demonstrating that desktop resilience assessments can substitute for assessments with field components under some circumstances.	[Gibbs, David A.] US EPA, Oak Ridge Inst Sci Educ, Washington, DC 20460 USA; [West, Jordan M.] US EPA, Off Res & Dev, Washington, DC 20460 USA; [Gibbs, David A.] World Resources Inst, Washington, DC 20006 USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency; United States Environmental Protection Agency	Gibbs, DA (corresponding author), US EPA, Oak Ridge Inst Sci Educ, Washington, DC 20460 USA.; Gibbs, DA (corresponding author), World Resources Inst, Washington, DC 20006 USA.	david.gibbs@wri.org		Gibbs, David/0000-0001-7389-8569	U.S. Environmental Protection Agency (EPA) [EP-C-12-060, EP-C-17-031]; ORISE (Oak Ridge Institute for Science and Education); Oak Ridge Institute for Science Education Fellowship at the U.S. Environmental Protection Agency (EPA); EPA [EP-C-12-060]	U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); ORISE (Oak Ridge Institute for Science and Education); Oak Ridge Institute for Science Education Fellowship at the U.S. Environmental Protection Agency (EPA); EPA(United States Environmental Protection Agency)	This research was funded by U.S. Environmental Protection Agency (EPA) contracts EP-C-12-060 and EP-C-17-031, with lead author support (DAG) from an ORISE (Oak Ridge Institute for Science and Education) Fellowship hosted at the EPA.; This research was supported by an Oak Ridge Institute for Science Education Fellowship (D. Gibbs) at the U.S. Environmental Protection Agency (EPA) and funding under EPA Contract EP-C-12-060. We would like to thank Jeff Maynard, Pat Bradley, Britt Parker, Randy Clark, Sarah Hile, Christina Horstmann, Scott Heron, Leah Oliver, Dave Eslinger, and Manoj Shivlani for their advice and assistance. We thank Debbie Santavy, Ernesto Diaz, Ernesto Weil, Nilda Jimenez, Lee Carrubba, and Caroline Rogers for serving on an expert panel to review the approach and results of the assessment. The manuscript also benefitted greatly from the feedback of two anonymous reviewers.	[Anonymous], 2014, R LANG ENV STAT COMP; Chung AE, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00098; Eslinger D.L., 2012, OPENNSPECT OPEN SOUR; Grimsditch G.D., 2009, CORAL REEF RESILIENC, P40; Guest JR, 2018, J APPL ECOL, V55, P2865, DOI 10.1111/1365-2664.13179; Heron SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38402; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; IPCC, 2007, CLIM CHANG 2007 WORK; IUCN, 2011, COR REEF RES ASS BON, P51; Koeneke R., 2011, SPATIAL CHARACTERIZA; Maynard J., 2017, GUIDE ASSESSING CORA; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; Maynard JA, 2012, NATURE CONSERVANCY; Maynard JA, 2016, RELATIVE RESILIENCE, P53; Maynard JA, 2015, ASSESSING RELATIVE R, P153; Maynard JA, 2017, CORAL REEF RESILIENC, P30; Maynard JA, 2014, NATURE CONSERVANCY N; Maynard JA, 2015, BIOL CONSERV, V192, P109, DOI 10.1016/j.biocon.2015.09.001; Maynard WB, 2012, PRINCETON: AMERICA'S CAMPUS, P62; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; Mumby PJ, 2014, CONSERV LETT, V7, P176, DOI 10.1111/conl.12047; NOAA, 2014, NOAA COR REEF CONS P; NOAA, 2015, NOAA COR REEF CONS P; NOAA, 2015, TOP COMPL SURV PROT; NOAA, 2017, PUERTO RICO COASTAL; NOAA, 2015, LIN POINT INT LPI SU; NOAA, 2015, BELT TRANS FISH SURV; Obura D., 2009, CORAL REEF RESILIENC, P35; Obura D.O., 2009, RESILIENCE ASSESSMEN, P70; Safaie A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04074-2; Shivlani M., 2011, SPATIAL CHARACTERIZA, P61; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stein B.A., 2014, CLIMATE SMART CONSER; United States Environmental Protection Agency (USEPA), 2016, EPA842R16001 USEPA; van Hooidonk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39666; West JM, 2018, ENVIRON MANAGE, V62, P644, DOI 10.1007/s00267-018-1065-y; West JM, 2017, ENVIRON MANAGE, V59, P102, DOI 10.1007/s00267-016-0774-3	37	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224360	10.1371/journal.pone.0224360	http://dx.doi.org/10.1371/journal.pone.0224360			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689312	Green Published, gold			2022-12-26	WOS:000532680100019
J	Gudata, ZG; Cochrane, L; Imana, G				Gudata, Zerihun Girma; Cochrane, Logan; Imana, Gutema			An assessment of khat consumption habit and its linkage to household economies and work culture: The case of Harar city	PLOS ONE			English	Article							CATHA-EDULIS; PERSPECTIVES; ETHIOPIA	Background This study investigates khat consumption habits and its linkage to the economy of a household and works culture in its 'homeland,' Harar. Khat consumption habit includes practices that are performed before, during, and after consuming khat. In Harar, it has permeated the local economy, social, political and spiritual lives. To evaluate how khat consumption habit is related to the economy of a household, this study compares the living standard and characteristics of khat consumers and non-consumers. Methods Both qualitative and quantitative approaches were used. Cluster sampling and lottery methods were used to identify respondents. Data were gathered through individual interviews and non-participant observation. Results The results of the study indicate that khat consumption habit affects the economy of the consumer household by negatively influencing their income usage and time management. Consumer households have significant, additional burdens on their income and time. The average monthly expenditure of a household on khat ceremonies is 1,800 ETB (30% of their income) and consumers spend an average of 112.5 hours monthly on khat related activities only. The habit of khat consumption also negatively associated with the work culture of consumers, as they leave for lunch break early and come back to work late. Conclusion Khat consumption habit does have a linkage to the bad economic situation of consumer households. It places a significant financial and time burdens on individuals, and as a result society. The work and saving culture of khat consumers are negatively affected. Khat consumption forces many into a cycle of borrowing and indebtedness. Concerned bodies should not underestimate the impacts of khat consumption on individuals and society.	[Gudata, Zerihun Girma] Haramaya Univ, CHAMPS Ethiopia, Harar, Ethiopia; [Cochrane, Logan] Hawassa Univ, Inst Policy & Dev Res, Hawasa, Ethiopia; [Imana, Gutema] Haramaya Univ, Dept Sociol, Harar, Ethiopia	Haramaya University; Hawassa University; Haramaya University	Gudata, ZG (corresponding author), Haramaya Univ, CHAMPS Ethiopia, Harar, Ethiopia.	zergirma@gmail.com	Cochrane, Logan/X-7882-2019	Cochrane, Logan/0000-0001-7321-8295; Girma, Zerihun/0000-0001-8751-0094	Haramaya University; School of Graduate Studies	Haramaya University; School of Graduate Studies	Had it not been for the support of many individuals and offices, this study would not have been successful. First may acknowledgments go to Haramaya University, to the staff of the College of Social Sciences and Humanities (chiefly, Department of Sociology) and the School of Graduate Studies for their support and cooperation during the study.	Anderson D., 2007, KHAT CONTROVERSY STI; Armstrong EG, 2008, J DRUG ISSUES, V38, P631, DOI 10.1177/002204260803800212; Burton F. R., 1856, 1 FOOTSTEPS E AFRICA; Carrier N., 2007, AFRICAN SOCIAL STUDI, V15, DOI [10.1163/ej.9789004156593.i-288, DOI 10.1163/EJ.9789004156593.I-288]; Carrier N, 2008, SUBST USE MISUSE, V43, P803, DOI 10.1080/10826080701739016; Carrier N, 2018, THIRD WORLD Q, V39, P350, DOI 10.1080/01436597.2017.1368383; CARRIER R, 2005, J AFRICAN CULTURAL S, V17, P201; Central Statistical Authority, 2011, 2011 POP HOUS CENS P, V1; Cochrane L, 2017, MULTIPLE FACES KHAT; Cochrane L, 2016, INT J DRUG POLICY, V30, P27, DOI 10.1016/j.drugpo.2016.02.009; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Dhaifalah Ishraq, 2004, Biomedical Papers (Olomouc), V148, P11; Feyisa TH, 2003, MT RES DEV, V23, P185, DOI 10.1659/0276-4741(2003)023[0185:KEITEH]2.0.CO;2; Gebissa E, 2010, TAKING PLACE FOOD KH; Gebissa E., 2013, CULTURE KHAT; Gebissa E, 2004, LEAF ALLAH KHAT AGRI; Gebissa E. K., 2012, SOCIOLOGY, V2, P204; Gebissa E, 2008, SUBST USE MISUSE, V43, P784, DOI 10.1080/10826080701738950; Gebissa E, 2010, J ETHNOPHARMACOL, V132, P607, DOI 10.1016/j.jep.2010.01.063; Gebrie A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195718; Gelaw Y, 2004, ETHIOP J HEALTH DEV, V18, P179; GETAHUN A, 1973, ECON BOT, V27, P353, DOI 10.1007/BF02860690; Girmay A, 2007, ETHIOPIA J HLTH SCI, V17; Guesh Gebremeskel Ambaye, 2012, Advances in Agriculture, Sciences and Engineering Research, V2, P414; Haile D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130460; Hassan N. A. G. M., 2007, Eastern Mediterranean Health Journal, V13, P706; Havell C., 2004, KHAT USE SOMALI ETHI; Manghi RA, 2009, J PSYCHOACTIVE DRUGS, V41, P1, DOI 10.1080/02791072.2009.10400669; Odenwald M, 2007, PLOS MED, V4, P1959, DOI 10.1371/journal.pmed.0040341; Omar YS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/472302; Reda AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033946; Teferra S, 2011, TRANSCULT PSYCHIATRY, V48, P455, DOI 10.1177/1363461511408494; WHO Expert Committee on Drug Dependence, 2006, ASS KHAT CATH ED FOR; Wuletaw Mekuria, 2018, Journal of Agricultural Extension and Rural Development, V10, P192, DOI 10.5897/JAERD2018.0984	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224606	10.1371/journal.pone.0224606	http://dx.doi.org/10.1371/journal.pone.0224606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1BP	31689323	Green Published, gold			2022-12-26	WOS:000532680100033
J	Aljohani, A; Khan, MI; Bonneville, A; Guo, CA; Jeffery, J; O'Neill, L; Syed, DN; Lewis, SA; Burhans, M; Mukhtar, H; Ntambi, JM				Aljohani, Ahmed; Khan, Mohammad Imran; Bonneville, Abram; Guo, Changan; Jeffery, Justin; O'Neill, Lucas; Syed, Deeba Nadeem; Lewis, Sarah A.; Burhans, Maggie; Mukhtar, Hasan; Ntambi, James M.			Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1??FGF21 axis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adiponectin; carbohydrate metabolism; fibroblast growth factor (FGF); glucose metabolism; glucose transport; lipid metabolism; liver metabolism; obesity; liver; lipid signaling; glucose transporters; insulin sensitivity; heptokine-FGF21; liver?adipocyte cross-talk; monounsaturated fatty acids; stearoyl-CoA desaturase-1	GROWTH-FACTOR 21; NONALCOHOLIC FATTY LIVER; GLUT4 TRANSLOCATION; INSULIN SENSITIVITY; METABOLIC SYNDROME; GENE-EXPRESSION; PROTECTS MICE; ACID; FGF21; ASSOCIATION	Increased carbohydrate consumption increases hepatic de novo lipogenesis, which has been linked to the development of chronic metabolic diseases, including obesity, hepatic steatosis, and insulin resistance. Stearoyl CoA desaturase 1 (SCD1) is a critical lipogenic enzyme that catalyzes the synthesis of two monounsaturated fatty acids, oleate and palmitoleate, from the saturated fatty acids stearate and palmitate, respectively. SCD1-deficient mouse models are protected against diet-induced adiposity, hepatic steatosis, and hyperglycemia. However, the mechanism of this protection by SCD1 deficiency is unclear. Using liver-specific SCD1 knockout (LKO) mice fed a high-carbohydrate, low-fat diet, we show that hepatic SCD1 deficiency increases systemic glucose uptake. Hepatic SCD1 deficiency enhanced glucose transporter type 1 (GLUT1) expression in the liver and also up-regulated GLUT4 and adiponectin expression in adipose tissue. The enhanced glucose uptake correlated with increased liver expression and elevated plasma levels of fibroblast growth factor 21 (FGF21), a hepatokine known to increase systemic insulin sensitivity and regulate whole-body lipid metabolism. Feeding LKO mice a triolein-supplemented but not tristearin-supplemented high-carbohydrate, low-fat diet reduced FGF21 expression and plasma levels. Consistently, SCD1 inhibition in primary hepatocytes induced FGF21 expression, which was repressed by treatment with oleate but not palmitoleate. Moreover, deletion of the transcriptional coactivator PPAR? coactivator 1? (PGC-1?) reduced hepatic and plasma FGF21 and white adipocyte tissue-specific GLUT4 expression and raised plasma glucose levels in LKO mice. These results suggest that hepatic oleate regulates glucose uptake in adipose tissue either directly or partially by modulating the hepatic PGC-1??FGF21 axis.	[Aljohani, Ahmed] Univ Wisconsin, Sch Med & Publ Hlth, Endocrinol & Reprod Physiol Grad Training Program, Madison, WI 53706 USA; [Khan, Mohammad Imran; Syed, Deeba Nadeem; Mukhtar, Hasan] Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA; [Aljohani, Ahmed] King Saud bin Abdulaziz Univ Hlth Sci, Coll Sci & Hlth Profess, Riyadh 11481, Saudi Arabia; [Khan, Mohammad Imran] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah, Saudi Arabia; [Bonneville, Abram; Guo, Changan; O'Neill, Lucas; Lewis, Sarah A.; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Burhans, Maggie; Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Jeffery, Justin] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ntambi, JM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.; Ntambi, JM (corresponding author), Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA.	james.ntambi@wisc.edu	Khan, Mohammad Dr/B-2030-2019; Khan, Mohammad Imran/AAH-3327-2020; Aljohani, Ahmed/HHD-3455-2022	Lewis, Sarah/0000-0002-5568-955X	National Institutes of Health [R01 DK062388, DK118093]; American Diabetes Association Grant [7-13-BS118]; Department of Agriculture [W2005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK118093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Grant(American Diabetes Association); Department of Agriculture; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK062388 and DK118093, American Diabetes Association Grant 7-13-BS118, and Department of Agriculture Hatch Grant W2005 (to J. M. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; de Souza CO, 2017, J CELL PHYSIOL, V232, P2168, DOI 10.1002/jcp.25715; Disselhorst JA, 2010, J NUCL MED, V51, P610, DOI 10.2967/jnumed.109.068858; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Fisher FM, 2017, MOL METAB, V6, P14, DOI 10.1016/j.molmet.2016.11.008; Forney LA, 2018, APPL PHYSIOL NUTR ME, V43, P123, DOI 10.1139/apnm-2017-0404; Fueger BJ, 2006, J NUCL MED, V47, P999; Garcia-Mendoza MG, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0703-7; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Jeyakumar SM, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-27; Jiang S, 2014, J BIOL CHEM, V289, P29751, DOI 10.1074/jbc.M114.565960; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Lamming DW, 2014, FASEB J, V28, P300, DOI 10.1096/fj.13-237743; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu MY, 2018, CELL PHYSIOL BIOCHEM, V45, P1423, DOI 10.1159/000487568; Liu XQ, 2016, J HEPATOL, V65, P103, DOI 10.1016/j.jhep.2016.03.001; Long SD, 1996, J BIOL CHEM, V271, P1138, DOI 10.1074/jbc.271.2.1138; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Mar-Heyming R, 2008, ARTERIOSCL THROM VAS, V28, P1193, DOI 10.1161/ATVBAHA.107.160150; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; QUON MJ, 1994, J BIOL CHEM, V269, P27920; Rahman SM, 2005, AM J PHYSIOL-ENDOC M, V288, pE381, DOI 10.1152/ajpendo.00314.2004; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; RANDLE PJ, 1963, LANCET, V1, P785; Saeidi N, 2013, SCIENCE, V341, P406, DOI 10.1126/science.1235103; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Sjogren P, 2008, DIABETOLOGIA, V51, P328, DOI 10.1007/s00125-007-0876-9; Tan CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18366; Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	44	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19475	19485		10.1074/jbc.RA119.009868	http://dx.doi.org/10.1074/jbc.RA119.009868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31690632	hybrid, Green Published			2022-12-26	WOS:000504093200003
J	Dalmolin, DA; Tozetti, AM; Pereira, MJR				Dalmolin, Diego Anderson; Tozetti, Alexandro Marques; Ramos Pereira, Maria Joao			Taxonomic and functional anuran beta diversity of a subtropical metacommunity respond differentially to environmental and spatial predictors	PLOS ONE			English	Article							COMMUNITY ECOLOGY; DISPERSAL MODE; AMPHIBIAN METACOMMUNITY; PHYLOGENETIC DIVERSITY; TRAIT COMPOSITION; NESTEDNESS; PATTERNS; TURNOVER; HETEROGENEITY; CONSERVATION	Anurans exhibit limited dispersion ability and have physiological and behavioural characteristics that narrow their relationships with both environmental and spatial predictors. So, the relative contributions of environmental and spatial predictors in the patterns of taxonomic and functional anuran beta diversity were examined in a metacommunity of 33 ponds along the coast of south Brazil. We expected that neutral processes and, in particular, niche-based processes could have similar influence on the taxonomic and functional beta diversity patterns. Distance-based methods (db-RDA) with variation partitioning were conducted with abundance data to examine taxonomic and functional facets and components (total, turnover and nestedness) in relation to environmental and spatial predictors. Processes determining metacommunity structure differed between the components of beta diversity and among taxonomic and functional diversity. While taxonomic beta diversity was further accounted by both environmental and spatial predictors, functional beta diversity responded more strongly to spatial predictors. These two contrasting patterns were different to what we had predicted, suggesting that while there is a taxonomic turnover mediated by environmental filters, the spatial distance promotes the trait dissimilarity between sites. In addition, our data confirm that neutral and niche-based processes operate on anuran metacommunities even at short geographic scales. Our results reinforce the idea that studies aiming to evaluate the patterns of structure in metacommunities should include different facets of diversity so that better interpretations can be achieved.	[Dalmolin, Diego Anderson; Ramos Pereira, Maria Joao] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Tozetti, Alexandro Marques] Univ Vale Rio dos Sinos, Sao Leopoldo, RS, Brazil; [Ramos Pereira, Maria Joao] Univ Aveiro, Ctr Environm & Marine Studies, Aveiro, Portugal	Universidade Federal do Rio Grande do Sul; Universidade do Vale do Rio dos Sinos (Unisinos); Universidade de Aveiro	Dalmolin, DA (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil.	diego.anura@gmail.com	Dalmolin, Diego Anderson/G-2873-2019; Pereira, Maria João Ramos/AAH-9411-2021	Dalmolin, Diego Anderson/0000-0003-1466-7407; Pereira, Maria João Ramos/0000-0002-9365-5166	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [163440/2015-8, 311297/2018-8]; Federal University of Rio Grande do Sul	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Rio Grande do Sul	DAD was supported by a Phd scholarship (process number 163440/2015-8) and MJRM (process number 311297/2018-8) was supported by a Research Productivity scholarship funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The study design, data collection and analysis of the project were also funded by by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Federal University of Rio Grande do Sul.	Arnan X, 2017, ECOGRAPHY, V40, P448, DOI 10.1111/ecog.01938; Arnan X, 2015, PEERJ, V3, DOI 10.7717/peerj.1241; Asefa M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00166-z; Baselga A, 2007, BIOLOGY LETT, V3, P642, DOI 10.1098/rsbl.2007.0449; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brooks DR, 2012, J ANIM ECOL, V81, P4, DOI 10.1111/j.1365-2656.2011.01897.x; Brown BL, 2017, OECOLOGIA, V183, P643, DOI 10.1007/s00442-016-3792-1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cisneros LM, 2016, PEERJ, V4, DOI 10.7717/peerj.2551; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Delatorre M, 2015, FRESHWATER BIOL, V60, P2197, DOI 10.1111/fwb.12648; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Du YB, 2017, ECOL EVOL, V7, P10941, DOI 10.1002/ece3.3613; Duellman WE, 1994, BIOL AMPHIBIANS; Gouveia SF, 2016, J BIOGEOGR, V43, P2075, DOI 10.1111/jbi.12842; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Heino J, 2017, LIMNOL OCEANOGR, V62, P2431, DOI 10.1002/lno.10577; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2013, ECOL EVOL, V3, P344, DOI 10.1002/ece3.470; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Hill MJ, 2017, OIKOS, V126, P1575, DOI 10.1111/oik.04266; Hubbell Stephen P., 2001, V32, pi; Knauth DS, 2018, FRESHW SCI, V37, P380, DOI 10.1086/697926; Landeiro VL, 2014, NAT CONSERVACAO, V12, P42, DOI 10.4322/natcon.2014.008; Lange K, 2014, FRESHWATER BIOL, V59, P2431, DOI 10.1111/fwb.12437; Leao-Pires TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196066; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Livingston G, 2017, J ANIM ECOL, V86, P501, DOI 10.1111/1365-2656.12639; Luiz AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153977; Maltchik L., 2003, PESQUISAS BOT, V53, P89; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Melchior LG, 2017, ECOL EVOL, V7, P2403, DOI 10.1002/ece3.2852; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Monnet AC, 2014, GLOBAL ECOL BIOGEOGR, V23, P780, DOI 10.1111/geb.12179; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olalla-Tarraga MA, 2007, GLOBAL ECOL BIOGEOGR, V16, P606, DOI 10.1111/j.1466-8238.2007.00309.x; Ouchi-Melo LS, 2018, BIODIVERS CONSERV, V27, P3247, DOI 10.1007/s10531-018-1600-4; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2012, ECOLOGY, V93, pS14, DOI 10.1890/11-0494.1; Prado VHM, 2014, ENVIRON MANAGE, V53, P823, DOI 10.1007/s00267-014-0241-y; Provete DB, 2014, HYDROBIOLOGIA, V734, P69, DOI 10.1007/s10750-014-1870-0; RAMSAR, 2018, LIST WETLANDS INT IM; Ribeiro J, 2017, LANDSCAPE ECOL, V32, P1599, DOI 10.1007/s10980-017-0525-8; Richter-Boix A, 2007, J ANIM ECOL, V76, P607, DOI 10.1111/j.1365-2656.2007.01232.x; Ricotta C, 2017, ECOL EVOL, V7, P4835, DOI 10.1002/ece3.2980; Ricotta C, 2015, ECOL INDIC, V54, P203, DOI 10.1016/j.ecolind.2015.02.026; Saito VS, 2016, ECOL EVOL, V6, P2925, DOI 10.1002/ece3.2081; Schalk CM, 2017, FRESHWATER BIOL, V62, P519, DOI 10.1111/fwb.12882; Scott Jr N. J., 1994, MEASURING MONITORING, P118; Si XF, 2016, J ANIM ECOL, V85, P409, DOI 10.1111/1365-2656.12478; Soininen J, 2016, GLOBAL ECOL BIOGEOGR, V25, P940, DOI 10.1111/geb.12452; Spasojevic MJ, 2016, J ECOL, V104, P487, DOI 10.1111/1365-2745.12518; Tagliani P. R. A., 1995, THESIS; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Van Buskirk J, 2000, ECOLOGY, V81, P2813, DOI 10.1890/0012-9658(2000)081[2813:TCOAID]2.0.CO;2; Van Buskirk J, 2005, J EVOLUTION BIOL, V18, P596, DOI 10.1111/j.1420-9101.2004.00869.x; Van Buskirk J, 1997, EVOLUTION, V51, P1983, DOI 10.1111/j.1558-5646.1997.tb05119.x; Vasconcelos Tiago da Silveira, 2008, PHYLLOMEDUSA, V7, P127; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Wellborn G A, 2002, ANNU REV ECOL SYST, V27, P337; Wells K. D., 2007, ECOLOGY BEHAV AMPHIB, DOI [10. 7208/chicago/9780226893334. 001. 0001, DOI 10.7208/CHICAG0/9780226893334.001.0001, DOI 10.7208/CHICAGO/9780226893334.001.0001]; Werner EE, 2007, OIKOS, V116, P1713, DOI 10.1111/j.2007.0030-1299.16039.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Williams D D, 2016, BIOL TEMPORARY WATER; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469; Wu NC, 2018, ECOL EVOL, V8, P2947, DOI 10.1002/ece3.3903; Yamada K, 2014, GLOB ECOL CONSERV, V2, P47, DOI 10.1016/j.gecco.2014.08.003; Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10068; Zhang M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00161	79	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0214902	10.1371/journal.pone.0214902	http://dx.doi.org/10.1371/journal.pone.0214902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725730	Green Submitted, Green Published, gold			2022-12-26	WOS:000532764500002
J	Huang, Q; Chan, KY; Tobey, IG; Chan, YA; Poterba, T; Boutros, CL; Balazs, AB; Daneman, R; Bloom, JM; Seed, C; Deverman, BE				Huang, Qin; Chan, Ken Y.; Tobey, Isabelle G.; Chan, Yujia Alina; Poterba, Tim; Boutros, Christine L.; Balazs, Alejandro B.; Daneman, Richard; Bloom, Jonathan M.; Seed, Cotton; Deverman, Benjamin E.			Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids	PLOS ONE			English	Article							THERAPY; IDENTIFICATION; GALACTOSE	The engineered AAV-PHP.B family of adeno-associated virus efficiently delivers genes throughout the mouse central nervous system. To guide their application across disease models, and to inspire the development of translational gene therapy vectors for targeting neurological diseases in humans, we sought to elucidate the host factors responsible for the CNS tropism of the AAV-PHP.B vectors. Leveraging CNS tropism differences across 13 mouse strains, we systematically determined a set of genetic variants that segregate with the permissivity phenotype, and rapidly identified LY6A as an essential receptor for the AAV-PHP.B vectors. Interfering with LY6A by CRISPR/Cas9-mediated Ly6a disruption or with blocking antibodies reduced transduction of mouse brain endothelial cells by AAV-PHP.eB, while ectopic expression of Ly6a increased AAV-PHP.eB transduction of HEK293T and CHO cells by 30-fold or more. Importantly, we demonstrate that this newly discovered mode of AAV binding and transduction can occur independently of other known AAV receptors. These findings illuminate the previously reported species- and strain-specific tropism characteristics of the AAV-PHP.B vectors and inform ongoing efforts to develop next-generation AAV vehicles for human CNS gene therapy.	[Huang, Qin; Chan, Ken Y.; Tobey, Isabelle G.; Chan, Yujia Alina; Poterba, Tim; Bloom, Jonathan M.; Seed, Cotton; Deverman, Benjamin E.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Boutros, Christine L.; Balazs, Alejandro B.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Daneman, Richard] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Daneman, Richard] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Deverman, BE (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	bdeverma@broadinstitute.org		Chan, Ken/0000-0002-8853-5186; Bloom, Jonathan/0000-0001-8497-1434; Balazs, Alejandro/0000-0002-1767-3944; Chan, Yujia Alina/0000-0002-0731-637X	Stanley Foundation; Stanley Center for Psychiatric Research; National Institute Of Neurological Disorders and Stroke of the National Institutes of Health [UG3NS111689]; NATIONAL INSTITUTE OF MENTAL HEALTH [UG3MH120096, R01MH071679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [UG3NS111689, R01NS081297] Funding Source: NIH RePORTER	Stanley Foundation; Stanley Center for Psychiatric Research; National Institute Of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Stanley Foundation and Stanley Center for Psychiatric Research and by the National Institute Of Neurological Disorders and Stroke of the National Institutes of Health under Award Number UG3NS111689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 2017, NEURON, V94, P891, DOI 10.1016/j.neuron.2017.04.017; Bedbrook CN, 2018, ANNU REV NEUROSCI, V41, P323, DOI 10.1146/annurev-neuro-080317-062048; Bell CL, 2012, J VIROL, V86, P7326, DOI 10.1128/JVI.00448-12; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Dayton RD, 2018, GENE THER, V25, P392, DOI 10.1038/s41434-018-0028-5; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Gao Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22071145; Gibson A. L., 2017, ADENO ASS VIRAL GENE; GUIDA JD, 1995, J VIROL, V69, P7674, DOI 10.1128/JVI.69.12.7674-7681.1995; Hillier D, 2017, NAT NEUROSCI, V20, P960, DOI 10.1038/nn.4566; Hordeaux J, 2019, MOL THER, V27, P912, DOI 10.1016/j.ymthe.2019.02.013; Hordeaux J, 2018, MOL THER, V26, P664, DOI 10.1016/j.ymthe.2018.01.018; Huang LY, 2014, CURR OPIN VIROL, V7, P108, DOI 10.1016/j.coviro.2014.05.007; Jackson KL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00116; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Korbelin J, 2016, EMBO MOL MED, V8, P609, DOI 10.15252/emmm.201506078; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Liu HC, 2003, CYTOGENET GENOME RES, V102, P304, DOI 10.1159/000075767; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Loughner CL, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0074-2; Mar KB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06000-y; Matsuzaki Y, 2018, NEUROSCI LETT, V665, P182, DOI 10.1016/j.neulet.2017.11.049; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Morabito G, 2017, MOL THER, V25, P2727, DOI 10.1016/j.ymthe.2017.08.004; Nathwani AC, 2017, HUM GENE THER, V28, P1004, DOI 10.1089/hum.2017.167; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Pillay S, 2016, NATURE, V530, P108, DOI 10.1038/nature16465; Pillay Sirika, 2017, J Virol, V91, DOI 10.1128/JVI.00391-17; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ravina B, 2017, HUM GENE THER, V28, pA6; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sah D., 2018, MOL THERAPY      MAY; Spindler KR, 2010, J IMMUNOL, V184, P3055, DOI 10.4049/jimmunol.0903363; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Zelikowsky M, 2018, CELL, V173, P1265, DOI 10.1016/j.cell.2018.03.037; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	39	78	80	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225206	10.1371/journal.pone.0225206	http://dx.doi.org/10.1371/journal.pone.0225206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725765	Green Published, gold, Green Submitted			2022-12-26	WOS:000532764500069
J	Farooqui, HH; Mehta, A; Selvaraj, S				Farooqui, Habib Hasan; Mehta, Aashna; Selvaraj, Sakthivel			Outpatient antibiotic prescription rate and pattern in the private sector in India: Evidence from medical audit data	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; PRIMARY-CARE; PRESCRIBING PRACTICES; COST BURDEN; LOW-INCOME; NEW-DELHI; RESISTANCE; PRACTITIONERS; SURVEILLANCE; EXPENDITURES	The key objective of this research was to generate new evidence on outpatient antibiotic prescription rate and patterns in the private sector in India. We used 12-month period (May 2013 to April 2014) medical audit dataset from IQVIA (formerly IMS Health). We coded the diagnosis provided in the medical audit data to International Statistical Classification of Diseases and Related Health Problems (ICD-10) and the prescribed antibiotics for the diagnosis to Anatomic Therapeutic Chemical (ATC) classification of World Health Organization (ATC index-2016). We calculated and reported antibiotic prescription rate per 1,000 persons per year, by age groups, antibiotic class and disease conditions. Our main findings are-approximately 519 million antibiotic prescriptions were dispensed in the private sector, which translates into 412 prescriptions per 1,000 persons per year. Majority of the antibiotic prescriptions were dispensed for acute upper respiratory infections (J06) (20.4%); unspecified acute lower respiratory infection (J22) (12.8%); disorders of urinary system (N39) (6.0%); cough (R05) (4.7%); and acute nasopharyngitis (J00) (4.6%) and highest antibiotic prescription rates were observed in the age group 0-4 years. To conclude our study reports first ever country level estimates of antibiotic prescription by antibiotic classes, age groups, and ICD-10 mapped disease conditions.	[Farooqui, Habib Hasan] Publ Hlth Fdn India, Indian Inst Publ Hlth Delhi, Gurugram, Haryana, India; [Mehta, Aashna; Selvaraj, Sakthivel] Publ Hlth Fdn India, Hlth Econ Financing & Policy, Gurugram, Haryana, India	Public Health Foundation of India; Public Health Foundation of India	Farooqui, HH (corresponding author), Publ Hlth Fdn India, Indian Inst Publ Hlth Delhi, Gurugram, Haryana, India.	drhabibhasan@gmail.com	Mehta, Aashna/GQA-8753-2022; Selvaraj, Sakthivel/ABD-5873-2021; Farooqui, Habib/AAD-8818-2021	Mehta, Aashna/0000-0003-4099-9915; Farooqui, Habib/0000-0002-3081-2929	Department of Science and Technology's Public Health Research Grant	Department of Science and Technology's Public Health Research Grant	Habib Hasan Farooqui is supported by Department of Science and Technology's Public Health Research Grant to the Public Health Foundation of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsan M, 2015, LANCET INFECT DIS, V15, P1203, DOI 10.1016/S1473-3099(15)00149-8; Ashworth M, 2004, J PUBLIC HEALTH-UK, V26, P268, DOI 10.1093/pubmed/fdh160; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; Bianco A, 2018, INFECT DRUG RESIST, V11, P2199, DOI 10.2147/IDR.S170349; Chandy SJ, 2014, J INFECT DEV COUNTR, V8, P1096, DOI 10.3855/jidc.4745; Chandy SJ, 2013, J ANTIMICROB CHEMOTH, V68, P229, DOI 10.1093/jac/dks355; Clavenna A, 2011, ARCH DIS CHILD, V96, P590, DOI 10.1136/adc.2010.183541; Durkin MJ, 2018, INFECT CONT HOSP EP, V39, P584, DOI 10.1017/ice.2018.26; Farooqui HH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204805; Gandra S, 2016, INT J INFECT DIS, V50, P75, DOI 10.1016/j.ijid.2016.08.002; GOI, 2006, POP PROJ IND STAT 20; Gopalakrishnan S, 2013, INDIAN J PHARMACOL, V45, P252, DOI 10.4103/0253-7613.111931; Hersh AL, 2013, PEDIATRICS, V132, P1146, DOI 10.1542/peds.2013-3260; Holloway KA, 2017, BMJ-BRIT MED J, V358, P9, DOI 10.1136/bmj.j2291; Holstiege J, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-174; Huang N, 2005, PEDIATRICS, V116, P826, DOI 10.1542/peds.2004-2800; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kotwani A, 2012, VALUE HEALTH, V15, pS116, DOI 10.1016/j.jval.2011.11.008; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Kourlaba G, 2015, J ANTIMICROB CHEMOTH, V70, P2405, DOI 10.1093/jac/dkv091; Kshirsagar MJ, 1998, B WORLD HEALTH ORGAN, V76, P271; Laxminarayan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001974; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Mackintosh M, 2016, LANCET, V388, P596, DOI 10.1016/S0140-6736(16)00342-1; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; NCDC, 2016, NAT TREATM GUID ANT; Pathak D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-32; Phadke AR, 1996, NATL MED J INDIA, V9, P60; Reddy KS, 2011, HIGH LEVEL EXPERT GR; Sakthivel Selvaraj, 2009, Economic and Political Weekly, V44, P55; Sharma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142317; Shet A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0098-8; Suda KJ, 2014, ANTIMICROB AGENTS CH, V58, P2763, DOI 10.1128/AAC.02239-13; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Walia K, 2016, INDIAN J MED MICROBI, V34, P413, DOI 10.4103/0255-0857.195378; Wattal Chand, 2010, J Assoc Physicians India, V58 Suppl, P32; WHOCC, 2015, WHO COLL CTR DRUG ST; World Health Organization, INT STAT CLASS DIS R, V10th; 2017, ROUT STUD GLOB INF, V11, P1	42	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224848	10.1371/journal.pone.0224848	http://dx.doi.org/10.1371/journal.pone.0224848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721809	Green Published, gold			2022-12-26	WOS:000532720700033
J	Lindqvist, J; Lee, EJ; Karimi, E; Kolb, J; Granzier, H				Lindqvist, Johan; Lee, Eun-Jeong; Karimi, Esmat; Kolb, Justin; Granzier, Henk			Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy	PLOS ONE			English	Article							CARDIAC MYOSIN ACTIVATOR; SKELETAL-MUSCLE; HEART-FAILURE; CALCIUM SENSITIVITY; FIBER TYPES; TITIN; FILAMENT; INCREASES; INSIGHTS; WEAKNESS	Nemaline myopathy (NEM) is a congenital neuromuscular disorder primarily caused by nebulin gene (NEB) mutations. NEM is characterized by muscle weakness for which currently no treatments exist. In NEM patients a predominance of type I fibers has been found. Thus, therapeutic options targeting type I fibers could be highly beneficial for NEM patients. Because type I muscle fibers express the same myosin isoform as cardiac muscle (Myh7), the effect of omecamtiv mecarbil (OM), a small molecule activator of Myh7, was studied in a nebulin-based NEM mouse model (Neb cKO). Skinned single fibers were activated by exogenous calcium and force was measured at a wide range of calcium concentrations. Maximal specific force of type I fibers was much less in fibers from Neb cKO animals and calcium sensitivity of permeabilized single fibers was reduced (pCa(50) 6.12 +/- 0.08 (cKO) vs 6.36 +/- 0.08 (CON)). OM increased the calcium sensitivity of type I single muscle fibers. The greatest effect occurred in type I fibers from Neb cKO muscle where OM restored the calcium sensitivity to that of the control type I fibers. Forces at submaximal activation levels (pCa 6.0-6.5) were significantly increased in Neb cKO fibers (similar to 50%) but remained below that of control fibers. OM also increased isometric force and power during isotonic shortening of intact whole soleus muscle of Neb cKO mice, with the largest effects at physiological stimulation frequencies. We conclude that OM has the potential to improve the quality of life of NEM patients by increasing the force of type I fibers at submaximal activation levels.	[Lindqvist, Johan; Lee, Eun-Jeong; Karimi, Esmat; Kolb, Justin; Granzier, Henk] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA	University of Arizona	Granzier, H (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA.	granzier@email.arizona.edu		, Henk/0000-0002-9516-407X; Lindqvist, Johan/0000-0003-4010-013X	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR053897]; Leducq Foundation [13CVD04]; A Foundation for Building Strength; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053897] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Leducq Foundation(Leducq Foundation); A Foundation for Building Strength; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR053897 (HG), by a grant from A Foundation for Building Strength (JL), and by a grant from the Leducq Foundation, 13CVD04 (HG).	Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BRENNER B, 1986, BASIC RES CARDIOL, V81, P1; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Chandra M, 2009, J BIOL CHEM, V284, P30889, DOI 10.1074/jbc.M109.049718; Chung CS, 2013, CIRCULATION, V128, P19, DOI 10.1161/CIRCULATIONAHA.112.001268; CLAFLIN DR, 1985, J PHYSIOL-LONDON, V359, P357, DOI 10.1113/jphysiol.1985.sp015589; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Collibee SE, 2018, ACS MED CHEM LETT, V9, P354, DOI 10.1021/acsmedchemlett.7b00546; Fukuda N, 2005, PFLUG ARCH EUR J PHY, V449, P449, DOI 10.1007/s00424-004-1354-6; Fusi L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13281; Gollapudi SK, 2017, BIOPHYS J, V113, P880, DOI 10.1016/j.bpj.2017.07.002; Hitomia Y, 2005, COMP BIOCHEM PHYS B, V140, P45, DOI 10.1016/j.cbpc.2004.09.021; Joureau B, 2017, NEUROMUSCULAR DISORD, V27, P83, DOI 10.1016/j.nmd.2016.10.004; Kampourakis T, 2018, J PHYSIOL-LONDON, V596, P31, DOI 10.1113/JP275050; Kaplinsky Edgardo, 2018, Drugs Context, V7, P212518, DOI 10.7573/dic.212518; Kiss B, 2018, P NATL ACAD SCI USA, V115, P10369, DOI 10.1073/pnas.1804726115; Kolb J, 2016, J MOL CELL CARDIOL, V97, P286, DOI 10.1016/j.yjmcc.2016.04.013; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Lawlor MW, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-23; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055861; Lehtokari VL, 2014, HUM MUTAT, V35, P1418, DOI 10.1002/humu.22693; Li F, 2015, HUM MOL GENET, V24, P5219, DOI 10.1093/hmg/ddv243; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Malfatti E, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-44; Mamidi R, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004257; Nagy L, 2015, BRIT J PHARMACOL, V172, P4506, DOI 10.1111/bph.13235; Ogut O, 1999, AM J PHYSIOL-CELL PH, V276, pC1162, DOI 10.1152/ajpcell.1999.276.5.C1162; Ottenheijm CAC, 2013, BRAIN, V136, P1718, DOI 10.1093/brain/awt113; Ottenheijm CAC, 2010, PHYSIOLOGY, V25, P304, DOI 10.1152/physiol.00016.2010; Ottenheijm CAC, 2010, J STRUCT BIOL, V170, P334, DOI 10.1016/j.jsb.2009.11.013; Ottenheijm CAC, 2009, J MOL BIOL, V393, P10, DOI 10.1016/j.jmb.2009.08.009; Pappas CT, 2010, J CELL BIOL, V189, P859, DOI 10.1083/jcb.201001043; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Piazzesi G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00736; Psotka MA, 2017, HANDB EXP PHARMACOL, V243, P465, DOI 10.1007/164_2017_13; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Sieck GC, 2013, COMPR PHYSIOL, V3, P1533, DOI 10.1002/cphy.c130003; Sieck GC, 2013, PHYSIOLOGY, V28, P7, DOI 10.1152/physiol.00049.2012; Swenson AM, 2017, J BIOL CHEM, V292, P3768, DOI 10.1074/jbc.M116.748780; Teerlink JR, 2016, J AM COLL CARDIOL, V67, P1444, DOI 10.1016/j.jacc.2016.01.031; Teerlink JR, 2011, LANCET, V378, P667, DOI 10.1016/S0140-6736(11)61219-1; Tirrell TF, 2012, J EXP BIOL, V215, P2551, DOI 10.1242/jeb.069385; Tonino P, 2010, J CELL SCI, V123, P384, DOI 10.1242/jcs.042234; Utter MS, 2015, J CARDIOVASC PHARM, V66, P347, DOI 10.1097/FJC.0000000000000286; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004; Wang CH, 2012, J CHILD NEUROL, V27, P363, DOI 10.1177/0883073812436605; WANG K, 1982, METHOD ENZYMOL, V85, P264; Wang L, 2013, J MUSCLE RES CELL M, V34, P407, DOI 10.1007/s10974-013-9366-5; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Woody MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06193-2; Zhang XM, 2017, ELIFE, V6, DOI [10.7554/eLife.24081.001, 10.7554/eLife.24081]	55	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224467	10.1371/journal.pone.0224467	http://dx.doi.org/10.1371/journal.pone.0224467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721788	Green Published, gold			2022-12-26	WOS:000532720700023
J	Anderson, DM; Kumar, VR; Arper, DL; Kruger, E; Bilir, SP; Richardson, JS				Anderson, Deborah M.; Kumar, Veena R.; Arper, Diana L.; Kruger, Eliza; Bilir, S. Pinar; Richardson, Jason S.			Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product	PLOS ONE			English	Article							UNITED-STATES; HOSPITALIZATION CHARGES; INFANT BOTULISM; OUTCOMES; TRENDS	Background Botulism is a rare, serious, and sometimes fatal paralytic illness caused by exposure to neurotoxins produced by Clostridium botulinum bacteria. Patients with documented or suspected exposure to botulinum toxin serotypes A-G can be treated with BAT (R) [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine)] product, which was approved in 2013 in the United States (US). Patients with botulism have demonstrated greater clinical benefit with early BAT product treatment (<= 2 days from symptom onset) versus late treatment (> 2 days). Objective Economic outcomes associated with improved clinical outcome benefits of BAT product treatment have not yet been reported. This ad hoc analysis aimed to estimate and compare costs associated with hospitalization, intensive care unit stay, and mechanical ventilation for patients with botulism administered BAT product treatment early or late. Methods Clinical outcomes data for early and late BAT product treatment were obtained from a patient registry conducted between October 2014 and July 2017. Total per patient mean daily costs were estimated based on information from published literature. Total population costs per group were calculated by multiplying estimated mean cost per patient by the average annual number of non-infant botulism cases in the US. Results Mean per patient costs were 2.5 times lower for patients treated with BAT product early versus late. On average in the US, early BAT product treatment could save greater than $3.9 million per year versus late treatment. Conclusion Substantial economic savings can be achieved with early BAT product treatment. The findings support the recommendation for public health authorities to ensure antitoxin treatment is readily available in sufficient quantities to manage botulism cases, including sporadic outbreaks and potential mass exposure biological attacks.	[Anderson, Deborah M.; Richardson, Jason S.] Emergent BioSolut Canada Inc, Winnipeg, MB, Canada; [Kumar, Veena R.] Emergent BioSolut Inc, Gaithersburg, MD USA; [Arper, Diana L.; Kruger, Eliza; Bilir, S. Pinar] IQVIA, San Francisco, CA USA	IQVIA	Anderson, DM; Richardson, JS (corresponding author), Emergent BioSolut Canada Inc, Winnipeg, MB, Canada.	andersond@ebsi.com; jrichardson@ebsi.com			Emergent BioSolutions, Inc.	Emergent BioSolutions, Inc.	This ad hoc study was sponsored and funded by Emergent BioSolutions, Inc. (www.emergentbiosolutions.com). DMA and JSR are employees of Emergent BioSolutions Canada Inc. and VRK is an employee of Emergent BioSolutions Inc. DMA and VRK hold stock. DLA and SPB are employees of IQVIA, which received funding from Emergent BioSolutions Inc. to conduct this analysis. EK was an employee of IQVIA at the time this study was conducted. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P299; Armada M, 2003, ANN EMERG MED, V42, P226, DOI 10.1067/mem.2003.259; Arnon S., 2004, TXB PEDIAT INFECT DI; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Becker's Hospital Review, 2016, AVERAGE COST INPATIE; Centers for Disease Control and Prevention, 2018, BOT BOT; Centers for Disease Control and Prevention, 2018, NAT BOT SURV; Centers for Disease Control and Prevention, 2018, BOT KINDS BOT; Centers for Disease Control and Prevention, 2018, BIOT AG DIS; Centers for Disease Control and Prevention, 2018, BOT DIAGN TREATM; Centers for Disease Control and Prevention, 2018, BOT SYMPT; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Durcan Robert, 2018, Pract Neurol, V18, P501, DOI 10.1136/practneurol-2018-001891; GANGAROSA EJ, 1971, AM J EPIDEMIOL, V93, P93, DOI 10.1093/oxfordjournals.aje.a121239; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Klompas M, 2013, NEW ENGL J MED, V368, P1472, DOI 10.1056/NEJMp1300633; KOENIG MG, 1964, MEDICINE, V43, P517, DOI 10.1097/00005792-196409000-00001; Kramer AA, 2017, CRIT CARE MED, V45, P1457, DOI 10.1097/CCM.0000000000002563; Opila T, 2017, PEDIATR NEUROL, V67, P53, DOI 10.1016/j.pediatrneurol.2016.10.009; Payne JR, 2018, J PEDIATR-US, V193, P172, DOI 10.1016/j.jpeds.2017.10.035; Richardson JS, 2020, CLIN INFECT DIS, V70, P1950, DOI 10.1093/cid/ciz515; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Souayah N, 2012, NEUROEPIDEMIOLOGY, V38, P233, DOI 10.1159/000336354; U.S. Department of Health and Human Services, 2019, STRAT NAT STOCK SNS; U.S. Food and Drug Administration, 2018, BAB; US Department of Labor Bureau of Labor Statistics, 2018, CONS PRIC IND MED CA; Weir E, 2001, CAN MED ASSOC J, V164, P538; World Health Organization, 2019, RAB DIS; World Health Organization, 2018, BOT; World Health Organization, 2019, RAB TREATM; Yu PA, 2018, CLIN INFECT DIS, V66, pS57, DOI 10.1093/cid/cix816	31	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224700	10.1371/journal.pone.0224700	http://dx.doi.org/10.1371/journal.pone.0224700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697731	gold, Green Published			2022-12-26	WOS:000532694400044
J	Semmler, G; Scheiner, B; Schwabl, P; Bucsics, T; Paternostro, R; Chromy, D; Stattermayer, AF; Trauner, M; Mandorfer, M; Ferlitsch, A; Reiberger, T				Semmler, Georg; Scheiner, Bernhard; Schwabl, Philipp; Bucsics, Theresa; Paternostro, Rafael; Chromy, David; Staettermayer, Albert Friedrich; Trauner, Michael; Mandorfer, Mattias; Ferlitsch, Arnulf; Reiberger, Thomas			The impact of hepatic steatosis on portal hypertension	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; LIVER STIFFNESS MEASUREMENT; NONALCOHOLIC STEATOHEPATITIS; HYPERDYNAMIC CIRCULATION; NATURAL-HISTORY; CIRRHOSIS; FIBROSIS; DISEASE; ALGORITHM; PRESSURE	Background and aims Studies in animal models have suggested that hepatic steatosis impacts on portal pressure, potentially by inducing liver sinusoidal endothelial dysfunction and thereby increasing intrahepatic resistance. Thus, we aimed to evaluate the impact of hepatic steatosis on hepatic venous pressure gradient (HVPG) in patients with chronic liver disease. Method 261 patients undergoing simultaneous HVPG measurements and controlled attenuation parameter (CAP)-based steatosis assessment were included in this retrospective study. Results The majority of patients had cirrhosis (n = 205; 78.5%) and n =191 (73.2%) had clinically significant portal hypertension (CSPH; HVPG >= 10mmHg). Hepatic steatosis (S1/2/3; CAP >= 248dB/m) was present in n = 102 (39.1%). Overall, HVPG was comparable between patients with vs. without hepatic steatosis (15.5 +/- 7.5 vs. 14.8 +/- 7.7mmHg; p = 0.465). Neither in patients with HVPG (<6mmHg; p = 0.371) nor in patients with mild portal hypertension (HVPG 6-9mmHg; p = 0.716) or CSPH (HVPG >= 10mmHg; p = 0.311) any correlation between CAP and HVPG was found. Interestingly, in patients with liver fibrosis F2/3, there was a negative correlation between CAP and HVPG (Pearson's p:-0.522; p <= 0.001). In multivariate analysis, higher CAP was an independent 'protective' factor for the presence of CSPH (odds ratio [OR] per 10dB/m: 0.92, 95% confidence interval [CI]:0.85-1.00; p = 0.045), while liver stiffness was associated with the presence of CSPH (OR per kPa: 1.26, 95%CI: 1.17-1.36; p<0.001). In 78 patients, in whom liver biopsy was performed, HVPG was neither correlated with percentage of histological steatosis (p = 0.714) nor with histological steatosis grade (p = 0.957). Conclusion Hepatic steatosis, as assessed by CAP and liver histology, did not impact on HVPG in our cohort comprising a high proportion of patients with advanced chronic liver disease. However, high CAP values (i.e. pronounced hepatic steatosis) might lead to overestimation of liver fibrosis by 'artificially' increasing transient elastography-based liver stiffness	[Semmler, Georg; Scheiner, Bernhard; Schwabl, Philipp; Bucsics, Theresa; Paternostro, Rafael; Chromy, David; Staettermayer, Albert Friedrich; Trauner, Michael; Mandorfer, Mattias; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Semmler, Georg; Scheiner, Bernhard; Schwabl, Philipp; Bucsics, Theresa; Paternostro, Rafael; Chromy, David; Staettermayer, Albert Friedrich; Mandorfer, Mattias; Reiberger, Thomas] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria; [Ferlitsch, Arnulf] Hosp St John God, Dept Internal Med 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Reiberger, T (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.; Reiberger, T (corresponding author), Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria.	thomas.reiberger@meduniwien.ac.at	Semmler, Georg/O-3323-2019; Paternostro, Rafael/AAU-8209-2020; Reiberger, Thomas/H-7613-2019; Mandorfer, Mattias/H-7603-2019; Chromy, David/Q-4079-2019	Semmler, Georg/0000-0002-0411-166X; Paternostro, Rafael/0000-0002-1813-5769; Reiberger, Thomas/0000-0002-4590-3583; Mandorfer, Mattias/0000-0003-2330-0017; Chromy, David/0000-0002-1807-8258; Stattermayer, Albert/0000-0003-0737-4091; Scheiner, Bernhard/0000-0002-4904-5133; Schwabl, Philipp/0000-0002-7183-8076; Trauner, Michael/0000-0002-1275-6425				Abraldes JG, 2003, HEPATOLOGY, V37, P902, DOI 10.1053/jhep.2003.50133; Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; Bedossa P, 2009, J HEPATOL, V50, P1, DOI 10.1016/j.jhep.2008.10.014; Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; Bucsics T, 2015, J GASTROEN HEPATOL, V30, P1657, DOI 10.1111/jgh.13002; Chalasani N, 2005, HEPATOLOGY, V41, P690, DOI 10.1002/hep.20671; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; de Ledinghen V, 2008, GASTROEN CLIN BIOL, V32, P58, DOI 10.1016/S0399-8320(08)73994-0; de Ledinghen V, 2016, J GASTROEN HEPATOL, V31, P848, DOI 10.1111/jgh.13219; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; Erice E, 2012, AM J PHYSIOL-GASTR L, V302, pG1458, DOI 10.1152/ajpgi.00389.2011; Ferlitsch A, 2015, LIVER INT, V35, P2115, DOI 10.1111/liv.12783; Francque S, 2012, LAB INVEST, V92, P1428, DOI 10.1038/labinvest.2012.103; Francque S, 2010, EUR J GASTROEN HEPAT, V22, P1449, DOI 10.1097/MEG.0b013e32833f14a1; Francque S, 2010, LIVER INT, V30, P365, DOI 10.1111/j.1478-3231.2009.02136.x; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Kalambokis G, 2007, J HEPATOL, V47, P284, DOI 10.1016/j.jhep.2007.05.001; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; Mendes LC, 2018, EUR J GASTROEN HEPAT, V30, P959, DOI 10.1097/MEG.0000000000001145; Nahon P, 2009, EUR J GASTROEN HEPAT, V21, P214, DOI 10.1097/MEG.0b013e32830eb8d7; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Petta S, 2017, HEPATOLOGY, V65, P1145, DOI 10.1002/hep.28843; Petta S, 2015, HEPATOLOGY, V62, P1101, DOI 10.1002/hep.27844; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Reiberger T, 2012, J GASTROENTEROL, V47, P561, DOI 10.1007/s00535-011-0517-4; Reiberger T, 2017, WIEN KLIN WOCHENSCHR, V129, pS135, DOI 10.1007/s00508-017-1262-3; Reiberger T, 2013, GUT, V62, P1634, DOI 10.1136/gutjnl-2012-304038; Reiberger T, 2012, WIEN KLIN WOCHENSCHR, V124, P395, DOI 10.1007/s00508-012-0190-5; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Saeed MJ, 2017, J CLIN GASTROENTEROL, V51, P70, DOI 10.1097/MCG.0000000000000566; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Schwabl P, 2017, ALIMENT PHARM THER, V45, P139, DOI 10.1111/apt.13844; Schwabl P, 2015, LIVER INT, V35, P381, DOI 10.1111/liv.12623; Semmler G, 2019, DIGEST DIS SCI, V64, P3642, DOI 10.1007/s10620-019-05702-7; Shi KQ, 2014, J GASTROEN HEPATOL, V29, P1149, DOI 10.1111/jgh.12519; Stift J, 2019, DIGEST LIVER DIS, V51, P1144, DOI 10.1016/j.dld.2019.01.020; Van der Graaff D, 2018, LAB INVEST, V98, P1263, DOI 10.1038/s41374-017-0018-z; van Werven JR, 2010, RADIOLOGY, V256, P159, DOI 10.1148/radiol.10091790; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wong GLH, 2010, ALIMENT PHARM THER, V31, P1095, DOI 10.1111/j.1365-2036.2010.04276.x	47	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224506	10.1371/journal.pone.0224506	http://dx.doi.org/10.1371/journal.pone.0224506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693695	Green Published, gold			2022-12-26	WOS:000532690100028
J	Wonde, M; Mulat, H; Birhanu, A; Biru, A; Kassew, T; Shumet, S				Wonde, Mesele; Mulat, Haregewoin; Birhanu, Addis; Biru, Aynalem; Kassew, Tilahun; Shumet, Shegaye			The magnitude of suicidal ideation, attempts and associated factors of HIV positive youth attending ART follow ups at St. Paul's hospital Millennium Medical College and St. Peter's specialized hospital, Addis Ababa, Ethiopia, 2018	PLOS ONE			English	Article							SOCIAL SUPPORT; DEPRESSION; ADOLESCENTS; RISK; HIV/AIDS; BEHAVIOR; IMPACT; STIGMA; INFECTION; DISTRESS	Background Suicide which is considered a psychiatric emergency, is a serious cause of mortality worldwide. Youth living with HIV/AIDS (YLWHA) have higher rates of suicidal behavior than the general public. This study aimed to assess the magnitude and associated factors of suicide ideation and attempt among the Human Immune deficiency Virus (HIV) positive youth attending anti-retroviral therapy (ART) follow up at St. Paul's hospital Millennium Medical College and St. Peter's specialized hospital, Addis Ababa, Ethiopia. Methods In this cross-sectional study, 413 HIV positive youth were recruited for interviews, using the systematic random sampling technique. The Composite International Diagnostic Interview (CIDI) was used to assess suicide. PHQ-9, the Oslo social support and HIV perceived stigma scale instruments were used to assess the factors. We computed bivariate and multivariable binary logistic regressions to assess factors associated with suicidal ideation and attempt. Statistical significance was declared at P-value < 0.05. Result The magnitude of suicidal ideation and attempts were found to be 27.1% and 16.9%, respectively. In the multivariate analysis, female sex (adjusted odd ratio(AOR) = 3.1, 95% CI, 1.6-6.0), family death (AOR = 2.1, 95%CI 1.15-3.85), WHO clinical stage III of HIV (AOR = 3.1 95% CI 1.3-7.35), WHO clinical stage IV of HIV (AOR = 4.76, 95%CI, 1.37.35), co-morbid depression (AOR = 7.14, 95%CI, 3.9-12.9), and perceived HIV stigma (AOR = 4.2, 95%CI, 2.27-8.2) were significantly associated with suicidal ideation, whereas female sex (AOR = 4.12, 95%CI, 1.82-9.78), opportunistic infections (AOR = 3.1, 95%CI, 1.6-6.04), WHO clinical stage III of HIV (AOR = 3.1 95%CI 1.24-7.81), co-morbid depression (AOR = 5.6 95% CI, 2.8-11.1), and poor social support (AOR = 3.4, 95%CI, 1.2-9.4) were statistically significant with suicidal attempt. The result suggests that the magnitude of suicidal ideation and attempts among HIV positive youth were high. We recommend that clinicians consider youth with comorbid depression, perceived HIV stigma and poor social support.	[Wonde, Mesele; Mulat, Haregewoin; Kassew, Tilahun; Shumet, Shegaye] Univ Gondar, Dept Psychiat, Gondar, Ethiopia; [Birhanu, Addis; Biru, Aynalem] Amanuel Mental Specialized Hosp, Addis Ababa, Ethiopia	University of Gondar	Shumet, S (corresponding author), Univ Gondar, Dept Psychiat, Gondar, Ethiopia.	shumetshegaye@yahoo.com	Birhanu, Addis Zeleke/AFR-1678-2022; shumet, shegaye/AAH-8322-2020; Birhanu, Addis Zeleke/ABE-6113-2021	Birhanu, Addis Zeleke/0000-0002-7566-1773; Birhanu, Addis Zeleke/0000-0002-7566-1773; Shumet, Shegaye/0000-0001-7714-7455				Abell WD, 2012, W INDIAN MED J, V61, P521, DOI 10.7727/wimj.2011.144; ABRAM HS, 1971, AM J PSYCHIAT, V127, P1199, DOI 10.1176/ajp.127.9.1199; [Anonymous], 2014, GLOB UPD HLTH SECT R; Arseniou S, 2014, PSYCHIAT CLIN NEUROS, V68, P96, DOI 10.1111/pcn.12097; Badiee J, 2012, J AFFECT DISORDERS, V136, P993, DOI 10.1016/j.jad.2011.06.044; Bitew H, 2016, DEPRESSION RES TREAT; Borges G, 2008, J AM ACAD CHILD PSY, V47, P41, DOI 10.1097/chi.0b013e31815896ad; Cheung Amy H, 2006, Healthc Policy, V2, P76; Chikezie UE, 2012, AIDS CARE, V24, P843, DOI 10.1080/09540121.2011.645008; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Courtet P, 2001, MOL PSYCHIATR, V6, P338, DOI 10.1038/sj.mp.4000856; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232; Fawzi MCS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3235; Gaughan DM, 2004, PEDIATRICS, V113, pE544, DOI 10.1542/peds.113.6.e544; Gebremariam EH, 2017, PSYCHIAT J 2017; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Greydanus Donald E., 2009, Keio Journal of Medicine, V58, P95; Hidaka Y, 2008, SOC PSYCH PSYCH EPID, V43, P752, DOI 10.1007/s00127-008-0352-y; Jin H, 2006, J AFFECT DISORDERS, V94, P269, DOI 10.1016/j.jad.2006.04.013; Kalichman SC, 2000, PSYCHIATR SERV, V51, P903, DOI 10.1176/appi.ps.51.7.903; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kinyanda E, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-63; Lee Benjamin, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P89, DOI 10.1177/1545109710397892; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Martinez J, 2012, AIDS PATIENT CARE ST, V26, P108, DOI 10.1089/apc.2011.0178; Martinez J, 2009, AIDS PATIENT CARE ST, V23, P469, DOI 10.1089/apc.2008.0178; Musisi S, 2009, E AFRICAN MED J, V86; Mutumba M, 2015, AIDS BEHAV, V19, P380, DOI 10.1007/s10461-014-0973-y; Ng LC, 2015, BRIT J PSYCHIAT, V207, P262, DOI 10.1192/bjp.bp.114.154591; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Rashid E, 2017, ETHIOPIAN J HLTH DEV, V10; Rizwan I, 2015, BAHRIA J PROFESSIONA, V14; Rundell JR, 1992, PSYCHOSOMATICS J CON, DOI [10.1016/S0033-3182(92)72017-9, DOI 10.1016/S0033-3182(92)72017-9]; Sadock BJ, 2015, SYNOPSIS PSYCHIAT BE; Shepard DS, 2016, SUICIDE LIFE-THREAT, V46, P352, DOI 10.1111/sltb.12225; Skinner R, 2012, CAN MED ASSOC J, V184, P1029, DOI 10.1503/cmaj.111867; Small L, 2014, GLOB SOC WELFARE, V1, P25, DOI 10.1007/s40609-014-0009-6; Swahn MH, 2012, INT J ENV RES PUB HE, V9, P596, DOI 10.3390/ijerph9020596; Taju NF., 2016, SAHEL MED J, V19, P196, DOI DOI 10.4103/1118-8561.196362; Topouzis D, 2003, ADDRESSING IMPACT HI; UNICEF, 2002, JOINT UN PROGR HIV A; Van Rie A, 2008, TROP MED INT HEALTH, V13, P21, DOI 10.1111/j.1365-3156.2007.01971.x; Vreeman RC, 2017, J INT AIDS SOC, V20; Vu L, 2017, J ADOLESCENT HEALTH, V60, pS22, DOI 10.1016/j.jadohealth.2016.09.007; Walsh AS, 2017, AIDS CARE, V29, P851, DOI 10.1080/09540121.2017.1281878; Wang W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192940; Wasserman Danuta, 2005, World Psychiatry, V4, P114; WHO, 2012, PUBL HLTH ACT PREV S; Woollett N, 2017, J CHILD ADOLESC MENT, V29, P11, DOI 10.2989/17280583.2017.1283320; World Health Organization, SCAL CAR MENT NEUR S; World Health Organization, 2009, UN UN ACC SCAL PRIOR; World Health Organization, 2014, PREV SUIC PREV SUIC	54	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224371	10.1371/journal.pone.0224371	http://dx.doi.org/10.1371/journal.pone.0224371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1BP	31689299	gold, Green Published, Green Submitted			2022-12-26	WOS:000532680100020
J	Osada, AH; Endo, K; Kimura, Y; Sakamoto, K; Nakamura, R; Sakamoto, K; Ueki, K; Yoshizawa, K; Miyazawa, K; Saitoh, M				Osada, Asami Hotta; Endo, Kaori; Kimura, Yujiro; Sakamoto, Kei; Nakamura, Ryosuke; Sakamoto, Kaname; Ueki, Koichiro; Yoshizawa, Kunio; Miyazawa, Keiji; Saitoh, Masao			Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; TGF-BETA; CANCER; METASTASIS; TRANSITION; RECEPTORS; CADHERIN; ESRP1; EMT	The epithelial-mesenchymal transition (EMT) is a crucial morphological event that occurs during epithelial tumor progression. ZEB1/2 are EMT transcription factors that are positively correlated with EMT phenotypes and breast cancer aggressiveness. ZEB1/2 regulate the alternative splicing and hence isoform switching of fibroblast growth factor receptors (FGFRs) by repressing the epithelial splicing regulatory proteins, ESRP1 and ESRP2. Here, we show that the mesenchymal-like phenotypes of oral squamous cell carcinoma (OSCC) cells are dependent on autocrine FGF-FGFR signaling. Mesenchymal-like OSCC cells express low levels of ESRP1/2 and high levels of ZEB1/2, resulting in constitutive expression of the IIIc-isoform of FGFR, FGFR(IIIc). By contrast, epithelial-like OSCC cells showed opposite expression profiles for these proteins and constitutive expression of the IIIb-isoform of FGFR2, FGFR2(IIIb). Importantly, ERK1/2 was constitutively phosphorylated through FGFR1(IIIc), which was activated by factors secreted autonomously by mesenchymal-like OSCC cells and involved in sustained high-level expression of ZEB1. Antagonizing FGFR1 with either inhibitors or siRNAs considerably repressed ZEB1 expression and restored epithelial-like traits. Therefore, autocrine FGF-FGFR(IIIc) signaling appears to be responsible for sustaining ZEB1/2 at high levels and the EMT phenotype in OSCC cells.	[Osada, Asami Hotta; Endo, Kaori; Kimura, Yujiro; Sakamoto, Kaname; Miyazawa, Keiji; Saitoh, Masao] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Biochem, Chuo, Yamanashi, Japan; [Osada, Asami Hotta; Kimura, Yujiro; Ueki, Koichiro; Yoshizawa, Kunio] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Oral & Maxillofacial Surg, Chuo, Yamanashi, Japan; [Osada, Asami Hotta; Nakamura, Ryosuke; Saitoh, Masao] Univ Yamanashi, Ctr Med Educ & Sci, Interdisciplinary Grad Sch Med, Chuo, Yamanashi, Japan; [Sakamoto, Kei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Bunkyo Ku, Tokyo, Japan; [Nakamura, Ryosuke] Kofu Municipal Hosp, Dept Oral Surg, Kofu, Yamanashi, Japan	University of Yamanashi; University of Yamanashi; University of Yamanashi; Tokyo Medical & Dental University (TMDU)	Saitoh, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Biochem, Chuo, Yamanashi, Japan.; Saitoh, M (corresponding author), Univ Yamanashi, Ctr Med Educ & Sci, Interdisciplinary Grad Sch Med, Chuo, Yamanashi, Japan.	msaitoh-ind@umin.ac.jp			Mitsubishi Foundation; JSPS KAKENHI [15H05018, 18H02969]	Mitsubishi Foundation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Mitsubishi Foundation, JSPS KAKENHI grant number 18H02969, and JSPS KAKENHI grant number 15H05018.	Nieto MA, 2017, NAT CELL BIOL, V19, P416, DOI 10.1038/ncb3520; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; BEDOSSA P, 1995, HEPATOLOGY, V21, P760, DOI 10.1016/0270-9139(95)90530-8; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Buss N, 2018, TOXICOL APPL PHARM, V355, P147, DOI 10.1016/j.taap.2018.06.033; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fukagawa A, 2015, CANCER MED-US, V4, P125, DOI 10.1002/cam4.347; Holzmann K, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/950508; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; ICHIJO H, 1990, EXP CELL RES, V187, P263, DOI 10.1016/0014-4827(90)90090-W; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Jibiki I, 2003, AM J RESP CRIT CARE, V167, P856, DOI 10.1164/rccm.2204042; Johnson Gemma, 2013, Methods Mol Biol, V943, P1, DOI 10.1007/978-1-60327-353-4_1; Matsuyama S, CANC RES; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; NAKAMOTO T, 1992, CANCER RES, V52, P571; Nakamura R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199442; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Saitoh M, 2018, J BIOCHEM, V164, P257, DOI 10.1093/jb/mvy047; Saitoh M, 2015, CANCER SCI, V106, P481, DOI 10.1111/cas.12630; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Sonvilla G, 2010, BRIT J CANCER, V102, P1145, DOI 10.1038/sj.bjc.6605596; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Vlotides G, 2009, ENDOCRINOLOGY, V150, P3252, DOI 10.1210/en.2008-1625; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Yoshizawa K, 2009, J ORAL PATHOL MED, V38, P535, DOI 10.1111/j.1600-0714.2009.00762.x	32	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2019	14	11							e0217451	10.1371/journal.pone.0217451	http://dx.doi.org/10.1371/journal.pone.0217451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1AJ	31682640	Green Published, Green Submitted, gold			2022-12-26	WOS:000532676800002
J	Asare-Werehene, M; Nakka, K; Reunov, A; Chiu, CT; Lee, WT; Abedini, MR; Wang, PW; Shieh, DB; Dilworth, FJ; Carmona, E; Le, T; Mes-Masson, AM; Burger, D; Tsang, BK				Asare-Werehene, Meshach; Nakka, Kiran; Reunov, Arkadiy; Chiu, Chen-Tzu; Lee, Wei-Ting; Abedini, Mohammad R.; Wang, Pei-Wen; Shieh, Dar-Bin; Dilworth, F. Jeffrey; Carmona, Euridice; Le, Tien; Mes-Masson, Anne-Marie; Burger, Dylan; Tsang, Benjamin K.			The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance	ONCOGENE			English	Article							PROTEIN-KINASE B; CISPLATIN RESISTANCE; AKT; ACTIVATION; CELLS; PROGRESSION; HYPOXIA; P53; EXPRESSION; APOPTOSIS	Ovarian cancer (OVCA) is the most lethal gynecological cancer, due predominantly to late presentation, high recurrence rate and common chemoresistance development. The expression of the actin-associated protein cytosolic gelsolin (GSN) regulates the gynecological cancer cell fate resulting in dysregulation in chemosensitivity. In this study, we report that elevated expression of plasma gelsolin (pGSN), a secreted isoform of GSN and expressed from the same GSN gene, correlates with poorer overall survival and relapse-free survival in patients with OVCA. In addition, it is highly expressed and secreted in chemoresistant OVCA cells than its chemosensitive counterparts. pGSN, secreted and transported via exosomes (Ex-pGSN), upregulates HIF1 alpha-mediated pGSN expression in chemoresistant OVCA cells in an autocrine manner as well as confers cisplatin resistance in otherwise chemosensitive OVCA cells. These findings support our hypothesis that exosomal pGSN promotes OVCA cell survival through both autocrine and paracrine mechanisms that transform chemosensitive cells to resistant counterparts. Specifically, pGSN transported via exosomes is a determinant of chemoresistance in OVCA.	[Asare-Werehene, Meshach; Le, Tien; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Asare-Werehene, Meshach; Nakka, Kiran; Dilworth, F. Jeffrey; Le, Tien; Burger, Dylan; Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Asare-Werehene, Meshach; Nakka, Kiran; Abedini, Mohammad R.; Dilworth, F. Jeffrey; Le, Tien; Burger, Dylan; Tsang, Benjamin K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1H 8L6, Canada; [Asare-Werehene, Meshach; Nakka, Kiran; Abedini, Mohammad R.; Dilworth, F. Jeffrey; Le, Tien; Burger, Dylan; Tsang, Benjamin K.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Nakka, Kiran; Dilworth, F. Jeffrey; Burger, Dylan; Tsang, Benjamin K.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Reunov, Arkadiy] St Francis Xavier Univ, Dept Biol, 2320 Notre Dame Ave, Antigonish, NS B2G 2W5, Canada; [Chiu, Chen-Tzu; Lee, Wei-Ting; Wang, Pei-Wen; Shieh, Dar-Bin] Natl Cheng Kung Univ, Inst Basic Med Sci, Inst Oral Med, Natl Cheng Kung Univ Hosp, Tainan 704, Taiwan; [Chiu, Chen-Tzu; Lee, Wei-Ting; Wang, Pei-Wen; Shieh, Dar-Bin] Natl Cheng Kung Univ, Dept Stomatol, Natl Cheng Kung Univ Hosp, Tainan 704, Taiwan; [Abedini, Mohammad R.] Birjand Univ Med Sci, Cellular & Mol Med Res Ctr, Dept Pharmacol, Birjand 97178, Iran; [Shieh, Dar-Bin] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Tainan 701, Taiwan; [Shieh, Dar-Bin] Natl Cheng Kung Univ, Ctr Micro Nano Sci & Technol, Tainan 701, Taiwan; [Carmona, Euridice; Mes-Masson, Anne-Marie] Ctr Rech CHUM, Montreal, PQ H2X 0A9, Canada; [Carmona, Euridice; Mes-Masson, Anne-Marie] Inst Canc Montreal, Montreal, PQ H2X 0A9, Canada; [Carmona, Euridice; Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Saint Francis Xavier University - Canada; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Tsang, BK (corresponding author), Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada.; Tsang, BK (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Tsang, BK (corresponding author), Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON K1H 8L6, Canada.; Tsang, BK (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada.; Tsang, BK (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	btsang@ohri.ca	Burger, Dylan/ABD-2727-2020; Nakka, Kiran/CAJ-3374-2022	Burger, Dylan/0000-0003-3951-2911; Dilworth, F. Jeffrey/0000-0002-6265-8102; Wang, Pei-Wen/0000-0002-1863-3661; Nakka, Kiran/0000-0002-8418-9343	Canadian Institutes of Health Research [MOP-15691]; Taiwan Ministry of Science and Technology [MOST 104-2314-B-006-063-MY3, 106-2627-M-006-001, 107-2321-B-006-019, 107-2314-B-006-029]; Center of Applied Nanomedicine, National Cheng Kung University; Dragon Gate Program [MOST 105-2911-I-006-529]; Taiwan Ministry of Education	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Taiwan Ministry of Science and Technology; Center of Applied Nanomedicine, National Cheng Kung University; Dragon Gate Program; Taiwan Ministry of Education(Ministry of Education, Taiwan)	This work was supported by the Canadian Institutes of Health Research (MOP-15691), the Dragon Gate Program (MOST 105-2911-I-006-529), and research grants (MOST 104-2314-B-006-063-MY3, 106-2627-M-006-001, 107-2321-B-006-019, and 107-2314-B-006-029) from the Taiwan Ministry of Science and Technology, the Center of Applied Nanomedicine, National Cheng Kung University, The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project, the Taiwan Ministry of Education.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2014, P NATL ACAD SCI USA, V111, P14442, DOI 10.1073/pnas.1401166111; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ali AY, 2012, ONCOGENE, V31, P2175, DOI 10.1038/onc.2011.399; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Ata R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010189; Bohgaki M, 2011, J CELL MOL MED, V15, P141, DOI 10.1111/j.1582-4934.2009.00940.x; Bruney L, 2016, ONCOTARGET, V7, P21968, DOI 10.18632/oncotarget.7880; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Burger D, 2015, AM J PATHOL, V185, P2309, DOI 10.1016/j.ajpath.2015.04.010; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen CC, 2017, ONCOTARGET, V8, P77152, DOI 10.18632/oncotarget.20414; Chen WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095240; Crow J, 2017, ONCOTARGET, V8, P11917, DOI 10.18632/oncotarget.14440; Dai CL, 2013, J BIOL CHEM, V288, P23875, DOI 10.1074/jbc.M112.445148; Daponte A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-335; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Elattar A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007565.pub2, 10.1002/14651858.CD007565]; Faridi J, 2003, AM J PHYSIOL-ENDOC M, V285, pE964, DOI 10.1152/ajpendo.00239.2003; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fraser M, 2003, CANCER RES, V63, P7081; Fu LJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-92; Gomez-Roman N, 2016, ONCOTARGET, V7, P22650, DOI 10.18632/oncotarget.7998; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Krieg T, 2003, CARDIOVASC RES, V58, P196, DOI 10.1016/S0008-6363(02)00861-1; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; Lee PS, 2006, AM J RESP CRIT CARE, V173, P685, DOI 10.1164/ajrccm.173.6.685; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Lofberg M, 1998, J NEUROL SCI, V157, P187, DOI 10.1016/S0022-510X(98)00056-2; Meng XD, 2016, ONCOTARGET, V7, P16923, DOI 10.18632/oncotarget.7850; Nakka KK, 2015, P NATL ACAD SCI USA, V112, pE3374, DOI 10.1073/pnas.1418603112; Nitulescu GM, 2016, INT J ONCOL, V48, P869, DOI 10.3892/ijo.2015.3306; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Pink RC, 2015, GYNECOL ONCOL, V137, P143, DOI 10.1016/j.ygyno.2014.12.042; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reunov A, 2018, GENE, V658, P1, DOI 10.1016/j.gene.2018.03.012; Roma-Rodrigues C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179486; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; SMITH DB, 1987, J LAB CLIN MED, V110, P189; Spinardi L., 2007, V45, P55; Stefanou DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117654; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Tsai MH, 2012, J MOL MED, V90, P187, DOI 10.1007/s00109-011-0817-4; Vinas JL, 2016, KIDNEY INT, V90, P1238, DOI 10.1016/j.kint.2016.07.015; Wang PW, 2014, INT J CANCER, V135, P2760, DOI 10.1002/ijc.28928; Wefers C, 2015, GYNECOL ONCOL, V137, P335, DOI 10.1016/j.ygyno.2015.02.019; Wei YF, 2014, BREAST CANCER RES TR, V147, P423, DOI 10.1007/s10549-014-3037-0; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yang ZY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07758; Yeung CLA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11150; YIN HL, 1984, J BIOL CHEM, V259, P5271; Yin J, 2012, J CELL MOL MED, V16, P337, DOI 10.1111/j.1582-4934.2011.01316.x; Ying X, 2016, ONCOTARGET, V7, P43076, DOI 10.18632/oncotarget.9246; Yu TC, 2017, YONSEI MED J, V58, P489, DOI 10.3349/ymj.2017.58.3.489; Zeng B, 2018, ONCOTARGETS THER, V11, P1333, DOI 10.2147/OTT.S154215	59	43	43	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	7					1600	1616		10.1038/s41388-019-1087-9	http://dx.doi.org/10.1038/s41388-019-1087-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KL2WP	31700155	Green Published, hybrid			2022-12-26	WOS:000513289600015
J	Chen, XY; Xiong, XF; Cui, DR; Yang, F; Wei, DP; Li, HM; Shu, JF; Bi, YL; Dai, XQ; Gong, LY; Sun, Y; Zhao, YC				Chen, Xiaoyu; Xiong, Xiufang; Cui, Danrui; Yang, Fei; Wei, Dongping; Li, Haomin; Shu, Jianfeng; Bi, Yanli; Dai, Xiaoqing; Gong, Longyuan; Sun, Yi; Zhao, Yongchao			DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals	ONCOGENE			English	Article							BETA-TRCP; CANCER; PTEN; PROGRESSION; ACTIVATION; GROWTH; RADIOTHERAPY; DEGRADATION; METABOLISM; TRANSITION	The DEPTOR-mTORC1/2 axis has been shown to play an important, but a context dependent role in the regulation of proliferation and the survival of various cancer cells in cell culture settings. The in vivo role of DEPTOR in tumorigenesis remains elusive. Here we showed that the levels of both DEPTOR protein and mRNA were substantially decreased in human prostate cancer tissues, which positively correlated with disease progression. DEPTOR depletion accelerated proliferation and survival, migration, and invasion in human prostate cancer cells. Mechanistically, DEPTOR depletion not only activated both mTORC1 and mTORC2 signals to promote cell proliferation and survival, but also induced an AKT-dependent epithelial-mesenchymal transition (EMT) and beta-catenin nuclear translocation to promote cell migration and invasion. Abrogation of mTOR or AKT activation rescued the biological consequences of DEPTOR depletion. Importantly, in a Deptor-KO mouse model, Deptor knockout accelerated prostate tumorigenesis triggered by Pten loss via the activation of mTOR signaling. Collectively, our study demonstrates that DEPTOR is a tumor suppressor in the prostate, and its depletion promotes tumorigenesis via the activation of mTORC1 and mTORC2 signals. Thus, DEPTOR reactivation via a variety of means would have therapeutic potential for the treatment of prostate cancer.	[Chen, Xiaoyu; Cui, Danrui; Shu, Jianfeng; Bi, Yanli; Dai, Xiaoqing; Gong, Longyuan; Zhao, Yongchao] Zhejiang Univ, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Sch Med, Hangzhou, Peoples R China; [Chen, Xiaoyu; Xiong, Xiufang; Cui, Danrui; Yang, Fei; Li, Haomin; Shu, Jianfeng; Bi, Yanli; Dai, Xiaoqing; Gong, Longyuan; Sun, Yi; Zhao, Yongchao] Zhejiang Univ, Inst Translat Med, Sch Med, Hangzhou, Peoples R China; [Xiong, Xiufang; Sun, Yi] Zhejiang Univ, Affiliated Hosp 2, Canc Inst, Sch Med, Hangzhou, Peoples R China; [Wei, Dongping] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Peoples R China; [Li, Haomin] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Sun, Yi] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	Zhejiang University; Zhejiang University; Zhejiang University; Nanjing Medical University; Zhejiang University; University of Michigan System; University of Michigan	Zhao, YC (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Sch Med, Hangzhou, Peoples R China.; Zhao, YC (corresponding author), Zhejiang Univ, Inst Translat Med, Sch Med, Hangzhou, Peoples R China.	yongchao@zju.edu.cn	Li, Haomin/AAY-5044-2021; Sun, Yi/K-1025-2014	Li, Haomin/0000-0002-6420-7719; Sun, Yi/0000-0002-5841-4287; Xiong, Xiufang/0000-0001-6842-3673	National Key R&D Program of China [2016YFA0501800]; National Natural Science Foundation of China [81672728, 81972591, 81721091, 81572708, 31501129, 81974429, 81572718, 81630076, 81672895]; Natural Science Foundation of Zhejiang Province [LR16C050001]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Key R&D Program of China (2016YFA0501800 to YZ, XX, and YS), the National Natural Science Foundation of China (81672728, 81972591, and 81721091 to YZ, 81572708, 31501129, and 81974429 to XX, 81572718 and 81630076 to YS, and 81672895 to DW), and the Natural Science Foundation of Zhejiang Province (LR16C050001 to YZ).	Beer TM, 2017, EUR UROL, V71, P151, DOI 10.1016/j.eururo.2016.07.032; Blando J, 2009, AM J PATHOL, V174, P1869, DOI 10.2353/ajpath.2009.080055; Brand D, 2018, EUR UROL, V73, P521, DOI 10.1016/j.eururo.2017.12.021; Caron A, 2018, PHYSIOL REV, V98, P1765, DOI 10.1152/physrev.00064.2017; Caron A, 2017, MOL METAB, V6, P447, DOI 10.1016/j.molmet.2017.02.005; Chiarini F, 2015, TRENDS PHARMACOL SCI, V36, P124, DOI 10.1016/j.tips.2014.11.004; Crabb SJ, 2017, INVEST NEW DRUG, V35, P599, DOI 10.1007/s10637-017-0433-4; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Edlind MP, 2014, ASIAN J ANDROL, V16, P378, DOI 10.4103/1008-682X.122876; El Sheikh SS, 2008, NEOPLASIA, V10, P949, DOI 10.1593/neo.08582; Ferraldeschi R, 2015, EUR UROL, V67, P795, DOI 10.1016/j.eururo.2014.10.027; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Goodall J, 2017, CANCER DISCOV, V7, P1006, DOI 10.1158/2159-8290.CD-17-0261; Henderson V, 2015, CELL ADHES MIGR, V9, P255, DOI 10.1080/19336918.2015.1013383; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Jamaspishvili T, 2018, NAT REV UROL, V15, P222, DOI 10.1038/nrurol.2018.9; Janku F, 2018, NAT REV CLIN ONCOL, V15, P273, DOI 10.1038/nrclinonc.2018.28; Ji YM, 2016, ONCOTARGET, V7, P14188, DOI 10.18632/oncotarget.7420; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Khamis ZI, 2012, MED RES REV, V32, P1026, DOI 10.1002/med.20232; Lai EY, 2014, ASIAN PAC J CANCER P, V15, P4589, DOI 10.7314/APJCP.2014.15.11.4589; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee YR, 2018, NAT REV MOL CELL BIO, V19, P547, DOI 10.1038/s41580-018-0015-0; Li H, 2014, ONCOTARGET, V5, P12811, DOI 10.18632/oncotarget.2659; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Lynch JT, 2018, MOL CANCER THER, V17, P2309, DOI 10.1158/1535-7163.MCT-18-0183; Mahal BA, 2018, EUR UROL, V74, P146, DOI 10.1016/j.eururo.2018.01.043; Obara A, 2015, BIOCHEM BIOPH RES CO, V460, P1047, DOI 10.1016/j.bbrc.2015.03.148; Pei L, 2011, MOL MED REP, V4, P817, DOI 10.3892/mmr.2011.503; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sole CV, 2013, EUR J NUCL MED MOL I, V40, P1635, DOI 10.1007/s00259-013-2479-7; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056664; Wang JC, 2018, BBA-MOL CELL RES, V1865, P1105, DOI 10.1016/j.bbamcr.2018.05.007; Yen CH, 2012, MOL MED, V18, P546, DOI 10.2119/molmed.2012.00003.erratum; Zhang S, 2019, CANCER RES, V79, P3725, DOI 10.1158/0008-5472.CAN-19-0180; Zhao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.125; Zhao YC, 2012, NEOPLASIA, V14, P360, DOI 10.1593/neo.12532; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029; Zhou XF, 2016, MOL CANCER RES, V14, P448, DOI 10.1158/1541-7786.MCR-15-0480; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	50	17	17	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	7					1557	1571		10.1038/s41388-019-1085-y	http://dx.doi.org/10.1038/s41388-019-1085-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KL2WP	31685947	Green Published, hybrid			2022-12-26	WOS:000513289600012
J	Datta, P; Hendrickson, B; Brendalen, S; Ruffcorn, A; Seo, SJ				Datta, Poppy; Hendrickson, Brandon; Brendalen, Sarah; Ruffcorn, Avri; Seo, Seongjin			The myosin-tail homology domain of centrosomal protein 290 is essential for protein confinement between the inner and outer segments in photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						outer segment; connecting cilium; ciliary gate; gatekeeper; diffusion barrier; cilia; retinal degeneration; photoreceptor; intracellular trafficking; genetic disease	INTRAFLAGELLAR TRANSPORT; TRANSITION ZONE; MEMBRANE-PROTEINS; HCN1 CHANNELS; CEP290; ROD; MUTATIONS; GENE; CILIA; TRAFFICKING	Mutations in the centrosomal protein 290 (CEP290) gene cause various ciliopathies involving retinal degeneration. CEP290 proteins localize to the ciliary transition zone and are thought to act as a gatekeeper that controls ciliary protein trafficking. However, precise roles of CEP290 in photoreceptors and pathomechanisms of retinal degeneration in CEP290-associated ciliopathies are not sufficiently understood. Using conditional Cep290 mutant mice, in which the C-terminal myosin-tail homology domain of CEP290 is disrupted after the connecting cilium is assembled, we show that this domain is essential for protein confinement between the inner and the outer segments. Upon disruption of the myosin-tail homology domain, inner segment plasma membrane proteins, including syntaxin 3 (STX3), synaptosome-associated protein 25 (SNAP25), and interphotoreceptor matrix proteoglycan 2 (IMPG2), rapidly accumulated in the outer segment. In contrast, localization of endomembrane proteins was not altered. Trafficking and confinement of most outer segment-resident proteins appeared to be unaffected or only minimally affected in Cep290 mutant mice. One notable exception was rhodopsin (RHO), which severely mislocalized to inner segments during the initial stage of degeneration. Similar mislocalization phenotypes were observed in Cep290(rd16) mice. These results suggest that a failure of protein confinement at the connecting cilium and consequent accumulation of inner segment membrane proteins in the outer segment, along with insufficient RHO delivery, is part of the disease mechanisms that cause retinal degeneration in CEP290-associated ciliopathies. Our study provides insights into the pathomechanisms of retinal degenerations associated with compromised ciliary gates.	[Datta, Poppy; Hendrickson, Brandon; Brendalen, Sarah; Ruffcorn, Avri; Seo, Seongjin] Univ Iowa, Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Datta, Poppy; Hendrickson, Brandon; Brendalen, Sarah; Ruffcorn, Avri; Seo, Seongjin] Univ Iowa, Inst Vis Res, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Seo, SJ (corresponding author), Univ Iowa, Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.	seongjin-seo@uiowa.edu		Datta, Poppy/0000-0003-4989-0975; Seo, Seongjin/0000-0002-7908-3210	NATIONAL EYE INSTITUTE [R01EY022616, R21EY027431, P30EY025580] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY022616, R21 EY027431, P30 EY025580] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acharya S, 2000, J BIOL CHEM, V275, P6945, DOI 10.1074/jbc.275.10.6945; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baehr W., 2018, PROG RETIN EYE RES; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; Barny I., 2018, HUM MOL GENET; Betleja E, 2010, CURR BIOL, V20, pR928, DOI 10.1016/j.cub.2010.09.058; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Datta P, 2015, P NATL ACAD SCI USA, V112, pE4400, DOI 10.1073/pnas.1510111112; Demontis GC, 2002, J PHYSIOL-LONDON, V542, P89, DOI 10.1113/jphysiol.2002.017640; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dilan TL, 2018, HUM MOL GENET, V27, P283, DOI 10.1093/hmg/ddx399; Drivas TG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5370; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Garcia-Gonzalo FR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028134; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Hallett MA, 1996, J CELL SCI, V109, P1803; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767; Hsu Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007057; Humbert MC, 2012, P NATL ACAD SCI USA, V109, P19691, DOI 10.1073/pnas.1210916109; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; JOHNSON LV, 1984, CURR EYE RES, V3, P969, DOI 10.3109/02713688409167215; KAMPS KMP, 1982, BIOCHIM BIOPHYS ACTA, V687, P296, DOI 10.1016/0005-2736(82)90558-2; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Lessieur EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213960; Li CM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002416; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P3646, DOI 10.1167/iovs.09-5074; Liu PW, 2018, P NATL ACAD SCI USA, V115, pE934, DOI 10.1073/pnas.1713226115; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; Meunier I, 2014, OPHTHALMOLOGY, V121, P2406, DOI 10.1016/j.ophtha.2014.06.028; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; Murga-Zamalloa CA, 2011, J BIOL CHEM, V286, P28276, DOI 10.1074/jbc.M111.237560; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nemet I, 2015, PROG MOL BIOL TRANSL, V132, P39, DOI 10.1016/bs.pmbts.2015.02.007; Pan Y, 2015, CELL MOL LIFE SCI, V72, P833, DOI 10.1007/s00018-014-1705-1; Rachel RA, 2015, HUM MOL GENET, V24, P3775, DOI 10.1093/hmg/ddv123; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Roosing S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8080208; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Seo S, 2017, HUM MOL GENET, V26, pR75, DOI 10.1093/hmg/ddx163; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Shimada H, 2017, CELL REP, V20, P384, DOI 10.1016/j.celrep.2017.06.045; Smith TS, 2013, CELL MOL LIFE SCI, V70, P4603, DOI 10.1007/s00018-013-1403-4; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; van Huet RAC, 2014, INVEST OPHTH VIS SCI, V55, P3939, DOI 10.1167/iovs.14-14129; Wiegering A, 2018, EMBO J, V37, DOI 10.15252/embj.201797791; Williams CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6813; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Yang TT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14096; Ye F, 2018, J CELL BIOL, V217, P1847, DOI 10.1083/jcb.201709041; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61	74	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19119	19136		10.1074/jbc.RA119.009712	http://dx.doi.org/10.1074/jbc.RA119.009712			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31694913	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000516527800015
J	McKibben, KM; Rhoades, E				McKibben, Kristen M.; Rhoades, Elizabeth			Independent tubulin binding and polymerization by the proline-rich region of tau is regulated by tau's N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; Tau protein (Tau); Alzheimer disease; microtubule-associated protein (MAP); single-molecule biophysics; cytoskeleton; tauopathy; tubulin polymerization; single-molecule FRET; fluorescence correlation spectroscopy (FCS)	MICROTUBULE-BINDING; SINGLE-MOLECULE; PROTEIN; PHOSPHORYLATION; ISOFORMS; BRAIN; IDENTIFICATION; DISEASE; FACES; JAWS	Tau is an intrinsically disordered, microtubule-associated protein that has a role in regulating microtubule dynamics. Despite intensive research, the molecular mechanisms of tau-mediated microtubule polymerization are poorly understood. Here, we used single-molecule fluorescence to investigate the role of tau's N-terminal domain (NTD) and proline-rich region (PRR) in regulating interactions of tau with soluble tubulin. We assayed both full-length tau isoforms and truncated variants for their ability to bind soluble tubulin and stimulate microtubule polymerization. We found that tau's PRR is an independent tubulin-binding domain that has tubulin polymerization capacity. In contrast to the relatively weak interactions with tubulin mediated by sites distributed throughout tau's microtubule-binding repeats (MTBR), resulting in heterogeneous tau:tubulin complexes, the PRR bound tubulin tightly and stoichiometrically. Moreover, we demonstrate that interactions between the PRR and MTBR are reduced by the NTD through a conserved conformational ensemble. On the basis of these results, we propose that tau's PRR can serve as a core tubulin-binding domain, whereas the MTBR enhances polymerization capacity by increasing the local tubulin concentration. Moreover, the NTD appears to negatively regulate tubulin-binding interactions of both of these domains. The findings of our study draw attention to a central role for the PRR in tau function and provide mechanistic insight into tau-mediated polymerization of tubulin.	[McKibben, Kristen M.; Rhoades, Elizabeth] Univ Penn, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA; [Rhoades, Elizabeth] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Rhoades, E (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	elizabeth.rhoades@sas.upenn.edu			NIH Institutional Training Grant [T32 GM071399]; NIH [AG053951]	NIH Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank: H.Y.J Fung, S. Wickramasinghe, I. Yannatos and H. Merens for assistance during the various tubulin purifications; the Chenoweth Lab for use of their fluorimeter; the Svitkina Lab for the use of their TEM microscope and C. Yang for assistance with the microscope and insightful suggestions. This work was supported by NIH Institutional Training Grant T32 GM071399 (to K.M.) and NIH Grant AG053951 (to E.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chong FP, 2018, CELL MOL NEUROBIOL, V38, P965, DOI 10.1007/s10571-017-0574-1; Chung PJ, 2015, P NATL ACAD SCI USA, V112, pE6416, DOI 10.1073/pnas.1513172112; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Elbaum-Garfinkle S, 2014, P NATL ACAD SCI USA, V111, P6311, DOI 10.1073/pnas.1315983111; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fauquant C., 2011, J BIOL CHEM; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Gigant B, 2014, J AM CHEM SOC, V136, P12615, DOI 10.1021/ja504864m; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Holehouse AS, 2017, BIOPHYS J, V112, P16, DOI 10.1016/j.bpj.2016.11.3200; Iwata M, 2019, MOL BIOL CELL, V30, P2441, DOI 10.1091/mbc.E19-03-0183; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Li XH, 2017, BIOPHYS J, V112, P2567, DOI 10.1016/j.bpj.2017.05.006; Li XH, 2015, J AM CHEM SOC, V137, P9218, DOI 10.1021/jacs.5b04561; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; Mandell JW, 1996, J NEUROSCI, V16, P5727; Melo AM, 2016, P NATL ACAD SCI USA, V113, P14336, DOI 10.1073/pnas.1610137113; Metskas LA, 2015, J AM CHEM SOC, V137, P11962, DOI 10.1021/jacs.5b04471; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Niewidok B, 2016, MOL BIOL CELL, V27, P3537, DOI 10.1091/mbc.E16-06-0402; O'Brien EP, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3082151; Preuss U, 1997, J CELL SCI, V110, P789; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SCOTT CW, 1992, J NEUROSCI RES, V33, P19, DOI 10.1002/jnr.490330104; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Trzeciakiewicz H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44102; Vemu A, 2018, SCIENCE, V361, DOI 10.1126/science.aau1504; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	55	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19381	19394		10.1074/jbc.RA119.010172	http://dx.doi.org/10.1074/jbc.RA119.010172			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699899	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000516527800034
J	Day, J; Passecker, A; Beck, HP; Vakonakis, I				Day, Jemma; Passecker, Armin; Beck, Hans-Peter; Vakonakis, Ioannis			The Plasmodium falciparum Hsp70-x chaperone assists the heat stress response of the malaria parasite	FASEB JOURNAL			English	Article						PfHsp70-x; protein structure; chaperone-cochaperone interactions; chaperone inhibition	NUCLEOTIDE-BINDING DOMAIN; HEAT-SHOCK-PROTEIN-70 HSP70; J-PROTEINS; EVOLUTION; ROLES; INHIBITOR; MKT-077; HSP40	Plasmodium falciparum is the most lethal of human-infective malaria parasites. A hallmark of P. falciparum malaria is extensive remodeling of host erythrocytes by the parasite, which facilitates the development of virulence properties such as host cell adhesion to the endothelial lining of the microvasculature. Host remodeling is mediated by a large complement of parasite proteins exported to the erythrocyte; among them is a single heat shock protein (Hsp)70-class protein chaperone, P. falciparum Hsp70-x (PfHsp70-x). PfHsp70-x was previously shown to assist the development of virulent cytoadherence characteristics. Here, we show that PfHsp70-x also supports parasite growth under elevated temperature conditions that simulate febrile episodes, especially at the beginning of the parasite life cycle when most of host cell remodeling takes place. Biochemical and biophysical analyses of PfHsp70-x, including crystallographic structures of its catalytic domain and the J-domain of its stimulatory Hsp40 cochaperone, suggest that PfHsp70-x is highly similar to human Hsp70 chaperones endogenous to the erythrocyte. Nevertheless, our results indicate that selective inhibition of PfHsp70-x function using small molecules may be possible and highlight specific sites of its catalytic domain as potentially of high interest. We discuss the likely roles of PfHsp70-x and human chaperones in P. falciparum biology and how specific inhibitors may assist us in disentangling their relative contributions.	[Day, Jemma; Vakonakis, Ioannis] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Passecker, Armin; Beck, Hans-Peter] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Passecker, Armin; Beck, Hans-Peter] Univ Basel, Basel, Switzerland	University of Oxford; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk			Medical Research Council UK [MR/N009274/1]; Swiss National Science Foundation [SNF 31003A_169347]; Wellcome Trust; Wellcome Institutional Strategic Support Fund; Edward Penley Abraham Cephalosporin Trust; John Fell Oxford University Press (OUP) Research Fund; Wellcome Trust [094872/Z/10/Z]; MRC [MR/N009274/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome Trust); Wellcome Institutional Strategic Support Fund; Edward Penley Abraham Cephalosporin Trust; John Fell Oxford University Press (OUP) Research Fund; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Nick Soffe and Christina Redfield (University of Oxford) for maintenance of the solution NMR facility, Edward Lowe (University of Oxford) for supporting the crystallization facility of Oxford Biochemistry, and Dr. Vasant Muralidharan (University of Georgia, Athens, GA, USA) for providing the PfHsp70-xglmS parasite clone. The authors thank the Medical Research Council UK (MR/N009274/1) for support to I.V., and the Swiss National Science Foundation (SNF 31003A_169347) for support to H.-P.B. J.D. was funded by a Ph.D. studentship from the Wellcome Trust. The Oxford Biochemistry NMR facility was supported by the Wellcome Trust (094872/Z/10/Z), the Wellcome Institutional Strategic Support Fund, the Edward Penley Abraham Cephalosporin Trust, and the John Fell Oxford University Press (OUP) Research Fund. The authors declare no conflicts of interest.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; Amick J, 2014, PROTEIN SCI, V23, P833, DOI 10.1002/pro.2466; Bell A, 2005, FEMS MICROBIOL LETT, V253, P171, DOI 10.1016/j.femsle.2005.09.035; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Bryk AH, 2017, J PROTEOME RES, V16, P2752, DOI 10.1021/acs.jproteome.7b00025; Charnaud SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181656; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28608-2; Cobb DW, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00363-17, 10.1128/msphere.00363-17]; Cockburn IL, 2014, BIOL CHEM, V395, P1353, DOI 10.1515/hsz-2014-0138; Craig AG, 2012, MALAYS J MED SCI, V19, P5; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Daniyan MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148517; de Koning-Ward TF, 2016, NAT REV MICROBIOL, V14, P494, DOI 10.1038/nrmicro.2016.79; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dicko Alassane, 2018, Lancet Infect Dis, V18, P627, DOI 10.1016/S1473-3099(18)30044-6; Dondorp Arjen M, 2011, N Engl J Med, V365, P1073, DOI 10.1056/NEJMp1108322; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enserink M, 2010, SCIENCE, V328, P844, DOI 10.1126/science.328.5980.844; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Fuxreiter M, 2018, J MOL BIOL, V430, P2278, DOI 10.1016/j.jmb.2018.02.015; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; Hussein HA, 2015, NUCLEIC ACIDS RES, V43, pW436, DOI 10.1093/nar/gkv462; Hviid L, 2015, ADV PARASIT, V88, P51, DOI 10.1016/bs.apar.2015.02.004; Johansson KE, 2018, CURR OPIN STRUC BIOL, V48, P157, DOI 10.1016/j.sbi.2018.01.010; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Keul ND, 2018, NATURE, V563, P584, DOI 10.1038/s41586-018-0699-5; Kirchgatter K, 2005, AN ACAD BRAS CIENC, V77, P455, DOI 10.1590/S0001-37652005000300008; Kityk R, 2018, MOL CELL, V69, P227, DOI 10.1016/j.molcel.2017.12.003; Kneller, 2003, SPARKY 3; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Li Z, 2013, NAT STRUCT MOL BIOL, V20, P929, DOI 10.1038/nsmb.2608; Loy DE, 2017, INT J PARASITOL, V47, P87, DOI 10.1016/j.ijpara.2016.05.008; Lu G, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1045-3; Mabate B, 2018, PROTEINS, V86, P1189, DOI 10.1002/prot.25600; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Moll K., 2013, METHODS MALARIA RES, V6th, DOI DOI 10.1007/S00436-008-0981-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Pesce ER, 2014, PARASITOLOGY, V141, P1167, DOI 10.1017/S003118201300228X; Pettinger J, 2017, ANGEW CHEM INT EDIT, V56, P3536, DOI 10.1002/anie.201611907; POLOGE LG, 1988, CELL, V55, P869, DOI 10.1016/0092-8674(88)90142-0; Proellocks NI, 2016, ADV PARASIT, V91, P1, DOI 10.1016/bs.apar.2015.09.002; Prommana P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073783; Rogala KB, 2015, ELIFE, V4, DOI 10.7554/eLife.07410; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Sinha S, 2014, PARASITE, V21, DOI 10.1051/parasite/2014059; Smith JD, 2013, CELL MICROBIOL, V15, P1976, DOI 10.1111/cmi.12183; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vial H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-396; Warncke JD, 2016, MICROBIOL MOL BIOL R, V80, P905, DOI 10.1128/MMBR.00014-16; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WERNSDORFER WH, 1991, PARASITOL TODAY, V7, P297, DOI 10.1016/0169-4758(91)90262-M; WHO, 2018, WORLD MAL REP 2018; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhang ZM, 2015, BIOCHIMIE, V108, P186, DOI 10.1016/j.biochi.2014.11.012; Zoungrana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001630; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	77	24	24	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14611	14624		10.1096/fj.201901741R	http://dx.doi.org/10.1096/fj.201901741R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690116	Green Published, hybrid			2022-12-26	WOS:000507466100119
J	D'Abramo, A; Lepore, L; Iannetta, M; Tekle, SG; Corpolongo, A; Scorzolini, L; Bevilacqua, N; Mariano, A; Giancola, ML; Vulcano, A; Maritti, M; Agresta, A; Antonini, M; D'Alessandro, U; Nicastri, E				D'Abramo, Alessandra; Lepore, Luciana; Iannetta, Marco; Tekle, Saba Gebremeskel; Corpolongo, Angela; Scorzolini, Laura; Bevilacqua, Nazario; Mariano, Andrea; Giancola, Maria Letizia; Vulcano, Antonella; Maritti, Micaela; Agresta, Alessandro; Antonini, Mario; D'Alessandro, Umberto; Nicastri, Emanuele		Spallanzani Grp Malaria Study	Imported severe malaria and risk factors for intensive care: A single-centre retrospective analysis	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; SCORE; ARTESUNATE; MORTALITY; QUININE; SEPSIS	Objectives This study aims to identify the risk factors for intensive care (IC) in severe malaria patients admitted to the "Lazzaro Spallanzani" National Institute for Infectious Diseases, Rome, Italy. Methods All patients with confirmed severe malaria and hospitalized between 2007 and 2015 were included in the analysis and stratified into two groups: those requiring IC and those who did not. Five prognostic malaria scores were estimated; clinical severity at IC unit admission was assessed using the Sequential Organ Failure Assessment and the quick-Sequential Organ Failure Assessment scores. Univariate and multivariate analysis were performed to assess factors independently associated to IC. Results A total of 98 severe malaria patients were included; 10 of them required IC. There were no deaths or sequelae. Patients requiring IC had higher severity scores. At the multivariate analysis, only the number of World Health Organization criteria and the aspartate aminotransferase value were independently associated with the need of IC. Conclusions An early and accurate assessment of the severity score is essential for the management of severe malaria patients.	[D'Abramo, Alessandra; Lepore, Luciana; Iannetta, Marco; Tekle, Saba Gebremeskel; Corpolongo, Angela; Scorzolini, Laura; Bevilacqua, Nazario; Mariano, Andrea; Giancola, Maria Letizia; Vulcano, Antonella; Maritti, Micaela; Agresta, Alessandro; Antonini, Mario; Nicastri, Emanuele] IRCCS Lazzaro Spallanzani, Natl Inst Infect Dis, Rome, Italy; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, MRC Unit Gambia, Atlantic Blvd, Fajara, Gambia	IRCCS Lazzaro Spallanzani; University of London; London School of Hygiene & Tropical Medicine	Iannetta, M (corresponding author), IRCCS Lazzaro Spallanzani, Natl Inst Infect Dis, Rome, Italy.	marco.iannetta@inmi.it	Scorzolini, Laura/AAC-7427-2022; MARITTI, MICAELA/AHD-4512-2022; Iannetta, Marco/M-4619-2019; D'Abramo, Alessandra/AAA-3054-2019; Iannetta, Marco/B-5596-2017; Di Caro, Antonino/K-6854-2016; Scognamiglio, Paola/B-4754-2017	MARITTI, MICAELA/0000-0003-0606-6353; Iannetta, Marco/0000-0002-6938-8627; D'Abramo, Alessandra/0000-0002-5160-9743; Iannetta, Marco/0000-0002-6938-8627; Lepore, Luciana/0000-0002-7965-8168; Di Caro, Antonino/0000-0001-6027-3009; Scognamiglio, Paola/0000-0002-7938-6457; Giancola, Maria Letizia/0000-0003-2481-6621	Ricerca Corrente and Ricerca finalizzata WFR [PE-2013-02357936]; Italian Ministry of Health	Ricerca Corrente and Ricerca finalizzata WFR; Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by Ricerca Corrente and Ricerca finalizzata WFR PE-2013-02357936 funded by the Italian Ministry of Health to EN.	Arama C, 2015, ACTA TROP, V146, P152, DOI 10.1016/j.actatropica.2015.03.023; Bruneel F., 2018, MED MAL INFECT; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 EM V; Faiz MA, 2005, LANCET, V366, P717; GREENBERG AE, 1990, ANN INTERN MED, V113, P326, DOI 10.7326/0003-4819-113-4-326; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Marks M, 2014, BRIT J ANAESTH, V113, P910, DOI 10.1093/bja/aeu157; Mishra SK, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-24; Mohapatra Biranchi Narayan, 2014, J Assoc Physicians India, V62, P14; Mohapatra M K, 2009, J Assoc Physicians India, V57, P119; SABATINELLI G, 1994, T ROY SOC TROP MED H, V88, P314, DOI 10.1016/0035-9203(94)90097-3; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Tatem AJ, 2017, LANCET INFECT DIS, V17, P98, DOI 10.1016/S1473-3099(16)30326-7; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WHO, 2015, WORLD MAL REP 2015; 2010, WORLD MAL REP 2010, P1	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225135	10.1371/journal.pone.0225135	http://dx.doi.org/10.1371/journal.pone.0225135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725774	Green Accepted, Green Published, gold			2022-12-26	WOS:000532764500059
J	Costa, F; Mateus, O				Costa, Francisco; Mateus, Octavio			Dacentrurine stegosaurs (Dinosauria): A new specimen of Miragaia longicollum from the Late Jurassic of Portugal resolves taxonomical validity and shows the occurrence of the Glade in North America	PLOS ONE			English	Article							CRETACEOUS TRANSITION; EVOLUTION; ORNITHISCHIA; PHYLOGENY; ATLANTIC; TERUEL	The stegosaur species Miragaia longicollum was erected based on a partial anterior skeleton from the Upper Jurassic of Portugal. Until then, almost all stegosaur specimens in Portugal and Spain had been identified as Dacentrurus armatus, the sister taxon of M. longicollum and only other member of the Glade Dacentrurinae. The holotypes of the two species have little overlap, since the holotype of D. armatus is mostly a posterior skeleton, so the classification of other specimens to either species is unclear and the validity of M. longicollum has been questioned and debated. Here we describe a largely complete specimen of M. longicollum discovered in 1959 in Atouguia da Baleia, Peniche, Portugal, consisting of both anterior and posterior portions of the skeleton. Comparisons to the holotypes of dacentrurines and other stegosaurs shed light on the convoluted relationships of this group. We conclude that M. longicollum is valid and rather different from D. armatus, and provide a revised diagnosis of M. longicollum, as well as revised diagnoses for D. armatus, Dacentrurinae, and the first diagnosis of the genus Miragaia, granting stability to these taxa and allowing new considerations to be given on the classification of other Iberian stegosaurs. This new specimen is, to date, the most complete dinosaur described from Portugal and the most complete stegosaur described from Europe. Miragaia shared anatomical features that show a close affinity to Alcovasaurus longispinus, confirming this to be the first known dacentrurine stegosaur in America, coherent with the hypothesis of an ephemeral land bridge between North America and Iberia that allowed faunal exchange.	[Costa, Francisco; Mateus, Octavio] Univ Nova Lisboa, Fac Ciencias & Tecnol, GeoBioTec, Caparica, Portugal; [Costa, Francisco; Mateus, Octavio] Museu Lourinha, Lourinha, Portugal	Universidade Nova de Lisboa	Costa, F (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, GeoBioTec, Caparica, Portugal.; Costa, F (corresponding author), Museu Lourinha, Lourinha, Portugal.	francisccostap@gmail.com	Mateus, Octávio/F-2910-2010	Mateus, Octávio/0000-0003-1253-3616; Costa Pinto, Francisco/0000-0002-8959-3708	Laboratorio Nacional de Energia e Geologia as part of the project "Investigacao da infraestrutura geologica e da base de recursos geologicos" [2/2016]	Laboratorio Nacional de Energia e Geologia as part of the project "Investigacao da infraestrutura geologica e da base de recursos geologicos"	FC received support to prepare in laboratory the specimen MG 4863 by a bachelor fellowship from Laboratorio Nacional de Energia e Geologia (www.LNEG.pt) as part of the project "Investigacao da infraestrutura geologica e da base de recursos geologicos" (Edital NO 2/2016). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; ATHERSTONE WG, 1857, E PROVINCE MONTHLY M, V1, P518; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; Bakker RT, 2014, GEOL SOC AM GSA ANN, V221; Brikiatis L, 2016, EARTH-SCI REV, V159, P47, DOI 10.1016/j.earscirev.2016.05.002; Brown B, 1908, B AMNH, V24; Buckland W., 1824, T GEOLOGICAL SOC LON, V1, P390, DOI DOI 10.1144/TRANSGSLB.1.2.390; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Camarate Franu║a, 1960, CARTA GEOLOGICA PORT, P1; Carpenter K, 2001, LIFE O PAST, P55; Carpenter K, 2005, LIFE O PAST, P325; Casanovas-Cladellas Ma Lourdes, 1999, Revista Espanola de Paleontologia, P57; Casanovas-Cladellas Maria Lourdes, 1995, Revista Espanola de Paleontologia, V10, P83; Casanovas-Cladellas ML, 1995, REV ESPANOLA PALEONT, P273; Casanovas-Cladellas ML, 1995, PALEONTOLOGIA EVOLUC, P269; Cobos A, 2009, S STEG SWITZ SCI M S, P2; Cobos A, 2008, 24 JORN SOC ESP PAL, P89; Cobos Alberto, 2013, Geogaceta, V53, P17; Cobos A, 2010, PALAEOGEOGR PALAEOCL, V293, P223, DOI 10.1016/j.palaeo.2010.05.024; Company J, 2010, J IBER GEOL, V36, P243, DOI 10.5209/rev_JIGE.2010.v36.n2.10; Costa F, 2017, 15 ENC JOPR INV PAL, P119; Dantas P, 1998, ACT 5 C NAC GEOL COM, V84, P91; de Lapparent AF, 1957, DINOSAURIENS PORTUGA; DONG Z.M., 1973, MEM I VERTEBR PALEON, V11, P45; DONG ZM, 1982, VERTEBRAT PALASIATIC, V20, P83; DONG ZM, 1977, VERTEBRAT PALASIATIC, V15, P307; Escaso F., 2007, CANTERA PALEONTOLOGI, P157; Escaso F., 2008, 24 JORN SOC ESP PAL, P107; Escaso F, 2007, NATURWISSENSCHAFTEN, V94, P367, DOI 10.1007/s00114-006-0209-8; Escaso F, 2011, J VERTEBR PALEONTOL, V31, P105; Farlow JO, 2010, SWISS J GEOSCI, V103, P173, DOI 10.1007/s00015-010-0021-5; Franca JC, 1961, CARTA GEOLOGICA PORT, P1; GALTON P M, 1981, Journal of Vertebrate Paleontology, V1, P245; Galton P.M., 1985, Journal of Vertebrate Paleontology, V5, P211; Galton P.M., 1982, Geologica et Palaeontologica, V15, P139; Galton P.M., 1988, Geologica et Palaeontologica, V22, P123; GALTON P M, 1980, Geobios (Villeurbanne), V13, P451, DOI 10.1016/S0016-6995(80)80081-7; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; Galton P.M., 1991, Geologica et Palaeontologica, V25, P299; GALTON P M, 1982, Journal of Vertebrate Paleontology, V2, P47; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P343; Galton PM, 2016, NEUES JAHRB GEOL P-A, V282, P1, DOI 10.1127/njgpa/2016/0603; Galton PM, 2016, NEUES JAHRB GEOL P-A, V279, P185, DOI 10.1127/njgpa/2016/0551; Gilmore C.W., 1914, US NATL MUSEUM B, V89, P1136, DOI DOI 10.5962/BHL.TITLE.63658; Guillaume A, 2019, CIENCIAS TERRA; Hennig, 1925, PALAEONTOGRAPHICA S, V7, P101; Hennig E., 1915, SITZUNGSBERICHTE NAT, V1915, P219; Hennig E., 1936, SCHWEIZERBARTSCHE VE, P309; JENSEN JA, 1985, GREAT BASIN NAT, V45, P697; Leidy, 1856, P ACAD NAT SCI PHILA, V8, P255; Lockley Martin, 2008, Oryctos, V8, P53; Lucas FA, 1902, SCIENCE, V16, P669, DOI 10.1126/science.16.408.669; Lydekker R, 1890, BRIT MUSEUM NATURAL, P294; Maidment SCR, 2006, GEOL MAG, V143, P621, DOI 10.1017/S0016756806002500; Maidment SCR, 2018, J VERTEBR PALEONTOL, V38, DOI 10.1080/02724634.2017.1406366; Maidment SCR, 2010, SWISS J GEOSCI, V103, P199, DOI 10.1007/s00015-010-0023-3; Maidment SCR, 2008, J SYST PALAEONTOL, V6, P367, DOI 10.1017/S1477201908002459; Maidment SCR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138352; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; Mallison H, 2011, PALAEONTOL ELECTRON, V14; Mallison H, 2010, SWISS J GEOSCI, V103, P211, DOI 10.1007/s00015-010-0024-2; Mantell GA., 1848, PHILOS T ROY SOC LON, VCXXXVIII, P183, DOI [10.1098/rstl.1848.0013, DOI 10.1098/RSTL.1848.0013]; Manuppella G., 1996, CARTA GEOLOGICA PORT; Marsh O. C., 1887, American Journal of Science (3), Vxxxiv, P413; Marsh O. C., 1884, American Journal of Science, V(3), P329; Marsh O. C., 1877, AM J SCI, V14, P34; Marsh O.C., 1879, AM J SCI, V3, P501; Marsh O. C, 1880, AM J SCI, V19, P253; Marsh OC., 1877, AM J SCI, V3, P514, DOI DOI 10.2475/AJS.S3-14.84.514; Mateus O., 2006, N MEX MUS NAT HIST S, V36, P223; Mateus O, 2008, 3 C LAT PAL VERT NEU, P157; Mateus O., 2017, CIENCIAS TERRA, V19, P75; Mateus O, 2006, PALEONTOLOGY GEOLOGY, V36, P123; Mateus O., 2016, SALT LATE CITY J VER, P185; Mateus O., 2005, THESIS; Mateus O, 2011, ACTA PALAEONTOL POL, V56, P651, DOI 10.4202/app.2009.0055; Mateus O, 2010, LETHAIA, V43, P245, DOI 10.1111/j.1502-3931.2009.00190.x; Mateus O, 2009, P ROY SOC B-BIOL SCI, V276, P1815, DOI 10.1098/rspb.2008.1909; Mateus S O, 2008, ORYCTOS, V8, P47; McWhinney LA, 2001, LIFE O PAST, P141; Mocho P, 2014, ZOOL J LINN SOC-LOND, V170, P875, DOI 10.1111/zoj.12113; Mota TSA, 2007, THESIS; NOPCSA F, 1911, B SOC GEOLOGIQUE NOR, V30, P23; Nopesa F., 1915, Jahrb Kgl Ungar Geol Reich Budapest, V23, P1; OLSHEVSKY G., 1993, DINO FRONTLINE, V4, P64; Ortega F., 2009, PALEOLUSITANA, V1, P43; Ostrom JA, 1999, COLLECTIONS COMO BLU; Ouyang H., 1992, SUMM YOUTH AC S NEW, V47; Owen, 1877, MONOGRAPHS PALAEONTO, V31, P95; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Owen R., 1861, MONOGRAPHS PALAEONTO, V13, P1; Owen R., 1875, MONOGRAPH FOSSIL REP; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Pereda Suberbiola X., 2005, Geogaceta, V38, P35; Pereda Suberbiola X., 2003, ESTUD GEOL-MADRID, V55, P267; Raven T, 2018, ALBUQUERQUE J VERTEB, P201; Raven T, 2016, PALAEONTOL NEWSL, V93, P64; Raven TJ, 2017, PALAEONTOLOGY, V60, P401, DOI 10.1111/pala.12291; Romer A, 1956, OSTEOLOGY REPTILES; Ruiz-Omenaca JI, 2000, RESTOS DINOSAURIOS S, V19, P39; Ruiz-Omenaca JI, 2013, 1 EVIDENCE STEGOSAUR; Saitta ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123503; Salminen J, 2014, SPR GEOL, P873, DOI 10.1007/978-3-319-04364-7_165; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 1992, J VERTEBR PALEONTOL, V12, P318, DOI 10.1080/02724634.1992.10011463; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 1998, NEUES JB GEOLOGIE PA, V10, P41; Suberbiola XP, 2005, NEUES JAHRB GEOL P-A, V235, P175; Ulanksy R. E, 2014, DINOLOGIA, P1; Ulansky RE, 2014, NATRONASAURUS LONGIS, P1; Zbyszewski G, 1955, CARTA GEOLOGICA PORT, P1; Zbyszewski G., 1946, COMUNICACOES SERVICO, V28, P135; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1	113	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224263	10.1371/journal.pone.0224263	http://dx.doi.org/10.1371/journal.pone.0224263			124	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721771	gold, Green Published, Green Submitted			2022-12-26	WOS:000532720700016
J	Nigwekar, SU; Pai, AB; Mueller, B; Dean, MC; Costello, G; Sherman, CR				Nigwekar, Sagar U.; Pai, Amy Barton; Mueller, Bruce; Dean, Michael C.; Costello, Gabrielle; Sherman, Craig R.			Impact of hemodialysis on the concentrations of sodium and potassium during infusion of sodium thiosulfate using an In Vitro hemodialysis model	PLOS ONE			English	Article							CALCIPHYLAXIS; BLOOD	Introduction The purpose of this study was to evaluate the impact of hemodialysis on the concentrations of sodium and potassium in the blood when a 25 g dose of sodium thiosulfate injection is infused over 60 minutes in combination with hemodialysis. Methods Sodium thiosulfate (25 g) was prepared by diluting 100 mL of 250 mg/mL Sodium Thiosulfate Injection with 800 mL of 5% dextrose. This was added to the circulating blood surrogate solution at a rate of 15 mL/minute using an infusion pump of an in vitro model of dialysis machine. Serial samples were collected before the administration of the sodium thiosulfate solution, after 15 minutes, 30 minutes, and 60 minutes of infusion from pre-and post-dialyzer ports in both the dialysate circuit and the extracorporeal circuit. Findings The concentration of sodium thiosulfate in pre-dialyzer and post-dialyzer samples of the circulating blood surrogate solution peaked at 30 minutes and 15 minutes, respectively and then remained relatively unchanged during the remainder of the infusion. Mean sodium concentrations (mEq/L) in the circulating blood surrogate solution collected after exposure to a dialyzer were 103.2 +/- 12.2, 114.2 +/- 18.8, 117.2 +/- 7.5, 93.5 +/- 5.9 at 0, 15, 30, and 60 minutes, respectively (p = 0.248). Mean potassium concentrations (mEq/L) in the circulating blood surrogate solution collected after exposure to a dialyzer were 1.4 +/- 0.3, 1.6 +/- 0.3, 1.5 +/- 0.1, 1.2 +/- 0.1 at 0, 15, 30, and 60 minutes, respectively (p = 0.365). Sodium and potassium concentrations in dialysate increased marginally after exposure to the dialyzer. Discussion Our study demonstrates that neither potassium nor sodium accumulated in circulating blood surrogate solution when a dose of sodium thiosulfate was infused in conjunction with hemodialysis.	[Nigwekar, Sagar U.] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Pai, Amy Barton; Mueller, Bruce; Dean, Michael C.; Costello, Gabrielle] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA; [Sherman, Craig R.] Hope Pharmaceut, Scottsdale, AZ 85260 USA	Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan	Sherman, CR (corresponding author), Hope Pharmaceut, Scottsdale, AZ 85260 USA.	sherman@hopepharm.com	Dean, Michael C/G-8172-2012	Dean, Michael C/0000-0003-2234-0631; Dean, Michael/0000-0002-4753-2114	Hope Pharmaceuticals	Hope Pharmaceuticals	This work was funded by the Hope Pharmaceuticals. The funder provided support in the form of salaries for author CRS. CRS played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cicone JS, 2004, AM J KIDNEY DIS, V43, P1104, DOI 10.1053/j.ajkd.2004.03.018; Gharibian KN, 2018, J NUCL CARDIOL, V25, P234, DOI 10.1007/s12350-016-0667-0; Hundemer GL, 2016, AM J KIDNEY DIS, V68, P499, DOI 10.1053/j.ajkd.2016.02.040; Kales SN, 2004, NEW ENGL J MED, V350, P800, DOI 10.1056/NEJMra030370; MICHAEL JM, 1975, TRANSFUSION, V15, P144; Morocco AP, 2005, CRIT CARE CLIN, V21, P691, DOI 10.1016/j.ccc.2005.06.002; Nigwekar SU, 2018, NEW ENGL J MED, V378, P1704, DOI 10.1056/NEJMra1505292; Nigwekar SU, 2013, CLIN J AM SOC NEPHRO, V8, P1162, DOI 10.2215/CJN.09880912; Noureddine L, 2011, CLIN NEPHROL, V75, P485, DOI 10.5414/CNP75485; Pani A, 2014, SEMIN DIALYSIS, V27, P571, DOI 10.1111/sdi.12272; Peng T, 2018, NEPHROLOGY, V23, P669, DOI 10.1111/nep.13081; Singh RP, 2011, CLIN J AM SOC NEPHRO, V6, P1155, DOI 10.2215/CJN.09671010; Tanhehco YC, 2012, SEMIN DIALYSIS, V25, P539, DOI 10.1111/j.1525-139X.2012.01089.x; Zitt E, 2013, NEPHROL DIAL TRANSPL, V28, P1232, DOI 10.1093/ndt/gfs548	14	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224767	10.1371/journal.pone.0224767	http://dx.doi.org/10.1371/journal.pone.0224767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721800	Green Submitted, gold, Green Published			2022-12-26	WOS:000532720700029
J	Mahallati, S; Bezdek, JC; Popovic, MR; Valiante, TA				Mahallati, Sara; Bezdek, James C.; Popovic, Milos R.; Valiante, Taufik A.			Cluster tendency assessment in neuronal spike data	PLOS ONE			English	Article							VISUAL ASSESSMENT; RECORDINGS	Sorting spikes from extracellular recording into clusters associated with distinct single units (putative neurons) is a fundamental step in analyzing neuronal populations. Such spike sorting is intrinsically unsupervised, as the number of neurons are not known a priori. Therefor, any spike sorting is an unsupervised learning problem that requires either of the two approaches: specification of a fixed value k for the number of clusters to seek, or generation of candidate partitions for several possible values of c, followed by selection of a best candidate based on various post-clustering validation criteria. In this paper, we investigate the first approach and evaluate the utility of several methods for providing lower dimensional visualization of the cluster structure and on subsequent spike clustering. We also introduce a visualization technique called improved visual assessment of cluster tendency (iVAT) to estimate possible cluster structures in data without the need for dimensionality reduction. Experimental results are conducted on two datasets with ground truth labels. In data with a relatively small number of clusters, iVAT is beneficial in estimating the number of clusters to inform the initialization of clustering algorithms. With larger numbers of clusters, iVAT gives a useful estimate of the coarse cluster structure but sometimes fails to indicate the presumptive number of clusters. We show that noise associated with recording extracellular neuronal potentials can disrupt computational clustering schemes, highlighting the benefit of probabilistic clustering models. Our results show that t-Distributed Stochastic Neighbor Embedding (t-SNE) provides representations of the data that yield more accurate visualization of potential cluster structure to inform the clustering stage. Moreover, The clusters obtained using t-SNE features were more reliable than the clusters obtained using the other methods, which indicates that t-SNE can potentially be used for both visualization and to extract features to be used by any clustering algorithm.	[Mahallati, Sara; Popovic, Milos R.; Valiante, Taufik A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Mahallati, Sara; Popovic, Milos R.] Univ Hlth Network, KITE Res Inst, Toronto, ON, Canada; [Mahallati, Sara; Valiante, Taufik A.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Bezdek, James C.] Univ Melbourne, Comp Sci & Informat Syst Dept, Melbourne, Vic, Australia; [Valiante, Taufik A.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Mahallati, Sara; Popovic, Milos R.; Valiante, Taufik A.] Univ Hlth Network, CRANIA, Toronto, ON, Canada; [Mahallati, Sara; Popovic, Milos R.; Valiante, Taufik A.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Melbourne; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Mahallati, S (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Mahallati, S (corresponding author), Univ Hlth Network, KITE Res Inst, Toronto, ON, Canada.; Mahallati, S (corresponding author), Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada.; Mahallati, S (corresponding author), Univ Hlth Network, CRANIA, Toronto, ON, Canada.; Mahallati, S (corresponding author), Univ Toronto, Toronto, ON, Canada.	sara.mahallati@mail.utoronto.ca	Valiante, Taufik A/C-3285-2015	Valiante, Taufik A/0000-0002-3443-3790	Natural Sciences and Engineering Research Council of Canada; Canadian Fund For Innovation and Natural Sciences and Engineering Research Council [RGPIN-2016-06358]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Fund For Innovation and Natural Sciences and Engineering Research Council	This research was supported by the Natural Sciences and Engineering Research Council of Canada. MRP was funded by Dean Connor and Maris Uffelmann Donation, Canadian Fund For Innovation and Natural Sciences and Engineering Research Council: Discovery Grant (RGPIN-2016-06358).	ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; Akam T, 2014, NAT REV NEUROSCI, V15, P111, DOI 10.1038/nrn3668; Aksenova TI, 2003, METHODS, V30, P178, DOI 10.1016/S1046-2023(03)00079-3; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Armananzas R, 2015, TRENDS NEUROSCI, V38, P307, DOI 10.1016/j.tins.2015.02.004; Bezdek JC, 2002, IEEE IJCNN, P2225, DOI 10.1109/IJCNN.2002.1007487; Bezdek JC, 1998, IEEE T SYST MAN CY B, V28, P301, DOI 10.1109/3477.678624; Bezdek JC., 2017, PRIMER CLUSTER ANAL; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Campadelli P, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/759567; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Dayan P, 2001, THEORETICAL NEUROSCI, P432; Dehghani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23176; Dimitriadis G, 2016, T SNE VISUALIZATION; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Fisher R.A., 1958, STAT METHODS RES WOR; Fournier J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160494; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2016, NAT NEUROSCI, V19, P1165, DOI 10.1038/nn.4365; Hattori S, 2015, HIPPOCAMPUS, V25, P655, DOI 10.1002/hipo.22401; Havens TC, 2012, IEEE T KNOWL DATA EN, V24, P813, DOI 10.1109/TKDE.2011.33; Havens TC, 2009, ANN MATH ARTIF INTEL, V55, P237, DOI 10.1007/s10472-009-9157-2; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0199340; Jorgenson LA, 2015, PHILOS T R SOC B, V370, P8, DOI 10.1098/rstb.2014.0164; Kumar D, 2017, VISUAL COMPUT, V33, P265, DOI 10.1007/s00371-015-1192-x; Kumar D, 2016, IEEE T CYBERNETICS, V46, P2372, DOI 10.1109/TCYB.2015.2477416; Lei Y, 2017, PATTERN RECOGN, V65, P58, DOI 10.1016/j.patcog.2016.12.003; Mahallati S, 2018, CLUSTER TENDENCY ASS; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mostaghim S, 2018, STUD COMPUT INTELL, V739, P73, DOI 10.1007/978-3-319-67789-7_6; Negi SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00952-9; Niediek J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166598; Pachitariu M, 2016, KILOSORT REALTIME SP; Paralikar KJ, 2009, J NEUROSCI METH, V181, P27, DOI 10.1016/j.jneumeth.2009.04.014; Pazienti A, 2006, J COMPUT NEUROSCI, V21, P329, DOI 10.1007/s10827-006-8899-7; Pedreira C, 2012, J NEUROSCI METH, V211, P58, DOI 10.1016/j.jneumeth.2012.07.010; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Ratha P., 2018, INT S CONS MAN TROP, P1; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Rossant C, 2016, NAT NEUROSCI, V19, P634, DOI 10.1038/nn.4268; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Takahashi S, 2003, J NEUROPHYSIOL, V89, P2245, DOI 10.1152/jn.00827.2002; Takekawa T, 2014, EUR J NEUROSCI, V39, P1943, DOI 10.1111/ejn.12614; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Todorova S, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056005; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Van Der Maaten L., 2009, J MACH LEARN RES, V10, P66, DOI DOI 10.1080/13506280444000102; van der Maaten L, 2014, J MACH LEARN RES, V15, P3221; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; Vega-Pons S, 2011, INT J PATTERN RECOGN, V25, P337, DOI 10.1142/S0218001411008683; Vendramin Lucas, 2010, Statistical Analysis and Data Mining, V3, P209, DOI 10.1002/sam.10080; Ventura V, 2012, P NATL ACAD SCI USA, V109, P7230, DOI 10.1073/pnas.1115236109; Wouters J, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aace8a; Yger P, 2016, FAST ACCURATE SPIKE; Zhao Z, 2013, IEEE T KNOWL DATA EN, V25, P619, DOI 10.1109/TKDE.2011.222; Zuo YF, 2015, CURR BIOL, V25, P357, DOI 10.1016/j.cub.2014.11.065	69	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224547	10.1371/journal.pone.0224547	http://dx.doi.org/10.1371/journal.pone.0224547			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714913	Green Published, Green Submitted, gold			2022-12-26	WOS:000532710400009
J	Bessonov, N; Pinna, G; Minarsky, A; Harel-Bellan, A; Morozova, N				Bessonov, Nikolay; Pinna, Guillaume; Minarsky, Andrey; Harel-Bellan, Annick; Morozova, Nadya			Mathematical modeling reveals the factors involved in the phenomena of cancer stem cells stabilization	PLOS ONE			English	Article							SELF-RENEWAL; TUMOR-SUPPRESSOR; BIMODAL SWITCH; DIVISION; LINEAGES; IDENTIFICATION; TRANSITIONS; TARGETS; NOTCH	Cancer Stem Cells (CSC), a subset of cancer cells resembling normal stem cells with self-renewal and asymmetric division capabilities, are present at various but low proportions in many tumors and are thought to be responsible for tumor relapses following conventional cancer therapies. In vitro, most intriguingly, isolated CSCs rapidly regenerate the original population of stem and non-stem cells (non-CSCs) as shown by various investigators. This phenomenon still remains to be explained. We propose a mathematical model of cancer cell population dynamics, based on the main parameters of cell population growth, including the proliferation rates, the rates of cell death and the frequency of symmetric and asymmetric cell divisions both in CSCs and non-CSCs sub-populations, and taking into account the stabilization phenomenon. The analysis of the model allows determination of time-varying corridors of probabilities for different cell fates, given the particular dynamics of cancer cells populations; and determination of a cell-cell communication factors influencing these time-varying probabilities of cell behavior (division, transition) scenarios. Though the results of the model have to be experimentally confirmed, we can anticipate the development of several fundamental and practical applications based on the theoretical results of the model.	[Bessonov, Nikolay] Russian Acad Sci, Inst Problems Mech Engn, St Petersburg, Russia; [Pinna, Guillaume; Harel-Bellan, Annick; Morozova, Nadya] Univ Paris Sud, Univ Paris Saclay, Inst Integrat Biol Cell I2BC, CNRS,CEA, Gif Sur Yvette, France; [Minarsky, Andrey] St Petersburg Acad Univ, Russian Acad Sci, St Petersburg, Russia; [Harel-Bellan, Annick; Morozova, Nadya] Inst Hautes Etud Sci IHES, Bures Sur Yvette, France	Russian Academy of Sciences; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University	Morozova, N (corresponding author), Univ Paris Sud, Univ Paris Saclay, Inst Integrat Biol Cell I2BC, CNRS,CEA, Gif Sur Yvette, France.; Morozova, N (corresponding author), Inst Hautes Etud Sci IHES, Bures Sur Yvette, France.	morozova@ihes.fr		Harel-Bellan, Annick/0000-0002-2339-153X	IHES (Institut des Hautes Etudes Scientiques, France) program on mathematical biology (Simons foundation); Ministry of Science and Higher Education of Russian Federation	IHES (Institut des Hautes Etudes Scientiques, France) program on mathematical biology (Simons foundation); Ministry of Science and Higher Education of Russian Federation	The work of N. Bessonov and A. Minarsky was supported by IHES (Institut des Hautes Etudes Scientiques, France) program on mathematical biology (Simons foundation). The work of A. Minarsky was supported by Ministry of Science and Higher Education of Russian Federation (assignment 1.9788.2017/BCh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian V, 2012, CYTOM PART A, V81A, P382, DOI 10.1002/cyto.a.22031; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beretta E, 2012, MATH MODEL NAT PHENO, V7, P279, DOI 10.1051/mmnp/20127113; Beretta E, 2012, SIMAI SPRINGER SERIE; Bu PC, 2013, CELL STEM CELL, V12, P602, DOI 10.1016/j.stem.2013.03.002; Buss EC, 2011, INT J CANCER, V129, P2328, DOI 10.1002/ijc.26318; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Charafe-Jauffret E, 2013, CANCER RES, V73, P7290, DOI 10.1158/0008-5472.CAN-12-4704; Chen SY, 2011, CELL TRANSPLANT, V20, P113, DOI 10.3727/096368910X532837; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Craig M, 2016, B MATH BIOL, V78, P2304, DOI 10.1007/s11538-016-0179-8; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; d'Onofrio A, 2018, PHYSICA A, V492, P2056, DOI 10.1016/j.physa.2017.11.123; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; El Helou R, 2017, CELL REP, V18, P2256, DOI 10.1016/j.celrep.2017.02.016; Enderling H, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00076; Fathi E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215678; Ginestier C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1741; Goldman A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7139; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Komarova NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072847; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Loeffler M, 2004, CURR OPIN HEMATOL, V11, P81, DOI 10.1097/01.moh.0000133648.83991.af; Lutz C, 2013, CANCER LETT, V338, P10, DOI 10.1016/j.canlet.2012.07.014; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Poleszczuk J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004025; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roeder I, 2009, B MATH BIOL, V71, P602, DOI 10.1007/s11538-008-9373-7; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Stiehl T, 2012, MATH MODEL NAT PHENO, V7, P166, DOI 10.1051/mmnp/20127199; Stiehl T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21115-4; Stiehl T, 2015, CANCER RES, V75, P940, DOI 10.1158/0008-5472.CAN-14-2508; Stiehl T, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0079; Taube JH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02687; Theise ND, 2004, BLOOD CELL MOL DIS, V32, P17, DOI 10.1016/j.bcmd.2003.09.010; Theise ND, 2004, EXP HEMATOL, V32, P25, DOI 10.1016/j.exphem.2003.10.012; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Wang H, 2014, J CLIN INVEST, V124, P4489, DOI 10.1172/JCI75284; Werner B, 2016, CANCER RES, V76, P1705, DOI 10.1158/0008-5472.CAN-15-2069; Yang J, 2017, J THEOR BIOL, V429, P190, DOI 10.1016/j.jtbi.2017.06.033; Yang JN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004629; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhou F, 2013, DEV BIOL, V373, P383, DOI 10.1016/j.ydbio.2012.10.023	57	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224787	10.1371/journal.pone.0224787	http://dx.doi.org/10.1371/journal.pone.0224787			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710617	gold, Green Published, Green Submitted			2022-12-26	WOS:000532699900020
J	Vazquez-Munoz, R; Meza-Villezcas, A; Fournier, PGJ; Soria-Castro, E; Juarez-Moreno, K; Gallego-Hernandez, AL; Bogdanchikova, N; Vazquez-Duhalt, R; Huerta-Saquero, A				Vazquez-Munoz, R.; Meza-Villezcas, A.; Fournier, P. G. J.; Soria-Castro, E.; Juarez-Moreno, K.; Gallego-Hernandez, A. L.; Bogdanchikova, N.; Vazquez-Duhalt, R.; Huerta-Saquero, A.			Enhancement of antibiotics antimicrobial activity due to the silver nanoparticles impact on the cell membrane	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ACTIVITY; INFECTIOUS-DISEASES; RESISTANCE; TOXICITY; COMBAT	The ability of microorganisms to generate resistance outcompetes with the generation of new and efficient antibiotics; therefore, it is critical to develop novel antibiotic agents and treatments to control bacterial infections. An alternative to this worldwide problem is the use of nanomaterials with antimicrobial properties. Silver nanoparticles (AgNPs) have been extensively studied due to their antimicrobial effect in different organisms. In this work, the synergistic antimicrobial effect of AgNPs and conventional antibiotics was assessed in Gram-positive and Gram-negative bacteria. AgNPs minimal inhibitory concentration was 10-12 mu g mL(-1) in all bacterial strains tested, regardless of their different susceptibility against antibiotics. Interestingly, a synergistic antimicrobial effect was observed when combining AgNPs and kanamycin according to the fractional inhibitory concentration index, FICI: <0.5), an additive effect by combining AgNPs and chloramphenicol (FICI: 0.5 to 1), whereas no effect was found with AgNPs and beta-lactam antibiotics combinations. Flow cytometry and TEM analysis showed that sublethal concentrations of AgNPs (6-7 mu g mL(-1)) altered the bacterial membrane potential and caused ultrastructural damage, increasing the cell membrane permeability. No chemical interactions between AgNPs and antibiotics were detected. We propose an experimental supported mechanism of action by which combinatorial effect of antimicrobials drives synergy depending on their specific target, facilitated by membrane alterations generated by AgNPs. Our results provide a deeper understanding about the synergistic mechanism of AgNPs and antibiotics, aiming to combat antimicrobial infections efficiently, especially those by multi-drug resistant microorganisms, in order to mitigate the current crisis due to antibiotic resistance.	[Vazquez-Munoz, R.; Meza-Villezcas, A.; Juarez-Moreno, K.; Bogdanchikova, N.; Vazquez-Duhalt, R.; Huerta-Saquero, A.] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico; [Vazquez-Munoz, R.; Meza-Villezcas, A.; Fournier, P. G. J.] Ctr Invest Cient & Educ Super Ensenada, Ensenada, Baja California, Mexico; [Soria-Castro, E.] Inst Nacl Cardiol Ignacio Chavez, Ciudad De Mexico, Mexico; [Gallego-Hernandez, A. L.] Univ Sonora, Dept Invest Fis, Hermosillo, Sonora, Mexico	Universidad Nacional Autonoma de Mexico; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; National Institute of Cardiology - Mexico; Universidad de Sonora	Huerta-Saquero, A (corresponding author), Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico.	saquero@cnyn.unam.mx	Juarez-Moreno, Karla Oyuky/E-2730-2016; Vazquez Muñoz, Roberto/C-7966-2018; Vazquez-Duhalt, Rafael/AGO-6764-2022; Saquero, Alejandro Huerta/E-2734-2016; Fournier, Pierrick/B-6560-2015; Bogdanchikova, Nina/ABE-4576-2020	Juarez-Moreno, Karla Oyuky/0000-0002-6171-8601; Vazquez Muñoz, Roberto/0000-0002-3847-1305; Vazquez-Duhalt, Rafael/0000-0003-1612-2996; Saquero, Alejandro Huerta/0000-0002-0156-6773; Fournier, Pierrick/0000-0001-7633-8129; Gallego-Hernandez, Ana L./0000-0001-7818-2244; Meza-Villezcas, Anaid/0000-0003-4993-3656; Bogdanchikova, Nina/0000-0003-0929-3535	DGAPA-UNAM [IN210618]; CONACyT [284385, 269071]; Bionanotechnology International Network	DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Bionanotechnology International Network	This work was supported by AHS: DGAPA-UNAM [Grant No. IN210618] and CONACyT [Grant No. 284385]; KOJM: CONACyT [Grant No. 269071]; and NB: Bionanotechnology International Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari M. A., 2011, Biology and Medicine, V3, P141; Bharadwaj R., 2003, Indian Journal of Pharmacology, V35, P220; Borrego B, 2016, NANOMED-NANOTECHNOL, V12, P1185, DOI 10.1016/j.nano.2016.01.021; Cassell GH, 2001, JAMA-J AM MED ASSOC, V285, P601, DOI 10.1001/jama.285.5.601; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Cui L, 2013, ANAL CHEM, V85, P5436, DOI 10.1021/ac400245j; Dakal TC, 2016, FRONT MICROBIOL, V7, DOI 10.7389/fmicb.2016.01831; de Souza A, 2006, CURR SCI INDIA, V91, P926; Deng H, 2016, ENVIRON SCI TECHNOL, V50, P8840, DOI 10.1021/acs.est.6b00998; Dilnawaz F, 2018, INT J PHARMACEUT, V538, P263, DOI 10.1016/j.ijpharm.2018.01.016; Done HY, 2015, J HAZARD MATER, V282, P10, DOI 10.1016/j.jhazmat.2014.08.075; Duran N, 2016, NANOMED-NANOTECHNOL, V12, P789, DOI 10.1016/j.nano.2015.11.016; Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426; Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; Fonkwo PN, 2008, EMBO REP, V9, pS13, DOI 10.1038/embor.2008.110; Fothergill AW, 2012, INTERACTIONS OF YEASTS, MOULDS, AND ANTIFUNGAL AGENTS: HOW TO DETECT RESISTANCE, P65, DOI 10.1007/978-1-59745-134-5_2; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Juarez-Moreno K, 2017, HUM EXP TOXICOL, V36, P931, DOI 10.1177/0960327116675206; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kora AJ, 2013, BIOINORG CHEM APPL, V2013, DOI 10.1155/2013/871097; Lara HH, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-30; Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Liu XY, 2019, J INORG BIOCHEM, V196, DOI 10.1016/j.jinorgbio.2019.04.001; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; NCCLS, 2007, PERF STAND ANT SUSP; Novo DJ, 2000, ANTIMICROB AGENTS CH, V44, P827, DOI 10.1128/AAC.44.4.827-834.2000; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Panacek A, 2016, COLLOID SURFACE B, V142, P392, DOI 10.1016/j.colsurfb.2016.03.007; Panacek A, 2016, MOLECULES, V21, DOI 10.3390/molecules21010026; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Paphitou NI, 2013, INT J ANTIMICROB AG, V42, pS25, DOI 10.1016/j.ijantimicag.2013.04.007; Paul P, 2018, ARTIF CELL NANOMED B, V46, pS572, DOI 10.1080/21691401.2018.1503598; Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011; Romero-Urbina DG, 2015, BEILSTEIN J NANOTECH, V6, P2396, DOI 10.3762/bjnano.6.246; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Rudramurthy GR, 2016, MOLECULES, V21, DOI 10.3390/molecules21070836; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Sharma D, 2019, ARAB J CHEM, V12, P3576, DOI 10.1016/j.arabjc.2015.11.002; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Taubes G, 2008, SCIENCE, V321; Vazquez-Munoz R, 2017, TOXICOL LETT, V276, P11, DOI 10.1016/j.toxlet.2017.05.007; Vazquez-Munoz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108876; Weissig V, 2014, INT J NANOMED, V9, P4357, DOI 10.2147/IJN.S46900; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xu HY, 2012, BIOMETALS, V25, P45, DOI 10.1007/s10534-011-9482-x; Yang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep18583	51	94	95	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224904	10.1371/journal.pone.0224904	http://dx.doi.org/10.1371/journal.pone.0224904			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703098	Green Published, Green Submitted, gold			2022-12-26	WOS:000532697200032
J	Abecassis, J; Hamy, AS; Laurent, C; Sadacca, B; Bonsang-Kitzis, H; Reyal, F; Vert, JP				Abecassis, Judith; Hamy, Anne-Sophie; Laurent, Cecile; Sadacca, Benjamin; Bonsang-Kitzis, Helene; Reyal, Fabien; Vert, Jean-Philippe			Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data	PLOS ONE			English	Article							CLONAL EVOLUTION; SURVIVAL ANALYSIS; CANCER; SELECTION; MODEL	Tumors are made of evolving and heterogeneous populations of cells which arise from successive appearance and expansion of subclonal populations, following acquisition of mutations conferring them a selective advantage. Those subclonal populations can be sensitive or resistant to different treatments, and provide information about tumor aetiology and future evolution. Hence, it is important to be able to assess the level of heterogeneity of tumors with high reliability for clinical applications. In the past few years, a large number of methods have been proposed to estimate intra-tumor heterogeneity from whole exome sequencing (WES) data, but the accuracy and robustness of these methods on real data remains elusive. Here we systematically apply and compare 6 computational methods to estimate tumor heterogeneity on 1,697 WES samples from the cancer genome atlas (TCGA) covering 3 cancer types (breast invasive carcinoma, bladder urothelial carcinoma, and head and neck squamous cell carcinoma), and two distinct input mutation sets. We observe significant differences between the estimates produced by different methods, and identify several likely confounding factors in heterogeneity assessment for the different methods. We further show that the prognostic value of tumor heterogeneity for survival prediction is limited in those datasets, and find no evidence that it improves over prognosis based on other clinical variables. In conclusion, heterogeneity inference from WES data on a single sample, and its use in cancer prognosis, should be considered with caution. Other approaches to assess intra-tumoral heterogeneity such as those based on multiple samples may be preferable for clinical applications.	[Abecassis, Judith; Hamy, Anne-Sophie; Laurent, Cecile; Sadacca, Benjamin; Bonsang-Kitzis, Helene; Reyal, Fabien] PSL Res Univ, Inst Curie, INSERM,RT2Lab,U932,Immun & Canc, Translat Res Dept,Residual Tumor & Response Treat, Paris, France; [Abecassis, Judith; Vert, Jean-Philippe] PSL Res Univ, MINES ParisTech, CBIO Ctr Computat Biol, Paris, France; [Abecassis, Judith] PSL Res Univ, Inst Curie, INSERM, U900, Paris, France; [Sadacca, Benjamin] Univ Toulouse, CNRS UPS IMT, UMR5219, Inst Math Toulouse, Toulouse, France; [Bonsang-Kitzis, Helene; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Vert, Jean-Philippe] Google Brain, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Toulouse; Universite Toulouse 1 Capitole; Universite Toulouse III - Paul Sabatier; Universite de Toulouse - Jean Jaures; Institut National des Sciences Appliquees de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Vert, JP (corresponding author), PSL Res Univ, MINES ParisTech, CBIO Ctr Computat Biol, Paris, France.; Vert, JP (corresponding author), Google Brain, Paris, France.	jpvert@google.com		Laurent, Cecile/0000-0002-3022-2283; Vert, Jean-Philippe/0000-0001-9510-8441	TCGA Research Network [10569]	TCGA Research Network	We thank Peter Van Loo and Kerstin Haase for sharing ASCAT results on the TCGA, and Christoffer Flensburg for his help with the liftover of ASCAT results. We thank Niko Beerenwickel for help with single-cell data analysis, and Elodie Girard for her help with NGS data processing. We also thank Alice Schoenauer Sebag for helpful discussions. The results shown here are based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/, under authorization for project 10569 (dbGaP).	Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhandari V, 2018, BIORXIV; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Caravagna G, 2019, MODEL BASED TUMOR SU, P1; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciccolella S., 2018, BIORXIV; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Cross WCH, 2016, J PATHOL, V240, P126, DOI 10.1002/path.4757; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; Dentro SC, 2018, BIORXIV; Dentro SC, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026625; Deshwar AG, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0602-8; Eaton J, 2018, BIOINFORMATICS, V34, P357, DOI 10.1093/bioinformatics/bty270; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gao Bo, 2018, F1000Res, V7, P319, DOI 10.12688/f1000research.14148.1; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gawad C, 2014, P NATL ACAD SCI USA, V111, P17947, DOI 10.1073/pnas.1420822111; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerstung M., 2017, BIORXIV; Institute B, PIC TOOLS; Jahn K, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0936-x; Karn T, 2017, JAMA ONCOL, V3, P1707, DOI 10.1001/jamaoncol.2017.2140; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kim C, 2018, CELL, V173, P879, DOI 10.1016/j.cell.2018.03.041; Leung ML, 2017, GENOME RES, V27, P1287, DOI 10.1101/gr.209973.116; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maley CC, 2017, NAT REV CANCER, V17, P605, DOI 10.1038/nrc.2017.69; Malikic S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10737-5; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Morris LGT, 2016, ONCOTARGET, V7, P10051, DOI 10.18632/oncotarget.7067; Mroz EA, 2013, ORAL ONCOL, V49, P211, DOI 10.1016/j.oraloncology.2012.09.007; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin NE, 2014, CELL REP, V6, P417, DOI 10.1016/j.celrep.2014.01.035; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Noorbakhsh J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29154-7; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Polsterl Sebastian, 2016, F1000Res, V5, P2676, DOI 10.12688/f1000research.8231.2; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenberg A., 2007, P EMNLP CONLL, P410; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Safonov A, 2017, CANCER RES, V77, P3317, DOI 10.1158/0008-5472.CAN-16-3478; Salcedo A, 2018, CREATING STANDARDS E; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Schwartz R, 2017, NAT REV GENET, V18, P213, DOI 10.1038/nrg.2016.170; Scott J, 2017, BBA-REV CANCER, V1867, P139, DOI 10.1016/j.bbcan.2017.01.006; Shi WW, 2018, CELL REP, V25, P1446, DOI 10.1016/j.celrep.2018.10.046; Sottoriva A, 2017, BBA-REV CANCER, V1867, P95, DOI 10.1016/j.bbcan.2016.12.003; Teng MX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0940-1; Turajlic S, 2017, NAT REV UROL, V14, P575, DOI 10.1038/nrurol.2017.112; Van Belle V, 2011, ARTIF INTELL MED, V53, P107, DOI 10.1016/j.artmed.2011.06.006; Venkatesan Subramanian, 2016, Am Soc Clin Oncol Educ Book, V35, pe141, DOI 10.14694/EDBK_158930; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhu WH, 2016, PROC INT CONF ANTI, P1, DOI 10.1109/ICASID.2016.7873885	67	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224143	10.1371/journal.pone.0224143	http://dx.doi.org/10.1371/journal.pone.0224143			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697689	Green Published, gold			2022-12-26	WOS:000532694400020
J	Eisenloffel, L; Reutter, T; Horn, M; Schlegel, S; Truyen, U; Speck, S				Eisenloeffel, Lisa; Reutter, Tobias; Horn, Matthias; Schlegel, Simon; Truyen, Uwe; Speck, Stephanie			Impact of UVC-sustained recirculating air filtration on airborne bacteria and dust in a pig facility	PLOS ONE			English	Article							ULTRAVIOLET GERMICIDAL IRRADIATION; RESPIRATORY SYNDROME VIRUS; PORCINE PARVOVIRUS; RELATIVE-HUMIDITY; MYCOPLASMA-HYOPNEUMONIAE; SERRATIA-MARCESCENS; INACTIVATION; VENTILATION; MICROORGANISMS; TRANSMISSION	High amounts of aerial pollutants like dust and microorganisms can pose serious health hazards to animals and humans. The aim of the current study therefore was, to assess the efficiency of UVC irradiation combined to air filtration in reducing airborne microorganisms at laboratory scale. In a second part, a UVC-combined recirculating air filtration module (UVC module) was implemented in a small animal facility in order to assess its improvement of air quality with regard to airborne bacteria and dust. Tests at laboratory scale were performed using aerosols of Staphylococcus (S.) aureus, Actinobacillus pleuropneumoniae, porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus. We varied relative humidity (RH) to evaluate its effect on UVC irradiation efficiency. In addition, viability of pathogens inside the filter material was determined over up to six months. UVC-combined air filtration resulted in a more than 99% reduction of viral and bacterial particles. RH had no influence on UVC efficiency. Viability in the filter matter varied depending on the pathogen used and RH with S. aureus and PPV being most resistant. In our small pig facility consisting of two separated barns, weekly air measurements were conducted over a period of 13 weeks (10 piglets) and 16 weeks (11 piglets), respectively. Airborne bacterial numbers were significantly lower in the barn equipped with the UVC module compared to the reference barn. On average a reduction to 37% of reference values could be achieved for bacteria, whereas the amount of total dust was reduced to a much lesser extent (i.e. to 78% of reference values). Measures taken in front of and behind the UVC module revealed a reduction of 99.4% for airborne bacteria and 95.0% for total dust. To conclude, recirculating air filtration combined to UVC provided efficient reduction of pathogens at laboratory and experimental scale. The implementation of such devices might improve the overall environmental quality in animal facilities.	[Eisenloeffel, Lisa; Truyen, Uwe; Speck, Stephanie] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany; [Reutter, Tobias] REVENTA GmbH, Horstmar, Germany; [Horn, Matthias] Univ Leipzig, Inst Med Informat Stat & Epidemiol IMISE, Leipzig, Germany; [Schlegel, Simon] SterilAir AG, Weinfelden, Switzerland	Leipzig University; Leipzig University	Speck, S (corresponding author), Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany.	stephanie.speck@vetmed.uni-leipzig.de			German federal government/Federal Ministry of Food and Agriculture/Bundesanstalt fur Landwirtschaft und Ernahrung/Landwirtschaftliche Rentenbank (University of Leipzig) [741 120/1]; German federal government/Federal Ministry of Food and Agriculture/Bundesanstalt fur Landwirtschaft und Ernahrung/Landwirtschaftliche Rentenbank (REVENTA(R) GmbH) [742 393/1]; German Research Foundation (DFG); Leipzig University	German federal government/Federal Ministry of Food and Agriculture/Bundesanstalt fur Landwirtschaft und Ernahrung/Landwirtschaftliche Rentenbank (University of Leipzig); German federal government/Federal Ministry of Food and Agriculture/Bundesanstalt fur Landwirtschaft und Ernahrung/Landwirtschaftliche Rentenbank (REVENTA(R) GmbH); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This project was funded in part from a special purpose fund of the German federal government/Federal Ministry of Food and Agriculture/Bundesanstalt fur Landwirtschaft und Ernahrung/Landwirtschaftliche Rentenbank (University of Leipzig grant number 741 120/1 and REVENTA (R) GmbH grant number 742 393/1). We further acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. REVENTA (R) GmbH provided support in the form of salaries for author TR. SterilAir AG provided support in the form of salaries for author SSchlegel. Both companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, TIERSCHUTZ NUTZTIERH; [Anonymous], 168901201708 DIN EN, DOI [10.31030/2510899, DOI 10.31030/2510899]; [Anonymous], 779201210 EN; Anthony TR, 2015, J OCCUP ENVIRON HYG, V12, P635, DOI 10.1080/15459624.2015.1029616; Anthony TR, 2014, J OCCUP ENVIRON HYG, V11, P434, DOI 10.1080/15459624.2013.875186; APPEL MJG, 1979, CORNELL VET, V69, P123; Assavacheep P, 2013, RES VET SCI, V94, P22, DOI 10.1016/j.rvsc.2012.07.024; BARBER EM, 1991, J AGR ENG RES, V50, P107, DOI 10.1016/S0021-8634(05)80009-5; CARPENTER GA, 1986, ANIM PROD, V43, P505, DOI 10.1017/S0003356100002725; CARPENTER GA, 1990, J AGR ENG RES, V46, P171, DOI 10.1016/S0021-8634(05)80039-3; Chang CW, 2013, INDOOR AIR, V23, P74, DOI 10.1111/j.1600-0668.2012.00793.x; Chmielowiec-Korzeniowska A, 2018, ANN AGR ENV MED, V25, P262, DOI 10.26444/aaem/78479; de Rooij MMT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151281; Dee S, 2005, CAN J VET RES, V69, P293; Dee S, 2010, VIRUS RES, V154, P177, DOI 10.1016/j.virusres.2010.07.022; DONHAM KJ, 1991, AM J VET RES, V52, P1723; Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043; Gloster J, 2003, VET REC, V152, P525, DOI 10.1136/vr.152.17.525; Green F.C., 2002, ENV ENG POLICY, V3, P101; Hartung J., 2007, LANDBAUFORSCH VOLK, V308, P111; Hertel E., 1905, Z ALLGEMEINE PHYSIOL, V5, P95; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Kaerber G., 1921, ARCH EXP PATHOL PH, V162, P480; Ko G, 2000, TUBERCLE LUNG DIS, V80, P217, DOI 10.1054/tuld.2000.0249; Ko G, 2002, ENVIRON HEALTH PERSP, V110, P95, DOI 10.1289/ehp.0211095; Kowalski W.J., 2000, QUANT MICROBIOL, V2, P249, DOI DOI 10.1023/A:1013951313398; Lau AK, 1996, CAN AGR ENG, V38, P297; Lin CY, 2002, AEROSOL SCI TECH, V36, P474, DOI 10.1080/027868202753571296; Mainelis G, 2001, J AEROSOL SCI, V32, P1087, DOI 10.1016/S0021-8502(01)00039-8; McDevitt JJ, 2012, APPL ENVIRON MICROB, V78, P1666, DOI 10.1128/AEM.06960-11; McDevitt JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003186; Mengeling WL, 2000, ANIM REPROD SCI, V60, P199, DOI 10.1016/S0378-4320(00)00135-4; Menzies D, 2003, LANCET, V362, P1785, DOI 10.1016/S0140-6736(03)14897-0; MORRISON RB, 1984, PREV VET MED, V2, P699, DOI 10.1016/0167-5877(84)90015-1; Mubareka S, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00023; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; PARKE CR, 1993, AUST VET J, V70, P177, DOI 10.1111/j.1751-0813.1993.tb06124.x; Peccia J, 2001, AEROSOL SCI TECH, V35, P728, DOI 10.1080/02786820152546770; Pedersen S, 2000, J Agric Saf Health, V6, P261; Rentschler HC, 1941, J BACTERIOL, V41, P745, DOI 10.1128/JB.41.6.745-774.1941; RILEY RL, 1972, APPL MICROBIOL, V23, P1113, DOI 10.1128/AEM.23.6.1113-1120.1972; Schulz J, 2013, BERL MUNCH TIERARZTL, V126, P143, DOI 10.2376/0005-9366-126-143; Seedorf J, 1998, J AGR ENG RES, V70, P97, DOI 10.1006/jaer.1997.0281; Seedorf J., 2000, LANDTECHNIK, V2, P182; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Spronk G, 2010, VET REC, V166, P758, DOI 10.1136/vr.b4848; Stark KDC, 1998, APPL ENVIRON MICROB, V64, P543; Terpstra FG, 2008, TRANSFUSION, V48, P304, DOI 10.1111/j.1537-2995.2007.01524.x; Tseng CC, 2005, AEROSOL SCI TECH, V39, P1136, DOI 10.1080/02786820500428575; VANTKLOOSTER CE, 1993, LIVEST PROD SCI, V33, P171, DOI 10.1016/0301-6226(93)90248-G; Walker CM, 2007, ENVIRON SCI TECHNOL, V41, P5460, DOI 10.1021/es070056u; Wenke C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194641; Wenke C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186558; Xu P, 2003, ATMOS ENVIRON, V37, P405, DOI 10.1016/S1352-2310(02)00825-7; Zhen HJ, 2013, APPL ENVIRON MICROB, V79, P7780, DOI 10.1128/AEM.02859-13	56	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0225047	10.1371/journal.pone.0225047	http://dx.doi.org/10.1371/journal.pone.0225047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697778	Green Submitted, gold, Green Published			2022-12-26	WOS:000532694400092
J	Read, JCA; Rafiq, S; Hugill, J; Casanova, T; Black, C; O'Neill, A; Puyat, V; Haggerty, H; Smart, K; Powell, C; Taylor, K; Clarke, MP; Vancleef, K				Read, Jenny C. A.; Rafiq, Sheima; Hugill, Jess; Casanova, Therese; Black, Carla; O'Neill, Adam; Puyat, Vicente; Haggerty, Helen; Smart, Kathryn; Powell, Christine; Taylor, Kate; Clarke, Michael P.; Vancleef, Kathleen			Characterizing the Randot Preschool stereotest: Testability, norms, reliability, specificity and sensitivity in children aged 2-11 years	PLOS ONE			English	Article							INTERPUPILLARY DISTANCE; STEREOACUITY; STEREOPSIS; REFRACTION; AMBLYOPIA; CONSENT; VISION; ACUITY; FRISBY; BIAS	Purpose To comprehensively assess the Randot Preschool stereo test in young children, including testability, normative values, test/retest reliability and sensitivity and specificity for detecting binocular vision disorders. Methods We tested 1005 children aged 2-11 years with the Randot Preschool stereo test, plus a cover/uncover test to detect heterotropia. Monocular visual acuity was assessed in both eyes using Keeler Crowded LogMAR visual acuity test for children aged 4 and over. Results Testability was very high: 65% in two-year-olds, 92% in three-year-olds and similar to 100% in older children. Normative values: In 389 children aged 2-5 with apparently normal vision, 6% of children scored nil (stereoblind). In those who obtained a threshold, the mean log threshold was 2.06 log(10) arcsec, corresponding to 114 arcsec, and the median threshold was 100 arcsec. Most older children score 40 arcsec, the best available score. We found a small sex difference, with girls scoring slightly but significantly better. Test/retest reliability: similar to 99% for obtaining any score vs nil. Agreement between stereo thresholds is poor in children aged 2-5; 95% limit of agreement = 0.7 log(10) arcsec: five-fold change in stereo threshold may occur without any change in vision. In children over 5, the test essentially acts only as a binary classifier since almost all non-stereoblind children score 40 arcsec. Specificity (true negative rate): > 95%. Sensitivity (true positive rate): poor, < 50%, i.e. around half of children with a demonstrable binocular vision abnormality score well on the Randot Preschool. Conclusions The Randot Preschool is extremely accessible for even very young children, and is very reliable at classifying children into those who have any stereo vision vs those who are stereoblind. However, its ability to quantify stereo vision is limited by poor repeatability in children aged 5 and under, and a very limited range of scores relevant to children aged over 5.	[Read, Jenny C. A.; Rafiq, Sheima; Hugill, Jess; Casanova, Therese; Black, Carla; O'Neill, Adam; Puyat, Vicente; Clarke, Michael P.; Vancleef, Kathleen] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Haggerty, Helen; Smart, Kathryn; Powell, Christine; Taylor, Kate; Clarke, Michael P.] Newcastle Tyne Hosp NHS Trust, Royal Victoria Infirm, Newcastle Eye Ctr, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Read, JCA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.	jenny.read@ncl.ac.uk	Read, Jenny/A-7493-2013	Read, Jenny/0000-0002-9029-5185	Wellcome Trust [HICF-R8-442, WT102565/z/13/z]; UK Department of Health [HICF-R8-442, WT102565/z/13/z]; Department of Health [HICF-R8-442, WT102565/z/13/z]	Wellcome Trust(Wellcome Trust); UK Department of Health; Department of Health	This manuscript presents independent research commissioned by the Health Innovation Challenge Fund (HICF-R8-442 and WT102565/z/13/z to JCAR and MPC), a parallel funding partnership between the Wellcome Trust (wellcome.ac.uk) and the UK Department of Health (www.gov.uk/government/organisations/department-of-health-and-social-care).The views expressed in this manuscript are those of the authors and not necessarily those of the Wellcome Trust or the Department of Health. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript presents independent research commissioned by the Health Innovation Challenge Fund (HICF-R8-442 and WT102565/z/13/z), a parallel funding partnership between the Wellcome Trust and the Department of Health. The views expressed in this manuscript are those of the authors and not necessarily those of the Wellcome Trust or the Department of Health.	Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; Afsari S, 2013, BRIT J OPHTHALMOL, V97, P308, DOI 10.1136/bjophthalmol-2012-302192; Anderman C, 1995, EVALUATION REV, V19, P663, DOI 10.1177/0193841X9501900604; Birch E, 2008, J AAPOS, V12, P23, DOI 10.1016/j.jaapos.2007.06.003; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bosten JM, 2015, VISION RES, V110, P34, DOI 10.1016/j.visres.2015.02.017; Bradshaw MF, 2006, SPATIAL VISION, V19, P21, DOI 10.1163/156856806775009250; BROADBENT H, 1990, OPHTHAL PHYSL OPT, V10, P3, DOI 10.1111/j.1475-1313.1990.tb01097.x; Ciner E, 2006, J AAPOS, V10, P507, DOI 10.1016/j.jaapos.2006.08.019; Elliott S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004917.pub3; Eom Y, 2013, JPN J OPHTHALMOL, V57, P486, DOI 10.1007/s10384-013-0253-9; Fawcett SL, 2000, J AAPOS, V4, P354, DOI 10.1067/mpa.2000.110340; FLEDELIUS HC, 1986, ACTA OPHTHALMOL, V64, P481; Gwiazda J, 1989, J Pediatr Ophthalmol Strabismus, V26, P128; Held R, 1996, INFANT VISION, DOI [10.1093/acprof:oso/9780198523161.003.0017, DOI 10.1093/ACPROF:OSO/9780198523161.003.0017]; Hess RF, 2016, INVEST OPHTH VIS SCI, V57, P798, DOI 10.1167/iovs.15-18690; Horwood AM, 2008, OPHTHAL PHYSL OPT, V28, P115, DOI 10.1111/j.1475-1313.2008.00547.x; Li TJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006460.pub2; Mai MN, 2010, INVEST OPHTHALMOL, P4359; Moore MJ, 2019, INT J STROKE, V14, P15; Pai ASI, 2012, J AAPOS, V16, P185, DOI 10.1016/j.jaapos.2011.09.017; PRYOR HB, 1969, PEDIATRICS, V44, P973; Public Health England, CHILD VIS SCREEN SER; Read JCA, 2015, EYE, V29, P214, DOI 10.1038/eye.2014.279; Rowe FJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006499.pub3; Serrano-Pedraza I, 2016, INVESTIG OPHTHALMOL, P57, DOI [10.1167/iovs.15-, DOI 10.1167/IOVS.15-]; Seuntiens P, 2000, ACM T APPL PERCEPT; SEVERSON HH, 1983, ADDICT BEHAV, V8, P433, DOI 10.1016/0306-4603(83)90046-1; Shafiee D, 2014, BULL ENVIRON PHARMAC, V3, P26; SIMONS K, 1981, ARCH OPHTHALMOL-CHIC, V99, P446; Smith SJ, 2012, OPHTHALMOLOGY, V119, P164, DOI 10.1016/j.ophtha.2011.06.041; Stewart CE, 2013, J AAPOS, V17, P166, DOI 10.1016/j.jaapos.2012.10.021; Stidwill D, 2011, NORMAL BINOCULAR VIS; Tarczy-Hornoch K, 2008, OPTOMETRY VISION SCI, V85, P158, DOI 10.1097/OPX.0b013e3181643ea7; Trager MJ, 2009, AM J OPHTHALMOL, V148, P235, DOI 10.1016/j.ajo.2009.02.037; Tsirlin I, 2011, IEEE T BROADCAST, V57, P445, DOI 10.1109/TBC.2011.2105630; Vancleef K, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.1.25; Venables W. N., MODERN APPL STAT S, V4th Fourth; Wong AME, 2008, CAN J OPHTHALMOL, V43, P643, DOI 10.3129/i08-115; Yang Jae Wook, 2004, Korean J Ophthalmol, V18, P154; YEH YY, 1990, HUM FACTORS, V32, P45, DOI 10.1177/001872089003200104; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224402	10.1371/journal.pone.0224402	http://dx.doi.org/10.1371/journal.pone.0224402			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697704	Green Published, gold			2022-12-26	WOS:000532694400026
J	Kaminski, B; Poulin, V; Pralat, P; Szufel, P; Theberge, F				Kaminski, Bogumil; Poulin, Valerie; Pralat, Pawel; Szufel, Przemyslaw; Theberge, Francois			Clustering via hypergraph modularity	PLOS ONE			English	Article								Despite the fact that many important problems (including clustering) can be described using hypergraphs, theoretical foundations as well as practical algorithms using hypergraphs are not well developed yet. In this paper, we propose a hypergraph modularity function that generalizes its well established and widely used graph counterpart measure of how clustered a network is. In order to define it properly, we generalize the Chung-Lu model for graphs to hypergraphs. We then provide the theoretical foundations to search for an optimal solution with respect to our hypergraph modularity function. A simple heuristic algorithm is described and applied to a few illustrative examples. We show that using a strict version of our proposed modularity function often leads to a solution where a smaller number of hyperedges get cut as compared to optimizing modularity of 2-section graph of a hypergraph.	[Kaminski, Bogumil; Szufel, Przemyslaw] SGH Warsaw Sch Econ, Warsaw, Poland; [Poulin, Valerie; Theberge, Francois] Tutte Inst Math & Comp, Ottawa, ON, Canada; [Pralat, Pawel] Ryerson Univ, Dept Math, Toronto, ON, Canada	Warsaw School of Economics; Toronto Metropolitan University	Pralat, P (corresponding author), Ryerson Univ, Dept Math, Toronto, ON, Canada.	pralat@ryerson.ca		Kaminski, Bogumil/0000-0002-0678-282X; Szufel, Przemyslaw/0000-0001-9525-3497	Polish National Agency for Academic Exchange (NAWA) [PPI/APM/2018/1/00037]; NSERC	Polish National Agency for Academic Exchange (NAWA)(Polish National Agency for Academic Exchange (NAWA)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The presented research was partially financed with the support of financed by the Polish National Agency for Academic Exchange (NAWA), on the basis of grant agreement no. PPI/APM/2018/1/00037. It is also related to the NSERC Discovery grant entitled "Modelling and Mining Complex Networks" received by Pawel Pralat.	Agarwal S, 2005, PROC CVPR IEEE, P838; Agarwal S., 2006, P 23 INT C MACH LEAR, P17, DOI DOI 10.1145/1143844.1143847; [Anonymous], NETWORKS AN INTRODUC; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chien I. E., 2018, INT C ART INT STAT, P871; Chung F., 2006, CBMS REGIONAL C SERI; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; GALLO G, 1993, DISCRETE APPL MATH, V42, P177, DOI 10.1016/0166-218X(93)90045-P; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Karypis G, 2000, VLSI DES, V11, P285, DOI 10.1155/2000/19436; Kolda TG, 2014, SIAM J SCI COMPUT, V36, pC424, DOI 10.1137/130914218; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Leordeanu M., 2012, P 15 INT C ART INT S, P676; Lu X, 2019, ARXIV190204243; McDiarmid C., 2013, ELECT NOTES DISCRETE, V43, P431, DOI DOI 10.1016/J.ENDM.2013.07.063; McDiarmid C, 2018, PREPRINT; McDiarmid C, 2018, J COMPLEX NETW, V6, P596, DOI 10.1093/comnet/cnx046; Newman MEJ, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052315; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Poulin V, 2018, PREPRINT; Prokhorenkova L.O., 2017, INTERNET MATH, DOI [10.24166/im.12.2017, DOI 10.24166/IM.12.2017]; Rodriguez JA, 2003, LINEAR MULTILINEAR A, V51, P285, DOI 10.1080/0308108031000084374; Samaga R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-43; Sanders G, 2015, LLNLTR678729; Sarkar S, 1998, IEEE T VEH TECHNOL, V47, P460, DOI 10.1109/25.669084; Seshadhri C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056109; SHEPHERD MA, 1990, INFORM PROCESS MANAG, V26, P395, DOI 10.1016/0306-4573(90)90099-N; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Voloshim VI, 2013, INTRO GRAPH HYPERGRA; Zhang ZK, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/10/P10005; Zhou D., 2006, ADV NEURAL INF PROCE, V19, P1601; Zien JY, 1999, IEEE T COMPUT AID D, V18, P1389, DOI 10.1109/43.784130	36	19	19	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224307	10.1371/journal.pone.0224307	http://dx.doi.org/10.1371/journal.pone.0224307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693701	gold, Green Submitted, Green Published			2022-12-26	WOS:000532690100022
J	Salazar, ML; Jimenez, JM; Villar, J; Rivera, M; Baez, M; Manubens, A; Becker, MI				Salazar, Michelle L.; Jimenez, Jose M.; Villar, Javiera; Rivera, Maira; Baez, Mauricio; Manubens, Augusto; Becker, Maria Ines			N-Glycosylation of mollusk hemocyanins contributes to their structural stability and immunomodulatory properties in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; carbohydrate function; protein stability; humoral response; cytokine induction; glycoprotein; immunotherapy; mollusk hemocyanin; quaternary structure; secondary structure	KEYHOLE LIMPET HEMOCYANIN; CONCHOLEPAS HEMOCYANIN; PROTEIN GLYCOSYLATION; CARBOHYDRATE MOIETY; ELECTRON-MICROSCOPY; ANTIBODY-RESPONSES; GLYCAN STRUCTURES; TUMOR-DEVELOPMENT; DENDRITIC CELLS; SUBUNIT	Hemocyanins are widely used as carriers, adjuvants, and nonspecific immunostimulants in cancer because they promote Th1 immunity in mammals. Hemocyanins also interact with glycan-recognizing innate immune receptors on antigen-presenting cells, such as the C-type lectin immune receptors mannose receptor (MR), macrophage galactose lectin (MGL), and the Toll-like receptors (TLRs), stimulating proinflammatory cytokine secretion. However, the role of N-linked oligosaccharides on the structural and immunological properties of hemocyanin is unclear. Mollusk hemocyanins, such as Concholepas concholepas (CCH), Fissurella latimarginata (FLH), and Megathura crenulata (KLH), are oligomeric glycoproteins with complex dodecameric quaternary structures and heterogeneous glycosylation patterns, primarily consisting of mannose-rich N-glycans. Here, we report that enzyme-catalyzed N-deglycosylation of CCH, FLH, and KLH disrupts their quaternary structure and impairs their immunogenic effects. Biochemical analyses revealed that the deglycosylation does not change hemocyanin secondary structure but alters their refolding mechanism and dodecameric structure. Immunochemical analyses indicated decreased binding of N-deglycosylated hemocyanins to the MR and MGL receptors and TLR4 and reduced endocytosis concomitant with an impaired production of tumor necrosis factor ?, and interleukins 6 and 12 (IL-6 and IL-12p40, respectively) in macrophages. Evaluating the function of N-deglycosylated hemocyanins in the humoral immune response and their nonspecific antitumor effects in the B16F10 melanoma model, we found that compared with native hemocyanins N-deglycosylated hemocyanins elicited reduced antibody titers, as well as partially diminished antitumor effects and altered carrier activities. In conclusion, the glycan content of hemocyanins is, among other structural characteristics, critically required for their immunological activities and should be considered in biomedical applications.	[Salazar, Michelle L.; Jimenez, Jose M.; Villar, Javiera; Becker, Maria Ines] Fdn Ciencia & Tecnol El Desarrollo FUCITED, Ave Alcalde Eduardo Castillo Velasco 2902, Santiago 7750269, Chile; [Rivera, Maira; Baez, Mauricio] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago 8380494, Chile; [Manubens, Augusto; Becker, Maria Ines] Biosonda Corp, Dept Invest & Desarrollo, Santiago 7750269, Chile; [Salazar, Michelle L.] Ave Alcalde Eduardo Castillo Velasco 2902, Santiago 7750269, Chile	Universidad de Chile	Becker, MI (corresponding author), Fdn Ciencia & Tecnol El Desarrollo FUCITED, Ave Alcalde Eduardo Castillo Velasco 2902, Santiago 7750269, Chile.	marianes.becker@fucited.cl		Rivera, Maira/0000-0002-2771-9248; Villar, Javiera/0000-0002-8581-4155	FONDEQUIP [EQM140151]; FONDECYT [1191153, 1151337]; CONICYT-CHILE National Ph.D. Fellowship [CONICYT-PCHA/Doctorado Nacional/2013-21130683]	FONDEQUIP; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-CHILE National Ph.D. Fellowship	This work was supported in part by FONDECYT Grant 1151337 (to M. I. B.), FONDEQUIP EQM140151 and FONDECYT Grant 1191153 (to M. B.), and CONICYT-CHILE National Ph.D. Fellowship CONICYT-PCHA/Doctorado Nacional/2013-21130683 (to J. M. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Antonova O, 2014, Z NATURFORSCH C, V69, P325, DOI 10.5560/ZNC.2013-0148; Arancibia S., 2012, BLADDER CANC FROM BA, P221, DOI [10.5772/28281, DOI 10.5772/28281]; Arancibia S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087240, 10.1371/journal.pone.0101786]; Arancibia S, 2012, EUR J IMMUNOL, V42, P688, DOI 10.1002/eji.201142011; Becker MI, 2009, INT IMMUNOPHARMACOL, V9, P330, DOI 10.1016/j.intimp.2008.12.011; Chia J, 2016, BBA-GEN SUBJECTS, V1860, P1623, DOI 10.1016/j.bbagen.2016.03.008; Cornelissen LAM, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020026; De Ioannes P, 2004, J BIOL CHEM, V279, P26134, DOI 10.1074/jbc.M400903200; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; del Campo M, 2011, REV MED CHILE, V139, P236, DOI /S0034-98872011000200015; Denda-Nagai K, 2010, J BIOL CHEM, V285, P19193, DOI 10.1074/jbc.M110.113613; Dolashka P, 2010, CARBOHYD RES, V345, P2361, DOI 10.1016/j.carres.2010.08.005; Dolashka-Angelova P, 2003, BBA-PROTEINS PROTEOM, V1646, P77, DOI 10.1016/S1570-9639(02)00549-6; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; Etxebarria J, 2012, ACS CHEM BIOL, V7, P1729, DOI 10.1021/cb300262x; Fierz W, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00551; Freeze Hudson H, 2010, Curr Protoc Mol Biol, VChapter 17, DOI [10.1002/0471140864.ps1204s62, 10.1002/0471142735.im0815s83, 10.1002/0471142727.mb1713as89]; Gai ZQ, 2015, STRUCTURE, V23, P2204, DOI 10.1016/j.str.2015.09.008; Garcia Villalobos J., 2016, THESIS UPSEHU LEIOA, P1; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gesheva V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0034-3; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; GLADHAUG IP, 1990, J CELL PHYSIOL, V143, P188, DOI 10.1002/jcp.1041430126; Gringhuis SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4898; Haka AS, 2009, MOL BIOL CELL, V20, P4932, DOI 10.1091/mbc.E09-07-0559; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Harris JR, 2000, MICRON, V31, P1, DOI 10.1016/S0968-4328(99)00059-1; Harvey DJ, 2000, J AM SOC MASS SPECTR, V11, P564, DOI 10.1016/S1044-0305(00)00122-7; Idakieva K, 2008, J FLUORESC, V18, P715, DOI 10.1007/s10895-008-0338-x; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jayaprakash NG, 2017, BIOCHEM J, V474, P2333, DOI 10.1042/BCJ20170111; Jimenez JM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01136; Kawai R, 2013, J IMMUNOTOXICOL, V10, P40, DOI 10.3109/1547691X.2012.691122; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kurokawa T, 2002, EUR J BIOCHEM, V269, P5459, DOI 10.1046/j.1432-1033.2002.03244.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Lieb B, 2001, P NATL ACAD SCI USA, V98, P4546, DOI 10.1073/pnas.071049998; Lingg N, 2012, BIOTECHNOL J, V7, P1462, DOI 10.1002/biot.201200078; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Mer G, 1996, NAT STRUCT BIOL, V3, P45, DOI 10.1038/nsb0196-45; Moltedo B, 2006, J UROLOGY, V176, P2690, DOI 10.1016/j.juro.2006.07.136; MOLTO LM, 1991, EUR UROL, V19, P74; MOOLENAAR WH, 1983, NATURE, V304, P645, DOI 10.1038/304645a0; Roman JJM, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7076942; Oyelaran O, 2010, PROTEOM CLIN APPL, V4, P285, DOI 10.1002/prca.200900130; Palacios M, 2018, EUR J MED CHEM, V150, P74, DOI 10.1016/j.ejmech.2018.02.082; Peixoto A, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00380; Presicce P, 2008, MOL IMMUNOL, V45, P1136, DOI 10.1016/j.molimm.2007.07.020; Rodriguez E, 2018, NAT REV IMMUNOL, V18, P204, DOI 10.1038/nri.2018.3; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; SIEZEN RJ, 1974, J MOL BIOL, V90, P77; Sola RJ, 2010, BIODRUGS, V24, P9, DOI 10.2165/11530550-000000000-00000; Sotillo J, 2014, PARASITOLOGY, V141, P1333, DOI 10.1017/S0031182014000596; SPIRO RG, 1964, J BIOL CHEM, V239, P567; Staudacher Erika, 2009, Curr Top Biochem Res, V11, P29; Stoeva S, 1999, BBA-PROTEIN STRUCT M, V1435, P94, DOI 10.1016/S0167-4838(99)00198-3; Swerdlow RD, 1996, COMP BIOCHEM PHYS B, V113, P537, DOI 10.1016/0305-0491(95)02091-8; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Van Die I., 2010, HDB GLYCOMICS; Varki A., 2009, ESSENTIALS GLYCOBIOL; Velkova L, 2010, COMP BIOCHEM PHYS B, V157, P16, DOI 10.1016/j.cbpb.2010.04.012; Velkova L, 2017, CARBOHYD RES, V449, P1, DOI 10.1016/j.carres.2017.06.012; Velkova L, 2011, GLYCOCONJUGATE J, V28, P385, DOI 10.1007/s10719-011-9337-2; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; WALSH MT, 1990, BIOCHEMISTRY-US, V29, P6250, DOI 10.1021/bi00478a020; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WIRGUIN I, 1995, CANCER IMMUNOL IMMUN, V40, P307, DOI 10.1007/BF01519630; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200; Zhang PQ, 2016, DRUG DISCOV TODAY, V21, P740, DOI 10.1016/j.drudis.2016.01.006; Zhang ZH, 2019, FEBS LETT, V593, P820, DOI 10.1002/1873-3468.13367; Zheng LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151801; Zhong TY, 2016, J IMMUNOL, V196, P4650, DOI 10.4049/jimmunol.1501156; Zou GZ, 2018, J BIOL CHEM, V293, P19277, DOI 10.1074/jbc.RA118.005294; Zou X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43560	80	14	14	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19546	19564		10.1074/jbc.RA119.009525	http://dx.doi.org/10.1074/jbc.RA119.009525			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31719148	Green Published, hybrid			2022-12-26	WOS:000504093200009
J	Cremer, SE; Catalfamo, JL; Goggs, R; Seemann, SE; Kristensen, AT; Brooks, MB				Cremer, Signe E.; Catalfamo, James L.; Goggs, Robert; Seemann, Stefan E.; Kristensen, Annemarie T.; Brooks, Marjory B.			Proteomic profiling of the thrombin-activated canine platelet secretome (CAPS)	PLOS ONE			English	Article							GENOMICS ANALYSIS; GRANULE PROTEOME; ANALYSIS REVEALS; ALPHA-THROMBIN; PROTEINS; DOGS; EXPRESSION; DISEASE; IDENTIFICATION; HEMOFILTRATE	Domestic dogs share the same environment as humans, and they represent a valuable animal model to study naturally-occurring human disease. Platelet proteomics holds promise for the discovery of biomarkers that capture the contribution of platelets to the pathophysiology of many disease states, however, canine platelet proteomic studies are lacking. Our study objectives were to establish a protocol for proteomic identification and quantification of the thrombin-activated canine platelet secretome (CAPS), and to compare the CAPS proteins to human and murine platelet proteomic data. Washed platelets were isolated from healthy dogs, and stimulated with saline (control) or gamma-thrombin (releasate). Proteins were separated by SDS-page, trypsin-digested and analyzed by liquid chromatography and tandem mass spectrometry (MS). CAPS proteins were defined as those with a MS1-abundance ratio of two or more for releasate vs. unstimulated saline control. A total of 1,918 proteins were identified, with 908 proteins common to all dogs and 693 characterized as CAPS proteins. CAPS proteins were similar to human and murine platelet secretomes and were highly represented in hemostatic pathways. Differences unique to CAPS included replacement of platelet factor 4 with other cleavage products of platelet basic protein (e.g. interleukin-8), novel proteins (e.g. C-C motif chemokine 14), and proteins in relatively high (e.g. protease nexin-1) or low (e.g. von Willebrand factor) abundance. This study establishes the first in-depth platelet releasate proteome from healthy dogs with a reference database of 693 CAPS proteins. Similarities between CAPS and the human secretome confirm the utility of dogs as translational models of human disease, but we also identify differences unique to canine platelets. Our findings provide a resource for further investigations into disease related CAPS profiles, and for comparative pathway analyses of platelet activation among species.	[Cremer, Signe E.; Kristensen, Annemarie T.] Univ Copenhagen, Dept Vet Clin Sci, Copenhagen, Denmark; [Cremer, Signe E.; Catalfamo, James L.; Brooks, Marjory B.] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Goggs, Robert] Cornell Univ, Dept Clin Sci, Ithaca, NY USA; [Seemann, Stefan E.] Univ Copenhagen, Dept Vet & Anim Sci, Copenhagen, Denmark	University of Copenhagen; Cornell University; Cornell University; University of Copenhagen	Cremer, SE (corresponding author), Univ Copenhagen, Dept Vet Clin Sci, Copenhagen, Denmark.; Cremer, SE (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	emilie@sund.ku.dk	Seemann, Stefan/M-7468-2019	Seemann, Stefan/0000-0002-2359-4927; Goggs, Robert/0000-0001-7446-6987; Cremer, Signe/0000-0002-8517-4805	Independent Research Fund Denmark [DFF-6111-00123, DFF-6111-00123B]	Independent Research Fund Denmark	This work was supported by the Independent Research Fund Denmark through an individual postdoc grant to SEC (ID: DFF-6111-00123) and an individual Sapare Aude grant to SEC (ID: DFF-6111-00123B). https://dff.dk/en.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JB, 1986, SEMIN THROMB HEMOST, V12, P216, DOI 10.1055/s-2007-1003554; Banfi C, 2010, EXP HEMATOL, V38, P341, DOI 10.1016/j.exphem.2010.03.001; Borresen B, 2018, VET COMP ONCOL, V16, pE1, DOI 10.1111/vco.12342; Boudreaux MK, 2001, AM J VET RES, V62, P1797, DOI 10.2460/ajvr.2001.62.1797; Boulaftali Y, 2011, CIRCULATION, V123, P1326, DOI 10.1161/CIRCULATIONAHA.110.000885; Boulaftali Y, 2010, BLOOD, V115, P97, DOI 10.1182/blood-2009-04-217240; Brooks MB, 2007, J THROMB HAEMOST, V5, P1972, DOI 10.1111/j.1538-7836.2007.02683.x; Brooks MB, 2015, J THROMB HAEMOST, V13, P2240, DOI 10.1111/jth.13157; Brooks MB, 2002, BLOOD, V99, P2434, DOI 10.1182/blood.V99.7.2434; Burkhart JM, 2014, CIRC RES, V114, P1204, DOI 10.1161/CIRCRESAHA.114.301598; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; CALLAN MB, 1995, THROMB HAEMOSTASIS, V74, P949; Capriotti AL, 2013, ANAL CHIM ACTA, V776, P57, DOI 10.1016/j.aca.2013.03.023; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Coppinger Judith, 2007, Methods Mol Biol, V357, P307; Coppinger JA, 2007, BLOOD, V109, P4786, DOI 10.1182/blood-2006-07-038539; De Paoli SH, 2018, CELL MOL LIFE SCI, V75, P3781, DOI 10.1007/s00018-018-2771-6; Della Corte A, 2008, PLATELETS, V19, P43, DOI 10.1080/09537100701609035; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Di Michele M, 2011, J PROTEOMICS, V74, P902, DOI 10.1016/j.jprot.2011.03.007; DODDS WJ, 1967, THROMB DIATH HAEMOST, VS, P241; DODDS WJ, 1984, MOD VET PRACT, V65, P681; Du LM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3773; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fenger JM, 2014, ILAR J, V55, P69, DOI 10.1093/ilar/ilu009; Parguina AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013404; Garcia A, 2006, PROTEOMICS, V6, P5332, DOI 10.1002/pmic.200600299; Garcia BA, 2005, J PROTEOME RES, V4, P1516, DOI 10.1021/pr0500760; Goggs R, 2018, J VET EMERG CRIT CAR, V28, P541, DOI 10.1111/vec.12777; Gohring K, 2004, BRIT J HAEMATOL, V126, P252, DOI 10.1111/j.1365-2141.2004.05027.x; Gonzalez-Sanchez M, 2018, MOL NEUROBIOL, V55, P8815, DOI 10.1007/s12035-018-1039-3; Gruba SM, 2015, BBA-BIOMEMBRANES, V1848, P1609, DOI 10.1016/j.bbamem.2015.04.006; Hernandez-Ruiz L, 2007, J PROTEOME RES, V6, P4449, DOI 10.1021/pr070380o; Kasprzyk J, 2017, CLIN BIOCHEM, V50, P241, DOI 10.1016/j.clinbiochem.2016.11.013; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; LeVine DN, 2014, BRIT J HAEMATOL, V167, P110, DOI 10.1111/bjh.13005; Lewandrowski U, 2009, BLOOD, V114, pE10, DOI 10.1182/blood-2009-02-203828; LEWIS SD, 1987, BIOCHEMISTRY-US, V26, P7597, DOI 10.1021/bi00398a010; Liu J, 2014, MOL BIOL REP, V41, P3179, DOI 10.1007/s11033-014-3177-7; Lopez-Farre AJ, 2011, PROTEOMICS, V11, P3335, DOI 10.1002/pmic.201000708; Maguire PB, 2002, PROTEOMICS, V2, P642, DOI 10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I; Martin-Granado V, 2017, ONCOTARGET, V8, P110994, DOI 10.18632/oncotarget.22339; Maynard DM, 2007, J THROMB HAEMOST, V5, P1945, DOI 10.1111/j.1538-7836.2007.02690.x; Maynard DM, 2010, J THROMB HAEMOST, V8, P1786, DOI 10.1111/j.1538-7836.2010.03932.x; Milioli M, 2015, J PROTEOMICS, V121, P56, DOI 10.1016/j.jprot.2015.03.013; Munch J, 2002, ANTIMICROB AGENTS CH, V46, P982, DOI 10.1128/AAC.46.4.982-990.2002; Nassa G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18985-5; O'Connor R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/107859; Parguina AF, 2011, ARTERIOSCL THROM VAS, V31, P2957, DOI 10.1161/ATVBAHA.111.235713; Parsons MEM, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800219; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piersma SR, 2009, J PROTEOMICS, V72, P91, DOI 10.1016/j.jprot.2008.10.009; Poole J, 2000, BLOOD REV, V14, P31, DOI 10.1054/blre.1999.0124; Randriamboavonjy V, 2012, BLOOD, V120, P415, DOI 10.1182/blood-2011-12-399980; RAYMOND SL, 1979, J LAB CLIN MED, V93, P607; Schuberth HJ, 2007, VET IMMUNOL IMMUNOP, V119, P47, DOI 10.1016/j.vetimm.2007.06.013; SchulzKnappe P, 1997, J CHROMATOGR A, V776, P125, DOI 10.1016/S0021-9673(97)00152-0; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Sharpe KS, 2010, AM J VET RES, V71, P1294, DOI 10.2460/ajvr.71.11.1294; Simpson K, 2018, J SMALL ANIM PRACT, V59, P674, DOI 10.1111/jsap.12912; Soslau G, 2004, PLATELETS, V15, P155, DOI 10.1080/0953710042000199848; Thomas CJ, 2017, ANAL BIOCHEM, V525, P46, DOI 10.1016/j.ab.2017.02.011; Vakili J, 2001, J IMMUNOL, V167, P3406, DOI 10.4049/jimmunol.167.6.3406; van Holten TC, 2014, CARDIOVASC RES, V103, P140, DOI 10.1093/cvr/cvu113; Velez P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08198; Walkowiak B, 2007, PLATELETS, V18, P386, DOI 10.1080/09537100601095871; Weber RJM, 2012, BIOINFORMATICS, V28, P2856, DOI 10.1093/bioinformatics/bts527; Wijten P, 2013, ARTERIOSCL THROM VAS, V33, P1635, DOI 10.1161/ATVBAHA.113.301147; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang YX, 2018, ELECTROPHORESIS, V39, P2332, DOI 10.1002/elps.201800042; Zougman A, 2014, PROTEOMICS, V14, P1006, DOI 10.1002/pmic.201300553; Zufferey A, 2014, J PROTEOMICS, V101, P130, DOI 10.1016/j.jprot.2014.02.008; Zufferey A, 2012, MASS SPECTROM REV, V31, P331, DOI 10.1002/mas.20345	74	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224891	10.1371/journal.pone.0224891	http://dx.doi.org/10.1371/journal.pone.0224891			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721811	Green Published, gold			2022-12-26	WOS:000532720700051
J	Geiger, F; Rudiger, D; Zahler, S; Engelke, H				Geiger, Florian; Ruediger, Daniel; Zahler, Stefan; Engelke, Hanna			Fiber stiffness, pore size and adhesion control migratory phenotype of MDA-MB-231 cells in collagen gels	PLOS ONE			English	Article							MODES; IMAGE; CONTRACTILITY; MECHANICS; INVASION; RESPOND	Cancer cell migration is influenced by cellular phenotype and behavior as well as by the mechanical and chemical properties of the environment. Furthermore, many cancer cells show plasticity of their phenotype and adapt it to the properties of the environment. Here, we study the influence of fiber stiffness, confinement, and adhesion properties on cancer cell migration in porous collagen gels. Collagen gels with soft fibers abrogate migration and promote a round, non-invasive phenotype. Stiffer collagen fibers are inherently more adhesive and lead to the existence of an adhesive phenotype and in general confined migration due to adhesion. Addition of TGF-beta lowers adhesion, eliminates the adhesive phenotype and increases the amount of highly motile amoeboid phenotypes. Highest migration speeds and longest displacements are achieved in stiff collagen fibers in pores of about cell size by amoeboid phenotypes. This elucidates the influence of the mechanical properties of collagen gels on phenotype and subsequently migration and shows that stiff fibers, cell sized pores, and low adhesion, are optimal conditions for an amoeboid phenotype and efficient migration.	[Geiger, Florian; Engelke, Hanna] Ludwig Maximilians Univ Munchen, Dept Chem, Munich, Germany; [Geiger, Florian; Engelke, Hanna] Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany; [Ruediger, Daniel; Zahler, Stefan] Ludwig Maximilians Univ Munchen, Dept Pharm, Munich, Germany	University of Munich; University of Munich; University of Munich	Engelke, H (corresponding author), Ludwig Maximilians Univ Munchen, Dept Chem, Munich, Germany.; Engelke, H (corresponding author), Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany.	hanna.engelke@cup.uni-muenchen.de		Engelke, Hanna/0000-0001-9529-9436	Deutsche Forschungsgemeinschaft [SFB1032]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors gratefully acknowledge funding from the Deutsche Forschungsgemeinschaft (SFB1032, project B08 to SZ and B11 to HE).	Anguiano M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171417; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Broda E, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201800083; Burov S, 2013, P NATL ACAD SCI USA, V110, P19689, DOI 10.1073/pnas.1319473110; Caswell PT, 2018, TRENDS CELL BIOL, V28, P823, DOI 10.1016/j.tcb.2018.06.003; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Condor M, 2019, BIOPHYS J, V116, P1305, DOI 10.1016/j.bpj.2019.02.029; Dietrich M, 2018, SOFT MATTER, V14, P2816, DOI 10.1039/c8sm00018b; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720; Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Holle AW, 2019, NANO LETT, V19, P2280, DOI 10.1021/acs.nanolett.8b04720; Kick K, 2016, ARTERIOSCL THROM VAS, V36, P2346, DOI 10.1161/ATVBAHA.116.307870; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lampi MC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0475; Licup AJ, 2015, P NATL ACAD SCI USA, V112, P9573, DOI 10.1073/pnas.1504258112; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Malawista SE, 2000, CELL MOTIL CYTOSKEL, V46, P183, DOI 10.1002/1097-0169(200007)46:3<183::AID-CM3>3.3.CO;2-U; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Ruprecht V, 2017, J CELL SCI, V130, P51, DOI 10.1242/jcs.196162; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sauer F, 2019, SOFT MATTER, V15, P3055, DOI 10.1039/c8sm02264j; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Talkenberger K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09300-3; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Wisdom KM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06641-z; Wolf K, PHYS LIMITS CELL MIG; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Wu PH, 2018, ANNU REV BIOPHYS, V47, P549, DOI 10.1146/annurev-biophys-070816-033854; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111	40	12	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0225215	10.1371/journal.pone.0225215	http://dx.doi.org/10.1371/journal.pone.0225215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721794	Green Published, gold			2022-12-26	WOS:000532720700045
J	Aivazidis, S; Jain, A; Rauniyar, AK; Anderson, CC; Marentette, JO; Orlicky, DJ; Fritz, KS; Harris, PS; Siegel, D; Maclean, KN; Roede, JR				Aivazidis, Stefanos; Jain, Abhilasha; Rauniyar, Abhishek K.; Anderson, Colin C.; Marentette, John O.; Orlicky, David J.; Fritz, Kristofer S.; Harris, Peter S.; Siegel, David; Maclean, Kenneth N.; Roede, James R.			SNARE proteins rescue impaired autophagic flux in Down syndrome	PLOS ONE			English	Article							LYSOSOMAL DYSFUNCTION; DRUG-SENSITIVITY; STORAGE DISORDER; SYNTAXIN 17; DISEASE; PROTEOSTASIS; DEGRADATION; LEUKEMIA; STRESS; FUSION	Down syndrome (DS) is a chromosomal disorder caused by trisomy of chromosome 21 (Ts21). Unbalanced karyotypes can lead to dysfunction of the proteostasis network (PN) and disrupted proteostasis is mechanistically associated with multiple DS comorbidities. Autophagy is a critical component of the PN that has not previously been investigated in DS. Based on our previous observations of PN disruption in DS, we investigated possible dysfunction of the autophagic machinery in human DS fibroblasts and other DS cell models. Following induction of autophagy by serum starvation, DS fibroblasts displayed impaired autophagic flux indicated by autophagolysosome accumulation and elevated p62, NBR1, and LC3-II abundance, compared to age- and sex-matched, euploid (CTL) fibroblasts. While lysosomal physiology was unaffected in both groups after serum starvation, we observed decreased basal abundance of the Soluble N-ethylmaleimide-sensitive-factor Attachment protein Receptor (SNARE) family members syntaxin 17 (STX17) and Vesicle Associated Membrane Protein 8 (VAMP8) indicating that decreased autophagic flux in DS is due at least in part to a possible impairment of autophagosome-lysosome fusion. This conclusion was further supported by the observation that over-expression of either STX17 or VAMP8 in DS fibroblasts restored autophagic degradation and reversed p62 accumulation. Collectively, our results indicate that impaired autophagic clearance is a characteristic of DS cells that can be reversed by enhancement of SNARE protein expression and provides further evidence that PN disruption represents a candidate mechanism for multiple aspects of pathogenesis in DS and a possible future target for therapeutic intervention.	[Aivazidis, Stefanos; Jain, Abhilasha; Rauniyar, Abhishek K.; Anderson, Colin C.; Marentette, John O.; Fritz, Kristofer S.; Harris, Peter S.; Siegel, David; Roede, James R.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Sch Med, Aurora, CO USA; [Maclean, Kenneth N.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [Maclean, Kenneth N.; Roede, James R.] Univ Colorado, Linda Crnic Inst Down Syndrome, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Roede, JR (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA.; Roede, JR (corresponding author), Univ Colorado, Linda Crnic Inst Down Syndrome, Aurora, CO 80045 USA.	james.roede@ucdenver.edu		Aivazids, Stefanos/0000-0003-0421-1473	National Institutes of Health NIH/NIEHS [R01 ES027593]; Linda Crinic Institute for Down Syndrome Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027593] Funding Source: NIH RePORTER	National Institutes of Health NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Linda Crinic Institute for Down Syndrome Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the National Institutes of Health NIH/NIEHS (R01 ES027593 to JRR) and the Linda Crinic Institute for Down Syndrome Research (KNM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto Maria R, 2012, Cells, V1, P428, DOI 10.3390/cells1030428; Aitken RJ, 2013, DIABETES CARE, V36, P1181, DOI 10.2337/dc12-1712; Aivazidis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176307; Amaya C, 2015, FEBS LETT, V589, P3343, DOI 10.1016/j.febslet.2015.09.021; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Bloemers BLP, 2010, J PEDIATR-US, V156, P804, DOI 10.1016/j.jpeds.2009.12.006; Blom NA, 2003, AM J CARDIOL, V91, P180, DOI 10.1016/S0002-9149(02)03106-5; Boghossian NS, 2014, PEDIATRICS, V133, P226, DOI 10.1542/peds.2013-1702; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Cell Gerald K, 2002, BIOL MOL; Chen ZQ, 2011, HUM VACCINES, V7, P849, DOI 10.4161/hv.7.8.16279; Cox TM, 2015, AM J HEMATOL, V90, pS25, DOI 10.1002/ajh.24057; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Dephoure N, 2014, ELIFE, V3, DOI 10.7554/eLife.03023; DeVorkin Lindsay, 2014, Cold Spring Harb Protoc, V2014, P951, DOI 10.1101/pdb.prot080325; Di Bartolomeo S, 2010, TRAFFIC, V11, P1280, DOI 10.1111/j.1600-0854.2010.01103.x; Di Domenico F, 2013, BBA-MOL BASIS DIS, V1832, P1249, DOI 10.1016/j.bbadis.2013.04.013; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Donnelly N, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.976491; Donnelly N, 2015, CELL CYCLE, V14, P495, DOI 10.1080/15384101.2015.1006043; Donnelly N, 2014, EMBO J, V33, P2374, DOI 10.15252/embj.201488648; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fimia GM, 2013, CELL DEATH DIFFER, V20, P1, DOI 10.1038/cdd.2012.97; Fraldi A, 2016, ANNU REV NEUROSCI, V39, P277, DOI 10.1146/annurev-neuro-070815-014031; Frost BM, 2000, LEUKEMIA, V14, P943, DOI 10.1038/sj.leu.2401753; Gretzmeier C, 2017, AUTOPHAGY, V13, P1064, DOI 10.1080/15548627.2016.1274485; Hegedus K, 2013, AUTOPHAGY, V9, P1642, DOI 10.4161/auto.25684; Huang L, 2018, INT J MOL MED, V42, P3278, DOI 10.3892/ijmm.2018.3866; Itakura E, 2013, AUTOPHAGY, V9, P917, DOI 10.4161/auto.24109; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Iyer AM, 2014, J NEUROPATH EXP NEUR, V73, P671, DOI 10.1097/NEN.0000000000000083; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jaisson S, 2014, DIABETOLOGIA, V57, P1517, DOI 10.1007/s00125-014-3257-1; James RA, 2016, J PAEDIATR CHILD H, V52, P262, DOI 10.1111/jpc.13122; Jiang Y, 2010, P NATL ACAD SCI USA, V107, P1630, DOI 10.1073/pnas.0908953107; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Klikova K, 2016, Klin Onkol, V29, P29; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lanzillotta C, 2018, J ALZHEIMERS DIS, V62, P347, DOI 10.3233/JAD-170617; Lash LH, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.1289/ehp.00108s2177; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li HX, 2018, AUTOPHAGY, V14, P1726, DOI 10.1080/15548627.2018.1483807; Li J, 2015, MOL NEUROBIOL, V51, P1024, DOI 10.1007/s12035-014-8762-1; Li LB, 2012, CELL STEM CELL, V11, P615, DOI 10.1016/j.stem.2012.08.004; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; Masouleh BK, 2014, P NATL ACAD SCI USA, V111, pE2219, DOI 10.1073/pnas.1400958111; Mateos MK, 2015, TRANSL PEDIATR, V4, P76, DOI 10.3978/j.issn.2224-4336.2015.03.03; Mazzulli JR, 2016, J NEUROSCI, V36, P7693, DOI 10.1523/JNEUROSCI.0628-16.2016; Mizunoe Y, 2017, AUTOPHAGY, V13, P642, DOI 10.1080/15548627.2016.1274850; Moreau K, 2013, TRENDS BIOCHEM SCI, V38, P57, DOI 10.1016/j.tibs.2012.11.004; Mukhopadhyay S, 2016, BIOCHEM BIOPH RES CO, V479, P940, DOI 10.1016/j.bbrc.2016.09.143; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; Orlicky DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066837; Oromendia AB, 2014, DIS MODEL MECH, V7, P15, DOI 10.1242/dmm.013391; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Pajares M, 2015, REDOX BIOL, V6, P409, DOI 10.1016/j.redox.2015.07.003; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Pericleous M, 2017, LANCET GASTROENTEROL, V2, P670, DOI 10.1016/S2468-1253(17)30052-3; Perluigi M, 2014, BBA-MOL BASIS DIS, V1842, P1144, DOI 10.1016/j.bbadis.2014.04.007; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; Redmann M, 2017, REDOX BIOL, V11, P73, DOI 10.1016/j.redox.2016.11.004; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005; Santaguida S, 2015, GENE DEV, V29, P2010, DOI 10.1101/gad.269118.115; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Shibutani ST, 2015, NAT IMMUNOL, V16, P1014, DOI 10.1038/ni.3273; Stingele S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.40; Sulistio YA, 2016, MOL NEUROBIOL, V53, P905, DOI 10.1007/s12035-014-9063-4; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Vincenz-Donnelly L, 2017, FREE RADICAL BIO MED, V108, P383, DOI 10.1016/j.freeradbiomed.2017.03.031; Wang X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-31; Wang YY, 2016, SEMIN CELL DEV BIOL, V60, P97, DOI 10.1016/j.semcdb.2016.07.009; Whyte LS, 2017, J NEUROCHEM, V140, P703, DOI 10.1111/jnc.13935; Wiseman FK, 2015, NAT REV NEUROSCI, V16, P564, DOI 10.1038/nrn3983; Zwaan CM, 2002, BLOOD, V99, P245, DOI 10.1182/blood.V99.1.245	85	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0223254	10.1371/journal.pone.0223254	http://dx.doi.org/10.1371/journal.pone.0223254			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714914	gold, Green Published, Green Submitted			2022-12-26	WOS:000532710400002
J	Serra, PA; Arrigo, P; Bacciu, A; Zuncheddu, D; Deliperi, R; Viana, DA; Monti, P; Varoni, MV; Sotgiu, MA; Bandiera, P; Rocchitta, G				Serra, Pier Andrea; Arrigo, Paola; Bacciu, Andrea; Zuncheddu, Daniele; Deliperi, Riccardo; Viana, Diego Anton; Monti, Patrizia; Varoni, Maria Vittoria; Sotgiu, Maria Alessandra; Bandiera, Pasquale; Rocchitta, Gaia			Real-time telemetry monitoring of oxygen in the central complex of freely-walking Gromphadorhina portentosa	PLOS ONE			English	Article							DISCONTINUOUS GAS-EXCHANGE; BRAIN-TISSUE OXYGEN; IMPLANTABLE BIOSENSOR; IN-VIVO; LACTATE; GLUCOSE; ETHANOL; SYSTEM; METABOLISM; ANESTHESIA	A new telemetric system for the electrochemical monitoring of dissolved oxygen is showed. The device, connected with two amperometric sensors, has been successfully applied to the wireless detection of the extracellular oxygen in the central complex of freely-walking Gromphadorhina portentosa. The unit was composed of a potentiostat, a two-channel sensor conditioning circuit, a microprocessor module, and a wireless serial transceiver. The amperometric signals were digitalized and sent to a notebook using a 2.4 GHz transceiver while a serial-to-USB converter was connected to a second transceiver for completing the communication bridge. The software, running on the laptop, allowed to save and graph the oxygen signals. The electronics showed excellent stability and the acquired data was linear in a range comprised between 0 and -165 nA, covering the entire range of oxygen concentrations. A series of experiments were performed to explore the dynamics of dissolved oxygen by exposing the animals to different gases (nitrogen, oxygen and carbon dioxide), to low temperature and anesthetic agents (chloroform and triethylamine). The resulting data are in agreement with previous O-2 changes recorded in the brain of awake rats and mice. The proposed system, based on simple and inexpensive components, can constitute a new experimental model for the exploration of central complex neurochemistry and it can also work with oxidizing sensors and amperometric biosensors.	[Serra, Pier Andrea; Arrigo, Paola; Bacciu, Andrea; Zuncheddu, Daniele; Deliperi, Riccardo; Viana, Diego Anton; Monti, Patrizia; Rocchitta, Gaia] Univ Sassari, Med Sch, Dept Med Surg & Expt Med, Sassari, Italy; [Serra, Pier Andrea] Italian Natl Res Council, Inst Sci Food Prod, Sassari, Italy; [Serra, Pier Andrea; Rocchitta, Gaia] Univ Sassari, Mediterranean Ctr Dis Control, Sassari, Italy; [Varoni, Maria Vittoria] Univ Sassari, Med Sch, Dept Vet Med, Sassari, Italy; [Sotgiu, Maria Alessandra; Bandiera, Pasquale] Univ Sassari, Med Sch, Dept Biomed Sci, Sassari, Italy	University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); University of Sassari; University of Sassari; University of Sassari	Serra, PA (corresponding author), Univ Sassari, Med Sch, Dept Med Surg & Expt Med, Sassari, Italy.; Serra, PA (corresponding author), Italian Natl Res Council, Inst Sci Food Prod, Sassari, Italy.; Serra, PA (corresponding author), Univ Sassari, Mediterranean Ctr Dis Control, Sassari, Italy.	paserra@uniss.it	Rocchitta, Gaia/HHM-8002-2022; BANDIERA, Pasquale/F-4276-2017	BANDIERA, Pasquale/0000-0002-0589-4539; SERRA, Pier Andrea/0000-0003-2401-5146	University of Sassari	University of Sassari	PAS: The research was supported by the University of Sassari ("Fondo di Ateneo per la Ricerca 2019"); GR: The research was supported by the University of Sassari ("Fondo di Ateneo per la Ricerca 2019"); www.uniss.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ML, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201720170238; Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102; Bazzu G, 2019, J NEUROSCI METH, V317, P20, DOI 10.1016/j.jneumeth.2019.01.012; Bazzu G, 2009, ANAL CHEM, V81, P2235, DOI 10.1021/ac802390f; Berman TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059967; Boardman L, 2012, P ROY SOC B-BIOL SCI, V279, P893, DOI 10.1098/rspb.2011.1243; Bolger FB, 2005, SENSORS-BASEL, V5, P473, DOI 10.3390/s5110473; Bovenkerk B, 2015, CURR TOP BEHAV NEURO, V19, P17, DOI 10.1007/7854_2014_329; Calia G, 2009, SENSORS-BASEL, V9, P2511, DOI 10.3390/s90402511; Carrel JE, 2002, J INSECT BEHAV, V15, P707, DOI 10.1023/A:1020704108399; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Castro MA, 2008, PFLUG ARCH EUR J PHY, V457, P519, DOI 10.1007/s00424-008-0526-1; Chen WK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056540, 10.1371/journal.pone.0053985, 10.1371/journal.pone.0073764]; Colinet H, 2012, BIOL LETTERS, V8, P1050, DOI 10.1098/rsbl.2012.0601; Contreras HL, 2010, J INSECT PHYSIOL, V56, P522, DOI 10.1016/j.jinsphys.2009.05.018; Dittmar A, 1997, SENSOR ACTUAT B-CHEM, V44, P316, DOI 10.1016/S0925-4005(97)00224-4; Elwood RW, 2009, ANIM BEHAV, V77, P1243, DOI 10.1016/j.anbehav.2009.01.028; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; GAMO S, 1981, ANESTHESIOLOGY, V54, P289, DOI 10.1097/00000542-198104000-00006; Groenewald B, 2014, J EXP BIOL, V217, P3407, DOI 10.1242/jeb.102814; Heinze S, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00156; Homberg U, 2018, J COMP NEUROL, V526, P2301, DOI 10.1002/cne.24497; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Kohler I, 1999, LAB ANIM, V33, P155, DOI 10.1258/002367799780578390; Li GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150667; Lowry JP, 1997, J NEUROSCI METH, V71, P177, DOI 10.1016/S0165-0270(96)00140-9; MacMillan HA, 2017, J INSECT PHYSIOL, V101, P97, DOI 10.1016/j.jinsphys.2017.07.005; Martin JP, 2015, CURR BIOL, V25, P2795, DOI 10.1016/j.cub.2015.09.044; Matthews PGD, 2013, J EXP BIOL, V216, P2012, DOI 10.1242/jeb.077479; Matthews PGD, 2011, J EXP BIOL, V214, P3062, DOI 10.1242/jeb.053991; McMahon CP, 2007, BIOSENS BIOELECTRON, V22, P1466, DOI 10.1016/j.bios.2006.06.027; O'Neill RD, 2008, TRAC-TREND ANAL CHEM, V27, P78, DOI 10.1016/j.trac.2007.11.008; Bordone MP, 2019, J NEUROCHEM, V151, P139, DOI 10.1111/jnc.14829; Pletcher D, 2001, INSTRUMENTAL METHODS, DOI [10.1533/9781782420545, DOI 10.1533/9781782420545]; Quinlan MC, 2006, RESP PHYSIOL NEUROBI, V154, P18, DOI 10.1016/j.resp.2006.04.004; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Rittschof CC, 2018, GLIA, V66, P1160, DOI 10.1002/glia.23235; Rocchitta G, 2019, ALCOHOL, V78, P69, DOI 10.1016/j.alcohol.2019.04.002; Rocchitta G, 2007, SENSOR ACTUAT B-CHEM, V126, P700, DOI 10.1016/j.snb.2007.04.019; Rocchitta G, 2013, ANAL CHEM, V85, P10282, DOI 10.1021/ac402071w; Rocchitta G, 2012, ANAL CHEM, V84, P7072, DOI 10.1021/ac301253h; Schimpf NG, 2009, J EXP BIOL, V212, P2773, DOI 10.1242/jeb.031310; Secchi O, 2013, SENSORS-BASEL, V13, P9522, DOI 10.3390/s130709522; SEIGER MB, 1993, BEHAV GENET, V23, P99, DOI 10.1007/BF01067559; Serra PA, 2007, SENSOR ACTUAT B-CHEM, V122, P118, DOI 10.1016/j.snb.2006.05.013; Sherwin CM, 2001, ANIM WELFARE, V10, pS103; Slama Karel, 2017, Life-The Excitement of Biology, V5, P4, DOI 10.9784/LEB5(1)Slama.01; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; Streicher JW, 2012, J EXP BIOL, V215, P1137, DOI 10.1242/jeb.061143; Tasbihgou SR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193062; Ueda I, 2000, KEIO J MED, V50, P20; Wipfler B, 2016, ARTHROPOD SYST PHYLO, V74, P267	53	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0224932	10.1371/journal.pone.0224932	http://dx.doi.org/10.1371/journal.pone.0224932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710629	Green Published, gold			2022-12-26	WOS:000532699900030
J	Nzila, A; Razzak, SA; Sankara, S; Nazal, MK; Al-Momani, M; Kang, GU; Ibal, JC; Shin, JH				Nzila, Alexis; Razzak, Shaikh Abdur; Sankara, Saravanan; Nazal, Mazen K.; Al-Momani, Marwan; Kang, Gi-Ung; Ibal, Jerald Conrad; Shin, Jae-Ho			Characterisation and microbial community analysis of lipid utilising microorganisms for biogas formation	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ANAEROBIC-DIGESTION; WASTE-WATER; HYDROCARBON DEGRADATION; RICH WASTE; INHIBITION; METHANOGENESIS; BACTERIA; SLUDGE; OIL	In the anaerobic process, fat-oil-grease (FOG) is hydrolysed to long-chain fatty acids (LCFAs) and glycerol (GLYC), which are then used as substrates to produce biogas. The increase in FOG and LCFAs inhibits methanogenesis, and so far, most work investigating this inhibition has been carried out when FOG or LCFAs were used as co-substrates. In the current work, the inhibition of methanogenesis by FOG, LCFAs and GLYC was investigated when used as sole substrates. To gain more insight on the dynamics of this process, the change of microbial community was analysed using 16S rRNA gene amplicon sequencing. The results indicate that, as the concentrations of cooking olive oil (CO, which represents FOG) and LCFAs increase, methanogenesis is inhibited. For instance, at 0.01 g. L-1 of FOG, the rate of biogas formation was around 8 ml.L-1.day(-1), and this decreased to < 4 ml.L-1.day(-1) at 40 g.L-1. Similar results were observed with the use of LCFAs. However, GLYC concentrations up to 100g.L-1 did not affect the rate of biogas formation. Acidic pH, temperature > = 45 degrees C and NaCl > 3% led to a significant decrease in the rate of biogas formation. Microbial community analyses were carried out from samples from 3 different bioreactors (CO, OLEI and GLYC), on day 1, 5 and 15. In each bioreactor, microbial communities were dominated by Proteobacteria, Firmicutes and Bacteroidetes phyla. The most important families were Enterobacteriaceae, Pseudomonadaceae and Shewanellaceae (Proteobacteria phylum), Clostridiacea and Ruminococcaceae (Firmicutes) and Porphyromonadaceae and Bacteroidaceae (Bacteroidetes). In CO bioreactor, Proteobacteria bacteria decreased over time, while those of OLEI and GLYC bioreactors increased. A more pronounced increase in Bacteroidetes and Firmicutes were observed in CO bioreactor. The methanogenic archaea Methanobacteriaceae and Methanocorpusculaceae were identified. This analysis has shown that a set of microbial population is selected as a function of the substrate.	[Nzila, Alexis; Sankara, Saravanan] King Fahd Univ Petr & Minerals, Dept Life Sci, Dhahran, Saudi Arabia; [Razzak, Shaikh Abdur] King Fahd Univ Petr & Minerals, Dept Chem Engn, Dhahran, Saudi Arabia; [Nazal, Mazen K.] King Fahd Univ Petr & Minerals, Ctr Environm & Water, Res Inst, Dhahran, Saudi Arabia; [Al-Momani, Marwan] King Fahd Univ Petr & Minerals, Dept Math & Stat, Dhahran, Saudi Arabia; [Kang, Gi-Ung; Ibal, Jerald Conrad; Shin, Jae-Ho] Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Appl Biosci, Daegu, South Korea	King Fahd University of Petroleum & Minerals; King Fahd University of Petroleum & Minerals; King Fahd University of Petroleum & Minerals; King Fahd University of Petroleum & Minerals; Kyungpook National University	Nzila, A (corresponding author), King Fahd Univ Petr & Minerals, Dept Life Sci, Dhahran, Saudi Arabia.	alexisnzila@kfupm.edu.sa	Nazal, Mazen Khaled/P-7491-2016; Al-Momani, Marwan/GLS-3162-2022; sankaran, saravanan s/E-2145-2016; Nazal, Mazen K/G-5863-2016; nzila, alexis/B-5993-2015; Abdur Razzak, Shaikh/C-4380-2015	Nazal, Mazen Khaled/0000-0001-5673-1900; Al-Momani, Marwan/0000-0003-3674-125X; nzila, alexis/0000-0002-0148-7063; Abdur Razzak, Shaikh/0000-0003-4316-7882; sankaran, saravanan/0000-0003-3562-422X	Deanship of Scientific Research (DSR) of the King Fahd University of Petroleum and Minerals (KFUPM) [IN131051]	Deanship of Scientific Research (DSR) of the King Fahd University of Petroleum and Minerals (KFUPM)	This work was funded by the Deanship of Scientific Research (DSR) of the King Fahd University of Petroleum and Minerals (KFUPM), grant IN131051 (www.kfupm.edu.sa/deanships/dsr/en/Pages/default.aspx) to AN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achinas S, 2017, ENGINEERING-PRC, V3, P299, DOI 10.1016/J.ENG.2017.03.002; An DS, 2013, GENOME, V56, P612, DOI 10.1139/gen-2013-0083; ANGELIDAKI I, 1992, APPL MICROBIOL BIOT, V37, P808, DOI 10.1007/BF00174850; Appels L, 2008, PROG ENERG COMBUST, V34, P755, DOI 10.1016/j.pecs.2008.06.002; Baek G, 2018, ENERGIES, V11, DOI 10.3390/en11010107; Baserba MG, 2012, BIORESOURCE TECHNOL, V106, P74, DOI 10.1016/j.biortech.2011.12.020; Beschkov V, 2012, BIOTECHNOL BIOTEC EQ, V26, P3244; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Campanaro S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0441-1; Cavaleiro AJ, 2008, BIORESOURCE TECHNOL, V99, P4086, DOI 10.1016/j.biortech.2007.09.005; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Chipasa KB, 2006, J IND MICROBIOL BIOT, V33, P635, DOI 10.1007/s10295-006-0099-y; Cirne DG, 2007, RENEW ENERG, V32, P965, DOI 10.1016/j.renene.2006.04.003; De Vrieze J, 2012, BIORESOURCE TECHNOL, V112, P1, DOI 10.1016/j.biortech.2012.02.079; Dube CD, 2015, ADV BIOCHEM ENG BIOT, V151, P101, DOI 10.1007/978-3-319-21993-6_4; Duda RM, 2015, BIORESOUR TECHNOL, V197; Fontana A, 2018, WATER RES, V134, P181, DOI 10.1016/j.watres.2018.02.001; Gilmore SP, 2019, ACS SYNTH BIOL; Goux X, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0309-9; Granada CE, 2018, RENEW ENERG, V118, P840, DOI 10.1016/j.renene.2017.11.077; Hahnke S, 2015, J BIOTECHNOL, V193, P34, DOI 10.1016/j.jbiotec.2014.11.010; He J, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0623-2; Hwu CS, 1997, ENZYME MICROB TECH, V21, P297, DOI 10.1016/S0141-0229(97)00050-1; Jain S, 2015, RENEW SUST ENERG REV, V52, P142, DOI 10.1016/j.rser.2015.07.091; Junemann S, 2017, J BIOTECHNOL, V261, P10, DOI 10.1016/j.jbiotec.2017.08.012; Kim HJ, 2010, FOOD SCI BIOTECHNOL, V19, P1097, DOI 10.1007/s10068-010-0155-2; KOMATSU T, 1991, WATER SCI TECHNOL, V23, P1189, DOI 10.2166/wst.1991.0570; KOSTER IW, 1987, APPL ENVIRON MICROB, V53, P403, DOI 10.1128/AEM.53.2.403-409.1987; Kougias PG, 2016, SCI REP-UK, V6, DOI 10.1038/srep28810; Kushkevych I, 2018, OPEN LIFE SCI, V13, P119, DOI 10.1515/biol-2018-0017; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; LOGINOVA LG, 1981, MICROBIOLOGY+, V50, P34; Long JH, 2012, PROCESS SAF ENVIRON, V90, P231, DOI [10.1016/j.psep.2011.10.001, 10.1016/j.psep.2012.04.002]; Mao CL, 2015, RENEW SUST ENERG REV, V45, P540, DOI 10.1016/j.rser.2015.02.032; Mendes AA, 2006, BIOCHEM ENG J, V32, P185, DOI 10.1016/j.bej.2006.09.021; Nisola GM, 2009, J ENVIRON ENG, V135, P876, DOI 10.1061/(ASCE)0733-9372(2009)135:9(876); Nzila A, 2017, ANAEROBE, V46, P3, DOI 10.1016/j.anaerobe.2016.11.007; Ozbayram EG, 2018, J APPL MICROBIOL, V124, P491, DOI 10.1111/jam.13668; Poehlein A, 2018, ARCHAEA, V2018, DOI 10.1155/2018/7609847; Pyzik A, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-1043-3; Rasit N, 2015, RENEW SUST ENERG REV, V45, P351, DOI 10.1016/j.rser.2015.01.066; Regueiro L, 2015, BIORESOURCE TECHNOL, V197, P208, DOI 10.1016/j.biortech.2015.08.076; RINZEMA A, 1994, WATER ENVIRON RES, V66, P40, DOI 10.2175/WER.66.1.7; Rui JP, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0339-3; Savant DV, 2004, WATER SCI TECHNOL, V50, P109, DOI 10.2166/wst.2004.0366; Shigematsu T, 2006, J BIOSCI BIOENG, V102, P535, DOI 10.1263/jbb.102.535; Shin H, 2003, WATER SCI TECHNOL, V47, P139; Silva SA, 2014, BIOMASS BIOENERG, V67, P297, DOI 10.1016/j.biombioe.2014.05.012; SORKHOH NA, 1993, APPL MICROBIOL BIOT, V39, P123, DOI 10.1007/BF00166860; Sousa DZ, 2008, WATER SCI TECHNOL, V57, P439, DOI 10.2166/wst.2008.090; Sousa DZ, 2007, FEMS MICROBIOL ECOL, V60, P252, DOI 10.1111/j.1574-6941.2007.00291.x; Sousa DZ, 2007, APPL ENVIRON MICROB, V73, P1054, DOI 10.1128/AEM.01723-06; Sousa DZ, 2013, EFFECT LONG CHAIN FA; Sowada J, 2014, FEMS MICROBIOL ECOL, V88, P129, DOI 10.1111/1574-6941.12276; Stolze Y, 2018, MICROB BIOTECHNOL, V11, P667, DOI 10.1111/1751-7915.12982; Su XB, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1237-2; Venkiteshwaran Kaushik, 2015, Microbiol Insights, V8, P37, DOI 10.4137/MBI.S33593; Viana M. B., 2012, Environmental Technology Reviews, V1, P81, DOI 10.1080/09593330.2012.692723; Wang SX, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-04692-8, 10.1038/s41598-017-10970-2]; Wang XQ, 2019, INT J HYDROGEN ENERG, V44, P15853, DOI 10.1016/j.ijhydene.2018.07.034; Wu YC, 2017, CHEM ENG J, V326, P462, DOI 10.1016/j.cej.2017.05.172; Xu XJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02885; Yang Y, 2014, APPL MICROBIOL BIOT, V98, P5709, DOI 10.1007/s00253-014-5648-0; Zahedi S, 2017, FUEL, V193, P15, DOI 10.1016/j.fuel.2016.12.024; Zamanzadeh M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15784-w; ZARILLA KA, 1987, SYST APPL MICROBIOL, V9, P258, DOI 10.1016/S0723-2020(87)80031-0; ZARILLA KA, 1986, INT J SYST BACTERIOL, V36, P13, DOI 10.1099/00207713-36-1-13; Zhou J, 2016, BIORESOURCE TECHNOL, V217, P44, DOI 10.1016/j.biortech.2016.02.077; Zhou X, 2013, ARCHAEA, V2013, DOI 10.1155/2013/106916; Ziels RM, 2016, WATER RES, V103, P372, DOI 10.1016/j.watres.2016.07.043	70	8	9	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224989	10.1371/journal.pone.0224989	http://dx.doi.org/10.1371/journal.pone.0224989			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703100	Green Published, gold			2022-12-26	WOS:000532697200035
J	Ustinova, M; Silamikelis, I; Kalnina, I; Ansone, L; Rovite, V; Elbere, I; Radovica-Spalvina, I; Fridmanis, D; Aladyeva, J; Konrade, I; Pirags, V; Klovins, J				Ustinova, Monta; Silamikelis, Ivars; Kalnina, Ineta; Ansone, Laura; Rovite, Vita; Elbere, Ilze; Radovica-Spalvina, Ilze; Fridmanis, Davids; Aladyeva, Jekaterina; Konrade, Ilze; Pirags, Valdis; Klovins, Janis			Metformin strongly affects transcriptome of peripheral blood cells in healthy individuals	PLOS ONE			English	Article							DOUBLE-BLIND; CHOLESTEROL; CANCER; LIVER; PHARMACOGENOMICS; ASSOCIATION; PREVENTION; MORTALITY; VARIANTS; PRESSURE	Metformin is a commonly used antihyperglycaemic agent for the treatment of type 2 diabetes mellitus. Nevertheless, the exact mechanisms of action, underlying the various therapeutic effects of metformin, remain elusive. The goal of this study was to evaluate the alterations in longitudinal whole-blood transcriptome profiles of healthy individuals after a one-week metformin intervention in order to identify the novel molecular targets and further prompt the discovery of predictive biomarkers of metformin response. Next generation sequencing-based transcriptome analysis revealed metformin-induced differential expression of genes involved in intestinal immune network for IgA production and cytokine-cytokine receptor interaction pathways. Significantly elevated faecal sIgA levels during administration of metformin, and its correlation with the expression of genes associated with immune response (CXCR4, HLA-DQA1, MAP3K14, TNFRSF21, CCL4, ACVR1B, PF4, EPOR, CXCL8) supports a novel hypothesis of strong association between metformin and intestinal immune system, and for the first time provide evidence for altered RNA expression as a contributing mechanism of metformin's action. In addition to universal effects, 4 clusters of functionally related genes with a subject-specific differential expression were distinguished, including genes relevant to insulin production (HNF1B, HNF1A, HNF4A, GCK, INS, NEUROD1, PAX4, PDX1, ABCC8, KCNJ11) and cholesterol homeostasis (APOB, LDLR, PCSK9). This inter-individual variation of the metformin effect on the transcriptional regulation goes in line with well-known variability of the therapeutic response to the drug.	[Ustinova, Monta; Silamikelis, Ivars; Kalnina, Ineta; Ansone, Laura; Rovite, Vita; Elbere, Ilze; Radovica-Spalvina, Ilze; Fridmanis, Davids; Aladyeva, Jekaterina; Pirags, Valdis; Klovins, Janis] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Konrade, Ilze] Riga Stradins Univ, Riga, Latvia	Latvian Biomedical Research & Study Centre; Riga Stradins University	Klovins, J (corresponding author), Latvian Biomed Res & Study Ctr, Riga, Latvia.	Klovins@biomed.lu.lv	Ustinova, Monta/AAQ-4637-2020; Fridmanis, Davids/I-3292-2017; Kalnina, Ineta/AAY-9281-2020; Klovins, Janis/C-5695-2011; Pirags, Valdis/AAQ-5492-2020	Fridmanis, Davids/0000-0003-0310-0448; Pirags, Valdis/0000-0002-3650-7394; Elbere, Ilze/0000-0003-4381-885X; Silamikelis, Ivars/0000-0002-7932-1047; Klovins, Janis/0000-0001-8362-5505; Aladyeva, Ekaterina/0000-0002-3483-6944; Kalnina, Ineta/0000-0003-3462-3196	European Regional Development Fund [1.1.1.1/16/A/091]	European Regional Development Fund(European Commission)	The study was supported by the European Regional Development Fund under the project "Investigation of interplay between multiple determinants influencing response to metformin: search for reliable predictors for efficacy of type 2 diabetes therapy"(Project No.: 1.1.1.1/16/A/091, https://ec.europa.eu/regional_policy/en/funding/erdf/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 2007, COMPUTING SCI ENG, V9, P10; Asadbegi M, 2016, BRAIN RES BULL, V121, P178, DOI 10.1016/j.brainresbull.2016.02.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruno S, 2015, ONCOTARGET, V6, P22624, DOI 10.18632/oncotarget.4168; Cameron AR, 2016, CIRC RES, V119, P652, DOI 10.1161/CIRCRESAHA.116.308445; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Choi JH, 2011, CLIN PHARMACOL THER, V90, P674, DOI 10.1038/clpt.2011.165; Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Dayeh T, 2016, EPIGENETICS-US, V11, P482, DOI 10.1080/15592294.2016.1178418; DIXON JL, 1993, J LIPID RES, V34, P167; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Elbere I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204317; Fadlallah J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1217; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; GODARTS, 2011, NAT GENET, V43, P117, DOI DOI 10.1038/NG.735; Guo J, 2018, CELL PHYSIOL BIOCHEM, V45, P1487, DOI 10.1159/000487575; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Gutzeit C, 2014, IMMUNOL REV, V260, P76, DOI 10.1111/imr.12189; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Johnson JA, 2005, DIABETIC MED, V22, P497, DOI 10.1111/j.1464-5491.2005.01448.x; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Lee MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05721-4; Malinska H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150924; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mendelsohn AR, 2011, REJUV RES, V14, P437, DOI 10.1089/rej.2011.1238; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Niu NF, 2016, HUM MOL GENET, V25, P4819, DOI 10.1093/hmg/ddw301; Padilla J, 2017, EXP BIOL MED, V242, P617, DOI 10.1177/1535370216689825; Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367; PENTIKAINEN PJ, 1990, ANN MED, V22, P307, DOI 10.3109/07853899009147912; Quinn BJ, 2013, TRENDS ENDOCRIN MET, V24, P469, DOI 10.1016/j.tem.2013.05.004; Radovica-Spalvina I, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0230-x; Rotroff DM, 2018, DIABETES, V67, P1428, DOI 10.2337/db17-1164; Rovite V, 2018, J EPIDEMIOL; Sacco F, 2016, CELL SYST, V2, P159, DOI 10.1016/j.cels.2016.02.005; Shikata E, 2007, J HUM GENET, V52, P117, DOI 10.1007/s10038-006-0087-0; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Tkac I, 2013, DIABETES OBES METAB, V15, P189, DOI 10.1111/j.1463-1326.2012.01691.x; Trapani L, 2012, WORLD J HEPATOL, V4, P184, DOI 10.4254/wjh.v4.i6.184; Udhane SS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09189-y; VELAZQUEZ EM, 1994, METABOLISM, V43, P647, DOI 10.1016/0026-0495(94)90209-7; Vila IK, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1304846; Wang QY, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/9469670; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wulffele MG, 2004, J INTERN MED, V256, P1, DOI 10.1111/j.1365-2796.2004.01328.x; Xiao ZH, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6589423; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou KX, 2014, LANCET DIABETES ENDO, V2, P481, DOI 10.1016/S2213-8587(14)70050-6; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	53	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224835	10.1371/journal.pone.0224835	http://dx.doi.org/10.1371/journal.pone.0224835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703101	gold, Green Published			2022-12-26	WOS:000532697200027
J	Kunishima, H; Yoshida, E; Caputo, J; Mikamo, H				Kunishima, Hiroyuki; Yoshida, Emiko; Caputo, Joe; Mikamo, Hiroshige			Estimating the national cost burden of in-hospital needlestick injuries among healthcare workers in Japan	PLOS ONE			English	Article							SHARPS INJURIES; HEPATITIS-C; PREVALENCE; CARRIERS; VIRUSES; CLIMATE	Background Needlestick injury (NSI) is one of the most burdensome professional hazards in any medical setting; it can lead to transmission of fatal infectious diseases, such as hepatitis B, hepatitis C and human immunodeficiency virus. In the United States, the annual cost burden was estimated as somewhere between $118 million to $591 million; in the United Kingdom it is approximated to be 500,000 pound (US$919,117.65) per the National Health Service. Method This is the first published paper on the national cost burden of NSIs in Japan. A systematic literature review was conducted to review previous study design in global studies and to extract parameter values from Japanese studies. We conducted abstract searches through PubMed and the Japan Medical Abstracts Society (Ichushi), together with grey literature and snowball searches. A simple economic model was developed to calculate cost burden of NSIs from a societal perspective over a one-year time horizon. We assumed all NSIs are reported and perfect adherence in post NSI management that presented in the labour compensation scheme. Local guidelines were also referenced to extract resource utilization. Lastly, a deterministic sensitivity analysis was conducted and a scenario analysis which considered a payer perspective was also included. Result and conclusion The national cost burden of in-hospital NSIs is estimated as (sic)33.4 billion (US$302 million) annually, based on an average cost per NSI of (sic)63,711 (US$577) and number of NSIs at 525,000/year. 70% of the cost is due to initial laboratory tests, followed by productivity loss, estimated at 20% of the total cost. Cost of contaminated NSIs remains at 5% of the total cost. Change in number of NSIs significantly influences outcomes. Variation in post-exposure management practices suggests a need for NSI specific National guidelines and holistic labour compensation scheme development in Japan.	[Kunishima, Hiroyuki] St Marianna Univ, Dept Infect Dis, Kawasaki, Kanagawa, Japan; [Yoshida, Emiko] Healthcare All Co Ltd, Tokyo, Japan; [Caputo, Joe] Vista Hlth Pte Ltd, Singapore, Singapore; [Mikamo, Hiroshige] Aichi Med Univ, Dept Clin Infect Dis, Nagakute, Aichi, Japan; [Kunishima, Hiroyuki] 2-16-1 Sugao Miyamaeku, Kawasaki, Kanagawa, Japan; [Mikamo, Hiroshige] 1-1 Yazakokarimata, Nagakute, Aichi, Japan	Saint Marianna University; Aichi Medical University	Yoshida, E (corresponding author), Healthcare All Co Ltd, Tokyo, Japan.	emiko.yoshida@healthcare2all.com			Nippon Becton Dickinson Company, Ltd. (BDJ)	Nippon Becton Dickinson Company, Ltd. (BDJ)	JC and EY are specialist research consultants in Vista Health Pte Ltd and Healthcare to All Co Ltd, which conduct health economic research on their clients' behalf. Both were funded for this study by Nippon Becton Dickinson Company, Ltd. (www.bdj.co.jp) (BDJ) whYich has pipeline products to prevent needlestick injury in insulin injection. BDJ provided support in the form of research fees for authors JC and EY but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2010, FUND LOCAL GOVT EMPL; Arise K, 2013, JPN J ENV INFECT, V28, P147; Center for Disease Control and Prevention, 2004, MEAS COST SHARPS INJ; de Jager P, 2018, SAMJ S AFR MED J, V108, P477, DOI [10.7196/samj.2018.v108i6.12913, 10.7196/SAMJ.2018.v108i6.12913]; de Perio M. A., 2012, NEEDLESTICK INJURIES; Hatanaka S, 2006, JAPANESE J ENV INFEC, V21, P185; Hiramitsu Y, 2017, JAPAN MED J, V4874, P42; Honda T, 1998, JAPANESE J MED INSTR, V68, P72; Horikawa S, 2007, J JAPANESE SOC CLIN, V9, P37; Japanese Association of Dialysis Physicians, 2015, GUID STAND HEM PROC; Jason J, 2013, J PUBLIC HEALTH-UK, V35, P422, DOI 10.1093/pubmed/fdt033; Kanda Y, 1998, JAPANESE J ENV INFEC, V13, P161, DOI [10.11550/jsei1986.13.161, DOI 10.11550/JSEI1986.13.161]; Kawatani T, 2000, INFECT CONTROL, V9, P86; Kidouchi K, 1997, Kansenshogaku Zasshi, V71, P108; Kidouchi K, 1998, INJURYTHE JAPANESE J, V68, P35; Kidouchi K, 2003, STATUS NEEDLESTICK I; Kidouchi K, 2000, STATUS NEEDLESTICK I, P243; Kimura S, 2002, NEEDLESTICK SHARPS I; Kimura S, 1997, EXPERIENCE CARE PATI, P41; Koyama S, 2008, JAPANESE J ENV INFEC, V23, P285; Maeda H, 2010, JAPANESE J ENV INFEC, V25, P229, DOI [10.4058/jsei.25.229, DOI 10.4058/JSEI.25.229]; Matsui Y, 2007, J HAMAMATSU MED CTR, V1, P80; Matsunami T, 1999, JAPANESE J NURSING A, V30, P59; Mitani M, 1999, MED J KOCHI RED CROS, V7, P55; Nagao Y, 2007, AM J INFECT CONTROL, V35, P407, DOI 10.1016/j.ajic.2006.03.015; *NAT AUD OFF, 2003, SAF PLAC WORK IMPR M; Nishiuchi Y, 2013, INFECT CONTROL, V22, P494; OECD, OECD DAT; OECD, 2017, HLTH GLANC 2017 OECD; Ohno S, 2000, JAPANESE J ENV INFEC, V15, P264; Onishi T, 2011, J OSAKI CITIZEN HOSP, V15, P44; Otsu S, 2013, INFECT CONTROL, V22, P510; Paterson C, 2005, SAFER SHARPS DEVICES; Sakurada N, 2003, JAPANESE J NURSING S, V28, P1066; Smith DR, 2006, J HOSP INFECT, V64, P44, DOI 10.1016/j.jhin.2006.03.021; Smith DR, 2010, IND HEALTH, V48, P85, DOI 10.2486/indhealth.48.85; Smith DR, 2009, AM J INFECT CONTROL, V37, P545, DOI 10.1016/j.ajic.2008.11.004; Suewaka M, 2007, MED J KAWASAKI HOSP, V2, P108; Sumimoto W, 2009, JAPANESE J OCCUPATIO, V57, P258; Suzuki Rie, 2006, Kansenshogaku Zasshi, V80, P39; Takahashi Y, 1999, JAPANESE J TRANSFUSI, V45, P442; Takase C, 2002, J NISHIWAKI CITY GEN, V2, P59; Tanaka J, 2018, J VIRAL HEPATITIS, V25, P363, DOI 10.1111/jvh.12828; Tanaka J, 2004, INTERVIROLOGY, V47, P32, DOI 10.1159/000076640; Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525; Tanaka M, 1996, JAPANESE J NURSING A, V6; The NHS staff council, 2015, MAN RISKS SHARPS INJ; The UK Health and Safety Executive, 2008, HSE0860 UK HLTH SAF; The UK Health and Safety Executive, APPR VAL UN COSTS; Umeoka S, 2003, MED B ONOMICHI GEN H, V13, P73; United States General Accounting Office, 2000, OCC SAF SEL COST BEN; Urano M, 1997, JAPANESE J ENV INFEC, V12, P94; Usami I, 1999, JAPANESE J ENV INFEC, V14, P212; Yagi T, 2013, 2013 MHLW GRANT REPO; Yamazaki I, 2005, INFECT CONTROL, V14, P182; Yoshikawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077524; Yukawa J, 2005, IGNAZZO	57	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224142	10.1371/journal.pone.0224142	http://dx.doi.org/10.1371/journal.pone.0224142			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697746	Green Submitted, Green Published, gold			2022-12-26	WOS:000532694400019
J	Pedersen, PBM; Olsen, JB; Sandel, B; Svenning, JC				Pedersen, Pil Birkefeldt Moller; Olsen, Joanna B.; Sandel, Brody; Svenning, Jens-Christian			Wild Steps in a semi-wild setting? Habitat selection and behavior of European bison reintroduced to an enclosure in an anthropogenic landscape	PLOS ONE			English	Article							LARGE HERBIVORES; CONSERVATION; MEGAFAUNA; TRAITS	Recently, several wild or semi-wild herds of European bison have been reintroduced across Europe. It is essential for future successful bison reintroductions to know how the European bison use different habitats, which environmental parameters drive their habitat selection, and whether their habitat use and behavioural patterns in new reintroduction sites differ from habitats where European bison have been roaming freely for a long time. Here, we address these questions for a 40-ha enclosed site that has been inhabited by semi-free ranging European bison since 2012. The site, Vorup Meadows, is adjacent to the Gudena river in Denmark and consists of human-modified riparian meadows. During 2013 we monitored the behavioural pattern and spatial use of the 11 bison present and in parallel carried out floristic analyses to assess habitat structure and food quality in the enclosure. We tested habitat use and selection against environmental parameters such as habitat characteristics, plant community traits, topography, and management area (release area vs. meadow area) using linear regression and spatial models. The bison herd had comparable diurnal activity patterns as observed in previous studies on free-roaming bison herds. Topography emerged as the main predictor of the frequency of occurrence in our spatial models, with high-lying drier areas being used more. Bison did not prefer open areas over areas with tree cover when accounting for habitat availability. However, they spent significantly more time in the release area, a former agricultural field with supplementary fodder, than expected from availability compared to the rest of the enclosure, a meadow with tree patches. We wish to increase awareness of possible long-term ethological effects of the release site and the management protocols accomplished here that might reduce the ecological impact by the bison in the target habitat, and thereby compromise or even oppose the conservation goals of the conservation efforts.	[Pedersen, Pil Birkefeldt Moller; Olsen, Joanna B.; Sandel, Brody; Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark; [Pedersen, Pil Birkefeldt Moller; Svenning, Jens-Christian] Aarhus Univ, Ctr Biodivers Dynam Changing World BIOCHANGE, Dept Biosci, Aarhus, Denmark; [Sandel, Brody] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA	Aarhus University; Aarhus University; Santa Clara University	Pedersen, PBM (corresponding author), Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark.; Pedersen, PBM (corresponding author), Aarhus Univ, Ctr Biodivers Dynam Changing World BIOCHANGE, Dept Biosci, Aarhus, Denmark.	pil.pedersen@bios.au.dk	Svenning, Jens-Christian/C-8977-2012	Svenning, Jens-Christian/0000-0002-3415-0862; Pedersen, Pil/0000-0002-8378-4677	Aarhus University, Science and Technology; Aage V. Jensen Nature Foundation; Carlsberg Foundation Semper Arden project MegaPast2Future [CF16-0005]; VILLUM Investigator project (VILLUM FONDEN) [16549]	Aarhus University, Science and Technology; Aage V. Jensen Nature Foundation; Carlsberg Foundation Semper Arden project MegaPast2Future; VILLUM Investigator project (VILLUM FONDEN)	This work was supported by: Aarhus University, Science and Technology, PhD stipendia (PBMP); Aage V. Jensen Nature Foundation (http://www.avjf.dk/avjnf/) (PBMP); Carlsberg Foundation Semper Arden project MegaPast2Future (grant CF16-0005) (http://www.carlsbergfondet.dk/en) (J-CS); VILLUM Investigator project (VILLUM FONDEN, grant 16549) (http://veluxfoundations.dk/en) (J-CS).	Bakker ES, 2016, P NATL ACAD SCI USA, V113, P847, DOI 10.1073/pnas.1502545112; Barton K., 2016, MUMIN MULTIMODEL INF; Bleyhl B, 2015, BIOL CONSERV, V191, P83, DOI 10.1016/j.biocon.2015.06.011; Bocherens H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115090; BOCHERENS ZA, 1987, ACTA THERIOL, V32, P335; BOCHERENS ZA, 1983, ACTA THERIOL, V28, P273; BOCHERENS ZA, 2007, THE NATURE MONOGRAPH; Bonasus Bison, 2008, IUCN RED LIST THREAT; BOROWSKI S, 1972, Acta Theriologica, V17, P151, DOI 10.4098/AT.arch.72-13; Brandtberg NH, 2013, EUROPEAN BISON CONSE, V6, P73; Briemle G., 2002, SCHRIFTR VEG, V38, P203; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cromsigt JPGM, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0440; Cromsigt JPGM, 2018, RESTOR ECOL, V26, P891, DOI 10.1111/rec.12661; Cromsigt JPGM, 2012, DIVERS DISTRIB, V18, P1253, DOI 10.1111/j.1472-4642.2012.00927.x; Daleszczyk K, 2007, CAN J ZOOL, V85, P261, DOI 10.1139/Z06-209; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Doughty CE, 2016, P NATL ACAD SCI USA, V113, P868, DOI 10.1073/pnas.1502549112; ESRI, 2010, ARCGIS; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Galetti M, 2018, BIOL REV, V93, P845, DOI 10.1111/brv.12374; GEBCZYNSKA Z, 1991, ACTA THERIOL, V36, P307; Graler B, 2016, R J, V8, P204; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JANZEN DH, 1984, AM NAT, V123, P338, DOI 10.1086/284208; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S., 2002, SCHRIFTENREIHE VEGET; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Krasinska M, 2000, ACTA THERIOL, V45, P321, DOI 10.4098/AT.arch.00-32; Kuemmerle T, 2012, DIVERS DISTRIB, V18, P1258, DOI 10.1111/ddi.12013; Kuemmerle T, 2012, DIVERS DISTRIB, V18, P47, DOI 10.1111/j.1472-4642.2011.00849.x; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; Massilani D, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0317-7; Nielsen Knud Erik, 2012, Biodiversity Ecol, V4, P375, DOI 10.7809/b-e.00165; Olech W., 2008, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2008.RLTS.T2814A9484719.en, DOI 10.2305/IUCN.UK.2008.RLTS.T2814A9484719.EN]; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Palacio P, 2017, GENOME DATA EXTINCT, V17, DOI [10.1186/s12862-017-0894-2, DOI 10.1186/S12862-017-0894-2]; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pedersen PBM, 2020, AMBIO, V49, P231, DOI 10.1007/s13280-019-01192-z; Pontes LDS, 2007, FUNCT ECOL, V21, P844, DOI 10.1111/j.1365-2435.2007.01316.x; R Core Team, 2018, R LANG ENV STAT COMP; Ramos A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147404; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Rosenkranz B, TECHNICAL REPORT SER; Schmitz P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143046; Schneider TC, 2013, MAMM BIOL, V78, P438, DOI 10.1016/j.mambio.2013.06.002; Steuer P, 2015, EUR J WILDLIFE RES, V61, P91, DOI 10.1007/s10344-014-0877-1; Svenning JC, 2016, P NATL ACAD SCI USA, V113, P898, DOI 10.1073/pnas.1502556112; van Klink R, 2015, BIOL REV, V90, P347, DOI 10.1111/brv.12113; van Vuure C, 2005, RETRACING AUROCHS HI; Vera FWM, 2000, GRAZING ECOLOGY FORE; Zielke L, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11040063	54	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0198308	10.1371/journal.pone.0198308	http://dx.doi.org/10.1371/journal.pone.0198308			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697680	gold, Green Published			2022-12-26	WOS:000532694400001
J	Stormark, KM; Fosse, HE; Pallesen, S; Hysing, M				Stormark, Kjell Morten; Fosse, Hedvik Elisabeth; Pallesen, Stale; Hysing, Mari			The association between sleep problems and academic performance in primary school-aged children: Findings from a Norwegian longitudinal population-based study	PLOS ONE			English	Article							MENTAL-HEALTH; BEHAVIORAL-PROBLEMS; INADEQUATE SLEEP; CHILDHOOD; ADOLESCENTS; PATTERNS; QUALITY; PREVALENCE; INSOMNIA; DIFFICULTIES	The purpose of this study was to examine the longitudinal association between concurrent, transitory and persistent difficulties initiating and maintaining sleep (DIMS) on academic performance in children in a. longitudinal child-cohort (N = 3986) targeting school-aged children when they were 7-9 years (T1) and 11-13 years (T2) old, whilst controlling for mental health problems. DIMS were parent-reported at T1 and T2 and academic performance teacher-reported at T2. Mental health was based on child self-report at T2 using the Strength and Difficulties Questionnaire (SDQ). In all, 10.6% (n = 423) of the children had poor school performance at T2. These had more symptoms of externalizing and internalizing mental health problems (p. < 001) compared to their peers at T2. A logistic regression analysis showed that both concurrent DIMS (at T2, but not at T1) and persistent DIMS (at both T1 and T2) was associated with elevated risk of poor academic performance. After controlling for mental health problems, only persistent DIMS was associated with increased risk of poor academic performance. Transitory DIMS (DIMS at T1 but not at T2) did not increase the risk of later poor academic performance. A mediation analysis also revealed that the association between DIMS and poor school performance was mediated by mental health problems, in addition to an overall significant direct relative effect of DIMS on poor school performance in the persistent DIMS group. These findings support the notion that sleep problems in children are associated with impaired academic performance, and extends past findings demonstrating that sleep problems may not increase the risk of poor academic performance unless they persist over time. The negative effects of persistent sleep problems suggest that more emphasis should be put on preventive interventions of sleep problems in school-aged children.	[Stormark, Kjell Morten; Fosse, Hedvik Elisabeth; Hysing, Mari] NORCE Norwegian Res Ctr, Reg Ctr Child & Youth Mental Hlth & Child Welf, N-5020 Bergen, Norway; [Stormark, Kjell Morten; Pallesen, Stale] Univ Bergen, Dept Hlth Promot & Dev, Bergen, Norway; [Pallesen, Stale] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, Bergen, Norway; [Hysing, Mari] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway	Norwegian Research Centre (NORCE); University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Stormark, KM (corresponding author), NORCE Norwegian Res Ctr, Reg Ctr Child & Youth Mental Hlth & Child Welf, N-5020 Bergen, Norway.; Stormark, KM (corresponding author), Univ Bergen, Dept Hlth Promot & Dev, Bergen, Norway.	kjell.stormark@norceresearch.no						Ahrberg K, 2012, J PSYCHIATR RES, V46, P1618, DOI 10.1016/j.jpsychires.2012.09.008; Allik H, 2006, J AUTISM DEV DISORD, V36, P585, DOI 10.1007/s10803-006-0099-9; Armstrong JM, 2014, SLEEP, V37, P901, DOI 10.5665/sleep.3656; Association A.P., 2013, DIAGNOSTIC STAT MANU; Astill RG, 2012, PSYCHOL BULL, V138, P1109, DOI 10.1037/a0028204; Bao ZZ, 2018, J SCHOOL HEALTH, V88, P315, DOI 10.1111/josh.12608; Barclay NL, 2015, SLEEP, V38, P109, DOI 10.5665/sleep.4334; Becker SP, 2014, SLEEP MED, V15, P1094, DOI 10.1016/j.sleep.2014.06.001; Blader JC, 1997, ARCH PEDIAT ADOL MED, V151, P473, DOI 10.1001/archpedi.1997.02170420043007; Blunden S, 2018, SLEEP HEALTH, V4, P135, DOI 10.1016/j.sleh.2017.12.006; Boe T, 2012, J PSYCHOSOM RES, V73, P430, DOI 10.1016/j.jpsychores.2012.09.008; Buckhalt JA, 2007, CHILD DEV, V78, P213, DOI 10.1111/j.1467-8624.2007.00993.x; Byars KC, 2012, PEDIATRICS; Calhoun SL, 2014, SLEEP MED, V15, P91, DOI 10.1016/j.sleep.2013.08.787; Chaput JP, 2016, APPL PHYSIOL NUTR ME, V41, pS266, DOI 10.1139/apnm-2015-0627; CLARKSON S, 1986, AUST PAEDIATR J, V22, P31; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dewald-Kaufmann JF, 2014, J CHILD PSYCHOL PSYC, V55, P273, DOI 10.1111/jcpp.12157; Fallone G, 2002, SLEEP MED REV, V6, P287, DOI 10.1053/smrv.2001.0192; Fredriksen K, 2004, CHILD DEV, V75, P84, DOI 10.1111/j.1467-8624.2004.00655.x; Fricke-Oerkermann L, 2007, SLEEP, V30, P1371, DOI 10.1093/sleep/30.10.1371; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Gregory AM, 2006, SLEEP, V29, P1063, DOI 10.1093/sleep/29.8.1063; Gregory AM, 2016, J CHILD PSYCHOL PSYC, V57, P296, DOI 10.1111/jcpp.12469; Gregory AM, 2012, SLEEP MED REV, V16, P129, DOI 10.1016/j.smrv.2011.03.007; Gregory AM, 2009, PEDIATRICS, V123, P1171, DOI 10.1542/peds.2008-0825; Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015; Gruber R, 2016, SLEEP MED, V21, P93, DOI 10.1016/j.sleep.2016.01.012; Hanson MD, 2010, HEALTH PSYCHOL, V29, P394, DOI 10.1037/a0019879; Hayes A., 2017, INTRO MEDIATION MODE; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Heiervang E, 2007, J AM ACAD CHILD PSY, V46, P438, DOI 10.1097/chi.0b013e31803062bf; Hochadel J, 2014, PSYCHOPATHOLOGY, V47, P119, DOI 10.1159/000345403; Hysing M, 2016, J SLEEP RES, V25, P318, DOI 10.1111/jsr.12373; Hysing M, 2015, SCAND J PUBLIC HEALT, V43, P2, DOI 10.1177/1403494814556647; Hysing M, 2013, J SLEEP RES, V22, P549, DOI 10.1111/jsr.12055; Hysing M, 2009, J PEDIATR PSYCHOL, V34, P665, DOI 10.1093/jpepsy/jsn095; Ipsiroglu OS, 2002, J ADOLESCENT HEALTH, V31, P436, DOI 10.1016/S1054-139X(02)00423-8; KAHN A, 1989, PEDIATRICS, V84, P542; Kaplan KA, 2017, BIOL PSYCHOL, V123, P37, DOI 10.1016/j.biopsycho.2016.11.010; Knutson KL, 2005, AM J HUM BIOL, V17, P418, DOI 10.1002/ajhb.20405; Krystal AD, 2008, SLEEP MED, V9, pS10, DOI 10.1016/S1389-9457(08)70011-X; Laberge L, 2001, J SLEEP RES, V10, P59, DOI 10.1046/j.1365-2869.2001.00242.x; Lee KA, 1999, J ADOLESCENT HEALTH, V24, P16, DOI 10.1016/S1054-139X(98)00074-3; Lin WH, 2015, J YOUTH ADOLESCENCE, V44, P431, DOI 10.1007/s10964-014-0169-9; Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F; Liu XC, 2002, PSYCHIAT RES, V111, P75, DOI 10.1016/S0165-1781(02)00131-2; Lo JC, 2016, SLEEP, V39, P687, DOI 10.5665/sleep.5552; Meijer AM, 2000, J SLEEP RES, V9, P145; Metsapelto RL, 2015, J EDUC PSYCHOL, V107, P246, DOI 10.1037/a0037389; Mindell JA, 2009, SLEEP MED, V10, P771, DOI 10.1016/j.sleep.2008.07.016; Mitru G, 2002, TEACH COLL REC, V104, P704, DOI 10.1111/1467-9620.00176; Owens J., 2007, SLEEP MED CLIN; Owens JA, 2000, J DEV BEHAV PEDIATR, V21, P27, DOI 10.1097/00004703-200002000-00005; Owens M, 2012, SCHOOL PSYCHOL INT, V33, P433, DOI 10.1177/0143034311427433; Paavonen EJ, 2000, ACTA PAEDIATR, V89, P223, DOI 10.1080/080352500750028870; Perfect MM, 2014, PSYCHOL SCHOOLS, V51, P273, DOI 10.1002/pits.21746; Petit D, 2007, PEDIATRICS, V119, pE1016, DOI 10.1542/peds.2006-2132; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Reid R, 2004, J SPEC EDUC, V38, P130, DOI 10.1177/00224669040380030101; Roberts RE, 2009, J ADOLESCENCE, V32, P1045, DOI 10.1016/j.adolescence.2009.03.007; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Shochat T, 2014, SLEEP MED REV, V18, P75, DOI 10.1016/j.smrv.2013.03.005; SIMMONS RG, 1987, CHILD DEV, V58, P1220, DOI 10.2307/1130616; Sivertsen B, 2017, J SLEEP RES, V26, P55, DOI 10.1111/jsr.12443; Sivertsen B, 2012, AUTISM, V16, P139, DOI 10.1177/1362361311404255; Sivertsen Borge, 2009, Child Adolesc Psychiatry Ment Health, V3, P22, DOI 10.1186/1753-2000-3-22; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Spruyt K, 2005, J SLEEP RES, V14, P163, DOI 10.1111/j.1365-2869.2005.00458.x; Steenari MR, 2003, J AM ACAD CHILD PSY, V42, P85, DOI 10.1097/00004583-200301000-00014; Stein MA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e60; Stormark KM, 2008, J ABNORM CHILD PSYCH, V36, P411, DOI 10.1007/s10802-007-9187-3; Turnbull K, 2013, SLEEP, V36, P1077, DOI 10.5665/sleep.2814; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wolfson AR, 2015, SLEEP HEALTH, V1, P197, DOI 10.1016/j.sleh.2015.07.002; Wolfson AR, 2003, SLEEP MED REV, V7, P491, DOI 10.1016/S1087-0792(03)90003-7; Zhang JH, 2009, SLEEP MED, V10, P1040, DOI 10.1016/j.sleep.2009.01.008	84	19	20	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224139	10.1371/journal.pone.0224139	http://dx.doi.org/10.1371/journal.pone.0224139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697711	Green Published, gold			2022-12-26	WOS:000532694400018
J	Yun, JH; Lee, HS; Yu, HY; Kim, YJ; Jeon, HJ; Oh, T; Kim, BJ; Choi, HJ; Kim, JM				Yun, Jun Ho; Lee, Heun-Sik; Yu, Ho-Yeong; Kim, Yeon-Jung; Jeon, Hyun Jeong; Oh, Taekeun; Kim, Bong-Jo; Choi, Hyung Jin; Kim, Jeong-Min			Metabolomics profiles associated with HbA1c levels in patients with type 2 diabetes	PLOS ONE			English	Article							DIAGNOSIS; RISK	Glycated hemoglobin (HbA1c) is an indicator of the average blood glucose concentration. Failing to control HbA1c levels can accelerate the development of complications in patients with diabetes. Although metabolite profiles associated with HbA1c level in diabetes patients have been characterized using different platforms, more studies using high-throughput technology will be helpful to identify additional metabolites related to diabetes. Type 2 diabetes (T2D) patients were divided into two groups based on the HbA1c level: normal (HbA1c <= 6%) and high (HbA1c >= 9%) in both discovery and replication sets. A targeted metabolomics approach was used to quantify serum metabolites and multivariate logistic regression was used to identify significant differences between groups. The concentrations of 22 metabolites differed significantly between the two groups in the discovery set. In the replication set, the levels of 21 metabolites, including 16 metabolites identified in the discovery set, differed between groups. Among these, concentrations of eleven amino acids and one phosphatidylcholine (PC), lysoPC a C16:1, were higher and four metabolites, including three PCs (PC ae C36:1, PC aa C26:0, PC aa C34:2) and hexose, were lower in the group with normal HbA1c group than in the group with high HbA1c. Metabolites with high concentrations in the normal HbA1c group, such as glycine, valine, and PCs, may contribute to reducing HbA1c levels in patients with T2D. The metabolite signatures identified in this study provide insight into the mechanisms underlying changes in HbA1c levels in T2D.	[Yun, Jun Ho; Lee, Heun-Sik; Yu, Ho-Yeong; Kim, Yeon-Jung; Kim, Bong-Jo; Kim, Jeong-Min] Korea Natl Inst Hlth, Ctr Genome Sci, Div Genome Res, Cheongju, Chungbuk, South Korea; [Yun, Jun Ho] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Jeon, Hyun Jeong; Oh, Taekeun] Chungbuk Natl Univ, Dept Internal Med, Coll Med, Cheongju, Chungbuk, South Korea; [Choi, Hyung Jin] Seoul Natl Univ, Wide River Inst Immunol, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Choi, Hyung Jin] Seoul Natl Univ, Wide River Inst Immunol, Coll Med, Dept Anat & Cell Biol, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Chungbuk National University; Chungbuk National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, JM (corresponding author), Korea Natl Inst Hlth, Ctr Genome Sci, Div Genome Res, Cheongju, Chungbuk, South Korea.; Choi, HJ (corresponding author), Seoul Natl Univ, Wide River Inst Immunol, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Choi, HJ (corresponding author), Seoul Natl Univ, Wide River Inst Immunol, Coll Med, Dept Anat & Cell Biol, Seoul, South Korea.	hjchoi@snu.ac.kr; goodmin@gmail.com	Choi, Hyung Jin/AAU-9629-2020	Kim, Jeong-Min/0000-0002-4305-5162; Choi, Hyung Jin/0000-0003-0593-6978	Korea National Institute of Health [2013-NG73001-00]; Korea Centers for Disease Control and Prevention, Republic of Korea [4851-307, 4845-301, 4851-302]	Korea National Institute of Health; Korea Centers for Disease Control and Prevention, Republic of Korea	This study was supported by intramural grants from the Korea National Institute of Health (Nos. 2013-NG73001-00). Biospecimens and data were provided by the Korean Genome Analysis Project (4845-301), the Korean Genome and Epidemiology Study (4851-302), and the Korea Biobank Projects (4851-307), which were supported by the Korea Centers for Disease Control and Prevention, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Cruz M, 2008, J ENDOCRINOL INVEST, V31, P694, DOI 10.1007/BF03346417; Deja S, 2013, J PHARMACEUT BIOMED, V83, P43, DOI 10.1016/j.jpba.2013.04.017; den Ouden H, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0930-4; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Lee HS, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1103-9; Nagata C, 2013, AM J EPIDEMIOL, V178, P1226, DOI 10.1093/aje/kwt112; Natarajan Sulochana K, 2002, MED SCI MONITOR, V8; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Preet A, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S6-001; Qiu Y, 2008, METABOLOMICS, V4, P337, DOI 10.1007/s11306-008-0123-5; Safai N, 2018, DIABETIC MED, V35, P944, DOI 10.1111/dme.13636; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Sherwani SI, 2016, BIOMARK INSIGHTS, V11, P95, DOI [10.4137/BMIMI.S38440, 10.4137/BMI.S38440]; Siskos AP, 2017, ANAL CHEM, V89, P656, DOI 10.1021/acs.analchem.6b02930; Suvitaival T, 2018, METABOLISM, V78, P1, DOI 10.1016/j.metabol.2017.08.014; 't Hart LM, 2018, J CLIN ENDOCR METAB, V103, P4569, DOI 10.1210/jc.2018-01165; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; World Health Organization, 2011, US GLYC HAEM HBA1C D; Xu FG, 2013, J CLIN ENDOCR METAB, V98, pE1060, DOI 10.1210/jc.2012-4132	24	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224274	10.1371/journal.pone.0224274	http://dx.doi.org/10.1371/journal.pone.0224274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697702	gold, Green Published			2022-12-26	WOS:000532694400022
J	Shimodaira, T; Mikoshiba, S; Taguchi, T				Shimodaira, Tetsuhiro; Mikoshiba, Shigeo; Taguchi, Toru			Nonsteroidal anti-inflammatory drugs and acetaminophen ameliorate muscular mechanical hyperalgesia developed after lengthening contractions via cyclooxygenase-2 independent mechanisms in rats	PLOS ONE			English	Article							POTENTIAL VANILLOID 1; PARACETAMOL ACETAMINOPHEN; PAIN; MUSCLE; ASPIRIN; PHARMACOKINETICS; INHIBITION; CAPSAICIN; INFLAMMATION; ANALGESICS	Nonsteroidal anti-inflammatory drugs and acetaminophen are cyclooxygenase inhibitors commonly used as symptomatic medicines for myofascial pain syndrome. Using the selective inhibitors celecoxib and zaltoprofen, cyclooxygenase-2 has been shown to be involved in the initiation, but not the maintenance, of muscular mechanical hyperalgesia induced by lengthening contractions, which serves as a useful model for the study of myofascial pain syndrome. The effect of other cyclooxygenase-2 inhibitors, such as acetylsalicylic acid, ibuprofen, loxoprofen sodium, and acetaminophen, on muscular mechanical hyperalgesia during maintenance has not been studied. Here, we examined the analgesic effects of the nonsteroidal anti-inflammatory drugs and acetaminophen on the model. Consistent with previous studies, mechanical withdrawal threshold of the muscle was significantly decreased and reached its lowest level 24 h after lengthening contractions. Celecoxib had no effect on muscular mechanical hyperalgesia, when orally administered 24 h after lengthening contractions. In contrast, acetylsalicylic acid, ibuprofen, loxoprofen sodium, and acetaminophen increased the withdrawal threshold, which had decreased by lengthening contractions, in a dose-dependent manner. These results demonstrate the analgesic actions of nonsteroidal anti-inflammatory drugs and acetaminophen in the maintenance process of lengthening contraction-induced muscular mechanical hyperalgesia, which may occur through cyclooxygenase-2 independent mechanisms.	[Shimodaira, Tetsuhiro; Mikoshiba, Shigeo] Lion Corp, Pharmaceut Res Labs, Odawara, Kanagawa, Japan; [Taguchi, Toru] Niigata Univ Hlth & Welf, Dept Phys Therapy, Kita Ku, Niigata, Japan; [Taguchi, Toru] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Kita Ku, Niigata, Japan	Lion Corporation; Niigata University; Niigata University	Shimodaira, T (corresponding author), Lion Corp, Pharmaceut Res Labs, Odawara, Kanagawa, Japan.	tshimo@lion.co.jp			Lion Corporation	Lion Corporation	This work was fully funded by Lion Corporation (https://www.lion.co.jp/en/).TS and SM are employees of Lion Corporation. The Lion Corporation provided support in the form of salaries for authors TS and SM. TT received technical assistance fee from Lion Corporation. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADAMS SS, 1969, ARCH INT PHARMACOD T, V178, P115; Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alloui A, 2002, EUR J PHARMACOL, V443, P71, DOI 10.1016/S0014-2999(02)01578-9; Amin AR, 2006, P NATL ACAD SCI USA, V92, P7926; Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Aronoff DM, 2006, CLIN PHARMACOL THER, V79, P9, DOI 10.1016/j.clpt.2005.09.009; Bonnefont J, 2003, ANESTHESIOLOGY, V99, P976, DOI 10.1097/00000542-200310000-00034; Bron C, 2012, CURR PAIN HEADACHE R, V16, P439, DOI 10.1007/s11916-012-0289-4; Cashman JN, 1996, DRUGS, V52, P13, DOI 10.2165/00003495-199600525-00004; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Costa R, 2018, MOL NEUROBIOL, V55, P2150, DOI 10.1007/s12035-017-0475-9; Courade JP, 2001, LIFE SCI, V69, P1455, DOI 10.1016/S0024-3205(01)01228-0; Crawley B, 2008, NEUROSCI LETT, V442, P50, DOI 10.1016/j.neulet.2008.06.062; Desai MJ, 2013, PAIN THER, V2, P21, DOI 10.1007/s40122-013-0006-y; Fleckenstein J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-32; FU CJ, 1991, J PHARMACOKINET BIOP, V19, P157, DOI 10.1007/BF01073867; Fujii Y, 2008, PAIN, V140, P292, DOI 10.1016/j.pain.2008.08.013; Gerwin R D, 2001, Curr Pain Headache Rep, V5, P412, DOI 10.1007/s11916-001-0052-8; Gerwin Robert D, 2004, Curr Pain Headache Rep, V8, P468, DOI 10.1007/s11916-004-0069-x; Greffrath W, 2002, NEUROSCI LETT, V320, P61, DOI 10.1016/S0304-3940(02)00033-2; Hayashi K, 2017, EUR J PAIN, V21, P125, DOI 10.1002/ejp.909; Hayashi K, 2013, PAIN, V154, P2344, DOI 10.1016/j.pain.2013.07.007; Itoh K, 2002, JPN J PHYSIOL, V52, P173, DOI 10.2170/jjphysiol.52.173; Itoh Kazunori, 2004, Acupunct Med, V22, P2; Joshi SK, 2006, NEUROSCIENCE, V143, P587, DOI 10.1016/j.neuroscience.2006.08.005; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; Lynagh T, 2017, J MED CHEM, V60, P8192, DOI 10.1021/acs.jmedchem.7b01072; Matsubara T, EUR J PAIN; Maurer K, 2014, NEUROSCI LETT, V563, P101, DOI 10.1016/j.neulet.2014.01.050; Mense S, 2015, J APPL PHYSIOL, V94, P2494; Mizumura K, 2016, J PHYSIOL SCI, V66, P43, DOI 10.1007/s12576-015-0397-0; Mizumura K, 2010, J MUSCULOSKELET PAIN, V18, P361, DOI 10.3109/10582452.2010.502625; Moore RA, 2011, COCHRANE DATABASE SY; Mori T, 2014, PHYSL REP, V2, P1; Muramatsu S, 2015, ANESTHESIOL PAIN MED, V6, P1; Murase S, 2010, J NEUROSCI; Murase S, 2013, J PHYSIOL-LONDON, V591, P3035, DOI 10.1113/jphysiol.2012.249235; Ohashi N, 2017, ANESTHESIOLOGY, V127, P355, DOI 10.1097/ALN.0000000000001700; Ota H, 2013, PLOS ONE, V8; Ottani A, 2006, EUR J PHARMACOL, V531, P280, DOI 10.1016/j.ejphar.2005.12.015; Pecikoza UB, 2017, ANESTH ANALG, V124, P1317, DOI 10.1213/ANE.0000000000001561; Rezende RM, 2008, BRIT J PHARMACOL, V153, P760, DOI 10.1038/sj.bjp.0707630; Roclofs PDDM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000396.pub3; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Sandrini M, 2007, INFLAMM RES, V56, P139, DOI 10.1007/s00011-006-6113-z; Sawamura R, 2015, PHARMAZIE, V70, P74, DOI 10.1691/ph.2015.4077; Schmelz M, 1996, NEUROSCI LETT, V214, P72; Shah JP, 2008, ARCH PHYS MED REHAB, V89, P16, DOI 10.1016/j.apmr.2007.10.018; Simons DG., 1998, MYOFASCIAL PAIN DYSF, V1; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2007, PAIN, V129, P102, DOI 10.1016/j.pain.2006.09.038; Smith CE, 2017, CELL CHEM BIOL, V24, P281, DOI 10.1016/j.chembiol.2017.02.003; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Taguchi T, 2005, J PHYSIOL-LONDON, V564, P259, DOI 10.1113/jphysiol.2004.079483; Tian ZH, 2017, J CHROMATOGR B, V1040, P136, DOI 10.1016/j.jchromb.2016.12.007; TJOLSEN A, 1991, EUR J PHARMACOL, V193, P193, DOI 10.1016/0014-2999(91)90036-P; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Vanegas H, 2002, CELL MOL NEUROBIOL, V22, P655, DOI 10.1023/A:1021896622089; Vellani V, 2013, J PAIN RES, V6, P111, DOI 10.2147/JPR.S36916; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Warner TD, 2002, P NATL ACAD SCI USA, V96, P7563; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yoshino T, 2011, ARZNEIMITTELFORSCH, V55, P394; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005	65	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224809	10.1371/journal.pone.0224809	http://dx.doi.org/10.1371/journal.pone.0224809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693705	Green Published, gold			2022-12-26	WOS:000532690100041
J	Hartman, R; Sherman, S; Contreras, D; Furler, A; Kok, R				Hartman, Rosemary; Sherman, Stacy; Contreras, Dave; Furler, Alison; Kok, Ryan			Characterizing macroinvertebrate community composition and abundance in freshwater tidal wetlands of the Sacramento-San Joaquin Delta	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; ESTUARINE BENTHIC INDEX; BIOTIC INTEGRITY; FISH ASSEMBLAGES; NEKTON USE; HABITAT; MARSH; INVERTEBRATES; RESTORATION; VEGETATION	Restored tidal wetlands may provide important food web support for at-risk fish species in the Sacramento-San Joaquin Delta (Delta) of California, including Delta Smelt (Hypomesus transpacificus) and Chinook Salmon (Oncorhynchus tshawytscha). Since many tidal wetland restoration projects are planned or have recently been constructed in the Delta, understanding the diversity and variability of wetland invertebrates that are fish prey items is of increasing importance. During this study, two different invertebrate sampling techniques were tested (leaf packs and sweep nets) in four habitat types within three different wetland areas to evaluate which sampling technique provided the most reliable metric of invertebrate abundance and community composition. Sweep nets provided a better measure of fish food availability than leaf packs and were better able to differentiate between habitat types. Generalized linear models showed submerged and floating vegetation had higher abundance and taxa richness than channel habitats or emergent vegetation. Permutational multivariate analysis of variance showed significantly different communities of invertebrates in different habitat types and in different wetlands, and point-biserial correlation coefficients found a greater number of mobile taxa associated with sweep nets. There were more taxa associated with vegetated habitats than channel habitats, and one area had more taxa associated with it than the other two areas. These results suggest that restoration sites that contain multiple habitat types may enhance fish invertebrate prey diversity and resilience. However, the effect of habitat diversity must be monitored as restoration sites develop to assess actual benefits to at-risk fish species.	[Hartman, Rosemary; Sherman, Stacy; Contreras, Dave] Calif Dept Fish & Wildlife, Stockton, CA 95206 USA; [Furler, Alison] Calif Dept Fish & Wildlife, Rancho Cordova, CA USA; [Kok, Ryan] Calif Dept Fish & Wildlife, Lagrange, CA USA		Hartman, R (corresponding author), Calif Dept Fish & Wildlife, Stockton, CA 95206 USA.	Rosemary.Hartman@water.ca.gov		Hartman, Rosemary/0000-0002-0642-183X; Sherman, Stacy/0000-0002-8392-7287	California Department of Water Resources State Water Project [R1630002]; California Department of Fish Restoration Program, CDFW [R1630002]	California Department of Water Resources State Water Project; California Department of Fish Restoration Program, CDFW	This work was funded by the California Department of Water Resources State Water Project and Fish Restoration Program, CDFW contract number R1630002. The funders approved the study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2016, LME4 LINEAR MIXED EF; BAXTER R., 2015, UPDATED CONCEPTUAL M; Blocksom KA, 2005, ENVIRON MONIT ASSESS, V102, P243, DOI 10.1007/s10661-005-6025-3; Boucek RE, 2013, OIKOS, V122, P1453, DOI 10.1111/j.1600-0706.2013.20994.x; Boyer K, 2013, HABITAT VALUES NATIV; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Caceres M, 2016, PACKAGE INDICSPECIES; California Natural Resources Agency, 2016, DELT SMELT RES STRAT; CAMPEAU S, 1994, CAN J FISH AQUAT SCI, V51, P681, DOI 10.1139/f94-068; Castellanos DL, 2001, ESTUARIES, V24, P184, DOI 10.2307/1352943; CDFW, 2009, CAL END SPEC ACT INC; CDWR CDFW, 2012, FISH REST PROGR AGR; Champely S, 2017, BASIC FUNCTIONS POWE; Cloern J.E., 2016, SAN FRANC ESTUARY WA, V14, DOI [10.15447/sfews.2016v14iss3art1, DOI 10.15447/sfews.2016v14iss3art1]; Conrad J.L., 2016, SAN FRANC ESTUARY WA, V14, P1; Conrad JL, 2016, T AM FISH SOC, V145, P249, DOI 10.1080/00028487.2015.1114521; Contreras D, 2016, PILOT STUDY PHASE; David AT, 2016, ESTUAR COAST, V39, P1491, DOI 10.1007/s12237-016-0091-3; Downing AL, 2014, ECOLOGY, V95, P173, DOI 10.1890/12-1406.1; Downing BD, 2016, ENVIRON SCI TECHNOL, V50, P13387, DOI 10.1021/acs.est.6b05745; [DSC] Delta Stewardship Council, 2013, DELT PLAN ENS REL WA; Ellings CS, 2016, RESTOR ECOL, V24, P415, DOI 10.1111/rec.12333; Ferrari MCO, 2014, ENVIRON BIOL FISH, V97, P79, DOI 10.1007/s10641-013-0125-7; Feyrer F, 2003, ENVIRON BIOL FISH, V67, P277, DOI 10.1023/A:1025839132274; Feyrer F, 2017, T AM FISH SOC, V146, P128, DOI 10.1080/00028487.2016.1243577; Gewant D, 2012, ENVIRON BIOL FISH, V94, P483, DOI 10.1007/s10641-011-9963-3; Harris R., 2000, ICES ZOOPLANKTON MET; Heck K.L. Jr, 1991, P281; Hering D, 2004, HYDROBIOLOGIA, V516, P1, DOI 10.1023/B:HYDR.0000025255.70009.a5; Hestir EL, 2016, ESTUAR COAST, V39, P1100, DOI 10.1007/s12237-015-0055-z; Hickson D, 2007, VEGETATION CLASSIFIC; Hinton, 2011, ESTUARINE HABITAT JU; Howe ER, 2014, SAN FRANC ESTUARY WA, V12, P1; ISO, 2012, 10870 ISO; Klemm D.J., 1990, MACROINVERTEBRATE FI; Kratina P, 2014, J APPL ECOL, V51, P1066, DOI 10.1111/1365-2664.12266; Lehman PW, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1068-6; Llanso RJ, 2002, ESTUARIES, V25, P1219, DOI 10.1007/BF02692219; Lopez CB, 2006, ECOSYSTEMS, V9, P422, DOI 10.1007/s10021-005-0113-7; Lucas LV, 2002, ECOL APPL, V12, P1528, DOI 10.1890/1051-0761(2002)012[1528:FVOHWT]2.0.CO;2; Magnusson A, 2019, COMPREHENSIVE R ARCH; Maier GO, 2009, ESTUAR COAST, V32, P984, DOI 10.1007/s12237-009-9197-1; MARINEAU ED, 2019, SAN FRANCISCO ESTUAR, V17, P18132, DOI DOI 10.15447/SFEWS.2019V17ISS5; Marklund O, 2000, HYDROBIOLOGIA, V432, P229, DOI 10.1023/A:1004050509925; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McLain J, 2009, SAN FRANCISCO ESTUAR, V7, DOI [10.15447/sfews.2009v7iss2art1, DOI 10.15447/SFEWS.2009V7ISS2ART1]; Merz JE, 2016, ESTUAR COAST, V39, P1526, DOI 10.1007/s12237-016-0097-x; Meyer CK, 2011, WETLANDS, V31, P101, DOI 10.1007/s13157-010-0122-y; Moyle P.B., 2010, SAN FRANCISCO ESTUAR, V8, DOI [10.15447/sfews.2010v8iss3art1, DOI 10.15447/SFEWS.2010V8ISS3ART1]; National Marine Fisheries Service, 2009, BIOL OP C OP LONG TE; Natural Resources Conservation Service, 2013, FED STAND PROC NAT W; Nelson SM, 2008, ECOL ENG, V33, P91, DOI 10.1016/j.ecoleng.2007.12.012; Odum EP, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P3; Oksanen J, 2016, COMMUNITY ECOLOGY PA; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; R Core Team, 2017, R PROJECT STAT COMPU; Robinson A., 2016, DELTA RENEWED GUIDE; Robinson A, 2014, DELTA TRANSFORMED EC, P729; Robinson AH, 2011, SAN FRANCISCO ESTUAR, V9, DOI [10.15447/sfews.2011v9iss3art5, DOI 10.15447/SFEWS.2011V9ISS3ART5]; Rozas LP, 1998, B MAR SCI, V63, P481; Sabal M, 2016, N AM J FISH MANAGE, V36, P309, DOI 10.1080/02755947.2015.1121938; Scatolini SR, 1996, WETLANDS, V16, P24, DOI 10.1007/BF03160643; Simenstad C, 1999, INTERAGENCY ECOLOGIC, V12, P15; Simenstad CA, 2000, ECOL ENG, V15, P283, DOI 10.1016/S0925-8574(00)00082-3; Slater SB, 2014, SFEWS, DOI DOI 10.15447/SFEWS.2014V12ISS3ART1; Sommer T., 2013, SAN FRANCISCO ESTUAR, V11, P25; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Sommer TR, 2004, AQUAT CONSERV, V14, P247, DOI 10.1002/aqc.620; Sommer TR, 2001, CAN J FISH AQUAT SCI, V58, P325, DOI 10.1139/cjfas-58-2-325; Ta J, 2017, SAN FRANC ESTUARY WA, V15, P1, DOI [10.15447/sfews.2017v15iss4art5, DOI 10.15447/sfews.2017v15iss4art5]; Thompson B, 2013, ENVIRON MONIT ASSESS, V185, P2281, DOI 10.1007/s10661-012-2708-8; Tiffan KF, 2014, T AM FISH SOC, V143, P219, DOI 10.1080/00028487.2013.839958; Toft JD, 2003, ESTUARIES, V26, P746, DOI 10.1007/BF02711985; Turner AM, 1997, J N AM BENTHOL SOC, V16, P694, DOI 10.2307/1468154; TURNER TF, 1994, COPEIA, P174; United States Fish and Wildlife Service, 2008, FORM END SPEC ACT C; Villamagna AM, 2010, FRESHWATER BIOL, V55, P282, DOI 10.1111/j.1365-2427.2009.02294.x; Warren RS, 2001, ESTUARIES, V24, P90, DOI 10.2307/1352816; Weinstein MP, 2016, ECOL RESTOR, V34, P27, DOI 10.3368/er.34.1.27; Weisberg SB, 1997, ESTUARIES, V20, P149, DOI 10.2307/1352728; Whitley SN, 2014, ENVIRON BIOL FISH, V97, P659, DOI 10.1007/s10641-013-0168-9; Winder M, 2011, ESTUAR COAST, V34, P675, DOI 10.1007/s12237-010-9342-x; Young Matthew J., 2018, San Francisco Estuary & Watershed Science, V16, P5; Young M, 2016, CURRICULUM AND THE SPECIALIZATION OF KNOWLEDGE: STUDIES IN THE SOCIOLOGY OF EDUCATION, P3	84	1	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0215421	10.1371/journal.pone.0215421	http://dx.doi.org/10.1371/journal.pone.0215421			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689295	Green Submitted, gold, Green Published			2022-12-26	WOS:000532680100003
J	Liu, F; Zhang, H; Xie, F; Tao, D; Xiao, XY; Huang, C; Wang, M; Gu, CH; Zhang, XP; Jiang, GS				Liu, Feng; Zhang, Hui; Xie, Fei; Tao, Dan; Xiao, Xingyuan; Huang, Chao; Wang, Miao; Gu, Chaohui; Zhang, Xiaoping; Jiang, Guosong			Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis	ONCOGENE			English	Article							MATRIX-METALLOPROTEINASE POLYMORPHISMS; CIRCULAR RNAS; TUMOR-SUPPRESSOR; EXPRESSION; ABUNDANT	Circular RNAs (circRNAs) have been increasingly indicated to be important participants in the development and progression of various malignant tumors. Our previous studies found that hundreds of circRNAs were aberrantly expressed in bladder cancer (BC) by high-throughput sequencing and we have confirmed that the downregulated circRNAs circHIPK3, circRNA BCRC-3, and circNR3C1 played inhibitory roles in BC progression. In this study, we focused on the upregulated circRNAs and identified a novel circular RNA, hsa_circ_0001361 (circ0001361), was expressed at high levels in BC tissues and cell lines based on RNA-Seq data and qRT-PCR analysis, and it was positively corelated with pathologic grade and muscle invasion. Moreover, Kaplan-Meier survival analysis implied that BC patients with high circ0001361 expression level had a poor overall survival. Functionally, circ0001361 promoted BC cell invasion and metastasis both in vitro and in vivo, but had no effect on cell cycle and proliferation. Mechanistically, RNA sequencing analysis indicated that MMP9 was upregulated in circ0001361-overexpressed BC cells, and MMP9 was verified to mediate circ0001361-induced cell migration and invasion. Furthermore, we demonstrated that circ0001361 could directly interact with miR-491-5p to upregulate MMP9 expression. Collectively, our findings indicate that circ0001361 plays oncogenic role in BC invasion and metastasis through targeting the miR-491-5p/MMP9 axis, and it might be a potential novel target for BC therapy.	[Liu, Feng; Zhang, Hui; Xie, Fei; Xiao, Xingyuan; Huang, Chao; Wang, Miao; Zhang, Xiaoping; Jiang, Guosong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, Wuhan 430022, Peoples R China; [Xie, Fei] Qingdao Univ, Affiliated Hosp, Dept Urol, Qingdao 266013, Peoples R China; [Tao, Dan] Fifth Hosp Wuhan, Dept Oncol, Wuhan 430050, Peoples R China; [Gu, Chaohui] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou 450052, Henan, Peoples R China	Huazhong University of Science & Technology; Qingdao University; Zhengzhou University	Zhang, XP; Jiang, GS (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Urol, Wuhan 430022, Peoples R China.	xzhang@hust.edu.cn; jiangguosongdoc@hotmail.com			National Natural Science Foundation of China [81672529, 81772724, 81874091, 81602234, 81702524]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 81672529, 81772724, 81874091, 81602234, 81702524).	Abdelmohsen K, 2017, RNA BIOL, V14, P361, DOI 10.1080/15476286.2017.1279788; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Arnaiz E, 2019, SEMIN CANCER BIOL, V58, P90, DOI 10.1016/j.semcancer.2018.12.002; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Barrett SP, 2016, DEVELOPMENT, V143, P1838, DOI 10.1242/dev.128074; Berindan-Neagoe I, 2014, CA-CANCER J CLIN, V64, P311, DOI 10.3322/caac.21244; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Bray F, 2018, CA-CANCER J CLIN, V68, P5; Brockschmidt A, 2012, BRAIN, V135, P1027, DOI 10.1093/brain/aws045; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Chen X, 2018, CLIN CANCER RES, V24, P6319, DOI 10.1158/1078-0432.CCR-18-1270; Chen ZL, 2019, ONCOGENE, V38, P6017, DOI 10.1038/s41388-019-0857-8; Cheng ZX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11129-5; Du WW, 2017, CELL DEATH DIFFER, V24, P357, DOI 10.1038/cdd.2016.133; Errichelli L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14741; Gu CH, 2018, MOL THER-NUCL ACIDS, V13, P633, DOI 10.1016/j.omtn.2018.10.008; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han D, 2017, HEPATOLOGY, V66, P1151, DOI 10.1002/hep.29270; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; HSU MT, 1979, NATURE, V280, P339, DOI 10.1038/280339a0; Huang WC, 2014, CANCER RES, V74, P751, DOI 10.1158/0008-5472.CAN-13-1297; Hui Zeng, 2015, FEBS Lett, V589, P812, DOI 10.1016/j.febslet.2015.02.014; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kader AK, 2007, CLIN CANCER RES, V13, P2614, DOI 10.1158/1078-0432.CCR-06-1187; Kader AK, 2006, CANCER RES, V66, P11644, DOI 10.1158/0008-5472.CAN-06-1212; Kamat AM, 2016, LANCET, V388, P2796, DOI 10.1016/S0140-6736(16)30512-8; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kristensen LS, 2018, ONCOGENE, V37, P555, DOI 10.1038/onc.2017.361; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Li YW, 2017, EMBO REP, V18, P1646, DOI 10.15252/embr.201643581; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Liu HW, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0908-8; Liu HW, 2018, AGING-US, V10, P2606, DOI 10.18632/aging.101573; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; Pirooz HJ, 2018, J CELL BIOCHEM, V119, P5126, DOI 10.1002/jcb.26471; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Sun RF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.134; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Vo JN, 2019, CELL, V176, P869, DOI 10.1016/j.cell.2018.12.021; Wang K, 2016, EUR HEART J, V37, P2602, DOI 10.1093/eurheartj/ehv713; Weren RDA, 2015, J PATHOL, V236, P155, DOI 10.1002/path.4520; Witjes JA, 2017, EUR UROL, V71, P462, DOI 10.1016/j.eururo.2016.06.020; Wu J, 2018, CANCER LETT, V430, P179, DOI 10.1016/j.canlet.2018.05.033; Xie F, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0892-z; Xu YJ, 2017, AM J CANCER RES, V7, P2545; Yang CD, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0771-7; Yang YB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx166; Zheng FX, 2019, CANCER LETT, V460, P139, DOI 10.1016/j.canlet.2019.06.018; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8; Zhong ZY, 2017, CANCER LETT, V403, P305, DOI 10.1016/j.canlet.2017.06.027; Zhong ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37840	56	61	62	6	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1696	1709		10.1038/s41388-019-1092-z	http://dx.doi.org/10.1038/s41388-019-1092-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31705065				2022-12-26	WOS:000514923000006
J	Sun, CY; Li, X; Guo, ES; Li, N; Zhou, B; Lu, H; Huang, J; Xia, M; Shan, WY; Wang, BB; Li, KZ; Weng, DH; Xu, XY; Gao, QL; Wang, SX; Hu, JB; Lu, YL; Mills, GB; Chen, G				Sun, Chaoyang; Li, Xi; Guo, Ensong; Li, Na; Zhou, Bo; Lu, Hao; Huang, Jia; Xia, Meng; Shan, Wanying; Wang, Beibei; Li, Kezhen; Weng, Danhui; Xu, Xiaoyan; Gao, Qinglei; Wang, Shixuan; Hu, Junbo; Lu, Yiling; Mills, Gordon B.; Chen, Gang			MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis	ONCOGENE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOTACTIC PROTEIN-1; GENE-EXPRESSION; LIGAND 2; METFORMIN; RECEPTOR; GROWTH; OBESITY; CCL2; IDENTIFICATION	Ovarian cancer selective metastasizes to the omentum contributing to the poor prognosis associated with ovarian cancer. However, the mechanism underlining this propensity and therapeutic approaches to counter this process has not been fully elucidated. Here, we show that MCP-1 produced by omental adipocytes binding to its cognate receptor CCR-2 on ovarian cancer cells facilitates migration and omental metastasis by activating the PI3K/AKT/mTOR pathway and its downstream effectors HIF-1 alpha and VEGF-A in cell lines, xenografts, and transgenic murine models. MCP-1 antibody significantly decreased tumor burden and increased survival of mice in vivo. Interestingly, metformin decreased omental metastasis at least partially by inhibiting MCP-1 secretion from adipocytes independent of direct effects on cancer cells. Together this suggests a novel target of MCP-1/CCR-2 axis that could benefit ovarian cancer patients.	[Sun, Chaoyang; Li, Xi; Guo, Ensong; Li, Na; Zhou, Bo; Lu, Hao; Huang, Jia; Xia, Meng; Shan, Wanying; Wang, Beibei; Li, Kezhen; Weng, Danhui; Xu, Xiaoyan; Gao, Qinglei; Wang, Shixuan; Hu, Junbo; Chen, Gang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gynecol & Obstet, Wuhan 430030, Hubei, Peoples R China; [Li, Na] Peter MacCallum Canc Ctr, Canc Genet Lab, Melbourne, Vic 3000, Australia; [Zhou, Bo] Wuhan Univ, Dept Gynecol Oncol, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China; [Lu, Hao; Xia, Meng] Cent Hosp Wuhan, Dept Gynecol & Obstet, Wuhan 430030, Hubei, Peoples R China; [Hu, Junbo] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan 430030, Hubei, Peoples R China; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Huazhong University of Science & Technology; Peter Maccallum Cancer Center; Wuhan University; Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center	Chen, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gynecol & Obstet, Wuhan 430030, Hubei, Peoples R China.	gumpc@126.com	chaoyang, sun/HCH-0905-2022	Chen, Gang/0000-0002-8320-6594; Sun, Chaoyang/0000-0003-2469-1638; Mills, Gordon/0000-0002-0144-9614	National Key R&D Program of China [2016YFC1303100]; National Basic Research Program of China (973 Program) [2015CB553903]; Nature and Science Foundation of China [81272859, 81572569, 81402163, 81402164, 81501530, 81671394, 81370469]; International S&T Cooperation Program of China [2013DFA31400]; NIH [P50CA217685]; Ovarian Cancer Research Foundation	National Key R&D Program of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Foundation	This study was supported by the National Key R&D Program of China (2016YFC1303100), the National Basic Research Program of China (973 Program, 2015CB553903), Nature and Science Foundation of China (81272859, 81572569, 81402163, 81402164, 81501530, 81671394, and 81370469), the International S&T Cooperation Program of China (No. 2013DFA31400). GBM has support from NIH P50CA217685, Ovarian Cancer Research Foundation, and a kind gift from the Adelson Medical Research Fund.	Al-Wahab Z, 2015, ONCOTARGET, V6, P10908, DOI 10.18632/oncotarget.3434; Algire C, 2012, CANCER PREV RES, V5, P536, DOI 10.1158/1940-6207.CAPR-11-0536; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Bae HS, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-41; Baldan V, 2015, BRIT J CANCER, V112, P1510, DOI 10.1038/bjc.2015.96; Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Broek IV, 2003, BRIT J CANCER, V88, P855, DOI 10.1038/sj.bjc.6600833; Castadot P, 2005, Cancer Radiother, V9, P183, DOI 10.1016/j.canrad.2005.03.001; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Furukawa S, 2013, ANTICANCER RES, V33, P4785; Giuliani M, 2017, MINERVA GINECOL, V8; Guru SK, 2015, CANCER RES, V75, P2886, DOI 10.1158/0008-5472.CAN-14-2312; He YY, 2007, HUM REPROD, V22, P2733, DOI 10.1093/humrep/dem208; Hoy AJ, 2017, TRENDS MOL MED, V23, P381, DOI 10.1016/j.molmed.2017.02.009; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Lim MC, 2009, GYNECOL ONCOL, V112, P28, DOI 10.1016/j.ygyno.2008.09.046; Liu GX, 2013, TUMOR BIOL, V34, P2741, DOI 10.1007/s13277-013-0827-7; Lu CH, 2016, EUR J PHARMACOL, V789, P60, DOI 10.1016/j.ejphar.2016.07.012; MANOME Y, 1995, CANCER IMMUNOL IMMUN, V41, P227; Milliken D, 2002, CLIN CANCER RES, V8, P1108; Mizutani K, 2009, ANTICANCER RES, V29, P3109; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pequeux C, 2012, CANCER RES, V72, P3010, DOI 10.1158/0008-5472.CAN-11-3768; Pienta KJ, 2013, INVEST NEW DRUG, V31, P760, DOI 10.1007/s10637-012-9869-8; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Robinson E, 2014, BIOCHEM SOC T, V42, P125, DOI 10.1042/BST20130203; Rodriguez GM, 2018, CANCERS, V10, DOI 10.3390/cancers10080242; Romero IL, 2015, CLIN CANCER RES, V21, P680, DOI 10.1158/1078-0432.CCR-14-2198; Shen H, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1250-8; Sica A, 2000, J IMMUNOL, V164, P733, DOI 10.4049/jimmunol.164.2.733; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Sikka A, 2012, CELL CYCLE, V11, P1374, DOI 10.4161/cc.19798; Tabuso M, 2017, WORLD J GASTROENTERO, V23, P5829, DOI 10.3748/wjg.v23.i32.5829; TARIN D, 1984, CANCER RES, V44, P3584; Teng PN, 2014, BRIT J CANCER, V110, P123, DOI 10.1038/bjc.2013.687; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang Y, 2018, CAN RESPIR J, V2018, DOI 10.1155/2018/8354892; Wang YX, 2019, J CELL PHYSL, P8; Wojnarowicz P, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.25; Xu TP, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0063-7; Xu XJ, 2012, J LIPID RES, V53, P792, DOI 10.1194/jlr.P022905; Yang HS, 2011, INT J GYNECOL CANCER, V21, P1525, DOI 10.1097/IGC.0b013e31822eb5f8; Yu HD, 2019, J CLIN INVEST, V129, P2485, DOI 10.1172/JCI125646; Yumimoto K, 2019, CANCER SCI, V110, P2090, DOI 10.1111/cas.14075; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044	50	30	31	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2020	39	8					1681	1695		10.1038/s41388-019-1090-1	http://dx.doi.org/10.1038/s41388-019-1090-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KN6CG	31705064	Green Accepted			2022-12-26	WOS:000514923000005
J	Qu, XX; Liu, Y; Cao, DY; Chen, JH; Liu, Z; Ji, HR; Chen, YW; Zhang, WJ; Zhu, P; Xiao, DY; Li, XH; Shou, WN; Chen, HY				Qu, Xiuxia; Liu, Ying; Cao, Dayan; Chen, Jinghai; Liu, Zhuo; Ji, Hongrui; Chen, Yuwen; Zhang, Wenjun; Zhu, Ping; Xiao, Deyong; Li, Xiaohui; Shou, Weinian; Chen, Hanying			BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); SMAD transcription factor; STAT transcription factor; heart failure; cell death; fibrosis	BONE MORPHOGENETIC PROTEIN-10; POLY(ADP-RIBOSE) POLYMERASE; FIBROBLAST PROLIFERATION; HEART-DISEASE; INHIBITION; EXPRESSION; FAMILY; MYOCARDIUM; APOPTOSIS; FIBROSIS	Bone morphogenetic protein 10 (BMP10) is a cardiac peptide growth factor belonging to the transforming growth factor ? superfamily that critically controls cardiovascular development, growth, and maturation. It has been shown that BMP10 elicits its intracellular signaling through a receptor complex of activin receptor-like kinase 1 with morphogenetic protein receptor type II or activin receptor type 2A. Previously, we generated and characterized a transgenic mouse line expressing BMP10 from the ?-myosin heavy chain gene promoter and found that these mice have normal cardiac hypertrophic responses to both physiological and pathological stimuli. In this study, we report that these transgenic mice exhibit significantly reduced levels of cardiomyocyte apoptosis and cardiac fibrosis in response to a prolonged administration of the ?-adrenoreceptor agonist isoproterenol. We further confirmed this cardioprotective function with a newly generated conditional Bmp10 transgenic mouse line, in which Bmp10 was activated in adult hearts by tamoxifen. Moreover, the intraperitoneal administration of recombinant human BMP10 was found to effectively protect hearts from injury, suggesting potential therapeutic utility of using BMP10 to prevent heart failure. Gene profiling and biochemical analyses indicated that BMP10 activates the SMAD-mediated canonical pathway and, unexpectedly, also the signal transducer and activator of transcription 3 (STAT3)?mediated signaling pathway both in vivo and in vitro. Additional findings further supported the notion that BMP10's cardioprotective function likely is due to its dual activation of SMAD- and STAT3-regulated signaling pathways, promoting cardiomyocyte survival and suppressing cardiac fibrosis.	[Qu, Xiuxia] Jiangnan Univ, Wuxi Sch Med, Wuxi 214122, Jiangsu, Peoples R China; [Qu, Xiuxia; Liu, Ying; Liu, Zhuo; Ji, Hongrui; Chen, Yuwen; Zhang, Wenjun; Zhu, Ping; Xiao, Deyong; Shou, Weinian; Chen, Hanying] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Cao, Dayan; Li, Xiaohui] Army Med Univ, Coll Pharm, Inst Mat Med, Chongqing 400038, Peoples R China; [Cao, Dayan; Li, Xiaohui] Army Med Univ, Coll Pharm, Ctr Translat Med, Chongqing 400038, Peoples R China; [Chen, Jinghai] Zhejiang Univ, Affiliate Hosp 2, Inst Translat Med, Sch Med,Dept Cardiol, Hangzhou 310029, Zhejiang, Peoples R China; [Ji, Hongrui] Harbin Univ Sci & Technol, Sch Chem & Environm Engn, Harbin 150040, Heilongjiang, Peoples R China; [Qu, Xiuxia] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Cardiovasc Inst, Guangzhou 510100, Guangdong, Peoples R China; [Xiao, Deyong] Fountain Valley Inst Life Sci, Dalian 116023, Liaoning, Peoples R China; [Xiao, Deyong] Fountain Valley Biotechnol Inc, Dalian 116023, Liaoning, Peoples R China	Jiangnan University; Indiana University System; Indiana University Bloomington; Army Medical University; Army Medical University; Zhejiang University; Harbin University of Science & Technology; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Shou, WN; Chen, HY (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.; Li, XH (corresponding author), Army Med Univ, Coll Pharm, Inst Mat Med, Chongqing 400038, Peoples R China.; Li, XH (corresponding author), Army Med Univ, Coll Pharm, Ctr Translat Med, Chongqing 400038, Peoples R China.	lps008@aliyun.com; wshou@iu.edu; hanchen@iu.edu		cao, dayan/0000-0001-7648-3668	National Institutes of Health [R01HL145060, R01HL81092, P01HL134599, P01HL85098]; Indiana University Showalter Research Trust Fund; National Science Foundation China Projects of International Cooperation and Exchanges [81720102004]; National Science Foundation China [81570279, 81974019]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL145060, P01HL134599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Showalter Research Trust Fund; National Science Foundation China Projects of International Cooperation and Exchanges; National Science Foundation China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants R01HL145060, R01HL81092, P01HL134599, and P01HL85098 (to W. S.), a grant from the Indiana University Showalter Research Trust Fund (to H. C.), and National Science Foundation China Projects of International Cooperation and Exchanges Grant 81720102004 and National Science Foundation China Grants 81570279 and 81974019 (to P. Z.) to support P. Z. as a visiting Scholar in Shou Lab. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bryson BL, 2017, CELL CYCLE, V16, P319, DOI 10.1080/15384101.2016.1259037; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Gianakopoulos PJ, 2009, IN VITRO CELL DEV-AN, V45, P566, DOI 10.1007/s11626-009-9228-z; Harada K, 2008, J BIOL CHEM, V283, P26705, DOI 10.1074/jbc.M801485200; Kahr PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026389; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Maruyama S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008441; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nakano N, 2007, AM J PHYSIOL-HEART C, V293, pH3396, DOI 10.1152/ajpheart.00311.2007; Nakayama T, 2000, CELL MOL LIFE SCI, V57, P943, DOI 10.1007/PL00000736; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Ning BB, 2017, ACTA PHARMACOL SIN, V38, P331, DOI 10.1038/aps.2016.142; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Ooi JYY, 2017, RNA BIOL, V14, P500, DOI 10.1080/15476286.2016.1181251; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Piotrowska I., 2007, THESIS; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Somi S, 2004, ANAT REC PART A, V279A, P579, DOI 10.1002/ar.a.20052; Tang LY, 2017, J BIOL CHEM, V292, P4302, DOI 10.1074/jbc.M116.773085; Teichmann U, 2004, DEV GENES EVOL, V214, P96, DOI 10.1007/s00427-003-0380-2; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Valkov N, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00065; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wang J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050749; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Zhang WJ, 2016, CIRCULATION, V133, P48, DOI 10.1161/CIRCULATIONAHA.115.017472; Zhang WJ, 2011, J BIOL CHEM, V286, P36820, DOI 10.1074/jbc.M111.279679; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	43	14	14	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19877	19888		10.1074/jbc.RA119.010943	http://dx.doi.org/10.1074/jbc.RA119.010943			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31712309	Green Published, hybrid			2022-12-26	WOS:000505005800005
J	Buchanan, BW; Mehrtash, AB; Broshar, CL; Runnebohm, AM; Snow, BJ; Scanameo, LN; Hochstrasser, M; Rubenstein, EM				Buchanan, Bryce W.; Mehrtash, Adrian B.; Broshar, Courtney L.; Runnebohm, Avery M.; Snow, Brian J.; Scanameo, Laura N.; Hochstrasser, Mark; Rubenstein, Eric M.			Endoplasmic reticulum stress differentially inhibits endoplasmic reticulum and inner nuclear membrane protein quality control degradation pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); endoplasmic reticulum?associated protein degradation (ERAD); E3 ubiquitin ligase; Saccharomyces cerevisiae; protein translocation; yeast genetics; inner nuclear membrane-associated degradation (INMAD); protein quality control; Ste24; translocon	UBIQUITIN LIGASE DOA10; IN-VIVO DEGRADATION; ER STRESS; SACCHAROMYCES-CEREVISIAE; YEAST; PROTEASOME; RETROTRANSLOCATION; GENE; TRANSPORTER; ELONGATION	Endoplasmic reticulum (ER) stress occurs when the abundance of unfolded proteins in the ER exceeds the capacity of the folding machinery. Despite the expanding cadre of characterized cellular adaptations to ER stress, knowledge of the effects of ER stress on cellular physiology remains incomplete. We investigated the impact of ER stress on ER and inner nuclear membrane protein quality control mechanisms in Saccharomyces cerevisiae. We analyzed the turnover of substrates of four ubiquitin ligases (Doa10, Rkr1/Ltn1, Hrd1, and the Asi complex) and the metalloprotease Ste24 in induced models of ER stress. ER stress did not substantially impact Doa10 or Rkr1 substrates. However, Hrd1-mediated destruction of a protein that aberrantly engages the translocon (Deg1-Sec62) and substrates with luminal degradation signals was markedly impaired by ER stress; by contrast, Hrd1-dependent degradation of proteins with intramembrane degrons was largely unperturbed by ER stress. ER stress impaired the degradation of one of two Asi substrates analyzed and caused a translocon-clogging Ste24 substrate to accumulate in a form consistent with persistent translocon occupation. Degradation of Deg1-Sec62 in the absence of stress and stabilization during ER stress were independent of four ER stress?sensing pathways. Our results indicate ER stress differentially impacts degradation of protein quality control substrates, including those mediated by the same ubiquitin ligase. These observations suggest the existence of additional regulatory mechanisms dictating substrate selection during ER stress.	[Buchanan, Bryce W.; Broshar, Courtney L.; Runnebohm, Avery M.; Snow, Brian J.; Scanameo, Laura N.; Rubenstein, Eric M.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [Mehrtash, Adrian B.; Hochstrasser, Mark] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Buchanan, Bryce W.] Indiana Univ Sch Med, Ctr Med Educ, Muncie, IN 47306 USA; [Runnebohm, Avery M.] Eli Lilly & Co, Diabet & Complicat Therapeut Area, Indianapolis, IN 46225 USA; [Snow, Brian J.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA	Ball State University; Yale University; Yale University; Indiana University System; Eli Lilly; University of Wisconsin System; University of Wisconsin Madison	Rubenstein, EM (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.	emrubenstein@bsu.edu		Hochstrasser, Mark/0000-0002-1131-5484; Runnebohm, Avery/0000-0001-6798-6407; Rubenstein, Eric/0000-0003-4983-1430	Ball State University ASPiRE Research Awards; Ball State University Department of Biology Sigma Zeta research award; National Institutes of Health [GM111713, GM046904]; Ball State University Faculty Advance research award; Indiana Academy of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046904, R15GM111713, R37GM046904] Funding Source: NIH RePORTER	Ball State University ASPiRE Research Awards; Ball State University Department of Biology Sigma Zeta research award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ball State University Faculty Advance research award; Indiana Academy of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Ball State University ASPiRE Research Awards (to B. W. B., C. L. B., and A. M. R.), a Ball State University Department of Biology Sigma Zeta research award (to B. J. S.), National Institutes of Health Grant GM046904 (to M. H.), a Ball State University Faculty Advance research award (to E. M. R.), an Indiana Academy of Science senior research grant (to E. M. R.), and National Institutes of Health Grant GM111713 (to E. M. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arakawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30795; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Babour A, 2010, CELL, V142, P256, DOI 10.1016/j.cell.2010.06.006; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Boban M, 2014, J CELL SCI, V127, P3603, DOI 10.1242/jcs.153163; Buchanan BW, 2016, JOVE-J VIS EXP, DOI 10.3791/53975; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Corazzari M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00078; Crowder JJ, 2015, J BIOL CHEM, V290, P18454, DOI 10.1074/jbc.M115.663559; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Engle SM, 2017, PEERJ, V5, DOI 10.7717/peerj.3728; Fabre B, 2019, BIOCHEM BIOPH RES CO, V517, P188, DOI 10.1016/j.bbrc.2019.07.040; Foresti O, 2014, SCIENCE, V346, P751, DOI 10.1126/science.1255638; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Guthrie C., 2004, GUIDE YEAST GENETICS, P1; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hirata R, 2013, J BIOL CHEM, V288, P37057, DOI 10.1074/jbc.M113.518340; HJELM H, 1972, FEBS LETT, V28, P73, DOI 10.1016/0014-5793(72)80680-X; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jaenicke LA, 2011, MOL BIOL CELL, V22, P2937, DOI 10.1091/mbc.E10-10-0832; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kadowaki H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25724-x; Kadowaki H, 2015, CELL REP, V13, P944, DOI 10.1016/j.celrep.2015.09.047; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Khmelinskii A, 2014, NATURE, V516, P410, DOI 10.1038/nature14096; Kim Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00030; Koch BA, 2019, J CELL BIOL, V218, P839, DOI 10.1083/jcb.201808024; Kostova KK, 2017, SCIENCE, V357, P414, DOI 10.1126/science.aam7787; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154; Lipatova Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005390; Loayza D, 1998, MOL CELL BIOL, V18, P779, DOI 10.1128/MCB.18.2.779; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; Mehrtash AB, 2019, SEMIN CELL DEV BIOL, V93, P111, DOI 10.1016/j.semcdb.2018.09.013; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2013, MOL BIOL CELL, V24, P1765, DOI 10.1091/mbc.E12-12-0907; Neal S, 2018, MOL CELL, V69, P306, DOI 10.1016/j.molcel.2017.12.012; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Olzmann JA, 2011, J BIOL CHEM, V286, P27872, DOI 10.1074/jbc.C111.266452; Pierre N, 2014, BIOCHEM BIOPH RES CO, V450, P459, DOI 10.1016/j.bbrc.2014.05.143; Pina FJ, 2015, ELIFE, V4, DOI 10.7554/eLife.06970; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Ruggiano A, 2016, EMBO J, V35, P1644, DOI 10.15252/embj.201593106; Ryu HY, 2016, GENE DEV, V30, P1881, DOI 10.1101/gad.282194.116; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; SIKORSKI RS, 1989, GENETICS, V122, P19; Smoyer CJ, 2019, CURR GENET, V65, P1099, DOI 10.1007/s00294-019-00971-1; Sozen E, 2017, REDOX BIOL, V12, P456, DOI 10.1016/j.redox.2017.02.025; Stolz A, 2013, P NATL ACAD SCI USA, V110, P15271, DOI 10.1073/pnas.1304928110; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szoradi T, 2018, MOL CELL, V70, P1025, DOI 10.1016/j.molcel.2018.04.027; Takenokuchi M, 2015, ANTICANCER RES, V35, P3307; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; Utecht KN, 2008, AM J HEALTH-SYST PH, V65, P1221, DOI 10.2146/ajhp070272; von der Malsburg K, 2015, MOL BIOL CELL, V26, P2168, DOI 10.1091/mbc.E15-01-0040; Watts SG, 2015, JOVE-J VIS EXP, DOI 10.3791/52428; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859; Wu HX, 2014, BIOSCIENCE REP, V34, P321, DOI 10.1042/BSR20140058; Xiang CC, 2017, APOPTOSIS, V22, P1, DOI 10.1007/s10495-016-1296-4	97	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19814	19830		10.1074/jbc.RA119.010295	http://dx.doi.org/10.1074/jbc.RA119.010295			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31723032	hybrid, Green Published			2022-12-26	WOS:000504093200028
J	Jiang, LY; Dai, SY; Li, J; Liang, XJ; Qu, LZ; Chen, XJ; Guo, M; Chen, ZC; Chen, L; Wei, HD; Chen, YH				Jiang, Longying; Dai, Shuyan; Li, Jun; Liang, Xujun; Qu, Lingzhi; Chen, Xiaojuan; Guo, Ming; Chen, Zhuchu; Chen, Lin; Wei, Hudie; Chen, Yongheng			Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; protein crystallization; protein?DNA interaction; protein?protein interaction; dimerization; crystal structure; gene regulation; nuclear receptor subfamily 4 group A member 2; Nur-responsive elements; transcription factor	HETERODIMERIZATION; MECHANISM; SUBFAMILY; SOFTWARE; DOMAIN; PHENIX; CELL	Proteins of nuclear receptor subfamily 4 group A (NR4A), including NR4A1/NGFI-B, NR4A2/Nurr1, and NR4A3/NOR-1, are nuclear transcription factors that play important roles in metabolism, apoptosis, and proliferation. NR4A proteins recognize DNA response elements as monomers or dimers to regulate the transcription of a variety of genes involved in multiple biological processes. In this study, we determined two crystal structures of the NR4A2 DNA-binding domain (NR4A2-DBD) bound to two Nur-responsive elements: an inverted repeat and an everted repeat at 2.6?2.8 ? resolution. The structures revealed that two NR4A2-DBD molecules bind independently to the everted repeat, whereas two other NR4A2-DBD molecules form a novel dimer interface on the inverted repeat. Moreover, substitution of the interfacial residue valine 298 to lysine as well as mutation of DNA bases involved in the interactions abolished the dimerization. Overall, our structural, biochemical, and bioinformatics analyses provide a molecular basis for the binding of the NR4A2 protein dimers to NurREs and advance our understanding of the dimerization specificity of nuclear receptors.	[Jiang, Longying; Dai, Shuyan; Li, Jun; Liang, Xujun; Qu, Lingzhi; Chen, Xiaojuan; Guo, Ming; Chen, Zhuchu; Chen, Lin; Wei, Hudie; Chen, Yongheng] Cent S Univ, Dept Oncol, Struct Biol Lab, NHC Key Lab Canc Prote,Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Chen, Lin] Univ Southern Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA; [Chen, Lin] Univ Southern Calif, Mol & Computat Biol Program, Dept Chem, Los Angeles, CA 90089 USA	Central South University; University of Southern California; University of Southern California	Wei, HD; Chen, YH (corresponding author), Cent S Univ, Dept Oncol, Struct Biol Lab, NHC Key Lab Canc Prote,Xiangya Hosp, Changsha 410008, Hunan, Peoples R China.	hudiewei18@163.com; yonghenc@163.com		dai, shuyan/0000-0002-8484-634X	National Natural Science Foundation of China [81372904, 81570537, 81272971]; Science and Technology Department of Hunan Province [2015SK2037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province	This work was supported by National Natural Science Foundation of China Grants 81372904 and 81570537 (to Y. C.) and 81272971 (to Z. C.) and the Science and Technology Department of Hunan Province Grant 2015SK2037 (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berwick DC, 2014, J MOL CELL BIOL, V6, P3, DOI 10.1093/jmcb/mjt037; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen XJ, 2019, NUCLEIC ACIDS RES, V47, P3752, DOI 10.1093/nar/gkz077; Chen YH, 2015, NUCLEIC ACIDS RES, V43, P1268, DOI 10.1093/nar/gku1373; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Helsen C, 2012, MOL CELL ENDOCRINOL, V348, P411, DOI 10.1016/j.mce.2011.07.025; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li J, 2017, ACTA BIOCH BIOPH SIN, V49, P792, DOI 10.1093/abbs/gmx079; Li J, 2017, BIOCHEMISTRY-US, V56, P3745, DOI 10.1021/acs.biochem.7b00211; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Meinke G, 1999, NAT STRUCT BIOL, V6, P471; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Murphy EP, 1997, MOL ENDOCRINOL, V11, P39, DOI 10.1210/me.11.1.39; Osz J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08216; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Scheepstra M, 2017, ACS CHEM NEUROSCI, V8, P2065, DOI 10.1021/acschemneuro.7b00216; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Shaffer PL, 2002, EMBO J, V21, P2242, DOI 10.1093/emboj/21.9.2242; Shigeishi H, 2011, CANCER LETT, V307, P227, DOI 10.1016/j.canlet.2011.04.008; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Wallen-Mackenzie A, 2003, GENE DEV, V17, P3036, DOI 10.1101/gad.276003; Wang J, 2013, ASIAN PAC J CANCER P, V14, P2023, DOI 10.7314/APJCP.2013.14.3.2023; Wu DC, 2018, CHEM COMMUN, V54, P12089, DOI 10.1039/c8cc07546h; Yan Ningning, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P345, DOI 10.11817/j.issn.1672-7347.2015.04.001; Yin K, 2017, MOL CANCER RES, V15, P1184, DOI 10.1158/1541-7786.MCR-17-0002; Zhan YY, 2012, NAT CHEM BIOL, V8, P897, DOI [10.1038/NCHEMBIO.1069, 10.1038/nchembio.1069]; Zhang L, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/9363461; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	46	12	12	6	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19795	19803		10.1074/jbc.RA119.010730	http://dx.doi.org/10.1074/jbc.RA119.010730			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31723028	Green Published, hybrid			2022-12-26	WOS:000504093200026
J	Masui, K; Harachi, M; Ikegami, S; Yang, HJ; Onizuka, H; Yong, WH; Cloughesy, TF; Muragaki, Y; Kawamata, T; Arai, N; Komori, T; Cavenee, WK; Mischel, PS; Shibata, N				Masui, Kenta; Harachi, Mio; Ikegami, Shiro; Yang, Huijun; Onizuka, Hiromi; Yong, William H.; Cloughesy, Timothy F.; Muragaki, Yoshihiro; Kawamata, Takakazu; Arai, Nobutaka; Komori, Takashi; Cavenee, Webster K.; Mischel, Paul S.; Shibata, Noriyuki			mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammalian target of rapamycin (mTOR); histone acetylation; glucose metabolism; acetyl coenzyme A (acetyl-CoA); iron metabolism; glioblastoma	MALIGNANT GLIOMAS; GLIAL PROGENITORS; HISTONE H3; CANCER; ACETYLATION; CHROMATIN; GENES; STEM; TRANSCRIPTION; HALLMARKS	In cancer, aberrant growth factor receptor signaling reprograms cellular metabolism and global gene transcription to drive aggressive growth, but the underlying mechanisms are not well-understood. Here we show that in the highly lethal brain tumor glioblastoma (GBM), mTOR complex 2 (mTORC2), a critical core component of the growth factor signaling system, couples acetyl-CoA production with nuclear translocation of histone-modifying enzymes including pyruvate dehydrogenase and class IIa histone deacetylases to globally alter histone acetylation. Integrated analyses in orthotopic mouse models and in clinical GBM samples reveal that mTORC2 controls iron metabolisms via histone H3 acetylation of the iron-related gene promoter, promoting tumor cell survival. These results nominate mTORC2 as a critical epigenetic regulator of iron metabolism in cancer.	[Masui, Kenta; Harachi, Mio; Onizuka, Hiromi; Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan; [Muragaki, Yoshihiro; Kawamata, Takakazu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan; [Ikegami, Shiro; Yang, Huijun; Cavenee, Webster K.; Mischel, Paul S.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Yong, William H.; Cloughesy, Timothy F.] David Geffen UCLA Sch Med, Henry Singleton Brain Tumor Program, Los Angeles, CA 90095 USA; [Yong, William H.; Cloughesy, Timothy F.] David Geffen UCLA Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.] David Geffen UCLA Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Arai, Nobutaka] Tokyo Metropolitan Inst Med Sci, Lab Neuropathol, Setagaya Ku, Tokyo 1568506, Japan; [Komori, Takashi] Tokyo Metropolitan Neurol Hosp, Dept Neuropathol, Tokyo 1830042, Japan; [Cavenee, Webster K.; Mischel, Paul S.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Mischel, Paul S.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Tokyo Women's Medical University; Tokyo Women's Medical University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute for Neuroscience; University of California System; University of California San Diego; University of California System; University of California San Diego	Masui, K (corresponding author), Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan.	masui-kn@twmu.ac.jp	Cloughesy, Timothy Francis/AGV-1013-2022; Ikegami, Shiro/GLS-7614-2022; MURAGAKI, YOSHIHIRO/AAZ-9863-2021		National Institutes of Health NINDS [NS73831]; Defeat GBM Research Collaborative; National Institutes of Health NCI [CA119347]; Ben and Catherine Ivy Foundation; Ziering Family Foundation in memory of Sigi Ziering; Takeda Science Foundation; Japan Society for the Promotion of Science KAKENHI Grant [19K07649]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073831] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Defeat GBM Research Collaborative; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ben and Catherine Ivy Foundation; Ziering Family Foundation in memory of Sigi Ziering; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NINDS Grant NS73831, the Defeat GBM Research Collaborative, a subsidiary of National Brain Tumor Society, National Institutes of Health NCI Grant CA119347, the Ben and Catherine Ivy Foundation, the Ziering Family Foundation in memory of Sigi Ziering, a Grant-in-Aid from Takeda Science Foundation, and Japan Society for the Promotion of Science KAKENHI Grant 19K07649. P.S.M. is a scientific co-founder and consultant for Pretzel Therapeutics, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gu YC, 2017, MOL CELL, V67, P128, DOI 10.1016/j.molcel.2017.05.030; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hailemariam K, 2010, J CELL SCI, V123, P3863, DOI 10.1242/jcs.073627; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao YX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01127; Harachi M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103267; Hirayama T, 2019, METALLOMICS, V11, P111, DOI 10.1039/c8mt00212f; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Liu F, 2015, MOL CELL, V60, P307, DOI 10.1016/j.molcel.2015.09.002; Martinez-Pastor B, 2013, CANCER DISCOV, V3, P497, DOI 10.1158/2159-8290.CD-13-0059; Masui K, 2019, NEUROPATHOLOGY, V39, P3, DOI 10.1111/neup.12535; Masui K, 2015, P NATL ACAD SCI USA, V112, P9406, DOI 10.1073/pnas.1511759112; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Masui K, 2010, GLIA, V58, P1050, DOI 10.1002/glia.20986; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002; Seibel Philipp N, 2006, BMC BIOINFORMATICS, V7, DOI [10.1186/1471-2105-7-498, DOI 10.1186/1471-2105-7-498, DOI 10.1186/1471-2105-7-109]; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vernieri C, 2016, CANCER DISCOV, V6, P1315, DOI 10.1158/2159-8290.CD-16-0615; Villa GR, 2016, CANCER CELL, V30, P683, DOI 10.1016/j.ccell.2016.09.008; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599	47	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19740	19751		10.1074/jbc.RA119.011519	http://dx.doi.org/10.1074/jbc.RA119.011519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31712311	hybrid, Green Published			2022-12-26	WOS:000504093200022
J	Jauss, B; Petriman, NA; Drepper, F; Franz, L; Sachelaru, I; Welte, T; Steinberg, R; Warscheid, B; Koch, HG				Jauss, Benjamin; Petriman, Narcis-Adrian; Drepper, Friedel; Franz, Lisa; Sachelaru, Ilie; Welte, Thomas; Steinberg, Ruth; Warscheid, Bettina; Koch, Hans-Georg			Non-competitive binding of PpiD and YidC to the SecYEG translocon expands the global view on the SecYEG interactome in E. coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SecYEG translocon; interaction proteomics; YidC; PpiD; protein cross-linking; protein translocation; quantitative affinity purification mass spectrometry (qAP-MS); protein-protein interaction	SIGNAL-RECOGNITION PARTICLE; MEMBRANE-PROTEIN INSERTION; GRAM-NEGATIVE BACTERIA; CRYO-EM STRUCTURE; ESCHERICHIA-COLI; INNER MEMBRANE; TRANSMEMBRANE HELICES; MOLECULAR CHAPERONE; MASS-SPECTROMETRY; SRP RECEPTOR	The SecYEG translocon constitutes the major protein transport channel in bacteria and transfers an enormous variety of different secretory and inner-membrane proteins. The minimal core of the SecYEG translocon consists of three inner-membrane proteins, SecY, SecE, and SecG, which, together with appropriate targeting factors, are sufficient for protein transport in vitro. However, in vivo the SecYEG translocon has been shown to associate with multiple partner proteins, likely allowing the SecYEG translocon to process its diverse substrates. To obtain a global view on SecYEG plasticity in Escherichia coli, here we performed a quantitative interaction proteomic analysis, which identified several known SecYEG-interacting proteins, verified the interaction of SecYEG with quality-control proteins, and revealed several previously unknown putative SecYEG interacting proteins. Surprisingly, we found that the chaperone complex PpiD/YfgM is the most prominent interaction partner of SecYEG. Detailed analyses of the PpiD-SecY interaction by site-directed cross-linking revealed that PpiD and the established SecY partner protein YidC use almost completely overlapping binding sites on SecY. Both PpiD and YidC contacted the lateral gate, the plug domain, and the periplasmic cavity of SecY. However, quantitative MS and cross-linking analyses revealed that despite having almost identical binding sites, their binding to SecY is noncompetitive. This observation suggests that the SecYEG translocon forms different substrate-independent subassemblies in which SecYEG either associates with YidC or with the PpiD/YfgM complex. In summary, the results of this study indicate that the PpiD/YfgM chaperone complex is a primary interaction partner of the SecYEG translocon.	[Jauss, Benjamin; Petriman, Narcis-Adrian; Franz, Lisa; Sachelaru, Ilie; Welte, Thomas; Steinberg, Ruth; Koch, Hans-Georg] Albert Ludwigs Univ Freiburg, ZBMZ, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany; [Petriman, Narcis-Adrian; Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, Fac Biol, Inst Biol Biochem & Funct Prote 2, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, Signalling Res Ctr BIOSS, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Albert Ludwigs Univ Freiburg, CIBSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Koch, HG (corresponding author), Albert Ludwigs Univ Freiburg, ZBMZ, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Hans-Georg.Koch@biochemie.uni-freiburg.de		Drepper, Friedel/0000-0002-2043-5795; Welte, Thomas/0000-0003-4583-9216; Koch, Hans-Georg/0000-0001-5913-0334; Steinberg, Ruth/0000-0003-4108-6085; Warscheid, Bettina/0000-0001-5096-1975; Petriman, Narcis Adrian/0000-0002-3189-7530	German Science Foundation (DFG) [KO2184/8-1, KO2184/8-2, 403222702, SFB 1381, 390939984]; Else-Kroner-Fresenius-Foundation/Motivate program of the University Freiburg Medical School; Konrad-Adenauer-Foundation; FF-Nord Fellowship	German Science Foundation (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Foundation/Motivate program of the University Freiburg Medical School; Konrad-Adenauer-Foundation; FF-Nord Fellowship	We thank Bettina Knapp for technical assistance in LC/MS analyses and Dan Daley and Gunnar von Heijne (University Stockholm) for antibodies, strains and plasmids. This work was supported by the German Science Foundation (DFG grants KO2184/8-1 & 8-2 to HGK, Project-ID 403222702, SFB 1381 to HGK and BW, and the Excellence Strategy (CIBBS-EXC-2189 Project ID 390939984 to BW), the Else-Kroner-Fresenius-Foundation/Motivate program of the University Freiburg Medical School and the Konrad-Adenauer-Foundation to BJ and by an FF-Nord Fellowship to RS.	Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Akopian D, 2013, J CELL BIOL, V200, P397, DOI 10.1083/jcb.201208045; ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Banerjee T, 2017, J BIOL CHEM, V292, P19693, DOI 10.1074/jbc.RA117.000130; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Botte M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38399; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Braig D, 2011, MOL BIOL CELL, V22, P2309, DOI 10.1091/mbc.E11-02-0152; Carlson ML, 2019, ELIFE, V8, DOI 10.7554/eLife.46615; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; Chan A, 2016, EUR J CELL BIOL, V95, P585, DOI 10.1016/j.ejcb.2016.10.004; Chorev DS, 2018, SCIENCE, V362, P829, DOI 10.1126/science.aau0976; Collinson I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0025; Cymer F, 2015, J BIOL CHEM, V290, P10208, DOI 10.1074/jbc.M115.641555; Cymer F, 2014, FEBS LETT, V588, P1930, DOI 10.1016/j.febslet.2014.03.050; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; de Keyzer J, 2007, FEBS LETT, V581, P1859, DOI 10.1016/j.febslet.2007.03.081; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Draycheva A, 2016, MOL MICROBIOL, V102, P152, DOI 10.1111/mmi.13452; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Furst M, 2018, BBA-MOL CELL RES, V1865, P273, DOI 10.1016/j.bbamcr.2017.10.012; Ge Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6263; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Gotzke H, 2015, MOL CELL PROTEOMICS, V14, P216, DOI 10.1074/mcp.M114.043216; Gotzke H, 2014, J BIOL CHEM, V289, P19089, DOI 10.1074/jbc.M113.541672; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris ME, 2009, METHOD ENZYMOL, V468, P127, DOI 10.1016/S0076-6879(09)68007-1; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Ismail N, 2015, NAT STRUCT MOL BIOL, V22, P145, DOI 10.1038/nsmb.2940; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Jomaa A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15470; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Keller R, 2012, J CELL BIOL, V199, P303, DOI 10.1083/jcb.201204149; Knyazev D. G, 2018, J MEMBRANE BIOL; Koch HG, 2000, J CELL BIOL, V150, P689, DOI 10.1083/jcb.150.3.689; Koch HG, 2002, J BIOL CHEM, V277, P5715, DOI 10.1074/jbc.C100683200; Komar J, 2016, BIOCH J; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; Kuhn A, 2016, ECOSAL PLUS, DOI [10.1128/ecosalplus.esp-0012-2016, DOI 10.1128/ECOSALPLUS.ESP-0012-2016, 10 .1128/ecosalplus.ESP-0012-2016., DOI 10.1128/EC0SALPLUS.ESP-0012-2016]; Kuhn P, 2015, J CELL BIOL, V211, P91, DOI 10.1083/jcb.201502103; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Lohmeyer E, 2012, BBA-BIOENERGETICS, V1817, P2005, DOI 10.1016/j.bbabio.2012.06.621; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Nijeholt JALA, 2013, FEBS LETT, V587, P3083, DOI 10.1016/j.febslet.2013.07.046; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petriman NA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19019-w; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; Sachelaru I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00109-8; Sachelaru I, 2014, J BIOL CHEM, V289, P21706, DOI 10.1074/jbc.M114.577916; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; Schulze RJ, 2014, P NATL ACAD SCI USA, V111, P4844, DOI 10.1073/pnas.1315901111; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Stull F, 2018, ECOSAL PLUS, V8; Sugai R, 2007, J BIOL CHEM, V282, P29540, DOI 10.1074/jbc.M704716200; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Weininger U, 2010, PROTEIN SCI, V19, P6, DOI 10.1002/pro.277; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z; Zhang XX, 2012, J PROTEOME RES, V11, P1454, DOI 10.1021/pr200846y; Zhu L, 2013, J BIOL CHEM, V288, P28180, DOI 10.1074/jbc.M113.491613; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	97	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19167	19183		10.1074/jbc.RA119.010686	http://dx.doi.org/10.1074/jbc.RA119.010686			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699901	Green Published, hybrid			2022-12-26	WOS:000516527800018
J	Jeon, SA; Kim, DW; Cho, JY				Jeon, Seon-Ae; Kim, Dong Wook; Cho, Je-Yoel			Neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) regulates hydrogen peroxide-induced cell proliferation and death through inhibition of Hippo signaling	FASEB JOURNAL			English	Article						hBMSCs; H2O2; NF-kappa B; YAP	KAPPA-B ACTIVATION; E3 LIGASE NEDD4-1; UP-REGULATION; YAP PATHWAY; PROTEIN; YAP/TAZ; DEGRADATION; HOMEOSTASIS; INDUCTION; APOPTOSIS	E3 ubiquitin ligases are involved in the regulation of oxidative stress-induced cell death. In this study, we investigated the role of neural precursor cell-expressed, developmentally down-regulated protein 4 (NEDD4) in regulation of hydrogen peroxide (H2O2)-induced cell proliferation and apoptosis in human bone marrow-derived stem cells (hBMSCs). Cell proliferation was increased in low doses of H2O2 (10(-4) to 10(-2) mu M), whereas sublethal concentrations of H2O2 (>200 mu M) induced apoptosis. A chromatin immunoprecipitation assay identified that recruitment of NF-kappa B onto the promoter region of NEDD4 mediated H2O2-induced NEDD4 expression. The increase of NEDD4 expression by H2O2 induced translocation of yes-associated protein (YAP) into the nucleus by decreasing the stability of large tumor suppressor kinase (LATS). Thus, the phosphorylation of serine 127 residue of YAP by LATS upstream kinase is decreased and thereby increased the transcriptional activity of YAP. The mRNA expression levels of catalase and manganese superoxide dismutase, which are well-known targets of YAP, were increased by H2O2 treatment but down-regulated by NEDD4 silencing using a specific small interfering RNA targeting NEDD4 (siNEDD4). H2O2-induced scavenging capacity of reactive oxygen species was also decreased by siNEDD4 in hBMSCs. Finally, hBMSC differentiation into osteoblast was decreased by siNEDD4 but reverted by reintroduction of the S127A mutant construction of YAP. Taken together, these results indicate that NEDD4 regulates H2O2-induced alteration of cell status through regulation of the Hippo signaling pathway.	[Jeon, Seon-Ae; Kim, Dong Wook; Cho, Je-Yoel] Seoul Natl Univ, Dept Vet Biochem, Sch Vet Med, BK21 Plus & Res Inst Vet Sci, Seoul, South Korea	Seoul National University (SNU)	Cho, JY (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Vet Biochem, 1 Gwanak Ro, Seoul 08826, South Korea.	jeycho@snu.ac.kr			National Research Foundation of Korea (NRF); Bio and Medical Technology Development Program - Ministry of Science, Information and Communications Technology (ICT), and Future Planning [2014M3A9D5A01073598, 2016M3A9B6026771]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Bio and Medical Technology Development Program - Ministry of Science, Information and Communications Technology (ICT), and Future Planning	The authors thank Dr. Jho's laboratory (Department of Life Science, University of Seoul, Seoul, South Korea) for the plasmid containing YAP and green fluorescent protein and Johannes Josephus Schabort (Department of Veterinary Biochemistry, Seoul National University) for English proofreading of the manuscript of this study. This research was supported by grants from the National Research Foundation of Korea (NRF) and the Bio and Medical Technology Development Program funded by the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (2014M3A9D5A01073598 and 2016M3A9B6026771). The authors declare no conflicts of interest.	Antunes F, 2017, REDOX BIOL, V13, P1, DOI 10.1016/j.redox.2017.04.039; Atashi F, 2015, STEM CELLS DEV, V24, P1150, DOI 10.1089/scd.2014.0484; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Choi JJ, 2007, FREE RADICAL RES, V41, P555, DOI 10.1080/10715760601173010; Cyrne L, 2013, METHOD ENZYMOL, V528, P173, DOI 10.1016/B978-0-12-405881-1.00010-0; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; Dupont S, 2016, EXP CELL RES, V343, P42, DOI 10.1016/j.yexcr.2015.10.034; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Harvey KF, 1998, J BIOL CHEM, V273, P13524, DOI 10.1074/jbc.273.22.13524; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong SW, 2014, CELL DEATH DIFFER, V21, P146, DOI 10.1038/cdd.2013.141; Hsia Hung-En, 2015, Commun Integr Biol, V8, pe1017161, DOI 10.1080/19420889.2015.1017161; Jeon SA, 2018, BONE, V116, P248, DOI 10.1016/j.bone.2018.08.012; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Jung S, 2013, INT J ONCOL, V43, P1587, DOI 10.3892/ijo.2013.2064; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Lee D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0562-5; Lee EH, 2011, J CELL PHYSIOL, V226, P1676, DOI 10.1002/jcp.22498; Lee JH, 2010, BONE, V46, P1522, DOI 10.1016/j.bone.2010.02.013; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Liu J, 2014, ONCOTARGET, V5, P1026, DOI 10.18632/oncotarget.1675; Mao BB, 2015, ACTA BIOCH BIOPH SIN, V47, P2, DOI 10.1093/abbs/gmu109; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Pan JX, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0018-7; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Su JN, 2017, BIOCHEM PHARMACOL, V140, P28, DOI 10.1016/j.bcp.2017.05.014; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weng M, 2017, ONCOTARGET, V8, P20288, DOI 10.18632/oncotarget.15446; Xiong JH, 2018, BONE, V112, P1, DOI 10.1016/j.bone.2018.04.001; Xu C, 2015, ONCOGENE, V34, P342, DOI 10.1038/onc.2013.557; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Ye XT, 2014, CURR CANCER DRUG TAR, V14, P549, DOI 10.2174/1568009614666140725092430; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhou XX, 2011, J PHARMACOL EXP THER, V339, P218, DOI 10.1124/jpet.111.182352; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006	53	6	7	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14772	14783		10.1096/fj.201901404R	http://dx.doi.org/10.1096/fj.201901404R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690112	Bronze			2022-12-26	WOS:000507466100131
J	Tsai, CK; Huang, LC; Wu, YP; Kan, IY; Hueng, DY				Tsai, Chia-Kuang; Huang, Li-Chun; Wu, Yi-Ping; Kan, I-Ying; Hueng, Dueng-Yuan			SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT	FASEB JOURNAL			English	Article						S-nitroso-N-acetylpenicillamine; NDRG1; apoptosis; HIF-1	NITRIC-OXIDE SYNTHASE; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; TUMOR-CELLS; POSTTRANSLATIONAL MODIFICATION; GENE-EXPRESSION; CANCER CELLS; P53; TRANSCRIPTION; PROMOTER; ACTIVATION	Glioblastoma multiforme (GBM) is the most frequently occurring and gravest primary tumor of the CNS in adults. The development of chemoresistance to temozolomide (TMZ), the first-line chemotherapy for GBM, is an important factor contributing to poor treatment outcomes. Down-regulation of O-6-methylguanine-DNA methyltransferase (MGMT) expression in GBM cells is an attractive strategy for overcoming TMZ resistance and improving outcomes. This study revealed that the nitric oxide (NO) donor S-nitroso-N-acetylpenicillamine (SNAP) exerts antitumorigenic effects on TMZ-sensitive and TMZ-resistant (TMZ-R) glioma cells. Pretreatment with SNAP not only induced apoptosis, mitochondrial dysfunction, and hypoxia-inducing factor 1, but also resensitized TMZ-R GBM cells to TMZ through down-regulation of MGMT expression. SNAP acted principally through posttranslational modification of p53, phosphorylated N-myc downstream regulated gene 1, and MGMT protein stability in TMZ-R GBM cells. Additionally, when applied together, SNAP and TMZ enhanced the inhibition of tumor growth in vitro and in vivo. This study sheds new light on a potential strategy to overcome TMZ resistance in GBM and thus possesses the potential for prolonging survival of patients with GBM.	[Tsai, Chia-Kuang] Triserv Gen Hosp, Dept Neurol, Taipei, Taiwan; [Huang, Li-Chun; Wu, Yi-Ping; Kan, I-Ying; Hueng, Dueng-Yuan] Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Hueng, Dueng-Yuan] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan	Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Hueng, DY (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, 325,Sec 2,Cheng Kung Rd, Taipei, Taiwan.	hondy2195@yahoo.com.tw	Tsai, Chia-Kuang/AAR-8144-2021; Hueng, Dueng-Yuan/AAM-7807-2021	Hueng, Dueng-Yuan/0000-0001-7868-3161; Tsai, Chia-Kuang/0000-0001-7693-1408	Ministry of Science and Technology [MOST 106-2314-B-016-012-MY3]; Tri-Service General Hospital [TSGH-2-C107-106-2314-B-016-012-MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tri-Service General Hospital	This work was supported, in part, by grants from the Ministry of Science and Technology (MOST 106-2314-B-016-012-MY3 to D.-Y.H.) and Tri-Service General Hospital (TSGH-2-C107-106-2314-B-016-012-MY3 to D.-Y.H). The authors declare no conflicts of interest.	Aranda E, 2012, CURR MOL MED, V12, P50, DOI 10.2174/156652412798376099; Binabaj MM, 2018, J CELL PHYSIOL, V233, P378, DOI 10.1002/jcp.25896; Bobustuc GC, 2010, NEURO-ONCOLOGY, V12, P917, DOI 10.1093/neuonc/noq044; Bocangel D, 2009, ANTICANCER RES, V29, P3741; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Brune B, 2003, TOXICOL LETT, V139, P119, DOI 10.1016/S0378-4274(02)00426-5; Cabrini G, 2015, INT J ONCOL, V47, P417, DOI 10.3892/ijo.2015.3026; Chang K, 2004, EXP MOL MED, V36, P311, DOI 10.1038/emm.2004.42; Chao JI, 2004, J BIOL CHEM, V279, P20267, DOI 10.1074/jbc.M312381200; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Ekmekcioglu S, 2006, INT J CANCER, V119, P861, DOI 10.1002/ijc.21767; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Garban HJ, 2001, J IMMUNOL, V167, P75, DOI 10.4049/jimmunol.167.1.75; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hara E, 1996, BIOCHEM BIOPH RES CO, V224, P153, DOI 10.1006/bbrc.1996.0999; HARRIS LC, 1991, NUCLEIC ACIDS RES, V19, P6163, DOI 10.1093/nar/19.22.6163; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hendrickson MD, 2015, RES REP BIOCHEM, V5, P147, DOI 10.2147/RRBC.S58280; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Huang SM, 2001, ONCOGENE, V20, P2134, DOI 10.1038/sj.onc.1204298; Jahani-Asl A, 2013, CURR MOL MED, V13, P1241, DOI 10.2174/1566524011313080002; Janssens MY, 1999, BRIT J CANCER, V79, P1085, DOI 10.1038/sj.bjc.6690173; Kang KB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-66; Kim RK, 2013, CANCER SCI, V104, P1172, DOI 10.1111/cas.12207; Kitagaki J, 2009, ONCOGENE, V28, P619, DOI 10.1038/onc.2008.401; Kitamura Y, 1998, NEUROCHEM INT, V32, P93, DOI 10.1016/S0197-0186(97)00029-6; Leung EL, 2008, BRIT J CANCER, V98, P1803, DOI 10.1038/sj.bjc.6604375; Loibl S, 2005, EUR J CANCER, V41, P265, DOI 10.1016/j.ejca.2004.07.010; Matsumoto H, 2007, CANCER RES, V67, P8574, DOI 10.1158/0008-5472.CAN-07-1913; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; MONCADA S, 1991, PHARMACOL REV, V43, P109; Natsume A, 2008, CANCER CHEMOTH PHARM, V61, P653, DOI 10.1007/s00280-007-0520-x; Ookawa S, 2018, WORLD NEUROSURG, V111, pE783, DOI 10.1016/j.wneu.2017.12.166; Riganti C, 2005, CANCER RES, V65, P516; Rizi BS, 2017, TRENDS CANCER, V3, P659, DOI 10.1016/j.trecan.2017.07.005; Schneiderhan N, 2003, ONCOGENE, V22, P2857, DOI 10.1038/sj.onc.1206431; Singh S, 2011, CANCER CHEMOTH PHARM, V67, P1211, DOI 10.1007/s00280-011-1654-4; Srivenugopal KS, 2001, CLIN CANCER RES, V7, P1398; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Su L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7287; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tsai Chia-Kuang, 2018, Oncotarget, V9, P15705, DOI 10.18632/oncotarget.24594; VAN MEIR EG, 1994, CANCER RES, V54, P649; Vieira H, 2003, IUBMB LIFE, V55, P613, DOI 10.1080/15216540310001639652; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Weiler M, 2014, P NATL ACAD SCI USA, V111, P409, DOI 10.1073/pnas.1314469111; Xu S, 2013, NEURO-ONCOLOGY, V15, P1160, DOI 10.1093/neuonc/not067	50	14	14	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14171	14184		10.1096/fj.201901021RR	http://dx.doi.org/10.1096/fj.201901021RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31725331	Bronze			2022-12-26	WOS:000507466100086
J	Goris, JM; Temple, VJ; Sumbis, J; Zomerdijk, N; Codling, K				Goris, Janny M.; Temple, Victor J.; Sumbis, Joan; Zomerdijk, Nienke; Codling, Karen			Iodine status of non-pregnant women and availability of food vehicles for fortification with iodine in a remote community in Gulf province, Papua New Guinea	PLOS ONE			English	Article							SALT; DEFICIENCY; KAMEA	Adequate iodine status of women of childbearing age is essential for optimal growth and development of their offspring. The objectives of the current study were to assess the iodine status of non-pregnant women, availability and use of commercial salt, extent to which it is iodised, and availability of other industrially processed foods suitable for fortification with iodine. This prospective cross-sectional study was carried out in 2018 in a remote area in Gulf province, Papua New Guinea. Multistage cluster sampling was used to randomly select 300 women visiting local markets. Of these, 284 met study criteria of being non-pregnant and non-lactating. Single urine samples were collected from each of them. Discretionary salt intake was assessed; salt samples were collected from a sub-sample of randomly selected households. A semi-structured, pre-tested questionnaire to assess use and availability of commercial salt and other processed foods was modified and used. Salt was available on the interview day in 51.6% of households. Mean iodine content in household salt samples was 37.8 +/- 11.8 ppm. Iodine content was below 30.0 ppm in 13.1% and below 15.0 ppm in 3.3% of salt samples. Mean iodine content of salt available at markets was 39.6 +/- 0.52 ppm. Mean discretionary intake of salt per capita per day was 3.9 +/- 1.21 g. Median UIC was 34.0 mu g/L (95% CI, 30.0-38.0 ppm), indicating moderate iodine deficiency. For women with salt in the household, median UIC was 39.5 mu g/L (95% CI, 32.0-47.0 mu g/L), compared to median UIC of 29.0 mu g/L (95% CI, 28.0-32.0 mu g/L) for those without salt. This community has low consumption of iodised salt, likely due to limited access. Investigation of other industrially processed foods indicated salt is the most widely consumed processed food in this remote community, although 39.8% of households did use salty flavourings.	[Goris, Janny M.] PNG Fdn, North Tamborine, Qld, Australia; [Temple, Victor J.; Sumbis, Joan] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea; [Zomerdijk, Nienke] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Codling, Karen] Iodine Global Network Southeast Asia & Pacific, Bangkok, Thailand	University of Papua New Guinea; University of Queensland	Temple, VJ (corresponding author), Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea.	templevj@upng.ac.pg	Zomerdijk, Nienke/AAV-5551-2021	Zomerdijk, Nienke/0000-0001-5008-6429; Temple, Victor/0000-0003-4212-8232	Iodine Global Network; Micronutrient Research Laboratory, School of Medicine and Health Sciences, University of Papua New Guinea	Iodine Global Network; Micronutrient Research Laboratory, School of Medicine and Health Sciences, University of Papua New Guinea	The findings and conclusions in this manuscript are those of the authors; they do not represent the official position of the institutions and authors' organisations. The authors declare no conflicts of interest. A small research grant was received from the Iodine Global Network for the fieldwork section of this project. The analyses of iodine in salt and urine were funded by and carried out in the Micronutrient Research Laboratory, School of Medicine and Health Sciences, University of Papua New Guinea.	Ali Amjad, 1992, JPMA (Journal of the Pakistan Medical Association), V42, P138; Amoa B, 1998, Asia Pac J Clin Nutr, V7, P128; [Anonymous], 2007, ASS IOD DEF DIS MON; [Anonymous], PNG NAT STAT; Ansari M, 2016, INT J COMMUNITY MED, V3, P1431, DOI [10.18203/2394-6040.ijcmph20161606, DOI 10.18203/2394-6040.IJCMPH20161606]; Barter P., 1995, PURE FOOD ACT AMENDM, pG 47; Bazezew Meseret Mamo, 2018, BMC Res Notes, V11, P734, DOI 10.1186/s13104-018-3847-y; BLAKE NM, 1981, HUM HERED, V31, P191, DOI 10.1159/000153205; Bourke R, 2011, FOOD AGR PAPUA NEW G; China National Salt Industry Corporation, 2012, WYD IOD CHECK INSTR; Department of Health of Papua New Guinea UNICEF Papua New Guinea University of Papua New Guinea US Centres of Disease Control and Prevention, 2011, PAC J MED SCI, V8, P54; Eastman, 2018, IODINE DEFICIENCY DI; Goris JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197647; Goris JM, 2017, ASIA PAC J CLIN NUTR, V26, P665, DOI 10.6133/apjcn.052016.09; Hynes KL, 2013, J CLIN ENDOCR METAB, V98, P1954, DOI 10.1210/jc.2012-4249; Knowles JM, 2017, J NUTR, V147, p1004S, DOI 10.3945/jn.116.242586; Lomutopa S, 2013, PAC J MED SCI, V11, P70; Lowe N, 2015, NUTRIENTS, V7, P9672, DOI 10.3390/nu7115490; National Statistical Office of Papua New Guinea, 2014, 2011 NAT POP HOUS CE; Papua New Guinea National Department of Health, 2007, FOOD SAN REG STAT IN; Pearce EN, 2016, AM J CLIN NUTR, V104, p918S, DOI 10.3945/ajcn.115.110429; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Sai Deepika P., 2019, INT J COMMUNITY MED, V6, P1083, DOI [10.18203/2394-6040.ijcmph20190590, DOI 10.18203/2394-6040.IJCMPH20190590]; Spohrer R, 2015, ANN NY ACAD SCI, V1357, P43, DOI 10.1111/nyas.12963; Temple V, 2005, J PUBLIC HEALTH-UK, V27, P45, DOI 10.1093/pubmed/fdh199; Temple V., 2006, IDD NEWSLETTER, V22, P11; Temple V, 2018, PAC J MED SCI, V18, P3; Temple V. J., 2009, African Journal of Food, Agriculture, Nutrition and Development, V9, P1807; Temple VJ, 2006, ASIA PAC J CLIN NUTR, V15, P533; The Worldbank Group, 2016, CLIM CHANG KNOWL POR; United Nations Children's Emergency Fund, 2018, GUIDANCE MONITORING; Vanderpump MPJ, 2011, LANCET, V377, P2007, DOI 10.1016/S0140-6736(11)60693-4; WHO UNICEF, 2007, REACH OPT IOD NUTR P; World Health Organization, 2014, GUID FORT FOODGR SAL; Zimmermann MB, 2015, LANCET DIABETES ENDO, V3, P286, DOI 10.1016/S2213-8587(14)70225-6	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224229	10.1371/journal.pone.0224229	http://dx.doi.org/10.1371/journal.pone.0224229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730622	Green Published, gold			2022-12-26	WOS:000532809500002
J	Vahidy, FS; Bambhroliya, AB; Meeks, JR; Rahman, O; Ely, EW; Slooter, AJC; Tyson, JE; Miller, CC; McCullough, LD; Savitz, SI; Khan, B				Vahidy, Farhaan S.; Bambhroliya, Arvind B.; Meeks, Jennifer R.; Rahman, Omar; Ely, E. Wesley; Slooter, Arjen J. C.; Tyson, Jon E.; Miller, Charles C.; McCullough, Louise D.; Savitz, Sean, I; Khan, Babar			In-hospital outcomes and 30-day readmission rates among ischemic and hemorrhagic stroke patients with delirium	PLOS ONE			English	Article							TERM COGNITIVE IMPAIRMENT; COMORBIDITY MEASURES; INSTITUTIONALIZATION; DECLINE; CLAIMS; CARE	Objective Delirium is associated with poor outcomes among critically ill patients. However, it is not well characterized among patients with ischemic or hemorrhagic stroke (IS and HS). We provide the population-level frequency of in-hospital delirium and assess its association with in-hospital outcomes and with 30-day readmission among IS and HS patients. Methods We analyzed Nationwide in-hospital and readmission data for years 2010-2015 and identified stroke patients using ICD-9 codes. Delirium was identified using validated algorithms. Outcomes were in-hospital mortality, length of stay, unfavorable discharge disposition, and 30-day readmission. We used survey design logistic regression methods to provide national estimates of proportions and 95% confidence intervals (CI) for delirium, and odds ratios (OR) for association between delirium and poor outcomes. Results We identified 3,107,437 stroke discharges of whom 7.45% were coded to have delirium. This proportion significantly increased between 2010 (6.3%) and 2015 (8.7%) (aOR, 95% CI: 1.04, 1.03-1.05). Delirium proportion was higher among HS patients (ICH: 10.0%, SAH: 9.8%) as compared to IS patients (7.0%). Delirious stroke patients had higher in-hospital mortality (12.3% vs. 7.8%), longer in-hospital stay (11.6 days vs. 7.3 days) and a significantly greater adjusted risk of 30-day-readmission (16.7%) as compared to those without delirium (12.2%) (aRR, 95% CI: 1.13, 1.11-1.15). Upon readmission, patients with delirium at initial admission continued to have a longer length of stay (7.7 days vs. 6.6 days) and a higher in-hospital mortality (9.3% vs. 6.4%). Conclusion Delirium identified through claims data in stroke patients is independently associated with poor in-hospital outcomes both at index admission and readmission. Identification and management of delirium among stroke patients provides an opportunity to improve outcomes.	[Vahidy, Farhaan S.; Bambhroliya, Arvind B.; Meeks, Jennifer R.; McCullough, Louise D.; Savitz, Sean, I] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Inst Stroke & Cerebrovasc Dis, Houston, TX 77030 USA; [Vahidy, Farhaan S.; Bambhroliya, Arvind B.; Meeks, Jennifer R.; McCullough, Louise D.; Savitz, Sean, I] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA; [Rahman, Omar; Khan, Babar] Indiana Univ Sch Med, Div Pulm Crit Care, Indianapolis, IN 46202 USA; [Ely, E. Wesley] Vanderbilt Univ, Med Ctr, Dept Med, Crit Illness Brain Dysfunct Survivorship CIBS Ctr, Nashville, TN USA; [Ely, E. Wesley] Tennessee Valley Vet Affairs Geriatr Res Educ Cli, Nashville, TN USA; [Slooter, Arjen J. C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Slooter, Arjen J. C.] Univ Utrecht, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Tyson, Jon E.; Miller, Charles C.] Univ Texas Hlth Sci Ctr Houston, Ctr Clin Res & Evidence Based Med, McGovern Med Sch, Houston, TX 77030 USA; [Khan, Babar] Indiana Univ, Ctr Hlth Innovat & Implementat Sci, Regenstrief Inst Inc, Ctr Aging Res, Indianapolis, IN 46204 USA; [Khan, Babar] Indiana Clin & Translat Sci Inst, Indianapolis, IN USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Indiana University System; Indiana University Bloomington; Vanderbilt University; Geriatric Research Education & Clinical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Texas System; University of Texas Health Science Center Houston; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	Vahidy, FS (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Inst Stroke & Cerebrovasc Dis, Houston, TX 77030 USA.; Vahidy, FS (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, Houston, TX 77030 USA.	Farhaan.Vahidy@uth.tmc.edu		Bambhroliya, Arvind/0000-0002-2584-2517	National Center for Advancing Translational Sciences (NCATS) [UL1 TR000371]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We acknowledge the infrastructural support provided by the Biostatistics/Epidemiology/Research Design (BERD) component of the Center for Clinical and Translational Sciences (CCTS) for this project. CCTS is mainly funded by a grant (UL1 TR000371) from the National Center for Advancing Translational Sciences (NCATS), awarded to University	Association A.P., 2013, DIAGNOSTIC STAT MANU; Brummel NE, 2017, AM J CRIT CARE, V26, P447, DOI 10.4037/ajcc2017263; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fong TG, 2009, NAT REV NEUROL, V5, P210, DOI 10.1038/nrneurol.2009.24; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Khan BA, 2015, AM J NURS, V115, P24, DOI 10.1097/01.NAJ.0000461807.42226.3e; Khan BA, 2012, J HOSP MED, V7, P580, DOI 10.1002/jhm.1949; Kim DH, 2017, PHARMACOEPIDEM DR S, V26, P945, DOI 10.1002/pds.4226; Krogseth M, 2014, J PSYCHOSOM RES, V76, P68, DOI 10.1016/j.jpsychores.2013.10.006; Lee CC, 2016, AURIS NASUS LARYNX, V43, P322, DOI 10.1016/j.anl.2015.10.004; Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB; Marra A, 2017, CRIT CARE CLIN, V33, P225, DOI 10.1016/j.ccc.2016.12.005; McCoy TH, 2016, PSYCHOSOMATICS, V57, P480, DOI 10.1016/j.psym.2016.06.001; Menendez ME, 2015, SPINE, V40, P809, DOI 10.1097/BRS.0000000000000892; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Naidech AM, 2013, AM J RESP CRIT CARE, V188, P1331, DOI 10.1164/rccm.201307-1256OC; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Patel MB, 2018, CRIT CARE MED, V46, P1832, DOI 10.1097/CCM.0000000000003349; Wei LA, 2008, J AM GERIATR SOC, V56, P823, DOI 10.1111/j.1532-5415.2008.01674.x	20	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225204	10.1371/journal.pone.0225204	http://dx.doi.org/10.1371/journal.pone.0225204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN2HK	31725810	Green Published, gold			2022-12-26	WOS:000532764500068
J	Courson, JA; Smith, I; Do, T; Landry, PT; Hargrave, A; Behzad, AR; Hanlon, SD; Rumbaut, RE; Smith, CW; Burns, AR				Courson, Justin A.; Smith, Ian; Do, Thao; Landry, Paul T.; Hargrave, Aubrey; Behzad, Ali R.; Hanlon, Sam D.; Rumbaut, Rolando E.; Smith, C. Wayne; Burns, Alan R.			Serial block-face scanning electron microscopy reveals neuronal-epithelial cell fusion in the mouse cornea	PLOS ONE			English	Article							VIVO CONFOCAL MICROSCOPY; BASAL NERVE PLEXUS; AXON DEGENERATION; MYOBLAST FUSION; SURFACE-AREA; MECHANISMS; MEMBRANE; CALCIUM; VOLUME; ORGANIZATION	The cornea is the most highly innervated tissue in the body. It is generally accepted that corneal stromal nerves penetrate the epithelial basal lamina giving rise to intra-epithelial nerves. During the course of a study wherein we imaged corneal nerves in mice, we observed a novel neuronal-epithelial cell interaction whereby nerves approaching the epithelium in the cornea fused with basal epithelial cells, such that their plasma membranes were continuous and the neuronal axoplasm freely abutted the epithelial cytoplasm. In this study we sought to determine the frequency, distribution, and morphological profile of neuronal-epithelial cell fusion events within the cornea. Serial electron microscopy images were obtained from the anterior stroma in the paralimbus and central cornea of 8-10 week old C57BLI6J mice. We found evidence of a novel alternative behavior involving a neuronal-epithelial interaction whereby 42.8% of central corneal nerve bundles approaching the epithelium contain axons that fuse with basal epithelial cells. The average surface-to-volume ratio of a penetrating nerve was 3.32, while the average fusing nerve was smaller at 1.39 (p < 0.0001). Despite this, both neuronal-epithelial cell interactions involve similarly sized discontinuities in the basal lamina. In order to verify the plasma membrane continuity between fused neurons and epithelial cells we used the lipophilic membrane tracer Dil. The majority of corneal nerves were labeled with Dil after application to the trigeminal ganglion and, consistent with our ultrastructural observations, fusion sites recognized as Dil-labeled basal epithelial cells were located at points of stromal nerve termination. These studies provide evidence that neuronal-epithelial cell fusion is a cell-cell interaction that occurs primarily in the central cornea, and fusing nerve bundles are morphologically distinct from penetrating nerve bundles. This is, to our knowledge, the first description of neuronal-epithelial cell fusion in the literature adding a new level of complexity to the current understanding of corneal innervation.	[Courson, Justin A.; Smith, Ian; Do, Thao; Landry, Paul T.; Hargrave, Aubrey; Hanlon, Sam D.; Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77004 USA; [Behzad, Ali R.] King Abdullah Univ Sci & Technol KAUST, Core Labs, Thuwal, Saudi Arabia; [Rumbaut, Rolando E.; Smith, C. Wayne; Burns, Alan R.] Baylor Coll Med, Childrens Nutr Ctr, Houston, TX 77030 USA; [Rumbaut, Rolando E.] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis CTRID, Houston, TX USA	University of Houston System; University of Houston; King Abdullah University of Science & Technology; Baylor College of Medicine; Baylor College of Medicine	Courson, JA (corresponding author), Univ Houston, Coll Optometry, Houston, TX 77004 USA.	JACourso@central.uh.edu	Courson, Justin/AAW-9273-2021; Courson, Justin/AAK-4802-2021	Courson, Justin/0000-0002-1036-097X; 	Agency: National Institutes of Health (NIH). Institute: National Eye Institute (NEI) [R01 EY018239, EY018239, P30 EY07551, EY07551]; NATIONAL EYE INSTITUTE [P30EY007551, R01EY018239] Funding Source: NIH RePORTER	Agency: National Institutes of Health (NIH). Institute: National Eye Institute (NEI); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funded by R01 EY018239. Agency: National Institutes of Health (NIH). Institute: National Eye Institute (NEI). Type: Research Project (R01). Funding number: EY018239. P30 EY07551. Agency: National Institutes of Health (NIH). Institute: National Eye Institute (NEI). Type: Center Core Grant. Funding Number: EY07551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2003, INT REV CYTOL, V225, P33, DOI 10.1016/S0074-7696(05)25002-7; Ackman JB, 2006, J NEUROSCI, V26, P11413, DOI 10.1523/JNEUROSCI.3340-06.2006; Al-Aqaba MA, 2010, BRIT J OPHTHALMOL, V94, P1251, DOI 10.1136/bjo.2009.178244; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Ambrosi DJ, 2005, J CELL MOL MED, V9, P320, DOI 10.1111/j.1582-4934.2005.tb00358.x; Anantharam A, 2012, J NEUROCHEM, V122, P661, DOI 10.1111/j.1471-4159.2012.07816.x; ANDERSON HR, 1994, ANAL QUANT CYTOL, V16, P253; AURAN JD, 1995, OPHTHALMOLOGY, V102, P33; Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; Baas PW, 2016, CYTOSKELETON, V73, P442, DOI 10.1002/cm.21286; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; Belmonte C., 1996, NEUROBIOLOGY NOCICEP, P146, DOI DOI 10.1093/ACPROF:OSO/9780198523345.001.0001; Belmonte Carlos, 2004, Ocul Surf, V2, P248; Bittner GD, 2016, J NEUROSCI RES, V94, P207, DOI 10.1002/jnr.23685; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; Brukman NG, 2019, J CELL BIOL, V218, P1436, DOI 10.1083/jcb.201901017; Caillaud M, 2019, NEURAL REGEN RES, V14, P24, DOI 10.4103/1673-5374.243699; CHANG DC, 1989, BIOPHYS J, V56, P641, DOI 10.1016/S0006-3495(89)82711-0; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Chi MM, 2019, J GEN VIROL, V100, P958, DOI 10.1099/jgv.0.001278; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Cruzat A, 2017, OCUL SURF, V15, P15, DOI 10.1016/j.jtos.2016.09.004; Daniels JT, 2001, WOUND REPAIR REGEN, V9, P483, DOI 10.1046/j.1524-475x.2001.00483.x; Defrancesco-Lisowitz A, 2015, NEUROSCIENCE, V302, P174, DOI 10.1016/j.neuroscience.2014.09.027; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Devor M, 2006, J PAIN, V7, pS3, DOI 10.1016/j.jpain.2005.09.006; DOANE MG, 1967, J GEN PHYSIOL, V50, P2603, DOI 10.1085/jgp.50.11.2603; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flegler SL., 1993, SCANNING TRANSMISSIO; Gagen D, 2010, EXP EYE RES, V91, P676, DOI 10.1016/j.exer.2010.08.007; Gibbons CH, 2009, NEUROLOGY, V72, P1479, DOI 10.1212/WNL.0b013e3181a2e8b8; Giordano-Santini R, 2016, SEMIN CELL DEV BIOL, V60, P146, DOI 10.1016/j.semcdb.2016.06.019; GODEMENT P, 1987, DEVELOPMENT, V101, P697; Gonzalez-Gonzalez O, 2017, INVEST OPHTH VIS SCI, V58, P404, DOI 10.1167/iovs.16-20033; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Hillenaar T, 2012, OPHTHALMOLOGY, V119, P241, DOI 10.1016/j.ophtha.2011.07.041; Hodor PG, 1998, DEV BIOL, V199, P111, DOI 10.1006/dbio.1998.8924; Hofmann MH, 1999, J NEUROSCI METH, V88, P27, DOI 10.1016/S0165-0270(99)00007-2; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Howard CV, 2005, UNBIASED STEREOLOGY; Huda F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164202; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Nguyen HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23721; Jackson M, 2014, BIOPROTOCOL, V4; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Kramer T, 2012, CELL HOST MICROBE, V11, P504, DOI 10.1016/j.chom.2012.03.005; Lafontant PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072388; Mahon GJ, 2004, CURR EYE RES, V28, P277, DOI 10.1076/ceyr.28.4.277.27835; MATZNER O, 1994, J NEUROPHYSIOL, V72, P349, DOI 10.1152/jn.1994.72.1.349; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Muller L, 1996, INVEST OPHTH VIS SCI, V37, P476; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Murphy MC, 2007, J NEUROSCI METH, V163, P213, DOI 10.1016/j.jneumeth.2007.03.001; Niederer RL, 2007, BRIT J OPHTHALMOL, V91, P1165, DOI 10.1136/bjo.2006.112656; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Oshima A, 2014, FEBS LETT, V588, P1230, DOI 10.1016/j.febslet.2014.01.042; Park JY, 2013, NEUROSCIENCE, V238, P258, DOI 10.1016/j.neuroscience.2013.02.033; Patel DV, 2009, BRIT J OPHTHALMOL, V93, P853, DOI 10.1136/bjo.2008.150615; Patel DV, 2008, INVEST OPHTH VIS SCI, V49, P3409, DOI 10.1167/iovs.08-1951; Patel DV, 2005, INVEST OPHTH VIS SCI, V46, P4485, DOI 10.1167/iovs.05-0794; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; Petroll WM, 2015, OCUL SURF, V13, P187, DOI 10.1016/j.jtos.2015.05.002; Pfannkuche K, 2015, METHODS MOL BIOL, pV; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Reichard M, 2016, CURR EYE RES, V41, P1021, DOI 10.3109/02713683.2015.1088952; Reith A., 1988, STEREOLOGY MORPHOMET; ROZSA AJ, 1982, PAIN, V14, P105, DOI 10.1016/0304-3959(82)90092-6; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schwann, 1847, MICROSCOPICAL RES AC; Simsek C, 2019, INVEST OPHTH VIS SCI, V60, P615, DOI 10.1167/iovs.18-26318; Sotnikov OS, 2012, USE CELL CULTURE PRO; SPOTL L, 1995, CYTOMETRY, V21, P160, DOI 10.1002/cyto.990210208; Sridhar MS, 2018, INDIAN J OPHTHALMOL, V66, P190, DOI 10.4103/ijo.IJO_646_17; Stein KK, 2004, J CELL SCI, V117, P6269, DOI 10.1242/jcs.01598; Stepp MA, 2017, GLIA, V65, P851, DOI 10.1002/glia.23102; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Vassilopoulos G, 2003, CURR OPIN GENET DEV, V13, P480, DOI 10.1016/S0959-437X(03)00110-2; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Waxman SG, 1995, AXON STRUCTURE FUNCT; WEIBEL ER, 1981, J HISTOCHEM CYTOCHEM, V29, P1043, DOI 10.1177/29.9.7026667; WOJCIESZYN JW, 1983, J CELL BIOL, V96, P151, DOI 10.1083/jcb.96.1.151; Woolf CJ, 2004, LIFE SCI, V74, P2605, DOI 10.1016/j.lfs.2004.01.003; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Yu DY, 2013, PROG RETIN EYE RES, V36, P217, DOI 10.1016/j.preteyeres.2013.07.001; Zhao J, 2006, INVEST OPHTHALMOL, V47, P3956; [No title captured]	99	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224434	10.1371/journal.pone.0224434	http://dx.doi.org/10.1371/journal.pone.0224434			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721785	gold, Green Published			2022-12-26	WOS:000532720700020
J	Friebertshauser, R; Shollenberger, K; Janosik, A; Garner, JT; Johnston, C				Friebertshauser, Ryan; Shollenberger, Kurtis; Janosik, Alexis; Garner, Jeffrey T.; Johnston, Carol			The effect of bivalve filtration on eDNA-based detection of aquatic organisms	PLOS ONE			English	Article							ENVIRONMENTAL DNA; CORBICULA-FLUMINEA; DEGRADATION; BIGHEAD; RATES	As the use of environmental-DNA (eDNA) expands as a method to detect the presence and quantity of aquatic taxa, factors potentially impacting the efficacy of this technique must be investigated. Many studies have examined the effects of abiotic parameters on the degradation of environmental-DNA (e.g. UV radiation, pH, temperature, etc.), however, few have focused on biotic effectors. Through high-filtering rates coupled with dense colonization, Asian clams (Corbicula fluminea) are able to drastically alter the quantity of particulate matter through translocation into the sediment, potentially including sources of eDNA in lotic and lentic systems. Using a longitudinal, laboratory experiment, we tested the effect of varying densities of Asian clams on the translocation rate of common goldfish (Carassius auratus) DNA. Target DNA in testing tanks was quantified through quantitative PCR (qPCR) at regular intervals and compared. Tanks housing the highest density of Asian clams produced significantly lower DNA concentrations over time compared to tanks of lower densities. These results show, for the first time, a density-dependent reduction of local eDNA sources by bivalve filtration that may lead to the obstructed detection of target species through the sampling of eDNA. Based on these findings, we recommend highly concentrated bivalve populations be taken into consideration when choosing the time and locality of eDNA sampling efforts.	[Friebertshauser, Ryan; Shollenberger, Kurtis; Johnston, Carol] Auburn Univ, Dept Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Janosik, Alexis] Univ West Florida, Dept Biol, Pensacola, FL USA; [Garner, Jeffrey T.] Alabama Dept Conservat & Nat Resources, Div Wildlife & Freshwater Fisheries, Florence, AL USA	Auburn University System; Auburn University; State University System of Florida; University of West Florida	Friebertshauser, R (corresponding author), Auburn Univ, Dept Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA.	rjf0030@tigermail.auburn.edu		Janosik, Alexis/0000-0002-4331-9703; Shollenberger, Kurtis/0000-0001-9920-8706	Alabama Department of Conservation & Natural Resources [G00012245]	Alabama Department of Conservation & Natural Resources	CJ, KS, and RF were supported by Alabama Department of Conservation & Natural Resources (Grant#:G00012245). JG of Alabama Department of Conservation & Naturual Resources assisted with conception and review of manuscript.	Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Basen T, 2013, CAN J FISH AQUAT SCI, V70, P198, DOI 10.1139/cjfas-2012-0188; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Dame R., 1980, ESTUARINE PERSPECTIV, P521, DOI [10.1016/B978-0-12-404060-1.50048-4, DOI 10.1016/B978-0-12-404060-1.50048-4]; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Furlan EM, 2016, MOL ECOL RESOUR, V16, P641, DOI 10.1111/1755-0998.12483; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Harper LR, 2018, ECOL EVOL, V8, P6330, DOI 10.1002/ece3.4013; Janosik AM, 2015, ENVIRON BIOL FISH, V98, P1889, DOI 10.1007/s10641-015-0405-5; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Jo T, 2017, MOL ECOL RESOUR, V17, pe25, DOI 10.1111/1755-0998.12685; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Lance RF, 2017, MANAG BIOL INVASION, V8, P343, DOI 10.3391/mbi.2017.8.3.08; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Lucy F, 2012, PREDICTIONS SPREAD P; Machler E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195529; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; Magurran AE, 2013, MEASURING BIOL DIVER; Marescaux J, 2016, HYDROBIOLOGIA, V777, P67, DOI 10.1007/s10750-016-2764-0; McMAHON RF, 1983, ECOLOGY, P505, DOI [10.1016/B978-0-12-751406-2.50019-2, DOI 10.1016/B978-0-12-751406-2.50019-2]; Pfleger MO, 2016, GLOB ECOL CONSERV, V8, P99, DOI 10.1016/j.gecco.2016.08.008; Pilliod DS, 2014, MOL ECOLOGY RESOURCE, DOI [10.1111/1755-0998.12281, DOI 10.1111/1755-0998.12281]; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Seymour M, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0005-3; Silverman H, 1995, BIOL BULL-US, V189, P308, DOI 10.2307/1542148; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Sugiura S, 2014, FISHERIES SCI, V80, P795, DOI 10.1007/s12562-014-0757-3; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; TENORE KR, 1973, MAR BIOL, V21, P190, DOI 10.1007/BF00355249; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Tsuji S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176608; Turek KA, 2015, FRESHW SCI, V34, P472, DOI 10.1086/680400; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Werner S, 2008, FUND APPL LIMNOL, V173, P145, DOI 10.1127/1863-9135/2008/0173-0145; Wilcox TM, 2015, CONSERV GENET RESOUR, V7, P639, DOI 10.1007/s12686-015-0465-z	37	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0222830	10.1371/journal.pone.0222830	http://dx.doi.org/10.1371/journal.pone.0222830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721779	Green Published, gold			2022-12-26	WOS:000532720700007
J	Sun, WJ; Reyes-Serratos, E; Barilla, D; Santos, JRL; Bujold, M; Graves, S; Marcet-Palacios, M				Sun, Weijie; Reyes-Serratos, Eduardo; Barilla, David; Santos, Joy Ramielle L.; Bujold, Mattea; Graves, Sean; Marcet-Palacios, Marcelo			Mathematical determination of the HIV-1 matrix shell structure and its impact on the biology of HIV-1	PLOS ONE			English	Article							VIRUS TYPE-1 MATRIX; CRYOELECTRON MICROSCOPY; ENVELOPE; MODEL; MECHANISMS; TRIMERS; VIRIONS	Since its discovery in the early 1980s, there has been significant progress in understanding the biology of type 1 human immunodeficiency virus (HIV-1). Structural biologists have made tremendous contributions to this challenge, guiding the development of current therapeutic strategies. Despite our efforts, there are unresolved structural features of the virus and consequently, significant knowledge gaps in our understanding. The superstructure of the HIV-1 matrix (MA) shell has not been elucidated. Evidence by various high-resolution microscopy techniques support a model composed of MA trimers arranged in a hexameric configuration consisting of 6 MA trimers forming a hexagon. In this manuscript we review the mathematical limitations of this model and propose a new model consisting of a 6-lune hosohedra structure, which aligns with available structural evidence. We used geometric and rotational matrix computation methods to construct our model and predict a new mechanism for viral entry that explains the increase in particle size observed during CD4 receptor engagement and the most common HIV-1 ellipsoidal shapes observed in cryo-EM tomo-grams. A better understanding of the HIV-1 MA shell structure is a key step towards better models for viral assembly, maturation and entry. Our new model will facilitate efforts to improve understanding of the biology of HIV-1.	[Sun, Weijie; Reyes-Serratos, Eduardo; Barilla, David; Marcet-Palacios, Marcelo] Univ Alberta, Alberta Resp Ctr, Dept Med, Edmonton, AB, Canada; [Santos, Joy Ramielle L.; Bujold, Mattea; Marcet-Palacios, Marcelo] Northern Alberta Inst Technol, Dept Biol Sci Technol, Lab Res & Biotechnol, Edmonton, AB, Canada; [Graves, Sean] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta	Marcet-Palacios, M (corresponding author), Univ Alberta, Alberta Resp Ctr, Dept Med, Edmonton, AB, Canada.; Marcet-Palacios, M (corresponding author), Northern Alberta Inst Technol, Dept Biol Sci Technol, Lab Res & Biotechnol, Edmonton, AB, Canada.	marcelo@ualberta.ca	Marcet-Palacios, Marcelo/AAZ-5994-2020; Marcet-Palacios, Marcelo/G-5707-2017; Reyes-Serratos, Eduardo A./I-2552-2016; Barilla, David/B-6780-2012; Santos, Joy Ramielle/AAP-9820-2021	Marcet-Palacios, Marcelo/0000-0002-4048-4658; Reyes-Serratos, Eduardo A./0000-0002-5616-2928; Barilla, David/0000-0001-7072-1290; Sun, Weijie/0000-0003-3099-0298	Alberta Innovates - Technology Futures [G2015000484]	Alberta Innovates - Technology Futures	This work was supported by Alberta Innovates - Technology Futures grant G2015000484 to MMP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; [Anonymous], 2013, SCI P, V2, P55; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Bharat TAM, 2014, P NATL ACAD SCI USA, V111, P8233, DOI 10.1073/pnas.1401455111; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2006, STRUCTURE, V14, P15, DOI 10.1016/j.str.2005.09.010; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Durrant JD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003720; Euler L, 1758, NOVI COMM ACAD SCI I, V4, P1752; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Hagan MF, 2016, CURR OPIN VIROL, V18, P36, DOI 10.1016/j.coviro.2016.02.012; Hagan MF, 2014, ADV CHEM PHYS, V155, P1; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Johnson GT, 2014, FARADAY DISCUSS, V169, P23, DOI 10.1039/c4fd00017j; Liu J, 2015, J COMPUTATIONAL MATH, V3, P43, DOI [10.1515/mlbmb-2015-0003, DOI 10.1515/MLBMB-2015-0003]; Liu YW, 2019, B MATH BIOL, V81, P1506, DOI 10.1007/s11538-019-00571-7; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Perlmutter JD, 2015, ANNU REV PHYS CHEM, V66, P217, DOI 10.1146/annurev-physchem-040214-121637; Pham S, 2015, VIROLOGY, V486, P121, DOI 10.1016/j.virol.2015.09.006; Quinn CM, 2018, P NATL ACAD SCI USA, V115, P11519, DOI 10.1073/pnas.1800796115; Roy NH, 2013, J VIROL, V87, P7516, DOI 10.1128/JVI.00790-13; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Tomasini MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196133; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224965	10.1371/journal.pone.0224965	http://dx.doi.org/10.1371/journal.pone.0224965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714942	Green Published, gold			2022-12-26	WOS:000532710400021
J	Peden, RSE; Akaichi, F; Camerlink, I; Boyle, LA; Turner, SP				Peden, Rachel S. E.; Akaichi, Faical; Camerlink, Irene; Boyle, Laura A.; Turner, Simon P.			Pig farmers' willingness to pay for management strategies to reduce aggression between pigs	PLOS ONE			English	Article							ANIMAL-WELFARE; SPACE ALLOWANCE; GROUP-SIZE; DECISION-MAKING; FINISHING PIGS; SOCIAL STRESS; BEHAVIOR; TRYPTOPHAN; TALK; PERFORMANCE	When deciding whether to invest in an improvement to animal welfare, farmers must tradeoff the relative costs and benefits. Despite the existence of effective solutions to many animal welfare issues, farmers' willingness to pay for them is largely unknown. This study modelled pig farmers' decisions to improve animal welfare using a discrete choice experiment focused on alleviating aggression between growing/finishing pigs at regrouping. Eighty-two UK and Irish pig farm owners and managers were asked to choose between hypothetical aggression control strategies described in terms of four attributes; installation cost, on-going cost, impact on skin lesions from aggression and impact on growth rate. If they did not like any of the strategies they could opt to keep their current farm practice. Systematic variations in product attributes allowed farmers' preferences and willingness to pay to be estimated and latent class modelling accounted for heterogeneity in responses. The overall willingness to pay to reduce lesions was low at 0.06 pound per pig place (installation cost) and 0.01 pound per pig produced (running cost) for each 1% reduction in lesions. Results revealed three independent classes of farmers. Farmers in Class 1 were unlikely to regroup unfamiliar growing/finishing pigs, and thus were unwilling to adopt measures to reduce aggression at regrouping. Farmers in Classes 2 and 3 were willing to adopt measures providing certain pre-conditions were met. Farmers in Class 2 were motivated mainly by business goals, whilst farmers in Class 3 were motivated by both business and animal welfare goals, and were willing to pay the most to reduce aggression; 0.11 pound per pig place and 0.03 pound per pig produced for each 1% reduction in lesions. Farmers should not be considered a homogeneous group regarding the adoption of animal welfare innovations. Instead, campaigns should be targeted at subgroups according to their independent preferences and willingness to pay.	[Peden, Rachel S. E.; Turner, Simon P.] Scotlands Rural Coll, Anim Behav & Welf, Anim & Vet Sci Res Grp, Edinburgh, Midlothian, Scotland; [Akaichi, Faical] Scotlands Rural Coll, Dept Rural Econ Environm & Soc, Edinburgh, Midlothian, Scotland; [Camerlink, Irene] Univ Vet Med, Inst Anim Welf Sci, Vienna, Austria; [Boyle, Laura A.] TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Fermoy, Cork, Ireland	Scotland's Rural College; Scotland's Rural College; University of Veterinary Medicine Vienna; Teagasc	Peden, RSE (corresponding author), Scotlands Rural Coll, Anim Behav & Welf, Anim & Vet Sci Res Grp, Edinburgh, Midlothian, Scotland.	Rachel.Peden@sruc.ac.uk		Akaichi, Faical/0000-0003-0395-2368; Turner, Simon/0000-0001-9198-9448; Boyle, Laura/0000-0001-7080-1776	Scotland's Rural College (SRUC); Scottish Government; BBSRC [BB/L000393/1] Funding Source: UKRI	Scotland's Rural College (SRUC); Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by Scotland's Rural College (SRUC). SRUC receives financial support from the Scottish Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHDB, 2014, UK REG BREAKD HERD 2; AHDB, 2017, PIG COST PROD SEL CO; AHDB, 2015, BPEX YB 2014 2015 KE; AHDB, 2016, PIG COST PROD SEL CO; AHDB/BPEX, 2013, PIG PROD COSTS PRIC; Akaichi F, 2016, 90 ANN C AGR EC SOC; Andersen IL, 2004, ANIM BEHAV, V68, P965, DOI 10.1016/j.anbehav.2003.12.016; Bech M, 2011, HEALTH ECON, V20, P273, DOI 10.1002/hec.1587; Bock BB, 2007, BRIT FOOD J, V109, P931, DOI 10.1108/00070700710835732; Bord Bia, 2014, PIGM QUAL ASS SCHEM; Breidert C., 2006, INNOV MARK, V2, P8; Camerlink I, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8110192; Camerlink I, 2017, APPL ANIM BEHAV SCI, V192, P42, DOI 10.1016/j.applanim.2016.11.009; Carrington MJ, 2014, J BUS RES, V67, P2759, DOI 10.1016/j.jbusres.2012.09.022; Carrington MJ, 2010, J BUS ETHICS, V97, P139, DOI 10.1007/s10551-010-0501-6; Coutellier L, 2007, APPL ANIM BEHAV SCI, V105, P102, DOI 10.1016/j.applanim.2006.05.007; Cummings RG, 1999, AM ECON REV, V89, P649, DOI 10.1257/aer.89.3.649; D'Eath RB, 2010, ANIMAL, V4, P604, DOI 10.1017/S1751731109991406; Dawkins MS, 2017, ANIM PROD SCI, V57, P201, DOI 10.1071/AN15383; Defra, 2017, AGR UK 2017; Dong ST, 2010, INT J RES MARK, V27, P25, DOI 10.1016/j.ijresmar.2009.09.004; Duijvesteijn N, 2014, J AGR ENVIRON ETHIC, V27, P1019, DOI 10.1007/s10806-014-9513-z; Dwyer CM, 2016, ANIMAL, V10, P449, DOI 10.1017/S1751731115001974; Edwards-Jones G, 2006, ANIM SCI, V82, P783, DOI 10.1017/ASC2006112; FEDER G, 1982, AM J AGR ECON, V64, P94, DOI 10.2307/1241177; FERA, 2013, BR0114 FERA; Gocsik E, 2015, ANIM WELFARE, V24, P211, DOI 10.7120/09627286.24.2.211; Gocsik E, 2014, J AGR ENVIRON ETHIC, V27, P287, DOI 10.1007/s10806-013-9464-9; Gocsik E, 2014, ANIMAL WELFARE DECIS; Greene WH, 2003, TRANSPORT RES B-METH, V37, P681, DOI 10.1016/S0191-2615(02)00046-2; Hensher DA, 2015, APPLIED CHOICE ANALYSIS, 2ND EDITION, P1, DOI 10.1017/CBO9781316136232; HENSHER DA, 1994, TRANSPORTATION, V21, P107, DOI 10.1007/BF01098788; Hensher DA, 2010, TRANSPORT RES B-METH, V44, P735, DOI 10.1016/j.trb.2009.12.012; Hoyos D, 2010, ECOL ECON, V69, P1595, DOI 10.1016/j.ecolecon.2010.04.011; Hubbard C, 2011, ANIM WELFARE, V20, P79; Ison SH, 2018, APPL ANIM BEHAV SCI, V205, P159, DOI 10.1016/j.applanim.2018.05.004; Ison SH, 2014, VET J, V202, P622, DOI 10.1016/j.tvjl.2014.10.003; Kauppinen T, 2010, ANIM WELFARE, V19, P523; Kauppinen T, 2012, LIVEST SCI, V143, P142, DOI 10.1016/j.livsci.2011.09.011; Koopmans SJ, 2005, PHYSIOL BEHAV, V85, P469, DOI 10.1016/j.physbeh.2005.05.010; Ladenburg J, 2014, RESOUR ENERGY ECON, V37, P39, DOI 10.1016/j.reseneeco.2014.05.002; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Li YZ, 2006, J ANIM SCI, V84, P212, DOI 10.2527/jas.2006-144; Lusk JL, 2011, APPL ECON PERSPECT P, V33, P463, DOI 10.1093/aepp/ppr036; Marchant-Forde J. N., 2005, Pig News and Information, V26, p63N; Matheny G, 2007, LAW CONTEMP PROBL, V70, P325; MCGLONE JJ, 1985, J ANIM SCI, V61, P559, DOI 10.2527/jas1985.613556x; Millman ST, 2004, APPL ANIM BEHAV SCI, V86, P299, DOI 10.1016/j.applanim.2004.02.008; MORROWTESCH JL, 1994, J ANIM SCI, V72, P2599, DOI 10.2527/1994.72102599x; Pannell DJ, 1999, AGROFOREST SYST, V45, P393, DOI 10.1023/A:1006282614791; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Peden RSE, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9010006; Peden RSE, 2018, APPL ANIM BEHAV SCI, V204, P1, DOI 10.1016/j.applanim.2018.03.003; PEDEN RSE, 2019, ANIMALS BASEL, V9, DOI DOI 10.3390/; Peden RSE, 2018, APPL ANIMAL BEHAV SC; PETHERICK JC, 1987, AUST J EXP AGR, V27, P605, DOI 10.1071/EA9870605; Poletto R, 2014, PHYSIOL BEHAV, V132, P36, DOI 10.1016/j.physbeh.2014.04.043; Poletto R, 2010, APPL ANIM BEHAV SCI, V122, P98, DOI 10.1016/j.applanim.2009.11.015; RANDOLPH JH, 1981, J ANIM SCI, V53, P922, DOI 10.2527/jas1981.534922x; Red Tractor Assurance, 2018, RED TRACT ASS FARMS; Revelt D, 1998, REV ECON STAT, V80, P647, DOI 10.1162/003465398557735; RSPCA, 2016, RSPCA WELF STAND PIG; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Ryan Mandy, 2003, Appl Health Econ Health Policy, V2, P55; Rydhmer L, 2006, ACTA AGR SCAND A-AN, V56, P109, DOI 10.1080/09064700601079527; Samarakone TS, 2009, APPL ANIM BEHAV SCI, V121, P8, DOI 10.1016/j.applanim.2009.08.006; Spoolder HAM, 1999, ANIM SCI, V69, P481, DOI 10.1017/S135772980005133X; STOOKEY JM, 1994, J ANIM SCI, V72, P2804, DOI 10.2527/1994.72112804x; Street DJ, 2007, CONSTRUCTION OPTIMAL, P647; Train K. E., 2003, DISCRETE CHOICE METH; Turner SP, 2010, ANIM WELFARE, V19, P123; Turner SP, 2000, LIVEST PROD SCI, V66, P47, DOI 10.1016/S0301-6226(00)00159-7; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Tuyttens FAM, 2010, LIVEST SCI, V131, P108, DOI 10.1016/j.livsci.2010.03.008; Velde HT, 2002, J AGR ENVIRON ETHIC, V15, P203	76	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224924	10.1371/journal.pone.0224924	http://dx.doi.org/10.1371/journal.pone.0224924			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1HV	31703105	gold, Green Published, Green Submitted			2022-12-26	WOS:000532697200033
J	Ajong, AB; Kenfack, B; Ali, IM; Yakum, MN; Telefo, PB				Ajong, Atem Bethel; Kenfack, Bruno; Ali, Innocent Mbulli; Yakum, Martin Ndinakie; Telefo, Phelix Bruno			Prevalence and correlates of low serum calcium in late pregnancy: A cross sectional study in the Nkongsamba Regional Hospital; Littoral Region of Cameroon	PLOS ONE			English	Article							DIETARY CALCIUM; BONE METABOLISM; FETAL; SUPPLEMENTATION	Introduction Women from low and middle income countries are generally more likely to have sub-optimal calcium intake. The objective of this study was to assess serum calcium disorders and correlates in late pregnancy. Methods We conducted from December 2018 to April 2019, a cross-sectional hospital-based study targeting pregnant women in late pregnancy in the Nkongsamba Regional Hospital. Data were collected by measurement of parameters (weight, height, blood pressure and foetal birthweight), administration of a semi-structured questionnaire and analysis of blood samples collected from each participant. Absorption spectrophotometry was used to measure serum calcium and albumin concentrations and corrected serum calcium calculated from the Payne's equation. With a statistical significant threshold set at p-value = 0.05, the odds ratio was used as a measure of the strength of association between hypocalcaemia and maternofoetal variables. Results We enrolled a total of 354 consenting participants with a mean age of 27.41 +/- 5.84 years. The prevalence of hypocalcaemia in late pregnancy was 58.76 [53.42-63.90]%. The rate of calcium supplementation in pregnancy was 57.63[52.28-62.80]% with a mean duration of supplementation of 3.69 +/- 1.47 months. When controlled for marital status, age, level of education, and gestational age at delivery, pregnant women with systolic blood pressures below 130 mmHg were significantly less likely to have hypocalcaemia than their counterparts with higher systolic blood pressures (Adjusted Odds Ratio = 0.41[0.18-0.89], p-value = 0.020). No statistically significant associations were found between diastolic blood pressure, body mass index, foetal birth weight and hypocalcaemia. Conclusion Hypocalcaemia in late pregnancy is highly prevalent (59%) among women accessing reproductive services at the Nkongsamba Regional Hospital. There is also a wide gap in calcium supplementation compared to World Health Organization recommendations. Hypocalcaemia is significantly associated to higher systolic blood pressure in pregnancy. Systematic calcium supplementation and consumption of high calcium containing locally available meals should be encouraged.	[Ajong, Atem Bethel] Kekem Dist Hosp, Kekem, West Region, Cameroon; [Ajong, Atem Bethel; Ali, Innocent Mbulli; Telefo, Phelix Bruno] Univ Dschang, Dept Biochem, Dschang, West Region, Cameroon; [Kenfack, Bruno] Univ Dschang, Dept Obstet Gynaecol & Maternal Hlth, Fac Med & Pharmaceut Sci, Dschang, West Region, Cameroon; [Yakum, Martin Ndinakie] Med Sans Frontieres Spain MSF OCBA, Maiduguri, Nigeria		Ajong, AB (corresponding author), Kekem Dist Hosp, Kekem, West Region, Cameroon.; Ajong, AB (corresponding author), Univ Dschang, Dept Biochem, Dschang, West Region, Cameroon.	christrah@yahoo.fr	Yakum, Martin/R-5738-2019	Yakum, Martin/0000-0003-3149-2020; Ali, Innocent/0000-0002-1112-6376				Agueh V. D., 2015, Food and Nutrition Sciences, V6, P945, DOI 10.4236/fns.2015.611098; Almaghamsi Abdulrahman, 2018, Oman Med J, V33, P453, DOI 10.5001/omj.2018.85; [Anonymous], 2012, GLOB TUB REP 2012; Balk EM, 2017, OSTEOPOROSIS INT, V28, P3315, DOI 10.1007/s00198-017-4230-x; Benali A. I., 2014, J NUTR FOOD SCI, V4, P4, DOI [10.4172/2155-9600.1000318, DOI 10.4172/2155-9600.1000318]; BIOLABO, 2019, CALCIUM CPC METH REA, P1; BIOLABO, 2011, ALBUMIN BCG METH RAA, P1; Breast K., 2017, J CLIN DIAGNOSTIC RE, V11, P9; Chen YM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45146; Chhabra S, 2017, J NUTR DISORD THER, V7, P1; Cifuentes M, 2002, J NUTR, V132, P2660, DOI 10.1093/jn/132.9.2660; Cormick G, 2018, BJOG-INT J OBSTET GY, V3, P1; Darnton-Hill I, 2015, NUTRIENTS, V7, P1744, DOI 10.3390/nu7031744; Gabbay A, 2014, HYPERTENS PREGNANCY, V33, P311, DOI 10.3109/10641955.2013.877925; Hacker AN, 2012, NUTR REV, V70, P397, DOI 10.1111/j.1753-4887.2012.00491.x; Hertz-Picciotto I, 2000, AM J EPIDEMIOL, V152, P829, DOI 10.1093/aje/152.9.829; Hofmeyr GJ, 2007, BJOG-INT J OBSTET GY, V114, P933, DOI 10.1111/j.1471-0528.2007.01389.x; Hofmeyr GJ, 2010, COCHRANE DB SYST REV, V4, P1; Hofmeyr GJ, 2014, COCHRANE DB SYST REV, P1; Imdad A, 2012, PAEDIATR PERINAT EP, V26, P138, DOI 10.1111/j.1365-3016.2012.01274.x; Kovacs CS, 2011, ENDOCRIN METAB CLIN, V40, P795, DOI 10.1016/j.ecl.2011.08.002; Kovacs CS, 2005, J MAMMARY GLAND BIOL, V10, P105, DOI 10.1007/s10911-005-5394-0; Kovacs CS, 2001, J CLIN ENDOCR METAB, V86, P2344, DOI 10.1210/jc.86.6.2344; Kumar A, 2010, BIOL TRACE ELEM RES, V136, P26, DOI 10.1007/s12011-009-8523-6; Mulligan ML, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.002; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; PAYNE RB, 1979, J CLIN PATHOL, V32, P56, DOI 10.1136/jcp.32.1.56; Prentice A, 2000, AM J CLIN NUTR, V71, p1312S, DOI 10.1093/ajcn/71.5.1312s; Ritchie LD, 2000, AM J CLIN NUTR, V71, p1371S, DOI 10.1093/ajcn/71.5.1371s; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; SCHAUBERGER CW, 1979, OBSTET GYNECOL, V53, P74; Scholl TO, 2014, AM J CLIN NUTR, V99, P918, DOI 10.3945/ajcn.113.076034; Weaver CM, 2015, CURR OSTEOPOROS REP, V13, P125, DOI 10.1007/s11914-015-0257-0; Yakoob MY, 2010, EXPERT REV OBSTET GY, V5, P1; Yumusakhuylu Y, 2013, GYNECOL ENDOCRINOL, V29, P763, DOI 10.3109/09513590.2013.801444; Zhou K, 2015, COCHRANE DB SYST REV, V11, P1	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224855	10.1371/journal.pone.0224855	http://dx.doi.org/10.1371/journal.pone.0224855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697767	Green Published, gold			2022-12-26	WOS:000532694400069
J	Fang, NN; Shi, YL; Chen, ZH; Sun, X; Zhang, L; Yi, YL				Fang, Nana; Shi, Yuanliang; Chen, Zhenhua; Sun, Xun; Zhang, Lei; Yi, Yanli			Effect of mechanochemical activation of natural phosphorite structure as well as phosphorus solubility	PLOS ONE			English	Article							MECHANICAL ACTIVATION; HYDROXYAPATITE	Mechanochemical treatment of phosphate rock is considered as an effective and ecologically clean way of treating the medium- and low-grade phosphorite which could be used as fertilizer instead of the high-grade phosphorite. In order to investigate the effects of different milling times on the mechanochemically activated phosphorite (lower total phosphorus content) by more efficient milling equipment with enhanced milling speed, phosphorus solubility in citric acid and structural characteristics of natural and mechanochemically activated phosphorite from Yichang, China were studied using scanning electron microscope, infrared spectroscopy and X-ray diffraction. Phosphorus solubility in citric acid increased proportionately with the milling time until 30 min (57.51%), but then gradually reached an equilibrium with the maximum (59.03%) in 50 min. These changes were mainly manifested in considerably reduced particle size, decreased crystallinity and increased structural defects of phosphorite due to substitution of PO43- with CO32- and the incorporation of OH-. With the incorporation of CO32- and OH-, the non-activated carbonate-fluorapatite (type B) was transformed into a mixture of carbonate-fluorapatite, hydroxyapatite, fluorocarbon hydroxyapatite and/or carbonate apatite, respectively during the process of mechanochemical activation. As a result of the structural and phase transformations after mechanochemical activation, phosphorus solubility remarkably increased.	[Fang, Nana; Yi, Yanli] Shenyang Agr Univ, Coll Land & Environm, Shenyang, Peoples R China; [Fang, Nana; Shi, Yuanliang; Chen, Zhenhua; Sun, Xun; Zhang, Lei] Chinese Acad Sci, Inst Appl Ecol, Shenyang, Peoples R China	Shenyang Agricultural University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Yi, YL (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Shenyang, Peoples R China.	yiyanli@126.com			Special Fund for Agro-scientific Research in the Public Interest of China [201503116]; National Key R&D Program of China [2018YFD0200603, 2018YFD0300300]	Special Fund for Agro-scientific Research in the Public Interest of China; National Key R&D Program of China	The research was supported by the Special Fund for Agro-scientific Research in the Public Interest of China (201503116) and National Key R&D Program of China (2018YFD0300300) granted to Shenyang Agricultural University. Substantial matching fund is provided by the National Key R&D Program of China (2018YFD0200603) granted to Institute of Applied Ecology, Chinese Academy of Sciences. The Shenyang New Fertilizer Co., provided the planetary mill and collected the tested phosphorite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid AZA, 2008, INT J MINER PROCESS, V85, P59, DOI 10.1016/j.minpro.2007.09.001; Chaikina M.V., 2002, MECHANOCHEMISTRY NAT, P11; Chaikina MV, 2005, SCI SINTER, V37, P93, DOI 10.2298/SOS0502093C; CRIADO JM, 1986, J MATER SCI LETT, V5, P467, DOI 10.1007/BF01672365; Fernandez-Bertran JF, 1999, PURE APPL CHEM, V71, P581, DOI 10.1351/pac199971040581; Fleet ME, 2008, AM MINERAL, V93, P1460, DOI 10.2138/am.2008.2786; Jin LL, 2013, RES J CHEM ENVIRON, V17, P156; Li Y, 1983, SOIL AGR CHEM ROUTIN; NELSON DGA, 1982, CALCIFIED TISSUE INT, V34, pS69; Petkova V, 2015, J THERM ANAL CALORIM, V121, P217, DOI 10.1007/s10973-014-4205-5; Rintoul L, 2007, J MATER SCI-MATER M, V18, P1701, DOI 10.1007/s10856-007-3052-3; Sukhov BG, 2007, RUSS J APPL CHEM+, V80, P853, DOI 10.1134/S1070427207060018; Tonsuaadu K, 2011, INT J MINER PROCESS, V100, P104, DOI 10.1016/j.minpro.2011.05.005; VIGNOLES M, 1988, CALCIFIED TISSUE INT, V43, P33, DOI 10.1007/BF02555165; Wei Z, 2015, CHIN POWDER SCI TECH, V6, P91; WINAND L, 1961, NATURE, V190, P164, DOI 10.1038/190164a0; Wu Q, 2002, B CHIN CERAM, P33; Yaneva V, 2005, CHEM SUSTAIN DEV, V13, P347; Yaneva V, 2009, MATER RES BULL, V44, P693, DOI 10.1016/j.materresbull.2008.06.004	19	3	4	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224423	10.1371/journal.pone.0224423	http://dx.doi.org/10.1371/journal.pone.0224423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KR5BD	31697699	Green Published, gold			2022-12-26	WOS:000517632900001
J	Fink, D; Pfeiffenberger, U; Bernthaler, T; Schober, S; Thonhauser, KE; Rulicke, T				Fink, Dieter; Pfeiffenberger, Ulrike; Bernthaler, Tina; Schober, Sophie; Thonhauser, Kerstin E.; Rulicke, Thomas			Capacity of the medullary cavity of tibia and femur for intra-bone marrow transplantation in mice	PLOS ONE			English	Article							CELLS; INJECTION; STRATEGY	Intra-bone marrow transplantation (IBMT) has been adapted for mouse models to improve the seeding efficiency of transplanted hematopoietic stem and progenitor cells. Commonly used injection volumes for IBMT into the tibia differ between 10 and 40 mu L even though considerable amounts of injected cells leak into the blood circulation immediately after injection. Injection of 3 mu L trypan blue into the tibia of dead BALB/c mice showed staining in large vessels of hind limbs, even without supporting circulation. We therefore tested the effective capacity of the medullary cavity of dissected tibiae and femora of different mouse strains by bioluminescence imaging after injection of luciferase expressing cells. Cell leakage was already observed at 3 mu L of injection volume and the measured emission rate increased significantly when 5 and 10 mu L of volume with the same cell concentration were injected. Surprisingly, increasing injection volumes containing constant cell amounts resulted in comparable emission rates, suggesting a similar amount of leaked and absorbed cells independent of the injection volume. However, the absorption of a specific amount of injected cells could not be confirmed, as the ratio of leaked to absorbed cells was similar between IBMT that were performed with a constant injection volume containing either low or high cell amounts. In summary, for optimal cell transplantation via IBMT in mice we suggest to inject a high concentrated cell suspension with a maximum injection volume of 3 mu L.	[Fink, Dieter; Pfeiffenberger, Ulrike; Bernthaler, Tina; Schober, Sophie; Thonhauser, Kerstin E.; Rulicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Dept Biomed Sci, Vienna, Austria; [Rulicke, Thomas] Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria	University of Veterinary Medicine Vienna; Ludwig Boltzmann Institute; Medical University of Vienna	Rulicke, T (corresponding author), Univ Vet Med Vienna, Inst Lab Anim Sci, Dept Biomed Sci, Vienna, Austria.; Rulicke, T (corresponding author), Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria.	thomas.ruelicke@vetmeduni.ac.at		Rulicke, Thomas/0000-0002-2121-9496; Auer (Thonhauser), Kerstin E./0000-0002-6399-1388; Schober, Sophie/0000-0002-1686-9937				Beerman I, 2017, EXP HEMATOL, V50, P22, DOI 10.1016/j.exphem.2017.01.008; Carbonneau CL, 2012, BLOOD, V119, P717, DOI 10.1182/blood-2011-06-361626; Cui JS, 1999, BRIT J HAEMATOL, V107, P895, DOI 10.1046/j.1365-2141.1999.01779.x; Eguchi H, 2008, TRANSPL P, V40, P574, DOI 10.1016/j.transproceed.2008.02.012; Gao JT, 2009, EXP HEMATOL, V37, P990, DOI 10.1016/j.exphem.2009.05.006; Gruneboom A, 2019, NAT METAB, V1, P236, DOI 10.1038/s42255-018-0016-5; Kushida T, 2001, BLOOD, V97, P3292, DOI 10.1182/blood.V97.10.3292; Lee MW, 2012, INT J ONCOL, V41, P2047, DOI 10.3892/ijo.2012.1634; Li Q, 2007, STEM CELLS, V25, P1186, DOI 10.1634/stemcells.2006-0354; Pfeiffenberger U, 2015, LAB ANIM-UK, V49, P121, DOI 10.1177/0023677214559627; Sanjuan-Pla A, 2016, STEM CELLS DEV, V25, P259, DOI 10.1089/scd.2015.0309; Valent P, 2018, WIEN KLIN WOCHENSCHR, V130, P517, DOI 10.1007/s00508-018-1355-7; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Yahata T, 2003, BLOOD, V101, P2905, DOI 10.1182/blood-2002-07-1995	14	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224576	10.1371/journal.pone.0224576	http://dx.doi.org/10.1371/journal.pone.0224576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697695	Green Published, gold			2022-12-26	WOS:000532694400033
J	Lu, HX; Marti, J				Lu, Huixia; Marti, Jordi			Binding and dynamics of melatonin at the interface of phosphatidylcholine-cholesterol membranes	PLOS ONE			English	Article							LOW-FREQUENCY SPECTRUM; MOLECULAR-DYNAMICS; CONSTANT-PRESSURE; DIMYRISTOYLPHOSPHATIDYLCHOLINE BILAYERS; INFRARED-SPECTROSCOPY; RHEUMATOID-ARTHRITIS; FORCE-FIELD; SIMULATIONS; WATER; DIPALMITOYLPHOSPHATIDYLCHOLINE	The characterization of interactions between melatonin, one main ingredient of medicines regulating sleeping rhythms, and basic components of cellular plasma membranes (phospholipids, cholesterol, metal ions and water) is very important to elucidate the main mechanisms for the introduction of melatonin into cells and also to identify its local structure and microscopic dynamics. Molecular dynamics simulations of melatonin inside mixtures of dimyristoylphosphatidylcholine and cholesterol in NaCl solution at physiological concentration have been performed at 303.15 K to systematically explore melatonin-cholesterol, melatonin-lipid and melatonin-water interactions. Properties such as the area per lipid and thickness of the membrane as well as selected radial distribution functions, binding free energies, angular distributions, atomic spectral densities and translational diffusion of melatonin are reported. The presence of cholesterol significantly affects the behavior of melatonin, which is mainly buried into the interfaces of membranes. Introducing cholesterol into the system helps melatonin change from folded to extended configurations more easily. Our results suggest that there exists a competition between the binding of melatonin to phospholipids and to cholesterol by means of hydrogen-bonds. Spectral densities of melatonin reported in this work, in overall good agreement with experimental data, revealed the participation of each atom of melatonin to its complete spectrum. Melatonin self-diffusion coefficients are of the order of 10(-7) cm(2)/s and they significantly increase when cholesterol is addeed to the membrane.	[Lu, Huixia; Marti, Jordi] Tech Univ Catalonia Barcelona Tech, Dept Phys, Barcelona, Catalonia, Spain	Universitat Politecnica de Catalunya	Marti, J (corresponding author), Tech Univ Catalonia Barcelona Tech, Dept Phys, Barcelona, Catalonia, Spain.	jordi.marti@upc.edu	Marti, Jordi/H-5414-2015; Marti, Jordi/AAL-6568-2021	Marti, Jordi/0000-0002-3721-9634; Marti, Jordi/0000-0002-3721-9634; LU, HUIXIA/0000-0003-2731-5283	China Scholarship Council (CSC) [201607040059]; Spanish Ministry of Economy and Knowledge [FIS2015-66879-C2-1-P]; Barcelona Supercomputing Center [FI-2018-2-0018, FI-2018-3-0023]; Spanish Ministry of Science, Innovation and Universities [PGC2018-099277-B-C21]	China Scholarship Council (CSC)(China Scholarship Council); Spanish Ministry of Economy and Knowledge(Spanish Government); Barcelona Supercomputing Center; Spanish Ministry of Science, Innovation and Universities(Spanish Government)	This work was supported by a doctoral grant from the China Scholarship Council (CSC) awarded to H.L. (grant number 201607040059), a grant from the Spanish Ministry of Economy and Knowledge (grant FIS2015-66879-C2-1-P), awarded to J.M., to computational resources provided by the Barcelona Supercomputing Center (grants FI-2018-2-0018 and FI-2018-3-0023) awarded to both authors, and a grant from the Spanish Ministry of Science, Innovation and Universities, Ref. number PGC2018-099277-B-C21 to J.M. The funders had no role in study design, simulations, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CL, 2012, EUR BIOPHYS J BIOPHY, V41, P901, DOI 10.1007/s00249-012-0826-4; Bang J, 2012, RHEUMATOL INT, V32, P379, DOI 10.1007/s00296-010-1641-9; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Chandler D., 1987, INTRO MODERN STAT ME; Chen W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33107-5; Choi Y, 2014, SOFT MATTER, V10, P206, DOI 10.1039/c3sm52064a; Dellago C, 2009, ADV POLYM SCI, V221, P167, DOI 10.1007/12_2008_3; Fleming GD, 2015, VIB SPECTROSC, V80, P70, DOI 10.1016/j.vibspec.2015.08.002; Drolle E, 2013, BBA-BIOMEMBRANES, V1828, P2247, DOI 10.1016/j.bbamem.2013.05.015; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Florio GM, 2003, J PHYS CHEM A, V107, P974, DOI 10.1021/jp027053i; Forrest CM, 2007, BRIT J CLIN PHARMACO, V64, P517, DOI 10.1111/j.1365-2125.2007.02911.x; Ganesan N, 2011, J COMPUT CHEM, V32, P2958, DOI 10.1002/jcc.21871; GORDILLO MC, 2005, J CHEM PHYS, V123, DOI DOI 10.1063/1.1884609; Hofsass C, 2003, BIOPHYS J, V84, P2192, DOI 10.1016/S0006-3495(03)75025-5; Huang CC, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12560; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Hussain SAR, 2007, J PINEAL RES, V42, P267, DOI 10.1111/j.1600-079X.2006.00415.x; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JOHNSON SJ, 1991, BIOPHYS J, V59, P289, DOI 10.1016/S0006-3495(91)82222-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kostoglou-Athanassiou I, 2013, THER ADV ENDOCRINOL, V4, P13, DOI 10.1177/2042018813476084; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Lemkul JA, 2016, CHEM REV, V116, P4983, DOI 10.1021/acs.chemrev.5b00505; Lim JB, 2012, J PHYS CHEM B, V116, P203, DOI 10.1021/jp207925m; Lopez CF, 2004, J PHYS CHEM B, V108, P6603, DOI 10.1021/jp037618q; Lu HX, 2018, CHEM PHYS LETT, V712, P190, DOI 10.1016/j.cplett.2018.10.006; Lu HX, 2018, J CHEM PHYS, V149, DOI 10.1063/1.5029430; Maestroni GJM, 2002, ANN NY ACAD SCI, V966, P271, DOI 10.1111/j.1749-6632.2002.tb04226.x; Marrink SJ, 2019, CHEM REV, V119, P6184, DOI 10.1021/acs.chemrev.8b00460; Marti J, 2000, CHEM PHYS LETT, V328, P169, DOI 10.1016/S0009-2614(00)00874-5; Marti J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061918; MARTI J, 1994, J CHEM PHYS, V101, P10883, DOI 10.1063/1.467838; MARTI J, 1993, MOL SIMULAT, V11, P321, DOI 10.1080/08927029308022517; Marti J, 2017, PROCEDIA COMPUT SCI, V108, P1242, DOI 10.1016/j.procs.2017.05.141; Martinez-Seara H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011162; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007; Modig K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075502; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Mousavi SS, 2018, IRAN J PHARM RES, V17, P136; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P4668, DOI 10.1021/bi00413a013; Nussinov R, 2018, CANCER RES, V78, P593, DOI 10.1158/0008-5472.CAN-17-2727; Padro JA, 2004, J CHEM PHYS, V120, P1659, DOI 10.1063/1.1634252; Padro JA, 2003, J CHEM PHYS, V118, P452, DOI 10.1063/1.1524619; Pandey PR, 2011, J PHYS CHEM B, V115, P3155, DOI 10.1021/jp1090203; Pandi-Perumal SR, 2006, FEBS J, V273, P2813, DOI 10.1111/j.1742-4658.2006.05322.x; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pieta E, 2017, APPL SURF SCI, V404, P168, DOI 10.1016/j.apsusc.2017.01.270; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Savoca A, 2019, ADMET DMPK, V7, P44, DOI 10.5599/admet.625; Senn H. M., 2006, ATOMISTIC APPROACHES, P173; Severcan F, 2005, BBA-BIOMEMBRANES, V1668, P215, DOI 10.1016/j.bbamem.2004.12.009; Singh G, 2014, SPECTROCHIM ACTA A, V118, P73, DOI 10.1016/j.saa.2013.08.077; Slominski AT, 2018, J INVEST DERMATOL, V138, P490, DOI 10.1016/j.jid.2017.10.025; Slominski AT, 2017, CELL MOL LIFE SCI, V74, P3913, DOI 10.1007/s00018-017-2617-7; Smondyrev AM, 2001, BIOPHYS J, V80, P1649, DOI 10.1016/S0006-3495(01)76137-1; STOCKTON GW, 1976, CHEM PHYS LIPIDS, V17, P251, DOI 10.1016/0009-3084(76)90070-0; Trouard TP, 1999, J CHEM PHYS, V110, P8802, DOI 10.1063/1.478787; Wang M, 2019, ECOTOX ENVIRON SAFE, V170, P68, DOI 10.1016/j.ecoenv.2018.11.127; Yang J, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4867385; Yang J, 2016, SOFT MATTER, V12, P4557, DOI 10.1039/c6sm00345a; Yang J, 2015, J CHEM THEORY COMPUT, V11, P4495, DOI 10.1021/acs.jctc.5b00540; Yeagle P. L., 2016, MEMBRANES CELLS, DOI DOI 10.1016/B978-0-12-800047-2.00015-2; Ytreberg FM, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2378907	75	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224624	10.1371/journal.pone.0224624	http://dx.doi.org/10.1371/journal.pone.0224624			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697738	Green Submitted, Green Published, gold			2022-12-26	WOS:000532694400038
J	Bellmunt, AM; Lopez-Puerto, L; Lorente, J; Closa, D				Maria Bellmunt, Angela; Lopez-Puerto, Laura; Lorente, Juan; Closa, Daniel			Involvement of extracellular vesicles in the macrophage-tumor cell communication in head and neck squamous cell carcinoma	PLOS ONE			English	Article							CANCER; PD-L1	Background Exosomes are cell-derived vesicles that mediate cellular communication in health and multiple diseases, including cancer. However, its role in head and neck cancer has been poorly defined. Here, we investigated the relevance of exosomes in the signaling between larynx cancer cells and macrophages. Methods Exosomes from THP1 macrophages and BICR18 cells (a larynx squamous cell carcinoma cell line) were purified and their role in the cancer cell migration, macrophage phenotype and immunosuppressive activity was evaluated. The activation of STAT3 signal transduction in macrophages in response to exosomes obtained from cancer cells was also evaluated. Results Macrophages foster the cancer cell migration and this effect is mediated by exosome signaling. On the other hand, exosomes also induce the expression of IL-10 in macrophages and PD-L1 in cancer cells, thus resulting in the promotion of an immunosuppressive environment. Moreover, we observed that the effects induced in cancer cells are mediated by the exosome-depending activation of STAT-3 signal transduction pathway. Conclusions Our study indicates that exosomes released by both macrophages and cancer cells plays a critical role in tumor progression in larynx cancer and might be a potential target for therapeutic intervention in head and neck cancer.	[Maria Bellmunt, Angela; Lorente, Juan] Univ Autonoma Barcelona UAB, Hosp Vall dHebron, Otolaryngol Dept, Barcelona, Spain; [Lopez-Puerto, Laura; Closa, Daniel] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Dept Expt Pathol, Inst Invest Biomed Barcelona, Consejo Super Invest Cient IIBB CSIC, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Closa, D (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Dept Expt Pathol, Inst Invest Biomed Barcelona, Consejo Super Invest Cient IIBB CSIC, Barcelona, Spain.	daniel.closa@iibb.csic.es		Closa Autet, Daniel/0000-0003-3797-3095	Carlos III Institute of Health [FIS PI16/00060]; European Union ERDF funds (European Regional Development Fund)	Carlos III Institute of Health(Instituto de Salud Carlos III); European Union ERDF funds (European Regional Development Fund)	This work was supported by a research grant from the Carlos III Institute of Health with reference FIS PI16/00060 (D.C.), co-funded with European Union ERDF funds (European Regional Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bae Susan, 2018, Genes Cancer, V9, P87, DOI 10.18632/genesandcancer.172; Bonjoch L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03244-4; Dannenmann SR, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23562; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gama RR, 2016, LARYNGOSCOPE, V126, P885, DOI 10.1002/lary.25738; Greening DW, 2015, SEMIN CELL DEV BIOL, V40, P72, DOI 10.1016/j.semcdb.2015.02.009; Halse H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28944-3; Ham S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00871; Hui LL, 2015, CANCER LETT, V368, P7, DOI 10.1016/j.canlet.2015.07.039; Komohara Y, 2017, J PATHOL, V241, P313, DOI 10.1002/path.4824; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Li M, 2018, GENE, V676, P101, DOI 10.1016/j.gene.2018.07.018; Lotfi Alireza, 2015, Asian Pac J Cancer Prev, V16, P6749; Mourad M, 2017, J ORAL MAXIL SURG, V75, P2562, DOI 10.1016/j.joms.2017.05.008; Ohaegbulam KC, 2015, TRENDS MOL MED, V21, P24, DOI 10.1016/j.molmed.2014.10.009; Patel KR, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1442168; Poh AR, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00049; Pollari M, 2018, HAEMATOLOGICA; Solomon B, 2018, SEMIN CANCER BIOL, DOI [10.18632/genesandcancer.172, DOI 10.18632/GENESANDCANCER.172]; Steuer CE, 2017, CA-CANCER J CLIN, V67, P32, DOI 10.3322/caac.21386; Vidyarthi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01650; Vieira T, 2016, LUNG CANCER, V98, P51, DOI 10.1016/j.lungcan.2016.05.013; Wang J, 2018, ONCOL REP; Whiteman DC, 2016, CANCER EPIDEMIOL, V44, P203, DOI 10.1016/j.canep.2016.06.013; Whiteside TL, 2018, SEMIN IMMUNOL, V35, P69, DOI 10.1016/j.smim.2017.12.003; Xu LJ, 2018, MOL ONCOL, V12, P269, DOI 10.1002/1878-0261.12135; Zheng BX, 2018, BIOCHEM BIOPH RES CO, V495, P1695, DOI 10.1016/j.bbrc.2017.12.032	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224710	10.1371/journal.pone.0224710	http://dx.doi.org/10.1371/journal.pone.0224710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697737	gold, Green Published			2022-12-26	WOS:000532694400048
J	Scott, J; Lecouturier, J; Rousseau, N; Stansby, G; Sims, A; Wilson, L; Allen, J				Scott, Jason; Lecouturier, Jan; Rousseau, Nikki; Stansby, Gerard; Sims, Andrew; Wilson, Lesley; Allen, John			Nurses' and patients' experiences and preferences of the ankle-brachial pressure index and multi-site photoplethysmography for the diagnosis of peripheral arterial disease: A qualitative study	PLOS ONE			English	Article							INTERVIEWS; USABILITY; IMPROVE; FOCUS	Peripheral arterial disease is a global health problem, affecting around 20% of people aged over 60 years. Whilst ankle-brachial pressure index (ABPI) is regularly used for diagnosis, it has a number of limitations, which have presented a need for alternative methods of diagnosis. Multi-site photoplethysmography (MPPG) is one such method, but evidence of acceptability of both methods is lacking. This study aims to describe and compare preferences and experiences amongst nurses and patients of ABPI and MPPG use in primary care. We used qualitative research methods in the context of a clinical diagnostic study comparing ABPI with MPPG. Use of ABPI and MPPG by 13 nurses were observed with 51 patients across general practice surgeries in North-East England in 2015/16. Follow-up semi-structured interviews were conducted with 12 nurses and 27 patients. Data were thematically analysed. Two major themes were identified: (1) device preferences; (2) test discomfort and anxiety. There was a compelling preference for MPPG due to ease of use, speed of the test, patient comfort, and perceived device accuracy/objectivity. However some patients struggled to identify a preference, describing ambivalence to medical testing. ABPI was deemed uncomfortable and painful, particularly when the blood pressure cuff was inflated at the lower limbs. There was also evidence of anxiety amongst patients when their foot pulses were not identified using ABPI. Whilst ABPI is a non-invasive and routine procedure it was associated with a number of drawbacks in clinical practice. Nurses required considerable dexterity to employ the test, and it resulted in anxiety amongst some patients. Conversely, MPPG was deemed to be easier and quicker to use, and perceived to be less subjective. Should diagnostic accuracy and cost be comparable to ABPI, then the findings of this study suggest MPPG would be preferable to ABPI for patients as well as nurses.	[Scott, Jason] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Lecouturier, Jan; Rousseau, Nikki] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Stansby, Gerard; Wilson, Lesley] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Vasc Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Stansby, Gerard] Newcastle Univ, Sch Surg & Reprod Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Sims, Andrew; Allen, John] Newcastle Upon Tyne Hosp NHS Fdn Trust, Northern Med Phys & Clin Engn Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Sims, Andrew; Allen, John] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Scott, J (corresponding author), Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England.; Rousseau, N (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.	jason.scott@northumbria.ac.uk; nikki.rousseau@newcastle.ac.uk	Sims, Andrew/AAT-8027-2021	Sims, Andrew/0000-0002-9553-7278; Rousseau, Nikki/0000-0001-8826-3515; Stansby, Gerard/0000-0001-5539-3049; Allen, John/0000-0002-7263-0533; Scott, Jason/0000-0001-7031-2171	National Institute for Health Research [II-C1-0412-20003]	National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript is independent research funded by the National Institute for Health Research (Invention for Innovation, "Innovative photoplethysmography technology for rapid noninvasive assessment of peripheral arterial disease in primary care", II-C1-0412-20003), www.nihr.ac.uk.JA was the Chief Investigator and grant holder. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript is independent research funded by the National Institute for Health Research (Invention for Innovation, "Innovative photoplethysmography technology for rapid non-invasive assessment of peripheral arterial disease in primary care", II-C1-0412-20003). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. We would like to thank all practices and participants for contributing to the study. We would also like to acknowledge the input of Kirsty Laing (KL) who contributed to collecting data in the early stages of the study, and the contributions of the wider NOTEPAD study team-particularly Shona Haining and Scott Wilkes who facilitated access to GP practices.	Al-Qaisi M, 2009, VASC HEALTH RISK MAN, V5, P833; Allen J, 1996, ANGIOLOGY, V47, P225, DOI 10.1177/000331979604700302; Allen J, 2008, J VASC SURG, V47, P794, DOI 10.1016/j.jvs.2007.11.057; Allen J, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab3545; Bamford C, 2016, INT PSYCHOGERIATR, V28, P123, DOI 10.1017/S1041610215001039; Boivin J, 2010, WOMENS HEALTH, V6, P59, DOI 10.2217/WHE.09.79; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burns P, 2003, BMJ-BRIT MED J, V326, P584, DOI 10.1136/bmj.326.7389.584; Chaudru S, 2016, EUR J VASC ENDOVASC, V51, P240, DOI 10.1016/j.ejvs.2015.09.005; Chaudru S, 2015, INT J CARDIOL, V184, P489, DOI 10.1016/j.ijcard.2015.03.017; Collins R, 2007, BMJ-BRIT MED J, V334, P1257, DOI 10.1136/bmj.39217.473275.55; Condon A, 2008, CAN J GASTROENTEROL, V22, P41, DOI 10.1155/2008/107467; Davies JH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-69; De Bleser L, 2010, SENSORS-BASEL, V10, P1535, DOI 10.3390/s100301535; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Emdin CA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4865; Giske T, 2007, J ADV NURS, V57, P87, DOI 10.1111/j.1365-2648.2006.04082.x; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hirsch AT, 2007, CIRCULATION, V116, P2086, DOI 10.1161/CIRCULATIONAHA.107.725101; Lecouturier Jan, 2019, BJGP Open, V3, DOI 10.3399/bjgpopen19X101659; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Munn Z, 2011, RADIOGRAPHY, V17, P323, DOI 10.1016/j.radi.2011.06.004; National Institute for Health and Clinical Excellence, 2012, LOW LIMB PER ART DIS; Nietert PJ, 2006, AM J HYPERTENS, V19, P147, DOI 10.1016/j.amjhyper.2005.08.016; OLC, 2019, QUAL FRAM; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; Parry O, 2004, FAM PRACT, V21, P131, DOI 10.1093/fampra/cmh203; Potier L, 2011, EUR J VASC ENDOVASC, V41, P110, DOI 10.1016/j.ejvs.2010.09.020; Rasmussen JB, DUPLEX ULTRASOUND SC, P507, DOI [10.1016/j.ejvs.2010.06.002, DOI 10.1016/J.EJVS.2010.06.002]; Rial D., 2010, Society for Neuroscience Abstract Viewer and Itinerary Planner, V40; Rose AF, 2005, J BIOMED INFORM, V38, P51, DOI 10.1016/j.jbi.2004.11.006; Rose MD, 2015, BRIT J CARDIAC NURSI, V10, P277, DOI [10.12968/bjca.2015.10.6.277, DOI 10.12968/BJCA.2015.10.6.277]; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Sen S, 2009, STROKE, V40, P3472, DOI 10.1161/STROKEAHA.109.559278; Sigvant B, 2007, J VASC SURG, V45, P1185, DOI 10.1016/j.jvs.2007.02.004; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ustundag H, 2016, INT J CARING SCI, V9, P838; Vaidya A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-89; Vowden K, 2001, J Wound Care, V10, P197; Wilkes S, 2015, BRIT J GEN PRACT, V65, P323, DOI 10.3399/bjgp15X685489; Xu DC, 2010, VASC MED, V15, P361, DOI 10.1177/1358863X10378376	45	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224546	10.1371/journal.pone.0224546	http://dx.doi.org/10.1371/journal.pone.0224546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1GV	31697713	Green Published, gold, Green Accepted			2022-12-26	WOS:000532694400029
J	Guo, YT; Wang, L; Chang, X				Guo, Yintong; Wang, Lei; Chang, Xin			Study on the damage characteristics of gas-bearing shale under different unloading stress paths	PLOS ONE			English	Article							MECHANICAL-BEHAVIOR; CONFINING PRESSURE; ENERGY EVOLUTION; COAL; FRACTURE; ROCK; FAILURE	In order to understand the influence of unloading on the mechanical properties of shale rock, triaxial unloading tests under different stress paths were conducted. In this paper, three types of tests are completed, including: 1) Conventional triaxial compression test;2) Pre-peak constant maximum principal stress-unloading confining pressure test with different initial confining pressures and rates;3) Increasing axial stress-unloading confining pressure test. The deformation and rupture modes characteristics of shale sample under different unloading stress paths were obtained. Research results show that: 1) The confining pressure effect is obvious and the peak strength increases with the increase of initial confining pressure, under conventional triaxial compression test, the samples show obvious elastic-plastic characteristics; Under unloading confining pressure test, it shows obvious elastic brittleness characteristics.2) Compared with conventional triaxial compression test, unloading confining pressure is more prone to deformation and rupture, and the damage is more serious. Under same initial stress level, the brittle characteristics in unloading confining pressure are more obvious and the expansion is more intense. 3) Under same unloading stress path, the higher the initial confining pressure is, the more severe the sample failure is. With the increase of unloading rate, the rupture degree of the sample becomes more complex.4) The brittle rupture characteristic increases with the increase of unloading rate and initial confining pressure. Increasing axial stress-unloading confining pressure, various types of tensile and shear fractures with different mechanisms are well developed. These conclusions reveal loading and unloading mechanical properties of gas-bearing shale under different stress paths; it provides theoretical basis for horizontal drilling, fracturing design and long-term fracturing effect analysis of shale gas reservoirs.	[Guo, Yintong; Wang, Lei; Chang, Xin] Chinese Acad Sci, Inst Rock & Soil Mech, State Key Lab Geomech & Geotech Engn, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Rock & Soil Mechanics, CAS	Guo, YT (corresponding author), Chinese Acad Sci, Inst Rock & Soil Mech, State Key Lab Geomech & Geotech Engn, Wuhan, Peoples R China.	ytguo@whrsm.ac.cn	WANG, LEI/ABA-6812-2021	WANG, LEI/0000-0002-0298-3472	National Science and Technology Major Project of China [51574218];  [2016ZX05060004];  [2017ZX05036-003]	National Science and Technology Major Project of China; ; 	This study was funded by grants to Yintong Guo: National Natural Science Foundation of China (51574218); National Science and Technology Major Project of China (2016ZX05060004, 2017ZX05036-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Torres-Suarez MC, 2014, J ROCK MECH GEOTECH, V6, P257, DOI 10.1016/j.jrmge.2014.04.004; Hua AZ, 2001, TUNN UNDERGR SP TECH, V16, P241, DOI 10.1016/S0886-7798(01)00046-3; Huang D, 2014, INT J ROCK MECH MIN, V66, P160, DOI 10.1016/j.ijrmms.2013.12.001; Ju Q.-H., 1993, CHIN J GEOTECH ENG, V15, P73; Li DY, 2017, ENG GEOL, V228, P270, DOI 10.1016/j.enggeo.2017.08.006; Li XB, 2014, TUNN UNDERGR SP TECH, V42, P237, DOI 10.1016/j.tust.2014.03.002; [李新平 Li Xinping], 2012, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V31, P882; Liu J, 2016, TRANSPORT POROUS MED, V111, P97, DOI 10.1007/s11242-015-0583-9; Ma D, 2019, ENG FRACT MECH, V220, DOI 10.1016/j.engfracmech.2019.106640; Ma D, 2019, TUNN UNDERGR SP TECH, V91, DOI 10.1016/j.tust.2019.102993; Meng QB, 2016, ROCK MECH ROCK ENG, V49, P3873, DOI 10.1007/s00603-016-1077-y; OLSSON WA, 1991, INT J ROCK MECH MIN, V28, P115, DOI 10.1016/0148-9062(91)93241-W; Pan RK, 2017, INT J MIN SCI TECHNO, V27, P825, DOI 10.1016/j.ijmst.2017.07.022; [苏承东 Su Chengdong], 2013, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V32, P943; Sukplum W, 2016, INT J ROCK MECH MIN, V86, P48, DOI 10.1016/j.ijrmms.2016.04.001; SWANSON SR, 1971, INT J ROCK MECH MIN, V8, P277, DOI 10.1016/0148-9062(71)90023-4; Wang DK, 2019, ENERGY SCI ENG, V7, P799, DOI 10.1002/ese3.309; Wang DK, 2018, J NAT GAS SCI ENG, V53, P67, DOI 10.1016/j.jngse.2018.02.026; Wang JG, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7924-2; Wang JG, 2015, J CLEAN PROD, V103, P685, DOI 10.1016/j.jclepro.2014.08.024; Wu G, 2004, INT J ROCK MECH MIN, V41, P437, DOI 10.1016/j.ijrmms.2003.12.077; Xue Y, 2017, J NAT GAS SCI ENG, V40, P336, DOI 10.1016/j.jngse.2017.02.030	22	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224654	10.1371/journal.pone.0224654	http://dx.doi.org/10.1371/journal.pone.0224654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693692	Green Published, gold			2022-12-26	WOS:000532690100034
J	Wang, XL; Li, DH; Song, SF; Zhang, YH; Li, YF; Wang, XN; Liu, DL; Zhang, CX; Cao, YF; Fu, YW; Han, RL; Li, WT; Liu, XJ; Sun, GR; Li, GX; Tian, YD; Li, ZJ; Kang, XT				Wang, Xinlei; Li, Donghua; Song, Sufang; Zhang, Yanhua; Li, Yuanfang; Wang, Xiangnan; Liu, Danli; Zhang, Chenxi; Cao, Yanfang; Fu, Yawei; Han, Ruili; Li, Wenting; Liu, Xiaojun; Sun, Guirong; Li, Guoxi; Tian, Yadong; Li, Zhuanjian; Kang, Xiangtao			Combined transcriptomics and proteomics forecast analysis for potential genes regulating the Columbian plumage color in chickens	PLOS ONE			English	Article							PROTEIN ABUNDANCE; TYROSINASE GENE; PIGMENTATION; PATHWAY; MELANOGENESIS; FOLLICLE; IDENTIFICATION; ASSOCIATIONS; MELANOCYTES; EXPRESSION	Background Coloration is one of the most recognizable characteristics in chickens, and clarifying the coloration mechanisms will help us understand feather color formation. "Yufen I" is a commercial egg-laying chicken breed in China that was developed by a three-line cross using lines H, N and D. Columbian plumage is a typical feather character of the "Yufen I" H line. To elucidate the molecular mechanism underlying the pigmentation of Columbian plumage, this study utilizes high-throughput sequencing technology to compare the transcriptome and proteome differences in the follicular tissue of different feathers, including the dorsal neck with black and white striped feather follicles (Group A) and the ventral neck with white feather follicles (Group B) in the "Yufen I" H line. Results In this study, we identified a total of 21,306 genes and 5,203 proteins in chicken feather follicles. Among these, 209 genes and 382 proteins were differentially expressed in two locations, Group A and Group B, respectively. A total of 8 differentially expressed genes (DEGs) and 9 differentially expressed proteins (DEPs) were found to be involved in the melanogenesis pathway. Additionally, a specifically expressed MED23 gene and a differentially expressed GNAQ protein were involved in melanin synthesis. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis mapped 190 DEGs and 322 DEPs to 175 and 242 pathways, respectively, and there were 166 pathways correlated with both DEGs and DEPs. 49 DEPs/DEGs overlapped and were enriched for 12 pathways. Transcriptomic and proteomic analyses revealed that the following pathways were activated: melanogenesis, cardiomyocyte adrenergic, calcium and cGMP-PKG. The expression of DEGs was validated by real-time quantitative polymerase chain reaction (qRT-PCR) that produced results similar to those from RNA-seq. In addition, we found that the expression of the MED23, FZD10, WNT7B and WNT11 genes peaked at approximately 8 weeks in the "Yufen I" H line, which is consistent with the molting cycle. As both groups showed significant differences in terms of the expression of the studied genes, this work opens up avenues for research in the future to assess their exact function in determining plumage color. Conclusion Common DEGs and DEPs were enriched in the melanogenesis pathway. MED23 and GNAQ were also reported to play a crucial role in melanin synthesis. In addition, this study is the first to reveal gene and protein variations in in the "Yufen I" H line during Columbian feather color development and to discover principal genes and proteins that will aid in functional genomics studies in the future. The results of the present study provide a significant conceptual basis for the future breeding schemes with the "Yufen I" H line and provide a basis for research on the mechanisms of feather pigmentation.	[Wang, Xinlei; Li, Donghua; Zhang, Yanhua; Li, Yuanfang; Wang, Xiangnan; Liu, Danli; Zhang, Chenxi; Cao, Yanfang; Fu, Yawei; Han, Ruili; Li, Wenting; Liu, Xiaojun; Sun, Guirong; Li, Guoxi; Tian, Yadong; Li, Zhuanjian; Kang, Xiangtao] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China; [Wang, Xinlei; Song, Sufang] Henan Univ Anim Husb & Econ, Coll Anim Sci & Technol, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan University of Animal Husbandry & Economy	Wang, XL; Li, ZJ; Kang, XT (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China.; Wang, XL (corresponding author), Henan Univ Anim Husb & Econ, Coll Anim Sci & Technol, Zhengzhou, Henan, Peoples R China.	xinlei_king@163.com; lizhuanjian@163.com; xtkang2001@263.net	Li, Yuan/GXV-1310-2022	li, zhuanjian/0000-0002-7595-0604; xinlei, wang/0000-0003-4213-8895	China Agriculture Research System [CARS-40-K04]; Program for Innovation Research Team of Ministry of Education [IRT16R23]; Key Science and Technology Research Project of Henan Province [151100110800]; Agriculture Research System of China [CARS-40-K04]	China Agriculture Research System; Program for Innovation Research Team of Ministry of Education; Key Science and Technology Research Project of Henan Province; Agriculture Research System of China	This work was supported by the China Agriculture Research System (CARS-40-K04), Program for Innovation Research Team of Ministry of Education (IRT16R23), Key Science and Technology Research Project of Henan Province (151100110800).; This study was carried out with the aid provided by the Agriculture Research System of China (CARS-40-K04), the Program for Innovation Research Team of Ministry of Education (IRT16R23), and the Key Science and Technology Research Project of Henan Province (151100110800).	Alexeev V, 2000, NAT BIOTECHNOL, V18, P43, DOI 10.1038/71901; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bouchal P, 2015, EUR J CANCER, V51, pS24, DOI 10.1016/S0959-8049(16)30082-X; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Chang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-19; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chen Q, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/8084032; Chen QZ, 2015, DATA BRIEF, V3, P24, DOI 10.1016/j.dib.2014.12.008; Chiang HM, 2014, FOOD CHEM TOXICOL, V65, P129, DOI 10.1016/j.fct.2013.12.032; Cooke TF, 2017, CELL, V171, P427, DOI 10.1016/j.cell.2017.08.016; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Demehri S, 2009, DEVELOPMENT, V136, P891, DOI 10.1242/dev.030700; Dupin E, 2000, P NATL ACAD SCI USA, V97, P7882, DOI 10.1073/pnas.97.14.7882; ENGLARO W, 1995, J BIOL CHEM, V270, P24315, DOI 10.1074/jbc.270.41.24315; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Galbraith H, 2010, ANIMAL, V4, P1490, DOI 10.1017/S175173111000025X; Gessi M, 2013, NEUROPATH APPL NEURO, V39, P417, DOI 10.1111/j.1365-2990.2012.01288.x; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gong H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190933; Greenbaum D, 2002, BIOINFORMATICS, V18, P585, DOI 10.1093/bioinformatics/18.4.585; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Gunnarsson U, 2007, GENETICS, V175, P867, DOI 10.1534/genetics.106.063107; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hou L, 2000, DEVELOPMENT, V127, P5379; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Jipeng X, 2011, THESIS; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kinoshita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086361; Klungland H, 2000, CURRENT GENOMICS, V1, DOI [10.2174/1389202003351535, DOI 10.2174/1389202003351535]; Le Pape E, 2008, PIGM CELL MELANOMA R, V21, P477, DOI 10.1111/j.1755-148X.2008.00479.x; Li A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14139; Li JM, 2015, PLANTA, V241, P1363, DOI 10.1007/s00425-015-2263-y; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125883; Li XH, 2010, INT J MOL MED, V25, P923, DOI 10.3892/ijmm_00000423; Lin SJ, 2013, SCIENCE, V340, P1442, DOI 10.1126/science.1230374; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Liu WB, 2010, POULTRY SCI, V89, P1110, DOI 10.3382/ps.2010-00628; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Ng CS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1966-6; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Nieminen M, 2015, ANIMAL GENETICS, V45, P750; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Petersen HO, 2015, MOL BIOL EVOL, V32, P1928, DOI 10.1093/molbev/msv079; Russell M, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P119; Rzepka Z, 2016, POSTEP HIG MED DOSW, V70, P695, DOI 10.5604/17322693.1208033; Sato S, 2007, POULTRY SCI, V86, P2126, DOI 10.1093/ps/86.10.2126; Savitski MM, 2015, MOL CELL PROTEOMICS, V14, P2394, DOI 10.1074/mcp.M114.046995; Schouwey K, 2008, HISTOL HISTOPATHOL, V23, P609, DOI 10.14670/HH-23.609; Sharov AA, 2005, P NATL ACAD SCI USA, V102, P93, DOI 10.1073/pnas.0408455102; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Sultana H, 2018, ASIAN AUSTRAL J ANIM, V31, P180, DOI 10.5713/ajas.17.0298; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Trevisan S, 2015, J EXP BOT, V66, P3699, DOI 10.1093/jxb/erv165; Vickrey AI, 2018, ELIFE, V7, DOI 10.7554/eLife.34803; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wagner AJ, 2006, DRUG DISCOV TODAY, V2, P179; Wang SH, 2014, J PROTEOME RES, V13, P735, DOI 10.1021/pr4008333; Wen B, 2014, PROTEOMICS, V14, P2280, DOI 10.1002/pmic.201300361; Wu SF, 2005, PROG BIOCHEM BIOPHYS, V32, P99; Xia M, 2017, CELL REP, V20, P1794, DOI 10.1016/j.celrep.2017.07.056; Yang J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4778-7; Yang L, 2017, ANIM GENET, V48, P611, DOI 10.1111/age.12573; Yeo GSH, 2000, QJM-INT J MED, V93, P7, DOI 10.1093/qjmed/93.1.7; Yeo J, 2014, MOL BIOL REP, V41, P4843, DOI 10.1007/s11033-014-3394-0; Yu SG, 2018, CELL PHYSIOL BIOCHEM, V46, P2373, DOI 10.1159/000489644; Zhang JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127301; Zhang L, 2013, GENE, V519, P77, DOI 10.1016/j.gene.2013.01.043; Zhang WW, 2006, ANTON LEEUW INT J G, V89, P221, DOI 10.1007/s10482-005-9024-z	75	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0210850	10.1371/journal.pone.0210850	http://dx.doi.org/10.1371/journal.pone.0210850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693656	Green Published, Green Submitted, gold			2022-12-26	WOS:000532690100002
J	Kim, SE; Hwang, JH; Kim, YK; Lee, HT				Kim, Sang Eun; Hwang, Jeong Ho; Kim, Young Kyu; Lee, Hoon Taek			Heterogeneity of porcine bone marrow-derived dendritic cells induced by GM-CSF	PLOS ONE			English	Article							MACROPHAGES; SUBSETS; COLONY	In vitro generation of dendritic cells (DCs) is advantageous for overcoming the low frequency of primary DCs and the difficulty of applying isolation techniques for studying DC immunobiology. The culture of bone marrow cells with granulocyte-macrophage colonystimulating factor (GM-CSF) has been used extensively to generate bone marrow-derived dendritic cells (BMDCs). Studies have reported the heterogeneity of cells grown in murine GM-CSF culture based on the levels of MHCII expression. Although porcine DCs are generated by this classical method, the exact characteristics of the BMDC population have not yet been defined. In this study, we discriminated GM-CSF-grown BMDCs from gnotobiotic miniature pigs according to several criteria including morphology, phenotype, gene expression pattern and function. We showed that porcine BMDCs were heterogeneous cells that differentially expressed MHCII. MHCIIhigh cells displayed more representative of DC-like morphology and phenotype, including costimulatory molecules, as well as they showed a superior T cell priming capacity as compared to MHCIIlow cell. Our data showed that the difference in MHCIIhigh and MHCIIlow cell populations involved distinct maturation states rather than the presence of different cell types. Overall, characterization of porcine BMDC cultures provides important information about this widely used cellular model.	[Kim, Sang Eun; Hwang, Jeong Ho; Kim, Young Kyu] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea; [Hwang, Jeong Ho] Korea Inst Toxicol, Jeonbuk Dept Inhalat Res, Anim Model Res Grp, Jeongeup, Jeollabuk Do, South Korea; [Lee, Hoon Taek] Konkuk Univ, Dept Stem Cell & Regenerat Biotechnol, Seoul, South Korea	Konkuk University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Konkuk University	Lee, HT (corresponding author), Konkuk Univ, Dept Stem Cell & Regenerat Biotechnol, Seoul, South Korea.	htl3675@konkuk.ac.kr		Hwang, Jeong Ho/0000-0002-4763-8373	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [2015M3A9C7030091]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (No. 2015M3A9C7030091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (No. 2015M3A9C7030091).	Anguille S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051851; Auray G, 2016, J IMMUNOL, V197, P4791, DOI 10.4049/jimmunol.1600672; Auray G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156019; Auray G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059629; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gunzer Florian, 2003, Methods Mol Med, V73, P307; Hartmann SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158503; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hwang JH, 2015, ANIM SCI J, V86, P468, DOI 10.1111/asj.12312; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Lutz MB, 2016, IMMUNITY, V44, P1, DOI 10.1016/j.immuni.2015.12.013; Marquet F, 2014, J IMMUNOL, V193, P5883, DOI 10.4049/jimmunol.1303150; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Na YR, 2016, MOL CELLS, V39, P734, DOI 10.14348/molcells.2016.0160; Oh S, 2018, J IMMUNOL, V200; Olatunde AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196591; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Proll MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187735; Rogers PB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181985; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Szulc-Dabrowska L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179166; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wan H, 2005, CELL MOL IMMUNOL, V2, P28; Wilkinson-Ryan I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125851	29	4	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0223590	10.1371/journal.pone.0223590	http://dx.doi.org/10.1371/journal.pone.0223590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689334	gold, Green Published			2022-12-26	WOS:000532680100007
J	Moon, DH; Park, CH; Kang, DY; Lee, HS; Lee, S				Moon, Duk Hwan; Park, Chul Hwan; Kang, Du-Young; Lee, Hye Sun; Lee, Sungsoo			Significance of the lobe-specific emphysema index to predict prolonged air leak after anatomical segmentectomy	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; SUBLOBAR RESECTION; CT QUANTIFICATION; LUNG; LOBECTOMY; DURATION; SURGERY; RISK	Prolonged air leak (PAL) is a major complication of pulmonary resection. Emphysema quantification with computed tomography is regarded as an important predictor of PAL for patients undergoing lobectomy. Therefore, we investigated whether this predictor might be applicable for segmentectomy. Herein, we characterized the factors that influence PAL in early stage lung cancer patients undergoing anatomical segmentectomy. Forty-one patients who underwent anatomical segmentectomy for early lung cancer between January 2014 and July 2017 were included for analysis. Several baseline and surgical variables were evaluated. In particular, the emphysema index (EI, %) and lobe-specific emphysema index (LEI, %) were assessed by using three-dimensional volumetric CT scan. PAL was observed in 13 patients (31.7%). There were statistically significant differences in DLCO (97.3% +/- 18.3% vs. 111.7% +/- 15.9%, p = 0.014), EI (4.61% +/- 4.66% vs. 1.17% +/- 1.76%, p = 0.023), and LEI (5.81% +/- 5.78% vs. 0.76% +/- 1.17%, p = 0.009) between patients with and without PAL. According to logistic regression analysis, both EI and LEI were significantly associated with PAL (p = 0.028 and p < 0.001, respectively). We found that EI and LEI significantly influenced the development of PAL after pulmonary resection. In particular, LEI showed stronger association with PAL, compared with EI, suggesting the importance of LEI in the prediction of PAL after anatomical segmentectomy.	[Moon, Duk Hwan; Lee, Sungsoo] Yonsei Univ, Gangnam Severance Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea; [Park, Chul Hwan] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Park, Chul Hwan] Yonsei Univ, Gangnam Severance Hosp, Res Inst Radiol Sci, Coll Med, Seoul, South Korea; [Kang, Du-Young] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Cardiovasc & Thorac Surg, Sch Med, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Biostat Collaborat Unit, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Lee, S (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea.	CHESTLEE@yuhs.ac	Lee, Hye Sun/J-2154-2015	Lee, Hye Sun/0000-0001-6328-6948; Lee, Sungsoo/0000-0001-8998-9510				Attaar A, 2017, J THORAC CARDIOV SUR, V153, P690, DOI 10.1016/j.jtcvs.2016.10.003; Brunelli A, 2017, EUR J CARDIO-THORAC, V52, P963, DOI 10.1093/ejcts/ezx105; Brunelli A, 2017, ANN THORAC SURG, V103, P1641, DOI 10.1016/j.athoracsur.2016.10.061; Brunelli A, 2010, ANN THORAC SURG, V90, P204, DOI 10.1016/j.athoracsur.2010.02.054; Cerfolio RJ, 2002, ANN THORAC SURG, V73, P1727, DOI 10.1016/S0003-4975(02)03531-2; Cho Jeong Su, 2011, Korean J Thorac Cardiovasc Surg, V44, P51, DOI 10.5090/kjtcs.2011.44.1.51; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Droghetti A, 2008, J THORAC CARDIOV SUR, V136, P383, DOI 10.1016/j.jtcvs.2008.04.014; Fabian T, 2003, ANN THORAC SURG, V75, P1587, DOI 10.1016/S0003-4975(02)04994-9; Ghaly G, 2016, ANN THORAC SURG, V101, P465, DOI 10.1016/j.athoracsur.2015.06.112; Ketchedjian A, 2005, SEMIN THORAC CARDIOV, V17, P128, DOI 10.1053/j.semtcvs.2005.04.003; Kim SS, 2017, KOREAN J RADIOL, V18, P739, DOI 10.3348/kjr.2017.18.4.739; Lynch DA, 2013, J THORAC IMAG, V28, P284, DOI 10.1097/RTI.0b013e318298733c; Moser C, 2008, J THORAC CARDIOV SUR, V136, P843, DOI 10.1016/j.jtcvs.2008.02.079; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Muto S, 2018, CLIN EXP NEPHROL, V22, P583, DOI 10.1007/s10157-017-1486-6; Ng T, 2010, J THORAC CARDIOV SUR, V139, P1007, DOI 10.1016/j.jtcvs.2009.07.023; Okada M, 2012, INTERACT CARDIOV TH, V14, P5, DOI 10.1093/icvts/ivr065; Petrella F, 2011, SURG-J R COLL SURG E, V9, P72, DOI 10.1016/j.surge.2010.07.010; Shimizu K, 2012, INTERACT CARDIOV TH, V15, P194, DOI 10.1093/icvts/ivs202; Sienel W, 2008, EUR J CARDIO-THORAC, V33, P728, DOI 10.1016/j.ejcts.2007.12.048; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z	23	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224519	10.1371/journal.pone.0224519	http://dx.doi.org/10.1371/journal.pone.0224519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689308	Green Published, gold			2022-12-26	WOS:000532680100029
J	Vishwakarma, G; Sanyal, RP; Saini, A; Sahu, PK; Patel, RRS; Sharma, D; Tiwari, R; Das Kishore, B				Vishwakarma, Gautam; Sanyal, Ravi Prakash; Saini, Ajay; Sahu, Parmeshwar Kumar; Patel, Ravi Raj Singh; Sharma, Deepak; Tiwari, Ratan; Das Kishore, Bikram			GLADS: A gel-less approach for detection of STMS markers in wheat and rice	PLOS ONE			English	Article							REAL-TIME PCR; SYBR-GREEN-I; DNA MELTING ANALYSIS; SSR-HRM ANALYSIS; ASSISTED SELECTION; GENETIC DIVERSITY; SCAR MARKERS; MICROSATELLITE; RESISTANCE; IDENTIFICATION	Sequence tagged microsatellite site (STMS) are useful PCR based DNA markers. Wide genome coverage, high polymorphic index and co-dominant nature make STMS a preferred choice for marker assisted selection (MAS), genetic diversity analysis, linkage mapping, seed genetic purity analysis etc. Routine STMS analysis involving low-throughput, laborious and time-consuming polyacrylamide/agarose gels often limit their full utility in crop breeding experiments that involve large populations. Therefore, convenient, gel-less marker detection methods are highly desirable for STMS markers. The present study demonstrated the utility of SYBR Green dye based melt-profiling as a simple and convenient gel-less approach for detection of STMS markers (referred to as GLADS) in bread wheat and rice. The method involves use of SYBR Green dye during PCR amplification (or post-PCR) of STMS markers followed by generation of a melt-profile using controlled temperature ramp rate. The STMS amplicons yielded characteristic melt-profiles with differences in melting temperature (Tm) and profile shape. These characteristic features enabled melt-profile based detection and differentiation of STMS markers/alleles in a gel-less manner. The meltprofile approach allowed assessment of the specificity of the PCR assay unlike the endpoint signal detection assays. The method also allowed multiplexing of two STMS markers with non-overlapping melt-profiles. In principle, the approach can be effectively used in any crop for STMS marker analysis. This SYBR Green melt-profiling based GLADS approach offers a convenient, low-cost (20-51%) and time-saving alternative for STMS marker detection that can reduce dependence on gel-based detection, and exposure to toxic chemicals.	[Vishwakarma, Gautam; Das Kishore, Bikram] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Mumbai, Maharashtra, India; [Vishwakarma, Gautam; Sanyal, Ravi Prakash; Saini, Ajay; Das Kishore, Bikram] Homi Bhabha Natl Inst, Mumbai, Maharashtra, India; [Sanyal, Ravi Prakash; Saini, Ajay] Bhabha Atom Res Ctr, Mol Biol Div, Mumbai, Maharashtra, India; [Sahu, Parmeshwar Kumar; Patel, Ravi Raj Singh; Sharma, Deepak] Indira Gandhi Krishi Vishwavidyalaya, Dept Genet & Plant Breeding, Raipur, Chhattisgarh, India; [Tiwari, Ratan] ICAR Indian Inst Wheat & Barley Res, Kernal, Haryana, India	Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute; Bhabha Atomic Research Center (BARC); Indira Gandhi Krishi Vishwavidyalaya (IGKV); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research	Das Kishore, B (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Mumbai, Maharashtra, India.; Das Kishore, B (corresponding author), Homi Bhabha Natl Inst, Mumbai, Maharashtra, India.	bkdas@barc.gov.in	Sahu, Parmeshwar K/GYU-5561-2022; Saini, Ajay/AAC-8031-2019; Sahu, Dr. Parmeshwar K./M-7265-2018	Sharma, Deepak/0000-0002-9456-4805; Sahu, Dr. Parmeshwar K./0000-0003-2199-1790	Bhabha Atomic Research Centre, Mumbai, India	Bhabha Atomic Research Centre, Mumbai, India	This study was supported by the institutional funding of Bhabha Atomic Research Centre, Mumbai, India. No separate funding was obtained from any other National/International funding body for this study.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; An JY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091942; APPELS R, 1990, AUST J PLANT PHYSIOL, V17, P253, DOI 10.1071/PP9900253; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Ashkani S, 2012, PLANT MOL BIOL REP, V30, P79, DOI 10.1007/s11105-011-0315-4; Bagge M, 2008, MOL BREEDING, V22, P319, DOI 10.1007/s11032-008-9190-6; Baris I, 2013, ANAL BIOCHEM, V441, P225, DOI 10.1016/j.ab.2013.07.007; Barkley NA, 2010, MOL BREEDING, V25, P541, DOI 10.1007/s11032-009-9338-z; Calderini DF, 1999, EUPHYTICA, V107, P51, DOI 10.1023/A:1003579715714; Vieira MLC, 2016, GENET MOL BIOL, V39, P312, DOI 10.1590/1678-4685-GMB-2016-0027; Cheng JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18919; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Croxford AE, 2008, NEW PHYTOL, V180, P594, DOI 10.1111/j.1469-8137.2008.02588.x; Das BK, 2006, PLANT BREEDING, V125, P544, DOI 10.1111/j.1439-0523.2006.01282.x; Das B. K., 2006, Journal of Genetics & Breeding, V60, P189; Distefano G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044202; Dong CM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-143; Fleury D, 2012, QUANTITATIVE TRAIT L, DOI [10.1002/9780470015902.a0023712, DOI 10.1002/9780470015902.A0023712]; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Ganopoulos I, 2011, FOOD CHEM, V129, P652, DOI 10.1016/j.foodchem.2011.04.109; Ganopoulos I, 2011, FOOD CONTROL, V22, P532, DOI 10.1016/j.foodcont.2010.09.040; Germer S, 1999, GENOME RES, V9, P72; Gibson NJ, 2006, CLIN CHIM ACTA, V363, P32, DOI 10.1016/j.cccn.2005.06.022; Gimenez MJ, 2010, FOOD CHEM, V118, P482, DOI 10.1016/j.foodchem.2009.05.012; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hayden MJ, 2004, THEOR APPL GENET, V109, P1641, DOI 10.1007/s00122-004-1787-5; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Helguera M, 2003, CROP SCI, V43, P1839, DOI 10.2135/cropsci2003.1839; Hernandez P, 2002, GENOME, V45, P198, DOI 10.1139/g01-087; Huang YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073890; Jaiswal S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02009; Kalendar R, 2006, NAT PROTOC, V1, P2478, DOI 10.1038/nprot.2006.377; Kuleung C, 2004, THEOR APPL GENET, V108, P1147, DOI 10.1007/s00122-003-1532-5; Kumar LS, 1999, BIOTECHNOL ADV, V17, P143, DOI 10.1016/S0734-9750(98)00018-4; Li JJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00407; Li WJ, 2003, BIOTECHNIQUES, V35, P702, DOI 10.2144/03354bm07; Lipsky RH, 2001, CLIN CHEM, V47, P635; Ma W, 2003, EUPHYTICA, V134, P51, DOI 10.1023/A:1026191918704; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Meyer N, 2011, PLANT BREEDING, V130, P16, DOI 10.1111/j.1439-0523.2010.01808.x; Mienie C. M. S., 2013, African Journal of Biotechnology, V12, P4283; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Nalini E., 2004, BARC NWSL, P208; Orsi I, 2012, MOL BREEDING, V30, P967, DOI 10.1007/s11032-011-9681-8; Pallavi J, 2015, J PLANT PATHOL MICRO, V6, DOI [10.4172/2157-7471.1000277, DOI 10.4172/2157-7471.1000277]; Paux E, 2010, PLANT BIOTECHNOL J, V8, P196, DOI 10.1111/j.1467-7652.2009.00477.x; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; Randhawa HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005752; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Roder MS, 1998, GENETICS, V149, P2007; Sanchez-Perez R, 2006, SCI HORTIC-AMSTERDAM, V108, P310, DOI 10.1016/j.scienta.2006.02.004; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Simko I, 2016, TRENDS PLANT SCI, V21, P528, DOI 10.1016/j.tplants.2016.01.004; Singh BD, 2015, MARKER ASSISTED PLAN; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Taheri S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020399; Tsilo TJ, 2008, CROP SCI, V48, P253, DOI 10.2135/cropsci2007.04.0204; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Varshney RK, 2005, TRENDS PLANT SCI, V10, P621, DOI 10.1016/j.tplants.2005.10.004; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Vemireddy LR, 2007, J AGR FOOD CHEM, V55, P8112, DOI 10.1021/jf0714517; Vishwakarma G, 2016, PLANT BREEDING, V135, P643, DOI 10.1111/pbr.12415; Xanthopoulou A, 2014, PLANT GENET RESOUR-C, V12, P273, DOI 10.1017/S147926211400001X; Yan ZZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18049-8; Zhou WC, 2003, PLANT BREEDING, V122, P40, DOI 10.1046/j.1439-0523.2003.00802.x; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	69	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224572	10.1371/journal.pone.0224572	http://dx.doi.org/10.1371/journal.pone.0224572			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689318	Green Published, gold			2022-12-26	WOS:000532680100031
J	Weldearegay, KT; Gebrekidan, MG; Gezahegne, AA				Weldearegay, Kissanet Tesfay; Gebrekidan, Mekonnen Gebremichael; Gezahegne, Alefech Adissu			Health impact of hepatic-venous-occlusive disease in a small town in Ethiopia-Case study from Tahtay koraro district in Tigray region, 2017	PLOS ONE			English	Article							VENOOCCLUSIVE DISEASE	Background Hepatic venous-occlusive disease is blockage of microscopic veins in the liver causing 20-50% mortality. Ingestion of pyrrolizidine alkaloid plant, radiation therapy, and post-bonemarrow-transplant reactions are the commonest causes. In Ethiopia, a venous-occlusive disease outbreak was identified in 2002 in Tahtay Koraro district, Tigray. Suspected due to ingestion of the toxic pyrrolizidine alkaloid plant Ageratum conyzoids, found throughout the district. We aimed to describe the surveillance data of venous-occlusive disease from September 2006 to August 2016 in Tahtay koraro district, Ethiopia, 2017. Methodology We defined a possible Hepatic venous-occlusive disease case as any patient with abdominal pain for at least 2 weeks, abdominal distention, and hepato-splenomegaly during September 2006-August 2016. We reviewed previous district line lists, weekly reports, and clinical records to identify and describe cases. Agricultural interventions were obtained from the agricultural offices of the district. Result We identified 179 possible cases with 83 deaths with a case-fatality rate of 46.3%. Among cases, 110 (61.5%) were males and 113 (63%) were > 15 years. In total, 164 (91.6%) cases were from one village (Kelakil). The pick number of cases of VOD in this village was during 2008/09 which was 1076. The highest incidence (86/100,000) occurred in 2008. During the study period, 2,746 years of potential life were lost due to Hepatic venous-occlusive disease. Mechanical removal of the Ageratum started in 2011. Conclusion Hepatic venous-occlusive disease was an ongoing problem in Tahtay Koraro; However, the problem has largely been alleviated by displacing people from the affected area and removing the causative weed. More research is needed to understand why Kelakil village was more affected despite the widespread presence of the weed. Chemical and mechanical removal of the Ageratum could strengthen intervention activities.	[Weldearegay, Kissanet Tesfay; Gezahegne, Alefech Adissu] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol, Mekelle, Ethiopia; [Gebrekidan, Mekonnen Gebremichael] Tigray Reg Hlth Bur, Mekelle, Ethiopia	Mekelle University	Weldearegay, KT (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol, Mekelle, Ethiopia.	tesfaykissanet@gmail.com		Tesfay, Kissanet/0000-0002-9271-8487; Gebremichael, Mekonnen/0000-0002-6216-9966				Abebe Dawit, 2012, Ethiop Med J, V50 Suppl 2, P17; Afewerki M IT, 2013, TECHNICAL REPORT PYR; Altaee MY, 1998, OUTBREAK VENO OCCLUS; [Anonymous], 2016, TAHTAY KORARO WOREDA; BEARMAN SI, 1995, BLOOD, V85, P3005, DOI 10.1182/blood.V85.11.3005.bloodjournal85113005; Bearman SI, 2001, BONE MARROW TRANSPL, V27, P1113, DOI 10.1038/sj.bmt.1703014; CARRERAS E, 1993, BLOOD REV, V7, P43, DOI 10.1016/0268-960X(93)90023-W; Chen Z, 2010, NETH J MED, V68, P252; Chiu C, 2013, EVALUATION PYRROLIZI; Coppell JA, 2003, BLOOD REV, V17, P63, DOI 10.1016/S0268-960X(03)00002-X; Debella Asfaw, 2012, Ethiop Med J, V50 Suppl 2, P27; Kakar F, 2010, J TOXICOL-US, V2010, DOI 10.1155/2010/313280; Mesfin Gebrekidan, 2012, Ethiop Med J, V50 Suppl 2, P1; Orfanidis T., 2016, VENO OCCULUSIVE DIS; Richardson P, 1999, BRIT J HAEMATOL, V107, P485, DOI 10.1046/j.1365-2141.1999.01680.x; Senzolo M, 2007, WORLD J GASTROENTERO, V13, P3918, DOI 10.3748/wjg.v13.i29.3918; TANDON BN, 1976, LANCET, V2, P271	17	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2019	14	11							e0224659	10.1371/journal.pone.0224659	http://dx.doi.org/10.1371/journal.pone.0224659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1BP	31689340	gold, Green Published			2022-12-26	WOS:000532680100036
J	Tian, SJ; Jia, WM; Lu, M; Zhao, J; Sun, XL				Tian, Shijiao; Jia, Wenming; Lu, Mei; Zhao, Juan; Sun, Xiulian			Dual-specificity tyrosine phosphorylation-regulated kinase 1A ameliorates insulin resistance in neurons by up-regulating IRS-1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin resistance; insulin receptor substrate 1 (IRS-1); DYRK1A; Alzheimer disease; diabetes; neurodegenerative disease; brain neuron; db; db mouse; metabolic disorder	PANCREATIC BETA-CELL; INTRANASAL INSULIN; RECEPTOR SUBSTRATE-1; ALZHEIMERS-DISEASE; FUNCTIONAL-LINK; DOWN-SYNDROME; DYRK1A; INHIBITION; DEGRADATION; COGNITION	Insulin resistance in the brain is a pathological mechanism that is shared between Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM). Although aberrant expression and phosphorylation of insulin receptor substrate 1 (IRS-1) contribute to insulin resistance, the underlying mechanism remains elusive. In this study, we used several approaches, including adeno-associated virus-based protein overexpression, immunoblotting, immunoprecipitation, immunohistochemistry, and in situ proximal ligation assays, to investigate the function of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) in IRS-1 regulation and the downstream insulin signaling in neurons. We found that DYRK1A overexpression up-regulated IRS-1 expression by slowing turnover of the IRS-1 protein. We further observed that DYRK1A directly interacted with IRS-1 and phosphorylated IRS-1's multiple serine residues. Of note, DYRK1A and IRS-1 were coordinately up-regulated in the prefrontal cortex of db/db mice brain. Furthermore, DYRK1A overexpression ameliorated chronic high insulin-induced insulin resistance in SH-SY5Y cells as well as in primary rat neurons. These findings suggest that DYRK1A protects against insulin resistance in the brain by elevating IRS-1 expression.	[Tian, Shijiao] Shandong Univ, Qilu Hosp, Dept Neurol, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Tian, Shijiao; Sun, Xiulian] Shandong Univ, Qilu Hosp, Brain Res Inst, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Jia, Wenming; Zhao, Juan] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, NHC Key Lab Otorhinolaryngol, 44 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Lu, Mei] Shandong Univ, Qilu Hosp, Dept Geriatr, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Sun, Xiulian] Shandong Univ, Qilu Hosp, Chinese Natl Hlth Commiss, Chinese Minist Educ,Key Lab Cardiovasc Remodeling, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Brain Res Inst, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.; Sun, XL (corresponding author), Shandong Univ, Qilu Hosp, Chinese Natl Hlth Commiss, Chinese Minist Educ,Key Lab Cardiovasc Remodeling, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.	xiulians@gmail.com			National Natural Science Foundation of China [91849130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 91849130. The authors declare that they have no conflicts of interest with the contents of this article.	Abbassi R, 2015, PHARMACOL THERAPEUT, V151, P87, DOI 10.1016/j.pharmthera.2015.03.004; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Becker W, 2011, FEBS J, V278, P246, DOI 10.1111/j.1742-4658.2010.07956.x; Belke Darrell D, 2012, Methods Mol Biol, V933, P47, DOI 10.1007/978-1-62703-068-7_4; Branca C, 2017, AGING CELL, V16, P1146, DOI 10.1111/acel.12648; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; del Rincon SV, 2004, ONCOGENE, V23, P9269, DOI 10.1038/sj.onc.1208104; Dirice E, 2016, DIABETES, V65, P1660, DOI 10.2337/db15-1127; Duchon A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00104; Fratantonio D, 2017, BBA-MOL CELL BIOL L, V1862, P351, DOI 10.1016/j.bbalip.2016.12.008; Hu Yusheng, 2015, MATH PROBL ENG, V1, P1, DOI DOI 10.1145/2835596.2835613; Jeong H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18081-8; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Ke YD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007917; Kullmann S, 2016, PHYSIOL REV, V96, P1169, DOI 10.1152/physrev.00032.2015; LEROITH D, 1989, J MOL NEUROSCI, V1, P3, DOI 10.1007/BF02896850; Liu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172985; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu Q, 2016, J BIOL CHEM, V291, P26399, DOI 10.1074/jbc.M116.717553; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Martins IVA, 2017, J ALZHEIMERS DIS, V55, P915, DOI 10.3233/JAD-160640; Mayer CM, 2010, ENDOCRINOLOGY, V151, P75, DOI 10.1210/en.2009-0838; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Novak V, 2014, DIABETES CARE, V37, P751, DOI 10.2337/dc13-1672; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Rachdi L, 2014, CELL CYCLE, V13, P2221, DOI 10.4161/cc.29250; Rachdi L, 2014, DIABETOLOGIA, V57, P960, DOI 10.1007/s00125-014-3174-3; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Reiss K, 2012, J CELL PHYSIOL, V227, P2992, DOI 10.1002/jcp.24019; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; Ruiz-Alcaraz AJ, 2005, BIOCHEM J, V392, P345, DOI 10.1042/BJ20051194; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Ryu YS, 2010, J NEUROCHEM, V115, P574, DOI 10.1111/j.1471-4159.2010.06769.x; Shen WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9372; Shi LJ, 2017, BEHAV BRAIN RES, V327, P65, DOI 10.1016/j.bbr.2017.03.032; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; Sykiotis GP, 2001, MOL ENDOCRINOL, V15, P1864, DOI 10.1210/me.15.11.1864; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Wang P, 2019, CELL METAB, V29, P638, DOI 10.1016/j.cmet.2018.12.005; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Wang P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07655-1; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhang H, 2015, DIABETES, V64, P1025, DOI 10.2337/db14-1000; Zhang JY, 2017, DIABETES RES CLIN PR, V124, P41, DOI 10.1016/j.diabres.2016.10.024	54	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					20164	20176		10.1074/jbc.RA119.010809	http://dx.doi.org/10.1074/jbc.RA119.010809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31723029	Green Published, hybrid			2022-12-26	WOS:000505005800027
J	Sun, LF; Liu, Y; Wang, J; Huang, LD; Yang, Y; Cheng, XY; Fan, YZ; Zhu, MX; Liang, H; Tian, Y; Wang, HS; Guo, CR; Yu, Y				Sun, Liang-Fei; Liu, Yan; Wang, Jin; Huang, Li-Dong; Yang, Yang; Cheng, Xiao-Yang; Fan, Ying-Zhe; Zhu, Michael X.; Liang, Hong; Tian, Yun; Wang, Heng-Shan; Guo, Chang-Run; Yu, Ye			Altered allostery of the left flipper domain underlies the weak ATP response of rat P2X5 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						purinergic receptor; allosteric regulation; gating; conformational change; molecular dynamics; ATP-evoked current; ATP-gated ion channel; left flipper domain; LF domain; ATP-evoked current	GATED ION CHANNELS; MOLECULAR-MECHANISM; EXPRESSION; P2X(5); ACTIVATION; CLONING; MUSCLE; LOCALIZATION; ANTAGONIST; DEFINE	Although the extracellular ATP-gated cation channel purinergic receptor P2X5 is widely expressed in heart, skeletal muscle, and immune and nervous systems in mammals, little is known about its functions and channel-gating activities. This lack of knowledge is due to P2X5's weak ATP responses in several mammalian species, such as humans, rats, and mice. WT human P2X5 (hP2X5(?328?349)) does not respond to ATP, whereas a full-length variant, hP2X5 (hP2X5-FL), containing exon 10 encoding the second hP2X5 transmembrane domain (TM2), does. However, although rat P2X5 (rP2X5) has a full-length TM2, ATP induces only weak currents in rP2X5, which prompted us to investigate the mechanism underlying this small ATP response. Here, we show that single replacements of specific rP2X5 residues with the corresponding residues in hP2X5 (S191F or F195H) significantly enhance the current amplitude of rP2X5. Using a combination of engineered disulfide cross-linking, single-channel recording, and molecular modeling, we interrogated the effects of S191F and F195H substitutions on the allostery of the left flipper (LF) domain. On the basis of our findings, we propose that the bound ATP-induced distinct allostery of the LF domain with that of other functional subtypes has caused the weak ATP response of rP2X5 receptors. The findings of our study provide the prerequisite for future transgenic studies on the physiological and pathological functions of P2X5 receptors.	[Sun, Liang-Fei; Liu, Yan; Wang, Jin; Huang, Li-Dong; Yang, Yang; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China; [Sun, Liang-Fei; Liu, Yan; Wang, Jin; Huang, Li-Dong; Yang, Yang; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol & Pharmacol, Shanghai 200025, Peoples R China; [Liang, Hong; Wang, Heng-Shan] Guangxi Normal Univ, Sch Pharm & Chem, State Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China; [Guo, Chang-Run; Yu, Ye] China Pharmaceut Univ, Dept Basic Med & Clin Pharm, Nanjing 210009, Jiangsu, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA; [Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Fan, Ying-Zhe] Shanghai Univ Chinese Tradit Med, Putuo Dist Ctr Hosp, Shanghai 200026, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangxi Normal University; China Pharmaceutical University; University of Texas System; University of Texas Health Science Center Houston; Hunan Agricultural University; Shanghai University of Traditional Chinese Medicine	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Physiol & Pharmacol, Shanghai 200025, Peoples R China.; Wang, HS (corresponding author), Guangxi Normal Univ, Sch Pharm & Chem, State Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China.; Guo, CR; Yu, Y (corresponding author), China Pharmaceut Univ, Dept Basic Med & Clin Pharm, Nanjing 210009, Jiangsu, Peoples R China.; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.	hshwang2002@163.com; crguocpu@126.com; yuye@shsmu.edu.cn	Cheng, Xiaoyang/M-1257-2017	Cheng, Xiaoyang/0000-0003-1446-2815; Yu, Ye/0000-0002-4054-8543	Guangxi Funds for Distinguished Experts, National Natural Science Foundation of China [31971146, 81603409, 31971042, 21977021, 31900808, 31570832, 31170787, 31400707, 81703677]; National Postdoctoral Program for Innovative Talents Grant [BX201700306]; China Postdoctoral Science Foundation [2018M632127]; Project Program of the State Key Laboratory of Natural Medicines of China Pharmaceutical University; National Program on Key Basic Research Project of China [2014CB910300/02]; National Excellent Young Scientist Foundation of China [31222018]; Hunan Provincial Natural Science Foundation of China [2018JJ1012]; Science and Technology Department of Hunan Province [2018RS3086]	Guangxi Funds for Distinguished Experts, National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Program for Innovative Talents Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Project Program of the State Key Laboratory of Natural Medicines of China Pharmaceutical University; National Program on Key Basic Research Project of China(National Basic Research Program of China); National Excellent Young Scientist Foundation of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Science and Technology Department of Hunan Province	This study was supported by Guangxi Funds for Distinguished Experts, National Natural Science Foundation of China, Grants 31971146, 81603409, 31971042, 21977021, 31900808, 31570832, 31170787, 31400707, and 81703677; National Postdoctoral Program for Innovative Talents Grant BX201700306; China Postdoctoral Science Foundation Grant 2018M632127; the Project Program of the State Key Laboratory of Natural Medicines of China Pharmaceutical University; National Program on Key Basic Research Project of China Grant 2014CB910300/02; National Excellent Young Scientist Foundation of China Grant 31222018; Hunan Provincial Natural Science Foundation of China Grant 2018JJ1012; and Science and Technology Department of Hunan Province Grant 2018RS3086. The authors declare that they have no conflicts of interest with the contents of this article.	Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; ADAMS L, 1995, J CELL BIOL, V131, P1341, DOI 10.1083/jcb.131.5.1341; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Chen L, 2016, PURINERG SIGNAL, V12, P79, DOI 10.1007/s11302-015-9481-4; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1996, J NEUROSCI, V16, P2495; Compan V, 2012, J NEUROSCI, V32, P4284, DOI 10.1523/JNEUROSCI.6332-11.2012; Cox JA, 2001, GENE, V270, P145, DOI 10.1016/S0378-1119(01)00484-X; Cremlyn R. J., 1996, AN INTRODUCTION TO O, P7; Geuder K I, 1992, Dev Immunol, V2, P69, DOI 10.1155/1992/40576; Groschel-Stewart U, 1999, CELL TISSUE RES, V296, P599, DOI 10.1007/s004410051321; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Huang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097528; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jensik PJ, 2001, AM J PHYSIOL-CELL PH, V281, pC954, DOI 10.1152/ajpcell.2001.281.3.C954; Karasawa A, 2016, ELIFE, V5, DOI 10.7554/eLife.22153; Kasuya G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00887-9; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kotnis S, 2010, MOL PHARMACOL, V77, P953, DOI 10.1124/mol.110.063636; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le KT, 1999, J BIOL CHEM, V274, P15415, DOI 10.1074/jbc.274.22.15415; Le KT, 1997, FEBS LETT, V418, P195, DOI 10.1016/S0014-5793(97)01380-X; Li B, 2018, SCI BULL, V63, P1616, DOI 10.1016/j.scib.2018.11.016; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; McCarthy AE, 2019, CELL, V179, P659, DOI 10.1016/j.cell.2019.09.017; Meyer MP, 1999, DEV DYNAM, V216, P442, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<442::AID-DVDY12>3.0.CO;2-Z; Niu YY, 2016, J BIOL CHEM, V291, P7571, DOI 10.1074/jbc.M115.710251; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Saul A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00250; Schwiebert EM, 2001, AM J PHYSIOL-RENAL, V280, pF945, DOI 10.1152/ajprenal.2001.280.6.F945; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Stephan G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03728-5; Stock TC, 2012, J RHEUMATOL, V39, P720, DOI 10.3899/jrheum.110874; Surprenant A, 2000, J AUTONOM NERV SYST, V81, P249, DOI 10.1016/S0165-1838(00)00123-5; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Verkhratsky A, 2014, ADV NEUROBIOL, V11, P55, DOI 10.1007/978-3-319-08894-5_4; Wang J, 2018, P NATL ACAD SCI USA, V115, P4939, DOI 10.1073/pnas.1800907115; Wang J, 2017, J BIOL CHEM, V292, P7619, DOI 10.1074/jbc.M116.771121; Wang J, 2016, ACTA PHARMACOL SIN, V37, P44, DOI 10.1038/aps.2015.127; Yang XN, 2017, J BIOL CHEM, V292, P21662, DOI 10.1074/jbc.M117.814707; Zhao WS, 2016, J BIOL CHEM, V291, P7990, DOI 10.1074/jbc.M115.711127; Zhao WS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5189	56	6	6	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19589	19603		10.1074/jbc.RA119.009959	http://dx.doi.org/10.1074/jbc.RA119.009959			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31727741	hybrid, Green Published			2022-12-26	WOS:000504093200012
J	Morris, DL; Kastner, DW; Johnson, S; Strub, MP; He, Y; Bleck, CKE; Lee, DY; Tjandra, N				Morris, Daniel L.; Kastner, David W.; Johnson, Sabrina; Strub, Marie-Paule; He, Yi; Bleck, Christopher K. E.; Lee, Duck-Yeon; Tjandra, Nico			Humanin induces conformational changes in the apoptosis regulator BAX and sequesters it into fibers, preventing mitochondrial outer-membrane permeabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; BCL-2-associated X apoptosis regulator (BAX); humanin; fibers; electron microscopy; conformational change; beta-sheet; protein aggregation; fibrillation	RETRACTED ARTICLE. SEE; CELL-DEATH; BH3-ONLY PROTEINS; PEPTIDE HUMANIN; RESCUE FACTOR; PG 480; ACTIVATION; BINDING; ANALOG; BIM	The mitochondrial, or intrinsic, apoptosis pathway is regulated mainly by members of the B-cell lymphoma 2 (BCL-2) protein family. BCL-2-associated X apoptosis regulator (BAX) plays a pivotal role in the initiation of mitochondria-mediated apoptosis as one of the factors causing mitochondrial outer-membrane permeabilization (MOMP). Of current interest are endogenous BAX ligands that inhibit its MOMP activity. Mitochondrial-derived peptides (MDPs) are a recently identified class of mitochondrial retrograde signaling molecules and are reported to be potent apoptosis inhibitors. Among them, humanin (HN), has been shown to suppress apoptosis by inhibiting BAX translocation to the mitochondrial outer membrane, but the molecular mechanism of this interaction is unknown. Here, using recombinant protein expression, along with light-scattering, CD, and fluorescence spectroscopy, we report that HN and BAX can form fibers together in vitro. Results from negative stain EM experiments suggest that BAX undergoes secondary and tertiary structural rearrangements and incorporates into the fibers, and that its membrane-associating C-terminal helix is important for the fibrillation process. Additionally, HN mutations known to alter its anti-apoptotic activity affect fiber morphology. Our findings reveal for the first time a potential mechanism by which BAX can be sequestered by fibril formation, which can prevent it from initiating MOMP and committing the cell to apoptosis.	[Morris, Daniel L.; Kastner, David W.; Johnson, Sabrina; Strub, Marie-Paule; He, Yi; Tjandra, Nico] NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, 50 South Dr, Bethesda, MD 20814 USA; [Strub, Marie-Paule; He, Yi] NHLBI, Prot Express Facil, Biochem & Biophys Ctr, NIH, 50 South Dr, Bethesda, MD 20814 USA; [Bleck, Christopher K. E.] NHLBI, Electron Microscopy Core Facil, NIH, 14 Serv Rd West, Bethesda, MD 20892 USA; [Lee, Duck-Yeon] NHLBI, Biochem Core Facil, NIH, 50 South Dr, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, 50 South Dr,Room 3503, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov	Kastner, David W./ABC-1599-2021	Kastner, David W./0000-0002-7766-4249; Bleck, Christopher/0000-0003-1029-3444; Morris, Daniel/0000-0001-5274-0172				Alsanousi N, 2016, BIOCHEM BIOPH RES CO, V477, P647, DOI 10.1016/j.bbrc.2016.06.114; Arakawa T, 2006, J PEPT SCI, V12, P639, DOI 10.1002/psc.773; Arakawa T, 2014, MOL MED REP, V9, P375, DOI 10.3892/mmr.2013.1797; Arakawa T, 2011, INT J BIOL MACROMOL, V49, P93, DOI 10.1016/j.ijbiomac.2011.04.003; Arisaka F, 2009, PROTEIN PEPTIDE LETT, V16, P132, DOI 10.2174/092986609787316225; Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Benaki D, 2005, BIOCHEM BIOPH RES CO, V329, P152, DOI 10.1016/j.bbrc.2005.01.100; Benaki D, 2007, COLLECT S SER, V9, P5; Benaki D, 2006, BIOCHEM BIOPH RES CO, V349, P634, DOI 10.1016/j.bbrc.2006.08.087; Bilinovich SM, 2014, J MOL BIOL, V426, P1753, DOI 10.1016/j.jmb.2014.01.007; Brahmbhatt H, 2016, BIOCHEM J, V473, P1073, DOI 10.1042/BCJ20160118; Choi JY, 2007, CHEM BIOL DRUG DES, V70, P383, DOI 10.1111/j.1747-0285.2007.00576.x; Chu Q, 2015, CRIT REV BIOCHEM MOL, V50, P134, DOI 10.3109/10409238.2015.1016215; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Edlich F, 2018, BIOCHEM BIOPH RES CO, V500, P26, DOI 10.1016/j.bbrc.2017.06.190; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Esckilsen D, 2016, 47 CENTR REG M AM CH; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gahl RF, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.593897; Garner TP, 2019, NAT CHEM BIOL, V15, P322, DOI 10.1038/s41589-018-0223-0; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2012, NAT CHEM BIOL, V8, P639, DOI [10.1038/NCHEMBIO.995, 10.1038/nchembio.995]; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; Gong ZW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00210; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hayashi K, 2012, AMINO ACIDS, V42, P2293, DOI 10.1007/s00726-011-0971-6; He Y, 2020, PROTEIN EXPRES PURIF, V165, DOI 10.1016/j.pep.2019.105501; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hirano A, 2011, INT J BIOL MACROMOL, V48, P360, DOI 10.1016/j.ijbiomac.2010.12.017; Hirano A, 2010, INT J BIOL MACROMOL, V46, P375, DOI 10.1016/j.ijbiomac.2010.01.012; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jia Y, 2013, ANDROLOGY-US, V1, P651, DOI 10.1111/j.2047-2927.2013.00091.x; Kale J, 2018, EMBO REP, V19, DOI 10.15252/embr.201745235; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kita Y, 2008, PROTEIN PEPTIDE LETT, V15, P510, DOI 10.2174/092986608784567555; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lee C, 2016, FREE RADICAL BIO MED, V100, P182, DOI 10.1016/j.freeradbiomed.2016.05.015; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Ma J, 2016, ANAL CHEM, V88, P3967, DOI 10.1021/acs.analchem.6b00191; Ma JH, 2012, P NATL ACAD SCI USA, V109, P20901, DOI 10.1073/pnas.1217094110; Ma ZW, 2018, ACTA PHARMACOL SIN, V39, P1012, DOI 10.1038/aps.2017.169; Maftei M, 2012, J PEPT SCI, V18, P373, DOI 10.1002/psc.2404; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Niu X, 2017, CELL CHEM BIOL, V24, P493, DOI 10.1016/j.chembiol.2017.03.011; Pistolesi S, 2009, BIOCHEMISTRY-US, V48, P5026, DOI 10.1021/bi900187s; Pritz JR, 2017, NAT CHEM BIOL, V13, P961, DOI [10.1038/NCHEMBIO.2433, 10.1038/nchembio.2433]; Ramirez-Galicia G, 2005, COLLECT S SER, V8, P62; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rojo-Dominguez A, 2007, PROTEIN PEPTIDE LETT, V14, P618; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Steger C, 1998, IEEE T PATTERN ANAL, V20, P113, DOI 10.1109/34.659930; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Todt F, 2013, CELL DEATH DIFFER, V20, P333, DOI 10.1038/cdd.2012.131; Todt F, 2015, EMBO J, V34, P67, DOI 10.15252/embj.201488806; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xin MG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5935; Yagisawa R, 2008, CHEM PHYS LETT, V455, P293, DOI 10.1016/j.cplett.2008.02.109; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zapala B, 2010, PHARMACOL REP, V62, P767, DOI 10.1016/S1734-1140(10)70337-6; Zarse K, 2015, CELL METAB, V21, P355, DOI 10.1016/j.cmet.2015.02.013; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200	68	17	18	6	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19055	19065		10.1074/jbc.RA119.011297	http://dx.doi.org/10.1074/jbc.RA119.011297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31690630	hybrid, Green Published			2022-12-26	WOS:000516527800010
J	Steimle, BL; Smith, FM; Kosman, DJ				Steimle, Brittany L.; Smith, Frances M.; Kosman, Daniel J.			The solute carriers ZIP8 and ZIP14 regulate manganese accumulation in brain microvascular endothelial cells and control brain manganese levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood-brain barrier; human brain microvascular endothelial cells; manganese transport; ZIP8; SLC39A8; ZIP14; SLC39A14; metal homeostasis; neurotoxicity; capillary bed	METAL-ION TRANSPORTER; BOUND IRON UPTAKE; ZINC TRANSPORTER; FUNCTIONAL-PROPERTIES; TRANSFERRIN RECEPTOR; SLC39A8 DEFICIENCY; MEMBRANE; BARRIER; DEPOSITION; MUTATIONS	Manganese (Mn) supports numerous neuronal functions but in excess is neurotoxic. Consequently, regulation of Mn flux at the blood-brain barrier (BBB)(1) is critical to brain homeostasis. However, the molecular pathways supporting the transcellular trafficking of divalent Mn ions within the microvascular capillary endothelial cells (BMVECs) that constitute the BBB have not been examined. In this study, we have determined that Zrt- and Irt-like protein 8 (ZIP8) and ZIP14 support Mn2+-uptake by BMVECs and that neither DMT1 nor an endocytosis-dependent pathway play any significant role in Mn2+-uptake. Specifically, siRNA-mediated knockdown of ZIP8 and ZIP14 coincided with a decrease in Mn uptake, and kinetic analyses revealed that Mn uptake depends on pH and bicarbonate and is up-regulated by lipopolysaccharide (LPS), all biochemical markers of ZIP8 or ZIP14 activity. Mn2+-uptake also was associated with cell-surface membrane presentation of ZIP8 and ZIP14, as indicated by membrane protein biotinylation. Importantly, surface ZIP8 and ZIP14 biotinylation, and Mn2+-uptake experiments together revealed that these transporters support Mn-uptake at both the apical, blood and basal, brain sides of BMVECs. This indicated that at in the BMVECs of the BBB, these two transporters support a bi-directional Mn2+ flux. We conclude that BMVECs play a critical role in controlling manganese homeostasis in the brain.	[Steimle, Brittany L.; Smith, Frances M.; Kosman, Daniel J.] SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, 955 Main St,Suite 4102, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, 955 Main St,Suite 4102, Buffalo, NY 14203 USA.	camkos@buffalo.edu		Kosman, Daniel/0000-0003-3570-7682; , Brittany/0000-0003-3638-8767; Smith, Frances M./0000-0001-5479-4692	National Institutes of Neurologic Diseases and Stroke of the Department of Health and Human Services USA [RO3NS095063, RO1NS102337]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102337] Funding Source: NIH RePORTER	National Institutes of Neurologic Diseases and Stroke of the Department of Health and Human Services USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Mitchell Knutson for generously sharing unpublished data and providing valuable suggestions about this project. We thank also our colleague Ms. Danielle Bailey who shared her ZIP8 and ZIP14 qPCR efficiency data presented in Fig. S1. This work was supported by grants RO3NS095063 and RO1NS102337 from the National Institutes of Neurologic Diseases and Stroke of the Department of Health and Human Services USA to DJK. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Aydemir TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048679; Barar J, 2016, BIOIMPACTS, V6, P225, DOI 10.15171/bi.2016.30; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P293, DOI 10.1081/CLT-100102427; Bowers K, 2018, TRAFFIC, V19, P813, DOI 10.1111/tra.12602; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Choi EK, 2019, FASEB J, V33, P2228, DOI 10.1096/fj.201800831R; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Chtourou Y, 2011, NEUROCHEM RES, V36, P1546, DOI 10.1007/s11064-011-0483-5; Coffey R, 2017, AM J PHYSIOL-CELL PH, V312, pC169, DOI 10.1152/ajpcell.00116.2016; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; Crossgrove JS, 2005, NEUROTOXICOLOGY, V26, P297, DOI 10.1016/j.neuro.2004.09.004; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; Ding DL, 2014, BIOMETALS, V27, P731, DOI 10.1007/s10534-014-9765-0; Dlouhy AC, 2019, J BIOL CHEM, V294, P4202, DOI 10.1074/jbc.RA118.005142; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Fitsanakis VA, 2005, J NEUROSCI RES, V81, P235, DOI 10.1002/jnr.20560; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Gunter TE, 2013, NEUROTOXICOLOGY, V34, P118, DOI 10.1016/j.neuro.2012.10.018; Gupta RC, 2014, BIOMARKERS IN TOXICOLOGY, P1; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Haller G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06705-0; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Ji CY, 2015, J NEUROCHEM, V133, P668, DOI 10.1111/jnc.13040; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mackenzie B, 2006, PFLUG ARCH EUR J PHY, V451, P544, DOI 10.1007/s00424-005-1494-3; Mackenzie B, 2007, BIOCHEM J, V403, P59, DOI 10.1042/BJ20061290; Marti-Sanchez L, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0758-x; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pandey KN, 2009, FRONT BIOSCI-LANDMRK, V14, P5339, DOI 10.2741/3599; Park JH, 2018, GENET MED, V20, P259, DOI 10.1038/gim.2017.106; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Pyle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169531; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Riley LG, 2017, J INHERIT METAB DIS, V40, P261, DOI 10.1007/s10545-016-0010-6; Rose C, 1999, GASTROENTEROLOGY, V117, P640, DOI 10.1016/S0016-5085(99)70457-9; Scheiber IF, 2019, J BIOL CHEM, V294, P9147, DOI 10.1074/jbc.RA119.008762; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; SUAREZ N, 1995, TOXICOL IN VITRO, V9, P717, DOI 10.1016/0887-2333(95)00062-D; Szpetnar M, 2016, NEUROCHEM RES, V41, P2129, DOI 10.1007/s11064-016-1928-7; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Taylor SC, 2019, TRENDS BIOTECHNOL, V37, P761, DOI 10.1016/j.tibtech.2018.12.002; Thompson KJ, 2018, AM J PHYSIOL-GASTR L, V315, pG351, DOI 10.1152/ajpgi.00103.2018; Troche C, 2016, AM J PHYSIOL-ENDOC M, V310, pE258, DOI 10.1152/ajpendo.00421.2015; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2013, INT REV NEUROBIOL, V110, P277, DOI 10.1016/B978-0-12-410502-7.00013-2; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Wahlberg K, 2018, NEUROTOXICOLOGY, V64, P103, DOI 10.1016/j.neuro.2017.09.003; Wahlberg KE, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00664; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Worzfeld T, 2016, J CEREBR BLOOD F MET, V36, P340, DOI 10.1177/0271678X15608644; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; Yokel Robert A, 2004, Res Rep Health Eff Inst, P7; Zhang RX, 2016, HUM MOL GENET, V25, P4117, DOI 10.1093/hmg/ddw236; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111	65	16	18	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2019	294	50					19197	19208		10.1074/jbc.RA119.009371	http://dx.doi.org/10.1074/jbc.RA119.009371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KP9CW	31699897	Green Published, hybrid			2022-12-26	WOS:000516527800020
J	Tavera-Montanez, C; Hainer, SJ; Cangussu, D; Gordon, SJV; Xiao, Y; Reyes-Gutierrez, P; Imbalzano, AN; Navea, JG; Fazzio, TG; Padilla-Benavides, T				Tavera-Montanez, Cristina; Hainer, Sarah J.; Cangussu, Daniella; Gordon, Shellaina J. V.; Xiao, Yao; Reyes-Gutierrez, Pablo; Imbalzano, Anthony N.; Navea, Juan G.; Fazzio, Thomas G.; Padilla-Benavides, Teresita			The classic metal-sensing transcription factor MTF1 promotes myogenesis in response to copper	FASEB JOURNAL			English	Article						myogenic differentiation 1; ChIP-Seq; copper binding	PLACENTA GROWTH-FACTOR; FACTOR-I MTF-1; NF-KAPPA-B; METALLOTHIONEIN-I; GENE-EXPRESSION; TRANSPORTING ATPASES; MITOCHONDRIAL BIOGENESIS; MUSCLE DIFFERENTIATION; REGULATORY ELEMENTS; CYSTEINE CLUSTER	Metal-regulatory transcription factor 1 (MTF1) is a conserved metal-binding transcription factor in eukaryotes that binds to conserved DNA sequence motifs, termed metal response elements. MTF1 responds to both metal excess and deprivation, protects cells from oxidative and hypoxic stresses, and is required for embryonic development in vertebrates. To examine the role for MTF1 in cell differentiation, we use multiple experimental strategies [including gene knockdown (KD) mediated by small hairpin RNA and clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9), immunofluorescence, chromatin immunopreciptation sequencing, subcellular fractionation, and atomic absorbance spectroscopy] and report a previously unappreciated role for MTF1 and copper (Cu) in cell differentiation. Upon initiation of myogenesis from primary myoblasts, both MTF1 expression and nuclear localization increased. Mtf1 KD impaired differentiation, whereas addition of nontoxic concentrations of Cu+-enhanced MTF1 expression and promoted myogenesis. Furthermore, we observed that Cu+ binds stoichiometrically to a C terminus tetra-cysteine of MTF1. MTF1 bound to chromatin at the promoter regions of myogenic genes, and Cu addition stimulated this binding. Of note, MTF1 formed a complex with myogenic differentiation (MYOD)1, the master transcriptional regulator of the myogenic lineage, at myogenic promoters. These findings uncover unexpected mechanisms by which Cu and MTF1 regulate gene expression during myoblast differentiation.	[Tavera-Montanez, Cristina; Cangussu, Daniella; Gordon, Shellaina J. V.; Reyes-Gutierrez, Pablo; Imbalzano, Anthony N.; Padilla-Benavides, Teresita] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA; [Hainer, Sarah J.; Fazzio, Thomas G.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Xiao, Yao; Navea, Juan G.] Skidmore Coll, Dept Chem, Saratoga Springs, NY 12866 USA; [Hainer, Sarah J.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Skidmore College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Padilla-Benavides, T (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA.	teresita.padilla@umassmed.edu	Padilla-Benavides, Teresita/K-1968-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; Hainer, Sarah/0000-0003-0503-1183	University of Massachusetts Medical School; U.S. National Institute of Health [NIH] (National Institute of General Medical Sciences) [R01GM56244]; U.S. National Institute of Health [NIH] (Eunice Kennedy Shriver National Institute of Child Health and Human Development) [R01HD072122]; University of Massachusetts Medical School funding for the Summer Undergraduate Research Experience Program [NIH] (National Heart, Lung, and Blood Institute) [2R25HL092610]; National Science Foundation [Division of Biological Infrastructure (DBI)] [0959476]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072122] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	University of Massachusetts Medical School; U.S. National Institute of Health [NIH] (National Institute of General Medical Sciences); U.S. National Institute of Health [NIH] (Eunice Kennedy Shriver National Institute of Child Health and Human Development); University of Massachusetts Medical School funding for the Summer Undergraduate Research Experience Program [NIH] (National Heart, Lung, and Blood Institute); National Science Foundation [Division of Biological Infrastructure (DBI)](National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Courtney McCann, Dr. Sabriya Syed, Dr. Hanna Witwicka, and members of the T.P.-B. laboratory for insightful discussions regarding this manuscript. This work was supported by the Faculty Diversity Scholars Award from the University of Massachusetts Medical School to T.P.-B. Funding from the U.S. National Institute of Health [NIH; Grants R01GM56244 (National Institute of General Medical Sciences) to A.N.I. and R01HD072122 (Eunice Kennedy Shriver National Institute of Child Health and Human Development) to T.G.F.). S.J.V.G was supported by the University of Massachusetts Medical School funding for the Summer Undergraduate Research Experience Program [NIH Grant 2R25HL092610 (National Heart, Lung, and Blood Institute)]. Funding from the National Science Foundation [Division of Biological Infrastructure (DBI) 0959476 to J.G.N.]. S.J.H. is a Special Fellow of the Leukemia and Lymphoma Society. The authors declare no conflicts of interest.	Andeol Y, 2018, BIOCHEM CELL BIOL, V96, P726, DOI 10.1139/bcb-2018-0073; Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bittel D, 1998, J BIOL CHEM, V273, P7127, DOI 10.1074/jbc.273.12.7127; Bittel DC, 2000, J BIOL CHEM, V275, P37194, DOI 10.1074/jbc.M003863200; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen XH, 2004, J BIOL CHEM, V279, P4515, DOI 10.1074/jbc.M308924200; Chen XH, 2008, NUCLEIC ACIDS RES, V36, P3128, DOI 10.1093/nar/gkn103; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Conejo R, 2001, J CELL PHYSIOL, V186, P82, DOI 10.1002/1097-4652(200101)186:1<82::AID-JCP1001>3.0.CO;2-R; Conejo R, 2001, J CELL PHYSIOL, V187, P96, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1058>3.0.CO;2-V; Cramer M, 2005, BIOL CHEM, V386, P865, DOI 10.1515/BC.2005.101; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; Ferenci P, 2004, ALIMENT PHARM THER, V19, P157, DOI 10.1046/j.1365-2036.2003.01813.x; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; FUJISAWASEHARA A, 1993, BIOCHEM BIOPH RES CO, V191, P351, DOI 10.1006/bbrc.1993.1224; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Gilmour J, 2014, DEVELOPMENT, V141, P2391, DOI 10.1242/dev.106054; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Goel HL, 2002, CELL PROLIFERAT, V35, P131, DOI 10.1046/j.1365-2184.2002.00232.x; Gordon S. J. V., 2019, JOVE-J VIS EXP, V157; Gordon SJV, 2019, METALLOMICS, V11, P1140, DOI 10.1039/c8mt00348c; Green CJ, 2001, CANCER RES, V61, P2696; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Gunther V, 2012, BBA-MOL CELL RES, V1823, P476, DOI 10.1016/j.bbamcr.2011.10.006; Gunther V, 2012, INT J BIOCHEM CELL B, V44, P404, DOI 10.1016/j.biocel.2011.11.016; Guidi CJ, 2004, J BIOL CHEM, V279, P4180, DOI 10.1074/jbc.M312043200; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; He XQ, 2009, J BIOL CHEM, V284, P12609, DOI 10.1074/jbc.M901204200; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; Himeda CL, 2010, MOL CELL BIOL, V30, P3430, DOI 10.1128/MCB.00302-10; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Jeney V, 2005, CIRC RES, V96, P723, DOI 10.1161/01.RES.0000162001.57896.66; Kaler SG, 1998, AM J CLIN NUTR, V67, p1029S, DOI 10.1093/ajcn/67.5.1029S; Karunadharma PP, 2015, FASEB J, V29, P3582, DOI 10.1096/fj.15-272666; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KERN SR, 1981, TOXICOL APPL PHARM, V59, P346, DOI 10.1016/0041-008X(81)90206-4; Kodama H, 1999, PEDIATR INT, V41, P423, DOI 10.1046/j.1442-200x.1999.01095.x; Kodama K, 1999, PEDIATR INT, V41, P430, DOI 10.1046/j.1442-200x.1999.01091.x; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; LaRochelle O, 2001, BIOCHEM J, V353, P591, DOI 10.1042/0264-6021:3530591; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Li Y, 2006, MOL CELL BIOL, V26, P5580, DOI 10.1128/MCB.00471-06; Lichten LA, 2009, AM J PHYSIOL-GASTR L, V296, pG860, DOI 10.1152/ajpgi.90676.2008; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Linder MC, 1996, AM J CLIN NUTR, V63, P797; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Liu YY, 2010, BIOCHEMISTRY-US, V49, P10006, DOI 10.1021/bi101423j; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Lutsenko S, 2016, METALLOMICS, V8, P840, DOI [10.1039/c6mt00176a, 10.1039/C6MT00176A]; Lynes MA, 2007, ANN NY ACAD SCI, V1113, P159, DOI 10.1196/annals.1391.010; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Merry TL, 2010, AM J PHYSIOL-ENDOC M, V298, pE577, DOI 10.1152/ajpendo.00239.2009; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Miles AT, 2000, CRIT REV BIOCHEM MOL, V35, P35, DOI 10.1080/10409230091169168; Mitchell DL, 2010, MOL BIOL CELL, V21, P2780, DOI 10.1091/mbc.E10-04-0290; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Muller PAJ, 2009, INT J BIOCHEM CELL B, V41, P1233, DOI 10.1016/j.biocel.2008.08.001; Murata M, 1999, J CELL PHYSIOL, V180, P105, DOI 10.1002/(SICI)1097-4652(199907)180:1<105::AID-JCP12>3.0.CO;2-5; Murphy BJ, 1999, CANCER RES, V59, P1315; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nasipak BT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8441; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; OUELLETTE AJ, 1982, DEV BIOL, V92, P240, DOI 10.1016/0012-1606(82)90168-3; Padilla-Benavides T, 2017, J BIOL CHEM, V292, P18592, DOI 10.1074/jbc.M117.799676; Padilla-Benavides T, 2016, METHODS MOL BIOL, V1377, P267, DOI 10.1007/978-1-4939-3179-8_24; Padilla-Benavides T, 2014, J BIOL CHEM, V289, P20492, DOI 10.1074/jbc.M114.577668; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Paskavitz AL, 2018, J TRACE ELEM MED BIO, V49, P27, DOI 10.1016/j.jtemb.2018.04.024; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; QUAIFE C, 1986, DEV BIOL, V118, P549, DOI 10.1016/0012-1606(86)90025-4; Raimunda D, 2014, MOL MICROBIOL, V91, P185, DOI 10.1111/mmi.12454; Raimunda D, 2013, METALLOMICS, V5, P144, DOI 10.1039/c2mt20191g; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Saini N, 2011, MOL CELL BIOL, V31, P2151, DOI 10.1128/MCB.05207-11; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saydam N, 2003, J BIOL CHEM, V278, P31879, DOI 10.1074/jbc.M302138200; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Seo SJ, 1996, GENE, V178, P177, DOI 10.1016/0378-1119(96)00383-6; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Siebert X, 2005, BIOPHYS J, V89, P3312, DOI 10.1529/biophysj.105.066100; Sims HI, 2012, P NATL ACAD SCI USA, V109, P16516, DOI 10.1073/pnas.1207737109; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Uno H, 1987, Am J Med Genet Suppl, V3, P367; VANWASSENAERVANHALL HN, 1995, AM J NEURORADIOL, V16, P2021; vanWassenaervanHall HN, 1997, METAB BRAIN DIS, V12, P1; Vendelboe TV, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500980; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; Vest KE, 2018, METALLOMICS, V10, P309, DOI 10.1039/c7mt00324b; Wang Y, 2004, FASEB J, V18, P1071, DOI 10.1096/fj.03-1282com; Yokoyama S, 2011, CELL MOL LIFE SCI, V68, P1843, DOI 10.1007/s00018-011-0629-2; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Yuan SM, 2017, METALLOMICS, V9, P1169, DOI 10.1039/c7mt00184c; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001	140	20	20	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14556	14574		10.1096/fj.201901606R	http://dx.doi.org/10.1096/fj.201901606R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31690123	Green Published, Green Submitted, Bronze			2022-12-26	WOS:000507466100115
J	Sato, K; Nagashima, Y; Mano, T; Iwata, A; Toda, T				Sato, Kenichiro; Nagashima, Yu; Mano, Tatsuo; Iwata, Atsushi; Toda, Tatsushi			Quantifying normal and parkinsonian gait features from home movies: Practical application of a deep learning-based 2D pose estimator	PLOS ONE			English	Article							MOTION; SYSTEMS; DISEASE	Objective Gait movies recorded in daily clinical practice are usually not filmed with specific devices, which prevents neurologists benefitting from leveraging gait analysis technologies. Here we propose a novel unsupervised approach to quantifying gait features and to extract cadence from normal and parkinsonian gait movies recorded with a home video camera by applying OpenPose, a deep learning-based 2D-pose estimator that can obtain joint coordinates from pictures or videos recorded with a monocular camera. Methods Our proposed method consisted of two distinct phases: obtaining sequential gait features from movies by extracting body joint coordinates with OpenPose; and estimating cadence of periodic gait steps from the sequential gait features using the short-time pitch detection approach. Results The cadence estimation of gait in its coronal plane (frontally viewed gait) as is frequently filmed in the daily clinical setting was successfully conducted in normal gait movies using the short-time autocorrelation function (ST-ACF). In cases of parkinsonian gait with prominent freezing of gait and involuntary oscillations, using ACF-based statistical distance metrics, we quantified the periodicity of each gait sequence; this metric clearly corresponded with the subjects' baseline disease statuses. Conclusion The proposed method allows us to analyze gait movies that have been underutilized to date in a completely data-driven manner, and might broaden the range of movies for which gait analyses can be conducted.	[Sato, Kenichiro; Nagashima, Yu; Mano, Tatsuo; Iwata, Atsushi; Toda, Tatsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Sato, K; Iwata, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo, Japan.	kenisatou-tky@umin.ac.jp; iwata@m.u-tokyo.ac.jp	Iwata, Atsushi/A-9598-2013; Iwata, Atsushi/AAH-8924-2019	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314; Mano, Tatsuo/0000-0002-0826-2596				Alcock L, 2018, J BIOMECH, V71, P30, DOI 10.1016/j.jbiomech.2017.12.002; Alcock L, 2016, J BIOMECH, V49, P2763, DOI 10.1016/j.jbiomech.2016.06.007; Bennett TR, 2016, IEEE SIGNAL PROC MAG, V33, P28, DOI 10.1109/MSP.2015.2499314; Cao Z., 2017, P IEEE C COMP VIS PA, P1302; FFmpeg Developers, 2016, FFMPEG TOOL VERS BEI; Fu SW, 2017, IEEE T BIO-MED ENG, V64, P2584, DOI 10.1109/TBME.2016.2644258; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Keenan D. Barry, 2005, V41, P329; Kharb Ashutosh, 2011, IJCEM INT J COMPUTAT, V13; Mannon K, 1997, FOOT ANKLE INT, V18, P427, DOI 10.1177/107110079701800710; Morris M, 1998, MOVEMENT DISORD, V13, P61, DOI 10.1002/mds.870130115; Muro-de-la-Herran A, 2014, SENSORS-BASEL, V14, P3362, DOI 10.3390/s140203362; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Pistacchi M, 2017, FUNCT NEUROL, V32, P28, DOI 10.11138/FNeur/2017.32.1.028; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Saini I, 2013, J ADV RES, V4, P331, DOI 10.1016/j.jare.2012.05.007; Schreven S, 2015, J ELECTROMYOGR KINES, V25, P808, DOI 10.1016/j.jelekin.2015.06.004; Sih BL, 2001, J BIOMECH, V34, P257, DOI 10.1016/S0021-9290(00)00185-8; Sofuwa O, 2005, ARCH PHYS MED REHAB, V86, P1007, DOI 10.1016/j.apmr.2004.08.012; Yang CC, 2011, SENSORS-BASEL, V11, P7314, DOI 10.3390/s110807314; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Yu Shiqi, 2006, 18 INT C PATT REC IC	24	31	32	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0223549	10.1371/journal.pone.0223549	http://dx.doi.org/10.1371/journal.pone.0223549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725754	Green Submitted, gold, Green Published			2022-12-26	WOS:000532764500010
J	Zeng, A; Peng, MJ; Liu, HZ; Guo, ZH; Xu, J; Wang, SP; He, L; Tan, ZJ				Zeng, Ao; Peng, Maijiao; Liu, Huizhi; Guo, Zhaohui; Xu, Jun; Wang, Shengping; He, Lu; Tan, Zhoujin			Effects of Debaryomyces hansenii treatment on intestinal mucosa microecology in mice with antibiotic-associated diarrhea	PLOS ONE			English	Article							GUT; MICROBIOTA; DIVERSITY	Aim To confirm the effects of Debaryomyces hansenii on intestinal microecology in mice with antibiotic-associated diarrhea (AAD). Methods This study took the mucosal microecology as the entry point and an antibiotic mixture was used to induce diarrhea in mice. D. hansenii suspension was used to treat the mice and the bacterial communities of mucosa was analyzed using high-throughput sequencing. Results The Shannon-Wiener index indicated that the sequencing depth is reasonable and reflected the majority of microbial information. The principal coordinate analysis results showed that mice in the treatment group and the normal group had a similar microbial community structure, while differences in microbial community structure were observed between the model group and the treatment group. The inter-group bacterial structures were analyzed at the phylum level and genus level. The results revealed that antibiotic treatment increased the proportion of Proteobacteria and decreased the proportion of Bacteroides, while D. hansenii treatment inhibited the increase in Proteobacteria. Linear discriminant analysis coupled with effect size measurements (LEfSe) suggested d that the beneficial bacteria Candidatus Arthromitus were the only common bacteria in the normal group (P < 0.05). Conclusion The treatment with D.hansenii could contribute to the maintenance of the structure of the mucosal microbiota in comparison with the normal group and inhibit the proliferation of opportunistic bacteria. However, high-dose antibiotic treatment causes mucosal dysbiosis and the proliferation of opportunistic bacteria during the self-recovery period, such as Pseudoalteromonas, Alteromonas, Vibrio.	[Zeng, Ao; Liu, Huizhi; Guo, Zhaohui; Xu, Jun; Wang, Shengping] Hunan Inst Microbiol, Changsha, Hunan, Peoples R China; [Zeng, Ao; Peng, Maijiao; He, Lu; Tan, Zhoujin] Hunan Univ Chinese Med, Changsha, Hunan, Peoples R China	Hunan University of Chinese Medicine	Tan, ZJ (corresponding author), Hunan Univ Chinese Med, Changsha, Hunan, Peoples R China.	tanzhjin@sohu.com	Ao, Zeng/AAR-3726-2020; Tan, Zhoujin/V-9258-2019	Ao, Zeng/0000-0002-5926-3126; Tan, Zhoujin/0000-0003-3193-073X	National Natural Science Foundation of China [81573951]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81573951). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Doron SI, 2008, J CLIN GASTROENTEROL, V42, pS58, DOI 10.1097/MCG.0b013e3181618ab7; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Garg M, 2018, J CROHNS COLITIS, V12, P963, DOI 10.1093/ecco-jcc/jjy052; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; He L, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0953-9; Jiang XL, 2002, WORLD J GASTROENTERO, V8, P158, DOI 10.3748/wjg.v8.i1.158; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; [刘又嘉 Liu Youjia], 2016, [航天医学与医学工程, Space Medicine & Medical Engineering], V29, P175; Long CX, 2017, WORLD J GASTROENTERO, V23, P7584, DOI 10.3748/wjg.v23.i42.7584; Long CX, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1191-5; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marteau P, 2004, ALIMENT PHARM THER, V20, P18, DOI 10.1111/j.1365-2036.2004.02062.x; Quigley EMM, 2012, J CLIN GASTROENTEROL, V46, P356, DOI 10.1097/MCG.0b013e318247157c; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Thompson CL, 2013, MUCOSAL IMMUNOL, V6, P200, DOI 10.1038/mi.2012.91; Wang SM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25760-7; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163	24	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224730	10.1371/journal.pone.0224730	http://dx.doi.org/10.1371/journal.pone.0224730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725747	Green Published, gold			2022-12-26	WOS:000532764500028
J	Sintov, ND; White, LV; Walpole, H				Sintov, Nicole D.; White, Lee, V; Walpole, Hugh			Thermostat wars? The roles of gender and thermal comfort negotiations in household energy use behavior	PLOS ONE			English	Article							PROGRAMMABLE THERMOSTATS; CONSERVATION; METAANALYSIS; MANAGEMENT; EFFICIENCY	Although advanced thermostat technologies offer energy efficiency potential, these devices alone do not guarantee savings. Household occupants often deviate from thermostat programs, perhaps due to differing thermal comfort preferences, which are strong drivers of residential energy use and vary across genders. This study aims to develop an initial typology of interpersonal interactions around thermal comfort, explore the role of gender in such interactions, and examine the impacts of interactions on thermostat adjustments. Using n = 1568 diary observations collected from 112 participants, we identify three interaction types: conflicts, compromises, and agreements. Fixed effects analyses find that women are marginally more likely to report engaging in conflicts, whereas men are significantly more likely to report engaging in agreements and compromises, both of which are associated with greater likelihood of adjusting thermostats within a given day. This work represents an early step in investigating the multiply determined nature of household energy decisions.	[Sintov, Nicole D.; White, Lee, V; Walpole, Hugh] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sintov, ND (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	sintov.2@osu.edu	Walpole, Hugh/HGD-5583-2022	Sintov, Nicole/0000-0001-9285-6444; Walpole, Hugh/0000-0001-5224-7601	U.S. National Science Foundation [1522054]	U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by U.S. National Science Foundation award #1522054 (N. D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nsf.gov.	Abowd JM, 1999, ECONOMETRICA, V67, P251, DOI 10.1111/1468-0262.00020; Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Babcock L, 2003, WOMEN DONT ASK: NEGOTIATION AND THE GENDER DIVIDE, P1; BECKER LJ, 1981, ENVIRON BEHAV, V13, P590, DOI 10.1177/0013916581135004; Brager G, 2015, BUILD RES INF, V43, P274, DOI 10.1080/09613218.2015.993536; Brager GS, 1998, ENERG BUILDINGS, V27, P83, DOI 10.1016/S0378-7788(97)00053-4; Carlsson-Kanyama A, 2007, ENERG POLICY, V35, P2163, DOI 10.1016/j.enpol.2006.06.018; Chang TY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216362; Chen CF, 2017, ENERGY RES SOC SCI, V26, P61, DOI 10.1016/j.erss.2017.01.009; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Dear R, 2001, INT J BIOMETEOROL, V45, P100, DOI 10.1007/s004840100093; De Dear R, 1998, ASHRAE T; de Dear RJ, 2013, INDOOR AIR, V23, P442, DOI 10.1111/ina.12046; Delmas MA, 2013, ENERG POLICY, V61, P729, DOI 10.1016/j.enpol.2013.05.109; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Eagly AH, 2002, PSYCHOL REV, V109, P573, DOI 10.1037//0033-295X.109.3.573; Energy Information Administration (EIA), 2018, 2015 RES EN CONS SUR; Eon C, 2017, ENRGY PROCED, V121, P198, DOI 10.1016/j.egypro.2017.08.018; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Gallup, 2018, CONS LEAD US ID IS S; Gupta SK, 2016, ENERG BUILDINGS, V125, P142, DOI 10.1016/j.enbuild.2016.04.084; Gupta SK, 2015, IEEE T AUTOM SCI ENG, V12, P1285, DOI 10.1109/TASE.2015.2468730; Hargreaves T, 2010, ENERG POLICY, V38, P6111, DOI 10.1016/j.enpol.2010.05.068; Holt JL, 2005, INT J INTERCULT REL, V29, P165, DOI 10.1016/j.ijintrel.2005.06.002; Hwang Y, 2007, SCI COMMUN, V29, P198, DOI 10.1177/1075547007308599; International Energy Agency, 2013, TRANS SUST BUILD STR, DOI 10.1787/9789264202955-en; Karjalainen S, 2007, BUILD ENVIRON, V42, P1594, DOI 10.1016/j.buildenv.2006.01.009; Kray LJ, 2001, J PERS SOC PSYCHOL, V80, P942, DOI 10.1037/0022-3514.80.6.942; Leier CR, 2015, WHY DONT WOMEN ASK M; Malinick T, 2012, DESTINED DISAPPOINT; Manning MM, 2007, EFFECTS THERMOSTAT S; Mazei J, 2015, PSYCHOL BULL, V141, P85, DOI 10.1037/a0038184; Meier A, 2010, PEOPLE ACTUALLY USE; Nelson LW, 1978, ASHRAE T, V83, P319; Paciuk MT, 1989, ROLE PERSONAL CONTRO; Peffer T, 2013, ERGONOMICS, V56, P463, DOI 10.1080/00140139.2012.718370; Peffer T, 2011, BUILD ENVIRON, V46, P2529, DOI 10.1016/j.buildenv.2011.06.002; Plumper T, 2007, POLIT ANAL, V15, P124, DOI 10.1093/pan/mpm002; Plumper T, 2011, POLIT ANAL, V19, P147, DOI 10.1093/pan/mpr008; Pritoni M, 2015, ENERGY RES SOC SCI, V8, P190, DOI 10.1016/j.erss.2015.06.002; Saldana J., 2015, CODING MANUAL QUALIT, P1; Sanchez M, 2008, ALSO APPEAR ENERGY P; Schweiker Marcel, 2018, Temperature (Austin), V5, P308, DOI 10.1080/23328940.2018.1534490; Sintov ND, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00410; Small DA, 2007, J PERS SOC PSYCHOL, V93, P600, DOI 10.1037/0022-3514.93.4.600; Southwell BG, 2014, ENERGY RES SOC SCI, V2, P59, DOI 10.1016/j.erss.2014.03.019; Urge-Vorsatz D, 2015, RENEW SUST ENERG REV, V41, P85, DOI 10.1016/j.rser.2014.08.039; United Nations Department of Economic and Social Affairs Population Division, 2017, STESASERA405; United States Census Bureau, 2017, 2013 2017 AM COMM SU; Walker IS, 2008, RESIDENTIAL THERMOST; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P3	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224198	10.1371/journal.pone.0224198	http://dx.doi.org/10.1371/journal.pone.0224198			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1QS	31721769	Green Published, gold			2022-12-26	WOS:000532720700013
J	O'Connor, K; Morrissette, M; Strandwitz, P; Ghiglieri, M; Caboni, M; Liu, HY; Khoo, C; D'Onofrio, A; Lewis, K				O'Connor, Kathleen; Morrissette, Madeleine; Strandwitz, Philip; Ghiglieri, Meghan; Caboni, Mariaelena; Liu, Haiyan; Khoo, Christina; D'Onofrio, Anthony; Lewis, Kim			Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model	PLOS ONE			English	Article							COMMENSAL BACTERIA; E. COLI; EPIDEMIOLOGY; RECOGNITION; MECHANISMS; MICROBIOTA; IMMUNE	The opportunistic pathogen Escherichia coli, a common member of the human gut microbiota belonging to the Enterobacteriaceae family, is the causative agent of the majority of urinary tract infections (UTIs). The gut microbiota serves as a reservoir for uropathogenic E. coli where they are shed in feces, colonize the periurethral area, and infect the urinary tract. Currently, front line treatment for UTIs consists of oral antibiotics, but the rise of antibiotic resistance is leading to higher rates of recurrence, and antibiotics cause collateral damage to other members of the gut microbiota. It is commonly believed that incorporation of the American cranberry, Vaccinium macrocarpon, into the diet is useful for reducing recurrence of UTIs. We hypothesized such a benefit might be explained by a prebiotic or antimicrobial effect on the gut microbiota. As such, we tested cranberry extracts and whole cranberry powder on a human gut microbiome-derived community in a gut simulator and found that cranberry components broadly modulate the microbiota by reducing the abundance of Enterobacteriaceae and increasing the abundance of Bacteroidaceae. To identify the specific compounds responsible for this, we tested a panel of compounds isolated from cranberries for activity against E. coli, and found that salicylate exhibited antimicrobial activity against both laboratory E. coli and human UTI E. coli isolates. In a gut simulator, salicylate reduced levels of Enterobacteriaceae and elevated Bacteroidaceae in a dose dependent manner.	[O'Connor, Kathleen; Morrissette, Madeleine; Strandwitz, Philip; Ghiglieri, Meghan; Caboni, Mariaelena; D'Onofrio, Anthony; Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA; [Liu, Haiyan; Khoo, Christina] Ocean Spray Cranberries Inc, Global Sci Affairs & Nutr Policy, Res & Dev, Lakeville Middleboro, MA USA	Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu		Caboni, Mariaelena/0000-0002-9742-0022; Strandwitz, Philip/0000-0001-6223-3713	Ocean Spray Cooperative [507259]	Ocean Spray Cooperative	Ocean Spray Cooperative (www.oceanspray.com) provided funding for this work (grant index 507259). The funder provided support in the form of salaries for authors KO and PS, but did not have any role in data collection and analysis or decision to publish. Ocean Spray cooperative provided all cranberry materials and cranberry material methodology for this manuscript and contributed to the initial conceptualization. The specific roles of these authors are articulated in the `author contributions' section.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Caillet S, 2012, FOOD CONTROL, V23, P419, DOI 10.1016/j.foodcont.2011.08.010; Comstock LE, 2009, CELL HOST MICROBE, V5, P522, DOI 10.1016/j.chom.2009.05.010; Cote J, 2011, FOOD CONTROL, V22, P1413, DOI 10.1016/j.foodcont.2011.02.024; Daoud Z, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00026; Duthie GG, 2005, J AGR FOOD CHEM, V53, P2897, DOI 10.1021/jf040393b; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jensen HD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00542; Jepson RG, 2012, COCHRANE DATABASE SY, P10; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Martin MA, 2015, FOOD RES INT, V71, P68, DOI 10.1016/j.foodres.2015.02.022; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; Mydock-McGrane L, 2016, J MED CHEM, V59, P9390, DOI 10.1021/acs.jmedchem.6b00948; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Rettedal EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5714; Sanz Y, 2015, PEDIATR RES, V77, P236, DOI 10.1038/pr.2014.170; Spaulding CN, 2017, NATURE, V546, P528, DOI 10.1038/nature22972; Spaulding CN, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010030; Strandwitz P, 2019, NAT MICROBIOL, V4, P396, DOI 10.1038/s41564-018-0307-3; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Yamamoto S, 1997, J UROLOGY, V157, P1127, DOI 10.1016/S0022-5347(01)65154-1; Zeng MY, 2017, MUCOSAL IMMUNOL, V10, P18, DOI 10.1038/mi.2016.75; Zimmermann P, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02268-16	31	16	16	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0224836	10.1371/journal.pone.0224836	http://dx.doi.org/10.1371/journal.pone.0224836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714906	Green Published, gold			2022-12-26	WOS:000532710400016
J	Woday, A; Muluneh, MD; Sherif, S				Woday, Abay; Muluneh, Muluken Dessalegn; Sherif, Samiha			Determinants of preterm birth among mothers who gave birth at public hospitals in the Amhara region, Ethiopia: A case-control study	PLOS ONE			English	Article								Background Preterm birth (PTB) is a public health issue worldwide. In developing nations, like Ethiopia, PTB is under reported and underestimated. However, it is the leading cause of neonatal and under-five mortality in Ethiopia. Besides, limited and non-comparative research studies to date has been conducted in the country to address the prevalence of PTB. Therefore, this study aims to determine predictors of PTB. Methods Hospital-based unmatched case control study was employed on a sample of 139 cases and 278 controls from October 2017 to December 2017 in the Amhara region, Ethiopia. The cases and controls were proportionally allocated in each hospital based on the last one-year case flows. As soon as a case was identified, the respective two controls were enrolled until the required sample size was satisfied. The outcome variable was measured by using either last menstrual period (LMP), early ultrasound result, or Ballard maturity examination. Face-to-face interviews were conducted using a standardized, structured, and pre-tested questionnaire to collect data. The collected data was entered into Epi-data and exported into SPSS for analysis. Independent variables with p-values < 0.25 in the bivariate analysis were entered into multivariable logistic regression models with forward logistic regressions method to control the influence of covariates. Ethical clearance was ensured. Results A total of 134 cases and 268 controls participated with a response rate of 96.4%. After adjusting for covariates, the following variables were associated with PTB: residing in rural areas [AOR = 2.99: 95% CI 1.19, 7.48], low maternal age [AOR = 3.47: 95% CI 1.11, 10.83], being illiterate [AOR = 4.56: 95% CI 1.11,8.62], short birth spacing [AOR = 2.48: 95% CI 1.07, 5.75], no antenatal care visits for this index pregnancy [AOR = 10.78: 95% CI 4.43, 26.25], having a history of previous adverse birth outcomes [AOR = 3.47: 95% CI 1.51, 8.02], and exposure to medical problems during pregnancy [AOR = 13.94: 95% CI 4.39, 24.27]. Conclusion The study revealed maternal sociodemographic factors, short birth space, lack of antenatal care, exposure to previous adverse birth outcomes and facing medical illnesses during pregnancy were the predictors of PTB. Therefore, inclusive preventive and control interventions should be developed at regional, zonal and district levels to reduce the burden of PTB among women resided in rural areas such as integrating antenatal care services into the existing health extension packages. Study results suggest increasing the awareness of PTB, contraceptive utilization and counseling to enhance birth spacing, antenatal care visits, and accessibility to services among women in Ethiopia should be given due attention. Health care providers should focus on mothers with previous adverse birth outcomes and those exposed to medical problems during pregnancy. Additional community based longitudinal studies supplemented with qualitative methods are recommended.	[Woday, Abay] Samara Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Samara, Ethiopia; [Muluneh, Muluken Dessalegn] Amref Hlth Africa Ethiopia Res Monitoring & Evalu, Addis Ababa, Ethiopia; [Muluneh, Muluken Dessalegn] Western Sydney Univ, Sydney, NSW, Australia; [Sherif, Samiha] Amref Hlth Africa Ethiopia, Business Dev, Addis Ababa, Ethiopia	Samara University; Western Sydney University; African Medical & Research Foundation (AMREF)	Muluneh, MD (corresponding author), Amref Hlth Africa Ethiopia Res Monitoring & Evalu, Addis Ababa, Ethiopia.; Muluneh, MD (corresponding author), Western Sydney Univ, Sydney, NSW, Australia.	destamule@gmail.com	Habte, Aklilu/ABB-7649-2020; sujan, Safaet Hossain/AAG-4445-2021; Nascimento, Teresa/AFP-2103-2022; Adam, Makka/CAF-4178-2022; Devaraj, Sankarganesh/AAQ-9360-2020; Soficaru, Andrei Dorian/S-5101-2019; Sim, Edmund Ui-Hang/J-2863-2019; Špacírová, Zuzana/ABF-9773-2021; van Loon, Gunther/B-8526-2009; Yasine, Toyeb/GLR-7429-2022; , 邹声瑞/AHC-8076-2022; Chalghaf, Nasr/H-2223-2017; Abd El-Raheem, Ghada Omer Hamad/AEZ-7021-2022; Mathur, Prashant/AAY-9373-2020; Kedir, Shemsu/ADA-7012-2022; Bahijri, Suhad M/AAF-4141-2020; Woday, Abay/AAI-4504-2020; Ghazi, Hasanain Faisal/H-5305-2017; Segers, Patrick/AAA-7844-2020; Rocha, Eduardo/B-7009-2009; sánchez-briones, eugenia/ABE-2865-2020; Saeed, Anwar/ABB-5007-2021; Nunes, Maria Carmo/AAV-5185-2020; Warman, Jodi/B-6062-2016; malekzadeh shamsabad, mohammad reza/GOK-0228-2022; lopez-duran, ana/ABE-1205-2021; Chalghaf, Nasr/GQZ-4252-2022; KWADZOKPUI, PRECIOUS KWABLAH/AAE-6125-2021; Kumar, Shiv/AAV-9958-2020; Krnjajic, Slobodan B/K-9449-2013; Wolf, Judith/H-8122-2014; Alatawi, Aishah/AFM-7691-2022; Nazzal, Zaher Ahmad/AAW-3875-2020; Pestana, Jose V./J-1922-2012; Mirrakhimov, Erkin/E-6900-2017; Machekano, Honest/AAL-7848-2020; Abera, Bayeh/AAU-8754-2020; Norhayati, Mohd Noor/E-3868-2012; Elansary, Hosam O./E-3684-2019; Alemayehu, Mussie/AAH-3016-2019	sujan, Safaet Hossain/0000-0003-0313-2423; Nascimento, Teresa/0000-0002-3966-6788; Adam, Makka/0000-0001-9394-3726; Soficaru, Andrei Dorian/0000-0001-8658-6695; Sim, Edmund Ui-Hang/0000-0001-8652-8495; Špacírová, Zuzana/0000-0002-2905-2934; van Loon, Gunther/0000-0001-5191-5241; Yasine, Toyeb/0000-0003-0383-5110; Chalghaf, Nasr/0000-0002-7693-0234; Abd El-Raheem, Ghada Omer Hamad/0000-0001-5668-0859; Mathur, Prashant/0000-0002-9271-1373; Kedir, Shemsu/0000-0003-0565-7610; Bahijri, Suhad M/0000-0001-6674-5409; Woday, Abay/0000-0003-0499-4690; Ghazi, Hasanain Faisal/0000-0003-0367-3596; Segers, Patrick/0000-0003-3870-3409; Rocha, Eduardo/0000-0001-7704-822X; Saeed, Anwar/0000-0003-1566-6457; Warman, Jodi/0000-0002-0187-2199; lopez-duran, ana/0000-0001-7661-8972; Chalghaf, Nasr/0000-0002-7693-0234; KWADZOKPUI, PRECIOUS KWABLAH/0000-0001-5044-7773; Kumar, Shiv/0000-0001-8407-3562; Krnjajic, Slobodan B/0000-0001-5278-4589; Wolf, Judith/0000-0001-7106-9142; Nazzal, Zaher Ahmad/0000-0002-2655-6109; Pestana, Jose V./0000-0002-8329-0650; Mirrakhimov, Erkin/0000-0003-2982-6108; Norhayati, Mohd Noor/0000-0002-6372-1476; Elansary, Hosam O./0000-0002-4476-2408; Alemayehu, Mussie/0000-0002-0035-631X				ABDO RA, 2016, J WOMENS HLTH CARE, V57; Adane AA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-90; American College of Obstetric and Gynecology (ACOG), 2016, DEF PRET PREM LAB BI; [Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; Bahareh Darakhshi NE, 2014, IRAN J PUBLIC HEALTH, V43, P8; Bekele I. DT, 2017, S W ETHIOPIA J WOMEN, V6; BelaYnew W., 2015, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V4, P12; Brock EF, 2015, PMC, V70; Central Statistical Agency (CSA), 2016, ETH DEM HLTH SURV IN; Cesar GV., 2010, BMC PREGN CHILDB S1, V10; Chen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099018; Di Renzo GC, 2011, J MATERN-FETAL NEO M, V24, P659, DOI 10.3109/14767058.2011.553694; Federal Minstry of Health, 2013, HLTH HLTH REL IND, V2; Florent Fuchs BM, 2018, PLOS ONE, V13; FMOH (Ethiopia) JSI, 2009, REP NAT SCOP EX NAT; Gebreslasie K., 2016, ADV IN NURSING, V2016; Hannah JL, 2013, LANCET, V381; Joy E, 2010, BMC PREGNANCY CHILDB, V10, P22, DOI [10.1186/1471-2393-10-22, DOI 10.1186/1471-2393-10-22]; Kashef Mona T., 2017, J CHINESE MED ASS; Kentucky F., 2011, FACT SHEET SHORT LON; Mahrokh Dolatian AM, 2014, J REPROD INFERTIL, V15; Maqbool A., 2011, NELSON TXB PEDIAT; March of Dimes WHO, 2016, WHO GLOBAL ACTION RE; Mengesha HG, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3979-8; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332; Sania A., 2017, BMJ-BRIT MED J, V7, P8; Snelgrove WJ, 2015, ACTA OBSTET GYNECOLO; Stay DW, 2010, B WHO, V88; Teklu Sisay, 2006, Ethiop Med J, V44, P17; Tigist B., 2015, GYNECOL OBSTET SUNNY, V5; United Nations, 2018, TRANSF OUR WORLD 203; WHO, 2016, REV FACT SHEET PRET; WHO, 2012, BORN TOO SOON GLOB A, P128; World Health Organization, 2015, EV WOM EV CHILD GLOB; World Health Organization, 2015, WHO RECOMMENDATIONS	36	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0225060	10.1371/journal.pone.0225060	http://dx.doi.org/10.1371/journal.pone.0225060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1IV	31710645	Green Published, gold			2022-12-26	WOS:000532699900040
J	Chagraoui, J; Lehnertz, B; Girard, S; Spinella, JF; Fares, I; Tomellini, E; Mayotte, N; Corneau, S; MacRae, T; Simon, L; Sauvageau, G				Chagraoui, Jalila; Lehnertz, Bernhard; Girard, Simon; Spinella, Jean Francois; Fares, Iman; Tomellini, Elisa; Mayotte, Nadine; Corneau, Sophie; MacRae, Tara; Simon, Laura; Sauvageau, Guy			UM171 induces a homeostatic inflammatory-detoxification response supporting human HSC self-renewal	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; NF-KAPPA-B; ACTIVATED PROTEIN-C; DIFFERENTIATION; EMERGENCE; INFECTION; CYTOKINES; RECEPTOR; REVEALS; SIGNALS	Elucidation of the molecular cues required to balance adult stem cell self-renewal and differentiation is critical for advancing cellular therapies. Herein, we report that the hematopoietic stem cell (HSC) self-renewal agonist UM171 triggers a balanced pro- and anti-inflammatory/detoxification network that relies on NFKB activation and protein C receptor-dependent ROS detoxification, respectively. We demonstrate that within this network, EPCR serves as a critical protective component as its deletion hypersensitizes primitive hematopoietic cells to pro-inflammatory signals and ROS accumulation resulting in compromised stem cell function. Conversely, abrogation of the pro-inflammatory activity of UM171 through treatment with dexamethasone, cAMP elevating agents or NFkB inhibitors abolishes EPCR upregulation and HSC expansion. Together, these results show that UM171 stimulates ex vivo HSC expansion by establishing a critical balance between key pro- and anti-inflammatory mediators of self-renewal.	[Chagraoui, Jalila; Lehnertz, Bernhard; Girard, Simon; Spinella, Jean Francois; Tomellini, Elisa; Mayotte, Nadine; Corneau, Sophie; MacRae, Tara; Simon, Laura; Sauvageau, Guy] Univ Montreal, Inst Res Immunol & Canc IRIC, Mol Genet Stem Cells Lab, Montreal, PQ, Canada; [Fares, Iman] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [Sauvageau, Guy] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada; [Sauvageau, Guy] Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada	Universite de Montreal; University of California System; University of California Los Angeles; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Univ Montreal, Inst Res Immunol & Canc IRIC, Mol Genet Stem Cells Lab, Montreal, PQ, Canada.; Sauvageau, G (corresponding author), Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada.; Sauvageau, G (corresponding author), Univ Montreal, Fac Med, Dept Med, Montreal, PQ, Canada.	guy.sauvageau@umontreal.ca		Lehnertz, Bernhard/0000-0003-1523-1410; Sauvageau, Guy/0000-0002-4333-7266; Corneau, Sophie/0000-0003-0408-3010	Canadian Institutes of Health Research; Stem Cell Network of Canada; Cole Foundation; IVADO scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stem Cell Network of Canada; Cole Foundation; IVADO scholarship	This work was supported by grants from the Canadian Institutes of Health Research and the Stem Cell Network of Canada (G.S.). E. Tomellini and L. Simon were supported by a fellowship from the Cole Foundation. J.F.S was supported by IVADO scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Clapes T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00487; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Espin-Palazon R, 2018, TRENDS CELL BIOL, V28, P58, DOI 10.1016/j.tcb.2017.08.003; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Fang J, 2018, CELL REP, V22, P1250, DOI 10.1016/j.celrep.2018.01.013; Fares I, 2017, BLOOD, V129, P3344, DOI 10.1182/blood-2016-11-750729; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Gazit R, 2014, J EXP MED, V211, P1314, DOI 10.1084/jem.20130428; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gorbacheva L, 2010, NEUROSCIENCE, V165, P1138, DOI 10.1016/j.neuroscience.2009.11.027; Guitton C, 2011, AM J PHYSIOL-CELL PH, V300, pC833, DOI 10.1152/ajpcell.00003.2010; Guo B, 2017, NAT MED, V23, P424, DOI 10.1038/nm.4298; Gur-Cohen S, 2016, ANN NY ACAD SCI, V1370, P65, DOI 10.1111/nyas.13013; He QP, 2016, CURR OPIN HEMATOL, V23, P18, DOI 10.1097/MOH.0000000000000197; He QP, 2015, BLOOD, V125, P1098, DOI 10.1182/blood-2014-09-601542; Herman AC, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.45; Iwaki T, 2005, BLOOD, V105, P2364, DOI 10.1182/blood-2004-06-2456; Kim PG, 2016, BLOOD, V128, P204, DOI 10.1182/blood-2016-01-689281; Levi M, 2007, CRIT CARE, V11, DOI 10.1186/cc6154; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Matatall KA, 2016, CELL REP, V17, P2584, DOI 10.1016/j.celrep.2016.11.031; Matatall KA, 2014, STEM CELLS, V32, P3023, DOI 10.1002/stem.1799; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Seol JW, 2011, INT J MOL MED, V27, P835, DOI 10.3892/ijmm.2011.649; Simon L, 2017, CLIN CANCER RES, V23, P6969, DOI 10.1158/1078-0432.CCR-17-1259; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Talkhoncheh MS, 2018, HAEMATOLOGICA, V103, P1444, DOI 10.3324/haematol.2018.188466; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055552; Zheng SW, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178041; Zuo L, 2016, NEUROSCI LETT, V627, P205, DOI 10.1016/j.neulet.2016.05.066	40	24	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224900	10.1371/journal.pone.0224900	http://dx.doi.org/10.1371/journal.pone.0224900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703090	Green Published, gold			2022-12-26	WOS:000532697200031
J	Luo, Y; Wu, Y; Qian, EF; Wang, Q; Wang, QY; Zhang, HL; Wang, XJ; Zhang, H; Yang, MQ; Ji, JY; Ren, Z; Zhang, Y; Tang, J; Huang, J				Luo, Ya; Wu, Yan; Qian, Enfang; Wang, Qian; Wang, Qiyan; Zhang, Hongling; Wang, Xiaojuan; Zhang, Han; Yang, Meiqing; Ji, Jingyan; Ren, Zheng; Zhang, Ying; Tang, Jing; Huang, Jiang			Population genetic analysis of 36 Y-chromosomal STRs yields comprehensive insights into the forensic features and phylogenetic relationship of Chinese Tai-Kadai-speaking Bouyei	PLOS ONE			English	Article							HAN POPULATION; DEVELOPMENTAL VALIDATION; ETHNIC-MINORITY; HENAN PROVINCE; PLUS KIT; LOCI; HAPLOTYPES; POLYMORPHISMS; MULTIPLEX; CASEWORK	Male-specifically inherited Y-STRs, harboring the features of haploidy and lack of crossing over, have gained considerable attention in population genetics and forensic investigations. Goldeneye (R) Y-PLUS kit was a recently developed amplification system focused on the genetic diversity of 36 Y-chromosomal short tandem repeats (Y-STRs) in East Asians. However, no population data and corresponding forensic features were reported in China. Here, 36 Y-STRs were first genotyped in 400 unrelated healthy Tai-Kadai-speaking Bouyei male individuals. A total of 371 alleles and 396 haplotypes could be detected, and the allelic frequencies ranged from 0.0025 to 0.9875. The haplotype diversity, random match probability and discrimination capacity values were 0.9999, 0.0026 and 0.9900, respectively. The gene diversity (GD) of 36 Y-STR loci in the studied group ranged from 0.0248 (DYS645) to 0.9601 (DYS385a/b). Population comparisons between the Guizhou Bouyei and 80 reference groups were performed via the AMOVA, MDS, and phylogenetic relationship reconstruction. The results showed that the population stratification was almost consistent with the geographic distribution and language-family, both among Chinese and worldwide ethnic groups. Our newly genotyped Bouyei samples show a close affinity with other Tai-Kadai-speaking groups in China and Southeast Asia. Our data may provide useful information for paternal lineage in the forensic application and population genetics, as well as evidence for archaeological and historical research.	[Luo, Ya; Qian, Enfang; Wang, Qiyan; Zhang, Hongling; Wang, Xiaojuan; Zhang, Han; Yang, Meiqing; Ji, Jingyan; Ren, Zheng; Huang, Jiang] Guizhou Med Univ, Dept Forens Med, Guiyang, Guizhou, Peoples R China; [Wu, Yan; Wang, Qian; Zhang, Ying; Tang, Jing] Guiyang Judicial Expertise Ctr Publ Secur, Guiyang, Guizhou, Peoples R China	Guizhou Medical University	Huang, J (corresponding author), Guizhou Med Univ, Dept Forens Med, Guiyang, Guizhou, Peoples R China.; Tang, J (corresponding author), Guiyang Judicial Expertise Ctr Publ Secur, Guiyang, Guizhou, Peoples R China.	33671175@qq.com; mmm_hj@126.com	wang, qi/HGV-1859-2022		National Natural Science Foundation of China [81601650]; Guizhou Province Engineering Technology Research Center Project, Qian High-Tech of Development and Reform Commission [[2016] 1345]; Guizhou Province Scientific and Technical Foundation, Qian Science LH [[2016] 7360]; Guizhou Scientific Support Project, Qian Science Support [[2019] 2825]; Guizhou Education Department Young Scientific and Technical Talents Project, Qian Education KY [[2018]199]; Guiyang Scientific and Technical Foundation, Guiyang Science [[2017] 5-13]; Guizhou Province Scientific and Technical Project, Qian Science SY [[2013]3109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guizhou Province Engineering Technology Research Center Project, Qian High-Tech of Development and Reform Commission; Guizhou Province Scientific and Technical Foundation, Qian Science LH; Guizhou Scientific Support Project, Qian Science Support; Guizhou Education Department Young Scientific and Technical Talents Project, Qian Education KY; Guiyang Scientific and Technical Foundation, Guiyang Science; Guizhou Province Scientific and Technical Project, Qian Science SY	This research was funded by the National Natural Science Foundation of China, 81601650 to ZR; Guizhou Province Engineering Technology Research Center Project, Qian High-Tech of Development and Reform Commission NO. [2016] 1345 to JH; Guizhou Province Scientific and Technical Foundation, Qian Science LH NO. [2016] 7360 to OW; Guizhou Scientific Support Project, Qian Science Support [2019] 2825 to JH; Guizhou Education Department Young Scientific and Technical Talents Project, Qian Education KY NO. [2018]199; Guiyang Scientific and Technical Foundation, Guiyang Science NO. [2017] 5-13; and Guizhou Province Scientific and Technical Project, Qian Science SY NO.[2013]3109 to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferi A, 2018, FORENSIC SCI INT-GEN, V34, pE1, DOI 10.1016/j.fsigen.2018.02.018; [Anonymous], 2018, FORENSIC SCI INT-GEN, V34, pE18, DOI 10.1016/j.fsigen.2018.02.005; Bai RF, 2016, INT J LEGAL MED, V130, P1191, DOI 10.1007/s00414-016-1326-3; Ballantyne KN, 2012, FORENSIC SCI INT-GEN, V6, P208, DOI 10.1016/j.fsigen.2011.04.017; Carracedo A, 2014, FORENSIC SCI INT-GEN, V10, pA1, DOI 10.1016/j.fsigen.2014.01.004; Chen PY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33751-x; D'Atanasio E, 2019, FORENSIC SCI INT-GEN, V38, P185, DOI 10.1016/j.fsigen.2018.11.002; Fan GY, 2019, INT J LEGAL MED, V133, P795, DOI 10.1007/s00414-018-1984-4; Fan HL, 2018, FORENSIC SCI INT-GEN, V37, pE6, DOI 10.1016/j.fsigen.2018.09.008; Fan HL, 2018, FORENSIC SCI INT-GEN, V34, pE20, DOI 10.1016/j.fsigen.2018.01.007; Gopinath S, 2016, FORENSIC SCI INT-GEN, V24, P164, DOI 10.1016/j.fsigen.2016.07.006; Guo F, 2017, FORENSIC SCI INT-GEN, V27, P182, DOI 10.1016/j.fsigen.2016.11.009; Guo Hua, 2008, Legal Medicine, V10, P163, DOI 10.1016/j.legalmed.2007.11.001; Haas C, 2006, FORENSIC SCI INT, V158, P213, DOI 10.1016/j.forsciint.2005.04.036; He GL, 2019, MOL GENET GENOMICS, V294, P1343, DOI 10.1007/s00438-019-01584-6; He GL, 2017, FORENSIC SCI INT-GEN, V31, pE33, DOI 10.1016/j.fsigen.2017.07.006; He GL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13190-w; He GL, 2017, LEGAL MED-TOKYO, V29, P6, DOI 10.1016/j.legalmed.2017.09.001; Iacovacci G, 2017, FORENSIC SCI INT-GEN, V27, P123, DOI 10.1016/j.fsigen.2016.12.015; Jankauskiene J, 2017, FORENS SCI INT-GEN S, V6, pE606, DOI 10.1016/j.fsigss.2017.10.009; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Kayser M, 2017, HUM GENET, V136, P621, DOI 10.1007/s00439-017-1776-9; Lee HY, 2007, INT J LEGAL MED, V121, P128, DOI 10.1007/s00414-006-0130-x; Liu YJ, 2018, FORENSIC SCI INT-GEN, V35, pE7, DOI 10.1016/j.fsigen.2018.04.006; Nei M., 1987, MOL EVOLUTIONARY GEN; Nothnagel M, 2017, HUM GENET, V136, P485, DOI 10.1007/s00439-017-1759-x; Prinz M, 1997, FORENSIC SCI INT, V85, P209, DOI 10.1016/S0379-0738(96)02096-8; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Rapone C, 2016, FORENSIC SCI INT-GEN, V21, pE1, DOI 10.1016/j.fsigen.2015.11.006; Ren Z, 2018, FORENSIC SCI INT-GEN, V33, pE11, DOI 10.1016/j.fsigen.2017.12.001; Song MY, 2019, FORENSIC SCI INT-GEN, V39, pE14, DOI 10.1016/j.fsigen.2018.11.016; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao RY, 2019, FORENSIC SCI INT-GEN, V39, pE10, DOI 10.1016/j.fsigen.2018.11.015; Thompson JM, 2013, FORENSIC SCI INT-GEN, V7, P240, DOI 10.1016/j.fsigen.2012.10.013; Wallace B, 1988, J HEREDITY, V79; Wang JF, 2018, FORENSIC SCI INT-GEN, V33, pE13, DOI 10.1016/j.fsigen.2017.12.014; Wang L, 2016, FORENSIC SCI INT-GEN, V22, pE25, DOI 10.1016/j.fsigen.2016.02.009; Wang Y, 2016, FORENSIC SCI INT-GEN, V21, P5, DOI 10.1016/j.fsigen.2015.09.013; Willuweit S, 2015, FORENSIC SCI INT-GEN, V15, P43, DOI 10.1016/j.fsigen.2014.11.024; Wu WW, 2011, FORENSIC SCI INT-GEN, V5, pE11, DOI 10.1016/j.fsigen.2009.12.005; Zhou YX, 2018, FORENSIC SCI INT-GEN, V32, pE1, DOI 10.1016/j.fsigen.2017.11.003; Zhu Bofeng, 2007, Legal Medicine, V9, P203, DOI 10.1016/j.legalmed.2007.01.003	42	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2019	14	11							e0224601	10.1371/journal.pone.0224601	http://dx.doi.org/10.1371/journal.pone.0224601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1HV	31703068	Green Published, gold			2022-12-26	WOS:000532697200015
J	Catania, S; Bottinelli, M; Fincato, A; Gastaldelli, M; Barberio, A; Gobbo, F; Vicenzoni, G				Catania, Salvatore; Bottinelli, Marco; Fincato, Alice; Gastaldelli, Michele; Barberio, Antonio; Gobbo, Federica; Vicenzoni, Gaddo			Evaluation of Minimum Inhibitory Concentrations for 154 Mycoplasma synoviae isolates from Italy collected during 2012-2017	PLOS ONE			English	Article							VITRO ANTIBIOTIC SUSCEPTIBILITY; RIBOSOMAL-RNA GENE; ANTIMICROBIAL SUSCEPTIBILITY; MACROLIDE-LINCOSAMIDE; MOLECULAR-BASIS; GALLISEPTICUM; RESISTANCE; MUTATIONS; ENROFLOXACIN; HYOPNEUMONIAE	Mycoplasma synoviae (MS) is a highly prevalent bacterial species in poultry causing disease and severe economic losses. Antibiotic treatment is one of the control strategies that can be applied to contain clinical outbreaks in MS-free flocks, especially because this bacterium can be transmitted in ovo. It becomes, then, very important for veterinarians to know the antibiotic susceptibility of the circulating strains in order to choose the most appropriate first-line antibiotic molecule as a proactive role in fighting antibiotic resistance. We evaluated the Minimum Inhibitory Concentrations (MICs) of enrofloxacin, oxytetracycline, doxycycline, erythromycin, tylosin, tilmicosin, spiramycin, tiamulin, florfenicol and lincomycin for MS isolates collected between 2012 and 2017 in Italy. A total of 154 MS isolates from different poultry commercial categories (broiler, layer, and turkey sectors) was tested using commercial MIC plates. All MS isolates showed very high MIC values of erythromycin (MIC90 >= 8 mu g/mL) and enrofloxacin (MIC90 >= 16 mu g/mL). MIC values of doxycycline and oxytetracycline obtained were superimposable to each other with only a one-fold dilution difference. Discrepancies between MIC values of tylosin and tilmicosin were observed. Interestingly, seven isolates showed very high MIC values of lincomycin and tilmicosin, but not all of them showed very high MIC values of tylosin. Most of the MS isolates showed low MIC values of spiramycin, but seven strains showed a MIC >= 16 mu g/mL. In the observation period, the frequency of the different MIC classes varied dependently on the tested antibiotic. Interestingly, tilmicosin MICs clearly showed a time-dependent progressive shift towards high-concentration classes, indicative of an on-going selection process among MS isolates. Until standardized breakpoints become available to facilitate data interpretation, it will be fundamental to continue studying MIC value fluctuations in the meantime in order to create a significant database that would facilitate veterinarians in selecting the proper drug for treating this impactful Mycoplasma.	[Catania, Salvatore; Bottinelli, Marco; Fincato, Alice; Gastaldelli, Michele; Barberio, Antonio; Gobbo, Federica; Vicenzoni, Gaddo] Ist Zooprofilatt Sperimentale Venezie, Viale Univ 10, Legnaro, PD, Italy	IZS delle Venezie	Catania, S (corresponding author), Ist Zooprofilatt Sperimentale Venezie, Viale Univ 10, Legnaro, PD, Italy.	scatania@izsvenezie.it	Barberio, Antonio/ABF-2297-2021; Gobbo, Federica/AHE-8399-2022; Bottinelli, Marco/GOK-1485-2022	Barberio, Antonio/0000-0002-3108-8354; Gobbo, Federica/0000-0001-9233-5737; Bottinelli, Marco/0000-0003-4654-206X; Catania, Salvatore/0000-0003-3258-172X	Italian Ministry of Health [RC IZSVE 15/2010, RC IZSVE 14/2012]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health with the RC IZSVE 15/2010 and RC IZSVE 14/2012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberio A, 2016, J DAIRY SCI, V99, P6578, DOI 10.3168/jds.2015-10572; Bayatzadeh MA, 2014, BRIT POULTRY SCI, V55, P148, DOI 10.1080/00071668.2013.878781; Behbahan N. G. G., 2008, International Journal of Poultry Science, V7, P1058; Bencina D, 2001, FEMS MICROBIOL LETT, V203, P115, DOI 10.1111/j.1574-6968.2001.tb10829.x; Blodgett R., 2010, FDAS BACTERIOLOGICAL; BRADBURY JM, 1994, AVIAN PATHOL, V23, P105, DOI 10.1080/03079459408418978; Brandao M. D. M., 2014, POULTRY SCI, V93, P1775; Catania S, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0680-1; Catania S, 2010, AVIAN DIS, V54, P961, DOI 10.1637/9121-110309-Case.1; Cerda RO, 2002, AVIAN DIS, V46, P215, DOI 10.1637/0005-2086(2002)046[0215:IVASOF]2.0.CO;2; Clincal and Laboratory Standards Institute, 2011, M43A CLSI, V31; Debets-Ossenkopp YJ, 1998, ANTIMICROB AGENTS CH, V42, P2749, DOI 10.1128/AAC.42.10.2749; Dufour-Gesbert F, 2006, VET MICROBIOL, V114, P148, DOI 10.1016/j.vetmic.2005.10.040; Feberwee A, 2009, AVIAN PATHOL, V38, P187, DOI 10.1080/03079450902782017; Fiorentin L, 2003, AVIAN PATHOL, V32, P213, DOI 10.1080/0307945021000071641; Gautier-Bouchardon AV, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0030-2018; Gautier-Bouchardon AV, 2002, VET MICROBIOL, V88, P47, DOI 10.1016/S0378-1135(02)00087-1; Gerchman I, 2008, VET MICROBIOL, V131, P266, DOI 10.1016/j.vetmic.2008.04.006; Giguere S, 2013, ANTIMICROBIAL THERAPY IN VETERINARY MEDICINE, 5TH EDITION, P199; Hammond PP, 2009, VET MICROBIOL, V136, P61, DOI 10.1016/j.vetmic.2008.10.011; Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100; Hannan PCT, 1997, ANTIMICROB AGENTS CH, V41, P2037, DOI 10.1128/AAC.41.9.2037; Hawkey PM, 1998, BRIT MED J, V317, P657, DOI 10.1136/bmj.317.7159.657; Hong YH, 2015, POULTRY SCI, V94, P2364, DOI 10.3382/ps/pev232; Hothorn T, 2008, J STAT SOFTW, V28, P1; Islam KMS, 2009, POULTRY SCI, V88, P2353, DOI 10.3382/ps.2009-00257; Jeon EO, 2014, J VET SCI, V15, P579, DOI 10.4142/jvs.2014.15.4.579; Kaiser GE, 2007, BIOL 230 MICROBIOLOG; Klein U, 2017, VET MICROBIOL, V204, P188, DOI 10.1016/j.vetmic.2017.04.012; Kleven SH, 2008, AVIAN DIS, V52, P367, DOI 10.1637/8323-041808-Review.1; Kreizinger Z, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1266-2; Landman WJM, 2008, AVIAN PATHOL, V37, P415, DOI 10.1080/03079450802216637; Landman WJM, 2014, AVIAN PATHOL, V43, P2, DOI 10.1080/03079457.2014.881049; Le Carrou JM, 2006, VET RES, V37, P145, DOI 10.1051/vetres:2005046; Lysnyansky I, 2013, ANTIMICROB AGENTS CH, V57, P3072, DOI 10.1128/AAC.00203-13; Lysnyansky I, 2015, MICROB DRUG RESIST, V21, P581, DOI 10.1089/mdr.2014.0290; Markey B., 2013, CLIN VET MICROBIOLOG, V2nd ed, P423; Marois C, 2000, VET MICROBIOL, V73, P311, DOI 10.1016/S0378-1135(00)00178-4; McAuliffe L, 2005, J MED MICROBIOL, V54, P731, DOI 10.1099/jmm.0.46058-0; Miller P.J., 2013, DIS POULTRY, V5th ed., P89; Moronato ML, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1669-8; NOEL-FERGUSON N., 2013, DIS POULTRY, P900; Ranck MF, 2010, BERL MUNCH TIERARZTL, V123, P111, DOI 10.2376/0005-9366-123-111; Sacristan RD, 2012, VET J, V194, P420, DOI 10.1016/j.tvjl.2012.04.015; Wand G, 1998, ANTIMICROB AGENTS CH, V42, P1952, DOI 10.1128/AAC.42.8.1952; Wang C, 2001, AVIAN DIS, V45, P456, DOI 10.2307/1592988; Zanella A, 1998, AVIAN PATHOL, V27, P591, DOI 10.1080/03079459808419389	47	16	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224903	10.1371/journal.pone.0224903	http://dx.doi.org/10.1371/journal.pone.0224903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697761	Green Published, gold			2022-12-26	WOS:000532694400079
J	Ghafouri, S; Fathollahi, Y; Semnanian, S; Shojaei, A; Asgari, A; Amini, AE; Mirnajafi-Zadeh, J				Ghafouri, Samireh; Fathollahi, Yaghoub; Semnanian, Saeed; Shojaei, Amir; Asgari, Azam; Amini, Azin Ebrahim; Mirnajafi-Zadeh, Javad			Deep brain stimulation restores the glutamatergic and GABAergic synaptic transmission and plasticity to normal levels in kindled rats	PLOS ONE			English	Article							LOW-FREQUENCY STIMULATION; LONG-TERM POTENTIATION; TEMPORAL-LOBE EPILEPSY; MESSENGER-RNA EXPRESSION; DENTATE GYRUS; GABA(A) RECEPTORS; DYSPLASTIC NEURONS; NMDA-RECEPTORS; UP-REGULATION; SEIZURES	Background The precise effect of low frequency stimulation (LFS) as a newly postulated, anticonvulsant therapeutic approach on seizure-induced changes in synaptic transmission has not been completely determined. Hypothesis In this study, the LFS effect on impaired, synaptic plasticity in kindled rats was investigated. Methods Hippocampal kindled rats received LFS (4 trials consisting of one train of 200 monophasic square waves, 0.1 ms pulse duration, 1 Hz) on four occasions. LTP induction was evaluated using whole-cell recordings of evoked excitatory and inhibitory post-synaptic potentials (EPSPs and IPSPs respectively) in CA1 neurons in hippocampal slices. In addition, the hippocampal excitatory and inhibitory post-synaptic currents (EPSCs and IPSCs), and the gene expression of NR(2)A, GluR(2) and. gamma(2) were evaluated. Results LTP induction was attenuated in excitatory and inhibitory synapses in hippocampal slices of kindled rats. When LFS was applied in kindled animals, LTP was induced in EPSPs and IPSPs. Moreover, LFS increased and decreased the threshold intensities of EPSCs and IPSCs respectively. In kindled animals, NR(2)A gene expression increased, while gamma(2) gene expression decreased. GluR2 gene expression did not significantly change. Applying LFS in kindled animals mitigated these changes: No significant differences were observed in NR(2)A, gamma(2) and GluR(2) gene expression in the kindled+LFS and control groups. Conclusion The application of LFS in kindled animals restored LTP induction in both EPSPs and IPSPs, and returned the threshold intensity for induction of EPSCs, IPSCs and gene expression to similar levels as controls.	[Ghafouri, Samireh; Fathollahi, Yaghoub; Semnanian, Saeed; Shojaei, Amir; Asgari, Azam; Mirnajafi-Zadeh, Javad] Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran; [Asgari, Azam] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Amini, Azin Ebrahim] Univ Toronto, Fac Appl Sci, Dept Biomat & Biomed Engn IBBME, Toronto, ON, Canada; [Mirnajafi-Zadeh, Javad] Tarbiat Modares Univ, Inst Brain Sci & Cognit, Tehran, Iran	Tarbiat Modares University; Universite de Montreal; University of Toronto; Tarbiat Modares University	Mirnajafi-Zadeh, J (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Physiol, Tehran, Iran.; Mirnajafi-Zadeh, J (corresponding author), Tarbiat Modares Univ, Inst Brain Sci & Cognit, Tehran, Iran.	mirnajaf@modares.ac.ir	Mirnajafi-Zadeh, Javad/AAD-4822-2022; Ghafouri, Samireh/B-7438-2018; Shojaei, Amir/ABF-6139-2021; fathollahi, yaghoub/C-1670-2010	Ghafouri, Samireh/0000-0001-5916-143X; fathollahi, yghoub/0000-0002-3695-4805	Tarbiat Modares University, Tehran, Iran [957513]; National Institute for Medical Research Development (NIMAD), Tehran, Iran	Tarbiat Modares University, Tehran, Iran; National Institute for Medical Research Development (NIMAD), Tehran, Iran	This work was supported by a grant (No. IG-37909) from Tarbiat Modares University, Tehran, Iran; and a grant (#957513) from National Institute for Medical Research Development (NIMAD), Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre VM, 2004, CEREB CORTEX, V14, P634, DOI 10.1093/cercor/bhh024; Asgari A, 2014, NEUROL SCI, V35, P1255, DOI 10.1007/s10072-014-1693-9; Ausubel F., 1992, SHORT PROTOCOLS MOL, P232; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bliss TVP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0129; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blumcke I, 2000, J NEUROPATH EXP NEUR, V59, P1; Bonansco C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8607038; CAIN DP, 1989, TRENDS NEUROSCI, V12, P6, DOI 10.1016/0166-2236(89)90146-X; CAIN DP, 1992, EXP NEUROL, V116, P330, DOI 10.1016/0014-4886(92)90011-E; Castillo PE, 2011, CURR OPIN NEUROBIOL, V21, P328, DOI 10.1016/j.conb.2011.01.006; Cifelli P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00108; CINCOTTA M, 1991, EXP BRAIN RES, V85, P650; CLARK M, 1994, MOL BRAIN RES, V26, P309, DOI 10.1016/0169-328X(94)90104-X; Cohen AS, 2003, EUR J NEUROSCI, V17, P1607, DOI 10.1046/j.1460-9568.2003.02597.x; Defazio RA, 2000, J NEUROPHYSIOL, V83, P315, DOI 10.1152/jn.2000.83.1.315; Ekonomou A, 2001, MOL BRAIN RES, V95, P27, DOI 10.1016/S0169-328X(01)00230-3; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Esmaeilpour K, 2013, BASIC CLIN NEUROSCI, V4, P250; Evans MS, 2006, EPILEPSIA, V47, P1655, DOI 10.1111/j.1528-1167.2006.00634.x; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; GAITO J, 1981, CAN J NEUROL SCI, V8, P249, DOI 10.1017/S0317167100043286; Ghafouri S, 2016, EPILEPSY RES, V126, P37, DOI 10.1016/j.eplepsyres.2016.06.010; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Gonzalez MI, 2015, NEUROBIOL DIS, V77, P246, DOI 10.1016/j.nbd.2015.03.001; Goodman JH, 2005, EPILEPSIA, V46, P1, DOI 10.1111/j.0013-9580.2005.03804.x; Halpern C, 2007, PARKINSONISM RELAT D, V13, P1, DOI 10.1016/j.parkreldis.2006.03.001; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Huang CC, 2001, J BIOL CHEM, V276, P48108, DOI 10.1074/jbc.M106388200; Huang L, 2014, NEUROSCIENCE, V277, P383, DOI 10.1016/j.neuroscience.2014.07.015; Jahanshahi A, 2009, EPILEPSIA, V50, P1768, DOI 10.1111/j.1528-1167.2009.02088.x; Joshi S., 2012, JASPERS BASIC MECH E; KAMPHUIS W, 1995, MOL BRAIN RES, V31, P33, DOI 10.1016/0169-328X(95)00022-K; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Keele NB, 2000, J NEUROPHYSIOL, V83, P2458, DOI 10.1152/jn.2000.83.4.2458; Khazipov R, 2015, CNS NEUROSCI THER, V21, P83, DOI 10.1111/cns.12353; Kile KB, 2010, EPILEPSIA, V51, P1745, DOI 10.1111/j.1528-1167.2010.02679.x; Klausnitzer J, 2004, NEUROPHARMACOLOGY, V46, P160, DOI 10.1016/j.neuropharm.2003.09.019; KOHR G, 1994, NEUROSCIENCE, V62, P975, DOI 10.1016/0306-4522(94)90336-0; Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007; Leung L Stan, 2006, Adv Neurol, V97, P63; Loscher W, 2017, NEUROCHEM RES, V42, P1873, DOI 10.1007/s11064-017-2222-z; Lund IV, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162396; Manahan-Vaughan D, 2003, CEREB CORTEX, V13, P123, DOI 10.1093/cercor/13.2.123; Maru E, 2002, EPILEPSIA, V43, P44, DOI 10.1046/j.1528-1157.43.s.9.11.x; Mikuni N, 1999, EPILEPSIA, V40, P1683, DOI 10.1111/j.1528-1157.1999.tb01584.x; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mohammad-Zadeh M, 2007, EPILEPSY RES, V75, P154, DOI 10.1016/j.eplepsyres.2007.05.003; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; O'Dell T J, 1994, Learn Mem, V1, P129; Olsen RW, 1997, EPILEPSIA, V38, P399, DOI 10.1111/j.1528-1157.1997.tb01728.x; Palma E, 2007, P NATL ACAD SCI USA, V104, P20944, DOI 10.1073/pnas.0710522105; RACINE R, 1977, CAN J NEUROL SCI, V4, P273, DOI 10.1017/S0317167100025117; Reid IC, 1997, SEIZURE, V6, P351, DOI 10.1016/S1059-1311(97)80034-9; Schubert M, 2005, LEARN MEMORY, V12, P520, DOI 10.1101/lm.4205; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Suarez LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048128; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TITULAER MNG, 1995, J NEUROCHEM, V64, P2615; Vizi ES, 1998, HIPPOCAMPUS, V8, P566, DOI 10.1002/(SICI)1098-1063(1998)8:6<566::AID-HIPO2>3.0.CO;2-W; WEISS SRB, 1995, NEUROREPORT, V6, P2171, DOI 10.1097/00001756-199511000-00018; White R, 2001, ANN NEUROL, V49, P67, DOI 10.1002/1531-8249(200101)49:1<67::AID-ANA10>3.0.CO;2-L; Woodin MA, 2010, SPRINGER SCI BUSINES; Yamamoto J, 2002, EPILEPSIA, V43, P491, DOI 10.1046/j.1528-1157.2002.29001.x; YEH GC, 1989, P NATL ACAD SCI USA, V86, P8157, DOI 10.1073/pnas.86.20.8157; Ying Z, 1998, J NEUROPATH EXP NEUR, V57, P47; ZENG X, 1995, NEUROSCIENCE, V66, P87, DOI 10.1016/0306-4522(94)00558-M; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	69	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224834	10.1371/journal.pone.0224834	http://dx.doi.org/10.1371/journal.pone.0224834			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697763	Green Published, gold			2022-12-26	WOS:000532694400067
J	Selvaraja, M; Abdullah, M; Arip, M; Chin, VK; Shah, A; Nordin, SA				Selvaraja, Malarvili; Abdullah, Maha; Arip, Masita; Chin, Voon Kin; Shah, Anim; Nordin, Syafinaz Amin			Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis	PLOS ONE			English	Article							DISEASE-ACTIVITY; T-CELLS; IL-4; BASOPHILS; SERUM; EXPRESSION; ONSET; IGE	Systemic lupus erythematosus (SLE) is an autoimmune disorder that is associated with lupus nephritis, initiated by the deposition of immune complexes in the kidney; subsequently, this induces the overexpression of cytokines. Lupus nephritis is known as one of the major clinical manifestations that affect the disease severity in SLE patients. An increased number of resident periglomerular and immune cells in the kidney has the potential to affect the equilibrium of different immune cell subsets, such as Th1, Th2, Th17, and Tregs, which may be central to the induction of tissue damage in kidney by exerting either proinflammatory or anti-inflammatory effects, or both. This equilibrium has yet to be confirmed, as new players such as IL-25 remain undiscovered. IL-25 is a cytokine of the IL-17 family, which stimulates Th2-mediated immune response when overly expressed. Thus, the aim of this research is to determine the plasma levels of IL-25 and Th2-associated cytokines (IL-4, IL-5, IL-6, IL-9, IL-10, IL-13) in SLE patients with (SLE-LN) and without lupus nephritis. Sixty-four (n = 64) SLE patients and fifteen (n = 15) healthy individuals were recruited. This study demonstrated that the IL-9, IL-10 and IL-25 had significantly increased expressions in SLE-LN, followed by SLE without LN, compared to healthy controls. Meanwhile, IL-5 and IL6 had significantly reduced. No significant difference was observed with IL-13, while the level of IL-4 was undetectable. Furthermore, IL-9 and IL-10 were significantly correlated with the IL-25, and IL-25, IL-9 and IL-10 were positively correlated with the disease severity score, SLEDAI. In conclusion, IL-25 and its associated Th2 cytokines (IL-9 and IL-10) may be involved in SLE pathogenesis. These cytokines could be potential biomarkers in monitoring and predicting the disease severity during SLE pathogenesis.	[Selvaraja, Malarvili; Abdullah, Maha] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Pathol, Serdang, Selangor, Malaysia; [Arip, Masita] Allergy & Immunol Res Ctr, Inst Med Res, Jalan Pahang, Kuala Lumpur, Malaysia; [Chin, Voon Kin] Taylors Univ, Sch Biosci, 1 Jalan Taylors, Subang Jaya, Selangor, Malaysia; [Shah, Anim] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med, Serdang, Selangor, Malaysia; [Nordin, Syafinaz Amin] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Kementerian Kesihatan Malaysia; Taylor's University; Universiti Putra Malaysia; Universiti Putra Malaysia	Nordin, SA (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Serdang, Selangor, Malaysia.	syafinaz@upm.edu.my	Nordin, Syafinaz Amin/AAY-9727-2021; Selvaraja, Malarvili/AAF-6349-2021	Selvaraja, Malarvili/0000-0002-8085-3585; Amin Nordin., Syafinaz/0000-0002-6054-2368	Ministry of Higher Education, Malaysia [FRGS/2/2013/SKK01/UPM/02/8, 5524400]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This study was supported by funding from the Ministry of Higher Education, Malaysia, FRGS/2/2013/SKK01/UPM/02/8, with the Grant No. 5524400. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Director General (DG) of Health Malaysia for his permission to publish this paper. We would also like to thank all staff in the Nephrology Unit, Hospital Serdang; and Immunology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia for their excellent assistance throughout this research.	Angkasekwinai P, 2013, INFECT IMMUN; Atta AM, 2004, BRAZ J MED BIOL RES, V37, P1497, DOI 10.1590/S0100-879X2004001000008; Bayry J, 2016, CELL RES, V26, P271, DOI 10.1038/cr.2016.12; Bosch X, 2011, J IMMUNOL, V186, P6083, DOI 10.4049/jimmunol.1002648; Brugos B, 2012, PHARMAZIE, V67, P411, DOI 10.1691/ph.2012.1694; Carneiro JRM, 2011, CLINICS, V66, P77, DOI 10.1590/S1807-59322011000100014; Charles N, 2011, CURR ALLERGY ASTHM R, V11, P378, DOI 10.1007/s11882-011-0216-5; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Dalia AN, 2018, J CLIN IMMUNOLOGY RE, V1, P1; Doria A, 2004, ARTHRIT RHEUM-ARTHR, V51, P989, DOI 10.1002/art.20837; FALLON PG, 2006, J EXP MED, V203, P1105, DOI DOI 10.1084/JEM.20051615; Ferretti C, 2016, BOOK CHAPTER, V55, P62; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Godsell J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34604; Gossner A, 2011, VET IMMUNOL IMMUNOP, V139, P319, DOI 10.1016/j.vetimm.2010.10.019; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Kasama S, 2016, CLIN MED INSIGHTS-AR, V9, P1, DOI 10.4137/CMAMD.S37477; Khan IH, 2009, CYTOM PART B-CLIN CY, V76B, P159, DOI 10.1002/cyto.b.20452; Liu CC, 2013, THER ADV MUSCULOSKEL, V5, P210, DOI 10.1177/1759720X13485503; McCarthy EM, 2014, RHEUMATOLOGY, V53, P1586, DOI 10.1093/rheumatology/ket428; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; Narayanan K, 2010, Med J Armed Forces India, V66, P102, DOI 10.1016/S0377-1237(10)80118-2; Ouyang H, 2013, MOL MED REP, V7, P1031, DOI 10.3892/mmr.2013.1258; Peterson E, 1996, LUPUS, V5, P571, DOI 10.1177/096120339600500603; Petri M, 1999, LUPUS, V8, P685, DOI 10.1191/096120399680411281; Ran C., 2012, CHINESE J RHEUMATOLO, V32; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Sewell WA, 1998, CLIN DIAGN LAB IMMUN, V5, P18, DOI 10.1128/CDLI.5.1.18-23.1998; Shaharir SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166270; Sharma M, 2015, NAT REV RHEUMATOL, V11, P129, DOI 10.1038/nrrheum.2014.199; Sigdel Keshav Raj, 2016, MEDIAT INFLAMM, V2016, P1, DOI DOI 10.1155/2016/4927530; Takatsu K., P JAPAN ACAD B, V87, P463; Uhm WS, 2003, RHEUMATOLOGY, V42, P935, DOI 10.1093/rheumatology/keg255; van der Linden MW, 2001, ANN RHEUM DIS, V60, P237, DOI 10.1136/ard.60.3.237; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Wu L. H., 2015, SCI REP, V5, P1, DOI DOI 10.1038/srep12975; Yap DYH, 2015, KIDNEY DIS-BASEL, V1, P100, DOI 10.1159/000430458; Yap DYH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/365083; Yin ZH, 2014, CENT EUR J IMMUNOL, V39, P228, DOI 10.5114/ceji.2014.43728	43	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224707	10.1371/journal.pone.0224707	http://dx.doi.org/10.1371/journal.pone.0224707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697750	gold, Green Published, Green Accepted			2022-12-26	WOS:000532694400046
J	Smeets, JSJ; Horstman, AMH; Vles, GF; Emans, PJ; Goessens, JPB; Gijsen, AP; van Kranenburg, JMX; van Loon, LJC				Smeets, Joey S. J.; Horstman, Astrid M. H.; Vles, Georges F.; Emans, Pieter J.; Goessens, Joy P. B.; Gijsen, Annemie P.; van Kranenburg, Janneau M. X.; van Loon, Luc J. C.			Protein synthesis rates of muscle, tendon, ligament, cartilage, and bone tissue in vivo in humans	PLOS ONE			English	Article							GROWTH-FACTOR-I; COLLAGEN-SYNTHESIS; SKELETAL-MUSCLE; QUADRICEPS MUSCLE; BASAL; EXERCISE; SUPPLEMENTATION; IMMOBILIZATION; HYDROLYSATE; INGESTION	Skeletal muscle plasticity is reflected by a dynamic balance between protein synthesis and breakdown, with basal muscle tissue protein synthesis rates ranging between 0.02 and 0.09%/h. Though it is evident that other musculoskeletal tissues should also express some level of plasticity, data on protein synthesis rates of most of these tissues in vivo in humans is limited. Six otherwise healthy patients (62 +/- 3 y), scheduled to undergo unilateral total knee arthroplasty, were subjected to primed continuous intravenous infusions with L-[ring-C-13(6)]-Phenylalanine throughout the surgical procedure. Tissue samples obtained during surgery included muscle, tendon, cruciate ligaments, cartilage, bone, menisci, fat, and synovium. Tissue-specific fractional protein synthesis rates (%/h) were assessed by measuring the incorporation of L-[ring-C-13(6)]-Phenylalanine in tissue protein and were compared with muscle tissue protein synthesis rates using a paired t test. Tendon, bone, cartilage, Hoffa's fat pad, anterior and posterior cruciate ligament, and menisci tissue protein synthesis rates averaged 0.06 +/- 0.01, 0.03 +/- 0.01, 0.04 +/- 0.01, 0.11 +/- 0.03, 0.07 +/- 0.02, 0.04 +/- 0.01, and 0.04 +/- 0.01%/h, respectively, and did not significantly differ from skeletal muscle protein synthesis rates (0.04 +/- 0.01%/h; P>0.05). Synovium derived protein (0.13 +/- 0.03%/h) and intercondylar notch bone tissue protein synthesis rates (0.03 +/- 0.01%/h) were respectively higher and lower compared to skeletal muscle protein synthesis rates (P<0.05 and P<0.01, respectively). Basal protein synthesis rates in various musculoskeletal tissues are within the same range of skeletal muscle protein synthesis rates, with fractional muscle, tendon, bone, cartilage, ligament, menisci, fat, and synovium protein synthesis rates ranging between 0.02 and 0.13% per hour in vivo in humans. Clinical trial registration: NTR5147	[Smeets, Joey S. J.; Horstman, Astrid M. H.; Goessens, Joy P. B.; Gijsen, Annemie P.; van Kranenburg, Janneau M. X.; van Loon, Luc J. C.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands; [Vles, Georges F.; Emans, Pieter J.] Maastricht Univ, Med Ctr, Dept Orthoped Surg, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	van Loon, LJC (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands.	L.vanLoon@maastrichtuniversity.nl	van Loon, Luc J C/G-5920-2010; van Loon, Luc J.C./ABG-9158-2020	van Loon, Luc J C/0000-0002-6768-9231; van Loon, Luc J.C./0000-0002-6768-9231; Smeets, Joey/0000-0003-2877-0114; Horstman, Astrid/0000-0003-4866-7368				Abrams SA, 2003, HORM RES, V60, P71, DOI 10.1159/000074505; Baar K, 2017, SPORTS MED, V47, pS5, DOI 10.1007/s40279-017-0719-x; Babraj JA, 2005, AM J PHYSIOL-ENDOC M, V289, pE864, DOI 10.1152/ajpendo.00243.2005; Babraj JA, 2005, J BONE MINER RES, V20, P930, DOI 10.1359/JBMR.050201; Bailey AJ, 1999, CALCIFIED TISSUE INT, V65, P203, DOI 10.1007/s002239900683; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bryceland JK, 2017, CARTILAGE, V8, P99, DOI 10.1177/1947603516654945; Burd NA, 2012, METABOLISM, V61, P931, DOI 10.1016/j.metabol.2011.11.004; Burd Nicholas A, 2011, Nutr Metab (Lond), V8, P15, DOI 10.1186/1743-7075-8-15; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; CHESLEY A, 1992, J APPL PHYSIOL, V73, P1383, DOI 10.1152/jappl.1992.73.4.1383; Clark KL, 2008, CURR MED RES OPIN, V24, P1485, DOI 10.1185/030079908X291967 ; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; DEITRICK JE, 1948, B NEW YORK ACAD MED, V24, P364; Dideriksen K, 2017, J APPL PHYSIOL, V122, P273, DOI 10.1152/japplphysiol.00809.2015; Dideriksen K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-109; Doessing S, 2010, J PHYSIOL-LONDON, V588, P341, DOI 10.1113/jphysiol.2009.179325; Ene R, 2015, ROM J MORPHOL EMBRYO, V56, P169; Finni T, 2000, EUR J APPL PHYSIOL, V83, P416, DOI 10.1007/s004210000289; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Gorissen SHM, 2017, AM J CLIN NUTR, V105, P332, DOI 10.3945/ajcn.115.129924; Gorissen SHM, 2016, J NUTR, V146, P1651, DOI 10.3945/jn.116.231340; Hansen M, 2013, SCAND J MED SCI SPOR, V23, P614, DOI 10.1111/j.1600-0838.2011.01431.x; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Heinemeier KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8335; Hursel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137183; INGEMANNHANSEN T, 1980, SCAND J REHABIL MED, V12, P27; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; KOHN D, 1995, ARCH ORTHOP TRAUM SU, V114, P72, DOI 10.1007/BF00422828; Kouw IWK, 2015, J CLIN ENDOCR METAB, V100, P3103, DOI 10.1210/jc.2015-1234; Kramer IF, 2017, CLIN NUTR, V36, P1440, DOI 10.1016/j.clnu.2016.09.023; Magnusson SP, 2016, ADV EXP MED BIOL, V920, P11, DOI 10.1007/978-3-319-33943-6_2; Majewski M, 2006, KNEE, V13, P184, DOI 10.1016/j.knee.2006.01.005; Marenzana M, 2013, BONE RES, V1, P203, DOI 10.4248/BR201303001; McAlindon TE, 2011, OSTEOARTHR CARTILAGE, V19, P399, DOI 10.1016/j.joca.2011.01.001; Miller BF, 2007, J APPL PHYSIOL, V102, P541, DOI 10.1152/japplphysiol.00797.2006; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; MUNDY GR, 1987, BONE, V8, pS9; NEMSCHAK G, 2012, ANAT RES INT, V2012; Nielsen RH, 2014, J APPL PHYSIOL, V117, P694, DOI 10.1152/japplphysiol.00157.2014; Nielsen RH, 2014, J APPL PHYSIOL, V116, P42, DOI 10.1152/japplphysiol.01084.2013; Nielsen RH, 2011, GROWTH HORM IGF RES, V21, P140, DOI 10.1016/j.ghir.2011.03.006; Paxton JZ, 2010, TISSUE ENG PT A, V16, P3515, DOI [10.1089/ten.tea.2010.0039, 10.1089/ten.TEA.2010.0039]; Petersen SG, 2011, MED SCI SPORT EXER, V43, P425, DOI 10.1249/MSS.0b013e3181f27375; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; RENNIE MJ, 1994, AM J PHYSIOL, V266, pE298, DOI 10.1152/ajpendo.1994.266.3.E298; Saddik D, 2004, SKELETAL RADIOL, V33, P433, DOI 10.1007/s00256-003-0724-z; Shaw G, 2017, AM J CLIN NUTR, V105, P136, DOI 10.3945/ajcn.116.138594; Shelbourne KD, 2015, AM J SPORT MED, V43, P648, DOI 10.1177/0363546514560877; Smeets JSJ, 2018, BRAIN, V141, DOI 10.1093/brain/awy015; Smith Malcolm D, 2011, Open Rheumatol J, V5, P100, DOI 10.2174/1874312901105010100; Travascio F, 2017, J BIOMECH, V61, P151, DOI 10.1016/j.jbiomech.2017.07.019; Vieira CP, 2015, ANAT REC, V298, P538, DOI 10.1002/ar.23041; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Wall BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140903; Waterlow JC, 2006, PROTEIN TURNOVER, P1; Yang Y, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-57; Yang YF, 2012, BRIT J NUTR, V108, P1780, DOI 10.1017/S0007114511007422; Zioupos P, 2001, J BIOMATER APPL, V15, P187, DOI 10.1106/5JUJ-TFJ3-JVVA-3RJ0	62	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224745	10.1371/journal.pone.0224745	http://dx.doi.org/10.1371/journal.pone.0224745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697717	gold, Green Published			2022-12-26	WOS:000532694400055
J	Webb, ALM; Hibbard, PB				Webb, Abigail L. M.; Hibbard, Paul B.			The effect of facial expression on contrast sensitivity: A behavioural investigation and extension of Hedger, Adams & Garner (2015)	PLOS ONE			English	Article							SPATIAL-FREQUENCY; FEARFUL FACES; LOW-LEVEL; PERCEPTION; AWARENESS; MODULATE	It has been argued that rapid visual processing for fearful face expressions is driven by the fact that effective contrast is higher in these faces compared to other expressions, when the contrast sensitivity function is taken into account. This proposal has been upheld by data from image analyses, but is yet to be tested at the behavioural level. The present study conducts a traditional contrast sensitivity task for face images of various facial expressions. Findings show that visual contrast thresholds do not differ for different facial expressions We re-conduct analysis of faces' effective contrast, using the procedure developed by Hedger, Adams and Garner, and show that higher effective contrast in fearful face expressions relies on face images first being normalised for RMS contrast. When not normalised for RMS contrast, effective contrast in fear expressions is no different, or sometimes even lower, compared to other expressions. However, the effect of facial expression on detection in a backward masking study did not depend on the type of contrast normalisation used. These findings are discussed in relation to the implications of contrast normalisation on the salience of face expressions in behavioural and neurophysiological experiments, and also the extent that natural physical differences between facial stimuli are masked during stimulus standardisation and normalisation.	[Webb, Abigail L. M.; Hibbard, Paul B.] Univ Essex, Dept Psychol, Colchester, Essex, England	University of Essex	Webb, ALM (corresponding author), Univ Essex, Dept Psychol, Colchester, Essex, England.	awebbc@essex.ac.uk		Hibbard, Paul/0000-0001-6133-6729; Webb, Abigail/0000-0001-9522-8355	 [ES/J500045/1]; ESRC [ES/T009098/1] Funding Source: UKRI	; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was conducted as part of an Economic and Social Research Council-funded PhD (https://esrc.ukri.org/).This funding was awarded to AW, grant number: ES/J500045/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman RL, 2012, EMOTION, V12, P1384, DOI 10.1037/a0028677; Bayle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021584; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carlson JM, 2008, EMOTION, V8, P522, DOI 10.1037/a0012653; Ekman P., 1976, PICTURES FACIAL AFFE; Gray KLH, 2013, EMOTION, V13, P537, DOI 10.1037/a0031403; Hedger N, 2015, J EXP PSYCHOL HUMAN, V41, P1748, DOI 10.1037/xhp0000127; Holmes A, 2005, COGNITION EMOTION, V19, P899, DOI 10.1080/02699930441000454; Horstmann G, 2006, EMOTION, V6, P193, DOI 10.1037/1528-3542.6.2.193; [Innocent M On Semiconductor Trading Ltd], 2011, United States patent, Patent No. [US 8,049,789, 8049789]; Kleiner M, 2007, PERCEPTION, V36, P14; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lundqvist D, 1998, KAROLINSKA DIRECTED, P630, DOI DOI 10.1080/02699930701626582; Menzel C, 2018, ACTA PSYCHOL, V188, P74, DOI 10.1016/j.actpsy.2018.05.012; O'Hare L, 2011, VISION RES, V51, P1767, DOI 10.1016/j.visres.2011.06.002; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Phelps E.A., 1993, HDB EMOTIONS, V109, P118; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Prins N, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01250; Stein T, 2014, PSYCHOL SCI, V25, P566, DOI 10.1177/0956797613512509; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Troiani V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00241; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Watson AB, 2005, J VISION, V5, P717, DOI 10.1167/5.9.6; Whalen PJ, 1998, J NEUROSCI, V18, P411; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yanof A, 2007, United States patent, Patent No. [US 7,236,190, 7236190]	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0205621	10.1371/journal.pone.0205621	http://dx.doi.org/10.1371/journal.pone.0205621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1FJ	31693664	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000532690100001
J	McNamar, R; Abu-Adas, Z; Rothblum, K; Knutson, BA; Rothblum, LI				McNamar, Rachel; Abu-Adas, Zakaria; Rothblum, Katrina; Knutson, Bruce A.; Rothblum, Lawrence, I			Conditional depletion of the RNA polymerase I subunit PAF53 reveals that it is essential for mitosis and enables identification of functional domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						auxin; nucleolus; RNA polymerase I; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); DNA-binding protein	SACCHAROMYCES-CEREVISIAE ENCODES; RIBOSOMAL DNA-TRANSCRIPTION; GROWTH-DEPENDENT REGULATION; CELL-CYCLE; TIF-IA; RDNA TRANSCRIPTION; FACTOR UBF; PREINITIATION COMPLEX; PROTEIN-STRUCTURE; A49 SUBUNIT	Our knowledge of the mechanism of rDNA transcription has benefited from the combined application of genetic and biochemical techniques in yeast. Nomura's laboratory (Nogi, Y., Vu, L., and Nomura, M. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 7026?7030 and Nogi, Y., Yano, R., and Nomura, M. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 3962?3966) developed a system in yeast to identify genes essential for ribosome biogenesis. Such systems have allowed investigators to determine whether a gene was essential and to determine its function in rDNA transcription. However, there are significant differences in both the structures and components of the transcription apparatus and the patterns of regulation between mammals and yeast. Thus, there are significant deficits in our understanding of mammalian rDNA transcription. We have developed a system combining CRISPR/Cas9 and an auxin-inducible degron that enables combining a ?genetics-like?approach with biochemistry to study mammalian rDNA transcription. We now show that the mammalian orthologue of yeast RPA49, PAF53, is required for rDNA transcription and mitotic growth. We have studied the domains of the protein required for activity. We have found that the C-terminal, DNA-binding domain (tandem-winged helix), the heterodimerization, and the linker domain were essential. Analysis of the linker identified a putative helix?turn?helix (HTH) DNA-binding domain. This HTH constitutes a second DNA-binding domain within PAF53. The HTH of the yeast and mammalian orthologues is essential for function. In summary, we show that an auxin-dependent degron system can be used to rapidly deplete nucleolar proteins in mammalian cells, that PAF53 is necessary for rDNA transcription and cell growth, and that all three PAF53 domains are necessary for its function.	[McNamar, Rachel; Abu-Adas, Zakaria; Rothblum, Katrina; Rothblum, Lawrence, I] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Knutson, Bruce A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Rothblum, LI (corresponding author), Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73104 USA.	Irothblu@ouhsc.edu		McNamar, Rachel/0000-0001-5422-5617	National Institutes of Health [GM069841, HL077814, 5R03DE027785]; OCAST Grant [HR15-166]; Carol Baldwin Research Foundation; University of Oklahoma; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE027785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCAST Grant; Carol Baldwin Research Foundation; University of Oklahoma; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants GM069841 (to L. I. R.), HL077814 (to L. I. R.), and 5R03DE027785 (to B. A. K.), OCAST Grant HR15-166 (to L. I. R.), the Carol Baldwin Research Foundation (to B. A. K.), and by the University of Oklahoma (to L. I. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera J, 2007, FEMS MICROBIOL REV, V31, P327, DOI 10.1111/j.1574-6976.2007.00066.x; Albert B, 2016, MOL CELL, V64, P720, DOI 10.1016/j.molcel.2016.10.003; Aprikian P, 2001, MOL CELL BIOL, V21, P4847, DOI 10.1128/MCB.21.15.4847-4855.2001; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Bertomeu T, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00302-17; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bier M, 2004, FEBS LETT, V564, P41, DOI 10.1016/S0014-5793(04)00311-4; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; Bodem J, 2000, EMBO REP, V1, P171, DOI 10.1093/embo-reports/kvd032; BURGESSCASSLER A, 1989, CLIN CHEM, V35, P2297; BUSCH H, 1963, CANCER RES, V23, P313; BUTTGEREIT D, 1985, NUCLEIC ACIDS RES, V13, P8165, DOI 10.1093/nar/13.22.8165; Cavanaugh AH, 2002, J BIOL CHEM, V277, P27423, DOI 10.1074/jbc.M201232200; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Cavanaugh AH, 2008, GENE EXPRESSION, V14, P131; Chedin S, 2007, CELL CYCLE, V6, P11, DOI 10.4161/cc.6.1.3649; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; Donati G, 2011, ONCOGENE, V30, P3274, DOI 10.1038/onc.2011.48; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Engel C, 2017, CELL, V169, P120, DOI 10.1016/j.cell.2017.03.003; Engel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12129; Farley KI, 2015, CHROMOSOMA, V124, P323, DOI 10.1007/s00412-015-0507-z; Farley-Barnes KI, 2018, CELL REP, V22, P1923, DOI 10.1016/j.celrep.2018.01.056; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Filby A, 2016, METHODS MOL BIOL, P71, DOI 10.1007/978-1-4939-3302-0_5; Fumagalli S, 2011, SEMIN HEMATOL, V48, P97, DOI 10.1053/j.seminhematol.2011.02.004; Gadal O, 1997, MOL CELL BIOL, V17, P1787, DOI 10.1128/MCB.17.4.1787; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Ganapathi KA, 2008, BRIT J HAEMATOL, V141, P376, DOI 10.1111/j.1365-2141.2008.07095.x; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Green MR, 2012, MOL CLONING LAB MANU, V1; Hamdane N, 2015, ONCOTARGET, V6, P27519, DOI 10.18632/oncotarget.4823; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; Hanada K, 1996, EMBO J, V15, P2217, DOI 10.1002/j.1460-2075.1996.tb00575.x; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; Hannan KM, 2000, ONCOGENE, V19, P3487, DOI 10.1038/sj.onc.1203690; Hannan KM, 1998, AM J PHYSIOL-CELL PH, V275, pC130, DOI 10.1152/ajpcell.1998.275.1.C130; Hannan KM, 1998, FRONT BIOSCI, V3, P376, DOI [10.2741/A282, DOI 10.2741/A282]; Hannan RD, 1998, J BIOL CHEM, V273, P1257, DOI 10.1074/jbc.273.2.1257; Hannan RD, 2013, EXPERT OPIN THER TAR, V17, P873, DOI 10.1517/14728222.2013.818658; Hayashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098586; Hirschler-Laszkiewicz I, 2003, J BIOL CHEM, V278, P18953, DOI 10.1074/jbc.M301093200; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Hu T, 2009, BIOTECHNOL LETT, V31, P353, DOI 10.1007/s10529-008-9882-3; HUET J, 1975, P NATL ACAD SCI USA, V72, P3034, DOI 10.1073/pnas.72.8.3034; Hung SS, 2017, GENE, V612, P36, DOI 10.1016/j.gene.2016.12.015; Jackobel AJ, 2018, TRANSCR-AUSTIN, V9, P255, DOI 10.1080/21541264.2017.1416268; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Kanke M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-8; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; KEYS DA, 1994, GENE DEV, V8, P2349, DOI 10.1101/gad.8.19.2349; Keys DA, 1996, GENE DEV, V10, P887, DOI 10.1101/gad.10.7.887; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; LILJELUND P, 1992, P NATL ACAD SCI USA, V89, P9302, DOI 10.1073/pnas.89.19.9302; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Ma HH, 2013, MOL BIOL CELL, V24, P1334, DOI 10.1091/mbc.E12-12-0881; Mahata B, 2012, ONCOGENE, V31, P3060, DOI 10.1038/onc.2011.482; Maraschin FD, 2009, PLANT J, V59, P100, DOI 10.1111/j.1365-313X.2009.03854.x; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; Montgomery T. S. H., 1898, J MORPHOL, V15, P265, DOI DOI 10.1002/JMOR.1050150204; Moorefield B, 2000, P NATL ACAD SCI USA, V97, P4724, DOI 10.1073/pnas.080063997; Morgado-Palacin L, 2014, CARCINOGENESIS, V35, P2822, DOI 10.1093/carcin/bgu220; Nakagawa K, 2003, GENES GENET SYST, V78, P199, DOI 10.1266/ggs.78.199; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P7026, DOI 10.1073/pnas.88.16.7026; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; NOGI Y, 1993, MOL CELL BIOL, V13, P114, DOI 10.1128/MCB.13.1.114; Penrod Y, 2015, GENE, V556, P61, DOI 10.1016/j.gene.2014.09.022; Penrod Y, 2012, BIOCHEMISTRY-US, V51, P6519, DOI 10.1021/bi300408q; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Philippi A, 2010, NUCLEIC ACIDS RES, V38, P5315, DOI 10.1093/nar/gkq264; Pianese G., 1896, BEITR PATHOL ANAT AL, V142, P1; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Rebello RJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020071; Rebello RJ, 2016, CLIN CANCER RES, V22, P5539, DOI 10.1158/1078-0432.CCR-16-0124; RIGGS DL, 1995, J BIOL CHEM, V270, P6205, DOI 10.1074/jbc.270.11.6205; Rothblum K, 2014, MOL CANCER RES, V12, P1586, DOI 10.1158/1541-7786.MCR-14-0229; Rothblum LI, 2017, GENE, V612, P55, DOI 10.1016/j.gene.2016.12.023; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russo A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010140; Sakai D, 2009, INT J BIOCHEM CELL B, V41, P1229, DOI 10.1016/j.biocel.2008.10.026; Sambrook J., 2006, CONDENSED PROTOCOLS; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schlosser A, 2002, PROTEOMICS, V2, P911, DOI 10.1002/1615-9861(200207)2:7<911::AID-PROT911>3.0.CO;2-K; SCHNAPP A, 1990, EMBO J, V9, P2857, DOI 10.1002/j.1460-2075.1990.tb07475.x; Schneider DA, 2004, P NATL ACAD SCI USA, V101, P15112, DOI 10.1073/pnas.0406746101; Seither P, 1997, CHROMOSOMA, V106, P216, DOI 10.1007/s004120050242; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Stepanchick A, 2013, J BIOL CHEM, V288, P9135, DOI 10.1074/jbc.M112.444265; Stephan F, 2004, J BIOL CHEM, V279, P25251, DOI 10.1074/jbc.M401867200; Tafur L, 2019, ELIFE, V8, DOI 10.7554/eLife.43204; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Taylor NMI, 2013, NUCLEIC ACIDS RES, V41, P9183, DOI 10.1093/nar/gkt664; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16273; Warner JR, 2015, RNA, V21, P758, DOI 10.1261/rna.050435.115; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wei YY, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00105-17; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; Yamamoto K, 2004, MOL CELL BIOL, V24, P6338, DOI 10.1128/MCB.24.14.6338-6349.2004; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yuan FW, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0572-3; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; Zatsepina OV, 2000, DEV BIOL, V223, P354, DOI 10.1006/dbio.2000.9762; Zhang LY, 2015, DEVELOPMENT, V142, P4374, DOI 10.1242/dev.129635; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao QS, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0369-1	126	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19907	19922		10.1074/jbc.RA119.009902	http://dx.doi.org/10.1074/jbc.RA119.009902			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31727736	Green Published, hybrid			2022-12-26	WOS:000505005800008
J	Chen, JH; Zhang, J; Shaik, NF; Yi, B; Wei, X; Yang, XF; Naik, UP; Summer, R; Yan, GJ; Xu, XY; Sun, JX				Chen, Jihui; Zhang, Jian; Shaik, Noor F.; Yi, Bing; Wei, Xin; Yang, Xiao-Feng; Naik, Ulhas P.; Summer, Ross; Yan, Guijun; Xu, Xinyun; Sun, Jianxin			The histone deacetylase inhibitor tubacin mitigates endothelial dysfunction by up-regulating the expression of endothelial nitric oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial dysfunction; endothelium; nitric oxide synthase; nitric oxide; gene regulation; diabetes; histone acetylase; endothelial cells; endothelial nitric oxide synthase (eNOS); cytoskeleton; histone deacetylase 6 (HDCA6); stroke; cardiovascular disorder; tubulin acetylation inducer (tubacin); inflammation	MESSENGER-RNA STABILITY; TRACT-BINDING PROTEIN; POSTTRANSCRIPTIONAL REGULATION; BLOOD-FLOW; CEREBRAL-ISCHEMIA; HDAC6 INHIBITOR; DOWN-REGULATION; SHEAR-STRESS; MICE; TUBULIN	Endothelial nitric oxide (NO) synthase (eNOS) plays a critical role in the maintenance of blood vessel homeostasis. Recent findings suggest that cytoskeletal dynamics play an essential role in regulating eNOS expression and activation. Here, we sought to test whether modulation of cytoskeletal dynamics through pharmacological regulation of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation affects eNOS expression and endothelial function in vitro and in vivo. We found that tubulin acetylation inducer (tubacin), a compound that appears to selectively inhibit HDAC6 activity, dramatically increased eNOS expression in several different endothelial cell lines, as determined by both immunoblotting and NO production assays. Mechanistically, we found that these effects were not mediated by tubacin's inhibitory effect on HDAC6 activity, but rather were due to its ability to stabilize eNOS mRNA transcripts. Consistent with these findings, tubacin also inhibited proinflammatory cytokine-induced degradation of eNOS transcripts and impairment of endothelium-dependent relaxation in the mouse aorta. Furthermore, we found that tubacin-induced up-regulation in eNOS expression in vivo is associated with improved endothelial function in diabetic db/db mice and with a marked attenuation of ischemic brain injury in a murine stroke model. Our findings indicate that tubacin exhibits potent eNOS-inducing effects and suggest that this compound might be useful for the prevention or management of endothelial dysfunction?associated cardiovascular diseases.	[Chen, Jihui; Yi, Bing; Summer, Ross; Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Rm 368G, Philadelphia, PA 19107 USA; [Shaik, Noor F.; Naik, Ulhas P.] Thomas Jefferson Univ, Dept Med, Cardeza Ctr Vasc Biol, Philadelphia, PA 19107 USA; [Chen, Jihui; Zhang, Jian; Wei, Xin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pharm, Shanghai 200092, Peoples R China; [Yang, Xiao-Feng] Temple Univ, Ctr Metab Dis Res, Lewis Katz Sch Med, Philadelphia, PA 19107 USA; [Yan, Guijun] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Reprod Med Ctr, Nanjing 210023, Jiangsu, Peoples R China; [Xu, Xinyun] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Gen Surg, Shanghai 200003, Peoples R China	Jefferson University; Jefferson University; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nanjing University; Naval Medical University	Sun, JX (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Rm 368G, Philadelphia, PA 19107 USA.	jianxin.sun@jefferson.edu		Wei, Xin/0000-0002-5272-1665; Shaik, Noor/0000-0002-9336-4238; Chen, Jihui/0000-0002-9819-9921	National Institutes of Health [R01 HL103869, R01GM123047]; American Heart Association Established Investigator Award [16EIA27710023]; Chinese Natural Science Foundation [81672927]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113188, R01HL132399, R01HL103869, R01HL138749, R01HL147565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL103869 and R01GM123047 and American Heart Association Established Investigator Award 16EIA27710023 (to J. S.) and Chinese Natural Science Foundation Grant 81672927 (to X. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Babic I, 2009, MOL CELL BIOL, V29, P5564, DOI 10.1128/MCB.00590-09; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chataigneau T, 1999, BRIT J PHARMACOL, V126, P219, DOI 10.1038/sj.bjp.0702300; Chen M, 2016, CARDIOVASC RES, V109, P141, DOI 10.1093/cvr/cvv250; DALKARA T, 1994, AM J PHYSIOL, V267, pH678, DOI 10.1152/ajpheart.1994.267.2.H678; Damaskos C, 2017, ANTICANCER RES, V37, P35, DOI 10.21873/anticanres.11286; Dekker FJ, 2014, DRUG DISCOV TODAY, V19, P654, DOI 10.1016/j.drudis.2013.11.012; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Fernandez-Barrera J, 2018, CELL MOL LIFE SCI, V75, P3181, DOI 10.1007/s00018-018-2855-3; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fred RG, 2006, CURR DIABETES REV, V2, P363, DOI 10.2174/157339906777950570; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jung SB, 2010, CIRC RES, V107, P877, DOI 10.1161/CIRCRESAHA.110.222968; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; LIAO JK, 1995, J BIOL CHEM, V270, P319, DOI 10.1074/jbc.270.1.319; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Martinez-Gonzalez J, 2001, ARTERIOSCL THROM VAS, V21, P804, DOI 10.1161/01.ATV.21.5.804; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Mayanagi K, 2008, J CEREBR BLOOD F MET, V28, P1927, DOI 10.1038/jcbfm.2008.81; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Olzscha Heidi, 2015, Critical Reviews in Oncogenesis, V20, P1; Pasyukova EG, 2017, MECH AGEING DEV, V166, P6, DOI 10.1016/j.mad.2017.08.008; Rafikov R, 2011, J ENDOCRINOL, V210, P271, DOI 10.1530/JOE-11-0083; Romanelli MG, 2013, INT J MOL SCI, V14, P22906, DOI 10.3390/ijms141122906; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Searles CD, 2004, CIRC RES, V95, P488, DOI 10.1161/01.RES.0000138953.21377.80; Searles CD, 2006, AM J PHYSIOL-CELL PH, V291, pC803, DOI 10.1152/ajpcell.00457.2005; Seidel C, 2015, EPIGENOMICS-UK, V7, P103, DOI [10.2217/EPI.14.69, 10.2217/epi.14.69]; Shin HK, 2007, J CEREBR BLOOD F MET, V27, P998, DOI 10.1038/sj.jcbfm.9600406; Su YC, 2002, AM J PHYSIOL-LUNG C, V282, pL1183, DOI 10.1152/ajplung.00388.2001; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB; Wang XX, 2018, EUR J MED CHEM, V143, P1406, DOI 10.1016/j.ejmech.2017.10.040; Weber M, 2005, CIRC RES, V96, P1161, DOI 10.1161/01.RES.0000170651.72198.fa; Xiao ZS, 1997, J CELL PHYSIOL, V171, P205, DOI 10.1002/(SICI)1097-4652(199705)171:2<205::AID-JCP11>3.3.CO;2-3; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xue C, 1996, J HISTOCHEM CYTOCHEM, V44, P463, DOI 10.1177/44.5.8627003; Yan GJ, 2008, CIRC RES, V103, P591, DOI 10.1161/CIRCRESAHA.108.173963; Yang PH, 2013, DRUG DISCOV THER, V7, P233, DOI 10.5582/ddt.2013.v7.6.233; Yi B, 2015, ARTERIOSCL THROM VAS, V35, P2153, DOI 10.1161/ATVBAHA.115.305750; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205; You XH, 2018, J BIOL CHEM, V293, P14001, DOI 10.1074/jbc.RA118.003099; Zhang F, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0030-4; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	58	11	12	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19565	19576		10.1074/jbc.RA119.011317	http://dx.doi.org/10.1074/jbc.RA119.011317			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31719145	hybrid, Green Published			2022-12-26	WOS:000504093200010
J	Wakabayashi, S; Morihara, H; Yokoe, S; Nakagawa, T; Moriwaki, K; Tomoda, K; Asahi, M				Wakabayashi, Shigeo; Morihara, Hirofumi; Yokoe, Shunichi; Nakagawa, Takatoshi; Moriwaki, Kazumasa; Tomoda, Kiichiro; Asahi, Michio			Overexpression of Na+/H+ exchanger 1 specifically induces cell death in human iPS cells via sustained activation of the Rho kinase ROCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						induced pluripotent stem cell (iPS cell) (iPSC); sodium?proton exchange; Rho (Rho-GTPase); pH regulation; cell death; cell differentiation; protein kinase; cell motility; NHE1; ROCK	PLURIPOTENT STEM-CELLS; H+ EXCHANGER; BINDING; CYTOSKELETON; DOWNSTREAM; INHIBITOR; PROTEIN; NHE1; PH	Understanding the specific properties of human induced pluripotent stem cells (iPSCs) is important for quality control of iPSCs. Having incidentally discovered that overexpression of plasma membrane Na+/H+ exchanger 1 (NHE1) induces cell death in iPSCs, we investigated the mechanism of NHE1-induced cell death. Doxycycline-induced NHE1 overexpression arrested cell growth, and nearly all cells were killed by a necrotic process within 72 h. NHE1 overexpression led to sustained activation of Rho-associated coiled-coil kinase (ROCK), accompanied by dramatic changes in cell shape, cell elongation, and swelling of peripheral cells in iPSC colonies, as well as marked stress fiber formation. The ROCK inhibitor Y27632 reduced NHE1-induced cell death. ROCK-dependent phenotypes were suppressed by a loss-of-function mutation of NHE1 and inhibited by an inhibitor of NHE1 activity, indicating that NHE1-mediated transport activity is required. Moreover, ROCK was activated by trimethylamine treatment?mediated cytosolic alkalinization and accumulated in the plasma membrane near NHE1 in peripheral iPSCs of cell colonies. By contrast, cell death did not occur in mesendoderm-like cells that had differentiated from iPSCs, indicating that the NHE1-mediated effects were specific for iPSCs. These results suggest that NHE1 overexpression specifically induces death of iPSCs via sustained ROCK activation, probably caused by an increase in local pH near NHE1. Finally, monensin, a Na+/H+ exchange ionophore, selectively killed iPSCs, suggesting that monensin could help eliminate iPSCs that remain after differentiation, a strategy that might be useful for improving regenerative medicine.	[Wakabayashi, Shigeo; Morihara, Hirofumi; Yokoe, Shunichi; Nakagawa, Takatoshi; Moriwaki, Kazumasa; Tomoda, Kiichiro; Asahi, Michio] Osaka Med Coll, Fac Med, Dept Pharmacol, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan	Osaka Medical College	Wakabayashi, S (corresponding author), Osaka Med Coll, Fac Med, Dept Pharmacol, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	pha047@osaka-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [17K08551, 17K07246]; Novartis; OMC Internal Research Grant; Suzuki Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novartis(Novartis); OMC Internal Research Grant; Suzuki Memorial Foundation	This work was supported by Grant-in-Aid for Scientific Research C 17K08551 (to S. W.) and 17K07246 (to K. T.) from the Ministry of Education, Culture, Sports, Science and Technology, Suzuki Memorial Foundation (to K. T. and M. A.), Novartis Research Grants (to K. T. and M. A.), and OMC Internal Research Grant (to K. T. and M. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Benning N, 1996, PFLUG ARCH EUR J PHY, V432, P126, DOI 10.1007/s004240050114; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gao W, 2014, CELL PHYSIOL BIOCHEM, V33, P185, DOI 10.1159/000356661; Hisamitsu T, 2012, MOL CELL BIOL, V32, P3265, DOI 10.1128/MCB.00145-12; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Huetsch JC, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13698; Julian Linda, 2014, Small GTPases, V5, pe29846, DOI 10.4161/sgtp.29846; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kime C, 2016, P NATL ACAD SCI USA, V113, P12478, DOI 10.1073/pnas.1608564113; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Kurosawa H, 2012, J BIOSCI BIOENG, V114, P577, DOI 10.1016/j.jbiosc.2012.07.013; Lee MO, 2013, P NATL ACAD SCI USA, V110, pE3281, DOI 10.1073/pnas.1303669110; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Monet M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28008; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Ohgushi M, 2011, TRENDS CELL BIOL, V21, P274, DOI 10.1016/j.tcb.2011.02.004; Rangel-Mata F, 2007, BIOCHEM BIOPH RES CO, V352, P264, DOI 10.1016/j.bbrc.2006.11.015; Shimada-Shimizu N, 2014, MOL PHARMACOL, V85, P18, DOI 10.1124/mol.113.089268; SWEATT JD, 1986, J BIOL CHEM, V261, P8667; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Truebestein Linda, 2016, Small GTPases, V7, P82, DOI 10.1080/21541248.2016.1173770; Truebestein L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10029; Vanneste M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38019-y; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wakabayashi S, 2013, J MOL CELL CARDIOL, V61, P68, DOI 10.1016/j.yjmcc.2013.02.007; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wen WY, 2008, J BIOL CHEM, V283, P26263, DOI 10.1074/jbc.M803417200; Yi YH, 2009, J BIOL CHEM, V284, P3855, DOI 10.1074/jbc.M804334200	42	8	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2019	294	51					19577	19588		10.1074/jbc.RA119.010329	http://dx.doi.org/10.1074/jbc.RA119.010329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY0CP	31723030	Green Published, hybrid			2022-12-26	WOS:000504093200011
J	Yu, W; Shin, MR; Sesti, F				Yu, Wei; Shin, Mi Ryung; Sesti, Federico			Complexes formed with integrin-alpha 5 and KCNB1 potassium channel wild type or epilepsy-susceptibility variants modulate cellular plasticity via Ras and Akt signaling	FASEB JOURNAL			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIN CYTOSKELETON; LARGE-CONDUCTANCE; PROTEIN-SYNTHESIS; SURVIVAL SIGNALS; DENDRITIC SPINE; BKCA CHANNELS; HIPPOCAMPAL; ACTIVATION; FILAMENTS	Voltage-gated potassium (K+) channel subfamily B member 1 (KCNB1, Kv2.1) and integrin-alpha 5 form macromolecular complexes-named integrin-alpha 5-KCNB1 complexes (IKCs)-in the human brain, but their function was poorly understood. Here we report that membrane depolarization triggered IKC intracellular signals mediated by small GTPases of the Ras subfamily and protein kinase B (Akt) to advance the development of filopodia and lamellipodia in Chinese hamster ovary cells, stimulate their motility, and enhance neurite outgrowth in mouse neuroblastoma Neuro2a cells. Five KCNB1 mutants (L211P, R312H G379R, G381R, and F416L) linked to severe infancy or early-onset epileptic encephalopathy exhibited markedly defective conduction. However, although L211P, G379R, and G381R normally engaged Ras/Akt and stimulated cell migration, R312H and F416L failed to activate Ras/Akt signaling and did not enhance cell migration. Taken together, these data suggest that IKCs modulate cellular plasticity via Ras and Akt signaling. As such, defective IKCs may cause epilepsy through mechanisms other than dysregulated excitability such as, for example, abnormal neuronal development and resulting synaptic connectivity.	[Yu, Wei; Shin, Mi Ryung; Sesti, Federico] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Rutgers Robert Wood Johnson Med Sch, 683 Hoes Lane, Piscataway, NJ 08854 USA.	federico.sesti@rutgers.edu			National Science Foundation (NSF) [1456675]; U.S. National Institute of Health (NIH) (National Institute on Aging) [R01AG060919]; U.S. National Institute of Health (NIH) (National Institute of Neurological Disorders and Stroke) [R21NS0966]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); U.S. National Institute of Health (NIH) (National Institute on Aging); U.S. National Institute of Health (NIH) (National Institute of Neurological Disorders and Stroke)	The authors thank Drs. Mladen-Roko Rasin and Huaye Zhang (Robert Wood Johnson Medical School, Rutgers University) for help with the confocal microscope and Drs. Kiram Madura and Li Chen (Robert Wood Johnson Medical School, Rutgers University) for help with the plate reader. The Lifeact-GFP construct was provided by the Addgene repository. This work was supported by National Science Foundation (NSF) Grant 1456675 and U.S. National Institutes of Health (NIH) Grants R01AG060919 (National Institute on Aging) and R21NS0966 (National Institute of Neurological Disorders and Stroke) to F.S. The authors declare no conflicts of interest.	Akama KT, 2003, J NEUROSCI, V23, P2333; Becchetti A, 2010, INT REV CEL MOL BIO, V279, P135, DOI 10.1016/S1937-6448(10)79005-5; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bianchi L, 2003, J BIOL CHEM, V278, P12415, DOI 10.1074/jbc.M212788200; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Brady Peter A., 1996, American Journal of Physiology, V271, pH2710; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Cai SQ, 2009, EMBO J, V28, P1601, DOI 10.1038/emboj.2009.112; Calhoun JD, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000198; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; D'Adamo MC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00134; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Kovel CGF, 2017, JAMA NEUROL, V74, P1228, DOI 10.1001/jamaneurol.2017.1714; de Kovel CGF, 2016, MOL GENET GENOM MED, V4, P568, DOI 10.1002/mgg3.235; Delgado-Ramirez M, 2019, J PHYSIOL SCI, V69, P513, DOI 10.1007/s12576-019-00671-y; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Ehrhardt AG, 1996, J PHYSIOL-LONDON, V496, P663, DOI 10.1113/jphysiol.1996.sp021717; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Furukawa T, 1996, PFLUG ARCH EUR J PHY, V431, P504, DOI 10.1007/s004240050028; GREENGARD P, 1994, ADV SEC MESS PHOSPH, V29, P31; He K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129498; Huang H, 2002, NEUROSCI LETT, V332, P141, DOI 10.1016/S0304-3940(02)00836-4; Hwang JU, 1997, PLANT PHYSIOL, V115, P335, DOI 10.1104/pp.115.2.335; Ilic D, 1998, J CELL BIOL, V143, P547; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Kim EY, 2010, AM J PHYSIOL-RENAL, V299, pF594, DOI 10.1152/ajprenal.00206.2010; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Latypova X, 2017, J HUM GENET, V62, P569, DOI 10.1038/jhg.2016.154; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Leung YM, 2011, J CELL PHYSIOL, V226, P1090, DOI 10.1002/jcp.22430; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Malin SA, 2002, J NEUROSCI, V22, P10094; Marini C, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000206; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Nakahira K, 1998, J MOL NEUROSCI, V11, P199, DOI 10.1385/JMN:11:3:199; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935; Parent JM, 1997, J NEUROSCI, V17, P3727; Piao L, 2003, PFLUG ARCH EUR J PHY, V446, P523, DOI 10.1007/s00424-003-1079-y; Piwkowska A, 2015, BBA-MOL BASIS DIS, V1852, P1599, DOI 10.1016/j.bbadis.2015.04.024; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rubboli G, 2019, ANN CLIN TRANSL NEUR, V6, P386, DOI 10.1002/acn3.708; Saitsu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15199; Scott BW, 2000, EXP NEUROL, V165, P231, DOI 10.1006/exnr.2000.7458; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Thiffault I, 2015, J GEN PHYSIOL, V146, P399, DOI 10.1085/jgp.201511444; Torkamani A, 2014, ANN NEUROL, V76, P529, DOI 10.1002/ana.24263; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; Wei JF, 2008, J CELL PHYSIOL, V217, P544, DOI 10.1002/jcp.21530; Wei Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0886-1; Wu XL, 2013, J BIOL CHEM, V288, P4128, DOI 10.1074/jbc.M112.440933; Yokoshiki H, 1997, PFLUG ARCH EUR J PHY, V434, P203, DOI 10.1007/s004240050384; Yu W, 2019, BIOCHEM BIOPH RES CO, V512, P665, DOI 10.1016/j.bbrc.2019.03.130; Yu W, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.160; Yu W, 2016, J NEUROSCI, V36, P11084, DOI 10.1523/JNEUROSCI.2273-16.2016; Zhang Y, 2016, CELL, V165, P434, DOI 10.1016/j.cell.2016.02.009	71	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					14680	14689		10.1096/fj.201901792R	http://dx.doi.org/10.1096/fj.201901792R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31682765	Bronze, Green Published			2022-12-26	WOS:000507466100124
J	Watanabe, E; Mano, S; Nishimura, M; Yamada, K				Watanabe, Etsuko; Mano, Shoji; Nishimura, Mikio; Yamada, Kenji			AtUBL5 regulates growth and development through pre-mRNA splicing in Arabidopsis thaliana	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; HUB1; ACTIVATION; UBL5; TRANSPORT; KINASE; GENE	Ubiquitin-like proteins play important roles in the regulation of many biological processes. UBL5 (Ubiquitin-like protein 5)/Hub1 (Homologous to ubiquitin 1), a member of the ubiquitin family, acts as a ubiquitin-like modifier on a specific target, the spliceosomal protein Snu66, in yeast and human cells. The 22nd aspartic acid (Asp22) is involved in the attachment of Hub1 to the Hub1 interaction domain (HIND) of Snu66 in yeast to modulate spliceosomal activity. Hub1 differs from other modifiers which interact covalently with their targets. It modulates pre-mRNA splicing by binding to Snu66 non-covalently in both yeast and human cells. However, the molecular mechanisms of Hub1-mediated pre-mRNA splicing in plant systems remains unclear. To better understand the function of Hub1 in plants, we examined the role of this ubiquitin-like modifier in Arabidopsis thaliana, which has two Hub1 homologues. Arabidopsis UBL5/Hub1(UBL5) is highly conserved at the amino acid level, compared to eukaryotic homologues in both plants and animals. In this study, phenotypic analysis of A. thaliana with reduced UBL5 gene expression, generated by RNA interference of AtUBL5a and AtUBL5b were performed. Interestingly, knock down plants of AtUBL5 showed abnormalities in root elongation, plant development, and auxin response. AtUBL5b is highly expressed in the vascular tissue of the leaf, stem, and root tissue. Yeast two-hybrid analysis revealed that AtUBL5a and AtUBL5b interact with the putative splicing factor AtPRP38 through its C-terminal domain (AtPRP38C). Knock down of AtUBL5b resulted in a pattern of insufficient pre-mRNA splicing in several introns of AtCDC2, and in introns of IAA1, IAA4, and IAA5. Defects of pre-mRNA splicing in an AtPRP38 mutant resulted in an insufficient pre-mRNA splicing pattern in the intron of IAA1. Based on these results, we showed that AtUBL5b positively regulates plant root elongation and development through pre-mRNA splicing with AtPRP38C in A. thaliana.	[Watanabe, Etsuko; Mano, Shoji; Nishimura, Mikio; Yamada, Kenji] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan; [Mano, Shoji] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Nishimura, Mikio] Konan Univ, Fac Sci & Engn, Dept Biol, Kobe, Hyogo, Japan; [Yamada, Kenji] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Konan University; Jagiellonian University	Watanabe, E (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan.	sakuraseattle@gmail.com	Yamada, Kenji/C-4336-2018	Yamada, Kenji/0000-0003-4872-3729; Nishimura, Mikio/0000-0001-7960-9721; Mano, Shoji/0000-0003-1323-3308	KAKENHI from the Japan Society for the Promotion of Science (JSPS) [19770040, 25440146, 22120007]; Wyeth Foundation	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Wyeth Foundation(Wyeth)	This work was supported by KAKENHI, Grants-in-Aid for Scientific Research to K.Y. (nos. 19770040 and 25440146) and M.N. (no. 22120007) from the Japan Society for the Promotion of Science (JSPS) and Wyeth Foundation.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ammon T, 2014, J MOL CELL BIOL, V6, P312, DOI 10.1093/jmcb/mju026; Bechtold N, 1998, METH MOL B, V82, P259; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Friedmann JS, 2001, GENOMICS, V71, P252, DOI 10.1006/geno.2000.6439; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Karaduman R, 2017, MOL CELL, V67, P423, DOI 10.1016/j.molcel.2017.06.021; Luders J, 2003, EMBO REP, V4, P1169, DOI 10.1038/sj.embor.7400025; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; McNally T, 2003, PROTEIN SCI, V12, P1562, DOI 10.1110/ps.0382803; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Patel M, 2015, PLANT BIOTECHNOL J, V13, P689, DOI 10.1111/pbi.12291; Ramelot Theresa A., 2003, Journal of Structural and Functional Genomics, V4, P25, DOI 10.1023/A:1024674220425; Sveda M, 2013, BIOCHEM BIOPH RES CO, V436, P240, DOI 10.1016/j.bbrc.2013.05.083; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Takahashi F, 2011, MOL CELL, V41, P649, DOI 10.1016/j.molcel.2011.02.029; Weigel D., 2006, CSH PROTOC, V2006, DOI 10.1101/pdb.prot4665; Wilkinson CRM, 2004, CURR BIOL, V14, P2283, DOI 10.1016/j.cub.2004.11.058; Yamada K, 2007, J BIOL CHEM, V282, P37794, DOI 10.1074/jbc.M707168200; Yashiroda H, 2004, GENES CELLS, V9, P1189, DOI 10.1111/j.1365-2443.2004.00807.x	26	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2019	14	11							e0224795	10.1371/journal.pone.0224795	http://dx.doi.org/10.1371/journal.pone.0224795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2YM	31730612	gold, Green Published			2022-12-26	WOS:000532809500007
J	Gokhman, VE; Cioffi, MD; Konig, C; Pollmann, M; Gantert, C; Krogmann, L; Steidle, JLM; Kosyakova, N; Liehr, T; Al-Rikabi, A				Gokhman, Vladimir E.; Cioffi, Marcelo de Bello; Konig, Christian; Pollmann, Marie; Gantert, Cornelia; Krogmann, Lars; Steidle, Johannes L. M.; Kosyakova, Nadezda; Liehr, Thomas; Al-Rikabi, Ahmed			Microdissection and whole chromosome painting confirm karyotype transformation in cryptic species of the Lariophagus distinguendus (Forster, 1841) complex (Hymenoptera: Pteromalidae)	PLOS ONE			English	Article							CYTOGENETICS; EVOLUTION; SIZE	Karyotypes of two cryptic species of parasitoid Hymenoptera with n = 5 and 6 belonging to the Lariophagus distinguendus (Forster, 1841) complex, which includes cosmopolitan parasitoids of coleopteran stored-product pests, were studied using glass-needle based microdissection, reverse and cross-species fluorescence in situ hybridisation (FISH). This experiment strongly indicates that the largest metacentric chromosome in the karyotype with n = 5 originated from a particular fusion between the only acrocentric and a smaller metacentric chromosome of the set with n = 6, therefore confirming our previous hypothesis based on the karyotypic analysis using chromosome morphometrics. This study represents the first successful application of both microdissection and whole chromosome painting for the reconstruction of karyotypic rearrangements in closely related species of parasitoids, as well as in the order Hymenoptera in general.	[Gokhman, Vladimir E.] Moscow MV Lomonosov State Univ, Bot Garden, Moscow, Russia; [Cioffi, Marcelo de Bello] Univ Fed Sao Carlos, Dept Genet & Evolut, Sao Carlos, SP, Brazil; [Cioffi, Marcelo de Bello; Kosyakova, Nadezda; Liehr, Thomas; Al-Rikabi, Ahmed] Jena Univ Hosp, Inst Human Genet, Jena, Germany; [Konig, Christian; Pollmann, Marie; Gantert, Cornelia; Krogmann, Lars; Steidle, Johannes L. M.] Univ Hohenheim, Inst Zool, Stuttgart, Germany; [Krogmann, Lars] State Museum Nat Hist Stuttgart, Dept Entomol, Stuttgart, Germany	Lomonosov Moscow State University; Universidade Federal de Sao Carlos; Friedrich Schiller University of Jena; University Hohenheim	Gokhman, VE (corresponding author), Moscow MV Lomonosov State Univ, Bot Garden, Moscow, Russia.	vegokhman@hotmail.com	Cioffi, Marcelo/AAG-4675-2022; Cioffi, Marcelo/AFK-6402-2022; Steidle, Johannes/ABB-5643-2021; Gokhman, Vladimir/A-4153-2009; Liehr, Thomas/H-2852-2019	Cioffi, Marcelo/0000-0003-4340-1464; Cioffi, Marcelo/0000-0003-4340-1464; Gokhman, Vladimir/0000-0001-9909-7559; Liehr, Thomas/0000-0003-1672-3054	Russian Foundation for Basic Research [18-04-00611]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The present study was partly supported by a research grant no. 18-04-00611 from the Russian Foundation for Basic Research (https://www.rfbr.ru) to VEG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldanza F, 1999, B ENTOMOL RES, V89, P209, DOI 10.1017/S0007485399000322; Martins CCC, 2013, APIDOLOGIE, V44, P75, DOI 10.1007/s13592-012-0157-6; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; Fernandes A, 2011, APIDOLOGIE, V42, P743, DOI 10.1007/s13592-011-0082-0; Gadau J, 2015, PROTOCOLS CYTOGENETI, P257, DOI [10.1201/b17450-8, DOI 10.1201/B17450-8]; Gokhman V. E., 2009, KARYOTYPES PARASITIC; Gokhman VE, 2017, COMP CYTOGENET, V11, P97, DOI 10.3897/CompCytogen.v11i1.10872; Gokhman VE, 2014, GENETICA, V142, P317, DOI 10.1007/s10709-014-9776-3; Graham M. W. R. de V., 1969, Bull. Br. Mus. nat. Hist. Ent., V16, P1; Huber JT, 2017, INSECT BIODIVERSITY: SCIENCE AND SOCIETY, VOL I, 2ND EDITION, P419; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; Konig C, 2019, COMP CYTOGENET, V13, P133, DOI 10.3897/CompCytogen.v13i2.34492; Koenig K, 2019, ECOL EVOL, V9, P10694, DOI 10.1002/ece3.5588; Konig K, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1850; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lopes DM, 2014, CARYOLOGIA, V67, P222, DOI 10.1080/0144235X.2014.974349; Nguyen P, 2013, P NATL ACAD SCI USA, V110, P6931, DOI 10.1073/pnas.1220372110; Niedermayer S, 2016, INSECTS, V7, DOI 10.3390/insects7030039; Noyes J.S., 2019, UNIVERSAL CHALCIDOID; ODIERNA G, 1993, GENOME, V36, P662, DOI 10.1139/g93-088; Quicke D. L. J., 1997, PARASITIC WASPS; Rodionov AV, 1999, RUSS J GENET+, V35, P215; Rutten KB, 2004, CYTOGENET GENOME RES, V105, P126, DOI 10.1159/000078019; Sharakhov IV, 2015, PROTOCOLS CYTOGENETI, DOI [10.1007/s10577-008-9001-2, DOI 10.1007/S10577-008-9001-2]; Speicher MR, 2005, NAT REV GENET, V6, P782, DOI 10.1038/nrg1692; Tavares MG, 2017, GENETICA, V145, P241, DOI 10.1007/s10709-017-9961-2; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; Trifonov VA, 2017, SPRINGER PROTOC HAND, P123, DOI 10.1007/978-3-662-52959-1_11; Vicari MR, 2015, FISH CYTOGENETIC TEC, P144, DOI [10.1038/nrg2199, DOI 10.1038/NRG2199]; Yang FT, 2017, SPRINGER PROTOC HAND, P63, DOI 10.1007/978-3-662-52959-1_6; Yang FT, 2017, SPRINGER PROTOC HAND, P395, DOI 10.1007/978-3-662-52959-1_42; Yano CF, 2017, SPRINGER PROTOC HAND, P429, DOI 10.1007/978-3-662-52959-1_44; Zhou RN, 2007, CURR GENOMICS, V8, P67, DOI 10.2174/138920207780076929; Zrzava M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060279; Zwick MS, 1997, GENOME, V40, P138, DOI 10.1139/g97-020	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0225257	10.1371/journal.pone.0225257	http://dx.doi.org/10.1371/journal.pone.0225257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725808	Green Published, gold			2022-12-26	WOS:000532764500073
J	Xiong, YY; Onufriev, AV				Xiong, Yeyue; Onufriev, Alexey, V			Exploring optimization strategies for improving explicit water models: Rigid n-point model and polarizable model based on Drude oscillator	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; COMPUTER-SIMULATIONS; LIQUID WATER; FORCE-FIELDS; IMPLEMENTATION; CLUSTERS; TIP4P/2005; SOLVATION; DENSITY; MOMENT	Rigid n-point water models are widely used in atomistic simulations, but have known accuracy drawbacks. Increasing the number of point charges, as well as adding electronic polarizability, are two common strategies for accuracy improvements. Both strategies come at considerable computational cost, which weighs heavily against modest possible accuracy improvements in practical simulations. In an effort to provide guidance for model development, here we have explored the limiting accuracy of "electrostatically globally optimal" n-point water models in terms of their ability to reproduce properties of water dimer-a mimic of the condensed state of water. For a given n, each model is built upon a set of reference multipole moments (e.g. ab initio) and then optimized to reproduce water dimer total dipole moment. The models are then evaluated with respect to the accuracy of reproducing the geometry of the water dimer. We find that global optimization of the charge distribution alone can deliver high accuracy of the water model: for n = 4 or n = 5, the geometry of the resulting water dimer can be almost within 50 of the ab initio reference, which is half that of the experimental error margin. Thus, global optimization of the charge distribution of classical n-point water models can lead to high accuracy models. We also find that while the accuracy improvement in going from n = 3 to n = 4 is substantial, the additional accuracy increase in going from n = 4 to n = 5 is marginal. Next, we have explored accuracy limitations of the standard practice of adding electronic polarizability (via a Drude particle) to a "rigid base"-pre-optimization rigid n-point water model. The resulting model (n = 3) shows a relatively small improvement in accuracy, suggesting that the strategy of merely adding the polarizability to an inferior accuracy water model used as the base cannot fix the defects of the latter. An alternative strategy in which the parameters of the rigid base model are globally optimized along with the polarizability parameter is much more promising: the resulting 3-point polarizable model out-performs even the 5-point optimal rigid model by a large margin. We suggest that future development efforts consider 3- and 4-point polarizable models where global optimization of the "rigid base" is coupled to optimization of the polarizability to deliver globally optimal solutions.	[Xiong, Yeyue] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Onufriev, Alexey, V] Virginia Tech, Dept Phys, Blacksburg, VA 24061 USA; [Onufriev, Alexey, V] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA; [Onufriev, Alexey, V] Virginia Tech, Ctr Soft Matter & Biol Phys, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Onufriev, AV (corresponding author), Virginia Tech, Dept Phys, Blacksburg, VA 24061 USA.; Onufriev, AV (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.; Onufriev, AV (corresponding author), Virginia Tech, Ctr Soft Matter & Biol Phys, Blacksburg, VA 24061 USA.	alexey@cs.vt.edu		Xiong, Yeyue/0000-0003-0348-1009				Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Akin-Ojo O, 2011, J COMPUT CHEM, V32, P453, DOI 10.1002/jcc.21634; Anandakrishnan R, 2019, J CHEM THEORY COMPUT, V15, P625, DOI 10.1021/acs.jctc.8b00485; Anandakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067715; Bachmann SJ, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897976; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Brini E, 2017, CHEM REV, V117, P12385, DOI 10.1021/acs.chemrev.7b00259; Brodsky A, 1996, CHEM PHYS LETT, V261, P563, DOI 10.1016/0009-2614(96)00997-9; CALDWELL J, 1990, J AM CHEM SOC, V112, P9144, DOI 10.1021/ja00181a017; Case D. A., 2019, AMBER 2019 AMBER TOO, DOI DOI 10.1038/nbt1273; CLOUGH SA, 1973, J CHEM PHYS, V59, P2254, DOI 10.1063/1.1680328; DANG LX, 1992, J CHEM PHYS, V97, P2659, DOI 10.1063/1.463054; Dharmawardhana CC, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4986070; Drude P., 1900, ANN PHYS, V306, P566, DOI [DOI 10.1002/ANDP.19003060312, 10.1002/andp.19003060312]; Finney JL, 2001, J MOL LIQ, V90, P303, DOI 10.1016/S0167-7322(01)00134-9; Florova P, 2010, J CHEM THEORY COMPUT, V6, P3569, DOI 10.1021/ct1003687; Gongadze E, 2013, ELECTROCHIM ACTA, V109, P656, DOI 10.1016/j.electacta.2013.07.126; Guillot B, 2002, J MOL LIQ, V101, P219, DOI 10.1016/S0167-7322(02)00094-6; Hasted J. B., 1972, LIQUID WATER DIELECT, P255, DOI 10.1007/978-1-4684-8334-5_7; Huang J, 2018, J COMPUT CHEM, V39, P1682, DOI 10.1002/jcc.25339; Huang J, 2014, J PHYS CHEM LETT, V5, P3144, DOI 10.1021/jz501315h; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izadi S, 2014, J PHYS CHEM LETT, V5, P3863, DOI 10.1021/jz501780a; Jiang W, 2011, J PHYS CHEM LETT, V2, P87, DOI 10.1021/jz101461d; Jing ZF, 2019, ANNU REV BIOPHYS, V48, P371, DOI 10.1146/annurev-biophys-070317-033349; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1985, MOL PHYS, V56, P1381, DOI 10.1080/00268978500103111; Klopper W, 2000, PHYS CHEM CHEM PHYS, V2, P2227, DOI 10.1039/a910312k; Kumar R, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3276460; KUWAJIMA S, 1990, J PHYS CHEM-US, V94, P460, DOI 10.1021/j100364a080; Lamoureux G, 2006, CHEM PHYS LETT, V418, P245, DOI 10.1016/j.cplett.2005.10.135; Lamoureux G, 2003, J CHEM PHYS, V119, P3025, DOI 10.1063/1.1589749; Lamoureux G, 2003, J CHEM PHYS, V119, P5185, DOI 10.1063/1.1598191; Laury ML, 2015, J PHYS CHEM B, V119, P9423, DOI 10.1021/jp510896n; Lemkul JA, 2016, CHEM REV, V116, P4983, DOI 10.1021/acs.chemrev.5b00505; Lemkul JA, 2015, J COMPUT CHEM, V36, P1473, DOI 10.1002/jcc.23937; Liu CW, 2019, J CHEM THEORY COMPUT, V15, P4122, DOI 10.1021/acs.jctc.9b00261; Ludwig R, 2001, ANGEW CHEM INT EDIT, V40, P1808, DOI 10.1002/1521-3773(20010518)40:10<1808::AID-ANIE1808>3.3.CO;2-T; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Masia M, 2004, J CHEM PHYS, V121, P7362, DOI 10.1063/1.1791637; Mukhopadhyay A, 2018, CHEM PHYS LETT, V700, P163, DOI 10.1016/j.cplett.2018.03.057; Mukhopadhyay A, 2015, CHEM PHYS LETT, V633, P13, DOI 10.1016/j.cplett.2015.04.016; Nguyen M, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5012682; Niu SQ, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3569563; Onufriev AV, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1347; Ouyang JF, 2015, CHIMIA, V69, P104, DOI 10.2533/chimia.2015.104; Pi HL, 2009, MOL PHYS, V107, P365, DOI 10.1080/00268970902784926; Rahman A, 1971, J CHEM PHYS, V55, P3336, DOI 10.1063/1.1676585; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Rick SW, 2004, J CHEM PHYS, V120, P6085, DOI 10.1063/1.1652434; Rodgers JM, 2017, J MOL LIQ, V228, P54, DOI 10.1016/j.molliq.2016.10.007; SOETENS JC, 1995, CHEM PHYS LETT, V235, P22, DOI 10.1016/0009-2614(95)00090-Q; SPRIK M, 1988, J CHEM PHYS, V89, P7556, DOI 10.1063/1.455722; Tan ML, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2177240; Troster P, 2014, J PHYS CHEM B, V118, P1589, DOI 10.1021/jp4125765; Tu YQ, 2000, CHEM PHYS LETT, V329, P283, DOI 10.1016/S0009-2614(00)01026-5; Vega C, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862245; Vega C, 2015, MOL PHYS, V113, P1145, DOI 10.1080/00268976.2015.1005191; Vega C, 2011, PHYS CHEM CHEM PHYS, V13, P19663, DOI 10.1039/c1cp22168j; Wang J, 2012, J PHYS CHEM B, V116, P7999, DOI 10.1021/jp212117d; Wang LP, 2014, J PHYS CHEM LETT, V5, P1885, DOI 10.1021/jz500737m; Wang LP, 2013, J PHYS CHEM B, V117, P9956, DOI 10.1021/jp403802c; Yu HB, 2004, J CHEM PHYS, V121, P9549, DOI 10.1063/1.1805516; Zhong DP, 2011, CHEM PHYS LETT, V503, P1, DOI 10.1016/j.cplett.2010.12.077	64	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2019	14	11							e0224991	10.1371/journal.pone.0224991	http://dx.doi.org/10.1371/journal.pone.0224991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN2HK	31725740	Green Published, gold			2022-12-26	WOS:000532764500039
J	Abadiga, M				Abadiga, Muktar			Magnitude and associated factors of postpartum depression among women in Nekemte town, East Wollega zone, west Ethiopia, 2019: A community-based study	PLOS ONE			English	Article							ANTENATAL RISK-FACTORS; POSTNATAL DEPRESSION; MATERNAL DEPRESSION; PREVALENCE; MOTHERS; SCALE	Background Postpartum depression is a non-psychotic disorder that happens during the first 1year after childbirth. It affects both the mother's health and child's development and is given significant public health concern in developed countries. However, in developing countries including Ethiopia, postnatal care is mainly concerned with obstetric problems and the baby's health, while the psychological well-being of the mother is given little attention. Therefore, this study was aimed to assess the magnitude and associated factors of postpartum depression among women in Nekemte town, East Wollega zone, West Ethiopia, 2019. Methods Community-based cross-sectional study was conducted on 295 postnatal women, from May 15 to June 5, 2019, in Nekemte town. The study participants were selected by a simple random sampling method and interviewed using structured questionnaires. Multivariable logistic regression was used to find the independent variables which are associated with postnatal depression. All associations between dependent and independent variables and statistical significance were measured using odds ratio at 95% confidence interval and p-value less than 0.05. Results From the total of 295 women sampled, 287 were participated in the study. Out of these 287 women participated, 20.9% had developed postnatal depression. Unplanned pregnancy (AOR = 7.84, 95% CI: 3.19, 19.26), Being first time mother (AOR = 4.99, 95% CI: 1.54, 16.09), History of previous depression (AOR = 3.06, 95% CI: 1.06, 8.82), Domestic violence (AOR = 5.92, 95% CI: 2.44, 14.40), History of substance use (AOR = 3.95, 95% CI: 1.52, 10.30) and poor social support (AOR = 6.59, 95% CI: 2.25, 19.29) were significantly associated with postnatal depression. Conclusion In this study, the magnitude of postnatal depression was found moderate compared to other studies. Perinatal depression screening and intervention need to be integrated with maternal health care services, especially for mothers at risk of postnatal depression.	[Abadiga, Muktar] Wollega Univ, Sch Nursing & Midwifery, Inst Hlth Sci, Nekemte, Ethiopia		Abadiga, M (corresponding author), Wollega Univ, Sch Nursing & Midwifery, Inst Hlth Sci, Nekemte, Ethiopia.	muktarabadiga@gmail.com						Agarwala A, 2019, CLIN EPIDEMIOL GLOB, V7, P342, DOI 10.1016/j.cegh.2018.08.009; Alasoom Lamia I, 2014, J Family Med Prim Care, V3, P146, DOI 10.4103/2249-4863.137654; Anokye R, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0188-0; Anoop S, 2004, ARCH DIS CHILD, V89, P325, DOI 10.1136/adc.2002.009738; Azad R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215735; Boen H, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-20; Chi XL, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01668; Cooper PJ, 1998, BMJ-BRIT MED J, V316, P1884; Crane DR, 2000, AM J FAM THER, V28, P53, DOI 10.1080/019261800261815; Craske MG, 2003, ORIGINS PHOBIAS ANXI, P13; Fantahun Addishiwet, 2018, Clin Pract Epidemiol Ment Health, V14, P196, DOI 10.2174/1745017901814010196; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Guille C, 2013, J MIDWIFERY WOM HEAL, V58, P632, DOI 10.1111/jmwh.12104; Guin G, INT J REPROD CONTRAC, V7, P1095; Halbreich U, 2006, J AFFECT DISORDERS, V91, P97, DOI 10.1016/j.jad.2005.12.051; Hammen C, 2003, Arch Womens Ment Health, V6, P9, DOI 10.1007/s00737-002-0160-4; Kerie Sitotaw, 2018, BMC Res Notes, V11, P623, DOI 10.1186/s13104-018-3730-x; Khalifa DS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009443; Leathers SJ, 2000, AM J ORTHOPSYCHIAT, V70, P523, DOI 10.1037/h0087671; Lester SW, 2002, J ORGAN BEHAV, V23, P39, DOI 10.1002/job.126; Mauthner NS., 1998, J REPROD INFANT PSYC, V16, P157, DOI DOI 10.1080/02646839808404566; McCoy SJB, 2006, J AM OSTEOPATH ASSOC, V106, P193; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Miller LJ, 2002, JAMA-J AM MED ASSOC, V287, P762, DOI 10.1001/jama.287.6.762; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Oklahoma State Department of Health, 2011, REC POSTP DEPR; Ongeri L, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1904-7; Rahman A, 2002, CHILD CARE HLTH DEV, V28, P51, DOI 10.1046/j.1365-2214.2002.00239.x; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Santos IS, 2007, CAD SAUDE PUBLICA, V23, P2577, DOI 10.1590/S0102-311X2007001100005; Spinelli MG, 2009, AM J PSYCHIAT, V166, P405, DOI 10.1176/appi.ajp.2008.08121899; Stewart DE., 2003, POSTPARTUM DEPRESSIO; Do TKL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4028913; Toru T, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2072-y; Vigod SN, 2010, BJOG-INT J OBSTET GY, V117, P540, DOI 10.1111/j.1471-0528.2009.02493.x; World Health Organization, 2008, MAT MENT HLTH CHILD	37	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0224792	10.1371/journal.pone.0224792	http://dx.doi.org/10.1371/journal.pone.0224792			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1QS	31721808	Green Published, gold			2022-12-26	WOS:000532720700030
J	Thomas, A; White, NM; Toms, LML; Mengersen, K				Thomas, Aleysha; White, Nicole M.; Toms, Leisa-Maree Leontjew; Mengersen, Kerrie			Application of ensemble methods to analyse the decline of organochlorine pesticides in relation to the interactions between age, gender and time	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; HUMAN BREAST-MILK; POLYCHLORINATED-BIPHENYLS; MATERNAL BLOOD; ADIPOSE-TISSUE; HUMAN SERUM; CORD BLOOD; PCBS; POPULATION; HEALTH	Organochlorine pesticides (OCPs) are toxic chemicals that persist in human tissue. Short and long term exposure to OCPs have been shown to have adverse effects on human health. This motivates studies into the concentrations of pesticides in humans. However these studies typically emphasise the analysis of the main effects of age group, gender and time of sample collection. The interactions between main effects can distinguish variation in OCP concentration such as the difference in concentrations between genders of the same age group as well as age groups over time. These are less studied but may be equally or more important in understanding effects of OCPs in a population. The aim of this study was to identify interactions relevant to understanding OCP concentrations and utilise them appropriately in models. We propose a two stage analysis comprising of boosted regression trees (BRTs) and hierarchical modelling to study OCP concentrations. BRTs are used to discover influential interactions between age group, gender and time of sampling. Hierarchical models are then employed to test and infer the effect of the interactions on OCP concentrations. Results of our analysis show that the best fitting model of an interaction effect varied between OCPs. The interaction between age group and gender was most influential for hexachlorobenzene (HCB) concentrations. There was strong evidence of an interaction effect between age group and time for beta-hexachlorocyclohexane (beta-HCH) concentrations in >60 year olds as well as an interaction effect between age group and gender for HCB concentrations for adults aged >45 years. This study highlights the need to consider appropriate interaction effects in the analysis of OCP concentrations and provides further insight into the interplay of main effects on OCP concentration trends.	[Thomas, Aleysha; White, Nicole M.; Mengersen, Kerrie] Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia; [White, Nicole M.; Toms, Leisa-Maree Leontjew] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	White, NM (corresponding author), Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia.; White, NM (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.	k.mengersen@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022; Toms, Leisa-Maree/C-9530-2009	Toms, Leisa-Maree/0000-0002-1444-1638; White, Nicole/0000-0002-9292-0773; Thomas, Aleysha/0000-0003-3185-3455	Australian Research Council (ARC) Laureate Fellowship [FL150100150]; ARC; Department of Sustainability, Environment, Water, Population and Communities Sustainability, Environment, Water, Population and Communities	Australian Research Council (ARC) Laureate Fellowship(Australian Research Council); ARC(Australian Research Council); Department of Sustainability, Environment, Water, Population and Communities Sustainability, Environment, Water, Population and Communities	KM's contribution to this study was supported by an Australian Research Council (ARC) Laureate Fellowship (Project ID: FL150100150). AT and NMW were supported by funding from the ARC awarded to KM during this study. This study was partly funded by the Department of Sustainability, Environment, Water, Population and Communities Sustainability, Environment, Water, Population and Communities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Arrebola JP, 2012, ENVIRON RES, V112, P40, DOI 10.1016/j.envres.2011.10.006; Australian Academy of Science, 1972, REP AUSTR AC SCI; Australian Pesticides and Veterinary Medicines Authority, 2013, HIST ORG PEST AUSTR; Beard J, 2006, SCI TOTAL ENVIRON, V355, P78, DOI 10.1016/j.scitotenv.2005.02.022; Bjermo H, 2013, ENVIRON INT, V51, P88, DOI 10.1016/j.envint.2012.10.010; Breiman L., 1984, CLASSIFICATION REGRE; Dewan P, 2013, CHEMOSPHERE, V90, P1704, DOI 10.1016/j.chemosphere.2012.09.083; EGAN H, 1965, BMJ-BRIT MED J, V2, P66, DOI 10.1136/bmj.2.5453.66; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fruge AD, 2016, J FOOD NUTR DISORDER, V5; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Hardell E, 2010, SCI TOTAL ENVIRON, V408, P4412, DOI 10.1016/j.scitotenv.2010.06.029; Jakszyn P, 2009, CHEMOSPHERE, V76, P1518, DOI 10.1016/j.chemosphere.2009.05.048; James RA, 2002, ENVIRON HEALTH PERSP, V110, P617, DOI 10.1289/ehp.02110617; JENSEN AA, 1987, SCI TOTAL ENVIRON, V64, P259, DOI 10.1016/0048-9697(87)90250-6; Johnson-Restrepo B, 2005, ENVIRON SCI TECHNOL, V39, P5177, DOI 10.1021/es050399x; Jung D, 1997, J TOXICOL ENV HEALTH, V51, P23, DOI 10.1080/009841097160203; Kang JH, 2012, SCI TOTAL ENVIRON, V433, P290, DOI 10.1016/j.scitotenv.2012.06.037; Kang JH, 2008, CHEMOSPHERE, V73, P1625, DOI 10.1016/j.chemosphere.2008.07.087; Laden F, 1999, ENVIRON HEALTH PERSP, V107, P75, DOI 10.2307/3434292; LaKind JS, 2009, ENVIRON HEALTH PERSP, V117, P1625, DOI 10.1289/ehp.0900876; LAUG EP, 1951, AMA ARCH IND HYG OCC, V3, P245; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Longnecker MP, 1997, ANNU REV PUBL HEALTH, V18, P211, DOI 10.1146/annurev.publhealth.18.1.211; Luo D, 2016, SCI REP-UK, V6, DOI 10.1038/srep25768; Malarvannan G, 2009, ENVIRON POLLUT, V157, P1924, DOI 10.1016/j.envpol.2009.01.010; Meng G, 2016, ENVIRON RES, V146, P125, DOI 10.1016/j.envres.2015.12.026; Mrema EJ, 2013, TOXICOLOGY, V307, P74, DOI 10.1016/j.tox.2012.11.015; Mueller JF, 2008, CHEMOSPHERE, V70, P712, DOI 10.1016/j.chemosphere.2007.06.037; Nguyen MT, 2010, CHEMOSPHERE, V81, P1006, DOI 10.1016/j.chemosphere.2010.09.013; Noren K, 2000, CHEMOSPHERE, V40, P1111, DOI 10.1016/S0045-6535(99)00360-4; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Polder A, 2008, SCI TOTAL ENVIRON, V391, P41, DOI 10.1016/j.scitotenv.2007.10.045; Porta M, 2008, ENVIRON INT, V34, P546, DOI 10.1016/j.envint.2007.10.004; Porta M, 2012, SCI TOTAL ENVIRON, V423, P151, DOI 10.1016/j.scitotenv.2012.02.001; Salihovic S, 2012, ENVIRON INT, V44, P59, DOI 10.1016/j.envint.2012.01.011; Saoudi A, 2014, SCI TOTAL ENVIRON, V472, P1089, DOI 10.1016/j.scitotenv.2013.11.044; Schade G, 1998, SCI TOTAL ENVIRON, V215, P31, DOI 10.1016/S0048-9697(98)00008-4; Schapire R. E., 2003, BOOSTING APPROACH MA, P149, DOI DOI 10.1007/978-0-387-21579-2_9; Shen L, 2005, ENVIRON SCI TECHNOL, V39, P409, DOI 10.1021/es049489c; SIDDIQUI MKJ, 1981, ENVIRON RES, V24, P24, DOI 10.1016/0013-9351(81)90128-6; Solomon GM, 2002, ENVIRON HEALTH PERSP, V110, pA339, DOI 10.1289/ehp.021100339; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; 't Mannetje A, 2013, SCI TOTAL ENVIRON, V458, P399, DOI 10.1016/j.scitotenv.2013.04.055; Thomas A, 2017, ENVIRON RES, V154, P10, DOI 10.1016/j.envres.2016.12.009; Toms LML, 2014, ENVIRON INT, V71, P74, DOI 10.1016/j.envint.2014.05.019; Toms LM, 2012, ORGANOHALOGEN COMPOU, V74, P775; Waliszewski SM, 2001, ARCH ENVIRON CON TOX, V40, P432, DOI 10.1007/s002440010194; Waliszewski SM, 2012, ENVIRON MONIT ASSESS, V184, P5613, DOI 10.1007/s10661-011-2366-2; Walsh CD, 2012, CASE STUDIES BAYESIA, P159; Wang HS, 2013, ENVIRON INT, V54, P18, DOI 10.1016/j.envint.2013.01.003; Wolff MS, 2007, CANCER EPIDEM BIOMAR, V16, P1925, DOI 10.1158/1055-9965.EPI-07-0394; Wolff MS, 2005, ENVIRON RES, V97, P170, DOI 10.1016/j.envres.2004.07.014; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727; Zhang H, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-6824-1	59	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2019	14	11							e0223956	10.1371/journal.pone.0223956	http://dx.doi.org/10.1371/journal.pone.0223956			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1QS	31721772	Green Published, gold			2022-12-26	WOS:000532720700008
J	Jelsma, JGM; Gale, J; Loyen, A; van Nassau, F; Bauman, A; van der Ploeg, HP				Jelsma, Judith G. M.; Gale, Joanne; Loyen, Anne; van Nassau, Femke; Bauman, Adrian; van der Ploeg, Hidde P.			Time trends between 2002 and 2017 in correlates of self-reported sitting time in European adults	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; CARDIOVASCULAR-DISEASE; ASSOCIATION; MORTALITY; RISK; RELIABILITY; VALIDITY	Background This study explores trends in the prevalence of high sitting time and its correlates among "high sitting" and "high sitting-least active" European adults from 2002 to 2017. Both groups have merit for future public health interventions to prevent development of a range of prevalent non-communicable diseases. Methods Data collected in the 2002 (15 countries), 2005 (30 countries), 2013 (28 countries) and 2017 (28 countries) Eurobarometer surveys were used, including around 15,000 respondents in 2002 and > 26,000 respondents in the other years. Sitting time and moderate to vigorous intensity physical activity were measured with the validated International Physical Activity Questionnaire-short. High sitting was defined as > 7.5 hours per day. Respondents in the lowest quartile of total reported days of physical activity (i.e. days walking, days in moderate activity, and days in vigorous activity) were defined as least active. Multivariate odds ratios of high sitting, and high sitting-least active were assessed by country and socio-demographic characteristics for each survey year using binary logistic regression analyses. Results Trends in sitting time were relatively stable over a 15-year period, although this time trend was limited by a change in the sitting question between 2005 and 2013. Men, higher educated people, students, retired people, white collar workers, people living in urban areas, people with lower physical activity levels, and people living in the Czech Republic, Denmark or the Netherlands were consistently more likely to be in the high sitting group across all four survey years. Similarly, men, students, retired people, unemployed people, white collar workers, and people living in the Czech Republic or Denmark were consistently more likely to be in the high sitting-least active group across all four surveys. Conclusion This study identified population sub-groups that need special attention in public health interventions to lower total sitting time.	[Jelsma, Judith G. M.; van Nassau, Femke; van der Ploeg, Hidde P.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam UMC, Van der Boechorststr, Amsterdam, Netherlands; [Gale, Joanne; Bauman, Adrian] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW, Australia; [Loyen, Anne] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Sydney; Netherlands National Institute for Public Health & the Environment	Jelsma, JGM; van der Ploeg, HP (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam UMC, Van der Boechorststr, Amsterdam, Netherlands.	j.jelsma@amsterdamumc.nl; hp.vanderploeg@amsterdamumc.nl	van der Ploeg, Hidde/ABD-6402-2021; van der Ploeg, Hidde P/B-2599-2013	van der Ploeg, Hidde P/0000-0002-3719-5249; Jelsma, Judith/0000-0001-7943-9160				Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bauman AE, 2013, CURR CARDIOVASC RISK, V7, P293, DOI 10.1007/s12170-013-0316-y; Baxter S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0336-3; Bennie JA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-107; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Clemes SA, 2012, J PHYS ACT HEALTH, V9, P533, DOI 10.1123/jpah.9.4.533; Commision European, 2006, EUR WAV 643 FOR LANG; Committee PAGA, 2018, PHYS ACT GUID ADV CO; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; European Commision, EUR SURV; European Commision, 2018, SPEC EUR 472 WAV 884; European Commision, 2013, SPEC EUR 412 WAV 802; European Commision, 2003, SPEC EUR 1836 WAV 58; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Loyen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149320; Martin A, 2015, BRIT J SPORT MED, V49, P1056, DOI 10.1136/bjsports-2014-094524; Milton K, 2011, BRIT J SPORT MED, V45, P203, DOI 10.1136/bjsm.2009.068395; Milton K, 2015, PREV MED, V77, P11, DOI 10.1016/j.ypmed.2015.04.016; Milton K, 2013, BRIT J SPORT MED, V47, P44, DOI 10.1136/bjsports-2011-090899; Ng MK, 2015, HEALTH EDUC J, V74, P270, DOI 10.1177/0017896914533953; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; Peachey MM, 2020, BRIT J SPORT MED, V54, P315, DOI 10.1136/bjsports-2017-098968; Prince SA, 2017, OBES REV, V18, P915, DOI 10.1111/obr.12529; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Rhodes RE, 2012, ANN BEHAV MED, V43, pS273; Rosenberg DE, 2008, J PHYS ACT HEALTH, V5, pS30, DOI 10.1123/jpah.5.s1.s30; Shrestha N, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010912.pub2; Stamatakis E, 2019, BRIT J SPORT MED, V53, P377, DOI 10.1136/bjsports-2018-099131; United Nations, 2011, STAND COUNTR AR COD; van der Ploeg HP, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0601-0; van der Ploeg HP, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0233-1; van der Ploeg HP, 2013, AM J PREV MED, V44, P382, DOI 10.1016/j.amepre.2012.11.034; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2019	14	11							e0225228	10.1371/journal.pone.0225228	http://dx.doi.org/10.1371/journal.pone.0225228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1MV	31714933	Green Published, gold			2022-12-26	WOS:000532710400039
J	Kniffin, KM; Bogan, VL; Just, DR				Kniffin, Kevin M.; Bogan, Vicki L.; Just, David R.			"Big men" in the office: The gender-specific influence of weight upon persuasiveness	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; SOCIAL-STATUS; BODY-WEIGHT; LEADERSHIP; OBESITY; SELF; STRENGTH; STIGMA; HEIGHT; BIAS	Height has been closely studied as a factor that influences myriad measures of leadership; however, the potential influence of weight on socially beneficial traits has been neglected. Using the anthropological concept of "big men" who relied on influence to lead their communities, we examine the role of weight upon persuasiveness. We present the results of six studies that suggest a tendency for raters to expect larger body mass to correspond with more persuasiveness among men. In the sixth, pre-registered study, we find evidence that fits the hypothesis that weight among men is positively associated with perceived persuasiveness. While the "big man" leadership concept is based on studies of pre-industrial societies where weight embodied status, our findings suggest an evolved bias to favor moderately big men-with respect to perceived persuasiveness-even in environments where there is no reason to interpret over-consumption of food and conservation of energy as a signal of wealth. Our studies contribute novel perspectives on the relevance of weight as an understudied dimension of "big" and offer an important qualification informed by evolutionary perspectives for the stigmatizing effects of relatively large body mass.	[Kniffin, Kevin M.; Bogan, Vicki L.; Just, David R.] Cornell Univ, SC Johnson Coll Business, Dyson Sch Appl Econ & Management, Ithaca, NY 14853 USA	Cornell University	Kniffin, KM (corresponding author), Cornell Univ, SC Johnson Coll Business, Dyson Sch Appl Econ & Management, Ithaca, NY 14853 USA.	kmk276@cornell.edu						Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Acker F, 2008, JUDGM DECIS MAK, V3, P292; Ackerman JM, 2010, SCIENCE, V328, P1712, DOI 10.1126/science.1189993; Addoum JM, 2017, MANAGE SCI, V63, P3393, DOI 10.1287/mnsc.2016.2508; Antonakis J, 2010, LEADERSHIP QUART, V21, P1086, DOI 10.1016/j.leaqua.2010.10.010; Ball S, 2010, J RISK UNCERTAINTY, V41, P167, DOI 10.1007/s11166-010-9105-x; Barkow J. H., 1992, ADAPTED MIND EVOLUTI, Patent No. [2201.07245, 220107245]; Blaker NM, 2013, GROUP PROCESS INTERG, V16, P17, DOI 10.1177/1368430212437211; BROWN PJ, 1987, ANN NY ACAD SCI, V499, P29, DOI 10.1111/j.1749-6632.1987.tb36195.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burch R. L, 2019, EVOLUTIONARY BEHAV S; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Burmeister JM, 2013, OBESITY, V21, P918, DOI 10.1002/oby.20171; Camerer C. F., 2018, NATURE HUMAN BEHAV, V1; CAMPBELL DT, 1975, AM PSYCHOL, V30, P1103, DOI 10.1037/0003-066X.30.12.1103; Campbell L, 2002, HUM NATURE-INT BIOS, V13, P345, DOI 10.1007/s12110-002-1019-0; Carr D, 2006, SOC PSYCHOL QUART, V69, P127, DOI 10.1177/019027250606900202; Chandler JJ, 2012, J EXP SOC PSYCHOL, V48, P948, DOI 10.1016/j.jesp.2012.03.003; Cowart KO, 2014, J RETAILING, V90, P365, DOI 10.1016/j.jretai.2014.03.003; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Cuddy AJC, 2018, PSYCHOL SCI, V29, P656, DOI 10.1177/0956797617746749; DeBeaumont R., 2009, J SOCIO-ECON, V38, P344, DOI [DOI 10.1016/J.SOCEC.2008.10.001, DOI 10.1016/j.socec.2008.10.001]; DeRue DS, 2011, PERS PSYCHOL, V64, P7, DOI 10.1111/j.1744-6570.2010.01201.x; DeWall CN, 2010, J EXP SOC PSYCHOL, V46, P619, DOI 10.1016/j.jesp.2010.02.008; Eckel CC, 2012, J RISK UNCERTAINTY, V45, P265, DOI 10.1007/s11166-012-9156-2; Granberg EM, 2011, SOC PSYCHOL QUART, V74, P29, DOI 10.1177/0190272511398020; Halpin A.W., 1957, MANUAL LEADER BEHAV; Harp JB, 2005, JAMA-J AM MED ASSOC, V293, P1061, DOI 10.1001/jama.293.9.1061-b; Hebl MR, 2001, INT J OBESITY, V25, P1246, DOI 10.1038/sj.ijo.0801681; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hu Y, 2018, PSYCHOL SCI, V29, P1969, DOI 10.1177/0956797618799300; Huberman BA, 2004, SOC PSYCHOL QUART, V67, P103, DOI 10.1177/019027250406700109; Hughes V, 2013, NATURE, V497, P428, DOI 10.1038/497428a; IJzerman H, 2013, REPLICABILITY SOCIAL; Jostmann NB, 2016, J EXP SOC PSYCHOL, V67, P93, DOI 10.1016/j.jesp.2015.12.001; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Jucker JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08653-z; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Kerry N, 2018, PERS INDIV DIFFER, V131, P216, DOI 10.1016/j.paid.2018.05.003; King EB, 2006, J APPL PSYCHOL, V91, P579, DOI 10.1037/0021-9010.91.3.579; Knapen J. E, 2018, PSYCHOL SCI; Knapen JEP, 2019, EVOL PSYCHOL-US, V17, DOI 10.1177/1474704919841914; Knapen JEP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188485; Kniffin KM, 2014, LEADERSHIP QUART, V25, P1143, DOI 10.1016/j.leaqua.2014.09.001; Kniffin KM, 2004, EVOL HUM BEHAV, V25, P88, DOI 10.1016/S1090-5138(04)00006-6; Li NP, 2018, CURR DIR PSYCHOL SCI, V27, P38, DOI 10.1177/0963721417731378; Lindqvist E, 2012, REV ECON STAT, V94, P1191, DOI 10.1162/REST_a_00239; Lukaszewski AW, 2016, J PERS SOC PSYCHOL, V110, P385, DOI 10.1037/pspi0000042; Major B, 2014, J EXP SOC PSYCHOL, V51, P74, DOI 10.1016/j.jesp.2013.11.009; Matthews WJ, 2009, JUDGM DECIS MAK, V4, P64; MCCANN SJH, 1992, J PERS SOC PSYCHOL, V62, P469, DOI 10.1037/0022-3514.62.3.469; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Murray Gregg R, 2014, Politics Life Sci, V33, P33, DOI 10.2990/33_1_33; Murray GR, 2011, SOC SCI QUART, V92, P1215, DOI 10.1111/j.1540-6237.2011.00815.x; Nickson D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159659; Penny H, 2007, J EXP SOC PSYCHOL, V43, P678, DOI 10.1016/j.jesp.2006.07.002; Petersen MB, 2013, PSYCHOL SCI, V24, P1098, DOI 10.1177/0956797612466415; Pierpoint G, 2018, BBC NEWS; Pollock N J, 1995, Asia Pac J Clin Nutr, V4, P357; Poutvaara P, 2014, LEADERSHIP QUART, V25, P801, DOI 10.1016/j.leaqua.2014.08.003; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Rabelo ALA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134808; Riggio HR, 2010, J NONVERBAL BEHAV, V34, P119, DOI 10.1007/s10919-009-0083-0; Ruth D, 2013, TAMPA BAY TIMES, p15A; SAHLINS MD, 1963, COMP STUD SOC HIST, V5, P285, DOI 10.1017/S0010417500001729; Sammons J. T, 1995, RING ROLE BOXING AM; Schafer MH, 2011, SOC PSYCHOL QUART, V74, P76, DOI 10.1177/0190272511398197; Sell A, 2017, EVOL HUM BEHAV, V38, P334, DOI 10.1016/j.evolhumbehav.2016.11.002; Sell A, 2016, EVOL HUM BEHAV, V37, P105, DOI 10.1016/j.evolhumbehav.2015.09.003; Simmons JP, 2017, PSYCHOL SCI, V28, P687, DOI 10.1177/0956797616658563; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; SINGH D, 1995, J PERS SOC PSYCHOL, V69, P1089, DOI 10.1037/0022-3514.69.6.1089; Sorokowski P, 2010, EUR J SOC PSYCHOL, V40, P1302, DOI 10.1002/ejsp.710; Spillius A, 2011, DAILY TELEGRAPH, P19; Spisak BR, 2014, LEADERSHIP QUART, V25, P805, DOI 10.1016/j.leaqua.2014.06.001; Spisak BR, 2012, LEADERSHIP QUART, V23, P273, DOI 10.1016/j.leaqua.2011.08.006; Stets J., 2008, HDB EMOTIONS, P32; Stulp G, 2013, LEADERSHIP QUART, V24, P159, DOI 10.1016/j.leaqua.2012.09.002; Stulp G, 2012, BEHAV ECOL SOCIOBIOL, V66, P375, DOI 10.1007/s00265-011-1283-2; Swami V, 2015, EUR PSYCHOL, V20, P44, DOI 10.1027/1016-9040/a000150; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17; Tuller HM, 2015, J EXP SOC PSYCHOL, V59, P18, DOI 10.1016/j.jesp.2015.02.003; Turner RN, 2012, J EXP SOC PSYCHOL, V48, P130, DOI 10.1016/j.jesp.2011.09.007; Van Vugt M, 2004, J EXP SOC PSYCHOL, V40, P1, DOI 10.1016/S0022-1031(03)00061-1; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; von Rueden C, 2008, EVOL HUM BEHAV, V29, P402, DOI 10.1016/j.evolhumbehav.2008.05.001; von Rueden C, 2015, LEADERSHIP QUART, V26, P978, DOI 10.1016/j.leaqua.2015.10.004; von Rueden C, 2014, HUM NATURE-INT BIOS, V25, P538, DOI 10.1007/s12110-014-9213-4; Wood W, 2010, SOC PSYCHOL QUART, V73, P334, DOI 10.1177/0190272510389005	91	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2019	14	11							e0222761	10.1371/journal.pone.0222761	http://dx.doi.org/10.1371/journal.pone.0222761			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN1IV	31710625	Green Published, gold			2022-12-26	WOS:000532699900003
J	Artim, SC; Sheh, A; Burns, MA; Fox, JG				Artim, Stephen C.; Sheh, Alexander; Burns, Monika A.; Fox, James G.			Evaluating rectal swab collection method for gut microbiome analysis in the common marmoset (Callithrix jacchus)	PLOS ONE			English	Article							SP NOV.; MODEL	The common marmoset (Callithrix jacchus) is increasingly used as an animal model for biomedical research; however, gastrointestinal diseases causing significant morbidity are endemic in many captive marmoset colonies. Establishing gut microbiome patterns in a marmoset colony may aid in clinical decision-making and model reproducibility. A standardized method of sample collection and storage is essential for proper interpretation of microbiome data. While microbiome studies commonly utilize fecal samples, the goal of this study was to determine whether the microbiome profile from a rectal swab performed on a sedated animal was comparable to the microbiome profile from a fecal sample. During routine physical exams, paired fecal and rectal swab samples were collected from each of 23 marmosets. DNA was extracted from all fecal and rectal swab samples and 16S ribosomal RNA gene sequences were amplified and analyzed. Initial comparison of the relative abundance of bacterial phyla between paired samples had a r(2) value of 0.70 with S of 0.08 with no significant differences in alpha and beta diversity metrics between fecal and rectal samples. Initial analysis however, revealed 5 discordant fecal-rectal pairs which corresponded only with the 5 rectal swabs that were classified as free of visible fecal matter during collection. Exclusion of these 5 pairs resulted in an optimized fit of the data as evidenced by a r(2) value of 0.91 with S of 0.05. These results demonstrate that rectal swabs are a reliable method for profiling the fecal microbiome in the marmoset since the bacterial composition from a rectal swab with visible fecal contents correlated well with the bacterial composition from a fecal sample from the same marmoset. This study highlights the importance of standardized sample collection methods and exclusion of inappropriate samples.	[Artim, Stephen C.; Sheh, Alexander; Burns, Monika A.; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Artim, SC; Fox, JG (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	sartim@mit.edu; jgfox@mit.edu		/0000-0003-4503-9024	Massachusetts Institute of Technology McGovern Institute; National Institute of Health [T32 OD010978]; National Institute of Environmental Health Sciences [P30-ES002109]; NIH [T32 OD010978]; MIT McGovern Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978] Funding Source: NIH RePORTER	Massachusetts Institute of Technology McGovern Institute; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT McGovern Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by a grant from the Massachusetts Institute of Technology McGovern Institute (https://mcgovern.mit.edu) (JGF), National Institute of Health (https://orip.nih.gov) grant T32 OD010978 (JGF) and by the National Institute of Environmental Health Sciences (https://www.niehs.nih.gov) under award P30-ES002109 (JGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jennifer Haupt, Dr. Robin Kramer, Monica Siddalls, Morgan Jamiel, Claudia Weaver, Kayla Messina, Shelly Sancricca and the DCM animal care staff for their help during the course of this study. This study was supported in part by a grant from the MIT McGovern Institute, NIH grant T32 OD010978 and by the National Institute of Environmental Health Sciences under award P30-ES002109.	Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012; BASSIS CM, 2017, BMC MICROBIOL, V17, DOI DOI 10.1186/S12866-016-0921-2; Baxter VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082747; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Debelius J, 2016, GENOME BIOL GENOME B, V17, P1, DOI [10.1186/s13059-015-0866-z, DOI 10.1186/S13059-015-0866-Z]; DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750; Ericsson AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21986-7; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; Franklin CL, 2017, LAB ANIMAL, V46, P114, DOI 10.1038/laban.1222; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kim D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0267-5; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Ladinsky MS, 2019, SCIENCE, V363, P1058, DOI 10.1126/science.aat4042; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Marini R. P., 2018, COMMON MARMOSET CAPT; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Nishijima K, 2012, BIOGERONTOLOGY, V13, P439, DOI 10.1007/s10522-012-9388-1; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Ross CN, 2017, AGING-US, V9, P2544, DOI 10.18632/aging.101340; Ross Corinna N, 2012, J Aging Res, V2012, P567143, DOI 10.1155/2012/567143; Shen ZL, 2015, J MED MICROBIOL, V64, P1063, DOI 10.1099/jmm.0.000113; 't Hart BA, 2012, DRUG DISCOV TODAY, V17, P1160, DOI 10.1016/j.drudis.2012.06.009; Tardif SD, 2011, ILAR J, V52, P54, DOI 10.1093/ilar.52.1.54; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI [DOI 10.18637/JSS.V077.B02, 10.18637/jss.v077.b02]; Won YS, 2007, FEMS MICROBIOL LETT, V271, P239, DOI 10.1111/j.1574-6968.2007.00721.x; Yasuda K, 2015, CELL HOST MICROBE, V17, P385, DOI 10.1016/j.chom.2015.01.015; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224950	10.1371/journal.pone.0224950	http://dx.doi.org/10.1371/journal.pone.0224950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697779	Green Published, gold			2022-12-26	WOS:000532694400085
J	Hellhammer, K; Piayda, K; Afzal, S; Veulemans, V; Hennig, I; Makosch, M; Polzin, A; Kelm, M; Zeus, T				Hellhammer, Katharina; Piayda, Kerstin; Afzal, Shazia; Veulemans, Verena; Hennig, Inga; Makosch, Matthias; Polzin, Amin; Kelm, Malte; Zeus, Tobias			Micro-dislodgement during transcatheter aortic valve implantation with a contemporary self-expandable prosthesis	PLOS ONE			English	Article							OUTCOMES; SOCIETY	Objectives To evaluate the incidence, risk factors and the clinical outcome of micro-dislodgement (MD) with a contemporary self-expandable prosthesis during transcatheter aortic valve implantation. Methods MD was defined as movement of the prosthesis of at least 1.5 mm upwards or downwards from its position directly before release compared to its final position. Patients were grouped according to the occurrence (+MD) or absence (-MD) of MD. Baseline characteristics, imaging data and outcome parameters were retrospectively analyzed. Results We identified 258 eligible patients. MD occurred in 31.8% (n = 82) of cases with a mean magnitude of 2.8 mm +/- 2.2 in relation to the left coronary cusp and 3.0 mm +/- 2.1 to the non-coronary cusp. Clinical and hemodynamic outcomes were similar in both groups with consistency over a follow-up period of three months. A larger aortic valve area (AVA) (-MD vs. +MD: 0.6 cm(2) +/- 0.3 vs. 0.7cm(2) +/- 0.2; p = 0.014), was the only independent risk factor for the occurrence of MD in a multivariate regression analysis (OR 5.3; 95% CI: 1.1-24.9; p = 0.036). Conclusions MD occurred in nearly one third of patients and did not affect clinical and hemodynamic outcome. A larger AVA seems to be a potential risk factor for MD.	[Hellhammer, Katharina; Piayda, Kerstin; Afzal, Shazia; Veulemans, Verena; Hennig, Inga; Makosch, Matthias; Polzin, Amin; Kelm, Malte; Zeus, Tobias] Univ Hosp Dusseldorf, Med Fac, Dept Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany; [Kelm, Malte] CARID Cardiovasc Res Inst Dusseldorf, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Zeus, T (corresponding author), Univ Hosp Dusseldorf, Med Fac, Dept Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.	zeus@med.uni-duesseldorf.de	Piayda, Kerstin/ABC-5443-2021	Afzal, Shazia Samreen/0000-0002-6312-8146; Piayda, Kerstin/0000-0002-9746-7592				Achenbach S, 2012, J CARDIOVASC COMPUT, V6, P366, DOI 10.1016/j.jcct.2012.11.002; Agarwal S, 2015, INT J CARDIOL, V197, P87, DOI 10.1016/j.ijcard.2015.06.002; Aksoy O, 2016, CARDIOVASC REVASCULA, V17, P199, DOI 10.1016/j.carrev.2016.03.005; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Bekeredjian R, 2019, EUR HEART J, V40, P1323, DOI 10.1093/eurheartj/ehy699; Cribier A., 2016, GLOB CARDIOL SCI PRA; Deharo P, 2018, JACC-CARDIOVASC INTE, V11, P1956, DOI 10.1016/j.jcin.2018.06.023; Finkelstein A, 2019, CATHETER CARDIO INTE, V94, pE44, DOI 10.1002/ccd.28021; Forrest John K., 2012, Yale Journal of Biology and Medicine, V85, P239; Geisbusch S, 2010, CIRC-CARDIOVASC INTE, V3, P531, DOI 10.1161/CIRCINTERVENTIONS.110.944983; Hachinohe D, 2018, CATHETER CARDIOVASC; Hell MM, 2017, EUR HEART J-CARD IMG, V18, P906, DOI 10.1093/ehjci/jew144; Hildick-Smith D, 2011, EUROINTERVENTION, V7, P621, DOI 10.4244/EIJV7I5A99; John D, 2010, JACC-CARDIOVASC INTE, V3, P233, DOI 10.1016/j.jcin.2009.11.015; Kaier K, 2017, INT J CARDIOL, V235, P17, DOI 10.1016/j.ijcard.2017.02.138; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Mack MJ, 2019, NEW ENGL J MED, V380, P1695, DOI 10.1056/NEJMoa1814052; Makkar RR, 2013, J AM COLL CARDIOL, V62, P418, DOI 10.1016/j.jacc.2013.04.037; Manoharan G, 2018, JACC-CARDIOVASC INTE, V11, P2326, DOI 10.1016/j.jcin.2018.07.032; Martin GP, 2017, J AM HEART; Mylotte D, 2015, EUR HEART J, V36, P1306, DOI 10.1093/eurheartj/ehu388; Osman M, 2019, AM J CARDIOL; Petronio AS, 2015, JACC-CARDIOVASC INTE, V8, P837, DOI 10.1016/j.jcin.2015.02.005; Popma JJ, 2019, NEW ENGL J MED, V380, P1706, DOI 10.1056/NEJMoa1816885; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Reardon MJ, 2016, JAMA CARDIOL, V1, P945, DOI 10.1001/jamacardio.2016.2257; Ussia GP, 2012, EUROINTERVENTION, V7, P1285, DOI 10.4244/EIJV7I11A203; van Rosendael PJ, 2018, EUR HEART J, V39, P2003, DOI 10.1093/eurheartj/ehx785; Vasa-Nicotera M, 2012, JACC-CARDIOVASC INTE, V5, P858, DOI 10.1016/j.jcin.2012.04.011; Vavuranakis M, 2017, J CARDIOL, V69, P245, DOI 10.1016/j.jjcc.2016.03.016	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224815	10.1371/journal.pone.0224815	http://dx.doi.org/10.1371/journal.pone.0224815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697759	Green Published, gold			2022-12-26	WOS:000532694400065
J	Nagasato, D; Tabuchi, H; Masumoto, H; Enno, H; Ishitobi, N; Kameoka, M; Niki, M; Mitamura, Y				Nagasato, Daisuke; Tabuchi, Hitoshi; Masumoto, Hiroki; Enno, Hiroki; Ishitobi, Naofumi; Kameoka, Masahiro; Niki, Masanori; Mitamura, Yoshinori			Automated detection of a nonperfusion area caused by retinal vein occlusion in optical coherence tomography angiography images using deep learning	PLOS ONE			English	Article							MACULAR EDEMA SECONDARY; FOVEAL AVASCULAR ZONE; DIABETIC-RETINOPATHY; SUSTAINED BENEFITS; 12-MONTH OUTCOMES; TRAP-EYE; RANIBIZUMAB; POPULATION; PREVALENCE; TERM	We aimed to assess the ability of deep learning (DL) and support vector machine (SVM) to detect a nonperfusion area (NPA) caused by retinal vein occlusion (RVO) with optical coherence tomography angiography (OCTA) images. The study included 322 OCTA images (normal: 148; NPA owing to RVO: 174 [128 branch RVO images and 46 central RVO images]). Training to construct the DL model using deep convolutional neural network (DNN) algorithms was provided using OCTA images. The SVM used a scikit-learn library with a radial basis function kernel. The area under the curve (AUC), sensitivity and specificity for detecting an NPA were examined. We compared the diagnostic ability (sensitivity, specificity and average required time) between the DNN, SVM and seven ophthalmologists. Heat maps were generated. With regard to the DNN, the mean AUC, sensitivity, specificity and average required time for distinguishing RVO OCTA images with an NPA from normal OCTA images were 0.986, 93.7%, 97.3% and 176.9 s, respectively. With regard to SVM, the mean AUC, sensitivity, and specificity were 0.880, 79.3%, and 81.1%, respectively. With regard to the seven ophthalmologists, the mean AUC, sensitivity, specificity and average required time were 0.962, 90.8%, 89.2%, and 700.6 s, respectively. The DNN focused on the foveal avascular zone and NPA in heat maps. The performance of the DNN was significantly better than that of SVM in all parameters (p < 0.01, all) and that of the ophthalmologists in AUC and specificity (p < 0.01, all). The combination of DL and OCTA images had high accuracy for the detection of an NPA, and it might be useful in clinical practice and retinal screening.	[Nagasato, Daisuke; Tabuchi, Hitoshi; Masumoto, Hiroki; Ishitobi, Naofumi; Kameoka, Masahiro] Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Enno, Hiroki] Rist Inc, Tokyo, Japan; [Niki, Masanori; Mitamura, Yoshinori] Tokushima Univ, Inst Biomed Sci, Dept Ophthalmol, Grad Sch, Tokushima, Japan	Tokushima University	Nagasato, D (corresponding author), Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan.	d.nagasato@tsukazaki-eye.net			Rist Incorporated	Rist Incorporated	The funder, Rist Incorporated, provided support in the form of salary for author HE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Agrawal P, 2014, LECT NOTES COMPUT SC, V8695, P329, DOI 10.1007/978-3-319-10584-0_22; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Boyer D, 2012, OPHTHALMOLOGY, V119, P1024, DOI 10.1016/j.ophtha.2012.01.042; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Brereton RG, 2010, ANALYST, V135, P230, DOI 10.1039/b918972f; Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campa C, 2016, CURR DRUG TARGETS, V17, P328, DOI 10.2174/1573399811666150615151324; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Fan WY, 2017, AM J OPHTHALMOL, V180, P110, DOI 10.1016/j.ajo.2017.05.024; Gargeya R, 2017, OPHTHALMOLOGY, V124, P962, DOI 10.1016/j.ophtha.2017.02.008; Glorot X., 2011, P 14 INT C ART INT S, P315; Gu YK, 2018, BIOMED OPT EXPRESS, V9, P5147, DOI 10.1364/BOE.9.005147; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heier JS, 2012, OPHTHALMOLOGY, V119, P802, DOI 10.1016/j.ophtha.2011.12.005; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P278, DOI 10.1136/bjophthalmol-2012-301504; Hosny KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217293; Hwang TS, 2016, JAMA OPHTHALMOL, V134, P367, DOI 10.1001/jamaophthalmol.2015.5658; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Kim KH, 2018, RADIOLOGY, V287, P658, DOI 10.1148/radiol.2017171154; Kim K, 2018, BRIT J OPHTHALMOL, V102, P1226, DOI 10.1136/bjophthalmol-2017-311149; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Koulisis N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176404; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee CY, 2015, JMLR WORKSH CONF PRO, V38, P562; Lee J, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0811-x; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Liu SQ, 2015, IEEE T BIO-MED ENG, V62, P1132, DOI 10.1109/TBME.2014.2372011; Macdonald D, 2014, CLIN EXP OPTOM, V97, P311, DOI 10.1111/cxo.12120; Mosteller F., 1968, HDB SOCIAL PSYCHOL, V2, P80, DOI DOI 10.1109/TNET.2015.2425146; Nagasato D, 2019, INT J OPHTHALMOL-CHI, V12, P94, DOI 10.18240/ijo.2019.01.15; Nagasato D, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/1875431; Nesterov Yu. E., 1983, Doklady Akademii Nauk SSSR, V269, P543; Ohsugi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09891-x; Pinaya WHL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38897; Qian N, 1999, NEURAL NETWORKS, V12, P145, DOI 10.1016/S0893-6080(98)00116-6; Redmon J., 2018, P IEEE C COMP VIS PA; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Rogers SL, 2010, OPHTHALMOLOGY, V117, P1094, DOI 10.1016/j.ophtha.2010.01.058; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Scherer D, 2010, LECT NOTES COMPUT SC, V6354, P92, DOI 10.1007/978-3-642-15825-4_10; Shariati MA, 2015, INVEST OPHTH VIS SCI, V56, P2790, DOI 10.1167/iovs.14-15145; Suzuki N, 2016, AM J OPHTHALMOL, V161, P126, DOI 10.1016/j.ajo.2015.09.038; Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849; Tang FY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02767-0; Yasuda M, 2010, INVEST OPHTH VIS SCI, V51, P3205, DOI 10.1167/iovs.09-4453; Yu C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193321; Zielinski B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184554	54	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0223965	10.1371/journal.pone.0223965	http://dx.doi.org/10.1371/journal.pone.0223965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697697	Green Published, gold			2022-12-26	WOS:000532694400016
J	Rieppo, L; Janssen, L; Rahunen, K; Lehenkari, P; Finnila, MAJ; Saarakkala, S				Rieppo, Lassi; Janssen, Lauriane; Rahunen, Krista; Lehenkari, Petri; Finnila, Mikko A. J.; Saarakkala, Simo			Histochemical quantification of collagen content in articular cartilage	PLOS ONE			English	Article							POLARIZED-LIGHT MICROSCOPY; GLYCOSAMINOGLYCANS; SECTIONS; TISSUES; MATRIX	Background Articular cartilage (AC) is mainly composed of water, type II collagen, proteoglycans (PGs) and chondrocytes. The amount of PGs in AC is routinely quantified with digital densitometry (DD) from Safranin O-stained sections, but it is unclear whether similar method could be used for collagens. Objective The aim of this study was to clarify whether collagens can be quantified from histological AC sections using DD. Material and methods Sixteen human AC samples were stained with Masson's trichrome or Picrosirius red. Optical densities of histological stains were compared to two commonly used collagen parameters (amide I and collagen CH2 side chain peak at 1338cm(-1)) measured using Fourier Transform Infrared (FTIR) spectroscopic imaging. Results Optical density of Modified Masson's trichrome staining, which included enzymatic removal of PGs before staining, correlated significantly with FTIR-derived collagen parameters at almost all depths of cartilage. The other studied staining protocols displayed significant correlations with the reference parameters at only few depth layers. Conclusions Based on our findings, modified Masson's trichrome staining protocol is suitable for quantification of AC collagen content. Enzymatic removal of PGs prior to staining is critical as us allows better staining of the collagen. Further optimization of staining protocols may improve the results in the future studies.	[Rieppo, Lassi; Janssen, Lauriane; Rahunen, Krista; Finnila, Mikko A. J.; Saarakkala, Simo] Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu, Finland; [Janssen, Lauriane] Univ Oulu, Fac Informat Technol & Elect Engn, Microelect Res Unit, Oulu, Finland; [Lehenkari, Petri] Oulu Univ Hosp, Dept Surg & Intens Care, Oulu, Finland; [Lehenkari, Petri] Univ Oulu, Fac Med, Canc & Translat Med Res Unit, Oulu, Finland; [Saarakkala, Simo] Univ Oulu, Infotech Oulu, Oulu, Finland; [Saarakkala, Simo] Oulu Univ Hosp, Dept Diagnost Radiol, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Rieppo, L (corresponding author), Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu, Finland.	lassi.rieppo@oulu.fi	Saarakkala, Simo/F-5839-2013	Saarakkala, Simo/0000-0003-2850-5484; Finnila, Mikko/0000-0002-3348-5759; Janssen, Lauriane/0000-0002-9896-0055; Rieppo, Lassi/0000-0001-5542-4060	Academy of Finland [268378, 273571, 310466]; Sigrid Juselius Foundation; European Research Council under the European Union [336267]; University of Oulu	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Research Council under the European Union(European Research Council (ERC)); University of Oulu	The financial support from the Academy of Finland grant no. 310466 (LR), Academy of Finland grants no. 268378 and 273571 (SS), Sigrid Juselius Foundation (SS), European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 336267 (SS), and the strategic funding of the University of Oulu is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3; Brama P A, 1999, Equine Vet J Suppl, P55; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477; Cheheltani R, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056014; CONSTANTINE VS, 1968, J INVEST DERMATOL, V50, P419, DOI 10.1038/jid.1968.68; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Hyllested JL, 2002, OSTEOARTHR CARTILAGE, V10, P333, DOI 10.1053/joca.2002.0519; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kiraly K, 1996, HISTOCHEM J, V28, P577, DOI 10.1007/BF02331378; KIVIRANTA I, 1985, HISTOCHEMISTRY, V82, P249, DOI 10.1007/BF00501401; Nieminen MT, 2001, MAGN RESON MED, V46, P487, DOI 10.1002/mrm.1218; PUCHTLER H, 1958, J HISTOCHEM CYTOCHEM, V6, P265, DOI 10.1177/6.4.265; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Rieppo J, 2008, MICROSC RES TECHNIQ, V71, P279, DOI 10.1002/jemt.20551; Rieppo L, 2012, OSTEOARTHR CARTILAGE, V20, P451, DOI 10.1016/j.joca.2012.01.010; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Wall A., 2014, CLASS PAP ORTHOP, V9, P431, DOI DOI 10.1007/978-1-4471-5451-8_109; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; WOLMAN M, 1986, HISTOCHEMISTRY, V85, P41, DOI 10.1007/BF00508652	19	23	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2019	14	11							e0224839	10.1371/journal.pone.0224839	http://dx.doi.org/10.1371/journal.pone.0224839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1GV	31697756	Green Published, gold			2022-12-26	WOS:000532694400068
J	Pal, M; Khan, J; Kumar, R; Surolia, A; Gupta, S				Pal, Madhuraka; Khan, Jasim; Kumar, Ravi; Surolia, Avadhesha; Gupta, Sarika			Testosterone supplementation improves insulin responsiveness in HFD fed male T2DM mice and potentiates insulin signaling in the skeletal muscle and C2C12 myocyte cell line	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ANDROGEN RECEPTOR; GLUCOSE; RESISTANCE; PHOSPHORYLATION; DIFFERENTIATION; SENSITIVITY; SUBSTRATE-1; SECRETION; GENE	Background Type 2 Diabetes Mellitus (T2DM) is characterised by hyperglycemia due to the incidence of insulin resistance. Testosterone supplementation has been shown to have a positive co-relation with improved glycemic control in T2DM males. Clinical studies have reported that Androgen Replacement Therapy (ART) to hypogonadic males with T2DM resulted in improved glycemic control and metabolic parameters, but, these studies did not address in detail how testosterone acted on the key glucose homeostatic organs. Method In this study, we delineate the effect of testosterone supplementation to high-fat diet (HFD) induced T2DM in male C57BL6J mice and the effect of testosterone supplementation on the skeletal muscle insulin responsiveness. We also studied the effect of testosterone on the insulin signaling pathway proteins in C2C12 myocyte cells to validate the in vivo findings. Results We found that testosterone had a potentiating effect on the skeletal muscle insulin signaling pathway to improve glycaemic control. We demonstrate that, in males, testosterone improves skeletal muscle insulin responsiveness by potentiating the PI3K-AKT pathway. The testosterone treated animals showed significant increase in the skeletal muscle Insulin Receptor (IR), p85 subunit of PI3K, P-GSK3 alpha (Ser-21), and P-AKT (Ser-473) levels as compared to the control animals; but there was no significant change in total AKT and GSK3 alpha. Testosterone supplementation inhibited GSK3 alpha in the myocytes in a PI3K/AKT pathway dependent manner; on the other hand GSK3 beta gene expression was reduced in the skeletal muscle upon testosterone supplementation. Conclusion Testosterone increases insulin responsiveness by potentiating insulin signaling in the skeletal muscle cells, which is in contrast to the increased insulin resistance in the liver of testosterone treated T2DM male animals.	[Pal, Madhuraka; Kumar, Ravi; Gupta, Sarika] Natl Inst Immunol, Mol Sci Lab, New Delhi, India; [Khan, Jasim] Jamia Hamdard, Dept Med Elementol & Toxicol, Mol Toxicol Lab, Sch Chem & Life Sci, New Delhi, India; [Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bengaluru, Karnataka, India; [Pal, Madhuraka] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Khan, Jasim] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jamia Hamdard University; Indian Institute of Science (IISC) - Bangalore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Alabama System; University of Alabama Birmingham	Gupta, S (corresponding author), Natl Inst Immunol, Mol Sci Lab, New Delhi, India.	sarika@nii.ac.in		Kumar, Ravi/0000-0002-2514-257X	SERB-DST, Govt. of India [SB/WEA/011/2013]; National Institute of Immunology Core Fund, New Delhi, India; University Grants Commission [F-25-1/2013-14(BSR)/7-91/2007(BSR)]; Science and Engineering Research Board, DST NPDF; Council of Scientific and Industrial Research, India; CSIR	SERB-DST, Govt. of India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); National Institute of Immunology Core Fund, New Delhi, India; University Grants Commission(University Grants Commission, India); Science and Engineering Research Board, DST NPDF; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from SERB-DST, SB/WEA/011/2013, Govt. of India, and National Institute of Immunology Core Fund, New Delhi, India to SG. This study was also supported by the University Grants Commission, F-25-1/2013-14(BSR)/7-91/2007(BSR) to JK, the Science and Engineering Research Board, DST NPDF to RK, and the The Council of Scientific and Industrial Research, India, CSIR-JRF and CSIR-SRF to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arha D, 2018, MOL CELL ENDOCRINOL, V460, P134, DOI 10.1016/j.mce.2017.07.015; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Iguchi K, 2012, J ANDROL, V33, P660, DOI 10.2164/jandrol.111.013888; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Li LL, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2985956; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Ma YM, 2017, MOL CELL ENDOCRINOL, V450, P83, DOI 10.1016/j.mce.2017.04.021; Mitsuhashi K, 2016, ENDOCRINE, V51, P174, DOI 10.1007/s12020-015-0666-y; NELSON JF, 1975, ACTA ENDOCRINOL-COP, V80, P744, DOI 10.1530/acta.0.0800744; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; Pal M, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.45; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Reis MAB, 1997, J NUTR, V127, P403, DOI 10.1093/jn/127.3.403; Roelandt P, 2010, NAT PROTOC, V5, P1324, DOI 10.1038/nprot.2010.80; Rossetti ML, 2017, MOL CELL ENDOCRINOL, V447, P35, DOI 10.1016/j.mce.2017.02.031; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Traish AM, 2009, J ANDROL, V30, P23, DOI 10.2164/jandrol.108.005751; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; Xu WW, 2017, J DIABETES COMPLICAT, V31, P787, DOI 10.1016/j.jdiacomp.2017.03.002; Yu IC, 2014, DIABETES, V63, P3180, DOI 10.2337/db13-1505; 2005, DIABETES CARE S1, V28, pS3	33	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224162	10.1371/journal.pone.0224162	http://dx.doi.org/10.1371/journal.pone.0224162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	31693697	Green Published, Green Accepted, gold			2022-12-26	WOS:000532690100014
